100050	AARSKOG SYNDROME, AUTOSOMAL DOMINANT
100070	AORTIC ANEURYSM, FAMILIAL ABDOMINAL, 1; AAA1
100100	PRUNE BELLY SYNDROME; PBS
100200	ABDUCENS PALSY
100300	ADAMS-OLIVER SYNDROME 1; AOS1
100500	MOVED TO 200150
100600	ACANTHOSIS NIGRICANS
100640	ALDEHYDE DEHYDROGENASE 1 FAMILY, MEMBER A1; ALDH1A1
100650	ALDEHYDE DEHYDROGENASE 2 FAMILY; ALDH2
100660	ALDEHYDE DEHYDROGENASE, FAMILY 3, SUBFAMILY A, MEMBER 1; ALDH3A1
100670	ALDEHYDE DEHYDROGENASE 1 FAMILY, MEMBER B1; ALDH1B1
100675	ACETAMINOPHEN METABOLISM
100678	ACETYL-CoA ACETYLTRANSFERASE 2; ACAT2
100680	MOVED TO 100740
100690	CHOLINERGIC RECEPTOR, NICOTINIC, ALPHA POLYPEPTIDE 1; CHRNA1
100700	ACHARD SYNDROME
100710	CHOLINERGIC RECEPTOR, NICOTINIC, BETA POLYPEPTIDE 1; CHRNB1
100720	CHOLINERGIC RECEPTOR, NICOTINIC, DELTA POLYPEPTIDE; CHRND
100725	CHOLINERGIC RECEPTOR, NICOTINIC, EPSILON POLYPEPTIDE; CHRNE
100730	CHOLINERGIC RECEPTOR, NICOTINIC, GAMMA POLYPEPTIDE; CHRNG
100735	MOVED TO 142445
100740	ACETYLCHOLINESTERASE; ACHE
100790	ACHAETE-SCUTE FAMILY bHLH TRANSCRIPTION FACTOR 1; ASCL1
100800	ACHONDROPLASIA; ACH
100820	ACHOO SYNDROME
100850	ACONITASE, MITOCHONDRIAL; ACO2
100880	ACONITASE 1, SOLUBLE; ACO1
100900	MOVED TO 100880
101000	SCHWANNOMATOSIS, VESTIBULAR; SWNV
101120	ACROCEPHALOPOLYSYNDACTYLY TYPE III
101200	APERT SYNDROME
101400	SAETHRE-CHOTZEN SYNDROME; SCS
101600	PFEIFFER SYNDROME
101800	ACRODYSOSTOSIS 1 WITH OR WITHOUT HORMONE RESISTANCE; ACRDYS1
101805	ACROFACIAL DYSOSTOSIS, CATANIA TYPE
101840	ACROKERATODERMA, HEREDITARY PAPULOTRANSLUCENT
101850	PALMOPLANTAR KERATODERMA, PUNCTATE TYPE III; PPKP3
101900	ACROKERATOSIS VERRUCIFORMIS; AKV
102000	ACROLEUKOPATHY, SYMMETRIC
102100	ACROMEGALOID CHANGES, CUTIS VERTICIS GYRATA, AND CORNEAL LEUKOMA
102150	ACROMEGALOID FACIAL APPEARANCE SYNDROME
102200	PITUITARY ADENOMA 1, MULTIPLE TYPES; PITA1
102300	RESTLESS LEGS SYNDROME, SUSCEPTIBILITY TO, 1; RLS1
102350	ACROMIAL DIMPLES
102370	ACROMICRIC DYSPLASIA; ACMICD
102400	ACROOSTEOLYSIS
102480	ACROSIN; ACR
102490	MOVED TO 607323
102500	HAJDU-CHENEY SYNDROME; HJCYS
102510	ACROPECTOROVERTEBRAL DYSPLASIA; ACRPV
102520	ACRORENAL SYNDROME
102525	ACROSOMAL VESICLE PROTEIN 1; ACRV1
102530	SPERMATOGENIC FAILURE 6; SPGF6
102540	ACTIN, ALPHA, CARDIAC MUSCLE; ACTC1
102545	ACTIN, GAMMA-2, SMOOTH MUSCLE, ENTERIC; ACTG2
102550	MOVED TO 102630
102560	ACTIN, GAMMA-1; ACTG1
102565	FILAMIN C; FLNC
102570	REMOVED FROM DATABASE
102573	ACTININ, ALPHA-2; ACTN2
102574	ACTININ, ALPHA-3; ACTN3
102575	ACTININ, ALPHA-1; ACTN1
102576	ACTIVIN A RECEPTOR, TYPE I; ACVR1
102577	REPLICATION FACTOR C, SUBUNIT 4; RFC4
102578	ACUTE PROMYELOCYTIC LEUKEMIA, INDUCER OF; PML
102579	REPLICATION FACTOR C, SUBUNIT 1; RFC1
102581	ACTIVIN A RECEPTOR, TYPE IIA; ACVR2A
102582	SIGNAL TRANSDUCER AND ACTIVATOR OF TRANSCRIPTION 3; STAT3
102590	MOVED TO 614413
102593	ACYLOXYACYL HYDROLASE; AOAH
102595	ACYLPHOSPHATASE 2, MUSCLE TYPE; ACYP2
102600	ADENINE PHOSPHORIBOSYLTRANSFERASE; APRT
102610	ACTIN, ALPHA-1, SKELETAL MUSCLE; ACTA1
102620	ACTIN, ALPHA-2, SMOOTH MUSCLE, AORTA; ACTA2
102630	ACTIN, BETA; ACTB
102640	MOVED TO 102630
102642	STEROL O-ACYLTRANSFERASE 1; SOAT1
102645	ACYLAMINOACYL-PEPTIDE HYDROLASE; APEH
102650	ADACTYLIA, UNILATERAL
102660	ADAMANTINOMA OF LONG BONES
102670	MUCOSAL VASCULAR ADDRESSIN CELL ADHESION MOLECULE 1; MADCAM1
102680	ADDUCIN 1; ADD1
102681	ADDUCIN 2; ADD2
102699	ADENO-ASSOCIATED VIRUS INTEGRATION SITE 1; AAVS1
102700	SEVERE COMBINED IMMUNODEFICIENCY, AUTOSOMAL RECESSIVE, T CELL-NEGATIVE, B CELL-NEGATIVE, NK CELL-NEGATIVE, DUE TO ADENOSINE DEAMINASE DEFICIENCY
102710	MOVED TO 102720
102720	DIPEPTIDYL PEPTIDASE IV; DPP4
102730	MOVED TO 301083
102750	ADENOSINE KINASE; ADK
102770	ADENOSINE MONOPHOSPHATE DEAMINASE 1; AMPD1
102771	ADENOSINE MONOPHOSPHATE DEAMINASE 2; AMPD2
102772	ADENOSINE MONOPHOSPHATE DEAMINASE 3; AMPD3
102775	ADENOSINE A1 RECEPTOR; ADORA1
102776	ADENOSINE A2A RECEPTOR; ADORA2A
102777	MOVED TO 600446
102800	ADENOSINE TRIPHOSPHATASE DEFICIENCY, ANEMIA DUE TO
102900	ADENOSINE TRIPHOSPHATE, ELEVATED, OF ERYTHROCYTES
102910	ATP SYNTHASE F1, SUBUNIT BETA; ATP5F1B
102920	REMOVED FROM DATABASE
102930	REMOVED FROM DATABASE
102940	REMOVED FROM DATABASE
102970	REMOVED FROM DATABASE
102980	ADENYLATE CYCLASE-ACTIVATING POLYPEPTIDE 1; ADCYAP1
102981	ADCYAP RECEPTOR, TYPE I; ADCYAP1R1
102990	MOVED TO 145600
103000	ADENYLATE KINASE 1; AK1
103020	ADENYLATE KINASE 2; AK2
103030	ADENYLATE KINASE 4; AK4
103050	ADENYLOSUCCINASE DEFICIENCY; ADSLD
103060	ADENYLOSUCCINATE SYNTHETASE; ADSS
103070	ADENYLATE CYCLASE 8; ADCY8
103071	ADENYLATE CYCLASE 2; ADCY2
103072	ADENYLATE CYCLASE 1; ADCY1
103100	ADIE PUPIL
103180	ADP-RIBOSYLATION FACTOR 1; ARF1
103188	ADP-RIBOSYLATION FACTOR 5; ARF5
103190	ADP-RIBOSYLATION FACTOR 3; ARF3
103195	PERILIPIN 2; PLIN2
103200	ADIPOSIS DOLOROSA
103220	SOLUTE CARRIER FAMILY 25 (MITOCHONDRIAL CARRIER, ADENINE NUCLEOTIDE TRANSLOCATOR), MEMBER 4; SLC25A4
103230	ADRENOCORTICAL HYPOFUNCTION, CHRONIC PRIMARY CONGENITAL
103260	FERREDOXIN 1; FDX1
103270	FERREDOXIN REDUCTASE; FDXR
103275	ADRENOMEDULLIN; ADM
103280	H19, IMPRINTED MATERNALLY EXPRESSED NONCODING TRANSCRIPT; H19
103285	ADULT SYNDROME
103300	HYPOGLOSSIA-HYPODACTYLIA
103320	AGRIN; AGRN
103321	MOVED TO 128239
103390	AHNAK NUCLEOPROTEIN; AHNAK
103400	AINHUM
103420	ALACRIMA, CONGENITAL, AUTOSOMAL DOMINANT
103470	MOVED TO 193510 AND 606952
103500	TIETZ ALBINISM-DEAFNESS SYNDROME; TADS
103580	PSEUDOHYPOPARATHYROIDISM, TYPE IA; PHP1A
103581	MOVED TO 103580
103600	ALBUMIN; ALB
103700	ALCOHOL DEHYDROGENASE 1A, CLASS I, ALPHA POLYPEPTIDE; ADH1A
103710	ALCOHOL DEHYDROGENASE 5, CHI POLYPEPTIDE; ADH5
103720	ALCOHOL DEHYDROGENASE 1B, CLASS I, BETA POLYPEPTIDE; ADH1B
103730	ALCOHOL DEHYDROGENASE 1C, GAMMA POLYPEPTIDE; ADH1C
103735	ALCOHOL DEHYDROGENASE 6; ADH6
103740	ALCOHOL DEHYDROGENASE 4; ADH4
103780	ALCOHOL DEPENDENCE
103800	MOVED TO 253200 AND 258870
103830	ALDO-KETO REDUCTASE FAMILY 1, MEMBER A1; AKR1A1
103850	ALDOLASE A, FRUCTOSE-BISPHOSPHATE; ALDOA
103870	ALDOLASE C, FRUCTOSE-BISPHOSPHATE; ALDOC
103880	ALDO-KETO REDUCTASE FAMILY 1, MEMBER B1; AKR1B1
103890	MOVED TO 103880
103900	HYPERALDOSTERONISM, FAMILIAL, TYPE I; HALD1
103920	ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS, FAMILIAL
103950	ALPHA-2-MACROGLOBULIN; A2M
104000	ALOPECIA AREATA 1; AA1
104100	PALMOPLANTAR KERATODERMA AND CONGENITAL ALOPECIA 1; PPKCA1
104110	ALOPECIA, FAMILIAL FOCAL; ALPF
104130	ALOPECIA, PSYCHOMOTOR EPILEPSY, PYORRHEA, AND MENTAL SUBNORMALITY
104145	AFAMIN; AFM
104150	ALPHA-FETOPROTEIN; AFP
104155	ZINC FINGER HOMEOBOX 3; ZFHX3
104160	GLUCOSIDASE, ALPHA, NEUTRAL AB; GANAB
104170	N-ACETYL-ALPHA-D-GALACTOSAMINIDASE; NAGA
104175	GLYCOPROTEIN, ALPHA-GALACTOSYLTRANSFERASE 1 PSEUDOGENE; GGTA1P
104180	GLUCOSIDASE, ALPHA, NEUTRAL C; GANC
104200	ALPORT SYNDROME 3A, AUTOSOMAL DOMINANT; ATS3A
104210	ALPHA-2A-ADRENERGIC RECEPTOR; ADRA2A
104219	ALPHA-1D-ADRENERGIC RECEPTOR; ADRA1D
104220	ALPHA-1B-ADRENERGIC RECEPTOR; ADRA1B
104221	ALPHA-1A-ADRENERGIC RECEPTOR; ADRA1A
104222	MOVED TO 104219
104225	LOW DENSITY LIPOPROTEIN RECEPTOR-RELATED PROTEIN-ASSOCIATED PROTEIN 1; LRPAP1
104230	FUCOSYLTRANSFERASE 4; FUT4
104240	ST3 BETA-GALACTOSIDE ALPHA-2,3-SIALYLTRANSFERASE 4; ST3GAL4
104250	ALPHA-2C-ADRENERGIC RECEPTOR; ADRA2C
104260	ALPHA-2B-ADRENERGIC RECEPTOR; ADRA2B
104290	ALTERNATING HEMIPLEGIA OF CHILDHOOD 1; AHC1
104300	ALZHEIMER DISEASE, FAMILIAL, 1; AD1
104310	ALZHEIMER DISEASE 2; AD2
104311	PRESENILIN 1; PSEN1
104350	AMASTIA, BILATERAL, WITH URETERAL TRIPLICATION AND DYSMORPHISM
104400	AMELIA AND TERMINAL TRANSVERSE HEMIMELIA
104500	AMELOGENESIS IMPERFECTA, TYPE IB; AI1B
104510	AMELOGENESIS IMPERFECTA, TYPE IV; AI4
104530	AMELOGENESIS IMPERFECTA, TYPE IA; AI1A
104570	AMELOONYCHOHYPOHIDROTIC SYNDROME
104600	AMENORRHEA-GALACTORRHEA SYNDROME
104610	AMILORIDE-BINDING PROTEIN 1; ABP1
104613	CHAPERONIN CONTAINING T-COMPLEX POLYPEPTIDE 1, SUBUNIT 6A; CCT6A
104614	SOLUTE CARRIER FAMILY 3 (CYSTINE, DIBASIC, AND NEUTRAL AMINO ACID TRANSPORTER), MEMBER 1; SLC3A1
104615	SOLUTE CARRIER FAMILY 7 (CATIONIC AMINO ACID TRANSPORTER, y+ SYSTEM), MEMBER 1; SLC7A1
104620	AMINOACYLASE 1; ACY1
104640	AMPHIREGULIN; AREG
104650	AMYLASE, PANCREATIC, A; AMY2A
104660	AMYLASE, PANCREATIC, B; AMY2B
104700	AMYLASE, SALIVARY, A; AMY1A
104701	AMYLASE, SALIVARY, B; AMY1B
104702	AMYLASE, SALIVARY, C; AMY1C
104740	MOVED TO 602414
104750	SERUM AMYLOID A1; SAA1
104751	SERUM AMYLOID A2; SAA2
104752	SERUM AMYLOID A4; SAA4
104760	AMYLOID BETA A4 PRECURSOR PROTEIN; APP
104770	AMYLOID P COMPONENT, SERUM; APCS
104775	AMYLOID BETA A4 PRECURSOR-LIKE PROTEIN 1; APLP1
104776	AMYLOID BETA A4 PRECURSOR-LIKE PROTEIN 2; APLP2
105120	AMYLOIDOSIS, FINNISH TYPE
105150	CEREBRAL AMYLOID ANGIOPATHY, CST3-RELATED
105200	AMYLOIDOSIS, FAMILIAL VISCERAL
105210	AMYLOIDOSIS, HEREDITARY, TRANSTHYRETIN-RELATED
105250	AMYLOIDOSIS, PRIMARY LOCALIZED CUTANEOUS, 1; PLCA1
105300	AMYOTROPHIC DYSTONIC PARAPLEGIA
105400	AMYOTROPHIC LATERAL SCLEROSIS 1; ALS1
105500	AMYOTROPHIC LATERAL SCLEROSIS-PARKINSONISM/DEMENTIA COMPLEX 1
105550	FRONTOTEMPORAL DEMENTIA AND/OR AMYOTROPHIC LATERAL SCLEROSIS 1; FTDALS1
105563	ANAL SPHINCTER DYSPLASIA; ASDP
105565	ANAL SPHINCTER MYOPATHY, INTERNAL
105570	ANDROSTENONE, ABILITY TO SMELL
105580	ANAL CANAL CARCINOMA
105590	ANAPLASTIC LYMPHOMA KINASE; ALK
105600	ANEMIA, CONGENITAL DYSERYTHROPOIETIC, TYPE IIIa; CDAN3A
105650	DIAMOND-BLACKFAN ANEMIA 1; DBA1
105800	ANEURYSM, INTRACRANIAL BERRY, 1; ANIB1
105805	ANEURYSM OF INTERVENTRICULAR SEPTUM
105830	ANGELMAN SYNDROME; AS
105835	ANGEL-SHAPED PHALANGOEPIPHYSEAL DYSPLASIA; ASPED
105850	ANGIOGENIN; ANG
106050	ANGIOMA SERPIGINOSUM, AUTOSOMAL DOMINANT
106070	ANGIOMA, HEREDITARY NEUROCUTANEOUS
106100	ANGIOEDEMA, HEREDITARY, 1; HAE1
106150	ANGIOTENSINOGEN; AGT
106160	MOVED TO 106165
106165	ANGIOTENSIN II RECEPTOR, TYPE 1; AGTR1
106180	ANGIOTENSIN I-CONVERTING ENZYME; ACE
106190	ANHIDROSIS, ISOLATED, WITH NORMAL SWEAT GLANDS; ANHD
106195	SOLUTE CARRIER FAMILY 4 (ANION EXCHANGER), MEMBER 3; SLC4A3
106200	MOVED TO 106210
106210	ANIRIDIA 1; AN1
106220	ANIRIDIA AND ABSENT PATELLA
106230	ANIRIDIA, MICROCORNEA, AND SPONTANEOUSLY REABSORBED CATARACT
106240	ANISOCORIA
106250	ANKYLOBLEPHARON FILIFORME ADNATUM AND CLEFT PALATE; AFA
106260	ANKYLOBLEPHARON-ECTODERMAL DEFECTS-CLEFT LIP/PALATE; AEC
106280	ANKYLOGLOSSIA WITH OR WITHOUT TOOTH ANOMALIES; ANKG
106300	SPONDYLOARTHROPATHY, SUSCEPTIBILITY TO, 1; SPDA1
106400	ANKYLOSING VERTEBRAL HYPEROSTOSIS WITH TYLOSIS
106410	ANKYRIN 2; ANK2
106490	ANNEXIN A3; ANXA3
106491	ANNEXIN A4; ANXA4
106500	ANNULAR ERYTHEMA
106600	TOOTH AGENESIS, SELECTIVE, 1; STHAG1
106700	TOTAL ANOMALOUS PULMONARY VENOUS RETURN 1; TAPVR1
106750	ANONYCHIA WITH FLEXURAL PIGMENTATION
106900	ANONYCHIA-ECTRODACTYLY
106990	ANONYCHIA-ONYCHODYSTROPHY WITH BRACHYDACTYLY TYPE B AND ECTRODACTYLY
106995	ANONYCHIA-ONYCHODYSTROPHY WITH HYPOPLASIA OR ABSENCE OF DISTAL PHALANGES
107000	NAIL DISORDER, NONSYNDROMIC CONGENITAL, 6; NDNC6
107100	ANORECTAL ANOMALIES
107200	ANOSMIA, ISOLATED CONGENITAL; ANIC
107240	MOVED TO 116930
107250	ANTERIOR SEGMENT DYSGENESIS 1; ASGD1
107253	REMOVED FROM DATABASE
107254	ANTIGEN IDENTIFIED BY MONOCLONAL ANTIBODY 30.2A8; MIC12
107257	MOVED TO 143030
107260	ANTIGEN MSK41 IDENTIFIED BY MONOCLONAL ANTIBODY E3; MSK41
107265	CD19 ANTIGEN; CD19
107266	CD22 ANTIGEN; CD22
107269	CD44 ANTIGEN; CD44
107270	CD38 ANTIGEN; CD38
107271	CD59 ANTIGEN; CD59
107272	CD72 ANTIGEN; CD72
107273	CD69 ANTIGEN; CD69
107280	SERPIN PEPTIDASE INHIBITOR, CLADE A, MEMBER 3; SERPINA3
107285	SECRETORY LEUKOCYTE PROTEASE INHIBITOR; SLPI
107290	ANTIPYRINE METABOLISM
107300	SERPIN PEPTIDASE INHIBITOR, CLADE C (ANTITHROMBIN), MEMBER 1; SERPINC1
107310	SOLUTE CARRIER FAMILY 9, MEMBER 1; SLC9A1
107320	ANTIPHOSPHOLIPID SYNDROME, FAMILIAL
107323	ALDEHYDE DEHYDROGENASE 7 FAMILY, MEMBER A1; ALDH7A1
107325	POLYMERASE I, RNA, SUBUNIT G; POLR1G
107400	SERPIN PEPTIDASE INHIBITOR, CLADE A, MEMBER 1; SERPINA1
107410	SERPIN PEPTIDASE INHIBITOR, CLADE A, MEMBER 2, PSEUDOGENE; SERPINA2P
107440	ANTIVIRAL STATE REPRESSOR, REGULATOR OF; AVRR
107450	INTERFERON-ALPHA, -BETA, AND -OMEGA RECEPTOR 1; IFNAR1
107460	MOVED TO 107450
107470	INTERFERON-GAMMA RECEPTOR 1; IFNGR1
107480	TOWNES-BROCKS SYNDROME 1; TBS1
107500	AORTIC ARCH ANOMALY WITH PECULIAR FACIES AND MENTAL RETARDATION
107550	AORTIC ARCH INTERRUPTION, FACIAL PALSY, AND RETINAL COLOBOMA
107580	TRANSCRIPTION FACTOR AP2-ALPHA; TFAP2A
107600	APLASIA CUTIS CONGENITA, NONSYNDROMIC; ACC
107601	MOVED TO 100300
107640	APNEA, CENTRAL SLEEP
107650	APNEA, OBSTRUCTIVE SLEEP
107670	APOLIPOPROTEIN A-II; APOA2
107680	APOLIPOPROTEIN A-I; APOA1
107690	APOLIPOPROTEIN A-IV; APOA4
107700	APPENDICITIS, PRONENESS TO
107710	APOLIPOPROTEIN C-I; APOC1
107720	APOLIPOPROTEIN C-III; APOC3
107730	APOLIPOPROTEIN B; APOB
107740	APOLIPOPROTEIN D; APOD
107741	APOLIPOPROTEIN E; APOE
107748	APEX NUCLEASE 1; APEX1
107750	ARBITRARY RESTRICTION POLYMORPHISM 1
107760	APOLIPOPROTEIN F; APOF
107770	LOW DENSITY LIPOPROTEIN RECEPTOR-RELATED PROTEIN 1; LRP1
107773	NUCLEAR RECEPTOR SUBFAMILY 2, GROUP F, MEMBER 2; NR2F2
107776	AQUAPORIN 1; AQP1
107777	AQUAPORIN 2; AQP2
107800	ARCUS CORNEAE
107820	ARGINYL-tRNA SYNTHETASE 1; RARS1
107830	ARGINASE 2; ARG2
107840	MOVED TO 215700
107850	ARM FOLDING PREFERENCE
107900	ARMS, MALFORMATION OF
107910	CYTOCHROME P450, FAMILY 19, SUBFAMILY A, POLYPEPTIDE 1; CYP19A1
107920	MOVED TO 154200
107930	DOPA DECARBOXYLASE; DDC
107940	ARRESTIN, BETA, 1; ARRB1
107941	ARRESTIN, BETA, 2; ARRB2
107950	MOVED TO 138800
107970	ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA, FAMILIAL, 1; ARVD1
108000	ARTERIES, ANOMALIES OF
108010	ARTERIOVENOUS MALFORMATIONS OF THE BRAIN
108050	ARTERITIS, FAMILIAL GRANULOMATOUS, WITH JUVENILE POLYARTHRITIS
108100	ARTHRITIS, SACROILIAC
108110	MOVED TO 108120
108120	ARTHROGRYPOSIS, DISTAL, TYPE 1A; DA1A
108130	MOVED TO 601680
108140	MOVED TO 601680
108145	ARTHROGRYPOSIS, DISTAL, TYPE 5; DA5
108200	ARTHROGRYPOSIS, DISTAL, TYPE 6; DA6
108300	STICKLER SYNDROME, TYPE I; STL1
108320	ARTICHOKE, MODIFICATION OF TASTE BY
108330	CYTOCHROME P450, SUBFAMILY I, POLYPEPTIDE 1; CYP1A1
108340	ARYL HYDROCARBON HYDROXYLASE INDUCIBILITY
108345	N-ACETYLTRANSFERASE 1; NAT1
108355	GROWTH FACTOR RECEPTOR-BOUND PROTEIN 2; GRB2
108360	ASIALOGLYCOPROTEIN RECEPTOR 1; ASGR1
108361	ASIALOGLYCOPROTEIN RECEPTOR 2; ASGR2
108370	ASPARAGINE SYNTHETASE; ASNS
108390	ASPARAGUS, SPECIFIC SMELL HYPERSENSITIVITY
108400	REMOVED FROM DATABASE
108410	ASPARAGINYL-tRNA SYNTHETASE 1; NARS1
108420	SPERMATOGENIC FAILURE 2; SPGF2
108450	ASYMMETRIC SHORT STATURE SYNDROME
108500	EPISODIC ATAXIA, TYPE 2; EA2
108600	SPASTIC ATAXIA 1, AUTOSOMAL DOMINANT; SPAX1
108650	SPASTIC ATAXIA 7, AUTOSOMAL DOMINANT; SPAX7
108700	ATAXIA WITH FASCICULATIONS
108720	ATELOSTEOGENESIS, TYPE I; AO1
108721	ATELOSTEOGENESIS, TYPE III; AO3
108725	ATHEROSCLEROSIS SUSCEPTIBILITY; ATHS
108728	ATP CITRATE LYASE; ACLY
108729	ATP SYNTHASE F1, SUBUNIT GAMMA; ATP5F1C
108730	ATPase, Ca(2+)-TRANSPORTING, FAST-TWITCH 1; ATP2A1
108731	ATPase, Ca(2+)-TRANSPORTING, PLASMA MEMBRANE, 1; ATP2B1
108732	ATPase, Ca(2+)-TRANSPORTING, PLASMA MEMBRANE, 4; ATP2B4
108733	ATPase, Ca(2+)-TRANSPORTING, PLASMA MEMBRANE, 2; ATP2B2
108740	ATPase, Ca(2+)-TRANSPORTING, SLOW-TWITCH; ATP2A2
108745	ATPase, H+ TRANSPORTING, LYSOSOMAL, 16-KD, V0 SUBUNIT C; ATP6V0C
108746	ATPase, H+ TRANSPORTING, LYSOSOMAL, 31-KD, V1 SUBUNIT E, ISOFORM 1; ATP6V1E1
108760	ATRESIA OF EXTERNAL AUDITORY CANAL AND CONDUCTIVE DEAFNESS
108770	ATRIAL STANDSTILL 1; ATRST1
108780	NATRIURETIC PEPTIDE PRECURSOR A; NPPA
108800	ATRIAL SEPTAL DEFECT 1; ASD1
108900	ATRIAL SEPTAL DEFECT 7 WITH OR WITHOUT ATRIOVENTRICULAR CONDUCTION DEFECTS; ASD7
108950	ATRIAL TACHYARRHYTHMIA WITH SHORT PR INTERVAL
108960	NATRIURETIC PEPTIDE RECEPTOR A/GUANYLATE CYCLASE A; NPR1
108961	NATRIURETIC PEPTIDE RECEPTOR 2; NPR2
108962	NATRIURETIC PEPTIDE RECEPTOR C; NPR3
108970	MOVED TO 120520
108980	PR INTERVAL, VARIATION IN
108985	SVEINSSON CHORIORETINAL ATROPHY; SCRA
108990	ATTACHED CELL ANTIGEN 28.3.7; MIC7
109000	AURICULOOSTEODYSPLASIA
109050	AUROCEPHALOSYNDACTYLY
109090	SMALL RNA-BINDING EXONUCLEASE PROTECTION FACTOR La; SSB
109091	CALRETICULIN; CALR
109092	TRIPARTITE MOTIF-CONTAINING PROTEIN 21; TRIM21
109100	AUTOIMMUNE DISEASE
109110	AUTONOMOUSLY REPLICATING SEQUENCE 1
109120	AXENFELD-RIEGER ANOMALY WITH PARTIALLY ABSENT EYE MUSCLES, DISTINCTIVE FACE, HYDROCEPHALY, AND SKELETAL ABNORMALITIES
109130	AXIAL OSTEOMALACIA
109135	AXL RECEPTOR TYROSINE KINASE; AXL
109150	MACHADO-JOSEPH DISEASE; MJD
109160	AZOTEMIA, FAMILIAL
109170	LEUKOCYTE-SPECIFIC TRANSCRIPT 1; LST1
109180	BABOON M7 VIRUS INTEGRATION SITE; BEVI
109190	SOLUTE CARRIER FAMILY 1 (NEUTRAL AMINO ACID TRANSPORTER), MEMBER 5; SLC1A5
109195	BACTERICIDAL PERMEABILITY-INCREASING PROTEIN; BPI
109200	ALOPECIA, ANDROGENETIC, 1; AGA1
109270	SOLUTE CARRIER FAMILY 4 (ANION EXCHANGER), MEMBER 1; SLC4A1
109280	SOLUTE CARRIER FAMILY 4 (ANION EXCHANGER), MEMBER 2; SLC4A2
109300	BANKI SYNDROME
109350	GASTROESOPHAGEAL REFLUX; GER
109390	MOVED TO 301845
109400	BASAL CELL NEVUS SYNDROME 1; BCNS1
109480	BASIGIN; BSG
109500	BASILAR IMPRESSION, PRIMARY
109530	CD48 ANTIGEN; CD48
109535	CD40 ANTIGEN; CD40
109540	B-CELL GROWTH FACTOR; BCGF
109543	LEUKEMIA, CHRONIC LYMPHOCYTIC, SUSCEPTIBILITY TO, 2
109545	TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY, MEMBER 17; TNFRSF17
109560	B-CELL LEUKEMIA/LYMPHOMA 3; BCL3
109565	BCL6 TRANSCRIPTION REPRESSOR; BCL6
109580	B-CELL ANTIPROLIFERATION FACTOR 1; BTG1
109600	BEETURIA
109610	TRANSLOCATOR PROTEIN, 18-KD; TSPO
109630	BETA-1-ADRENERGIC RECEPTOR; ADRB1
109635	G PROTEIN-COUPLED RECEPTOR KINASE 2; GRK2
109636	BETA-ADRENERGIC RECEPTOR KINASE 2; ADRBK2
109640	BETA-GLYCEROL PHOSPHATASE; GPB
109650	BEHCET SYNDROME
109660	BETA-AMINO ACIDS, RENAL TRANSPORT OF; AABT
109670	BETA-ADRENERGIC STIMULATION, RESPONSE TO; BAS
109675	ST6 BETA-GALACTOSAMIDE ALPHA-2,6-SIALYLTRANSFERASE 1; ST6GAL1
109684	17-BETA-HYDROXYSTEROID DEHYDROGENASE I; HSD17B1
109685	17-BETA-HYDROXYSTEROID DEHYDROGENASE II; HSD17B2
109690	BETA-2-ADRENERGIC RECEPTOR; ADRB2
109691	BETA-3-ADRENERGIC RECEPTOR; ADRB3
109700	BETA-2-MICROGLOBULIN; B2M
109710	BETA-2-MICROGLOBULIN REGULATOR; B2MR
109715	3-BETA-HYDROXYSTEROID DEHYDROGENASE 1; HSD3B1
109720	BILIARY CIRRHOSIS, PRIMARY, 1; PBC1
109730	AORTIC VALVE DISEASE 1; AOVD1
109740	BIFID NOSE, AUTOSOMAL DOMINANT
109750	BILIVERDIN REDUCTASE A; BLVRA
109760	5-HYDROXYTRYPTAMINE RECEPTOR 1A; HTR1A
109770	CEA CELL ADHESION MOLECULE 1; CEACAM1
109780	BKM DNA
109800	BLADDER CANCER
109820	BLADDER DIVERTICULUM
109900	BLEPHAROCHALASIS AND DOUBLE LIP
110000	BLEPHAROCHALASIS, SUPERIOR
110050	BLEPHARONASOFACIAL MALFORMATION SYNDROME
110100	BLEPHAROPHIMOSIS, PTOSIS, AND EPICANTHUS INVERSUS; BPES
110150	BLEPHAROPTOSIS, MYOPIA, AND ECTOPIA LENTIS
110250	BLOOD GROUP--ABO SUPPRESSOR
110300	ABO GLYCOSYLTRANSFERASE; ABO
110310	BLOOD GROUP--ABH ANTIGEN, TYPE 2
110350	BLOOD GROUP--AHONEN; AN
110450	BLOOD GROUP, COLTON SYSTEM; CO
110500	BLOOD GROUP, DIEGO SYSTEM; DI
110600	ADP-RIBOSYLTRANSFERASE 4; ART4
110700	BLOOD GROUP, DUFFY SYSTEM; FY
110720	BLOOD GROUP--En
110750	GLYCOPHORIN C; GYPC
110800	BLOOD GROUP, I SYSTEM; Ii
110900	BLOOD GROUP--KELL SYSTEM; KEL
111000	BLOOD GROUP, KIDD SYSTEM; JK
111100	FUCOSYLTRANSFERASE 3; FUT3
111130	BLOOD GROUP--LKE; LKE
111150	BLOOD GROUP--LUTHERAN INHIBITOR; INLU
111200	BLOOD GROUP--LUTHERAN SYSTEM; LU
111250	BLOOD GROUP SYSTEM, LANDSTEINER-WIENER; LW
111300	BLOOD GROUP, MN; MN
111360	BLOOD GROUP--NEWFOUNDLAND; NFLD
111380	BLOOD GROUP--OK; OK
111400	BLOOD GROUP, P1PK SYSTEM
111410	MOVED TO 111400
111500	BLOOD GROUP--PRIVATE SYSTEMS
111600	BLOOD GROUP, LANGEREIS SYSTEM; LAN
111620	RADIN BLOOD GROUP ANTIGEN; RD
111680	RHESUS BLOOD GROUP, D ANTIGEN; RHD
111690	BLOOD GROUP, RH SYSTEM
111700	RHESUS BLOOD GROUP, CcEe ANTIGENS; RHCE
111730	BETA-1,4-N-ACETYL-GALACTOSAMINYLTRANSFERASE 2; B4GALNT2
111740	BLOOD GROUP, Ss; Ss
111750	BLOOD GROUP--SCIANNA SYSTEM; SC
111800	BLOOD GROUP--STOLTZFUS SYSTEM; Sf
112000	BLOOD GROUP--Ul SYSTEM; UL
112010	BLOOD GROUP--WALDNER TYPE; WD
112050	BLOOD GROUP--WRIGHT ANTIGEN; WR
112100	YT BLOOD GROUP ANTIGEN
112200	BLUE RUBBER BLEB NEVUS
112203	CD80 ANTIGEN; CD80
112205	CD79A ANTIGEN; CD79A
112210	MEMBRANE-SPANNING 4 DOMAINS, SUBFAMILY A, MEMBER 1; MS4A1
112240	COLE-CARPENTER SYNDROME 1; CLCRP1
112250	DIAPHYSEAL MEDULLARY STENOSIS WITH MALIGNANT FIBROUS HISTIOCYTOMA; DMSMFH
112260	GAMMA-CARBOXYGLUTAMIC ACID PROTEIN, BONE; BGLAP
112261	BONE MORPHOGENETIC PROTEIN 2; BMP2
112262	BONE MORPHOGENETIC PROTEIN 4; BMP4
112263	BONE MORPHOGENETIC PROTEIN 3; BMP3
112264	BONE MORPHOGENETIC PROTEIN 1; BMP1
112265	BONE MORPHOGENETIC PROTEIN 5; BMP5
112266	BONE MORPHOGENETIC PROTEIN 6; BMP6
112267	BONE MORPHOGENETIC PROTEIN 7; BMP7
112270	BONE PAIN, PERIODIC
112300	BOOK SYNDROME
112310	BOOMERANG DYSPLASIA; BOOMD
112350	WEISMANN-NETTER SYNDROME; WNS
112370	BRACHMANN-DE LANGE-LIKE FACIAL CHANGES WITH MICROCEPHALY, METATARSUS ADDUCTUS, AND DEVELOPMENTAL DELAY
112410	HYPERTENSION AND BRACHYDACTYLY SYNDROME; HTNB
112430	LONG-THUMB BRACHYDACTYLY SYNDROME
112440	BRACHYDACTYLY, COMBINED B AND E TYPES
112450	BRACHYDACTYLY, PREAXIAL, WITH HALLUX VARUS AND THUMB ABDUCTION
112500	BRACHYDACTYLY, TYPE A1; BDA1
112600	BRACHYDACTYLY, TYPE A2; BDA2
112700	BRACHYDACTYLY, TYPE A3; BDA3
112800	BRACHYDACTYLY, TYPE A4; BDA4
112900	MOVED TO 112800
112910	OSEBOLD-REMONDINI SYNDROME
113000	BRACHYDACTYLY, TYPE B1; BDB1
113100	BRACHYDACTYLY, TYPE C; BDC
113200	BRACHYDACTYLY, TYPE D; BDD
113300	BRACHYDACTYLY, TYPE E1; BDE1
113301	BRACHYDACTYLY, TYPE E, WITH ATRIAL SEPTAL DEFECT, TYPE II
113310	BRACHYDACTYLY-ECTRODACTYLY WITH FIBULAR APLASIA OR HYPOPLASIA
113400	BRACHYDACTYLY-NYSTAGMUS-CEREBELLAR ATAXIA
113450	BRACHYDACTYLY-DISTAL SYMPHALANGISM SYNDROME
113470	BRACHYMESOMELIA-RENAL SYNDROME
113475	BRACHYMETATARSUS IV
113477	BRACHYMORPHISM-ONYCHODYSPLASIA-DYSPHALANGISM SYNDROME
113480	BRACHYTELEPHALANGY WITH CHARACTERISTIC FACIES AND KALLMANN SYNDROME
113500	BRACHYOLMIA TYPE 3; BCYM3
113503	BRADYKININ RECEPTOR B2; BDKRB2
113505	BRAIN-DERIVED NEUROTROPHIC FACTOR; BDNF
113508	TYROSINE 3-MONOOXYGENASE/TRYPTOPHAN 5-MONOOXYGENASE ACTIVATION PROTEIN, ETA ISOFORM; YWHAH
113510	BRAIN-SPECIFIC PROTEIN Pc-1
113520	BRANCHED-CHAIN AMINOTRANSFERASE 1; BCAT1
113530	BRANCHED-CHAIN AMINOTRANSFERASE 2; BCAT2
113600	BRANCHIAL CLEFT ANOMALIES
113610	BRANCHIAL MYOCLONUS WITH SPASTIC PARAPARESIS AND CEREBELLAR ATAXIA
113620	BRANCHIOOCULOFACIAL SYNDROME; BOFS
113630	MOVED TO 151410
113640	MOVED TO 151410
113650	BRANCHIOOTORENAL SYNDROME 1; BOR1
113660	MOVED TO 151410
113670	HYPERTROPHY OF THE BREAST, JUVENILE; JHB
113700	BREASTS AND/OR NIPPLES, APLASIA OR HYPOPLASIA OF, 1; BNAH1
113703	RIBOSOMAL PROTEIN L13; RPL13
113705	BRCA1 DNA REPAIR-ASSOCIATED PROTEIN; BRCA1
113710	TREFOIL FACTOR 1; TFF1
113720	MOVED TO 158340
113721	BREAST CANCER-RELATED REGULATOR OF TP53
113725	POU DOMAIN, CLASS 4, TRANSCRIPTION FACTOR 2; POU4F2
113730	UNCOUPLING PROTEIN 1; UCP1
113750	ALBINISM, OCULOCUTANEOUS, TYPE VI; OCA6
113800	EPIDERMOLYTIC HYPERKERATOSIS 1; EHK1
113810	DYSTONIN; DST
113811	COLLAGEN, TYPE XVII, ALPHA-1; COL17A1
113900	PROGRESSIVE FAMILIAL HEART BLOCK, TYPE IA; PFHB1A
113950	BUNDLE BRANCH BLOCK, FAMILIAL ISOLATED COMPLETE RIGHT
113955	BUNGAROTOXIN, ALPHA, RECEPTOR FOR; BGTXR
113960	BUTYRYLESTERASE 1
113970	BURKITT LYMPHOMA; BL
113995	COMPLEMENT COMPONENT 5a RECEPTOR 1; C5AR1
114000	CAFFEY DISEASE; CAFYD
114010	CARBAMOYL PHOSPHATE SYNTHETASE/ASPARTATE TRANSCARBAMYLASE/DIHYDROOROTASE; CAD
114019	CADHERIN 15; CDH15
114020	CADHERIN 2; CDH2
114021	CADHERIN 3; CDH3
114025	CATENIN, ALPHA-2; CTNNA2
114030	CAFE-AU-LAIT SPOTS, MULTIPLE
114050	CALBINDIN 1; CALB1
114051	CALBINDIN 2; CALB2
114065	CALCIFIC AORTIC DISEASE WITH IMMUNOLOGIC ABNORMALITIES, FAMILIAL
114070	ANNEXIN A6; ANXA6
114078	CALCIUM/CALMODULIN-DEPENDENT PROTEIN KINASE II-ALPHA; CAMK2A
114080	CALCIUM/CALMODULIN-DEPENDENT PROTEIN KINASE IV; CAMK4
114085	S100 CALCIUM-BINDING PROTEIN A10; S100A10
114090	CALPASTATIN; CAST
114100	BASAL GANGLIA CALCIFICATION, IDIOPATHIC, CHILDHOOD-ONSET
114105	PROTEIN PHOSPHATASE 3, CATALYTIC SUBUNIT, ALPHA ISOFORM; PPP3CA
114106	PROTEIN PHOSPHATASE 3, CATALYTIC SUBUNIT, BETA ISOFORM; PPP3CB
114107	PROTEIN PHOSPHATASE 3, CATALYTIC SUBUNIT, GAMMA ISOFORM; PPP3CC
114110	S100 CALCIUM-BINDING PROTEIN A6; S100A6
114120	MOVED TO 211900
114130	CALCITONIN/CALCITONIN-RELATED POLYPEPTIDE, ALPHA; CALCA
114131	CALCITONIN RECEPTOR; CALCR
114140	CALLOSITIES, HEREDITARY PAINFUL
114150	CAMPTOBRACHYDACTYLY
114160	CALCITONIN-RELATED POLYPEPTIDE, BETA; CALCB
114170	CALPAIN, SMALL SUBUNIT 1; CAPNS1
114180	CALMODULIN 1; CALM1
114181	MOVED TO 114180
114182	CALMODULIN 2; CALM2
114183	CALMODULIN 3; CALM3
114184	CALMODULIN-LIKE 3; CALML3
114190	CALCITONIN RECEPTOR-LIKE RECEPTOR; CALCRL
114200	CAMPTODACTYLY 1; CAMPD1
114204	CALCIUM CHANNEL, VOLTAGE-DEPENDENT, ALPHA-2/DELTA SUBUNIT 1; CACNA2D1
114205	CALCIUM CHANNEL, VOLTAGE-DEPENDENT, L TYPE, ALPHA-1C SUBUNIT; CACNA1C
114206	CALCIUM CHANNEL, VOLTAGE-DEPENDENT, L TYPE, ALPHA-1D SUBUNIT; CACNA1D
114207	CALCIUM CHANNEL, VOLTAGE-DEPENDENT, BETA-1 SUBUNIT; CACNB1
114208	CALCIUM CHANNEL, VOLTAGE-DEPENDENT, L TYPE, ALPHA-1S SUBUNIT; CACNA1S
114209	CALCIUM CHANNEL, VOLTAGE-DEPENDENT, GAMMA-1 SUBUNIT; CACNG1
114210	S100 CALCIUM-BINDING PROTEIN A4; S100A4
114212	CALCYPHOSINE; CAPS
114213	CALDESMON 1; CALD1
114217	CALNEXIN; CANX
114220	CALPAIN 1; CAPN1
114230	CALPAIN 2; CAPN2
114240	CALPAIN 3; CAPN3
114250	CALSEQUESTRIN 1; CASQ1
114251	CALSEQUESTRIN 2; CASQ2
114260	MOVED TO 300006
114280	CAMPATH-1 ANTIGEN; CDW52
114290	CAMPOMELIC DYSPLASIA; CMPD
114300	ARTHROGRYPOSIS, DISTAL, TYPE 3; DA3
114350	NUCLEOPORIN, 214-KD; NUP214
114400	MOVED TO 120435
114450	CANCER, FAMILIAL, WITH IN VITRO RADIORESISTANCE
114480	BREAST CANCER
114500	COLORECTAL CANCER; CRC
114550	HEPATOCELLULAR CARCINOMA
114580	CANDIDIASIS, FAMILIAL, 1; CANDF1
114600	CANINE TEETH, ABSENCE OF UPPER PERMANENT
114610	CANNABINOID RECEPTOR 1; CNR1
114620	CRANIOFACIOFRONTODIGITAL SYNDROME
114650	CAR FACTOR DEFICIENCY
114700	CARABELLI ANOMALY OF MAXILLARY MOLAR TEETH
114750	CARBONIC ANHYDRASE III; CA3
114760	CARBONIC ANHYDRASE IV; CA4
114761	CARBONIC ANHYDRASE VA; CA5A
114770	CARBONIC ANHYDRASE VII; CA7
114780	CARBONIC ANHYDRASE VI; CA6
114800	CARBONIC ANHYDRASE I; CA1
114815	CARBONIC ANHYDRASE VIII; CA8
114830	CARBONYL REDUCTASE 1; CBR1
114835	CARBOXYLESTERASE 1; CES1
114836	MOVED TO 114835
114840	CARBOXYL-ESTER LIPASE; CEL
114841	MOVED TO 114840
114850	CARBOXYPEPTIDASE A1; CPA1
114851	CARBOXYPEPTIDASE A3, MAST CELL; CPA3
114852	CARBOXYPEPTIDASE B1, TISSUE; CPB1
114855	CARBOXYPEPTIDASE E; CPE
114860	CARBOXYPEPTIDASE M; CPM
114890	CEA CELL ADHESION MOLECULE 5; CEACAM5
114900	CARCINOID TUMORS, INTESTINAL
115000	VENTRICULAR ARRHYTHMIAS DUE TO CARDIAC RYANODINE RECEPTOR CALCIUM RELEASE DEFICIENCY SYNDROME; VACRDS
115080	CARDIAC CONDUCTION DEFECT
115150	CARDIOFACIOCUTANEOUS SYNDROME 1; CFC1
115195	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 2; CMH2
115196	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 3; CMH3
115197	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 4; CMH4
115198	MOVED TO 192600 AND 115197
115200	CARDIOMYOPATHY, DILATED, 1A; CMD1A
115210	CARDIOMYOPATHY, FAMILIAL RESTRICTIVE, 1; RCM1
115250	COLLAGENOMA, FAMILIAL CUTANEOUS
115300	HYPERCAROTENEMIA AND VITAMIN A DEFICIENCY, AUTOSOMAL DOMINANT; HCVAD
115310	PHEOCHROMOCYTOMA/PARAGANGLIOMA SYNDROME 4; PPGL4
115400	CARPAL DISPLACEMENT
115430	CARPAL TUNNEL SYNDROME 1; CTS1
115435	HYALURONAN AND PROTEOGLYCAN LINK PROTEIN 1; HAPLN1
115437	MATRILIN 1; MATN1
115440	CASEIN KINASE II, ALPHA-1; CSNK2A1
115441	CASEIN KINASE II, BETA; CSNK2B
115442	CASEIN KINASE II, ALPHA-2; CSNK2A2
115450	CASEIN, ALPHA; CSN1
115460	CASEIN, BETA; CSN2
115470	CAT EYE SYNDROME; CES
115500	CATALASE; CAT
115501	TYROSINASE-RELATED PROTEIN 1; TYRP1
115645	CATARACT, ABERRANT ORAL FRENULA, AND GROWTH RETARDATION
115650	CATARACT 32, MULTIPLE TYPES; CTRCT32
115660	CATARACT 7; CTRCT7
115665	CATARACT 8, MULTIPLE TYPES; CTRCT8
115700	CATARACT 4, MULTIPLE TYPES; CTRCT4
115800	CATARACT 29; CTRCT29
115900	CATARACT 42; CTRCT42
116100	CATARACT 20, MULTIPLE TYPES; CTRCT20
116150	MOVED TO 116200 AND 107250
116200	CATARACT 1, MULTIPLE TYPES; CTRCT1
116300	CATARACT 30, MULTIPLE TYPES; CTRCT30
116400	CATARACT 41; CTRCT41
116600	CATARACT 6, MULTIPLE TYPES; CTRCT6
116700	CATARACT 13 WITH ADULT i PHENOTYPE; CTRCT13
116790	CATECHOL-O-METHYLTRANSFERASE; COMT
116800	CATARACT 5, MULTIPLE TYPES; CTRCT5
116805	CATENIN, ALPHA-1; CTNNA1
116806	CATENIN, BETA-1; CTNNB1
116810	CATHEPSIN B; CTSB
116820	CATHEPSIN H; CTSH
116830	CATHEPSIN G; CTSG
116831	GRANZYME H; GZMH
116840	CATHEPSIN D; CTSD
116845	CATHEPSIN S; CTSS
116850	CATATRICHY
116860	CEREBRAL CAVERNOUS MALFORMATIONS; CCM
116870	CELIAC ARTERY STENOSIS FROM COMPRESSION BY MEDIAN ARCUATE LIGAMENT OF DIAPHRAGM
116880	CATHEPSIN L; CTSL
116890	CATHEPSIN E; CTSE
116896	CUT-LIKE HOMEOBOX 1; CUX1
116897	CCAAT/ENHANCER-BINDING PROTEIN, ALPHA; CEBPA
116898	CCAAT/ENHANCER-BINDING PROTEIN, DELTA; CEBPD
116899	CYCLIN-DEPENDENT KINASE INHIBITOR 1A; CDKN1A
116900	CDC28 PROTEIN KINASE 1B; CKS1B
116901	CDC2-ASSOCIATED PROTEIN CKS2; CKS2
116920	LEUKOCYTE ADHESION DEFICIENCY, TYPE I; LAD1
116930	CELL ADHESION MOLECULE, NEURAL, 1; NCAM1
116935	MOVED TO 602783
116940	CYCLIN-DEPENDENT KINASE 1; CDK1
116945	MINICHROMOSOME MAINTENANCE COMPLEX COMPONENT 2; MCM2
116946	CELL DIVISION CYCLE 27; CDC27
116947	CELL DIVISION CYCLE 25A; CDC25A
116948	CELL DIVISION CYCLE 34, UBIQUITIN-CONJUGATING ENZYME; CDC34
116949	CELL DIVISION CYCLE 25B; CDC25B
116950	TEMPERATURE-SENSITIVE AF8 COMPLEMENT; AF8T
116951	CYCLIN-DEPENDENT KINASE 11A; CDK11A
116952	CELL DIVISION CYCLE 42; CDC42
116953	CYCLIN-DEPENDENT KINASE 2; CDK2
116954	MOVED TO 120920
116955	CCHC-TYPE ZINC FINGER NUCLEIC ACID-BINDING PROTEIN; CNBP
116957	RB TRANSCRIPTIONAL COREPRESSOR-LIKE 1; RBL1
116960	MORTALITY FACTOR 4, PSEUDOGENE; MORF4
117000	CONGENITAL MYOPATHY 1A, AUTOSOMAL DOMINANT, WITH SUSCEPTIBILITY TO MALIGNANT HYPERTHERMIA; CMYP1A
117100	CENTRALOPATHIC EPILEPSY
117139	CENTROMERIC PROTEIN A; CENPA
117140	CENTROMERIC PROTEIN B; CENPB
117141	CENTROMERIC PROTEIN C1; CENPC1
117142	MOVED TO 117140
117143	CENTROMERIC PROTEIN E; CENPE
117200	REMOVED FROM DATABASE
117210	SPINOCEREBELLAR ATAXIA 31; SCA31
117300	CEREBRAL AMYLOID ANGIOPATHY, ITM2B-RELATED, 2
117340	CEREBELLAR DEGENERATION-RELATED AUTOANTIGEN 2; CDR2
117350	MOVED TO 183090
117360	SPINOCEREBELLAR ATAXIA 29; SCA29
117400	MOVED TO 164400 AND 117210
117550	SOTOS SYNDROME; SOTOS
117600	CEREBRAL SARCOMA
117650	CEREBROCOSTOMANDIBULAR SYNDROME; CCMS
117700	CERULOPLASMIN; CP
117800	APOCRINE GLAND SECRETION, VARIATION IN
117850	CERVICAL HYPERTRICHOSIS WITH UNDERLYING KYPHOSCOLIOSIS
117900	CERVICAL RIB
118000	CERVICAL VERTEBRAL BRIDGE
118005	CERVICAL VERTEBRAL DYSPLASIA
118100	KLIPPEL-FEIL SYNDROME 1, AUTOSOMAL DOMINANT; KFS1
118150	MOVED TO 107776
118190	HEAT-SHOCK 60-KD PROTEIN 1; HSPD1
118200	CHARCOT-MARIE-TOOTH DISEASE, DEMYELINATING, TYPE 1B; CMT1B
118210	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2A1; CMT2A1
118220	CHARCOT-MARIE-TOOTH DISEASE, DEMYELINATING, TYPE 1A; CMT1A
118230	CHARCOT-MARIE-TOOTH DISEASE, GUADALAJARA NEURONAL TYPE
118300	CHARCOT-MARIE-TOOTH DISEASE AND DEAFNESS
118301	CHARCOT-MARIE-TOOTH DISEASE WITH PTOSIS AND PARKINSONISM
118330	CHEILITIS GLANDULARIS
118350	CHEMODECTOMA, INTRAABDOMINAL, WITH CUTANEOUS ANGIOLIPOMAS
118400	CHERUBISM
118420	CHIARI MALFORMATION TYPE I
118423	CHIMERIN 1; CHN1
118425	CHLORIDE CHANNEL 1, SKELETAL MUSCLE; CLCN1
118430	CHLORPROPAMIDE-ALCOHOL FLUSHING; CPAF
118440	CHOLECYSTOKININ; CCK
118444	CHOLECYSTOKININ A RECEPTOR; CCKAR
118445	CHOLECYSTOKININ B RECEPTOR; CCKBR
118450	ALAGILLE SYNDROME 1; ALGS1
118455	CYTOCHROME P450, SUBFAMILY VIIA, POLYPEPTIDE 1; CYP7A1
118457	CHOLESTEROL CRYSTALLIZATION INHIBITOR; CCI
118470	CHOLESTERYL ESTER TRANSFER PROTEIN, PLASMA; CETP
118480	MOVED TO 134634
118485	CYTOCHROME P450, SUBFAMILY XIA, POLYPEPTIDE 1; CYP11A1
118490	CHOLINE ACETYLTRANSFERASE; CHAT
118491	CHOLINE KINASE, ALPHA; CHKA
118493	CHOLINERGIC RECEPTOR, MUSCARINIC, 2; CHRM2
118494	CHOLINERGIC RECEPTOR, MUSCARINIC, 3; CHRM3
118495	CHOLINERGIC RECEPTOR, MUSCARINIC, 4; CHRM4
118496	CHOLINERGIC RECEPTOR, MUSCARINIC, 5; CHRM5
118502	CHOLINERGIC RECEPTOR, NEURONAL NICOTINIC, ALPHA POLYPEPTIDE 2; CHRNA2
118503	CHOLINERGIC RECEPTOR, NEURONAL NICOTINIC, ALPHA POLYPEPTIDE 3; CHRNA3
118504	CHOLINERGIC RECEPTOR, NEURONAL NICOTINIC, ALPHA POLYPEPTIDE 4; CHRNA4
118505	CHOLINERGIC RECEPTOR, NEURONAL NICOTINIC, ALPHA POLYPEPTIDE 5; CHRNA5
118507	CHOLINERGIC RECEPTOR, NEURONAL NICOTINIC, BETA POLYPEPTIDE 2; CHRNB2
118508	CHOLINERGIC RECEPTOR, NEURONAL NICOTINIC, BETA POLYPEPTIDE 3; CHRNB3
118509	CHOLINERGIC RECEPTOR, NEURONAL NICOTINIC, BETA POLYPEPTIDE 4; CHRNB4
118510	CHOLINERGIC RECEPTOR, MUSCARINIC, 1; CHRM1
118511	CHOLINERGIC RECEPTOR, NEURONAL NICOTINIC, ALPHA POLYPEPTIDE 7; CHRNA7
118600	CHONDROCALCINOSIS 2; CCAL2
118610	CHONDROCALCINOSIS DUE TO APATITE CRYSTAL DEPOSITION
118650	CHONDRODYSPLASIA PUNCTATA, AUTOSOMAL DOMINANT
118651	CHONDRODYSPLASIA PUNCTATA, TIBIA-METACARPAL TYPE
118661	VERSICAN; VCAN
118670	CHONDRONECTIN
118700	CHOREA, BENIGN HEREDITARY; BHC
118750	CHOREOATHETOSIS, FAMILIAL INVERTED
118800	PAROXYSMAL NONKINESIGENIC DYSKINESIA 1; PNKD1
118820	CHORIONIC SOMATOMAMMOTROPIN HORMONE 2; CSH2
118825	CHM-LIKE; CHML
118830	CHYLOMICRONEMIA, FAMILIAL, DUE TO CIRCULATING INHIBITOR OF LIPOPROTEIN LIPASE
118840	CHROMATE RESISTANCE; CHR
118850	CHORIONIC GONADOTROPIN, ALPHA CHAIN; CGA
118860	CHORIONIC GONADOTROPIN, BETA CHAIN; CGB
118865	CHOROIDAL OSTEOMA, BILATERAL
118870	CHROMOSOMAL PROTEIN, NONHISTONE 1; NHCP1
118880	CHROMOSOMAL PROTEIN, NONHISTONE 2; NHCP2
118888	CHYMOTRYPSIN-LIKE PROTEASE; CTRL
118890	CHYMOTRYPSINOGEN B1; CTRB1
118900	CIRRHOSIS, FAMILIAL
118910	CHROMOGRANIN A; CHGA
118920	CHROMOGRANIN B; CHGB
118930	SECRETOGRANIN II; SCG2
118938	CHYMASE 1; CMA1
118940	MOVED TO 118938
118943	CHYMOSIN PSEUDOGENE; CYMP
118945	CILIARY NEUROTROPHIC FACTOR; CNTF
118946	CILIARY NEUROTROPHIC FACTOR RECEPTOR; CNTFR
118950	CITRATE SYNTHASE, MITOCHONDRIAL; CS
118953	MOVED TO 192020
118955	CLATHRIN, HEAVY POLYPEPTIDE; CLTC
118960	CLATHRIN, LIGHT POLYPEPTIDE A; CLTA
118970	CLATHRIN, LIGHT POLYPEPTIDE B; CLTB
118980	CLAVICLE, PSEUDARTHROSIS OF, CONGENITAL
118990	ITPR-INTERACTING DOMAIN-CONTAINING PROTEIN 2; ITPRID2
119000	CLEFT CHIN
119100	SPLIT-HAND/FOOT MALFORMATION WITH LONG BONE DEFICIENCY 1; SHFLD1
119300	VAN DER WOUDE SYNDROME 1; VWS1
119500	POPLITEAL PTERYGIUM SYNDROME; PPS
119530	OROFACIAL CLEFT 1; OFC1
119540	CLEFT PALATE, ISOLATED; CPI
119550	SYNGNATHIA
119570	CLEFT SOFT PALATE
119580	BLEPHAROCHEILODONTIC SYNDROME 1; BCDS1
119600	CLEIDOCRANIAL DYSPLASIA 1; CLCD1
119650	CLEIDORHIZOMELIC SYNDROME
119800	CLUBFOOT, CONGENITAL, WITH OR WITHOUT DEFICIENCY OF LONG BONES AND/OR MIRROR-IMAGE POLYDACTYLY; CCF
119900	DIGITAL CLUBBING, ISOLATED CONGENITAL; DIGC
119915	CLUSTER HEADACHE, FAMILIAL
120000	COARCTATION OF AORTA
120040	COCHLEOSACCULAR DEGENERATION WITH PROGRESSIVE CATARACTS
120050	COXSACKIEVIRUS B3 SUSCEPTIBILITY; CXB3S
120070	COLLAGEN, TYPE IV, ALPHA-3; COL4A3
120080	COLCHICINE RESISTANCE
120090	COLLAGEN, TYPE IV, ALPHA-2; COL4A2
120100	FAMILIAL COLD AUTOINFLAMMATORY SYNDROME 1; FCAS1
120105	COLIPASE, PANCREATIC; CLPS
120110	COLLAGEN, TYPE X, ALPHA-1; COL10A1
120120	COLLAGEN, TYPE VII, ALPHA-1; COL7A1
120130	COLLAGEN, TYPE IV, ALPHA-1; COL4A1
120131	COLLAGEN, TYPE IV, ALPHA-4; COL4A4
120140	COLLAGEN, TYPE II, ALPHA-1; COL2A1
120150	COLLAGEN, TYPE I, ALPHA-1; COL1A1
120160	COLLAGEN, TYPE I, ALPHA-2; COL1A2
120165	COLLAGEN, TYPE XIX, ALPHA-1; COL19A1
120170	MOVED TO 120190
120180	COLLAGEN, TYPE III, ALPHA-1; COL3A1
120190	COLLAGEN, TYPE V, ALPHA-2; COL5A2
120200	MICROPHTHALMIA/COLOBOMA 12; MCOPCB12
120210	COLLAGEN, TYPE IX, ALPHA-1; COL9A1
120215	COLLAGEN, TYPE V, ALPHA-1; COL5A1
120216	COLLAGEN, TYPE V, ALPHA-3; COL5A3
120220	COLLAGEN, TYPE VI, ALPHA-1; COL6A1
120240	COLLAGEN, TYPE VI, ALPHA-2; COL6A2
120250	COLLAGEN, TYPE VI, ALPHA-3; COL6A3
120251	COLLAGEN, TYPE VIII, ALPHA-1; COL8A1
120252	COLLAGEN, TYPE VIII, ALPHA-2; COL8A2
120260	COLLAGEN, TYPE IX, ALPHA-2; COL9A2
120270	COLLAGEN, TYPE IX, ALPHA-3; COL9A3
120280	COLLAGEN, TYPE XI, ALPHA-1; COL11A1
120290	COLLAGEN, TYPE XI, ALPHA-2; COL11A2
120300	COLOBOMA OF MACULA
120310	MOVED TO 120140
120320	COLLAGEN, TYPE XII, ALPHA-1; COL12A1
120321	MOVED TO 120320
120324	COLLAGEN, TYPE XIV, ALPHA-1; COL14A1
120325	COLLAGEN, TYPE XV, ALPHA-1; COL15A1
120326	COLLAGEN, TYPE XVI, ALPHA-1; COL16A1
120327	MOVED TO 113811
120328	COLLAGEN, TYPE XVIII, ALPHA-1; COL18A1
120330	PAPILLORENAL SYNDROME; PAPRS
120340	COLLAGEN, TYPE I, ALPHA, RECEPTOR; COL1AR
120350	COLLAGEN, TYPE XIII, ALPHA-1; COL13A1
120353	MATRIX METALLOPROTEINASE 1; MMP1
120355	MATRIX METALLOPROTEINASE 8; MMP8
120360	MATRIX METALLOPROTEINASE 2; MMP2
120361	MATRIX METALLOPROTEINASE 9; MMP9
120400	COLOBOMA OF MACULA WITH TYPE B BRACHYDACTYLY
120420	COLONY-STIMULATING FACTOR 1; CSF1
120430	COLOBOMA OF OPTIC NERVE
120433	COLOBOMA, OCULAR, WITH OR WITHOUT HEARING IMPAIRMENT, CLEFT LIP/PALATE, AND/OR IMPAIRED INTELLECTUAL DEVELOPMENT; COB1
120435	LYNCH SYNDROME 1; LYNCH1
120436	DNA MISMATCH REPAIR PROTEIN MLH1; MLH1
120440	COLONIC VARICES WITHOUT PORTAL HYPERTENSION
120450	COMEDONES, FAMILIAL DYSKERATOTIC
120460	MOVED TO 191170
120470	DCC NETRIN 1 RECEPTOR; DCC
120500	COMMISSURAL LIP PITS
120502	BRANCHIOOTIC SYNDROME 2; BOS2
120520	MEMBRANE METALLOENDOPEPTIDASE; MME
120550	COMPLEMENT COMPONENT 1, q SUBCOMPONENT, A CHAIN; C1QA
120560	COMPLEMENT COMPONENT C1q, FIBROBLAST TYPE
120570	COMPLEMENT COMPONENT 1, q SUBCOMPONENT, B CHAIN; C1QB
120575	COMPLEMENT COMPONENT 1, q SUBCOMPONENT, C CHAIN; C1QC
120577	COMPLEMENT COMPONENT 1, q SUBCOMPONENT, RECEPTOR 1; C1QR1
120580	COMPLEMENT COMPONENT 1, s SUBCOMPONENT; C1S
120620	COMPLEMENT COMPONENT RECEPTOR 1; CR1
120650	COMPLEMENT COMPONENT RECEPTOR 2; CR2
120700	COMPLEMENT COMPONENT 3; C3
120790	COMPLEMENT COMPONENT 4, PARTIAL DEFICIENCY OF
120810	COMPLEMENT COMPONENT 4A; C4A
120820	COMPLEMENT COMPONENT 4B; C4B
120830	COMPLEMENT COMPONENT 4-BINDING PROTEIN, ALPHA; C4BPA
120831	COMPLEMENT COMPONENT 4-BINDING PROTEIN, BETA CHAIN; C4BPB
120832	MOVED TO 120830
120900	COMPLEMENT COMPONENT 5; C5
120920	CD46 ANTIGEN; CD46
120930	COMPLEMENT COMPONENT 8, GAMMA SUBUNIT; C8G
120940	COMPLEMENT COMPONENT 9; C9
120950	COMPLEMENT COMPONENT 8, ALPHA SUBUNIT; C8A
120960	COMPLEMENT COMPONENT 8, BETA SUBUNIT; C8B
120970	CONE-ROD DYSTROPHY 2; CORD2
120980	INTEGRIN, ALPHA-M; ITGAM
121000	REMOVED FROM DATABASE
121009	CELLULAR COMMUNICATION NETWORK FACTOR 2; CCN2
121010	PRO-PLATELET BASIC PROTEIN; PPBP
121011	GAP JUNCTION PROTEIN, BETA-2; GJB2
121012	GAP JUNCTION PROTEIN, ALPHA-4; GJA4
121013	GAP JUNCTION PROTEIN, ALPHA-5; GJA5
121014	GAP JUNCTION PROTEIN, ALPHA-1; GJA1
121015	GAP JUNCTION PROTEIN, ALPHA-3; GJA3
121020	MOVED TO 160120
121050	CONTRACTURAL ARACHNODACTYLY, CONGENITAL; CCA
121070	ARTHROGRYPOSIS, DISTAL, TYPE 2E
121200	SEIZURES, BENIGN FAMILIAL NEONATAL, 1; BFNS1
121201	SEIZURES, BENIGN FAMILIAL NEONATAL, 2; BFNS2
121210	FEBRILE SEIZURES, FAMILIAL, 1; FEB1
121250	MOVED TO 300088
121270	COPPER DEFICIENCY, FAMILIAL BENIGN
121300	COPROPORPHYRIA, HEREDITARY; HCP
121350	CORACOCLAVICULAR JOINT, ANOMALOUS
121360	CORE-BINDING FACTOR, BETA SUBUNIT; CBFB
121390	CORNEA GUTTATA WITH ANTERIOR POLAR CATARACTS
121400	CORNEA PLANA 1, AUTOSOMAL DOMINANT; CNA1
121450	CORNEAL DEGENERATION, RIBBONLIKE, WITH DEAFNESS
121700	MOVED TO 122000
121800	SCHNYDER CORNEAL DYSTROPHY; SCCD
121820	CORNEAL DYSTROPHY, EPITHELIAL BASEMENT MEMBRANE; EBMD
121850	CORNEAL DYSTROPHY, FLECK; CFD
121900	CORNEAL DYSTROPHY, GROENOUW TYPE I; CDGG1
122000	CORNEAL DYSTROPHY, POSTERIOR POLYMORPHOUS, 1; PPCD1
122100	CORNEAL DYSTROPHY, MEESMANN, 1; MECD1
122200	CORNEAL DYSTROPHY, LATTICE TYPE I; CDL1
122400	EPITHELIAL RECURRENT EROSION DYSTROPHY; ERED
122430	CORNEAL HYPESTHESIA WITH RETINAL ABNORMALITIES, SENSORINEURAL DEAFNESS, UNUSUAL FACIES, PERSISTENT DUCTUS ARTERIOSUS, AND MENTAL RETARDATION
122440	CORNEODERMATOOSSEOUS SYNDROME
122450	CORNEAL HYPESTHESIA, FAMILIAL
122455	CORONARY ARTERY DISSECTION, SPONTANEOUS
122460	HUMAN CORONAVIRUS SENSITIVITY; HCVS
122470	CORNELIA DE LANGE SYNDROME 1; CDLS1
122480	MOVED TO 166740
122500	SERPIN PEPTIDASE INHIBITOR, CLADE A, MEMBER 6; SERPINA6
122550	CORTICOSTERONE SIDE-CHAIN ISOMERASE; CSCI
122559	CORTICOTROPIN-RELEASING HORMONE-BINDING PROTEIN; CRHBP
122560	CORTICOTROPIN-RELEASING HORMONE; CRH
122561	CORTICOTROPIN-RELEASING HORMONE RECEPTOR 1; CRHR1
122580	COSTOCORACOID LIGAMENT, CONGENITALLY SHORT
122600	SPONDYLOCOSTAL DYSOSTOSIS 5; SCDO5
122700	COUMARIN RESISTANCE
122720	CYTOCHROME P450, SUBFAMILY IIA, POLYPEPTIDE 6; CYP2A6
122750	COXA VARA
122780	COXOAURICULAR SYNDROME
122850	CRANIOACROFACIAL SYNDROME
122860	CRANIODIAPHYSEAL DYSPLASIA, AUTOSOMAL DOMINANT; CDD
122880	CRANIOFACIAL-DEAFNESS-HAND SYNDROME; CDHS
122900	CRANIOFACIAL DYSOSTOSIS WITH DIAPHYSEAL HYPERPLASIA
122920	MOVED TO 304110
123000	CRANIOMETAPHYSEAL DYSPLASIA, AUTOSOMAL DOMINANT; CMDD
123050	CRANIORHINY
123100	CRANIOSYNOSTOSIS 1; CRS1
123101	MSH HOMEOBOX 2; MSX2
123150	JACKSON-WEISS SYNDROME; JWS
123155	HYDROCEPHALUS, AUTOSOMAL DOMINANT; HDCPH1
123260	C-REACTIVE PROTEIN; CRP
123270	CREATINE KINASE, BRAIN TYPE, ECTOPIC EXPRESSION OF; CKBE
123280	CREATINE KINASE, BRAIN TYPE; CKB
123290	CREATINE KINASE, MITOCHONDRIAL 1B; CKMT1B
123295	CREATINE KINASE, MITOCHONDRIAL 2; CKMT2
123310	CREATINE KINASE, MUSCLE TYPE; CKM
123320	CREATINE PHOSPHOKINASE, ELEVATED SERUM
123400	CREUTZFELDT-JAKOB DISEASE; CJD
123450	CRI-DU-CHAT SYNDROME
123500	CROUZON SYNDROME
123540	CRYOFIBRINOGENEMIA, FAMILIAL PRIMARY
123550	CRYOGLOBULINEMIA, FAMILIAL MIXED
123555	MOVED TO 125220
123557	CRYPTOTIA, FAMILIAL
123560	CRYPTOMICROTIA-BRACHYDACTYLY SYNDROME
123570	CRYPTOPHTHALMOS, UNILATERAL OR BILATERAL, ISOLATED; CRYPTOP
123580	CRYSTALLIN, ALPHA-A; CRYAA
123590	CRYSTALLIN, ALPHA-B; CRYAB
123610	CRYSTALLIN, BETA-A1; CRYBA1
123620	CRYSTALLIN, BETA-B2; CRYBB2
123630	CRYSTALLIN, BETA-B3; CRYBB3
123631	CRYSTALLIN, BETA-A4; CRYBA4
123660	CRYSTALLIN, GAMMA-A; CRYGA
123670	CRYSTALLIN, GAMMA-B; CRYGB
123680	CRYSTALLIN, GAMMA-C; CRYGC
123690	CRYSTALLIN, GAMMA-D; CRYGD
123691	CRYSTALLIN, ZETA; CRYZ
123695	PHOSPHATE CYTIDYLYLTRANSFERASE 1, CHOLINE, ALPHA ISOFORM; PCYT1A
123700	CUTIS LAXA, AUTOSOMAL DOMINANT 1; ADCL1
123710	MOVED TO 123660
123720	MOVED TO 123660
123730	CRYSTALLIN, GAMMA-S; CRYGS
123740	CRYSTALLIN, MU; CRYM
123790	BEARE-STEVENSON CUTIS GYRATA SYNDROME; BSTVS
123803	ACTIVATING TRANSCRIPTION FACTOR 1; ATF1
123805	PHOSPHODIESTERASE 3A; PDE3A
123810	cAMP RESPONSE ELEMENT-BINDING PROTEIN 1; CREB1
123811	ACTIVATING TRANSCRIPTION FACTOR 2; ATF2
123812	cAMP RESPONSE ELEMENT MODULATOR; CREM
123825	CYCLIC NUCLEOTIDE-GATED CHANNEL, ALPHA-1; CNGA1
123828	CYCLIN-DEPENDENT KINASE 3; CDK3
123829	CYCLIN-DEPENDENT KINASE 4; CDK4
123830	CYCLIC NUCLEOTIDE PHOSPHODIESTERASE; CNP
123831	CYCLIN-DEPENDENT KINASE 5; CDK5
123832	CYCLIN-DEPENDENT KINASE INHIBITOR 3; CDKN3
123833	CYCLIN D2; CCND2
123834	CYCLIN D3; CCND3
123835	CYCLIN A2; CCNA2
123836	CYCLIN B1; CCNB1
123837	CYCLIN E1; CCNE1
123838	CYCLIN C; CCNC
123839	MOVED TO 600262
123840	PEPTIDYL-PROLYL ISOMERASE A; PPIA
123841	PEPTIDYL-PROLYL ISOMERASE B; PPIB
123842	PEPTIDYL-PROLYL ISOMERASE C; PPIC
123850	MOVED TO 132700
123853	CYPRUS FACIAL NEUROMUSCULOSKELETAL SYNDROME
123855	CYSTATIN 1; CST1
123856	CYSTATIN 2; CST2
123857	CYSTATIN 4; CST4
123858	CYSTATIN 5; CST5
123859	CYSTEINYL-tRNA SYNTHETASE 1; CARS1
123860	CYTIDINE 5-PRIME TRIPHOSPHATE SYNTHETASE 1; CTPS1
123864	CYTOCHROME c OXIDASE, SUBUNIT 4I1; COX4I1
123866	CYTOCHROME c OXIDASE, SUBUNIT 5B; COX5B
123870	CYTOCHROME c OXIDASE, SUBUNIT 8A; COX8A
123875	CYSTEINE-RICH INTESTINAL PROTEIN 1; CRIP1
123876	CYSTEINE- AND GLYCINE-RICH PROTEIN 1; CSRP1
123880	CYSTIC ANGIOMATOSIS OF BONE, DIFFUSE
123885	S100 CALCIUM-BINDING PROTEIN A8; S100A8
123886	S100 CALCIUM-BINDING PROTEIN A9; S100A9
123889	INTERLEUKIN 10 RECEPTOR, BETA; IL10RB
123890	CYTOTOXIC T LYMPHOCYTE-ASSOCIATED 4; CTLA4
123900	EZRIN; EZR
123910	GRANZYME B; GZMB
123920	CYTIDINE DEAMINASE; CDA
123930	CYTOCHROME P450, SUBFAMILY IIB, POLYPEPTIDE 6; CYP2B6
123940	KERATIN 4, TYPE II; KRT4
123950	MOVED TO 250790
123960	MOVED TO 122720
123970	CYTOCHROME C, SOMATIC; CYCS
123980	CYTOCHROME C1; CYC1
123995	CYTOCHROME c OXIDASE, SUBUNIT 7A1; COX7A1
123996	CYTOCHROME c OXIDASE, SUBUNIT 7A2; COX7A2
123997	CYTOCHROME c OXIDASE, SUBUNIT 7A2, PSEUDOGENE 2; COX7A2P2
124000	MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 1; MC3DN1
124010	CYTOCHROME P450, SUBFAMILY IIIA, POLYPEPTIDE 4; CYP3A4
124015	CYTOCHROME P450 OXIDOREDUCTASE; POR
124020	CYTOCHROME P450, SUBFAMILY IIC, POLYPEPTIDE 19; CYP2C19
124030	CYTOCHROME P450, SUBFAMILY IID, POLYPEPTIDE 6; CYP2D6
124040	CYTOCHROME P450, SUBFAMILY IIE; CYP2E1
124050	D-AMINO ACID OXIDASE; DAO
124060	CYTOCHROME P450, SUBFAMILY I, POLYPEPTIDE 2; CYP1A2
124070	CYTOCHROME P450, SUBFAMILY IIF, POLYPEPTIDE 1; CYP2F1
124075	CYTOCHROME P450, SUBFAMILY IVB, MEMBER 1; CYP4B1
124080	CYTOCHROME P450, SUBFAMILY XIB, POLYPEPTIDE 2; CYP11B2
124089	CYTOCHROME c OXIDASE, SUBUNIT 6B1; COX6B1
124090	CYTOCHROME c OXIDASE, SUBUNIT 6C; COX6C
124092	INTERLEUKIN 10; IL10
124095	C-TERMINAL SRC KINASE; CSK
124097	D-BOX-BINDING PAR bZIP TRANSCRIPTION FACTOR; DBP
124100	DANUBIAN ENDEMIC FAMILIAL NEPHROPATHY
124200	DARIER-WHITE DISEASE; DAR
124300	DARWINIAN TUBERCLE OF PINNA
124400	MOVED TO 124300
124450	D-ASPARTATE OXIDASE; DDO
124480	DEAFNESS, CONGENITAL, WITH ONYCHODYSTROPHY, AUTOSOMAL DOMINANT; DDOD
124490	DEAFNESS, CONDUCTIVE STAPEDIAL, WITH EAR MALFORMATION AND FACIAL PALSY
124500	VOHWINKEL SYNDROME; VOWNKL
124580	REMOVED FROM DATABASE
124700	DEAFNESS, MID-TONE NEURAL
124800	MOVED TO 600994
124900	DEAFNESS, AUTOSOMAL DOMINANT 1, WITH OR WITHOUT THROMBOCYTOPENIA; DFNA1
124910	MOVED TO 124900
124950	DEAFNESS, SENSORINEURAL, WITH PERIPHERAL NEUROPATHY AND ARTERIAL DISEASE
125000	DEAFNESS, UNILATERAL
125050	DEAFNESS WITH ANHIDROTIC ECTODERMAL DYSPLASIA
125100	MOVED TO 602588
125220	DEFENSIN, ALPHA, 1; DEFA1
125230	DEAFNESS-CRANIOFACIAL SYNDROME
125240	CD55 ANTIGEN; CD55
125250	OPTIC ATROPHY WITH OR WITHOUT DEAFNESS, OPHTHALMOPLEGIA, MYOPATHY, ATAXIA, AND NEUROPATHY
125255	DECORIN; DCN
125260	DEFECTIVE INTERFERING PARTICLE INDUCTION, CONTROL OF
125263	SULFOTRANSFERASE FAMILY 2A, DEHYDROEPIANDROSTERONE-PREFERRING, MEMBER 1; SULT2A1
125264	DEK ONCOGENE; DEK
125265	RECEPTOR EXPRESSION-ENHANCING PROTEIN 5; REEP5
125270	DELTA-AMINOLEVULINATE DEHYDRATASE; ALAD
125280	DENS EVAGINATUS
125290	DELTA-AMINOLEVULINATE SYNTHASE 1; ALAS1
125300	DENS IN DENTE AND PALATAL INVAGINATIONS
125305	ERYTHROCYTE MEMBRANE PROTEIN BAND 4.9; EPB49
125310	CEREBRAL ARTERIOPATHY, AUTOSOMAL DOMINANT, WITH SUBCORTICAL INFARCTS AND LEUKOENCEPHALOPATHY, TYPE 1; CADASIL1
125320	DEMENTIA/PARKINSONISM WITH NON-ALZHEIMER AMYLOID PLAQUES
125350	FAILURE OF TOOTH ERUPTION, PRIMARY; PFE
125370	DENTATORUBRAL-PALLIDOLUYSIAN ATROPHY; DRPLA
125400	DENTIN DYSPLASIA, TYPE I; DTDP1
125420	DENTIN DYSPLASIA, TYPE II; DTDP2
125440	DENTIN DYSPLASIA WITH SCLEROTIC BONES
125450	DEOXYCYTIDINE KINASE; DCK
125460	DEOXYRIBOSE-5-PHOSPHATE ALDOLASE DEFICIENCY
125480	MAJOR AFFECTIVE DISORDER 1; MAFD1
125485	DENTIN SIALOPHOSPHOPROTEIN; DSPP
125490	DENTINOGENESIS IMPERFECTA 1; DGI1
125500	DENTINOGENESIS IMPERFECTA, SHIELDS TYPE III
125505	DEOXYRIBONUCLEASE I; DNASE1
125510	REMOVED FROM DATABASE
125520	CAYLER CARDIOFACIAL SYNDROME
125530	DERMAL RIDGES, NELSON SYNDROME
125540	DERMAL RIDGES, PATTERNLESS
125550	DERMAL RIDGES-OFF-THE-END; ROES
125570	DERMATOGLYPHICS--ARCH ON ANY DIGIT
125580	DERMATOGLYPHICS--FINGER RIDGE COUNT
125590	DERMATOGLYPHICS--FINGERPRINT PATTERN
125595	DERMATOPATHIA PIGMENTOSA RETICULARIS; DPR
125597	DERMATOPONTIN; DPT
125600	DERMATOSIS PAPULOSA NIGRA
125630	VIBRATORY URTICARIA; VBU
125635	DERMOGRAPHISM, FAMILIAL
125640	DERMOODONTODYSPLASIA
125643	DESMOCOLLIN 1; DSC1
125645	DESMOCOLLIN 2; DSC2
125647	DESMOPLAKIN; DSP
125650	MOVED TO 606418
125660	DESMIN; DES
125670	DESMOGLEIN 1; DSG1
125671	DESMOGLEIN 2; DSG2
125700	DIABETES INSIPIDUS, NEUROHYPOPHYSEAL
125800	DIABETES INSIPIDUS, NEPHROGENIC, 2, AUTOSOMAL; NDI2
125850	MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 1; MODY1
125851	MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 2; MODY2
125852	TYPE 1 DIABETES MELLITUS 2; T1D2
125853	TYPE 2 DIABETES MELLITUS; T2D
125855	DIACYLGLYCEROL KINASE, ALPHA, 80-KD; DGKA
125860	NAD(P)H DEHYDROGENASE, QUINONE 1; NQO1
125870	MOVED TO 600941
125880	DIAPHORASE 3; DIA3
125890	DIARRHEA, GLUCOSE-STIMULATED SECRETORY, WITH COMMON VARIABLE IMMUNODEFICIENCY
125900	DIASTEMA, DENTAL MEDIAL
125950	DIAZEPAM BINDING INHIBITOR; DBI
126050	DIGITOTALAR DYSMORPHISM
126060	DIHYDROFOLATE REDUCTASE; DHFR
126061	MOVED TO 126060
126063	DIHYDROLIPOAMIDE S-SUCCINYLTRANSFERASE; DLST
126064	DIHYDROOROTATE DEHYDROGENASE; DHODH
126065	CYTOCHROME P450, FAMILY 24, SUBFAMILY A, POLYPEPTIDE 1; CYP24A1
126070	DILUTION, PIGMENTARY
126090	PTERIN-4-ALPHA-CARBINOLAMINE DEHYDRATASE 1; PCBD1
126100	DIMPLES, FACIAL
126110	ARYL HYDROCARBON RECEPTOR NUCLEAR TRANSLOCATOR; ARNT
126140	MOVED TO 102720
126141	DIPEPTIDYL PEPTIDASE VI; DPP6
126150	HEPARIN-BINDING EGF-LIKE GROWTH FACTOR; HBEGF
126180	DISCRIMINATION, TWO-POINT, REDUCTION IN
126190	DISPROPORTIONATE SHORT STATURE WITH PTOSIS AND VALVULAR HEART LESIONS
126200	MULTIPLE SCLEROSIS, SUSCEPTIBILITY TO; MS
126250	DISTAL OSTEOSCLEROSIS
126255	DISTAL-LESS HOMEOBOX 2; DLX2
126300	DISTICHIASIS
126320	DISTICHIASIS WITH CONGENITAL ANOMALIES OF THE HEART AND PERIPHERAL VASCULATURE
126330	DNA, CYTOPLASMIC-MEMBRANE; DNCM
126335	GROWTH ARREST- AND DNA DAMAGE-INDUCIBLE GENE, ALPHA; GADD45A
126337	DNA DAMAGE-INDUCIBLE TRANSCRIPT 3; DDIT3
126340	ERCC EXCISION REPAIR 2, TFIIH CORE COMPLEX HELICASE SUBUNIT; ERCC2
126350	DEOXYRIBONUCLEASE II, LYSOSOMAL; DNASE2
126370	DNA, SATELLITE, III; HS3; D1Z1
126375	DNA METHYLTRANSFERASE 1; DNMT1
126380	ERCC EXCISION REPAIR 1, ENDONUCLEASE NONCATALYTIC SUBUNIT; ERCC1
126390	DNA, LOW-REPETITIVE SEQUENCES OF
126391	LIGASE I, DNA, ATP-DEPENDENT; LIG1
126410	DNA, SATELLITE, ALPHA TYPE
126420	TOPOISOMERASE, DNA, I; TOP1
126430	TOPOISOMERASE, DNA, II, ALPHA; TOP2A
126431	TOPOISOMERASE, DNA, II, BETA; TOP2B
126440	REMOVED FROM DATABASE
126448	MOVED TO 126453
126449	DOPAMINE RECEPTOR D1; DRD1
126450	DOPAMINE RECEPTOR D2; DRD2
126451	DOPAMINE RECEPTOR D3; DRD3
126452	DOPAMINE RECEPTOR D4; DRD4
126453	DOPAMINE RECEPTOR D5; DRD5
126455	SOLUTE CARRIER FAMILY 6 (NEUROTRANSMITTER TRANSPORTER, DOPAMINE), MEMBER 3; SLC6A3
126500	DOUBLE NAIL FOR FIFTH TOE
126550	CALVARIAL DOUGHNUT LESIONS WITH BONE FRAGILITY; CDL
126600	DOYNE HONEYCOMB RETINAL DYSTROPHY; DHRD
126650	SOLUTE CARRIER FAMILY 26, MEMBER 3; SLC26A3
126660	DREBRIN E; DBN1
126700	BASAL LAMINAR DRUSEN
126800	DUANE RETRACTION SYNDROME 1; DURS1
126830	MOVED TO 169100
126840	DUODENAL ULCER DUE TO ANTRAL G-CELL HYPERFUNCTION
126850	DUODENAL ULCER, HYPERPEPSINOGENEMIC I
126900	DUPUYTREN CONTRACTURE
126950	DWARFISM WITH TALL VERTEBRAE
127000	KENNY-CAFFEY SYNDROME, TYPE 2; KCS2
127100	DWARFISM, LEVI TYPE
127200	DWARFISM WITH STIFF JOINTS AND OCULAR ABNORMALITIES
127300	LERI-WEILL DYSCHONDROSTEOSIS; LWD
127350	DYSCHONDROSTEOSIS AND NEPHRITIS
127400	DYSCHROMATOSIS SYMMETRICA HEREDITARIA; DSH
127500	DYSCHROMATOSIS UNIVERSALIS HEREDITARIA 1; DUH1
127550	DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 1; DKCA1
127600	DYSKERATOSIS, HEREDITARY BENIGN INTRAEPITHELIAL; HBID
127700	DYSLEXIA, SUSCEPTIBILITY TO, 1; DYX1
127750	DEMENTIA, LEWY BODY; DLB
127800	DYSPLASIA EPIPHYSEALIS HEMIMELICA
127820	DYSPLASIA EPIPHYSEALIS HEMIMELICA WITH CHONDROMAS AND OSTEOCHONDROMAS
128000	DYSTELEPHALANGY
128100	DYSTONIA 1, TORSION, AUTOSOMAL DOMINANT; DYT1
128101	DYSTONIA 4, TORSION, AUTOSOMAL DOMINANT; DYT4
128200	EPISODIC KINESIGENIC DYSKINESIA 1; EKD1
128230	DYSTONIA, DOPA-RESPONSIVE; DRD
128235	DYSTONIA 12; DYT12
128239	DYSTROGLYCAN 1; DAG1
128240	UTROPHIN; UTRN
128260	SMALL NUCLEAR RIBONUCLEOPROTEIN POLYPEPTIDE E; SNRPE
128290	EAR ANTITRAGUS, TAG AT BASE OF
128300	EAR EXOSTOSES
128400	EAR FLARE
128500	EAR FOLDING
128600	EAR MALFORMATION
128700	PREAURICULAR FISTULAE, CONGENITAL
128710	EAR PITS, POSTERIOR HELICAL
128800	EAR WITHOUT HELIX
128900	EARLOBE ATTACHMENT, ATTACHED VS UNATTACHED
128950	EARLOBE CREASE
128980	EARLOBES, THICKENED, WITH CONDUCTIVE DEAFNESS FROM INCUDOSTAPEDIAL ABNORMALITIES
128990	EARLY GROWTH RESPONSE 1; EGR1
128992	EARLY GROWTH RESPONSE 4; EGR4
129000	EARRING HOLES, NATURAL
129010	EARLY GROWTH RESPONSE 2; EGR2
129100	EARS, ABILITY TO MOVE
129150	ECHO VIRUS 11 SENSITIVITY; E11S
129190	ECTO-5-PRIME NUCLEOTIDASE; NT5E
129200	BASAN SYNDROME
129400	RAPP-HODGKIN SYNDROME; RHS
129490	ECTODERMAL DYSPLASIA 10A, HYPOHIDROTIC/HAIR/NAIL TYPE, AUTOSOMAL DOMINANT; ECTD10A
129500	CLOUSTON SYNDROME
129510	ECTODERMAL DYSPLASIA, TRICHOODONTOONYCHIAL TYPE
129540	ECTODERMAL DYSPLASIA SYNDROME WITH DISTINCTIVE FACIAL APPEARANCE AND PREAXIAL POLYDACTYLY OF FEET
129550	ECTODERMAL DYSPLASIA WITH ADRENAL CYST
129600	ECTOPIA LENTIS 1, ISOLATED, AUTOSOMAL DOMINANT; ECTOL1
129750	ECTOPIA PUPILLAE
129810	ECTRODACTYLY AND ECTODERMAL DYSPLASIA WITHOUT CLEFT LIP/PALATE
129830	ECTRODACTYLY-CLEFT PALATE SYNDROME
129840	EDEMA, FAMILIAL IDIOPATHIC, PREPUBERTAL
129850	EDINBURGH MALFORMATION SYNDROME
129900	ECTRODACTYLY, ECTODERMAL DYSPLASIA, AND CLEFT LIP/PALATE SYNDROME 1; EEC1
129905	EGASYN
130000	EHLERS-DANLOS SYNDROME, CLASSIC TYPE, 1; EDSCL1
130010	EHLERS-DANLOS SYNDROME, CLASSIC TYPE, 2; EDSCL2
130020	EHLERS-DANLOS SYNDROME, HYPERMOBILITY TYPE; EDSHMB
130050	EHLERS-DANLOS SYNDROME, VASCULAR TYPE; EDSVASC
130060	EHLERS-DANLOS SYNDROME, ARTHROCHALASIA TYPE, 1; EDSARTH1
130070	EHLERS-DANLOS SYNDROME, SPONDYLODYSPLASTIC TYPE, 1; EDSSPD1
130080	EHLERS-DANLOS SYNDROME, PERIODONTAL TYPE, 1; EDSPD1
130090	EHLERS-DANLOS SYNDROME, AUTOSOMAL DOMINANT, TYPE UNSPECIFIED
130100	ELASTOSIS PERFORANS SERPIGINOSA; EPS
130120	CHYMOTRYPSIN-LIKE ELASTASE FAMILY, MEMBER 1; CELA1
130130	ELASTASE, NEUTROPHIL-EXPRESSED; ELANE
130135	SERPIN PEPTIDASE INHIBITOR, CLADE B (OVALBUMIN), MEMBER 1; SERPINB1
130160	ELASTIN; ELN
130180	ELECTROENCEPHALOGRAM, LOW-VOLTAGE
130190	ELECTROENCEPHALOGRAPHIC PATTERN, BETA FREQUENCY, QUANTITATIVE TRAIT LOCUS; EEGBQTL
130200	ELECTROENCEPHALOGRAPHIC PECULIARITY: 14 AND 6 PER SEC. POSITIVE SPIKE PHENOMENON
130300	ELECTROENCEPHALOGRAPHIC PECULIARITY: FRONTO-PRECENTRAL BETA WAVE GROUPS
130400	ELECTROENCEPHALOGRAPHIC PECULIARITY: OCCIPITAL SLOW BETA WAVES
130410	ELECTRON TRANSFER FLAVOPROTEIN, BETA POLYPEPTIDE; ETFB
130500	ERYTHROCYTE MEMBRANE PROTEIN BAND 4.1; EPB41
130590	EUKARYOTIC TRANSLATION ELONGATION FACTOR 1, ALPHA-1; EEF1A1
130591	MOVED TO 600655
130592	EUKARYOTIC TRANSLATION ELONGATION FACTOR 1, DELTA; EEF1D
130593	EUKARYOTIC TRANSLATION ELONGATION FACTOR 1, GAMMA; EEF1G
130600	ELLIPTOCYTOSIS 2; EL2
130610	EUKARYOTIC TRANSLATION ELONGATION FACTOR 2; EEF2
130620	RIBOSOMAL PROTEIN S14; RPS14
130650	BECKWITH-WIEDEMANN SYNDROME; BWS
130660	ELASTIN MICROFIBRIL INTERFACER 1; EMILIN1
130700	EMPHYSEMA, HEREDITARY PULMONARY
130710	EMPHYSEMA, CONGENITAL LOBAR; CLE
130720	LATERAL MENINGOCELE SYNDROME; LMNS
130900	AMELOGENESIS IMPERFECTA, TYPE IIIA; AI3A
130950	ENCEPHALOPATHY, RECURRENT, OF CHILDHOOD
131100	MULTIPLE ENDOCRINE NEOPLASIA, TYPE I; MEN1
131150	ENDOGENOUS RETROVIRAL SEQUENCE 1; ERV1
131170	ENDOGENOUS RETROVIRAL SEQUENCE 3; ERV3
131180	ENDOGENOUS RETROVIRAL POL-LIKE SEQUENCE-2; ERPL2
131190	ENDOGENOUS RETROVIRAL POL-LIKE SEQUENCE-1; ERPL1
131195	ENDOGLIN; ENG
131200	ENDOMETRIOSIS, SUSCEPTIBILITY TO, 1
131210	SELECTIN E; SELE
131220	FIBROBLAST GROWTH FACTOR 1; FGF1
131222	THYMIDINE PHOSPHORYLASE; TYMP
131230	ANNEXIN A5; ANXA5
131235	KDEL ENDOPLASMIC RETICULUM PROTEIN RETENTION RECEPTOR 1; KDELR1
131240	ENDOTHELIN 1; EDN1
131241	ENDOTHELIN 2; EDN2
131242	ENDOTHELIN 3; EDN3
131243	ENDOTHELIN RECEPTOR, TYPE A; EDNRA
131244	ENDOTHELIN RECEPTOR, TYPE B; EDNRB
131290	ENGRAILED 1; EN1
131300	CAMURATI-ENGELMANN DISEASE; CAEND
131310	ENGRAILED 2; EN2
131320	GATA-BINDING PROTEIN 3; GATA3
131330	PROENKEPHALIN; PENK
131340	PRODYNORPHIN; PDYN
131360	ENOLASE 2; ENO2
131370	ENOLASE 3; ENO3
131375	ENOLASE 4; ENO4
131390	NIDOGEN 1; NID1
131398	RIBONUCLEASE, RNase A FAMILY, 3; RNASE3
131399	EOSINOPHIL PEROXIDASE; EPX
131400	EOSINOPHILIA, FAMILIAL
131410	RIBONUCLEASE, RNase A FAMILY, 2; RNASE2
131430	EOSINOPHILOPENIA
131440	MYELOPROLIFERATIVE DISORDER, CHRONIC, WITH EOSINOPHILIA
131445	MOVED TO 137800
131450	EPIBLEPHARON OF LOWER LID
131460	EPIBLEPHARON OF UPPER LID
131500	EPICANTHUS
131530	EPIDERMAL GROWTH FACTOR; EGF
131550	EPIDERMAL GROWTH FACTOR RECEPTOR; EGFR
131560	FLOTILLIN 2; FLOT2
131600	EPIDERMOID CYSTS
131705	TRANSIENT BULLOUS DERMOLYSIS OF THE NEWBORN; TBDN
131750	EPIDERMOLYSIS BULLOSA DYSTROPHICA, AUTOSOMAL DOMINANT; DDEB
131760	EPIDERMOLYSIS BULLOSA SIMPLEX 1A, GENERALIZED SEVERE; EBS1A
131800	EPIDERMOLYSIS BULLOSA SIMPLEX 1C, LOCALIZED; EBS1C
131850	EPIDERMOLYSIS BULLOSA DYSTROPHICA, PRETIBIAL
131880	EPIDERMOLYSIS BULLOSA WITH DEFICIENCY OF GALACTOSYLHYDROXYLYSYL GLUCOSYLTRANSFERASE
131900	EPIDERMOLYSIS BULLOSA SIMPLEX 1B, GENERALIZED INTERMEDIATE; EBS1B
131950	EPIDERMOLYSIS BULLOSA SIMPLEX 5A, OGNA TYPE; EBS5A
131960	EPIDERMOLYSIS BULLOSA SIMPLEX 2F, WITH MOTTLED PIGMENTATION; EBS2F
132000	EPIDERMOLYSIS BULLOSA WITH CONGENITAL LOCALIZED ABSENCE OF SKIN AND DEFORMITY OF NAILS
132090	EPILEPSY, BENIGN OCCIPITAL; BOE
132100	PHOTOPAROXYSMAL RESPONSE 1; PPR1
132300	EPILEPSY, READING
132350	SYNTAXIN 2; STX2
132400	EPIPHYSEAL DYSPLASIA, MULTIPLE, 1; EDM1
132450	EPIPHYSEAL DYSPLASIA, MULTIPLE, WITH MYOPIA AND CONDUCTIVE DEAFNESS; EDMMD
132500	EPISTAXIS, HEREDITARY
132600	PILOMATRIXOMA
132700	CYLINDROMATOSIS, FAMILIAL
132800	MULTIPLE SELF-HEALING SQUAMOUS EPITHELIOMA, SUSCEPTIBILITY TO; MSSE
132810	EPOXIDE HYDROLASE 1, MICROSOMAL; EPHX1
132811	EPOXIDE HYDROLASE 2, CYTOSOLIC; EPHX2
132850	EPSTEIN-BARR VIRUS INSERTION SITE 1; EBVS1
132860	REMOVED FROM DATABASE
132880	NUCLEAR RECEPTOR SUBFAMILY 2, GROUP F, MEMBER 6; NR2F6
132890	NUCLEAR RECEPTOR SUBFAMILY 2, GROUP F, MEMBER 1; NR2F1
132900	AORTIC ANEURYSM, FAMILIAL THORACIC 4; AAT4
132990	ERYTHEMA NODOSUM, FAMILIAL
133000	ERYTHEMA PALMARE HEREDITARIUM
133020	ERYTHERMALGIA, PRIMARY
133090	STOMATIN; STOM
133100	ERYTHROCYTOSIS, FAMILIAL, 1; ECYT1
133170	ERYTHROPOIETIN; EPO
133171	ERYTHROPOIETIN RECEPTOR; EPOR
133180	ERYTHROLEUKEMIA, FAMILIAL, SUSCEPTIBILITY TO; FERLK
133190	SPINOCEREBELLAR ATAXIA 34; SCA34
133200	ERYTHROKERATODERMIA VARIABILIS ET PROGRESSIVA 1; EKVP1
133220	ESTERASE A4; ESA4
133230	ESTERASE A-5; ESA5
133239	ESOPHAGEAL CANCER
133240	ESOPHAGEAL RING, LOWER
133250	MOVED TO 172460
133260	ESTERASE B; ESB
133270	ESTERASE C; ESC
133280	ESTERASE D; ESD
133290	ESTERASE B3; ESB3
133300	ESTERASE ES-2, REGULATOR FOR
133420	MOVED TO 113710
133430	ESTROGEN RECEPTOR 1; ESR1
133435	RUNT-RELATED TRANSCRIPTION FACTOR 1, TRANSLOCATED TO, 1; RUNX1T1
133440	EUKARYOTIC TRANSLATION INITIATION FACTOR 4E; EIF4E
133450	EWS RNA-BINDING PROTEIN 1; EWSR1
133500	EXCHONDROSIS OF PINNA, POSTERIOR
133510	ERCC EXCISION REPAIR 3, TFIIH CORE COMPLEX HELICASE SUBUNIT; ERCC3
133520	ERCC EXCISION REPAIR 4, ENDONUCLEASE CATALYTIC SUBUNIT; ERCC4
133530	ERCC EXCISION REPAIR 5, ENDONUCLEASE; ERCC5
133535	MOVED TO 613208
133540	COCKAYNE SYNDROME B; CSB
133550	SOLUTE CARRIER FAMILY 1 (NEURONAL/EPITHELIAL HIGH AFFINITY GLUTAMATE TRANSPORTER), MEMBER 1; SLC1A1
133600	EXOSTOSES OF HEEL
133690	EXOSTOSES WITH ANETODERMIA AND BRACHYDACTYLY, TYPE E
133700	EXOSTOSES, MULTIPLE, TYPE I; EXT1
133701	EXOSTOSES, MULTIPLE, TYPE II; EXT2
133705	EXTERNAL AUDITORY CANAL, BILATERAL ATRESIA OF, WITH CONGENITAL VERTICAL TALUS
133710	REMOVED FROM DATABASE
133730	REMOVED FROM DATABASE
133740	REMOVED FROM DATABASE
133750	EXTRASYSTOLES, MULTIFORM VENTRICULAR, WITH SHORT STATURE, HYPERPIGMENTATION AND MICROCEPHALY
133780	EXUDATIVE VITREORETINOPATHY 1; EVR1
133800	EYEBROW, WHORL IN
133900	HEMIFACIAL HYPERPLASIA
134000	FACIAL HYPERTRICHOSIS
134100	MOVED TO 601471
134200	FACIAL PALSY, FAMILIAL RECURRENT PERIPHERAL
134300	FACIAL SPASM
134350	COMPLEMENT FACTOR D; CFD
134370	COMPLEMENT FACTOR H; CFH
134371	COMPLEMENT FACTOR H-RELATED 1; CFHR1
134390	COAGULATION FACTOR III; F3
134400	FACTOR V EXCESS WITH SPONTANEOUS THROMBOSIS
134430	FACTOR VII AND FACTOR VIII, COMBINED DEFICIENCY OF
134450	MOVED TO 613878
134500	FACTOR VIII DEFICIENCY
134510	FACTOR VIII AND FACTOR IX, COMBINED DEFICIENCY OF; F8F9D
134520	FACTORS VIII, IX AND XI, COMBINED DEFICIENCY OF
134530	MOVED TO 227600
134540	FACTOR IX AND FACTOR XI, COMBINED DEFICIENCY OF
134570	FACTOR XIII, A1 SUBUNIT; F13A1
134580	FACTOR XIII, B SUBUNIT; F13B
134600	FANCONI RENOTUBULAR SYNDROME 1; FRTS1
134610	FAMILIAL MEDITERRANEAN FEVER, AUTOSOMAL DOMINANT
134629	FARNESYL DIPHOSPHATE SYNTHASE; FDPS
134631	MOVED TO 134629
134632	MOVED TO 134629
134633	MOVED TO 134629
134634	MOVED TO 134629
134635	FARNESYLTRANSFERASE, CAAX BOX, ALPHA; FNTA
134636	FARNESYLTRANSFERASE, CAAX BOX, BETA; FNTB
134637	FAS CELL SURFACE DEATH RECEPTOR; FAS
134638	FAS LIGAND; FASLG
134640	FATTY ACID-BINDING PROTEIN 2; FABP2
134650	FATTY ACID-BINDING PROTEIN 1; FABP1
134651	FATTY ACID-BINDING PROTEIN 3; FABP3
134660	GLUTATHIONE S-TRANSFERASE, PI; GSTP1
134690	FAU UBIQUITIN-LIKE AND RIBOSOMAL PROTEIN S30 FUSION; FAU
134700	MOVED TO 300908
134720	FECUNDITY GENE, BOOROOLA, OF SHEEP, HOMOLOG OF
134750	FELTY SYNDROME
134770	FERRITIN HEAVY CHAIN 1; FTH1
134780	FEMORAL-FACIAL SYNDROME; FFS
134790	FERRITIN LIGHT CHAIN; FTL
134795	FIBRILLARIN; FBL
134797	FIBRILLIN 1; FBN1
134820	FIBRINOGEN, A ALPHA POLYPEPTIDE; FGA
134830	FIBRINOGEN, B BETA POLYPEPTIDE; FGB
134850	FIBRINOGEN, G GAMMA POLYPEPTIDE; FGG
134900	FIBRINOLYTIC DEFECT
134920	FIBROBLAST GROWTH FACTOR 2; FGF2
134921	FIBROBLAST GROWTH FACTOR 6; FGF6
134934	FIBROBLAST GROWTH FACTOR RECEPTOR 3; FGFR3
134935	FIBROBLAST GROWTH FACTOR RECEPTOR 4; FGFR4
135000	MOVED TO 178500
135100	FIBRODYSPLASIA OSSIFICANS PROGRESSIVA; FOP
135150	BIRT-HOGG-DUBE SYNDROME 1; BHD1
135290	DESMOID DISEASE, HEREDITARY; DESMD
135300	FIBROMATOSIS, GINGIVAL, 1; GINGF1
135400	HYPERTRICHOSIS, CONGENITAL GENERALIZED, WITH OR WITHOUT GINGIVAL HYPERPLASIA; HTC3
135500	ZIMMERMANN-LABAND SYNDROME 1; ZLS1
135550	FIBROMATOSIS, GINGIVAL, WITH PROGRESSIVE DEAFNESS
135580	FIBROMUSCULAR DYSPLASIA, ARTERIAL; FMDA
135600	FIBRONECTIN 1; FN1
135610	FIBRONECTIN-LIKE 2; FNL2
135620	INTEGRIN, ALPHA-5; ITGA5
135630	INTEGRIN, BETA-1; ITGB1
135631	MOVED TO 135630
135700	FIBROSIS OF EXTRAOCULAR MUSCLES, CONGENITAL, 1; CFEOM1
135750	LAURIN-SANDROW SYNDROME; LSS
135800	FIBULA, RECURRENT DISLOCATION OF HEAD OF
135820	FIBULIN 1; FBLN1
135821	FIBULIN 2; FBLN2
135900	COFFIN-SIRIS SYNDROME 1; CSS1
135940	FILAGGRIN; FLG
135950	FINGER LOCKING, RECURRENT, WITH INTRAUTERINE GROWTH RETARDATION AND PROPORTIONATE SHORT STATURE
136000	ADERMATOGLYPHIA; ADERM
136100	FINGERS, RELATIVE LENGTH OF
136120	FISH-EYE DISEASE; FED
136130	FLAVIN-CONTAINING DIMETHYLANILINE MONOOXYGENASE 1; FMO1
136131	FLAVIN-CONTAINING DIMETHYLANILINE MONOOXYGENASE 4; FMO4
136132	FLAVIN-CONTAINING DIMETHYLANILINE MONOOXYGENASE 3; FMO3
136140	FLOATING-HARBOR SYNDROME; FLHS
136150	FLOOD FACTOR DEFICIENCY
136200	FLUSHING OF EARS AND SOMNOLENCE
136300	FLYNN-AIRD SYNDROME
136350	FIBROBLAST GROWTH FACTOR RECEPTOR 1; FGFR1
136351	FMS-RELATED TYROSINE KINASE 3; FLT3
136352	FMS-LIKE TYROSINE KINASE 4; FLT4
136400	FOCAL EPITHELIAL HYPERPLASIA OF THE ORAL MUCOSA
136425	FOLATE RECEPTOR, BETA; FOLR2
136430	FOLATE RECEPTOR, ALPHA; FOLR1
136435	FOLLICLE-STIMULATING HORMONE RECEPTOR; FSHR
136440	3-KETODIHYDROSPHINGOSINE REDUCTASE; KDSR
136470	FOLLISTATIN; FST
136480	FOURTH CRANIAL NERVE PALSY, FAMILIAL CONGENITAL
136490	MOVED TO 103710
136500	FOCAL FACIAL DERMAL DYSPLASIA 1, BRAUER TYPE; FFDD1
136510	FOLYLPOLYGLUTAMATE SYNTHETASE; FPGS
136515	FOS-LIKE 1, AP-1 TRANSCRIPTION FACTOR SUBUNIT; FOSL1
136520	FOVEAL HYPOPLASIA 1; FVH1
136530	FOLLICLE-STIMULATING HORMONE, BETA POLYPEPTIDE; FSHB
136533	FORKHEAD BOX O1A; FOXO1A
136535	FORMIN 1; FMN1
136537	FORMYL PEPTIDE RECEPTOR 1; FPR1
136538	FORMYL PEPTIDE RECEPTOR 2; FPR2
136539	FORMYL PEPTIDE RECEPTOR 3; FPR3
136540	FRAGILE SITE 10q23
136550	MACULAR DYSTROPHY, RETINAL, 1, NORTH CAROLINA TYPE; MCDR1
136560	MOVED TO 616109
136570	CHROMOSOME 16p12.1 DELETION SYNDROME, 520-KB
136580	FRAGILE SITE, DISTAMYCIN A TYPE, RARE, FRA(16)(q22.1); FRA16B
136590	FRAGILE SITE 20p11
136600	FRIEDREICH ATAXIA, SO-CALLED, WITH OPTIC ATROPHY AND SENSORINEURAL DEAFNESS
136610	MOVED TO 601464
136620	FRAGILE SITE 10q25; FRA10B
136630	INTELLECTUAL DEVELOPMENTAL DISORDER, FRA12A TYPE
136640	FRAGILE SITE 9q32
136650	MOVED TO 601153
136660	FRAGILE SITE 17p12
136670	REMOVED FROM DATABASE
136680	FRASIER SYNDROME
136750	MOVED TO 164770
136760	FRONTONASAL DYSPLASIA 1; FND1
136770	MOVED TO 164770
136800	CORNEAL DYSTROPHY, FUCHS ENDOTHELIAL, 1; FECD1
136820	FUCOSIDASE, ALPHA-L, 2; FUCA2
136830	FUCOSIDASE REGULATOR
136835	FUCOSYLTRANSFERASE 5; FUT5
136836	FUCOSYLTRANSFERASE 6; FUT6
136840	FULL-LENGTH RETROVIRAL SEQUENCE 1; FRV1
136850	FUMARATE HYDRATASE; FH
136870	FULL-LENGTH RETROVIRAL SEQUENCE 2; FRV2
136880	FUNDUS ALBIPUNCTATUS
136890	FULL-LENGTH RETROVIRAL SEQUENCE 3; FRV3
136900	SORSBY FUNDUS DYSTROPHY; SFD
136950	FURIN, PAIRED BASIC AMINO ACID CLEAVING ENZYME; FURIN
137000	FUTCHER LINE
137010	F9 EMBRYONIC ANTIGEN; FEA
137020	GDP-L-FUCOSE SYNTHASE; GFUS
137025	FYN PROTOONCOGENE, SRC FAMILY TYROSINE KINASE; FYN
137026	G PROTEIN-COUPLED RECEPTOR KINASE 4; GRK4
137028	GALACTOKINASE 2; GALK2
137030	GALACTOSE MUTAROTASE; GALM
137033	MOVED TO 153619
137035	GALANIN; GAL
137040	GALLBLADDER, AGENESIS OF
137050	GAMMA-A-GLOBULIN, DEFECT IN ASSEMBLY OF
137060	BETA-1,4-GALACTOSYLTRANSFERASE 1; B4GALT1
137061	MOVED TO 137060
137070	FUS RNA-BINDING PROTEIN; FUS
137100	IMMUNOGLOBULIN A DEFICIENCY 1; IGAD1
137130	GASTRIC SNEEZING
137140	GAMMA-AMINOBUTYRIC ACID RECEPTOR, ALPHA-2; GABRA2
137141	GAMMA-AMINOBUTYRIC ACID RECEPTOR, ALPHA-4; GABRA4
137142	GAMMA-AMINOBUTYRIC ACID RECEPTOR, ALPHA-5; GABRA5
137143	GAMMA-AMINOBUTYRIC ACID RECEPTOR, ALPHA-6; GABRA6
137150	4-AMINOBUTYRATE AMINOTRANSFERASE; ABAT
137160	GAMMA-AMINOBUTYRIC ACID RECEPTOR, ALPHA-1; GABRA1
137161	GAMMA-AMINOBUTYRIC ACID RECEPTOR, RHO-1; GABRR1
137162	GAMMA-AMINOBUTYRIC ACID RECEPTOR, RHO-2; GABRR2
137163	GAMMA-AMINOBUTYRIC ACID RECEPTOR, DELTA; GABRD
137164	GAMMA-AMINOBUTYRIC ACID RECEPTOR, GAMMA-2; GABRG2
137165	SOLUTE CARRIER FAMILY 6 (NEUROTRANSMITTER TRANSPORTER, GABA), MEMBER 1; SLC6A1
137166	GAMMA-AMINOBUTYRIC ACID RECEPTOR, GAMMA-1; GABRG1
137167	GAMMA-GLUTAMYL CARBOXYLASE; GGCX
137168	GAMMA-GLUTAMYLTRANSFERASE 5; GGT5
137170	GAMMA-GLUTAMYL CYCLOTRANSFERASE; GGCT
137181	GAMMA-GLUTAMYLTRANSFERASE 2; GGT2
137190	GAMMA-AMINOBUTYRIC ACID RECEPTOR, BETA-1; GABRB1
137192	GAMMA-AMINOBUTYRIC ACID RECEPTOR, BETA-3; GABRB3
137200	NEUROMYOTONIA AND AXONAL NEUROPATHY, AUTOSOMAL RECESSIVE; NMAN
137207	LEUCINE-RICH REPEAT-CONTAINING PROTEIN 32; LRRC32
137210	GASTRIC VOLVULUS, INTRATHORACIC
137215	DIFFUSE GASTRIC AND LOBULAR BREAST CANCER SYNDROME; DGLBC
137216	ATPase, H+,K+ EXCHANGING, ALPHA SUBUNIT; ATP4A
137217	ATPase, H+,K+ EXCHANGING, BETA POLYPEPTIDE; ATP4B
137220	GASTRIC JUICE PEPTIDES
137240	GASTRIC INHIBITORY POLYPEPTIDE; GIP
137241	GASTRIC INHIBITORY POLYPEPTIDE RECEPTOR; GIPR
137245	LYMPHOMA, MUCOSA-ASSOCIATED LYMPHOID TYPE
137250	GASTRIN; GAST
137260	GASTRIN-RELEASING PEPTIDE; GRP
137270	GASTROCUTANEOUS SYNDROME
137280	GASTRITIS, FAMILIAL GIANT HYPERTROPHIC
137290	TUMOR-ASSOCIATED CALCIUM SIGNAL TRANSDUCER 2; TACSTD2
137295	GATA-BINDING PROTEIN 2; GATA2
137350	GELSOLIN; GSN
137357	MOVED TO 194072
137360	GENOCHONDROMATOSIS
137370	GENU VALGUM, ST. HELENA FAMILIAL
137400	GEOGRAPHIC AND FISSURED TONGUE
137440	GERSTMANN-STRAUSSLER DISEASE; GSD
137500	GIANT NEUTROPHIL LEUKOCYTES
137550	MELANOCYTIC NEVUS SYNDROME, CONGENITAL; CMNS
137560	MOVED TO 155100
137570	SOLUTE CARRIER FAMILY 20 (PHOSPHATE TRANSPORTER), MEMBER 1; SLC20A1
137575	GIGANTIFORM CEMENTOMA, FAMILIAL; FGC
137580	GILLES DE LA TOURETTE SYNDROME; GTS
137600	ANTERIOR SEGMENT DYSGENESIS 4; ASGD4
137700	GLAUCOMA WITH ELEVATED EPISCLERAL VENOUS PRESSURE
137750	GLAUCOMA 1, OPEN ANGLE, A; GLC1A
137760	GLAUCOMA, PRIMARY OPEN ANGLE; POAG
137763	GLAUCOMA AND SLEEP APNEA
137765	MOVED TO 608328
137780	GLIAL FIBRILLARY ACIDIC PROTEIN; GFAP
137800	GLIOMA SUSCEPTIBILITY 1; GLM1
137900	GLOBULIN ANOMALY INVOLVING BETA (2A)-GLOBULIN
137920	RENAL CYSTS AND DIABETES SYNDROME; RCAD
137940	HYPOTRICHOSIS-LYMPHEDEMA-TELANGIECTASIA-RENAL DEFECT SYNDROME; HLTRS
137950	GLOMERULOPATHY WITH FIBRONECTIN DEPOSITS 1; GFND1
137960	MITOCHONDRIAL INNER MEMBRANE PROTEIN MPV17; MPV17
138000	GLOMUVENOUS MALFORMATIONS; GVM
138030	GLUCAGON; GCG
138032	GLUCAGON-LIKE PEPTIDE 1 RECEPTOR; GLP1R
138033	GLUCAGON RECEPTOR; GCGR
138035	MOVED TO 230800
138040	NUCLEAR RECEPTOR SUBFAMILY 3, GROUP C, MEMBER 1; NR3C1
138060	GLUCOCORTICOID RECEPTOR-LIKE 1; GRLL1
138070	GLUCOGLYCINURIA
138079	GLUCOKINASE; GCK
138090	HEXOSE-6-PHOSPHATE DEHYDROGENASE; H6PD
138100	MOVED TO 138090
138110	GLUCOSE-6-PHOSPHATE DEHYDROGENASE-LIKE; G6PDL
138120	HEAT-SHOCK 70-KD PROTEIN 5; HSPA5
138130	GLUTAMATE DEHYDROGENASE 1; GLUD1
138140	SOLUTE CARRIER FAMILY 2 (FACILITATED GLUCOSE TRANSPORTER), MEMBER 1; SLC2A1
138150	GLUTAMATE OXALOACETATE TRANSAMINASE, MITOCHONDRIAL; GOT2
138160	SOLUTE CARRIER FAMILY 2 (FACILITATED GLUCOSE TRANSPORTER), MEMBER 2; SLC2A2
138170	SOLUTE CARRIER FAMILY 2 (FACILITATED GLUCOSE TRANSPORTER), MEMBER 3; SLC2A3
138180	GLUTAMATE OXALOACETATE TRANSAMINASE, SOLUBLE; GOT1
138190	SOLUTE CARRIER FAMILY 2 (FACILITATED GLUCOSE TRANSPORTER), MEMBER 4; SLC2A4
138200	GLUTAMATE PYRUVATE TRANSAMINASE; GPT
138210	GLUTAMATE PYRUVATE TRANSAMINASE 2; GPT2
138220	MOVED TO 138200
138230	SOLUTE CARRIER FAMILY 2 (FACILITATED GLUCOSE/FRUCTOSE TRANSPORTER), MEMBER 5; SLC2A5
138240	MOVED TO 138170
138243	GLUTAMATE RECEPTOR, IONOTROPIC, KAINATE 3; GRIK3
138244	GLUTAMATE RECEPTOR, IONOTROPIC, KAINATE 2; GRIK2
138245	GLUTAMATE RECEPTOR, IONOTROPIC, KAINATE 1; GRIK1
138246	GLUTAMATE RECEPTOR, IONOTROPIC, AMPA 4; GRIA4
138247	GLUTAMATE RECEPTOR, IONOTROPIC, AMPA 2; GRIA2
138248	GLUTAMATE RECEPTOR, IONOTROPIC, AMPA 1; GRIA1
138249	GLUTAMATE RECEPTOR, IONOTROPIC, N-METHYL-D-ASPARTATE, SUBUNIT 1; GRIN1
138250	ALDEHYDE DEHYDROGENASE 18 FAMILY, MEMBER A1; ALDH18A1
138251	GLUTAMATE RECEPTOR, IONOTROPIC, N-METHYL-D-ASPARTATE, ASSOCIATED PROTEIN; GRINA
138252	GLUTAMATE RECEPTOR, IONOTROPIC, N-METHYL-D-ASPARTATE, SUBUNIT 2B; GRIN2B
138253	GLUTAMATE RECEPTOR, IONOTROPIC, N-METHYL-D-ASPARTATE, SUBUNIT 2A; GRIN2A
138254	GLUTAMATE RECEPTOR, IONOTROPIC, N-METHYL-D-ASPARTATE, SUBUNIT 2C; GRIN2C
138270	MOVED TO 138385
138275	GLUTAMATE DECARBOXYLASE 2; GAD2
138276	MOVED TO 605363
138277	GLUTAMIC ACID DECARBOXYLASE, BRAIN, MEMBRANE FORM
138280	GLUTAMINASE; GLS
138290	GLUTAMATE-AMMONIA LIGASE; GLUL
138292	GLUTAMINE:FRUCTOSE-6-PHOSPHATE AMIDOTRANSFERASE 1; GFPT1
138295	GLUTAMYL-PROLYL-tRNA SYNTHETASE 1; EPRS1
138297	GLUTAMYL AMINOPEPTIDASE; ENPEP
138300	GLUTATHIONE REDUCTASE; GSR
138319	GLUTATHIONE PEROXIDASE 2; GPX2
138320	GLUTATHIONE PEROXIDASE 1; GPX1
138321	GLUTATHIONE PEROXIDASE 3; GPX3
138322	GLUTATHIONE PEROXIDASE 4; GPX4
138330	GLUTATHIONE S-TRANSFERASE, MICROSOMAL, 1; MGST1
138333	GLUTATHIONE S-TRANSFERASE, MU-4; GSTM4
138335	MOVED TO 138370
138340	GLUTATHIONE TRANSFERASE ACTIVITY TOWARD TRANS-STILBENE OXIDE
138350	GLUTATHIONE S-TRANSFERASE, MU-1; GSTM1
138359	GLUTATHIONE S-TRANSFERASE, ALPHA-1; GSTA1
138360	GLUTATHIONE S-TRANSFERASE, ALPHA-2; GSTA2
138370	MOVED TO 134660
138380	GLUTATHIONE S-TRANSFERASE, MU-2; GSTM2
138385	GLUTATHIONE S-TRANSFERASE, MU-5; GSTM5
138390	GLUTATHIONE S-TRANSFERASE, MU-3; GSTM3
138391	REMOVED FROM DATABASE
138400	GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE; GAPDH
138420	GLYCEROL-3-PHOSPHATE DEHYDROGENASE 1; GPD1
138430	GLYCEROL-3-PHOSPHATE DEHYDROGENASE 2; GPD2
138440	PHOSPHORIBOSYLGLYCINAMIDE FORMYLTRANSFERASE/PHOSPHORIBOSYLGLYCINAMIDE SYNTHETASE/PHOSPHORIBOSYLAMINOIMIDAZOLE SYNTHETASE; GART
138450	SERINE HYDROXYMETHYLTRANSFERASE, MITOCHONDRIAL; SHMT2
138470	COMPLEMENT FACTOR B; CFB
138480	SOLUTE CARRIER FAMILY 25 (MITOCHONDRIAL CARRIER, FOLATE), MEMBER 32; SLC25A32
138491	GLYCINE RECEPTOR, ALPHA-1 SUBUNIT; GLRA1
138492	GLYCINE RECEPTOR, BETA SUBUNIT; GLRB
138500	HYPERGLYCINURIA
138550	GLYCOGEN PHOSPHORYLASE, BRAIN TYPE; PYGB
138570	GLYCOGEN SYNTHASE 1; GYS1
138571	GLYCOGEN SYNTHASE 2; GYS2
138590	GLYCOPHORIN E; GYPE
138600	OROSOMUCOID 1; ORM1
138610	OROSOMUCOID 2; ORM2
138670	ALPHA-1-B-GLYCOPROTEIN; A1BG
138680	ALPHA-2-HS-GLYCOPROTEIN; AHSG
138700	APOLIPOPROTEIN H; APOH
138710	GLYCOPROTEIN, RENAL
138720	GLYCOPROTEIN Ib, PLATELET, BETA POLYPEPTIDE; GP1BB
138750	GLYOXALASE I; GLO1
138760	HYDROXYACYL GLUTATHIONE HYDROLASE; HAGH
138770	GMS SYNDROME
138790	GOITER, MULTINODULAR, CYSTIC RENAL DISEASE, AND DIGITAL ANOMALIES
138800	GOITER, MULTINODULAR 1, WITH OR WITHOUT SERTOLI-LEYDIG CELL TUMORS; MNG1
138850	GONADOTROPIN-RELEASING HORMONE RECEPTOR; GNRHR
138890	GOOSECOID HOMEOBOX; GSC
138900	URIC ACID CONCENTRATION, SERUM, QUANTITATIVE TRAIT LOCUS 1; UAQTL1
138920	GRANDDAD SYNDROME
138930	GRANT SYNDROME
138945	GRANULIN PRECURSOR; GRN
138960	COLONY-STIMULATING FACTOR 2; CSF2
138965	CHEMOKINE, CXC MOTIF, LIGAND 6; CXCL6
138970	COLONY-STIMULATING FACTOR 3; CSF3
138971	COLONY-STIMULATING FACTOR 3 RECEPTOR, GRANULOCYTE; CSF3R
138972	CCAAT/ENHANCER-BINDING PROTEIN, GAMMA; CEBPG
138981	GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR RECEPTOR, BETA; CSF2RB
138990	MOVED TO 306400
139000	GRANULOSIS RUBRA NASI
139080	SOLUTE CARRIER FAMILY 25 (MITOCHONDRIAL CARRIER, GRAVES DISEASE AUTOANTIGEN), MEMBER 16; SLC25A16
139090	GRAY PLATELET SYNDROME; GPS
139100	GRAYING OF HAIR, PRECOCIOUS
139110	CHEMOKINE, CXC MOTIF, LIGAND 2; CXCL2
139111	CHEMOKINE, CXC MOTIF, LIGAND 3; CXCL3
139130	GUANINE NUCLEOTIDE-BINDING PROTEIN, BETA-3; GNB3
139139	NUCLEAR RECEPTOR SUBFAMILY 4, GROUP A, MEMBER 1; NR4A1
139145	MOVED TO 139139
139150	RAS p21 PROTEIN ACTIVATOR 1; RASA1
139160	GUANINE NUCLEOTIDE-BINDING PROTEIN, ALPHA Z POLYPEPTIDE; GNAZ
139180	GUANINE NUCLEOTIDE-BINDING PROTEIN, ALPHA-INHIBITING, POLYPEPTIDE 2 PSEUDOGENE 1; GNAI2P1
139185	GROWTH ARREST-SPECIFIC 1; GAS1
139190	GROWTH HORMONE-RELEASING HORMONE; GHRH
139191	GROWTH HORMONE-RELEASING HORMONE RECEPTOR; GHRHR
139200	GROUP-SPECIFIC COMPONENT; GC
139210	MYHRE SYNDROME; MYHRS
139220	REMOVED FROM DATABASE
139230	REMOVED FROM DATABASE
139240	GROWTH HORMONE 2; GH2
139250	GROWTH HORMONE 1; GH1
139255	METALLOTHIONEIN 3; MT3
139259	G1- TO S-PHASE TRANSITION 1; GSPT1
139260	GUANINE DEAMINASE; GDA
139265	GUANOSINE MONOPHOSPHATE REDUCTASE; GMPR
139270	GUANYLATE KINASE 1; GUK1
139280	GUANYLATE KINASE 2; GUK2
139290	GUANYLATE KINASE 3; GUK3
139300	AROMATASE EXCESS SYNDROME; AEXS
139310	GUANINE NUCLEOTIDE-BINDING PROTEIN, ALPHA-INHIBITING ACTIVITY POLYPEPTIDE 1; GNAI1
139311	GUANINE NUCLEOTIDE-BINDING PROTEIN, ALPHA-ACTIVATING ACTIVITY POLYPEPTIDE O; GNAO1
139312	GUANINE NUCLEOTIDE-BINDING PROTEIN, ALPHA-ACTIVATING ACTIVITY POLYPEPTIDE, OLFACTORY TYPE; GNAL
139313	GUANINE NUCLEOTIDE-BINDING PROTEIN, ALPHA-11; GNA11
139314	GUANINE NUCLEOTIDE-BINDING PROTEIN, ALPHA-15; GNA15
139320	GNAS COMPLEX LOCUS; GNAS
139330	GUANINE NUCLEOTIDE-BINDING PROTEIN, ALPHA-TRANSDUCING ACTIVITY POLYPEPTIDE 1; GNAT1
139340	GUANINE NUCLEOTIDE-BINDING PROTEIN, ALPHA-TRANSDUCING ACTIVITY POLYPEPTIDE 2; GNAT2
139350	KERATIN 1, TYPE II; KRT1
139360	GUANINE NUCLEOTIDE-BINDING PROTEIN, ALPHA-INHIBITING ACTIVITY POLYPEPTIDE 2; GNAI2
139370	GUANINE NUCLEOTIDE-BINDING PROTEIN, ALPHA-INHIBITING ACTIVITY POLYPEPTIDE 3; GNAI3
139380	GUANINE NUCLEOTIDE-BINDING PROTEIN, BETA-1; GNB1
139390	GUANINE NUCLEOTIDE-BINDING PROTEIN, BETA-2; GNB2
139391	GUANINE NUCLEOTIDE-BINDING PROTEIN, GAMMA-TRANSDUCING ACTIVITY POLYPEPTIDE 2; GNGT2
139392	GUANYLATE CYCLASE ACTIVATOR 2A; GUCA2A
139393	GUILLAIN-BARRE SYNDROME, FAMILIAL; GBS
139395	GUANINE NUCLEOTIDE-BINDING PROTEIN, ALPHA-TRANSDUCING ACTIVITY POLYPEPTIDE 3; GNAT3
139396	GUANYLATE CYCLASE 1, SOLUBLE, ALPHA-3; GUCY1A3
139397	GUANYLATE CYCLASE 1, SOLUBLE, BETA-3; GUCY1B3
139400	HAIR WHORL
139450	HAIR MORPHOLOGY 2; HRM2
139500	HAIRY EARS
139600	HAIRY ELBOWS
139605	HES FAMILY bHLH TRANSCRIPTION FACTOR 1; HES1
139630	HAIRY NOSE TIP
139650	HAIRY PALMS AND SOLES
139750	HAND AND FOOT DEFORMITY WITH FLAT FACIES
139800	HAND CLASPING PATTERN
139900	HAND SKILL, RELATIVE; HSR
140000	HAND-FOOT-GENITAL SYNDROME; HFG
140050	GRANZYME A; GZMA
140090	MOVED TO 189903
140100	HAPTOGLOBIN; HP
140210	HAPTOGLOBIN-RELATED PROTEIN; HPR
140300	HASHIMOTO THYROIDITIS
140340	MOVED TO 125370
140350	HAWKINSINURIA; HWKS
140400	PROGRESSIVE FAMILIAL HEART BLOCK, TYPE II; PFHB2
140450	HEART-HAND SYNDROME, SPANISH TYPE
140500	HEART, MALFORMATION OF
140550	HEAT-SHOCK 70-KD PROTEIN 1A; HSPA1A
140555	HEAT-SHOCK 70-KD PROTEIN 6; HSPA6
140556	HEAT-SHOCK PROTEIN FAMILY A (HSP70), MEMBER 7, PSEUDOGENE; HSPA7
140559	HEAT-SHOCK 70-KD PROTEIN-LIKE 1; HSPA1L
140560	HEAT-SHOCK 70-KD PROTEIN 2; HSPA2
140570	MOVED TO 140550
140571	HEAT-SHOCK PROTEIN, 90-KD, ALPHA, CLASS A, MEMBER 1; HSP90AA1
140572	HEAT-SHOCK PROTEIN, 90-KD, ALPHA, CLASS B, MEMBER 1; HSP90AB1
140573	MOVED TO 140571
140574	MOVED TO 140571
140575	HEAT-SHOCK PROTEIN, 90-KD, ALPHA, CLASS A, MEMBER 2, PSEUDOGENE; HSP90AA2P
140576	MOVED TO 140571
140580	HEAT-SHOCK TRANSCRIPTION FACTOR 1; HSF1
140581	HEAT-SHOCK TRANSCRIPTION FACTOR 2; HSF2
140600	OSTEOARTHRITIS SUSCEPTIBILITY 2; OS2
140700	HEINZ BODY ANEMIAS
140750	SUPPRESSOR OF TUMORIGENICITY 5; ST5
140850	HEMANGIOMAS, CAVERNOUS, OF FACE AND SUPRAUMBILICAL MIDLINE RAPHE
140900	HEMANGIOMAS OF SMALL INTESTINE
141000	HEMANGIOMA-THROMBOCYTOPENIA SYNDROME
141180	NCK-ASSOCIATED PROTEIN 1-LIKE; NCKAP1L
141200	HEMATURIA, BENIGN FAMILIAL, 1; BFH1
141250	HEME OXYGENASE 1; HMOX1
141251	HEME OXYGENASE 2; HMOX2
141300	HEMIFACIAL ATROPHY, PROGRESSIVE; HFA
141350	HEMIFACIAL HYPERPLASIA WITH STRABISMUS
141400	HEMIFACIAL MICROSOMIA WITH RADIAL DEFECTS
141405	HEMIFACIAL SPASM, FAMILIAL
141500	MIGRAINE, FAMILIAL HEMIPLEGIC, 1; FHM1
141700	HEMOLYTIC POIKILOCYTIC ANEMIA DUE TO REDUCED ANKYRIN BINDING SITES
141749	FETAL HEMOGLOBIN QUANTITATIVE TRAIT LOCUS 1; HBFQTL1
141750	ALPHA-THALASSEMIA/IMPAIRED INTELLECTUAL DEVELOPMENT SYNDROME, DELETION TYPE
141800	HEMOGLOBIN--ALPHA LOCUS 1; HBA1
141850	HEMOGLOBIN--ALPHA LOCUS 2; HBA2
141860	HEMOGLOBIN--ALPHA LOCUS 3
141900	HEMOGLOBIN--BETA LOCUS; HBB
141940	MOVED TO 141900
142000	HEMOGLOBIN--DELTA LOCUS; HBD
142100	HEMOGLOBIN--EPSILON LOCUS; HBE1
142200	HEMOGLOBIN, GAMMA A; HBG1
142210	HISTONE GENE CLUSTER 1, H1 HISTONE FAMILY, MEMBER D; HIST1H1D
142220	HISTONE GENE CLUSTER 1, H1 HISTONE FAMILY, MEMBER E; HIST1H1E
142230	CD34 ANTIGEN; CD34
142240	HEMOGLOBIN--THETA-1 LOCUS; HBQ1
142250	HEMOGLOBIN, GAMMA G; HBG2
142270	MOVED TO 142200
142290	HEMOPEXIN; HPX
142300	MOVED TO 142310
142309	HEMOGLOBIN--VARIANTS FOR WHICH THE CHAIN CARRYING THE MUTATION IS UNKNOWN OR UNCERTAIN
142310	HEMOGLOBIN--ZETA LOCUS; HBZ
142330	HEPATIC ADENOMAS, FAMILIAL
142333	MOVED TO 114550
142335	FETAL HEMOGLOBIN QUANTITATIVE TRAIT LOCUS 5; HBFQTL5
142340	DIAPHRAGMATIC HERNIA, CONGENITAL
142350	HERNIA, DOUBLE INGUINAL
142360	HEPARIN COFACTOR II; HCF2
142370	HCK PROTOONCOGENE, SRC FAMILY TYROSINE KINASE; HCK
142380	MOVED TO 114550
142385	HEPATIC LEUKEMIA FACTOR; HLF
142390	HEPATIC PROTEIN; HEP10
142395	HEPATITIS B VACCINE, RESPONSE TO
142400	HERNIA, HIATUS
142408	MACROPHAGE STIMULATING 1; MST1
142409	HEPATOCYTE GROWTH FACTOR; HGF
142410	HNF1 HOMEOBOX A; HNF1A
142420	REMOVED FROM DATABASE
142440	HEPSIN; HPN
142445	NEUREGULIN 1; NRG1
142450	MOVED TO 600644
142460	SYNDECAN 2; SDC2
142461	HEPARAN SULFATE PROTEOGLYCAN OF BASEMENT MEMBRANE; HSPG2
142470	FETAL HEMOGLOBIN QUANTITATIVE TRAIT LOCUS 2; HBFQTL2
142500	HETEROCHROMIA IRIDIS
142510	MOVED TO 300049
142550	MOVED TO 142600
142560	DExD-BOX HELICASE 39B; DDX39B
142570	HEXOKINASE 3; HK3
142580	PROLINE-RICH COILED-COIL PROTEIN 2A; PRRC2A
142590	BAG COCHAPERONE 6; BAG6
142600	HEXOKINASE 1; HK1
142610	G-PATCH DOMAIN- AND ANKYRIN REPEATS-CONTAINING PROTEIN 1; GPANK1
142620	ABHYDROLASE DOMAIN-CONTAINING PROTEIN 16A, PHOSPHOLIPASE; ABHD16A
142622	HIPPOCALCIN; HPCA
142623	HIRSCHSPRUNG DISEASE, SUSCEPTIBILITY TO, 1; HSCR1
142625	HIRSUTISM, SKELETAL DYSPLASIA, AND MENTAL RETARDATION
142630	HISTIOCYTOSIS, PROGRESSIVE MUCINOUS
142640	HISTIDINE-RICH GLYCOPROTEIN; HRG
142660	HEXOSAMINIDASE C; HEXC
142669	BEUKES HIP DYSPLASIA; HDB
142680	PERIODIC FEVER, FAMILIAL, AUTOSOMAL DOMINANT; FPF
142690	ACNE INVERSA, FAMILIAL, 1; ACNINV1
142695	HIGH DENSITY LIPOPROTEIN-BINDING PROTEIN; HDLBP
142700	DEVELOPMENTAL DYSPLASIA OF THE HIP 1; DDH1
142701	HISTATIN 1; HTN1
142702	HISTATIN 3; HTN3
142703	HISTAMINE RECEPTOR H2; HRH2
142704	HISTIDINE DECARBOXYLASE; HDC
142705	HISTIDINE-RICH CALCIUM-BINDING PROTEIN; HRC
142708	H1 HISTONE FAMILY, MEMBER 0; H1F0
142709	HISTONE GENE CLUSTER 1, H1 HISTONE FAMILY, MEMBER A; HIST1H1A
142710	HISTONE GENE CLUSTER 1, H1 HISTONE FAMILY, MEMBER C; HIST1H1C
142711	HISTONE GENE CLUSTER 1, H1 HISTONE FAMILY, MEMBER B; HIST1H1B
142712	HISTONE GENE CLUSTER 1, H1 HISTONE FAMILY, MEMBER T; HIST1H1T
142720	HISTONE GENE CLUSTER 2, H2A HISTONE FAMILY, MEMBER A3; HIST2H2AA3
142730	HISTIOCYTIC DERMATOARTHRITIS
142750	H4 CLUSTERED HISTONE 14; H4C14
142760	MOVED TO 142720
142763	H2A.Z VARIANT HISTONE 1; H2AZ1
142765	REGULATORY FACTOR X, 2; RFX2
142770	HLA MODIFIER
142780	HISTONE GENE CLUSTER 2, H3 HISTONE FAMILY, MEMBER C; HIST2H3C
142790	CD74 ANTIGEN; CD74
142795	HLA-8 HISTOCOMPATIBILITY TYPE; HLA8
142800	MAJOR HISTOCOMPATIBILITY COMPLEX, CLASS I, A; HLA-A
142810	HISTIDYL-tRNA SYNTHETASE 1; HARS1
142830	MAJOR HISTOCOMPATIBILITY COMPLEX, CLASS I, B; HLA-B
142840	MAJOR HISTOCOMPATIBILITY COMPLEX, CLASS I, C; HLA-C
142850	MOVED TO 142860
142855	MAJOR HISTOCOMPATIBILITY COMPLEX, CLASS II, DM ALPHA; HLA-DMA
142856	MAJOR HISTOCOMPATIBILITY COMPLEX, CLASS II, DM BETA; HLA-DMB
142857	MAJOR HISTOCOMPATIBILITY COMPLEX, CLASS II, DR BETA-1; HLA-DRB1
142858	MAJOR HISTOCOMPATIBILITY COMPLEX, CLASS II, DP BETA-1; HLA-DPB1
142860	MAJOR HISTOCOMPATIBILITY COMPLEX, CLASS II, DR ALPHA; HLA-DRA
142870	REMOVED FROM DATABASE
142871	HLA-G HISTOCOMPATIBILITY ANTIGEN, CLASS I; HLA-G
142880	MAJOR HISTOCOMPATIBILITY COMPLEX, CLASS II, DP ALPHA-1; HLA-DPA1
142890	HLA-MT HISTOCOMPATIBILITY TYPE; HLA-MT
142900	HOLT-ORAM SYNDROME; HOS
142910	3-HYDROXY-3-METHYLGLUTARYL-CoA REDUCTASE; HMGCR
142920	HLA-DO HISTOCOMPATIBILITY TYPE; HLA-DO
142925	MOVED TO 142800
142930	MAJOR HISTOCOMPATIBILITY COMPLEX, CLASS II, DN ALPHA; HLA-DNA
142940	3-HYDROXY-3-METHYLGLUTARYL-CoA SYNTHASE 1; HMGCS1
142945	HOLOPROSENCEPHALY 3; HPE3
142946	HOLOPROSENCEPHALY 4; HPE4
142950	HOMEOBOX A7; HOXA7
142951	HOMEOBOX A6; HOXA6
142952	HOMEOBOX A5; HOXA5
142953	HOMEOBOX A4; HOXA4
142954	HOMEOBOX A3; HOXA3
142955	HOMEOBOX A1; HOXA1
142956	HOMEOBOX A9; HOXA9
142957	HOMEOBOX A10; HOXA10
142958	HOMEOBOX A11; HOXA11
142959	HOMEOBOX A13; HOXA13
142960	HOMEOBOX B5; HOXB5
142961	HOMEOBOX B6; HOXB6
142962	HOMEOBOX B7; HOXB7
142963	HOMEOBOX B8; HOXB8
142964	HOMEOBOX B9; HOXB9
142965	HOMEOBOX B4; HOXB4
142966	HOMEOBOX B3; HOXB3
142967	HOMEOBOX B2; HOXB2
142968	HOMEOBOX B1; HOXB1
142970	HOMEOBOX C8; HOXC8
142971	HOMEOBOX C9; HOXC9
142972	HOMEOBOX C6; HOXC6
142973	HOMEOBOX C5; HOXC5
142974	HOMEOBOX C4; HOXC4
142975	HOMEOBOX C12; HOXC12
142976	HOMEOBOX C13; HOXC13
142980	HOMEOBOX D3; HOXD3
142981	HOMEOBOX D4; HOXD4
142982	HOMEOBOX D9; HOXD9
142983	MSH HOMEOBOX 1; MSX1
142984	HOMEOBOX D10; HOXD10
142985	HOMEOBOX D8; HOXD8
142986	HOMEOBOX D11; HOXD11
142987	HOMEOBOX D1; HOXD1
142988	HOMEOBOX D12; HOXD12
142989	HOMEOBOX D13; HOXD13
142990	MOVED TO 142981
142991	EVEN-SKIPPED HOMEOBOX 2; EVX2
142992	H6 FAMILY HOMEOBOX 1; HMX1
142993	VISUAL SYSTEM HOMEOBOX 2; VSX2
142994	MOTOR NEURON AND PANCREAS HOMEOBOX 1; MNX1
142995	H.20-LIKE HOMEOBOX; HLX
142996	EVEN-SKIPPED HOMEOBOX 1; EVX1
143000	HORNER SYNDROME, CONGENITAL
143010	MAJOR HISTOCOMPATIBILITY COMPLEX, CLASS I, E; HLA-E
143020	HPA I RECOGNITION POLYMORPHISM, BETA-GLOBIN-RELATED; HPA1
143023	RAS ASSOCIATION DOMAIN FAMILY, MEMBER 7; RASSF7
143024	GUANINE NUCLEOTIDE-BINDING PROTEIN-LIKE 1; GNL1
143025	HTLV-RELATED ENDOGENOUS SEQUENCE 1; HRES1
143030	CD9 ANTIGEN; CD9
143040	ANTIGEN DEFINED BY MONOCLONAL ANTIBODY F10.44.2
143050	HUMERORADIAL SYNOSTOSIS
143054	HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 ENHANCER-BINDING PROTEIN 2; HIVEP2
143055	CYCLIN T1; CCNT1
143060	HUMAN LEUKOCYTE ANTIGEN MIC6; MIC6
143065	MOVED TO 107271
143070	REMOVED FROM DATABASE
143080	REMOVED FROM DATABASE
143089	FORKHEAD BOX N2; FOXN2
143090	MOVED TO 138140
143095	SPONDYLOEPIPHYSEAL DYSPLASIA WITH CONGENITAL JOINT DISLOCATIONS; SEDCJD
143100	HUNTINGTON DISEASE; HD
143110	MAJOR HISTOCOMPATIBILITY COMPLEX, CLASS I, F; HLA-F
143150	MOVED TO 426000
143170	MALE-ENHANCED ANTIGEN 1; MEA1
143200	WAGNER VITREORETINOPATHY; WGVRP
143400	CONGENITAL ANOMALIES OF KIDNEY AND URINARY TRACT 2; CAKUT2
143450	HYDROXYACYL-CoA DEHYDROGENASE/3-KETOACYL-CoA THIOLASE/ENOYL-CoA HYDRATASE, BETA SUBUNIT; HADHB
143460	5-HYDROXYTRYPTAMINE OXYGENASE REGULATOR; HTOR
143465	ATTENTION DEFICIT-HYPERACTIVITY DISORDER; ADHD
143470	HYPERALPHALIPOPROTEINEMIA 1; HALP1
143500	GILBERT SYNDROME
143850	ORTHOSTATIC HYPOTENSIVE DISORDER, STREETEN TYPE
143860	HYPERCHLORHIDROSIS, ISOLATED; HYCHL
143870	HYPERCALCIURIA, ABSORPTIVE, 2; HCA2
143880	HYPERCALCEMIA, INFANTILE, 1; HCINF1
143890	HYPERCHOLESTEROLEMIA, FAMILIAL, 1; FHCL1
144010	HYPERCHOLESTEROLEMIA, FAMILIAL, 2; FHCL2
144020	HYPERCHOLESTEROLEMIA SUPPRESSOR
144050	HYPERHEPARINEMIA
144100	HYPERHIDROSIS, GUSTATORY; HYPRG
144110	HYPERHIDROSIS PALMARIS ET PLANTARIS; HYPRPP
144120	HYPERIMMUNOGLOBULIN G1(A1) SYNDROME
144150	HYPERKERATOSIS LENTICULARIS PERSTANS; HLP
144190	HYPERKERATOSIS-HYPERPIGMENTATION SYNDROME
144200	PALMOPLANTAR KERATODERMA, EPIDERMOLYTIC, 1; EPPK1
144250	HYPERLIPIDEMIA, FAMILIAL COMBINED, 3; FCHL3
144300	HYPERLIPOPROTEINEMIA, TYPE II, AND DEAFNESS
144400	MOVED TO 143890
144600	HYPERLIPOPROTEINEMIA, TYPE IV
144650	HYPERLIPOPROTEINEMIA, TYPE V
144700	RENAL CELL CARCINOMA, NONPAPILLARY; RCC
144750	ENDOSTEAL HYPEROSTOSIS, AUTOSOMAL DOMINANT
144755	HYPEROSTOSIS CRANIALIS INTERNA; HCIN
144800	HYPEROSTOSIS FRONTALIS INTERNA
145000	HYPERPARATHYROIDISM 1; HRPT1
145001	HYPERPARATHYROIDISM 2 WITH JAW TUMORS; HRPT2
145100	HYPERPIGMENTATION OF EYELIDS
145200	HYPERPIGMENTATION OF FULDAUER AND KUIJPERS
145250	HYPERPIGMENTATION WITH OR WITHOUT HYPOPIGMENTATION, FAMILIAL PROGRESSIVE; FPHH
145260	PSEUDOHYPOALDOSTERONISM, TYPE IIA; PHA2A
145270	HYPERPROGLUCAGONEMIA
145290	HYPERREFLEXIA; HRX
145295	HYPERSECRETION OF ADRENAL ANDROGENS, FAMILIAL
145300	HYPERSENSITIVITY PNEUMONITIS, FAMILIAL
145350	HYPOTAURINEMIC RETINAL DEGENERATION AND CARDIOMYOPATHY; HTRDC
145400	HYPERTELORISM
145410	MOVED TO 145420
145420	TEEBI HYPERTELORISM SYNDROME 1; TBHS1
145500	HYPERTENSION, ESSENTIAL
145505	ACYL-CoA SYNTHETASE MEDIUM CHAIN FAMILY, MEMBER 3; ACSM3
145590	HYPERTHERMIA, CUTANEOUS, WITH HEADACHES AND NAUSEA
145600	MALIGNANT HYPERTHERMIA, SUSCEPTIBILITY TO, 1; MHS1
145650	THYROID HORMONE RESISTANCE, SELECTIVE PITUITARY; PRTH
145680	HYPERTHYROXINEMIA, DYSTRANSTHYRETINEMIC; DTTRH
145700	HYPERTRICHOSIS LANUGINOSA CONGENITA
145701	HYPERTRICHOSIS UNIVERSALIS CONGENITA, AMBRAS TYPE; HTC1
145750	HYPERTRIGLYCERIDEMIA 1; HYTG1
145800	HYPERTROPHIA MUSCULORUM VERA
145900	HYPERTROPHIC NEUROPATHY OF DEJERINE-SOTTAS
145980	HYPOCALCIURIC HYPERCALCEMIA, FAMILIAL, TYPE I; HHC1
145981	HYPOCALCIURIC HYPERCALCEMIA, FAMILIAL, TYPE II; HHC2
146000	HYPOCHONDROPLASIA; HCH
146110	HYPOGONADOTROPIC HYPOGONADISM 7 WITH OR WITHOUT ANOSMIA; HH7
146150	MOVED TO 300337
146160	HYPOMELIA WITH MULLERIAN DUCT ANOMALIES
146200	HYPOPARATHYROIDISM, FAMILIAL ISOLATED, 1; FIH1
146255	HYPOPARATHYROIDISM, SENSORINEURAL DEAFNESS, AND RENAL DYSPLASIA SYNDROME; HDRS
146300	HYPOPHOSPHATASIA, ADULT; HPPA
146350	HYPOPHOSPHATEMIC BONE DISEASE; HBD
146390	CHROMOSOME 18p DELETION SYNDROME
146400	MOVED TO 125400
146450	HYPOSPADIAS 3, AUTOSOMAL; HYSP3
146500	MULTIPLE SYSTEM ATROPHY 1, SUSCEPTIBILITY TO; MSA1
146510	PALLISTER-HALL SYNDROME; PHS
146520	HYPOTRICHOSIS 2; HYPT2
146530	MOVED TO 301845
146550	HYPOTRICHOSIS 4; HYPT4
146580	HYPOXANTHINE GUANINE PHOSPHORIBOSYLTRANSFERASE SUPPRESSOR
146590	ICHTHYOSIS HYSTRIX, CURTH-MACKLIN TYPE; IHCM
146600	ICHTHYOSIS HYSTRIX, LAMBERT TYPE; IHL
146630	INTERCELLULAR ADHESION MOLECULE 2; ICAM2
146631	INTERCELLULAR ADHESION MOLECULE 3; ICAM3
146640	INTER-ALPHA-TRYPSIN INHIBITOR, HEAVY CHAIN 2; ITIH2
146650	INTER-ALPHA-TRYPSIN INHIBITOR, HEAVY CHAIN 3; ITIH3
146660	INTERLEUKIN 7; IL7
146661	INTERLEUKIN 7 RECEPTOR; IL7R
146680	INSULIN-DEGRADING ENZYME; IDE
146690	IMP DEHYDROGENASE 1; IMPDH1
146691	IMP DEHYDROGENASE 2; IMPDH2
146692	MOVED TO 146690
146700	ICHTHYOSIS VULGARIS
146710	INTERLEUKIN 2 RECEPTOR, BETA; IL2RB
146720	ICHTHYOSIS--CHEEK--EYEBROW SYNDROME
146730	INSULIN-LIKE GROWTH FACTOR-BINDING PROTEIN 1; IGFBP1
146731	INSULIN-LIKE GROWTH FACTOR-BINDING PROTEIN 2; IGFBP2
146732	INSULIN-LIKE GROWTH FACTOR-BINDING PROTEIN 3; IGFBP3
146733	INSULIN-LIKE GROWTH FACTOR-BINDING PROTEIN 4; IGFBP4
146734	INSULIN-LIKE GROWTH FACTOR-BINDING PROTEIN 5; IGFBP5
146735	INSULIN-LIKE GROWTH FACTOR-BINDING PROTEIN 6; IGFBP6
146738	INSULIN-LIKE 3; INSL3
146740	Fc FRAGMENT OF IgG RECEPTOR IIIa; FCGR3A
146750	ICHTHYOSIS, LAMELLAR, AUTOSOMAL DOMINANT; ADLI
146760	Fc FRAGMENT OF IgG RECEPTOR Ia; FCGR1A
146770	IMMUNOGLOBULIN LAMBDA-LIKE POLYPEPTIDE 1; IGLL1
146771	MOVED TO 146770
146780	IMMUNOGLOBULIN KAPPA DELETING ELEMENT; IGKDEL
146790	Fc GAMMA RECEPTOR IIa; FCGR2A
146800	ICHTHYOSIS BULLOSA OF SIEMENS; IBS
146810	IMMUNE RESPONSE TO SYNTHETIC POLYPEPTIDE--IRPHEGAL; IPHEG
146820	IMMUNE RESPONSE TO SYNTHETIC POLYPEPTIDE--IRGAT; IGAT
146830	IMMUNE DEFICIENCY, FAMILIAL VARIABLE
146840	MOVED TO 147060
146850	IMMUNE SUPPRESSION; IS
146880	MAJOR HISTOCOMPATIBILITY COMPLEX, CLASS II, DQ ALPHA-1; HLA-DQA1
146900	IgA CONSTANT HEAVY CHAIN 1; IGHA1
146910	IMMUNOGLOBULIN HEAVY CHAIN DIVERSITY GENE CLUSTER; IGHD@
146920	ADENOSINE DEAMINASE, RNA-SPECIFIC; ADAR
146928	CHEMOKINE, CXC MOTIF, RECEPTOR 2; CXCR2
146929	CHEMOKINE, CXC MOTIF, RECEPTOR 1; CXCR1
146930	CHEMOKINE, CXC MOTIF, LIGAND 8; CXCL8
146931	INTERLEUKIN 9; IL9
146932	MOVED TO 300007
146933	INTERLEUKIN 10 RECEPTOR, ALPHA; IL10RA
146940	MOVED TO 147220
146950	IMMUNE RESPONSE TO SYNTHETIC POLYPEPTIDE--IRHGAL; IHG
146960	IMMUNE RESPONSE TO SYNTHETIC POLYPEPTIDE--IRTGAL; ITG
146970	IMMUNOGLOBULIN KAPPA LIGHT CHAIN JOINING GENE CLUSTER; IGKJ@
146980	IMMUNOGLOBULIN KAPPA LIGHT CHAIN VARIABLE GENE CLUSTER; IGKV@
146990	IMMUNOGLOBULIN HEAVY CHAIN DIVERSITY REGION 2; IGHDY2
147000	IgA CONSTANT HEAVY CHAIN 2; IGHA2
147010	IMMUNOGLOBULIN HEAVY CHAIN JOINING GENE CLUSTER; IGHJ@
147020	IMMUNOGLOBULIN HEAVY CHAIN CONSTANT REGION MU; IGHM
147040	INTERFERON-INDUCED PROTEIN WITH TETRATRICOPEPTIDE REPEATS 2; IFIT2
147045	Fc FRAGMENT OF IgA, RECEPTOR FOR; FCAR
147050	IgE RESPONSIVENESS, ATOPIC; IGER
147060	HYPER-IgE SYNDROME 1, AUTOSOMAL DOMINANT, WITH RECURRENT INFECTIONS; HIES1
147061	IMMUNOGLOBULIN E CONCENTRATION, SERUM; IGES
147070	IMMUNOGLOBULIN HEAVY CHAIN VARIABLE GENE CLUSTER; IGHV@
147080	IMMUNE RESPONSE TO SYNTHETIC POLYPEPTIDE--IRGLPHE 1; IGLP1
147090	IMMUNE RESPONSE TO SYNTHETIC POLYPEPTIDE--IRGLPHE 2; IGLP2
147100	IgG HEAVY CHAIN LOCUS; IGHG1
147110	IMMUNOGLOBULIN HEAVY CHAIN CONSTANT REGION GAMMA-2; IGHG2
147120	IMMUNOGLOBULIN Gm3; IGHG3
147130	IMMUNOGLOBULIN Gm4; IGHG4
147138	MEMBRANE-SPANNING 4 DOMAINS, SUBFAMILY A, MEMBER 2; MS4A2
147139	Fc FRAGMENT OF IgE, HIGH AFFINITY I, RECEPTOR FOR, GAMMA SUBUNIT; FCER1G
147140	Fc FRAGMENT OF IgE, HIGH AFFINITY I, RECEPTOR FOR, ALPHA SUBUNIT; FCER1A
147141	TRANSCRIPTION FACTOR 3; TCF3
147150	MX DYNAMIN-LIKE GTPase 1; MX1
147160	MOVED TO 147180
147170	IMMUNOGLOBULIN: HEAVY DELTA CHAIN; IGHD
147180	IMMUNOGLOBULIN: HEAVY EPSILON CHAIN; IGHE
147183	RECOMBINATION SIGNAL-BINDING PROTEIN FOR IMMUNOGLOBULIN KAPPA J REGION; RBPJ
147185	IMMUNOGLOBULIN KAPPA VARIABLE 1/OR2-108; IGKV1OR2108
147200	IMMUNOGLOBULIN KAPPA LIGHT CHAIN CONSTANT REGION; IGKC
147210	MOVED TO 147180
147220	IMMUNOGLOBULIN LAMBDA CONSTANT REGION 1; IGLC1
147230	IMMUNOGLOBULIN LAMBDA LIGHT CHAIN JOINING GENE CLUSTER; IGLJ@
147240	IMMUNOGLOBULIN LAMBDA LIGHT CHAIN VARIABLE GENE CLUSTER; IGLV@
147245	CD79B ANTIGEN; CD79B
147250	SOLITARY MEDIAN MAXILLARY CENTRAL INCISOR; SMMCI
147251	INCISORS, FUSED MANDIBULAR
147260	IMMUNOGLOBULIN SWITCH SEQUENCES
147263	INOSITOL POLYPHOSPHATE-1-PHOSPHATASE; INPP1
147264	INOSITOL POLYPHOSPHATE-5-PHOSPHATASE, 75-KD; INPP5B
147265	INOSITOL 1,4,5-TRIPHOSPHATE RECEPTOR, TYPE 1; ITPR1
147267	INOSITOL 1,4,5-TRISPHOSPHATE RECEPTOR, TYPE 3; ITPR3
147270	INTER-ALPHA-TRYPSIN INHIBITOR, HEAVY CHAIN 1; ITIH1
147280	INSULIN-LIKE GROWTH FACTOR II RECEPTOR; IGF2R
147290	INHIBIN, BETA A; INHBA
147300	INCISORS, LONG UPPER CENTRAL
147310	CHEMOKINE, CXC MOTIF, LIGAND 10; CXCL10
147320	INSULIN RECEPTORS, FAMILIAL INCREASE IN
147330	INCISORS, LOWER CENTRAL, ABSENCE OF
147350	INCISORS, ROTATION OF UPPER CENTRAL
147360	INVOLUCRIN; IVL
147370	INSULIN-LIKE GROWTH FACTOR I RECEPTOR; IGF1R
147380	INHIBIN, ALPHA; INHA
147390	INHIBIN, BETA B; INHBB
147400	INCISORS, SHOVEL-SHAPED
147410	REMOVED FROM DATABASE
147420	MOVED TO 601419
147421	INCLUSION BODY MYOSITIS
147430	MARSILI SYNDROME; MARSIS
147435	INDOLEAMINE 2,3-DIOXYGENASE; IDO1
147440	INSULIN-LIKE GROWTH FACTOR I; IGF1
147450	SUPEROXIDE DISMUTASE 1; SOD1
147460	SUPEROXIDE DISMUTASE 2; SOD2
147470	INSULIN-LIKE GROWTH FACTOR II; IGF2
147480	CHOLESTASIS, INTRAHEPATIC, OF PREGNANCY, 1; ICP1
147485	INTRACISTERNAL A PARTICLE-PROMOTED POLYPEPTIDE; IPP
147490	REMOVED FROM DATABASE
147510	INSULIN-RELATED DNA POLYMORPHISM; IRDN
147520	INOSINE TRIPHOSPHATASE; ITPA
147521	INOSITOL 1,4,5-TRISPHOSPHATE 3-KINASE A; ITPKA
147522	INOSITOL 1,4,5-TRISPHOSPHATE 3-KINASE B; ITPKB
147530	INSENSITIVITY TO PAIN WITH HYPERPLASTIC MYELINOPATHY
147540	INSECT STINGS, HYPERSENSITIVITY TO
147545	INSULIN RECEPTOR SUBSTRATE 1; IRS1
147553	INTERFERON, OMEGA-1; IFNW1
147554	MOVED TO 147553
147556	INTEGRIN, ALPHA-6; ITGA6
147557	INTEGRIN, BETA-4; ITGB4
147558	INTEGRIN, BETA-6; ITGB6
147559	INTEGRIN, BETA-7; ITGB7
147560	INTERFERON ANTIVIRAL DEPRESSOR
147561	INTEGRIN, BETA-5; ITGB5
147562	INTERFERON, ALPHA-2; IFNA2
147563	INTEGRIN-BINDING SIALOPROTEIN; IBSP
147564	INTERFERON, ALPHA-4; IFNA4
147565	INTERFERON, ALPHA-5; IFNA5
147566	INTERFERON, ALPHA-6; IFNA6
147567	INTERFERON, ALPHA-7; IFNA7
147568	INTERFERON, ALPHA-8; IFNA8
147569	INTERFERON-GAMMA RECEPTOR 2; IFNGR2
147570	INTERFERON, GAMMA; IFNG
147571	UBIQUITIN-LIKE MODIFIER ISG15; ISG15
147572	INTERFERON-ALPHA-INDUCIBLE PROTEIN 6; IFI6
147573	INTERFERON PRODUCTION REGULATOR; IFNR
147574	INTERFERON REGULATORY FACTOR 9; IRF9
147575	INTERFERON REGULATORY FACTOR 1; IRF1
147576	INTERFERON REGULATORY FACTOR 2; IRF2
147577	INTERFERON, ALPHA-10; IFNA10
147578	INTERFERON, ALPHA-13; IFNA13
147579	INTERFERON, ALPHA-14; IFNA14
147580	INTERFERON, ALPHA-16; IFNA16
147581	MOVED TO 100880
147582	IRON-RESPONSIVE ELEMENT-BINDING PROTEIN 2; IREB2
147583	INTERFERON, ALPHA-17; IFNA17
147584	INTERFERON, ALPHA-21; IFNA21
147585	MOVED TO 147660
147586	INTERFERON-GAMMA-INDUCIBLE PROTEIN 16; IFI16
147590	MOVED TO 109120
147610	IRIS PIGMENT LAYER, CLEAVAGE OF
147620	INTERLEUKIN 6; IL6
147625	ISLET CELL AUTOANTIGEN 1; ICA1
147630	INSULINOMATOSIS AND DIABETES MELLITUS; INSDM
147640	INTERFERON, BETA-1; IFNB1
147650	ISOCITRATE DEHYDROGENASE 2; IDH2
147660	INTERFERON, ALPHA-1; IFNA1
147670	INSULIN RECEPTOR; INSR
147671	INSULIN RECEPTOR-RELATED RECEPTOR; INSRR
147678	CASPASE 1, APOPTOSIS-RELATED CYSTEINE PROTEASE; CASP1
147679	INTERLEUKIN 1 RECEPTOR ANTAGONIST; IL1RN
147680	INTERLEUKIN 2; IL2
147681	INTERLEUKIN 11; IL11
147683	INTERLEUKIN 13; IL13
147684	REMOVED FROM DATABASE
147685	FORKHEAD BOX K2; FOXK2
147686	MOVED TO 300119
147690	INTERFERON-INDUCED PROTEIN WITH TETRATRICOPEPTIDE REPEATS 1; IFIT1
147700	ISOCITRATE DEHYDROGENASE 1; IDH1
147710	INTUSSUSCEPTION
147720	INTERLEUKIN 1-BETA; IL1B
147730	INTERLEUKIN 2 RECEPTOR, ALPHA; IL2RA
147740	INTERLEUKIN 3; IL3
147750	IVIC SYNDROME; IVIC
147760	INTERLEUKIN 1-ALPHA; IL1A
147770	JOHNSON NEUROECTODERMAL SYNDROME
147780	INTERLEUKIN 4; IL4
147781	INTERLEUKIN 4 RECEPTOR; IL4R
147790	JOINING CHAIN OF MULTIMERIC IgA AND IgM; JCHAIN
147791	JACOBSEN SYNDROME; JBS
147795	JANUS KINASE 1; JAK1
147796	JANUS KINASE 2; JAK2
147800	AASE-SMITH SYNDROME I
147810	INTERLEUKIN 1 RECEPTOR, TYPE I; IL1R1
147811	INTERLEUKIN 1 RECEPTOR, TYPE II; IL1R2
147820	INTERNAL CAROTID ARTERY, SPONTANEOUS DISSECTION OF
147830	T-CELL TUMOR INVASION AND METASTASIS 1; TTIM1
147840	INTERCELLULAR ADHESION MOLECULE 1; ICAM1
147850	INTERLEUKIN 5; IL5
147851	INTERLEUKIN 5 RECEPTOR, ALPHA; IL5RA
147860	INTERFERON, BETA-3; IFNB3
147870	WINGLESS-TYPE MMTV INTEGRATION SITE FAMILY, MEMBER 2; WNT2
147880	INTERLEUKIN 6 RECEPTOR; IL6R
147890	MX DYNAMIN-LIKE GTPase 2; MX2
147891	ISCHIOCOXOPODOPATELLAR SYNDROME WITH OR WITHOUT PULMONARY ARTERIAL HYPERTENSION; ICPPS
147892	DEIODINASE, IODOTHYRONINE, TYPE I; DIO1
147900	JOINT LAXITY, FAMILIAL
147910	KALLIKREIN 1; KLK1
147920	KABUKI SYNDROME 1; KABUK1
147935	SERPIN PEPTIDASE INHIBITOR, CLADE A, MEMBER 4; SERPINA4
147940	ISLET AMYLOID POLYPEPTIDE; IAPP
147950	HYPOGONADOTROPIC HYPOGONADISM 2 WITH OR WITHOUT ANOSMIA; HH2
147960	KALLIKREIN-RELATED PEPTIDASE 2; KLK2
148000	KAPOSI SARCOMA, SUSCEPTIBILITY TO
148020	KERATIN 19; KRT19
148021	KERATIN ASSOCIATED PROTEIN 5-9; KRTAP5-9
148022	KERATIN-ASSOCIATED PROTEIN 5-1; KRTAP5-1
148030	KERATIN 15, TYPE I; KRT15
148040	KERATIN 5, TYPE II; KRT5
148041	KERATIN 6A, TYPE II; KRT6A
148042	KERATIN 6B, TYPE II; KRT6B
148043	KERATIN 3, TYPE II; KRT3
148050	KBG SYNDROME; KBGS
148059	KERATIN 7, TYPE II; KRT7
148060	KERATIN 8, TYPE II; KRT8
148065	KERATIN 13, TYPE I; KRT13
148066	KERATIN 14, TYPE I; KRT14
148067	KERATIN 16, TYPE I; KRT16
148069	KERATIN 17, TYPE I; KRT17
148070	KERATIN 18, TYPE I; KRT18
148080	KERATIN 10, TYPE I; KRT10
148100	KELOID FORMATION; KLDF
148180	FIBROBLAST GROWTH FACTOR 7; FGF7
148181	MOVED TO 176943
148190	KERATITIS, HEREDITARY
148200	KERATOENDOTHELIITIS FUGAX HEREDITARIA; KEFH
148210	KERATITIS-ICHTHYOSIS-DEAFNESS SYNDROME, AUTOSOMAL DOMINANT; KIDAD
148300	KERATOCONUS 1; KTCN1
148350	KERATODERMA, PALMOPLANTAR, WITH DEAFNESS
148360	KERATODERMA, PALMOPLANTAR, WITH NAIL DYSTROPHY AND HEREDITARY MOTOR-SENSORY NEUROPATHY
148370	KERATOLYTIC WINTER ERYTHEMA; KWE
148390	KERATOSIS, FAMILIAL ACTINIC
148500	TYLOSIS WITH ESOPHAGEAL CANCER; TOC
148520	KERATOSIS PALMARIS ET PLANTARIS WITH CLINODACTYLY
148600	PALMOPLANTAR KERATODERMA, PUNCTATE TYPE IA; PPKP1A
148700	PALMOPLANTAR KERATODERMA I, STRIATE, FOCAL, OR DIFFUSE; PPKS1
148730	KERATOSIS, FOCAL PALMOPLANTAR AND GINGIVAL
148750	KINASE-LIKE PROTEIN G7P1; G7P1
148760	KINESIN FAMILY MEMBER 11; KIF11
148800	KLEEBLATTSCHAEDEL
148820	WAARDENBURG SYNDROME, TYPE 3; WS3
148840	KLEINE-LEVIN HIBERNATION SYNDROME
148860	MOVED TO 601076
148870	MOVED TO 118100
148900	MOVED TO 118100
149000	KLIPPEL-TRENAUNAY-WEBER SYNDROME
149100	KNUCKLE PADS
149200	BART-PUMPHREY SYNDROME; BAPS
149300	NAIL DISORDER, NONSYNDROMIC CONGENITAL, 2; NDNC2
149400	HYPEREKPLEXIA 1; HKPX1
149500	KYRLE DISEASE
149600	LABIA MINORA, INCOMPLETE ADHESION OF
149700	LACRIMAL DUCT DEFECT; LCDD
149730	LACRIMOAURICULODENTODIGITAL SYNDROME 1; LADD1
149750	LACTALBUMIN, ALPHA; LALBA
150000	LACTATE DEHYDROGENASE A; LDHA
150100	LACTATE DEHYDROGENASE B; LDHB
150150	LACTATE DEHYDROGENASE C; LDHC
150160	MOVED TO 150000
150170	LACTIC ACIDOSIS, CHRONIC ADULT FORM
150200	CHORIONIC SOMATOMAMMOTROPIN HORMONE 1; CSH1
150205	LACTOPEROXIDASE; LPO
150210	LACTOTRANSFERRIN; LTF
150220	MOVED TO 223000
150230	TRICHORHINOPHALANGEAL SYNDROME, TYPE II; TRPS2
150240	LAMININ, BETA-1; LAMB1
150250	LARSEN SYNDROME; LRS
150260	LARYNGEAL ABDUCTOR PARALYSIS
150270	LARYNGEAL ADDUCTOR PARALYSIS; LAP
150280	LARYNGOMALACIA
150290	LAMININ, GAMMA-1; LAMC1
150292	LAMININ, GAMMA-2; LAMC2
150300	LARYNX, CONGENITAL PARTIAL ATRESIA OF
150310	LAMININ, BETA-3; LAMB3
150320	LAMININ, ALPHA-1; LAMA1
150325	LAMININ, BETA-2; LAMB2
150330	LAMIN A/C; LMNA
150340	LAMIN B1; LMNB1
150341	LAMIN B2; LMNB2
150360	LARYNGEAL WEB, FAMILIAL
150370	RIBOSOMAL PROTEIN SA; RPSA
150390	LATENT TRANSFORMING GROWTH FACTOR-BETA-BINDING PROTEIN 1; LTBP1
150400	TOOTH AGENESIS, SELECTIVE, 4; STHAG4
150500	LATTICE DEGENERATION OF RETINA LEADING TO RETINAL DETACHMENT
150550	PERIODIC FEVER, IMMUNODEFICIENCY, AND THROMBOCYTOPENIA SYNDROME; PFITS
150570	LECTIN, GALACTOSIDE-BINDING, SOLUBLE, 1; LGALS1
150571	LECTIN, GALACTOSIDE-BINDING, SOLUBLE, 2; LGALS2
150590	LEG ULCERS, FAMILIAL, OF JUVENILE ONSET
150600	LEGG-CALVE-PERTHES DISEASE; LCPD
150699	LEIOMYOMA, UTERINE; UL
150700	LEIOMYOMA OF VULVA AND ESOPHAGUS
150800	HEREDITARY LEIOMYOMATOSIS AND RENAL CELL CANCER; HLRCC
150900	LENTIGINES
151000	LENTIGINOSIS, CENTROFACIAL NEURODYSRAPHIC
151001	LENTIGINOSIS, INHERITED PATTERNED
151020	LENTIL AGGLUTININ BINDING
151050	LENZ-MAJEWSKI HYPEROSTOTIC DWARFISM; LMHD
151100	LEOPARD SYNDROME 1; LPRD1
151200	CHROMOSOME 8q22.1 DUPLICATION SYNDROME
151210	PLATYSPONDYLIC LETHAL SKELETAL DYSPLASIA, TORRANCE TYPE; PLSDT
151250	LETHAL ANTIGEN--A1; AL-A1
151290	BETA-1,3-GLUCURONYLTRANSFERASE 1; B3GAT1
151300	LEUCYL-CYSTINYL AMINOPEPTIDASE; LNPEP
151310	LEUCINE TRANSPORT, HIGH; LEUT
151350	LEUCYL-tRNA SYNTHETASE 1; LARS1
151380	LEUKEMIA, ACUTE MONOCYTIC
151385	RUNT-RELATED TRANSCRIPTION FACTOR 1; RUNX1
151390	MOVED TO 180385
151400	LEUKEMIA, CHRONIC LYMPHOCYTIC; CLL
151410	BCR ACTIVATOR OF RhoGEF AND GTPase; BCR
151430	B-CELL CLL/LYMPHOMA 2; BCL2
151440	LYMPHOBLASTIC LEUKEMIA-DERIVED SEQUENCE 1; LYL1
151441	LEUKEMIA/LYMPHOMA, CHRONIC B-CELL, 5; BCL5
151442	STATHMIN 1; STMN1
151443	LEUKEMIA INHIBITORY FACTOR RECEPTOR; LIFR
151445	Fc FRAGMENT OF IgE, LOW AFFINITY II, RECEPTOR FOR; FCER2
151450	LEUKOCYTE ANTIGEN GROUP FIVE; LAG5
151460	PROTEIN-TYROSINE PHOSPHATASE, RECEPTOR-TYPE, C; PTPRC
151465	MOVED TO 162643
151500	LEUKOCYTE NUCLEAR APPENDAGES, HEREDITARY PREVALENCE OF
151510	INTEGRIN, ALPHA-X; ITGAX
151520	LEUKOCYTE TYROSINE KINASE; LTK
151523	LEUKOCYTE SURFACE ANTIGEN CD37; CD37
151525	LEUKOCYTE SURFACE ANTIGEN CD53; CD53
151530	ALANYL AMINOPEPTIDASE; ANPEP
151540	MOVED TO 600623
151550	REMOVED FROM DATABASE
151570	LEUKOTRIENE A4 HYDROLASE; LTA4H
151580	MOVED TO 142360
151590	LICHEN SCLEROSUS ET ATROPHICUS; LSA
151600	NAIL DISORDER, NONSYNDROMIC CONGENITAL, 3; NDNC3
151610	OCULOMOTOR-LEVATOR SYNKINESIS; OCLEVS
151620	LICHEN PLANUS, FAMILIAL
151623	LI-FRAUMENI SYNDROME; LFS
151625	LIGATIN; LGTN
151626	LINE RETROTRANSPOSABLE ELEMENT 1; LRE1
151627	LINKIN
151628	LINE RETROTRANSPOSABLE ELEMENT 2; LRE2
151630	LIP, MEDIAN NODULE OF UPPER
151640	LIP, HAMARTOMATOUS
151660	LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 2; FPLD2
151670	LIPASE, HEPATIC; LIPC
151675	LIPOCALIN 1; LCN1
151680	MOVED TO 269880
151690	ANNEXIN A1; ANXA1
151700	LIPOMA OF THE CONJUNCTIVA
151710	MOVED TO 151740
151720	MOVED TO 151740
151730	MOVED TO 151740
151740	ANNEXIN A2; ANXA2
151750	LIPASE, HORMONE-SENSITIVE; LIPE
151800	LIPOMATOSIS, MULTIPLE SYMMETRIC, WITH OR WITHOUT AXONAL PERIPHERAL NEUROPATHY; MSL
151900	LIPOMATOSIS, FAMILIAL MULTIPLE; FML
151990	LIPOPOLYSACCHARIDE-BINDING PROTEIN; LBP
152100	LIPOPROTEIN TYPES--Ld SYSTEM
152200	LIPOPROTEIN(a); LPA
152300	LIPOPROTEIN TYPES--Lt SYSTEM
152310	TISSUE FACTOR PATHWAY INHIBITOR; TFPI
152390	ARACHIDONATE 5-LIPOXYGENASE; ALOX5
152391	ARACHIDONATE 12-OXIDOREDUCTASE; ALOX12
152392	ARACHIDONATE 15-LIPOXYGENASE; ALOX15
152400	LIPOPROTEIN, VARIANT OF BETA
152420	LITHIUM TRANSPORT
152422	LOCUS CONTROL REGION, ALPHA
152423	MOVED TO 192090
152424	LOCUS CONTROL REGION, BETA
152425	ACYL-CoA SYNTHETASE LONG CHAIN FAMILY, MEMBER 1; ACSL1
152426	MOVED TO 152425
152427	POTASSIUM CHANNEL, VOLTAGE-GATED, SUBFAMILY H, MEMBER 2; KCNH2
152430	LONGEVITY 1
152445	LORICRIN; LOR
152450	LOW DENSITY LIPOPROTEIN, VARIATION IN MOLECULAR WEIGHT OF
152460	MOVED TO 137950
152550	LUMBAR STENOSIS, FAMILIAL
152600	LUNULAE OF FINGERNAILS
152690	X-RAY REPAIR CROSS COMPLEMENTING 6; XRCC6
152700	SYSTEMIC LUPUS ERYTHEMATOSUS; SLE
152760	GONADOTROPIN-RELEASING HORMONE 1; GNRH1
152761	MOVED TO 138850
152780	LUTEINIZING HORMONE, BETA POLYPEPTIDE; LHB
152790	LUTEINIZING HORMONE/CHORIOGONADOTROPIN RECEPTOR; LHCGR
152800	LYMPHANGIECTASIA, INTESTINAL
152900	LYMPHEDEMA AND CEREBRAL ARTERIOVENOUS ANOMALY
152950	MICROCEPHALY WITH OR WITHOUT CHORIORETINOPATHY, LYMPHEDEMA, OR IMPAIRED INTELLECTUAL DEVELOPMENT; MCLMR
153000	MOVED TO 153400
153100	LYMPHATIC MALFORMATION 1; LMPHM1
153200	LYMPHATIC MALFORMATION 5; LMPHM5
153240	SELECTIN L; SELL
153243	TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY, MEMBER 8; TNFRSF8
153245	LYMPHOID ENHANCER-BINDING FACTOR 1; LEF1
153280	LYMPHOCYTE CYTOSOL POLYPEPTIDE, 40-KD
153290	LYMPHOCYTE CYTOSOL POLYPEPTIDE, 49-KD
153300	YELLOW NAIL SYNDROME
153310	CHARCOT-LEYDEN CRYSTAL PROTEIN; CLC
153330	LYSOSOME-ASSOCIATED MEMBRANE PROTEIN 1; LAMP1
153335	MOVED TO 182284
153337	LYMPHOCYTE ACTIVATION GENE 3; LAG3
153340	LYMPHOCYTE ANTIGEN CD5; CD5
153360	MOVED TO 300257
153370	INTEGRIN, ALPHA-L; ITGAL
153380	LYMPHOCYTE CYTOSOL POLYPEPTIDE, 20-KD
153390	LCK PROTOONCOGENE, SRC FAMILY TYROSINE KINASE; LCK
153400	LYMPHEDEMA-DISTICHIASIS SYNDROME; LPHDST
153420	CD58 ANTIGEN; CD58
153430	LYMPHOCYTE CYTOSOLIC PROTEIN 1; LCP1
153432	LYMPHOCYTE-SPECIFIC PROTEIN;  LSP1
153435	LYMPHOKINE-ACTIVATED KILLER CELL LIGAND; LAKL
153440	LYMPHOTOXIN-ALPHA; LTA
153450	LYSOZYME; LYZ
153454	PROCOLLAGEN-LYSINE, 2-OXOGLUTARATE 5-DIOXYGENASE; PLOD1
153455	LYSYL OXIDASE; LOX
153456	LYSYL OXIDASE-LIKE 1; LOXL1
153460	MOVED TO 232600
153470	MACROCEPHALY, BENIGN FAMILIAL
153480	MOVED TO 158350
153550	CHROMOSOME 5q DELETION SYNDROME
153600	MACROGLOBULINEMIA, WALDENSTROM, SUSCEPTIBILITY TO, 1; WM1
153615	CAPPING PROTEIN, GELSOLIN-LIKE; CAPG
153618	MANNOSE RECEPTOR, C-TYPE, 1; MRC1
153619	LECTIN, GALACTOSIDE-BINDING, SOLUBLE, 3; LGALS3
153620	MACROPHAGE MIGRATION INHIBITORY FACTOR; MIF
153622	MACROPHAGE SCAVENGER RECEPTOR; MSR1
153630	MACROGLOSSIA
153634	MACROPHAGE ANTIGEN CD68; CD68
153640	MOVED TO 155100
153650	MOVED TO 155100
153670	BERNARD-SOULIER SYNDROME, TYPE A2, AUTOSOMAL DOMINANT; BSSA2
153700	MACULAR DYSTROPHY, VITELLIFORM, 2; VMD2
153800	MACULAR DEGENERATION, AGE-RELATED, 2; ARMD2
153840	MACULAR DYSTROPHY, VITELLIFORM, 1; VMD1
153860	MOVED TO 169150
153870	RETINITIS PIGMENTOSA 91; RP91
153880	MACULAR DYSTROPHY, DOMINANT CYSTOID; DCMD
153890	MACULAR DYSTROPHY, FENESTRATED SHEEN TYPE
153900	MOVED TO 600110
154000	MOVED TO 145250
154020	HYPOMAGNESEMIA 2, RENAL; HOMG2
154030	Y-BOX BINDING PROTEIN 1; YBX1
154040	NEGATIVE ELONGATION FACTOR COMPLEX, MEMBER E; NELFE
154045	LENS INTRINSIC MEMBRANE PROTEIN 2, 19-KD; LIM2
154050	MAJOR INTRINSIC PROTEIN OF LENS FIBER; MIP
154100	MALATE DEHYDROGENASE, MITOCHONDRIAL; MDH2
154200	MALATE DEHYDROGENASE, SOLUBLE; MDH1
154230	46,XY SEX REVERSAL 4; SRXY4
154235	MALE GERM CELL-ASSOCIATED KINASE; MAK
154250	MALIC ENZYME 1; ME1
154270	MALIC ENZYME 2; ME2
154275	MALIGNANT HYPERTHERMIA, SUSCEPTIBILITY TO, 2
154276	MALIGNANT HYPERTHERMIA, SUSCEPTIBILITY TO, 3
154280	SUPPRESSOR OF ANCHORAGE INDEPENDENCE 1; SAI1
154300	MALOCCLUSION DUE TO PROTUBERANT UPPER FRONT TEETH
154360	MALTASE-GLUCOAMYLASE; MGAM
154365	PROTEASOME 26S SUBUNIT, ATPase, 2; PSMC2
154370	MAMMASTATIN
154400	ACROFACIAL DYSOSTOSIS 1, NAGER TYPE; AFD1
154500	TREACHER COLLINS SYNDROME 1; TCS1
154540	MANNOSE 6-PHOSPHATE RECEPTOR, CATION-DEPENDENT; M6PR
154545	MANNOSE-BINDING LECTIN 2; MBL2
154550	MANNOSEPHOSPHATE ISOMERASE; MPI
154570	MANNOSE 6-PHOSPHATE RECEPTOR RECOGNITION DEFECT, LEBANESE TYPE
154580	MANNOSIDASE, ALPHA, CLASS 2C, MEMBER 1; MAN2C1
154582	MANNOSIDASE, ALPHA, CLASS 2A, MEMBER 1; MAN2A1
154600	MARCUS GUNN PHENOMENON
154700	MARFAN SYNDROME; MFS
154705	MOVED TO 610380
154750	MARFANOID HYPERMOBILITY SYNDROME
154780	MARSHALL SYNDROME; MRSHS
154790	PROTEASE INHIBITOR 5; PI5
154800	MASTOCYTOSIS, CUTANEOUS; MASTC
154850	MASTICATORY MUSCLES, HYPERTROPHY OF
154870	MATRIX GAMMA-CARBOXYGLUTAMIC ACID; MGP
154950	MAX PROTEIN; MAX
155000	MAXILLOFACIAL DYSOSTOSIS
155050	MAXILLONASAL DYSPLASIA, BINDER TYPE
155100	MACROTHROMBOCYTOPENIA AND GRANULOCYTE INCLUSIONS WITH OR WITHOUT NEPHRITIS OR SENSORINEURAL HEARING LOSS; MATINS
155120	A DISINTEGRIN AND METALLOPROTEINASE DOMAIN 11; ADAM11
155140	MECKEL DIVERTICULUM
155145	CLEFT, MEDIAN, OF UPPER LIP WITH POLYPS OF FACIAL SKIN AND NASAL MUCOSA
155150	MEDIAN-ULNAR NERVE COMMUNICATIONS
155200	MEDIOSTERNAL DEPIGMENTATION LINE
155240	THYROID CARCINOMA, FAMILIAL MEDULLARY; MTC
155250	MOVED TO 130130
155255	MEDULLOBLASTOMA; MDB
155310	VISCERAL MYOPATHY 1; VSCM1
155350	MEGALENCEPHALY, AUTOSOMAL DOMINANT
155500	MACRODACTYLY
155540	MELANOCORTIN 3 RECEPTOR; MC3R
155541	MELANOCORTIN 4 RECEPTOR; MC4R
155550	PREMELANOSOME PROTEIN; PMEL
155555	MELANOCORTIN 1 RECEPTOR; MC1R
155600	MELANOMA, CUTANEOUS MALIGNANT, SUSCEPTIBILITY TO, 1; CMM1
155601	MELANOMA, CUTANEOUS MALIGNANT, SUSCEPTIBILITY TO, 2; CMM2
155700	MELANOMA, MALIGNANT FAMILIAL INTRAOCULAR
155720	MELANOMA, UVEAL
155730	CHEMOKINE, CXC MOTIF, LIGAND 1; CXCL1
155735	MELANOMA ADHESION MOLECULE; MCAM
155740	CD63 ANTIGEN; CD63
155741	MOVED TO 600186
155750	MELANOTRANSFERRIN; MELTF
155755	MELANOMA-ASTROCYTOMA SYNDROME
155760	AGGRECAN; ACAN
155770	MELANOMA TUMOR ANTIGEN GP90
155800	MOVED TO 145250
155900	MELKERSSON-ROSENTHAL SYNDROME
155950	MELORHEOSTOSIS, ISOLATED; MEL
155960	REMOVED FROM DATABASE
155970	MEMBRANE GLYCOPROTEIN MRC OX-2; MOX2
155975	MOVED TO 112205
155980	MEMBRANOUS CRANIAL OSSIFICATION, DELAYED
156000	MENIERE DISEASE
156100	MN1 PROTOONCOGENE, TRANSCRIPTIONAL REGULATOR; MN1
156190	MENTAL AND GROWTH RETARDATION WITH AMBLYOPIA
156200	INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 1; MRD1
156220	MERALGIA PARAESTHETICA, FAMILIAL
156225	LAMININ, ALPHA-2; LAMA2
156230	MESOMELIC DWARFISM OF HYPOPLASTIC TIBIA AND RADIUS TYPE
156232	MESOMELIC DYSPLASIA, KANTAPUTRA TYPE; MMDK
156240	MESOTHELIOMA, MALIGNANT; MESOM
156250	METACHONDROMATOSIS; METCDS
156300	METACHROMASIA OF FIBROBLASTS
156310	METACHROMATIC LEUKODYSTROPHY, ADULT-ONSET, WITH NORMAL ARYLSULFATASE A
156340	MOVED TO 156360
156349	METALLOTHIONEIN 1B; MT1B
156350	METALLOTHIONEIN 1A; MT1A
156351	METALLOTHIONEIN 1E; MT1E
156352	METALLOTHIONEIN 1F; MT1F
156353	METALLOTHIONEIN 1G; MT1G
156354	METALLOTHIONEIN 1H; MT1H
156355	METALLOTHIONEIN 1I, PSEUDOGENE; MT1IP
156356	METALLOTHIONEIN 1J, PSEUDOGENE; MT1JP
156357	METALLOTHIONEIN 1K; MT1K
156358	METALLOTHIONEIN 1L, PSEUDOGENE; MT1LP
156359	METALLOTHIONEIN 1X; MT1X
156360	METALLOTHIONEIN 2A; MT2A
156400	METAPHYSEAL CHONDRODYSPLASIA, JANSEN TYPE; MCDJ
156490	NME/NM23 NUCLEOSIDE DIPHOSPHATE KINASE 1; NME1
156491	NME/NM23 NUCLEOSIDE DIPHOSPHATE KINASE 2; NME2
156500	METAPHYSEAL CHONDRODYSPLASIA, SCHMID TYPE; MCDS
156510	METAPHYSEAL DYSPLASIA WITH MAXILLARY HYPOPLASIA WITH OR WITHOUT BRACHYDACTYLY; MDMHB
156520	METATARSUS VARUS, TYPE I
156530	METATROPIC DYSPLASIA; MTD
156535	METHYL-CpG-BINDING DOMAIN PROTEIN 1; MBD1
156536	MOVED TO 600113
156540	METHYLTHIOADENOSINE PHOSPHORYLASE; MTAP
156550	KNIEST DYSPLASIA
156560	METHIONYL-tRNA SYNTHETASE 1; MARS1
156565	N-METHYLPURINE DNA GLYCOSYLASE; MPG
156569	METHYLGUANINE-DNA METHYLTRANSFERASE; MGMT
156570	5-METHYLTETRAHYDROFOLATE-HOMOCYSTEINE S-METHYLTRANSFERASE; MTR
156575	MOVED TO 600682
156580	MICROCEPHALY, AUTOSOMAL DOMINANT
156590	MOVED TO 152950
156600	MICROCORIA, CONGENITAL
156610	SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 1; CSCSC1
156620	MICROCEPHALY-DEAFNESS SYNDROME
156700	MICROCORNEA, GLAUCOMA, AND ABSENT FRONTAL SINUSES
156790	MICROFIBRILLAR-ASSOCIATED PROTEIN 2; MFAP2
156810	MICROGASTRIA-LIMB REDUCTION DEFECTS ASSOCIATION; MLRD
156830	MICROMELIC BONE DYSPLASIA WITH CLOVERLEAF SKULL
156845	MICROPHTHALMIA-ASSOCIATED TRANSCRIPTION FACTOR; MITF
156850	MICROPHTHALMIA, ISOLATED, WITH CATARACT 1; MCOPCT1
156900	MICROPHTHALMIA, ISOLATED, WITH CORECTOPIA; MCOPCR
157100	MOVED TO 193220
157129	MICROTUBULE-ASSOCIATED PROTEIN 1B; MAP1B
157130	MICROTUBULE-ASSOCIATED PROTEIN 2; MAP2
157132	MICROTUBULE-ASSOCIATED PROTEIN 4; MAP4
157140	MICROTUBULE-ASSOCIATED PROTEIN TAU; MAPT
157145	MICROSEMINOPROTEIN, BETA; MSMB
157147	MICROSOMAL TRIGLYCERIDE TRANSFER PROTEIN; MTTP
157150	MICROSPHEROPHAKIA WITH HERNIA
157151	MICROSPHEROPHAKIA-METAPHYSEAL DYSPLASIA
157160	MOVED TO 157140
157170	HOLOPROSENCEPHALY 2; HPE2
157200	MIDPHALANGEAL HAIR
157300	MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 1
157400	MILIA, MULTIPLE ERUPTIVE; MEM
157500	MOVED TO 173310
157550	MOVED TO 117000
157560	MINISATELLITE 33.6
157570	MINISATELLITE 33.15
157600	MIRROR MOVEMENTS 1; MRMV1
157640	PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 1; PEOA1
157650	MOVED TO 500002
157655	NADH-UBIQUINONE OXIDOREDUCTASE Fe-S PROTEIN 1; NDUFS1
157660	MITOCHONDRIAL RNA-PROCESSING ENDORIBONUCLEASE, RNA COMPONENT OF; RMRP
157670	MOVED TO 600438
157680	CELL DIVISION CYCLE 25C; CDC25C
157700	MITRAL VALVE PROLAPSE 1; MVP1
157800	CARDIOSPONDYLOCARPOFACIAL SYNDROME; CSCF
157860	MOVED TO 142860
157900	MOEBIUS SYNDROME; MBS
157910	MOVED TO 157900
157920	MOVED TO 309845
157950	PERMANENT MOLARS, SECONDARY RETENTION OF
157960	MOLONEY LEUKEMIA VIRUS INTEGRATION SITE 2, MOUSE, HOMOLOG OF; MLVI2
157970	PROTEASOME 26S SUBUNIT, NON-ATPase, 7; PSMD7
157975	MOVED TO 172411
157980	MOMO SYNDROME
158000	MONILETHRIX; MNLIX
158020	MOVED TO 600182
158030	ANTIGEN DEFINED BY MONOCLONAL ANTIBODY AJ9
158040	ANTIGEN DEFINED BY MONOCLONAL ANTIBODY T87
158050	MONKEY RED BLOOD CELL RECEPTOR; MRBC
158070	SOLUTE CARRIER FAMILY 3 (ACTIVATOR OF DIBASIC AND NEUTRAL AMINO ACID TRANSPORT), MEMBER 2; SLC3A2
158100	MONOPHALANGY OF GREAT TOE
158105	CHEMOKINE, CC MOTIF, LIGAND 2; CCL2
158106	CHEMOKINE, CC MOTIF, LIGAND 7; CCL7
158120	MONOCYTE DIFFERENTIATION ANTIGEN CD14; CD14
158130	MOVED TO 158105
158150	MOVED TO 172250
158170	CHROMOSOME 9p DELETION SYNDROME
158250	NONDISJUNCTION
158270	MOTILIN; MLN
158280	MOTION SICKNESS
158300	ARTHROGRYPOSIS, DISTAL, TYPE 7; DA7
158310	MUCOEPITHELIAL DYSPLASIA, HEREDITARY; HMD
158320	MUIR-TORRE SYNDROME; MRTES
158330	MULLERIAN APLASIA AND HYPERANDROGENISM
158340	MUCIN 1, CELL SURFACE ASSOCIATED; MUC1
158343	ATP-BINDING CASSETTE, SUBFAMILY C, MEMBER 1; ABCC1
158345	MULTIPLE EXOSTOSES WITH SPASTIC TETRAPARESIS
158350	COWDEN SYNDROME 1; CWS1
158370	MUCIN 2, INTESTINAL; MUC2
158371	MUCIN 3A, INTESTINAL; MUC3A
158372	MUCIN 4, TRACHEOBRONCHIAL; MUC4
158373	MUCIN 5, SUBTYPES A AND C, TRACHEOBRONCHIAL; MUC5AC
158374	MUCIN 6, GASTRIC; MUC6
158375	MUCIN 7, SALIVARY; MUC7
158378	SOLUTE CARRIER FAMILY 20 (PHOSPHATE TRANSPORTER), MEMBER 2; SLC20A2
158380	ECOTROPIC VIRAL INTEGRATION SITE 2A; EVI2A
158381	ECOTROPIC VIRAL INTEGRATION SITE 2B; EVI2B
158400	MUSCLE CRAMPS, FAMILIAL
158500	MUSCULAR ATROPHY, ATAXIA, RETINITIS PIGMENTOSA, AND DIABETES MELLITUS
158580	NEURONOPATHY, DISTAL HEREDITARY MOTOR, AUTOSOMAL DOMINANT 7; HMND7
158590	NEURONOPATHY, DISTAL HEREDITARY MOTOR, AUTOSOMAL DOMINANT 2; HMND2
158600	SPINAL MUSCULAR ATROPHY, LOWER EXTREMITY-PREDOMINANT, 1, AUTOSOMAL DOMINANT; SMALED1
158650	MUSCULAR ATROPHY, MALIGNANT NEUROGENIC
158700	MOVED TO 105400
158800	MUSCULAR DYSTROPHY, BARNES TYPE
158810	BETHLEM MYOPATHY 1A; BTHLM1A
158900	FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY 1; FSHD1
158901	FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY 2, DIGENIC; FSHD2
159000	MOVED TO 609200
159001	MOVED TO 181350
159050	MUSCULAR DYSTROPHY, PSEUDOHYPERTROPHIC, WITH INTERNALIZED CAPILLARIES
159100	MUSCULAR HYPOPLASIA, CONGENITAL UNIVERSAL, OF KRABBE
159300	MUSICAL PERFECT PITCH
159350	MCC REGULATOR OF WNT SIGNALING PATHWAY; MCC
159400	MYASTHENIA, LIMB-GIRDLE, AUTOIMMUNE
159405	MYB PROTOONCOGENE LIKE 1; MYBL1
159410	MYDRIATIC RESPONSE TO PHARMACOLOGIC AGENTS
159420	MYDRIASIS, CONGENITAL
159430	MYELIN BASIC PROTEIN; MBP
159440	MYELIN PROTEIN ZERO; MPZ
159455	MOVED TO 170715
159460	MYELIN-ASSOCIATED GLYCOPROTEIN; MAG
159465	MYELIN-OLIGODENDROCYTE GLYCOPROTEIN; MOG
159500	MYELINATED OPTIC NERVE FIBERS
159530	MPL PROTOONCOGENE, THROMBOPOIETIN RECEPTOR; MPL
159540	LEUKEMIA-INHIBITORY FACTOR; LIF
159550	ATAXIA-PANCYTOPENIA SYNDROME; ATXPC
159552	MYELOID CELL LEUKEMIA SEQUENCE 1; MCL1
159553	MYELOID CELL NUCLEAR DIFFERENTIATION ANTIGEN; MNDA
159555	LYSINE-SPECIFIC METHYLTRANSFERASE 2A; KMT2A
159556	MLLT1 SUPER ELONGATION COMPLEX SUBUNIT; MLLT1
159557	ALF TRANSCRIPTION ELONGATION FACTOR 1; AFF1
159558	MLLT3 SUPER ELONGATION COMPLEX SUBUNIT; MLLT3
159559	AFADIN; AFDN
159580	MYELOPATHY, HTLV-1-ASSOCIATED; HAM
159590	CD33 ANTIGEN; CD33
159595	MYELOPROLIFERATIVE SYNDROME, TRANSIENT
159600	MYOCLONIC EPILEPSY, HARTUNG TYPE
159700	MOVED TO 213400
159800	MYOCLONUS, CEREBELLAR ATAXIA, AND DEAFNESS
159900	DYSTONIA 11, MYOCLONIC; DYT11
159950	SPINAL MUSCULAR ATROPHY WITH PROGRESSIVE MYOCLONIC EPILEPSY; SMAPME
159970	MYOGENIC DIFFERENTIATION ANTIGEN 1; MYOD1
159980	MYOGENIN; MYOG
159990	MYOGENIC FACTOR 5; MYF5
159991	MYOGENIC FACTOR 6; MYF6
160000	MYOGLOBIN; MB
160010	MYOGLOBINURIA, AUTOSOMAL DOMINANT
160100	MOVED TO 160120
160120	EPISODIC ATAXIA, TYPE 1; EA1
160150	MYOPATHY, CENTRONUCLEAR, 1; CNM1
160200	MOVED TO 161800
160300	MYOPATHY, DISTAL, INFANTILE-ONSET
160500	MYOPATHY, DISTAL, 1; MPD1
160550	MOVED TO 157640
160565	MYOPATHY, TUBULAR AGGREGATE, 1; TAM1
160570	MYOPATHY WITH STORAGE OF GLYCOPROTEINS AND GLYCOSAMINOGLYCANS
160700	MYOPIA 2, AUTOSOMAL DOMINANT; MYP2
160710	MYOSIN, HEAVY CHAIN 6, CARDIAC MUSCLE, ALPHA; MYH6
160720	MYOSIN, HEAVY CHAIN 3, SKELETAL MUSCLE, EMBRYONIC; MYH3
160730	MYOSIN, HEAVY CHAIN 1, SKELETAL MUSCLE, ADULT; MYH1
160740	MYOSIN, HEAVY CHAIN 2, SKELETAL MUSCLE, ADULT; MYH2
160741	MYOSIN, HEAVY CHAIN 8, SKELETAL MUSCLE, PERINATAL; MYH8
160742	MYOSIN, HEAVY CHAIN 4, SKELETAL MUSCLE; MYH4
160745	MYOSIN, HEAVY CHAIN 11, SMOOTH MUSCLE; MYH11
160750	MYOSITIS
160760	MYOSIN, HEAVY CHAIN 7, CARDIAC MUSCLE, BETA; MYH7
160770	MYOSIN, LIGHT CHAIN 4, ALKALI, ATRIAL, EMBRYONIC; MYL4
160775	MYOSIN, HEAVY CHAIN 9, NONMUSCLE; MYH9
160776	MYOSIN, HEAVY CHAIN 10, NONMUSCLE; MYH10
160777	MYOSIN VA; MYO5A
160780	MYOSIN, LIGHT POLYPEPTIDE 1, ALKALI, SKELETAL, FAST; MYL1
160781	MYOSIN, LIGHT CHAIN 2, REGULATORY, CARDIAC, SLOW; MYL2
160782	MYOSIN, LIGHT CHAIN 5, REGULATORY; MYL5
160790	MYOSIN, LIGHT CHAIN 3, ALKALI, VENTRICULAR, SKELETAL, SLOW; MYL3
160793	MYOSIN-BINDING PROTEIN C, FAST TYPE; MYBPC2
160794	MYOSIN-BINDING PROTEIN C, SLOW TYPE; MYBPC1
160795	MYOSIN-BINDING PROTEIN H; MYBPH
160800	MYOTONIA CONGENITA, AUTOSOMAL DOMINANT
160900	MYOTONIC DYSTROPHY 1; DM1
160980	CARNEY COMPLEX, TYPE 1; CNC1
160990	MYOTONIC MYOPATHY WITH CYLINDRICAL SPIRALS
160993	N-MYRISTOYLTRANSFERASE 1; NMT1
160994	HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN M; HNRNPM
160995	ALPHA-1,3-MANNOSYL-GLYCOPROTEIN BETA-1,2-N-ACETYLGLUCOSAMINYLTRANSFERASE; MGAT1
160998	NAD(P)H DEHYDROGENASE, QUINONE 2; NQO2
161000	NAEGELI-FRANCESCHETTI-JADASSOHN SYNDROME; NFJS
161015	NADH-UBIQUINONE OXIDOREDUCTASE FLAVOPROTEIN 1; NDUFV1
161050	NAIL DISORDER, NONSYNDROMIC CONGENITAL, 1; NDNC1
161070	NAIL HIGH-SULFUR PROTEIN
161080	NAIL LOW-SULFUR PROTEIN
161100	NAILBEDS, PIGMENTATION OF
161200	NAIL-PATELLA SYNDROME; NPS
161400	NARCOLEPSY 1; NRCLP1
161470	NASAL ALAR COLLAPSE, BILATERAL
161480	NASAL BONES, ABSENCE OF
161500	NASAL GROOVE, FAMILIAL TRANSVERSE
161530	NASAL HYPERPIGMENTATION, FAMILIAL TRANSVERSE
161550	NASOPHARYNGEAL CARCINOMA, SUSCEPTIBILITY TO, 2; NPCA2
161555	KILLER CELL LECTIN-LIKE RECEPTOR, SUBFAMILY C, MEMBER 1; KLRC1
161560	INTERLEUKIN 12A; IL12A
161561	INTERLEUKIN 12B; IL12B
161565	NATURAL KILLER CELL TRIGGERING RECEPTOR; NKTR
161600	NAVICULAR BONE, ACCESSORY
161650	NEBULIN; NEB
161700	NECROTIZING ENCEPHALOMYELOPATHY, SUBACUTE, OF LEIGH, ADULT
161800	CONGENITAL MYOPATHY 2A, TYPICAL, AUTOSOMAL DOMINANT; CMYP2A
161900	RENAL FAILURE, PROGRESSIVE, WITH HYPERTENSION; RFH1
161950	IgA NEPHROPATHY, SUSCEPTIBILITY TO, 1; IGAN1
162000	TUBULOINTERSTITIAL KIDNEY DISEASE, AUTOSOMAL DOMINANT, 1; ADTKD1
162010	NERVE GROWTH FACTOR RECEPTOR; NGFR
162020	MOVED TO 147910
162030	NERVE GROWTH FACTOR; NGF
162040	MOVED TO 147960
162060	GROWTH-ASSOCIATED PROTEIN 43; GAP43
162080	NEURAL RETINA LEUCINE ZIPPER; NRL
162091	SCHWANNOMATOSIS 1; SWN1
162095	PLEIOTROPHIN; PTN
162096	MIDKINE; MDK
162100	AMYOTROPHY, HEREDITARY NEURALGIC; HNA
162150	PROPROTEIN CONVERTASE, SUBTILISIN/KEXIN-TYPE, 1; PCSK1
162151	PROPROTEIN CONVERTASE, SUBTILISIN/KEXIN-TYPE, 2; PCSK2
162200	NEUROFIBROMATOSIS, TYPE I; NF1
162210	NEUROFIBROMATOSIS, FAMILIAL SPINAL
162220	MOVED TO 162200 AND 606764
162230	NEUROFILAMENT PROTEIN, HEAVY POLYPEPTIDE; NEFH
162240	NEUROFIBROMATOSIS-PHEOCHROMOCYTOMA-DUODENAL CARCINOID SYNDROME
162250	NEUROFILAMENT PROTEIN, MEDIUM POLYPEPTIDE; NEFM
162260	NEUROFIBROMATOSIS, TYPE III, MIXED CENTRAL AND PERIPHERAL; NF3A
162270	NEUROFIBROMATOSIS, TYPE IV, OF RICCARDI; NF4
162280	NEUROFILAMENT PROTEIN, LIGHT POLYPEPTIDE; NEFL
162300	MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIB; MEN2B
162320	TACHYKININ 1; TAC1
162321	TACHYKININ RECEPTOR 2; TACR2
162323	TACHYKININ RECEPTOR 1; TACR1
162330	TACHYKININ 3; TAC3
162332	TACHYKININ RECEPTOR 3; TACR3
162340	NEUROMEDIN B; NMB
162341	NEUROMEDIN B RECEPTOR; NMBR
162350	CEROID LIPOFUSCINOSIS, NEURONAL, 4 (KUFS TYPE); CLN4
162360	NESCIENT HELIX LOOP HELIX 1; NHLH1
162361	NESCIENT HELIX LOOP HELIX 2; NHLH2
162370	NEUROPATHY, CONGENITAL, WITH ARTHROGRYPOSIS MULTIPLEX
162375	MOVED TO 118200
162380	NEUROPATHY, HEREDITARY SENSORIMOTOR, WITH UPPER MOTOR NEURON, VISUAL PATHWAY AND AUTONOMIC DISTURBANCE
162400	NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE IA; HSAN1A
162500	NEUROPATHY, HEREDITARY, WITH LIABILITY TO PRESSURE PALSIES; HNPP
162600	NEUROPATHY, WITH PARAPROTEIN IN SERUM, CEREBROSPINAL FLUID AND URINE
162640	NEUROPEPTIDE Y; NPY
162641	NEUROPEPTIDE Y RECEPTOR Y1; NPY1R
162642	NEUROPEPTIDE Y RECEPTOR Y2; NPY2R
162643	CHEMOKINE, CXC MOTIF, RECEPTOR 4; CXCR4
162650	NEUROTENSIN; NTS
162651	NEUROTENSIN RECEPTOR 1; NTSR1
162660	NEUROTROPHIN 3; NTF3
162661	MOVED TO 162662
162662	NEUROTROPHIN 4; NTF4
162700	NEUTROPENIA, CHRONIC FAMILIAL
162800	CYCLIC NEUTROPENIA
162815	NEUTROPHIL AZUROCIDIN; NAZC
162820	MOVED TO 147060, 150550, AND 252270
162830	NEUTROPHILIA, HEREDITARY
162860	CD177 ANTIGEN; CD177
162870	MOVED TO 146740
162880	NEUTROPHIL-SPECIFIC ANTIGEN: ND1
162890	NEUTROPHIL-SPECIFIC ANTIGEN: NE1
162900	NEVUS, EPIDERMAL
163000	CAPILLARY MALFORMATIONS, CONGENITAL; CMC
163050	NEVUS ANEMICUS
163100	NEVUS FLAMMEUS OF NAPE OF NECK
163200	SCHIMMELPENNING-FEUERSTEIN-MIMS SYNDROME; SFM
163260	NUCLEAR FACTOR ERYTHROID 2-LIKE 1; NFE2L1
163400	NIEVERGELT SYNDROME
163500	NIGHT BLINDNESS, CONGENITAL STATIONARY, AUTOSOMAL DOMINANT 2; CSNBAD2
163600	NIPPLES INVERTED
163700	NIPPLES, SUPERNUMERARY
163728	MOVED TO 163730
163729	NITRIC OXIDE SYNTHASE 3; NOS3
163730	NITRIC OXIDE SYNTHASE 2; NOS2
163731	NITRIC OXIDE SYNTHASE 1; NOS1
163800	SICK SINUS SYNDROME 2; SSS2
163850	NODULI CUTANEI, MULTIPLE, WITH URINARY TRACT ABNORMALITIES
163890	SYNUCLEIN, ALPHA; SNCA
163900	REMOVED FROM DATABASE
163905	HIGH MOBILITY GROUP BOX 1; HMGB1
163906	HIGH MOBILITY GROUP BOX 2; HMGB2
163910	HIGH MOBILITY GROUP NUCLEOSOMAL BINDING PROTEIN 2; HMGN2
163920	HIGH MOBILITY GROUP NUCLEOSOMAL BINDING PROTEIN 1; HMGN1
163950	NOONAN SYNDROME 1; NS1
163955	MOVED TO 163950 AND 610733
163970	SOLUTE CARRIER FAMILY 6 (NEUROTRANSMITTER TRANSPORTER, NORADRENALINE), MEMBER 2; SLC6A2
163980	CEA CELL ADHESION MOLECULE 6; CEACAM6
164000	NOSE, ANOMALOUS SHAPE OF
164005	NUCLEAR FACTOR I/X; NFIX
164008	NUCLEAR FACTOR KAPPA-B INHIBITOR, ALPHA; NFKBIA
164009	NUCLEAR MITOTIC APPARATUS PROTEIN 1; NUMA1
164010	CHARGED MULTIVESICULAR BODY PROTEIN 1A; CHMP1A
164011	NUCLEAR FACTOR KAPPA-B, SUBUNIT 1; NFKB1
164012	NUCLEAR FACTOR KAPPA-B, SUBUNIT 2; NFKB2
164013	NUCLEAR FACTOR RELATED TO KAPPA-B BINDING PROTEIN; NFRKB
164014	RELA PROTOONCOGENE, NFKB SUBUNIT; RELA
164015	MATRIN 3; MATR3
164016	MOVED TO 600489
164017	HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN A1; HNRNPA1
164018	MOVED TO 600124
164019	MOVED TO 600124
164020	HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN C; HNRNPC
164021	MOVED TO 603083
164022	MOVED TO 300199
164031	NUCLEOLAR PROTEIN NOP2; NOP2
164035	NUCLEOLIN; NCL
164040	NUCLEOPHOSMIN/NUCLEOPLASMIN FAMILY, MEMBER 1; NPM1
164050	PURINE NUCLEOSIDE PHOSPHORYLASE; PNP
164060	NUCLEOSOME ASSEMBLY PROTEIN 1-LIKE 1; NAP1L1
164100	NYSTAGMUS 2, CONGENITAL, AUTOSOMAL DOMINANT; NYS2
164150	NYSTAGMUS, HEREDITARY VERTICAL
164160	LEPTIN; LEP
164170	NYSTAGMUS, VOLUNTARY
164175	POU DOMAIN, CLASS 2, TRANSCRIPTION FACTOR 1; POU2F1
164176	POU DOMAIN, CLASS 2, TRANSCRIPTION FACTOR 2; POU2F2
164177	POU DOMAIN, CLASS 5, TRANSCRIPTION FACTOR 1; POU5F1
164180	OCULOCEREBROCUTANEOUS SYNDROME
164185	OCULAR CICATRICIAL PEMPHIGOID; OCP
164190	OCULAR DOMINANCE
164200	OCULODENTODIGITAL DYSPLASIA; ODDD
164210	CRANIOFACIAL MICROSOMIA 1; CFM1
164220	SCHILBACH-ROTT SYNDROME; SBRS
164230	OBSESSIVE-COMPULSIVE DISORDER; OCD
164280	FEINGOLD SYNDROME 1; FGLDS1
164300	OCULOPHARYNGEAL MUSCULAR DYSTROPHY 1; OPMD1
164310	OCULOPHARYNGODISTAL MYOPATHY 1; OPDM1
164320	ODORANT-BINDING PROTEIN 2A; OBP2A
164330	ODONTOMA-DYSPHAGIA SYNDROME
164340	OLFACTORY MARKER PROTEIN; OMP
164342	OLFACTORY RECEPTOR, FAMILY 1, SUBFAMILY D, MEMBER 2; OR1D2
164343	EARLY B-CELL FACTOR 1; EBF1
164345	OLIGODENDROCYTE-MYELIN GLYCOPROTEIN; OMG
164350	2-PRIME,5-PRIME-OLIGOADENYLATE SYNTHETASE 1; OAS1
164360	ATP SYNTHASE F1, SUBUNIT ALPHA; ATP5F1A
164400	SPINOCEREBELLAR ATAXIA 1; SCA1
164500	SPINOCEREBELLAR ATAXIA 7; SCA7
164600	MOVED TO 164400
164680	ONYCHOGRYPOSIS, PEDAL, WITH KERATOSIS PLANTARIS AND COARSE HAIR
164690	ABL PROTOONCOGENE 2, NONRECEPTOR TYROSINE KINASE; ABL2
164700	MOVED TO 607136
164710	REMOVED FROM DATABASE
164720	ETS PROTOONCOGENE 1, TRANSCRIPTION FACTOR; ETS1
164730	AKT SERINE/THREONINE KINASE 1; AKT1
164731	AKT SERINE/THREONINE KINASE 2; AKT2
164740	ETS PROTOONCOGENE 2, TRANSCRIPTION FACTOR; ETS2
164745	OMODYSPLASIA 2; OMOD2
164750	OMPHALOCELE, AUTOSOMAL
164755	VIRAL INTEGRATION SITE 1; VIS1
164756	MOVED TO 164755
164757	B-RAF PROTOONCOGENE, SERINE/THREONINE KINASE; BRAF
164759	MOVED TO 167000
164760	RAF1 PROTOONCOGENE, SERINE/THREONINE KINASE ; RAF1
164761	RET PROTOONCOGENE; RET
164762	CRK PROTOONCOGENE, ADAPTOR PROTEIN; CRK
164765	CORTACTIN; CTTN
164770	COLONY-STIMULATING FACTOR 1 RECEPTOR; CSF1R
164772	FOSB PROTOONCOGENE, AP1 TRANSCRIPTION FACTOR SUBUNIT; FOSB
164780	SKI PROTOONCOGENE; SKI
164785	MDM2 PROTOONCOGENE; MDM2
164790	NRAS PROTOONCOGENE, GTPase; NRAS
164795	ONCOMODULIN; OCM
164800	NAIL DISORDER, NONSYNDROMIC CONGENITAL, 5; NDNC5
164810	FOS PROTOONCOGENE, AP1 TRANSCRIPTION FACTOR SUBUNIT; FOS
164820	WINGLESS-TYPE MMTV INTEGRATION SITE FAMILY, MEMBER 1; WNT1
164830	REMOVED FROM DATABASE
164831	BMI1 PROTOONCOGENE, POLYCOMB RING FINGER; BMI1
164840	MYCN PROTOONCOGENE, bHLH TRANSCRIPTION FACTOR; MYCN
164850	MYCL PROTOONCOGENE, bHLH TRANSCRIPTION FACTOR; MYCL
164860	MET PROTOONCOGENE, RECEPTOR TYROSINE KINASE; MET
164865	V-MYC AVIAN MYELOCYTOMATOSIS VIRAL ONCOGENE HOMOLOG-LIKE 1; MYCLK1
164870	ERB-B2 RECEPTOR TYROSINE KINASE 2; ERBB2
164873	ETS VARIANT TRANSCRIPTION FACTOR 3; ETV3
164874	FORKHEAD BOX G1; FOXG1
164875	VAV GUANINE NUCLEOTIDE EXCHANGE FACTOR 1; VAV1
164880	V-YES-1 YAMAGUCHI SARCOMA VIRAL ONCOGENE; YES1
164891	MOVED TO 164757
164900	OPHTHALMOMANDIBULOMELIC DYSPLASIA
164905	MOVED TO 600326
164910	REL PROTOONCOGENE, NF-KAPPA-B SUBUNIT; REL
164920	KIT PROTOONCOGENE, RECEPTOR TYROSINE KINASE; KIT
164940	FGR PROTOONCOGENE, SRC FAMILY TYROSINE KINASE; FGR
164950	FIBROBLAST GROWTH FACTOR 3; FGF3
164951	NOTCH RECEPTOR 4; NOTCH4
164953	ONCOGENE LIPOSARCOMA; LPSA
164958	CELLULAR COMMUNICATION NETWORK FACTOR 3; CCN3
164960	ONCOGENE PIM 1; PIM1
164970	MOVED TO 191315 AND 191030
164975	WINGLESS-TYPE MMTV INTEGRATION SITE FAMILY, MEMBER 5A; WNT5A
164980	FIBROBLAST GROWTH FACTOR 4; FGF4
165000	OPHTHALMOPLEGIA, FAMILIAL STATIC
165010	MOVED TO 164710
165020	ROS PROTOONCOGENE 1, RECEPTOR TYROSINE KINASE; ROS1
165040	RAS-ASSOCIATED PROTEIN RAB8A; RAB8A
165060	tRNA SELENOCYSTEINE (ANTICODON TCA) 1-1; TRU-TCA1-1
165070	FMS-RELATED TYROSINE KINASE 1; FLT1
165080	ETS TRANSCRIPTION FACTOR ERG; ERG
165090	RELATED RAS VIRAL ONCOGENE HOMOLOG; RRAS
165095	ONCOSTATIN M; OSM
165098	OPHTHALMOPLEGIA, FAMILIAL TOTAL, WITH IRIS TRANSILLUMINATION
165110	S13 AVIAN ERYTHROBLASTOSIS ONCOGENE HOMOLOG; SEA
165120	LYN PROTOONCOGENE, SRC FAMILY TYROSINE KINASE; LYN
165140	ONCOGENE PVT1; PVT1
165150	OPHTHALMOPLEGIA, PROGRESSIVE, WITH SCROTAL TONGUE AND MENTAL DEFICIENCY
165160	JUN PROTOONCOGENE, AP-1 TRANSCRIPTION FACTOR SUBUNIT; JUN
165161	ONCOGENE JUN-B; JUNB
165162	ONCOGENE JUN-D; JUND
165170	SPI1 PROTOONCOGENE; SPI1
165180	MAS1 ONCOGENE; MAS1
165190	FIBROBLAST GROWTH FACTOR 5; FGF5
165195	OPIOID RECEPTOR, DELTA-1; OPRD1
165196	OPIOID RECEPTOR, KAPPA-1; OPRK1
165199	OPTIC ATROPHY, HEARING LOSS, AND PERIPHERAL NEUROPATHY, AUTOSOMAL DOMINANT
165200	OPTIC ATROPHY WITH DEMYELINATING DISEASE OF CNS
165210	ONCOGENE BMYC; BMYC
165215	MDS1 AND EVI1 COMPLEX LOCUS; MECOM
165220	GLI FAMILY ZINC FINGER 1; GLI1
165230	GLI-KRUPPEL FAMILY MEMBER 2; GLI2
165240	GLI-KRUPPEL FAMILY MEMBER 3; GLI3
165250	ZINC FINGER PROTEIN 875; ZNF875
165260	ZINC FINGER- AND SCAN DOMAIN-CONTAINING PROTEIN 22; ZSCAN22
165270	ZINC FINGER- AND BTB DOMAIN-CONTAINING PROTEIN 48; ZBTB48
165280	GLI-KRUPPEL FAMILY MEMBER 4; GLI4
165290	ONCOGENE RMYC; RMYC
165300	OPTIC ATROPHY 3, AUTOSOMAL DOMINANT; OPA3
165320	LIVER CANCER ONCOGENE; LCO
165330	WINGLESS-TYPE MMTV INTEGRATION SITE FAMILY, MEMBER 3; WNT3
165340	SKI-LIKE; SKIL
165350	MOVED TO 311040
165360	CBL PROTOONCOGENE; CBL
165370	RAS HOMOLOG GENE FAMILY, MEMBER B; RHOB
165380	RAS HOMOLOG GENE FAMILY, MEMBER C; RHOC
165390	RAS HOMOLOG GENE FAMILY, MEMBER A; RHOA
165490	MOVED TO 165500
165500	OPTIC ATROPHY 1; OPA1
165510	OPTIC ATROPHY 13 WITH RETINAL AND FOVEAL ABNORMALITIES; OPA13
165550	OPTIC NERVE HYPOPLASIA, BILATERAL
165590	OROFACIODIGITAL SYNDROME X; OFD10
165600	ORBITAL MARGIN, HYPOPLASIA OF
165630	MOVED TO 163200
165635	MOVED TO 258870
165640	ORNITHINE DECARBOXYLASE 1; ODC1
165650	MOVED TO 165640
165660	OSLAM SYNDROME
165670	OSSIFIED EAR CARTILAGES
165680	OSSICULAR MALFORMATIONS, FAMILIAL
165700	THIEMANN DISEASE
165720	OSTEOARTHRITIS SUSCEPTIBILITY 1; OS1
165800	SHORT STATURE AND ADVANCED BONE AGE, WITH OR WITHOUT EARLY-ONSET OSTEOARTHRITIS AND/OR OSTEOCHONDRITIS DISSECANS; SSOAOD
166000	ENCHONDROMATOSIS, MULTIPLE, OLLIER TYPE
166200	OSTEOGENESIS IMPERFECTA, TYPE I; OI1
166210	OSTEOGENESIS IMPERFECTA, TYPE II; OI2
166220	OSTEOGENESIS IMPERFECTA, TYPE IV; OI4
166230	OSTEOGENESIS IMPERFECTA WITH OPALESCENT TEETH, BLUE SCLERAE AND WORMIAN BONES, BUT WITHOUT FRACTURES
166240	MOVED TO 166200
166250	OSTEOGLOPHONIC DYSPLASIA; OGD
166260	GNATHODIAPHYSEAL DYSPLASIA; GDD
166300	MULTICENTRIC CARPOTARSAL OSTEOLYSIS SYNDROME; MCTO
166350	OSSEOUS HETEROPLASIA, PROGRESSIVE; POH
166400	OSTEOMAS OF MANDIBLE
166450	OSTEOMESOPYKNOSIS
166490	SECRETED PHOSPHOPROTEIN 1; SPP1
166500	MOVED TO 300373
166600	OSTEOPETROSIS, AUTOSOMAL DOMINANT 2; OPTA2
166700	BUSCHKE-OLLENDORFF SYNDROME; BOS
166705	OSTEOPOIKILOSIS AND DACRYOCYSTITIS
166710	OSTEOPOROSIS
166720	MOVED TO 130720
166740	OSTEOSCLEROSIS WITH ICHTHYOSIS AND FRACTURES
166750	OTODENTAL DYSPLASIA
166760	OTITIS MEDIA, SUSCEPTIBILITY TO; OMS
166780	OTOFACIOCERVICAL SYNDROME 1; OTFCS
166800	OTOSCLEROSIS 1; OTSC1
166900	OVALOCYTOSIS, SOUTHEAST ASIAN; SAO
166910	OVALOCYTOSIS, HEREDITARY HEMOLYTIC, WITH DEFECTIVE ERYTHROPOIESIS
166945	NBR1 AUTOPHAGY CARGO RECEPTOR; NBR1
166950	TERATOMA, OVARIAN
166970	OVARIAN FIBROMATA
166990	OSTEOCHONDRODYSPLASIA, RHIZOMELIC, WITH CALLOSAL AGENESIS, THROMBOCYTOPENIA, HYDROCEPHALUS, AND HYPERTENSION
167000	OVARIAN CANCER
167030	NEPHROLITHIASIS, CALCIUM OXALATE, 1; CAON1
167040	OXYSTEROL-BINDING PROTEIN; OSBP
167050	OXYTOCIN; OXT
167055	OXYTOCIN RECEPTOR; OXTR
167100	HYPERTROPHIC OSTEOARTHROPATHY, PRIMARY, AUTOSOMAL DOMINANT; PHOAD
167200	PACHYONYCHIA CONGENITA 1; PC1
167210	PACHYONYCHIA CONGENITA 2; PC2
167220	PACMAN DYSPLASIA
167250	PAGET DISEASE OF BONE 3; PDB3
167300	PAGET DISEASE, EXTRAMAMMARY
167320	INCLUSION BODY MYOPATHY WITH EARLY-ONSET PAGET DISEASE WITH OR WITHOUT FRONTOTEMPORAL DEMENTIA 1; IBMPFD1
167400	PAROXYSMAL EXTREME PAIN DISORDER; PEXPD
167405	PROPROTEIN CONVERTASE SUBTILISIN/KEXIN TYPE 6; PCSK6
167409	PAIRED BOX GENE 2; PAX2
167410	PAIRED BOX GENE 7; PAX7
167411	PAIRED BOX GENE 1; PAX1
167413	PAIRED BOX GENE 4; PAX4
167414	PAIRED BOX GENE 5; PAX5
167415	PAIRED BOX GENE 8; PAX8
167416	PAIRED BOX GENE 9; PAX9
167420	PAIRED-RELATED HOMEOBOX GENE 1; PRRX1
167500	PALATOPHARYNGEAL INCOMPETENCE
167600	PALMARIS LONGUS MUSCLE, ABSENCE OF
167700	PALMOMENTAL REFLEX
167730	NASOPALPEBRAL LIPOMA-COLOBOMA SYNDROME; NPLCS
167750	PANCREAS, ANNULAR
167755	PANCREAS, DORSAL, AGENESIS OF
167770	REGENERATING ISLET-DERIVED 1-ALPHA; REG1A
167771	REGENERATING ISLET-DERIVED 1-BETA; REG1B
167780	PANCREATIC POLYPEPTIDE/PANCREATIC ICOSAPEPTIDE; PPY
167790	SERINE PROTEASE INHIBITOR, KAZAL-TYPE, 1; SPINK1
167800	PANCREATITIS, HEREDITARY; PCTT
167805	REGENERATING ISLET-DERIVED 3-ALPHA; REG3A
167850	PANCYTOPENIA AND OCCLUSIVE VASCULAR DISEASE
167870	PANIC DISORDER 1; PAND1
167900	PAPILLOMATOSIS, CONFLUENT AND RETICULATED; CARP
167950	PAPILLOMATOSIS, FLORID, OF NIPPLE
167959	HUMAN PAPILLOMAVIRUS TYPE 18 INTEGRATION SITE 1; HPV18I1
167960	HUMAN PAPILLOMAVIRUS TYPE 18 INTEGRATION SITE 2; HPV18I2
168000	PHEOCHROMOCYTOMA/PARAGANGLIOMA SYNDROME 1; PPGL1
168100	PARALYSIS AGITANS, JUVENILE, OF HUNT
168200	PARAMOLAR TUBERCLE OF BOLK
168300	PARAMYOTONIA CONGENITA; PMC
168350	MOVED TO 168300
168360	ELAV-LIKE RNA-BINDING PROTEIN 4; ELAVL4
168400	PARASTREMMATIC DWARFISM
168440	PARATHYMOSIN; PTMS
168450	PARATHYROID HORMONE; PTH
168460	MOVED TO 145001
168461	CYCLIN D1; CCND1
168468	PARATHYROID HORMONE 1 RECEPTOR; PTH1R
168470	PARATHYROID HORMONE-LIKE HORMONE; PTHLH
168500	PARIETAL FORAMINA 1; PFM1
168550	PARIETAL FORAMINA WITH CLEIDOCRANIAL DYSPLASIA; PFMCCD
168600	PARKINSON DISEASE, LATE-ONSET; PD
168601	PARKINSON DISEASE 1, AUTOSOMAL DOMINANT; PARK1
168605	PERRY SYNDROME
168610	MOVED TO 600274
168710	PAROTID PROLINE-RICH SALIVARY PROTEIN Pc
168730	PROLINE-RICH PROTEIN, HaeIII SUBFAMILY, 1; PRH1
168790	PROLINE-RICH PROTEIN, HaeIII SUBFAMILY, 2; PRH2
168800	PAROTIDOMEGALY, HEREDITARY BILATERAL
168810	PROLINE-RICH PROTEIN, BstNI SUBFAMILY, 2; PRB2
168820	PARAOXONASE 1; PON1
168830	PASSOVOY FACTOR DEFECT
168840	PROLINE-RICH PROTEIN, BstNI SUBFAMILY, 3; PRB3
168850	MOVED TO 147891
168860	PATELLA APLASIA-HYPOPLASIA; PTLAH
168885	PAROXYSMAL TONIC UPGAZE, BENIGN CHILDHOOD, WITH ATAXIA
168890	PARVALBUMIN; PVALB
168900	PATELLA, CHONDROMALACIA OF
169000	PATELLA, FAMILIAL RECURRENT DISLOCATION OF
169100	CHAR SYNDROME; CHAR
169150	MACULAR DYSTROPHY, PATTERNED, 1; MDPT1
169170	PATTERSON PSEUDOLEPRECHAUNISM SYNDROME
169190	CYCLIN-DEPENDENT KINASE 18; CDK18
169200	PECHET FACTOR DEFICIENCY
169300	PECTUS EXCAVATUM
169400	PELGER-HUET ANOMALY; PHA
169500	LEUKODYSTROPHY, DEMYELINATING, ADULT-ONSET, AUTOSOMAL DOMINANT; ADLD
169545	PELVIC LIPOMATOSIS WITH CROSSED RENAL ECTOPIA
169550	PELVIS-SHOULDER DYSPLASIA
169600	HAILEY-HAILEY DISEASE; HHD
169610	PEMPHIGUS VULGARIS, FAMILIAL
169615	DESMOGLEIN 3; DSG3
169700	PEPSINOGEN; PG
169710	PEPSINOGEN 3, GROUP I; PGA3
169720	PEPSINOGEN 4, GROUP I; PGA4
169730	PEPSINOGEN 5, GROUP I; PGA5
169740	PROGASTRICSIN; PGC
169800	CARNOSINE DIPEPTIDASE 2; CNDP2
169900	PEPTIDASE B; PEPB
170000	PEPTIDASE C; PEPC
170100	PROLIDASE DEFICIENCY
170200	PEPTIDASE E; PEPE
170250	LEUCINE AMINOPEPTIDASE 3; LAP3
170260	TRANSPORTER, ATP-BINDING CASSETTE, MAJOR HISTOCOMPATIBILITY COMPLEX, 1; TAP1
170261	TRANSPORTER, ATP-BINDING CASSETTE, MAJOR HISTOCOMPATIBILITY COMPLEX, 2; TAP2
170270	PEPTIDYLGLYCINE ALPHA-AMIDATING MONOOXYGENASE; PAM
170280	PERFORIN 1; PRF1
170285	NUCLEOPORIN, 85-KD; NUP85
170290	PERILIPIN 1; PLIN1
170300	MOVED TO 142680
170390	ANDERSEN CARDIODYSRHYTHMIC PERIODIC PARALYSIS
170400	HYPOKALEMIC PERIODIC PARALYSIS, TYPE 1; HOKPP1
170500	HYPERKALEMIC PERIODIC PARALYSIS; HYPP
170600	NORMOKALEMIC PERIODIC PARALYSIS
170650	PERIODONTITIS, AGGRESSIVE, 1
170700	PERIPHERAL DYSOSTOSIS
170710	PERIPHERIN; PRPH
170715	PERIPHERAL MYELIN PROTEIN 2; PMP2
170900	PERNICIOUS ANEMIA
170950	REMOVED FROM DATABASE
170980	PERONEAL NERVE, ACCESSORY DEEP
170990	PEROXIDASE, SALIVARY; SAPX
170993	PEROXISOME BIOGENESIS FACTOR 2; PEX2
170995	ATP-BINDING CASSETTE, SUBFAMILY D, MEMBER 3; ABCD3
170998	PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR-ALPHA; PPARA
171000	PEYRONIE DISEASE
171050	ATP-BINDING CASSETTE, SUBFAMILY B, MEMBER 1; ABCB1
171060	ATP-BINDING CASSETTE, SUBFAMILY B, MEMBER 4; ABCB4
171100	PHAGOCYTOSIS, PLASMA-RELATED DEFECT IN
171150	SULFOTRANSFERASE FAMILY 1A, CYTOSOLIC, PHENOL-PREFERRING, MEMBER 1; SULT1A1
171190	PHENYLETHANOLAMINE N-METHYLTRANSFERASE; PNMT
171200	THIOUREA TASTING; THIOT
171300	PHEOCHROMOCYTOMA
171350	MOVED TO 115310
171400	MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIA; MEN2A
171420	PHEOCHROMOCYTOMA--ISLET CELL TUMOR SYNDROME
171450	PHLEBECTASIA OF LIPS
171480	PHOCOMELIA-ECTRODACTYLY, EAR MALFORMATION, DEAFNESS, AND SINUS ARRHYTHMIA
171490	PHOSDUCIN; PDC
171500	ACID PHOSPHATASE 1, SOLUBLE; ACP1
171640	PHOSPHATASE, ACID, TYPE 5, TARTRATE-RESISTANT; ACP5
171650	ACID PHOSPHATASE 2, LYSOSOMAL; ACP2
171660	PHOSPHATASE, ACID, OF TISSUES
171700	REMOVED FROM DATABASE
171720	ALKALINE PHOSPHATASE, PLASMA LEVEL OF, QUANTITATIVE TRAIT LOCUS 1
171740	ALKALINE PHOSPHATASE, INTESTINAL; ALPI
171750	ALKALINE PHOSPHATASE, INTESTINAL, FETAL FORM
171760	ALKALINE PHOSPHATASE, LIVER; ALPL
171790	PHOSPHATASE, PROSTATE-SPECIFIC ACID; ACPP
171800	ALKALINE PHOSPHATASE, PLACENTAL; ALPP
171810	ALKALINE PHOSPHATASE, PLACENTAL-LIKE 2; ALPPL2
171820	PHOSPHATASE, SALIVARY ACID, A; SACP; ACPS
171830	PHOSPHATASE, SALIVARY ACID, B
171833	PHOSPHATIDYLINOSITOL 3-KINASE, REGULATORY SUBUNIT 1; PIK3R1
171834	PHOSPHATIDYLINOSITOL 3-KINASE, CATALYTIC, ALPHA; PIK3CA
171835	6-PHOSPHOFRUCTO-2-KINASE/FRUCTOSE-2,6-BISPHOSPHATASE 2; PFKFB2
171840	PHOSPHOFRUCTOKINASE, PLATELET TYPE; PFKP
171850	MOVED TO 171860 AND 610681
171860	PHOSPHOFRUCTOKINASE, LIVER TYPE; PFKL
171880	MOVED TO 610681
171885	PHOSPHODIESTERASE 7A; PDE7A
171890	PHOSPHODIESTERASE 1A; PDE1A
171891	PHOSPHODIESTERASE 1B; PDE1B
171900	PHOSPHOGLUCOMUTASE 1; PGM1
172000	PHOSPHOGLUCOMUTASE 2; PGM2
172100	PHOSPHOGLUCOMUTASE 3; PGM3
172110	PHOSPHOGLUCOMUTASE 4
172150	6-PHOSPHOGLUCONOLACTONASE DEFICIENCY
172200	6-PHOSPHOGLUCONATE DEHYDROGENASE; PGD
172250	PHOSPHOGLYCERATE MUTASE 1; PGAM1
172270	PHOSPHOGLYCERATE KINASE 2; PGK2
172280	PHOSPHOGLYCOLATE PHOSPHATASE; PGP
172290	PHOSPHOGLYCOPROTEIN 1; PGP1
172300	MOVED TO 171860
172400	GLUCOSE-6-PHOSPHATE ISOMERASE; GPI
172405	PHOSPHOLAMBAN; PLN
172410	PHOSPHOLIPASE A2, GROUP IB; PLA2G1B
172411	PHOSPHOLIPASE A2, GROUP IIA; PLA2G2A
172420	PHOSPHOLIPASE C, GAMMA-1; PLCG1
172425	PHOSPHOLIPID TRANSFER PROTEIN; PLTP
172430	ENOLASE 1; ENO1
172439	PHOSPHORIBOSYLAMINOIMIDAZOLE CARBOXYLASE; PAICS
172450	PHOSPHORIBOSYLPYROPHOSPHATE AMIDOTRANSFERASE; PPAT
172460	METHYLENETETRAHYDROFOLATE DEHYDROGENASE 1; MTHFD1
172470	PHOSPHORYLASE KINASE, MUSCLE, GAMMA-1; PHKG1
172471	PHOSPHORYLASE KINASE, TESTIS/LIVER, GAMMA-2; PHKG2
172480	PHOSPHOSERINE PHOSPHATASE; PSPH
172490	PHOSPHORYLASE KINASE, BETA SUBUNIT; PHKB
172500	PHOTOMYOCLONUS, DIABETES MELLITUS, DEAFNESS, NEPHROPATHY, AND CEREBRAL DYSFUNCTION
172700	PICK DISEASE OF BRAIN
172800	PIEBALD TRAIT; PBT
172850	PIEBALD TRAIT WITH NEUROLOGIC DEFECTS
172860	SERPIN PEPTIDASE INHIBITOR, CLADE F, MEMBER 1; SERPINF1
172870	PIGMENTED PARAVENOUS CHORIORETINAL ATROPHY; PPCRA
172880	PIERRE ROBIN SYNDROME AND OLIGODACTYLY
172900	PIGMENTED PURPURIC ERUPTION
173000	PILONIDAL SINUS
173100	ISOLATED GROWTH HORMONE DEFICIENCY, TYPE II; IGHD2
173110	POU DOMAIN, CLASS 1, TRANSCRIPTION FACTOR 1; POU1F1
173120	SECRETORY GRANULE NEUROENDOCRINE PROTEIN 1; SGNE1
173200	PITYRIASIS RUBRA PILARIS; PRP
173310	PROGESTAGEN-ASSOCIATED ENDOMETRIAL PROTEIN; PAEP
173320	RIBONUCLEASE/ANGIOGENIN INHIBITOR 1; RNH1
173321	SERPIN PEPTIDASE INHIBITOR, CLADE B (OVALBUMIN), MEMBER 6; SERPINB6
173325	JUNCTION PLAKOGLOBIN; JUP
173335	ECTONUCLEOTIDE PYROPHOSPHATASE/PHOSPHODIESTERASE 1; ENPP1
173340	PLASMINOGEN-LIKE B1; PLGLB1
173350	PLASMINOGEN; PLG
173360	SERPIN PEPTIDASE INHIBITOR, CLADE E (NEXIN, PLASMINOGEN ACTIVATOR INHIBITOR TYPE 1), MEMBER 1; SERPINE1
173370	PLASMINOGEN ACTIVATOR, TISSUE; PLAT
173390	SERPIN PEPTIDASE INHIBITOR, CLADE B (OVALBUMIN), MEMBER 2; SERPINB2
173391	PLASMINOGEN ACTIVATOR RECEPTOR, UROKINASE-TYPE; PLAUR
173393	PLATELET-ACTIVATING FACTOR RECEPTOR; PTAFR
173395	PLATELET ADENYLATE CYCLASE ACTIVITY
173400	PLATELET AGGREGATION, SPONTANEOUS
173410	PLATELET-DERIVED GROWTH FACTOR RECEPTOR, BETA; PDGFRB
173420	PLATELET DISORDER, UNDEFINED
173430	PLATELET-DERIVED GROWTH FACTOR, ALPHA POLYPEPTIDE; PDGFA
173445	PLATELET-ENDOTHELIAL CELL ADHESION MOLECULE 1; PECAM1
173450	PLATELET FACTOR 3 DEFICIENCY
173460	PLATELET FACTOR 4; PF4
173461	PLATELET FACTOR 4, VARIANT 1; PF4V1
173470	INTEGRIN, BETA-3; ITGB3
173490	PLATELET-DERIVED GROWTH FACTOR RECEPTOR, ALPHA; PDGFRA
173500	PLATELET GROUPS--Ko SYSTEM; HPA-2
173510	CD36 ANTIGEN; CD36
173511	GLYCOPROTEIN V, PLATELET; GP5
173515	GLYCOPROTEIN IX, PLATELET; GP9
173540	PLATELET GROUPS--Pl(E) SYSTEM
173560	PLATELET MEMBRANE FLUIDITY; PMF
173570	PLECKSTRIN; PLEK
173580	PLATELET RESPONSIVENESS TO ADRENALINE, DEPRESSED
173590	PLATELET SIGNAL PROCESSING DEFECT
173600	PNEUMOTHORAX, PRIMARY SPONTANEOUS; PSP
173610	SELECTIN P; SELP
173650	KINDLER SYNDROME; KNDLRS
173700	POIKILODERMA, HEREDITARY SCLEROSING
173750	MOVED TO 173800 AND 157900
173800	POLAND SYNDROME
173850	POLIOVIRUS RECEPTOR; PVR
173865	MOVED TO 604680
173870	POLY(ADP-RIBOSE) POLYMERASE 1; PARP1
173871	MOVED TO 173870
173880	POLYMERIC IMMUNOGLOBULIN RECEPTOR; PIGR
173900	POLYCYSTIC KIDNEY DISEASE 1 WITH OR WITHOUT POLYCYSTIC LIVER DISEASE; PKD1
173910	POLYCYSTIN 2; PKD2
174000	TUBULOINTERSTITIAL KIDNEY DISEASE, AUTOSOMAL DOMINANT, 2; ADTKD2
174050	POLYCYSTIC LIVER DISEASE 1 WITH OR WITHOUT KIDNEY CYSTS; PCLD1
174100	MOVED TO 192350
174200	POLYDACTYLY, POSTAXIAL, TYPE A1; PAPA1
174300	OROFACIODIGITAL SYNDROME V; OFD5
174310	POLYDACTYLY, POSTAXIAL, WITH PROGRESSIVE MYOPIA
174400	POLYDACTYLY, PREAXIAL I; PPD1
174500	POLYDACTYLY, PREAXIAL II; PPD2
174600	POLYDACTYLY, PREAXIAL III; PPD3
174700	POLYDACTYLY, PREAXIAL IV; PPD4
174750	POLYKARYOCYTOSIS INDUCER; FUSE
174760	POLYMERASE, DNA, BETA; POLB
174761	POLYMERASE (DNA-DIRECTED), DELTA 1, CATALYTIC SUBUNIT; POLD1
174762	POLYMERASE, DNA, EPSILON; POLE
174763	POLYMERASE, DNA, GAMMA; POLG
174770	ACTINIC PRURIGO
174800	MCCUNE-ALBRIGHT SYNDROME; MAS
174810	FAMILIAL EXPANSILE OSTEOLYSIS; FEO
174880	LYMPHOCYTE CYTOSOL POLYPEPTIDE, 100-KD
174900	JUVENILE POLYPOSIS SYNDROME; JPS
175000	MOVED TO 174900
175020	MOVED TO 619182
175050	JUVENILE POLYPOSIS/HEREDITARY HEMORRHAGIC TELANGIECTASIA SYNDROME; JPHT
175100	FAMILIAL ADENOMATOUS POLYPOSIS 1; FAP1
175200	PEUTZ-JEGHERS SYNDROME; PJS
175400	POLYPOSIS, INTESTINAL, SCATTERED AND DISCRETE
175450	POLYPOSIS, INTESTINAL, WITH MULTIPLE EXOSTOSES
175500	POLYPOSIS, SKIN PIGMENTATION, ALOPECIA, AND FINGERNAIL CHANGES
175505	MOVED TO 619182
175510	GIST-PLUS SYNDROME; GISTPS
175690	POLYSYNDACTYLY, CROSSED
175700	GREIG CEPHALOPOLYSYNDACTYLY SYNDROME; GCPS
175750	POPLITEAL CYST
175780	BRAIN SMALL VESSEL DISEASE 1 WITH OR WITHOUT OCULAR ANOMALIES; BSVD1
175800	POROKERATOSIS 1, MULTIPLE TYPES; POROK1
175850	POROKERATOSIS 2, PALMAR, PLANTAR, AND DISSEMINATED TYPE; POROK2
175860	PALMOPLANTAR KERATODERMA, PUNCTATE TYPE II; PPKP2
175900	POROKERATOSIS 3, MULTIPLE TYPES; POROK3
176000	PORPHYRIA, ACUTE INTERMITTENT; AIP
176010	MOVED TO 176000
176090	PORPHYRIA CUTANEA TARDA, TYPE I
176100	PORPHYRIA CUTANEA TARDA
176200	VARIEGATE PORPHYRIA; VP
176240	POSTAXIAL OLIGODACTYLY, TETRAMELIC
176250	POSTERIOR COLUMN ATAXIA
176256	POTASSIUM CHANNEL, VOLTAGE-GATED, SHAW-RELATED SUBFAMILY, MEMBER 2; KCNC2
176257	POTASSIUM CHANNEL, VOLTAGE-GATED, SHAKER-RELATED SUBFAMILY, MEMBER 6; KCNA6
176258	POTASSIUM CHANNEL, VOLTAGE-GATED, SHAW-RELATED SUBFAMILY, MEMBER 1; KCNC1
176260	POTASSIUM CHANNEL, VOLTAGE-GATED, SHAKER-RELATED SUBFAMILY, MEMBER 1; KCNA1
176261	POTASSIUM CHANNEL, VOLTAGE-GATED, ISK-RELATED SUBFAMILY, MEMBER 1; KCNE1
176262	POTASSIUM CHANNEL, VOLTAGE-GATED, SHAKER-RELATED SUBFAMILY, MEMBER 2; KCNA2
176263	POTASSIUM CHANNEL, VOLTAGE-GATED, SHAKER-RELATED SUBFAMILY, MEMBER 3; KCNA3
176264	POTASSIUM CHANNEL, VOLTAGE-GATED, SHAW-RELATED SUBFAMILY, MEMBER 3; KCNC3
176265	POTASSIUM CHANNEL, VOLTAGE-GATED, SHAW-RELATED SUBFAMILY, MEMBER 4; KCNC4
176266	POTASSIUM CHANNEL, VOLTAGE-GATED, SHAKER-RELATED SUBFAMILY, MEMBER 4; KCNA4
176267	POTASSIUM CHANNEL, VOLTAGE-GATED, SHAKER-RELATED SUBFAMILY, MEMBER 5; KCNA5
176268	POTASSIUM CHANNEL, VOLTAGE-GATED, SHAKER-RELATED SUBFAMILY, MEMBER 7; KCNA7
176269	MOVED TO 176266
176270	PRADER-WILLI SYNDROME; PWS
176290	DELTA-LIKE NONCANONICAL NOTCH LIGAND 1; DLK1
176300	TRANSTHYRETIN; TTR
176305	PREAXIAL DEFICIENCY, POSTAXIAL POLYDACTYLY, AND HYPOSPADIAS
176310	PRE-B-CELL LEUKEMIA TRANSCRIPTION FACTOR 1; PBX1
176311	PRE-B-CELL LEUKEMIA TRANSCRIPTION FACTOR 2; PBX2
176312	PRE-B-CELL LEUKEMIA TRANSCRIPTION FACTOR 3; PBX3
176385	PAPPALYSIN 1; PAPPA
176390	PREGNANCY-SPECIFIC BETA-1-GLYCOPROTEIN 1; PSG1
176391	PREGNANCY-SPECIFIC BETA-1-GLYCOPROTEIN 2; PSG2
176392	PREGNANCY-SPECIFIC BETA-1-GLYCOPROTEIN 3; PSG3
176393	PREGNANCY-SPECIFIC BETA-1-GLYCOPROTEIN 4; PSG4
176394	PREGNANCY-SPECIFIC BETA-1-GLYCOPROTEIN 5; PSG5
176395	PREGNANCY-SPECIFIC BETA-1-GLYCOPROTEIN 6; PSG6
176396	PREGNANCY-SPECIFIC BETA-1-GLYCOPROTEIN 7; PSG7
176397	PREGNANCY-SPECIFIC BETA-1-GLYCOPROTEIN 8; PSG8
176398	PREGNANCY-SPECIFIC BETA-1-GLYCOPROTEIN 9; PSG9
176399	PREGNANCY-SPECIFIC BETA-1-GLYCOPROTEIN 10, PSEUDOGENE; PSG10P
176400	PRECOCIOUS PUBERTY, CENTRAL, 1; CPPB1
176401	PREGNANCY-SPECIFIC BETA-1-GLYCOPROTEIN 11; PSG11
176410	PRECOCIOUS PUBERTY, MALE-LIMITED
176420	PREGNANCY ZONE PROTEIN; PZP
176430	PREMATURE CHROMATID SEPARATION TRAIT; PCS
176440	MOVED TO 311360
176450	CURRARINO SYNDROME
176500	CEREBRAL AMYLOID ANGIOPATHY, ITM2B-RELATED, 1
176590	PROFILIN 2; PFN2
176600	PRESENILE DEMENTIA, KRAEPELIN TYPE
176610	PROFILIN 1; PFN1
176620	PRIAPISM, FAMILIAL IDIOPATHIC
176630	PRIMARY RELEASE DISORDER OF PLATELETS
176635	PRIMASE POLYPEPTIDE 1; PRIM1
176636	PRIMASE POLYPEPTIDE 2A; PRIM2A
176640	PRION PROTEIN; PRNP
176670	HUTCHINSON-GILFORD PROGERIA SYNDROME; HGPS
176680	MOVED TO 142880
176690	PROGEROID SHORT STATURE WITH PIGMENTED NEVI
176700	PROGNATHISM, MANDIBULAR
176705	PROHIBITIN; PHB
176710	PROCOLLAGEN-PROLINE, 2-OXOGLUTARATE-4-DIOXYGENASE, ALPHA SUBUNIT, ISOFORM 1; P4HA1
176720	PROLACTIN-INDUCIBLE PROTEIN; PIP
176730	INSULIN; INS
176740	PROLIFERATING CELL NUCLEAR ANTIGEN; PCNA
176741	MARKER OF PROLIFERATION KI67; MKI67
176760	PROLACTIN; PRL
176761	PROLACTIN RECEPTOR; PRLR
176763	PEROXIREDOXIN 1; PRDX1
176770	PROLINE-NEGATIVE AUXOTROPH OF HAMSTER, COMPLEMENTATION OF; PROA
176780	PELVIC ORGAN PROLAPSE, SUSCEPTIBILITY TO
176785	PROLYLCARBOXYPEPTIDASE; PRCP
176790	PROCOLLAGEN-PROLINE, 2-OXOGLUTARATE-4-DIOXYGENASE, BETA SUBUNIT; P4HB
176793	PRO-MELANIN-CONCENTRATING HORMONE-LIKE 1, PSEUDOGENE; PMCHL1
176794	PRO-MELANIN-CONCENTRATING HORMONE-LIKE 2, PSEUDOGENE; PMCHL2
176795	PRO-MELANIN-CONCENTRATING HORMONE; PMCH
176797	ZINC FINGER- AND BTB DOMAIN-CONTAINING PROTEIN 16; ZBTB16
176800	PRONATION-SUPINATION OF THE FOREARM, IMPAIRMENT OF
176801	PROSAPOSIN; PSAP
176802	PROSTAGLANDIN E RECEPTOR 1, EP1 SUBTYPE; PTGER1
176803	PROSTAGLANDIN D2 SYNTHASE, BRAIN; PTGDS
176804	PROSTAGLANDIN E RECEPTOR 2, EP2 SUBTYPE; PTGER2
176805	PROSTAGLANDIN-ENDOPEROXIDE SYNTHASE 1; PTGS1
176806	PROSTAGLANDIN E RECEPTOR 3, EP3 SUBTYPE; PTGER3
176807	PROSTATE CANCER
176820	KALLIKREIN-RELATED PEPTIDASE 3; KLK3
176830	PROOPIOMELANOCORTIN; POMC
176842	PROTEASOME SUBUNIT, ALPHA-TYPE, 2; PSMA2
176843	PROTEASOME SUBUNIT, ALPHA-TYPE, 3; PSMA3
176844	PROTEASOME SUBUNIT, ALPHA-TYPE, 5; PSMA5
176845	PROTEASOME COMPONENT 8; PSC8
176846	PROTEASOME SUBUNIT, ALPHA-TYPE, 4; PSMA4
176847	PROTEASOME 20S SUBUNIT, BETA-TYPE, 10; PSMB10
176851	PROTEIN-L-ISOASPARTATE (D-ASPARTATE) O-METHYLTRANSFERASE; PCMT1
176860	THROMBOPHILIA DUE TO PROTEIN C DEFICIENCY, AUTOSOMAL DOMINANT; THPH3
176870	ALPHA-1 MICROGLOBULIN/BIKUNIN PRECURSOR; AMBP
176871	EUKARYOTIC TRANSLATION INITIATION FACTOR 2-ALPHA KINASE 2; EIF2AK2
176872	MITOGEN-ACTIVATED PROTEIN KINASE KINASE 1; MAP2K1
176873	CYCLIN-DEPENDENT KINASE 11B; CDK11B
176874	MOVED TO 114085
176875	PROTEIN PHOSPHATASE 1, CATALYTIC SUBUNIT, ALPHA ISOFORM; PPP1CA
176876	PROTEIN-TYROSINE PHOSPHATASE, NONRECEPTOR-TYPE, 11; PTPN11
176877	PROTEIN-TYROSINE PHOSPHATASE, NONRECEPTOR-TYPE, 3; PTPN3
176878	PROTEIN-TYROSINE PHOSPHATASE, NONRECEPTOR-TYPE, 4; PTPN4
176879	PROTEIN-TYROSINE PHOSPHATASE, NONRECEPTOR-TYPE, 5; PTPN5
176880	PROTEIN S; PROS1
176882	PROTEIN-TYROSINE PHOSPHATASE, RECEPTOR-TYPE, BETA; PTPRB
176883	PROTEIN-TYROSINE PHOSPHATASE, NONRECEPTOR-TYPE, 6; PTPN6
176884	PROTEIN-TYROSINE PHOSPHATASE, RECEPTOR-TYPE, ALPHA; PTPRA
176885	PROTEIN-TYROSINE PHOSPHATASE, NONRECEPTOR-TYPE, 1; PTPN1
176886	PROTEIN-TYROSINE PHOSPHATASE, RECEPTOR-TYPE, GAMMA; PTPRG
176887	PROTEIN-TYROSINE PHOSPHATASE, NONRECEPTOR-TYPE, 2; PTPN2
176888	PROTEIN-TYROSINE PHOSPHATASE, RECEPTOR-TYPE, MU; PTPRM
176889	PROTEIN-TYROSINE PHOSPHATASE, NONRECEPTOR-TYPE, 7; PTPN7
176891	PROTEIN-TYROSINE PHOSPHATASE, RECEPTOR-TYPE, ZETA-1; PTPRZ1
176892	PROTEIN KINASE, cAMP-DEPENDENT, CATALYTIC, BETA; PRKACB
176893	PROTEIN KINASE, cAMP-DEPENDENT, CATALYTIC, GAMMA; PRKACG
176894	PROTEIN KINASE, cGMP-DEPENDENT, REGULATORY, TYPE I; PRKG1
176895	PROTEIN Z; PROZ
176900	PROTEOLYTIC CAPACITY OF PLASMA
176910	PROTEIN KINASE, cAMP-DEPENDENT, REGULATORY, TYPE II, ALPHA; PRKAR2A
176911	PROTEIN KINASE, cAMP-DEPENDENT, REGULATORY, TYPE I, BETA; PRKAR1B
176912	PROTEIN KINASE, cAMP-DEPENDENT, REGULATORY, TYPE II, BETA; PRKAR2B
176914	PROTEIN PHOSPHATASE 1, CATALYTIC SUBUNIT, GAMMA ISOFORM; PPP1CC
176915	PROTEIN PHOSPHATASE 2, CATALYTIC SUBUNIT, ALPHA ISOFORM; PPP2CA
176916	PROTEIN PHOSPHATASE 2, CATALYTIC SUBUNIT, BETA ISOFORM; PPP2CB
176920	PROTEUS SYNDROME
176930	COAGULATION FACTOR II; F2
176940	S100 CALCIUM-BINDING PROTEIN A1; S100A1
176941	TYROSINE KINASE 2; TYK2
176942	FPS/FES-RELATED TYROSINE KINASE; FER
176943	FIBROBLAST GROWTH FACTOR RECEPTOR 2; FGFR2
176944	MOVED TO 134935
176945	EPHRIN RECEPTOR EphA8; EPHA8
176946	EPHRIN RECEPTOR EphA2; EPHA2
176947	ZETA-CHAIN-ASSOCIATED PROTEIN KINASE; ZAP70
176948	MITOGEN-ACTIVATED PROTEIN KINASE 1; MAPK1
176949	MITOGEN-ACTIVATED PROTEIN KINASE 4; MAPK4
176950	MOVED TO 262890
176960	PROTEIN KINASE C, ALPHA; PRKCA
176970	PROTEIN KINASE C, BETA; PRKCB
176975	PROTEIN KINASE C, EPSILON; PRKCE
176977	PROTEIN KINASE C, DELTA; PRKCD
176980	PROTEIN KINASE C, GAMMA; PRKCG
176981	RECEPTOR FOR ACTIVATED PROTEIN KINASE C, 1; RACK1
176982	PROTEIN KINASE C, ZETA FORM; PRKCZ
176990	S100 CALCIUM-BINDING PROTEIN, BETA; S100B
176991	S100 CALCIUM-BINDING PROTEIN A5; S100A5
176992	S100 CALCIUM-BINDING PROTEIN A3; S100A3
176993	S100 CALCIUM-BINDING PROTEIN A2; S100A2
177000	PROTOPORPHYRIA, ERYTHROPOIETIC, 1; EPP1
177010	SERPIN PEPTIDASE INHIBITOR, CLADE E (NEXIN, PLASMINOGEN ACTIVATOR INHIBITOR TYPE 1), MEMBER 2; SERPINE2
177015	PROTEIN SERINE KINASE H1; PSKH1
177020	PROTEINASE 3; PRTN3
177030	MOVED TO 176880
177040	SERGLYCIN; SRGN
177045	PROTEASOME SUBUNIT, BETA-TYPE, 9; PSMB9
177046	PROTEASOME SUBUNIT, BETA-TYPE, 8; PSMB8
177050	PROTRUSIO ACETABULI
177060	PROTEIN KINASE C SUBSTRATE, 80-KD, HEAVY CHAIN; PRKCSH
177061	MYRISTOYLATED ALANINE-RICH PROTEIN KINASE C SUBSTRATE; MARCKS
177070	PROTEIN 4.2, ERYTHROCYTIC; EPB42
177075	MAF bZIP TRANSCRIPTION FACTOR; MAF
177100	PRURITUS, HEREDITARY LOCALIZED
177150	MOVED TO 177170
177170	PSEUDOACHONDROPLASIA; PSACH
177200	LIDDLE SYNDROME 1; LIDLS1
177300	PSEUDOARTHROGRYPOSIS
177350	PSEUDOATROPHODERMA COLLI
177400	BUTYRYLCHOLINESTERASE; BCHE
177500	MOVED TO 177400
177600	PSEUDOCHOLINESTERASE, INCREASE IN PLASMA LEVEL OF
177650	EXFOLIATION SYNDROME; XFS
177700	GLAUCOMA 1, OPEN ANGLE, P; GLC1P
177720	MOVED TO 194380
177735	PSEUDOHYPOALDOSTERONISM, TYPE I, AUTOSOMAL DOMINANT; PHA1A
177750	PSEUDOMONILETHRIX
177800	PSEUDOPAPILLEDEMA
177820	VON WILLEBRAND DISEASE, PLATELET-TYPE; VWDP
177850	PSEUDOXANTHOMA ELASTICUM, FORME FRUSTE
177860	REMOVED FROM DATABASE
177900	PSORIASIS 1, SUSCEPTIBILITY TO; PSORS1
177980	PTERYGIA, IMPAIRED INTELLECTUAL DEVELOPMENT, AND DISTINCTIVE CRANIOFACIAL FEATURES
177990	PTERYGIUM COLLI, ISOLATED
178000	PTERYGIUM OF CONJUNCTIVA AND CORNEA
178110	CONTRACTURES, PTERYGIA, AND SPONDYLOCARPOTARSAL FUSION SYNDROME 1A; CPSFS1A
178200	PTERYGIUM, ANTECUBITAL
178300	PTOSIS, HEREDITARY CONGENITAL 1; PTOS1
178330	PTOSIS, STRABISMUS, AND ECTOPIC PUPILS
178350	PUBIC BONE DYSPLASIA
178370	PULMONARY ATRESIA WITH VENTRICULAR SEPTAL DEFECT
178400	PULMONARY EDEMA OF MOUNTAINEERS, SUSCEPTIBILITY TO
178500	INTERSTITIAL LUNG DISEASE 2; ILD2
178550	PULMONARY HEMOSIDEROSIS
178600	PULMONARY HYPERTENSION, PRIMARY, 1; PPH1
178610	PULMONARY NODULAR LYMPHOID HYPERPLASIA, FAMILIAL
178620	SURFACTANT, PULMONARY-ASSOCIATED PROTEIN C; SFTPC
178630	SURFACTANT, PULMONARY-ASSOCIATED PROTEIN A1; SFTPA1
178635	SURFACTANT, PULMONARY-ASSOCIATED PROTEIN D; SFTPD
178640	SURFACTANT, PULMONARY-ASSOCIATED PROTEIN B; SFTPB
178642	SURFACTANT, PULMONARY-ASSOCIATED PROTEIN A2; SFTPA2
178650	PULMONIC STENOSIS, ATRIAL SEPTAL DEFECT, AND UNIQUE ELECTROCARDIOGRAPHIC ABNORMALITIES
178651	PULMONIC STENOSIS AND DEAFNESS
178800	PUPIL, EGG-SHAPED
178900	PUPILLARY MEMBRANE, PERSISTENCE OF
178990	MATRIX METALLOPROTEINASE 7; MMP7
178995	PRURITIC URTICARIAL PAPULES AND PLAQUES OF PREGNANCY; PUPPP
179000	PURPURA SIMPLEX
179010	PYLORIC STENOSIS, INFANTILE HYPERTROPHIC, 1; IHPS1
179020	PYRIDOXAL KINASE; PDXK
179030	PYROPHOSPHATASE, INORGANIC, 1; PPA1
179035	PYRROLINE-5-CARBOXYLATE REDUCTASE 1; PYCR1
179040	MOVED TO 179050
179050	PYRUVATE KINASE, MUSCLE; PKM
179060	PYRUVATE DEHYDROGENASE, BETA POLYPEPTIDE; PDHB
179061	PYRUVATE DEHYDROGENASE, ALPHA-2; PDHA2
179080	RAB GERANYLGERANYL TRANSFERASE, BETA SUBUNIT; RABGGTB
179090	MOVED TO 164730
179095	UBIQUITIN-CONJUGATING ENZYME E2 B; UBE2B
179200	RADIAL HEADS, POSTERIOR DISLOCATION OF
179250	RADIAL HYPOPLASIA, TRIPHALANGEAL THUMBS, HYPOSPADIAS, AND MAXILLARY DIASTEMA
179270	RADIAL RAY HYPOPLASIA WITH CHOANAL ATRESIA
179280	RADIAL-RENAL SYNDROME
179300	RADIOULNAR SYNOSTOSIS, NONSYNDROMIC, SUSCEPTIBILITY TO; RUS
179400	RADIUS, APLASIA OF, WITH CLEFT LIP/PALATE
179410	RADIXIN; RDX
179450	RAGWEED SENSITIVITY
179490	RAS-ASSOCIATED PROTEIN RAB3A; RAB3A
179500	RAINDROP HYPOPIGMENTATION
179502	RAP1, GTPase-GDP DISSOCIATION STIMULATOR 1; RAP1GDS1
179503	RRAD RAS-RELATED GLYCOLYSIS INHIBITOR AND CALCIUM CHANNEL REGULATOR; RRAD
179505	RAS HOMOLOG GENE FAMILY, MEMBER G; RHOG
179508	RAS-ASSOCIATED PROTEIN RAB1; RAB1
179509	RAS-ASSOCIATED PROTEIN RAB2; RAB2
179510	RAS-ASSOCIATED PROTEIN RAB3B; RAB3B
179511	RAS-ASSOCIATED PROTEIN RAB4A; RAB4A
179512	RAS-ASSOCIATED PROTEIN RAB5A; RAB5A
179513	RAS-ASSOCIATED PROTEIN RAB6A; RAB6A
179514	RAS-ASSOCIATED PROTEIN RAB5B; RAB5B
179520	RAS-RELATED PROTEIN 1A; RAP1A
179530	RAS-RELATED PROTEIN 1B; RAP1B
179540	RAS-RELATED PROTEIN 2A; RAP2A
179541	RAS-RELATED PROTEIN 2B; RAP2B
179550	RAS-LIKE PROTOONCOGENE A; RALA
179551	RAS-LIKE PROTOONCOGENE B; RALB
179555	RAS SUPPRESSOR PROTEIN 1; RSU1
179590	PROTEIN-TYROSINE PHOSPHATASE, RECEPTOR-TYPE, F; PTPRF
179600	RAYNAUD DISEASE
179605	PERIPHERIN 2; PRPH2
179610	EPHRIN RECEPTOR EphA1; EPHA1
179611	EPHRIN RECEPTOR EphA3; EPHA3
179613	RECOMBINANT CHROMOSOME 8 SYNDROME
179615	RECOMBINATION-ACTIVATING GENE 1; RAG1
179616	RECOMBINATION-ACTIVATING GENE 2; RAG2
179617	RAD51 RECOMBINASE; RAD51
179618	RECOVERIN; RCVRN
179620	RAPH BLOOD GROUP SYSTEM
179650	RED CELL PERMEABILITY DEFECT
179700	RED CELL PHOSPHOLIPID DEFECT WITH HEMOLYSIS
179710	REGULATOR OF CHROMOSOME CONDENSATION 1; RCC1
179715	REMOVED FROM DATABASE
179730	RELAXIN 1; RLN1
179740	RELAXIN 2; RLN2
179755	PROLINE-RICH MITOTIC CHECKPOINT CONTROL FACTOR; PRCC
179760	MOVED TO 144700
179770	MOVED TO 144700
179780	DIPEPTIDASE 1; DPEP1
179800	RENAL TUBULAR ACIDOSIS, DISTAL, 1; DRTA1
179820	RENIN; REN
179830	RENAL TUBULAR ACIDOSIS, PROXIMAL
179835	REPLICATION PROTEIN A1, 70-KD; RPA1
179836	REPLICATION PROTEIN A2, 32-KD; RPA2
179837	REPLICATION PROTEIN A3, 14-KD; RPA3
179838	CAP-GLY DOMAIN-CONTAINING LINKER PROTEIN 1; CLIP1
179840	RETICULAR DYSTROPHY OF RETINAL PIGMENT EPITHELIUM
179850	DOWLING-DEGOS DISEASE 1; DDD1
179900	RETINAL APLASIA
180000	RETINAL ARTERIES, TORTUOSITY OF; RATOR
180020	RETINAL CONE DYSTROPHY 1; RCD1
180040	RD3 REGULATOR OF GUCY2D; RD3
180050	RETINAL DETACHMENT
180060	MOVED TO 152950
180069	RETINOID ISOMEROHYDROLASE RPE65; RPE65
180070	MOVED TO 221900
180071	PHOSPHODIESTERASE 6A; PDE6A
180072	PHOSPHODIESTERASE 6B; PDE6B
180073	PHOSPHODIESTERASE 6G; PDE6G
180080	RETINAL VENOUS BEADING
180090	RETINALDEHYDE-BINDING PROTEIN 1; RLBP1
180100	RETINITIS PIGMENTOSA 1; RP1
180102	MOVED TO 180380
180103	MOVED TO 500004
180104	RETINITIS PIGMENTOSA 9; RP9
180105	RETINITIS PIGMENTOSA 10; RP10
180190	RETINOIC ACID RECEPTOR, GAMMA; RARG
180200	RETINOBLASTOMA; RB1
180201	AT-RICH INTERACTION DOMAIN-CONTAINING PROTEIN 4A; ARID4A
180202	LYSINE DEMETHYLASE 5A; KDM5A
180203	RB TRANSCRIPTIONAL COREPRESSOR-LIKE 2; RBL2
180210	RETINOPATHY, PERICENTRAL PIGMENTARY, DOMINANT
180220	RETINOIC ACID RECEPTOR, BETA; RARB
180230	RETINOIC ACID-BINDING PROTEIN, CELLULAR, TYPE I; CRABP1
180231	RETINOIC ACID-BINDING PROTEIN, CELLULAR, TYPE II; CRABP2
180240	RETINOIC ACID RECEPTOR, ALPHA; RARA
180245	RETINOID X RECEPTOR, ALPHA; RXRA
180246	RETINOID X RECEPTOR, BETA; RXRB
180247	RETINOID X RECEPTOR, GAMMA; RXRG
180250	RETINOL-BINDING PROTEIN 4; RBP4
180260	RETINOL-BINDING PROTEIN 1; RBP1
180270	RETINOSCHISIS, AUTOSOMAL DOMINANT
180280	RETINOL-BINDING PROTEIN 2; RBP2
180290	RETINOL-BINDING PROTEIN 3; RBP3
180295	RHABDOMYOSARCOMA, EMBRYONAL, 2; RMSE2
180297	RHESUS BLOOD GROUP-ASSOCIATED GLYCOPROTEIN; RHAG
180300	RHEUMATOID ARTHRITIS; RA
180330	REMOVED FROM DATABASE
180350	RHEUMATOID NODULOSIS
180360	RHINY
180370	THIOSULFATE SULFURTRANSFERASE; TST
180380	RHODOPSIN; RHO
180381	G PROTEIN-COUPLED RECEPTOR KINASE 1; GRK1
180385	LIM DOMAIN ONLY 2; LMO2
180386	LIM DOMAIN ONLY 3; LMO3
180390	RIBONUCLEOTIDE REDUCTASE REGULATORY SUBUNIT M2; RRM2
180410	RIBONUCLEOTIDE REDUCTASE CATALYTIC SUBUNIT M1; RRM1
180420	RNA, 5S RIBOSOMAL, GENE CLUSTER 1; RN5S1@
180430	RIBOSE 5-PHOSPHATE ISOMERASE A; RPIA
180435	RIBONUCLEASE L; RNASEL
180440	RIBONUCLEASE, RNase A FAMILY, 1; RNASE1
180450	RIBOSOMAL RNA 1; RNR1
180451	RIBOSOMAL RNA 2; RNR2
180452	RIBOSOMAL RNA 3; RNR3
180453	RIBOSOMAL RNA 4; RNR4
180454	RIBOSOMAL RNA 5; RNR5
180460	RIBOSOMAL PROTEIN S6; RPS6
180461	MOVED TO 180472
180462	MOVED TO 180472
180463	RIBOSOMAL PROTEIN S20A; RPS20A
180464	RIBOSOMAL PROTEIN S20B; RPS20B
180465	RIBOSOMAL PROTEIN S25; RPS25
180466	RIBOSOMAL PROTEIN L19; RPL19
180467	RIBOSOMAL PROTEIN L30; RPL30
180468	RIBOSOMAL PROTEIN L35A; RPL35A
180469	RIBOSOMAL PROTEIN L36A-LIKE; RPL36AL
180470	RIBOPHORIN I; RPN1
180471	RIBOSOMAL PROTEIN S11; RPS11
180472	RIBOSOMAL PROTEIN S17; RPS17
180473	RIBOSOMAL PROTEIN S18; RPS18
180474	RIBOSOMAL PROTEIN L22; RPL22
180475	RIBOSOMAL PROTEIN L12; RPL12
180476	RIBOSOMAL PROTEIN S13; RPS13
180477	RIBOSOMAL PROTEIN S21; RPS21
180478	RIBOSOMAL PROTEIN S3a; RPS3A
180479	RIBOSOMAL PROTEIN L4; RPL4
180480	RIBULOSE 5-PHOSPHATE 3-EPIMERASE; RPE
180490	RIBOPHORIN II; RPN2
180500	AXENFELD-RIEGER SYNDROME, TYPE 1; RIEG1
180510	RIBOSOMAL PROTEIN LATERAL STALK SUBUNIT P0; RPLP0
180520	RIBOSOMAL PROTEIN LATERAL STALK SUBUNIT P1; RPLP1
180530	RIBOSOMAL PROTEIN LATERAL STALK SUBUNIT P2; RPLP2
180535	RIBOSOMAL PROTEIN S15; RPS15
180540	MOVED TO 131410
180550	RING DERMOID OF CORNEA; RDC
180600	RINGED HAIR
180610	REARRANGED LMYC FUSION; RLF
180620	tRNA INITIATOR METHIONINE (ANTICODON CAT) 2-1; TRX-CAT2-1
180621	tRNA INITIATOR METHIONINE (ANTICODON CAT) 1-2; TRX-CAT1-2
180630	DEAD-BOX HELICASE 5; DDX5
180640	tRNA GLUTAMIC ACID (ANTICODON TTC) 3-1; TRE-TTC3-1
180645	SMALL NUCLEOLAR RNA, H/ACA BOX, 73A; SNORA73A
180646	SMALL NUCLEOLAR RNA, H/ACA BOX, 62; SNORA62
180647	SMALL NUCLEOLAR RNA, H/ACA BOX, 63; SNORA63
180660	POLYMERASE II, RNA, SUBUNIT A; POLR2A
180661	POLYMERASE II, RNA, SUBUNIT B; POLR2B
180662	POLYMERASE II, RNA, SUBUNIT I; POLR2I
180663	POLYMERASE II, RNA, SUBUNIT C; POLR2C
180664	POLYMERASE II, RNA, SUBUNIT E; POLR2E
180670	RNA POLYMERASE III TRANSCRIPTIONAL UNITS
180680	RNA, U1A SMALL NUCLEAR; RNU1A
180690	RNA, U2 SMALL NUCLEAR, 1; RNU2-1
180691	RNA, U5A SMALL NUCLEAR 1; RNU5A-1
180692	RNA, U6 SMALL NUCLEAR, 1; RNU6-1
180700	ROBINOW SYNDROME, AUTOSOMAL DOMINANT 1; DRS1
180710	SMALL NUCLEOLAR RNA, C/D BOX, 3A; SNORD3A
180720	MOVED TO 180680
180721	ROD OUTER SEGMENT PROTEIN 1; ROM1
180730	ROMBO SYNDROME
180740	SMALL NUCLEAR RIBONUCLEOPROTEIN, U1 SUBUNIT, 70-KD; SNRNP70
180750	ROBINOW-SORAUF SYNDROME
180800	ROUSSY-LEVY HEREDITARY AREFLEXIC DYSTASIA
180840	MOVED TO 601625
180849	RUBINSTEIN-TAYBI SYNDROME 1; RSTS1
180850	MOVED TO 180849
180860	SILVER-RUSSELL SYNDROME 1; SRS1
180870	RUVALCABA SYNDROME
180900	RUTHERFURD SYNDROME
180901	RYANODINE RECEPTOR 1; RYR1
180902	RYANODINE RECEPTOR 2; RYR2
180903	RYANODINE RECEPTOR 3; RYR3
180910	SALIVARY ESTERASE
180920	APLASIA OF LACRIMAL AND SALIVARY GLANDS; ALSG
180930	REMOVED FROM DATABASE
180940	REMOVED FROM DATABASE
180950	SALIVARY SUBSTANCE, CLOSTRIDIUM BOTULINUM TYPE
180960	S-ADENOSYLHOMOCYSTEINE HYDROLASE; AHCY
180980	S-ADENOSYLMETHIONINE DECARBOXYLASE; AMD1
180989	PROLINE-RICH PROTEIN, BstNI SUBFAMILY, 1; PRB1
180990	PROLINE-RICH PROTEIN, BstNI SUBFAMILY, 4; PRB4
181000	SARCOIDOSIS, SUSCEPTIBILITY TO, 1; SS1
181010	SALIVARY DUCT CALCULI
181030	SALIVARY GLAND ADENOMA, PLEOMORPHIC
181031	S-ANTIGEN; SAG
181035	TETRASPANIN 31; TSPAN31
181180	SAY SYNDROME
181200	SC(1) TRAIT OF SALIVA
181250	SCALP DEFECTS AND POSTAXIAL POLYDACTYLY
181270	SCALP-EAR-NIPPLE SYNDROME; SENS
181300	SCAPULA, CONTOUR OF VERTEBRAL BORDER OF
181350	EMERY-DREIFUSS MUSCULAR DYSTROPHY 2, AUTOSOMAL DOMINANT; EDMD2
181400	SCAPULOPERONEAL SYNDROME, NEUROGENIC, KAESER TYPE; SCPNK
181405	SCAPULOPERONEAL SPINAL MUSCULAR ATROPHY; SPSMA
181430	MOVED TO 608358
181440	SCHEUERMANN DISEASE
181450	ULNAR-MAMMARY SYNDROME; UMS
181460	SCHISTOSOMA MANSONI INFECTION, SUSCEPTIBILITY/RESISTANCE TO
181500	SCHIZOPHRENIA; SCZD
181510	SCHIZOPHRENIA 1; SCZD1
181515	MOVED TO 300977
181520	MOVED TO 104640
181590	SCL/TAL1-INTERRUPTING LOCUS; STIL
181600	HURIEZ SYNDROME; HRZ
181700	SCLEROCORNEA, AUTOSOMAL DOMINANT
181750	SCLERODERMA, FAMILIAL PROGRESSIVE
181800	SCOLIOSIS, ISOLATED, SUSCEPTIBILITY TO, 1; IS1
182000	KERATOSIS, SEBORRHEIC
182090	SIMIAN SARCOMA-ASSOCIATED VIRUS-1/GIBBON APE LEUKEMIA VIRUS; SSAV1
182098	SECRETIN RECEPTOR; SCTR
182099	SECRETIN; SCT
182100	FUCOSYLTRANSFERASE 2; FUT2
182115	CYTOHESIN 1; CYTH1
182120	SECRETED PROTEIN, ACIDIC, CYSTEINE-RICH; SPARC
182125	SEPIAPTERIN REDUCTASE; SPR
182128	SERINE DEHYDRATASE; SDS
182131	5-HYDROXYTRYPTAMINE RECEPTOR 1B; HTR1B
182132	5-HYDROXYTRYPTAMINE RECEPTOR 1E; HTR1E
182133	5-HYDROXYTRYPTAMINE RECEPTOR 1D; HTR1D
182134	5-HYDROXYTRYPTAMINE RECEPTOR 1F; HTR1F
182135	5-HYDROXYTRYPTAMINE RECEPTOR 2A; HTR2A
182137	5-HYDROXYTRYPTAMINE RECEPTOR 7; HTR7
182138	SOLUTE CARRIER FAMILY 6 (NEUROTRANSMITTER TRANSPORTER, SEROTONIN), MEMBER 4; SLC6A4
182139	5-HYDROXYTRYPTAMINE RECEPTOR 3A; HTR3A
182140	SEMENOGELIN I; SEMG1
182141	SEMENOGELIN II; SEMG2
182143	MOVED TO 177040
182144	SERINE HYDROXYMETHYLTRANSFERASE, CYTOSOLIC; SHMT1
182145	SERUM PROTEIN POLYMORPHISM M-158
182150	SIMOSA CRANIOFACIAL SYNDROME
182160	SIALOPHORIN; SPN
182170	ANEMIA, SIDEROBLASTIC, 4; SIDBA4
182175	SIGNAL RECOGNITION PARTICLE, 19-KD; SRP19
182180	SRP RECEPTOR SUBUNIT, ALPHA; SRPRA
182190	SINUS NODE DISEASE AND MYOPIA
182200	SELLA TURCICA, BRIDGED
182203	MOVED TO 162643
182205	SEX HORMONE-BINDING GLOBULIN; SHBG
182210	SHPRINTZEN OMPHALOCELE SYNDROME
182212	SHPRINTZEN-GOLDBERG CRANIOSYNOSTOSIS SYNDROME; SGS
182220	SISTER CHROMATID EXCHANGE, FREQUENCY OF
182230	SEPTOOPTIC DYSPLASIA
182250	SINGLETON-MERTEN SYNDROME 1; SGMRT1
182255	SKELETAL DYSPLASIA WITH DELAYED EPIPHYSEAL AND CARPAL BONE OSSIFICATION
182257	PROTEINASE INHIBITOR 3; PI3
182260	SLIPPED FEMORAL CAPITAL EPIPHYSES
182265	SMALL PROLINE-RICH PROTEIN 1A; SPRR1A
182266	SMALL PROLINE-RICH PROTEIN 1B; SPRR1B
182267	SMALL PROLINE-RICH PROTEIN 2A; SPRR2A
182268	SMALL PROLINE-RICH PROTEIN 2B; SPRR2B
182269	SMALL PROLINE-RICH PROTEIN 2C, PSEUDOGENE; SPRR2C
182270	KETONE COMPOUNDS, ABILITY TO SMELL
182271	SMALL PROLINE-RICH PROTEIN 3; SPRR3
182279	SMALL NUCLEAR RIBONUCLEOPROTEIN POLYPEPTIDE N; SNRPN
182280	SMALL CELL CANCER OF THE LUNG
182281	CHEMOKINE, CC MOTIF, LIGAND 1; CCL1
182282	SMALL NUCLEAR RIBONUCLEOPROTEIN POLYPEPTIDES B AND B1; SNRPB
182283	CHEMOKINE, CC MOTIF, LIGAND 3; CCL3
182284	CHEMOKINE, CC MOTIF, LIGAND 4; CCL4
182285	SMALL NUCLEAR RIBONUCLEOPROTEIN POLYPEPTIDE A; SNRPA
182290	SMITH-MAGENIS SYNDROME; SMS
182305	SOLUTE CARRIER FAMILY 8 (SODIUM-CALCIUM EXCHANGER), MEMBER A1; SLC8A1
182307	SOLUTE CARRIER FAMILY 9, MEMBER 3; SLC9A3
182308	SOLUTE CARRIER FAMILY 17 (ORGANIC ANION COTRANSPORTER), MEMBER 1; SLC17A1
182309	SOLUTE CARRIER FAMILY 34 (TYPE II SODIUM/PHOSPHATE COTRANSPORTER), MEMBER 1; SLC34A1
182310	ATPase, Na+/K+ TRANSPORTING, ALPHA-1 POLYPEPTIDE; ATP1A1
182330	ATPase, Na+/K+ TRANSPORTING, BETA-1 POLYPEPTIDE; ATP1B1
182331	ATPase, Na+/K+ TRANSPORTING, BETA-2 POLYPEPTIDE; ATP1B2
182340	ATPase, Na+/K+ TRANSPORTING, ALPHA-2 POLYPEPTIDE; ATP1A2
182350	ATPase, Na+/K+ TRANSPORTING, ALPHA-3 POLYPEPTIDE; ATP1A3
182360	ATPase, H+/K+ TRANSPORTING, NONGASTRIC, ALPHA POLYPEPTIDE; ATP12A
182370	MOVED TO 182330
182380	SOLUTE CARRIER FAMILY 5 (SODIUM/GLUCOSE COTRANSPORTER), MEMBER 1; SLC5A1
182381	SOLUTE CARRIER FAMILY 5 (SODIUM/GLUCOSE COTRANSPORTER), MEMBER 2; SLC5A2
182389	SODIUM VOLTAGE-GATED CHANNEL, ALPHA SUBUNIT 1; SCN1A
182390	SODIUM VOLTAGE-GATED CHANNEL, ALPHA SUBUNIT 2; SCN2A
182391	SODIUM VOLTAGE-GATED CHANNEL, ALPHA SUBUNIT 3; SCN3A
182392	SODIUM VOLTAGE-GATED CHANNEL, ALPHA SUBUNIT 7; SCN7A
182396	SOLUTE CARRIER FAMILY 10 (SODIUM/BILE ACID COTRANSPORTER FAMILY), MEMBER 1; SLC10A1
182400	SOMATOMEDIN, EMBRYONIC
182410	SNEDDON SYNDROME; SNDNS
182450	SOMATOSTATIN; SST
182451	SOMATOSTATIN RECEPTOR 1; SSTR1
182452	SOMATOSTATIN RECEPTOR 2; SSTR2
182453	SOMATOSTATIN RECEPTOR 3; SSTR3
182454	SOMATOSTATIN RECEPTOR 4; SSTR4
182455	SOMATOSTATIN RECEPTOR 5; SSTR5
182465	SON DNA-BINDING PROTEIN; SON
182500	SORBITOL DEHYDROGENASE; SORD
182520	SORCIN; SRI
182530	SOS RAS/RAC GUANINE NUCLEOTIDE EXCHANGE FACTOR 1; SOS1
182590	TREFOIL FACTOR 2; TFF2
182600	SPASTIC PARAPLEGIA 3, AUTOSOMAL DOMINANT; SPG3A
182601	SPASTIC PARAPLEGIA 4, AUTOSOMAL DOMINANT; SPG4
182610	SPASTIC PARAPLEGIA, EPILEPSY, AND MENTAL RETARDATION; SPEMR
182690	SPASTIC PARAPLEGIA, SENSORINEURAL DEAFNESS, MENTAL RETARDATION, AND PROGRESSIVE NEPHROPATHY
182700	MOVED TO 270685
182790	SPECTRIN, BETA, NONERYTHROCYTIC, 1; SPTBN1
182800	SPASTIC PARAPLEGIA WITH ASSOCIATED EXTRAPYRAMIDAL SIGNS
182810	SPECTRIN, ALPHA, NONERYTHROCYTIC 1; SPTAN1
182815	SPASTIC PARAPLEGIA WITH NEUROPATHY AND POIKILODERMA
182820	SPASTIC PARAPLEGIA WITH PRECOCIOUS PUBERTY
182830	SPASTIC PARAPLEGIA, OPTIC ATROPHY, AND DEMENTIA
182860	SPECTRIN, ALPHA, ERYTHROCYTIC 1; SPTA1
182870	SPECTRIN, BETA, ERYTHROCYTIC; SPTB
182875	SPEECH DEVELOPMENT, DELAYED, WITH FACIAL ASYMMETRY, STRABISMUS, AND TRANSVERSE EARLOBE CREASE
182878	OUTER DENSE FIBER OF SPERM TAILS 1; ODF1
182879	MOVED TO 104776
182880	SPERM PROTAMINE P1; PRM1
182882	SPERM PROTAMINE P4; PRM4
182888	ZONA PELLUCIDA GLYCOPROTEIN 2; ZP2
182889	ZONA PELLUCIDA GLYCOPROTEIN 3; ZP3
182890	SPERM PROTAMINE P2; PRM2
182891	SPERMIDINE SYNTHASE; SRM
182892	MOVED TO 300105
182900	SPHEROCYTOSIS, TYPE 1; SPH1
182920	MOVED TO 609200
182930	MOVED TO 167800
182940	NEURAL TUBE DEFECTS, SUSCEPTIBILITY TO; NTD
182950	SPINAL ARACHNOIDITIS
182960	NEURONOPATHY, DISTAL HEREDITARY MOTOR, AUTOSOMAL DOMINANT 1; HMND1
182970	SPINAL MUSCULAR ATROPHY, FACIOSCAPULOHUMERAL TYPE
182980	SPINAL MUSCULAR ATROPHY, LATE-ONSET, FINKEL TYPE; SMAFK
182990	SPINAL INTRADURAL ARACHNOID CYSTS
183000	MOVED TO 137440
183020	SPINAL MUSCULAR ATROPHY, SEGMENTAL
183050	SPINOCEREBELLAR ATAXIA WITH RIGIDITY AND PERIPHERAL NEUROPATHY
183085	MOVED TO 109150
183086	SPINOCEREBELLAR ATAXIA 6; SCA6
183090	SPINOCEREBELLAR ATAXIA 2; SCA2
183100	SPINOCEREBELLAR ATROPHY WITH PUPILLARY PARALYSIS
183250	REMOVED FROM DATABASE
183300	SPLENOGONADAL FUSION WITH LIMB DEFECTS AND MICROGNATHIA
183350	SPLENOMEGALY SYNDROME WITH SPLENIC GERMINAL CENTER HYPOPLASIA AND REDUCED CIRCULATING T HELPER CELLS
183400	SPLIT LOWER LIP
183500	SPLIT-HAND AND SPLIT-FOOT WITH HYPODONTIA
183600	SPLIT-HAND/FOOT MALFORMATION 1; SHFM1
183700	SPLIT-FOOT DEFORMITY WITH MANDIBULOFACIAL DYSOSTOSIS
183800	SPLIT-HAND WITH CONGENITAL NYSTAGMUS, FUNDAL CHANGES, AND CATARACTS
183802	SPLIT-HAND WITH OBSTRUCTIVE UROPATHY, SPINA BIFIDA, AND DIAPHRAGMATIC DEFECTS
183840	SPONDYLOARTHROPATHY, SUSCEPTIBILITY TO, 2; SPDA2
183849	SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH HYPOTRICHOSIS
183850	SPONDYLOEPIPHYSEAL DYSPLASIA WITH PUNCTATE CORNEAL DYSTROPHY
183900	SPONDYLOEPIPHYSEAL DYSPLASIA CONGENITA; SEDC
184000	SPONDYLOEPIPHYSEAL DYSPLASIA, MYOPIA, AND SENSORINEURAL DEAFNESS
184095	SPONDYLOEPIPHYSEAL DYSPLASIA, MAROTEAUX TYPE
184100	SPONDYLOEPIPHYSEAL DYSPLASIA TARDA, AUTOSOMAL DOMINANT
184200	SPONDYLOLISTHESIS
184250	SPONDYLOEPIMETAPHYSEAL DYSPLASIA, STRUDWICK TYPE; SEMDSTWK
184252	SPONDYLOMETAPHYSEAL DYSPLASIA, KOZLOWSKI TYPE; SMDK
184253	SPONDYLOMETAPHYSEAL DYSPLASIA, ALGERIAN TYPE
184255	SPONDYLOMETAPHYSEAL DYSPLASIA, CORNER FRACTURE TYPE; SMDCF
184260	ODONTOCHONDRODYSPLASIA 1; ODCD1
184300	SPONDYLOSIS, CERVICAL
184400	SPRENGEL DEFORMITY
184420	FARNESYLDIPHOSPHATE FARNESYLTRANSFERASE 1; FDFT1
184429	SRY-BOX 2; SOX2
184430	SRY-BOX 4; SOX4
184450	STUTTERING, FAMILIAL PERSISTENT, 1; STUT1
184460	STAPES ANKYLOSIS WITH BROAD THUMBS AND TOES
184470	STATHERIN; STATH
184500	STEATOCYSTOMA MULTIPLEX
184510	STEATOCYSTOMA MULTIPLEX WITH NATAL TEETH
184600	CYSTATIN A; CSTA
184601	MOVED TO 601145
184700	POLYCYSTIC OVARY SYNDROME 1; PCOS1
184705	STEINFELD SYNDROME
184745	KIT LIGAND; KITLG
184747	MOVED TO 136351
184753	STEROID 5-ALPHA-REDUCTASE 1; SRD5A1
184754	MOVED TO 201910
184755	STEROL CARRIER PROTEIN 2; SCP2
184756	STEROL REGULATORY ELEMENT-BINDING TRANSCRIPTION FACTOR 1; SREBF1
184757	NUCLEAR RECEPTOR SUBFAMILY 5, GROUP A, MEMBER 1; NR5A1
184800	STERNUM, PREMATURE OBLITERATION OF SUTURES OF
184840	OTOSPONDYLOMEGAEPIPHYSEAL DYSPLASIA, AUTOSOMAL DOMINANT; OSMEDA
184850	STIFF-PERSON SYNDROME; SPS
184900	STIFF SKIN SYNDROME; SSKS
185000	OVERHYDRATED HEREDITARY STOMATOCYTOSIS; OHST
185010	MOVED TO 194380
185020	CRYOHYDROCYTOSIS; CHC
185050	STORAGE POOL PLATELET DISEASE
185069	STORM SYNDROME
185070	STORMORKEN SYNDROME; STRMK
185100	STRABISMUS, SUSCEPTIBILITY TO
185120	STRATTON-PARKER SYNDROME
185200	STRIAE DISTENSAE, FAMILIAL
185250	MATRIX METALLOPROTEINASE 3; MMP3
185260	MATRIX METALLOPROTEINASE 10; MMP10
185261	MATRIX METALLOPROTEINASE 11; MMP11
185300	STURGE-WEBER SYNDROME; SWS
185400	MOVED TO 150360
185430	CLUSTERIN; CLU
185440	SUPPRESSOR OF TUMORIGENICITY 2; ST2
185450	REMOVED FROM DATABASE
185460	SULFHEMOGLOBINEMIA, CONGENITAL
185470	SUCCINATE DEHYDROGENASE COMPLEX, SUBUNIT B, IRON SULFUR PROTEIN; SDHB
185480	SUPRABULBAR PARESIS, CONGENITAL
185490	SUPEROXIDE DISMUTASE 3; SOD3
185500	SUPRAVALVULAR AORTIC STENOSIS; SVAS
185510	SURFACE ANTIGEN 5; S5
185520	SURFACE ANTIGEN 6; S6
185535	EPITHELIAL CELLULAR ADHESION MOLECULE; EPCAM
185540	SURFACE ANTIGEN, GLYCOPROTEIN 75
185560	SURFACE ANTIGEN 8; S8
185570	SURFACE ANTIGEN 17; SA17
185580	SURFACE ANTIGEN 22; S13
185590	SURFACE ANTIGEN 21; S14
185595	REMOVED FROM DATABASE
185600	SYMPHALANGISM OF TOES
185605	SYNAPTOTAGMIN 1; SYT1
185610	SURFACE POLYPEPTIDES, ANONYMOUS
185620	SURFEIT 1; SURF1
185630	SURFEIT 2; SURF2
185640	RIBOSOMAL PROTEIN L7a; RPL7A
185641	MEDIATOR COMPLEX SUBUNIT 22; MED22
185642	SURFEIT 6; SURF6
185650	SYMPHALANGISM, C. S. LEWIS TYPE
185660	SURFEIT 4; SURF4
185700	SYMPHALANGISM, DISTAL
185750	SYMPHALANGISM WITH MULTIPLE ANOMALIES OF HANDS AND FEET
185800	SYMPHALANGISM, PROXIMAL, 1A; SYM1A
185860	SYNAPTIC VESICLE GLYCOPROTEIN 2A; SV2A
185861	SYNAPTIC VESICLE GLYCOPROTEIN 2B; SV2B
185880	VESICLE-ASSOCIATED MEMBRANE PROTEIN 1; VAMP1
185881	VESICLE-ASSOCIATED MEMBRANE PROTEIN 2; VAMP2
185900	CHROMOSOME 2q35 DUPLICATION SYNDROME
186000	SYNPOLYDACTYLY 1; SPD1
186100	SYNDACTYLY, TYPE III; SDTY3
186200	SYNDACTYLY, TYPE IV; SDTY4
186300	SYNDACTYLY, TYPE V; SDTY5
186350	SYNDACTYLY-POLYDACTYLY-EARLOBE SYNDROME
186355	SYNDECAN 1; SDC1
186357	SYNDECAN 3; SDC3
186360	ANNEXIN A7; ANXA7
186400	SYNOSTOSES, TARSAL, CARPAL, AND DIGITAL
186500	MULTIPLE SYNOSTOSES SYNDROME 1; SYNS1
186550	LIEBENBERG SYNDROME; LBNBG
186570	TARSAL-CARPAL COALITION SYNDROME; TCC
186575	SYNOVIAL CHONDROMATOSIS, FAMILIAL, WITH DWARFISM
186580	BLAU SYNDROME; BLAUS
186590	SYNTAXIN 1A; STX1A
186591	SYNTAXIN 4; STX4
186600	SYRINGOMAS, MULTIPLE
186690	REMOVED FROM DATABASE
186700	SYRINGOMYELIA, NONCOMMUNICATING ISOLATED
186710	MOVED TO 102720
186711	CD27 ANTIGEN; CD27
186720	CD6 ANTIGEN; CD6
186730	CD8 ANTIGEN, BETA POLYPEPTIDE; CD8B
186740	CD3 ANTIGEN, GAMMA SUBUNIT; CD3G
186745	TALIN 1; TLN1
186750	TALONAVICULAR COALITION
186760	ANTIGEN CD28; CD28
186770	T-CELL LEUKEMIA, HOMEOBOX 1; TLX1
186780	CD247 ANTIGEN; CD247
186790	CD3 ANTIGEN, DELTA SUBUNIT; CD3D
186810	T-CELL RECEPTOR DELTA CHAIN CONSTANT REGION; TRDC
186820	T-CELL ANTIGEN CD7; CD7
186830	CD3 ANTIGEN, EPSILON SUBUNIT; CD3E
186845	CD81 ANTIGEN; CD81
186850	TARSAL COALITION
186852	PROTEASOME 26S SUBUNIT, ATPase, 3; PSMC3
186854	SOLUTE CARRIER FAMILY 6 (NEUROTRANSMITTER TRANSPORTER, TAURINE), MEMBER 6; SLC6A6
186855	T-CELL ACUTE LYMPHOCYTIC LEUKEMIA 2; TAL2
186860	T-CELL LEUKEMIA/LYMPHOMA 4; TCL4
186880	T-CELL RECEPTOR ALPHA CHAIN CONSTANT REGION; TRAC
186890	TEAR PROTEIN, ANODAL
186910	CD8 ANTIGEN, ALPHA POLYPEPTIDE; CD8A
186920	REMOVED FROM DATABASE
186921	LIM DOMAIN ONLY 1; LMO1
186930	T-CELL RECEPTOR BETA CHAIN CONSTANT REGION 1; TRBC1
186940	CD4 ANTIGEN; CD4
186945	FK506-BINDING PROTEIN 1A; FKBP1A
186946	FK506-BINDING PROTEIN 2; FKBP2
186947	FK506-BINDING PROTEIN 3; FKBP3
186950	T-CELL SUBGROUPS, NON-HLA-LINKED
186960	T-CELL LEUKEMIA/LYMPHOMA 1A; TCL1A
186970	T-CELL RECEPTOR GAMMA CHAIN CONSTANT REGION 1; TRGC1
186973	IL2-INDUCIBLE T-CELL KINASE; ITK
186975	T COMPLEX-ASSOCIATED TESTIS-EXPRESSED 1; TCTE1
186977	T COMPLEX-ASSOCIATED TESTIS-EXPRESSED 3; TCTE3
186980	T-COMPLEX 1; TCP1
186982	T-COMPLEX PROTEIN 11; TCP11
186990	T-LYMPHOCYTE SURFACE CD2 ANTIGEN; CD2
187000	TEETH, ODD SHAPES OF
187010	MOVED TO 187011
187011	CHEMOKINE, CC MOTIF, LIGAND 5; CCL5
187020	T-COMPLEX 10; TCP10
187030	T-COMPLEX LOCUS TCP10B; TCP10B
187040	T-CELL ACUTE LYMPHOCYTIC LEUKEMIA 1; TAL1
187050	TEETH PRESENT AT BIRTH
187100	TEETH, SUPERNUMERARY
187260	TELANGIECTASIA, HEREDITARY BENIGN
187270	TELOMERASE REVERSE TRANSCRIPTASE; TERT
187280	POLYMERASE III, RNA, SUBUNIT D; POLR3D
187290	TEMPERATURE SENSITIVITY COMPLEMENTATION, CELL CYCLE SPECIFIC, H142; H142T
187300	TELANGIECTASIA, HEREDITARY HEMORRHAGIC, TYPE 1; HHT1
187310	TEMPERATURE SENSITIVITY COMPLEMENTATION, CELL CYCLE SPECIFIC, K12
187320	TEMPERATURE SENSITIVITY COMPLEMENTATION, CELL CYCLE SPECIFIC, ts13; TS13
187330	TEMPERATURE SENSITIVITY COMPLEMENTATION, CELL CYCLE SPECIFIC, ts546; TS546
187340	TEMPERATURE-SENSITIVE LETHAL MUTATION
187350	TELECANTHUS
187360	TEMPORAL ARTERITIS
187370	ARTHROGRYPOSIS, DISTAL, TYPE 10; DA10
187380	TENASCIN C; TNC
187390	TENDONS, EXTENSOR, OF FINGERS, ANOMALOUS INSERTION OF
187395	TERATOCARCINOMA-DERIVED GROWTH FACTOR 1; TDGF1
187400	TESTICULAR TORSION
187410	DEOXYNUCLEOTIDYLTRANSFERASE, TERMINAL; DNTT
187430	CYSTEINE-RICH SECRETORY PROTEIN 2; CRISP2
187450	MOVED TO 182205
187500	TETRALOGY OF FALLOT; TOF
187501	TETRALOGY OF FALLOT AND GLAUCOMA
187510	TETRAMELIC MONODACTYLY
187520	C-TYPE LECTIN DOMAIN FAMILY 3, MEMBER B; CLEC3B
187550	THALASSEMIA, BETA+, SILENT ALLELE
187600	THANATOPHORIC DYSPLASIA, TYPE I; TD1
187601	THANATOPHORIC DYSPLASIA, TYPE II; TD2
187650	THEOPHYLLINE BIOTRANSFORMATION
187680	THIOPURINE S-METHYLTRANSFERASE; TPMT
187700	THIOREDOXIN; TXN
187750	THORACIC DYSOSTOSIS, ISOLATED
187760	THORACOLARYNGOPELVIC DYSPLASIA; TLPD
187770	THORACOPELVIC DYSOSTOSIS
187790	THREONYL-tRNA SYNTHETASE 1; TARS1
187800	BLEEDING DISORDER, PLATELET-TYPE, 16; BDPLT16
187900	BLEEDING DISORDER, PLATELET-TYPE, 17; BDPLT17
187930	COAGULATION FACTOR II RECEPTOR; F2R
187940	THROMBOCYTE B; THB
187950	THROMBOCYTHEMIA 1; THCYT1
188000	THROMBOCYTOPENIA 2; THC2
188020	THROMBOCYTOPENIA, CYCLIC
188025	THROMBOCYTOPENIA, PARIS-TROUSSEAU TYPE; TCPT
188030	IMMUNE THROMBOCYTOPENIA; ITP
188035	PRO-PLATELET BASIC PROTEIN-LIKE 1; PPBPL1
188040	THROMBOMODULIN; THBD
188050	THROMBOPHILIA DUE TO THROMBIN DEFECT; THPH1
188055	THROMBOPHILIA DUE TO ACTIVATED PROTEIN C RESISTANCE; THPH2
188060	THROMBOSPONDIN I; THBS1
188061	THROMBOSPONDIN II; THBS2
188062	THROMBOSPONDIN III; THBS3
188070	THROMBOXANE A2 RECEPTOR, PLATELET; TBXA2R
188100	THUMB DEFORMITY
188150	THUMB DEFORMITY AND ALOPECIA
188200	MOVED TO 107000
188201	THUMBS, STIFF, WITH BRACHYDACTYLY TYPE A1 AND DEVELOPMENTAL DELAY
188230	THY-1 T-CELL ANTIGEN; THY1
188250	THYMIDINE KINASE, MITOCHONDRIAL; TK2
188300	THYMIDINE KINASE, SOLUBLE; TK1
188340	THYMOCYTE ANTIGEN CD1C; CD1C
188345	DEOXYTHYMIDYLATE KINASE; DTYMK
188350	THYMIDYLATE SYNTHETASE; TYMS
188360	THYMOCYTE ANTIGEN CD1B; CD1B
188370	THYMOCYTE ANTIGEN CD1A; CD1A
188380	THYMOPOIETIN; TMPO
188390	PROTHYMOSIN, ALPHA; PTMA
188395	MOVED TO 300159
188399	THYMOSIN, BETA-10; TMSB10
188400	DIGEORGE SYNDROME; DGS
188410	THYMOCYTE ANTIGEN CD1D; CD1D
188411	THYMOCYTE ANTIGEN CD1E; CD1E
188450	THYROGLOBULIN; TG
188455	THYROGLOSSAL DUCT CYST, FAMILIAL
188470	THYROID CANCER, NONMEDULLARY, 2; NMTC2
188530	MOVED TO 118850
188540	THYROID-STIMULATING HORMONE, BETA CHAIN; TSHB
188545	THYROTROPIN-RELEASING HORMONE RECEPTOR; TRHR
188550	THYROID CANCER, NONMEDULLARY, 1; NMTC1
188555	MOVED TO 179050
188560	THYROID HORMONE PLASMA MEMBRANE TRANSPORT DEFECT
188570	THYROID HORMONE RESISTANCE, GENERALIZED, AUTOSOMAL DOMINANT; GRTHD
188580	THYROTOXIC PERIODIC PARALYSIS, SUSCEPTIBILITY TO, 1; TTPP1
188590	MOVED TO 190120
188595	THYROTROPH EMBRYONIC FACTOR; TEF
188600	MOVED TO 314200
188700	BLOUNT DISEASE, INFANTILE
188740	TIBIA, HYPOPLASIA OR APLASIA OF, WITH POLYDACTYLY; THYP
188770	MOVED TO 188740
188800	TIBIAL TORSION, BILATERAL MEDIAL
188825	TISSUE INHIBITOR OF METALLOPROTEINASE 2; TIMP2
188826	TISSUE INHIBITOR OF METALLOPROTEINASE 3; TIMP3
188830	PROTEIN KINASE, cAMP-DEPENDENT, REGULATORY, TYPE I, ALPHA; PRKAR1A
188840	TITIN; TTN
188850	TL ANTIGEN
188855	GRANULYSIN; GNLY
188860	MYELIN AND LYMPHOCYTE PROTEIN; MAL
188890	TOBACCO ADDICTION, SUSCEPTIBILITY TO
189000	TOE, FIFTH, NUMBER OF PHALANGES IN
189100	TOE, MISSHAPEN
189150	TOE, ROTATED FIFTH
189200	TOES, RELATIVE LENGTH OF FIRST AND SECOND
189230	TOES, SPACE BETWEEN FIRST AND SECOND
189300	TONGUE CURLING, FOLDING, OR ROLLING
189490	MALPOSITION OF TEETH WITH OR WITHOUT HYPODONTIA/OLIGODONTIA
189500	WITKOP SYNDROME
189600	TORTICOLLIS
189700	TORUS PALATINUS AND TORUS MANDIBULARIS
189800	PREECLAMPSIA/ECLAMPSIA 1; PEE1
189880	tRNA ASPARAGINE (ANTICODON GTT) 2-7; TRN-GTT2-7
189889	TRANSCRIPTION FACTOR CP2; TFCP2
189890	TRANSFER RNA ASPARAGINE-LIKE; TRNL
189901	TRANSCRIPTION FACTOR 9; TCF9
189902	TRANSCRIPTION FACTOR DP1; TFDP1
189903	NUCLEAR TRANSCRIPTION FACTOR Y, ALPHA; NFYA
189904	NUCLEAR TRANSCRIPTION FACTOR Y, BETA; NFYB
189905	TRANSCOBALAMIN I; TCN1
189906	TRANSCRIPTION FACTOR Sp1; SP1
189907	HNF1 HOMEOBOX B; HNF1B
189908	TRANSCRIPTION FACTOR 7; TCF7
189909	ZINC FINGER E BOX-BINDING HOMEOBOX 1; ZEB1
189910	tRNA SERINE (ANTICODON AGA) 2-3; TRS-AGA2-3
189911	tRNA GLYCINE (ANTICODON CCC) 1-1; TRG-CCC1-1
189912	tRNA PROLINE (ANTICODON TGG) 3-1; TRP-TGG3-1
189913	tRNA THREONINE (ANTICODON TGT) 6-1; TRT-TGT6-1
189918	tRNA LYSINE (ANTICODON TTT) 3-5; TRK-TTT3-5
189919	tRNA GLUTAMINE (ANTICODON CTG) 1-5; TRQ-CTG1-5
189920	tRNA LEUCINE (ANTICODON TAG) 1-1; TRL-TAG1-1
189921	tRNA VALINE (ANTICODON AAC) 1-4; TRV-AAC1-4
189923	tRNA GLUTAMINE (ANTICODON TTG) 1-1; TRQ-TTG1-1
189930	tRNA PROLINE (ANTICODON AGG) 2-5; TRP-AGG2-5
189931	tRNA PROLINE (ANTICODON AGG) 2-6; TRP-AGG2-6
189932	tRNA LEUCINE (ANTICODON AAG) 2-3; TRL-AAG2-3
189933	tRNA THREONINE (ANTICODON TGT) 3-1; TRT-TGT3-1
189940	TRANSLOCATED PROMOTER REGION; TPR
189960	TRACHEOESOPHAGEAL FISTULA WITH OR WITHOUT ESOPHAGEAL ATRESIA
189961	TRACHEOPATHIA OSTEOPLASTICA
189962	GENERAL TRANSCRIPTION FACTOR IIE, POLYPEPTIDE 1; GTF2E1
189963	GENERAL TRANSCRIPTION FACTOR IIB; GTF2B
189964	GENERAL TRANSCRIPTION FACTOR IIE, POLYPEPTIDE 2; GTF2E2
189965	CCAAT/ENHANCER-BINDING PROTEIN, BETA; CEBPB
189967	TEA DOMAIN FAMILY MEMBER 1; TEAD1
189968	GENERAL TRANSCRIPTION FACTOR IIF, POLYPEPTIDE 1, 74-KD; GTF2F1
189969	GENERAL TRANSCRIPTION FACTOR IIF, POLYPEPTIDE 2, 30-KD; GTF2F2
189970	GUANINE NUCLEOTIDE-BINDING PROTEIN, GAMMA-TRANSDUCING ACTIVITY POLYPEPTIDE 1; GNGT1
189971	E2F TRANSCRIPTION FACTOR 1; E2F1
189972	GENERAL TRANSCRIPTION FACTOR IIH, POLYPEPTIDE 1; GTF2H1
189973	E74-LIKE ETS TRANSCRIPTION FACTOR 1; ELF1
189974	MOVED TO 139380
189980	ABL PROTOONCOGENE 1, NONRECEPTOR TYROSINE KINASE; ABL1
189990	MYB PROTOONCOGENE, TRANSCRIPTION FACTOR; MYB
190000	TRANSFERRIN; TF
190010	TRANSFERRIN RECEPTOR; TFRC
190020	HRAS PROTOONCOGENE, GTPase; HRAS
190030	FES PROTOONCOGENE, TYROSINE KINASE; FES
190040	PLATELET-DERIVED GROWTH FACTOR, BETA POLYPEPTIDE; PDGFB
190060	MOS PROTOONCOGENE, SERINE/THREONINE KINASE; MOS
190070	KRAS PROTOONCOGENE, GTPase; KRAS
190080	MYC PROTOONCOGENE, bHLH TRANSCRIPTION FACTOR; MYC
190090	SRC PROTOONCOGENE, NONRECEPTOR TYROSINE KINASE; SRC
190100	GENIOSPASM 1; GSM1
190110	MOVED TO 190070
190120	THYROID HORMONE RECEPTOR, ALPHA-1; THRA
190151	ERB-B2 RECEPTOR TYROSINE KINASE 3; ERBB3
190160	THYROID HORMONE RECEPTOR, BETA; THRB
190170	TRANSFORMING GROWTH FACTOR, ALPHA; TGFA
190180	TRANSFORMING GROWTH FACTOR, BETA-1; TGFB1
190181	TRANSFORMING GROWTH FACTOR-BETA RECEPTOR, TYPE I; TGFBR1
190182	TRANSFORMING GROWTH FACTOR-BETA RECEPTOR, TYPE II; TGFBR2
190190	MOVED TO 154280
190195	TRANSGLUTAMINASE 1; TGM1
190196	TRANSGLUTAMINASE 2; TGM2
190197	CONTACTIN 2; CNTN2
190198	NOTCH RECEPTOR 1; NOTCH1
190200	TREMOR OF INTENTION, ATAXIA, AND LIPOFUSCINOSIS
190220	TRANSFORMING GROWTH FACTOR, BETA-2; TGFB2
190230	TRANSFORMING GROWTH FACTOR, BETA-3; TGFB3
190231	TRANSITION PROTEIN 1; TNP1
190232	TRANSITION PROTEIN 2; TNP2
190300	TREMOR, HEREDITARY ESSENTIAL, 1; ETM1
190310	TREMOR, NYSTAGMUS, AND DUODENAL ULCER
190315	SOLUTE CARRIER FAMILY 25 (MITOCHONDRIAL CARRIER, CITRATE TRANSPORTER), MEMBER 1; SLC25A1
190320	TRICHODENTOOSSEOUS SYNDROME; TDO
190330	TRICHOMEGALY; TCMGLY
190340	DISCOID FIBROMAS, FAMILIAL MULTIPLE; FMDF
190345	TRICHOEPITHELIOMAS, MULTIPLE DESMOPLASTIC
190350	TRICHORHINOPHALANGEAL SYNDROME, TYPE I; TRPS1
190351	TRICHORHINOPHALANGEAL SYNDROME, TYPE III; TRPS3
190360	TRICHODYSPLASIA-XERODERMA
190370	TRICHOHYALIN; TCHH
190400	TRIGEMINAL NEURALGIA
190410	TRIGGER THUMB
190420	TRIGLYCERIDE STORAGE DISEASE, TYPE I
190430	TRIGLYCERIDE STORAGE DISEASE, TYPE II
190440	TRIGONOCEPHALY 1; TRIGNO1
190445	TRIIODOTHYRONINE RECEPTOR AUXILIARY PROTEIN; TRAP
190450	TRIOSEPHOSPHATE ISOMERASE 1; TPI1
190470	TRIPEPTIDYL PEPTIDASE II; TPP2
190500	TRIPHALANGEAL THUMB WITH DOUBLE PHALANGES
190600	TRIPHALANGEAL THUMB, NONOPPOSABLE
190605	TRIPHALANGEAL THUMB WITH POLYSYNDACTYLY; TPTPS
190650	TRIPHALANGEAL THUMBS AND DISLOCATION OF PATELLA
190680	TRIPHALANGEAL THUMBS WITH BRACHYECTRODACTYLY
190685	DOWN SYNDROME
190700	ZFP36 RING FINGER PROTEIN; ZFP36
190800	TRISTICHIASIS
190900	TRITANOPIA
190920	TROPHOBLAST GLYCOPROTEIN; TPBG
190930	TROPOMODULIN 1; TMOD1
190940	ENDOGENOUS RETROVIRAL SEQUENCE, TRUNCATED 1; ERVT1
190950	ENDOGENOUS RETROVIRAL SEQUENCE, TRUNCATED 2; ERVT2
190960	ENDOGENOUS RETROVIRAL SEQUENCE, TRUNCATED 3; ERVT3
190970	ENDOGENOUS RETROVIRAL SEQUENCE, TRUNCATED 4; ERVT4
190980	ENDOGENOUS RETROVIRAL SEQUENCE, TRUNCATED 5; ERVT5
190990	TROPOMYOSIN 2; TPM2
191000	TROCHLEA OF THE HUMERUS, APLASIA OF
191010	TROPOMYOSIN 1; TPM1
191020	MOVED TO 120920
191030	TROPOMYOSIN 3; TPM3
191039	TROPONIN C, FAST; TNNC2
191040	TROPONIN C, SLOW; TNNC1
191041	TROPONIN T1, SKELETAL, SLOW; TNNT1
191042	TROPONIN I, SLOW-TWITCH SKELETAL MUSCLE ISOFORM; TNNI1
191043	TROPONIN I, FAST-TWITCH SKELETAL MUSCLE ISOFORM; TNNI2
191044	TROPONIN I, CARDIAC; TNNI3
191045	TROPONIN T2, CARDIAC; TNNT2
191050	TRYPTOPHANYL-tRNA SYNTHETASE 1; WARS1
191060	TRYPTOPHAN HYDROXYLASE 1; TPH1
191070	TRYPTOPHAN 2,3-DIOXYGENASE; TDO2
191080	TRYPTASE, ALPHA/BETA-1; TPSAB1
191081	TRYPTASE, BETA-2; TPSB2
191090	MOVED TO 191100
191091	MOVED TO 191100
191092	TSC COMPLEX SUBUNIT 2; TSC2
191100	TUBEROUS SCLEROSIS 1; TSC1
191110	TUBULIN, ALPHA-4A; TUBA4A
191120	TUBULIN, ALPHA-LIKE 1; TUBAL1
191130	TUBULIN, BETA; TUBB
191135	TUBULIN, GAMMA-1; TUBG1
191150	TUFTSIN DEFICIENCY
191155	TRANSMEMBRANE 4 L SIX FAMILY MEMBER 1; TM4SF1
191160	TUMOR NECROSIS FACTOR; TNF
191161	TUMOR NECROSIS FACTOR-ALPHA-INDUCED PROTEIN 1; TNFAIP1
191163	TUMOR NECROSIS FACTOR-ALPHA-INDUCED PROTEIN 3; TNFAIP3
191164	EPHRIN A1; EFNA1
191170	TUMOR PROTEIN p53; TP53
191175	HEAT-SHOCK PROTEIN, 90-KD, BETA, 1; HSP90B1
191181	SUPPRESSOR OF TUMORIGENICITY 3; ST3
191190	TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY, MEMBER 1A; TNFRSF1A
191191	TUMOR NECROSIS FACTOR RECEPTOR SUBFAMILY, MEMBER 1B; TNFRSF1B
191195	MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE 8; MAP3K8
191200	TUNE DEAFNESS
191250	TWINNING DUE TO SUPERFETATION
191270	TYROSINASE-LIKE; TYRL
191275	DOPACHROME TAUTOMERASE; DCT
191290	TYROSINE HYDROXYLASE; TH
191305	BLK PROTOONCOGENE, SRC FAMILY TYROSINE KINASE; BLK
191306	KINASE INSERT DOMAIN RECEPTOR; KDR
191309	MOVED TO 190151
191311	DISCOIDIN DOMAIN RECEPTOR FAMILY, MEMBER 2; DDR2
191315	NEUROTROPHIC TYROSINE KINASE, RECEPTOR, TYPE 1; NTRK1
191316	NEUROTROPHIC TYROSINE KINASE, RECEPTOR, TYPE 3; NTRK3
191317	U2 SMALL NUCLEAR RNA AUXILIARY FACTOR 1; U2AF1
191318	U2 SMALL NUCLEAR RNA AUXILIARY FACTOR 2; U2AF2
191320	MOVED TO 191339
191321	UBIQUITIN A-52-RESIDUE RIBOSOMAL PROTEIN FUSION PRODUCT; UBA52
191325	UBIQUITIN-LIKE MODIFIER ACTIVATING ENZYME 7; UBA7
191327	UBIQUINOL-CYTOCHROME c REDUCTASE, RIESKE IRON-SULFUR; UQCRFS1
191328	UBIQUINOL-CYTOCHROME c REDUCTASE CORE PROTEIN I; UQCRC1
191329	UBIQUINOL-CYTOCHROME c REDUCTASE CORE PROTEIN II; UQCRC2
191330	UBIQUINOL-CYTOCHROME c REDUCTASE-BINDING PROTEIN; UQCRB
191339	UBIQUITIN B; UBB
191340	UBIQUITIN C; UBC
191342	UBIQUITIN CARBOXYL-TERMINAL ESTERASE L1; UCHL1
191343	RIBOSOMAL PROTEIN S27a; RPS27A
191344	MOVED TO 191321
191350	DOLICHYL-PHOSPHATE N-ACETYLGLUCOSAMINE PHOSPHOTRANSFERASE; DPAGT1
191390	INFLAMMATORY BOWEL DISEASE 11; IBD11
191400	ULNA AND FIBULA, HYPOPLASIA OF
191420	ULNA METAPHYSEAL DYSPLASIA SYNDROME
191440	ULNAR HYPOPLASIA
191480	UNCOMBABLE HAIR SYNDROME 1; UHS1
191482	UNCOMBABLE HAIR, RETINAL PIGMENTARY DYSTROPHY, DENTAL ANOMALIES, AND BRACHYDACTYLY
191500	UNDRITZ ANOMALY
191510	COLD-SHOCK DOMAIN-CONTAINING E1, RNA-BINDING; CSDE1
191520	UPINGTON DISEASE
191523	UPSTREAM TRANSCRIPTION FACTOR 1; USF1
191525	URACIL-DNA GLYCOSYLASE; UNG
191530	URATE-BINDING GLOBULIN, DECREASE IN
191540	URATE OXIDASE, PSEUDOGENE; UOX
191550	URETER, BIFID OR DOUBLE
191600	URETER, CANCER OF
191650	URETEROCELE
191700	UROLITHIASIS, URIC ACID, AUTOSOMAL DOMINANT
191710	CYTIDINE MONOPHOSPHATE (UMP-CMP) KINASE 1, CYTOSOLIC; CMPK1
191720	5-PRIME,3-PRIME-NUCLEOTIDASE, CYTOSOLIC; NT5C
191730	URIDINE PHOSPHORYLASE 1; UPP1
191740	UDP-GLYCOSYLTRANSFERASE 1 FAMILY, POLYPEPTIDE A1; UGT1A1
191741	MOVED TO 191740
191742	MOVED TO 600067 AND 191740
191743	MOVED TO 191742
191750	MOVED TO 191760
191760	URIDYL DIPHOSPHATE GLUCOSE PYROPHOSPHORYLASE 2; UGP2
191800	BLADDER DYSFUNCTION, AUTONOMIC, WITH IMPAIRED PUPILLARY REFLEX AND SECONDARY CAKUT; BAIPRCK
191810	MOVED TO 131530
191830	RENAL HYPODYSPLASIA/APLASIA 1; RHDA1
191840	PLASMINOGEN ACTIVATOR, URINARY; PLAU
191845	UROMODULIN; UMOD
191850	URTICARIA, AQUAGENIC
191900	MUCKLE-WELLS SYNDROME; MWS
191950	URTICARIA, FAMILIAL LOCALIZED HEAT
192000	UTERINE ANOMALIES
192020	SECRETOGLOBIN, FAMILY 1A, MEMBER 1; SCGB1A1
192050	UTERUS BICORNIS BICOLLIS WITH PARTIAL VAGINAL SEPTUM AND UNILATERAL HEMATOCOLPOS WITH IPSILATERAL RENAL AGENESIS
192070	REMOVED FROM DATABASE
192090	CADHERIN 1; CDH1
192100	UVULA, BIFID
192130	ATPase, H+ TRANSPORTING, LYSOSOMAL, V0 SUBUNIT A1; ATP6V0A1
192132	ATPase, H+ TRANSPORTING, LYSOSOMAL, 56/58-KD, V1 SUBUNIT B, ISOFORM 1; ATP6V1B1
192150	VALYL-tRNA SYNTHETASE 1; VARS1
192200	VARICOSE VEINS
192225	VASCULAR CELL ADHESION MOLECULE 1; VCAM1
192240	VASCULAR ENDOTHELIAL GROWTH FACTOR A; VEGFA
192300	VASCULAR HELIX OF UMBILICAL CORD
192310	VASCULITIS, LYMPHOCYTIC, NODULAR
192315	VASCULOPATHY, RETINAL, WITH CEREBRAL LEUKOENCEPHALOPATHY AND SYSTEMIC MANIFESTATIONS; RVCLS
192320	VASOACTIVE INTESTINAL PEPTIDE; VIP
192321	VASOACTIVE INTESTINAL PEPTIDE RECEPTOR 1; VIPR1
192340	ARGININE VASOPRESSIN; AVP
192350	VATER/VACTERL ASSOCIATION
192400	VEINS, PATTERN OF, ON ANTERIOR THORAX
192430	VELOCARDIOFACIAL SYNDROME; VCFS
192445	VENTRICULAR EXTRASYSTOLES WITH SYNCOPE, PERODACTYLY, AND ROBIN SEQUENCE
192450	MOVED TO 603829
192500	LONG QT SYNDROME 1; LQT1
192600	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 1; CMH1
192605	VENTRICULAR TACHYCARDIA, FAMILIAL
192700	VENULAR INSUFFICIENCY, SYSTEMIC
192800	VERTEBRAL FUSION, POSTERIOR LUMBOSACRAL, WITH BLEPHAROPTOSIS
192900	VERTEBRAL HYPOPLASIA WITH LUMBAR KYPHOSIS
192950	VERTICAL TALUS, CONGENITAL; CVT
192968	INTEGRIN, ALPHA-1; ITGA1
192972	MOVED TO 192975
192974	INTEGRIN, ALPHA-2; ITGA2
192975	INTEGRIN, ALPHA-4; ITGA4
192977	VERY LOW DENSITY LIPOPROTEIN RECEPTOR; VLDLR
193000	VESICOURETERAL REFLUX 1; VUR1
193001	SOLUTE CARRIER FAMILY 18 (VESICULAR MONOAMINE), MEMBER 2; SLC18A2
193002	SOLUTE CARRIER FAMILY 18 (VESICULAR MONOAMINE), MEMBER 1; SLC18A1
193003	SPINOCEREBELLAR ATAXIA 27A; SCA27A
193005	VESTIBULOCOCHLEAR DYSFUNCTION, PROGRESSIVE
193007	VERTIGO, BENIGN RECURRENT; BRV
193010	MOVED TO 112266
193040	VILLIN 1; VIL1
193050	MOVED TO 125630
193060	VIMENTIN; VIM
193065	VINCULIN; VCL
193067	FLI1 PROTOONCOGENE, ETS TRANSCRIPTION FACTOR; FLI1
193070	VIRUS RD114 RNA COMPLEMENTARITY
193090	TRANSCOBALAMIN I DEFICIENCY
193100	HYPOPHOSPHATEMIC RICKETS, AUTOSOMAL DOMINANT; ADHR
193190	VITRONECTIN; VTN
193200	VITILIGO-ASSOCIATED MULTIPLE AUTOIMMUNE DISEASE SUSCEPTIBILITY 6; VAMAS6
193210	INTEGRIN, ALPHA-V; ITGAV
193220	VITREORETINOCHOROIDOPATHY; VRCP
193230	VITREORETINAL DEGENERATION, SNOWFLAKE TYPE; SVD
193235	VITREORETINOPATHY, NEOVASCULAR INFLAMMATORY; VRNI
193240	VOCAL CORD PARALYSIS AND PTOSIS
193245	VOLTAGE-DEPENDENT ANION CHANNEL 2; VDAC2
193250	VOLVULUS OF MIDGUT
193290	MOVED TO 151675
193300	VON HIPPEL-LINDAU SYNDROME; VHLS
193400	VON WILLEBRAND DISEASE, TYPE 1; VWD1
193450	VULVOVAGINITIS, ALLERGIC SEMINAL
193500	WAARDENBURG SYNDROME, TYPE 1; WS1
193510	WAARDENBURG SYNDROME, TYPE 2A; WS2A
193520	WATSON SYNDROME; WTSN
193525	WEE1 G2 CHECKPOINT KINASE; WEE1
193530	WEYERS ACROFACIAL DYSOSTOSIS; WAD
193670	WHIM SYNDROME 1; WHIMS1
193675	REMOVED FROM DATABASE
193680	MOVED TO 128101
193700	ARTHROGRYPOSIS, DISTAL, TYPE 2A; DA2A
193900	WHITE SPONGE NEVUS 1; WSN1
194000	WIDOW'S PEAK
194050	WILLIAMS-BEUREN SYNDROME; WBS
194070	WILMS TUMOR 1; WT1
194071	WILMS TUMOR 2; WT2
194072	WILMS TUMOR, ANIRIDIA, GENITOURINARY ANOMALIES, AND IMPAIRED INTELLECTUAL DEVELOPMENT SYNDROME; WAGR
194080	DENYS-DRASH SYNDROME; DDS
194090	WILMS TUMOR 3; WT3
194100	MOVED TO 106600
194190	WOLF-HIRSCHHORN SYNDROME; WHS
194200	WOLFF-PARKINSON-WHITE SYNDROME; WPW
194300	WOOLLY HAIR, AUTOSOMAL DOMINANT; ADWH
194320	WORONETS TRAIT
194350	WT LIMB-BLOOD SYNDROME
194355	X BOX-BINDING PROTEIN 1; XBP1
194360	X-RAY REPAIR CROSS COMPLEMENTING 1; XRCC1
194363	X-RAY REPAIR CROSS COMPLEMENTING 4; XRCC4
194364	X-RAY REPAIR CROSS COMPLEMENTING 5; XRCC5
194370	X-RAY SENSITIVITY; XRS
194380	DEHYDRATED HEREDITARY STOMATOCYTOSIS 1 WITH OR WITHOUT PSEUDOHYPERKALEMIA AND/OR PERINATAL EDEMA; DHS1
194400	XERODERMA PIGMENTOSUM, AUTOSOMAL DOMINANT, MILD
194450	YEAST FACTOR
194460	ALPHA-2-GLYCOPROTEIN, ZINC; AZGP1
194470	ZINC, ELEVATED PLASMA
194480	ZFP3 RING FINGER PROTEIN; ZFP3
194490	ZINC FINGER PROTEIN 1; ZNF1
194500	ZINC FINGER PROTEIN 2; ZNF2
194510	ZINC FINGER PROTEIN 3; ZNF3
194520	REMOVED FROM DATABASE
194521	ZINC FINGER PROTEIN 33A; ZNF33A
194522	ZINC FINGER PROTEIN 33B; ZNF33B
194524	ZINC FINGER PROTEIN 18; ZNF18
194525	ZINC FINGER PROTEIN 19; ZNF19
194526	ZINC FINGER PROTEIN 34; ZNF34
194527	ZINC FINGER PROTEIN 23; ZNF23
194528	ZINC FINGER PROTEIN 25; ZNF25
194529	ZINC FINGER PROTEIN 22; ZNF22
194530	REMOVED FROM DATABASE
194531	ZINC FINGER PROTEIN 7; ZNF7
194532	ZINC FINGER PROTEIN 8; ZNF8
194533	ZINC FINGER PROTEIN 35; ZNF35
194534	ZINC FINGER PROTEIN 24; ZNF24
194535	ZINC FINGER PROTEIN 29, PSEUDOGENE; ZNF29P
194536	ZINC FINGER PROTEIN 12; ZNF12
194537	ZINC FINGER PROTEIN 26; ZNF26
194538	ZINC FINGER PROTEIN 10; ZNF10
194539	ZINC FINGER PROTEIN 32; ZNF32
194540	HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 ENHANCER-BINDING PROTEIN 1; HIVEP1
194541	ZINC FINGER- AND BTB DOMAIN-CONTAINING PROTEIN 25; ZBTB25
194542	ZINC FINGER PROTEIN 44; ZNF44
194543	ZINC FINGER PROTEIN 69; ZNF69
194544	ZINC FINGER PROTEIN 70; ZNF70
194545	ZINC FINGER PROTEIN 71; ZNF71
194546	ZINC FINGER PROTEIN 72; ZNF72
194547	ZINC FINGER PROTEIN 73; ZNF73
194548	ZINC FINGER PROTEIN 74; ZNF74
194549	ZINC FINGER PROTEIN 76; ZNF76
194550	MYELOID ZINC FINGER 1; MZF1
194551	ZINC FINGER PROTEIN 77; ZNF77
194552	ZINC FINGER PROTEIN 79; ZNF79
194553	ZINC FINGER PROTEIN 80; ZNF80
194554	ZINC FINGER PROTEIN 45; ZNF45
194555	ZINC FINGER PROTEIN 224; ZNF224
194556	ZINC FINGER PROTEIN 14; ZNF14
194557	ZINC FINGER PROTEIN 20; ZNF20
194558	ZINC FINGER PROTEIN 83; ZNF83
194624	ZINC FINGER PROTEIN 117; ZNF117
194628	ZINC FINGER PROTEIN 121; ZNF121
194630	ZINC FINGER PROTEIN 123, PSEUDOGENE; ZNF123P
194631	ZINC FINGER PROTEIN 124; ZNF124
194632	ZINC FINGER PROTEIN 125; ZNF125
194633	ZINC FINGER PROTEIN 126; ZNF126
194648	ZINC FINGER PROTEIN 141; ZNF141
195000	ZONA PELLUCIDA GLYCOPROTEIN 1; ZP1
195002	MOVED TO 182889
200100	ABETALIPOPROTEINEMIA; ABL
200110	ABLEPHARON-MACROSTOMIA SYNDROME; AMS
200130	ABSENT EYEBROWS AND EYELASHES WITH MENTAL RETARDATION
200150	CHOREOACANTHOCYTOSIS; CHAC
200170	ACANTHOSIS NIGRICANS WITH MUSCLE CRAMPS AND ACRAL ENLARGEMENT
200300	ACETOPHENETIDIN SENSITIVITY
200350	ACETYL-CoA CARBOXYLASE-ALPHA; ACACA
200400	ACHALASIA, FAMILIAL ESOPHAGEAL
200440	MOVED TO 231550
200450	ACHALASIA-MICROCEPHALY SYNDROME
200500	ACHEIROPODY; ACHP
200600	ACHONDROGENESIS, TYPE IA; ACG1A
200610	ACHONDROGENESIS, TYPE II; ACG2
200700	ACROMESOMELIC DYSPLASIA 2A; AMD2A
200710	MOVED TO 200610
200720	MOVED TO 200610
200900	SHORT-LIMB SKELETAL DYSPLASIA WITH SEVERE COMBINED IMMUNODEFICIENCY
200930	REMOVED FROM DATABASE
200950	ACID PHOSPHATASE DEFICIENCY
200970	ACKERMAN SYNDROME
200980	ACRORENAL-MANDIBULAR SYNDROME
200990	ACROCALLOSAL SYNDROME; ACLS
200995	ACROCEPHALOPOLYDACTYLOUS DYSPLASIA
201000	CARPENTER SYNDROME 1; CRPT1
201020	ACROCEPHALOPOLYSYNDACTYLY TYPE IV
201050	ACROCRANIOFACIAL DYSOSTOSIS
201100	ACRODERMATITIS ENTEROPATHICA, ZINC-DEFICIENCY TYPE; AEZ
201170	ACROFACIAL DYSOSTOSIS SYNDROME OF RODRIGUEZ
201180	ACROFRONTOFACIONASAL DYSOSTOSIS 1
201181	MOVED TO 239710
201200	ACROGERIA, GOTTRON TYPE
201250	ACROMESOMELIC DYSPLASIA 2C; AMD2C
201300	NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE IIA; HSAN2A
201310	ACRORENAL SYNDROME, AUTOSOMAL RECESSIVE
201400	ACTH DEFICIENCY, ISOLATED; IAD
201450	ACYL-CoA DEHYDROGENASE, MEDIUM-CHAIN, DEFICIENCY OF; ACADMD
201460	MOVED TO 201475
201470	ACYL-CoA DEHYDROGENASE, SHORT-CHAIN, DEFICIENCY OF; ACADSD
201475	ACYL-CoA DEHYDROGENASE, VERY LONG-CHAIN, DEFICIENCY OF; ACADVLD
201550	ADDUCTED THUMBS SYNDROME
201710	LIPOID CONGENITAL ADRENAL HYPERPLASIA; LCAH
201750	ANTLEY-BIXLER SYNDROME WITH GENITAL ANOMALIES AND DISORDERED STEROIDOGENESIS; ABS1
201810	ADRENAL HYPERPLASIA, CONGENITAL, DUE TO 3-BETA-HYDROXYSTEROID DEHYDROGENASE 2 DEFICIENCY
201910	ADRENAL HYPERPLASIA, CONGENITAL, DUE TO 21-HYDROXYLASE DEFICIENCY
202010	ADRENAL HYPERPLASIA, CONGENITAL, DUE TO STEROID 11-BETA-HYDROXYLASE DEFICIENCY
202110	ADRENAL HYPERPLASIA, CONGENITAL, DUE TO 17-ALPHA-HYDROXYLASE DEFICIENCY
202150	ADRENAL HYPOPLASIA, CONGENITAL, WITH ABSENT PITUITARY LUTEINIZING HORMONE
202155	ADRENAL HYPOPLASIA, CYTOMEGALIC TYPE
202200	GLUCOCORTICOID DEFICIENCY 1; GCCD1
202300	ADRENOCORTICAL CARCINOMA, HEREDITARY; ADCC
202355	ADRENOCORTICAL UNRESPONSIVENESS TO ACTH WITH POSTRECEPTOR DEFECT
202370	PEROXISOME BIOGENESIS DISORDER 2B; PBD2B
202400	AFIBRINOGENEMIA, CONGENITAL
202500	MOVED TO 600899 AND 601457
202550	AGANGLIONOSIS, TOTAL INTESTINAL
202600	AGENESIS OF CEREBRAL WHITE MATTER
202650	AGNATHIA-OTOCEPHALY COMPLEX; AGOTC
202660	PAGOD SYNDROME
202700	NEUTROPENIA, SEVERE CONGENITAL, 1, AUTOSOMAL DOMINANT; SCN1
202900	ALANINURIA WITH MICROCEPHALY, DWARFISM, ENAMEL HYPOPLASIA, AND DIABETES MELLITUS
203000	FRONTONASAL DYSPLASIA WITH ALAR CLEFTS
203100	ALBINISM, OCULOCUTANEOUS, TYPE IA; OCA1A
203200	ALBINISM, OCULOCUTANEOUS, TYPE II; OCA2
203280	MOVED TO 606952
203285	MOVED TO 608233
203290	ALBINISM, OCULOCUTANEOUS, TYPE III; OCA3
203300	HERMANSKY-PUDLAK SYNDROME 1; HPS1
203310	MOVED TO 203200
203330	PSEUDOHYPOPARATHYROIDISM, TYPE II; PHP2
203340	ALBINISM-MICROCEPHALY-DIGITAL ANOMALIES SYNDROME
203400	CORTICOSTERONE METHYLOXIDASE TYPE I DEFICIENCY
203450	ALEXANDER DISEASE; ALXDRD
203500	ALKAPTONURIA; AKU
203550	ALOPECIA-CONTRACTURES-DWARFISM MENTAL RETARDATION SYNDROME
203600	ALOPECIA-EPILEPSY-OLIGOPHRENIA SYNDROME OF MOYNAHAN
203650	ALOPECIA-INTELLECTUAL DISABILITY SYNDROME 1; APMR1
203655	ALOPECIA UNIVERSALIS CONGENITA; ALUNC
203700	MITOCHONDRIAL DNA DEPLETION SYNDROME 4A (ALPERS TYPE); MTDPS4A
203740	OXOGLUTARATE DEHYDROGENASE DEFICIENCY; OGDHD
203750	ALPHA-METHYLACETOACETIC ACIDURIA
203760	ALPHA-2-DEFICIENT COLLAGEN DISEASE
203780	ALPORT SYNDROME 2, AUTOSOMAL RECESSIVE; ATS2
203800	ALSTROM SYNDROME; ALMS
204000	LEBER CONGENITAL AMAUROSIS 1; LCA1
204100	LEBER CONGENITAL AMAUROSIS 2; LCA2
204110	AMAUROSIS CONGENITA, CONE-ROD TYPE, WITH CONGENITAL HYPERTRICHOSIS
204200	CEROID LIPOFUSCINOSIS, NEURONAL, 3; CLN3
204300	CEROID LIPOFUSCINOSIS, NEURONAL, 6B (KUFS TYPE); CLN6B
204400	REMOVED FROM DATABASE
204500	CEROID LIPOFUSCINOSIS, NEURONAL, 2; CLN2
204600	MOVED TO 204500
204650	AMELOGENESIS IMPERFECTA, TYPE IC; AI1C
204690	AMELOGENESIS IMPERFECTA, TYPE IG; AI1G
204700	AMELOGENESIS IMPERFECTA, HYPOMATURATION TYPE, IIA1; AI2A1
204730	AMINO ACIDURIA WITH MENTAL DEFICIENCY, DWARFISM, MUSCULAR DYSTROPHY, OSTEOPOROSIS, AND ACIDOSIS
204750	ALPHA-AMINOADIPIC AND ALPHA-KETOADIPIC ACIDURIA; AAKAD
204800	AMOBARBITAL, DEFICIENT N-HYDROXYLATION OF
204850	AMYLOIDOSIS OF GINGIVA AND CONJUNCTIVA WITH IMPAIRED INTELLECTUAL DEVELOPMENT
204870	CORNEAL DYSTROPHY, GELATINOUS DROP-LIKE; GDLD
204900	AMYLOIDOSIS, CUTANEOUS BULLOUS
205000	AMYOTONIA CONGENITA
205100	AMYOTROPHIC LATERAL SCLEROSIS 2, JUVENILE; ALS2
205200	AMYOTROPHIC LATERAL SCLEROSIS, JUVENILE, WITH DEMENTIA
205250	AMYOTROPHIC LATERAL SCLEROSIS WITH POLYGLUCOSAN BODIES
205400	TANGIER DISEASE; TGD
205600	MOVED TO 105650
205700	ANEMIA, AUTOIMMUNE HEMOLYTIC
205900	MOVED TO 105650
205950	ANEMIA, SIDEROBLASTIC, 2, PYRIDOXINE-REFRACTORY; SIDBA2
206000	ANEMIA, SIDEROBLASTIC, PYRIDOXINE-RESPONSIVE, AUTOSOMAL RECESSIVE
206100	ANEMIA, HYPOCHROMIC MICROCYTIC, WITH IRON OVERLOAD 1; AHMIO1
206200	IRON-REFRACTORY IRON DEFICIENCY ANEMIA; IRIDA
206300	ANEMIA, NONSPHEROCYTIC HEMOLYTIC, ASSOCIATED WITH ABNORMALITY OF RED CELL MEMBRANE
206400	ANEMIA, NONSPHEROCYTIC HEMOLYTIC, POSSIBLY DUE TO DEFECT IN PORPHYRIN METABOLISM
206500	ANENCEPHALY 1; ANPH1
206550	ANGIOLIPOMATOSIS, FAMILIAL
206570	ANGIOMATOSIS, DIFFUSE CORTICOMENINGEAL, OF DIVRY AND VAN BOGAERT
206600	ANHIDROSIS, FAMILIAL GENERALIZED, WITH ABNORMAL OR ABSENT SWEAT GLANDS
206700	GILLESPIE SYNDROME; GLSP
206750	ANIRIDIA, PARTIAL, WITH UNILATERAL RENAL AGENESIS AND PSYCHOMOTOR RETARDATION
206780	ANODONTIA OF PERMANENT DENTITION
206800	NAIL DISORDER, NONSYNDROMIC CONGENITAL, 4; NDNC4
206900	MICROPHTHALMIA, SYNDROMIC 3; MCOPS3
206920	MICROPHTHALMIA WITH LIMB ANOMALIES; MLA
207000	ANOSMIA FOR ISOBUTYRIC ACID
207300	ANTITHROMBIN, FAMILIAL HEMORRHAGIC DIATHESIS DUE TO
207410	ANTLEY-BIXLER SYNDROME WITHOUT GENITAL ANOMALIES OR DISORDERED STEROIDOGENESIS; ABS2
207500	ANUS, IMPERFORATE
207600	TAKAYASU ARTERITIS
207620	APHALANGY WITH HEMIVERTEBRAE
207700	MOVED TO 107600
207720	APNEA, CENTRAL SLEEP
207731	APLASIA CUTIS CONGENITA WITH INTESTINAL LYMPHANGIECTASIA
207740	APLASIA OF EXTENSOR MUSCLES OF FINGERS, UNILATERAL, WITH GENERALIZED POLYNEUROPATHY
207750	APOLIPOPROTEIN C-II DEFICIENCY
207765	MOVED TO 218030
207770	APROSENCEPHALY SYNDROME
207780	AREDYLD
207790	ARACHNOID CYSTS, INTRACRANIAL
207800	ARGININEMIA
207900	ARGININOSUCCINIC ACIDURIA
207950	CHIARI MALFORMATION TYPE II
208000	ARTERIAL CALCIFICATION, GENERALIZED, OF INFANCY, 1; GACI1
208050	ARTERIAL TORTUOSITY SYNDROME; ATORS
208060	ARTERIOSCLEROSIS, SEVERE JUVENILE
208080	MOVED TO 615547
208081	ARTHROGRYPOSIS, DISTAL, WITH IMPAIRED INTELLECTUAL DEVELOPMENT AND CHARACTERISTIC FACIES
208085	ARTHROGRYPOSIS, RENAL DYSFUNCTION, AND CHOLESTASIS 1; ARCS1
208100	ARTHROGRYPOSIS MULTIPLEX CONGENITA 2, NEUROGENIC TYPE; AMC2
208110	MOVED TO 208155
208150	FETAL AKINESIA DEFORMATION SEQUENCE 1; FADS1
208155	ILLUM SYNDROME
208158	ARTHROGRYPOSIS WITH HYPERKERATOSIS
208200	MOVED TO 259450
208230	PROGRESSIVE PSEUDORHEUMATOID DYSPLASIA; PPRD
208250	CAMPTODACTYLY-ARTHROPATHY-COXA VARA-PERICARDITIS SYNDROME; CACP
208300	ASCITES, CHYLOUS
208400	ASPARTYLGLUCOSAMINURIA; AGU
208500	SHORT-RIB THORACIC DYSPLASIA 1 WITH OR WITHOUT POLYDACTYLY; SRTD1
208530	RIGHT ATRIAL ISOMERISM; RAI
208540	RENAL-HEPATIC-PANCREATIC DYSPLASIA 1; RHPD1
208550	ASTHMA, NASAL POLYPS, AND ASPIRIN INTOLERANCE
208600	ASTHMA, SHORT STATURE, AND ELEVATED IgA
208700	ATAXIA WITH MYOCLONIC EPILEPSY AND PRESENILE DEMENTIA
208750	ATAXIA, DEAFNESS, AND CARDIOMYOPATHY
208800	MOVED TO 312170
208850	ATAXIA-DEAFNESS-RETARDATION SYNDROME
208870	ATAXIA-MICROCEPHALY-CATARACT SYNDROME
208900	ATAXIA-TELANGIECTASIA; AT
208905	MOVED TO 208900
208910	ATAXIA-TELANGIECTASIA WITH GENERALIZED SKIN PIGMENTATION AND EARLY DEATH
208920	ATAXIA, EARLY-ONSET, WITH OCULOMOTOR APRAXIA AND HYPOALBUMINEMIA; EAOH
209000	MOVED TO 613179
209010	ATHEROSCLEROSIS, PREMATURE, WITH DEAFNESS, NEPHROPATHY, DIABETES MELLITUS, PHOTOMYOCLONUS, AND DEGENERATIVE NEUROLOGIC DISEASE
209050	ATHROMBIA, ESSENTIAL
209100	ATONIC-ASTATIC SYNDROME OF FOERSTER
209300	ATRANSFERRINEMIA
209400	MOVED TO 600309
209500	ATRICHIA WITH PAPULAR LESIONS; APL
209600	ATRIOVENTRICULAR DISSOCIATION
209700	ATROPHODERMA VERMICULATA; AVA
209750	MOVED TO 209950
209770	AURAL ATRESIA, MULTIPLE CONGENITAL ANOMALIES, AND MENTAL RETARDATION
209800	AUSTRALIA ANTIGEN
209850	AUTISM
209880	CENTRAL HYPOVENTILATION SYNDROME, CONGENITAL, 1; CCHS1
209885	BARBER-SAY SYNDROME; BBRSAY
209900	BARDET-BIEDL SYNDROME 1; BBS1
209901	BBS1 GENE; BBS1
209920	BARE LYMPHOCYTE SYNDROME, TYPE II
209930	MOVED TO 241200
209950	IMMUNODEFICIENCY 27A; IMD27A
209970	BEEMER LETHAL MALFORMATION SYNDROME
210000	BEHR SYNDROME; BEHRS
210050	BERRY ANEURYSM, CIRRHOSIS, PULMONARY EMPHYSEMA, AND CEREBRAL CALCIFICATION
210100	BETA-AMINOISOBUTYRIC ACIDURIA; BAIBA
210200	3-METHYLCROTONYL-CoA CARBOXYLASE 1 DEFICIENCY; MCC1D
210210	3-METHYLCROTONYL-CoA CARBOXYLASE 2 DEFICIENCY; MCC2D
210250	SITOSTEROLEMIA 1; STSL1
210300	MOVED TO 201300
210350	BIEMOND SYNDROME II
210370	BIETTI CRYSTALLINE CORNEORETINAL DYSTROPHY; BCD
210400	BIFID NOSE, AUTOSOMAL RECESSIVE
210450	MOVED TO 607765
210500	BILIARY ATRESIA, EXTRAHEPATIC; EHBA
210550	BILIARY MALFORMATION WITH RENAL TUBULAR INSUFFICIENCY
210600	SECKEL SYNDROME 1; SCKL1
210700	MICROCEPHALIC PRIMORDIAL DWARFISM, MONTREAL TYPE
210710	MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE I; MOPD1
210720	MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE II; MOPD2
210730	MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE III
210740	BANGSTAD SYNDROME
210745	BLEPHAROPHIMOSIS WITH PTOSIS, SYNDACTYLY, AND SHORT STATURE
210750	SKIN/HAIR/EYE PIGMENTATION, VARIATION IN, 6; SHEP6
210900	BLOOM SYNDROME; BLM
211000	BLUE DIAPER SYNDROME
211100	FUCOSYLTRANSFERASE 1; FUT1
211120	BONE DYSPLASIA, LETHAL, HOLMGREN TYPE
211170	MOVED TO 249420
211180	BOWEN-CONRADI SYNDROME; BWCNS
211200	BOWEN SYNDROME OF MULTIPLE MALFORMATIONS
211350	KYPHOMELIC DYSPLASIA
211355	BOWING OF LONG BONES, ASYMMETRIC AND SYMMETRIC
211369	BRACHYDACTYLY, TYPE A2, WITH MICROCEPHALY
211370	BRACHYMETAPODY-ANODONTIA-HYPOTRICHOSIS-ALBINOIDISM
211380	ELSAHY-WATERS SYNDROME; ESWS
211390	SABINAS BRITTLE HAIR SYNDROME
211400	BRONCHIECTASIS WITH OR WITHOUT ELEVATED SWEAT CHLORIDE 1; BESC1
211410	MOVED TO 114450
211420	REMOVED FROM DATABASE
211450	WILLIAMS-CAMPBELL SYNDROME
211480	BUERGER DISEASE
211500	FAZIO-LONDE DISEASE
211530	BROWN-VIALETTO-VAN LAERE SYNDROME 1; BVVLS1
211550	MOVED TO 113900
211600	CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC, 1; PFIC1
211750	C SYNDROME
211770	CAHMR SYNDROME
211800	CALCIFICATION OF JOINTS AND ARTERIES; CALJA
211890	CAMPOMELIA, CUMMING TYPE
211900	TUMORAL CALCINOSIS, HYPERPHOSPHATEMIC, FAMILIAL, 1; HFTC1
211910	CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE I; GCS1
211920	CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE II
211930	CAMPTODACTYLY WITH FIBROUS TISSUE HYPERPLASIA AND SKELETAL DYSPLASIA
211960	CAMPTODACTYLY WITH MUSCULAR HYPOPLASIA, SKELETAL DYSPLASIA, AND ABNORMAL PALMAR CREASES
211965	CAMPTODACTYLY-ICHTHYOSIS SYNDROME
211970	MOVED TO 114290
211980	LUNG CANCER
211990	CAMPTOMELIC SYNDROME, LONG-LIMB TYPE
212050	IMMUNODEFICIENCY 103, SUSCEPTIBILITY TO FUNGAL INFECTIONS; IMD103
212060	CARBIMAZOLE SENSITIVITY
212065	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ia; CDG1A
212066	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIa; CDG2A
212067	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE I/IIx
212070	CARBOXYPEPTIDASE N DEFICIENCY
212080	CARDIAC LIPIDOSIS, FAMILIAL
212090	CARDIAC SEPTAL DEFECTS WITH COARCTATION OF THE AORTA
212093	CARDIAC VALVULAR DYSPLASIA 1; CVDP1
212100	CARDIOAUDITORY SYNDROME OF SANCHEZ CASCOS
212110	MOVED TO 611880
212112	CARDIOMYOPATHY, DILATED, WITH HYPERGONADOTROPIC HYPOGONADISM
212120	MOVED TO 212112
212130	CARDIOMYOPATHY ASSOCIATED WITH MYOPATHY AND SUDDEN DEATH
212135	CARDIOSKELETAL SYNDROME, KUWAITI TYPE
212138	CARNITINE-ACYLCARNITINE TRANSLOCASE DEFICIENCY; CACTD
212140	CARNITINE DEFICIENCY, SYSTEMIC PRIMARY; CDSP
212160	CARNITINE DEFICIENCY, MYOPATHIC
212200	CARNOSINEMIA
212350	SENGERS SYNDROME
212360	PALMOPLANTAR KERATODERMA AND CONGENITAL ALOPECIA 2; PPKCA2
212400	CATARACT AND CONGENITAL ICHTHYOSIS
212500	CATARACT 46, JUVENILE-ONSET, WITH OR WITHOUT ARRHYTHMIC CARDIOMYOPATHY; CTRCT46
212540	CATARACT, MICROCEPHALY, FAILURE TO THRIVE, KYPHOSCOLIOSIS SYNDROME
212550	OPTIC DISC ANOMALIES WITH RETINAL AND/OR MACULAR DYSTROPHY; ODRMD
212600	REMOVED FROM DATABASE
212700	REMOVED FROM DATABASE
212710	CATARACT-ATAXIA-DEAFNESS-RETARDATION SYNDROME
212720	MARTSOLF SYNDROME 1; MARTS1
212750	CELIAC DISEASE, SUSCEPTIBILITY TO, 1; CELIAC1
212780	CENANI-LENZ SYNDACTYLY SYNDROME; CLSS
212790	PREMATURE CENTROMERE DIVISION; PCD
212800	CEPHALIN LIPIDOSIS
212835	CEREBELLAR ATAXIA AND ECTODERMAL DYSPLASIA
212840	GORDON HOLMES SYNDROME; GDHS
212850	CEREBELLAR ATAXIA AND NEUROSENSORY DEAFNESS
212890	CEREBELLAR ATAXIA, BENIGN, WITH THERMOANALGESIA
212895	CEREBELLAR ATAXIA, EARLY-ONSET, WITH RETAINED TENDON REFLEXES; EOCA
212900	MOVED TO 258450
212905	MOVED TO 606854
213000	CEREBELLAR HYPOPLASIA/ATROPHY, EPILEPSY, AND GLOBAL DEVELOPMENTAL DELAY; CHEGDD
213002	MOVED TO 614381
213010	CEREBELLAR VERMIS APLASIA WITH ASSOCIATED FEATURES SUGGESTING SMITH-LEMLI-OPITZ SYNDROME AND MECKEL SYNDROME
213100	MOVED TO 607136
213200	SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 2; SCAR2
213300	JOUBERT SYNDROME 1; JBTS1
213400	DYSSYNERGIA CEREBELLARIS MYOCLONICA OF HUNT
213500	CEREBRAL ANGIOPATHY, DYSPHORIC
213600	BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 1; IBGC1
213700	CEREBROTENDINOUS XANTHOMATOSIS; CTX
213820	CEREBRAL MALFORMATION, SEIZURES, HYPERTRICHOSIS, AND OVERLAPPING FINGERS
213900	CEREBRAL SCLEROSIS SIMILAR TO PELIZAEUS-MERZBACHER DISEASE
213950	CEREBROCORTICAL DEGENERATION OF INFANCY
213980	CRANIOFACIAL DYSMORPHISM, SKELETAL ANOMALIES, AND IMPAIRED INTELLECTUAL DEVELOPMENT SYNDROME 1; CFSMR1
214100	PEROXISOME BIOGENESIS DISORDER 1A (ZELLWEGER); PBD1A
214110	PEROXISOME BIOGENESIS DISORDER 2A (ZELLWEGER); PBD2A
214150	CEREBROOCULOFACIOSKELETAL SYNDROME 1; COFS1
214200	MOVED TO 256730
214290	CERVICAL VERTEBRAE, AGENESIS OF
214300	KLIPPEL-FEIL SYNDROME 2, AUTOSOMAL RECESSIVE; KFS2
214350	CHAND SYNDROME; CHANDS
214370	NEUROPATHY, HEREDITARY MOTOR AND SENSORY, WITH DEAFNESS, IMPAIRED INTELLECTUAL DEVELOPMENT, AND ABSENT SENSORY LARGE MYELINATED FIBERS
214380	MOVED TO 606002
214400	CHARCOT-MARIE-TOOTH DISEASE, TYPE 4A; CMT4A
214450	GRISCELLI SYNDROME, TYPE 1; GS1
214500	CHEDIAK-HIGASHI SYNDROME; CHS
214700	DIARRHEA 1, SECRETORY CHLORIDE, CONGENITAL; DIAR1
214800	CHARGE SYNDROME
214900	CHOLESTASIS-LYMPHEDEMA SYNDROME
214950	BILE ACID SYNTHESIS DEFECT, CONGENITAL, 4; CBAS4
214980	CHOLESTASIS WITH GALLSTONE, ATAXIA, AND VISUAL DISTURBANCE
215030	CHOLESTEROL PNEUMONIA
215045	CHONDRODYSPLASIA, BLOMSTRAND TYPE; BOCD
215050	CHONDRODYSPLASIA CALCIFICANS METAPHYSEALIS
215100	RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 1; RCDP1
215105	CHONDRODYSPLASIA PUNCTATA SYNDROME
215140	GREENBERG DYSPLASIA; GRBGD
215150	OTOSPONDYLOMEGAEPIPHYSEAL DYSPLASIA, AUTOSOMAL RECESSIVE; OSMEDB
215250	CHONDROITIN-6-SULFATURIA, DEFECTIVE CELLULAR IMMUNITY, NEPHROTIC SYNDROME
215300	CHONDROSARCOMA
215400	CHORDOMA, SUSCEPTIBILITY TO; CHDM
215450	CHOREA, BENIGN FAMILIAL
215470	BOUCHER-NEUHAUSER SYNDROME; BNHS
215480	CHOROID PLEXUS CALCIFICATION AND MENTAL RETARDATION
215500	CHOROIDAL DYSTROPHY, CENTRAL AREOLAR, 1; CACD1
215510	CHROMOSOMAL INSTABILITY WITH TISSUE-SPECIFIC RADIOSENSITIVITY
215518	CILIARY DISCOORDINATION DUE TO RANDOM CILIARY ORIENTATION
215520	CILIARY DYSKINESIA WITH TRANSPOSITION OF CILIARY MICROTUBULES
215550	CIRCUMVALLATE PLACENTA SYNDROME
215600	CIRRHOSIS, FAMILIAL
215700	CITRULLINEMIA, CLASSIC
215720	CITRULLINE TRANSPORT DEFECT
215800	CLEFT LARYNX, POSTERIOR
215850	CLEFT-LIMB-HEART MALFORMATION SYNDROME
216100	JUBERG-HAYWARD SYNDROME; JHS
216300	CLEFT PALATE, DEAFNESS, AND OLIGODONTIA
216330	CLEIDOCRANIAL DYSPLASIA, RECESSIVE FORM
216340	YUNIS-VARON SYNDROME; YVS
216360	COACH SYNDROME 1; COACH1
216400	COCKAYNE SYNDROME A; CSA
216411	MOVED TO 216400
216550	COHEN SYNDROME; COH1
216700	COLLAGENOSIS, FAMILIAL REACTIVE PERFORATING; RPC
216800	COLOBOMA OF MACULA AND SKELETAL ANOMALIES
216820	COLOBOMA, OCULAR, AUTOSOMAL RECESSIVE
216900	ACHROMATOPSIA 2; ACHM2
216920	MOVED TO 615816
216950	COMPLEMENT COMPONENT C1r/C1s DEFICIENCY
217000	COMPLEMENT COMPONENT 2 DEFICIENCY; C2D
217030	COMPLEMENT FACTOR I; CFI
217050	COMPLEMENT COMPONENT 6; C6
217070	COMPLEMENT COMPONENT 7; C7
217080	JALILI SYNDROME
217085	CONGENITAL HEART DEFECTS, HAMARTOMAS OF TONGUE, AND POLYSYNDACTYLY; CHDTHP
217090	PLASMINOGEN DEFICIENCY, TYPE I
217095	CONOTRUNCAL HEART MALFORMATIONS; CTHM
217100	CONSTRICTING BANDS, CONGENITAL
217150	CONTRACTURES, CONGENITAL, TORTICOLLIS, AND MALIGNANT HYPERTHERMIA
217200	CONVULSIVE DISORDER, FAMILIAL, WITH PRENATAL OR EARLY ONSET
217300	CORNEA PLANA 2, AUTOSOMAL RECESSIVE; CNA2
217400	CORNEAL DYSTROPHY AND PERCEPTIVE DEAFNESS; CDPD
217500	CORNEAL DYSTROPHY, BAND-SHAPED
217520	CORNEAL DEGENERATION, BAND-SHAPED SPHEROID
217600	CENTRAL CLOUDY DYSTROPHY OF FRANCOIS; CCDF
217700	CORNEAL ENDOTHELIAL DYSTROPHY; CHED
217800	MACULAR DYSTROPHY, CORNEAL; MCD
217980	CORPUS CALLOSUM, AGENESIS OF, WITH FACIAL ANOMALIES AND ROBIN SEQUENCE
217990	CORPUS CALLOSUM, AGENESIS OF
218000	AGENESIS OF THE CORPUS CALLOSUM WITH PERIPHERAL NEUROPATHY; ACCPN
218010	CORTICAL BLINDNESS, RETARDATION, AND POSTAXIAL POLYDACTYLY
218030	APPARENT MINERALOCORTICOID EXCESS; AME
218040	COSTELLO SYNDROME; CSTLO
218050	CRAMPS, FAMILIAL ADOLESCENT
218090	CRANE-HEISE SYNDROME
218100	CRANIAL NERVES, CONGENITAL PARESIS OF
218200	CRANIAL NERVES, RECURRENT PARESIS OF
218300	CRANIODIAPHYSEAL DYSPLASIA; CDD
218330	CRANIOECTODERMAL DYSPLASIA 1; CED1
218340	TEMTAMY SYNDROME; TEMTYS
218350	CRANIOFACIAL DYSSYNOSTOSIS WITH SHORT STATURE
218400	CRANIOMETAPHYSEAL DYSPLASIA, AUTOSOMAL RECESSIVE; CMDR
218450	CRANIOSTENOSIS, SAGITTAL, WITH CONGENITAL HEART DISEASE, MENTAL DEFICIENCY, AND MANDIBULAR ANKYLOSIS
218455	MOVED TO 251200
218500	MOVED TO 123100 AND 123150
218530	CRANIOSYNOSTOSIS WITH ANOMALIES OF THE CRANIAL BASE AND DIGITS
218550	CRANIOSYNOSTOSIS WITH FIBULAR APLASIA
218600	BALLER-GEROLD SYNDROME; BGS
218649	CRANIOSYNOSTOSIS-MENTAL RETARDATION SYNDROME OF LIN AND GETTIG
218650	CRANIOSYNOSTOSIS-MENTAL RETARDATION-CLEFTING SYNDROME
218670	CRANIOTELENCEPHALIC DYSPLASIA
218700	HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 2; CHNG2
218800	CRIGLER-NAJJAR SYNDROME, TYPE I
218900	CROME SYNDROME
219000	FRASER SYNDROME 1; FRASRS1
219050	CRYPTORCHIDISM, UNILATERAL OR BILATERAL
219070	CURVED NAIL OF FOURTH TOE
219080	ACTH-INDEPENDENT MACRONODULAR ADRENAL HYPERPLASIA; AIMAH1
219090	PITUITARY ADENOMA 4, ACTH-SECRETING; PITA4
219095	CUTANEOUS PHOTOSENSITIVITY AND COLITIS, LETHAL
219100	CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IA; ARCL1A
219150	CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIIA; ARCL3A
219200	CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIA; ARCL2A
219250	CUTIS MARMORATA TELANGIECTATICA CONGENITA; CMTC
219300	CUTIS VERTICIS GYRATA AND MENTAL RETARDATION; CVG/MR
219400	CYANOSIS AND HEPATIC DISEASE
219500	CYSTATHIONINURIA
219550	CYSTEINE PEPTIDURIA
219600	POLYCYSTIC LUNG DISEASE; PCLUD
219700	CYSTIC FIBROSIS; CF
219721	CYSTIC FIBROSIS WITH HELICOBACTER PYLORI GASTRITIS, MEGALOBLASTIC ANEMIA, AND MENTAL RETARDATION
219730	VENTRICULOMEGALY WITH CYSTIC KIDNEY DISEASE; VMCKD
219750	CYSTINOSIS, ADULT NONNEPHROPATHIC
219800	CYSTINOSIS, NEPHROPATHIC; CTNS
219900	CYSTINOSIS, LATE-ONSET JUVENILE OR ADOLESCENT NEPHROPATHIC TYPE
220100	CYSTINURIA
220110	MITOCHONDRIAL COMPLEX IV DEFICIENCY, NUCLEAR TYPE 1; MC4DN1
220111	MITOCHONDRIAL COMPLEX IV DEFICIENCY, NUCLEAR TYPE 5; MC4DN5
220120	D-GLYCERIC ACIDURIA
220150	HYPOURICEMIA, RENAL, 1; RHUC1
220200	DANDY-WALKER SYNDROME; DWS
220210	RITSCHER-SCHINZEL SYNDROME 1; RTSC1
220219	DANDY-WALKER MALFORMATION WITH MENTAL RETARDATION, MACROCEPHALY, MYOPIA, AND BRACHYTELEPHALANGY
220220	DANDY-WALKER MALFORMATION WITH POSTAXIAL POLYDACTYLY
220290	DEAFNESS, AUTOSOMAL RECESSIVE 1A; DFNB1A
220300	DEAFNESS, CONGENITAL, AND FAMILIAL MYOCLONIC EPILEPSY
220400	JERVELL AND LANGE-NIELSEN SYNDROME 1; JLNS1
220500	DEAFNESS, ONYCHODYSTROPHY, OSTEODYSTROPHY, IMPAIRED INTELLECTUAL DEVELOPMENT, AND SEIZURES SYNDROME; DOORS
220600	SPLIT-HAND/FOOT MALFORMATION 1 WITH SENSORINEURAL HEARING LOSS, AUTOSOMAL RECESSIVE; SHFM1D
220700	MOVED TO 220290
220800	MOVED TO 220700
220900	DEAFNESS, CONGENITAL, WITH TOTAL ALBINISM
221000	REMOVED FROM DATABASE
221200	DEAFNESS AND MYOPIA; DFNMYP
221300	DEAFNESS, CONDUCTIVE, WITH MALFORMED EXTERNAL EAR
221320	DEAFNESS, CONDUCTIVE, WITH PTOSIS AND SKELETAL ANOMALIES
221350	DEAFNESS, CONGENITAL, WITH VITILIGO AND ACHALASIA
221400	DEAFNESS, NERVE TYPE, WITH MESENTERIC DIVERTICULA OF SMALL BOWEL AND PROGRESSIVE SENSORY NEUROPATHY
221500	DEAFNESS, NEURAL, CONGENITAL MODERATE
221600	MOVED TO 220290
221650	MOVED TO 220290
221700	DEAFNESS, NEURAL, WITH ATYPICAL ATOPIC DERMATITIS
221740	DEAFNESS-OLIGODONTIA SYNDROME
221745	DEAFNESS, SENSORINEURAL, AUTOSOMAL-MITOCHONDRIAL TYPE
221750	PITUITARY HORMONE DEFICIENCY, COMBINED, 3; CPHD3
221760	DERMATOGLYPHICS--PALMAR TRIRADIUS d, ABSENCE OF
221770	POLYCYSTIC LIPOMEMBRANOUS OSTEODYSPLASIA WITH SCLEROSING LEUKOENCEPHALOPATHY 1; PLOSL1
221780	DERMATOGLYPHICS--HYPOTHENAR RADIAL ARCH
221790	DERMATOLEUKODYSTROPHY
221800	DERMOCHONDROCORNEAL DYSTROPHY
221810	DERMATOOSTEOLYSIS, KIRGHIZIAN TYPE
221820	LEUKOENCEPHALOPATHY, HEREDITARY DIFFUSE, WITH SPHEROIDS 1; HDLS1
221900	PERSISTENT HYPERPLASTIC PRIMARY VITREOUS, AUTOSOMAL RECESSIVE; PHPVAR
221950	DEXTROCARDIA WITH UNUSUAL FACIES AND MICROPHTHALMIA
221995	DIABETES INSIPIDUS, NEPHROGENIC, WITH MENTAL RETARDATION AND INTRACEREBRAL CALCIFICATION
222000	MOVED TO 125800
222100	TYPE 1 DIABETES MELLITUS; T1D
222300	WOLFRAM SYNDROME 1; WFS1
222350	DIAMINOPENTANURIA
222400	DIAPHRAGMATIC HERNIA 2; DIH2
222448	DONNAI-BARROW SYNDROME; DBS
222470	TRICHOHEPATOENTERIC SYNDROME 1; THES1
222500	DIASTEMATOMYELIA
222600	DIASTROPHIC DYSPLASIA; DTD
222690	DIBASIC AMINO ACIDURIA I
222700	LYSINURIC PROTEIN INTOLERANCE; LPI
222730	DICARBOXYLIC AMINOACIDURIA; DCBXA
222745	2,4-DIENOYL-CoA REDUCTASE 1, MITOCHONDRIAL; DECR1
222748	DIHYDROPYRIMIDINASE DEFICIENCY; DPYSD
222760	MOVED TO 220500
222765	RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 2; RCDP2
222800	ERYTHROCYTOSIS, FAMILIAL, 8; ECYT8
222900	SUCRASE-ISOMALTASE DEFICIENCY, CONGENITAL; CSID
223000	LACTASE DEFICIENCY, CONGENITAL
223100	LACTOSE INTOLERANCE, ADULT TYPE
223200	DISORGANIZATION, MOUSE, HOMOLOG OF
223300	DISSEMINATED SCLEROSIS WITH NARCOLEPSY
223320	DIVERTICULOSIS, SMALL-INTESTINAL
223330	DIVERTICULOSIS OF BOWEL, HERNIA, AND RETINAL DETACHMENT
223340	DK PHOCOMELIA SYNDROME
223350	DOHLE BODIES AND LEUKEMIA
223360	ORTHOSTATIC HYPOTENSION 1; ORTHYP1
223370	DUBOWITZ SYNDROME
223380	DOPAMINE BETA-HYDROXYLASE, PLASMA, THERMOLABILITY OF
223400	DUODENAL ATRESIA
223500	DWARFISM, LOW-BIRTH-WEIGHT TYPE, WITH UNRESPONSIVENESS TO GROWTH HORMONE
223540	DWARFISM, MENTAL RETARDATION, AND EYE ABNORMALITY
223550	DWARFISM, PROPORTIONATE, WITH HIP DISLOCATION
223600	MOVED TO 127100
223610	MOVED TO 228900
223800	DYGGVE-MELCHIOR-CLAUSEN DISEASE; DMC
223900	NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE III; HSAN3
224000	DYSAUTONOMIA-LIKE DISORDER
224050	CEREBELLAR ATAXIA, IMPAIRED INTELLECTUAL DEVELOPMENT, AND DYSEQUILIBRIUM SYNDROME 1; CAMRQ1
224100	ANEMIA, CONGENITAL DYSERYTHROPOIETIC, TYPE II; CDAN2
224120	ANEMIA, CONGENITAL DYSERYTHROPOIETIC, TYPE Ia; CDAN1A
224200	MOVED TO 229200
224230	DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 1; DKCB1
224250	DYSMYELINATION WITH JAUNDICE
224300	DYSOSTEOSCLEROSIS
224400	DYSSEGMENTAL DYSPLASIA, ROLLAND-DESBUQUOIS TYPE; DDRD
224410	DYSSEGMENTAL DYSPLASIA, SILVERMAN-HANDMAKER TYPE; DDSH
224500	DYSTONIA 2, TORSION, AUTOSOMAL RECESSIVE; DYT2
224550	DYSTONIA WITH RINGBINDEN
224570	MOVED TO 500001
224600	MOVED TO 128200
224690	MEIER-GORLIN SYNDROME 1; MGORS1
224700	EBSTEIN ANOMALY
224750	SCHOPF-SCHULZ-PASSARGE SYNDROME; SSPS
224800	ECTODERMAL DYSPLASIA AND NEUROSENSORY DEAFNESS
224900	ECTODERMAL DYSPLASIA 10B, HYPOHIDROTIC/HAIR/TOOTH TYPE, AUTOSOMAL RECESSIVE; ECTD10B
225000	ROSSELLI-GULIENETTI SYNDROME
225040	ECTODERMAL DYSPLASIA, HYPOHIDROTIC, WITH HYPOTHYROIDISM AND AGENESIS OF THE CORPUS CALLOSUM
225050	ECTODERMAL DYSPLASIA, HYPOHIDROTIC, WITH HYPOTHYROIDISM AND CILIARY DYSKINESIA
225060	CLEFT LIP/PALATE-ECTODERMAL DYSPLASIA SYNDROME; CLPED1
225100	ECTOPIA LENTIS 2, ISOLATED, AUTOSOMAL RECESSIVE; ECTOL2
225200	ECTOPIA LENTIS ET PUPILLAE
225250	HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 5; CHNG5
225280	ECTODERMAL DYSPLASIA, ECTRODACTYLY, AND MACULAR DYSTROPHY SYNDROME; EEMS
225290	ECTRODACTYLY-POLYDACTYLY
225300	SPLIT-HAND/FOOT MALFORMATION 6; SHFM6
225310	EHLERS-DANLOS SYNDROME WITH PLATELET DYSFUNCTION FROM FIBRONECTIN ABNORMALITY
225320	EHLERS-DANLOS SYNDROME, CARDIAC VALVULAR TYPE; EDSCV
225350	MOVED TO 130050
225360	REMOVED FROM DATABASE
225400	EHLERS-DANLOS SYNDROME, KYPHOSCOLIOTIC TYPE, 1; EDSKSCL1
225410	EHLERS-DANLOS SYNDROME, DERMATOSPARAXIS TYPE; EDSDERMS
225450	MOVED TO 182860
225500	ELLIS-VAN CREVELD SYNDROME; EVC
225700	ENCEPHALOMALACIA, MULTILOCULAR
225740	ENCEPHALOPATHY, AXONAL, WITH NECROTIZING MYOPATHY, CARDIOMYOPATHY, AND CATARACTS
225750	AICARDI-GOUTIERES SYNDROME 1; AGS1
225753	PONTOCEREBELLAR HYPOPLASIA, TYPE 4; PCH4
225755	ENCEPHALOPATHY WITH INTRACRANIAL CALCIFICATION, GROWTH HORMONE DEFICIENCY, MICROCEPHALY, AND RETINAL DEGENERATION
225790	PROLIFERATIVE VASCULOPATHY AND HYDRANENCEPHALY-HYDROCEPHALY SYNDROME; PVHH
225795	MOVED TO 166000
226000	ENDOCARDIAL FIBROELASTOSIS; EFE
226100	ENDOCARDIAL FIBROELASTOSIS AND COARCTATION OF ABDOMINAL AORTA
226110	ENDOTHELIAL DYSTROPHY, CONGENITAL HEREDITARY, WITH NAIL HYPOPLASIA
226150	ENTEROCOLITIS
226200	ENTEROKINASE DEFICIENCY
226300	COMPLEMENT HYPERACTIVATION, ANGIOPATHIC THROMBOSIS, AND PROTEIN-LOSING ENTEROPATHY; CHAPLE
226350	EOSINOPHILIC FASCIITIS
226400	EPIDERMODYSPLASIA VERRUCIFORMIS, SUSCEPTIBILITY TO, 1; EV1
226440	EPIDERMOLYSIS BULLOSA, LATE-ONSET LOCALIZED JUNCTIONAL, WITH MENTAL RETARDATION
226450	MOVED TO 226600 AND 226650
226500	EPIDERMOLYSIS BULLOSA DYSTROPHICA NEUROTROPHICA
226600	EPIDERMOLYSIS BULLOSA DYSTROPHICA, AUTOSOMAL RECESSIVE; RDEB
226650	EPIDERMOLYSIS BULLOSA, JUNCTIONAL 1A, INTERMEDIATE; JEB1A
226670	EPIDERMOLYSIS BULLOSA SIMPLEX 5B, WITH MUSCULAR DYSTROPHY; EBS5B
226700	EPIDERMOLYSIS BULLOSA, JUNCTIONAL 1B, SEVERE; JEB1B
226730	EPIDERMOLYSIS BULLOSA, JUNCTIONAL 5B, WITH PYLORIC ATRESIA; JEB5B
226735	EPIDERMOLYSIS BULLOSA WITH DIAPHRAGMATIC HERNIA
226750	KOHLSCHUTTER-TONZ SYNDROME; KTZS
226800	EPILEPSY, PHOTOGENIC, WITH SPASTIC DIPLEGIA AND MENTAL RETARDATION
226810	EPILEPSY WITH BILATERAL OCCIPITAL CALCIFICATIONS
226850	EPILEPSY-TELANGIECTASIA
226900	EPIPHYSEAL DYSPLASIA, MULTIPLE, 4; EDM4
226950	EPIPHYSEAL DYSPLASIA OF FEMORAL HEAD, MYOPIA, AND DEAFNESS
226960	LOWRY-WOOD SYNDROME; LWS
226980	EPIPHYSEAL DYSPLASIA, MULTIPLE, WITH EARLY-ONSET DIABETES MELLITUS
226985	EPITHELIAL SQUAMOUS DYSPLASIA, KERATINIZING DESQUAMATIVE, OF URINARY TRACT
226990	IMMUNODEFICIENCY 32B; IMD32B
227000	ERYTHEMA OF ACRAL REGIONS
227010	ERMINE PHENOTYPE
227050	TRANSIENT ERYTHROBLASTOPENIA OF CHILDHOOD; TEC
227090	ERYTHRODERMA, LETHAL CONGENITAL
227100	MOVED TO 120900
227150	ETHANOLAMINOSIS
227200	MOVED TO 614841
227210	EYEBROWS, DUPLICATION OF, WITH STRETCHABLE SKIN AND SYNDACTYLY
227220	SKIN/HAIR/EYE PIGMENTATION, VARIATION IN, 1; SHEP1
227240	SKIN/HAIR/EYE PIGMENTATION, VARIATION IN, 5; SHEP5
227250	FACIAL ABNORMALITIES, KYPHOSCOLIOSIS, AND MENTAL RETARDATION
227255	FACIAL DYSMORPHISM WITH MULTIPLE MALFORMATIONS
227260	FOCAL FACIAL DERMAL DYSPLASIA 3, SETLEIS TYPE; FFDD3
227270	FACIOCARDIOMELIC DYSPLASIA, LETHAL
227280	FACIOCARDIORENAL SYNDROME
227290	MOVED TO 222448
227295	MOVED TO 211910
227300	FACTOR V AND FACTOR VIII, COMBINED DEFICIENCY OF, 1; F5F8D1
227310	FACTOR V AND FACTOR VIII, COMBINED DEFICIENCY OF, WITH NORMAL PROTEIN C AND PROTEIN C INHIBITOR
227320	FACIOTHORACOGENITAL SYNDROME
227330	FACIODIGITOGENITAL SYNDROME, AUTOSOMAL RECESSIVE
227400	FACTOR V DEFICIENCY
227500	FACTOR VII DEFICIENCY
227600	FACTOR X DEFICIENCY
227645	FANCONI ANEMIA, COMPLEMENTATION GROUP C; FANCC
227646	FANCONI ANEMIA, COMPLEMENTATION GROUP D2; FANCD2
227650	FANCONI ANEMIA, COMPLEMENTATION GROUP A; FANCA
227660	MOVED TO 300514
227700	MOVED TO 134600
227800	MOVED TO 134600
227810	FANCONI-BICKEL SYNDROME; FBS
227850	FANCONI-LIKE SYNDROME
228000	FARBER LIPOGRANULOMATOSIS; FRBRL
228020	FASCIAL DYSTROPHY, CONGENITAL
228100	VISCERAL STEATOSIS, CONGENITAL
228200	FEMUR-FIBULA-ULNA SYNDROME
228250	FEMUR, UNILATERAL BIFID, WITH MONODACTYLOUS ECTRODACTYLY
228300	HYPOGONADOTROPIC HYPOGONADISM 23 WITH OR WITHOUT ANOSMIA; HH23
228355	FETAL IODINE DEFICIENCY DISORDER; FIDD
228400	FEVER, FAMILIAL LIFELONG PERSISTENT
228520	FIBROCHONDROGENESIS 1; FBCG1
228550	MYOFIBROMATOSIS, INFANTILE, 1; IMF1
228560	FIBROMATOSIS, GINGIVAL, WITH DISTINCTIVE FACIES
228600	HYALINE FIBROMATOSIS SYNDROME; HFS
228800	FIBROSCLEROSIS, MULTIFOCAL
228900	ACROMESOMELIC DYSPLASIA 2B; AMD2B
228930	FIBULAR APLASIA OR HYPOPLASIA, FEMORAL BOWING AND POLY-, SYN-, AND OLIGODACTYLY
228940	FIBULOULNAR APLASIA OR HYPOPLASIA WITH RENAL ABNORMALITIES
228960	HIGH MOLECULAR WEIGHT KININOGEN DEFICIENCY
228980	FLECK RETINA, FAMILIAL BENIGN; FRFB
228990	FLECK RETINA OF KANDORI
229000	KALLIKREIN B, PLASMA, 1; KLKB1
229045	FOCAL EPITHELIAL HYPERPLASIA, ORAL
229050	FOLATE MALABSORPTION, HEREDITARY
229070	HYPOGONADOTROPIC HYPOGONADISM 24 WITH OR WITHOUT ANOSMIA; HH24
229100	GLUTAMATE FORMIMINOTRANSFERASE DEFICIENCY
229120	FOUNTAIN SYNDROME
229150	MOVED TO 300624
229200	BRITTLE CORNEA SYNDROME 1; BCS1
229230	FRASER-LIKE SYNDROME
229250	FREESIA FLOWERS, INABILITY TO SMELL
229300	FRIEDREICH ATAXIA; FRDA
229310	FRIEDREICH ATAXIA AND CONGENITAL GLAUCOMA
229400	FRONTOFACIONASAL DYSPLASIA
229500	FRUCTOSE AND GALACTOSE INTOLERANCE
229600	FRUCTOSE INTOLERANCE, HEREDITARY; HFI
229650	FRUCTOSE UTILIZATION
229700	FRUCTOSE-1,6-BISPHOSPHATASE DEFICIENCY; FBP1D
229800	FRUCTOSURIA, ESSENTIAL
229850	FRYNS SYNDROME; FRNS
229900	MOVED TO 258870
229950	MOVED TO 136820
230000	FUCOSIDOSIS
230200	GALACTOSEMIA II; GALAC2
230300	GALACTORRHEA
230350	GALACTOSEMIA III; GALAC3
230400	GALACTOSEMIA I; GALAC1
230430	MOVED TO 300622
230450	GAMMA-GLUTAMYLCYSTEINE SYNTHETASE DEFICIENCY, HEMOLYTIC ANEMIA DUE TO
230500	GM1-GANGLIOSIDOSIS, TYPE I; GM1G1
230600	GM1-GANGLIOSIDOSIS, TYPE II; GM1G2
230650	GM1-GANGLIOSIDOSIS, TYPE III; GM1G3
230700	MOVED TO 272800
230710	MOVED TO 272800
230740	GAPO SYNDROME; GAPOS
230750	GASTROSCHISIS
230800	GAUCHER DISEASE, TYPE I; GD1
230900	GAUCHER DISEASE, TYPE II; GD2
231000	GAUCHER DISEASE, TYPE III; GD3
231005	GAUCHER DISEASE, TYPE IIIC; GD3C
231050	GELEOPHYSIC DYSPLASIA 1; GPHYSD1
231060	GENITOPALATOCARDIAC SYNDROME
231070	GERODERMA OSTEODYSPLASTICUM; GO
231080	GERMAN SYNDROME
231090	HYDATIDIFORM MOLE, RECURRENT, 1; HYDM1
231095	GHOSAL HEMATODIAPHYSEAL DYSPLASIA; GHDD
231100	HEMOCHROMATOSIS, NEONATAL
231200	BERNARD-SOULIER SYNDROME; BSS
231300	GLAUCOMA 3, PRIMARY CONGENITAL, A; GLC3A
231400	REMOVED FROM DATABASE
231500	MOVED TO 231300
231520	MOVED TO 273750
231530	3-HYDROXYACYL-CoA DEHYDROGENASE DEFICIENCY
231550	ACHALASIA-ADDISONIANISM-ALACRIMA SYNDROME; AAAS
231610	REMOVED FROM DATABASE
231630	MONOSODIUM GLUTAMATE SENSITIVITY
231670	GLUTARIC ACIDEMIA I; GA1
231675	ELECTRON TRANSFER FLAVOPROTEIN DEHYDROGENASE; ETFDH
231680	MULTIPLE ACYL-CoA DEHYDROGENASE DEFICIENCY; MADD
231690	GLUTARIC ACIDURIA III; GA3
231900	GLUTATHIONE SYNTHETASE DEFICIENCY OF ERYTHROCYTES, HEMOLYTIC ANEMIA DUE TO; GSSDE
231950	GLUTATHIONURIA
231970	GLUTEAL MUSCLES, ABSENCE OF
232000	PROPIONYL-CoA CARBOXYLASE, ALPHA SUBUNIT; PCCA
232050	PROPIONYL-CoA CARBOXYLASE, BETA SUBUNIT; PCCB
232200	GLYCOGEN STORAGE DISEASE Ia; GSD1A
232210	MOVED TO 232200
232220	GLYCOGEN STORAGE DISEASE Ib; GSD1B
232240	GLYCOGEN STORAGE DISEASE Ic; GSD1C
232300	GLYCOGEN STORAGE DISEASE II; GSD2
232330	MOVED TO 300257
232400	GLYCOGEN STORAGE DISEASE III; GSD3
232500	GLYCOGEN STORAGE DISEASE IV; GSD4
232600	GLYCOGEN STORAGE DISEASE V; GSD5
232700	GLYCOGEN STORAGE DISEASE VI; GSD6
232800	GLYCOGEN STORAGE DISEASE VII; GSD7
232900	GLYCOPROTEIN STORAGE DISEASE
233100	RENAL GLUCOSURIA; GLYS
233270	GOMBO SYNDROME
233300	OVARIAN DYSGENESIS 1; ODG1
233400	PERRAULT SYNDROME 1; PRLTS1
233420	46,XY SEX REVERSAL 7; SRXY7
233430	MOVED TO 618419
233450	GOODPASTURE SYNDROME
233500	MOVED TO 612289
233600	IMMUNODEFICIENCY 59 AND HYPOGLYCEMIA; IMD59
233650	COMBINED CELLULAR AND HUMORAL IMMUNE DEFECTS WITH GRANULOMAS; CCHIDG
233670	MOVED TO 233700 AND 306400
233690	GRANULOMATOUS DISEASE, CHRONIC, AUTOSOMAL RECESSIVE, 4; CGD4
233700	GRANULOMATOUS DISEASE, CHRONIC, AUTOSOMAL RECESSIVE, 1; CGD1
233710	GRANULOMATOUS DISEASE, CHRONIC, AUTOSOMAL RECESSIVE, 2; CGD2
233800	GROUPED PIGMENTATION OF THE RETINA
233805	GROWTH FACTORS, COMBINED DEFECT OF
233810	GROWTH RETARDATION, SMALL AND PUFFY HANDS AND FEET, AND ECZEMA
233910	HYPERPHENYLALANINEMIA, BH4-DEFICIENT, B; HPABH4B
234000	FACTOR XII DEFICIENCY
234030	HAIR DEFECT WITH PHOTOSENSITIVITY AND MENTAL RETARDATION
234050	TRICHOTHIODYSTROPHY 4, NONPHOTOSENSITIVE; TTD4
234100	HALLERMANN-STREIFF SYNDROME; HSS
234200	NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 1; NBIA1
234250	HALL-RIGGS SYNDROME
234280	HALLUX VARUS AND PREAXIAL POLYSYNDACTYLY
234300	HALO NEVI
234350	HALOTHANE HEPATITIS
234500	HARTNUP DISORDER; HND
234580	HEIMLER SYNDROME 1; HMLR1
234700	HEART BLOCK, CONGENITAL
234750	HEART, MALFORMATION OF
234800	HEMANGIOMATOSIS, CUTANEOUS, WITH ASSOCIATED FEATURES
234810	PULMONARY VENOOCCLUSIVE DISEASE 2, AUTOSOMAL RECESSIVE; PVOD2
234820	HEMANGIOPERICYTOMA, MALIGNANT
235000	HEMIHYPERPLASIA, ISOLATED; IH
235200	HEMOCHROMATOSIS, TYPE 1; HFE1
235255	MULLERIAN DERIVATIVES, PERSISTENCE OF, WITH LYMPHANGIECTASIA AND POSTAXIAL POLYDACTYLY
235360	MOVED TO 219100
235370	HEMOLYTIC ANEMIA WITH THERMAL SENSITIVITY OF RED CELLS
235400	HEMOLYTIC UREMIC SYNDROME, ATYPICAL, SUSCEPTIBILITY TO, 1; AHUS1
235500	HEMOSIDEROSIS, PULMONARY, WITH DEFICIENCY OF GAMMA-A GLOBULIN
235510	HENNEKAM LYMPHANGIECTASIA-LYMPHEDEMA SYNDROME 1; HKLLS1
235550	HEPATIC VENOOCCLUSIVE DISEASE WITH IMMUNODEFICIENCY; VODI
235555	BILE ACID SYNTHESIS DEFECT, CONGENITAL, 2; CBAS2
235600	MOVED TO 400045
235700	HEMOLYTIC ANEMIA, NONSPHEROCYTIC, DUE TO HEXOKINASE DEFICIENCY
235730	MOWAT-WILSON SYNDROME; MOWS
235735	MOVED TO 277580
235740	HIRSCHSPRUNG DISEASE WITH POLYDACTYLY, RENAL AGENESIS, AND DEAFNESS
235750	HIRSCHSPRUNG DISEASE WITH ULNAR POLYDACTYLY, POLYSYNDACTYLY OF BIG TOES, AND VENTRICULAR SEPTAL DEFECT
235760	HIRSCHSPRUNG DISEASE WITH HYPOPLASTIC NAILS AND DYSMORPHIC FACIAL FEATURES
235800	HISTIDINEMIA
235830	HISTIDINURIA DUE TO A RENAL TUBULAR DEFECT
235900	HISTIOCYTOSIS, FAMILIAL LIPOCHROME
236000	LYMPHOMA, HODGKIN, CLASSIC; CHL
236100	HOLOPROSENCEPHALY 1; HPE1
236110	HOLZGREVE SYNDROME
236130	HOMOCARNOSINOSIS
236200	HOMOCYSTINURIA DUE TO CYSTATHIONINE BETA-SYNTHASE DEFICIENCY
236250	HOMOCYSTINURIA DUE TO DEFICIENCY OF N(5,10)-METHYLENETETRAHYDROFOLATE REDUCTASE ACTIVITY
236270	HOMOCYSTINURIA-MEGALOBLASTIC ANEMIA, cblE COMPLEMENTATION TYPE; HMAE
236300	HOOFT DISEASE
236400	HUMERORADIAL SYNOSTOSIS
236410	HUMERORADIAL SYNOSTOSIS WITH CRANIOFACIAL ANOMALIES
236450	HUTTERITE CEREBROOSTEONEPHRODYSPLASIA SYNDROME
236490	MOVED TO 228600
236500	MULTINUCLEATED NEURONS, ANHYDRAMNIOS, RENAL DYSPLASIA, CEREBELLAR HYPOPLASIA, AND HYDRANENCEPHALY; MARCH
236600	HYDROCEPHALUS, CONGENITAL, 1; HYC1
236635	HYDROCEPHALUS DUE TO CONGENITAL STENOSIS OF AQUEDUCT OF SYLVIUS
236640	HYDROCEPHALUS WITH ASSOCIATED MALFORMATIONS
236660	HYDROCEPHALUS, TALL STATURE, JOINT LAXITY, AND KYPHOSCOLIOSIS
236670	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 1; MDDGA1
236680	HYDROLETHALUS SYNDROME 1; HLS1
236690	HYDROCEPHALUS, NORMAL-PRESSURE, 1; HYDNP1
236700	MCKUSICK-KAUFMAN SYNDROME; MKKS
236730	UROFACIAL SYNDROME 1; UFS1
236750	HYDROPS FETALIS, NONIMMUNE; NIHF
236792	L-2-HYDROXYGLUTARIC ACIDURIA; L2HGA
236795	3-HYDROXYISOBUTYRIC ACIDURIA
236800	HYDROXYKYNURENINURIA
236900	HYDROXYLYSINURIA
237000	HYDROXYPROLINEMIA
237100	HYMEN, IMPERFORATE
237300	CARBAMOYL PHOSPHATE SYNTHETASE I DEFICIENCY, HYPERAMMONEMIA DUE TO
237310	N-ACETYLGLUTAMATE SYNTHASE DEFICIENCY; NAGSD
237400	HYPER-BETA-ALANINEMIA
237450	HYPERBILIRUBINEMIA, ROTOR TYPE; HBLRR
237500	DUBIN-JOHNSON SYNDROME; DJS
237550	HYPERBILIRUBINEMIA, CONJUGATED, TYPE III
237800	HYPERBILIRUBINEMIA, SHUNT, PRIMARY; PSHB
237900	HYPERBILIRUBINEMIA, TRANSIENT FAMILIAL NEONATAL; HBLRTFN
238200	MOVED TO 220100
238300	GLYCINE DECARBOXYLASE; GLDC
238310	AMINOMETHYLTRANSFERASE; AMT
238320	LEYDIG CELL HYPOPLASIA, TYPE I
238330	GLYCINE CLEAVAGE SYSTEM H PROTEIN; GCSH
238331	DIHYDROLIPOAMIDE DEHYDROGENASE; DLD
238340	HYPERLEUCINE-ISOLEUCINEMIA
238350	HYPERLEXIA
238400	MOVED TO 144650
238500	MOVED TO 144650
238600	HYPERLIPOPROTEINEMIA, TYPE I
238700	HYPERLYSINEMIA, TYPE I
238710	HYPERLYSINEMIA DUE TO DEFECT IN LYSINE TRANSPORT INTO MITOCHONDRIA
238750	HYPERLYSINURIA WITH HYPERAMMONEMIA
238800	HYPERMETABOLISM DUE TO UNCOUPLED MITOCHONDRIAL OXIDATIVE PHOSPHORYLATION 1; HUMOP1
238950	HYPEROPIA, HIGH
238970	HYPERORNITHINEMIA-HYPERAMMONEMIA-HOMOCITRULLINURIA SYNDROME; HHHS
239000	PAGET DISEASE OF BONE 5, JUVENILE-ONSET; PDB5
239100	VAN BUCHEM DISEASE; VBCH
239199	HYPERPARATHYROIDISM, NEONATAL SELF-LIMITED PRIMARY, WITH HYPERCALCIURIA
239200	HYPERPARATHYROIDISM, NEONATAL SEVERE; NSHPT
239300	HYPERPHOSPHATASIA WITH IMPAIRED INTELLECTUAL DEVELOPMENT SYNDROME 1; HPMRS1
239350	HYPERPHOSPHATEMIA, POLYURIA, AND SEIZURES
239400	REMOVED FROM DATABASE
239500	HYPERPROLINEMIA, TYPE I; HYRPRO1
239510	HYPERPROLINEMIA, TYPE II; HYRPRO2
239710	ACROFRONTOFACIONASAL DYSOSTOSIS 2
239711	HYPERTELORISM AND TETRALOGY OF FALLOT
239800	HYPERTELORISM, MICROTIA, FACIAL CLEFTING SYNDROME
239840	HYPERTRICHOSIS, CONGENITAL ANTERIOR CERVICAL, WITH PERIPHERAL SENSORY AND MOTOR NEUROPATHY
239850	CANTU SYNDROME
239900	HYPERTROPHIC NEUROPATHY AND CATARACT
240000	HYPERURICEMIA, INFANTILE, WITH ABNORMAL BEHAVIOR AND NORMAL HYPOXANTHINE GUANINE PHOSPHORIBOSYLTRANSFERASE
240100	REMOVED FROM DATABASE
240150	HYPERVITAMINOSIS A, SUSCEPTIBILITY TO
240200	HYPOADRENOCORTICISM, FAMILIAL
240300	AUTOIMMUNE POLYENDOCRINE SYNDROME, TYPE I, WITH OR WITHOUT REVERSIBLE METAPHYSEAL DYSPLASIA; APS1
240400	HYPOASCORBEMIA
240500	IMMUNODEFICIENCY, COMMON VARIABLE, 2; CVID2
240600	GLYCOGEN STORAGE DISEASE 0, LIVER; GSD0A
240800	HYPOGLYCEMIA, LEUCINE-INDUCED; LIH
240900	HYPOINSULINEMIC HYPOGLYCEMIA WITH HEMIHYPERTROPHY; HIHGHH
240950	HYPOGONADISM-CATARACT SYNDROME
241000	HYPOGONADISM WITH LOW-GRADE MENTAL DEFICIENCY AND MICROCEPHALY
241080	WOODHOUSE-SAKATI SYNDROME; WDSKS
241090	HYPERGONADOTROPIC HYPOGONADISM AND PARTIAL ALOPECIA
241100	HYPOGONADISM, MALE
241120	HYPOHIDROSIS WITH ABNORMAL PALMAR DERMAL RIDGES
241150	HYPOKALEMIC ALKALOSIS, FAMILIAL, WITH SPECIFIC RENAL TUBULOPATHY
241200	BARTTER SYNDROME, TYPE 2, ANTENATAL; BARTS2
241310	HYPOMANDIBULAR FACIOCRANIAL DYSOSTOSIS
241400	MOVED TO 146200
241410	HYPOPARATHYROIDISM-RETARDATION-DYSMORPHISM SYNDROME; HRDS
241500	HYPOPHOSPHATASIA, INFANTILE; HPPI
241510	HYPOPHOSPHATASIA, CHILDHOOD; HPPC
241519	HYPOPHOSPHATEMIA, RENAL, WITH INTRACEREBRAL CALCIFICATIONS
241520	HYPOPHOSPHATEMIC RICKETS, AUTOSOMAL RECESSIVE, 1; ARHR1
241530	HYPOPHOSPHATEMIC RICKETS WITH HYPERCALCIURIA, HEREDITARY; HHRH
241540	HYPOPITUITARISM, CONGENITAL, WITH CENTRAL DIABETES INSIPIDUS
241550	HYPOPLASTIC LEFT HEART SYNDROME 1; HLHS1
241600	IMMUNODEFICIENCY 43; IMD43
241750	MOVED TO 146450
241760	HYPOSPADIAS-MENTAL RETARDATION SYNDROME
241800	PALLISTER-HALL-LIKE SYNDROME; PHLS
241850	BAMFORTH-LAZARUS SYNDROME; BAMLAZ
241900	MOVED TO 203655
242050	HYPOURICEMIA, HYPERCALCINURIA, AND DECREASED BONE DENSITY
242100	ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 2; ARCI2
242150	KERATITIS-ICHTHYOSIS-DEAFNESS SYNDROME, AUTOSOMAL RECESSIVE; KIDAR
242170	MOVED TO 601675
242300	ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 1; ARCI1
242400	ICHTHYOSIS CONGENITA WITH BILIARY ATRESIA
242500	ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 4B; ARCI4B
242510	ICHTHYOSIS WITH ALOPECIA, ECLABIUM, ECTROPION, AND MENTAL RETARDATION
242520	ICHTHYOSIS, HEPATOSPLENOMEGALY, AND CEREBELLAR DEGENERATION
242530	ICHTHYOSIS, MENTAL RETARDATION, DWARFISM, AND RENAL IMPAIRMENT
242550	ICHTHYOSIS, SPLIT HAIRS, AND AMINO ACIDURIA
242600	IMINOGLYCINURIA
242650	MOVED TO 244400
242670	CILIARY DYSKINESIA WITH DEFECTIVE RADIAL SPOKES
242680	CILIARY DYSKINESIA WITH EXCESSIVELY LONG CILIA
242700	T-CELL IMMUNODEFICIENCY WITH THYMIC APLASIA; TIDTA
242800	REMOVED FROM DATABASE
242840	VICI SYNDROME; VICIS
242850	IMMUNE DEFICIENCY DISEASE
242860	IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 1; ICF1
242870	IMMUNODEFICIENCY, PARTIAL COMBINED, WITH ABSENCE OF HLA DETERMINANTS AND BETA-2-MICROGLOBULIN FROM LYMPHOCYTES
242880	IMMUNOERYTHROMYELOID HYPOPLASIA
242890	IMMUNOGLOBULIN D LEVEL IN PLASMA, LOW
242900	SCHIMKE IMMUNOOSSEOUS DYSPLASIA; SIOD
243000	INDIFFERENCE TO PAIN, CONGENITAL, AUTOSOMAL RECESSIVE; CIP
243050	INDOLYLACROYL GLYCINURIA WITH MENTAL RETARDATION
243060	SPERMATOGENIC FAILURE 5; SPGF5
243080	INOSINE PHOSPHORYLASE DEFICIENCY, IMMUNE DEFECT DUE TO
243095	MOVED TO 270450
243100	INTERNAL CAROTID ARTERIES, HYPOPLASIA OF
243110	IMMUNODEFICIENCY WITH DEFECTIVE T-CELL RESPONSE TO INTERLEUKIN 1
243150	GASTROINTESTINAL DEFECTS AND IMMUNODEFICIENCY SYNDROME 1; GIDID1
243180	VISCERAL NEUROPATHY, FAMILIAL, 1, AUTOSOMAL RECESSIVE; VSCN1
243185	INTESTINAL PSEUDOOBSTRUCTION WITH PATENT DUCTUS ARTERIOSUS AND NATAL TEETH
243200	INTRACRANIAL HYPERTENSION, IDIOPATHIC
243300	CHOLESTASIS, BENIGN RECURRENT INTRAHEPATIC, 1; BRIC1
243305	INVERSIN; INVS
243310	BARAITSER-WINTER SYNDROME 1; BRWS1
243320	INTRINSIC FACTOR AND R BINDER, COMBINED CONGENITAL DEFICIENCY OF
243340	MOVED TO 242860
243400	ACETYLATION, SLOW
243440	ISOTRETINOIN EMBRYOPATHY-LIKE SYNDROME
243450	ISOVALERIC ACID, INABILITY TO SMELL
243500	ISOVALERIC ACIDEMIA; IVA
243600	JEJUNAL ATRESIA
243605	STROMME SYNDROME; STROMS
243700	HYPER-IgE SYNDROME 2, AUTOSOMAL RECESSIVE, WITH RECURRENT INFECTIONS; HIES2
243800	JOHANSON-BLIZZARD SYNDROME; JBS
243910	ARIMA SYNDROME
244100	JUMPING FRENCHMEN OF MAINE
244200	HYPOGONADOTROPIC HYPOGONADISM 3 WITH OR WITHOUT ANOSMIA; HH3
244300	KAPUR-TORIELLO SYNDROME
244400	CILIARY DYSKINESIA, PRIMARY, 1; CILD1
244450	KAUFMAN OCULOCEREBROFACIAL SYNDROME; KOS
244460	KENNY-CAFFEY SYNDROME, TYPE 1; KCS1
244500	MOVED TO 148300
244510	KERATOCONUS AND CONGENITAL HIP DYSPLASIA
244600	KERATOCONUS POSTICUS CIRCUMSCRIPTUS; KPC
244850	PALMOPLANTAR KERATODERMA, NORRBOTTEN RECESSIVE TYPE; PPKNR
245000	PAPILLON-LEFEVRE SYNDROME; PALS
245010	HAIM-MUNK SYNDROME; HMS
245050	SUCCINYL-CoA:3-OXOACID-CoA TRANSFERASE DEFICIENCY; SCOTD
245100	RICHARDS-RUNDLE SYNDROME; RRNS
245130	MOVED TO 204750
245150	KEUTEL SYNDROME; KTLS
245160	KNIEST-LIKE DYSPLASIA WITH PURSED LIPS AND ECTOPIA LENTIS
245180	KIFAFA SEIZURE DISORDER
245190	KNIEST-LIKE DYSPLASIA, LETHAL
245200	KRABBE DISEASE; KRB
245210	MOVED TO 192430 AND 188400
245300	KURU, SUSCEPTIBILITY TO
245340	ERYTHROCYTE LACTATE TRANSPORTER DEFECT
245348	PYRUVATE DEHYDROGENASE E2 DEFICIENCY; PDHDD
245349	PYRUVATE DEHYDROGENASE E3-BINDING PROTEIN DEFICIENCY; PDHXD
245400	MITOCHONDRIAL DNA DEPLETION SYNDROME 9 (ENCEPHALOMYOPATHIC TYPE WITH METHYLMALONIC ACIDURIA); MTDPS9
245450	D-LACTIC ACIDURIA WITH GOUT; DLACD
245480	SPECIFIC GRANULE DEFICIENCY 1; SGD1
245500	REMOVED FROM DATABASE
245550	LAMBERT SYNDROME
245552	LAMBOTTE SYNDROME
245570	EPILEPSY, FOCAL, WITH SPEECH DISORDER AND WITH OR WITHOUT IMPAIRED INTELLECTUAL DEVELOPMENT; FESD
245590	GROWTH HORMONE INSENSITIVITY SYNDROME WITH IMMUNE DYSREGULATION 1, AUTOSOMAL RECESSIVE; GHISID1
245600	MULTIPLE JOINT DISLOCATIONS, SHORT STATURE, AND CRANIOFACIAL DYSMORPHISM WITH OR WITHOUT CONGENITAL HEART DEFECTS; JDSCD
245650	LARSEN-LIKE SYNDROME, LETHAL TYPE
245660	EPIDERMOLYSIS BULLOSA, JUNCTIONAL 2C, LARYNGOONYCHOCUTANEOUS; JEB2C
245800	LAURENCE-MOON SYNDROME; LNMS
245900	LECITHIN:CHOLESTEROL ACYLTRANSFERASE DEFICIENCY
246000	LEG, ABSENCE DEFORMITY OF, WITH CONGENITAL CATARACT
246200	DONOHUE SYNDROME
246300	LEPROSY, SUSCEPTIBILITY TO, 3; LPRS3
246400	LETTERER-SIWE DISEASE
246450	3-HYDROXY-3-METHYLGLUTARYL-CoA LYASE DEFICIENCY; HMGCLD
246470	LEUKEMIA, ACUTE MYELOCYTIC, WITH POLYPOSIS COLI AND COLON CANCER
246490	MOVED TO 266265
246500	LEUKOMELANODERMA, INFANTILISM, MENTAL RETARDATION, HYPODONTIA, HYPOTRICHOSIS
246530	LEUKOTRIENE C4 SYNTHASE; LTC4S
246550	LICHTENSTEIN SYNDROME
246555	LIMB DEFECTS, DISTAL TRANSVERSE, WITH MENTAL RETARDATION AND SPASTICITY
246560	SPLIT-HAND/FOOT MALFORMATION 3; SHFM3
246570	FIBULAR APLASIA, TIBIAL CAMPOMELIA, AND OLIGOSYNDACTYLY SYNDROME
246600	PANCREATIC LIPASE; PNLIP
246650	LIPASE DEFICIENCY, COMBINED
246700	CHYLOMICRON RETENTION DISEASE; CMRD
246800	MOVED TO 257220
246900	DIHYDROLIPOAMIDE DEHYDROGENASE DEFICIENCY; DLDD
247100	LIPOID PROTEINOSIS OF URBACH AND WIETHE
247150	LIP PRINTS
247200	MILLER-DIEKER LISSENCEPHALY SYNDROME; MDLS
247400	MOVED TO 210710
247410	LYMPHEDEMA-HYPOPARATHYROIDISM SYNDROME
247420	LUTHERAN NULL
247430	LYMPHOBLASTIC TRANSFORMATION, INHIBITION OF
247440	MOVED TO 153100 AND 616843
247450	LYMPHOBLASTIC TRANSFORMATION, INTRINSIC DEFECT IN
247610	LYMPHOID INTERSTITIAL PNEUMONIA; LIP
247630	LYMPHOID SYSTEM DETERIORATION, PROGRESSIVE
247640	LYMPHOBLASTIC LEUKEMIA, ACUTE, WITH LYMPHOMATOUS FEATURES; LALL
247650	LYMPHOKINE DEFICIENCY
247800	LYMPHOPENIC HYPERGAMMAGLOBULINEMIA, ANTIBODY DEFICIENCY, AUTOIMMUNE HEMOLYTIC ANEMIA, AND GLOMERULONEPHRITIS
247900	MOVED TO 238700
247950	LYSINE MALABSORPTION SYNDROME
247980	LIPASE B, LYSOSOMAL ACID; LIPB
247990	MACDERMOT-WINTER SYNDROME
248000	MACROCEPHALY/MEGALENCEPHALY SYNDROME, AUTOSOMAL RECESSIVE; MGCPH
248010	MACROEPIPHYSEAL DYSPLASIA WITH OSTEOPOROSIS, WRINKLED SKIN, AND AGED APPEARANCE
248100	MACROSOMIA ADIPOSA CONGENITA
248110	MACROSOMIA WITH MICROPHTHALMIA, LETHAL
248190	HYPOMAGNESEMIA 5, RENAL, WITH OR WITHOUT OCULAR INVOLVEMENT; HOMG5
248200	STARGARDT DISEASE 1; STGD1
248250	HYPOMAGNESEMIA 3, RENAL; HOMG3
248260	MAGNESIUM, ELEVATED RED CELL
248300	MAL DE MELEDA; MDM
248310	PLASMODIUM FALCIPARUM BLOOD INFECTION LEVEL
248340	3MC SYNDROME 3; 3MC3
248350	MALOCCLUSION AND SHORT STATURE
248360	MALONYL-CoA DECARBOXYLASE DEFICIENCY
248370	MANDIBULOACRAL DYSPLASIA WITH TYPE A LIPODYSTROPHY; MADA
248390	TREACHER COLLINS SYNDROME 3; TCS3
248400	MANDIBULOFACIAL DYSOSTOSIS WITH MENTAL RETARDATION
248450	MANITOBA OCULOTRICHOANAL SYNDROME; MOTA
248500	MANNOSIDOSIS, ALPHA B, LYSOSOMAL; MANSA
248510	MANNOSIDOSIS, BETA A, LYSOSOMAL; MANSB
248600	MAPLE SYRUP URINE DISEASE, TYPE IA; MSUD1A
248610	DIHYDROLIPOAMIDE BRANCHED-CHAIN TRANSACYLASE; DBT
248611	BRANCHED-CHAIN KETO ACID DEHYDROGENASE E1, BETA POLYPEPTIDE; BCKDHB
248700	MARDEN-WALKER SYNDROME; MWKS
248750	MOVED TO 154700
248760	MARFANOID HABITUS WITH MICROCEPHALY AND GLOMERULONEPHRITIS
248770	MARFANOID MENTAL RETARDATION SYNDROME, AUTOSOMAL
248800	MARINESCO-SJOGREN SYNDROME; MSS
248810	MOVED TO 248800
248900	MAST SYNDROME; MASTS
248910	CUTANEOUS MASTOCYTOSIS, CONDUCTIVE HEARING LOSS AND MICROTIA
248950	MCDONOUGH SYNDROME
249000	MECKEL SYNDROME, TYPE 1; MKS1
249100	FAMILIAL MEDITERRANEAN FEVER; FMF
249210	MEGACYSTIS-MICROCOLON-INTESTINAL HYPOPERISTALSIS SYNDROME 1; MMIHS1
249230	MEGAEPIPHYSEAL DWARFISM
249240	MEGALENCEPHALY WITH DYSMYELINATION
249270	THIAMINE-RESPONSIVE MEGALOBLASTIC ANEMIA SYNDROME; TRMA
249300	MEGALOCORNEA
249310	NEUHAUSER SYNDROME
249400	MELANOSIS, NEUROCUTANEOUS; NCMS
249420	FRANK-TER HAAR SYNDROME; FTHS
249500	INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 1; MRT1
249599	MENTAL RETARDATION SYNDROME, BELGIAN TYPE
249600	MENTAL RETARDATION SYNDROME, MIETENS-WEBER TYPE
249620	OHDO SYNDROME
249630	MENTAL RETARDATION, BUENOS AIRES TYPE
249650	MERCAPTOLACTATE-CYSTEINE DISULFIDURIA; MCDU
249660	MOVED TO 614199
249670	MESOAXIAL HEXADACTYLY AND CARDIAC MALFORMATION
249700	LANGER MESOMELIC DYSPLASIA; LMD
249710	MESOMELIC LIMB SHORTENING AND BOWING
249800	REMOVED FROM DATABASE
249900	METACHROMATIC LEUKODYSTROPHY DUE TO SAPOSIN B DEFICIENCY; MLDSAPB
250100	METACHROMATIC LEUKODYSTROPHY; MLD
250215	METAPHYSEAL ACROSCYPHODYSPLASIA
250220	SPONDYLOMETAPHYSEAL DYSPLASIA, SEDAGHATIAN TYPE; SMDS
250230	METAPHYSEAL CHONDRODYSPLASIA, KAITILA TYPE
250250	CARTILAGE-HAIR HYPOPLASIA; CHH
250300	METAPHYSEAL CHONDRODYSPLASIA, PENA TYPE
250400	METAPHYSEAL DYSPLASIA, SPAHR TYPE; MDST
250410	RETINITIS PIGMENTOSA WITH OR WITHOUT SKELETAL ANOMALIES; RPSKA
250420	METAPHYSEAL DYSOSTOSIS, IMPAIRED INTELLECTUAL DEVELOPMENT, AND CONDUCTIVE DEAFNESS
250450	METAPHYSEAL DYSPLASIA, ANETODERMA, AND OPTIC ATROPHY
250460	METAPHYSEAL DYSPLASIA WITHOUT HYPOTRICHOSIS; MDWH
250500	METAPHYSEAL MODELING ABNORMALITY, SKIN LESIONS, AND SPASTIC PARAPLEGIA
250600	MOVED TO 156530
250620	3-HYDROXYISOBUTYRYL-CoA HYDROLASE DEFICIENCY; HIBCHD
250650	METHANE PRODUCTION
250700	METHEMOGLOBIN REDUCTASE DEFICIENCY
250790	METHEMOGLOBINEMIA AND AMBIGUOUS GENITALIA; METAG
250800	METHEMOGLOBINEMIA DUE TO DEFICIENCY OF METHEMOGLOBIN REDUCTASE
250850	METHIONINE ADENOSYLTRANSFERASE I/III DEFICIENCY
250900	METHIONINE MALABSORPTION SYNDROME
250940	HOMOCYSTINURIA-MEGALOBLASTIC ANEMIA, cblG COMPLEMENTATION TYPE; HMAG
250950	3-METHYLGLUTACONIC ACIDURIA, TYPE I; MGCA1
250951	3-METHYLGLUTACONIC ACIDURIA, TYPE IV; MGCA4
251000	METHYLMALONIC ACIDURIA DUE TO METHYLMALONYL-CoA MUTASE DEFICIENCY
251100	METHYLMALONIC ACIDURIA, cblA TYPE
251110	METHYLMALONIC ACIDURIA, cblB TYPE
251120	METHYLMALONYL-CoA EPIMERASE DEFICIENCY
251170	MEVALONATE KINASE; MVK
251190	MICROCEPHALIC PRIMORDIAL DWARFISM, TORIELLO TYPE
251200	MICROCEPHALY 1, PRIMARY, AUTOSOMAL RECESSIVE; MCPH1
251220	MICROCEPHALY-CARDIOMYOPATHY
251230	MICROCEPHALY-MICROMELIA SYNDROME; MIMIS
251240	MICROCEPHALY WITH CHEMOTACTIC DEFECT AND TRANSIENT HYPOGAMMAGLOBULINEMIA
251250	MICROCEPHALY WITH CERVICAL SPINE FUSION ANOMALIES
251255	JAWAD SYNDROME; JWDS
251260	NIJMEGEN BREAKAGE SYNDROME; NBS
251270	MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 1; MCCRP1
251280	DIENCEPHALIC-MESENCEPHALIC JUNCTION DYSPLASIA SYNDROME 1; DMJDS1
251290	PSEUDO-TORCH SYNDROME 1; PTORCH1
251300	GALLOWAY-MOWAT SYNDROME 1; GAMOS1
251400	MICROCOLON
251450	DESBUQUOIS DYSPLASIA 1; DBQD1
251455	MOVED TO 258315
251500	MOVED TO 600118
251505	MICROPHTHALMIA/COLOBOMA 4; MCOPCB4
251600	MICROPHTHALMIA, ISOLATED 1; MCOP1
251700	MICROPHTHALMIA WITH HYPEROPIA, RETINAL DEGENERATION, MACROPHAKIA, AND DENTAL ANOMALIES
251750	MICROSPHEROPHAKIA AND/OR MEGALOCORNEA, WITH ECTOPIA LENTIS AND WITH OR WITHOUT SECONDARY GLAUCOMA; MSPKA
251800	MICROTIA WITH MEATAL ATRESIA AND CONDUCTIVE DEAFNESS
251850	DIARRHEA 2, WITH MICROVILLUS ATROPHY, WITH OR WITHOUT CHOLESTASIS; DIAR2
251880	MITOCHONDRIAL DNA DEPLETION SYNDROME 3 (HEPATOCEREBRAL TYPE); MTDPS3
251890	MOVED TO 143450
251900	MITOCHONDRIAL MYOPATHY, EPISODIC, WITH OR WITHOUT OPTIC ATROPHY AND REVERSIBLE LEUKOENCEPHALOPATHY; MEOAL
251945	MITOCHONDRIAL MYOPATHY WITH A DEFECT IN MITOCHONDRIAL-PROTEIN TRANSPORT
251950	MITOCHONDRIAL MYOPATHY WITH LACTIC ACIDOSIS; MMLA
252010	MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 1; MC1DN1
252011	MITOCHONDRIAL COMPLEX II DEFICIENCY, NUCLEAR TYPE 1; MC2DN1
252030	REMOVED FROM DATABASE
252100	OROFACIODIGITAL SYNDROME II; OFD2
252150	MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP A; MOCODA
252160	MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP B; MOCODB
252200	MOVED TO 158000 AND 607903
252250	MONOCYTE CHEMOTACTIC DISORDER
252270	MONOSOMY 7 MYELODYSPLASIA AND LEUKEMIA SYNDROME 1; M7MLS1
252300	MORQUIO SYNDROME C
252320	MOTOR NEUROPATHY, PERIPHERAL, WITH DYSAUTONOMIA
252350	MOYAMOYA DISEASE 1; MYMY1
252500	MUCOLIPIDOSIS II ALPHA/BETA
252600	MUCOLIPIDOSIS III ALPHA/BETA
252605	MUCOLIPIDOSIS III GAMMA
252650	MUCOLIPIDOSIS IV; ML4
252700	MOVED TO 607014 AND 607016
252800	ALPHA-L-IDURONIDASE; IDUA
252900	MUCOPOLYSACCHARIDOSIS, TYPE IIIA; MPS3A
252920	MUCOPOLYSACCHARIDOSIS, TYPE IIIB; MPS3B
252930	MUCOPOLYSACCHARIDOSIS, TYPE IIIC; MPS3C
252940	MUCOPOLYSACCHARIDOSIS, TYPE IIID; MPS3D
253000	MUCOPOLYSACCHARIDOSIS, TYPE IVA; MPS4A
253010	MUCOPOLYSACCHARIDOSIS, TYPE IVB; MPS4B
253200	MUCOPOLYSACCHARIDOSIS, TYPE VI; MPS6
253220	MUCOPOLYSACCHARIDOSIS, TYPE VII; MPS7
253230	MOVED TO 601492
253240	MUCUS INSPISSATION OF RESPIRATORY TRACT
253250	MULIBREY NANISM; MUL
253260	BIOTINIDASE DEFICIENCY
253270	HOLOCARBOXYLASE SYNTHETASE DEFICIENCY
253280	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 3; MDDGA3
253290	MULTIPLE PTERYGIUM SYNDROME, LETHAL TYPE; LMPS
253300	SPINAL MUSCULAR ATROPHY, TYPE I; SMA1
253310	LETHAL CONGENITAL CONTRACTURE SYNDROME 1; LCCS1
253320	MULTICORE MYOPATHY WITH MENTAL RETARDATION, SHORT STATURE, AND HYPOGONADOTROPIC HYPOGONADISM
253400	SPINAL MUSCULAR ATROPHY, TYPE III; SMA3
253500	REMOVED FROM DATABASE
253550	SPINAL MUSCULAR ATROPHY, TYPE II; SMA2
253590	MUSCULAR DYSTROPHY, ADULT-ONSET, WITH LEUKOENCEPHALOPATHY
253600	MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 1; LGMDR1
253601	MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 2; LGMDR2
253700	MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 5; LGMDR5
253800	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 4; MDDGA4
253850	MOVED TO 602771
253900	MOVED TO 618484 AND 619334
254000	MUSCULAR DYSTROPHY, CONGENITAL, WITH INFANTILE CATARACT AND HYPOGONADISM
254090	ULLRICH CONGENITAL MUSCULAR DYSTROPHY 1A; UCMD1A
254100	MUSCULAR DYSTROPHY, CONGENITAL, WITH RAPID PROGRESSION; MDRP
254110	MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 8; LGMDR8
254120	MUSCULAR HYPERTONIA, LETHAL
254130	MIYOSHI MUSCULAR DYSTROPHY 1; MMD1
254150	MUSK, INABILITY TO SMELL
254190	MYASTHENIA, CONGENITAL, REFRACTORY TO ACETYLCHOLINESTERASE INHIBITORS
254195	MOVED TO 608931
254200	MYASTHENIA GRAVIS; MG
254210	MYASTHENIC SYNDROME, CONGENITAL, 6, PRESYNAPTIC; CMS6
254300	MYASTHENIC SYNDROME, CONGENITAL, 10; CMS10
254400	MYCOSIS FUNGOIDES
254450	MYELOFIBROSIS
254500	MYELOMA, MULTIPLE
254600	MYELOPEROXIDASE DEFICIENCY; MPOD
254700	MYELOPROLIFERATIVE DISEASE, AUTOSOMAL RECESSIVE
254770	EPILEPSY, MYOCLONIC JUVENILE; EJM
254780	MYOCLONIC EPILEPSY OF LAFORA 1; MELF1
254800	MYOCLONIC EPILEPSY OF UNVERRICHT AND LUNDBORG
254900	EPILEPSY, PROGRESSIVE MYOCLONIC, 4, WITH OR WITHOUT RENAL FAILURE; EPM4
254940	CAREY-FINEMAN-ZITER SYNDROME 1; CFZS1
254950	MYOPATHY, GRANULOVACUOLAR LOBULAR, WITH ELECTRICAL MYOTONIA
254960	MYOPATHY DUE TO MALATE-ASPARTATE SHUTTLE DEFECT
255100	LIPID STORAGE MYOPATHY DUE TO FLAVIN ADENINE DINUCLEOTIDE SYNTHETASE DEFICIENCY; LSMFLAD
255110	CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, MYOPATHIC, STRESS-INDUCED
255120	CARNITINE PALMITOYLTRANSFERASE I DEFICIENCY
255125	MYOPATHY WITH LACTIC ACIDOSIS, HEREDITARY; HML
255140	MYOPATHY WITH GIANT ABNORMAL MITOCHONDRIA
255160	CONGENITAL MYOPATHY 7B, MYOSIN STORAGE, AUTOSOMAL RECESSIVE; CMYP7B
255170	MOVED TO 603280
255200	MYOPATHY, CENTRONUCLEAR, 2; CNM2
255300	BATTEN-TURNER CONGENITAL MYOPATHY
255310	CONGENITAL MYOPATHY 4A, AUTOSOMAL DOMINANT; CMYP4A
255320	CONGENITAL MYOPATHY 1B, AUTOSOMAL RECESSIVE; CMYP1B
255500	MYOPIA 18, AUTOSOMAL RECESSIVE; MYP18
255600	MYOSCLEROSIS, AUTOSOMAL RECESSIVE
255700	MYOTONIA CONGENITA, AUTOSOMAL RECESSIVE
255710	MYOTONIA WITH SKELETAL ABNORMALITIES AND MENTAL RETARDATION
255800	SCHWARTZ-JAMPEL SYNDROME, TYPE 1; SJS1
255900	MYXEDEMA
255960	MYXOMA, INTRACARDIAC
255980	MOVED TO 301026
255990	NATHALIE SYNDROME
255995	CONGENITAL MYOPATHY 13; CMYP13
256000	LEIGH SYNDROME; LS
256020	FOCAL SEGMENTAL GLOMERULOSCLEROSIS 10; FSGS10
256030	NEMALINE MYOPATHY 2; NEM2
256040	PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 1; PRAAS1
256050	ATELOSTEOGENESIS, TYPE II; AO2
256100	NEPHRONOPHTHISIS 1; NPHP1
256120	NEPHROPATHY, DEAFNESS, AND HYPERPARATHYROIDISM
256150	NEPHROSIALIDOSIS
256200	NEPHROSIS WITH DEAFNESS AND URINARY TRACT AND DIGITAL MALFORMATIONS
256300	NEPHROTIC SYNDROME, TYPE 1; NPHS1
256340	MOVED TO 146255
256350	MOVED TO 600995
256370	NEPHROTIC SYNDROME, TYPE 4; NPHS4
256450	HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 1; HHF1
256500	NETHERTON SYNDROME; NETH
256520	NEU-LAXOVA SYNDROME 1; NLS1
256540	GALACTOSIALIDOSIS; GSL
256550	NEURAMINIDASE DEFICIENCY
256600	NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 2A; NBIA2A
256690	NEUROFACIODIGITORENAL SYNDROME
256700	NEUROBLASTOMA, SUSCEPTIBILITY TO, 1; NBLST1
256710	ELEJALDE NEUROECTODERMAL MELANOLYSOSOMAL SYNDROME
256720	NEUROLOGIC DISEASE, INFANTILE MULTISYSTEM, WITH OSSEOUS FRAGILITY
256730	CEROID LIPOFUSCINOSIS, NEURONAL, 1; CLN1
256731	CEROID LIPOFUSCINOSIS, NEURONAL, 5; CLN5
256800	INSENSITIVITY TO PAIN, CONGENITAL, WITH ANHIDROSIS; CIPA
256810	MITOCHONDRIAL DNA DEPLETION SYNDROME 6 (HEPATOCEREBRAL TYPE); MTDPS6
256840	NEUROPATHY, HEREDITARY SENSORY, WITH SPASTIC PARAPLEGIA, AUTOSOMAL RECESSIVE
256850	GIANT AXONAL NEUROPATHY 1, AUTOSOMAL RECESSIVE; GAN1
256851	MOVED TO 256850
256855	NEUROPATHY, HEREDITARY MOTOR AND SENSORY, WITH EXCESSIVE MYELIN FOLDING COMPLEX, AUTOSOMAL RECESSIVE
256860	NEUROPATHY, HEREDITARY SENSORY, ATYPICAL
256870	NEUROPATHY, PAINFUL
257000	NEUROVISCERAL STORAGE DISEASE WITH CURVILINEAR BODIES
257050	MOVED TO 257220
257100	NEUTROPENIA, LETHAL CONGENITAL, WITH EOSINOPHILIA
257150	NEUTROPHIL ACTIN DYSFUNCTION; NAD
257200	NIEMANN-PICK DISEASE, TYPE A
257220	NIEMANN-PICK DISEASE, TYPE C1; NPC1
257250	MOVED TO 257220
257270	NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1B; CSNB1B
257300	MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 1; MVA1
257320	LISSENCEPHALY 2; LIS2
257350	NUCHAL BLEB, FAMILIAL
257400	NYSTAGMUS 8, CONGENITAL, AUTOSOMAL RECESSIVE; NYS8
257500	OBESITY-HYPOVENTILATION SYNDROME
257550	OCULAR MOTOR APRAXIA
257600	OCULAR MYOPATHY WITH CURARE SENSITIVITY
257790	OCULOCEREBRAL HYPOPIGMENTATION SYNDROME OF PREUS
257800	OCULOCEREBRAL SYNDROME WITH HYPOPIGMENTATION
257850	OCULODENTODIGITAL DYSPLASIA, AUTOSOMAL RECESSIVE
257910	OCULOPALATOCEREBRAL SYNDROME
257920	3MC SYNDROME 1; 3MC1
257950	MOVED TO 164300
257960	OCULOTRICHODYSPLASIA; OTD
257970	OCULORENOCEREBELLAR SYNDROME
257980	ODONTOONYCHODERMAL DYSPLASIA; OODD
258040	OEIS COMPLEX
258100	OGUCHI DISEASE 1
258120	MOVED TO 271245
258150	SPERMATOGENIC FAILURE 1; SPGF1
258200	OLIVER SYNDROME
258300	CEREBELLAR ATAXIA AND ALBINISM
258315	OMODYSPLASIA 1; OMOD1
258320	OMPHALOCELE-CLEFT PALATE SYNDROME, LETHAL
258360	ONYCHOTRICHODYSPLASIA AND NEUTROPENIA
258400	OPHTHALMOPLEGIA TOTALIS WITH PTOSIS AND MIOSIS
258450	PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL RECESSIVE 1; PEOB1
258470	OPHTHALMOPLEGIC NEUROMUSCULAR DISORDER WITH ABNORMAL MITOCHONDRIA
258480	OPSISMODYSPLASIA; OPSMD
258500	OPTIC ATROPHY 6; OPA6
258501	3-METHYLGLUTACONIC ACIDURIA, TYPE III; MGCA3
258650	OPTIC ATROPHY, HEARING LOSS, AND PERIPHERAL NEUROPATHY, AUTOSOMAL RECESSIVE
258660	NONARTERITIC ANTERIOR ISCHEMIC OPTIC NEUROPATHY, SUSCEPTIBILITY TO; NAION
258700	OPTICOCOCHLEODENTATE DEGENERATION
258800	ORAL SENSIBILITY, DISTURBANCE OF
258840	ORAL AND DIGITAL ANOMALIES WITH ICHTHYOSIS
258850	OROFACIODIGITAL SYNDROME III; OFD3
258860	OROFACIODIGITAL SYNDROME IV; OFD4
258865	OROFACIODIGITAL SYNDROME IX; OFD9
258870	GYRATE ATROPHY OF CHOROID AND RETINA; GACR
258900	OROTIC ACIDURIA
258920	MOVED TO 258900
259050	PRIMROSE SYNDROME; PRIMS
259100	HYPERTROPHIC OSTEOARTHROPATHY, PRIMARY, AUTOSOMAL RECESSIVE, 1; PHOAR1
259200	BLOUNT DISEASE, ADOLESCENT
259250	OSTEODYSPLASIA, FAMILIAL, ANDERSON TYPE
259270	OSTEODYSPLASTY, PRECOCIOUS, OF DANKS, MAYNE, AND KOZLOWSKI
259400	MOVED TO 166210
259410	OSTEOGENESIS IMPERFECTA CONGENITA, MICROCEPHALY, AND CATARACTS
259420	OSTEOGENESIS IMPERFECTA, TYPE III; OI3
259440	OSTEOGENESIS IMPERFECTA, TYPE IX; OI9
259450	BRUCK SYNDROME 1; BRKS1
259500	OSTEOGENIC SARCOMA
259550	OSTEOID OSTEOMA
259600	MULTICENTRIC OSTEOLYSIS, NODULOSIS, AND ARTHROPATHY; MONA
259610	OSTEOLYSIS SYNDROME, RECESSIVE
259650	OSTEOMA OF MIDDLE EAR
259660	MOVED TO 259775
259680	CHRONIC RECURRENT MULTIFOCAL OSTEOMYELITIS 3; CRMO3
259690	OSTEOPENIA AND SPARSE HAIR
259700	OSTEOPETROSIS, AUTOSOMAL RECESSIVE 1; OPTB1
259710	OSTEOPETROSIS, AUTOSOMAL RECESSIVE 2; OPTB2
259720	OSTEOPETROSIS, AUTOSOMAL RECESSIVE 5; OPTB5
259730	OSTEOPETROSIS, AUTOSOMAL RECESSIVE 3; OPTB3
259750	OSTEOPOROSIS, JUVENILE
259770	OSTEOPOROSIS-PSEUDOGLIOMA SYNDROME; OPPG
259775	RAINE SYNDROME; RNS
259780	OTOONYCHOPERONEAL SYNDROME
259900	HYPEROXALURIA, PRIMARY, TYPE I; HP1
260000	HYPEROXALURIA, PRIMARY, TYPE II; HP2
260005	5-OXOPROLINASE DEFICIENCY; OPLAHD
260100	PA POLYMORPHISM OF ALPHA-2-GLOBULIN
260130	PACHYONYCHIA CONGENITA, AUTOSOMAL RECESSIVE
260150	PALANT CLEFT PALATE SYNDROME
260200	PALLIDAL DEGENERATION, PROGRESSIVE, WITH RETINITIS PIGMENTOSA
260300	PARKINSON DISEASE 15, AUTOSOMAL RECESSIVE EARLY-ONSET; PARK15
260350	PANCREATIC CANCER
260370	PANCREATIC AGENESIS 1; PAGEN1
260400	SHWACHMAN-DIAMOND SYNDROME 1; SDS1
260450	MOVED TO 243800
260470	SUBACUTE SCLEROSING PANENCEPHALITIS; SSPE
260480	PANCREATITIS, SCLEROSING CHOLANGITIS, AND SICCA COMPLEX
260490	MOVED TO 174800
260500	PAPILLOMA OF CHOROID PLEXUS; CPP
260530	PARANA HARD-SKIN SYNDROME
260540	PARKINSON-DEMENTIA SYNDROME
260555	PARTINGTON-ANDERSON SYNDROME
260565	PEHO SYNDROME; PEHO
260570	IMMUNODEFICIENCY 108 WITH AUTOINFLAMMATION; IMD108
260600	LEUKODYSTROPHY, HYPOMYELINATING, 3; HLD3
260650	PELLAGRA-LIKE SYNDROME
260660	COUSIN SYNDROME
260800	PENTOSURIA; PNTSU
260900	PERICARDIAL EFFUSION, CHRONIC
260910	PERIFOLLICULITIS CAPITIS ABSCEDENS ET SUFFODIENS, FAMILIAL
260920	HYPER-IgD SYNDROME; HIDS
260950	PERIODONTITIS, CHRONIC
260970	PERIPHERAL NEUROPATHY, ATAXIA, FOCAL NECROTIZING ENCEPHALOPATHY, AND SPONGY DEGENERATION OF BRAIN
260980	MOVED TO 300388
261000	INTRINSIC FACTOR DEFICIENCY; IFD
261100	IMERSLUND-GRASBECK SYNDROME 1; IGS1
261400	PERONEUS TERTIUS MUSCLE, ABSENCE OF
261500	EOSINOPHIL PEROXIDASE DEFICIENCY; EPXD
261510	MOVED TO 261515
261515	D-BIFUNCTIONAL PROTEIN DEFICIENCY
261540	PETERS-PLUS SYNDROME; PTRPLS
261550	PERSISTENT MULLERIAN DUCT SYNDROME, TYPES I AND II; PMDS
261560	PFEIFFER-PALM-TELLER SYNDROME
261575	PHAVER SYNDROME
261590	PHENFORMIN 4-HYDROXYLATION
261600	PHENYLKETONURIA; PKU
261630	HYPERPHENYLALANINEMIA, BH4-DEFICIENT, C; HPABH4C
261640	HYPERPHENYLALANINEMIA, BH4-DEFICIENT, A; HPABH4A
261650	PHOSPHOENOLPYRUVATE CARBOXYKINASE DEFICIENCY, MITOCHONDRIAL; PCKDM
261660	REMOVED FROM DATABASE
261670	GLYCOGEN STORAGE DISEASE X; GSD10
261680	PHOSPHOENOLPYRUVATE CARBOXYKINASE DEFICIENCY, CYTOSOLIC; PCKDC
261740	GLYCOGEN STORAGE DISEASE OF HEART, LETHAL CONGENITAL
261750	GLYCOGEN STORAGE DISEASE IXb; GSD9B
261800	PIERRE ROBIN SYNDROME; PRBNS
261900	PILI TORTI, EARLY-ONSET
261990	ABNORMAL HAIR, JOINT LAXITY, AND DEVELOPMENTAL DELAY; HJDD
262000	BJORNSTAD SYNDROME; BJS
262020	PILODENTAL DYSPLASIA WITH REFRACTIVE ERRORS
262190	PINEAL HYPERPLASIA, INSULIN-RESISTANT DIABETES MELLITUS, AND SOMATIC ABNORMALITIES
262300	ACHROMATOPSIA 3; ACHM3
262350	MOVED TO 194190
262400	ISOLATED GROWTH HORMONE DEFICIENCY, TYPE IA; IGHD1A
262500	LARON SYNDROME
262600	PITUITARY HORMONE DEFICIENCY, COMBINED, 2; CPHD2
262650	KOWARSKI SYNDROME
262700	PITUITARY HORMONE DEFICIENCY, COMBINED, 4; CPHD4
262710	PITUITARY DWARFISM WITH LARGE SELLA TURCICA
262780	MOVED TO 107910
262800	PLASMA CLOT RETRACTION FACTOR, DEFICIENCY OF
262850	ALPHA-2-PLASMIN INHIBITOR DEFICIENCY
262875	PLATELET PROSTACYCLIN RECEPTOR DEFECT
262890	SCOTT SYNDROME; SCTS
262900	PLEOCONIAL MYOPATHY WITH SALT CRAVING
263000	INTERSTITIAL PNEUMONITIS, DESQUAMATIVE, FAMILIAL; DIP
263100	POLYCYSTIC KIDNEY, CATARACT, AND CONGENITAL BLINDNESS
263200	POLYCYSTIC KIDNEY DISEASE 4 WITH OR WITHOUT POLYCYSTIC LIVER DISEASE; PKD4
263210	GILLESSEN-KAESBACH-NISHIMURA SYNDROME; GIKANIS
263300	POLYCYTHEMIA VERA; PV
263400	ERYTHROCYTOSIS, FAMILIAL, 2; ECYT2
263450	POLYDACTYLY, POSTAXIAL, TYPE A5; PAPA5
263510	MOVED TO 613091
263520	SHORT-RIB THORACIC DYSPLASIA 6 WITH OR WITHOUT POLYDACTYLY; SRTD6
263530	MOVED TO 613091
263540	POLYDACTYLY, POSTAXIAL, WITH DENTAL AND VERTEBRAL ANOMALIES
263550	POLYMYOCLONUS, INFANTILE
263560	MOVED TO 214400
263570	POLYGLUCOSAN BODY NEUROPATHY, ADULT FORM; APBN
263600	POLYSACCHARIDE, STORAGE OF UNUSUAL
263610	POLYHYDRAMNIOS, CHRONIC IDIOPATHIC
263620	MOVED TO 240300
263630	POLYSYNDACTYLY WITH CARDIAC MALFORMATION
263650	BARTSOCAS-PAPAS SYNDROME 1; BPS1
263700	PORPHYRIA, CONGENITAL ERYTHROPOIETIC; CEP
263750	POSTAXIAL ACROFACIAL DYSOSTOSIS; POADS
263800	GITELMAN SYNDROME; GTLMNS
264010	PRADER-WILLI HABITUS, OSTEOPENIA, AND CAMPTODACTYLY
264050	PRENATAL BOWING
264060	PREPAPILLARY VASCULAR LOOPS
264070	HYPERPHENYLALANINEMIA, BH4-DEFICIENT, D; HPABH4D
264080	PROGESTERONE RESISTANCE
264090	WIEDEMANN-RAUTENSTRAUCH SYNDROME; WDRTS
264110	PROLACTIN DEFICIENCY, ISOLATED
264120	PROLACTIN DEFICIENCY WITH OBESITY AND ENLARGED TESTES
264140	PRUNE BELLY SYNDROME WITH PULMONIC STENOSIS, MENTAL RETARDATION, AND DEAFNESS
264150	MOVED TO 177170
264160	MOVED TO 177170
264180	PSEUDODIASTROPHIC DYSPLASIA; PDD
264200	MOVED TO 221900
264270	PSEUDOHERMAPHRODITISM, FEMALE, WITH SKELETAL ANOMALIES
264300	17-BETA HYDROXYSTEROID DEHYDROGENASE III DEFICIENCY
264350	PSEUDOHYPOALDOSTERONISM, TYPE IB1, AUTOSOMAL RECESSIVE; PHA1B1
264420	FUNDUS DYSTROPHY, PSEUDOINFLAMMATORY, RECESSIVE FORM
264450	MOVED TO 190685
264470	PEROXISOMAL ACYL-CoA OXIDASE DEFICIENCY
264475	PSEUDOPAPILLEDEMA, OCULAR HYPOTELORISM, BLEPHAROPHIMOSIS, AND HAND ANOMALIES
264480	PSEUDOTRISOMY 13 SYNDROME
264500	PSEUDOURIDINURIA AND MENTAL DEFECT
264600	PSEUDOVAGINAL PERINEOSCROTAL HYPOSPADIAS; PPSH
264700	VITAMIN D HYDROXYLATION-DEFICIENT RICKETS, TYPE 1A; VDDR1A
264800	PSEUDOXANTHOMA ELASTICUM; PXE
264810	REMOVED FROM DATABASE
264900	COAGULATION FACTOR XI; F11
265000	MULTIPLE PTERYGIUM SYNDROME, ESCOBAR VARIANT; EVMPS
265050	3MC SYNDROME 2; 3MC2
265100	PULMONARY ALVEOLAR MICROLITHIASIS; PULAM
265120	SURFACTANT METABOLISM DYSFUNCTION, PULMONARY, 1; SMDP1
265140	PULMONARY ARTERIOVENOUS FISTULAS
265150	PULMONARY ATRESIA WITH INTACT VENTRICULAR SEPTUM
265200	PULMONARY BULLAE CAUSING PNEUMOTHORAX
265300	LYMPHANGIECTASIA, PULMONARY, CONGENITAL; CPL
265380	ALVEOLAR CAPILLARY DYSPLASIA WITH MISALIGNMENT OF PULMONARY VEINS; ACDMPV
265400	PULMONARY HYPERTENSION, PRIMARY, 5; PPH5
265430	PULMONARY HYPOPLASIA, PRIMARY
265450	PULMONARY VENOOCCLUSIVE DISEASE 1, AUTOSOMAL DOMINANT; PVOD1
265500	PULMONIC STENOSIS
265600	PULMONIC STENOSIS AND CONGENITAL NEPHROSIS
265800	PYCNODYSOSTOSIS
265850	PYGMY
265880	PYKNOACHONDROGENESIS
265900	PYLE DISEASE; PYL
265950	PYLORIC ATRESIA
266100	EPILEPSY, EARLY-ONSET, 4, VITAMIN B6-DEPENDENT; EPEO4
266120	URIDINE 5-PRIME MONOPHOSPHATE HYDROLASE DEFICIENCY, HEMOLYTIC ANEMIA DUE TO
266130	GLUTATHIONE SYNTHETASE DEFICIENCY; GSSD
266140	PYROPOIKILOCYTOSIS, HEREDITARY; HPP
266150	PYRUVATE CARBOXYLASE DEFICIENCY
266200	PYRUVATE KINASE DEFICIENCY OF RED CELLS
266250	RADICULONEUROPATHY, FATAL NEONATAL
266255	RADIOULNAR SYNOSTOSIS, UNILATERAL, WITH DEVELOPMENTAL RETARDATION AND HYPOTONIA
266265	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIc; CDG2C
266270	RAMON SYNDROME
266280	RAPADILINO SYNDROME
266300	SKIN/HAIR/EYE PIGMENTATION, VARIATION IN, 2; SHEP2
266350	RED SKIN PIGMENT ANOMALY OF NEW GUINEA
266400	REESE RETINAL DYSPLASIA
266500	REFSUM DISEASE, CLASSIC
266510	PEROXISOME BIOGENESIS DISORDER 3B; PBD3B
266600	INFLAMMATORY BOWEL DISEASE (CROHN DISEASE) 1; IBD1
266810	RENAL AND MULLERIAN DUCT HYPOPLASIA
266900	SENIOR-LOKEN SYNDROME 1; SLSN1
266910	RENAL DYSPLASIA-LIMB DEFECTS SYNDROME
266920	SHORT-RIB THORACIC DYSPLASIA 9 WITH OR WITHOUT POLYDACTYLY; SRTD9
267000	PERLMAN SYNDROME; PRLMNS
267010	MECKEL SYNDROME, TYPE 7; MKS7
267200	RENAL TUBULAR ACIDOSIS III
267300	RENAL TUBULAR ACIDOSIS, DISTAL, 2, WITH PROGRESSIVE SENSORINEURAL HEARING LOSS; DRTA2
267400	RENAL, GENITAL, AND MIDDLE EAR ANOMALIES
267430	RENAL TUBULAR DYSGENESIS; RTD
267450	RESPIRATORY DISTRESS SYNDROME IN PREMATURE INFANTS
267480	RESPIRATORY UNDERRESPONSIVENESS TO HYPOXIA AND HYPERCAPNIA
267500	RETICULAR DYSGENESIS
267700	HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 1; FHL1
267730	RETICULUM CELL SARCOMA
267740	RETINAL DEGENERATION AND EPILEPSY
267750	KNOBLOCH SYNDROME 1; KNO1
267760	RETINAL DEGENERATION WITH NANOPHTHALMOS, CYSTIC MACULAR DEGENERATION, AND ANGLE CLOSURE GLAUCOMA
267800	RETINAL DYSTROPHY, RETICULAR PIGMENTARY, OF POSTERIOR POLE
267900	RETINAL TELANGIECTASIA AND HYPOGAMMAGLOBULINEMIA
268000	RETINITIS PIGMENTOSA; RP
268010	RETINITIS PIGMENTOSA INVERSA WITH DEAFNESS
268020	RETINITIS PIGMENTOSA, DEAFNESS, MENTAL RETARDATION, AND HYPOGONADISM
268025	RETINITIS PIGMENTOSA, LATE-ADULT ONSET
268030	MOVED TO 600105
268040	RETINOHEPATOENDOCRINOLOGIC SYNDROME
268050	MIRHOSSEINI-HOLMES-WALTON SYNDROME
268060	RETINOPATHY, PERICENTRAL PIGMENTARY, AUTOSOMAL RECESSIVE
268080	RETINOSCHISIS OF FOVEA
268100	ENHANCED S-CONE SYNDROME; ESCS
268130	REVESZ SYNDROME
268150	RH-NULL, REGULATOR TYPE; RHNR
268200	MYOGLOBINURIA, ACUTE RECURRENT, AUTOSOMAL RECESSIVE
268210	RHABDOMYOSARCOMA, EMBRYONAL, 1; RMSE1
268220	RHABDOMYOSARCOMA 2; RMS2
268240	RHEUMATIC FEVER-RELATED ANTIGEN
268250	RHIZOMELIC SYNDROME
268300	ROBERTS-SC PHOCOMELIA SYNDROME; RBS
268305	ROBIN SEQUENCE WITH CLEFT MANDIBLE AND LIMB ANOMALIES
268310	ROBINOW SYNDROME, AUTOSOMAL RECESSIVE 1; RRS1
268315	ROD-CONE DYSTROPHY, SENSORINEURAL DEAFNESS, AND FANCONI-TYPE RENAL DYSFUNCTION; RCDFRD
268320	RODRIGUES BLINDNESS
268400	ROTHMUND-THOMSON SYNDROME, TYPE 2; RTS2
268500	ROWLEY-ROSENBERG SYNDROME
268650	RUDIGER SYNDROME
268670	MOVED TO 270400
268700	SACCHAROPINURIA
268800	SANDHOFF DISEASE
268850	RICHIERI-COSTA/GUION-ALMEIDA SYNDROME
268900	SARCOSINEMIA; SARCOS
268950	MOVED TO 254110
269000	MOVED TO 268300
269150	SCHINZEL-GIEDION MIDFACE RETRACTION SYNDROME
269160	SCHIZENCEPHALY
269200	AUTOIMMUNE POLYENDOCRINE SYNDROME, TYPE II; APS2
269250	SCHNECKENBECKEN DYSPLASIA; SHNKND
269300	CRANIOMETADIAPHYSEAL DYSPLASIA; CRMDD
269400	ANTERIOR SEGMENT DYSGENESIS 7; ASGD7
269500	SCLEROSTEOSIS 1; SOST1
269600	SEA-BLUE HISTIOCYTE DISEASE
269630	SECOND METATARSAL-METACARPAL SYNDROME
269650	SECRETORY COMPONENT DEFICIENCY
269700	LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 2; CGL2
269720	SEIZURES, BENIGN FAMILIAL NEONATAL, AUTOSOMAL RECESSIVE
269800	SENILE PLAQUE FORMATION
269840	IMMUNODEFICIENCY 48; IMD48
269860	SHORT-RIB THORACIC DYSPLASIA 12; SRTD12
269870	SHORT STATURE-OBESITY SYNDROME; SSOS
269880	SHORT SYNDROME
269920	INFANTILE SIALIC ACID STORAGE DISEASE; ISSD
269921	SIALURIA
269950	MOVED TO 206000
270050	MOVED TO 180860
270100	HETEROTAXY, VISCERAL, 5, AUTOSOMAL; HTX5
270150	SJOGREN SYNDROME
270200	SJOGREN-LARSSON SYNDROME; SLS
270220	SJOGREN-LARSSON-LIKE ICHTHYOSIS WITHOUT CNS OR EYE INVOLVEMENT
270230	MOVED TO 187600
270240	MOVED TO 268400
270300	PEELING SKIN SYNDROME 1; PSS1
270350	ANOSMIA FOR BUTYL MERCAPTAN
270400	SMITH-LEMLI-OPITZ SYNDROME; SLOS
270420	DIARRHEA 3, SECRETORY SODIUM, CONGENITAL, WITH OR WITHOUT OTHER CONGENITAL ANOMALIES; DIAR3
270425	SODIUM-POTASSIUM-ATPase ACTIVITY OF RED CELL
270450	INSULIN-LIKE GROWTH FACTOR I, RESISTANCE TO; IGF1RES
270460	SONODA SYNDROME
270500	ATAXIA, SPASTIC, CHILDHOOD-ONSET, AUTOSOMAL RECESSIVE, WITH OPTIC ATROPHY AND MENTAL RETARDATION
270550	SPASTIC ATAXIA, CHARLEVOIX-SAGUENAY TYPE; SACS
270600	SPASTIC DIPLEGIA AND IMPAIRED INTELLECTUAL DEVELOPMENT
270680	MOVED TO 270750
270685	SPASTIC PARAPLEGIA 17, AUTOSOMAL DOMINANT; SPG17
270700	SPASTIC PARAPLEGIA 15, AUTOSOMAL RECESSIVE; SPG15
270710	MOVED TO 270550, 190350, AND 616944
270750	SPASTIC PARAPLEGIA 23, AUTOSOMAL RECESSIVE; SPG23
270800	SPASTIC PARAPLEGIA 5A, AUTOSOMAL RECESSIVE; SPG5A
270805	SPASTIC PARAPLEGIA WITH MYOCLONIC EPILEPSY
270850	SPASTIC PARESIS, GLAUCOMA, AND MENTAL RETARDATION
270900	SPASTIC PSEUDOSCLEROSIS
270950	SPASTIC QUADRIPLEGIA, RETINITIS PIGMENTOSA, AND MENTAL RETARDATION
270960	SPERMATOGENIC FAILURE 4; SPGF4
270970	SPHEROCYTOSIS, TYPE 3; SPH3
271100	MOVED TO 153400
271109	SPINAL MUSCULAR ATROPHY WITH MENTAL RETARDATION
271110	SPINAL MUSCULAR ATROPHY WITH MICROCEPHALY AND MENTAL SUBNORMALITY
271120	MOVED TO 182960
271150	SPINAL MUSCULAR ATROPHY, TYPE IV; SMA4
271200	SPINAL MUSCULAR ATROPHY, RYUKYUAN TYPE
271220	SPINAL MUSCULAR ATROPHY, SCAPULOPERONEAL
271225	MOVED TO 616866
271245	MITOCHONDRIAL DNA DEPLETION SYNDROME 7 (HEPATOCEREBRAL TYPE); MTDPS7
271250	SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 3; SCAR3
271270	SPINOCEREBELLAR ATAXIA WITH DYSMORPHISM
271310	SPINOCEREBELLAR DEGENERATION AND CORNEAL DYSTROPHY
271320	SPINOCEREBELLAR DEGENERATION WITH MACULAR CORNEAL DYSTROPHY, CONGENITAL CATARACTS, AND MYOPIA
271322	SPINOCEREBELLAR DEGENERATION WITH SLOW EYE MOVEMENTS; SDSEM
271400	ASPLENIA, ISOLATED CONGENITAL; ICAS
271500	SPLENOPORTAL VASCULAR ANOMALIES
271510	SPONDYLOEPIMETAPHYSEAL DYSPLASIA, SPONASTRIME TYPE; SEMDSP
271520	SPONDYLOCOSTAL DYSOSTOSIS WITH ANAL ATRESIA AND UROGENITAL ANOMALIES
271530	BRACHYOLMIA TYPE 1, HOBAEK TYPE; BCYM1A
271550	MOVED TO 607944
271600	SPONDYLOEPIPHYSEAL DYSPLASIA TARDA, AUTOSOMAL RECESSIVE
271620	SPONDYLOEPIPHYSEAL DYSPLASIA TARDA WITH MENTAL RETARDATION
271630	BRACHYOLMIA TYPE 1, TOLEDO TYPE; BCYM1B
271640	SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH JOINT LAXITY, TYPE 1, WITH OR WITHOUT FRACTURES; SEMDJL1
271650	SPONDYLOEPIMETAPHYSEAL DYSPLASIA, IRAPA TYPE; SEMDIT
271665	SPONDYLOMETAEPIPHYSEAL DYSPLASIA, SHORT LIMB-HAND TYPE
271700	SPONDYLOPERIPHERAL DYSPLASIA
271900	CANAVAN DISEASE
271930	STRIATONIGRAL DEGENERATION, INFANTILE; SNDI
271950	SUBAORTIC STENOSIS, MEMBRANOUS
271960	SUBAORTIC STENOSIS--SHORT STATURE SYNDROME
271980	SUCCINIC SEMIALDEHYDE DEHYDROGENASE DEFICIENCY; SSADHD
272000	SUCROSURIA, HIATUS HERNIA, AND IMPAIRED INTELLECTUAL DEVELOPMENT
272100	SUDANOPHILIC CEREBRAL SCLEROSIS
272120	SUDDEN INFANT DEATH SYNDROME
272150	SUGARMAN BRACHYDACTYLY
272200	MULTIPLE SULFATASE DEFICIENCY; MSD
272300	SULFITE OXIDASE DEFICIENCY, ISOLATED; ISOD
272350	SUMMITT SYNDROME
272370	SUSCEPTIBILITY TO LYSIS BY ALLOREACTIVE NATURAL KILLER CELLS; EC1
272430	CRISPONI/COLD-INDUCED SWEATING SYNDROME 1; CISS1
272440	FILIPPI SYNDROME; FLPIS
272450	SYNDESMODYSPLASIC DWARFISM
272460	SPONDYLOCARPOTARSAL SYNOSTOSIS SYNDROME; SCT
272480	MOVED TO 186700
272500	MOVED TO 269700
272550	MOVED TO 138500
272600	TAPETORETINAL DEGENERATION WITH ATAXIA
272620	TARDIVE DYSKINESIA
272650	TATSUMI FACTOR DEFICIENCY
272700	TAURODONTISM
272750	GM2-GANGLIOSIDOSIS, AB VARIANT
272800	TAY-SACHS DISEASE; TSD
272950	TEEBI-SHALTOUT SYNDROME; TBSH
272980	TEETH, CONGENITAL ABSENCE OF, WITH TAURODONTIA AND SPARSE HAIR
273000	TEETH, FUSED
273050	TEETH, NONERUPTION OF, WITH MAXILLARY HYPOPLASIA AND GENU VALGUM
273120	TERATOMA, PINEAL
273150	TESTES, RUDIMENTARY
273250	46,XY SEX REVERSAL 11; SRXY11
273300	TESTICULAR GERM CELL TUMOR; TGCT
273350	MOVED TO 154230
273390	TETRAAMELIA WITH ECTODERMAL DYSPLASIA AND LACRIMAL DUCT ABNORMALITIES
273395	TETRAAMELIA SYNDROME 1; TETAMS1
273400	TETRAMELIC DEFICIENCIES, ECTODERMAL DYSPLASIA, DEFORMED EARS, AND OTHER ABNORMALITIES
273490	THALAMIC DEGENERATION, SYMMETRIC INFANTILE
273600	THALIDOMIDE SUSCEPTIBILITY
273680	THANATOPHORIC DYSPLASIA, GLASGOW VARIANT
273730	THORACIC DYSPLASIA-HYDROCEPHALUS SYNDROME
273740	THORACOMELIC DYSPLASIA
273750	THREE M SYNDROME 1; 3M1
273770	THREONINEMIA
273800	GLANZMANN THROMBASTHENIA 1; GT1
273900	THROMBOCYTOPENIA 3; THC3
274000	THROMBOCYTOPENIA-ABSENT RADIUS SYNDROME; TAR
274150	THROMBOTIC THROMBOCYTOPENIC PURPURA, HEREDITARY; TTP
274180	THROMBOXANE A SYNTHASE 1; TBXAS1
274190	THUMB AGENESIS, SHORT STATURE, AND IMMUNODEFICIENCY
274200	THUMB, DISTAL HYPEREXTENSIBILITY OF
274205	THUMB, HYPOPLASTIC, WITH CHOROID COLOBOMA, POORLY DEVELOPED ANTIHELIX, AND DEAFNESS
274210	THYMIC APLASIA WITH FETAL DEATH
274230	THYMOMA, FAMILIAL
274240	THYROCEREBRORETINAL SYNDROME
274260	MOVED TO 274230
274265	THYMIC-RENAL-ANAL-LUNG DYSPLASIA
274270	DIHYDROPYRIMIDINE DEHYDROGENASE DEFICIENCY; DPYDD
274300	THYROID HORMONE RESISTANCE, GENERALIZED, AUTOSOMAL RECESSIVE; GRTHR
274400	THYROID DYSHORMONOGENESIS 1; TDH1
274500	THYROID DYSHORMONOGENESIS 2A; TDH2A
274600	PENDRED SYNDROME; PDS
274700	THYROID DYSHORMONOGENESIS 3; TDH3
274800	THYROID DYSHORMONOGENESIS 4; TDH4
274900	THYROID DYSHORMONOGENESIS 5; TDH5
275000	GRAVES DISEASE; GRD
275100	HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 4; CHNG4
275120	THYROTROPIN-RELEASING HORMONE DEFICIENCY
275190	TIGLIC ACIDEMIA
275200	HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 1; CHNG1
275210	RESTRICTIVE DERMOPATHY 1; RSDM1
275220	TIBIAL HEMIMELIA
275230	TIBIA, ABSENCE OF, WITH CONGENITAL DEAFNESS
275240	TINEA IMBRICATA, SUSCEPTIBILITY TO
275250	TONGUE, PIGMENTED FUNGIFORM PAPILLAE OF
275300	TRACHEOBRONCHOMEGALY
275350	TRANSCOBALAMIN II DEFICIENCY
275355	SQUAMOUS CELL CARCINOMA, HEAD AND NECK; HNSCC
275360	TREHALASE; TREH
275370	TRICARBOXYLIC ACID CYCLE, DEFECT OF
275400	OLIVER-MCFARLANE SYNDROME; OMCS
275450	TRICHOODONTOONYCHIAL DYSPLASIA WITH BONE DEFICIENCY
275500	MOVED TO 190350
275550	MOVED TO 234050
275595	TRIGONOBRACHYCEPHALY, BULBOUS BIFID NOSE, MICROGNATHIA, AND ABNORMALITIES OF THE HANDS AND FEET
275600	REMOVED FROM DATABASE
275630	CHANARIN-DORFMAN SYNDROME; CDS
275650	MOVED TO 214950
275900	SPASTIC PARAPLEGIA 20, AUTOSOMAL RECESSIVE; SPG20
276000	PROTEASE, SERINE, 1; PRSS1
276100	TRYPTOPHANURIA WITH DWARFISM
276200	T-SUBSTANCE ANOMALY
276300	MISMATCH REPAIR CANCER SYNDROME 1; MMRCS1
276400	TWINNING, DIZYGOTIC
276410	TWINNING, MONOZYGOTIC
276500	MOVED TO 276710
276600	TYROSINEMIA, TYPE II; TYRSN2
276700	TYROSINEMIA, TYPE I; TYRSN1
276710	TYROSINEMIA, TYPE III; TYRSN3
276800	TYROSINOSIS
276820	ULNA AND FIBULA, ABSENCE OF, WITH SEVERE LIMB DEFICIENCY
276821	ULNAR HYPOPLASIA WITH MENTAL RETARDATION
276822	ULNAR AGENESIS AND ENDOCARDIAL FIBROELASTOSIS
276850	MOVED TO 274150
276880	UROCANASE DEFICIENCY; UROCD
276900	USHER SYNDROME, TYPE I; USH1
276901	USHER SYNDROME, TYPE IIA; USH2A
276902	USHER SYNDROME, TYPE IIIA; USH3A
276903	MYOSIN VIIA; MYO7A
276904	USHER SYNDROME, TYPE IC; USH1C
276905	MOVED TO 605472
276950	VACTERL ASSOCIATION WITH HYDROCEPHALUS
277000	MAYER-ROKITANSKY-KUSTER-HAUSER SYNDROME; MRKH
277100	VALINEMIA
277150	VAN BOGAERT-HOZAY SYNDROME
277170	OROFACIODIGITAL SYNDROME VI; OFD6
277175	VASCULAR HYALINOSIS
277180	VAS DEFERENS, CONGENITAL BILATERAL APLASIA OF; CBAVD
277200	RIGHT VENTRICULAR HYPOPLASIA, ISOLATED
277300	SPONDYLOCOSTAL DYSOSTOSIS 1, AUTOSOMAL RECESSIVE; SCDO1
277320	VISCERAL MYOPATHY, FAMILIAL, WITH EXTERNAL OPHTHALMOPLEGIA
277350	HYPERCAROTENEMIA AND VITAMIN A DEFICIENCY, AUTOSOMAL RECESSIVE
277380	METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, cblF TYPE; MAHCF
277400	METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, cblC TYPE; MAHCC
277410	METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, cblD TYPE; MAHCD
277420	MOVED TO 277440
277440	VITAMIN D-DEPENDENT RICKETS, TYPE 2A; VDDR2A
277450	VITAMIN K-DEPENDENT CLOTTING FACTORS, COMBINED DEFICIENCY OF, 1; VKCFD1
277460	ATAXIA WITH VITAMIN E DEFICIENCY; AVED
277465	VITILIGO, PROGRESSIVE, WITH MENTAL RETARDATION AND URETHRAL DUPLICATION
277470	PONTOCEREBELLAR HYPOPLASIA, TYPE 2A; PCH2A
277480	VON WILLEBRAND DISEASE, TYPE 3; VWD3
277580	WAARDENBURG SYNDROME, TYPE 4A; WS4A
277590	WEAVER SYNDROME; WVS
277600	WEILL-MARCHESANI SYNDROME 1; WMS1
277610	MOVED TO 184840
277700	WERNER SYNDROME; WRN
277720	WHISTLING FACE SYNDROME, RECESSIVE FORM
277730	WERNICKE-KORSAKOFF SYNDROME
277740	WHITE FORELOCK WITH MALFORMATIONS
277900	WILSON DISEASE; WND
277950	WINCHESTER SYNDROME; WNCHRS
277970	MOVED TO 614493
277990	WOLFF MENTAL RETARDATION SYNDROME
278000	CHOLESTERYL ESTER STORAGE DISEASE; CESD
278100	MOVED TO 278000
278150	HYPOTRICHOSIS 8; HYPT8
278200	WOOLLY HAIR, HYPOTRICHOSIS, EVERTED LOWER LIP, AND OUTSTANDING EARS
278205	MOVED TO 601214
278250	WRINKLY SKIN SYNDROME; WSS
278300	XANTHINURIA, TYPE I; XAN1
278400	MOVED TO 203290
278600	MOVED TO 236800
278700	XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP A; XPA
278720	XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP C; XPC
278730	XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP D; XPD
278740	XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP E
278750	XERODERMA PIGMENTOSUM, VARIANT TYPE; XPV
278760	XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP F; XPF
278780	XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP G; XPG
278800	DE SANCTIS-CACCHIONE SYNDROME
278810	MOVED TO 278720
278850	46,XX SEX REVERSAL 2; SRXX2
278900	XYLOSIDASE DEFICIENCY
279000	YOUNG SYNDROME
280000	COLOBOMA, CONGENITAL HEART DISEASE, ICHTHYOSIFORM DERMATOSIS, IMPAIRED INTELLECTUAL DEVELOPMENT, AND EAR ANOMALIES SYNDROME; CHIME
300000	OPITZ GBBB SYNDROME; GBBB
300001	ICHTHYOSIS, X-LINKED, WITHOUT STEROID SULFATASE DEFICIENCY
300002	ARYLSULFATASE D; ARSD
300003	ARYLSULFATASE F; ARSF
300004	CORPUS CALLOSUM, AGENESIS OF, WITH ABNORMAL GENITALIA
300005	METHYL-CpG-BINDING PROTEIN 2; MECP2
300006	CENTRIN 2; CETN2
300007	INTERLEUKIN 9 RECEPTOR; IL9R
300008	CHLORIDE CHANNEL 5; CLCN5
300009	DENT DISEASE 1; DENT1
300010	A-11 GENE; A11
300011	ATPase, Cu(2+)-TRANSPORTING, ALPHA POLYPEPTIDE; ATP7A
300012	SWI/SNF-RELATED, MATRIX-ASSOCIATED, ACTIN-DEPENDENT REGULATOR OF CHROMATIN, SUBFAMILY A, MEMBER 1; SMARCA1
300013	N-ALPHA-ACETYLTRANSFERASE 10, NatA CATALYTIC SUBUNIT; NAA10
300014	ATPase, Ca(2+)-TRANSPORTING, PLASMA MEMBRANE, 3; ATP2B3
300015	ACETYLSEROTONIN METHYLTRANSFERASE, X-CHROMOSOMAL; ASMT
300016	MELANOMA ANTIGEN, FAMILY A, 1; MAGEA1
300017	FILAMIN A; FLNA
300018	46,XY SEX REVERSAL 2; SRXY2
300019	HOST CELL FACTOR C1; HCFC1
300020	MOVED TO 102610
300021	MOVED TO 301830
300022	PLEXIN A3; PLXNA3
300023	RHO GTPase-ACTIVATING PROTEIN 4; ARHGAP4
300024	ZINC FINGER PROTEIN 157; ZNF157
300025	CAUDAL-TYPE HOMEOBOX TRANSCRIPTION FACTOR 4; CDX4
300026	NUCLEOSOME ASSEMBLY PROTEIN 1-LIKE 2; NAP1L2
300027	RNA-BINDING MOTIF PROTEIN 3; RBM3
300028	ZINC FINGER-, CCCH DOMAIN-, AND RNA-BINDING MOTIF-CONTAINING SERINE/ARGININE-RICH PROTEIN 2; ZRSR2
300029	RETINITIS PIGMENTOSA 3; RP3
300030	DEAFNESS, X-LINKED 3; DFNX3
300031	FAMILY WITH SEQUENCE SIMILARITY 11, MEMBER A; FAM11A
300032	ATRX CHROMATIN REMODELER; ATRX
300033	FORKHEAD BOX O4; FOXO4
300034	ANGIOTENSIN II RECEPTOR, TYPE 2; AGTR2
300035	EPHRIN B1; EFNB1
300036	SOLUTE CARRIER FAMILY 6 (NEUROTRANSMITTER TRANSPORTER, CREATINE), MEMBER 8; SLC6A8
300037	GLYPICAN 3; GPC3
300038	PYRIMIDINERGIC RECEPTOR P2Y, G PROTEIN-COUPLED, 4; P2RY4
300039	POU DOMAIN, CLASS 3, TRANSCRIPTION FACTOR 4; POU3F4
300040	STRUCTURAL MAINTENANCE OF CHROMOSOMES 1A; SMC1A
300041	GUANYLATE CYCLASE 2F, RETINAL; GUCY2F
300042	ALOPECIA, CONGENITAL; ALPC
300043	MOVED TO 611663
300044	TRANSKETOLASE-LIKE 1; TKTL1
300045	MOVED TO 602081
300046	INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 23; XLID23
300047	INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 20; XLID20
300048	INTESTINAL PSEUDOOBSTRUCTION, NEURONAL, CHRONIC IDIOPATHIC, X-LINKED
300049	PERIVENTRICULAR NODULAR HETEROTOPIA 1; PVNH1
300050	UBIQUITIN-SPECIFIC PROTEASE 11; USP11
300051	GLYCOPROTEIN M6B; GPM6B
300052	DYSTROPHIN-RELATED PROTEIN 2; DRP2
300053	VESICLE-ASSOCIATED MEMBRANE PROTEIN 7: VAMP7
300054	BODY LENGTH, MOUSE, HUMAN HOMOLOG
300055	INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED, SYNDROMIC 13; MRXS13
300056	HOLOCYTOCHROME C SYNTHASE; HCCS
300057	MOVED TO 601324
300058	MOVED TO 300446
300059	TRANSMEMBRANE PROTEIN 187; TMEM187
300060	L ANTIGEN FAMILY, MEMBER 3; LAGE3
300061	ZINC FINGER, MYM-TYPE 3; ZMYM3
300062	INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 14; XLID14
300063	MOVED TO 304930
300064	MENTAL RETARDATION, X-LINKED, WITH CRANIOFACIAL DYSMORPHISM
300065	CENTROMERIC PROTEIN I; CENPI
300066	DEAFNESS, X-LINKED 4; DFNX4
300067	LISSENCEPHALY, X-LINKED, 1; LISX1
300068	ANDROGEN INSENSITIVITY SYNDROME; AIS
300069	MOVED TO 302060
300070	FIBROBLAST GROWTH FACTOR 13; FGF13
300071	NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 2A; CSNB2A
300072	UBIQUITIN-SPECIFIC PROTEASE 9, X-LINKED; USP9X
300073	FETAL AKINESIA SYNDROME, X-LINKED
300074	X CHROMOSOME-CONTROLLING ELEMENT; XCE
300075	RIBOSOMAL PROTEIN S6 KINASE A3; RPS6KA3
300076	IMMUNONEUROLOGIC DISORDER, X-LINKED
300077	MOVED TO 300419
300078	NADH-UBIQUINONE OXIDOREDUCTASE SUBUNIT A1; NDUFA1
300079	INHIBITOR OF APOPTOSIS, X-LINKED; XIAP
300080	RNA-BINDING MOTIF PROTEIN 10; RBM10
300081	DEOXYRIBONUCLEASE I-LIKE 1; DNASE1L1
300082	COGNITIVE FUNCTION 1, SOCIAL; CGF1
300083	PROTEIN KINASE, X-LINKED; PRKX
300084	NON-POU DOMAIN-CONTAINING OCTAMER-BINDING PROTEIN; NONO
300085	CONE-ROD DYSTROPHY, X-LINKED, 2; CORDX2
300086	LYSOPHOSPHATIDIC ACID RECEPTOR 4; LPAR4
300087	X INACTIVATION, FAMILIAL SKEWED, 1; SXI1
300088	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 9; DEE9
300089	ISOCITRATE DEHYDROGENASE 3, GAMMA SUBUNIT; IDH3G
300090	SIGNAL SEQUENCE RECEPTOR, DELTA; SSR4
300091	FOS-INDUCED GROWTH FACTOR; FIGF
300092	TESTIS-EXPRESSED GENE 28; TEX28
300093	GAMMA-AMINOBUTYRIC ACID RECEPTOR, EPSILON; GABRE
300094	MOVED TO 600539
300095	SOLUTE CARRIER FAMILY 16 (MONOCARBOXYLIC ACID TRANSPORTER), MEMBER 2; SLC16A2
300096	TETRASPANIN 7; TSPAN7
300097	MELANOMA ANTIGEN, FAMILY B, 1; MAGEB1
300098	MELANOMA ANTIGEN, FAMILY B, 2; MAGEB2
300099	MOVED TO 300097
300100	ADRENOLEUKODYSTROPHY; ALD
300101	BONE MARROW KINASE, X-LINKED; BMX
300102	PATATIN-LIKE PHOSPHOLIPASE DOMAIN-CONTAINING PROTEIN 4; PNPLA4
300103	SHROOM FAMILY MEMBER 2; SHROOM2
300104	GDP DISSOCIATION INHIBITOR 1; GDI1
300105	SPERMINE SYNTHASE; SMS
300106	SPONDYLOEPIMETAPHYSEAL DYSPLASIA, X-LINKED; SEMDX
300107	BOMBESIN-LIKE RECEPTOR 3; BRS3
300108	DIAPHANOUS-RELATED FORMIN 2; DIAPH2
300109	PROTEIN PHOSPHATASE, EF-HAND CALCIUM-BINDING DOMAIN 1; PPEF1
300110	CALCIUM CHANNEL, VOLTAGE-DEPENDENT, ALPHA-1F SUBUNIT; CACNA1F
300111	PRICKLE PLANAR CELL POLARITY PROTEIN 3; PRICKLE3
300112	PROTEOLIPID PROTEIN 2; PLP2
300113	X-LINKED B CELL SURFACE ANTIGEN, MOUSE, HOMOLOG-LIKE 1; XLRL
300114	RAYNAUD-CLAES SYNDROME; MRXSRC
300115	INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 50; XLID50
300116	MATURE T-CELL PROLIFERATION 1; MTCP1
300117	NUCLEOSOME ASSEMBLY PROTEIN 1-LIKE 3; NAP1L3
300118	RHO GTPase-ACTIVATING PROTEIN 6; ARHGAP6
300119	INTERLEUKIN 13 RECEPTOR, ALPHA-1; IL13RA1
300120	MASTERMIND-LIKE DOMAIN-CONTAINING PROTEIN 1; MAMLD1
300121	DOUBLECORTIN; DCX
300122	MOVED TO 300000
300123	INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED, WITH PANHYPOPITUITARISM
300124	GTP-BINDING PROTEIN 6; GTPBP6
300125	MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 2
300126	DYSKERIN; DKC1
300127	OLIGOPHRENIN 1; OPHN1
300128	LYSINE DEMETHYLASE 6A; KDM6A
300129	HEMATOPOIETIC STEM CELL KINETICS, CONTROL OF
300130	INTERLEUKIN 13 RECEPTOR, ALPHA-2; IL13RA2
300131	PLASTIN 3; PLS3
300132	TROPHININ; TRO
300133	VON HIPPEL-LINDAU BINDING PROTEIN 1; VBP1
300134	DUAL-SPECIFICITY PHOSPHATASE 9; DUSP9
300135	ATP-BINDING CASSETTE, SUBFAMILY B, MEMBER 7; ABCB7
300136	TYPE 1 DIABETES MELLITUS, X-LINKED, SUSCEPTIBILITY TO; T1DX
300137	IMMUNOGLOBULIN SUPERFAMILY, MEMBER 1; IGSF1
300138	CHLORIDE INTRACELLULAR CHANNEL 2; CLIC2
300139	IMMUNOGLOBULIN-BINDING PROTEIN 1; IGBP1
300140	MOVED TO 600655
300141	MOVED TO 612725
300142	p21 PROTEIN-ACTIVATED KINASE 3; PAK3
300143	INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 21; XLID21
300144	GLUTAMATE DEHYDROGENASE 2; GLUD2
300145	X-PROLYL AMINOPEPTIDASE 2; XPNPEP2
300146	CALPAIN 6; CAPN6
300147	PROSTATE CANCER, HEREDITARY, X-LINKED 1; HPCX1
300148	MEHMO SYNDROME; MEHMO
300149	CBP/p300-INTERACTING TRANSACTIVATOR WITH GLU/ASP-RICH C-TERMINAL DOMAIN, 1; CITED1
300150	SOLUTE CARRIER FAMILY 25 (MITOCHONDRIAL CARRIER, ADENINE NUCLEOTIDE TRANSLOCATOR), MEMBER A5; SLC25A5
300151	SOLUTE CARRIER FAMILY 25 (MITOCHONDRIAL CARRIER, ADENINE NUCLEOTIDE TRANSLOCATOR), MEMBER A6; SLC25A6
300152	MELANOMA ANTIGEN, FAMILY B, 3; MAGEB3
300153	MELANOMA ANTIGEN, FAMILY B, 4; MAGEB4
300154	ESX1-LIKE PROTEIN; ESX1L
300155	RETINITIS PIGMENTOSA 24; RP24
300156	CANCER/TESTIS ANTIGEN 1B; CTAG1B
300157	ACYL-CoA SYNTHETASE LONG CHAIN FAMILY, MEMBER 4; ACSL4
300158	ARTHROGRYPOSIS, CONGENITAL, LOWER LIMB, X-LINKED; ACLLX
300159	THYMOSIN, BETA-4, X CHROMOSOME; TMSB4X
300160	DEAD-BOX HELICASE 3, X-LINKED; DDX3X
300161	EUKARYOTIC TRANSLATION INITIATION FACTOR 2, SUBUNIT 3; EIF2S3
300162	ACETYLSEROTONIN METHYLTRANSFERASE-LIKE; ASMTL
300163	FOUR-AND-A-HALF LIM DOMAINS 1; FHL1
300164	INACTIVATION ESCAPE 1; INE1
300165	INACTIVATION ESCAPE 2; INE2
300166	MICROPHTHALMIA, SYNDROMIC 2; MCOPS2
300167	HEPHAESTIN; HEPH
300168	GLYPICAN 4; GPC4
300169	APOPTOSIS-INDUCING FACTOR, MITOCHONDRIA-ASSOCIATED, 1; AIFM1
300170	OFD1 CENTRIOLE AND CENTRIOLAR SATELLITE PROTEIN; OFD1
300171	MYOTUBULARIN-RELATED PROTEIN 1; MTMR1
300172	CALCIUM/CALMODULIN-DEPENDENT SERINE PROTEIN KINASE; CASK
300173	MELANOMA ANTIGEN, FAMILY A, 2; MAGEA2
300174	MELANOMA ANTIGEN, FAMILY A, 3; MAGEA3
300175	MELANOMA ANTIGEN, FAMILY A, 4; MAGEA4
300176	MELANOMA ANTIGEN, FAMILY A, 6; MAGEA6
300177	MELANOMA ANTIGEN, FAMILY A, 12; MAGEA12
300178	ZINC FINGER BED DOMAIN-CONTAINING PROTEIN 1; ZBED1
300179	X INACTIVATION, FAMILIAL SKEWED, 2; SXI2
300180	ARYLSULFATASE L; ARSL
300181	X INACTIVATION-SPECIFIC TRANSCRIPT-ANTISENSE; TSIX
300182	MEDIATOR COMPLEX SUBUNIT 14; MED14
300183	MOVED TO 302060
300184	HYPOTONIA, CONGENITAL NYSTAGMUS, ATAXIA, AND ABNORMAL AUDITORY BRAINSTEM RESPONSES
300185	A-KINASE ANCHOR PROTEIN 4; AKAP4
300186	EUKARYOTIC TRANSLATION INITIATION FACTOR 1A, X-LINKED; EIF1AX
300187	SUSHI REPEAT-CONTAINING PROTEIN, X-LINKED; SRPX
300188	MEDIATOR COMPLEX SUBUNIT 12; MED12
300189	DISCS LARGE MAGUK SCAFFOLD PROTEIN 3; DLG3
300190	SH3 DOMAIN-BINDING GLUTAMIC ACID-RICH PROTEIN-LIKE PROTEIN; SH3BGRL
300191	TETRASPANIN 6; TSPAN6
300192	SARCOMA, SYNOVIAL, X BREAKPOINT 2; SSX2
300193	HIGH MOBILITY GROUP BOX 3; HMGB3
300194	AMME COMPLEX
300195	AMMECR NUCLEAR PROTEIN 1; AMMECR1
300196	TRANSDUCIN-BETA-LIKE 1, X-LINKED; TBL1X
300197	ATPase, H+ TRANSPORTING, LYSOSOMAL, ACCESSORY PROTEIN 1; ATP6AP1
300198	GLYCOGENIN 2; GYG2
300199	RNA-BINDING MOTIF PROTEIN, X CHROMOSOME; RBMX
300200	ADRENAL HYPOPLASIA, CONGENITAL; AHC
300201	CYSTEINYL LEUKOTRIENE RECEPTOR 1; CYSLTR1
300202	TRACKING PROTEIN PARTICLE COMPLEX, SUBUNIT 2; TRAPPC2
300203	CYCLIN-DEPENDENT KINASE-LIKE 5; CDKL5
300204	MIDLINE 2; MID2
300205	EMOPAMIL-BINDING PROTEIN; EBP
300206	INTERLEUKIN 1 RECEPTOR ACCESSORY PROTEIN-LIKE 1; IL1RAPL1
300207	G PROTEIN-COUPLED RECEPTOR 50; GPR50
300208	SCM POLYCOMB GROUP PROTEIN-LIKE 2; SCML2
300209	SIMPSON-GOLABI-BEHMEL SYNDROME, TYPE 2; SGBS2
300210	INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 58; XLID58
300211	EPISODIC MUSCLE WEAKNESS, X-LINKED; EMWX
300212	REGUCALCIN; RGN
300213	CAAX BOX PROTEIN 1; CXX1
300214	PLEXIN B3; PLXNB3
300215	LISSENCEPHALY, X-LINKED, 2; LISX2
300216	COATS DISEASE
300217	RETINOIC ACID-INDUCED 2; RAI2
300218	INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED, SYNDROMIC 7; MRXS7
300219	MYOTUBULAR MYOPATHY WITH ABNORMAL GENITAL DEVELOPMENT
300220	MOVED TO 300438
300221	LYMPHOMA, HODGKIN, X-LINKED PSEUDOAUTOSOMAL
300222	INTEGRAL MEMBRANE PROTEIN 2A; ITM2A
300223	MELANOMA ANTIGEN, FAMILY C, 1; MAGEC1
300224	MELANOMA ANTIGEN, FAMILY D, 1; MAGED1
300225	NADPH OXIDASE 1; NOX1
300226	SMALL MUSCLE PROTEIN, X-LINKED; SMPX
300227	SCM POLYCOMB GROUP PROTEIN-LIKE 1; SCML1
300228	TESTICULAR GERM CELL TUMOR 1; TGCT1
300229	VARIABLY CHARGED, X CHROMOSOME; VCX
300230	CARBONIC ANHYDRASE VB, MITOCHONDRIAL; CA5B
300231	SOLUTE CARRIER FAMILY 9, MEMBER 6; SLC9A6
300232	SPONDYLOEPIMETAPHYSEAL DYSPLASIA, X-LINKED, WITH HYPOMYELINATING LEUKODYSTROPHY; SEMDHL
300233	RADIOULNAR SYNOSTOSIS, RADIAL RAY ABNORMALITIES, AND SEVERE MALFORMATIONS IN THE MALE
300234	UBIQUITOUSLY EXPRESSED TRANSCRIPT; UXT
300235	ZINC FINGER-ENCODING GENE, X-LINKED, DUPLICATED, A; ZXDA
300236	ZINC FINGER-ENCODING GENE, X-LINKED, DUPLICATED, B; ZXDB
300237	TRANSCRIPTION ELONGATION FACTOR A-LIKE 1; TCEAL1
300238	INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED, SYNDROMIC, SHASHI TYPE; MRXSSH
300239	EPIDERMAL GROWTH FACTOR-LIKE 6; EGFL6
300240	MOVED TO 305000
300241	G PROTEIN-COUPLED RECEPTOR 34; GPR34
300242	SOLUTE CARRIER FAMILY 25 (MITOCHONDRIAL CARRIER, BRAIN), MEMBER 14; SLC25A14
300243	INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED, SYNDROMIC, CHRISTIANSON TYPE; MRXSCH
300244	TERMINAL OSSEOUS DYSPLASIA; TOD
300245	PTOSIS, HEREDITARY CONGENITAL 2
300246	PROTOCADHERIN 11, X-LINKED; PCDH11X
300247	BONE MORPHOGENETIC PROTEIN 15; BMP15
300248	INHIBITOR OF NUCLEAR FACTOR KAPPA-B KINASE, REGULATORY SUBUNIT GAMMA; IKBKG
300249	TRANSLOCASE OF INNER MITOCHONDRIAL MEMBRANE 17B; TIMM17B
300250	MOVED TO 202200
300251	MOVED TO 605875
300252	PEPTIDYL-PROLYL CIS/TRANS ISOMERASE, NIMA-INTERACTING, 4; PIN4
300253	G PROTEIN-COUPLED RECEPTOR 173; GPR173
300254	SUV39H1 HISTONE LYSINE METHYLTRANSFERASE; SUV39H1
300255	O-LINKED N-ACETYLGLUCOSAMINE TRANSFERASE; OGT
300256	17-BETA-HYDROXYSTEROID DEHYDROGENASE X; HSD17B10
300257	DANON DISEASE
300258	MOVED TO 616651
300259	MYCOBACTERIUM TUBERCULOSIS, SUSCEPTIBILITY TO, X-LINKED
300260	INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED, SYNDROMIC, LUBS TYPE; MRXSL
300261	INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED, SYNDROMIC, ARMFIELD TYPE; MRXSA
300262	INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED, SYNDROMIC, ABIDI TYPE; MRXSAB
300263	INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED, SYNDROMIC, SIDERIUS TYPE; MRXSSD
300264	UBIQUILIN 2; UBQLN2
300265	ZIC FAMILY, MEMBER 3; ZIC3
300266	SPASTIC PARAPLEGIA 16, X-LINKED; SPG16
300267	RHO GUANINE NUCLEOTIDE EXCHANGE FACTOR 6; ARHGEF6
300268	MOVED TO 610618
300269	HISTONE DEACETYLASE 8; HDAC8
300270	ADRENOMYODYSTROPHY
300271	INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 72; XLID72
300272	HISTONE DEACETYLASE 6; HDAC6
300273	GOITER, MULTINODULAR 2; MNG2
300274	MOVED TO 300068
300275	NAD(P)H STEROID DEHYDROGENASE-LIKE PROTEIN; NSDHL
300276	ECTODYSPLASIN A2 RECEPTOR; EDA2R
300277	INTERLEUKIN 1 RECEPTOR ACCESSORY PROTEIN-LIKE 2; IL1RAPL2
300278	NYCTALOPIN; NYX
300279	MOVED TO 300260
300280	URUGUAY FACIOCARDIOMUSCULOSKELETAL SYNDROME; FCMSU
300281	POTASSIUM VOLTAGE-GATED CHANNEL, SHAL-RELATED SUBFAMILY, MEMBER 1; KCND1
300282	ECTO-NOX DISULFIDE-THIOL EXCHANGER 2; ENOX2
300283	INTERLEUKIN 1 RECEPTOR-ASSOCIATED KINASE 1; IRAK1
300284	RAS-ASSOCIATED PROTEIN RAB9; RAB9
300285	RAS-ASSOCIATED PROTEIN 9B; RAB9B
300286	KRUPPEL-LIKE FACTOR 8; KLF8
300287	P ANTIGEN FAMILY, MEMBER 4; PAGE4
300288	P ANTIGEN FAMILY, MEMBER 1; PAGE1
300289	X ANTIGEN FAMILY, MEMBER 1B; XAGE1B
300290	MOVED TO 614732
300291	ECTODERMAL DYSPLASIA AND IMMUNODEFICIENCY 1; EDAID1
300292	FORKHEAD BOX P3; FOXP3
300293	MOVED TO 301410
300294	MEMBRANE-BOUND TRANSCRIPTION FACTOR PROTEASE, SITE 2; MBTPS2
300295	PIM2 PROTOONCOGENE, SERINE/THREONINE KINASE; PIM2
300296	PLACENTA-SPECIFIC GENE 1; PLAC1
300297	APELIN; APLN
300298	UPF3B REGULATOR OF NONSENSE-MEDIATED mRNA DECAY; UPF3B
300299	NEUTROPENIA, SEVERE CONGENITAL, X-LINKED; SCNX
300300	BRUTON AGAMMAGLOBULINEMIA TYROSINE KINASE; BTK
300301	MOVED TO 300291
300302	DYNEIN, LIGHT CHAIN, TCTEX TYPE, 3; DYNLT3
300303	RIBOSOMAL PROTEIN S6 KINASE A6; RPS6KA6
300304	CULLIN 4B; CUL4B
300305	SPERM PROTEIN ASSOCIATED WITH THE NUCLEUS, X CHROMOSOME, FAMILY MEMBER A1; SPANXA1
300306	BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 11; BMIQ11
300307	T-BOX TRANSCRIPTION FACTOR 22; TBX22
300308	FERRITIN HEAVY POLYPEPTIDE-LIKE 17; FTHL17
300309	UBIQUITIN-SPECIFIC PROTEASE 26; USP26
300310	IMMUNODEFICIENCY 61; IMD61
300311	TESTIS-EXPRESSED GENE 11; TEX11
300312	TESTIS-EXPRESSED GENE 13A; TEX13A
300313	TESTIS-EXPRESSED GENE 13B; TEX13B
300314	TATA BOX-BINDING PROTEIN-ASSOCIATED FACTOR 7-LIKE; TAF7L
300315	NUCLEAR RNA EXPORT FACTOR 2; NXF2
300316	NUCLEAR RNA EXPORT FACTOR 3; NXF3
300317	RALBP1-ASSOCIATED EPS DOMAIN-CONTAINING PROTEIN 2; REPS2
300318	NUCLEAR RNA EXPORT FACTOR 4; NXF4
300319	NUCLEAR RNA EXPORT FACTOR 5; NXF5
300320	NTF2-LIKE EXPORT FACTOR 2; NXT2
300321	FG SYNDROME 2; FGS2
300322	LESCH-NYHAN SYNDROME; LNS
300323	HYPERURICEMIA, HPRT-RELATED; HRH
300324	INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 53; XLID53
300325	SYNOVIAL SARCOMA, X BREAKPOINT 3; SSX3
300326	SYNOVIAL SARCOMA, X BREAKPOINT 4; SSX4
300327	SYNOVIAL SARCOMA, X BREAKPOINT 5; SSX5
300328	POTASSIUM CHANNEL, VOLTAGE-GATED, ISK-RELATED FAMILY, MEMBER 1-LIKE; KCNE1L
300329	ZINC FINGER- AND BTB DOMAIN-CONTAINING PROTEIN 33; ZBTB33
300330	SPANX FAMILY, MEMBER C; SPANXC
300331	MOVED TO 187950
300332	INTEGRIN, BETA-1, BINDING PROTEIN OF, 2; ITGB1BP2
300333	RAS-ASSOCIATED PROTEIN RAB33A; RAB33A
300334	TRANSIENT RECEPTOR POTENTIAL CATION CHANNEL, SUBFAMILY C, MEMBER 5; TRPC5
300335	ANGIOTENSIN I-CONVERTING ENZYME 2; ACE2
300336	NEUROLIGIN 3; NLGN3
300337	HYPOMELANOSIS OF ITO; HMI
300338	CYCLIC NUCLEOTIDE-GATED CHANNEL, ALPHA-2; CNGA2
300339	PROTEIN PHOSPHATASE 2, REGULATORY SUBUNIT B-DOUBLE PRIME, BETA; PPP2R3B
300340	MELANOMA ANTIGEN, FAMILY A, 5; MAGEA5
300341	MELANOMA ANTIGEN, FAMILY A, 8; MAGEA8
300342	MELANOMA ANTIGEN, FAMILY A, 9; MAGEA9
300343	MELANOMA ANTIGEN, FAMILY A, 10; MAGEA10
300344	MELANOMA ANTIGEN, FAMILY A, 11; MAGEA11
300345	MICROPHTHALMIA/COLOBOMA 1; MCOPCB1
300346	HIV-1 TAT STIMULATORY FACTOR 1; HTATSF1
300347	DIAPH2 ANTISENSE RNA 1; DIAPH2AS1
300348	KELCH-LIKE 4; KLHL4
300349	GAMMA-AMINOBUTYRIC ACID RECEPTOR, THETA; GABRQ
300350	CHORDIN-LIKE 1; CHRDL1
300351	GRAVES DISEASE, SUSCEPTIBILITY TO, X-LINKED 1
300352	CEREBRAL CREATINE DEFICIENCY SYNDROME 1; CCDS1
300353	V-SET AND IMMUNOGLOBULIN DOMAINS-CONTAINING PROTEIN 4; VSIG4
300354	INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED, SYNDROMIC, CABEZAS TYPE; MRXSC
300355	INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 73; XLID73
300356	TRANSLOCASE OF INNER MITOCHONDRIAL MEMBRANE 8A; TIMM8A
300357	CYTOKINE RECEPTOR-LIKE FACTOR 2; CRLF2
300358	PROTEIN KINASE, LYSINE-DEFICIENT 3; WNK3
300359	SARCOMA ANTIGEN 1; SAGE1
300360	MOVED TO 300354
300361	NERVE GROWTH FACTOR RECEPTOR-ASSOCIATED PROTEIN 1; NGFRAP1
300362	ARMADILLO REPEAT-CONTAINING PROTEIN, X-LINKED 1; ARMCX1
300363	ARMADILLO REPEAT-CONTAINING PROTEIN, X-LINKED 2; ARMCX2
300364	ARMADILLO REPEAT-CONTAINING PROTEIN, X-LINKED 3; ARMCX3
300365	TOLL-LIKE RECEPTOR 7; TLR7
300366	TOLL-LIKE RECEPTOR 8; TLR8
300367	THROMBOCYTOPENIA, X-LINKED, WITH OR WITHOUT DYSERYTHROPOIETIC ANEMIA; XLTDA
300368	SOLUTE CARRIER FAMILY 9, MEMBER 7; SLC9A7
300369	GERM CELL NUCLEAR ACIDIC PEPTIDASE; GCNA
300370	3-PRIME REPAIR EXONUCLEASE 2; TREX2
300371	ATP-BINDING CASSETTE, SUBFAMILY D, MEMBER 1; ABCD1
300372	INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 42; XLID42
300373	OSTEOPATHIA STRIATA WITH CRANIAL SCLEROSIS; OSCS
300374	SH3-DOMAIN KINASE-BINDING PROTEIN 1; SH3KBP1
300375	CARBOHYDRATE SULFOTRANSFERASE 7; CHST7
300376	MUSCULAR DYSTROPHY, BECKER TYPE; BMD
300377	DYSTROPHIN; DMD
300378	RADIAL RAY DEFICIENCY, X-LINKED
300379	RING FINGER PROTEIN, LIM DOMAIN-INTERACTING; RLIM
300380	CYTIDINE 5-PRIME TRIPHOSPHATE SYNTHETASE 2; CTPS2
300381	ZINC FINGER PROTEIN 185; ZNF185
300382	ARISTALESS-RELATED HOMEOBOX, X-LINKED; ARX
300383	COMPLEMENT FACTOR PROPERDIN; CFP
300384	EMERIN; EMD
300385	NUCLEOSOMAL BINDING PROTEIN 1; NSBP1
300386	CD40 LIGAND; CD40LG
300387	INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 63; XLID63
300388	POLYMICROGYRIA, BILATERAL PERISYLVIAN, X-LINKED; BPPX
300389	MOVED TO 300029
300390	CHM RAB ESCORT PROTEIN; CHM
300391	AMELOGENIN; AMELX
300392	WASP ACTIN NUCLEATION PROMOTING FACTOR; WAS
300393	G PROTEIN-COUPLED RECEPTOR 101; GPR101
300394	TAFAZZIN, PHOSPHOLIPID-LYSOPHOSPHOLIPID TRANSACYLASE; TAFAZZIN
300395	THO COMPLEX, SUBUNIT 2; THOC2
300396	CANCER/TESTIS ANTIGEN 2; CTAG2
300397	MOVED TO 300352
300398	B-CELL RECEPTOR-ASSOCIATED PROTEIN 31; BCAP31
300399	PROPROTEIN CONVERTASE, SUBTILISIN/KEXIN-TYPE, 1, INHIBITOR OF; PCSK1N
300400	SEVERE COMBINED IMMUNODEFICIENCY, X-LINKED; SCIDX1
300401	PROTEOLIPID PROTEIN 1; PLP1
300402	LEUCINE ZIPPER, DOWNREGULATED IN CANCER 1; LDOC1
300403	NADH-UBIQUINONE OXIDOREDUCTASE 1 BETA SUBCOMPLEX, 11; NDUFB11
300404	MOVED TO 308205
300405	RAS-ASSOCIATED PROTEIN RAB40A-LIKE; RAB40AL
300406	FG SYNDROME 3; FGS3
300407	POLYADENYLATE-BINDING PROTEIN, CYTOPLASMIC, 5; PABPC5
300408	GRIP1-ASSOCIATED PROTEIN 1; GRIPAP1
300409	MORTALITY FACTOR 4-LIKE PROTEIN 2; MORF4L2
300410	ANGIOMOTIN; AMOT
300411	TRANSFORMING GROWTH FACTOR-BETA-INDUCED FACTOR 2-LIKE, X-LINKED; TGIF2LX
300412	MOVED TO 300166
300413	MUSCLEBLIND-LIKE SPLICING REGULATOR 3; MBNL3
300414	PHD FINGER PROTEIN 6; PHF6
300415	MYOTUBULARIN; MTM1
300416	X ANTIGEN FAMILY, MEMBER 2; XAGE2
300417	G PROTEIN-COUPLED RECEPTOR-ASSOCIATED SORTING PROTEIN 1; GPRASP1
300418	G1- TO S-PHASE TRANSITION 2; GSPT2
300419	INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 29; XLID29
300420	PRAJA RING FINGER UBIQUITIN LIGASE 1; PJA1
300421	MOVED TO 194190
300422	FG SYNDROME 4; FGS4
300423	INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED, SYNDROMIC, HEDERA TYPE; MRXSH
300424	RETINITIS PIGMENTOSA 23; RP23
300425	AUTISM, SUSCEPTIBILITY TO, X-LINKED 1; AUTSX1
300426	MOVED TO 300143
300427	NEUROLIGIN 4, X-LINKED; NLGN4X
300428	INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 2; XLID2
300429	RHO GUANINE NUCLEOTIDE EXCHANGE FACTOR 9; ARHGEF9
300430	MOVED TO 300419
300431	ATKIN-FLAITZ SYNDROME
300432	MOVED TO 308350
300433	INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 81; XLID81
300434	INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED, SYNDROMIC, STOCCO DOS SANTOS TYPE; SDSX
300435	PROGESTERONE RECEPTOR MEMBRANE COMPONENT 1; PGRMC1
300436	INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 46; XLID46
300437	EMBRYONIC STEM CELL-EXPRESSED RAS; ERAS
300438	HSD10 MITOCHONDRIAL DISEASE; HSD10MD
300439	RING FINGER PROTEIN 128; RNF128
300440	NFKB-REPRESSING FACTOR; NKRF
300441	SAM- AND SH3 DOMAIN-CONTAINING PROTEIN 3; SASH3
300442	MOVED TO 311900
300443	SOLUTE CARRIER FAMILY 7 (CATIONIC AMINO ACID TRANSPORTER, y+ SYSTEM), MEMBER 3; SLC7A3
300444	SOLUTE CARRIER FAMILY 6 (NEUROTRANSMITTER TRANSPORTER), MEMBER 14; SLC6A14
300445	H2A.B VARIANT HISTONE 3; H2AB3
300446	RHOX HOMEOBOX FAMILY, MEMBER 1; RHOXF1
300447	RHOX HOMEOBOX FAMILY, MEMBER 2; RHOXF2
300448	ALPHA-THALASSEMIA MYELODYSPLASIA SYNDROME; ATMDS
300449	MOVED TO 300448
300450	FETAL AND ADULT TESTIS-EXPRESSED GENE 1; FATE1
300451	ECTODYSPLASIN A; EDA
300452	INHIBITOR OF GROWTH, X-LINKED; INGX
300453	FAMILY WITH SEQUENCE SIMILARITY 50, MEMBER A; FAM50A
300454	INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 77; XLID77
300455	RETINITIS PIGMENTOSA, X-LINKED, AND SINORESPIRATORY INFECTIONS WITH OR WITHOUT DEAFNESS; RPSRDF
300456	CYCLIN B3; CCNB3
300457	NHS ACTIN REMODELING REGULATOR; NHS
300458	MOVED TO 300055
300459	TENOMODULIN; TNMD
300460	PROTOCADHERIN 19; PCDH19
300461	ORNITHINE CARBAMOYLTRANSFERASE; OTC
300462	A-KINASE ANCHOR PROTEIN 14; AKAP14
300463	POLYGLUTAMINE-BINDING PROTEIN 1; PQBP1
300464	CORONARY HEART DISEASE, SUSCEPTIBILITY TO, 3
300465	MOVED TO 301040
300466	MELANOMA ANTIGEN, FAMILY B, 5; MAGEB5
300467	MELANOMA ANTIGEN, FAMILY B, 6; MAGEB6
300468	MELANOMA ANTIGEN, FAMILY C, 2; MAGEC2
300469	MELANOMA ANTIGEN, FAMILY C, 3; MAGEC3
300470	MELANOMA ANTIGEN, FAMILY D, 2; MAGED2
300471	CUBITUS VALGUS WITH IMPAIRED INTELLECTUAL DEVELOPMENT AND UNUSUAL FACIES
300472	CORPUS CALLOSUM, AGENESIS OF, WITH IMPAIRED INTELLECTUAL DEVELOPMENT, OCULAR COLOBOMA, AND MICROGNATHIA
300473	NUCLEAR RECEPTOR SUBFAMILY 0, GROUP B, MEMBER 1; NR0B1
300474	GLYCEROL KINASE; GK
300475	DEAFNESS, DYSTONIA, AND CEREBRAL HYPOMYELINATION; DDCH
300476	CONE-ROD DYSTROPHY, X-LINKED, 3; CORDX3
300477	FAMILY WITH SEQUENCE SIMILARITY 9, MEMBER A; FAM9A
300478	FAMILY WITH SEQUENCE SIMILARITY 9, MEMBER B; FAM9B
300479	FAMILY WITH SEQUENCE SIMILARITY 9, MEMBER C; FAM9C
300480	TAK1-BINDING PROTEIN 3; TAB3
300481	CYTOCHROME b(-245), BETA SUBUNIT; CYBB
300482	GRB2-ASSOCIATED BINDING PROTEIN 3; GAB3
300483	MOVED TO 300031
300484	OROFACIODIGITAL SYNDROME VIII; OFD8
300485	BCL6 COREPRESSOR; BCOR
300486	INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED, SYNDROMIC, BILLUART TYPE; MRXSBL
300487	ACTIN-RELATED PROTEIN T1; ACTRT1
300488	MENOPAUSE, NATURAL, AGE AT, QUANTITATIVE TRAIT LOCUS 1; MENOQ1
300489	NEURONOPATHY, DISTAL HEREDITARY MOTOR, X-LINKED; HMNX
300490	SH2 DOMAIN PROTEIN 1A; SH2D1A
300491	EPILEPSY, X-LINKED 1, WITH VARIABLE LEARNING DISABILITIES AND BEHAVIOR DISORDERS; EPILX1
300492	FAMILY WITH SEQUENCE SIMILARITY 3, MEMBER A; FAM3A
300493	SPERM PROTEIN ASSOCIATED WITH THE NUCLEUS, X CHROMOSOME, FAMILY MEMBER A2; SPANXA2
300494	MOVED TO 300425
300495	AUTISM, SUSCEPTIBILITY TO, X-LINKED 2; AUTSX2
300496	AUTISM, SUSCEPTIBILITY TO, X-LINKED 3; AUTSX3
300497	MOVED TO 300495
300498	INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 45; XLID45
300499	FTSJ RNA 2-PRIME-O-METHYLTRANSFERASE 1; FTSJ1
300500	ALBINISM, OCULAR, TYPE I; OA1
300501	MOVED TO 309549
300502	PYRUVATE DEHYDROGENASE, ALPHA-1; PDHA1
300503	MOVED TO 300419
300504	MOVED TO 300419
300505	INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 84; XLID84
300506	TSC22 DOMAIN FAMILY, MEMBER 3; TSC22D3
300507	H2B HISTONE FAMILY, MEMBER W, TESTIS-SPECIFIC; H2BFWT
300508	UTP14A SMALL SUBUNIT PROCESSOME COMPONENT; UTP14A
300509	DYSLEXIA, SUSCEPTIBILITY TO, 9; DYX9
300510	OVARIAN DYSGENESIS 2; ODG2
300511	PREMATURE OVARIAN FAILURE 2A; POF2A
300512	WD REPEAT-CONTAINING PROTEIN 13; WDR13
300513	G PROTEIN-COUPLED RECEPTOR 119; GPR119
300514	FANCONI ANEMIA, COMPLEMENTATION GROUP B; FANCB
300515	FANCB GENE; FANCB
300516	ATPase, CLASS VI, TYPE 11C; ATP11C
300517	SPINDLIN FAMILY, MEMBER 2B; SPIN2B
300518	INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 82; XLID82
300519	MARTIN-PROBST SYNDROME; MRXSMP
300520	CLAUDIN 2; CLDN2
300521	KINESIN FAMILY MEMBER 4A; KIF4A
300522	IQ MOTIF- AND SEC7 DOMAIN-CONTAINING PROTEIN 2; IQSEC2
300523	ALLAN-HERNDON-DUDLEY SYNDROME; AHDS
300524	NEURITE EXTENSION AND MIGRATION FACTOR; NEXMIF
300525	PYRIMIDINERGIC RECEPTOR P2Y, G PROTEIN-COUPLED, 8; P2RY8
300526	WD REPEAT-CONTAINING PROTEIN 45; WDR45
300527	NUDIX HYDROLASE 10; NUDT10
300528	NUDIX HYDROLASE 11; NUDT11
300529	PURINERGIC RECEPTOR P2Y, G PROTEIN-COUPLED, 10; P2RY10
300530	MOVED TO 611775
300531	SPROUTY RTK SIGNALING ANTAGONIST 3; SPRY3
300532	VARIABLY CHARGED, X CHROMOSOME, 2; VCX2
300533	VARIABLY CHARGED, X CHROMOSOME, 3A; VCX3A
300534	INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED, SYNDROMIC, CLAES-JENSEN TYPE; MRXSCJ
300535	OCRL INOSITOL POLYPHOSPHATE-5-PHOSPHATASE; OCRL
300536	BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS 4; BMND4
300537	MOVED TO 300049
300538	ARGININE VASOPRESSIN RECEPTOR 2; AVPR2
300539	NEPHROGENIC SYNDROME OF INAPPROPRIATE ANTIDIURESIS; NSIAD
300540	HAUS AUGMIN-LIKE COMPLEX, SUBUNIT 7; HAUS7
300541	SARCOMA, SYNOVIAL, X BREAKPOINT 6; SSX6
300542	SARCOMA, SYNOVIAL, X BREAKPOINT 7; SSX7
300543	SARCOMA, SYNOVIAL, X BREAKPOINT 8; SSX8
300544	SARCOMA, SYNOVIAL, X BREAKPOINT 9; SSX9
300545	HEPARAN SULFATE 6-O-SULFOTRANSFERASE 2; HS6ST2
300546	FYVE, RhoGEF, AND PH DOMAIN-CONTAINING PROTEIN 1; FGD1
300547	SERINE/THREONINE KINASE 26; STK26
300548	MELANOMA ANTIGEN, FAMILY H, 1; MAGEH1
300549	MELANOMA ANTIGEN, FAMILY A, 2B; MAGEA2B
300550	PHOSPHATE-REGULATING ENDOPEPTIDASE, X-LINKED; PHEX
300551	MOVED TO 309530
300552	MIDLINE 1; MID1
300553	BROMODOMAIN- AND WD REPEAT-CONTAINING PROTEIN 3; BRWD3
300554	HYPOPHOSPHATEMIC RICKETS, X-LINKED RECESSIVE
300555	DENT DISEASE 2; DENT2
300556	ATPase, H+ TRANSPORTING, LYSOSOMAL, ACCESSORY PROTEIN 2; ATP6AP2
300557	PARKINSON DISEASE 12; PARK12
300558	INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 30; XLID30
300559	GLYCOGEN STORAGE DISEASE IXd; GSD9D
300560	PHD FINGER PROTEIN 8; PHF8
300561	SLIT- AND NTRK-LIKE FAMILY, MEMBER 2; SLITRK2
300562	SLIT- AND NTRK-LIKE FAMILY, MEMBER 4; SLITRK4
300563	MOVED TO 311070
300564	TSPY-LIKE 2; TSPYL2
300565	MOVED TO 300561
300566	LHFPL TETRASPAN SUBFAMILY, MEMBER 1; LHFPL1
300567	PHOSPHOGLYCERATE MUTASE FAMILY MEMBER 4; PGAM4
300568	MICRO RNA 221; MIR221
300569	MICRO RNA 222; MIR222
300570	TRANSCRIPTION FACTOR YY2; YY2
300571	MOVED TO 615465
300572	ADHESION G PROTEIN-COUPLED RECEPTOR G2; ADGRG2
300573	ZINC FINGER PROTEIN 674; ZNF674
300574	CHEMOKINE, CXC MOTIF, RECEPTOR 3; CXCR3
300575	RIPPLY TRANSCRIPTIONAL REPRESSOR 1; RIPPLY1
300576	ZINC FINGER DHHC DOMAIN-CONTAINING PROTEIN 15; ZDHHC15
300577	INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 91; XLID91
300578	CHROMOSOME Xp11.3 DELETION SYNDROME
300579	SHROOM FAMILY MEMBER 4; SHROOM4
300580	MYOPATHY, CONGENITAL, WITH FIBER-TYPE DISPROPORTION, X-LINKED; CFTDX
300581	FG SYNDROME 5; FGS5
300582	SHORT STATURE, IDIOPATHIC, X-LINKED; ISS
300583	VESTIGIAL-LIKE 1; VGLL1
300584	MOVED TO 300636
300585	ZINC FINGER PROTEIN 673; ZNF673
300586	ARYLSULFATASE H; ARSH
300587	MALIGNANT T-CELL AMPLIFIED SEQUENCE 1; MCTS1
300588	TENEURIN TRANSMEMBRANE PROTEIN 1; TENM1
300589	NYSTAGMUS 5, CONGENITAL, X-LINKED; NYS5
300590	CORNELIA DE LANGE SYNDROME 2; CDLS2
300591	STATURE QUANTITATIVE TRAIT LOCUS 6; STQTL6
300592	CANCER/TESTIS ANTIGEN FAMILY 47, MEMBER A11; CT47A11
300593	SPERM ACROSOME-ASSOCIATED PROTEIN 5; SPACA5
300594	G ANTIGEN 1; GAGE1
300595	G ANTIGEN 2C; GAGE2C
300596	G ANTIGEN 3; GAGE3
300597	G ANTIGEN 4; GAGE4
300598	G ANTIGEN 5; GAGE5
300599	G ANTIGEN 6; GAGE6
300600	ALAND ISLAND EYE DISEASE; AIED
300601	G ANTIGEN 7; GAGE7
300602	MOVED TO 617752
300603	POF1B ACTIN-BINDING PROTEIN; POF1B
300604	PREMATURE OVARIAN FAILURE 2B; POF2B
300605	RETINITIS PIGMENTOSA 34; RP34
300606	MOVED TO 313500
300607	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 8; DEE8
300608	DACHSHUND FAMILY TRANSCRIPTION FACTOR 2; DACH2
300609	MSL COMPLEX SUBUNIT 3; MSL3
300610	HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN H2; HNRNPH2
300611	C1GALT1-SPECIFIC CHAPERONE 1; C1GALT1C1
300612	MOVED TO 309590
300613	MYOPIA 13, X-LINKED; MYP13
300614	DEAFNESS, X-LINKED 5, WITH PERIPHERAL NEUROPATHY; DFNX5
300615	BRUNNER SYNDROME; BRNRS
300616	LEUCINE ZIPPER PROTEIN 4; LUZP4
300617	BRCA1/BRCA2-CONTAINING COMPLEX, SUBUNIT 3; BRCC3
300618	PHD FINGER PROTEIN 16; PHF16
300619	CATARACT, ATAXIA, SHORT STATURE, AND IMPAIRED INTELLECTUAL DEVELOPMENT
300620	V-SET AND IMMUNOGLOBULIN DOMAINS-CONTAINING PROTEIN 1; VSIG1
300621	SPINDLIN FAMILY, MEMBER 2A; SPIN2A
300622	TN POLYAGGLUTINATION SYNDROME; TNPS
300623	FRAGILE X TREMOR/ATAXIA SYNDROME; FXTAS
300624	FRAGILE X SYNDROME; FXS
300625	CANCER/TESTIS ANTIGEN 83; CT83
300626	ANKYRIN REPEAT- AND SOCS BOX-CONTAINING PROTEIN 11; ASB11
300627	ZINC FINGER PROTEIN 449; ZNF449
300628	FERM DOMAIN-CONTAINING PROTEIN 7; FRMD7
300629	ADAPTOR-RELATED PROTEIN COMPLEX 1, SIGMA-2 SUBUNIT; AP1S2
300630	MOVED TO 304340
300631	COLLECTRIN, AMINO ACID TRANSPORT REGULATOR; CLTRN
300632	PDZ DOMAIN-CONTAINING 11; PDZD11
300633	HYPOSPADIAS 1, X-LINKED; HYSP1
300634	PDZ DOMAIN-CONTAINING 4; PDZD4
300635	LYMPHOPROLIFERATIVE SYNDROME, X-LINKED, 2; XLP2
300636	IMMUNODEFICIENCY 33; IMD33
300637	G ANTIGEN 12I; GAGE12I
300638	G ANTIGEN 8; GAGE8
300639	MOVED TO 300354
300640	MOVED TO 300636
300641	SOLUTE CARRIER FAMILY 25, MEMBER 43; SLC25A43
300642	SUSHI REPEAT-CONTAINING PROTEIN, X-LINKED, 2; SRPX2
300643	ROLANDIC EPILEPSY, IMPAIRED INTELLECTUAL DEVELOPMENT, AND SPEECH DYSPRAXIA, X-LINKED; RESDX
300644	GALACTOSIDASE, ALPHA; GLA
300645	IMMUNODEFICIENCY 34; IMD34
300646	ZINC FINGER DHHC DOMAIN-CONTAINING PROTEIN 9; ZDHHC9
300647	APC MEMBRANE RECRUITMENT PROTEIN 1; AMER1
300648	CANCER/TESTIS ANTIGEN FAMILY 45, MEMBER A1; CT45A1
300649	SOLUTE CARRIER FAMILY 38 (AMINO ACID TRANSPORTER), MEMBER 5; SLC38A5
300650	ALBINISM, OCULAR, WITH LATE-ONSET SENSORINEURAL DEAFNESS; OASD
300651	PORCUPINE O-ACYLTRANSFERASE; PORCN
300652	ANGIOMA SERPIGINOSUM, X-LINKED
300653	PHOSPHOGLYCERATE KINASE 1 DEFICIENCY
300654	FATTY ACID AMIDE HYDROLASE 2; FAAH2
300655	KELCH-LIKE 13; KLHL13
300656	URACIL PHOSPHORIBOSYLTRANSFERASE HOMOLOG; UPRT
300657	CANCER/TESTIS ANTIGEN 1A; CTAG1A
300658	NORRIN CYSTINE KNOT GROWTH FACTOR NDP; NDP
300659	INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 93; XLID93
300660	MOVED TO 300232
300661	PHOSPHORIBOSYLPYROPHOSPHATE SYNTHETASE SUPERACTIVITY
300662	SMALL NUCLEOLAR RNA, H/ACA BOX, 11; SNORA11
300663	AUTOPHAGY-RELATED 4A CYSTEINE PEPTIDASE; ATG4A
300664	SPANX FAMILY, MEMBER N1; SPANXN1
300665	SPANX FAMILY, MEMBER N2; SPANXN2
300666	SPANX FAMILY, MEMBER N3; SPANXN3
300667	SPANX FAMILY, MEMBER N4; SPANXN4
300668	SPANX FAMILY, MEMBER N5; SPANXN5
300669	SPANX FAMILY, MEMBER B1; SPANXB1
300670	SPANX FAMILY, MEMBER D; SPANXD
300671	MOVED TO 300670
300672	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 2; DEE2
300673	ENCEPHALOPATHY, NEONATAL SEVERE, DUE TO MECP2 MUTATIONS
300674	MOTILE SPERM DOMAIN-CONTAINING PROTEIN 1; MOSPD1
300675	PARANEOPLASTIC MA ANTIGEN 3; PNMA3
300676	INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED, SYNDROMIC 14; MRXS14
300677	TAXILIN, GAMMA; TXLNG
300678	DUAL-SPECIFICITY PHOSPHATASE 21; DUSP21
300679	CHROMOSOME Xp21 DELETION SYNDROME
300680	PREGNANCY-UPREGULATED, NONUBIQUITOUS, CAM KINASE; PNCK
300681	DEDICATOR OF CYTOKINESIS 11; DOCK11
300682	MICRO RNA 424; MIR424
300683	SEPTIN 6; SEPT6
300684	X KELL BLOOD GROUP PRECURSOR-RELATED, X-LINKED; XKRX
300685	PROLINE-RICH GAMMA-CARBOXYGLUTAMIC ACID PROTEIN 3; PRRG3
300686	MICRO RNA 448; MIR448
300687	ERCC EXCISION REPAIR 6-LIKE, SPINDLE ASSEMBLY CHECKPOINT HELICASE; ERCC6L
300688	BCL6 COREPRESSOR-LIKE 1; BCORL1
300689	START DOMAIN-CONTAINING PROTEIN 8; STARD8
300690	BRAIN-EXPRESSED X-LINKED GENE 1; BEX1
300691	BRAIN-EXPRESSED X-LINKED GENE 2; BEX2
300692	BEX FAMILY MEMBER 4; BEX4
300693	BEX FAMILY MEMBER 5; BEX5
300694	MICRO RNA 223; MIR223
300695	SCAPULOPERONEAL MYOPATHY, X-LINKED DOMINANT; SPM
300696	MYOPATHY, X-LINKED, WITH POSTURAL MUSCLE ATROPHY; XMPMA
300697	HECT, UBA, AND WWE DOMAINS-CONTAINING PROTEIN 1; HUWE1
300698	TRANSMEMBRANE PROTEIN 47; TMEM47
300699	INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED, SYNDROMIC, WU TYPE; MRXSW
300700	ALBINISM-DEAFNESS SYNDROME; ADFN
300701	ZINC FINGER CCHC DOMAIN-CONTAINING PROTEIN 12; ZCCHC12
300702	MELANOMA ANTIGEN, FAMILY D, 4; MAGED4
300703	SPINOCEREBELLAR ATAXIA, X-LINKED 5; SCAX5
300704	PROSTATE CANCER, HEREDITARY, X-LINKED 2; HPCX2
300705	CHROMOSOME Xp11.22 DUPLICATION SYNDROME
300706	MOVED TO 309590
300707	TOE SYNDACTYLY, TELECANTHUS, AND ANOGENITAL AND RENAL MALFORMATIONS; STAR
300708	CYCLIN Q; CCNQ
300709	INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED, SYNDROMIC 9; MRXS9
300710	ALOPECIA, ANDROGENETIC, 2; AGA2
300711	PYLORIC STENOSIS, INFANTILE HYPERTROPHIC, 4; IHPS4
300712	CRANIOFACIOSKELETAL SYNDROME
300713	OTU DOMAIN-CONTAINING PROTEIN 5; OTUD5
300714	OTU DOMAIN-CONTAINING PROTEIN 6A; OTUD6A
300715	MAGNESIUM TRANSPORTER 1; MAGT1
300716	INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 95; XLID95
300717	REDUCING BODY MYOPATHY, X-LINKED 1A, SEVERE, WITH INFANTILE OR EARLY CHILDHOOD ONSET; RBMX1A
300718	REDUCING BODY MYOPATHY, X-LINKED 1B, WITH LATE CHILDHOOD OR ADULT ONSET; RBMX1B
300719	DEAFNESS, CATARACT, RETINITIS PIGMENTOSA, AND SPERM ABNORMALITIES
300720	G ANTIGEN 2A; GAGE2A
300721	MICRO RNA LET7F2; MIRLET7F2
300722	MICRO RNA 19B2; MIR19B2
300723	SYNAPTOTAGMIN-LIKE 4; SYTL4
300724	CONNECTOR ENHANCER OF KINASE SUPPRESSOR OF RAS 2; CNKSR2
300725	RAS-RELATED GTP-BINDING PROTEIN B; RRAGB
300726	G ANTIGEN 2B; GAGE2B
300727	G ANTIGEN 12C; GAGE12C
300728	G ANTIGEN 12D; GAGE12D
300729	G ANTIGEN 12E; GAGE12E
300730	G ANTIGEN 12F; GAGE12F
300731	G ANTIGEN 12G; GAGE12G
300732	G ANTIGEN 12H; GAGE12H
300733	G ANTIGEN 12J; GAGE12J
300734	G ANTIGEN 13; GAGE13
300735	G ANTIGEN 2D; GAGE2D
300736	G ANTIGEN 2E; GAGE2E
300737	G ANTIGEN 10; GAGE10
300738	P ANTIGEN FAMILY, MEMBER 2; PAGE2
300739	P ANTIGEN FAMILY, MEMBER 3; PAGE3
300740	X ANTIGEN FAMILY, MEMBER 3; XAGE3
300741	FAMILY WITH SEQUENCE SIMILARITY 120, MEMBER C; FAM120C
300742	X ANTIGEN FAMILY, MEMBER 1A; XAGE1A
300743	MOVED TO 300742
300744	MOVED TO 300289
300745	MOVED TO 300289
300746	COAGULATION FACTOR IX; F9
300747	STEROID SULFATASE; STS
300748	G PROTEIN-COUPLED RECEPTOR 82; GPR82
300749	INTELLECTUAL DEVELOPMENTAL DISORDER WITH MICROCEPHALY AND PONTINE AND CEREBELLAR HYPOPLASIA; MICPCH
300750	SPASTIC PARAPLEGIA 34, X-LINKED; SPG34
300751	ANEMIA, SIDEROBLASTIC, 1; SIDBA1
300752	PROTOPORPHYRIA, ERYTHROPOIETIC, X-LINKED; XLEPP
300753	APOLIPOPROTEIN O; APOO
300754	TAF9B RNA POLYMERASE II, TATA BOX-BINDING PROTEIN-ASSOCIATED FACTOR, 31-KD; TAF9B
300755	AGAMMAGLOBULINEMIA, X-LINKED; XLA
300756	ALZHEIMER DISEASE 16; AD16
300757	RP2 ACTIVATOR OF ARL3 GTPase; RP2
300758	HYPOSPADIAS 2, X-LINKED; HYSP2
300759	MELANOMA ANTIGEN, FAMILY E, 1; MAGEE1
300760	MELANOMA ANTIGEN, FAMILY E, 2; MAGEE2
300761	MELANOMA ANTIGEN, FAMILY B, 10; MAGEB10
300762	MELANOMA ANTIGEN, FAMILY B, 16; MAGEB16
300763	MELANOMA ANTIGEN, FAMILY B, 17; MAGEB17
300764	MELANOMA ANTIGEN, FAMILY A, 9B; MAGEA9B
300765	MELANOMA ANTIGEN, FAMILY D, 4B; MAGED4B
300766	NFKB-ACTIVATING PROTEIN; NKAP
300767	REPLICATION PROTEIN A4; RPA4
300768	CYLICIN 1; CYLC1
300769	MICRO RNA 224; MIR224
300770	SURFACTANT METABOLISM DYSFUNCTION, PULMONARY, 4; SMDP4
300771	TRANSCRIPTION ELONGATION FACTOR A-LIKE 7; TCEAL7
300772	TRANSCRIPTION FACTOR DP FAMILY, MEMBER 3; TFDP3
300773	APEX NUCLEASE (APURINIC/APYRIMIDINIC ENDONUCLEASE) 2; APEX2
300774	RAB39B, MEMBER RAS ONCOGENE FAMILY; RAB39B
300775	E74-LIKE ETS TRANSCRIPTION FACTOR 4; ELF4
300776	ALG13 UDP-N-ACETYLGLUCOSAMINYLTRANSFERASE SUBUNIT; ALG13
300777	EPSILON-TRIMETHYLLYSINE HYDROXYLASE; TMLHE
300778	MOVED TO 620763
300779	CORNEAL DYSTROPHY, ENDOTHELIAL, X-LINKED; XECD
300780	CANCER/TESTIS ANTIGEN FAMILY 47, MEMBER A1; CT47A1
300781	CANCER/TESTIS ANTIGEN FAMILY 47, MEMBER A2; CT47A2
300782	CANCER/TESTIS ANTIGEN FAMILY 47, MEMBER A3; CT47A3
300783	CANCER/TESTIS ANTIGEN FAMILY 47, MEMBER A4; CT47A4
300784	CANCER/TESTIS ANTIGEN FAMILY 47, MEMBER A5; CT47A5
300785	CANCER/TESTIS ANTIGEN FAMILY 47, MEMBER A6; CT47A6
300786	CANCER/TESTIS ANTIGEN FAMILY 47, MEMBER A7; CT47A7
300787	CANCER/TESTIS ANTIGEN FAMILY 47, MEMBER A8; CT47A8
300788	CANCER/TESTIS ANTIGEN FAMILY 47, MEMBER A9; CT47A9
300789	CANCER/TESTIS ANTIGEN FAMILY 47, MEMBER A10; CT47A10
300790	CANCER/TESTIS ANTIGEN FAMILY 47, MEMBER B1; CT47B1
300791	NIK-RELATED KINASE; NRK
300792	MICRO RNA 106A; MIR106A
300793	CANCER/TESTIS ANTIGEN FAMILY 45, MEMBER A2; CT45A2
300794	CANCER/TESTIS ANTIGEN FAMILY 45, MEMBER A3; CT45A3
300795	CANCER/TESTIS ANTIGEN FAMILY 45, MEMBER A4; CT45A4
300796	CANCER/TESTIS ANTIGEN FAMILY 45, MEMBER A5; CT45A5
300797	CANCER/TESTIS ANTIGEN FAMILY 45, MEMBER A6; CT45A6
300798	PHOSPHORYLASE KINASE, LIVER, ALPHA-2 SUBUNIT; PHKA2
300799	INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED, SYNDROMIC, RAYMOND TYPE; MRXSR
300800	MOVED TO 103580
300801	CHROMOSOME Xp11.23-p11.22 DUPLICATION SYNDROME
300802	INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 96; XLID96
300803	INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 97; XLID97
300804	JOUBERT SYNDROME 10; JBTS10
300805	FMR1 ANTISENSE RNA 1; FMR1AS1
300806	ALF TRANSCRIPTION ELONGATION FACTOR 2; AFF2
300807	THROMBOPHILIA, X-LINKED, DUE TO FACTOR IX DEFECT; THPH8
300808	G PROTEIN-COUPLED RECEPTOR 143; GPR143
300809	SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO, 15; SLEB15
300810	MICRO RNA 98; MIR98
300811	MICRO RNA 105-1; MIR105-1
300812	MICRO RNA 105-2; MIR105-2
300813	SARCOMA, SYNOVIAL
300814	NYSTAGMUS 6, CONGENITAL, X-LINKED; NYS6
300815	CHROMOSOME Xq28 DUPLICATION SYNDROME
300816	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 6; COXPD6
300817	EF-HAND DOMAIN (C-TERMINAL)-CONTAINING PROTEIN 2; EFHC2
300818	PAROXYSMAL NOCTURNAL HEMOGLOBINURIA 1; PNH1
300819	ZINC FINGER PROTEIN 630; ZNF630
300820	MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE 15; MAP3K15
300821	OPSIN 1, MEDIUM-WAVE-SENSITIVE; OPN1MW
300822	OPSIN 1, LONG-WAVE-SENSITIVE; OPN1LW
300823	IDURONATE 2-SULFATASE; IDS
300824	OPN1LW AND OPN1MW GENES, CONTROLLER OF
300825	RETINOBLASTOMA-BINDING PROTEIN 7; RBBP7
300826	STROMAL ANTIGEN 2; STAG2
300827	FIBROBLAST GROWTH FACTOR 16; FGF16
300828	PATCHED DOMAIN-CONTAINING PROTEIN 1; PTCHD1
300829	CARDIOMYOPATHY, FATAL FETAL, DUE TO MYOCARDIAL CALCIFICATION
300830	AUTISM, SUSCEPTIBILITY TO, X-LINKED 4; AUTSX4
300831	CK SYNDROME; CKS
300832	JUST PROXIMAL TO XIST; JPX
300833	46,XX SEX REVERSAL 3; SRXX3
300834	MACULAR DEGENERATION, ATROPHIC, X-LINKED
300835	ANEMIA, X-LINKED, WITH OR WITHOUT NEUTROPENIA AND/OR PLATELET ABNORMALITIES; XLANP
300836	ANOSMIN 1; ANOS1
300837	DIACYLGLYCEROL KINASE, KAPPA, 142-KD; DGKK
300838	FERM AND PDZ DOMAINS-CONTAINING PROTEIN 4; FRMPD4
300839	RETINOSCHISIN; RS1
300840	PRA1 DOMAIN FAMILY, MEMBER 2; PRAF2
300841	COAGULATION FACTOR VIII; F8
300842	MCLEOD SYNDROME; MCLDS
300843	BORNHOLM EYE DISEASE; BED
300844	INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 19; XLID19
300845	MOYAMOYA DISEASE 4 WITH SHORT STATURE, HYPERGONADOTROPIC HYPOGONADISM, AND FACIAL DYSMORPHISM; MYMY4
300846	CD99 ANTIGEN-LIKE 2; CD99L2
300847	AUTISM, SUSCEPTIBILITY TO, X-LINKED 5; AUTSX5
300848	INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 89; XLID89
300849	INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 41; XLID41
300850	INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 90; XLID90
300851	INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 92; XLID92
300852	INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 88; XLID88
300853	IMMUNODEFICIENCY, X-LINKED, WITH MAGNESIUM DEFECT, EPSTEIN-BARR VIRUS INFECTION, AND NEOPLASIA; XMEN
300854	RENAL CELL CARCINOMA, Xp11-ASSOCIATED; RCCX1
300855	OGDEN SYNDROME; OGDNS
300856	HYPOSPADIAS 4, X-LINKED, SUSCEPTIBILITY TO; HYSP4
300857	AMYOTROPHIC LATERAL SCLEROSIS 15 WITH OR WITHOUT FRONTOTEMPORAL DEMENTIA; ALS15
300858	INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED, SYNDROMIC 17; MRXS17
300859	COILED-COIL DOMAIN-CONTAINING PROTEIN 22; CCDC22
300860	INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED, SYNDROMIC, NASCIMENTO TYPE; MRXSN
300861	INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED, SYNDROMIC, CHUDLEY-SCHWARTZ TYPE; MRXSCS
300862	ACYL-CoA THIOESTERASE 9; ACOT9
300863	CHONDRODYSPLASIA WITH PLATYSPONDYLY, DISTINCTIVE BRACHYDACTYLY, HYDROCEPHALY, AND MICROPHTHALMIA
300864	CEREBRAL-CEREBELLAR-COLOBOMA SYNDROME, X-LINKED
300865	MICRO RNA 503; MIR503
300866	MICRO RNA 510; MIR510
300867	KABUKI SYNDROME 2; KABUK2
300868	MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 2; MCAHS2
300869	CHROMOSOME Xq27.3-q28 DUPLICATION SYNDROME
300870	ANEURYSM, INTRACRANIAL BERRY, 5; ANIB5
300871	FUN14 DOMAIN-CONTAINING PROTEIN 1; FUNDC1
300872	AUTISM, SUSCEPTIBILITY TO, X-LINKED 6; AUTSX6
300873	GUANINE NUCLEOTIDE-BINDING PROTEIN-LIKE 3-LIKE PROTEIN; GNL3L
300874	MICRO RNA 508; MIR508
300875	MICRO RNA 509-1; MIR509-1
300876	MICRO RNA 509-3; MIR509-3
300877	MICRO RNA 506; MIR506
300878	DOUBLESEX- AND MAB3-RELATED TRANSCRIPTION FACTOR C1; DMRTC1
300879	XG GLYCOPROTEIN; XG
300880	PROTEASOME 26S SUBUNIT, NON-ATPase, 10; PSMD10
300881	MOVED TO 615777
300882	CORNELIA DE LANGE SYNDROME 5; CDLS5
300883	SORTING NEXIN 12; SNX12
300884	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 36; DEE36
300885	CYTOCHROME c OXIDASE, SUBUNIT 7B; COX7B
300886	INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED, SYNDROMIC 32; MRXS32
300887	LINEAR SKIN DEFECTS WITH MULTIPLE CONGENITAL ANOMALIES 2; LSDMCA2
300888	HYPOTHYROIDISM, CENTRAL, WITH TESTICULAR ENLARGEMENT; CHTE
300889	ZINC FINGER CCCH DOMAIN-CONTAINING PROTEIN 12B; ZC3H12B
300890	ANKYRIN REPEAT- AND SOCS BOX-CONTAINING PROTEIN 9; ASB9
300891	ANKYRIN REPEAT- AND SOCS BOX-CONTAINING PROTEIN 12; ASB12
300892	LONG INTERGENIC NONCODING RNA 850; LINC00850
300893	MICRO RNA 502; MIR502
300894	NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 5; NBIA5
300895	OHDO SYNDROME, X-LINKED; OHDOX
300896	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIm; CDG2M
300897	ZINC FINGER C4H2 DOMAIN-CONTAINING PROTEIN; ZC4H2
300898	CDR1 ANTISENSE RNA ; CDR1AS
300899	RIBOSOMAL PROTEIN L39; RPL39
300900	REMOVED FROM DATABASE
300901	X-ACTIVE-SPECIFIC NONCODING TRANSCRIPT; XACT
300902	RIBOSOMAL PROTEIN L36A; RPL36A
300903	G PROTEIN-COUPLED RECEPTOR 174; GPR174
300904	INSULIN RECEPTOR SUBSTRATE 4; IRS4
300905	CHARCOT-MARIE-TOOTH DISEASE, X-LINKED DOMINANT, 6; CMTX6
300906	PYRUVATE DEHYDROGENASE KINASE, ISOENZYME 3; PDK3
300907	CLEAVAGE STIMULATION FACTOR, 3-PRIME PRE-RNA, SUBUNIT 2, 64-KD; CSTF2
300908	ANEMIA, NONSPHEROCYTIC HEMOLYTIC, DUE TO G6PD DEFICIENCY
300909	ANGIOEDEMA INDUCED BY ACE INHIBITORS, SUSCEPTIBILITY TO; AEACEI
300910	BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS 18; BMND18
300911	PARKINSONISM WITH SPASTICITY, X-LINKED; XPDS
300912	INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 98; XLID98
300913	VACUOLAR ATPase ASSEMBLY FACTOR VMA21; VMA21
300914	DEAFNESS, X-LINKED 6; DFNX6
300915	MICROPHTHALMIA, SYNDROMIC 13; MCOPS13
300916	PARANEOPLASTIC MA ANTIGEN FAMILY, MEMBER 5; PNMA5
300917	PARANEOPLASTIC MA ANTIGEN FAMILY, MEMBER 6A; PNMA6A
300918	OLMSTED SYNDROME, X-LINKED; OLMSX
300919	INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 99; XLID99
300920	ATAXIN 3-LIKE; ATXN3L
300921	BASIC HELIX-LOOP-HELIX DOMAIN-CONTAINING PROTEIN, CLASS B, 9; BHLHB9
300922	CYSTEINE-RICH HYDROPHOBIC DOMAIN PROTEIN 1; CHIC1
300923	INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 100; XLID100
300924	ACYL-CoA WAX ALCOHOL ACYLTRANSFERASE 1; AWAT1
300925	ACYL-CoA WAX ALCOHOL ACYLTRANSFERASE 2; AWAT2
300926	DIACYLGLYCEROL O-ACYLTRANSFERASE 2-LIKE 6; DGAT2L6
300927	PEROXIREDOXIN 4; PRDX4
300928	INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 101; XLID101
300929	MICRO RNA 718; MIR718
300930	MAP7 DOMAIN-CONTAINING PROTEIN 3; MAP7D3
300931	PIRIN; PIR
300932	THYROXINE-BINDING GLOBULIN QUANTITATIVE TRAIT LOCUS; TBGQTL
300933	PIH1 DOMAIN-CONTAINING PROTEIN 3; PIH1D3
300934	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Iy; CDG1Y
300935	PROLINE-RICH GAMMA-CARBOXYGLUTAMIC ACID PROTEIN 1; PRRG1
300936	FTX TRANSCRIPT, XIST REGULATOR, NONCODING; FTX
300937	RHO GTPase-ACTIVATING PROTEIN 36; ARHGAP36
300938	MATRIX REMODELING-ASSOCIATED PROTEIN 5; MXRA5
300939	THYMOSIN, BETA-15A; TMSB15A
300940	GLYCEROPHOSPHODIESTER PHOSPHODIESTERASE DOMAIN-CONTAINING PROTEIN 2; GDPD2
300941	SOLUTE CARRIER FAMILY 25, MEMBER 53; SLC25A53
300942	CHROMOSOME Xq26.3 DUPLICATION SYNDROME
300943	PITUITARY ADENOMA 2, GROWTH HORMONE-SECRETING; PITA2
300944	CSAG FAMILY, MEMBER 1; CSAG1
300945	TSR2 RIBOSOME MATURATION FACTOR; TSR2
300946	DIAMOND-BLACKFAN ANEMIA 14 WITH MANDIBULOFACIAL DYSOSTOSIS; DBA14
300947	COILED-COIL DOMAIN-CONTAINING PROTEIN 120; CCDC120
300948	PHOSPHATE CYTIDYLYLTRANSFERASE 1, CHOLINE, BETA ISOFORM; PCYT1B
300949	FORKHEAD BOX R2; FOXR2
300950	MICRO RNA 20B; MIR20B
300951	RING FINGER PROTEIN 113A; RNF113A
300952	LINEAR SKIN DEFECTS WITH MULTIPLE CONGENITAL ANOMALIES 3; LSDMCA3
300953	TRICHOTHIODYSTROPHY 5, NONPHOTOSENSITIVE; TTD5
300954	ENDOTHELIUM- AND LYMPHOCYTE-ASSOCIATED ASCH DOMAIN 1; EOLA1
300955	APOLIPOPROTEIN O-LIKE; APOOL
300956	BRAF PSEUDOGENE 1; BRAFP1
300957	INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 12; XLID12
300958	INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED, SYNDROMIC, SNIJDERS BLOK TYPE; MRXSSB
300959	DIVERGENT PROTEIN KINASE DOMAIN 2B; DIPK2B
300960	MEND SYNDROME; MEND
300961	MID1-INTERACTING PROTEIN 1; MID1IP1
300962	GEM NUCLEAR ORGANELLE-ASSOCIATED PROTEIN 8; GEMIN8
300963	RITSCHER-SCHINZEL SYNDROME 2; RTSC2
300964	LAS1-LIKE RIBOSOME BIOGENESIS FACTOR; LAS1L
300965	RETROTRANSPOSON GAG DOMAIN-CONTAINING PROTEIN 1; RGAG1
300966	INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED, SYNDROMIC 33; MRXS33
300967	INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED, SYNDROMIC 34; MRXS34
300968	INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 99, SYNDROMIC, FEMALE-RESTRICTED; MRXS99F
300969	G PROTEIN-COUPLED RECEPTOR-ASSOCIATED SORTING PROTEIN 2; GPRASP2
300970	MORC FAMILY CW-TYPE ZINC FINGER PROTEIN 4; MORC4
300971	BARTTER SYNDROME, TYPE 5, ANTENATAL, TRANSIENT; BARTS5
300972	IMMUNODEFICIENCY 47; IMD47
300973	RHOX HOMEOBOX FAMILY MEMBER 1, PSEUDOGENE 1; RHOXF1P1
300974	PHOSPHOLIPASE C, PHOSPHATIDYLINOSITOL-SPECIFIC, X DOMAIN-CONTAINING PROTEIN 1; PLCXD1
300975	UBIQUITIN-SPECIFIC PROTEASE 27, X-LINKED; USP27X
300976	FAMILY WITH SEQUENCE SIMILARITY 46, MEMBER D; FAM46D
300977	SCHOLTE SYNDROME; SHLTS
300978	TONNE-KALSCHEUER SYNDROME; TOKAS
300979	CHROMOSOME Xq25 DUPLICATION SYNDROME
300980	KELCH-LIKE 15; KLHL15
300981	VARIABLY CHARGED, X CHROMOSOME, 3B; VCX3B
300982	INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 103; XLID103
300983	INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 104; XLID104
300984	INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 105; XLID105
300985	VAS DEFERENS, CONGENITAL BILATERAL APLASIA OF, X-LINKED; CBAVDX
300986	INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED, SYNDROMIC, BAIN TYPE; MRXSB
300987	MOVED TO 300148
300988	IMMUNODEFICIENCY 50; IMD50
300989	MEESTER-LOEYS SYNDROME; MRLS
300990	MIDFACE HYPOPLASIA, HEARING IMPAIRMENT, ELLIPTOCYTOSIS, AND NEPHROCALCINOSIS; MFHIEN
300991	CILIARY DYSKINESIA, PRIMARY, 36, X-LINKED; CILD36
300992	NEGATIVE REGULATOR OF P-BODY ASSOCIATION; NBDY
300993	PAS DOMAIN-CONTAINING REPRESSOR 1; PASD1
300994	HIGHLY DIVERGENT HOMEOBOX; HDX
300995	KIAA1210 GENE; KIAA1210
300996	YIP1 DOMAIN FAMILY, MEMBER 6; YIPF6
300997	INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 106; XLID106
300998	INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED, SYNDROMIC 35; MRXS35
300999	FUNCTIONAL INTERGENIC REPEATING RNA ELEMENT; FIRRE
301000	WISKOTT-ALDRICH SYNDROME; WAS
301001	DXZ4-ASSOCIATED NONCODING TRANSCRIPT 1, PROXIMAL; DANT1
301002	SRSF PROTEIN KINASE 3; SRPK3
301003	G-PATCH DOMAIN AND KOW MOTIFS; GPKOW
301004	DXZ4-ASSOCIATED NONCODING TRANSCRIPT 2, DISTAL; DANT2
301005	FERM- AND PDZ DOMAIN-CONTAINING PROTEIN 3; FRMPD3
301006	GALLOWAY-MOWAT SYNDROME 2, X-LINKED; GAMOS2
301007	ZINC FINGER, MATRIN-TYPE 1; ZMAT1
301008	INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED, SYNDROMIC, HOUGE TYPE; MRXSHG
301009	P ANTIGEN FAMILY, MEMBER 5; PAGE5
301010	MYOPIA 26, X-LINKED, FEMALE-LIMITED; MYP26
301011	THYMOSIN, BETA-15B; TMSB15B
301012	STING1 ER EXIT PROTEIN 1; STEEP1
301013	INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 107; XLID107
301014	OSTEOGENESIS IMPERFECTA, TYPE XIX; OI19
301015	HEMOLYTIC ANEMIA, CONGENITAL, X-LINKED; HACXL
301016	RAS-RELATED PROTEIN 2C; RAP2C
301017	PROTEIN PHOSPHATASE 1, REGULATORY SUBUNIT 2C; PPP1R2C
301018	DEAFNESS, X-LINKED 7; DFNX7
301019	KDM5C ADJACENT TRANSCRIPT, NONCODING; KANTR
301020	MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 12; MC1DN12
301021	MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 30; MC1DN30
301022	MULLEGAMA-KLEIN-MARTINEZ SYNDROME; MKMS
301023	MICRO RNA 532; MIR532
301024	INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 108; MRX108
301025	PAGANINI-MIOZZO SYNDROME; MRXSPM
301026	KEIPERT SYNDROME; KPTS
301027	TBC1 DOMAIN FAMILY, MEMBER 8B; TBC1D8B
301028	NEPHROTIC SYNDROME, TYPE 20; NPHS20
301029	SHUKLA-VERNON SYNDROME; SHUVER
301030	VAN ESCH-O'DRISCOLL SYNDROME; VEODS
301031	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Icc; CDG1CC
301032	BASILICATA-AKHTAR SYNDROME; MRXSBA
301033	HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 8; CHNG8
301034	DEHYDROGENASE/REDUCTASE, X-LINKED; DHRSX
301035	HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 9; CHNG9
301036	EZH INHIBITORY PROTEIN; EZHIP
301037	H2A.B VARIANT HISTONE 1; H2AB1
301038	H2A.B VARIANT HISTONE 2; H2AB2
301039	INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED, SYNDROMIC, HACKMANN-DI DONATO TYPE; MRXSHD
301040	ALPHA-THALASSEMIA/IMPAIRED INTELLECTUAL DEVELOPMENT SYNDROME, X-LINKED; ATRX
301041	WIEACKER-WOLFF SYNDROME, FEMALE-RESTRICTED; WRWFFR
301042	FUN14 DOMAIN-CONTAINING PROTEIN 2; FUNDC2
301043	HOLOPROSENCEPHALY 13, X-LINKED; HPE13
301044	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 85 WITH OR WITHOUT MIDLINE BRAIN DEFECTS; DEE85
301045	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIr; CDG2R
301046	ARMADILLO REPEAT-CONTAINING PROTEIN, X-LINKED 4; ARMCX4
301047	ARMADILLO REPEAT-CONTAINING PROTEIN, X-LINKED 5; ARMCX5
301048	ARMADILLO REPEAT-CONTAINING PROTEIN, X-LINKED 6; ARMCX6
301049	TLR ADAPTOR INTERACTING WITH ENDOLYSOSOMAL SLC15A4; TASL
301050	ALPORT SYNDROME 1, X-LINKED; ATS1
301051	IMMUNODEFICIENCY 74, COVID19-RELATED, X-LINKED; IMD74
301052	WARFARIN SENSITIVITY, X-LINKED
301053	MICRO RNA 505; MIR505
301054	VEXAS SYNDROME; VEXAS
301055	CPX CHROMOSOME REGION, CANDIDATE GENE 1; CPXCR1
301056	MULTIPLE CONGENITAL ANOMALIES-NEURODEVELOPMENTAL SYNDROME, X-LINKED; MCAND
301057	CILIA- AND FLAGELLA-ASSOCIATED PROTEIN 47; CFAP47
301058	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 90; DEE90
301059	SPERMATOGENIC FAILURE, X-LINKED, 3; SPGFX3
301060	AZOOSPERMIA, OBSTRUCTIVE, WITH NEPHROLITHIASIS; OAZON
301061	MYOTUBULARIN-RELATED PROTEIN 8; MTMR8
301062	MICRO RNA 766; MIR766
301063	X ANTIGEN FAMILY, MEMBER 5; XAGE5
301064	MELANOMA ANTIGEN, FAMILY B, 18; MAGEB18
301065	RAB40A, MEMBER RAS ONCOGENE FAMILY; RAB40A
301066	INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED, SYNDROMIC, WITH PIGMENTARY MOSAICISM AND COARSE FACIES; MRXSPF
301067	FAMILY WITH SEQUENCE SIMILARITY 47, MEMBER C; FAM47C
301068	HARDIKAR SYNDROME; HDKR
301069	CHROMOSOME Xq13 DUPLICATION SYNDROME
301070	WD REPEAT DOMAIN-CONTAINING PROTEIN 44; WDR44
301071	THROMBOPHILIA, X-LINKED, DUE TO FACTOR VIII DEFECT; THPH13
301072	NEURODEVELOPMENTAL DISORDER WITH EPILEPSY AND HEMOCHROMATOSIS; NEDEPH
301073	ATPase, NA+/K+ TRANSPORTING FAMILY, MEMBER BETA-4; ATP1B4
301074	AUTOINFLAMMATORY SYNDROME, FAMILIAL, X-LINKED, BEHCET-LIKE 2; AIFBL2
301075	MYOPATHY, DISTAL, 7, ADULT-ONSET, X-LINKED; MPD7
301076	INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED, SYNDROMIC, PILORGE TYPE; MRXSP
301077	SPERMATOGENIC FAILURE, X-LINKED, 4; SPGFX4
301078	IMMUNODEFICIENCY 98 WITH AUTOINFLAMMATION, X-LINKED; IMD98
301079	DEAD-BOX HELICASE 53; DDX53
301080	SYSTEMIC LUPUS ERYTHEMATOSUS 17; SLEB17
301081	AUTOINFLAMMATORY DISEASE, SYSTEMIC, X-LINKED; SAIDX
301082	IMMUNODEFICIENCY 102; IMD102
301083	ADENOSINE DEAMINASE, ELEVATED, HEMOLYTIC ANEMIA DUE TO; HAEADA
301084	TRANSCRIPTION ELONGATION FACTOR A N-TERMINAL AND CENTRAL DOMAIN-CONTAINING PROTEIN; TCEANC
301085	ADHESION G PROTEIN-COUPLED RECEPTOR G4; ADGRG4
301086	MOTILE SPERM DOMAIN-CONTAINING PROTEIN 2; MOSPD2
301087	FGF13 ANTISENSE RNA 1, NONCODING; FGF13AS1
301088	C-X9-C MOTIF-CONTAINING PROTEIN 4; CMC4
301089	WWC FAMILY, MEMBER 3; WWC3
301090	MOVED TO 273395
301091	EPILEPSY, X-LINKED 2, WITH OR WITHOUT IMPAIRED INTELLECTUAL DEVELOPMENT AND DYSMORPHIC FEATURES; EPILX2
301092	MICRO RNA 92A2; MIR92A2
301093	NHS-LIKE PROTEIN 2; NHSL2
301094	HIJAZI-REIS SYNDROME; HIJRS
301095	INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 110; XLID110
301096	CSAG FAMILY, MEMBER 2; CSAG2
301097	CSAG FAMILY, MEMBER 3; CSAG3
301098	MEMBRANE MAGNESIUM TRANSPORTER 1; MMGT1
301099	SPERMATOGENIC FAILURE, X-LINKED, 5; SPGFX5
301100	MOVED TO 301200
301101	SPERMATOGENIC FAILURE, X-LINKED, 6; SPGFX6
301102	TRANSMEMBRANE PROTEIN 31; TMEM31
301103	MITOCHONDRIAL PYRUVATE CARRIER 1-LIKE PROTEIN; MPC1L
301104	PROTEIN PHOSPHATASE 1, REGULATORY SUBUNIT 3F; PPP1R3F
301105	CANCER/TESTIS ANTIGEN 55; CT55
301106	SPERMATOGENIC FAILURE, X-LINKED, 7; SPGFX7
301107	INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 111; XLID111
301108	CATARACTS, HEARING IMPAIRMENT, NEPHROTIC SYNDROME, AND ENTEROCOLITIS 1; CHINE1
301109	AUTOINFLAMMATORY DISEASE, MULTISYSTEM, WITH IMMUNE DYSREGULATION, X-LINKED; ADMIDX
301110	HEMOLYTIC UREMIC SYNDROME, ATYPICAL, 8, WITH RHIZOMELIC SHORT STATURE; AHUS8
301111	INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 112; XLID112
301112	GLYOXALASE DOMAIN-CONTAINING PROTEIN 5; GLOD5
301113	SPINDLIN FAMILY, MEMBER 4; SPIN4
301114	LUI-JEE-BARON SYNDROME; LJBS
301115	IMMUNODEFICIENCY 118; IMD118
301116	INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 113; XLID113
301117	CHROMOSOME X OPEN READING FRAME 38; CXORF38
301118	INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED, SYNDROMIC 37; MRXS37
301200	AMELOGENESIS IMPERFECTA, TYPE IE; AI1E
301201	AMELOGENESIS IMPERFECTA, HYPOPLASTIC/HYPOMATURATION, X-LINKED 2
301220	PIGMENTARY DISORDER, RETICULATE, WITH SYSTEMIC MANIFESTATIONS, X-LINKED; PDR
301300	DELTA-AMINOLEVULINATE SYNTHASE 2; ALAS2
301310	ANEMIA, SIDEROBLASTIC, AND SPINOCEREBELLAR ATAXIA; ASAT
301410	NEURAL TUBE DEFECTS, X-LINKED
301500	FABRY DISEASE
301590	MOVED TO 309800
301700	ANOSMIA, ISOLATED CONGENITAL, X-LINKED
301770	ARRESTIN 3, RETINAL; ARR3
301780	ARYLSULFATASE C, ISOZYME F; ARSC2
301790	SPINOCEREBELLAR ATAXIA, X-LINKED 3
301800	ANUS, IMPERFORATE
301810	MOVED TO 215700
301815	ARTHROGRYPOSIS, ECTODERMAL DYSPLASIA, CLEFT LIP/PALATE, AND DEVELOPMENTAL DELAY
301820	MOVED TO 208085
301830	SPINAL MUSCULAR ATROPHY, X-LINKED 2; SMAX2
301835	ARTS SYNDROME; ARTS
301840	SPINOCEREBELLAR ATAXIA, X-LINKED 4
301845	BAZEX-DUPRE-CHRISTOL SYNDROME; BDCS
301850	TUBULIN, BETA
301870	BIGLYCAN; BGN
301880	REMOVED FROM DATABASE
301900	BORJESON-FORSSMAN-LEHMANN SYNDROME; BFLS
301940	BRACHYDACTYLY, MONONEN TYPE
301950	BRANCHIAL ARCH SYNDROME, X-LINKED
302000	BULLOUS DYSTROPHY, HEREDITARY MACULAR TYPE; HBDM
302020	S100 CALCIUM-BINDING PROTEIN G; S100G
302030	CALVARIAL HYPEROSTOSIS
302045	CARDIOMYOPATHY, DILATED, 3B; CMD3B
302060	BARTH SYNDROME; BTHS
302200	CATARACT 40; CTRCT40
302300	MOVED TO 302200
302350	NANCE-HORAN SYNDROME; NHS
302380	MOVED TO 616145
302400	CENTRAL INCISORS, ABSENCE OF
302500	SPINOCEREBELLAR ATAXIA, X-LINKED 1; SCAX1
302600	SPINOCEREBELLAR ATAXIA, X-LINKED 2
302650	CEREBELLAR DEGENERATION-RELATED AUTOANTIGEN 1; CDR1
302700	CEREBRAL SCLEROSIS, DIFFUSE, SCHOLZ TYPE
302800	CHARCOT-MARIE-TOOTH DISEASE, X-LINKED DOMINANT, 1; CMTX1
302801	CHARCOT-MARIE-TOOTH DISEASE, X-LINKED RECESSIVE, 2; CMTX2
302802	CHARCOT-MARIE-TOOTH DISEASE, X-LINKED RECESSIVE, 3; CMTX3
302803	CHARCOT-MARIE-TOOTH PERONEAL MUSCULAR ATROPHY, X-LINKED, WITH APLASIA CUTIS CONGENITA
302900	CHARCOT-MARIE-TOOTH PERONEAL MUSCULAR ATROPHY AND FRIEDREICH ATAXIA, COMBINED
302905	ABRUZZO-ERICKSON SYNDROME; ABERS
302910	CHLORIDE CHANNEL 4; CLCN4
302920	MOVED TO 305425
302940	MOVED TO 302950
302950	CHONDRODYSPLASIA PUNCTATA 1, X-LINKED RECESSIVE; CDPX1
302960	CHONDRODYSPLASIA PUNCTATA 2, X-LINKED DOMINANT; CDPX2
303100	CHOROIDEREMIA; CHM
303110	CHROMOSOME Xq21 DELETION SYNDROME
303350	MASA SYNDROME
303400	CLEFT PALATE WITH OR WITHOUT ANKYLOGLOSSIA, X-LINKED; CPX
303600	COFFIN-LOWRY SYNDROME; CLS
303630	COLLAGEN, TYPE IV, ALPHA-5; COL4A5
303631	COLLAGEN, TYPE IV, ALPHA-6; COL4A6
303650	COLONIC ATRESIA
303700	BLUE CONE MONOCHROMACY; BCM
303800	COLORBLINDNESS, PARTIAL, DEUTAN SERIES; CBD
303900	COLORBLINDNESS, PARTIAL, PROTAN SERIES; CBP
304000	MOVED TO 613522
304020	CONE-ROD DYSTROPHY, X-LINKED, 1; CORDX1
304030	CONE DYSTROPHY, X-LINKED, WITH TAPETAL-LIKE SHEEN
304040	GAP JUNCTION PROTEIN, BETA-1; GJB1
304050	AICARDI SYNDROME; AIC
304100	CORPUS CALLOSUM, PARTIAL AGENESIS OF, X-LINKED
304110	CRANIOFRONTONASAL SYNDROME; CFNS
304120	OTOPALATODIGITAL SYNDROME, TYPE II; OPD2
304150	OCCIPITAL HORN SYNDROME; OHS
304200	CUTIS VERTICIS GYRATA, THYROID APLASIA, AND MENTAL RETARDATION
304300	CYANIDE, INABILITY TO SMELL
304340	PETTIGREW SYNDROME; PGS
304350	DEAFNESS-HYPOGONADISM SYNDROME
304400	DEAFNESS, X-LINKED 2; DFNX2
304500	DEAFNESS, X-LINKED 1; DFNX1
304590	MOVED TO 304500
304600	MOVED TO 304590
304700	MOHR-TRANEBJAERG SYNDROME; MTS
304730	DERMOIDS OF CORNEA; CND
304750	MOVED TO 306955
304790	IMMUNODYSREGULATION, POLYENDOCRINOPATHY, AND ENTEROPATHY, X-LINKED; IPEX
304800	DIABETES INSIPIDUS, NEPHROGENIC, 1, X-LINKED; NDI1
304900	DIABETES INSIPIDUS, NEUROHYPOPHYSEAL, X-LINKED
304930	MOVED TO 304790
304950	DYGGVE-MELCHIOR-CLAUSEN SYNDROME, X-LINKED
304990	REMOVED FROM DATABASE
305000	DYSKERATOSIS CONGENITA, X-LINKED; DKCX
305050	MOVED TO 304700
305100	ECTODERMAL DYSPLASIA 1, HYPOHIDROTIC, X-LINKED; XHED
305200	MOVED TO 314400
305300	MOVED TO 302060
305350	EPIDERMODYSPLASIA VERRUCIFORMIS, X-LINKED; EVX
305360	MEMBRANE PROTEIN, PALMITOYLATED 1; MPP1
305370	TISSUE INHIBITOR OF METALLOPROTEINASE 1; TIMP1
305371	GATA-BINDING PROTEIN 1; GATA1
305390	EXUDATIVE VITREORETINOPATHY 2, X-LINKED; EVR2
305400	AARSKOG-SCOTT SYNDROME; AAS
305423	COAGULATION FACTOR VIII-ASSOCIATED PROTEIN 1; F8A1
305424	FACTOR VIII-ASSOCIATED GENE 2
305425	MOVED TO 134629
305435	FETAL HEMOGLOBIN QUANTITATIVE TRAIT LOCUS 3; HBFQTL3
305450	OPITZ-KAVEGGIA SYNDROME; OKS
305550	FINGERPRINT BODY MYOPATHY
305600	FOCAL DERMAL HYPOPLASIA; FDH
305620	FRONTOMETAPHYSEAL DYSPLASIA 1; FMD1
305645	MOVED TO 136760
305650	REMOVED FROM DATABASE
305660	GAMMA-AMINOBUTYRIC ACID RECEPTOR, ALPHA-3; GABRA3
305670	GASTRIN-RELEASING PEPTIDE RECEPTOR; GRPR
305690	GENITOURINARY TRACT ANOMALIES
305700	SPERMATOGENIC FAILURE, X-LINKED, 1; SPGFX1
305800	MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS, X-LINKED
305900	GLUCOSE-6-PHOSPHATE DEHYDROGENASE; G6PD
305910	MOVED TO 138130
305915	GLUTAMATE RECEPTOR, IONOTROPIC, AMPA 3; GRIA3
305920	GLUTAMYL RIBOSE-5-PHOSPHATE STORAGE DISEASE
305980	MOVED TO 138400
305990	GLYCINE RECEPTOR, ALPHA-2 SUBUNIT; GLRA2
306000	GLYCOGEN STORAGE DISEASE IXa1; GSD9A1
306100	MOVED TO 400044
306190	MOVED TO 300200
306250	COLONY-STIMULATING FACTOR 2 RECEPTOR, ALPHA; CSF2RA
306300	GRANULOMAS, CONGENITAL CEREBRAL
306400	GRANULOMATOUS DISEASE, CHRONIC, X-LINKED; CGDX
306480	HALOACID DEHALOGENASE-LIKE HYDROLASE DOMAIN-CONTAINING 1A; HDHD1A
306500	MOVED TO 312300
306600	REMOVED FROM DATABASE
306700	HEMOPHILIA A; HEMA
306800	HEMOPHILIA A WITH VASCULAR ABNORMALITY
306900	HEMOPHILIA B; HEMB
306930	HEMOPOIETIC PROLIFERATION
306950	DIAPHRAGMATIC HERNIA 5, X-LINKED; DIH5
306955	HETEROTAXY, VISCERAL, 1, X-LINKED; HTX1
306960	HHHH SYNDROME
306970	MOVED TO 426000
306980	HIRSCHSPRUNG DISEASE WITH TYPE D BRACHYDACTYLY
306990	MICROHYDRANENCEPHALY, X-LINKED; MHACX
306995	HOMOSEXUALITY 1; HMS1
307000	HYDROCEPHALUS, CONGENITAL, X-LINKED; HYCX
307010	HYDROCEPHALUS WITH CEREBELLAR AGENESIS
307030	GLYCEROL KINASE DEFICIENCY; GKD
307150	HYPERTRICHOSIS, CONGENITAL GENERALIZED; HTC2
307200	ISOLATED GROWTH HORMONE DEFICIENCY, TYPE III, WITH AGAMMAGLOBULINEMIA; IGHD3
307300	MOVED TO 312300
307500	HYPOGONADISM, MALE, WITH MENTAL RETARDATION AND SKELETAL ANOMALIES
307600	MOVED TO 602014
307700	HYPOPARATHYROIDISM, X-LINKED; HYPX
307800	HYPOPHOSPHATEMIC RICKETS, X-LINKED DOMINANT; XLHR
307810	MOVED TO 307800 AND 300550
307830	HYPOURICEMIA, FAMILIAL RENAL, DUE TO TUBULAR HYPERSECRETION
308000	HYPOXANTHINE GUANINE PHOSPHORIBOSYLTRANSFERASE 1; HPRT1
308050	CONGENITAL HEMIDYSPLASIA WITH ICHTHYOSIFORM ERYTHRODERMA AND LIMB DEFECTS
308100	ICHTHYOSIS, X-LINKED; XLI
308200	ICHTHYOSIS AND MALE HYPOGONADISM
308205	IFAP SYNDROME 1, WITH OR WITHOUT BRESHECK SYNDROME; IFAP1
308210	REMOVED FROM DATABASE
308220	IMMUNODEFICIENCY, X-LINKED, WITH DEFICIENCY OF 115,000 DALTON SURFACE GLYCOPROTEIN
308230	IMMUNODEFICIENCY WITH HYPER-IgM, TYPE 1; HIGM1
308240	LYMPHOPROLIFERATIVE SYNDROME, X-LINKED, 1; XLP1
308250	IMMUNOGLOBULIN M, LEVEL OF
308280	IMPACTED TEETH, MULTIPLE
308290	IMPRINTING GENE RELATED TO RETINOBLASTOMA
308300	INCONTINENTIA PIGMENTI; IP
308310	MOVED TO 308300
308350	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 1; DEE1
308370	MOVED TO 312300
308380	INTERLEUKIN 2 RECEPTOR, GAMMA; IL2RG
308385	INTERLEUKIN 3 RECEPTOR, ALPHA; IL3RA
308400	REMOVED FROM DATABASE
308500	IRIS HYPOPLASIA WITH GLAUCOMA; IHG
308600	JAUNDICE, FAMILIAL OBSTRUCTIVE, OF INFANCY
308700	HYPOGONADOTROPIC HYPOGONADISM 1 WITH OR WITHOUT ANOSMIA; HH1
308750	KALLMANN SYNDROME WITH SPASTIC PARAPLEGIA
308800	KERATOSIS FOLLICULARIS SPINULOSA DECALVANS, X-LINKED; KFSDX
308830	KERATOSIS FOLLICULARIS, DWARFISM, AND CEREBRAL ATROPHY
308840	L1 CELL ADHESION MOLECULE; L1CAM
308850	LARYNGEAL ABDUCTOR PARALYSIS
308905	LEBER HEREDITARY OPTIC NEUROPATHY, MODIFIER OF; LOAM
308930	MOVED TO 312170
308940	LEIOMYOMATOSIS, DIFFUSE, WITH ALPORT SYNDROME; DL-ATS
308950	LESCH-NYHAN PHENOTYPE WITH NORMAL HGPRT
308960	LEUKEMIA, ACUTE, X-LINKED
308980	MOVED TO 151660
308990	PROTEINURIA, LOW MOLECULAR WEIGHT, WITH HYPERCALCIURIA AND NEPHROCALCINOSIS
309000	LOWE OCULOCEREBRORENAL SYNDROME; OCRL
309050	LUTHERAN SUPPRESSOR, X-LINKED; XS
309060	LYSOSOME-ASSOCIATED MEMBRANE PROTEIN 2; LAMP2
309100	MACULAR DYSTROPHY, X-LINKED
309120	SPERMATOGENIC FAILURE, X-LINKED, 2; SPGFX2
309150	MOVED TO 614279
309200	MAJOR AFFECTIVE DISORDER 2; MAFD2
309300	MEGALOCORNEA; MGC1
309350	MELNICK-NEEDLES SYNDROME; MNS
309400	MENKES DISEASE; MNK
309470	MOVED TO 309500
309480	MENTAL RETARDATION AND PSORIASIS
309490	MOVED TO 309580
309500	RENPENNING SYNDROME 1; RENS1
309510	PARTINGTON SYNDROME; PRTS
309520	INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED, SYNDROMIC, LUJAN-FRYNS TYPE; MRXSLF
309530	INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 1; XLID1
309540	MOVED TO 309548
309541	METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, cblX TYPE; MAHCX
309545	INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED, SYNDROMIC 12; MRXS12
309548	INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 109; XLID109
309549	INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 9; XLID9
309550	FRAGILE X MESSENGER RIBONUCLEOPROTEIN 1; FMR1
309555	INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED, SYNDROMIC, GUSTAVSON TYPE; MRXSG
309560	MENTAL RETARDATION WITH SPASTIC PARAPLEGIA AND PALMOPLANTAR HYPERKERATOSIS
309580	INTELLECTUAL DISABILITY-HYPOTONIC FACIES SYNDROME, X-LINKED, 1; MRXHF1
309583	INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED, SYNDROMIC, SNYDER-ROBINSON TYPE; MRXSSR
309585	INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED, SYNDROMIC, WILSON-TURNER TYPE; WTS
309590	INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED, SYNDROMIC, TURNER TYPE; MRXST
309600	MOVED TO 300523
309605	MOVED TO 314580
309610	PRIETO SYNDROME; PRS
309620	MENTAL RETARDATION, SKELETAL DYSPLASIA, AND ABDUCENS PALSY; MRSD
309630	METACARPAL 4-5 FUSION; MF4
309640	MENTAL RETARDATION WITH SPASTIC PARAPLEGIA
309645	MOVED TO 602111
309660	MOVED TO 300257
309700	MOVED TO 310600
309800	MICROPHTHALMIA, SYNDROMIC 1; MCOPS1
309801	LINEAR SKIN DEFECTS WITH MULTIPLE CONGENITAL ANOMALIES 1; LSDMCA1
309840	MODIFIER, X-LINKED, FOR NEUROFUNCTIONAL DEFECTS
309845	MOESIN; MSN
309850	MONOAMINE OXIDASE A; MAOA
309860	MONOAMINE OXIDASE B; MAOB
309900	MUCOPOLYSACCHARIDOSIS, TYPE II; MPS2
309930	MUSCULAR DYSTROPHY, CARDIAC TYPE
309950	MUSCULAR DYSTROPHY, HEMIZYGOUS LETHAL TYPE
310000	MUSCULAR DYSTROPHY, MABRY TYPE
310095	MUSCULAR DYSTROPHY, PROGRESSIVE PECTORODORSAL
310200	MUSCULAR DYSTROPHY, DUCHENNE TYPE; DMD
310300	EMERY-DREIFUSS MUSCULAR DYSTROPHY 1, X-LINKED; EDMD1
310305	MOVED TO 601415
310310	MYCL-RELATED PROCESSED GENE; MYCL2
310350	MYELOLYMPHATIC INSUFFICIENCY
310370	MYOCLONIC EPILEPSY, PROGRESSIVE
310400	MYOPATHY, CENTRONUCLEAR, X-LINKED; CNMX
310440	MYOPATHY, X-LINKED, WITH EXCESSIVE AUTOPHAGY; MEAX
310450	MOVED TO 159000
310460	MYOPIA 1, X-LINKED; MYP1
310465	N SYNDROME; NSX
310468	NEPHROLITHIASIS, X-LINKED RECESSIVE, WITH RENAL FAILURE; XRN
310470	NEUROPATHY, HEREDITARY SENSORY, X-LINKED
310490	CHARCOT-MARIE-TOOTH DISEASE, X-LINKED RECESSIVE, 4, WITH OR WITHOUT CEREBELLAR ATAXIA; CMTX4
310500	NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1A; CSNB1A
310600	NORRIE DISEASE; ND
310650	NUCLEAR RIBONUCLEIC ACID; nRNA
310700	NYSTAGMUS 1, CONGENITAL, X-LINKED; NYS1
310800	NYSTAGMUS, MYOCLONIC
310900	OCCIPITAL HAIR, WHITE LOCK OF
310980	OMPHALOCELE, X-LINKED
310990	MOVED TO 190020
311000	OPHTHALMOPLEGIA, EXTERNAL, AND MYOPIA; OPEM
311010	ARAF PROTOONCOGENE, SERINE/THREONINE KINASE; ARAF
311020	MOVED TO 311010
311030	MCF.2 CELL LINE-DERIVED TRANSFORMING SEQUENCE; MCF2
311040	ELK1, MEMBER OF ETS ONCOGENE FAMILY; ELK1
311050	OPTIC ATROPHY 2; OPA2
311070	CHARCOT-MARIE-TOOTH DISEASE, X-LINKED RECESSIVE, 5; CMTX5
311100	OPTIC ATROPHY--SPASTIC PARAPLEGIA SYNDROME
311150	MOVED TO 304700
311200	OROFACIODIGITAL SYNDROME I; OFD1
311240	TBC1 DOMAIN FAMILY, MEMBER 25; TBC1D25
311241	MOVED TO 258870
311250	ORNITHINE TRANSCARBAMYLASE DEFICIENCY, HYPERAMMONEMIA DUE TO
311280	MOVED TO 300373
311300	OTOPALATODIGITAL SYNDROME, TYPE I; OPD1
311350	OUABAIN RESISTANCE; OUBR
311360	PREMATURE OVARIAN FAILURE 1; POF1
311400	PAINE SYNDROME
311450	PALLISTER W SYNDROME
311510	WAISMAN SYNDROME; WSMN
311550	CYCLIN-DEPENDENT KINASE 16; CDK16
311601	MOVED TO 312080
311700	REMOVED FROM DATABASE
311750	MOVED TO 170650
311770	PHOSPHATIDYLINOSITOL GLYCAN ANCHOR BIOSYNTHESIS CLASS A PROTEIN; PIGA
311790	6-PHOSPHOFRUCTO-2-KINASE/FRUCTOSE-2,6-BISPHOSPHATASE 1; PFKFB1
311800	PHOSPHOGLYCERATE KINASE 1; PGK1
311810	MOVED TO 311800
311850	PHOSPHORIBOSYLPYROPHOSPHATE SYNTHETASE I; PRPS1
311860	PHOSPHORIBOSYLPYROPHOSPHATE SYNTHETASE II; PRPS2
311870	PHOSPHORYLASE KINASE, MUSCLE, ALPHA-1 SUBUNIT; PHKA1
311895	PIERRE ROBIN SEQUENCE WITH FACIAL AND DIGITAL ANOMALIES
311900	TARP SYNDROME; TARPS
312000	PANHYPOPITUITARISM, X-LINKED; PHPX
312030	REMOVED FROM DATABASE
312040	DNA POLYMERASE ALPHA-1, CATALYTIC SUBUNIT; POLA1
312060	PROPERDIN DEFICIENCY, X-LINKED; CFPD
312070	UBIQUITIN-LIKE 4A; UBL4A
312080	PELIZAEUS-MERZBACHER DISEASE; PMD
312090	SOLUTE CARRIER FAMILY 10 (SODIUM/BILE ACID COTRANSPORTER FAMILY) MEMBER 3; SLC10A3
312095	A-KINASE ANCHOR PROTEIN 17A; AKAP17A
312100	MOVED TO 312300
312150	MULTIPLE PTERYGIUM SYNDROME, X-LINKED
312170	PYRUVATE DEHYDROGENASE E1-ALPHA DEFICIENCY; PDHAD
312173	RIBOSOMAL PROTEIN L10; RPL10
312180	UBIQUITIN-CONJUGATING ENZYME E2 A; UBE2A
312190	RADIAL APLASIA, X-LINKED
312200	RADIAL LOOP, PLAIN, ON RIGHT INDEX FINGER
312210	RADIATION SENSITIVITY OF NATURAL KILLER ACTIVITY
312300	ANDROGEN INSENSITIVITY, PARTIAL; PAIS
312390	MOVED TO 314310
312400	MOVED TO 604278
312420	RENIN-BINDING PROTEIN; RENBP
312450	MOVED TO 252010
312500	RETICULOENDOTHELIOSIS, X-LINKED
312530	REMOVED FROM DATABASE
312550	RETINAL DYSPLASIA, PRIMARY; PRD
312600	RETINITIS PIGMENTOSA 2; RP2
312610	RETINITIS PIGMENTOSA GTPase REGULATOR; RPGR
312612	RETINITIS PIGMENTOSA 6; RP6
312700	RETINOSCHISIS 1, X-LINKED, JUVENILE; RS1
312750	RETT SYNDROME; RTT
312760	RIBOSOMAL PROTEIN S4, X-LINKED; RPS4X
312780	RUSSELL-SILVER SYNDROME, X-LINKED
312800	MOVED TO 600145
312820	SARCOMA, SYNOVIAL, X BREAKPOINT 1; SSX1
312830	SCARF SYNDROME
312840	SCHIMKE X-LINKED MENTAL RETARDATION SYNDROME
312860	MOVED TO 272440
312861	5-HYDROXYTRYPTAMINE RECEPTOR 2C; HTR2C
312863	COMBINED IMMUNODEFICIENCY, X-LINKED; CIDX
312865	SHORT STATURE HOMEOBOX; SHOX
312870	SIMPSON-GOLABI-BEHMEL SYNDROME, TYPE 1; SGBS1
312890	MOVED TO 312920
312900	MOVED TO 303350
312910	SPASTIC PARAPARESIS AND DEAFNESS
312920	SPASTIC PARAPLEGIA 2, X-LINKED; SPG2
313000	SPATIAL VISUALIZATION, APTITUDE FOR
313020	SPERMIDINE/SPERMINE N(1)-ACETYLTRANSFERASE 1; SAT1
313100	MOVED TO 605041
313200	SPINAL AND BULBAR MUSCULAR ATROPHY, X-LINKED 1; SMAX1
313350	SPLIT-HAND/FOOT MALFORMATION 2; SHFM2
313400	SPONDYLOEPIPHYSEAL DYSPLASIA TARDA, X-LINKED; SEDT
313420	SPONDYLOMETAPHYSEAL DYSPLASIA, X-LINKED; SMDXL
313430	SRY-BOX 3; SOX3
313440	SYNAPSIN I; SYN1
313450	REMOVED FROM DATABASE
313460	REMOVED FROM DATABASE
313470	CD99 ANTIGEN, X CHROMOSOME; CD99
313475	SYNAPTOPHYSIN; SYP
313480	TaqI POLYMORPHISM; TAQ1
313490	TAURODONTISM, MICRODONTIA, AND DENS INVAGINATUS; TMDI
313500	TOOTH AGENESIS, SELECTIVE, X-LINKED, 1; STHAGX1
313550	REMOVED FROM DATABASE
313650	TAF1 RNA POLYMERASE II, TATA BOX-BINDING PROTEIN-ASSOCIATED FACTOR, 250-KD; TAF1
313680	MOVED TO 187395
313700	ANDROGEN RECEPTOR; AR
313850	THORACOABDOMINAL SYNDROME; THAS
313900	THROMBOCYTOPENIA 1; THC1
314000	THROMBOCYTOPENIA WITH ELEVATED SERUM IgA AND RENAL DISEASE
314050	THROMBOCYTOPENIA WITH BETA-THALASSEMIA, X-LINKED; XLTT
314100	ADDUCTED THUMBS, CONGENITAL
314200	THYROXINE-BINDING GLOBULIN OF SERUM; TBG
314240	TOOTH SIZE
314250	DYSTONIA 3, TORSION, X-LINKED; DYT3
314300	TORTICOLLIS, KELOIDS, CRYPTORCHIDISM, AND RENAL DYSPLASIA; TKCR
314310	TRANSCRIPTION FACTOR FOR IMMUNOGLOBULIN HEAVY-CHAIN ENHANCER 3; TFE3
314320	TRIGONOCEPHALY WITH SHORT STATURE AND DEVELOPMENTAL DELAY
314350	REMOVED FROM DATABASE
314360	ULNAR HYPOPLASIA WITH LOBSTER-CLAW DEFORMITY OF FEET
314370	UBIQUITIN-LIKE MODIFIER-ACTIVATING ENZYME 1; UBA1
314375	SOLUTE CARRIER FAMILY 35 (UDP-GALACTOSE TRANSPORTER), MEMBER 2; SLC35A2
314380	UNIQUE GREEN PHENOMENON
314390	VACTERL ASSOCIATION, X-LINKED, WITH OR WITHOUT HYDROCEPHALUS; VACTERLX
314400	CARDIAC VALVULAR DYSPLASIA, X-LINKED; CVDPX
314500	VAN DEN BOSCH SYNDROME
314550	VESICOURETERAL REFLUX, X-LINKED; VURX
314555	MOVED TO 604492
314560	VON WILLEBRAND DISEASE, X-LINKED FORM
314570	WIDOW'S PEAK SYNDROME
314580	WIEACKER-WOLFF SYNDROME; WRWF
314600	WILDERVANCK SYNDROME
314670	X INACTIVATION-SPECIFIC TRANSCRIPT; XIST
314690	LYSINE DEMETHYLASE 5C; KDM5C
314700	BLOOD GROUP, XG SYSTEM; XG
314705	XG REGULATOR; XGR
314800	XH ANTIGEN
314850	KELL BLOOD GROUP PROTEIN, MCLEOD SYNDROME-ASSOCIATED; XK
314900	XM SYSTEM
314920	REMOVED FROM DATABASE
314940	REMOVED FROM DATABASE
314960	REMOVED FROM DATABASE
314980	ZINC FINGER PROTEIN, X-LINKED; ZFX
314990	ZINC FINGER PROTEIN 711; ZNF711
314993	ZINC FINGER PROTEIN 182; ZNF182
314995	ZINC FINGER PROTEIN 41; ZNF41
314997	ZINC FINGER PROTEIN 75D; ZNF75D
314998	ZINC FINGER PROTEIN 81; ZNF81
315000	MOVED TO 302200
400000	REMOVED FROM DATABASE
400001	MOVED TO 426000
400002	MOVED TO 314700
400003	DELETED IN AZOOSPERMIA 1; DAZ1
400004	RETINITIS PIGMENTOSA, Y-LINKED; RPY
400005	UBIQUITIN-SPECIFIC PROTEASE 9, Y CHROMOSOME; USP9Y
400006	RNA-BINDING MOTIF PROTEIN, Y CHROMOSOME, FAMILY 1, MEMBER A1; RBMY1A1
400007	MOVED TO 400006
400008	PROTEIN KINASE, Y-LINKED; PRKY
400009	UBIQUITOUSLY TRANSCRIBED TETRATRICOPEPTIDE REPEAT GENE ON Y CHROMOSOME; UTY
400010	DEAD-BOX HELICASE 3, Y-LINKED; DDX3Y
400011	ACETYLSEROTONIN METHYLTRANSFERASE-LIKE, Y-LINKED
400012	VARIABLY CHARGED, Y CHROMOSOME; VCY
400013	BASIC PROTEIN, Y CHROMOSOME, 2; BPY2
400014	EUKARYOTIC TRANSLATION INITIATION FACTOR 1A, Y-LINKED; EIF1AY
400015	XK-RELATED PROTEIN ON Y CHROMOSOME
400016	CHROMODOMAIN PROTEIN, Y-LINKED, 1; CDY1
400017	THYMOSIN, BETA-4, Y CHROMOSOME; TMSB4Y
400018	CHROMODOMAIN PROTEIN, Y-LINKED, 2A; CDY2A
400019	PTPBL-RELATED GENE ON Y; PRY
400020	SHORT STATURE HOMEOBOX, Y-LINKED; SHOXY
400021	LYMPHOMA, HODGKIN, Y-LINKED PSEUDOAUTOSOMAL
400022	PROTOCADHERIN 11, Y-LINKED; PCDH11Y
400023	CYTOKINE RECEPTOR-LIKE FACTOR 2, Y-LINKED; CRLF2Y
400024	MOVED TO 415000
400025	TRANSFORMING GROWTH FACTOR-BETA-INDUCED FACTOR 2-LIKE, Y-LINKED; TGIF2LY
400026	DELETED IN AZOOSPERMIA 2; DAZ2
400027	DELETED IN AZOOSPERMIA 3; DAZ3
400028	NEUROLIGIN 4, Y-LINKED; NLGN4Y
400029	HEAT-SHOCK TRANSCRIPTION FACTOR, Y-LINKED; HSFY
400030	RIBOSOMAL PROTEIN S4, Y-LINKED, 2; RPS4Y2
400031	TAXILIN, GAMMA, Y-LINKED, PSEUDOGENE; TXLNGY
400032	MOVED TO 400031
400033	TRANSDUCIN-BETA-LIKE 1, Y-LINKED; TBL1Y
400034	CHONDROITIN SULFATE PROTEOGLYCAN 4 PSEUDOGENE 1, Y-LINKED; CSPG4P1Y
400035	GOLGA2 PSEUDOGENE 2, Y-LINKED; GOLGA2P2Y
400036	TESTIS-SPECIFIC TRANSCRIPT, Y-LINKED, 3; TTTY3
400037	TESTIS-SPECIFIC TRANSCRIPT, Y-LINKED, 4; TTTY4
400038	TESTIS-SPECIFIC TRANSCRIPT, Y-LINKED, 5; TTTY5
400039	TESTIS-SPECIFIC TRANSCRIPT, Y-LINKED, 6; TTTY6
400040	TESTIS-SPECIFIC TRANSCRIPT, Y-LINKED, 17; TTTY17
400041	PTPBL-RELATED GENE ON Y, 2; PRY2
400042	SPERMATOGENIC FAILURE, Y-LINKED, 1; SPGFY1
400043	DEAFNESS, Y-LINKED 1; DFNY1
400044	46,XY SEX REVERSAL 1; SRXY1
400045	46,XX SEX REVERSAL 1; SRXX1
400046	PHOSPHOLIPASE C, PHOSPHATIDYLINOSITOL-SPECIFIC, X DOMAIN-CONTAINING PROTEIN 1, Y-LINKED
400047	DEAFNESS, Y-LINKED 2; DFNY2
400048	DELETED IN AZOOSPERMIA 4; DAZ4
400049	DEHYDROGENASE/REDUCTASE, Y-LINKED; DHRSY
400050	VARIABLY CHARGED, Y CHROMOSOME, 1B; VCY1B
402500	ACETYLSEROTONIN METHYLTRANSFERASE, Y-CHROMOSOMAL; ASMT
403000	SOLUTE CARRIER FAMILY 25 (MITOCHONDRIAL CARRIER, ADENINE NUCLEOTIDE TRANSLOCATOR), MEMBER A6, Y-CHROMOSOMAL; SLC25A6
410000	AMELOGENIN, Y-CHROMOSOMAL; AMELY
415000	SPERMATOGENIC FAILURE, Y-LINKED, 2; SPGFY2
424000	REMOVED FROM DATABASE
424500	GONADOBLASTOMA; GBY
425000	GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR RECEPTOR, ALPHA SUBUNIT, Y-CHROMOSOMAL; CSF2RY
425500	HAIRY EARS, Y-LINKED
426000	LYSINE DEMETHYLASE 5D; KDM5D
430000	INTERLEUKIN 3 RECEPTOR, Y-CHROMOSOMAL; IL3RA
450000	CD99 ANTIGEN, Y CHROMOSOME
465000	A-KINASE ANCHOR PROTEIN 17A, Y-CHROMOSOMAL; AKAP17A
470000	RIBOSOMAL PROTEIN S4, Y-LINKED, 1; RPS4Y1
475000	GROWTH CONTROL, Y-CHROMOSOME INFLUENCED; GCY
480000	SEX-DETERMINING REGION Y; SRY
480100	TESTIS-SPECIFIC PROTEIN, Y-LINKED, 1; TSPY1
488000	MOVED TO 475000
489000	UBIQUITIN-ACTIVATING ENZYME, Y-LINKED
489500	XG REGULATOR; XGR
490000	ZINC FINGER PROTEIN, Y-LINKED; ZFY
500000	CARDIOMYOPATHY, INFANTILE HISTIOCYTOID
500001	LEBER OPTIC ATROPHY AND DYSTONIA
500002	MITOCHONDRIAL MYOPATHY WITH DIABETES
500003	STRIATONIGRAL DEGENERATION, INFANTILE, MITOCHONDRIAL
500004	RETINITIS PIGMENTOSA-DEAFNESS SYNDROME
500005	HYPOMAGNESEMIA, HYPERTENSION, AND HYPERCHOLESTEROLEMIA, MITOCHONDRIAL
500006	CARDIOMYOPATHY, INFANTILE HYPERTROPHIC
500007	CYCLIC VOMITING SYNDROME; CVS
500008	DEAFNESS, NONSYNDROMIC SENSORINEURAL, MITOCHONDRIAL
500009	MITOCHONDRIAL MYOPATHY, INFANTILE, TRANSIENT; MMIT
500010	ATAXIA AND POLYNEUROPATHY, ADULT-ONSET
500011	MYOPATHY, LACTIC ACIDOSIS, AND SIDEROBLASTIC ANEMIA 3; MLASA3
500013	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, MITOCHONDRIAL FORM, 1; CMTMA1
500014	MITOCHONDRIAL COMPLEX I DEFICIENCY, MITOCHONDRIAL TYPE 1; MC1DM1
500015	MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, MITOCHONDRIAL TYPE 1; MC5DM1
502000	AGING
502500	ALZHEIMER DISEASE, SUSCEPTIBILITY TO, MITOCHONDRIAL
510000	REMOVED FROM DATABASE
515000	CHLORAMPHENICOL TOXICITY
516000	COMPLEX I, SUBUNIT ND1; MTND1
516001	COMPLEX I, SUBUNIT ND2; MTND2
516002	COMPLEX I, SUBUNIT ND3; MTND3
516003	COMPLEX I, SUBUNIT ND4; MTND4
516004	COMPLEX I, SUBUNIT ND4L; MTND4L
516005	COMPLEX I, SUBUNIT ND5; MTND5
516006	COMPLEX I, SUBUNIT ND6; MTND6
516020	CYTOCHROME b OF COMPLEX III; MTCYB
516030	COMPLEX IV, CYTOCHROME c OXIDASE SUBUNIT I; MTCO1
516040	COMPLEX IV, CYTOCHROME c OXIDASE SUBUNIT II; MTCO2
516050	CYTOCHROME c OXIDASE III; MTCO3
516060	ATP SYNTHASE 6; MTATP6
516070	ATP SYNTHASE 8; MTATP8
520000	DIABETES AND DEAFNESS, MATERNALLY INHERITED; MIDD
520100	DIARRHEA, CHRONIC, WITH VILLOUS ATROPHY
530000	KEARNS-SAYRE SYNDROME; KSS
535000	LEBER OPTIC ATROPHY
540000	MITOCHONDRIAL MYOPATHY, ENCEPHALOPATHY, LACTIC ACIDOSIS, AND STROKE-LIKE EPISODES; MELAS
545000	MYOCLONIC EPILEPSY ASSOCIATED WITH RAGGED-RED FIBERS; MERRF
550000	MOVED TO 157640
550500	MYOGLOBINURIA, RECURRENT
550900	MOVED TO 603041
551000	MITOCHONDRIAL MYOPATHY, LETHAL, INFANTILE; LIMM
551200	NEPHROPATHY, CHRONIC TUBULOINTERSTITIAL
551500	NEUROPATHY, ATAXIA, AND RETINITIS PIGMENTOSA
553000	ONCOCYTOMA
555000	MOVED TO 607313
556500	PARKINSON DISEASE, MITOCHONDRIAL
557000	PEARSON MARROW-PANCREAS SYNDROME
560000	RENAL TUBULOPATHY, DIABETES MELLITUS, AND CEREBELLAR ATAXIA
561000	RIBOSOMAL RNA, MITOCHONDRIAL, 12S; MTRNR1
561010	RIBOSOMAL RNA, MITOCHONDRIAL, 16S; MTRNR2
580000	DEAFNESS, AMINOGLYCOSIDE-INDUCED
590000	TRANSFER RNA, MITOCHONDRIAL, ALANINE; MTTA
590005	TRANSFER RNA, MITOCHONDRIAL, ARGININE; MTTR
590010	TRANSFER RNA, MITOCHONDRIAL, ASPARAGINE; MTTN
590015	TRANSFER RNA, MITOCHONDRIAL, ASPARTIC ACID; MTTD
590020	TRANSFER RNA, MITOCHONDRIAL, CYSTEINE; MTTC
590025	TRANSFER RNA, MITOCHONDRIAL, GLUTAMIC ACID; MTTE
590030	TRANSFER RNA, MITOCHONDRIAL, GLUTAMINE; MTTQ
590035	TRANSFER RNA, MITOCHONDRIAL, GLYCINE; MTTG
590040	TRANSFER RNA, MITOCHONDRIAL, HISTIDINE; MTTH
590045	TRANSFER RNA, MITOCHONDRIAL, ISOLEUCINE; MTTI
590050	TRANSFER RNA, MITOCHONDRIAL, LEUCINE, 1; MTTL1
590055	TRANSFER RNA, MITOCHONDRIAL, LEUCINE, 2; MTTL2
590060	TRANSFER RNA, MITOCHONDRIAL, LYSINE; MTTK
590065	TRANSFER RNA, MITOCHONDRIAL, METHIONINE; MTTM
590070	TRANSFER RNA, MITOCHONDRIAL, PHENYLALANINE; MTTF
590075	TRANSFER RNA, MITOCHONDRIAL, PROLINE; MTTP
590080	TRANSFER RNA, MITOCHONDRIAL, SERINE, 1; MTTS1
590085	TRANSFER RNA, MITOCHONDRIAL, SERINE, 2; MTTS2
590090	TRANSFER RNA, MITOCHONDRIAL, THREONINE; MTTT
590095	TRANSFER RNA, MITOCHONDRIAL, TRYPTOPHAN; MTTW
590100	TRANSFER RNA, MITOCHONDRIAL, TYROSINE; MTTY
590105	TRANSFER RNA, MITOCHONDRIAL, VALINE; MTTV
598500	WOLFRAM SYNDROME, MITOCHONDRIAL FORM
600000	SPONDYLOCAMPTODACTYLY
600001	HEART DEFECTS, CONGENITAL, AND OTHER CONGENITAL ANOMALIES; HDCA
600002	EIKEN SYNDROME; EKNS
600003	CALCIUM CHANNEL, VOLTAGE-DEPENDENT, BETA-2 SUBUNIT; CACNB2
600004	EPHRIN RECEPTOR EphA5; EPHA5
600005	CLASS II MAJOR HISTOCOMPATIBILITY COMPLEX TRANSACTIVATOR; CIITA
600006	REGULATORY FACTOR X, 1; RFX1
600007	FMS-RELATED TYROSINE KINASE 3 LIGAND; FLT3LG
600008	NICOTINAMIDE N-METHYLTRANSFERASE; NNMT
600009	INTERFERON-ALPHA-INDUCIBLE PROTEIN 27; IFI27
600010	INSULINOMA-ASSOCIATED 1; INSM1
600011	EPHRIN RECEPTOR EphB4; EPHB4
600012	UBIQUITIN-CONJUGATING ENZYME E2 L1, PSEUDOGENE; UBE2L1
600013	TRANSCRIPTION FACTOR YY1; YY1
600014	SWI/SNF-RELATED, MATRIX-ASSOCIATED, ACTIN-DEPENDENT REGULATOR OF CHROMATIN, SUBFAMILY A, MEMBER 2; SMARCA2
600015	MOVED TO 106165
600016	CONTACTIN 1; CNTN1
600017	SYNDECAN 4; SDC4
600018	OPIOID RECEPTOR, MU-1; OPRM1
600019	CYTOCHROME b561; CYB561
600020	MAX-INTERACTING PROTEIN 1; MXI1
600021	MAX DIMERIZATION PROTEIN 1; MXD1
600022	PROSTAGLANDIN I2 RECEPTOR; PTGIR
600023	CADHERIN 11; CDH11
600024	LAMIN B RECEPTOR; LBR
600025	KINESIN LIGHT CHAIN 1; KLC1
600026	SYNTROPHIN, BETA-1; SNTB1
600027	SYNTROPHIN, BETA-2; SNTB2
600028	DISTAL-LESS HOMEOBOX 5; DLX5
600029	DISTAL-LESS HOMEOBOX 1; DLX1
600030	DISTAL-LESS HOMEOBOX 6; DLX6
600031	CHITINASE 1; CHIT1
600032	MOVED TO 182455
600033	TISSUE FACTOR PATHWAY INHIBITOR 2; TFPI2
600034	EMPTY SPIRACLES HOMEOBOX 1; EMX1
600035	EMPTY SPIRACLES HOMEOBOX 2; EMX2
600036	ORTHODENTICLE HOMEOBOX 1; OTX1
600037	ORTHODENTICLE HOMEOBOX 2; OTX2
600038	MEGAKARYOCYTE-ASSOCIATED TYROSINE KINASE; MATK
600039	BCL2-LIKE 1; BCL2L1
600040	BCL2-ASSOCIATED X PROTEIN; BAX
600041	PURINERGIC RECEPTOR P2Y, G PROTEIN-COUPLED, 2; P2RY2
600042	MELANOCORTIN 5 RECEPTOR; MC5R
600043	SULFOTRANSFERASE FAMILY 1E, ESTROGEN-PREFERRING, MEMBER 1; SULT1E1
600044	THROMBOPOIETIN; THPO
600045	DNA DAMAGE-BINDING PROTEIN 1; DDB1
600046	ATP-BINDING CASSETTE, SUBFAMILY A, MEMBER 1; ABCA1
600047	ATP-BINDING CASSETTE, SUBFAMILY A, MEMBER 2; ABCA2
600048	MOVED TO 114480
600049	MDS1 GENE; MDS1
600050	MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE 11; MAP3K11
600051	EPIDERMAL GROWTH FACTOR RECEPTOR PATHWAY SUBSTRATE 15; EPS15
600052	APELIN RECEPTOR; APLNR
600053	CYCLIC NUCLEOTIDE-GATED CHANNEL, ALPHA-3; CNGA3
600054	MOVED TO 300338
600055	MOVED TO 426000
600056	MOVED TO 314690
600057	BLADDER EXSTROPHY AND EPISPADIAS COMPLEX; BEEC
600058	PROTEIN TYROSINE KINASE TXK; TXK
600059	RETINITIS PIGMENTOSA 13; RP13
600060	DEAFNESS, AUTOSOMAL RECESSIVE 2; DFNB2
600061	RAD23 HOMOLOG A, NUCLEOTIDE EXCISION REPAIR PROTEIN; RAD23A
600062	RAD23 HOMOLOG B, NUCLEOTIDE EXCISION REPAIR PROTEIN; RAD23B
600063	TROVE DOMAIN FAMILY, MEMBER 2; TROVE2
600064	KERATIN-ASSOCIATED PROTEIN 11-1; KRTAP11-1
600065	INTEGRIN, BETA-2; ITGB2
600066	EPHRIN RECEPTOR EphA6; EPHA6
600067	URIDINE DIPHOSPHATE GLYCOSYLTRANSFERASE 2 FAMILY, MEMBER B4; UGT2B4
600068	URIDINE DIPHOSPHATE GLYCOSYLTRANSFERASE 2 FAMILY, MEMBER B7; UGT2B7
600069	URIDINE DIPHOSPHATE GLYCOSYLTRANSFERASE 2 FAMILY, MEMBER B15; UGT2B15
600070	URIDINE DIPHOSPHATE GLYCOSYLTRANSFERASE 2 FAMILY, MEMBER B10; UGT2B10
600071	MOVED TO 600067
600072	FATAL FAMILIAL INSOMNIA; FFI
600073	LOW DENSITY LIPOPROTEIN RECEPTOR-RELATED PROTEIN 2; LRP2
600074	CD24 ANTIGEN; CD24
600075	TATA BOX-BINDING PROTEIN; TBP
600076	TENSIN 1; TNS1
600077	MOVED TO 224750
600078	MOVED TO 300012
600079	PROTEIN-TYROSINE PHOSPHATASE, NONRECEPTOR-TYPE, 12; PTPN12
600080	MYELOCYTIC LEUKEMIA-LIKE SYNDROME, FAMILIAL, CHRONIC
600081	VITAMIN D HYDROXYLATION-DEFICIENT RICKETS, TYPE 1B; VDDR1B
600082	PROSTATIC HYPERPLASIA, BENIGN; BPH
600083	MOVED TO 300144
600084	MACROCYTOSIS, FAMILIAL
600085	PROTEIN-TYROSINE KINASE SYK; SYK
600086	ALCOHOL DEHYDROGENASE 7; ADH7
600087	TUFTELIN; TUFT1
600088	MOVED TO 113810
600089	PANCREATIC BETA CELL AGENESIS WITH NEONATAL DIABETES MELLITUS
600090	MOVED TO 300013
600091	MOVED TO 158600
600092	NIVELON-NIVELON-MABILLE SYNDROME; NNMS
600093	SPONDYLOEPIPHYSEAL DYSPLASIA TARDA WITH CHARACTERISTIC FACIES
600094	MOVED TO 300095
600095	MOVED TO 246560
600096	PUERTO RICAN INFANT HYPOTONIA SYNDROME
600097	MOVED TO 300106
600098	RELATED RAS VIRAL ONCOGENE HOMOLOG 2; RRAS2
600099	MOVED TO 246530
600100	MOVED TO 601792
600101	DEAFNESS, AUTOSOMAL DOMINANT 2A; DFNA2A
600102	MOVED TO 300067
600103	SYNAPTOTAGMIN 4; SYT4
600104	SYNAPTOTAGMIN 2; SYT2
600105	RETINITIS PIGMENTOSA 12; RP12
600106	INOSITOL POLYPHOSPHATE-5-PHOSPHATASE, 40-KD; INPP5A
600107	MOVED TO 300014
600108	MATRIX METALLOPROTEINASE 13; MMP13
600109	MOVED TO 602668
600110	STARGARDT DISEASE 3; STGD3
600111	SOLUTE CARRIER FAMILY 1 (GLIAL HIGH AFFINITY GLUTAMATE TRANSPORTER), MEMBER 3; SLC1A3
600112	DYNEIN, CYTOPLASMIC 1, HEAVY CHAIN 1; DYNC1H1
600113	MOVED TO 300005
600114	CHAPERONIN CONTAINING T-COMPLEX POLYPEPTIDE 1, SUBUNIT 3; CCT3
600115	MOVED TO 163260
600116	PARKINSON DISEASE 2, AUTOSOMAL RECESSIVE JUVENILE; PARK2
600117	DYSPHASIA, FAMILIAL DEVELOPMENTAL
600118	WARBURG MICRO SYNDROME 1; WARBM1
600119	SARCOGLYCAN, ALPHA; SGCA
600120	MOVED TO 186100
600121	RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 3; RCDP3
600122	MALE PSEUDOHERMAPHRODITISM/MENTAL RETARDATION SYNDROME, VERLOES TYPE
600123	ATRIOVENTRICULAR SEPTAL DEFECT WITH BLEPHAROPHIMOSIS AND ANAL AND RADIAL DEFECTS
600124	HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN A2/B1; HNRNPA2B1
600125	MOVED TO 126065
600126	PHOSPHODIESTERASE 4A; PDE4A
600127	PHOSPHODIESTERASE 4B; PDE4B
600128	PHOSPHODIESTERASE 4C; PDE4C
600129	PHOSPHODIESTERASE 4D; PDE4D
600130	APOLIPOPROTEIN B mRNA-EDITING ENZYME, CATALYTIC POLYPEPTIDE 1; APOBEC1
600131	EPILEPSY, CHILDHOOD ABSENCE, SUSCEPTIBILITY TO, 1; ECA1
600132	RETINITIS PIGMENTOSA 14; RP14
600133	LAMININ, ALPHA-4; LAMA4
600134	MOVED TO 605158
600135	CORTEXIN 1; CTXN1
600136	MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE 9; MAP3K9
600137	MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE 10; MAP3K10
600138	RETINITIS PIGMENTOSA 11; RP11
600139	MOVED TO 137800
600140	CREB-BINDING PROTEIN; CREBBP
600141	HEAT-SHOCK 10-KD PROTEIN; HSPE1
600142	CEREBRAL ARTERIOPATHY, AUTOSOMAL RECESSIVE, WITH SUBCORTICAL INFARCTS AND LEUKOENCEPHALOPATHY; CARASIL
600143	CEROID LIPOFUSCINOSIS, NEURONAL, 8; CLN8
600144	INOSITOL 1,4,5-TRIPHOSPHATE RECEPTOR, TYPE 2; ITPR2
600145	SACRAL DEFECT WITH ANTERIOR MENINGOCELE
600146	MOVED TO 270800
600147	MESENCHYME HOMEOBOX 1; MEOX1
600148	GLYCEROL KINASE 2; GK2
600149	GLYCEROL KINASE 3 PSEUDOGENE; GK3P
600150	POTASSIUM CHANNEL, CALCIUM-ACTIVATED, LARGE CONDUCTANCE, SUBFAMILY M, ALPHA MEMBER 1; KCNMA1
600151	BARDET-BIEDL SYNDROME 3; BBS3
600152	SEC13 HOMOLOG, NUCLEAR PORE AND COPII COAT COMPLEX COMPONENT; SEC13
600153	PHOSPHATIDYLINOSITOL GLYCAN ANCHOR BIOSYNTHESIS CLASS F PROTEIN; PIGF
600154	PHOSPHATIDYLINOSITOL GLYCAN ANCHOR BIOSYNTHESIS CLASS H PROTEIN; PIGH
600155	HIRSCHSPRUNG DISEASE, SUSCEPTIBILITY TO, 2; HSCR2
600156	HIRSCHSPRUNG DISEASE, SUSCEPTIBILITY TO, 5; HSCR5
600157	ADAPTOR-RELATED PROTEIN COMPLEX 1, BETA-1 SUBUNIT; AP1B1
600158	MOVED TO 251290
600159	PTERYGIUM COLLI AND MENTAL RETARDATION WITH FACIAL AND DIGITAL ANOMALIES
600160	CYCLIN-DEPENDENT KINASE INHIBITOR 2A; CDKN2A
600161	PRADER-WILLI/ANGELMAN REGION RNA 1; PWAR1
600162	PRADER-WILLI/ANGELMAN REGION RNA 5; PWAR5
600163	SODIUM VOLTAGE-GATED CHANNEL, ALPHA SUBUNIT 5; SCN5A
600164	GTP-BINDING MITOGEN-INDUCED T-CELL PROTEIN; GEM
600165	NANOPHTHALMOS 1; NNO1
600166	HYPERPARATHYROIDISM, PRIMARY, CAUSED BY WATER CLEAR CELL HYPERPLASIA
600167	HISTAMINE RECEPTOR H1; HRH1
600168	MACROPHAGE STIMULATING 1 RECEPTOR; MST1R
600169	MAJOR HISTOCOMPATIBILITY COMPLEX CLASS I CHAIN-RELATED GENE A; MICA
600170	AQUAPORIN 3; AQP3
600171	GONADAL AGENESIS
600172	METAL-REGULATORY TRANSCRIPTION FACTOR 1; MTF1
600173	JANUS KINASE 3; JAK3
600174	PHOSPHATIDYLINOSITOL TRANSFER PROTEIN, ALPHA; PITPNA
600175	NEURONOPATHY, DISTAL HEREDITARY MOTOR, AUTOSOMAL DOMINANT 8; HMND8
600176	PACHYGYRIA WITH IMPAIRED INTELLECTUAL DEVELOPMENT, SEIZURES, AND ARACHNOID CYSTS
600177	MOVED TO 300102
600178	MICROTUBULE-ASSOCIATED PROTEIN 1A; MAP1A
600179	GUANYLATE CYCLASE 2D, RETINAL; GUCY2D
600180	MOVED TO 108355
600181	LIPOCALIN 2; LCN2
600182	SOLUTE CARRIER FAMILY 7 (CATIONIC AMINO ACID TRANSPORTER, y+ SYSTEM), MEMBER 5; SLC7A5
600183	DUAL-SPECIFICITY PHOSPHATASE 3; DUSP3
600184	CARNITINE ACETYLTRANSFERASE; CRAT
600185	BRCA2 DNA REPAIR-ASSOCIATED PROTEIN; BRCA2
600186	MOVED TO 300016
600187	EUKARYOTIC TRANSLATION INITIATION FACTOR 5A; EIF5A
600188	TLE FAMILY MEMBER 5, TRANSCRIPTIONAL MODULATOR; TLE5
600189	TLE FAMILY MEMBER 1, TRANSCRIPTIONAL COREPRESSOR; TLE1
600190	TLE FAMILY MEMBER 3, TRANSCRIPTIONAL COREPRESSOR; TLE3
600191	MOVED TO 300018
600192	SYNOVIAL SARCOMA TRANSLOCATION, CHROMOSOME 18; SS18
600193	WAARDENBURG SYNDROME, TYPE 2B; WS2B
600194	KERATIN 2, TYPE II; KRT2
600195	VENOUS MALFORMATIONS, MULTIPLE CUTANEOUS AND MUCOSAL; VMCM
600196	MOVED TO 300019
600197	MAF bZIP TRANSCRIPTION FACTOR K; MAFK
600198	MOVED TO 163260
600199	MOVED TO 300021
600200	MOVED TO 133440
600201	AGOUTI SIGNALING PROTEIN; ASIP
600202	DYSLEXIA, SUSCEPTIBILITY TO, 2; DYX2
600203	MOVED TO 300030
600204	EPIPHYSEAL DYSPLASIA, MULTIPLE, 2; EDM2
600205	MOVED TO 107748
600206	EPIDERMAL GROWTH FACTOR RECEPTOR PATHWAY SUBSTRATE 8; EPS8
600207	HIPPOCALCIN-LIKE 1; HPCAL1
600208	MOVED TO 155100
600209	EXOSTOSES, MULTIPLE, TYPE III; EXT3
600210	RUNT-RELATED TRANSCRIPTION FACTOR 3; RUNX3
600211	RUNT-RELATED TRANSCRIPTION FACTOR 2; RUNX2
600212	FATTY ACID SYNTHASE; FASN
600213	MOVED TO 176310
600214	ADVANCED GLYCOSYLATION END PRODUCT-SPECIFIC RECEPTOR; AGER
600215	MICROFIBRILLAR-ASSOCIATED PROTEIN 1; MFAP1
600216	MOVED TO 400002
600217	MOVED TO 601545
600218	MOVED TO 600068
600219	MOVED TO 600069
600220	PHOSPHOLIPASE C, GAMMA-2; PLCG2
600221	TEK TYROSINE KINASE, ENDOTHELIAL; TEK
600222	TYROSINE KINASE WITH IMMUNOGLOBULIN AND EGF FACTOR HOMOLOGY DOMAINS 1; TIE1
600223	SPINOCEREBELLAR ATAXIA 4; SCA4
600224	SPINOCEREBELLAR ATAXIA 5; SCA5
600225	GTP CYCLOHYDROLASE I; GCH1
600226	MOVED TO 300031
600227	CYCLIN F; CCNF
600228	SODIUM CHANNEL, EPITHELIAL 1, ALPHA SUBUNIT; SCNN1A
600229	SOLUTE CARRIER FAMILY 1 (GLUTAMATE/NEUTRAL AMINO ACID TRANSPORTER), MEMBER 4; SLC1A4
600230	PHOSPHOLIPASE C, BETA-3; PLCB3
600231	PALMOPLANTAR KERATODERMA, BOTHNIAN TYPE; PPKB
600232	GAMMA-AMINOBUTYRIC ACID RECEPTOR, BETA-2; GABRB2
600233	GAMMA-AMINOBUTYRIC ACID RECEPTOR, GAMMA-3; GABRG3
600234	3-HYDROXY-3-METHYLGLUTARYL-CoA SYNTHASE 2; HMGCS2
600235	SODIUM VOLTAGE-GATED CHANNEL, BETA SUBUNIT 1; SCN1B
600236	CENTROMERIC PROTEIN F; CENPF
600237	HISTONE CELL CYCLE REGULATOR; HIRA
600238	TRANSGLUTAMINASE 3; TGM3
600239	CHEMERIN CHEMOKINE-LIKE RECEPTOR 2; CMKLR2
600240	CHEMOKINE (C-C) RECEPTOR 10; CCR10
600241	G PROTEIN-COUPLED RECEPTOR 3; GPR3
600242	CHEMOKINE, CC MOTIF, RECEPTOR 7; CCR7
600243	DEFENDER AGAINST CELL DEATH 1; DAD1
600244	PROGRAMMED CELL DEATH 1; PDCD1
600245	FIBROMODULIN; FMOD
600246	ELK4, ETS-DOMAIN PROTEIN; ELK4
600247	ELK3, ETS-DOMAIN PROTEIN; ELK3
600248	MOVED TO 300009
600249	ALDEHYDE DEHYDROGENASE 1 FAMILY, MEMBER L1; ALDH1L1
600250	CHEMOKINE, C MOTIF, LIGAND 1; XCL1
600251	FACIAL CLEFTING, OBLIQUE, 1; OBLFC1
600252	LOWRY-MACLEAN SYNDROME
600253	ARYL HYDROCARBON RECEPTOR; AHR
600254	MOVED TO 300032
600255	MOVED TO 400000
600256	MOVED TO 123155
600257	CHROMOSOME 8q12.1-q21.2 DELETION SYNDROME
600258	PMS1 HOMOLOG 1, MISMATCH REPAIR SYSTEM COMPONENT; PMS1
600259	PMS1 HOMOLOG 2, MISMATCH REPAIR SYSTEM COMPONENT; PMS2
600260	MOVED TO 300008
600261	REMOVED FROM DATABASE
600262	PROSTAGLANDIN-ENDOPEROXIDE SYNTHASE 2; PTGS2
600263	HELICOBACTER PYLORI INFECTION, SUSCEPTIBILITY TO
600264	ARGININE VASOPRESSIN RECEPTOR 1B; AVPR1B
600265	MOVED TO 300033
600266	SOLUTE CARRIER FAMILY 11 (PROTON-COUPLED DIVALENT METAL ION TRANSPORTER), MEMBER 1; SLC11A1
600267	PROTEIN-TYROSINE PHOSPHATASE, NONRECEPTOR-TYPE, 13; PTPN13
600268	OCULOECTODERMAL SYNDROME; OES
600269	SHORT TARSUS WITH ABSENCE OF LOWER EYELASHES; STALE
600270	PROCOLLAGEN C-ENDOPEPTIDASE ENHANCER; PCOLCE
600271	DESMOCOLLIN 3; DSC3
600272	COILIN; COIL
600273	POLYCYSTIC KIDNEY DISEASE, INFANTILE SEVERE, WITH TUBEROUS SCLEROSIS; PKDTS
600274	FRONTOTEMPORAL DEMENTIA; FTD
600275	NOTCH RECEPTOR 2; NOTCH2
600276	NOTCH RECEPTOR 3; NOTCH3
600277	INHIBITOR OF DNA BINDING 3; ID3
600278	RAP1 GTPase-ACTIVATING PROTEIN; RAP1GAP
600279	PEROXISOME BIOGENESIS FACTOR 19; PEX19
600280	NUCLEOTIDE-BINDING PROTEIN 1; NUBP1
600281	HEPATOCYTE NUCLEAR FACTOR 4-ALPHA; HNF4A
600282	GLUTAMATE RECEPTOR, IONOTROPIC, KAINATE 4; GRIK4
600283	GLUTAMATE RECEPTOR, IONOTROPIC, KAINATE 5; GRIK5
600284	ELONGATION FACTOR RNA POLYMERASE II; ELL
600285	EUKARYOTIC TRANSLATION TERMINATION FACTOR 1; ETF1
600286	PHOSPHATIDYLINOSITOL 4-KINASE, ALPHA; PI4KA
600287	GLYCYL-tRNA SYNTHETASE 1; GARS1
600288	FORKHEAD BOX A2; FOXA2
600289	MITOGEN-ACTIVATED PROTEIN KINASE 14; MAPK14
600290	MOVED TO 600289
600291	ADENYLATE CYCLASE 3; ADCY3
600292	ADENYLATE CYCLASE 4; ADCY4
600293	ADENYLATE CYCLASE 5; ADCY5
600294	ADENYLATE CYCLASE 6; ADCY6
600295	NATRIURETIC PEPTIDE PRECURSOR B; NPPB
600296	NATRIURETIC PEPTIDE PRECURSOR C; NPPC
600297	CAUDAL-TYPE HOMEOBOX TRANSCRIPTION FACTOR 2; CDX2
600298	LIM HOMEOBOX TRANSCRIPTION FACTOR 1, ALPHA; LMX1A
600299	PERICENTRIOLAR MATERIAL 1; PCM1
600300	SOLUTE CARRIER FAMILY 1 (GLIAL HIGH AFFINITY GLUTAMATE TRANSPORTER), MEMBER 2; SLC1A2
600301	ACYL-CoA DEHYDROGENASE, SHORT/BRANCHED CHAIN; ACADSB
600302	FRYNS MACROCEPHALY
600303	RAP GUANINE NUCLEOTIDE EXCHANGE FACTOR 1; RAPGEF1
600304	MOVED TO 170400
600305	ENOYL-CoA DELTA ISOMERASE 1; ECI1
600306	PROTEASOME SUBUNIT, BETA-TYPE, 5; PSMB5
600307	PROTEASOME SUBUNIT, BETA-TYPE, 6; PSMB6
600308	AQUAPORIN 4; AQP4
600309	MOVED TO 606215
600310	CARTILAGE OLIGOMERIC MATRIX PROTEIN; COMP
600311	GRANZYME M; GZMM
600312	NUDIX HYDROLASE 1; NUDT1
600313	MOVED TO 600535
600314	SH2 DOMAIN-CONTAINING ADAPTOR PROTEIN B; SHB
600315	TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY, MEMBER 4; TNFRSF4
600316	DEAFNESS, AUTOSOMAL RECESSIVE 3; DFNB3
600317	TROPOMYOSIN 4; TPM4
600318	TYPE 1 DIABETES MELLITUS 3; T1D3
600319	TYPE 1 DIABETES MELLITUS 4; T1D4
600320	TYPE 1 DIABETES MELLITUS 5; T1D5
600321	TYPE 1 DIABETES MELLITUS 7; T1D7
600322	SYNAPTOSOMAL-ASSOCIATED PROTEIN, 25-KD; SNAP25
600323	REGULATOR OF G PROTEIN SIGNALING 1; RGS1
600324	CHEMOKINE, CXC MOTIF, LIGAND 5; CXCL5
600325	AMINOPTERIN SYNDROME SINE AMINOPTERIN; ASSA
600326	DEAD-BOX HELICASE 6; DDX6
600327	SYNAPTOTAGMIN 3; SYT3
600328	MLLT6, PHD FINGER-CONTAINING; MLLT6
600329	OSTEOPETROSIS AND INFANTILE NEUROAXONAL DYSTROPHY
600330	MOVED TO 102500
600331	PARC SYNDROME
600332	RIPPLING MUSCLE DISEASE 1; RMD1
600333	MOTOR NEURON DISEASE WITH DEMENTIA AND OPHTHALMOPLEGIA
600334	TIBIAL MUSCULAR DYSTROPHY, TARDIVE; TMD
600335	SUCCINIC ACIDEMIA
600336	SOLUTE CARRIER FAMILY 18 (VESICULAR ACETYLCHOLINE), MEMBER 3; SLC18A3
600337	BRADYKININ RECEPTOR B1; BDKRB1
600338	ARYLACETAMIDE DEACETYLASE; AADAC
600339	HEPATOMA-DERIVED GROWTH FACTOR; HDGF
600340	PLASMOLIPIN; PLLP
600341	TYRO3 PROTEIN TYROSINE KINASE; TYRO3
600342	G PROTEIN-COUPLED RECEPTOR, RETINAL; RGR
600343	PAROTID SALIVARY GLANDS, POLYCYSTIC DYSGENETIC DISEASE OF; PDDP
600344	MOVED TO 300058
600345	BETACELLULIN; BTC
600346	POLYCOMB GROUP RING FINGER PROTEIN 2; PCGF2
600347	BREVICAN; BCAN
600348	BAND HETEROTOPIA; BH
600349	INHIBITOR OF DNA BINDING 1; ID1
600350	MOVED TO 300034
600351	ENTEROPATHY, FAMILIAL, WITH VILLOUS EDEMA AND IMMUNOGLOBULIN G2 DEFICIENCY
600352	MOVED TO 112205
600353	S100 CALCIUM-BINDING PROTEIN A7; S100A7
600354	SURVIVAL OF MOTOR NEURON 1; SMN1
600355	NEURONAL APOPTOSIS INHIBITORY PROTEIN; NAIP
600356	PACHYDERMODACTYLY, FAMILIAL
600357	RIBOSOMAL PROTEIN S8; RPS8
600358	GUANINE MONOPHOSPHATE SYNTHETASE; GMPS
600359	POTASSIUM CHANNEL, INWARDLY RECTIFYING, SUBFAMILY J, MEMBER 1; KCNJ1
600360	APLASIA CUTIS CONGENITA OF LIMBS, AUTOSOMAL RECESSIVE
600361	HEREDITARY MOTOR AND SENSORY NEUROPATHY V
600362	FLII ACTIN REMODELING PROTEIN; FLII
600363	SPASTIC PARAPLEGIA 6, AUTOSOMAL DOMINANT; SPG6
600364	GUANYLATE CYCLASE ACTIVATOR 1A; GUCA1A
600365	ABR ACTIVATOR OF RhoGEF AND GTPase; ABR
600366	ISL LIM HOMEOBOX 1; ISL1
600367	CLEAVAGE STIMULATION FACTOR, 3-PRIME PRE-RNA, SUBUNIT 3, 77-KD; CSTF3
600368	MOVED TO 300907
600369	CLEAVAGE STIMULATION FACTOR, 3-PRIME PRE-RNA, SUBUNIT 1, 50-KD; CSTF1
600370	SOLUTE CARRIER FAMILY 25 (MITOCHONDRIAL CARRIER), MEMBER 3; SLC25A3
600371	MOVED TO 142695
600372	NEURAL PRECURSOR CELL EXPRESSED, DEVELOPMENTALLY DOWNREGULATED 1; NEDD1
600373	CODAS SYNDROME
600374	BBS4 GENE; BBS4
600375	X-RAY REPAIR CROSS COMPLEMENTING 2; XRCC2
600376	TELANGIECTASIA, HEREDITARY HEMORRHAGIC, TYPE 2; HHT2
600377	GALANIN RECEPTOR 1; GALR1
600378	INNER MEMBRANE PROTEIN, MITOCHONDRIAL; IMMT
600379	MYELIN TRANSCRIPTION FACTOR 1; MYT1
600380	NUCLEAR RECEPTOR SUBFAMILY 1, GROUP H, MEMBER 2; NR1H2
600381	KINECTIN; KTN1
600382	MYC PROMOTER-BINDING PROTEIN
600383	MESOMELIA-SYNOSTOSES SYNDROME
600384	APHALANGIA, PARTIAL, WITH SYNDACTYLY AND DUPLICATION OF METATARSAL IV
600385	ADENYLATE CYCLASE 7; ADCY7
600386	INHIBITOR OF DNA BINDING 2; ID2
600387	BONE MARROW STROMAL CELL ANTIGEN 1; BST1
600388	MEPRIN, ALPHA SUBUNIT; MEP1A
600389	MEPRIN, BETA SUBUNIT; MEP1B
600390	UPSTREAM TRANSCRIPTION FACTOR 2, FOS-INTERACTING; USF2
600391	GLUCOSAMINYL (N-ACETYL) TRANSFERASE 1, CORE 2; GCNT1
600392	RAD52 HOMOLOG, DNA REPAIR PROTEIN; RAD52
600393	FLAP STRUCTURE-SPECIFIC ENDONUCLEASE 1; FEN1
600394	MOVED TO 300036
600395	GLYPICAN 1; GPC1
600396	DEAH-BOX HELICASE 8; DHX8
600397	POTASSIUM CHANNEL, VOLTAGE-GATED, SHAB-RELATED SUBFAMILY, MEMBER 1; KCNB1
600398	ZINC FINGER PROTEIN 160; ZNF160
600399	PECTUS EXCAVATUM, MACROCEPHALY, SHORT STATURE, AND DYSPLASTIC NAILS
600400	PROLYL ENDOPEPTIDASE; PREP
600401	MOVED TO 600247
600402	MOVED TO 300035
600403	FIBROBLAST ACTIVATION PROTEIN, ALPHA; FAP
600404	REPLICATION FACTOR C, SUBUNIT 2; RFC2
600405	REPLICATION FACTOR C, SUBUNIT 3; RFC3
600406	MOVED TO 102577
600407	REPLICATION FACTOR C, SUBUNIT 5; RFC5
600408	DISCOIDIN DOMAIN RECEPTOR FAMILY, MEMBER 1; DDR1
600409	PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR-DELTA; PPARD
600410	TUMOR NECROSIS FACTOR-ALPHA-INDUCED PROTEIN 6; TNFAIP6
600411	GUANYLATE-BINDING PROTEIN 1, INTERFERON-INDUCIBLE, 67-KD; GBP1
600412	GUANYLATE-BINDING PROTEIN 2, INTERFERON-INDUCIBLE; GBP2
600413	GUANYLATE-BINDING PROTEIN 3; GBP3
600414	PEROXISOME BIOGENESIS FACTOR 5; PEX5
600415	TOCOPHEROL TRANSFER PROTEIN, ALPHA; TTPA
600416	MUSCULAR DYSTROPHY, SCAPULOHUMERAL
600417	5-PRIME-NUCLEOTIDASE, CYTOSOLIC II; NT5C2
600418	AMPHIPHYSIN; AMPH
600419	ANGIOKERATOMA CORPORIS DIFFUSUM WITH ARTERIOVENOUS FISTULAS
600420	MOVED TO 300039
600421	GLYCINE RECEPTOR, ALPHA-3 SUBUNIT; GLRA3
600422	FATTY ACID-BINDING PROTEIN 6; FABP6
600423	ENDOTHELIN-CONVERTING ENZYME 1; ECE1
600424	SOLUTE CARRIER FAMILY 19 (FOLATE TRANSPORTER), MEMBER 1; SLC19A1
600425	MOVED TO 189902
600426	E2F TRANSCRIPTION FACTOR 2; E2F2
600427	E2F TRANSCRIPTION FACTOR 3; E2F3
600428	VAV GUANINE NUCLEOTIDE EXCHANGE FACTOR 2; VAV2
600429	GLUCOSAMINYL (N-ACETYL) TRANSFERASE 2, I-BRANCHING ENZYME; GCNT2
600430	CHROMOSOME 2q37 DELETION SYNDROME
600431	CYCLIN-DEPENDENT KINASE INHIBITOR 2B; CDKN2B
600432	PRECEREBELLIN 1; CBLN1
600433	PRECEREBELLIN 2; CBLN2
600434	FATTY ACID-BINDING PROTEIN 4; FABP4
600435	CARDIOTROPHIN 1; CTF1
600436	GLUTATHIONE S-TRANSFERASE, THETA-1; GSTT1
600437	GLUTATHIONE S-TRANSFERASE, THETA-2; GSTT2
600438	TRANSCRIPTION FACTOR A, MITOCHONDRIAL; TFAM
600439	SINGLE-STRANDED DNA-BINDING PROTEIN 1; SSBP1
600440	ENDONUCLEASE G, MITOCHONDRIAL; ENDOG
600441	GROWTH ARREST-SPECIFIC 6; GAS6
600442	AQUAPORIN 5; AQP5
600443	GLUTAREDOXIN; GLRX
600444	SOLUTE CARRIER FAMILY 5 (INOSITOL TRANSPORTER), MEMBER 3; SLC5A3
600445	ADENOSINE A3 RECEPTOR; ADORA3
600446	ADENOSINE A2B RECEPTOR; ADORA2B
600447	MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE 12; MAP3K12
600448	PROTEIN KINASE C, THETA; PRKCQ
600449	ALDO-KETO REDUCTASE FAMILY 1, MEMBER 1; AKR1C1
600450	ALDO-KETO REDUCTASE FAMILY 1, MEMBER C2; AKR1C2
600451	ALDO-KETO REDUCTASE FAMILY 1, MEMBER C4; AKR1C4
600452	MOVED TO 600408
600453	TRIPARTITE MOTIF-CONTAINING PROTEIN 25; TRIM25
600454	RIBOSOMAL PROTEIN S3; RPS3
600455	RNA, U15A SMALL NUCLEOLAR; RNU15A
600456	NEUROTROPHIC TYROSINE KINASE, RECEPTOR, TYPE 2; NTRK2
600457	HYPERTRICHOSIS, ANTERIOR CERVICAL
600458	ADENOMYOSIS
600459	ARTERIAL DISSECTION WITH LENTIGINOSIS
600460	CLEFT PALATE, CARDIAC DEFECT, GENITAL ANOMALIES, AND ECTRODACTYLY
600461	HEMOLYTIC ANEMIA, LETHAL CONGENITAL NONSPHEROCYTIC, WITH GENITAL AND OTHER ABNORMALITIES
600462	MYOPATHY, LACTIC ACIDOSIS, AND SIDEROBLASTIC ANEMIA 1; MLASA1
600463	ALDEHYDE DEHYDROGENASE 1 FAMILY, MEMBER A3; ALDH1A3
600464	ADP-RIBOSYLATION FACTOR 6; ARF6
600465	ANKYRIN 3; ANK3
600466	ALDEHYDE DEHYDROGENASE 3 FAMILY, MEMBER B1; ALDH3B1
600467	MALIGNANT HYPERTHERMIA, SUSCEPTIBILITY TO, 4
600468	MOVED TO 300011
600469	NUCLEAR CAP-BINDING PROTEIN 1; NCBP1
600470	ZIC FAMILY, MEMBER 1; ZIC1
600471	DEFENSIN, ALPHA, 6; DEFA6
600472	DEFENSIN, ALPHA, 5; DEFA5
600473	PURINE-RICH ELEMENT-BINDING PROTEIN A; PURA
600474	CATHELICIDIN ANTIMICROBIAL PEPTIDE; CAMP
600475	TAF10 RNA POLYMERASE II, TATA BOX-BINDING PROTEIN-ASSOCIATED FACTOR, 30-KD; TAF10
600476	MOVED TO 300040
600477	SOLUTE CARRIER FAMILY 9, MEMBER 5; SLC9A5
600478	SKI2 SUBUNIT OF SUPERKILLER COMPLEX; SKIC2
600479	MOVED TO 120324
600480	TRANSCRIPTION FACTOR 12; TCF12
600481	STEROL REGULATORY ELEMENT-BINDING TRANSCRIPTION FACTOR 2; SREBF2
600482	MOVED TO 300116
600483	FIBROBLAST GROWTH FACTOR 8; FGF8
600484	MOVED TO 300002
600485	MOVED TO 300003
600486	MOVED TO 300076
600487	PROPROTEIN CONVERTASE, SUBTILISIN/KEXIN-TYPE, 4; PCSK4
600488	PROPROTEIN CONVERTASE, SUBTILISIN/KEXIN-TYPE, 5; PCSK5
600489	NUCLEAR FACTOR OF ACTIVATED T CELLS, CYTOPLASMIC, CALCINEURIN-DEPENDENT 1; NFATC1
600490	NUCLEAR FACTOR OF ACTIVATED T CELLS, CYTOPLASMIC, CALCINEURIN-DEPENDENT 2; NFATC2
600491	MICROFIBRILLAR-ASSOCIATED PROTEIN 3; MFAP3
600492	NUCLEAR FACTOR ERYTHROID 2-LIKE 2; NFE2L2
600493	ADHESION G PROTEIN-COUPLED RECEPTOR E1; ADGRE1
600494	POU DOMAIN, CLASS 3, TRANSCRIPTION FACTOR 2; POU3F2
600495	EUKARYOTIC TRANSLATION INITIATION FACTOR 4-GAMMA, 1; EIF4G1
600496	MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 3; MODY3
600497	PROTEIN KINASE, AMP-ACTIVATED, CATALYTIC, ALPHA-2; PRKAA2
600498	MOVED TO 313470
600499	REMOVED FROM DATABASE
600500	MOVED TO 600758
600501	ABCD SYNDROME; ABCDS
600502	IMMUNOGLOBULIN MU-BINDING PROTEIN 2; IGHMBP2
600503	SUB1 REGULATOR OF TRANSCRIPTION; SUB1
600504	POTASSIUM CHANNEL, INWARDLY RECTIFYING, SUBFAMILY J, MEMBER 4; KCNJ4
600505	CASEIN KINASE I, ALPHA-1; CSNK1A1
600506	MOVED TO 604286
600507	MOVED TO 601177
600508	NCK ADAPTOR PROTEIN 1; NCK1
600509	ATP-BINDING CASSETTE, SUBFAMILY C, MEMBER 8; ABCC8
600510	OCULAR PIGMENT DISPERSION WITH OR WITHOUT GLAUCOMA; OPDG
600511	SCHIZOPHRENIA 3; SCZD3
600512	EPILEPSY, FAMILIAL TEMPORAL LOBE, 1; ETL1
600513	EPILEPSY, NOCTURNAL FRONTAL LOBE, 1; ENFL1
600514	REELIN; RELN
600515	PURINERGIC RECEPTOR P2Y, G PROTEIN-COUPLED, 12; P2RY12
600516	BCL2 ANTAGONIST KILLER 1; BAK1
600517	SERPIN PEPTIDASE INHIBITOR, CLADE B (OVALBUMIN), MEMBER 3; SERPINB3
600518	SERPIN PEPTIDASE INHIBITOR, CLADE B (OVALBUMIN), MEMBER 4; SERPINB4
600519	GENERAL TRANSCRIPTION FACTOR IIA, GAMMA SUBUNIT; GTF2A2
600520	GENERAL TRANSCRIPTION FACTOR IIA, ALPHA/BETA SUBUNITS; GTF2A1
600521	MANNAN-BINDING LECTIN SERINE PROTEASE 1; MASP1
600522	PHOSPHOLIPASE A2, GROUP IVA; PLA2G4A
600523	SOLUTE CARRIER FAMILY 11 (PROTON-COUPLED DIVALENT METAL ION TRANSPORTER), MEMBER 2; SLC11A2
600524	RYK RECEPTOR-LIKE TYROSINE KINASE; RYK
600525	DISTAL-LESS HOMEOBOX 3; DLX3
600526	MAP/MICROTUBULE AFFINITY-REGULATING KINASE 2; MARK2
600527	EPHRIN B2; EFNB2
600528	CARNITINE PALMITOYLTRANSFERASE I, LIVER; CPT1A
600529	AU-SPECIFIC RNA-BINDING PROTEIN; AUH
600530	SOLUTE CARRIER FAMILY 9, MEMBER 2; SLC9A2
600531	SOLUTE CARRIER FAMILY 9, MEMBER 4; SLC9A4
600532	NADH-UBIQUINONE OXIDOREDUCTASE FLAVOPROTEIN 2; NDUFV2
600533	VANGL PLANAR CELL POLARITY PROTEIN 2; VANGL2
600534	BONE MARROW STROMAL CELL ANTIGEN 2; BST2
600535	MESENCHYME HOMEOBOX 2; MEOX2
600536	INTEGRIN, ALPHA-7; ITGA7
600537	RECQ PROTEIN-LIKE; RECQL
600538	PEROXIREDOXIN 2; PRDX2
600539	PROTEIN KINASE C, IOTA FORM; PRKCI
600540	TRANSCRIPTION FACTOR Sp4; SP4
600541	ETS VARIANT TRANSCRIPTION FACTOR 1; ETV1
600542	NUCLEAR RECEPTOR SUBFAMILY 4, GROUP A, MEMBER 3; NR4A3
600543	ERB-B2 RECEPTOR TYROSINE KINASE 4; ERBB4
600544	SOLUTE CARRIER FAMILY 15 (OLIGOPEPTIDE TRANSPORTER), MEMBER 1; SLC15A1
600545	MOVED TO 300240
600546	INTRAUTERINE GROWTH RETARDATION WITH INCREASED MITOMYCIN C SENSITIVITY
600547	CYSTEINE CONJUGATE BETA-LYASE 1; CCBL1
600548	HEAT-SHOCK 70-KD PROTEIN 9; HSPA9
600549	IK CYTOKINE, DOWNREGULATOR OF HLA II; IK
600550	CATHEPSIN O; CTSO
600551	G PROTEIN-COUPLED RECEPTOR 4; GPR4
600552	CHEMOKINE, C MOTIF, RECEPTOR 1; XCR1
600553	G PROTEIN-COUPLED RECEPTOR 6; GPR6
600554	INTERLEUKIN 15; IL15
600555	SIGNAL TRANSDUCER AND ACTIVATOR OF TRANSCRIPTION 1; STAT1
600556	SIGNAL TRANSDUCER AND ACTIVATOR OF TRANSCRIPTION 2; STAT2
600557	MOVED TO 102582
600558	SIGNAL TRANSDUCER AND ACTIVATOR OF TRANSCRIPTION 4; STAT4
600559	HYDROCEPHALUS, ENDOCARDIAL FIBROELASTOSIS, AND CATARACTS
600560	SHC TRANSFORMING PROTEIN 1; SHC1
600561	SPONDYLOEPIPHYSEAL DYSPLASIA WITH ATLANTOAXIAL INSTABILITY
600562	CADHERIN 12; CDH12
600563	PROSTAGLANDIN F RECEPTOR; PTGFR
600564	INTER-ALPHA-TRYPSIN INHIBITOR, HEAVY CHAIN 4; ITIH4
600565	NEUREXIN I; NRXN1
600566	NEUREXIN II; NRXN2
600567	NEUREXIN III; NRXN3
600568	NEUROLIGIN 1; NLGN1
600569	MOVED TO 300103
600570	CHLORIDE CHANNEL 2; CLCN2
600571	RE1-SILENCING TRANSCRIPTION FACTOR; REST
600572	SPLICING FACTOR, SERINE/ARGININE-RICH, 7; SRSF7
600573	TAF7 RNA POLYMERASE II, TATA BOX-BINDING PROTEIN-ASSOCIATED FACTOR, 55-KD; TAF7
600574	LEUCINE ZIPPER-LIKE TRANSCRIPTIONAL REGULATOR 1; LZTR1
600575	TRANSLIN; TSN
600576	GATA-BINDING PROTEIN 4; GATA4
600577	LIM HOMEOBOX GENE 3; LHX3
600578	OLFACTORY RECEPTOR, FAMILY 2, SUBFAMILY H, MEMBER 3; OR2H3
600579	PROTEIN-TYROSINE PHOSPHATASE, RECEPTOR-TYPE, O; PTPRO
600580	CHLORIDE CHANNEL 3; CLCN3
600581	INHIBITOR OF DNA BINDING 4; ID4
600582	ASPARTATE BETA-HYDROXYLASE; ASPH
600583	TEC PROTEIN TYROSINE KINASE; TEC
600584	NK2 HOMEOBOX 5; NKX2-5
600585	TRANSGLUTAMINASE 4; TGM4
600586	EPITHELIAL CELL TRANSFORMING SEQUENCE 2 ONCOGENE; ECT2
600587	POM121/ZP3 FUSION PROTEIN; POMZP3
600588	MOVED TO 188025
600589	SERUM RESPONSE FACTOR; SRF
600590	PROTEIN PHOSPHATASE 1, CATALYTIC SUBUNIT, BETA ISOFORM; PPP1CB
600591	SMALL NUCLEAR RNA-ACTIVATING PROTEIN COMPLEX, POLYPEPTIDE 1; SNAPC1
600592	MINICHROMOSOME MAINTENANCE COMPLEX COMPONENT 7; MCM7
600593	CRANIOSYNOSTOSIS, ADELAIDE TYPE; CRSA
600594	DIGEORGE SYNDROME CRITICAL REGION GENE 2; DGCR2
600595	INTRAFLAGELLAR TRANSPORT 88; IFT88
600596	MICROFIBRILLAR-ASSOCIATED PROTEIN 4; MFAP4
600597	PHOSPHOLIPASE C-LIKE 1; PLCL1
600598	SETTING-SUN PHENOMENON, FAMILIAL BENIGN
600599	KRUPPEL-LIKE FACTOR 1; KLF1
600600	EPHRIN RECEPTOR EphB1; EPHB1
600601	MOVED TO 600289
600602	MOVED TO 300083
600603	MOVED TO 300071
600604	MOVED TO 600376
600605	METAXIN 1; MTX1
600606	REMOVED FROM DATABASE
600607	VACUOLAR PROTEIN SORTING 72 HOMOLOG; VPS72
600608	PROCOLLAGEN-PROLINE, 2-OXOGLUTARATE-4-DIOXYGENASE, ALPHA SUBUNIT, ISOFORM 2; P4HA2
600609	GA-BINDING PROTEIN TRANSCRIPTION FACTOR, ALPHA SUBUNIT; GABPA
600610	GA-BINDING PROTEIN TRANSCRIPTION FACTOR, BETA SUBUNIT; GABPB
600611	FK506-BINDING PROTEIN 4; FKBP4
600612	MOVED TO 300101
600613	NEUROBLASTOMA CANDIDATE REGION, SUPPRESSION OF TUMORIGENICITY 1; NBL1
600614	S100 CALCIUM-BINDING PROTEIN P; S100P
600615	LECTIN, GALACTOSIDE-BINDING, SOLUBLE, 7; LGALS7
600616	LUMICAN; LUM
600617	STEROIDOGENIC ACUTE REGULATORY PROTEIN; STAR
600618	ETS VARIANT TRANSCRIPTION FACTOR 6; ETV6
600619	MOVED TO 300097
600620	FK506-BINDING PROTEIN 1B; FKBP1B
600621	STATHMIN-LIKE 2; STMN2
600622	MOVED TO 300069
600623	CD82 ANTIGEN; CD82
600624	CONE-ROD DYSTROPHY 1; CORD1
600625	OROFACIAL CLEFT 11; OFC11
600626	LECTIN, GALACTOSIDE-BINDING, SOLUBLE, 3 BINDING PROTEIN; LGALS3BP
600627	HYPERTRYPTOPHANEMIA; HYPTRP
600628	LOOSE ANAGEN HAIR SYNDROME
600629	MAJOR HISTOCOMPATIBILITY COMPLEX, CLASS II, DO BETA; HLA-DOB
600630	UV-SENSITIVE SYNDROME 1; UVSS1
600631	ENURESIS, NOCTURNAL, 1; ENUR1
600632	OPIOID-BINDING PROTEIN/CELL ADHESION MOLECULE-LIKE; OPCML
600633	TREFOIL FACTOR 3; TFF3
600634	MOVED TO 102200
600635	NK2 HOMEOBOX 1; NKX2-1
600636	CASPASE 3, APOPTOSIS-RELATED CYSTEINE PROTEASE; CASP3
600637	SOLUTE CARRIER FAMILY 1 (HIGH AFFINITY ASPARTATE/GLUTAMATE TRANSPORTER), MEMBER 6; SLC1A6
600638	FIBROSIS OF EXTRAOCULAR MUSCLES, CONGENITAL, 3A, WITH OR WITHOUT EXTRAOCULAR INVOLVEMENT; CFEOM3A
600639	CASPASE 2, APOPTOSIS-RELATED CYSTEINE PROTEASE; CASP2
600640	MOVED TO 311770
600641	SULFOTRANSFERASE FAMILY 1A, CYTOSOLIC, PHENOL-PREFERRING, MEMBER 3; SULT1A3
600642	MYOSIN IG; MYO1G
600643	CAROLI DISEASE, ISOLATED
600644	NECTIN CELL ADHESION MOLECULE 1; NECTIN1
600645	MOVED TO 600579
600646	PROTEIN C RECEPTOR; PROCR
600647	H6 FAMILY HOMEOBOX 2; HMX2
600648	MOVED TO 113800
600649	CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, INFANTILE
600650	CARNITINE PALMITOYLTRANSFERASE II; CPT2
600651	FRAGILE SITE 11B; FRA11B
600652	DEAFNESS, AUTOSOMAL DOMINANT 4A; DFNA4A
600653	MOVED TO 600381
600654	PROTEASOME ACTIVATOR SUBUNIT 1; PSME1
600655	EUKARYOTIC TRANSLATION ELONGATION FACTOR 1, BETA-2; EEF1B2
600656	MOVED TO 600655
600657	MOVED TO 300140
600658	PROTEIN PHOSPHATASE 5, CATALYTIC SUBUNIT; PPP5C
600659	E2F TRANSCRIPTION FACTOR 4; E2F4
600660	MYOCYTE ENHANCER FACTOR 2A; MEF2A
600661	MYOCYTE ENHANCER FACTOR 2B; MEF2B
600662	MYOCYTE ENHANCER FACTOR 2C; MEF2C
600663	MYOCYTE ENHANCER FACTOR 2D; MEF2D
600664	COMPONENT OF NUCLEAR FACTOR KAPPA-B KINASE COMPLEX; CHUK
600665	MELATONIN RECEPTOR 1A; MTNR1A
600666	POLYCYSTIC KIDNEY DISEASE 3 WITH OR WITHOUT POLYCYSTIC LIVER DISEASE; PKD3
600667	FRIZZLED CLASS RECEPTOR 2; FZD2
600668	CHONDROCALCINOSIS 1; CCAL1
600669	EPILEPSY, IDIOPATHIC GENERALIZED; EIG
600670	VARICELLA, SEVERE RECURRENT
600671	MOVED TO 600594
600672	MOVED TO 300025
600673	UPSTREAM BINDING TRANSCRIPTION FACTOR (RNA POLYMERASE I); UBTF
600674	MICROTIA-ANOTIA
600675	X-RAY REPAIR CROSS COMPLEMENTING 3; XRCC3
600676	CATR TUMORIGENIC CONVERSION 1; CATR1
600677	MOVED TO 300192
600678	MutS HOMOLOG 6; MSH6
600679	DERMOID CYSTS, FAMILIAL FRONTONASAL
600680	MOVED TO 256730
600681	POTASSIUM CHANNEL, INWARDLY RECTIFYING, SUBFAMILY J, MEMBER 2; KCNJ2
600682	SOLUTE CARRIER FAMILY 16 (MONOCARBOXYLIC ACID TRANSPORTER), MEMBER 1; SLC16A1
600683	MOVED TO 109190
600684	T-LYMPHOCYTE SURFACE ANTIGEN LY-9; LY9
600685	KARYOPHERIN ALPHA-2; KPNA2
600686	KARYOPHERIN ALPHA-1; KPNA1
600687	T-CELL LYMPHOMA INVASION AND METASTASIS 1; TIAM1
600688	CARBOXYPEPTIDASE A2, PANCREATIC; CPA2
600689	MOVED TO 300096
600690	T-CELL LEUKEMIA TRANSLOCATION-ASSOCIATED GENE; TCTA
600691	SOLUTE CARRIER FAMILY 27 (FATTY ACID TRANSPORTER), MEMBER 1; SLC27A1
600692	TROPONIN T3, FAST SKELETAL; TNNT3
600693	POLYPYRIMIDINE TRACT-BINDING PROTEIN 1; PTBP1
600694	INTERLEUKIN 6 CYTOKINE FAMILY SIGNAL TRANSDUCER; IL6ST
600695	MOVED TO 601434
600696	ENOYL-CoA HYDRATASE 1, PEROXISOMAL; ECH1
600697	RETINOBLASTOMA-BINDING PROTEIN 5; RBBP5
600698	HIGH MOBILITY GROUP AT-HOOK 2; HMGA2
600699	MOVED TO 400003
600700	LIM DOMAIN-CONTAINING PREFERRED TRANSLOCATION PARTNER IN LIPOMA; LPP
600701	HIGH MOBILITY GROUP AT-HOOK 1; HMGA1
600702	SODIUM VOLTAGE-GATED CHANNEL, ALPHA SUBUNIT 8; SCN8A
600703	RIBOSOMAL PROTEIN S1-LIKE; RPS1L
600704	MOVED TO 300047
600705	SATOYOSHI SYNDROME
600706	PROXIMAL MYOPATHY WITH FOCAL DEPLETION OF MITOCHONDRIA
600707	SIGNAL RECOGNITION PARTICLE, 9-KD; SRP9
600708	SIGNAL RECOGNITION PARTICLE, 14-KD; SRP14
600709	ISOLEUCYL-tRNA SYNTHETASE 1; IARS1
600710	MOVED TO 600564
600711	ETS VARIANT TRANSCRIPTION FACTOR 4; ETV4
600712	HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN K; HNRNPK
600713	11-BETA-HYDROXYSTEROID DEHYDROGENASE, TYPE I; HSD11B1
600714	DUAL-SPECIFICITY PHOSPHATASE 1; DUSP1
600715	THROMBOSPONDIN IV; THBS4
600716	PROTEIN TYROSINE PHOSPHATASE, NONRECEPTOR-TYPE, 22; PTPN22
600717	MOVED TO 120165
600718	MOVED TO 185535
600719	NITRIC OXIDE SYNTHASE 2B; NOS2B
600720	NITRIC OXIDE SYNTHASE 2 PSEUDOGENE 1; NOS2P1
600721	D-2-HYDROXYGLUTARIC ACIDURIA 1; D2HGA1
600722	PALMITOYL-PROTEIN THIOESTERASE 1; PPT1
600723	MEMBRANE PROTEIN, PALMITOYLATED 2; MPP2
600724	CYCLIC NUCLEOTIDE-GATED CHANNEL, BETA-1; CNGB1
600725	SONIC HEDGEHOG SIGNALING MOLECULE; SHH
600726	INDIAN HEDGEHOG SIGNALING MOLECULE; IHH
600727	NUCLEAR FACTOR I/A; NFIA
600728	NUCLEAR FACTOR I/B; NFIB
600729	NUCLEAR FACTOR I/C; NFIC
600730	NEUROPEPTIDES B AND W RECEPTOR 1; NPBWR1
600731	G PROTEIN-COUPLED RECEPTOR 8; GPR8
600732	ADP-RIBOSYLATION FACTOR-LIKE GTPase 4D; ARL4D
600733	PANCREAS/DUODENUM HOMEOBOX PROTEIN 1; PDX1
600734	POTASSIUM CHANNEL, INWARDLY RECTIFYING, SUBFAMILY J, MEMBER 5; KCNJ5
600735	INTERFERON-INDUCED PROTEIN 35; IFI35
600736	VELOFACIOSKELETAL SYNDROME
600737	MOVED TO 605820
600738	SELECTIN P LIGAND; SELPLG
600739	SHC-LIKE PROTEIN; SHCL1
600740	HYPOCALCIURIC HYPERCALCEMIA, FAMILIAL, TYPE III; HHC3
600741	MOVED TO 176636
600742	TRANSFORMING GROWTH FACTOR-BETA RECEPTOR, TYPE III; TGFBR3
600743	TRANSCRIPTION FACTOR AP4; TFAP4
600744	T-CELL TRANSCRIPTION FACTOR EB; TFEB
600745	APOLIPOPROTEIN C-IV; APOC4
600746	CAUDAL-TYPE HOMEOBOX TRANSCRIPTION FACTOR 1; CDX1
600747	T-BOX TRANSCRIPTION FACTOR 2; TBX2
600748	TRANSMEMBRANE BAX INHIBITOR MOTIF-CONTAINING PROTEIN 6; TMBIM6
600749	CCAAT/ENHANCER-BINDING PROTEIN, EPSILON; CEBPE
600750	NEURONAL PENTRAXIN 2; NPTX2
600751	SIALIC ACID-BINDING IMMUNOGLOBULIN-LIKE LECTIN 1; SIGLEC1
600752	G PROTEIN-COUPLED RECEPTOR 12; GPR12
600753	GOLGI APPARATUS PROTEIN 1; GLG1
600754	MATRIX METALLOPROTEINASE 14; MMP14
600755	SYNAPSIN II; SYN2
600756	PROTEIN PHOSPHATASE 2 PHOSPHATASE ACTIVATOR; PTPA
600757	OROFACIAL CLEFT 3; OFC3
600758	PROTEIN-TYROSINE KINASE, CYTOPLASMIC; PTK2
600759	PRESENILIN 2; PSEN2
600760	SODIUM CHANNEL, EPITHELIAL 1, BETA SUBUNIT; SCNN1B
600761	SODIUM CHANNEL, EPITHELIAL 1, GAMMA SUBUNIT; SCNN1G
600762	HUMAN PAPILLOMAVIRUS E5 CENTRAL SEQUENCE-LIKE 1; HPVC1
600763	TUMOR PROTEIN, TRANSLATIONALLY-CONTROLLED 1; TPT1
600764	MAJOR HISTOCOMPATIBILITY COMPLEX, CLASS I-RELATED; MR1
600765	MOVED TO 600137
600766	MOVED TO 300104
600767	GDP-DISSOCIATION INHIBITOR 2; GDI2
600768	PROTEIN-TYROSINE PHOSPHATASE, NONRECEPTOR-TYPE, 9; PTPN9
600769	TETRASPANIN 8; TSPAN8
600770	MUCIN 5, SUBTYPE B, TRACHEOBRONCHIAL; MUC5B
600771	DWARFISM, FAMILIAL, WITH MUSCLE SPASMS
600772	TAF11 RNA POLYMERASE II, TATA BOX-BINDING PROTEIN-ASSOCIATED FACTOR, 28-KD; TAF11
600773	TAF12 RNA POLYMERASE II, TATA BOX-BINDING PROTEIN-ASSOCIATED FACTOR, 20-KD; TAF12
600774	TAF13 RNA POLYMERASE II, TATA BOX-BINDING PROTEIN-ASSOCIATED FACTOR, 18-KD; TAF13
600775	CRANIOSYNOSTOSIS 4; CRS4
600776	FRYNS MICROPHTHALMIA SYNDROME
600777	TRANSCRIPTION TERMINATION FACTOR, RNA POLYMERASE I; TTF1
600778	CYCLIN-DEPENDENT KINASE INHIBITOR 1B; CDKN1B
600779	MOVED TO 164874
600780	MOVED TO 241410
600781	PEPTIDE YY; PYY
600782	SYNAPTOTAGMIN 5; SYT5
600783	HISTIDYL-tRNA SYNTHETASE 2; HARS2
600784	GRANZYME K; GZMK
600785	VITAMIN D-DEPENDENT RICKETS, TYPE 2B, WITH NORMAL VITAMIN D RECEPTOR; VDDR2B
600786	ELONGIN A; ELOA
600787	ELONGIN B; ELOB
600788	ELONGIN C; ELOC
600789	RIBOSOMAL PROTEIN L23-LIKE; RPL23L
600790	CHORIORETINAL ATROPHY, PROGRESSIVE BIFOCAL; PBCRA
600791	DEAFNESS, AUTOSOMAL RECESSIVE 4, WITH ENLARGED VESTIBULAR AQUEDUCT; DFNB4
600792	DEAFNESS, AUTOSOMAL RECESSIVE 5; DFNB5
600793	MOVED TO 300081
600794	NEURONOPATHY, DISTAL HEREDITARY MOTOR, AUTOSOMAL DOMINANT 5; HMND5
600795	FRONTOTEMPORAL DEMENTIA AND/OR AMYOTROPHIC LATERAL SCLEROSIS 7; FTDALS7
600796	SPLICING FACTOR 3A, SUBUNIT 2; SF3A2
600797	INSULIN RECEPTOR SUBSTRATE 2; IRS2
600798	NECTIN CELL ADHESION MOLECULE 2; NECTIN2
600799	BONE MORPHOGENETIC PROTEIN RECEPTOR, TYPE II; BMPR2
600800	NGFIA-BINDING PROTEIN; NAB1
600801	ISOPROTERENOL-MEDIATED VASODILATATION
600802	SEVERE COMBINED IMMUNODEFICIENCY, AUTOSOMAL RECESSIVE, T CELL-NEGATIVE, B CELL-POSITIVE, NK CELL-NEGATIVE
600803	GALLBLADDER DISEASE 1; GBD1
600804	MELATONIN RECEPTOR 1B; MTNR1B
600805	LAMININ, ALPHA-3; LAMA3
600806	CALPONIN 1; CNN1
600807	ASTHMA, SUSCEPTIBILITY TO
600808	ENURESIS, NOCTURNAL, 2; ENUR2
600809	MOVED TO 132890
600810	PHOSPHOLIPASE C, BETA-4; PLCB4
600811	DNA DAMAGE-BINDING PROTEIN 2; DDB2
600812	SPLICING FACTOR, SERINE/ARGININE-RICH, 1; SRSF1
600813	SPLICING FACTOR, SERINE/ARGININE-RICH, 2; SRSF2
600814	MRE11 HOMOLOG, DOUBLE-STRAND BREAK REPAIR NUCLEASE; MRE11
600815	POLYMERASE (DNA-DIRECTED), DELTA 2, REGULATORY SUBUNIT; POLD2
600816	HEAT-SHOCK 70-KD PROTEIN 8; HSPA8
600817	VISININ-LIKE 1; VSNL1
600818	TRANSGELIN; TAGLN
600819	FMR1 AUTOSOMAL HOMOLOG 1; FXR1
600820	ARCHAIN 1; ARCN1
600821	ARGININE VASOPRESSIN RECEPTOR 1A; AVPR1A
600822	TATA BOX-BINDING PROTEIN-ASSOCIATED FACTOR 9; TAF9
600823	PROTEASE, SERINE, 8; PRSS8
600824	CYSTEINE- AND GLYCINE-RICH PROTEIN 3; CSRP3
600825	RAR-RELATED ORPHAN RECEPTOR A; RORA
600826	CHONDROITIN SULFATE PROTEOGLYCAN 3; CSPG3
600827	PHOSPHODIESTERASE 6C; PDE6C
600828	ATP SYNTHASE PERIPHERAL STALK, SUBUNIT OSCP; ATP5PO
600829	INOSITOL POLYPHOSPHATE PHOSPHATASE-LIKE 1; INPPL1
600830	TRIPARTITE MOTIF-CONTAINING PROTEIN 26; TRIM26
600831	DEATH-ASSOCIATED PROTEIN KINASE 1; DAPK1
600832	ACIDIC NUCLEAR PHOSPHOPROTEIN 32 FAMILY, MEMBER A; ANP32A
600833	SUPPRESSOR OF TUMORIGENICITY 7; ST7
600834	ZINC FINGER PROTEIN 165; ZNF165
600835	CHEMOKINE, CXC MOTIF, LIGAND 12; CXCL12
600836	CRYSTALLIN, BETA-A2; CRYBA2
600837	GLIAL CELL LINE-DERIVED NEUROTROPHIC FACTOR; GDNF
600838	FORKHEAD BOX N1; FOXN1
600839	SOLUTE CARRIER FAMILY 12 (SODIUM/POTASSIUM/CHLORIDE TRANSPORTER), MEMBER 1; SLC12A1
600840	SOLUTE CARRIER FAMILY 12 (SODIUM/POTASSIUM/CHLORIDE TRANSPORTER), MEMBER 2; SLC12A2
600841	EUKARYOTIC TRANSLATION ELONGATION FACTOR 1 ALPHA-1-LIKE 14; EEF1A1L14
600842	GLUCOKINASE REGULATORY PROTEIN; GCKR
600843	PURINERGIC RECEPTOR P2X, LIGAND-GATED ION CHANNEL, 3; P2RX3
600844	PURINERGIC RECEPTOR P2X, LIGAND-GATED ION CHANNEL, 2; P2RX2
600845	PURINERGIC RECEPTOR P2X, LIGAND-GATED ION CHANNEL, 1; P2RX1
600846	PURINERGIC RECEPTOR P2X, LIGAND-GATED ION CHANNEL, 4; P2RX4
600847	MOVED TO 600695
600848	NUCLEAR RECEPTOR COREPRESSOR 2; NCOR2
600849	NUCLEAR RECEPTOR COREPRESSOR 1; NCOR1
600850	SCHIZOPHRENIA 4; SCZD4
600851	MITOCHONDRIAL IMPORT-STIMULATING FACTOR
600852	RETINITIS PIGMENTOSA 17; RP17
600853	N-DEACETYLASE/N-SULFOTRANSFERASE 1; NDST1
600854	MOVED TO 600877
600855	DUAL-SPECIFICITY TYROSINE PHOSPHORYLATION-REGULATED KINASE 1A; DYRK1A
600856	CYCLIN-DEPENDENT KINASE INHIBITOR 1C; CDKN1C
600857	SUCCINATE DEHYDROGENASE COMPLEX, SUBUNIT A, FLAVOPROTEIN; SDHA
600858	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 6; CMH6
600859	AMINOACYL tRNA SYNTHETASE COMPLEX-INTERACTING MULTIFUNCTIONAL PROTEIN 2; AIMP2
600860	GENERAL TRANSCRIPTION FACTOR IIIA; GTF3A
600861	REGULATOR OF G PROTEIN SIGNALING 2; RGS2
600862	ADP-RIBOSYLATION FACTOR GTPase-ACTIVATING PROTEIN WITH FG REPEATS 1; AGFG1
600863	CASEIN KINASE I, EPSILON; CSNK1E
600864	CASEIN KINASE I, DELTA; CSNK1D
600865	RETICULON 1; RTN1
600866	PROGRAMMED CELL DEATH 2; PDCD2
600867	SIGNAL SEQUENCE RECEPTOR, BETA; SSR2
600868	SIGNAL SEQUENCE RECEPTOR, ALPHA; SSR1
600869	G PROTEIN-COUPLED RECEPTOR KINASE 6; GRK6
600870	G PROTEIN-COUPLED RECEPTOR KINASE 5; GRK5
600871	GROWTH FACTOR-INDEPENDENT 1; GFI1
600872	MOVED TO 300113
600873	CHITOBIASE, DI-N-ACETYL-; CTBS
600874	GUANINE NUCLEOTIDE-BINDING PROTEIN, GAMMA-5; GNG5
600875	ACYLPHOSPHATASE, ERYTHROCYTE; ACYP1
600876	SYNTAXIN 3; STX3
600877	POTASSIUM CHANNEL, INWARDLY RECTIFYING, SUBFAMILY J, MEMBER 6; KCNJ6
600878	MOVED TO 601296
600879	NUCLEAR RESPIRATORY FACTOR 1; NRF1
600880	BUDD-CHIARI SYNDROME; BDCHS
600881	CATARACT 10, MULTIPLE TYPES; CTRCT10
600882	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2B; CMT2B
600883	TYPE 1 DIABETES MELLITUS 8; T1D8
600884	CARDIOMYOPATHY, DILATED, 1B; CMD1B
600885	MOVED TO 251260
600886	HYPERFERRITINEMIA WITH OR WITHOUT CATARACT; HRFTC
600887	MutS HOMOLOG 3; MSH3
600888	RHO GUANINE NUCLEOTIDE EXCHANGE FACTOR 5; ARHGEF5
600889	COMPLEMENT FACTOR H-RELATED 2; CFHR2
600890	HYDROXYACYL-CoA DEHYDROGENASE/3-KETOACYL-CoA THIOLASE/ENOYL-CoA HYDRATASE, ALPHA SUBUNIT; HADHA
600891	MOVED TO 300098
600892	SIM bHLH TRANSCRIPTION FACTOR 2; SIM2
600893	MOVED TO 300099
600894	MOVED TO 300574
600895	PROLACTIN-RELEASING HORMONE RECEPTOR; PRLHR
600896	G PROTEIN-COUPLED RECEPTOR 14; GPR14
600897	GAP JUNCTION PROTEIN, ALPHA-8; GJA8
600898	SRY-BOX 11; SOX11
600899	PROTEIN KINASE, DNA-ACTIVATED, CATALYTIC SUBUNIT; PRKDC
600900	SARCOGLYCAN, BETA; SGCB
600901	FANCONI ANEMIA, COMPLEMENTATION GROUP E; FANCE
600902	SELENOPHOSPHATE SYNTHETASE 1; SEPHS1
600903	WISKOTT-ALDRICH SYNDROME, AUTOSOMAL DOMINANT
600904	ASTROTACTIN 1; ASTN1
600905	MOVED TO 600600
600906	ECTODERMAL DYSPLASIA WITH MENTAL RETARDATION AND SYNDACTYLY
600907	ENAMEL HYPOPLASIA, CATARACTS, AND AQUEDUCTAL STENOSIS
600908	MOVED TO 618419
600909	LANOSTEROL SYNTHASE; LSS
600910	INSULIN-LIKE 4; INSL4
600911	METALLOPHOSPHOESTERASE DOMAIN-CONTAINING PROTEIN 2; MPPED2
600912	TRANSCRIPTION FACTOR 19; TCF19
600913	MOVED TO 602055
600914	SPLICING FACTOR, SERINE/ARGININE-RICH, 5; SRSF5
600915	NESTIN; NES
600916	INOSITOL POLYPHOSPHATE-4-PHOSPHATASE, TYPE I, 107-KD; INPP4A
600917	PROTEIN PHOSPHATASE 1, REGULATORY SUBUNIT 3A; PPP1R3A
600918	MOVED TO 220100
600919	CARDIAC ARRHYTHMIA, ANKYRIN-B-RELATED
600920	VAN DEN ENDE-GUPTA SYNDROME; VDEGS
600921	FIBROBLAST GROWTH FACTOR 9; FGF9
600922	MYOSIN LIGHT CHAIN KINASE; MYLK
600923	PROTOPORPHYRINOGEN OXIDASE; PPOX
600924	GROWTH FACTOR, ERV1-LIKE; GFER
600925	PROTEIN-TYROSINE PHOSPHATASE, RECEPTOR-TYPE, J; PTPRJ
600926	PROTEIN-TYROSINE PHOSPHATASE, RECEPTOR-TYPE, EPSILON; PTPRE
600927	CYCLIN-DEPENDENT KINASE INHIBITOR 2D; CDKN2D
600928	NITROGEN PERMEASE REGULATOR-LIKE 3; NPRL3
600929	CRYSTALLIN, BETA-B1; CRYBB1
600930	SPERM ADHESION MOLECULE 1; SPAM1
600931	PROTOCADHERIN 3
600932	POTASSIUM INWARDLY-RECTIFYING CHANNEL, SUBFAMILY J, MEMBER 9; KCNJ9
600933	COAGULATION FACTOR II RECEPTOR-LIKE 1; F2RL1
600934	FOLATE HYDROLASE 1; FOLH1
600935	POTASSIUM CHANNEL, INWARDLY RECTIFYING, SUBFAMILY J, MEMBER 8; KCNJ8
600936	HYALURONAN-MEDIATED MOTILITY RECEPTOR; HMMR
600937	POTASSIUM CHANNEL, INWARDLY RECTIFYING, SUBFAMILY J, MEMBER 11; KCNJ11
600938	RETINOBLASTOMA-BINDING PROTEIN 6; RBBP6
600939	INTERLEUKIN 11 RECEPTOR, ALPHA; IL11RA
600940	LIGASE III, DNA, ATP-DEPENDENT; LIG3
600941	BILIVERDIN REDUCTASE B; BLVRB
600942	MOVED TO 600943
600943	SERPIN PEPTIDASE INHIBITOR, CLADE H, MEMBER 1; SERPINH1
600944	DEOXYHYPUSINE SYNTHASE; DHPS
600945	UROCORTIN; UCN
600946	GROWTH HORMONE RECEPTOR; GHR
600947	HUNTINGTIN-ASSOCIATED PROTEIN 1; HAP1
600948	MYELIN-ASSOCIATED OLIGODENDROCYTE BASIC PROTEIN; MOBP
600949	IMMUNOGLOBULIN HEAVY CHAIN VARIABLE REGION-2
600950	ARYLALKYLAMINE N-ACETYLTRANSFERASE; AANAT
600951	TELOMERIC REPEAT-BINDING FACTOR 1; TERF1
600952	TRANSSEXUALITY
600953	INTERLEUKIN 18; IL18
600954	DEATH-ASSOCIATED PROTEIN; DAP
600955	PROPROTEIN CONVERTASE 1/3 DEFICIENCY
600956	ANTI-MULLERIAN HORMONE TYPE II RECEPTOR; AMHR2
600957	ANTI-MULLERIAN HORMONE; AMH
600958	MYOSIN-BINDING PROTEIN C, CARDIAC; MYBPC3
600959	COATOMER PROTEIN COMPLEX, SUBUNIT BETA 1; COPB1
600960	SET NUCLEAR PROTOONCOGENE; SET
600961	MOVED TO 601498
600962	PALMOPLANTAR KERATODERMA, NONEPIDERMOLYTIC; NEPPK
600963	SIX HOMEOBOX 5; SIX5
600964	MOVED TO 266500
600965	DEAFNESS, AUTOSOMAL DOMINANT 6; DFNA6
600966	LLGL SCRIBBLE CELL POLARITY COMPLEX COMPONENT 1; LLGL1
600967	E2F TRANSCRIPTION FACTOR 5; E2F5
600968	SOLUTE CARRIER FAMILY 12 (SODIUM/CHLORIDE TRANSPORTER), MEMBER 3; SLC12A3
600969	EPIPHYSEAL DYSPLASIA, MULTIPLE, 3; EDM3
600970	MYOSIN VI; MYO6
600971	DEAFNESS, AUTOSOMAL RECESSIVE 6; DFNB6
600972	ACHONDROGENESIS, TYPE IB; ACG1B
600973	MOVED TO 600308
600974	DEAFNESS, AUTOSOMAL RECESSIVE 7; DFNB7
600975	GLAUCOMA 3, PRIMARY INFANTILE, B; GLC3B
600976	FAT ATYPICAL CADHERIN 1; FAT1
600977	CONE-ROD DYSTROPHY 5; CORD5
600978	LYMPHOTOXIN-BETA; LTB
600979	LYMPHOTOXIN B RECEPTOR; LTBR
600980	DENTIN MATRIX ACIDIC PHOSPHOPROTEIN 1; DMP1
600981	PHOSPHOGLUCOMUTASE 5; PGM5
600982	MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE 1; MAP3K1
600983	NUCLEAR RECEPTOR SUBFAMILY 3, GROUP C, MEMBER 2; NR3C2
600984	ACTIVATING TRANSCRIPTION FACTOR 6, BETA; ATF6B
600985	TENASCIN XB; TNXB
600986	TRIPARTITE MOTIF-CONTAINING PROTEIN 46; TRIM46
600987	CLEFT PALATE, CARDIAC DEFECTS, AND IMPAIRED INTELLECTUAL DEVELOPMENT; CPCMR
600988	MANNOSIDASE, ALPHA, CLASS 2A, MEMBER 2; MAN2A2
600989	INFUNDIBULOPELVIC DYSGENESIS
600990	MOVED TO 119580
600991	HYDROCEPHALUS, SPRENGEL ANOMALY, AND COSTOVERTEBRAL DYSPLASIA
600992	MOVED TO 206900
600993	SMAD FAMILY MEMBER 4; SMAD4
600994	DEAFNESS, AUTOSOMAL DOMINANT 5; DFNA5
600995	NEPHROTIC SYNDROME, TYPE 2; NPHS2
600996	MOVED TO 604772
600997	EPHRIN RECEPTOR EphB2; EPHB2
600998	GUANINE NUCLEOTIDE-BINDING PROTEIN, Q POLYPEPTIDE; GNAQ
600999	MYC-ASSOCIATED ZINC FINGER PROTEIN; MAZ
601000	MOVED TO 109170
601001	EPIDERMOLYSIS BULLOSA SIMPLEX 1D, GENERALIZED, INTERMEDIATE OR SEVERE, AUTOSOMAL RECESSIVE; EBS1D
601002	GLUTATHIONE SYNTHETASE; GSS
601003	BRODY DISEASE; BROD
601004	PORTAL VEIN, CAVERNOUS TRANSFORMATION OF
601005	TIMOTHY SYNDROME; TS
601006	MOVED TO 138890
601007	LEPTIN RECEPTOR; LEPR
601008	MOVED TO 148760
601009	TIGHT JUNCTION PROTEIN 1; TJP1
601010	TRANSCRIPTION FACTOR 15; TCF15
601011	CALCIUM CHANNEL, VOLTAGE-DEPENDENT, P/Q TYPE, ALPHA-1A SUBUNIT; CACNA1A
601012	CALCIUM CHANNEL, VOLTAGE-DEPENDENT, N TYPE, ALPHA-1B SUBUNIT; CACNA1B
601013	CALCIUM CHANNEL, VOLTAGE-DEPENDENT, ALPHA-1E SUBUNIT; CACNA1E
601014	DISCS LARGE MAGUK SCAFFOLD PROTEIN 1; DLG1
601015	NPC INTRACELLULAR CHOLESTEROL TRANSPORTER 2; NPC2
601016	MIDLINE MALFORMATIONS, MULTIPLE, WITH LIMB ABNORMALITIES AND HYPOPITUITARISM
601017	SYNTROPHIN, ALPHA-1; SNTA1
601018	MOVED TO 600027
601019	SOLUTE CARRIER FAMILY 6 (NEUROTRANSMITTER TRANSPORTER, GLYCINE), MEMBER 9; SLC6A9
601020	CD86 ANTIGEN; CD86
601021	NUCLEOPORIN, 98-KD; NUP98
601022	NUCLEAR FACTOR-KAPPA-B INHIBITOR-LIKE PROTEIN 1; NFKBIL1
601023	VALOSIN-CONTAINING PROTEIN; VCP
601024	ADAPTOR-RELATED PROTEIN COMPLEX 2, MU-1 SUBUNIT; AP2M1
601025	ADAPTOR-RELATED PROTEIN COMPLEX 2, BETA-1 SUBUNIT; AP2B1
601026	ADAPTOR-RELATED PROTEIN COMPLEX 2, ALPHA-1 SUBUNIT; AP2A1
601027	TIBIA, ABSENCE OR HYPOPLASIA OF, WITH POLYDACTYLY, RETROCEREBELLAR ARACHNOID CYST, AND OTHER ANOMALIES
601028	CD47 ANTIGEN; CD47
601029	MESODERM-SPECIFIC TRANSCRIPT; MEST
601030	RIBONUCLEASE, RNase A FAMILY, 4; RNASE4
601031	RHOPHILIN 1; RHPN1
601032	PROTEIN KINASE N1; PKN1
601033	LAMININ, ALPHA-5; LAMA5
601034	MOVED TO 155735
601035	HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN H1; HNRNPH1
601036	MOVED TO 300610
601037	HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN F; HNRNPF
601038	DEIODINASE, IODOTHYRONINE, TYPE III; DIO3
601039	ICHTHYOSIS-MENTAL RETARDATION SYNDROME WITH LARGE KERATOHYALIN GRANULES IN THE SKIN
601040	SCAVENGER RECEPTOR CLASS B, MEMBER 1; SCARB1
601041	TLE FAMILY MEMBER 2, TRANSCRIPTIONAL COREPRESSOR; TLE2
601042	DYSTONIA 9; DYT9
601043	MOVED TO 600701
601044	MOVED TO 600701
601045	CATENIN, DELTA-1; CTNND1
601046	MATRIX METALLOPROTEINASE 12; MMP12
601047	CAVEOLIN 1; CAV1
601048	CAVEOLIN 2; CAV2
601049	MOVED TO 300119
601050	REMOVED FROM DATABASE
601051	MESOTHELIN; MSLN
601052	PEPTIDYL-PROLYL CIS/TRANS ISOMERASE, NIMA-INTERACTING, 1; PIN1
601053	PLEXIN B1; PLXNB1
601054	PLEXIN A2; PLXNA2
601055	PLEXIN A1; PLXNA1
601056	BCL2-RELATED PROTEIN A1; BCL2A1
601057	PROGRAMMED CELL DEATH 6; PDCD6
601058	H3 HISTONE, FAMILY 3B; H3F3B
601059	MOVED TO 146920
601060	ECTONUCLEOTIDE PYROPHOSPHATASE/PHOSPHODIESTERASE 2; ENPP2
601061	SMALL NUCLEAR RIBONUCLEOPROTEIN POLYPEPTIDE D2; SNRPD2
601062	SMALL NUCLEAR RIBONUCLEOPROTEIN POLYPEPTIDE D3; SNRPD3
601063	SMALL NUCLEAR RIBONUCLEOPROTEIN POLYPEPTIDE D1; SNRPD1
601064	ZINC FINGER PROTEIN 36-LIKE 1; ZFP36L1
601065	ALANYL-tRNA SYNTHETASE 1; AARS1
601066	OXIDASE, CYTOCHROME c, ASSEMBLY 1-LIKE; OXA1L
601067	USHER SYNDROME, TYPE ID; USH1D
601068	EPILEPSY, FAMILIAL ADULT MYOCLONIC, 1; FAME1
601069	ZINC FINGER PROTEIN 239; ZNF239
601070	INTERLEUKIN 15 RECEPTOR, ALPHA; IL15RA
601071	DEAFNESS, AUTOSOMAL RECESSIVE 9; DFNB9
601072	DEAFNESS, AUTOSOMAL RECESSIVE 8; DFNB8
601073	MOVED TO 600737
601074	CUGBP- AND ELAV-LIKE FAMILY, MEMBER 1; CELF1
601075	APLASIA CUTIS CONGENITA, HIGH MYOPIA, AND CONE-ROD DYSFUNCTION
601076	MULLERIAN DUCT APLASIA, UNILATERAL RENAL AGENESIS, AND CERVICOTHORACIC SOMITE ANOMALIES; MURCS
601077	KERATIN 31, TYPE I; KRT31
601078	KERATIN 82, TYPE II; KRT82
601079	ZRSR2 PSEUDOGENE 1; ZRSR2P1
601080	U2 SMALL NUCLEAR RNA AUXILIARY FACTOR 1-LIKE 4; U2AF1L4
601081	ATP-BINDING CASSETTE, SUBFAMILY 3, MEMBER 2; ABCD2
601082	UBIQUITIN-CONJUGATING ENZYME E2 H; UBE2H
601083	CD4/CD8 T-CELL RATIO
601084	MOVED TO 606634
601085	MOVED TO 245570
601086	LATERALITY DEFECTS, AUTOSOMAL DOMINANT
601087	MOVED TO 121210
601088	AYME-GRIPP SYNDROME; AYGRP
601089	FORKHEAD BOX F1; FOXF1
601090	FORKHEAD BOX C1; FOXC1
601091	FORKHEAD BOX D1; FOXD1
601092	FORKHEAD BOX D4; FOXD4
601093	FORKHEAD BOX I1; FOXI1
601094	FORKHEAD BOX E3; FOXE3
601095	HARROD SYNDROME
601096	SPONDYLOEPIMETAPHYSEAL DYSPLASIA, MICROMELIC
601097	PERIPHERAL MYELIN PROTEIN 22; PMP22
601098	CHARCOT-MARIE-TOOTH DISEASE, DEMYELINATING, TYPE 1C; CMT1C
601099	SRC-LIKE ADAPTOR; SLA
601100	HEAT SHOCK 70-KD PROTEIN 13; HSPA13
601101	TELANGIECTASIA, HEREDITARY HEMORRHAGIC, TYPE 3; HHT3
601102	EUKARYOTIC TRANSLATION INITIATION FACTOR 4A, ISOFORM 2; EIF4A2
601103	MICROFIBRILLAR-ASSOCIATED PROTEIN 5; MFAP5
601104	SUPRANUCLEAR PALSY, PROGRESSIVE, 1; PSNP1
601105	CATHEPSIN K; CTSK
601106	REMOVED FROM DATABASE
601107	ATP-BINDING CASSETTE, SUBFAMILY C, MEMBER 2; ABCC2
601108	MOVED TO 300283
601109	5-HYDROXYTRYPTAMINE RECEPTOR 6; HTR6
601110	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Id; CDG1D
601111	MOVED TO 600941
601112	THIOREDOXIN REDUCTASE 1; TXNRD1
601113	HEAT-SHOCK PROTEIN FAMILY A (HSP70), MEMBER 4; HSPA4
601114	MEMBRANE PROTEIN, PALMITOYLATED 3; MPP3
601115	GLUTAMATE RECEPTOR, METABOTROPIC, 3; GRM3
601116	GLUTAMATE RECEPTOR, METABOTROPIC, 8; GRM8
601117	THIMET OLIGOPEPTIDASE 1; THOP1
601118	CALCIUM-MODULATING LIGAND; CAMLG
601119	CASEINOLYTIC MITOCHONDRIAL MATRIX PEPTIDASE PROTEOLYTIC SUBUNIT; CLPP
601120	CADHERIN 5; CDH5
601121	PLACENTAL GROWTH FACTOR; PGF
601122	5-HYDROXYTRYPTAMINE RECEPTOR 2B; HTR2B
601123	ST8 ALPHA-N-ACETYL-NEURAMINIDE ALPHA-2,8-SIALYLTRANSFERASE 1; ST8SIA1
601124	SEMAPHORIN 3F; SEMA3F
601125	HEXOKINASE 2; HK2
601126	TATA ELEMENT MODULATORY FACTOR 1; TMF1
601127	FALLOT COMPLEX WITH SEVERE MENTAL AND GROWTH RETARDATION
601128	H3 HISTONE, FAMILY 3A; H3F3A
601129	CYTOCHROME P450, SUBFAMILY IIC, POLYPEPTIDE 8; CYP2C8
601130	CYTOCHROME P450, SUBFAMILY IIC, POLYPEPTIDE 9; CYP2C9
601131	CYTOCHROME P450, SUBFAMILY IIC, POLYPEPTIDE 18; CYP2C18
601132	KINASE SUPPRESSOR OF RAS 1; KSR1
601133	CYTOCHROME P450, FAMILY 2, SUBFAMILY G, MEMBER 1, PSEUDOGENE; CYP2G1P
601134	OLIGOSACCHARYLTRANSFERASE COMPLEX, CATALYTIC SUBUNIT STT3A; STT3A
601135	GASTRULATION BRAIN HOMEOBOX 2; GBX2
601136	TRANSSUPPRESSOR OF EXPRESSION 2
601137	MOVED TO 601138
601138	GUANYLATE CYCLASE 2E, PSEUDOGENE; GUCY2EP
601139	ZINC FINGER PROTEIN 175; ZNF175
601140	PROTEIN PHOSPHATASE 1, REGULATORY SUBUNIT 14B; PPP1R14B
601141	POTASSIUM CHANNEL, VOLTAGE-GATED, SHAKER-RELATED SUBFAMILY, BETA MEMBER 1; KCNAB1
601142	POTASSIUM CHANNEL, VOLTAGE-GATED, SHAKER-RELATED SUBFAMILY, BETA MEMBER 2; KCNAB2
601143	DYNACTIN 1; DCTN1
601144	BRUGADA SYNDROME 1; BRGDA1
601145	CYSTATIN B; CSTB
601146	GROWTH/DIFFERENTIATION FACTOR 5; GDF5
601147	GROWTH/DIFFERENTIATION FACTOR 6; GDF6
601148	SPERM MITOCHONDRIA-ASSOCIATED CYSTEINE-RICH PROTEIN; SMCP
601149	ISOCITRATE DEHYDROGENASE 3, ALPHA SUBUNIT; IDH3A
601150	DEAD/H-BOX HELICASE 11; DDX11
601151	DEAD/H-BOX HELICASE 12, PSEUDOGENE; DDX12P
601152	NEUROPATHY, HEREDITARY MOTOR AND SENSORY, TYPE VIA, WITH OPTIC ATROPHY; HMSN6A
601153	FRAGILE HISTIDINE TRIAD DIADENOSINE TRIPHOSPHATASE; FHIT
601154	CARDIOMYOPATHY, DILATED, 1E; CMD1E
601155	MINOR HISTOCOMPATIBILITY ANTIGEN HA-1; HMHA1
601156	CHEMOKINE, CC MOTIF, LIGAND 11; CCL11
601157	DEFENSIN, ALPHA, 4; DEFA4
601158	MITOGEN-ACTIVATED PROTEIN KINASE 8; MAPK8
601159	CHEMOKINE, CC MOTIF, RECEPTOR 1; CCR1
601160	LISSENCEPHALY TYPE III AND BONE DYSPLASIA
601161	TRISOMY 18-LIKE SYNDROME
601162	SPASTIC PARAPLEGIA 9A, AUTOSOMAL DOMINANT; SPG9A
601163	DIAPHRAGMATIC DEFECTS, LIMB DEFICIENCIES, AND OSSIFICATION DEFECTS OF SKULL
601164	MOVED TO 241080
601165	CLEFT LIP/PALATE WITH CHARACTERISTIC FACIES, INTESTINAL MALROTATION, AND LETHAL CONGENITAL HEART DISEASE
601166	G PROTEIN-COUPLED RECEPTOR 15; GPR15
601167	PURINERGIC RECEPTOR P2Y, G PROTEIN-COUPLED, 1; P2RY1
601168	DIHYDROPYRIMIDINASE-LIKE 3; DPYSL3
601169	REMOVED FROM DATABASE
601170	MUSCULAR DYSTROPHY, CONGENITAL, WITH SEVERE CENTRAL NERVOUS SYSTEM ATROPHY AND ABSENCE OF LARGE MYELINATED FIBERS
601171	MOVED TO 173321
601172	CHONDROITIN SULFATE PROTEOGLYCAN 4; CSPG4
601173	MOVED TO 253600
601174	MOVED TO 123280
601175	ADP-RIBOSYLATION FACTOR-LIKE GTPase 2; ARL2
601176	GLUTAMATE-CYSTEINE LIGASE, MODIFIER SUBUNIT; GCLM
601177	ADP-RIBOSYLATION FACTOR 4; ARF4
601178	CELL CYCLE-ASSOCIATED PROTEIN 1; CAPRIN1
601179	RAS-RELATED NUCLEAR PROTEIN; RAN
601180	RAN-BINDING PROTEIN 1; RANBP1
601181	RAN-BINDING PROTEIN 2; RANBP2
601182	ORIGIN RECOGNITION COMPLEX, SUBUNIT 2; ORC2
601183	CYSTEINE-RICH INTESTINAL PROTEIN 2; CRIP2
601184	DNAJ/HSP40 HOMOLOG, SUBFAMILY C, MEMBER 3; DNAJC3
601185	STANNIOCALCIN 1; STC1
601186	MICROPHTHALMIA, SYNDROMIC 9; MCOPS9
601187	GURRIERI SYNDROME
601188	SUPPRESSION OF TUMORIGENICITY 12; ST12
601189	POLYMERASE II, RNA, SUBUNIT L; POLR2L
601190	PHOSPHODIESTERASE 6H; PDE6H
601191	ERH mRNA SPLICING AND MITOSIS FACTOR; ERH
601192	PHOSPHOLIPASE A2, GROUP V; PLA2G5
601193	CYSTEINE-RICH SECRETORY PROTEIN 1; CRISP1
601194	TOLL-LIKE RECEPTOR 1; TLR1
601195	IRON OVERLOAD IN AFRICA
601196	PR DOMAIN-CONTAINING PROTEIN 2; PRDM2
601197	TUB BIPARTITE TRANSCRIPTION FACTOR; TUB
601198	HYPOCALCEMIA, AUTOSOMAL DOMINANT 1; HYPOC1
601199	CALCIUM-SENSING RECEPTOR; CASR
601200	PLEUROPULMONARY BLASTOMA; PPB
601201	METHYLATION MODIFIER FOR CLASS I HLA
601202	CATARACT 24; CTRCT24
601203	INTERLEUKIN 1 RECEPTOR-LIKE 1; IL1RL1
601204	PROSTAGLANDIN F2 RECEPTOR NEGATIVE REGULATOR; PTGFRN
601205	SIX HOMEOBOX 1; SIX1
601206	POU CLASS 2 HOMEOBOX-ASSOCIATING FACTOR 1; POU2AF1
601207	DIACYLGLYCEROL KINASE, THETA, 110-KD; DGKQ
601208	TYPE 1 DIABETES MELLITUS 11; T1D11
601209	POLY(rC)-BINDING PROTEIN 1; PCBP1
601210	POLY(rC)-BINDING PROTEIN 2; PCBP2
601211	ADHESION G PROTEIN-COUPLED RECEPTOR E5; ADGRE5
601212	PROTEIN-TYROSINE KINASE 2, BETA; PTK2B
601213	RIBONUCLEASE 4 INHIBITOR; RNS4I
601214	NAXOS DISEASE; NXD
601215	ATR SERINE/THREONINE KINASE; ATR
601216	DENTAL ANOMALIES AND SHORT STATURE; DASS
601217	ALOPECIA-MENTAL RETARDATION SYNDROME WITH CONVULSIONS AND HYPERGONADOTROPIC HYPOGONADISM
601218	ADENOSINE DEAMINASE, RNA-SPECIFIC, B1; ADARB1
601219	MOVED TO 182390
601220	OSTEOPOROSIS AND OCULOCUTANEOUS HYPOPIGMENTATION SYNDROME; OOCH
601221	TISSUE-SPECIFIC EXTINGUISHER 3
601222	MOVED TO 185900
601223	NEURONAL INTESTINAL DYSPLASIA, TYPE B
601224	POTOCKI-SHAFFER SYNDROME
601225	DISHEVELLED 1-LIKE 1; DVL1L1
601226	MOVED TO 601227
601227	MOVED TO 157640
601228	POLYPOSIS SYNDROME, HEREDITARY MIXED, 1; HMPS1
601229	MOVED TO 151430
601230	DERMATITIS HERPETIFORMIS, FAMILIAL
601231	MECHANISTIC TARGET OF RAPAMYCIN; MTOR
601232	PHOSPHATIDYLINOSITOL 3-KINASE, CATALYTIC, GAMMA; PIK3CG
601233	INHIBIN, BETA C; INHBC
601234	NASCENT POLYPEPTIDE-ASSOCIATED COMPLEX, ALPHA POLYPEPTIDE; NACA
601235	DEAD-BOX HELICASE 10; DDX10
601236	DAB ADAPTOR PROTEIN 2; DAB2
601237	RING FINGER PROTEIN 112; RNF112
601238	CEREBELLAR ATAXIA, CAYMAN TYPE; ATCAY
601239	DYSTROBREVIN, ALPHA; DTNA
601240	GUANIDINOACETATE METHYLTRANSFERASE; GAMT
601241	HISTONE DEACETYLASE 1; HDAC1
601242	MICROTUBULE-ASSOCIATED PROTEIN 1, LIGHT CHAIN 3, ALPHA; MAP1LC3A
601243	TOPOISOMERASE, DNA, III, ALPHA; TOP3A
601244	GUANYLATE CYCLASE 1, SOLUBLE, ALPHA-2; GUCY1A2
601245	CHROMATIN ASSEMBLY FACTOR I, SUBUNIT B; CHAF1B
601246	CHROMATIN ASSEMBLY FACTOR I, SUBUNIT A; CHAF1A
601247	SOS RAS/RAC GUANINE NUCLEOTIDE EXCHANGE FACTOR 2; SOS2
601248	BRIDGING INTEGRATOR 1; BIN1
601249	PHOSPHORIBOSYLPYROPHOSPHATE SYNTHETASE-ASSOCIATED PROTEIN 1; PRPSAP1
601250	PEPTIDE METHIONINE SULFOXIDE REDUCTASE; MSRA
601251	MOVED TO 601777
601252	FICOLIN 1; FCN1
601253	CAVEOLIN 3; CAV3
601254	MITOGEN-ACTIVATED PROTEIN KINASE KINASE 6; MAP2K6
601255	KINESIN FAMILY MEMBER 1A; KIF1A
601256	MOVED TO 106165
601257	DEAD-BOX HELICASE 1; DDX1
601258	CYTOCHROME P450, SUBFAMILY IIJ, POLYPEPTIDE 2; CYP2J2
601259	AMELOBLASTIN ENAMEL MATRIX PROTEIN; AMBN
601260	ZINC FINGER PROTEIN WITH KRAB AND SCAN DOMAINS 1; ZKSCAN1
601261	ZINC FINGER- AND SCAN DOMAIN-CONTAINING PROTEIN 21; ZSCAN21
601262	ZINC FINGER PROTEIN 16; ZNF16
601263	MITOGEN-ACTIVATED PROTEIN KINASE KINASE 2; MAP2K2
601264	MOVED TO 601271
601265	NODAL GROWTH DIFFERENTIATION FACTOR; NODAL
601266	dUTP PYROPHOSPHATASE; DUT
601267	CHEMOKINE, CC MOTIF, RECEPTOR 2; CCR2
601268	CHEMOKINE, CC MOTIF, RECEPTOR 3; CCR3
601269	COMPLEMENT COMPONENT C1q-BINDING PROTEIN; C1QBP
601270	CYTOCHROME P450, FAMILY 4, SUBFAMILY F, POLYPEPTIDE 3; CYP4F3
601271	GUANYLATE CYCLASE ACTIVATOR 2B; GUCA2B
601272	SORTING NEXIN 1; SNX1
601273	CLATHRIN, HEAVY POLYPEPTIDE-LIKE 1; CLTCL1
601274	PROSTAGLANDIN REDUCTASE 1; PTGR1
601275	GLYCOPROTEIN M6A; GPM6A
601276	ZINC FINGER PROTEIN 177; ZNF177
601277	ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 4A; ARCI4A
601278	FSHD REGION GENE 1; FRG1
601279	DIGEORGE SYNDROME CRITICAL REGION GENE 6; DGCR6
601280	MAB21-LIKE 1; MAB21L1
601281	SEMAPHORIN 3B; SEMA3B
601282	PLECTIN; PLEC
601283	TYPE 2 DIABETES MELLITUS 1; T2D1
601284	ACTIVIN A RECEPTOR, TYPE II-LIKE 1; ACVRL1
601285	PROTEASOME 26S SUBUNIT SEM1; SEM1
601286	MOVED TO 115700
601287	MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 6; LGMDR6
601288	TYROSINE 3-MONOOXYGENASE/TRYPTOPHAN 5-MONOOXYGENASE ACTIVATION PROTEIN, ZETA ISOFORM; YWHAZ
601289	TYROSINE 3-MONOOXYGENASE/TRYPTOPHAN 5-MONOOXYGENASE ACTIVATION PROTEIN, BETA ISOFORM; YWHAB
601290	STRATIFIN; SFN
601291	URIDINE DIPHOSPHATE GLYCOSYLTRANSFERASE 8; UGT8
601292	SULFOTRANSFERASE FAMILY 1A, CYTOSOLIC, PHENOL-PREFERRING, MEMBER 2; SULT1A2
601293	RAS HOMOLOG ENRICHED IN BRAIN; RHEB
601294	REMOVED FROM DATABASE
601295	SOLUTE CARRIER FAMILY 10 (SODIUM/BILE ACID COTRANSPORTER FAMILY), MEMBER 2; SLC10A2
601296	MUSCLE, SKELETAL, RECEPTOR TYROSINE KINASE; MUSK
601297	SRY-BOX 15; SOX15
601298	MOVED TO 102576
601299	BONE MORPHOGENETIC PROTEIN RECEPTOR, TYPE IA; BMPR1A
601300	ACTIVIN A RECEPTOR, TYPE IB; ACVR1B
601301	PEPTIDYL-PROLYL ISOMERASE-LIKE 1; PPIL1
601302	PROTEIN PHOSPHATASE 3, REGULATORY SUBUNIT B, ALPHA; PPP3R1
601303	CYTOSKELETON-ASSOCIATED PROTEIN 1; CKAP1
601304	SMALL NUCLEAR RIBONUCLEOPROTEIN (U4/U6.U5), SNU13 HOMOLOG; SNU13
601305	5-HYDROXYTRYPTAMINE RECEPTOR 5A; HTR5A
601306	HEMATOPOIETIC CELL-SPECIFIC LYN SUBSTRATE 1; HCLS1
601307	MOVED TO 600924
601308	MYELOID TUMOR SUPPRESSOR
601309	PATCHED 1; PTCH1
601310	CYTOCHROME P450, SUBFAMILY IVA, POLYPEPTIDE 11; CYP4A11
601311	STEROL O-ACYLTRANSFERASE 2; SOAT2
601312	MOVED TO 600408
601313	POLYCYSTIN 1; PKD1
601314	HISTIDINE TRIAD NUCLEOTIDE-BINDING PROTEIN 1; HINT1
601315	EPITHELIAL BASOLATERAL CHLORIDE CONDUCTANCE REGULATOR, RABBIT, HOMOLOG OF
601316	DEAFNESS, AUTOSOMAL DOMINANT 10; DFNA10
601317	DEAFNESS, AUTOSOMAL DOMINANT 11; DFNA11
601318	TYPE 1 DIABETES MELLITUS 13; T1D13
601319	ODONTOMICRONYCHIAL DYSPLASIA
601320	MOVED TO 601984
601321	NEUROFIBROMATOSIS-NOONAN SYNDROME; NFNS
601322	PORENCEPHALY, CEREBELLAR HYPOPLASIA, AND INTERNAL MALFORMATIONS
601323	NUCLEOBINDIN 1; NUCB1
601324	HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN D; HNRNPD
601325	CONTACTIN 3; CNTN3
601326	CLAUDIN 11; CLDN11
601327	SODIUM VOLTAGE-GATED CHANNEL, BETA SUBUNIT 2; SCN2B
601328	SODIUM CHANNEL, EPITHELIAL 1, DELTA SUBUNIT; SCNN1D
601329	LIM DOMAIN KINASE 1; LIMK1
601330	GUANYLATE CYCLASE 2C; GUCY2C
601331	RENAL DYSPLASIA, CYSTIC, SUSCEPTIBILITY TO; CYSRD
601332	MOHAWK HOMEOBOX; MKX
601333	SPT6 HOMOLOG, HISTONE CHAPERONE AND TRANSCRIPTION ELONGATION FACTOR; SUPT6H
601334	KINESIN LIGHT CHAIN 3; KLC3
601335	MITOGEN-ACTIVATED PROTEIN KINASE KINASE 4; MAP2K4
601336	MANNOSYL-OLIGOSACCHARIDE GLYCOSIDASE; MOGS
601337	REGULATORY FACTOR X, 3; RFX3
601338	CEREBELLAR ATAXIA, AREFLEXIA, PES CAVUS, OPTIC ATROPHY, AND SENSORINEURAL HEARING LOSS; CAPOS
601339	MOVED TO 601112
601340	MIA SH3 DOMAIN-CONTAINING PROTEIN; MIA
601341	ATROPHIA MACULOSA VARIOLIFORMIS CUTIS, FAMILIAL; AMVC
601342	CHROMOSOME SEGREGATION 1-LIKE; CSE1L
601343	MOVED TO 276821
601344	SPINAL DYSPLASIA, ANHALT TYPE
601345	ECTODERMAL DYSPLASIA WITH NATAL TEETH, TURNPENNY TYPE
601346	MARTINEZ-FRIAS SYNDROME
601347	MYELODYSPLASIA, IMMUNODEFICIENCY, FACIAL DYSMORPHISM, SHORT STATURE, AND PSYCHOMOTOR DELAY
601348	ECTRODACTYLY OF LOWER LIMBS, CONGENITAL HEART DEFECT, AND MICROGNATHIA
601349	MICROPHTHALMIA, SYNDROMIC 8; MCOPS8
601350	SHORT STATURE SYNDROME, BRUSSELS TYPE
601351	GROWTH RETARDATION, DEAFNESS, FEMORAL EPIPHYSEAL DYSPLASIA, AND LACRIMAL DUCT OBSTRUCTION
601352	MENTAL RETARDATION, MICROCEPHALY, EPILEPSY, AND COARSE FACE
601353	BRACHYCEPHALY, DEAFNESS, CATARACT, MICROSTOMIA, AND IMPAIRED INTELLECTUAL DEVELOPMENT
601354	MOVED TO 300166
601355	MICROCEPHALY, CONGENITAL HEART DISEASE, UNILATERAL RENAL AGENESIS, AND HYPOSEGMENTED LUNGS
601356	LETHAL SHORT-LIMB SKELETAL DYSPLASIA, AL GAZALI TYPE
601357	BRACHIAL AMELIA, CLEFT LIP, AND HOLOPROSENCEPHALY; ACLH
601358	NICOLAIDES-BARAITSER SYNDROME; NCBRS
601359	MOVED TO 163200
601360	AMELIA, POSTERIOR, WITH PELVIC AND PULMONARY HYPOPLASIA SYNDROME; PAPPAS
601361	GROWTH/DIFFERENTIATION FACTOR 10; GDF10
601362	DIGEORGE SYNDROME/VELOCARDIOFACIAL SYNDROME COMPLEX 2
601363	WILMS TUMOR 4; WT4
601364	CADHERIN 13; CDH13
601365	DISHEVELLED 1; DVL1
601366	SMAD FAMILY MEMBER 2; SMAD2
601367	STROKE, ISCHEMIC
601368	DISHEVELLED 3; DVL3
601369	DEAFNESS, AUTOSOMAL DOMINANT 9; DFNA9
601370	HOLOPROSENCEPHALY, SEMILOBAR, WITH CRANIOSYNOSTOSIS
601371	CATARACT, AGE-RELATED NUCLEAR
601372	CHOREA, REMITTING, WITH NYSTAGMUS AND CATARACT
601373	CHEMOKINE, CC MOTIF, RECEPTOR 5; CCR5
601374	APROSENCEPHALY AND CEREBELLAR DYSGENESIS
601375	ECTODERMAL DYSPLASIA, HIDROTIC, CHRISTIANSON-FOURIE TYPE
601376	CHONDRODYSPLASIA, LETHAL, WITH LONG BONE ANGULATION AND MIXED BONE DENSITY
601377	MOVED TO 218340
601378	MOVED TO 272430
601379	HUNTER-MCALPINE CRANIOSYNOSTOSIS SYNDROME
601380	EPHRIN A4; EFNA4
601381	EPHRIN A3; EFNA3
601382	CHARCOT-MARIE-TOOTH DISEASE, TYPE 4B1; CMT4B1
601383	AQUAPORIN 6; AQP6
601384	LYMPHOCYTE ANTIGEN 6 COMPLEX, LOCUS E; LY6E
601385	TUMOR SUPPRESSOR CANDIDATE 3; TUSC3
601386	DEAFNESS, AUTOSOMAL RECESSIVE 12; DFNB12
601387	TUMOR SUSCEPTIBILITY GENE 101; TSG101
601388	TYPE 1 DIABETES MELLITUS 12; T1D12
601389	CERVICAL RIBS, SPRENGEL ANOMALY, ANAL ATRESIA, AND URETHRAL OBSTRUCTION
601390	VAN MALDERGEM SYNDROME 1; VMLDS1
601391	CHEMOKINE, CC MOTIF, LIGAND 13; CCL13
601392	CHEMOKINE, CC MOTIF, LIGAND 14; CCL14
601393	CHEMOKINE, CC MOTIF, LIGAND 15; CCL15
601394	CHEMOKINE, CC MOTIF, LIGAND 16; CCL16
601395	CHEMOKINE, CC MOTIF, LIGAND 3-LIKE 1; CCL3L1
601396	WINGLESS-TYPE MMTV INTEGRATION SITE FAMILY, MEMBER 8B; WNT8B
601397	T-BOX TRANSCRIPTION FACTOR T; TBXT
601398	VASCULAR ENDOTHELIAL GROWTH FACTOR B; VEGFB
601399	PLATELET DISORDER, FAMILIAL, WITH ASSOCIATED MYELOID MALIGNANCY; FPDMM
601400	MOVED TO 275355
601401	MYELOID LEUKEMIA FACTOR 2; MLF2
601402	MYELOID LEUKEMIA FACTOR 1; MLF1
601403	DEDICATOR OF CYTOKINESIS 1; DOCK1
601404	G PROTEIN-COUPLED RECEPTOR 68; GPR68
601405	CHYMOTRYPSIN C; CTRC
601406	B-CELL CLL/LYMPHOMA 7A; BCL7A
601407	TYPE 2 DIABETES MELLITUS 2; T2D2
601408	LYSINE ACETYLTRANSFERASE 6A; KAT6A
601409	LYSINE ACETYLTRANSFERASE 5; KAT5
601410	DIABETES MELLITUS, TRANSIENT NEONATAL, 1; TNDM1
601411	SARCOGLYCAN, DELTA; SGCD
601412	DEAFNESS, AUTOSOMAL DOMINANT 7; DFNA7
601413	DEIODINASE, IODOTHYRONINE, TYPE II; DIO2
601414	RETINITIS PIGMENTOSA 18; RP18
601415	MYB PROTOONCOGENE LIKE 2; MYBL2
601416	SOLUTE CARRIER FAMILY 39 (ZINC TRANSPORTER), MEMBER 7; SLC39A7
601417	17-BETA-HYDROXYSTEROID DEHYDROGENASE VIII; HSD17B8
601418	RIBOSOME BINDING PROTEIN 1; RRBP1
601419	MYOPATHY, MYOFIBRILLAR, 1; MFM1
601420	MICROCEPHALY, CORPUS CALLOSUM DYSGENESIS, AND CLEFT LIP/PALATE
601421	LYSYL-tRNA SYNTHETASE 1; KARS1
601422	LEUCINE ZIPPER PROTEIN 1; LUZP1
601423	THYMINE-DNA GLYCOSYLASE; TDG
601424	3-OXOACID CoA TRANSFERASE 1; OXCT1
601425	TRANSCRIPTION ELONGATION FACTOR A, 1; TCEA1
601426	NUCLEAR RECEPTOR SUBFAMILY 2, GROUP C, MEMBER 2; NR2C2
601427	ANTERIOR CHAMBER CLEAVAGE DISORDER, CEREBELLAR HYPOPLASIA, HYPOTHYROIDISM, AND TRACHEAL STENOSIS
601428	RNA, U4ATAC SMALL NUCLEAR; RNU4ATAC
601429	RNA, U6ATAC SMALL NUCLEAR; RNU6ATAC
601430	UPF1 RNA HELICASE AND ATPase; UPF1
601431	tRNA ALANINE (ANTICODON TGC) 7-1; TRA-TGC7-1
601432	tRNA ARGININE (ANTICODON TCG) 4-1; TRR-TCG4-1
601433	MOVED TO 180621
601434	S-PHASE KINASE-ASSOCIATED PROTEIN 1; SKP1
601435	S-PHASE KINASE-ASSOCIATED PROTEIN 1 PSEUDOGENE 2; SKP1P2
601436	S-PHASE KINASE-ASSOCIATED PROTEIN 2; SKP2
601437	Fc FRAGMENT OF IgG RECEPTOR AND TRANSPORTER; FCGRT
601438	RHIZOMELIC DYSPLASIA, PATTERSON-LOWRY TYPE
601439	ATP-BINDING CASSETTE, SUBFAMILY C, MEMBER 9; ABCC9
601440	DIACYLGLYCEROL KINASE, EPSILON, 64-KD; DGKE
601441	DIACYLGLYCEROL KINASE, ZETA, 104-KD: DGKZ
601442	COFILIN 1; CFL1
601443	COFILIN 2; CFL2
601444	BIOGENESIS OF LYSOSOME-RELATED ORGANELLES COMPLEX 1, SUBUNIT 1; BLOC1S1
601445	NADH-UBIQUINONE OXIDOREDUCTASE SUBUNIT B9; NDUFB9
601446	MOVED TO 300707
601447	UBIQUITIN-SPECIFIC PROTEASE 5; USP5
601448	NUCLEAR PROTEIN, ATAXIA-TELANGIECTASIA LOCUS; NPAT
601449	DEAFNESS, PROGRESSIVE, WITH STAPES FIXATION
601450	DISLOCATION OF HIP, CONGENITAL, WITH HYPEREXTENSIBILITY OF FINGERS AND FACIAL DYSMORPHISM
601451	MOVED TO 225400
601452	OCULOAURICULOFRONTONASAL SYNDROME; OAFNS
601453	TRICHODENTAL DYSPLASIA
601454	PSORIASIS 3, SUSCEPTIBILITY TO; PSORS3
601455	CHARCOT-MARIE-TOOTH DISEASE, TYPE 4D; CMT4D
601456	MULTIMERIN 1; MMRN1
601457	SEVERE COMBINED IMMUNODEFICIENCY, AUTOSOMAL RECESSIVE, T CELL-NEGATIVE, B CELL-NEGATIVE, NK CELL-POSITIVE
601458	INFLAMMATORY BOWEL DISEASE 2; IBD2
601459	PREPRONOCICEPTIN; PNOC
601460	SOLUTE CARRIER ORGANIC ANION TRANSPORTER FAMILY, MEMBER 2A1; SLCO2A1
601461	ATONAL bHLH TRANSCRIPTION FACTOR 1; ATOH1
601462	MYASTHENIC SYNDROME, CONGENITAL, 1A, SLOW-CHANNEL; CMS1A
601463	HYALURONAN SYNTHASE 1; HAS1
601464	ALF TRANSCRIPTION ELONGATION FACTOR 3; AFF3
601465	DEOXYGUANOSINE KINASE; DGUOK
601466	PATENT DUCTUS VENOSUS; PDV
601467	MITOTIC ARREST-DEFICIENT 2 LIKE 1; MAD2L1
601468	METHIONINE ADENOSYLTRANSFERASE II, ALPHA; MAT2A
601469	PARATHYROID HORMONE 2 RECEPTOR; PTH2R
601470	CHEMOKINE, CX3C MOTIF, RECEPTOR 1; CX3CR1
601471	FACIAL PARESIS, HEREDITARY CONGENITAL, 1; HCFP1
601472	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2D; CMT2D
601473	ZINC FINGER PROTEIN 75A; ZNF75A
601474	MOVED TO 314997
601475	PWP2 SMALL SUBUNIT PROCESSOME COMPONENT; PWP2
601476	LYSOSOME-ASSOCIATED PROTEIN, TRANSMEMBRANE 5; LAPTM5
601477	RIBBING DISEASE
601478	MYOSIN IA; MYO1A
601479	MYOSIN IE; MYO1E
601480	MYOSIN IF; MYO1F
601481	MYOSIN X; MYO10
601482	DOWNREGULATOR OF TRANSCRIPTION 1, TBP-BINDING; DR1
601483	PATERNALLY EXPRESSED GENE 3; PEG3
601484	SELENOPROTEIN P; SELENOP
601485	SYNTAXIN 1B; STX1B
601486	DELETED IN AZOOSPERMIA-LIKE; DAZL
601487	PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR-GAMMA; PPARG
601488	NEUTROPHIL CYTOSOLIC FACTOR 4; NCF4
601489	INSULIN-LIKE GROWTH FACTOR-BINDING PROTEIN, ACID-LABILE SUBUNIT; IGFALS
601490	NUCLEAR FACTOR ERYTHROID 2, p45 SUBUNIT; NFE2
601491	IMPRINTED IN PRADER-WILLI SYNDROME; IPW
601492	MUCOPOLYSACCHARIDOSIS, TYPE IX; MPS9
601493	CARDIOMYOPATHY, DILATED, 1C, WITH OR WITHOUT LEFT VENTRICULAR NONCOMPACTION; CMD1C
601494	CARDIOMYOPATHY, DILATED, 1D; CMD1D
601495	AGAMMAGLOBULINEMIA 1, AUTOSOMAL RECESSIVE; AGM1
601496	GDNF FAMILY RECEPTOR ALPHA-1; GFRA1
601497	BAG COCHAPERONE 1; BAG1
601498	PEROXISOME BIOGENESIS FACTOR 6; PEX6
601499	AXENFELD-RIEGER SYNDROME, TYPE 2; RIEG2
601500	SMOOTHENED, FRIZZLED CLASS RECEPTOR; SMO
601501	VPS35 RETROMER COMPLEX COMPONENT; VPS35
601502	Fc FRAGMENT OF IgG RECEPTOR Ib; FCGR1B
601503	Fc FRAGMENT OF IgG RECEPTOR Ic, PSEUDOGENE; FCGR1CP
601504	SEC14-LIKE LIPID-BINDING PROTEIN 1; SEC14L1
601505	ZINC FINGER PROTEIN 146; ZNF146
601506	SEPTIN 2; SEPT2
601507	ADAPTOR-RELATED PROTEIN COMPLEX 3, SIGMA-1 SUBUNIT; AP3S1
601508	MOVED TO 168601
601509	GAMMA-GLUTAMYL HYDROLASE; GGH
601510	SREBP CLEAVAGE-ACTIVATING PROTEIN; SCAP
601511	SIGNAL TRANSDUCER AND ACTIVATOR OF TRANSCRIPTION 5A; STAT5A
601512	SIGNAL TRANSDUCER AND ACTIVATOR OF TRANSCRIPTION 6; STAT6
601513	FIBROBLAST GROWTH FACTOR 12; FGF12
601514	FIBROBLAST GROWTH FACTOR 11; FGF11
601515	FIBROBLAST GROWTH FACTOR 14; FGF14
601516	SPLICING FACTOR 1; SF1
601517	ATAXIN 2; ATXN2
601518	PROSTATE CANCER, HEREDITARY, 1; HPC1
601519	ATP SYNTHASE MEMBRANE SUBUNIT E; ATP5ME
601520	CHEMOKINE, CC MOTIF, LIGAND 17; CCL17
601521	ENDOTHELIAL CELL-SPECIFIC MOLECULE 1; ESM1
601522	GROWTH FACTOR RECEPTOR-BOUND PROTEIN 7; GRB7
601523	GROWTH FACTOR RECEPTOR-BOUND PROTEIN 10; GRB10
601524	GROWTH FACTOR RECEPTOR-BOUND PROTEIN 14; GRB14
601525	CHITINASE 3-LIKE 1; CHI3L1
601526	CHITINASE 3-LIKE 2; CHI3L2
601527	ARISTALESS-LIKE HOMEOBOX 1; ALX1
601528	VASCULAR ENDOTHELIAL GROWTH FACTOR C; VEGFC
601529	NUCLEAR RECEPTOR SUBFAMILY 2, GROUP C, MEMBER 1; NR2C1
601530	SEQUESTOSOME 1; SQSTM1
601531	LEUKOTRIENE B4 RECEPTOR; LTB4R
601532	CASPASE 6, APOPTOSIS-RELATED CYSTEINE PROTEASE; CASP6
601533	A DISINTEGRIN AND METALLOPROTEINASE DOMAIN 2; ADAM2
601534	POTASSIUM CHANNEL, INWARDLY RECTIFYING, SUBFAMILY J, MEMBER 3; KCNJ3
601535	EPHRIN A5; EFNA5
601536	ATHABASKAN BRAINSTEM DYSGENESIS SYNDROME; ABDS
601537	MICROCEPHALY, RETINITIS PIGMENTOSA, AND SUTURAL CATARACT
601538	PROP PAIRED-LIKE HOMEOBOX 1; PROP1
601539	PEROXISOME BIOGENESIS DISORDER 1B; PBD1B
601540	BROMODOMAIN-CONTAINING PROTEIN 2; BRD2
601541	BROMODOMAIN-CONTAINING PROTEIN 3; BRD3
601542	PAIRED-LIKE HOMEODOMAIN TRANSCRIPTION FACTOR 2; PITX2
601543	DEAFNESS, AUTOSOMAL DOMINANT 12; DFNA12
601544	DEAFNESS, AUTOSOMAL DOMINANT 3A; DFNA3A
601545	PLATELET-ACTIVATING FACTOR ACETYLHYDROLASE, ISOFORM 1B, ALPHA SUBUNIT; PAFAH1B1
601546	PROSPERO-RELATED HOMEOBOX 1; PROX1
601547	CATARACT 3, MULTIPLE TYPES; CTRCT3
601548	EGF-CONTAINING FIBULIN-LIKE EXTRACELLULAR MATRIX PROTEIN 1; EFEMP1
601549	ALACRIMA, CONGENITAL, AUTOSOMAL RECESSIVE
601550	BLOOD GROUP--SWANN SYSTEM; SW
601551	BLOOD GROUP--FROESE
601552	TRABOULSI SYNDROME
601553	HYPOTRICHOSIS, CONGENITAL, WITH JUVENILE MACULAR DYSTROPHY; HJMD
601554	DYNEIN, LIGHT CHAIN, TCTEX TYPE, 1; DYNLT1
601555	RHO FAMILY GTPase 2; RND2
601556	ATAXIN 1; ATXN1
601557	ACETYL-CoA CARBOXYLASE-BETA; ACACB
601558	RNA-BINDING PROTEIN, mRNA-PROCESSING FACTOR; RBPMS
601559	STUVE-WIEDEMANN SYNDROME 1; STWS1
601560	MULTIPLE EPIPHYSEAL DYSPLASIA WITH ROBIN PHENOTYPE
601561	DYSSEGMENTAL DYSPLASIA WITH GLAUCOMA
601562	DYNEIN, LIGHT CHAIN, LC8 TYPE, 1; DYNLL1
601563	MOVED TO 606655
601564	PROTEASE, SERINE, 2; PRSS2
601565	INTERFERON REGULATORY FACTOR 8; IRF8
601566	INHIBITOR OF GROWTH 1; ING1
601567	LECTIN, MANNOSE-BINDING 1; LMAN1
601568	ADDUCIN 3; ADD3
601569	UBIQUITIN-CONJUGATING ENZYME E2 G1; UBE2G1
601570	WINGLESS-TYPE MMTV INTEGRATION SITE FAMILY, MEMBER 7A; WNT7A
601571	CAPPING PROTEIN, ALPHA-2; CAPZA2
601572	CAPPING PROTEIN, BETA; CAPZB
601573	ENHANCER OF ZESTE 2 POLYCOMB REPRESSIVE COMPLEX 2 SUBUNIT; EZH2
601574	TAF15 RNA POLYMERASE II, TATA BOX-BINDING PROTEIN-ASSOCIATED FACTOR, 68-KD; TAF15
601575	FOS-LIKE 2, AP-1 TRANSCRIPTION FACTOR SUBUNIT; FOSL2
601576	PROTEIN-TYROSINE PHOSPHATASE, RECEPTOR-TYPE, SIGMA; PTPRS
601577	PROTEIN-TYROSINE PHOSPHATASE, RECEPTOR-TYPE, C POLYPEPTIDE-ASSOCIATED PROTEIN; PTPRCAP
601578	CYCLIN G1; CCNG1
601579	ORNITHINE DECARBOXYLASE ANTIZYME 1; OAZ1
601580	CAPPING PROTEIN, ALPHA-1; CAPZA1
601581	NEURONAL CELL ADHESION MOLECULE; NRCAM
601582	INOSITOL POLYPHOSPHATE-5-PHOSPHATASE, 145-KD; INPP5D
601583	WILMS TUMOR 5; WT5
601584	PROTEIN-TYROSINE PHOSPHATASE, TYPE 4A, 2; PTP4A2
601585	PROTEIN-TYROSINE PHOSPHATASE, TYPE 4A, 1; PTP4A1
601586	PROSTAGLANDIN E RECEPTOR 4, EP4 SUBTYPE; PTGER4
601587	MOVED TO 300939
601588	MOVED TO 152445
601589	RAS p21 PROTEIN ACTIVATOR 2; RASA2
601590	ENVOPLAKIN; EVPL
601591	PROTEIN KINASE, cGMP-DEPENDENT, TYPE II; PRKG2
601592	RECEPTOR-ASSOCIATED PROTEIN OF THE SYNAPSE, 43-KD; RAPSN
601593	BRCA1-ASSOCIATED RING DOMAIN 1; BARD1
601594	JUMONJI, AT-RICH INTERACTIVE DOMAIN 2; JARID2
601595	SMAD FAMILY MEMBER 1; SMAD1
601596	CHARCOT-MARIE-TOOTH DISEASE, TYPE 4C; CMT4C
601597	B-CELL ANTIPROLIFERATION FACTOR 2; BTG2
601598	PROTEIN-TYROSINE PHOSPHATASE, RECEPTOR-TYPE, DELTA; PTPRD
601599	SARCOSPAN; SSPN
601600	ETS VARIANT TRANSCRIPTION FACTOR 5; ETV5
601601	TRANSCRIPTION FACTOR AP2-BETA; TFAP2B
601602	TRANSCRIPTION FACTOR AP2-GAMMA; TFAP2C
601603	LYMPHOCYTE CYTOSOLIC PROTEIN 2; LCP2
601604	INTERLEUKIN 12 RECEPTOR, BETA-1; IL12RB1
601605	MOVED TO 601448
601606	TRICHOEPITHELIOMA, MULTIPLE FAMILIAL, 1
601607	SWI/SNF-RELATED, MATRIX-ASSOCIATED, ACTIN-DEPENDENT REGULATOR OF CHROMATIN, SUBFAMILY B, MEMBER 1; SMARCB1
601608	SPASTIC PARAPLEGIA AND EVANS SYNDROME
601609	3-HYDROXYACYL-CoA DEHYDROGENASE; HADH
601610	BUTYROPHILIN, SUBFAMILY 1, MEMBER A1; BTN1A1
601611	SOLUTE CARRIER FAMILY 14 (UREA TRANSPORTER), MEMBER 2; SLC14A2
601612	LUNG AGENESIS, CONGENITAL HEART DEFECTS, AND THUMB ANOMALIES SYNDROME; LACHT
601613	CHEMOKINE, CXC MOTIF, RECEPTOR 5; CXCR5
601614	NETRIN 1; NTN1
601615	ATP-BINDING CASSETTE, SUBFAMILY A, MEMBER 3; ABCA3
601616	IRIS PIGMENT EPITHELIUM ANOMALIES
601617	RETINOL DEHYDROGENASE 5; RDH5
601618	SRY-BOX 18; SOX18
601619	RAL GUANINE NUCLEOTIDE DISSOCIATION STIMULATOR; RALGDS
601620	T-BOX TRANSCRIPTION FACTOR 5; TBX5
601621	T-BOX TRANSCRIPTION FACTOR 3; TBX3
601622	TWIST FAMILY bHLH TRANSCRIPTION FACTOR 1; TWIST1
601623	UBIQUITIN-PROTEIN LIGASE E3A; UBE3A
601624	FICOLIN 2; FCN2
601625	ADP-RIBOSYLTRANSFERASE 1; ART1
601626	LEUKEMIA, ACUTE MYELOID; AML
601627	SURVIVAL OF MOTOR NEURON 2; SMN2
601628	MOVED TO 111730
601629	PURKINJE CELL PROTEIN 4; PCP4
601630	MOVED TO 600274
601631	ANTERIOR SEGMENT DYSGENESIS 3; ASGD3
601632	POU DOMAIN, CLASS 4, TRANSCRIPTION FACTOR 1; POU4F1
601633	N-ETHYLMALEIMIDE-SENSITIVE FACTOR; NSF
601634	NEURAL TUBE DEFECTS, FOLATE-SENSITIVE; NTDFS
601635	MOVED TO 608317
601636	HYALURONAN SYNTHASE 2; HAS2
601637	CYTOCHROME P450, FAMILY 51, SUBFAMILY A, POLYPEPTIDE 1; CYP51A1
601638	ADP-RIBOSYLATION FACTOR-INTERACTING PROTEIN 2; ARFIP2
601639	PROTEIN KINASE, cAMP-DEPENDENT, CATALYTIC, ALPHA; PRKACA
601640	MOVED TO 601314
601641	ACYL-CoA OXIDASE 2, BRANCHED-CHAIN; ACOX2
601642	INTERLEUKIN 12 RECEPTOR, BETA-2; IL12RB2
601643	PROTEIN PHOSPHATASE 2, REGULATORY SUBUNIT B (B56), ALPHA; PPP2R5A
601644	PROTEIN PHOSPHATASE 2, REGULATORY SUBUNIT B (B56), BETA; PPP2R5B
601645	PROTEIN PHOSPHATASE 2, REGULATORY SUBUNIT B (B56), GAMMA; PPP2R5C
601646	PROTEIN PHOSPHATASE 2, REGULATORY SUBUNIT B (B56), DELTA; PPP2R5D
601647	PROTEIN PHOSPHATASE 2, REGULATORY SUBUNIT B (B56), EPSILON; PPP2R5E
601648	PROTEASOME 26S SUBUNIT, NON-ATPase, 4; PSMD4
601649	MOVED TO 101400
601650	PHEOCHROMOCYTOMA/PARAGANGLIOMA SYNDROME 2; PPGL2
601651	NUCLEOSOME ASSEMBLY PROTEIN 1-LIKE 4; NAP1L4
601652	MYOCILIN; MYOC
601653	EYA TRANSCRIPTIONAL COACTIVATOR AND PHOSPHATASE 1; EYA1
601654	EYA TRANSCRIPTIONAL COACTIVATOR AND PHOSPHATASE 2; EYA2
601655	EYA TRANSCRIPTIONAL COACTIVATOR AND PHOSPHATASE 3; EYA3
601656	GATA-BINDING PROTEIN 6; GATA6
601657	EPIPHYCAN; EPYC
601658	OTOCONIN 90; OC90
601659	GLUTAMINE AMIDOTRANSFERASE-LIKE CLASS 1 DOMAIN-CONTAINING PROTEIN 3A; GATD3A
601660	MOVED TO 601150
601661	UBIQUITIN-CONJUGATING ENZYME E2 I; UBE2I
601662	ACTIVATED LEUKOCYTE CELL ADHESION MOLECULE; ALCAM
601663	ESTROGEN RECEPTOR 2; ESR2
601664	SMALL NUCLEAR RIBONUCLEOPROTEIN, 200-KD; SNRNP200
601665	OBESITY
601666	TYPE 1 DIABETES MELLITUS 15; T1D15
601667	ANGIOPOIETIN 1; ANGPT1
601668	SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH ABNORMAL DENTITION; SEMDAD
601669	MOVED TO 602229
601670	D4, ZINC, AND DOUBLE PHD FINGERS FAMILY, MEMBER 1; DPF1
601671	D4, ZINC, AND DOUBLE PHD FINGERS FAMILY, MEMBER 2; DPF2
601672	D4, ZINC, AND DOUBLE PHD FINGERS FAMILY, MEMBER 3; DPF3
601673	ELAV-LIKE RNA-BINDING PROTEIN 2; ELAVL2
601674	ENHANCER OF ZESTE 1 POLYCOMB REPRESSIVE COMPLEX 2 SUBUNIT; EZH1
601675	TRICHOTHIODYSTROPHY 1, PHOTOSENSITIVE; TTD1
601676	ACUTE INSULIN RESPONSE
601677	NADH-UBIQUINONE OXIDOREDUCTASE SUBUNIT A5; NDUFA5
601678	BARTTER SYNDROME, TYPE 1, ANTENATAL; BARTS1
601679	GENERAL TRANSCRIPTION FACTOR II-I; GTF2I
601680	ARTHROGRYPOSIS, DISTAL, TYPE 2B1; DA2B1
601681	PROTEASOME 26S SUBUNIT, ATPase, 5; PSMC5
601682	GLAUCOMA 1, PRIMARY OPEN ANGLE, C; GLC1C
601683	COENZYME Q7, HYDROXYLASE; COQ7
601684	RIBOSOMAL PROTEIN S6 KINASE A1; RPS6KA1
601685	RIBOSOMAL PROTEIN S6 KINASE A2; RPS6KA2
601686	TELOMERASE-ASSOCIATED PROTEIN 1; TEP1
601687	KERATIN 12, TYPE I; KRT12
601688	15-HYDROXYPROSTAGLANDIN DEHYDROGENASE; HPGD
601689	TAF4B RNA POLYMERASE II, TATA BOX-BINDING PROTEIN-ASSOCIATED FACTOR, 105-KD; TAF4B
601690	PHOSPHOLIPASE A2, GROUP VII; PLA2G7
601691	ATP-BINDING CASSETTE, SUBFAMILY A, MEMBER 4; ABCA4
601692	TRANSFORMING GROWTH FACTOR, BETA-INDUCED, 68-KD; TGFBI
601693	UNCOUPLING PROTEIN 2; UCP2
601694	LEPTIN, SERUM LEVEL OF, QUANTITATIVE TRAIT LOCUS 1; LEPQTL1
601695	CASEIN, KAPPA; CSN3
601696	NOVELTY SEEKING PERSONALITY TRAIT
601697	SERPIN FAMILY B, MEMBER 8; SERPINB8
601698	PROTEIN-TYROSINE PHOSPHATASE, RECEPTOR-TYPE, N, POLYPEPTIDE 2; PTPRN2
601699	PROSTAGLANDIN I2 SYNTHASE; PTGIS
601700	SEBACEOUS GLAND HYPERPLASIA, FAMILIAL PRESENILE
601701	ARTHROGRYPOSIS AND ECTODERMAL DYSPLASIA
601702	RHO-ASSOCIATED COILED-COIL-CONTAINING PROTEIN KINASE 1; ROCK1
601703	VASODILATOR-STIMULATED PHOSPHOPROTEIN; VASP
601704	CHEMOKINE, CXC MOTIF, LIGAND 9; CXCL9
601705	T-CELL IMMUNODEFICIENCY, CONGENITAL ALOPECIA, AND NAIL DYSTROPHY; TIDAND
601706	YEMENITE DEAF-BLIND HYPOPIGMENTATION SYNDROME
601707	CURRY-JONES SYNDROME; CRJS
601708	SUPERIOR TRANSVERSE SCAPULAR LIGAMENT, CALCIFICATION OF, FAMILIAL
601709	QUEBEC PLATELET DISORDER; QPD
601710	EUKARYOTIC TRANSLATION INITIATION FACTOR 5; EIF5
601711	TNF RECEPTOR-ASSOCIATED FACTOR 1; TRAF1
601712	BACULOVIRAL IAP REPEAT-CONTAINING PROTEIN 2; BIRC2
601713	GLIA MATURATION FACTOR, BETA; GMFB
601714	TEA DOMAIN FAMILY MEMBER 4; TEAD4
601715	MOVED TO 601582
601716	STAUFEN DOUBLE-STRANDED RNA-BINDING PROTEIN 1; STAU1
601717	SYNTAXIN-BINDING PROTEIN 2; STXBP2
601718	RETINITIS PIGMENTOSA 19; RP19
601719	T-BOX TRANSCRIPTION FACTOR 4; TBX4
601720	KIN17 DNA- AND RNA-BINDING PROTEIN; KIN
601721	BACULOVIRAL IAP REPEAT-CONTAINING PROTEIN 3; BIRC3
601722	MOVED TO 601712
601723	FRIZZLED CLASS RECEPTOR 5; FZD5
601724	NEUROGENIC DIFFERENTIATION 1; NEUROD1
601725	NEUROGENIC DIFFERENTIATION 2; NEUROD2
601726	NEUROGENIN 1; NEUROG1
601727	MOVED TO 601714
601728	PHOSPHATASE AND TENSIN HOMOLOG; PTEN
601729	TEA DOMAIN FAMILY MEMBER 2; TEAD2
601730	PHOSPHATIDYLINOSITOL GLYCAN ANCHOR BIOSYNTHESIS CLASS C PROTEIN; PIGC
601731	5-AMINOIMIDAZOLE-4-CARBOXAMIDE RIBONUCLEOTIDE FORMYLTRANSFERASE/IMP CYCLOHYDROLASE; ATIC
601732	SWI/SNF-RELATED, MATRIX-ASSOCIATED, ACTIN-DEPENDENT REGULATOR OF CHROMATIN, SUBFAMILY C, MEMBER 1; SMARCC1
601733	GLUTATHIONE S-TRANSFERASE, MICROSOMAL, 2; MGST2
601734	SWI/SNF-RELATED, MATRIX-ASSOCIATED, ACTIN-DEPENDENT REGULATOR OF CHROMATIN, SUBFAMILY C, MEMBER 2; SMARCC2
601735	SWI/SNF-RELATED, MATRIX-ASSOCIATED, ACTIN-DEPENDENT REGULATOR OF CHROMATIN, SUBFAMILY D, MEMBER 1; SMARCD1
601736	SWI/SNF-RELATED, MATRIX-ASSOCIATED, ACTIN-DEPENDENT REGULATOR OF CHROMATIN, SUBFAMILY D, MEMBER 2; SMARCD2
601737	SWI/SNF-RELATED, MATRIX-ASSOCIATED, ACTIN-DEPENDENT REGULATOR OF CHROMATIN, SUBFAMILY D, MEMBER 3; SMARCD3
601738	EXOSTOSIN-LIKE GLYCOSYLTRANSFERASE 1; EXTL1
601739	MEIS HOMEOBOX 1; MEIS1
601740	MEIS HOMEOBOX 2; MEIS2
601741	CULLIN 5; CUL5
601742	TRIPARTITE MOTIF-CONTAINING PROTEIN 28; TRIM28
601743	ONCOSTATIN M RECEPTOR; OSMR
601744	SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO, 1; SLEB1
601745	POTASSIUM CHANNEL, SUBFAMILY K, MEMBER 1; KCNK1
601746	HYPOXIA UP-REGULATED 1; HYOU1
601747	TRIPARTITE MOTIF-CONTAINING PROTEIN 23; TRIM23
601748	GENERAL TRANSCRIPTION FACTOR IIH, POLYPEPTIDE 2; GTF2H2
601749	GLOMULIN; GLMN
601750	GENERAL TRANSCRIPTION FACTOR IIH, POLYPEPTIDE 3; GTF2H3
601751	MELANIN-CONCENTRATING HORMONE RECEPTOR 1; MCHR1
601752	ECTONUCLEOSIDE TRIPHOSPHATE DIPHOSPHOHYDROLASE 1; ENTPD1
601753	PEPTIDYL-PROLYL ISOMERASE D; PPID
601754	UBIQUITIN FUSION DEGRADATION 1-LIKE; UFD1L
601755	ESS2 SPLICING FACTOR, XENOPUS, HOMOLOG OF; ESS2
601756	UDP-N-ACETYL-ALPHA-D-GALACTOSAMINE:POLYPEPTIDE N-ACETYLGALACTOSAMINYLTRANSFERASE 3; GALNT3
601757	PEROXISOME BIOGENESIS FACTOR 7; PEX7
601758	PEROXISOME BIOGENESIS FACTOR 12; PEX12
601759	PREAXIAL HALLUCAL POLYDACTYLY
601760	GENERAL TRANSCRIPTION FACTOR IIH, POLYPEPTIDE 4; GTF2H4
601761	CASPASE 7, APOPTOSIS-RELATED CYSTEINE PROTEASE; CASP7
601762	CASPASE 10, APOPTOSIS-RELATED CYSTEINE PROTEASE; CASP10
601763	CASPASE 8, APOPTOSIS-RELATED CYSTEINE PROTEASE; CASP8
601764	SEIZURES, BENIGN FAMILIAL INFANTILE, 1; BFIS1
601765	MOVED TO 601542
601766	FRIZZLED CLASS RECEPTOR 9; FZD9
601767	HUNTINGTIN-INTERACTING PROTEIN 1; HIP1
601768	SH3 DOMAIN, GRB2-LIKE, 1; SH3GL1
601769	VITAMIN D RECEPTOR; VDR
601770	NEUROPEPTIDE Y RECEPTOR Y6; NPY6R
601771	CYTOCHROME P450, SUBFAMILY I, POLYPEPTIDE 1; CYP1B1
601772	H2A HISTONE FAMILY, MEMBER X; H2AFX
601773	PROTEIN-TYROSINE PHOSPHATASE, RECEPTOR-TYPE, N; PTPRN
601774	ALPHA-1,6-MANNOSYL-GLYCOPROTEIN BETA-1,6-N-ACETYLGLUCOSAMINYLTRANSFERASE; MGAT5
601775	MEGALOBLASTIC ANEMIA, FOLATE-RESPONSIVE; MEGAF
601776	EHLERS-DANLOS SYNDROME, MUSCULOCONTRACTURAL TYPE, 1; EDSMC1
601777	CONE-ROD DYSTROPHY 6; CORD6
601778	POLYMERASE, RNA, MITOCHONDRIAL; POLRMT
601779	MOVED TO 258450
601780	CEROID LIPOFUSCINOSIS, NEURONAL, 6A; CLN6A
601781	MOVED TO 194554
601782	TESTIS-ASSOCIATED ACTIN-MODELING KINASE 1; TESK1
601783	MICROTUBULE-ASSOCIATED PROTEIN 6; MAP6
601784	ACID-SENSING ION CHANNEL, SUBUNIT 2; ASIC2
601785	PHOSPHOMANNOMUTASE 2; PMM2
601786	PHOSPHOMANNOMUTASE 1; PMM1
601787	TAF5 RNA POLYMERASE II, TATA BOX-BINDING PROTEIN-ASSOCIATED FACTOR, 100-KD; TAF5
601788	MYOSTATIN; MSTN
601789	PEROXISOME BIOGENESIS FACTOR 13; PEX13
601790	PANCREATIC POLYPEPTIDE RECEPTOR 1; PPYR1
601791	PEROXISOME BIOGENESIS FACTOR 14; PEX14
601792	PROTEIN PHOSPHATASE 1, REGULATORY SUBUNIT 2; PPP1R2
601793	MOVED TO 600724
601794	COLOBOMA-OBESITY-HYPOGENITALISM-MENTAL RETARDATION SYNDROME
601795	MITOGEN-ACTIVATED PROTEIN KINASE 3; MAPK3
601796	TAF4 RNA POLYMERASE II, TATA BOX-BINDING PROTEIN-ASSOCIATED FACTOR, 135-KD; TAF4
601797	CRYSTALLIN BETA-GAMMA DOMAIN-CONTAINING PROTEIN 1; CRYBG1
601798	GLUCOSAMINE-6-PHOSPHATE DEAMINASE 1; GNPDA1
601799	PROTEASE INHIBITOR 9, OVALBUMIN TYPE; PI9
601800	SKIN/HAIR/EYE PIGMENTATION, VARIATION IN, 3; SHEP3
601801	TRANSCRIPTION FACTOR Sp2; SP2
601802	HESX HOMEOBOX 1; HESX1
601803	PALLISTER-KILLIAN SYNDROME; PKS
601804	TRANSCRIPTION FACTOR Sp3; SP3
601805	G PROTEIN-COUPLED ESTROGEN RECEPTOR 1; GPER1
601806	MINICHROMOSOME MAINTENANCE COMPLEX COMPONENT 6; MCM6
601807	MATRIX METALLOPROTEINASE 19; MMP19
601808	CHROMOSOME 18q DELETION SYNDROME
601809	SPONDYLOSPINAL THORACIC DYSOSTOSIS
601810	DNA REPLICATION HELICASE/NUCLEASE 2; DNA2
601811	PREMATURE AGING SYNDROME, OKAMOTO TYPE
601812	PREMATURE AGING SYNDROME, PENTTINEN TYPE; PENTT
601813	EXUDATIVE VITREORETINOPATHY 4; EVR4
601814	FXYD DOMAIN-CONTAINING ION TRANSPORT REGULATOR 2; FXYD2
601815	PHOSPHOGLYCERATE DEHYDROGENASE DEFICIENCY; PHGDHD
601816	BILIRUBIN, SERUM LEVEL OF, QUANTITATIVE TRAIT LOCUS 1; BILIQTL1
601817	NME/NM23 NUCLEOSIDE DIPHOSPHATE KINASE 3; NME3
601818	NME/NM23 NUCLEOSIDE DIPHOSPHATE KINASE 4; NME4
601819	BROMODOMAIN PHD FINGER TRANSCRIPTION FACTOR; BPTF
601820	HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 2; HHF2
601821	RNA, Y1 SMALL CYTOPLASMIC; RNY1
601822	RNA, Y3 SMALL CYTOPLASMIC; RNY3
601823	RNA, Y4 SMALL CYTOPLASMIC; RNY4
601824	RNA, Y5 SMALL CYTOPLASMIC; RNY5
601825	NADH-UBIQUINONE OXIDOREDUCTASE Fe-S PROTEIN 7; NDUFS7
601826	DIACYLGLYCEROL KINASE, DELTA, 130-KD; DGKD
601827	MOVED TO 601659
601828	NUCLEAR RECEPTOR SUBFAMILY 4, GROUP A, MEMBER 2; NR4A2
601829	ACROFACIAL DYSOSTOSIS, PALAGONIA TYPE
601830	MOVED TO 601770
601831	HISTONE GENE CLUSTER 2, H2B HISTONE FAMILY, MEMBER E; HIST2H2BE
601832	RIBOSOMAL PROTEIN L29; RPL29
601833	ALLOGRAFT INFLAMMATORY FACTOR 1; AIF1
601834	CHEMOKINE, CC MOTIF, RECEPTOR 8; CCR8
601835	CHEMOKINE, CC MOTIF, RECEPTOR 6; CCR6
601836	KINESIN-ASSOCIATED PROTEIN 3; KIFAP3
601837	LIGASE IV, DNA, ATP-DEPENDENT; LIG4
601838	INOSITOL 1,3,4-TRISPHOSPHATE 5/6-KINASE; ITPK1
601839	EPHRIN RECEPTOR EphB3; EPHB3
601840	MOVED TO 600286
601841	SERPIN PEPTIDASE INHIBITOR, CLADE A, MEMBER 5; SERPINA5
601842	MOVED TO 601543
601843	SOLUTE CARRIER FAMILY 5 (SODIUM IODIDE SYMPORTER), MEMBER 5; SLC5A5
601844	PROTEIN KINASE, LYSINE-DEFICIENT 4; WNK4
601845	GOOSECOID HOMEOBOX 2; GSC2
601846	MYOPATHY WITH RIMMED UBIQUITIN-POSITIVE AUTOPHAGIC VACUOLATION, AUTOSOMAL DOMINANT; MRUPAV
601847	CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC, 2; PFIC2
601848	TRANSLOCASE OF OUTER MITOCHONDRIAL MEMBRANE 20; TOMM20
601849	MOVED TO 228930
601850	MOVED TO 500004
601851	CIRCADIAN LOCOMOTOR OUTPUT CYCLES KAPUT; CLOCK
601852	INTERCELLULAR ADHESION MOLECULE 5; ICAM5
601853	GOMEZ-LOPEZ-HERNANDEZ SYNDROME; GLHS
601854	DIACYLGLYCEROL KINASE, GAMMA, 90-KD; DGKG
601855	RHO GUANINE NUCLEOTIDE EXCHANGE FACTOR 1; ARHGEF1
601856	ZINC FINGER PROTEIN 211; ZNF211
601857	MOVED TO 601056
601858	CALMEGIN; CLGN
601859	AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME; ALPS
601860	17-BETA-HYDROXYSTEROID DEHYDROGENASE IV; HSD17B4
601861	REGULATORY FACTOR X-ASSOCIATED PROTEIN; RFXAP
601862	MOVED TO 104160
601863	REGULATORY FACTOR X, 5; RFX5
601864	MOVED TO 177060
601865	PROCOLLAGEN-LYSINE, 2-OXOGLUTARATE 5-DIOXYGENASE 2; PLOD2
601866	SEMAPHORIN 4D; SEMA4D
601867	ATPase, Na+/K+ TRANSPORTING, BETA-3 POLYPEPTIDE; ATP1B3
601868	DEAFNESS, AUTOSOMAL DOMINANT 13; DFNA13
601869	DEAFNESS, AUTOSOMAL RECESSIVE 15; DFNB15
601870	METHIONINE AMINOPEPTIDASE 2; METAP2
601871	CYSTEINE- AND GLYCINE-RICH PROTEIN 2; CSRP2
601872	SOLUTE CARRIER FAMILY 7 (CATIONIC AMINO ACID TRANSPORTER, y+ SYSTEM), MEMBER 2; SLC7A2
601873	BETA-1,4-N-ACETYLGALACTOSAMINYLTRANSFERASE 1; B4GALNT1
601874	ELONGATION FACTOR, RNA POLYMERASE II, 2; ELL2
601875	MOVED TO 601630
601876	SPERM-SPECIFIC ANTIGEN 1; SSFA1
601877	LEFT-RIGHT DETERMINATION FACTOR 2; LEFTY2
601878	KRUPPEL-LIKE FACTOR 10; KLF10
601879	LECTIN, GALACTOSIDE-BINDING, SOLUBLE, 9; LGALS9
601880	CHEMOKINE, CX3C MOTIF, LIGAND 1; CX3CL1
601881	RETINA AND ANTERIOR NEURAL FOLD HOMEOBOX GENE; RAX
601882	DNA FRAGMENTATION FACTOR, 45-KD, ALPHA SUBUNIT; DFFA
601883	DNA FRAGMENTATION FACTOR, 40-KD, BETA SUBUNIT; DFFB
601884	BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS 1; BMND1
601885	CATARACT 14, MULTIPLE TYPES; CTRCT14
601886	ACHAETE-SCUTE FAMILY bHLH TRANSCRIPTION FACTOR 2; ASCL2
601887	MALIGNANT HYPERTHERMIA, SUSCEPTIBILITY TO, 5; MHS5
601888	MALIGNANT HYPERTHERMIA, SUSCEPTIBILITY TO, 6
601889	NEUROBEACHIN PSEUDOGENE 1; NBEAP1
601890	PROTEIN-TYROSINE KINASE PTK7; PTK7
601891	CYSTATIN 6; CST6
601892	KARYOPHERIN ALPHA-3; KPNA3
601893	TRIPLE FUNCTIONAL DOMAIN; TRIO
601894	GLOMERULOPATHY WITH FIBRONECTIN DEPOSITS 2; GFND2
601895	TNF RECEPTOR-ASSOCIATED FACTOR 2; TRAF2
601896	TNF RECEPTOR-ASSOCIATED FACTOR 3; TRAF3
601897	ZINC FINGER PROTEIN 148; ZNF148
601898	GROWTH HORMONE SECRETAGOGUE RECEPTOR; GHSR
601899	SIGNAL-TRANSDUCING ADAPTOR MOLECULE 1; STAM
601900	INTERFERON REGULATORY FACTOR 4; IRF4
601901	SOLUTE CARRIER FAMILY 8 (SODIUM-CALCIUM EXCHANGER), MEMBER A2; SLC8A2
601902	ORIGIN RECOGNITION COMPLEX, SUBUNIT 1; ORC1
601903	URIDINE DIPHOSPHATE GLYCOSYLTRANSFERASE 2 FAMILY, MEMBER B17; UGT2B17
601904	MOVED TO 300899
601905	RAB GERANYLGERANYL TRANSFERASE, ALPHA SUBUNIT; RABGGTA
601906	WINGLESS-TYPE MMTV INTEGRATION SITE FAMILY, MEMBER 10B; WNT10B
601907	NEOGENIN; NEO1
601908	G PROTEIN-COUPLED RECEPTOR 20; GPR20
601909	G PROTEIN-COUPLED RECEPTOR 21; GPR21
601910	G PROTEIN-COUPLED RECEPTOR 22; GPR22
601911	DISTAL-LESS HOMEOBOX 4; DLX4
601912	SMALL UBIQUITIN-LIKE MODIFIER 1; SUMO1
601913	GUIDED ENTRY OF TAIL-ANCHORED PROTEINS FACTOR 3, ATPase; GET3
601914	PROLINE-ARGININE-RICH END LEUCINE-RICH REPEAT PROTEIN; PRELP
601915	TISSUE INHIBITOR OF METALLOPROTEINASE 4; TIMP4
601916	MESENCEPHALIC ASTROCYTE-DERIVED NEUROTROPHIC FACTOR; MANF
601917	ALDEHYDE DEHYDROGENASE 3 FAMILY, MEMBER B2; ALDH3B2
601918	GROWTH/DIFFERENTIATION FACTOR 9; GDF9
601919	COAGULATION FACTOR II RECEPTOR-LIKE 2; F2RL2
601920	JAGGED 1; JAG1
601921	MOVED TO 156535
601922	ANGIOPOIETIN 2; ANGPT2
601923	MOVED TO 601124
601924	COATOMER PROTEIN COMPLEX, SUBUNIT ALPHA; COPA
601925	RHO GDP-DISSOCIATION INHIBITOR ALPHA; ARHGDIA
601926	THYROID HORMONE-RESPONSIVE PROTEIN; THRSP
601927	LYMPHEDEMA, CARDIAC SEPTAL DEFECTS, AND CHARACTERISTIC FACIES
601928	KERATIN 86, TYPE II; KRT86
601929	ATPase, Ca(2+)-TRANSPORTING, UBIQUITOUS; ATP2A3
601930	BASONUCLIN 1; BNC1
601931	BCL2-LIKE 2; BCL2L2
601932	MUCIN 8, TRACHEOBRONCHIAL; MUC8
601933	CRYPTOCHROME 1; CRY1
601934	G PROTEIN PATHWAY SUPPRESSOR 1; GPS1
601935	G PROTEIN PATHWAY SUPPRESSOR 2; GPS2
601936	PRKC, APOPTOSIS, WT1, REGULATOR; PAWR
601937	NUCLEAR RECEPTOR COACTIVATOR 3; NCOA3
601938	MOVED TO 600523
601939	SRSF PROTEIN KINASE 1; SRPK1
601940	SPLICING FACTOR, SERINE/ARGININE-RICH, 4; SRSF4
601941	TYPE 1 DIABETES MELLITUS 6; T1D6
601942	TYPE 1 DIABETES MELLITUS 10; T1D10
601943	SPLICING FACTOR, SERINE/ARGININE-RICH, 9; SRSF9
601944	SPLICING FACTOR, SERINE/ARGININE-RICH, 6; SRSF6
601945	SPLICING FACTOR, SUPPRESSOR-OF-WHITE-APRICOT FAMILY; SFSWAP
601946	MOVED TO 601531
601947	SRY-BOX 12; SOX12
601948	MOVED TO 601784
601949	CALCIUM CHANNEL, VOLTAGE-DEPENDENT, BETA-4 SUBUNIT; CACNB4
601950	ZINC FINGER PROTEIN, FOG FAMILY MEMBER 1; ZFPM1
601951	CDC-LIKE KINASE 1; CLK1
601952	KERATOSIS LINEARIS WITH ICHTHYOSIS CONGENITA AND SCLEROSING KERATODERMA; KLICK
601953	CYCLIN H; CCNH
601954	MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 7; LGMDR7
601955	CYCLIN-DEPENDENT KINASE 7; CDK7
601956	GDNF FAMILY RECEPTOR ALPHA-2; GFRA2
601957	ODONTOTRICHOUNGUAL-DIGITAL-PALMAR SYNDROME
601958	CALCIUM CHANNEL, VOLTAGE-DEPENDENT, BETA-3 SUBUNIT; CACNB3
601959	NIMA-RELATED KINASE 4; NEK4
601960	CHEMOKINE, CC MOTIF, LIGAND 20; CCL20
601961	PROTEIN ARGININE METHYLTRANSFERASE 2; PRMT2
601962	TAP-BINDING PROTEIN; TAPBP
601963	TETRATRICOPEPTIDE REPEAT DOMAIN-CONTAINING PROTEIN 1; TTC1
601964	DNAJ/HSP40 HOMOLOG, SUBFAMILY C, MEMBER 7; DNAJC7
601965	SPHINGOSINE-1-PHOSPHATE RECEPTOR 3; S1PR3
601966	REGULATORY SOLUTE CARRIER PROTEIN, FAMILY 1, MEMBER 1; RSC1A1
601967	WINGLESS-TYPE MMTV INTEGRATION SITE FAMILY, MEMBER 7B; WNT7B
601968	WINGLESS-TYPE MMTV INTEGRATION SITE FAMILY, MEMBER 2B; WNT2B
601969	DELETED IN MALIGNANT BRAIN TUMORS 1; DMBT1
601970	VASOACTIVE INTESTINAL PEPTIDE RECEPTOR 2; VIPR2
601971	MOVED TO 600825
601972	RAR-RELATED ORPHAN RECEPTOR B; RORB
601973	RETINOIC ACID RECEPTOR RESPONDER 2; RARRES2
601974	SPHINGOSINE-1-PHOSPHATE RECEPTOR 1; S1PR1
601975	PLAKOPHILIN 1; PKP1
601976	OTOFACIOOSSEOUS-GONADAL SYNDROME
601977	THROMBOCYTHEMIA 2; THCYT2
601978	SIGMA NONOPIOID INTRACELLULAR RECEPTOR 1; SIGMAR1
601979	HYPERZINCEMIA WITH FUNCTIONAL ZINC DEPLETION
601980	LIPASE, GASTRIC; LIPF
601981	RIBONUCLEASE, RNase A FAMILY, 6; RNASE6
601982	8-OXOGUANINE DNA GLYCOSYLASE; OGG1
601983	MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE KINASE 1; MAP4K1
601984	NUCLEAR RECEPTOR COACTIVATOR 4; NCOA4
601985	COILED-COIL DOMAIN-CONTAINING PROTEIN 6; CCDC6
601986	MOVED TO 601698
601987	CARNITINE PALMITOYLTRANSFERASE I, MUSCLE; CPT1B
601988	LIM DOMAIN KINASE 2; LIMK2
601989	S100 CALCIUM-BINDING PROTEIN A13; S100A13
601990	TUMOR PROTEIN p73; TP73
601991	NOVA ALTERNATIVE SPLICING REGULATOR 2; NOVA2
601992	FRIEDREICH ATAXIA 2; FRDA2
601993	NUCLEAR RECEPTOR COACTIVATOR 2; NCOA2
601994	TRANSFER RNA ARGININE
601995	TENASCIN R; TNR
601996	MOVED TO 602026
601997	BH3-INTERACTING DOMAIN DEATH AGONIST; BID
601998	ESTROGEN-RELATED RECEPTOR, ALPHA; ESRRA
601999	LIM HOMEOBOX GENE 1; LHX1
602000	POLYMERASE I, RNA, SUBUNIT B; POLR1B
602001	NEUROPEPTIDE Y RECEPTOR Y5; NPY5R
602002	ZYXIN; ZYX
602003	LYMPHOID-RESTRICTED MEMBRANE PROTEIN; LRMP
602004	PROTEIN-TYROSINE KINASE 6; PTK6
602005	SORTILIN-RELATED RECEPTOR; SORL1
602006	MITOGEN-ACTIVATED PROTEIN KINASE-ACTIVATED PROTEIN KINASE 2; MAPKAPK2
602007	CRK-LIKE PROTOONCOGENE, ADAPTOR PROTEIN; CRKL
602008	IMPORTIN 5; IPO5
602009	CYTOCHROME c OXIDASE, SUBUNIT 6A2; COX6A2
602010	SPLICING FACTOR, SERINE/ARGININE-RICH, 11; SRSF11
602011	SUPPRESSOR OF TUMORIGENICITY 11; ST11
602012	ECTONUCLEOSIDE TRIPHOSPHATE DIPHOSPHOHYDROLASE 2; ENTPD2
602013	POLYMERASE II, RNA, SUBUNIT G; POLR2G
602014	HYPOMAGNESEMIA 1, INTESTINAL; HOMG1
602015	OUTER DENSE FIBER OF SPERM TAILS 2; ODF2
602016	KRUPPEL-LIKE FACTOR 2; KLF2
602017	PROTEASOME SUBUNIT, BETA-TYPE, 1; PSMB1
602018	NEURTURIN; NRTN
602019	SQUALENE EPOXIDASE; SQLE
602020	MAF bZIP TRANSCRIPTION FACTOR G; MAFG
602021	PROTEIN PHOSPHATASE 1, REGULATORY SUBUNIT 12A; PPP1R12A
602022	MAL-LIKE; MALL
602023	CHLORIDE CHANNEL, KIDNEY, B; CLCNKB
602024	CHLORIDE CHANNEL, KIDNEY, A; CLCNKA
602025	BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 9; BMIQ9
602026	PHYTANOYL-CoA HYDROXYLASE; PHYH
602027	TELOMERIC REPEAT-BINDING FACTOR 2; TERF2
602028	MOVED TO 601900
602029	REMOVED FROM DATABASE
602030	FUCOSYLTRANSFERASE 7; FUT7
602031	PROTEIN GERANYLGERANYLTRANSFERASE TYPE I, BETA SUBUNIT; PGGT1B
602032	ECTODERMAL DYSPLASIA 4, HAIR/NAIL TYPE; ECTD4
602033	ECHINODERM MICROTUBULE-ASSOCIATED PROTEIN-LIKE 1; EML1
602034	CORTICOTROPIN-RELEASING HORMONE RECEPTOR 2; CRHR2
602035	PROTEIN PHOSPHATASE 4, CATALYTIC SUBUNIT; PPP4C
602036	MOVED TO 133200
602037	RAS HOMOLOG GENE FAMILY, MEMBER H; RHOH
602038	DUAL-SPECIFICITY PHOSPHATASE 8; DUSP8
602039	EUKARYOTIC TRANSLATION INITIATION FACTOR 3, SUBUNIT A; EIF3A
602040	CELL ADHESION MOLECULE, NEURAL, 2; NCAM2
602041	NK3 HOMEOBOX 1; NKX3-1
602042	G PROTEIN-COUPLED RECEPTOR 18; GPR18
602043	G PROTEIN-COUPLED RECEPTOR 31; GPR31
602044	UNCOUPLING PROTEIN 3; UCP3
602045	RING FINGER PROTEIN 1; RING1
602046	PROTEIN DISULFIDE ISOMERASE, FAMILY A, MEMBER 3; PDIA3
602047	PHOSPHODIESTERASE 3B; PDE3B
602048	RAS-RELATED C3 BOTULINUM TOXIN SUBSTRATE 1; RAC1
602049	RAS-RELATED C3 BOTULINUM TOXIN SUBSTRATE 2; RAC2
602050	RAS-RELATED C3 BOTULINUM TOXIN SUBSTRATE 3; RAC3
602051	PEPTIDYL-PROLYL CIS/TRANS ISOMERASE, NIMA-INTERACTING, 1-LIKE; PIN1L
602052	CYCLIN G-ASSOCIATED KINASE; GAK
602053	KRUPPEL-LIKE FACTOR 6; KLF6
602054	T-BOX TRANSCRIPTION FACTOR 1; TBX1
602055	INSULIN-INDUCED GENE 1; INSIG1
602056	DEFENSIN, BETA, 1; DEFB1
602057	MOVED TO 300256
602058	PROTEASE INHIBITOR 10; PI10
602059	IMMUNOGLOBULIN SUPERFAMILY CONTAINING LEUCINE-RICH REPEAT; ISLR
602060	TRANSMEMBRANE SERINE PROTEASE 2; TMPRSS2
602061	EPIREGULIN; EREG
602062	NERVE INJURY-INDUCED PROTEIN 1; NINJ1
602063	TRANSALDOLASE 1; TALDO1
602064	MYOINOSITOL MONOPHOSPHATASE 1; IMPA1
602065	ADENOSINE DEAMINASE, RNA-SPECIFIC, B2; ADARB2
602066	CONVULSIONS, FAMILIAL INFANTILE, WITH PAROXYSMAL CHOREOATHETOSIS; ICCA
602067	MOVED TO 601419
602068	LEISHMANIASIS, TEGUMENTARY, SUSCEPTIBILITY TO
602069	NEUROPILIN 1; NRP1
602070	NEUROPILIN 2; NRP2
602071	BROAD TERMINAL PHALANGES, FAMILIAL
602072	CYTOCHROME c OXIDASE, SUBUNIT 6A1; COX6A1
602073	MOVED TO 601533
602074	DEATH-ASSOCIATED PROTEIN 3; DAP3
602075	SPECIAL AT-RICH SEQUENCE-BINDING PROTEIN 1; SATB1
602076	TRANSIENT RECEPTOR POTENTIAL CATION CHANNEL, SUBFAMILY V, MEMBER 1; TRPV1
602077	MOVED TO 604292
602078	FIBROSIS OF EXTRAOCULAR MUSCLES, CONGENITAL, 2; CFEOM2
602079	TRIMETHYLAMINURIA; TMAU
602080	PAGET DISEASE OF BONE 2, EARLY-ONSET; PDB2
602081	SPEECH-LANGUAGE DISORDER 1; SPCH1
602082	CORNEAL DYSTROPHY, THIEL-BEHNKE TYPE; CDTB
602083	USHER SYNDROME, TYPE IF; USH1F
602084	MOVED TO 601728
602085	POLYDACTYLY, POSTAXIAL, TYPE A2; PAPA2
602086	ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA, FAMILIAL, 3; ARVD3
602087	ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA, FAMILIAL, 4; ARVD4
602088	NEPHRONOPHTHISIS 2; NPHP2
602089	HEMANGIOMA, CAPILLARY INFANTILE
602090	LATENT TRANSFORMING GROWTH FACTOR-BETA-BINDING PROTEIN 3; LTBP3
602091	LATENT TRANSFORMING GROWTH FACTOR-BETA-BINDING PROTEIN 2; LTBP2
602092	DEAFNESS, AUTOSOMAL RECESSIVE 18A; DFNB18A
602093	CONE DYSTROPHY 3; COD3
602094	MOVED TO 151660
602095	SOLUTE CARRIER FAMILY 30 (ZINC TRANSPORTER), MEMBER 4; SLC30A4
602096	ALZHEIMER DISEASE 5
602097	USHER SYNDROME, TYPE IE; USH1E
602098	POLO-LIKE KINASE 1; PLK1
602099	AMYOTROPHIC LATERAL SCLEROSIS 5, JUVENILE; ALS5
602100	PBX/KNOTTED 1 HOMEOBOX 1; PKNOX1
602101	CLAUDIN 5; CLDN5
602102	SPT5 HOMOLOG, DSIF ELONGATION FACTOR SUBUNIT; SUPT5H
602103	TRAFFICKING PROTEIN PARTICLE COMPLEX, SUBUNIT 10; TRAPPC10
602104	SH3 DOMAIN-BINDING PROTEIN 2; SH3BP2
602105	MutS HOMOLOG 4; MSH4
602106	POTASSIUM CHANNEL, INWARDLY RECTIFYING, SUBFAMILY J, MEMBER 15; KCNJ15
602107	NEUROPATHY, HEREDITARY THERMOSENSITIVE
602108	MATRILIN 2; MATN2
602109	MATRILIN 3; MATN3
602110	SOLUTE CARRIER FAMILY 29 (NUCLEOSIDE TRANSPORTER), MEMBER 2; SLC29A2
602111	SPONDYLOEPIMETAPHYSEAL DYSPLASIA, MISSOURI TYPE; SEMDM
602112	METALLOPHOSPHOESTERASE DOMAIN-CONTAINING PROTEIN 1; MPPED1
602113	LYSINE-SPECIFIC METHYLTRANSFERASE 2D; KMT2D
602114	NEPHROPATHY, PROGRESSIVE TUBULOINTERSTITIAL, WITH CHOLESTATIC LIVER DISEASE
602115	FIBROBLAST GROWTH FACTOR 10; FGF10
602116	YEATS DOMAIN-CONTAINING PROTEIN 4; YEATS4
602117	NECDIN; NDN
602118	CHROMODOMAIN HELICASE DNA-BINDING PROTEIN 1; CHD1
602119	CHROMODOMAIN HELICASE DNA-BINDING PROTEIN 2; CHD2
602120	CHROMODOMAIN HELICASE DNA-BINDING PROTEIN 3; CHD3
602121	DIAPHANOUS-RELATED FORMIN 1; DIAPH1
602122	SIGNAL RECOGNITION PARTICLE, 72-KD; SRP72
602123	CALCIUM/CALMODULIN-DEPENDENT PROTEIN KINASE II-GAMMA; CAMK2G
602124	DYSTONIA 7, TORSION; DYT7
602125	CYTOCHROME c OXIDASE ASSEMBLY FACTOR COX10; COX10
602126	ZINC FINGER- AND BTB DOMAIN-CONTAINING PROTEIN 14; ZBTB14
602127	SMOOTHELIN; SMTN
602128	GROWTH ARREST-SPECIFIC 2-LIKE 1; GAS2L1
602129	MYOSIN IXB; MYO9B
602130	MITOGEN-ACTIVATED PROTEIN KINASE-ACTIVATED PROTEIN KINASE 3; MAPKAPK3
602131	PLECKSTRIN HOMOLOGY-LIKE DOMAIN, FAMILY A, MEMBER 2; PHLDA2
602132	MIA SH3 DOMAIN ER EXPORT FACTOR 2; MIA2
602133	PHOSPHORIBOSYLFORMYLGLYCINAMIDINE SYNTHASE; PFAS
602134	TREMOR, HEREDITARY ESSENTIAL, 2; ETM2
602135	DYNEIN, AXONEMAL, LIGHT INTERMEDIATE POLYPEPTIDE 1; DNALI1
602136	PEROXISOME BIOGENESIS FACTOR 1; PEX1
602137	NADH-UBIQUINONE OXIDOREDUCTASE SUBUNIT A2; NDUFA2
602138	NADH-UBIQUINONE OXIDOREDUCTASE SUBUNIT A6; NDUFA6
602139	NADH-UBIQUINONE OXIDOREDUCTASE SUBUNIT A7; NDUFA7
602140	NADH-UBIQUINONE OXIDOREDUCTASE SUBUNIT B8; NDUFB8
602141	NADH-UBIQUINONE OXIDOREDUCTASE Fe-S PROTEIN 8; NDUFS8
602142	PHOSPHOLIPASE C, DELTA-1; PLCD1
602143	TUMOR PROTEIN p53-BINDING PROTEIN 2; TP53BP2
602144	BROMODOMAIN, TESTIS-SPECIFIC; BRDT
602145	PROLIFERATION-ASSOCIATED 2G4, 38-KD; PA2G4
602146	LIM HOMEOBOX GENE 4; LHX4
602147	REMOVED FROM DATABASE
602148	SRY-BOX 1; SOX1
602149	PAIRED-LIKE HOMEODOMAIN TRANSCRIPTION FACTOR 1; PITX1
602150	SNAIL FAMILY TRANSCRIPTIONAL REPRESSOR 2; SNAI2
602151	DISHEVELLED 2; DVL2
602152	RHYNS SYNDROME; RHYNS
602153	KERATIN 81, TYPE II; KRT81
602154	NONCODING TRANSCRIPT IN T CELLS
602155	UBX DOMAIN PROTEIN 8; UBXN8
602156	MOVED TO 601134
602157	NOVA ALTERNATIVE SPLICING REGULATOR 1; NOVA1
602158	CHLORIDE CHANNEL, NUCLEOTIDE SENSITIVE, 1A; CLNS1A
602159	CORONIN 2A; CORO2A
602160	TRANSCRIPTION FACTOR DP2; TFDP2
602161	PROTEASOME ACTIVATOR SUBUNIT 2; PSME2
602162	SYNAPTONEMAL COMPLEX PROTEIN 1; SYCP1
602163	UBIQUITIN-CONJUGATING ENZYME E2 E2; UBE2E2
602164	5-HYDROXYTRYPTAMINE RECEPTOR 4; HTR4
602165	TRIPARTITE MOTIF-CONTAINING PROTEIN 27; TRIM27
602166	ADAPTOR-RELATED PROTEIN COMPLEX 3, BETA-2 SUBUNIT; AP3B2
602167	ESTROGEN-RELATED RECEPTOR, BETA; ESRRB
602168	VRK SERINE/THREONINE KINASE 1; VRK1
602169	VRK SERINE/THREONINE KINASE 2; VRK2
602170	MYD88 INNATE IMMUNE SIGNAL TRANSDUCTION ADAPTOR; MYD88
602171	GLYCOPROTEIN A33; GPA33
602172	CYTOCHROME P450, SUBFAMILY VIIIB, POLYPEPTIDE 1; CYP8B1
602173	SEC62 HOMOLOG, PREPROTEIN TRANSLOCATION FACTOR; SEC62
602174	G PROTEIN-COUPLED RECEPTOR 25; GPR25
602175	PROTEASOME SUBUNIT, BETA-TYPE, 2; PSMB2
602176	PROTEASOME SUBUNIT, BETA-TYPE, 3; PSMB3
602177	PROTEASOME SUBUNIT, BETA-TYPE, 4; PSMB4
602178	CHONDROADHERIN; CHAD
602179	HEAT-SHOCK 27-KD PROTEIN 2; HSPB2
602180	SIGNAL-INDUCED PROLIFERATION-ASSOCIATED GENE 1; SIPA1
602181	STAPHYLOCOCCAL NUCLEASE DOMAIN- AND TUDOR DOMAIN-CONTAINING PROTEIN 1; SND1
602182	ECTONUCLEOTIDE PYROPHOSPHATASE/PHOSPHODIESTERASE 3; ENPP3
602183	NK3 HOMEOBOX 2; NKX3-2
602184	NADH-UBIQUINONE OXIDOREDUCTASE FLAVOPROTEIN 3; NDUFV3
602185	MOVED TO 600004
602186	VGF, NERVE GROWTH FACTOR-INDUCIBLE; VGF
602187	ZINC FINGER PROTEIN 195; ZNF195
602188	EPHRIN RECEPTOR EphA4; EPHA4
602189	REGULATOR OF G PROTEIN SIGNALING 3; RGS3
602190	EPHRIN RECEPTOR EphA7; EPHA7
602191	E74-LIKE ETS TRANSCRIPTION FACTOR 3; ELF3
602192	A DISINTEGRIN AND METALLOPROTEINASE DOMAIN 10; ADAM10
602193	SOLUTE CARRIER FAMILY 29 (NUCLEOSIDE TRANSPORTER), MEMBER 1; SLC29A1
602194	HTRA SERINE PEPTIDASE 1; HTRA1
602195	HEAT-SHOCK 27-KD PROTEIN 1; HSPB1
602196	PIERRE ROBIN SEQUENCE WITH PECTUS EXCAVATUM AND RIB AND SCAPULAR ANOMALIES
602197	CEREBELLAR DEGENERATION-RELATED AUTOANTIGEN 3
602198	CDK2-ASSOCIATED PROTEIN 1; CDK2AP1
602199	MEDIUM CHAIN 3-KETOACYL-CoA THIOLASE DEFICIENCY
602200	VENTRICULOMEGALY WITH DEFECTS OF THE RADIUS AND KIDNEY
602201	EXTRACELLULAR MATRIX PROTEIN 1; ECM1
602202	DOLICHYL-DIPHOSPHOOLIGOSACCHARIDE-PROTEIN GLYCOSYLTRANSFERASE; DDOST
602203	SARCOLIPIN; SLN
602204	BICD CARGO ADAPTOR 1; BICD1
602205	MOVED TO 601805
602206	RAS-ASSOCIATED PROTEIN RAB17; RAB17
602207	RAS-ASSOCIATED PROTEIN RAB18; RAB18
602208	POTASSIUM CHANNEL, INWARDLY RECTIFYING, SUBFAMILY J, MEMBER 10; KCNJ10
602209	RAS-RESPONSIVE ELEMENT BINDING PROTEIN 1; RREB1
602210	EUKARYOTIC TRANSLATION INITIATION FACTOR 3, SUBUNIT E; EIF3E
602211	FORKHEAD BOX D2; FOXD2
602212	SIAH E3 UBIQUITIN PROTEIN LIGASE FAMILY, MEMBER 1; SIAH1
602213	SIAH E3 UBIQUITIN PROTEIN LIGASE FAMILY, MEMBER 2; SIAH2
602214	CASEIN KINASE I, GAMMA-2; CSNK1G2
602215	DEFENSIN, BETA, 4A; DEFB4A
602216	SERINE/THREONINE PROTEIN KINASE 11; STK11
602217	SYNDECAN-BINDING PROTEIN; SDCBP
602218	SAL-LIKE 1; SALL1
602219	SAL-LIKE 2; SALL2
602220	RAS-LIKE, FAMILY 10, MEMBER A; RASL10A
602221	ZINC FINGER, MYM-TYPE 2; ZMYM2
602222	MOVED TO 602022
602223	EUKARYOTIC TRANSLATION INITIATION FACTOR 4E-BINDING PROTEIN 1; EIF4EBP1
602224	EUKARYOTIC TRANSLATION INITIATION FACTOR 4E-BINDING PROTEIN 2; EIF4EBP2
602225	CONE-ROD HOMEOBOX-CONTAINING GENE; CRX
602226	CD180 ANTIGEN; CD180
602227	CHEMOKINE, CC MOTIF, LIGAND 19; CCL19
602228	TRANSCRIPTION FACTOR 7-LIKE 2; TCF7L2
602229	SRY-BOX 10; SOX10
602230	SH3 DOMAIN-BINDING GLUTAMIC ACID-RICH PROTEIN; SH3BGR
602231	SMALL UBIQUITIN-LIKE MODIFIER 3; SUMO3
602232	POTASSIUM CHANNEL, VOLTAGE-GATED, KQT-LIKE SUBFAMILY, MEMBER 3; KCNQ3
602233	APOPTOTIC PROTEASE ACTIVATING FACTOR 1; APAF1
602234	CASPASE 9, APOPTOSIS-RELATED CYSTEINE PROTEASE; CASP9
602235	POTASSIUM CHANNEL, VOLTAGE-GATED, KQT-LIKE SUBFAMILY, MEMBER 2; KCNQ2
602236	MOVED TO 601880
602237	MOVED TO 601470
602238	EXOSOME COMPONENT 2; EXOSC2
602239	CYTOCHROME P450, SUBFAMILY XXVIA, POLYPEPTIDE 1; CYP26A1
602240	ZINC FINGER PROTEIN 192; ZNF192
602241	MITOCHONDRIAL INTERMEDIATE PEPTIDASE; MIPEP
602242	ADAPTOR-RELATED PROTEIN COMPLEX 2, SIGMA-1 SUBUNIT; AP2S1
602243	CD151 ANTIGEN; CD151
602244	DEOXYRIBONUCLEASE I-LIKE 3; DNASE1L3
602245	GTP-BINDING PROTEIN 1; GTPBP1
602246	ZINC FINGER PROTEIN 193; ZNF193
602247	XANTHOMATOSIS, SUSCEPTIBILITY TO
602248	MALIGNANT ATROPHIC PAPULOSIS
602249	PROGEROID FACIAL APPEARANCE WITH HAND ANOMALIES
602250	TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY, MEMBER 9; TNFRSF9
602251	TRANSLOCASE OF INNER MITOCHONDRIAL MEMBRANE 10; TIMM10
602252	MITOCHONDRIAL INTERMEMBRANE SPACE PROTEIN TIM12, YEAST, HOMOLOG OF
602253	KRUPPEL-LIKE FACTOR 4; KLF4
602254	SRR1 DOMAIN-CONTAINING PROTEIN; SRRD
602255	SERINE/THREONINE PROTEIN KINASE 25; STK25
602256	PROTEIN PHOSPHATASE, EF-HAND CALCIUM-BINDING DOMAIN 2; PPEF2
602257	SCAVENGER RECEPTOR CLASS B, MEMBER 2; SCARB2
602258	MOVED TO 601040
602259	TETRATRICOPEPTIDE REPEAT DOMAIN-CONTAINING PROTEIN 3; TTC3
602260	PERIOD CIRCADIAN REGULATOR 1; PER1
602261	MATRIX METALLOPROTEINASE 15; MMP15
602262	MATRIX METALLOPROTEINASE 16; MMP16
602263	MOVED TO 601807
602264	SPARC/OSTEONECTIN, CWCV, AND KAZAL-LIKE DOMAINS PROTEOGLYCAN; SPOCK1
602265	NEURAL PRECURSOR CELL EXPRESSED, DEVELOPMENTALLY DOWNREGULATED 9; NEDD9
602266	MOVED TO 300135
602267	A DISINTEGRIN AND METALLOPROTEINASE DOMAIN 8; ADAM8
602268	AMINE OXIDASE, COPPER-CONTAINING, 2; AOC2
602269	ARVCF DELTA CATENIN FAMILY MEMBER; ARVCF
602270	ANTIOXIDANT PROTEIN 1; ATOX1
602271	SPONDYLOMETAPHYSEAL DYSPLASIA, AXIAL; SMDAX
602272	TRANSCRIPTION FACTOR 4; TCF4
602273	UDP-N-ACETYL-ALPHA-D-GALACTOSAMINE:POLYPEPTIDE N-ACETYLGALACTOSAMINYLTRANSFERASE 1; GALNT1
602274	UDP-N-ACETYL-ALPHA-D-GALACTOSAMINE:POLYPEPTIDE N-ACETYLGALACTOSAMINYLTRANSFERASE 2; GALNT2
602275	GUANYLATE CYCLASE ACTIVATOR 1B; GUCA1B
602276	TRANSCRIPTIONAL ADAPTOR 2A; TADA2A
602277	ZINC FINGER PROTEIN 184; ZNF184
602278	NEURAL PRECURSOR CELL EXPRESSED, DEVELOPMENTALLY DOWNREGULATED 4; NEDD4
602279	POLYADENYLATE-BINDING PROTEIN, NUCLEAR, 1; PABPN1
602280	TUB-LIKE PROTEIN 1; TULP1
602281	MILK FAT GLOBULE-EGF FACTOR 8; MFGE8
602282	LYSOPHOSPHATIDIC ACID RECEPTOR 1; LPAR1
602283	CHEMOKINE, CC MOTIF, LIGAND 8; CCL8
602284	BONE MORPHOGENETIC PROTEIN 8B; BMP8B
602285	MATRIX METALLOPROTEINASE 17; MMP17
602286	STEROL C5-DESATURASE; SC5D
602287	ENDOPLASMIC RETICULUM PROTEIN, 29-KD; ERP29
602288	RHOTEKIN; RTKN
602289	DR1-ASSOCIATED PROTEIN 1; DRAP1
602290	TRIPARTITE MOTIF-CONTAINING PROTEIN 32; TRIM32
602291	FORKHEAD BOX J1; FOXJ1
602292	ENOYL-CoA HYDRATASE, SHORT-CHAIN, 1, MITOCHONDRIAL; ECHS1
602293	CALCIUM- AND INTEGRIN-BINDING PROTEIN 1; CIB1
602294	FORKHEAD BOX A1; FOXA1
602295	FORKHEAD BOX A3; FOXA3
602296	ADAPTOR-RELATED PROTEIN COMPLEX 4, MU-1 SUBUNIT; AP4M1
602297	EPHRIN B3; EFNB3
602298	RAS-ASSOCIATED PROTEIN RAB7; RAB7
602299	MOVED TO 300284
602300	GALACTOSE-3-O-SULFOTRANSFERASE 1; GAL3ST1
602301	LYSINE ACETYLTRANSFERASE 2A; KAT2A
602302	HR LYSINE DEMETHYLASE AND NUCLEAR RECEPTOR COREPRESSOR; HR
602303	LYSINE ACETYLTRANSFERASE 2B; KAT2B
602304	NUCLEAR RECEPTOR SUBFAMILY 1, GROUP D, MEMBER 2; NR1D2
602305	MOVED TO 602162
602306	RAL GUANINE NUCLEOTIDE DISSOCIATION STIMULATOR-LIKE 2; RGL2
602307	WW DOMAIN-CONTAINING PROTEIN 1; WWP1
602308	WW DOMAIN-CONTAINING PROTEIN 2; WWP2
602309	TUB-LIKE PROTEIN 2; TULP2
602310	RNA-BINDING MOTIF PROTEIN, SINGLE STRAND-INTERACTING, 1; RBMS1
602311	AGOUTI-RELATED NEUROPEPTIDE; AGRP
602312	MOVED TO 142711
602313	OVO-LIKE 1; OVOL1
602314	LADININ 1; LAD1
602315	MITOGEN-ACTIVATED PROTEIN KINASE KINASE 3; MAP2K3
602316	PEROXIREDOXIN 6; PRDX6
602317	SH3 AND CYSTEINE-RICH DOMAINS 1; STAC1
602318	TRANSCRIPTION TERMINATION FACTOR 1, MITOCHONDRIAL; MTERF1
602319	NEURAL EPIDERMAL GROWTH FACTOR-LIKE PROTEIN 1; NELL1
602320	NEURAL EPIDERMAL GROWTH FACTOR-LIKE PROTEIN 2; NELL2
602321	GLUTATHIONE S-TRANSFERASE, KAPPA-1; GSTK1
602322	TELOMERASE RNA COMPONENT; TERC
602323	POTASSIUM CHANNEL, INWARDLY RECTIFYING, SUBFAMILY J, MEMBER 12; KCNJ12
602324	HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN H3; HNRNPH3
602325	EUKARYOTIC TRANSLATION INITIATION FACTOR 4-GAMMA, 2; EIF4G2
602326	RIBOSOMAL PROTEIN L23A; RPL23A
602327	PLECKSTRIN AND SEC7 DOMAINS-CONTAINING PROTEIN; PSD
602328	MOVED TO 300118
602329	SUPPRESSOR OF LIN12-LIKE; SEL1L
602330	ACTIN-BINDING LIM PROTEIN FAMILY, MEMBER 1; ABLIM1
602331	ORIGIN RECOGNITION COMPLEX, SUBUNIT 5; ORC5
602332	NON-SMC CONDENSIN I COMPLEX SUBUNIT H; NCAPH
602333	EPITHELIAL MEMBRANE PROTEIN 1; EMP1
602334	EPITHELIAL MEMBRANE PROTEIN 2; EMP2
602335	EPITHELIAL MEMBRANE PROTEIN 3; EMP3
602336	RECEPTOR TYROSINE KINASE-LIKE ORPHAN RECEPTOR 1; ROR1
602337	RECEPTOR TYROSINE KINASE-LIKE ORPHAN RECEPTOR 2; ROR2
602338	PRE-mRNA-PROCESSING FACTOR 4B; PRPF4B
602339	SOLUTE CARRIER FAMILY 15 (H+/PEPTIDE TRANSPORTER), MEMBER 2; SLC15A2
602340	SENSORINEURAL HEARING LOSS, RETINAL PIGMENT EPITHELIUM LESIONS, DISCOLORED TEETH
602341	FORKHEAD BOX M1; FOXM1
602342	PIERPONT SYNDROME; PRPTS
602343	TRANSIENT RECEPTOR POTENTIAL CATION CHANNEL, SUBFAMILY C, MEMBER 1; TRPC1
602344	PLATELET-ACTIVATING FACTOR ACETYLHYDROLASE 2; PAFAH2
602345	TRANSIENT RECEPTOR POTENTIAL CATION CHANNEL, SUBFAMILY C, MEMBER 3; TRPC3
602346	CONTACTIN-ASSOCIATED PROTEIN 1; CNTNAP1
602347	CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC, 3; PFIC3
602348	SMALL NUCLEAR RNA-ACTIVATING PROTEIN COMPLEX, POLYPEPTIDE 3; SNAPC3
602349	NETRIN 3; NTN3
602350	NEUROGRANIN; NRGN
602351	CHEMERIN CHEMOKINE-LIKE RECEPTOR 1; CMKLR1
602352	GONADOTROPIN-RELEASING HORMONE 2; GNRH2
602353	TRANSFORMING GROWTH FACTOR, BETA-1-INDUCED 1; TGFB1I1
602354	LINKER FOR ACTIVATION OF T CELLS; LAT
602355	TNF RECEPTOR-ASSOCIATED FACTOR 6; TRAF6
602356	TNF RECEPTOR-ASSOCIATED FACTOR 5; TRAF5
602357	WAS/WASL-INTERACTING PROTEIN FAMILY, MEMBER 1; WIPF1
602358	HYPOCRETIN; HCRT
602359	FXYD DOMAIN-CONTAINING ION TRANSPORT REGULATOR 1; FXYD1
602360	L-ARGININE:GLYCINE AMIDINOTRANSFERASE; GATM
602361	GRACILE BONE DYSPLASIA; GCLEB
602362	GTPase-ACTIVATING PROTEIN, RAN, 1; RANGAP1
602363	MOVED TO 225500
602364	CATHEPSIN W; CTSW
602365	CATHEPSIN C; CTSC
602366	INTEGRIN-LINKED KINASE; ILK
602367	NEURONAL PENTRAXIN 1; NPTX1
602368	GLUTAMATE RECEPTOR, IONOTROPIC, DELTA 2; GRID2
602369	CELLULAR COMMUNICATION NETWORK FACTOR 1; CCN1
602370	GLYCOSYLPHOSPHATIDYLINOSITOL-ANCHORED MOLECULE-LIKE PROTEIN; GML
602371	ACYL-CoA SYNTHETASE LONG CHAIN FAMILY, MEMBER 3; ACSL3
602372	ZONADHESIN; ZAN
602373	CALPONIN 2; CNN2
602374	CALPONIN 3; CNN3
602375	MITOCHONDRIAL RIBOSOMAL PROTEIN L12; MRPL12
602376	INTERFERON-ALPHA, -BETA, AND -OMEGA RECEPTOR 2; IFNAR2
602377	DYNAMIN 1; DNM1
602378	DYNAMIN 2; DNM2
602379	MOVED TO 300141
602380	UROPLAKIN 1B; UPK1B
602381	NGFIA-BINDING PROTEIN 2; NAB2
602382	PHOSPHOLIPASE D1, PHOSPHATIDYLCHOLINE-SPECIFIC; PLD1
602383	OSTEOGLYCIN; OGN
602384	PHOSPHOLIPASE D2; PLD2
602385	SULFOTRANSFERASE FAMILY 1C, MEMBER 2; SULT1C2
602386	ZINC FINGER PROTEIN 212; ZNF212
602387	RNA-BINDING MOTIF PROTEIN, SINGLE STRAND-INTERACTING, 2; RBMS2
602388	SYMPLEKIN; SYMPK
602389	Tu TRANSLATION ELONGATION FACTOR, MITOCHONDRIAL; TUFM
602390	HEMOCHROMATOSIS, TYPE 2A; HFE2A
602391	PHOSPHATIDYLETHANOLAMINE N-METHYLTRANSFERASE; PEMT
602392	HYPOCRETIN RECEPTOR 1; HCRTR1
602393	HYPOCRETIN RECEPTOR 2; HCRTR2
602394	NUCLEOLAR AND COILED-BODY PHOSPHOPROTEIN 1; NOLC1
602395	GLYCEROL-3-PHOSPHATE ACYLTRANSFERASE, MITOCHONDRIAL; GPAM
602396	ANNEXIN A8; ANXA8
602397	ATPase, CLASS I, TYPE 8B, MEMBER 1; ATP8B1
602398	DESMOSTEROLOSIS
602399	MITOGEN-ACTIVATED PROTEIN KINASE 12; MAPK12
602400	ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 11; ARCI11
602401	ECTODERMAL DYSPLASIA 8, HAIR/TOOTH/NAIL TYPE; ECTD8
602402	FORKHEAD BOX C2; FOXC2
602403	BLEOMYCIN HYDROLASE; BLMH
602404	PARKINSON DISEASE 3, AUTOSOMAL DOMINANT; PARK3
602405	MOVED TO 600910
602406	HEART- AND NEURAL CREST DERIVATIVES-EXPRESSED 1; HAND1
602407	HEART- AND NEURAL CREST DERIVATIVES-EXPRESSED 2; HAND2
602408	NUCLEAR RECEPTOR SUBFAMILY 1, GROUP D, MEMBER 1; NR1D1
602409	MLLT10 HISTONE LYSINE METHYLTRANSFERASE DOT1L COFACTOR; MLLT10
602410	BROMODOMAIN- AND PHD FINGER-CONTAINING PROTEIN; BRPF1
602411	EXOSTOSIN-LIKE GLYCOSYLTRANSFERASE 2; EXTL2
602412	RIBOSOMAL PROTEIN S24; RPS24
602413	SUCCINATE DEHYDROGENASE COMPLEX, SUBUNIT C, INTEGRAL MEMBRANE PROTEIN, 15-KD; SDHC
602414	AMYLOID BETA A4 PRECURSOR PROTEIN-BINDING, FAMILY A, MEMBER 1; APBA1
602415	DYSTROBREVIN, BETA; DTNB
602416	ADAPTOR-RELATED PROTEIN COMPLEX 3, SIGMA-2 SUBUNIT; AP3S2
602417	MOVED TO 602974
602418	WEYERS ULNAR RAY/OLIGODACTYLY SYNDROME
602419	EARLY GROWTH RESPONSE 3; EGR3
602420	POTASSIUM CHANNEL, VOLTAGE-GATED, SHAKER-RELATED SUBFAMILY, MEMBER 10; KCNA10
602421	CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; CFTR
602422	STEM-LOOP BINDING PROTEIN; SLBP
602423	NUCLEAR RECEPTOR SUBFAMILY 1, GROUP H, MEMBER 3; NR1H3
602424	DOUBLESEX- AND MAB3-RELATED TRANSCRIPTION FACTOR 1; DMRT1
602425	MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE 4; MAP3K4
602426	NUCLEAR VALOSIN-CONTAINING PROTEIN-LIKE; NVL
602427	T-BOX TRANSCRIPTION FACTOR 6; TBX6
602428	HYALURONAN SYNTHASE 3; HAS3
602429	GLAUCOMA 1, OPEN ANGLE, D; GLC1D
602430	ROUNDABOUT GUIDANCE RECEPTOR 1; ROBO1
602431	ROUNDABOUT GUIDANCE RECEPTOR 2; ROBO2
602432	OPTINEURIN; OPTN
602433	AMYOTROPHIC LATERAL SCLEROSIS 4, JUVENILE; ALS4
602434	ANCIENT UBIQUITOUS PROTEIN 1; AUP1
602435	PEPTIDYL-PROLYL ISOMERASE E; PPIE
602436	MAJOR HISTOCOMPATIBILITY COMPLEX CLASS I CHAIN-RELATED GENE B; MICB
602437	GTP CYCLOHYDROLASE I FEEDBACK REGULATORY PROTEIN; GCHFR
602438	HEAT-SHOCK TRANSCRIPTION FACTOR 4; HSF4
602439	MOVED TO 601626
602440	AMYOTROPHY, MONOMELIC
602441	CYTOKINE-INDUCIBLE SH2-CONTAINING PROTEIN; CISH
602442	INTERSECTIN 1; ITSN1
602443	X-PROLYL AMINOPEPTIDASE 1; XPNPEP1
602444	ZINC FINGER PROTEIN 354A; ZNF354A
602445	SERINE PROTEASE INHIBITOR, CLADE I, MEMBER 1; SERPINI1
602446	GLYPICAN 5; GPC5
602447	PARAOXONASE 2; PON2
602448	MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE 5; MAP3K5
602449	A-KINASE ANCHOR PROTEIN 1; AKAP1
602450	SEVERE COMBINED IMMUNODEFICIENCY WITH SENSITIVITY TO IONIZING RADIATION
602451	PYRIMIDINERGIC RECEPTOR P2Y, G PROTEIN-COUPLED, 6; P2RY6
602452	BUB1 MITOTIC CHECKPOINT SERINE/THREONINE KINASE; BUB1
602453	INTEGRIN, ALPHA-D; ITGAD
602454	PROTEIN-TYROSINE PHOSPHATASE, RECEPTOR-TYPE, U; PTPRU
602455	MOVED TO 605271
602456	REMOVED FROM DATABASE
602457	FAS-ASSOCIATED VIA DEATH DOMAIN; FADD
602458	SORTILIN; SORT1
602459	DEAFNESS, AUTOSOMAL DOMINANT 15; DFNA15
602460	POU DOMAIN, CLASS 4, TRANSCRIPTION FACTOR 3; POU4F3
602461	PROTEIN-TYROSINE PHOSPHATASE, NONRECEPTOR TYPE, SUBSTRATE 1; PTPNS1
602462	COLLAPSIN RESPONSE MEDIATOR PROTEIN 1; CRMP1
602463	DIHYDROPYRIMIDINASE-LIKE 2; DPYSL2
602464	TNF RECEPTOR-ASSOCIATED FACTOR 4; TRAF4
602465	SPROUTY RTK SIGNALING ANTAGONIST 1; SPRY1
602466	SPROUTY RTK SIGNALING ANTAGONIST 2; SPRY2
602467	MOVED TO 300531
602468	PROTEIN PHOSPHATASE 1, REGULATORY SUBUNIT 9A; PPP1R9A
602469	FOLATE RECEPTOR 3; FOLR3
602470	PROSTATE STEM CELL ANTIGEN; PSCA
602471	SHORT STATURE, AUDITORY CANAL ATRESIA, MANDIBULAR HYPOPLASIA, AND SKELETAL ABNORMALITIES; SAMS
602472	CREASES, INFRA-AURICULAR CUTANEOUS, WITH TALL STATURE AND ADVANCED BONE AGE
602473	ENCEPHALOPATHY, ETHYLMALONIC; EE
602474	PROTEIN KINASE, MEMBRANE-ASSOCIATED TYROSINE/THREONINE, 1; PKMYT1
602475	OSSIFICATION OF THE POSTERIOR LONGITUDINAL LIGAMENT OF SPINE; OPLL
602476	MOVED TO 121210
602477	EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 17; EIG17
602478	tRNA ASPARTIC ACID METHYLTRANSFERASE 1; TRDMT1
602479	POU DOMAIN, CLASS 3, TRANSCRIPTION FACTOR 1; POU3F1
602480	POU DOMAIN, CLASS 3, TRANSCRIPTION FACTOR 3; POU3F3
602481	MIGRAINE, FAMILIAL HEMIPLEGIC, 2; FHM2
602482	AXENFELD-RIEGER SYNDROME, TYPE 3; RIEG3
602483	AURICULOCONDYLAR SYNDROME 1; ARCND1
602484	PELVIC HYPOPLASIA WITH LOWER-LIMB ARTHROGRYPOSIS
602485	HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 3; HHF3
602486	POP1 HOMOLOG, RIBONUCLEASE P/MRP SUBUNIT; POP1
602487	HEAT-RESPONSIVE PROTEIN 12; HRSP12
602488	CYTOHESIN 2; CYTH2
602489	KH DOMAIN-CONTAINING, RNA-BINDING, SIGNAL TRANSDUCTION-ASSOCIATED PROTEIN 1; KHDRBS1
602490	NUCLEAR RECEPTOR-INTERACTING PROTEIN 1; NRIP1
602491	HYPERLIPIDEMIA, FAMILIAL COMBINED, 1; FCHL1
602492	PENTRAXIN 3; PTX3
602493	UV RADIATION RESISTANCE-ASSOCIATED GENE; UVRAG
602494	CHEMOKINE, CC MOTIF, LIGAND 23; CCL23
602495	CHEMOKINE, CC MOTIF, LIGAND 24; CCL24
602496	MERCAPTOPYRUVATE SULFURTRANSFERASE; MPST
602497	CHONDRODYSPLASIA PUNCTATA, BRACHYTELEPHALANGIC, AUTOSOMAL
602498	TRAFFICKING FROM ER TO GOLGI REGULATOR; TFG
602499	MACROPHTHALMIA, COLOBOMATOUS, WITH MICROCORNEA; MACOM
602500	GOLGI AUTOANTIGEN, GOLGIN SUBFAMILY B, 1; GOLGB1
602501	MEGALENCEPHALY-CAPILLARY MALFORMATION-POLYMICROGYRIA SYNDROME; MCAP
602502	GOLGIN A1; GOLGA1
602503	FREQUENTLY REARRANGED IN ADVANCED T-CELL LYMPHOMAS; FRAT1
602504	SHORT STATURE HOMEOBOX 2; SHOX2
602505	PAXILLIN; PXN
602506	MOVED TO 143055
602507	RING FINGER PROTEIN 103; RNF103
602508	PLATELET-ACTIVATING FACTOR ACETYLHYDROLASE, ISOFORM 1B, BETA SUBUNIT; PAFAH1B2
602509	GOLGIN A4; GOLGA4
602510	PROTEIN-TYROSINE PHOSPHATASE, RECEPTOR-TYPE, H; PTPRH
602511	PSEUDOACROMEGALY WITH SEVERE INSULIN RESISTANCE
602512	REGULATOR OF G PROTEIN SIGNALING 12; RGS12
602513	REGULATOR OF G PROTEIN SIGNALING 14; RGS14
602514	REGULATOR OF G PROTEIN SIGNALING 16; RGS16
602515	PHOSPHOLIPASE D1, GLYCOSYLPHOSPHATIDYLINOSITOL-SPECIFIC; GPLD1
602516	REGULATOR OF G PROTEIN SIGNALING 4; RGS4
602517	REGULATOR OF G PROTEIN SIGNALING 7; RGS7
602518	LECTIN, GALACTOSIDE-BINDING, SOLUBLE, 4; LGALS4
602519	UBIQUITIN-SPECIFIC PROTEASE 7; USP7
602520	MITOGEN-ACTIVATED PROTEIN KINASE KINASE 5; MAP2K5
602521	MITOGEN-ACTIVATED PROTEIN KINASE 7; MAPK7
602522	BARTTER SYNDROME, TYPE 4A, NEONATAL, WITH SENSORINEURAL DEAFNESS; BARTS4A
602523	DOWN SYNDROME CELL ADHESION MOLECULE; DSCAM
602524	PYRUVATE DEHYDROGENASE KINASE, ISOENZYME 1; PDK1
602525	PYRUVATE DEHYDROGENASE KINASE, ISOENZYME 2; PDK2
602526	MOVED TO 300906
602527	PYRUVATE DEHYDROGENASE KINASE, ISOENZYME 4; PDK4
602528	TUBULIN, ALPHA-3C; TUBA3C
602529	TUBULIN, ALPHA-1A; TUBA1A
602530	TUBULIN, ALPHA-1B; TUBA1B
602531	GRANGE SYNDROME; GRNG
602532	RNF217 ANTISENSE RNA 1; RNF217AS1
602533	ONCOGENE DJ1; DJ1
602534	SYNAPTOSOMAL-ASSOCIATED PROTEIN, 23-KD; SNAP23
602535	MARSHALL-SMITH SYNDROME; MRSHSS
602536	RAB3 GTPase-ACTIVATING PROTEIN, CATALYTIC SUBUNIT; RAB3GAP1
602537	CALPAIN 5; CAPN5
602538	CUGBP- AND ELAV-LIKE FAMILY, MEMBER 2; CELF2
602539	MITOGEN-ACTIVATED KINASE KINASE KINASE 3; MAP3K3
602540	ICHTHYOSIS, HYSTRIX-LIKE, WITH DEAFNESS
602541	MUSCULAR DYSTROPHY, CONGENITAL, MEGACONIAL TYPE; MDCMC
602542	BASIC TRANSCRIPTION FACTOR 3; BTF3
602543	BASIC TRANSCRIPTION FACTOR 3 PSEUDOGENE 11; BTF3P11
602544	PARKIN RBR E3 UBIQUITIN PROTEIN LIGASE; PRKN
602545	PROTEIN-TYROSINE PHOSPHATASE, RECEPTOR-TYPE, KAPPA; PTPRK
602546	ST8 ALPHA-N-ACETYL-NEURAMINIDE ALPHA-2,8-SIALYLTRANSFERASE 2; ST8SIA2
602547	ST8 ALPHA-N-ACETYL-NEURAMINIDE ALPHA-2,8-SIALYLTRANSFERASE 4; ST8SIA4
602548	OPIOID RECEPTOR-LIKE 1; OPRL1
602549	PROTEIN KINASE N2; PKN2
602550	BRAIN AND MUSCLE ARNT-LIKE PROTEIN 1; BMAL1
602551	JEJUNAL ATRESIA WITH RENAL ADYSPLASIA
602552	NUCLEOPORIN, 88-KD; NUP88
602553	ANAL ATRESIA, HYPOSPADIAS, AND PENOSCROTAL INVERSION
602554	TORSION DYSTONIA WITH ONSET IN INFANCY
602555	MICROCEPHALY, MACROTIA, AND MENTAL RETARDATION
602556	FACIAL DYSMORPHISM, CLEFT PALATE, HEARING LOSS, AND CAMPTODACTYLY
602557	SPONDYLOEPIMETAPHYSEAL DYSPLASIA, SHOHAT TYPE; SEMDSH
602558	CRANIOMICROMELIC SYNDROME
602559	EXPORTIN 1; XPO1
602560	TRACHEAL ANTIMICROBIAL PEPTIDE
602561	BRACHYDACTYLY, INTRAVENTRICULAR SEPTAL DEFECT, AND DEAFNESS
602562	MANDIBULOFACIAL DYSOSTOSIS WITH MACROBLEPHARON AND MACROSTOMIA
602563	NK6 HOMEOBOX 1; NKX6-1
602564	EMPHYSEMA, CONGENITAL, WITH DEAFNESS, PENOSCROTAL WEB, AND MENTAL RETARDATION
602565	CHEMOKINE, CC MOTIF, LIGAND 25; CCL25
602566	PURINERGIC RECEPTOR P2X, LIGAND-GATED ION CHANNEL, 7; P2RX7
602567	LIM ZINC FINGER-CONTAINING PROTEIN 1; LIMS1
602568	METHIONINE SYNTHASE REDUCTASE; MTRR
602569	SYNUCLEIN, BETA; SNCB
602570	JAGGED 2; JAG2
602571	RNA-BINDING MOTIF PROTEIN 4; RBM4
602572	ANNEXIN A11; ANXA11
602573	ANNEXIN A13; ANXA13
602574	TECTORIN, ALPHA; TECTA
602575	LIM HOMEOBOX TRANSCRIPTION FACTOR 1, BETA; LMX1B
602576	LFNG O-FUCOSYLPEPTIDE 3-BETA-N-ACETYLGLUCOSAMINYLTRANSFERASE; LFNG
602577	MFNG O-FUCOSYLPEPTIDE 3-BETA-N-ACETYLGLUCOSAMINYLTRANSFERASE; MFNG
602578	RFNG O-FUCOSYLPEPTIDE 3-BETA-N-ACETYLGLUCOSAMINYLTRANSFERASE; RFNG
602579	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ib; CDG1B
602580	GOLGIN A2; GOLGA2
602581	GOLGIN A3; GOLGA3
602582	DELTEX E3 UBIQUITIN LIGASE 1; DTX1
602583	G PROTEIN-COUPLED RECEPTOR 37; GPR37
602584	RETICULOCALBIN 2; RCN2
602585	MOVED TO 164280
602586	MOVED TO 602857
602587	ACYL-CoA THIOESTERASE 7; ACOT7
602588	BRANCHIOOTIC SYNDROME 1; BOS1
602589	FUCOSYLTRANSFERASE 8; FUT8
602590	p21 PROTEIN-ACTIVATED KINASE 1; PAK1
602591	KINESIN FAMILY MEMBER 2A; KIF2A
602592	LYMPHOCYTE ANTIGEN CD5-LIKE; CD5L
602593	CORNEODESMOSIN; CDSN
602594	RETINITIS PIGMENTOSA 22; RP22
602595	GEM NUCLEAR ORGANELLE-ASSOCIATED PROTEIN 2; GEMIN2
602596	PANCREATIC LYMPHOMA, FAMILIAL
602597	B-CELL CLL/LYMPHOMA 9; BCL9
602598	PROSTAGLANDIN D SYNTHASE, HEMATOPOIETIC; HPGDS
602599	MOVED TO 602631
602600	LOW DENSITY LIPOPROTEIN RECEPTOR-RELATED PROTEIN 8; LRP8
602601	LOW DENSITY LIPOPROTEIN, OXIDIZED, RECEPTOR 1; OLR1
602602	SECRETED AND TRANSMEMBRANE 1; SECTM1
602603	MAGO HOMOLOG, EXON JUNCTION COMPLEX SUBUNIT; MAGOH
602604	MOVED TO 602323
602605	MOVED TO 602221
602606	CART PREPROPEPTIDE; CARTPT
602607	SOLUTE CARRIER FAMILY 22 (ORGANIC CATION TRANSPORTER), MEMBER 1; SLC22A1
602608	SOLUTE CARRIER FAMILY 22 (ORGANIC CATION TRANSPORTER), MEMBER 2; SLC22A2
602609	PHOSPHATIDYLINOSITOL 3-KINASE, CLASS 3; PIK3C3
602610	PHOSPHATIDYLINOSITOL 3-KINASE, REGULATORY SUBUNIT 4; PIK3R4
602611	SPONDYLOEPIPHYSEAL DYSPLASIA WITH CORONAL CRANIOSYNOSTOSIS, CATARACTS, CLEFT PALATE, AND MENTAL RETARDATION
602612	CAMPTODACTYLY, MYOPIA, AND FIBROSIS OF THE MEDIAL RECTUS MUSCLE OF EYE
602613	SKELETAL DYSPLASIA AND PROGRESSIVE CENTRAL NERVOUS SYSTEM DEGENERATION, LETHAL
602614	MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE 7; MAP3K7
602615	TAK1-BINDING PROTEIN 1; TAB1
602616	ALPHA-1,6-MANNOSYL-GLYCOPROTEIN BETA-1,2-N-ACETYLGLUCOSAMINYLTRANSFERASE; MGAT2
602617	FORKHEAD BOX E1; FOXE1
602618	C-TERMINAL-BINDING PROTEIN 1; CTBP1
602619	C-TERMINAL-BINDING PROTEIN 2; CTBP2
602620	LEGUMAIN; LGMN
602621	COXSACKIEVIRUS AND ADENOVIRUS RECEPTOR; CXADR
602622	DEOXYRIBONUCLEASE I-LIKE 2; DNASE1L2
602623	FK506-BINDING PROTEIN 5; FKBP5
602624	MOVED TO 602570
602625	MEMBRANE-ASSOCIATED GUANYLATE KINASE, WW AND PDZ DOMAINS-CONTAINING, 1; MAGI1
602626	INTERLEUKIN 1 RECEPTOR ACCESSORY PROTEIN; IL1RAP
602627	CELL DIVISION CYCLE 6; CDC6
602628	FORKHEAD BOX N3; FOXN3
602629	DYSTONIA 6, TORSION; DYT6
602630	TRANSFORMING GROWTH FACTOR-BETA-INDUCED FACTOR; TGIF
602631	SOLUTE CARRIER FAMILY 22 (ORGANIC CATION TRANSPORTER), MEMBER 18; SLC22A18
602632	PODOCALYXIN-LIKE; PODXL
602633	FOUR-AND-A-HALF LIM DOMAINS 2; FHL2
602634	DNAJ/HSP40 HOMOLOG, SUBFAMILY B, MEMBER 9; DNAJB9
602635	DEAF1 TRANSCRIPTION FACTOR; DEAF1
602636	PROTEIN PHOSPHATASE 1, REGULATORY SUBUNIT 8; PPP1R8
602637	SECRETED PHOSPHOPROTEIN 2; SPP2
602638	MINICHROMOSOME MAINTENANCE COMPLEX COMPONENT 4; MCM4
602639	TOOTH AGENESIS, SELECTIVE, 2; STHAG2
602640	N-ACETYLATED ALPHA-LINKED ACIDIC DIPEPTIDASE-LIKE 1; NAALADL1
602641	EUKARYOTIC TRANSLATION INITIATION FACTOR 4A, ISOFORM 1; EIF4A1
602642	TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY, MEMBER 11; TNFSF11
602643	TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY, MEMBER 11B; TNFRSF11B
602644	TETRASPANIN 4; TSPAN4
602645	SEMAPHORIN 3C; SEMA3C
602646	G PROTEIN-COUPLED RECEPTOR 35; GPR35
602647	NUCLEAR RNA EXPORT FACTOR 1; NXF1
602648	ATYPICAL CHEMOKINE RECEPTOR 2; ACKR2
602649	COLD-INDUCIBLE RNA-BINDING PROTEIN; CIRBP
602650	SPECKLE-TYPE BTB/POZ PROTEIN; SPOP
602651	NARDILYSIN; NRD1
602652	KALLIKREIN-RELATED PEPTIDASE 6; KLK6
602653	TECTORIN, BETA; TECTB
602654	FERM, ARHGEF, AND PLECKSTRIN DOMAINS-CONTAINING PROTEIN 1; FARP1
602655	SOLUTE CARRIER FAMILY 4 (ANION EXCHANGER), MEMBER 1, ADAPTOR PROTEIN; SLC4A1AP
602656	ENDONUCLEASE III-LIKE 1; NTHL1
602657	MOVED TO 300572
602658	PHOSPHODIESTERASE 2A; PDE2A
602659	MENAGE A TROIS 1; MNAT1
602660	TUBULIN, BETA-4B; TUBB4B
602661	TUBULIN, BETA-3; TUBB3
602662	TUBULIN, BETA-4A; TUBB4A
602663	PROLACTIN-RELEASING HORMONE; PRLH
602664	CASPASE 4, APOPTOSIS-RELATED CYSTEINE PROTEASE; CASP4
602665	CASPASE 5, APOPTOSIS-RELATED CYSTEINE PROTEASE; CASP5
602666	MYOSIN XVA; MYO15A
602667	NIBRIN; NBN
602668	MYOTONIC DYSTROPHY 2; DM2
602669	PAIRED-LIKE HOMEODOMAIN TRANSCRIPTION FACTOR 3; PITX3
602670	POLYMERASE, DNA, EPSILON-2; POLE2
602671	SOLUTE CARRIER FAMILY 37 (GLUCOSE-6-PHOSPHATE TRANSPORTER), MEMBER 4; SLC37A4
602672	RAS-ASSOCIATED PROTEIN RAB13; RAB13
602673	KALLIKREIN-RELATED PEPTIDASE 10; KLK10
602674	MOVED TO 601802
602675	ARGINYL AMINOPEPTIDASE; RNPEP
602676	PHOSPHODIESTERASE 6D; PDE6D
602677	RING FINGER PROTEIN 5; RNF5
602678	MAP/MICROTUBULE AFFINITY-REGULATING KINASE 3; MARK3
602679	PHOSPHATE CYTIDYLYLTRANSFERASE 2, ETHANOLAMINE; PCYT2
602680	RHO GTPase-ACTIVATING PROTEIN 5; ARHGAP5
602681	FORKHEAD BOX O3A; FOXO3A
602682	ADHESION G PROTEIN-COUPLED RECEPTOR B1; ADGRB1
602683	ADHESION G PROTEIN-COUPLED RECEPTOR B2; ADGRB2
602684	ADHESION G PROTEIN-COUPLED RECEPTOR B3; ADGRB3
602685	MENTAL RETARDATION, SEVERE, WITH SPASTICITY AND PIGMENTARY TAPETORETINAL DEGENERATION
602686	MITOTIC ARREST DEFICIENT 1 LIKE 1; MAD1L1
602687	MOVED TO 603072
602688	HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN A/B; HNRNPAB
602689	FASCIN ACTIN-BUNDLING PROTEIN 1; FSCN1
602690	SUCCINATE DEHYDROGENASE COMPLEX, SUBUNIT D, INTEGRAL MEMBRANE PROTEIN; SDHD
602691	NUCLEAR RECEPTOR COACTIVATOR 1; NCOA1
602692	GLIOMA PATHOGENESIS-RELATED PROTEIN 1; GLIPR1
602693	MINICHROMOSOME MAINTENANCE COMPLEX COMPONENT 3; MCM3
602694	NADH-UBIQUINONE OXIDOREDUCTASE Fe-S PROTEIN 4; NDUFS4
602695	TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY, MEMBER 12; TNFSF12
602696	MINICHROMOSOME MAINTENANCE COMPLEX COMPONENT 5; MCM5
602697	PURINERGIC RECEPTOR P2Y, G PROTEIN-COUPLED, 11; P2RY11
602698	NUCLEAR FACTOR OF ACTIVATED T CELLS, CYTOPLASMIC, CALCINEURIN-DEPENDENT 3; NFATC3
602699	NUCLEAR FACTOR OF ACTIVATED T CELLS, CYTOPLASMIC, CALCINEURIN-DEPENDENT 4; NFATC4
602700	E1A-BINDING PROTEIN, 300-KD; EP300
602701	SARCOLEMMAL-ASSOCIATED PROTEIN; SLMAP
602702	PERILIPIN 3; PLIN3
602703	KATANIN, p80 SUBUNIT, B1; KATNB1
602704	MDM4 REGULATOR OF p53; MDM4
602705	SYNAPSIN III; SYN3
602706	PROTEASOME 26S SUBUNIT, ATPase, 1; PSMC1
602707	PROTEASOME 26S SUBUNIT, ATPase, 4; PSMC4
602708	PROTEASOME 26S SUBUNIT, ATPase, 6; PSMC6
602709	AMYLOID BETA A4 PRECURSOR PROTEIN-BINDING, FAMILY B, MEMBER 1; APBB1
602710	AMYLOID BETA A4 PRECURSOR PROTEIN-BINDING, FAMILY B, MEMBER 2; APBB2
602711	AMYLOID BETA A4 PRECURSOR PROTEIN-BINDING, FAMILY B, MEMBER 3; APBB3
602712	AMYLOID BETA A4 PRECURSOR PROTEIN-BINDING, FAMILY A, MEMBER 2; APBA2
602713	A DISINTEGRIN AND METALLOPROTEINASE DOMAIN 9; ADAM9
602714	A DISINTEGRIN AND METALLOPROTEINASE DOMAIN 12; ADAM12
602715	LEIOMODIN 1; LMOD1
602716	NEPHRIN; NPHS1
602717	GLUTAMATE RECEPTOR, IONOTROPIC, N-METHYL-D-ASPARTATE, SUBUNIT 2D; GRIN2D
602718	TRANSFORMER 2 ALPHA HOMOLOG; TRA2A
602719	TRANSFORMER 2 BETA HOMOLOG; TRA2B
602720	PARAOXONASE 3; PON3
602721	DNA MEIOTIC RECOMBINASE 1; DMC1
602722	RENAL TUBULAR ACIDOSIS, DISTAL, 3, WITH OR WITHOUT SENSORINEURAL HEARING LOSS; DRTA3
602723	PSORIASIS 2; PSORS2
602724	SEPTIN 5; SEPT5
602725	INTERFERON-RELATED DEVELOPMENTAL REGULATOR 2; IFRD2
602726	CHLORIDE CHANNEL 6; CLCN6
602727	CHLORIDE CHANNEL 7; CLCN7
602728	SCAVENGER RECEPTOR CLASS A, MEMBER 3; SCARA3
602729	GAMMA-AMINOBUTYRIC ACID RECEPTOR, PI; GABRP
602730	ACTIVIN A RECEPTOR, TYPE IIB; ACVR2B
602731	FYN-BINDING PROTEIN 1; FYB1
602732	RHO GTPase-ACTIVATING PROTEIN 1; ARHGAP1
602733	ALDEHYDE DEHYDROGENASE, FAMILY 9, SUBFAMILY A, MEMBER 1; ALDH9A1
602734	PLASTIN 1; PLS1
602735	RETICULOCALBIN 1; RCN1
602736	ATP SYNTHASE MEMBRANE SUBUNIT C, LOCUS 3; ATP5MC3
602737	CHEMOKINE, CC MOTIF, LIGAND 21; CCL21
602738	KARYOPHERIN BETA-1; KPNB1
602739	PROTEIN KINASE, AMP-ACTIVATED, CATALYTIC, ALPHA-1; PRKAA1
602740	PROTEIN KINASE, AMP-ACTIVATED, NONCATALYTIC, BETA-1; PRKAB1
602741	PROTEIN KINASE, AMP-ACTIVATED, NONCATALYTIC, BETA-2; PRKAB2
602742	PROTEIN KINASE, AMP-ACTIVATED, NONCATALYTIC, GAMMA-1; PRKAG1
602743	PROTEIN KINASE, AMP-ACTIVATED, NONCATALYTIC, GAMMA-2; PRKAG2
602744	GLYCERONEPHOSPHATE O-ACYLTRANSFERASE; GNPAT
602745	PHOSPHATIDYLINOSITOL 4-PHOSPHATE 5-KINASE, TYPE I, BETA; PIP5K1B
602746	TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY, MEMBER 14; TNFRSF14
602747	DUAL-SPECIFICITY PHOSPHATASE 4; DUSP4
602748	DUAL-SPECIFICITY PHOSPHATASE 6; DUSP6
602749	DUAL-SPECIFICITY PHOSPHATASE 7; DUSP7
602750	D-DOPACHROME TAUTOMERASE; DDT
602751	BTB AND CNC HOMOLOGY 1; BACH1
602752	RANBP2-LIKE AND GRIP DOMAIN-CONTAINING PROTEIN 8; RGPD8
602753	PAIRED-LIKE HOMEOBOX 2A; PHOX2A
602754	POTASSIUM CHANNEL, CALCIUM-ACTIVATED, INTERMEDIATE/SMALL CONDUCTANCE, SUBFAMILY N, MEMBER 4; KCNN4
602755	CYCLIN B2; CCNB2
602756	EPHRIN A2; EFNA2
602757	EPHRIN RECEPTOR EphB6; EPHB6
602758	PHOSPHATIDYLINOSITOL 4-KINASE, BETA; PI4KB
602759	PROSTATE CANCER, HEREDITARY, 8; HPC8
602760	KERATIN 32, TYPE I; KRT32
602761	KERATIN 33A, TYPE I; KRT33A
602762	KERATIN 33B, TYPE I; KRT33B
602763	KERATIN 34, TYPE I; KRT34
602764	KERATIN 35, TYPE I; KRT35
602765	KERATIN 83, TYPE II; KRT83
602766	KERATIN 84, TYPE II; KRT84
602767	KERATIN 85, TYPE II; KRT85
602768	DELTA-LIKE CANONICAL NOTCH LIGAND 3; DLL3
602769	DNA METHYLTRANSFERASE 3A; DNMT3A
602770	CHROMOBOX 2; CBX2
602771	CONGENITAL MYOPATHY 3 WITH RIGID SPINE; CMYP3
602772	RETINITIS PIGMENTOSA 25; RP25
602773	SOLUTE CARRIER FAMILY 49, MEMBER 4; SLC49A4
602774	RAD51 PARALOG C; RAD51C
602775	SHOC2 LEUCINE-RICH REPEAT SCAFFOLD PROTEIN; SHOC2
602776	REV3-LIKE, DNA-DIRECTED POLYMERASE ZETA CATALYTIC SUBUNIT; REV3L
602777	SMALL NUCLEAR RNA-ACTIVATING PROTEIN COMPLEX, POLYPEPTIDE 4; SNAPC4
602778	NUCLEAR RECEPTOR SUBFAMILY 6, GROUP A, MEMBER 1; NR6A1
602779	COAGULATION FACTOR II RECEPTOR-LIKE 3; F2RL3
602780	HYPERPOLARIZATION-ACTIVATED CYCLIC NUCLEOTIDE-GATED POTASSIUM CHANNEL 1; HCN1
602781	HYPERPOLARIZATION-ACTIVATED CYCLIC NUCLEOTIDE-GATED POTASSIUM CHANNEL 2; HCN2
602782	HISTIOCYTOSIS-LYMPHADENOPATHY PLUS SYNDROME
602783	SPG7 MATRIX AAA PEPTIDASE SUBUNIT, PARAPLEGIN; SPG7
602784	CORTISTATIN; CORT
602785	H1 HISTONE FAMILY, MEMBER X; H1FX
602786	HISTONE GENE CLUSTER 1, H2A HISTONE FAMILY, MEMBER E; HIST1H2AE
602787	HISTONE GENE CLUSTER 1, H2A HISTONE FAMILY, MEMBER I; HIST1H2AI
602788	HISTONE GENE CLUSTER 1, H2A HISTONE FAMILY, MEMBER K; HIST1H2AK
602789	MOVED TO 300163
602790	FOUR-AND-A-HALF LIM DOMAINS 3; FHL3
602791	HISTONE GENE CLUSTER 1, H2A HISTONE FAMILY, MEMBER J; HIST1H2AJ
602792	HISTONE GENE CLUSTER 1, H2A HISTONE FAMILY, MEMBER D; HIST1H2AD
602793	HISTONE GENE CLUSTER 1, H2A HISTONE FAMILY, MEMBER L; HIST1H2AL
602794	HISTONE GENE CLUSTER 1, H2A HISTONE FAMILY, MEMBER C; HIST1H2AC
602795	HISTONE GENE CLUSTER 1, H2A HISTONE FAMILY, MEMBER B; HIST1H2AB
602796	HISTONE GENE CLUSTER 1, H2A HISTONE FAMILY, MEMBER M; HIST1H2AM
602797	HISTONE GENE CLUSTER 2, H2A HISTONE FAMILY, MEMBER C; HIST2H2AC
602798	HISTONE GENE CLUSTER 1, H2B HISTONE FAMILY, MEMBER G; HIST1H2BG
602799	HISTONE GENE CLUSTER 1, H2B HISTONE FAMILY, MEMBER D; HIST1H2BD
602800	HISTONE GENE CLUSTER 1, H2B HISTONE FAMILY, MEMBER L; HIST1H2BL
602801	HISTONE GENE CLUSTER 1, H2B HISTONE FAMILY, MEMBER N; HIST1H2BN
602802	HISTONE GENE CLUSTER 1, H2B HISTONE FAMILY, MEMBER M; HIST1H2BM
602803	HISTONE GENE CLUSTER 1, H2B HISTONE FAMILY, MEMBER B; HIST1H2BB
602804	HISTONE GENE CLUSTER 1, H2B HISTONE FAMILY, MEMBER F; HIST1H2BF
602805	HISTONE GENE CLUSTER 1, H2B HISTONE FAMILY, MEMBER E; HIST1H2BE
602806	HISTONE GENE CLUSTER 1, H2B HISTONE FAMILY, MEMBER H; HIST1H2BH
602807	HISTONE GENE CLUSTER 1, H2B HISTONE FAMILY, MEMBER I; HIST1H2BI
602808	HISTONE GENE CLUSTER 1, H2B HISTONE FAMILY, MEMBER O; HIST1H2BO
602809	KINESIN FAMILY MEMBER 5B; KIF5B
602810	HISTONE GENE CLUSTER 1, H3 HISTONE FAMILY, MEMBER A; HIST1H3A
602811	HISTONE GENE CLUSTER 1, H3 HISTONE FAMILY, MEMBER D; HIST1H3D
602812	HISTONE GENE CLUSTER 1, H3 HISTONE FAMILY, MEMBER C; HIST1H3C
602813	HISTONE GENE CLUSTER 1, H3 HISTONE FAMILY, MEMBER E; HIST1H3E
602814	HISTONE GENE CLUSTER 1, H3 HISTONE FAMILY, MEMBER I; HIST1H3I
602815	HISTONE GENE CLUSTER 1, H3 HISTONE FAMILY, MEMBER G; HIST1H3G
602816	HISTONE GENE CLUSTER 1, H3 HISTONE FAMILY, MEMBER F; HIST1H3F
602817	HISTONE GENE CLUSTER 1, H3 HISTONE FAMILY, MEMBER J; HIST1H3J
602818	HISTONE GENE CLUSTER 1, H3 HISTONE FAMILY, MEMBER H; HIST1H3H
602819	HISTONE GENE CLUSTER 1, H3 HISTONE FAMILY, MEMBER B; HIST1H3B
602820	HISTONE GENE CLUSTER 3, H3 HISTONE; HIST3H3
602821	KINESIN FAMILY MEMBER 5A; KIF5A
602822	H4 CLUSTERED HISTONE 1; H4C1
602823	H4 CLUSTERED HISTONE 4; H4C4
602824	H4 CLUSTERED HISTONE 6; H4C6
602825	H4 CLUSTERED HISTONE 12; H4C12
602826	H4 CLUSTERED HISTONE 11; H4C11
602827	H4 CLUSTERED HISTONE 3; H4C3
602828	H4 CLUSTERED HISTONE 8; H4C8
602829	H4 CLUSTERED HISTONE 2; H4C2
602830	H4 CLUSTERED HISTONE 5; H4C5
602831	H4 CLUSTERED HISTONE 13; H4C13
602832	H4 CLUSTERED HISTONE 7; H4C7
602833	H4 CLUSTERED HISTONE 9; H4C9
602834	MOVED TO 600279
602835	GROWTH ARREST-SPECIFIC 2; GAS2
602836	PURINERGIC RECEPTOR P2X, LIGAND-GATED ION CHANNEL, 5; P2RX5
602837	DNAJ/HSP40 HOMOLOG, SUBFAMILY A, MEMBER 1; DNAJA1
602838	PHOSPHATIDYLINOSITOL 3-KINASE, CLASS 2, BETA; PIK3C2B
602839	PHOSPHATIDYLINOSITOL 3-KINASE, CATALYTIC, DELTA; PIK3CD
602840	CD70 ANTIGEN; CD70
602841	ALDEHYDE OXIDASE 1; AOX1
602842	GEMININ DNA REPLICATION INHIBITOR; GMNN
602843	RHO GDP-DISSOCIATION INHIBITOR BETA; ARHGDIB
602844	RHO GDP-DISSOCIATION INHIBITOR GAMMA; ARHGDIG
602845	KINESIN FAMILY MEMBER 3C; KIF3C
602846	UBIQUITIN-CONJUGATING ENZYME E2 K; UBE2K
602847	HISTONE GENE CLUSTER 1, H2B HISTONE FAMILY, MEMBER C; HIST1H2BC
602848	BROMODOMAIN-CONTAINING PROTEIN 8; BRD8
602849	MUENKE SYNDROME; MNKES
602850	RING FINGER PROTEIN 4; RNF4
602851	ADHESION G PROTEIN-COUPLED RECEPTOR V1; ADGRV1
602852	NUDIX HYDROLASE 2; NUDT2
602853	PROTEIN-TYROSINE PHOSPHATASE, RECEPTOR-TYPE, R; PTPRR
602854	PROTEASOME SUBUNIT, ALPHA-TYPE, 1; PSMA1
602855	PROTEASOME SUBUNIT, ALPHA-TYPE, 6; PSMA6
602856	REGULATOR OF G PROTEIN SIGNALING 10; RGS10
602857	CHIMERIN 2; CHN2
602858	7-DEHYDROCHOLESTEROL REDUCTASE; DHCR7
602859	PEROXISOME BIOGENESIS FACTOR 10; PEX10
602860	BUB1 MITOTIC CHECKPOINT SERINE/THREONINE KINASE B; BUB1B
602861	PLAKOPHILIN 2; PKP2
602862	UDP-N-ACETYLGLUCOSAMINE PYROPHOSPHORYLASE 1; UAP1
602863	WINGLESS-TYPE MMTV INTEGRATION SITE FAMILY, MEMBER 9A; WNT9A
602864	WINGLESS-TYPE MMTV INTEGRATION SITE FAMILY, MEMBER 9B; WNT9B
602865	BONE MORPHOGENETIC PROTEIN/RETINOIC ACID-INDUCIBLE NEURAL-SPECIFIC PROTEIN 1; BRINP1
602866	ACID-SENSING ION CHANNEL, SUBUNIT 1; ASIC1
602867	INSULIN-LIKE GROWTH FACTOR-BINDING PROTEIN 7; IGFBP7
602868	CELL DIVISION CYCLE 5-LIKE; CDC5L
602869	HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN U; HNRNPU
602870	INTERPHOTORECEPTOR MATRIX PROTEOGLYCAN 1; IMPG1
602871	PERIPLAKIN; PPL
602872	CHLORIDE INTRACELLULAR CHANNEL 1; CLIC1
602873	NEBULIN-RELATED ANCHORING PROTEIN; NRAP
602874	UDP-GLUCOSE CERAMIDE GLUCOSYLTRANSFERASE; UGCG
602875	ACROMESOMELIC DYSPLASIA 1; AMD1
602876	OCCLUDIN; OCLN
602877	PROTEIN PHOSPHATASE 1, REGULATORY SUBUNIT 7; PPP1R7
602878	SOLUTE CARRIER FAMILY 30 (ZINC TRANSPORTER), MEMBER 3; SLC30A3
602879	ERYTHROCYTE MEMBRANE PROTEIN BAND 4.1-LIKE 1; EPB41L1
602880	GROWTH/DIFFERENTIATION FACTOR 1; GDF1
602881	PHD FINGER PROTEIN 1; PHF1
602882	LEUKOCYTE CELL-DERIVED CHEMOTAXIN 2; LECT2
602883	SOLUTE CARRIER ORGANIC ANION TRANSPORTER FAMILY, MEMBER 1A2; SLCO1A2
602884	GDP-MANNOSE 4,6-DEHYDRATASE; GMDS
602885	MOTILIN RECEPTOR; MLNR
602886	G PROTEIN-COUPLED RECEPTOR 39; GPR39
602887	DISCS LARGE MAGUK SCAFFOLD PROTEIN 4; DLG4
602888	BETAINE-HOMOCYSTEINE METHYLTRANSFERASE; BHMT
602889	MOVED TO 601533
602890	KILLER CELL LECTIN-LIKE RECEPTOR, SUBFAMILY B, MEMBER 1; KLRB1
602891	KILLER CELL LECTIN-LIKE RECEPTOR, SUBFAMILY C, MEMBER 2; KLRC2
602892	KILLER CELL LECTIN-LIKE RECEPTOR, SUBFAMILY C, MEMBER 3; KLRC3
602893	KILLER CELL LECTIN-LIKE RECEPTOR, SUBFAMILY C, MEMBER 4; KLRC4
602894	KILLER CELL LECTIN-LIKE RECEPTOR, SUBFAMILY D, MEMBER 1; KLRD1
602895	SCAFFOLD ATTACHMENT FACTOR B; SAFB
602896	MITOGEN-ACTIVATED PROTEIN KINASE 9; MAPK9
602897	MITOGEN-ACTIVATED PROTEIN KINASE 10; MAPK10
602898	MITOGEN-ACTIVATED PROTEIN KINASE 11; MAPK11
602899	MITOGEN-ACTIVATED PROTEIN KINASE 13; MAPK13
602900	DNA METHYLTRANSFERASE 3B; DNMT3B
602901	TRANSPORTIN 1; TNPO1
602902	KRUPPEL-LIKE FACTOR 9; KLF9
602903	KRUPPEL-LIKE FACTOR 5; KLF5
602904	MITOGEN-ACTIVATED PROTEIN KINASE 6; MAPK6
602905	POTASSIUM CHANNEL, VOLTAGE-GATED, DELAYED-RECTIFIER, SUBFAMILY S, MEMBER 1; KCNS1
602906	POTASSIUM CHANNEL, VOLTAGE-GATED, DELAYED-RECTIFIER, SUBFAMILY S, MEMBER 2; KCNS2
602907	CENTRIN 3; CETN3
602908	RETINOBLASTOMA-BINDING PROTEIN 9; RBBP9
602909	CLAUDIN 4; CLDN4
602910	CLAUDIN 3; CLDN3
602911	CALCIUM CHANNEL, VOLTAGE-DEPENDENT, GAMMA-2 SUBUNIT; CACNG2
602912	EUKARYOTIC TRANSLATION INITIATION FACTOR 6; EIF6
602913	POLO-LIKE KINASE 3; PLK3
602914	AQUAPORIN 9; AQP9
602915	GUIDED ENTRY OF TAIL-ANCHORED PROTEINS FACTOR 1; GET1
602916	UBIQUITIN-CONJUGATING ENZYME E2 E1; UBE2E1
602917	REGULATOR OF CALCINEURIN 1; RCAN1
602918	PHENYLALANINE-tRNA SYNTHETASE, ALPHA SUBUNIT; FARSA
602919	DOCKING PROTEIN 1; DOK1
602920	LIM AND SH3 PROTEIN 1; LASP1
602921	PERSEPHIN; PSPN
602922	MOVED TO 300825
602923	RETINOBLASTOMA-BINDING PROTEIN 4; RBBP4
602924	RHO FAMILY GTPase 3; RND3
602925	PHOSPHATIDYLINOSITOL 3-KINASE, CATALYTIC, BETA; PIK3CB
602926	SYNTAXIN-BINDING PROTEIN 1; STXBP1
602927	G PROTEIN-COUPLED RECEPTOR 19; GPR19
602928	TROPOMODULIN 2; TMOD2
602929	VON WILLEBRAND FACTOR A DOMAIN-CONTAINING PROTEIN 5A; VWA5A
602930	REX4 HOMOLOG, 3-PRIME,5-PRIME-EXONUCLEASE; REXO4
602931	SMAD FAMILY MEMBER 6; SMAD6
602932	SMAD FAMILY MEMBER 7; SMAD7
602933	THYROID HORMONE RECEPTOR INTERACTOR 6; TRIP6
602934	STROMAL CELL-DERIVED FACTOR 2; SDF2
602935	FATTY ACID AMIDE HYDROLASE; FAAH
602936	MOVED TO 300149
602937	CBP/p300-INTERACTING TRANSACTIVATOR, WITH GLU/ASP-RICH C-TERMINAL DOMAIN, 2; CITED2
602938	BILE ACID CoA:AMINO ACID N-ACYLTRANSFERASE; BAAT
602939	FORKHEAD BOX S1; FOXS1
602940	MARCKS-LIKE PROTEIN 1; MARCKSL1
602941	BCAR1 SCAFFOLD PROTEIN, CAS FAMILY MEMBER; BCAR1
602942	ECOTROPIC VIRAL INTEGRATION SITE 5; EVI5
602943	RAR-RELATED ORPHAN RECEPTOR C; RORC
602944	E2F TRANSCRIPTION FACTOR 6; E2F6
602945	TRANSCRIPTIONAL ADAPTOR 3; TADA3
602946	TAF6-LIKE RNA POLYMERASE II; TAF6L
602947	SPT3 HOMOLOG, SAGA AND STAGA COMPLEX COMPONENT; SUPT3H
602948	RAD51 PARALOG B; RAD51B
602949	SIN3-ASSOCIATED POLYPEPTIDE, 18-KD; SAP18
602950	PROTEIN ARGININE METHYLTRANSFERASE 1; PRMT1
602951	ZFP37 ZINC FINGER PROTEIN; ZFP37
602952	NUCLEAR RECEPTOR-BINDING SET DOMAIN PROTEIN 2; NSD2
602953	HES-RELATED FAMILY bHLH TRANSCRIPTION FACTOR WITH YRPW MOTIF 1; HEY1
602954	RAD51 PARALOG D; RAD51D
602955	TAF6 RNA POLYMERASE II, TATA BOX-BINDING PROTEIN-ASSOCIATED FACTOR, 80-KD; TAF6
602956	FANCG GENE; FANCG
602957	CHEMOKINE, CC MOTIF, LIGAND 22; CCL22
602958	SERUM/GLUCOCORTICOID-REGULATED KINASE 1; SGK1
602959	EUKARYOTIC TRANSLATION ELONGATION FACTOR 1, ALPHA-2; EEF1A2
602960	MOVED TO 300506
602961	UBIQUITIN-CONJUGATING ENZYME E2 D1; UBE2D1
602962	UBIQUITIN-CONJUGATING ENZYME E2 D2; UBE2D2
602963	UBIQUITIN-CONJUGATING ENZYME E2 D3; UBE2D3
602964	TRANSLIN-ASSOCIATED FACTOR X; TSNAX
602965	FATTY ACID-BINDING PROTEIN 7; FABP7
602966	OROFACIAL CLEFT 2; OFC2
602967	ZINC FINGER PROTEIN 217; ZNF217
602968	BRAIN-ENRICHED MYELIN-ASSOCIATED PROTEIN 1; BCAS1
602969	ESTROGEN-RELATED RECEPTOR, GAMMA; ESRRG
602970	KARYOPHERIN ALPHA-4; KPNA4
602971	TUBULIN-SPECIFIC CHAPERONE C; TBCC
602972	PHOSPHODIESTERASE 8A; PDE8A
602973	PHOSPHODIESTERASE 9A; PDE9A
602974	AQUAPORIN 7; AQP7
602975	MOVED TO 608833
602976	MAX-LIKE PROTEIN X; MLX
602977	GLYCOPROTEIN 2, ZYMOGEN GRANULE MEMBRANE; GP2
602978	POLYHOMEOTIC HOMOLOG 1; PHC1
602979	POLYHOMEOTIC HOMOLOG 2; PHC2
602980	SRSF PROTEIN KINASE 2; SRPK2
602981	AE-BINDING PROTEIN 1; AEBP1
602982	POTASSIUM CHANNEL, CALCIUM-ACTIVATED, INTERMEDIATE/SMALL CONDUCTANCE, SUBFAMILY N, MEMBER 1; KCNN1
602983	POTASSIUM CHANNEL, CALCIUM-ACTIVATED, INTERMEDIATE/SMALL CONDUCTANCE, SUBFAMILY N, MEMBER 3; KCNN3
602984	MEDIATOR COMPLEX SUBUNIT 6; MED6
602985	NADH-UBIQUINONE OXIDOREDUCTASE Fe-S PROTEIN 2; NDUFS2
602986	DEVELOPMENTALLY REGULATED GTP-BINDING PROTEIN 2; DRG2
602987	PHOSPHODIESTERASE 1C; PDE1C
602988	PROTOCADHERIN 7; PCDH7
602989	CDC-LIKE KINASE 2; CLK2
602990	CDC-LIKE KINASE 3; CLK3
602991	NOGGIN; NOG
602992	LEUKOCYTE-ASSOCIATED IMMUNOGLOBULIN-LIKE RECEPTOR 1; LAIR1
602993	LEUKOCYTE-ASSOCIATED IMMUNOGLOBULIN-LIKE RECEPTOR 2; LAIR2
602994	LEUKOREGULIN
602995	UBIQUITIN-CONJUGATING ENZYME E2 V1; UBE2V1
602996	IMMEDIATE-EARLY RESPONSE 3; IER3
602997	CUBILIN; CUBN
602998	SYNUCLEIN, GAMMA; SNCG
602999	PROTEIN PHOSPHATASE 1, REGULATORY SUBUNIT 3C; PPP1R3C
603000	MITOCHONDRIAL RIBOSOMAL PROTEIN L58; MRPL58
603001	UBIQUITIN-CONJUGATING ENZYME E2 V2; UBE2V2
603002	TRANSPORTIN 2; TNPO2
603003	BILE DUCT CYSTS
603004	NIPSNAP HOMOLOG 2; NIPSNAP2
603005	3-PRIME-PHOSPHOADENOSINE 5-PRIME-PHOSPHOSULFATE SYNTHASE 2; PAPSS2
603006	CADHERIN 4; CDH4
603007	CADHERIN 6; CDH6
603008	CADHERIN 8; CDH8
603009	DYSFERLIN; DYSF
603010	DEAFNESS, AUTOSOMAL RECESSIVE 17; DFNB17
603011	SMALL EDRK-RICH FACTOR 1A; SERF1A
603012	HEAT-SHOCK 70-KD PROTEIN 1B; HSPA1B
603013	SCHIZOPHRENIA 6; SCZD6
603014	MITOGEN-ACTIVATED PROTEIN KINASE KINASE 7; MAP2K7
603015	TRANSFORMATION/TRANSCRIPTION DOMAIN-ASSOCIATED PROTEIN; TRRAP
603016	CADHERIN 19; CDH19
603017	CADHERIN 17; CDH17
603018	BETA-3-GALACTOSYLTRANSFERASE 2; B3GALT2
603019	CADHERIN 18; CDH18
603020	AFG3-LIKE MATRIX AAA PEPTIDASE, SUBUNIT 1, PSEUDOGENE; AFG3L1P
603021	MITOCHONDRIAL RIBOSOMAL PROTEIN S12; MRPS12
603022	E4F TRANSCRIPTION FACTOR 1; E4F1
603023	IKAROS FAMILY ZINC FINGER 1; IKZF1
603024	AT-RICH INTERACTION DOMAIN-CONTAINING PROTEIN 1A; ARID1A
603025	PHOSPHATIDYLINOSITOL-BINDING CLATHRIN ASSEMBLY PROTEIN; PICALM
603026	PLAG1 ZINC FINGER PROTEIN; PLAG1
603027	FRUCTOSE-1,6-BISPHOSPHATASE 2; FBP2
603028	TOLL-LIKE RECEPTOR 2; TLR2
603029	TOLL-LIKE RECEPTOR 3; TLR3
603030	TOLL-LIKE RECEPTOR 4; TLR4
603031	TOLL-LIKE RECEPTOR 5; TLR5
603032	STANNIN; SNN
603033	COLLAGENIC TAIL OF ENDPLATE ACETYLCHOLINESTERASE; COLQ
603034	MYASTHENIC SYNDROME, CONGENITAL, 5; CMS5
603035	INTERLEUKIN 16; IL16
603036	MOVED TO 601877
603037	LEFT-RIGHT DETERMINATION FACTOR 1; LEFTY1
603038	SPERM-ASSOCIATED ANTIGEN 4; SPAG4
603039	MAX NETWORK TRANSCRIPTIONAL REPRESSOR; MNT
603040	TUMOR SUPPRESSOR GENE ON CHROMOSOME 11
603041	MITOCHONDRIAL DNA DEPLETION SYNDROME 1 (MNGIE TYPE); MTDPS1
603042	SMALL UBIQUITIN-LIKE MODIFIER 2; SUMO2
603043	NEUTRAL SPHINGOMYELINASE ACTIVATION-ASSOCIATED FACTOR; NSMAF
603044	PLAG1-LIKE ZINC FINGER 1; PLAGL1
603045	MOVED TO 603499
603046	RING FINGER PROTEIN 139; RNF139
603047	ASTIGMATISM
603048	GLYCOSYLPHOSPHATIDYLINOSITOL ANCHOR ATTACHMENT PROTEIN 1; GPAA1
603049	THIOREDOXIN-LIKE 1; TXNL1
603050	ABL INTERACTOR 1; ABI1
603051	ALKYLGLYCERONE-PHOSPHATE SYNTHASE; AGPS
603052	CLEAVAGE AND POLYADENYLATION SPECIFICITY FACTOR 4; CPSF4
603053	HISTONE ACETYLTRANSFERASE 1; HAT1
603054	GREMLIN 1, DAN FAMILY BMP ANTAGONIST; GREM1
603055	SKI-INTERACTING PROTEIN; SKIIP
603056	ORIGIN RECOGNITION COMPLEX, SUBUNIT 4; ORC4
603057	DACHSOUS CADHERIN-RELATED 1; DCHS1
603058	PROTOCADHERIN-GAMMA, SUBFAMILY B, MEMBER 4; PCDHGB4
603059	PROTOCADHERIN-GAMMA, SUBFAMILY A, MEMBER 12; PCDHGA12
603060	KINESIN FAMILY MEMBER 1C; KIF1C
603061	ENDOSULFINE, ALPHA; ENSA
603062	TRANS-GOLGI NETWORK PROTEIN 2; TGOLN2
603063	3-HYDROXYBUTYRATE DEHYDROGENASE 1; BDH1
603064	URIDINE DIPHOSPHATE GLYCOSYLTRANSFERASE 2 FAMILY, MEMBER B11; UGT2B11
603065	NUCLEAR RECEPTOR SUBFAMILY 1, GROUP I, MEMBER 2; NR1I2
603066	PROCOLLAGEN-LYSINE, 2-OXOGLUTARATE 5-DIOXYGENASE 3; PLOD3
603067	MOVED TO 602413
603068	DUAL-SPECIFICITY PHOSPHATASE 2; DUSP2
603069	DUAL-SPECIFICITY PHOSPHATASE 5; DUSP5
603070	RAD51-ASSOCIATED PROTEIN 1; RAD51AP1
603071	G PROTEIN-COUPLED RECEPTOR 17; GPR17
603072	AURORA KINASE A; AURKA
603073	ZIC FAMILY, MEMBER 2; ZIC2
603074	PLATELET-ACTIVATING FACTOR ACETYLHYDROLASE, ISOFORM 1B, GAMMA SUBUNIT; PAFAH1B3
603075	MACULAR DEGENERATION, AGE-RELATED, 1; ARMD1
603076	ATP-BINDING CASSETTE, SUBFAMILY G, MEMBER 1; ABCG1
603077	MOVED TO 300157
603078	CHECKPOINT KINASE 1; CHEK1
603079	CHROMOBOX 4; CBX4
603080	SOLUTE CARRIER FAMILY 6 (NEUROTRANSMITTER TRANSPORTER, BETAINE/GABA), MEMBER 12; SLC6A12
603081	ADP-RIBOSYLARGININE HYDROLASE; ADPRH
603082	MOVED TO 188855
603083	HETEROGENEOUS NUCLEAR RIBOPROTEIN L; HNRNPL
603084	ASPARTYL-tRNA SYNTHETASE 1; DARS1
603085	SOLUTE CARRIER FAMILY 31 (COPPER TRANSPORTER), MEMBER 1; SLC31A1
603086	ADP-RIBOSYLTRANSFERASE 3; ART3
603087	MOVED TO 110600
603088	SOLUTE CARRIER FAMILY 31 (COPPER TRANSPORTER), MEMBER 2; SLC31A2
603089	BRCA1-ASSOCIATED PROTEIN 1; BAP1
603090	UBIQUITIN CARBOXYL-TERMINAL ESTERASE L3; UCHL3
603091	UBIQUITIN-SPECIFIC PROTEASE 12; USP12
603092	DUAL-SPECIFICITY PHOSPHATASE 11; DUSP11
603093	BETA-3-GALACTOSYLTRANSFERASE 1; B3GALT1
603094	BETA-1,3-N-ACETYLGALACTOSAMINYLTRANSFERASE 1; B3GALNT1
603095	UDP-GAL:BETA-GlcNAc BETA-1,3-GALACTOSYLTRANSFERASE, POLYPEPTIDE 4; B3GALT4
603096	MOVED TO 262300
603097	ATPase, H+ TRANSPORTING, LYSOSOMAL, 42-KD, V1 SUBUNIT C, ISOFORM 1; ATP6V1C1
603098	DEAFNESS, AUTOSOMAL RECESSIVE 13; DFNB13
603099	1-ACYLGLYCEROL-3-PHOSPHATE O-ACYLTRANSFERASE 1; AGPAT1
603100	1-ACYLGLYCEROL-3-PHOSPHATE O-ACYLTRANSFERASE 2; AGPAT2
603101	CARBOXYPEPTIDASE B2, PLASMA; CPB2
603102	CARBOXYPEPTIDASE D; CPD
603103	CARBOXYPEPTIDASE N, POLYPEPTIDE 1, 50-KD; CPN1
603104	CARBOXYPEPTIDASE N, POLYPEPTIDE 2, 83-KD; CPN2
603105	CARBOXYPEPTIDASE Z; CPZ
603106	NEURONATIN; NNAT
603107	TRANSCRIPTION FACTOR 20; TCF20
603108	MICROTUBULE-ASSOCIATED PROTEIN, RP/EB FAMILY, MEMBER 1; MAPRE1
603109	SMAD FAMILY MEMBER 3; SMAD3
603110	SMAD FAMILY MEMBER 5; SMAD5
603111	SWI/SNF-RELATED, MATRIX-ASSOCIATED, ACTIN-DEPENDENT REGULATOR OF CHROMATIN, SUBFAMILY E, MEMBER 1; SMARCE1
603112	S100 CALCIUM-BINDING PROTEIN A12; S100A12
603113	PROTEIN PHOSPHATASE 2, STRUCTURAL/REGULATORY SUBUNIT A, BETA; PPP2R1B
603114	S100 CALCIUM-BINDING PROTEIN A11; S100A11
603115	DExH-BOX HELICASE 9; DHX9
603116	CDAGS SYNDROME
603117	SPASTIC PARAPLEGIA, OPTIC ATROPHY, MICROCEPHALY, AND XY SEX REVERSAL
603118	CADHERIN 16; CDH16
603119	APRAXIA OF EYELID OPENING
603120	QUIESCIN Q6 SULFHYDRYL OXIDASE 1; QSOX1
603121	MOVED TO 300768
603122	DEDICATOR OF CYTOKINESIS 2; DOCK2
603123	DEDICATOR OF CYTOKINESIS 3; DOCK3
603124	UBIQUITIN-CONJUGATING ENZYME E2 G2; UBE2G2
603125	TYROSYLPROTEIN SULFOTRANSFERASE 1; TPST1
603126	TYROSYLPROTEIN SULFOTRANSFERASE 2; TPST2
603127	GROWTH ARREST-SPECIFIC 7; GAS7
603128	SIM bHLH TRANSCRIPTION FACTOR 1; SIM1
603129	LIM DOMAIN ONLY 4; LMO4
603130	ATTRACTIN; ATRN
603131	PEPTIDASE, MITOCHONDRIAL PROCESSING, BETA; PMPCB
603132	ZINC FINGER PROTEIN 189; ZNF189
603133	DISLOCATED ELBOWS, BOWED TIBIAS, SCOLIOSIS, DEAFNESS, CATARACT, MICROCEPHALY, AND MENTAL RETARDATION
603134	CULLIN 1; CUL1
603135	CULLIN 2; CUL2
603136	CULLIN 3; CUL3
603137	CULLIN 4A; CUL4A
603138	MOVED TO 300304
603139	RAD17 CHECKPOINT CLAMP LOADER COMPONENT; RAD17
603140	PHOSPHATIDYLINOSITOL 5-PHOSPHATE 4-KINASE, TYPE II, ALPHA; PIP4K2A
603141	PPFIA-BINDING PROTEIN 1; PPFIBP1
603142	PPFIA-BINDING PROTEIN 2; PPFIBP2
603143	PTPRF-INTERACTING PROTEIN ALPHA-2; PPFIA2
603144	PTPRF-INTERACTING PROTEIN ALPHA-3; PPFIA3
603145	PTPRF-INTERACTING PROTEIN ALPHA-4; PPFIA4
603146	PROTEASOME 26S SUBUNIT, NON-ATPase, 9; PSMD9
603147	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ic; CDG1C
603148	ACTIVATING TRANSCRIPTION FACTOR 3; ATF3
603149	INTERLEUKIN 17A; IL17A
603150	ATP SYNTHASE F1, SUBUNIT DELTA; ATP5F1D
603151	SEPTIN 7; SEPT7
603152	ATP SYNTHASE PERIPHERAL STALK, SUBUNIT F6; ATP5PF
603153	RAD1 CHECKPOINT DNA EXONUCLEASE; RAD1
603154	PININ; PNN
603155	PROTEIN-TYROSINE PHOSPHATASE, NONRECEPTOR-TYPE, 14; PTPN14
603156	BIPHENYL HYDROLASE-LIKE; BPHL
603157	PHOSPHATIDYLINOSITOL 3-KINASE, REGULATORY SUBUNIT 2; PIK3R2
603158	UBIQUITIN-SPECIFIC PROTEASE 8; USP8
603159	LOW DENSITY LIPOPROTEIN RECEPTOR-RELATED PROTEIN 3; LRP3
603160	ECTONUCLEOSIDE TRIPHOSPHATE DIPHOSPHOHYDROLASE 6; ENTPD6
603161	ECTONUCLEOSIDE TRIPHOSPHATE DIPHOSPHOHYDROLASE 3; ENTPD3
603162	ECTONUCLEOSIDE TRIPHOSPHATE DIPHOSPHOHYDROLASE 5; ENTPD5
603163	STIMULATOR OF CHONDROGENESIS 1; SCRG1
603164	PEROXISOME BIOGENESIS FACTOR 3; PEX3
603165	DERMATITIS, ATOPIC
603166	MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE KINASE 2; MAP4K2
603167	BCL2-ASSOCIATED AGONIST OF CELL DEATH; BAD
603168	UNC51-LIKE AUTOPHAGY-ACTIVATING KINASE 1; ULK1
603169	CATHEPSIN Z; CTSZ
603170	TEA DOMAIN FAMILY MEMBER 3; TEAD3
603171	NEURAL PRECURSOR CELL EXPRESSED, DEVELOPMENTALLY DOWNREGULATED 8; NEDD8
603172	UBIQUITIN-LIKE MODIFIER-ACTIVATING ENZYME 3; UBA3
603173	UBIQUITIN-CONJUGATING ENZYME E2 M; UBE2M
603174	HYPERHOMOCYSTEINEMIA
603175	SCHIZOPHRENIA 5; SCZD5
603176	SCHIZOPHRENIA 7; SCZD7
603177	VESICLE-ASSOCIATED MEMBRANE PROTEIN 8; VAMP8
603178	ALDEHYDE DEHYDROGENASE 6 FAMILY, MEMBER A1; ALDH6A1
603179	CARBONIC ANHYDRASE IX; CA9
603180	EXPORTIN, tRNA; XPOT
603181	INTERLEUKIN ENHANCER-BINDING FACTOR 2; ILF2
603182	INTERLEUKIN ENHANCER-BINDING FACTOR 3; ILF3
603183	RETICULON 2; RTN2
603184	CYCLIN-DEPENDENT KINASE 8; CDK8
603185	NUCLEAR AUTOANTIGENIC SPERM PROTEIN; NASP
603186	DEATH-ASSOCIATED PROTEIN 6; DAXX
603187	CENTRIN 1; CETN1
603188	BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 8; BMIQ8
603189	SYNTAXIN 5; STX5
603190	PROTEIN ARGININE METHYLTRANSFERASE 3; PRMT3
603191	CILIA- AND FLAGELLA-ASSOCIATED PROTEIN 410; CFAP410
603192	ATP SYNTHASE, H+ TRANSPORTING, MITOCHONDRIAL FO COMPLEX, SUBUNIT C, ISOFORM 1; ATP5G1
603193	ATP SYNTHASE, H+ TRANSPORTING, MITOCHONDRIAL FO COMPLEX, SUBUNIT C, ISOFORM 2; ATP5G2
603194	MECKEL SYNDROME, TYPE 2; MKS2
603195	G PROTEIN-COUPLED RECEPTOR 32; GPR32
603196	COCHLIN; COCH
603197	PATATIN-LIKE PHOSPHOLIPASE DOMAIN-CONTAINING PROTEIN 6; PNPLA6
603198	CAVEOLAE-ASSOCIATED PROTEIN 1; CAVIN1
603199	PALS1-ASSOCIATED TIGHT JUNCTION PROTEIN; PATJ
603200	REGULATORY FACTOR X, ANKYRIN REPEAT-CONTAINING; RFXANK
603201	ATP-BINDING CASSETTE, SUBFAMILY B, MEMBER 11; ABCB11
603202	LACTASE; LCT
603203	CYCLIN G2; CCNG2
603204	EPILEPSY, NOCTURNAL FRONTAL LOBE, 2; ENFL2
603205	MORC FAMILY CW-TYPE ZINC FINGER PROTEIN 1; MORC1
603206	SCHIZOPHRENIA 8; SCZD8
603207	VESICLE TRANSPORT THROUGH INTERACTION WITH T-SNARES 1B; VTI1B
603208	POTASSIUM CHANNEL, INWARDLY RECTIFYING, SUBFAMILY J, MEMBER 13; KCNJ13
603209	CYTIDINE MONOPHOSPHO-N-ACETYLNEURAMINIC ACID HYDROXYLASE, PSEUDOGENE; CMAHP
603210	JRK HELIX-TURN-HELIX PROTEIN; JRK
603211	JRK-LIKE PROTEIN; JRKL
603212	BEADED FILAMENT STRUCTURAL PROTEIN 2; BFSP2
603213	KINESIN FAMILY MEMBER 22; KIF22
603214	ATP-BINDING CASSETTE, SUBFAMILY D, MEMBER 4; ABCD4
603215	NSF ATTACHMENT PROTEIN ALPHA; NAPA
603216	NSF ATTACHMENT PROTEIN GAMMA; NAPG
603217	SYNTAXIN 7; STX7
603218	HUNTINGTON DISEASE-LIKE 1; HDL1
603219	POTASSIUM CHANNEL, SUBFAMILY K, MEMBER 2; KCNK2
603220	POTASSIUM CHANNEL, SUBFAMILY K, MEMBER 3; KCNK3
603221	MYOPIA 3, AUTOSOMAL DOMINANT; MYP3
603222	U22 HOST GENE
603223	RNA, U22 SMALL NUCLEOLAR; RNU22
603224	RNA, U25 SMALL NUCLEOLAR; RNU25
603225	RNA, U26 SMALL NUCLEOLAR; RNU26
603226	RNA, U27 SMALL NUCLEOLAR; RNU27
603227	RNA, U28 SMALL NUCLEOLAR; RNU28
603228	RNA, U29 SMALL NUCLEOLAR; RNU29
603229	RNA, U30 SMALL NUCLEOLAR; RNU30
603230	RNA, U31 SMALL NUCLEOLAR; RNU31
603231	ZINC FINGER PROTEIN 200; ZNF200
603232	OLFACTORY RECEPTOR, FAMILY 1, SUBFAMILY F, MEMBER 1; OR1F1
603233	PSEUDOHYPOPARATHYROIDISM, TYPE IB; PHP1B
603234	ATP-BINDING CASSETTE, SUBFAMILY C, MEMBER 6; ABCC6
603235	SELENOPROTEIN W; SELENOW
603236	MEVALONATE PYROPHOSPHATE DECARBOXYLASE; MVD
603237	ERYTHROCYTE MEMBRANE PROTEIN 4.1-LIKE 2; EPB41L2
603238	RNA, U17D SMALL NUCLEOLAR; RNU17D
603239	SMALL NUCLEOLAR RNA, H/ACA BOX, 73B; SNORA73B
603240	SOLUTE CARRIER FAMILY 22 (ORGANIC CATION TRANSPORTER), MEMBER 18, ANTISENSE; SLC22A18AS
603241	LIMBIC SYSTEM-ASSOCIATED MEMBRANE PROTEIN; LSAMP
603242	C-TYPE LECTIN DOMAIN FAMILY 2, MEMBER B; CLEC2B
603243	AUTOCRINE MOTILITY FACTOR RECEPTOR; AMFR
603244	HEPARAN SULFATE-GLUCOSAMINE 3-SULFOTRANSFERASE 1; HS3ST1
603245	NK2 HOMEOBOX 8; NKX2-8
603246	GENERAL TRANSCRIPTION FACTOR 3C, POLYPEPTIDE 1; GTF3C1
603247	SOLUTE CARRIER FAMILY 27 (FATTY ACID TRANSPORTER), MEMBER 2; SLC27A2
603248	BONE MORPHOGENETIC PROTEIN RECEPTOR, TYPE IB; BMPR1B
603249	NIPSNAP HOMOLOG 1; NIPSNAP1
603250	FORKHEAD BOX F2; FOXF2
603251	CYCLIN-DEPENDENT KINASE 9; CDK9
603252	FORKHEAD BOX L1; FOXL1
603253	CYSTATIN 7; CST7
603254	SWI/SNF-RELATED, MATRIX-ASSOCIATED, ACTIN-DEPENDENT REGULATOR OF CHROMATIN, SUBFAMILY A, MEMBER 4; SMARCA4
603255	NUCLEAR TRANSCRIPTION FACTOR, X BOX-BINDING, 1; NFX1
603256	LEUCINE-RICH REPEAT IN FLII-INTERACTING PROTEIN 1; LRRFIP1
603257	SWI/SNF-RELATED, MATRIX-ASSOCIATED, ACTIN-DEPENDENT REGULATOR OF CHROMATIN, SUBFAMILY A, MEMBER 3; SMARCA3
603258	INHIBITOR OF NUCLEAR FACTOR KAPPA-B KINASE, SUBUNIT BETA; IKBKB
603259	MOVED TO 191195
603260	BARX HOMEOBOX 1; BARX1
603261	PHOSPHATIDYLINOSITOL 5-PHOSPHATE 4-KINASE, TYPE II, BETA; PIP4K2B
603262	3-PRIME-PHOSPHOADENOSINE 5-PRIME-PHOSPHOSULFATE SYNTHASE 1; PAPSS1
603263	CARBONIC ANHYDRASE XII; CA12
603264	RHOMBOID-LIKE 1; RHBDL1
603265	AT-RICH INTERACTION DOMAIN-CONTAINING PROTEIN 3A; ARID3A
603266	TYPE 1 DIABETES MELLITUS 17; TID17
603267	CALPAIN 15; CAPN15
603268	N-DEACETYLASE/N-SULFOTRANSFERASE 2; NDST2
603269	SPLICING FACTOR, SERINE/ARGININE-RICH, 8; SRSF8
603270	ATP SYNTHASE PERIPHERAL STALK MEMBRANE, SUBUNIT B; ATP5PB
603271	PROTEIN-TYROSINE PHOSPHATASE, NONRECEPTOR-TYPE, 21; PTPN21
603272	CONNECTOR ENHANCER OF KINASE SUPPRESSOR OF RAS 1; CNKSR1
603273	TUMOR PROTEIN p63; TP63
603274	MOVED TO 602961
603275	PHOSPHATIDYLINOSITOL 4-PHOSPHATE 5-KINASE, TYPE I, ALPHA; PIP5K1A
603276	REGULATOR OF G PROTEIN SIGNALING 5; RGS5
603277	CHROMODOMAIN HELICASE DNA-BINDING PROTEIN 4; CHD4
603278	FOCAL SEGMENTAL GLOMERULOSCLEROSIS 1; FSGS1
603279	EXPANDED REPEAT DOMAIN, CAG/CTG, 1; ERDA1
603280	MOVED TO 157640
603281	2-PRIME,5-PRIME-OLIGOADENYLATE SYNTHETASE-LIKE; OASL
603282	ZINC FINGER PROTEIN 204; ZNF204
603283	TRIADIN; TRDN
603284	CEREBRAL CAVERNOUS MALFORMATIONS 2; CCM2
603285	CEREBRAL CAVERNOUS MALFORMATIONS 3; CCM3
603286	KISS1 METASTASIS SUPPRESSOR; KISS1
603287	PYRIDOXAMINE 5-PRIME-PHOSPHATE OXIDASE; PNPO
603288	KERATOCAN; KERA
603289	DEATH-ASSOCIATED PROTEIN KINASE 3; DAPK3
603290	SH3 AND MULTIPLE ANKYRIN REPEAT DOMAINS 2; SHANK2
603291	BCL2/ADENOVIRUS E1B 19-KD PROTEIN-INTERACTING PROTEIN 1; BNIP1
603292	BCL2/ADENOVIRUS E1B 19-KD PROTEIN-INTERACTING PROTEIN 2; BNIP2
603293	BCL2/ADENOVIRUS E1B 19-KD PROTEIN-INTERACTING PROTEIN 3; BNIP3
603294	MINICHROMOSOME MAINTENANCE 3-ASSOCIATED PROTEIN; MCM3AP
603295	SMAD FAMILY MEMBER 9; SMAD9
603296	LATE ENDOSOMAL/LYSOSOMAL ADAPTOR, MITOGEN-ACTIVATED PROTEIN KINASE AND MAMMALIAN TARGET OF RAPAMYCIN ACTIVATOR 3; LAMTOR3
603297	DYNEIN, CYTOPLASMIC 2, HEAVY CHAIN 1; DYNC2H1
603298	PALMITOYL-PROTEIN THIOESTERASE 2; PPT2
603299	MOVED TO 603339
603300	TUMOR NECROSIS FACTOR-ALPHA-INDUCED PROTEIN 2; TNFAIP2
603301	KRUPPEL-LIKE FACTOR 11; KLF11
603302	ADENYLATE CYCLASE 9; ADCY9
603303	TANKYRASE; TNKS
603304	INTERLEUKIN 1 RECEPTOR-ASSOCIATED KINASE 2; IRAK2
603305	POTASSIUM CHANNEL, VOLTAGE-GATED, SUBFAMILY H, MEMBER 1; KCNH1
603306	TRANSCRIPTION FACTOR 21; TCF21
603307	BEADED FILAMENT STRUCTURAL PROTEIN 1; BFSP1
603308	CATHEPSIN V; CTSV
603309	CYCLIN-DEPENDENT KINASE 13; CDK13
603310	PHOSPHODIESTERASE 5A; PDE5A
603311	CELL DIVISION CYCLE 7; CDC7
603312	BUTYROBETAINE-GAMMA,2-OXOGLUTARATE DIOXYGENASE 1; BBOX1
603313	ALG10 ALPHA-1,2-GLUCOSYLTRANSFERASE B; ALG10B
603314	SOLUTE CARRIER FAMILY 27 (FATTY ACID TRANSPORTER), MEMBER 5; SLC27A5
603315	NEURONAL CALCIUM SENSOR 1; NCS1
603316	CYTIDINE 5-PRIME-MONOPHOSPHATE N-ACETYLNEURAMINIC ACID SYNTHETASE; CMAS
603317	PROTEIN-TYROSINE PHOSPHATASE, RECEPTOR-TYPE, Q; PTPRQ
603318	MOVED TO 603345
603319	ANNEXIN A9; ANXA9
603320	MATRIX METALLOPROTEINASE 23A; MMP23A
603321	MATRIX METALLOPROTEINASE 23B; MMP23B
603322	NADH-UBIQUINONE OXIDOREDUCTASE 1 BETA SUBCOMPLEX, 6; NDUFB6
603323	MUSCULAR DYSTROPHY, CONGENITAL, WITH CEREBELLAR ATROPHY
603324	GAP JUNCTION PROTEIN, BETA-3; GJB3
603325	PROTEIN PHOSPHATASE 1, REGULATORY SUBUNIT 9B; PPP1R9B
603326	PROTEIN PHOSPHATASE 1, REGULATORY SUBUNIT 3D; PPP1R3D
603327	RAN-BINDING PROTEIN 3; RANBP3
603328	MUSASHI RNA BINDING PROTEIN 1; MSI1
603329	MOVED TO 300931
603330	DYNEIN, AXONEMAL, HEAVY CHAIN 9; DNAH9
603331	DYNEIN, CYTOPLASMIC 1, INTERMEDIATE CHAIN 2; DYNC1I2
603332	DYNEIN, AXONEMAL, HEAVY CHAIN 1; DNAH1
603333	DYNEIN, AXONEMAL, HEAVY CHAIN 2; DNAH2
603334	DYNEIN, AXONEMAL, HEAVY CHAIN 3; DNAH3
603335	DYNEIN, AXONEMAL, HEAVY CHAIN 5; DNAH5
603336	DYNEIN, AXONEMAL, HEAVY CHAIN 6; DNAH6
603337	DYNEIN, AXONEMAL, HEAVY CHAIN 8; DNAH8
603338	MOVED TO 603330
603339	DYNEIN, AXONEMAL, HEAVY CHAIN 11; DNAH11
603340	DYNEIN, AXONEMAL, HEAVY CHAIN 12; DNAH12
603341	DYNEIN, AXONEMAL, HEAVY CHAIN 14; DNAH14
603342	SCHIZOPHRENIA 2; SCZD2
603343	RIBONUCLEIC ACID EXPORT PROTEIN 1; RAE1
603344	USO1 VESICLE TRANSPORT FACTOR; USO1
603345	SOLUTE CARRIER FAMILY 4 (SODIUM BICARBONATE COTRANSPORTER), MEMBER 4; SLC4A4
603346	NEURONAL PAS DOMAIN PROTEIN 1; NPAS1
603347	NEURONAL PAS DOMAIN PROTEIN 2; NPAS2
603348	HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; HIF1A
603349	ENDOTHELIAL PAS DOMAIN PROTEIN 1; EPAS1
603350	2-PRIME,5-PRIME-OLIGOADENYLATE SYNTHETASE 2; OAS2
603351	2-PRIME,5-PRIME-OLIGOADENYLATE SYNTHETASE 3; OAS3
603352	BACULOVIRAL IAP REPEAT-CONTAINING PROTEIN 5; BIRC5
603353	SOLUTE CARRIER FAMILY 4 (SODIUM BICARBONATE COTRANSPORTER), MEMBER 7; SLC4A7
603354	GASTRULATION BRAIN HOMEOBOX 1; GBX1
603355	MEMBRANE-BOUND TRANSCRIPTION FACTOR PROTEASE, SITE 1; MBTPS1
603356	CD164 ANTIGEN; CD164
603357	SERPIN PEPTIDASE INHIBITOR, CLADE B (OVALBUMIN), MEMBER 7; SERPINB7
603358	GRACILE SYNDROME
603359	NADH-UBIQUINONE OXIDOREDUCTASE SUBUNIT A8; NDUFA8
603360	PEROXISOME BIOGENESIS FACTOR 16; PEX16
603361	TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY, MEMBER 6B; TNFRSF6B
603362	SH3 DOMAIN, GRB2-LIKE, 3; SH3GL3
603363	CGG-BINDING PROTEIN 1; CGGBP1
603364	SPLICING FACTOR, SERINE/ARGININE-RICH, 3; SRSF3
603365	HIRA-INTERACTING PROTEIN 3; HIRIP3
603366	TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY, MEMBER 25; TNFRSF25
603367	MOVED TO 300255
603368	CYCLIN-DEPENDENT KINASE 6; CDK6
603369	CYCLIN-DEPENDENT KINASE INHIBITOR 2C; CDKN2C
603370	UDP-GLUCOSE DEHYDROGENASE; UGDH
603371	GLE1, RNA EXPORT MEDIATOR; GLE1
603372	THYROID-STIMULATING HORMONE RECEPTOR; TSHR
603373	HYPERTHYROIDISM, FAMILIAL GESTATIONAL
603374	MOVED TO 300186
603375	SWI/SNF-RELATED, MATRIX-ASSOCIATED, ACTIN-DEPENDENT REGULATOR OF CHROMATIN, SUBFAMILY A, MEMBER 5; SMARCA5
603376	LONG CHAIN FATTY ACIDS, DEFECT IN TRANSPORT OF
603377	SOLUTE CARRIER FAMILY 22 (ORGANIC CATION TRANSPORTER), MEMBER 5; SLC22A5
603378	SIN3-ASSOCIATED POLYPEPTIDE, 30-KD; SAP30
603379	IQ MOTIF-CONTAINING GTPase-ACTIVATING PROTEIN 1; IQGAP1
603380	LIN7 HOMOLOG A, CRUMBS CELL POLARITY COMPLEX COMPONENT; LIN7A
603381	FILAMIN B; FLNB
603382	MutS HOMOLOG 5; MSH5
603383	GLAUCOMA 1, OPEN ANGLE, F; GLC1F
603384	SYNAPTIC RAS-GTPase-ACTIVATING PROTEIN 1; SYNGAP1
603385	NEDD8-ACTIVATING ENZYME E1, SUBUNIT 1; NAE1
603386	THYROID CARCINOMA, NONMEDULLARY, WITH OR WITHOUT CELL OXYPHILIA
603387	MEGALENCEPHALY-POLYMICROGYRIA-POLYDACTYLY-HYDROCEPHALUS SYNDROME 1; MPPH1
603388	GRAVES DISEASE, SUSCEPTIBILITY TO, 2
603389	OSEBOLD SKELETAL DYSPLASIA/OSTEOLYSIS SYNDROME
603390	PHOSPHODIESTERASE 8B; PDE8B
603391	MOVED TO 139210
603392	BCL2-INTERACTING KILLER; BIK
603393	OSTEOSCLEROTIC CHONDRODYSPLASIA, LETHAL, WITH INTRACELLULAR INCLUSIONS
603394	MICROCEPHALY, SEVERE, WITH SKELETAL ANOMALIES INCLUDING POSTERIOR RIB-GAP DEFECTS
603395	SPERM-ASSOCIATED ANTIGEN 1; SPAG1
603396	TONOKI SYNDROME
603397	ZINC FINGER PROTEIN 282; ZNF282
603398	CELLULAR COMMUNICATION NETWORK FACTOR 4; CCN4
603399	CELLULAR COMMUNICATION NETWORK FACTOR 5; CCN5
603400	CELLULAR COMMUNICATION NETWORK FACTOR 6; CCN6
603401	ADAPTOR-RELATED PROTEIN COMPLEX 3, BETA-1 SUBUNIT; AP3B1
603402	ACYL-CoA OXIDASE 3, PRISTANOYL; ACOX3
603403	DEAH-BOX HELICASE 15; DHX15
603404	ZINC FINGER PROTEIN 169; ZNF169
603405	DEAH-BOX HELICASE 16; DHX16
603406	TRIPARTITE MOTIF-CONTAINING PROTEIN 24; TRIM24
603407	POLYADENYLATE-BINDING PROTEIN, CYTOPLASMIC, 4; PABPC4
603408	FRIZZLED CLASS RECEPTOR 1; FZD1
603409	FRIZZLED CLASS RECEPTOR 6; FZD6
603410	FRIZZLED CLASS RECEPTOR 7; FZD7
603411	EFFECTOR CELL PROTEASE RECEPTOR 1; EPR1
603412	CDC42-BINDING PROTEIN KINASE, ALPHA; CDC42BPA
603413	TIA1 CYTOTOXIC GRANULE-ASSOCIATED RNA-BINDING PROTEIN-LIKE 1; TIAL1
603414	TRANSMEMBRANE 7 SUPERFAMILY, MEMBER 2; TM7SF2
603415	SODIUM VOLTAGE-GATED CHANNEL, ALPHA SUBUNIT 9; SCN9A
603416	RIBOSOMAL PROTEIN L21 PSEUDOGENE 1; RPL21P1
603417	RAB-INTERACTING FACTOR; RABIF
603418	ALDO-KETO REDUCTASE FAMILY 7, MEMBER A2; AKR7A2
603419	SMALL GLUTAMINE-RICH TETRATRICOPEPTIDE REPEAT-CONTAINING COCHAPERONE, ALPHA; SGTA
603420	CALUMENIN; CALU
603421	TRANSMEMBRANE PROTEIN WITH EGF-LIKE AND 2 FOLLISTATIN-LIKE DOMAINS 1; TMEFF1
603422	PDZ AND LIM DOMAIN PROTEIN 4; PDLIM4
603423	PR DOMAIN-CONTAINING PROTEIN 1; PRDM1
603424	PROTEIN KINASE, INTERFERON-INDUCIBLE DOUBLE-STRANDED RNA-DEPENDENT ACTIVATOR; PRKRA
603425	ADP-RIBOSYLATION FACTOR-LIKE GTPase 1; ARL1
603426	PERIOD CIRCADIAN REGULATOR 2; PER2
603427	PERIOD CIRCADIAN REGULATOR 3; PER3
603428	ZINC FINGER PROTEIN 207; ZNF207
603429	ATP-BINDING CASSETTE, SUBFAMILY F, MEMBER 1; ABCF1
603430	ZINC FINGER PROTEIN 202; ZNF202
603431	EUKARYOTIC TRANSLATION INITIATION FACTOR 4H; EIF4H
603432	CAP-GLY DOMAIN-CONTAINING LINKER PROTEIN 2; CLIP2
603433	ZINC FINGER PROTEIN 143; ZNF143
603434	PROLIFERATION AND APOPTOSIS ADAPTOR PROTEIN 15; PEA15
603435	GLUTATHIONE PEROXIDASE 5; GPX5
603436	ZINC FINGER PROTEIN 205; ZNF205
603437	Y-BOX BINDING PROTEIN 3; YBX3
603438	RADIOULNAR SYNOSTOSIS WITH MICROCEPHALY, SHORT STATURE, SCOLIOSIS, AND MENTAL RETARDATION
603439	EXPANSILE BONE LESIONS
603440	CYCLIN-DEPENDENT KINASE 17; CDK17
603441	CYCLIN-DEPENDENT KINASE-LIKE 1; CDKL1
603442	CYCLIN-DEPENDENT KINASE-LIKE 2; CDKL2
603443	VPS52 SUBUNIT OF GARP COMPLEX; VPS52
603444	FAR UPSTREAM ELEMENT-BINDING PROTEIN 1; FUBP1
603445	KH-TYPE SPLICING REGULATORY PROTEIN; KHSRP
603446	OROACRAL SYNDROME, VERLOES-KOULISCHER TYPE
603447	HARAKIRI; HRK
603448	DAB ADAPTOR PROTEIN 1; DAB1
603449	RUVB-LIKE AAA ATPase 1; RUVBL1
603450	LIM DOMAIN-BINDING 2; LDB2
603451	LIM DOMAIN-BINDING 1; LDB1
603452	MOVED TO 602712
603453	RECEPTOR-INTERACTING SERINE/THREONINE KINASE 1; RIPK1
603454	CASP2 AND RIPK1 DOMAIN-CONTAINING ADAPTOR WITH DEATH DOMAIN; CRADD
603455	RECEPTOR-INTERACTING SERINE/THREONINE KINASE 2; RIPK2
603456	DIPHTHAMIDE BIOSYNTHESIS PROTEIN 2; DPH2
603457	BOSMA ARHINIA MICROPHTHALMIA SYNDROME; BAMS
603458	ELAV-LIKE RNA-BINDING PROTEIN 3; ELAVL3
603459	MOVED TO 160980
603460	CYCLIN-DEPENDENT KINASE 5, REGULATORY SUBUNIT 1; CDK5R1
603461	CELL DIVISION CYCLE 16; CDC16
603462	CELL DIVISION CYCLE 23; CDC23
603463	MOVED TO 211380
603464	CYCLIN-DEPENDENT KINASE 10; CDK10
603465	CELL DIVISION CYCLE 45; CDC45
603466	ELAV-LIKE RNA-BINDING PROTEIN 1; ELAVL1
603467	FANCONI ANEMIA, COMPLEMENTATION GROUP F; FANCF
603468	MOVED TO 227650
603469	MOVED TO 603240
603470	ARGININOSUCCINATE SYNTHETASE 1; ASS1
603471	CITRULLINEMIA, TYPE II, ADULT-ONSET; CTLN2
603472	NEURONAL INTRANUCLEAR INCLUSION DISEASE; NIID
603473	LARGE TUMOR SUPPRESSOR KINASE 1; LATS1
603474	RIBOSOMAL PROTEIN S19; RPS19
603475	CHORDIN; CHRD
603476	cAMP RESPONSE ELEMENT-BINDING PROTEIN-LIKE 2; CREBL2
603477	BUD31 HOMOLOG; BUD31
603478	UBIQUITIN-SPECIFIC PROTEASE 1; USP1
603479	EXTRACELLULAR MATRIX PROTEIN 2; ECM2
603480	MOVED TO 300880
603481	PROTEASOME 26S SUBUNIT, NON-ATPase, 13; PSMD13
603482	BETA-TRANSDUCIN REPEAT-CONTAINING PROTEIN; BTRC
603483	EUKARYOTIC TRANSLATION INITIATION FACTOR 4E-BINDING PROTEIN 3; EIF4EBP3
603484	PROTEIN REGULATING CYTOKINESIS 1; PRC1
603485	NFS1 CYSTEINE DESULFURASE 1; NFS1
603486	UBIQUITIN-SPECIFIC PROTEASE 4; USP4
603487	MYOSIN, SKELETAL MUSCLE, HEAVY CHAIN 13; MYH13
603488	ANGIO-ASSOCIATED MIGRATORY CELL PROTEIN; AAMP
603489	CARTILAGE INTERMEDIATE LAYER PROTEIN; CILP
603490	WINGLESS-TYPE MMTV INTEGRATION SITE FAMILY, MEMBER 4; WNT4
603491	IMMUNOGLOBULIN SUPERFAMILY, MEMBER 3; IGSF3
603492	SLAM FAMILY, MEMBER 1; SLAMF1
603493	POTASSIUM CHANNEL, SUBFAMILY K, MEMBER 5; KCNK5
603494	PREFOLDIN-LIKE CHAPERONE URI1; URI1
603495	AURORA KINASE C; AURKC
603496	DUAL-SPECIFICITY TYROSINE PHOSPHORYLATION-REGULATED KINASE 2; DYRK2
603497	DUAL-SPECIFICITY TYROSINE PHOSPHORYLATION-REGULATED KINASE 3; DYRK3
603498	SPHINGOMYELIN PHOSPHODIESTERASE 2, NEUTRAL MEMBRANE; SMPD2
603499	TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY, MEMBER 11A; TNFRSF11A
603500	TUMOR NECROSIS FACTOR RECEPTOR 1-ASSOCIATED DEATH DOMAIN PROTEIN; TRADD
603501	POLY(ADP-RIBOSE) GLYCOHYDROLASE; PARG
603502	INTERFERON-RELATED DEVELOPMENTAL REGULATOR 1; IFRD1
603503	DOLICHYL-PHOSPHATE MANNOSYLTRANSFERASE 1, CATALYTIC SUBUNIT; DPM1
603504	CELL DIVISION CYCLE 14A; CDC14A
603505	CELL DIVISION CYCLE 14B; CDC14B
603506	LOW DENSITY LIPOPROTEIN RECEPTOR-RELATED PROTEIN 5; LRP5
603507	LOW DENSITY LIPOPROTEIN RECEPTOR-RELATED PROTEIN 6; LRP6
603508	MYOMESIN 1; MYOM1
603509	MYOMESIN 2; MYOM2
603510	MOVED TO 300904
603511	MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL DOMINANT 1; LGMDD1
603512	RNA GUANYLYLTRANSFERASE AND 5-PRIME-PHOSPHATASE; RNGTT
603513	MOVED TO 619026 AND 612900
603514	RNA GUANINE-7-METHYLTRANSFERASE; RNMT
603515	CHORIONIC SOMATOMAMMOTROPIN HORMONE-LIKE 1; CSHL1
603516	SPINOCEREBELLAR ATAXIA 10; SCA10
603517	B-CELL CLL/LYMPHOMA 10; BCL10
603518	TIA1 CYTOTOXIC GRANULE-ASSOCIATED RNA-BINDING PROTEIN; TIA1
603519	SURVIVAL MOTOR NEURON DOMAIN-CONTAINING PROTEIN 1; SMNDC1
603520	SMALL NUCLEAR RIBONUCLEOPROTEIN POLYPEPTIDE B-DOUBLE PRIME; SNRPB2
603521	SMALL NUCLEAR RIBONUCLEOPROTEIN POLYPEPTIDE A-PRIME; SNRPA1
603522	SMALL NUCLEAR RIBONUCLEOPROTEIN POLYPEPTIDE C; SNRPC
603523	CHYLOTHORAX, CONGENITAL
603524	RCC1 DOMAIN- AND BTB DOMAIN-CONTAINING PROTEIN 2; RCBTB2
603525	NMYC INTERACTOR; NMI
603526	METASTASIS-ASSOCIATED GENE 1; MTA1
603527	DIPHTHAMIDE BIOSYNTHESIS PROTEIN 1; DPH1
603528	MOVED TO 194380
603529	DYSERYTHROPOIESIS, CONGENITAL, WITH ULTRASTRUCTURALLY NORMAL ERYTHROBLAST HETEROCHROMATIN
603530	MOVED TO 615398
603531	ADAPTOR-RELATED PROTEIN COMPLEX 1, SIGMA-1 SUBUNIT; AP1S1
603532	MOVED TO 300629
603533	ADAPTOR-RELATED PROTEIN COMPLEX 1, GAMMA-1 SUBUNIT; AP1G1
603534	ADAPTOR-RELATED PROTEIN COMPLEX 1, GAMMA-2 SUBUNIT; AP1G2
603535	ADAPTOR-RELATED PROTEIN COMPLEX 1, MU-1 SUBUNIT; AP1M1
603536	FAR UPSTREAM ELEMENT-BINDING PROTEIN 3; FUBP3
603537	POTASSIUM CHANNEL, VOLTAGE-GATED, KQT-LIKE SUBFAMILY, MEMBER 4; KCNQ4
603538	KYNURENINE 3-MONOOXYGENASE; KMO
603539	CATHEPSIN F; CTSF
603540	GAMMA-AMINOBUTYRIC ACID B RECEPTOR 1; GABBR1
603541	SMALL NUCLEAR RIBONUCLEOPROTEIN POLYPEPTIDE F; SNRPF
603542	SMALL NUCLEAR RIBONUCLEOPROTEIN POLYPEPTIDE G; SNRPG
603543	LIMB-MAMMARY SYNDROME; LMS
603544	CYCLIN K; CCNK
603545	MOVED TO 600791
603546	SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH JOINT LAXITY, TYPE 2; SEMDJL2
603547	METHYL-CpG-BINDING DOMAIN PROTEIN 2; MBD2
603548	CDP-DIACYLGLYCEROL SYNTHASE 1; CDS1
603549	CDP-DIACYLGLYCEROL SYNTHASE 2; CDS2
603550	EYA TRANSCRIPTIONAL COACTIVATOR AND PHOSPHATASE 4; EYA4
603551	HYALURONOGLUCOSAMINIDASE 2; HYAL2
603552	HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 4; FHL4
603553	HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 2; FHL2
603554	OMENN SYNDROME
603555	SPT4 HOMOLOG, DSIF ELONGATION FACTOR SUBUNIT; SUPT4H1
603556	MOVED TO 300171
603557	MYOTUBULARIN-RELATED PROTEIN 2; MTMR2
603558	MYOTUBULARIN-RELATED PROTEIN 3; MTMR3
603559	MYOTUBULARIN-RELATED PROTEIN 4; MTMR4
603560	SET-BINDING FACTOR 1; SBF1
603561	MYOTUBULARIN-RELATED PROTEIN 6; MTMR6
603562	MYOTUBULARIN-RELATED PROTEIN 7; MTMR7
603563	SPASTIC PARAPLEGIA 8, AUTOSOMAL DOMINANT; SPG8
603564	DOLICHYL-PHOSPHATE MANNOSYLTRANSFERASE 2, REGULATORY SUBUNIT; DPM2
603565	UDP-N-ACETYL-ALPHA-D-GALACTOSAMINE:POLYPEPTIDE N-ACETYLGALACTOSAMINYLTRANSFERASE 4; GALNT4
603566	PROTEIN INHIBITOR OF ACTIVATED STAT1; PIAS1
603567	PROTEIN INHIBITOR OF ACTIVATED STAT2; PIAS2
603568	RNA, U73 SMALL NUCLEOLAR; RNU73
603569	TRACHEOBRONCHIAL STENOSIS, CONGENITAL
603570	VANIN 1; VNN1
603571	VANIN 2; VNN2
603572	MICROCEPHALY, FACIAL ABNORMALITIES, MICROMELIA, AND MENTAL RETARDATION
603573	METHYL-CpG-BINDING DOMAIN PROTEIN 3; MBD3
603574	METHYL-CpG-BINDING DOMAIN PROTEIN 4; MBD4
603575	NME/NM23 FAMILY, MEMBER 5; NME5
603576	TRANSIENT RECEPTOR POTENTIAL CATION CHANNEL, SUBFAMILY M, MEMBER 1; TRPM1
603577	NUCLEOLAR PROTEIN 4; NOL4
603578	OVIDUCTAL GLYCOPROTEIN 1; OVGP1
603579	RIO KINASE 3; RIOK3
603580	PROTOCADHERIN 8; PCDH8
603581	PROTOCADHERIN 9; PCDH9
603582	TOPOISOMERASE, DNA, III, BETA; TOP3B
603583	DISCS LARGE MAGUK SCAFFOLD PROTEIN 2; DLG2
603584	MAP KINASE-ACTIVATING DEATH DOMAIN; MADD
603585	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIf; CDG2F
603586	MOVED TO 603147
603587	FOLLICULAR ATROPHODERMA, PERIORAL PIGMENTED, WITH MILIA AND EPIDERMOID CYSTS
603588	PAROTITIS, JUVENILE RECURRENT
603589	FACIAL DYSMORPHISM, SELECTIVE TOOTH AGENESIS, AND CHOROID CALCIFICATION
603590	ACETYLGLUCOSAMINYLTRANSFERASE-LIKE PROTEIN; LARGE1
603591	UBIQUITIN-SPECIFIC PROTEASE 13; USP13
603592	XANTHINURIA, TYPE II; XAN2
603593	SOLUTE CARRIER FAMILY 7 (CATIONIC AMINO ACID TRANSPORTER, y+ SYSTEM), MEMBER 7; SLC7A7
603594	TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY, MEMBER 4; TNFSF4
603595	CRANIOSYNOSTOSIS WITH ECTOPIA LENTIS
603596	POLYDACTYLY
603597	SUPPRESSOR OF CYTOKINE SIGNALING 1; SOCS1
603598	TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY, MEMBER 10; TNFSF10
603599	CASP8- AND FADD-LIKE APOPTOSIS REGULATOR; CFLAR
603600	OSTEOMA OF CRANIAL VAULT, FAMILIAL
603601	PHOSPHATIDYLINOSITOL 3-KINASE, CLASS 2, ALPHA; PIK3C2A
603602	PHOSPHOLIPASE A2, GROUP IVC; PLA2G4C
603603	PHOSPHOLIPASE A2, GROUP X; PLA2G10
603604	PHOSPHOLIPASE A2, GROUP VI; PLA2G6
603605	AMINOACYL-tRNA SYNTHETASE COMPLEX-INTERACTING MULTIFUNCTIONAL PROTEIN 1; AIMP1
603606	RIBOSOMAL PROTEIN S6 KINASE A4; RPS6KA4
603607	RIBOSOMAL PROTEIN S6 KINASE A5; RPS6KA5
603608	CARBONYL REDUCTASE 3; CBR3
603609	FUCOSE-1-PHOSPHATE GUANYLYLTRANSFERASE; FPGT
603610	UNC5 NETRIN RECEPTOR C; UNC5C
603611	TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY, MEMBER 10A; TNFRSF10A
603612	TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY, MEMBER 10B; TNFRSF10B
603613	TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY, MEMBER 10C; TNFRSF10C
603614	TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY, MEMBER 10D; TNFRSF10D
603615	RAD54-LIKE; RAD54L
603616	RABAPTIN, RAB GTPase-BINDING EFFECTOR PROTEIN 1; RABEP1
603617	SOLUTE CARRIER FAMILY 24 (SODIUM/POTASSIUM/CALCIUM EXCHANGER), MEMBER 1; SLC24A1
603618	CELL DIVISION CYCLE 20; CDC20
603619	FIZZY AND CELL DIVISION CYCLE 20-RELATED PROTEIN 1; FZR1
603620	PC4- AND SFRS1-INTERACTING PROTEIN 1; PSIP1
603621	FORKHEAD BOX H1; FOXH1
603622	DEAFNESS, AUTOSOMAL DOMINANT 17; DFNA17
603623	TYROSYL-tRNA SYNTHETASE 1; YARS1
603624	RIBOSOMAL PROTEIN S2; RPS2
603625	LYMPHOCYTE ANTIGEN 6 COMPLEX, LOCUS H; LY6H
603626	PROTOCADHERIN 1; PCDH1
603627	PROTOCADHERIN-GAMMA, SUBFAMILY C, MEMBER 3; PCDHGC3
603628	MUSCULIN; MSC
603629	DEAFNESS, AUTOSOMAL RECESSIVE 21; DFNB21
603630	RIBOSOMAL PROTEIN S5; RPS5
603631	RIBOSOMAL PROTEIN S9; RPS9
603632	RIBOSOMAL PROTEIN S10; RPS10
603633	RIBOSOMAL PROTEIN S29; RPS29
603634	RIBOSOMAL PROTEIN L5; RPL5
603635	SMALL NUCLEOLAR RNA, C/D box, 21; SNORD21
603636	RIBOSOMAL PROTEIN L21; RPL21
603637	RIBOSOMAL PROTEIN L27a; RPL27A
603638	RIBOSOMAL PROTEIN L28; RPL28
603639	A DISINTEGRIN AND METALLOPROTEINASE DOMAIN 17; ADAM17
603640	A DISINTEGRIN AND METALLOPROTEINASE DOMAIN 19; ADAM19
603641	NEUROENDOCRINE CARCINOMA OF SALIVARY GLANDS, SENSORINEURAL HEARING LOSS, AND ENAMEL HYPOPLASIA
603642	ATRIAL SEPTAL DEFECT, SECUNDUM, WITH VARIOUS CARDIAC AND NONCARDIAC DEFECTS
603643	SITUS INVERSUS TOTALIS WITH CYSTIC DYSPLASIA OF KIDNEYS AND PANCREAS
603644	SYNTHESIS OF CYTOCHROME c OXIDASE 1; SCO1
603645	GLUTAMYL-tRNA AMIDOTRANSFERASE, SUBUNIT B; GATB
603646	CYTOCHROME c OXIDASE ASSEMBLY FACTOR COX15; COX15
603647	BCS1 HOMOLOG, UBIQUINOL-CYTOCHROME C REDUCTASE COMPLEX CHAPERONE; BCS1L
603648	CYTOCHROME c OXIDASE COPPER CHAPERONE COX11; COX11
603649	CONE-ROD DYSTROPHY 7; CORD7
603650	BBS5 GENE; BBS5
603651	TRANSIENT RECEPTOR POTENTIAL CATION CHANNEL, SUBFAMILY C, MEMBER 4; TRPC4
603652	TRANSIENT RECEPTOR POTENTIAL CATION CHANNEL, SUBFAMILY C, MEMBER 6; TRPC6
603653	REMOVED FROM DATABASE
603654	SOLUTE CARRIER FAMILY 16 (MONOCARBOXYLIC ACID TRANSPORTER), MEMBER 7; SLC16A7
603655	MOVED TO 139391
603656	EXOSTOSIS, DUPUYTREN SUBUNGUAL
603657	VESICLE-ASSOCIATED MEMBRANE PROTEIN 3; VAMP3
603658	RIBOSOMAL PROTEIN S7; RPS7
603659	GLUCAGON-LIKE PEPTIDE 2 RECEPTOR; GLP2R
603660	RIBOSOMAL PROTEIN S12; RPS12
603661	RIBOSOMAL PROTEIN L17; RPL17
603662	RIBOSOMAL PROTEIN L23; RPL23
603663	MENTAL HEALTH WELLNESS 1
603664	MENTAL HEALTH WELLNESS 2
603665	STANNIOCALCIN 2; STC2
603666	SYNTAXIN 16; STX16
603667	SOLUTE CARRIER FAMILY 25 (MITOCHONDRIAL CARRIER, ARALAR), MEMBER 12; SLC25A12
603668	SR-RELATED C-TERMINAL DOMAIN-ASSOCIATED FACTOR 11; SCAF11
603669	ECCRINE SYRINGOFIBROADENOMATOSIS WITH EYELID ABNORMALITIES
603670	BLUE NEVI, FAMILIAL MULTIPLE
603671	ACROMELIC FRONTONASAL DYSOSTOSIS; AFND
603672	CORE-BINDING FACTOR, RUNT DOMAIN, ALPHA SUBUNIT 2, TRANSLOCATED TO, 2; CBFA2T2
603673	PATCHED 2; PTCH2
603674	RIBOSOMAL PROTEIN S15a; RPS15A
603675	RIBOSOMAL PROTEIN S16; RPS16
603676	MOVED TO 181350
603677	MYELIN TRANSCRIPTION FACTOR 2; MYT2
603678	DEAFNESS, AUTOSOMAL RECESSIVE 14; DFNB14
603679	UBIQUITIN-CONJUGATING ENZYME E2 N; UBE2N
603680	ATAXIN 8 OPPOSITE STRAND; ATXN8OS
603681	OTOFERLIN; OTOF
603682	RIBOSOMAL PROTEIN S20; RPS20
603683	RIBOSOMAL PROTEIN S23; RPS23
603684	LIPASE, ENDOTHELIAL; LIPG
603685	RIBOSOMAL PROTEIN S28; RPS28
603686	RIBOSOMAL PROTEIN L9; RPL9
603687	ALDEHYDE DEHYDROGENASE 1 FAMILY, MEMBER A2; ALDH1A2
603688	PROSTATE CANCER/BRAIN CANCER SUSCEPTIBILITY
603689	MYOPATHY, MYOFIBRILLAR, 9, WITH EARLY RESPIRATORY FAILURE; MFM9
603690	SOLUTE CARRIER FAMILY 33 (ACETYL-CoA TRANSPORTER), MEMBER 1; SLC33A1
603691	GALANIN RECEPTOR 2; GALR2
603692	GALANIN RECEPTOR 3; GALR3
603693	ZINC FINGER PROTEIN, FOG FAMILY MEMBER 2; ZFPM2
603694	TYPE 2 DIABETES MELLITUS 3; T2D3
603695	GUANYLATE CYCLASE 1, SOLUBLE, BETA-2; GUCY1B2
603696	SEPTIN 4; SEPT4
603697	ARACHIDONATE 15-LIPOXYGENASE, SECOND TYPE; ALOX15B
603698	GOLGI-SPECIFIC BREFELDIN-A RESISTANCE FACTOR 1; GBF1
603699	WINGLESS-TYPE MMTV INTEGRATION SITE FAMILY, MEMBER 11; WNT11
603700	ARACHIDONATE 5-LIPOXYGENASE-ACTIVATING PROTEIN; ALOX5AP
603701	RIBOSOMAL PROTEIN S26; RPS26
603702	RIBOSOMAL PROTEIN S27; RPS27
603703	RIBOSOMAL PROTEIN L6; RPL6
603704	RIBOSOMAL PROTEIN L26; RPL26
603705	ANGIOPOIETIN 4; ANGPT4
603706	SEMAPHORIN 4F; SEMA4F
603707	MOLYBDENUM COFACTOR SYNTHESIS GENE 1; MOCS1
603708	MOLYBDENUM COFACTOR SYNTHESIS GENE 2; MOCS2
603709	A DISINTEGRIN AND METALLOPROTEINASE DOMAIN 22; ADAM22
603710	A DISINTEGRIN AND METALLOPROTEINASE DOMAIN 23; ADAM23
603711	CYTOCHROME P450, FAMILY 7, SUBFAMILY B, POLYPEPTIDE 1; CYP7B1
603712	A DISINTEGRIN AND METALLOPROTEINASE DOMAIN 20; ADAM20
603713	A DISINTEGRIN AND METALLOPROTEINASE DOMAIN 21; ADAM21
603714	SIX HOMEOBOX 3; SIX3
603715	GLIAL CELLS MISSING TRANSCRIPTION FACTOR 1; GCM1
603716	GLIAL CELLS MISSING TRANSCRIPTION FACTOR 2; GCM2
603717	ATPase, H+ TRANSPORTING, LYSOSOMAL, 21-KD, V0 SUBUNIT C-PRIME, PRIME; ATP6V0B
603718	CLAUDIN 1; CLDN1
603719	BUB3 MITOTIC CHECKPOINT PROTEIN; BUB3
603720	DEAFNESS, AUTOSOMAL RECESSIVE 16; DFNB16
603721	UBIQUITIN-CONJUGATING ENZYME E2 L3; UBE2L3
603722	ELONGATOR COMPLEX PROTEIN 1; ELP1
603723	MOVED TO 300248
603724	MOVED TO 300827
603725	FIBROBLAST GROWTH FACTOR 17; FGF17
603726	FIBROBLAST GROWTH FACTOR 18; FGF18
603727	GLUTAMINYL-tRNA SYNTHETASE 1; QARS1
603728	NUMB ENDOCYTIC ADAPTOR PROTEIN; NUMB
603729	SPHINGOSINE-1-PHOSPHATE LYASE 1; SGPL1
603730	SPHINGOSINE KINASE 1; SPHK1
603731	CCR4-NOT TRANSCRIPTION COMPLEX, SUBUNIT 8; CNOT8
603732	CRYPTOCHROME 2; CRY2
603733	SOLUTE CARRIER FAMILY 43 (L-TYPE AMINO ACID TRANSPORTER), MEMBER 1; SLC43A1
603734	INTERFERON REGULATORY FACTOR 3; IRF3
603735	AMINE OXIDASE, COPPER-CONTAINING, 3; AOC3
603736	OHDO SYNDROME, SBBYS VARIANT; SBBYSS
603737	OVARIAN GERM CELL CANCER
603738	BASIC TRANSCRIPTION FACTOR 3 PSEUDOGENE 12; BTF3P12
603739	BASIC TRANSCRIPTION FACTOR 3 PSEUDOGENE 13; BTF3P13
603740	ACRODYSPLASIA WITH OSSIFICATION ABNORMALITIES, SHORT STATURE, AND FIBULAR HYPOPLASIA
603741	ARACHIDONATE 12-LIPOXYGENASE, R TYPE; ALOX12B
603742	SLIT GUIDANCE LIGAND 1; SLIT1
603743	APOLIPOPROTEIN L1; APOL1
603744	PAPILLARY THYROID MICROCARCINOMA
603745	SLIT GUIDANCE LIGAND 3; SLIT3
603746	SLIT GUIDANCE LIGAND 2; SLIT2
603747	TUMOR PROTEIN D52-LIKE 2; TPD52L2
603748	MOVED TO 300297
603749	TRANSIENT RECEPTOR POTENTIAL CATION CHANNEL, SUBFAMILY M, MEMBER 2; TRPM2
603750	AQUAPORIN 8; AQP8
603751	SPHINGOSINE-1-PHOSPHATE RECEPTOR 4; S1PR4
603752	SOLUTE CARRIER FAMILY 7 (CATIONIC AMINO ACID TRANSPORTER, y+ SYSTEM), MEMBER 4; SLC7A4
603753	UBIQUITINATION FACTOR E4A; UBE4A
603754	KINESIN FAMILY MEMBER 3B; KIF3B
603755	ZINC FINGER FYVE TYPE-CONTAINING PROTEIN 9; ZFYVE9
603756	ATP-BINDING CASSETTE, SUBFAMILY G, MEMBER 2; ABCG2
603757	CHEMOKINE, CC MOTIF, LIGAND 18; CCL18
603758	GLUTATHIONE S-TRANSFERASE, ZETA-1; GSTZ1
603759	LIM HOMEOBOX GENE 2; LHX2
603760	HUS1 CHECKPOINT CLAMP COMPONENT; HUS1
603761	RAD9A CHECKPOINT CLAMP COMPONENT A; RAD9A
603762	PHOSPHORIBOSYLPYROPHOSPHATE SYNTHETASE-ASSOCIATED PROTEIN 2; PRPSAP2
603763	KINESIN FAMILY MEMBER C1; KIFC1
603764	CYCLIN-DEPENDENT KINASE 5, REGULATORY SUBUNIT 2; CDK5R2
603765	SYNTAXIN 10; STX10
603766	MITOCHONDRIAL TRANSLATIONAL INITIATION FACTOR 2; MTIF2
603767	KALLIKREIN-RELATED PEPTIDASE 4; KLK4
603768	PROTEIN PHOSPHATASE 1, REGULATORY SUBUNIT 12B; PPP1R12B
603769	T-CELL LYMPHOMA/LEUKEMIA 1B; TCL1B
603770	PROTEIN PHOSPHATASE, MAGNESIUM/MANGANESE-DEPENDENT, 1B; PPM1B
603771	PROTEIN PHOSPHATASE 1, REGULATORY SUBUNIT 10; PPP1R10
603772	DYNEIN, CYTOPLASMIC 1, INTERMEDIATE CHAIN 1; DYNC1I1
603773	CYTOCHROME c OXIDASE, SUBUNIT 5A; COX5A
603774	CYTOCHROME c OXIDASE, SUBUNIT 7C; COX7C
603775	CYCLIN E2; CCNE2
603776	HYPERCHOLESTEROLEMIA, FAMILIAL, 3; FHCL3
603777	CERBERUS 1, DAN FAMILY BMP ANTAGONIST; CER1
603778	CDY-LIKE PROTEIN; CDYL
603779	SYNUCLEIN-ALPHA-INTERACTING PROTEIN; SNCAIP
603780	RECQ PROTEIN-LIKE 4; RECQL4
603781	RECQ PROTEIN-LIKE 5; RECQL5
603782	CHEMOKINE, CC MOTIF, LIGAND 4-LIKE 1; CCL4L1
603783	INTELLIGENCE QUANTITATIVE TRAIT LOCUS 1
603784	PPTG1-INTERACTING PROTEIN; PTTG1IP
603785	MULTIPLE PDZ DOMAIN CRUMBS CELL POLARITY COMPLEX COMPONENT; MPDZ
603786	STARGARDT DISEASE 4; STGD4
603787	POTASSIUM CHANNEL, VOLTAGE-GATED, SUBFAMILY F, MEMBER 1; KCNF1
603788	POTASSIUM CHANNEL, VOLTAGE-GATED, SUBFAMILY G, MEMBER 1; KCNG1
603789	MOVED TO 300237
603790	SOLUTE CARRIER FAMILY 23 (NUCLEOBASE TRANSPORTER), MEMBER 1; SLC23A1
603791	SOLUTE CARRIER FAMILY 23 (NUCLEOBASE TRANSPORTER), MEMBER 2; SLC23A2
603792	MOVED TO 300885
603793	REMOVED FROM DATABASE
603794	HYDROA VACCINIFORME, FAMILIAL
603795	LIPOPOLYSACCHARIDE-INDUCED TUMOR NECROSIS FACTOR; LITAF
603796	POTASSIUM CHANNEL, VOLTAGE-GATED, ISK-RELATED SUBFAMILY, MEMBER 2; KCNE2
603797	CARBOHYDRATE SULFOTRANSFERASE 1; CHST1
603798	CARBOHYDRATE SULFOTRANSFERASE 2; CHST2
603799	CARBOHYDRATE SULFOTRANSFERASE 3; CHST3
603800	MEDIATOR COMPLEX SUBUNIT 21; MED21
603801	N-MYRISTOYLTRANSFERASE 2; NMT2
603802	MICROCEPHALY WITH SIMPLIFIED GYRAL PATTERN
603803	DACHSHUND FAMILY TRANSCRIPTION FACTOR 1; DACH1
603804	NEURALIZED E3 UBIQUITIN PROTEIN LIGASE 1; NEURL1
603805	TRANSGLUTAMINASE 5; TGM5
603806	URINARY TRACT INFECTIONS, RECURRENT, SUSCEPTIBILITY TO
603807	MOVED TO 107250
603808	MEDIATOR COMPLEX SUBUNIT 13; MED13
603809	THYROID HORMONE RECEPTOR-ASSOCIATED PROTEIN 3; THRAP3
603810	MEDIATOR COMPLEX SUBUNIT 17; MED17
603811	BARRIER-TO-AUTOINTEGRATION FACTOR 1; BANF1
603812	DDB1- AND CUL4-ASSOCIATED FACTOR 5; DCAF5
603813	HYPERCHOLESTEROLEMIA, FAMILIAL, 4; FHCL4
603814	RING-BOX 1; RBX1
603815	KINESIN FAMILY MEMBER 25; KIF25
603816	AXIS INHIBITOR 1; AXIN1
603817	DEVELOPMENT- AND DIFFERENTIATION-ENHANCING FACTOR 2; DDEF2
603818	NEUREGULIN 2; NRG2
603819	STEROID RECEPTOR RNA ACTIVATOR 1; SRA1
603820	FREE FATTY ACID RECEPTOR 1; FFAR1
603821	FREE FATTY ACID RECEPTOR 3; FFAR3
603822	G PROTEIN-COUPLED RECEPTOR 42; GPR42
603823	FREE FATTY ACID RECEPTOR 2; FFAR2
603824	UDP-N-ACETYLGLUCOSAMINE 2-EPIMERASE/N-ACETYLMANNOSAMINE KINASE; GNE
603825	HYPERMETHYLATED IN CANCER 1; HIC1
603826	NUCLEAR RECEPTOR SUBFAMILY 1, GROUP H, MEMBER 4; NR1H4
603827	BCL2-LIKE 11; BCL2L11
603828	BRITTLE BONE DISORDER
603829	VENTRICULAR FIBRILLATION, PAROXYSMAL FAMILIAL, 1; VF1
603830	LONG QT SYNDROME 3; LQT3
603831	PDZ DOMAIN-CONTAINING 1; PDZK1
603832	NADH-UBIQUINONE OXIDOREDUCTASE SUBUNIT A3; NDUFA3
603833	CYTOCHROME C OXIDASE SUBUNIT FA4; COXFA4
603834	NADH-UBIQUINONE OXIDOREDUCTASE SUBUNIT A9; NDUFA9
603835	NADH-UBIQUINONE OXIDOREDUCTASE SUBUNIT A10; NDUFA10
603836	NADH-UBIQUINONE OXIDOREDUCTASE SUBUNIT AB1; NDUFAB1
603837	NADH-UBIQUINONE OXIDOREDUCTASE SUBUNIT B1; NDUFB1
603838	NADH-UBIQUINONE OXIDOREDUCTASE 1 BETA SUBCOMPLEX, 2; NDUFB2
603839	NADH-UBIQUINONE OXIDOREDUCTASE SUBUNIT B3; NDUFB3
603840	NADH-UBIQUINONE OXIDOREDUCTASE SUBUNIT B4; NDUFB4
603841	NADH-UBIQUINONE OXIDOREDUCTASE SUBUNIT B5; NDUFB5
603842	NADH-UBIQUINONE OXIDOREDUCTASE SUBUNIT B7; NDUFB7
603843	NADH-UBIQUINONE OXIDOREDUCTASE SUBUNIT B10; NDUFB10
603844	NADH-UBIQUINONE OXIDOREDUCTASE SUBUNIT C1; NDUFC1
603845	NADH-UBIQUINONE OXIDOREDUCTASE SUBUNIT C2; NDUFC2
603846	NADH-UBIQUINONE OXIDOREDUCTASE Fe-S PROTEIN 3; NDUFS3
603847	NADH-UBIQUINONE OXIDOREDUCTASE Fe-S PROTEIN 5; NDUFS5
603848	NADH-UBIQUINONE OXIDOREDUCTASE Fe-S PROTEIN 6; NDUFS6
603849	NUCLEAR RECEPTOR SUBFAMILY 2, GROUP E, MEMBER 1; NR2E1
603850	DYNAMIN 1-LIKE; DNM1L
603851	PAIRED-LIKE HOMEOBOX 2B; PHOX2B
603852	TUMOR-SUPPRESSING SUBCHROMOSOMAL TRANSFERABLE FRAGMENT CANDIDATE GENE 4; TSSC4
603853	TETRASPANIN 32; TSPAN32
603854	RAN-BINDING PROTEIN 9; RANBP9
603855	CYSTIC FIBROSIS, MODIFIER OF, 1; CFM1
603856	MAKORIN 3; MKRN3
603857	MKRN3 ANTISENSE RNA; MKRN3AS
603858	MOVED TO 256370
603859	SOLUTE CARRIER FAMILY 25 (CITRIN), MEMBER 13; SLC25A13
603860	MOVED TO 162000
603861	SOLUTE CARRIER FAMILY 25 (MITOCHONDRIAL CARRIER, ORNITHINE TRANSPORTER), MEMBER 15; SLC25A15
603862	CYCLIN T2; CCNT2
603863	RING FINGER PROTEIN 7; RNF7
603864	COPPER CHAPERONE FOR SUPEROXIDE DISMUTASE; CCS
603865	GLUTAMINE:FRUCTOSE-6-PHOSPHATE AMIDOTRANSFERASE 2; GFPT2
603866	PEROXISOME BIOGENESIS FACTOR 11A; PEX11A
603867	PEROXISOME BIOGENESIS FACTOR 11B; PEX11B
603868	RAS-ASSOCIATED PROTEIN RAB27A; RAB27A
603869	RAS-ASSOCIATED PROTEIN RAB27B; RAB27B
603870	CORE-BINDING FACTOR, ALPHA SUBUNIT 2, TRANSLOCATED TO, 3; CBFA2T3
603871	BYSTIN-LIKE; BYSL
603872	TROPHININ-ASSOCIATED PROTEIN; TROAP
603873	PHOSPHOLIPASE A2-ACTIVATING PROTEIN; PLAA
603874	ANGIOPOIETIN-LIKE 1; ANGPTL1
603875	TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY, MEMBER 8; TNFSF8
603876	A DISINTEGRIN-LIKE AND METALLOPROTEINASE WITH THROMBOSPONDIN TYPE 1 MOTIF, 4; ADAMTS4
603877	SOLUTE CARRIER FAMILY 16 (MONOCARBOXYLIC ACID TRANSPORTER), MEMBER 3; SLC16A3
603878	SOLUTE CARRIER FAMILY 16 (MONOCARBOXYLIC ACID TRANSPORTER), MEMBER 4; SLC16A4
603879	SOLUTE CARRIER FAMILY 16 (MONOCARBOXYLIC ACID TRANSPORTER), MEMBER 5; SLC16A5
603880	SOLUTE CARRIER FAMILY 16 (MONOCARBOXYLIC ACID TRANSPORTER), MEMBER 6; SLC16A6
603881	NUCLEAR RECEPTOR SUBFAMILY 1, GROUP I, MEMBER 3; NR1I3
603882	BAG COCHAPERONE 2; BAG2
603883	BCL2-ASSOCIATED ATHANOGENE 3; BAG3
603884	BAG COCHAPERONE 4; BAG4
603885	BAG COCHAPERONE 5; BAG5
603886	ARTEMIN; ARTN
603887	TIMELESS CIRCADIAN REGULATOR; TIMELESS
603888	POTASSIUM CHANNEL, VOLTAGE-GATED, DELAYED-RECTIFIER, SUBFAMILY S, MEMBER 3; KCNS3
603889	SIGNAL REGULATORY PROTEIN, BETA-1; SIRPB1
603890	UBIQUITIN-CONJUGATING ENZYME E2 L6; UBE2L6
603891	FIBROBLAST GROWTH FACTOR 19; FGF19
603892	ELONGATION FACTOR Tu GTP-BINDING DOMAIN-CONTAINING 2; EFTUD2
603893	TRAF FAMILY MEMBER-ASSOCIATED NF-KAPPA-B ACTIVATOR; TANK
603894	REGULATOR OF G PROTEIN SIGNALING 6; RGS6
603895	REGULATOR OF G PROTEIN SIGNALING 11; RGS11
603896	LEUKOENCEPHALOPATHY WITH VANISHING WHITE MATTER 1; VWM1
603897	MATRILIN 4; MATN4
603898	TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY, MEMBER 18; TNFSF18
603899	ZINC FINGER PROTEIN 85; ZNF85
603900	ZINC FINGER PROTEIN 174; ZNF174
603901	ZPR1 ZINC FINGER PROTEIN; ZPR1
603902	BETA-THALASSEMIA, DOMINANT INCLUSION BODY TYPE
603903	SICKLE CELL DISEASE
603904	INTEGRAL MEMBRANE PROTEIN 2B; ITM2B
603905	TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY, MEMBER 18; TNFRSF18
603906	CHLORIDE CHANNEL ACCESSORY 1; CLCA1
603907	EUKARYOTIC TRANSLATION INITIATION FACTOR 2, SUBUNIT 1; EIF2S1
603908	EUKARYOTIC TRANSLATION INITIATION FACTOR 2, SUBUNIT 2; EIF2S2
603909	AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME, TYPE IIA; ALPS2A
603910	EUKARYOTIC TRANSLATION INITIATION FACTOR 3, SUBUNIT J; EIF3J
603911	EUKARYOTIC TRANSLATION INITIATION FACTOR 3, SUBUNIT I; EIF3I
603912	EUKARYOTIC TRANSLATION INITIATION FACTOR 3, SUBUNIT H; EIF3H
603913	EUKARYOTIC TRANSLATION INITIATION FACTOR 3, SUBUNIT G; EIF3G
603914	EUKARYOTIC TRANSLATION INITIATION FACTOR 3, SUBUNIT F; EIF3F
603915	EUKARYOTIC TRANSLATION INITIATION FACTOR 3, SUBUNIT D; EIF3D
603916	EUKARYOTIC TRANSLATION INITIATION FACTOR 3, SUBUNIT C; EIF3C
603917	EUKARYOTIC TRANSLATION INITIATION FACTOR 3, SUBUNIT B; EIF3B
603918	HYPERTENSION, ESSENTIAL, SUSCEPTIBILITY TO, 1
603919	SERINE/THREONINE PROTEIN KINASE 10; STK10
603920	CRYSTALLIN, ZETA-LIKE 1; CRYZL1
603921	SUCCINATE-CoA LIGASE, ADP-FORMING, BETA SUBUNIT; SUCLA2
603922	SUCCINATE-CoA LIGASE, GDP-FORMING, BETA SUBUNIT; SUCLG2
603923	MOVED TO 139260
603924	HYALURONAN-BINDING PROTEIN 2; HABP2
603925	SYNAPTOGYRIN 1; SYNGR1
603926	SYNAPTOGYRIN 2; SYNGR2
603927	SYNAPTOGYRIN 3; SYNGR3
603928	EUKARYOTIC TRANSLATION INITIATION FACTOR 4B; EIF4B
603929	EUKARYOTIC TRANSLATION INITIATION FACTOR 4-GAMMA, 3; EIF4G3
603930	GEPHYRIN; GPHN
603931	ATPase, H+ TRANSPORTING, LYSOSOMAL, 9-KD, V0 SUBUNIT E1; ATP6V0E1
603932	INTERVERTEBRAL DISC DISEASE; IDD
603933	MICROVASCULAR COMPLICATIONS OF DIABETES, SUSCEPTIBILITY TO, 1; MVCD1
603934	COACTIVATOR-ASSOCIATED ARGININE METHYLTRANSFERASE 1; CARM1
603935	PSORIASIS 4, SUSCEPTIBILITY TO; PSORS4
603936	GROWTH/DIFFERENTIATION FACTOR 11; GDF11
603937	RP1 AXONEMAL MICROTUBULE-ASSOCIATED PROTEIN; RP1
603938	MOVED TO 300205
603939	POTASSIUM CHANNEL, SUBFAMILY K, MEMBER 6; KCNK6
603940	POTASSIUM CHANNEL, SUBFAMILY K, MEMBER 7; KCNK7
603941	SOLUTE CARRIER FAMILY 19 (THIAMINE TRANSPORTER), MEMBER 2; SLC19A2
603942	GLYCOGENIN 1; GYG1
603943	CYSTEINE DIOXYGENASE; CDO
603944	SYNTAXIN 6; STX6
603945	EUKARYOTIC TRANSLATION INITIATION FACTOR 2B, SUBUNIT 5; EIF2B5
603946	HELICASE, LYMPHOID-SPECIFIC; HELLS
603947	METASTASIS-ASSOCIATED PROTEIN 2; MTA2
603948	NUCLEOPORIN, 153-KD; NUP153
603949	RAB7-LIKE 1; RAB7L1
603950	N-DEACETYLASE/N-SULFOTRANSFERASE 3; NDST3
603951	POTASSIUM CHANNEL, CALCIUM-ACTIVATED, LARGE CONDUCTANCE, SUBFAMILY M, BETA MEMBER 1; KCNMB1
603952	DEVELOPMENTALLY REGULATED GTP-BINDING PROTEIN 1; DRG1
603953	POTASSIUM INWARDLY-RECTIFYING CHANNEL, SUBFAMILY J, MEMBER 14; KCNJ14
603954	ZW10 KINETOCHORE PROTEIN; ZW10
603955	FLAVIN-CONTAINING DIMETHYLANILINE MONOOXYGENASE 2; FMO2
603956	CERVICAL CANCER
603957	FLAVIN-CONTAINING DIMETHYLANILINE MONOOXYGENASE 5; FMO5
603958	REGULATORY FACTOR X, 4; RFX4
603959	CLAUDIN 16; CLDN16
603960	CALICIN; CCIN
603961	SEMAPHORIN 3A; SEMA3A
603962	RAS GUANYL NUCLEOTIDE-RELEASING PROTEIN 1; RASGRP1
603963	INTEGRIN, ALPHA-9; ITGA9
603964	DEAFNESS, AUTOSOMAL DOMINANT 16; DFNA16
603965	FOCAL SEGMENTAL GLOMERULOSCLEROSIS 2; FSGS2
603966	ALDO-KETO REDUCTASE FAMILY 1, MEMBER C3; AKR1C3
603967	SODIUM VOLTAGE-GATED CHANNEL, ALPHA SUBUNIT 4; SCN4A
603968	POLYMERASE, DNA, ETA; POLH
603969	TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY, MEMBER 13B; TNFSF13B
603970	PARANEOPLASTIC MA ANTIGEN 2; PNMA2
603971	ZINC FINGER PROTEIN 91; ZNF91
603972	ZINC FINGER PROTEIN 43; ZNF43
603973	ZINC FINGER PROTEIN 90; ZNF90
603974	ZINC FINGER PROTEIN 92; ZNF92
603975	ZINC FINGER PROTEIN 93; ZNF93
603976	ZINC FINGER PROTEIN 94; ZNF94
603977	ZINC FINGER PROTEIN 208; ZNF208
603978	ZINC FINGER- AND SCAN DOMAIN-CONTAINING PROTEIN 12; ZSCAN12
603979	ZINC FINGER PROTEIN 97; ZNF97
603980	ZINC FINGER PROTEIN 98; ZNF98
603981	ZINC FINGER PROTEIN 99; ZNF99
603982	ZINC FINGER PROTEIN 100; ZNF100
603983	ZINC FINGER PROTEIN 101; ZNF101
603984	ZINC FINGER PROTEIN 737; ZNF737
603985	ZINC FINGER PROTEIN 103; ZNF103
603986	REMOVED FROM DATABASE
603987	ZINC FINGER PROTEIN 105; ZNF105
603988	ZINC FINGER PROTEIN 106; ZNF106
603989	ZINC FINGER PROTEIN 107; ZNF107
603990	REMOVED FROM DATABASE
603991	ZINC FINGER PROTEIN 109; ZNF109
603992	ZINC FINGER PROTEIN 110; ZNF110
603993	ZINC FINGER PROTEIN 111; ZNF111
603994	ZINC FINGER PROTEIN 112; ZNF112
603995	ZINC FINGER PROTEIN 113; ZNF113
603996	ZINC FINGER PROTEIN 114; ZNF114
603997	ZINC FINGER PROTEIN 118; ZNF118
603998	ZINC FINGER PROTEIN 119; ZNF119
603999	ZINC FINGER PROTEIN 120; ZNF120
604000	ZINC FINGER PROTEIN 122; ZNF122
604001	A-KINASE ANCHOR PROTEIN 9; AKAP9
604002	RHO-ASSOCIATED COILED-COIL-CONTAINING PROTEIN KINASE 2; ROCK2
604003	CHLORIDE CHANNEL ACCESSORY 2; CLCA2
604004	MEGALENCEPHALIC LEUKOENCEPHALOPATHY WITH SUBCORTICAL CYSTS 1; MLC1
604005	MOVED TO 157640
604006	REMOVED FROM DATABASE
604007	REMOVED FROM DATABASE
604008	PROTEIN-TYROSINE PHOSPHATASE, RECEPTOR-TYPE, ZETA-2; PTPRZ2
604009	BAI1-ASSOCIATED PROTEIN 3; BAIAP3
604010	PARANEOPLASTIC MA ANTIGEN 1; PNMA1
604011	UNC119 LIPID-BINDING CHAPERONE; UNC119
604012	RNA, U20 SMALL NUCLEOLAR; RNU20
604013	UDP-GAL:BETA-GlcNAc BETA-1,4-GALACTOSYLTRANSFERASE, POLYPEPTIDE 2; B4GALT2
604014	UDP-GAL:BETA-GlcNAc BETA-1,4-GALACTOSYLTRANSFERASE, POLYPEPTIDE 3; B4GALT3
604015	UDP-GAL:BETA-GlcNAc BETA-1,4-GALACTOSYLTRANSFERASE, POLYPEPTIDE 4; B4GALT4
604016	UDP-GAL:BETA-GlcNAc BETA-1,4-GALACTOSYLTRANSFERASE, POLYPEPTIDE 5; B4GALT5
604017	UDP-GAL:BETA-GlcNAc BETA-1,4-GALACTOSYLTRANSFERASE, POLYPEPTIDE 6; B4GALT6
604018	NUMB-LIKE ENDOCYTIC ADAPTOR PROTEIN; NUMBL
604019	ADP-RIBOSYLATION FACTOR GTPase-ACTIVATING PROTEIN WITH FG REPEATS 2; AGFG2
604020	BASSOON PRESYNAPTIC CYTOMATRIX PROTEIN; BSN
604021	MOVED TO 162662
604022	MOVED TO 162662
604023	MOVED TO 162662
604024	SOLUTE CARRIER FAMILY 5 (SODIUM-DEPENDENT VITAMIN TRANSPORTER), MEMBER 6; SLC5A6
604025	AXIS INHIBITOR 2; AXIN2
604026	GOLGI SNAP RECEPTOR COMPLEX MEMBER 1; GOSR1
604027	GOLGI SNAP RECEPTOR COMPLEX MEMBER 2; GOSR2
604028	SEC22 HOMOLOG C, VESICLE TRAFFICKING PROTEIN; SEC22C
604029	SEC22 HOMOLOG B, VESICLE TRAFFICKING PROTEIN; SEC22B
604030	PROTEASOME SUBUNIT, BETA-TYPE, 7; PSMB7
604031	STEAROYL-CoA DESATURASE; SCD
604032	EUKARYOTIC TRANSLATION INITIATION FACTOR 2-ALPHA KINASE 3; EIF2AK3
604033	ENDOPLASMIC RETICULUM-TO-NUCLEUS SIGNALING 1; ERN1
604034	ENDOPLASMIC RETICULUM-TO-NUCLEUS SIGNALING 2; ERN2
604035	CYLICIN 2; CYLC2
604036	CYCLIN A1; CCNA1
604037	RAS-ASSOCIATED PROTEIN RAB5C; RAB5C
604038	HYALURONOGLUCOSAMINIDASE 3; HYAL3
604039	O-GlcNAcase; OGA
604040	RAD50 DOUBLE-STRAND BREAK REPAIR PROTEIN; RAD50
604041	MANNOSE-P-DOLICHOL UTILIZATION DEFECT 1; MPDU1
604042	INTEGRIN, ALPHA-10; ITGA10
604043	NIMA-RELATED KINASE 2; NEK2
604044	NIMA-RELATED KINASE 3; NEK3
604045	PROTEIN ARGININE METHYLTRANSFERASE 5; PRMT5
604046	OXIDATIVE STRESS-RESPONSIVE 1; OXSR1
604047	SOLUTE CARRIER FAMILY 22 (ORGANIC ANION/URATE TRANSPORTER), MEMBER 13; SLC22A13
604048	SOLUTE CARRIER FAMILY 22, MEMBER 14; SLC22A14
604049	XYLULOKINASE; XYLB
604050	DELETED IN LUNG AND ESOPHAGEAL CANCER 1; DLEC1
604051	ENDO/EXONUCLEASE, ENDOG-LIKE; EXOG
604052	TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY, MEMBER 15; TNFSF15
604053	3-PRIME(2-PRIME),5-PRIME-BISPHOSPHATE NUCLEOTIDASE 1; BPNT1
604054	ACETYL-CoA ACYLTRANSFERASE 1; ACAA1
604055	ISOPENTENYL-DIPHOSPHATE DELTA ISOMERASE 1; IDI1
604056	HEPARAN SULFATE-GLUCOSAMINE 3-SULFOTRANSFERASE 2; HS3ST2
604057	HEPARAN SULFATE-GLUCOSAMINE 3-SULFOTRANSFERASE 3A1; HS3ST3A1
604058	HEPARAN SULFATE-GLUCOSAMINE 3-SULFOTRANSFERASE 3B1; HS3ST3B1
604059	HEPARAN SULFATE-GLUCOSAMINE 3-SULFOTRANSFERASE 4; HS3ST4
604060	DEAFNESS, AUTOSOMAL RECESSIVE 20; DFNB20
604061	SEPTIN 9; SEPT9
604062	MEDIATOR COMPLEX SUBUNIT 16; MED16
604063	INTEGRIN, ALPHA-8; ITGA8
604064	ACTIVATING TRANSCRIPTION FACTOR 4; ATF4
604065	CALCIUM CHANNEL, VOLTAGE-DEPENDENT, T TYPE, ALPHA-1G SUBUNIT; CACNA1G
604066	UDP-GAL:BETA-GlcNAc BETA-1,3-GALACTOSYLTRANSFERASE, POLYPEPTIDE 5; B3GALT5
604067	REGULATOR OF G PROTEIN SIGNALING 9; RGS9
604068	TUMOR PROTEIN D52; TPD52
604069	TUMOR PROTEIN D52-LIKE 1; TPD52L1
604070	DIACYLGLYCEROL KINASE, BETA, 90-KD; DGKB
604071	DIACYLGLYCEROL KINASE, ETA, 130-KD; DGKH
604072	DIACYLGLYCEROL KINASE, IOTA, 130-KD; DGKI
604073	ZINC FINGER PROTEIN 131; ZNF131
604074	ZINC FINGER PROTEIN 132; ZNF132
604075	ZINC FINGER PROTEIN 133; ZNF133
604076	ZINC FINGER PROTEIN 134; ZNF134
604077	ZINC FINGER PROTEIN 135; ZNF135
604078	ZINC FINGER PROTEIN 136; ZNF136
604079	ZINC FINGER PROTEIN 137; ZNF137
604080	ZINC FINGER PROTEIN 138; ZNF138
604081	MOVED TO 601260
604082	ZINC FINGER PROTEIN 140; ZNF140
604083	ZINC FINGER PROTEIN 142; ZNF142
604084	ZINC FINGER- AND BTB DOMAIN-CONTAINING PROTEIN 17; ZBTB17
604085	ZINC FINGER PROTEIN 154; ZNF154
604086	ZINC FINGER PROTEIN 155; ZNF155
604087	CYTOCHROME P450, FAMILY 46, SUBFAMILY A, POLYPEPTIDE 1; CYP46A1
604088	PROTEIN PHOSPHATASE 1, REGULATORY SUBUNIT 17; PPP1R17
604089	HEMATOPOIETIC CELL SIGNAL TRANSDUCER; HCST
604090	DISCS LARGE MAGUK SCAFFOLD PROTEIN 5; DLG5
604091	HYPOALPHALIPOPROTEINEMIA, PRIMARY, 1
604092	TTK PROTEIN KINASE; TTK
604093	KERATOSIS PILARIS ATROPHICANS; KPA
604094	MITOTIC ARREST-DEFICIENT 2 LIKE 2; MAD2L2
604095	ECTODYSPLASIN A RECEPTOR; EDAR
604096	GLUTAMATE RECEPTOR, METABOTROPIC, 6; GRM6
604097	UROTENSIN II; UTS2
604098	SGT1 HOMOLOG, MIS12 KINETOCHORE COMPLEX ASSEMBLY COCHAPERONE; SUGT1
604099	GLUTAMATE RECEPTOR, METABOTROPIC, 2; GRM2
604100	GLUTAMATE RECEPTOR, METABOTROPIC, 4; GRM4
604101	GLUTAMATE RECEPTOR, METABOTROPIC, 7; GRM7
604102	GLUTAMATE RECEPTOR, METABOTROPIC, 5; GRM5
604103	MYOTILIN; MYOT
604104	GLIA MATURATION FACTOR, GAMMA; GMFG
604105	SYNAPTONEMAL COMPLEX PROTEIN 2; SYCP2
604106	G PROTEIN-COUPLED RECEPTOR 52; GPR52
604107	G PROTEIN-COUPLED RECEPTOR 55; GPR55
604108	MICROTUBULE-ASSOCIATED PROTEIN 7; MAP7
604109	HUMAN ENDOGENOUS RETROVIRUS-H LONG TERMINAL REPEAT-ASSOCIATING 1; HHLA1
604110	ADHESION G PROTEIN-COUPLED RECEPTOR G1; ADGRG1
604111	POTASSIUM CHANNEL, VOLTAGE-GATED, SHAKER-RELATED SUBFAMILY, BETA MEMBER 3; KCNAB3
604112	SCIELLIN; SCEL
604113	INTERLEUKIN 18-BINDING PROTEIN; IL18BP
604114	PHOSPHOLIPASE C, BETA-2; PLCB2
604115	KCNQ1-OPPOSITE STRAND/ANTISENSE TRANSCRIPT 1; KCNQ1OT1
604116	CONE-ROD DYSTROPHY 3; CORD3
604117	VOHWINKEL SYNDROME, VARIANT FORM
604118	RAS PROTEIN ACTIVATOR-LIKE 1; RASAL1
604119	SOLUTE CARRIER FAMILY 12 (POTASSIUM/CHLORIDE TRANSPORTER), MEMBER 4; SLC12A4
604120	MOVED TO 600894
604121	CEREBELLAR ATAXIA, DEAFNESS, AND NARCOLEPSY, AUTOSOMAL DOMINANT; ADCADN
604122	PHOSPHATIDYLINOSITOL GLYCAN ANCHOR BIOSYNTHESIS CLASS B PROTEIN; PIGB
604123	RIBONUCLEASE H1; RNASEH1
604124	RETINOBLASTOMA-BINDING PROTEIN 8; RBBP8
604125	SULFOTRANSFERASE FAMILY 2B, MEMBER 1; SULT2B1
604126	SUPERVILLIN; SVIL
604127	T-BOX TRANSCRIPTION FACTOR 15; TBX15
604128	TRANSCRIPTION ELONGATION FACTOR A, 3; TCEA3
604129	EPIDERMOLYSIS BULLOSA PRURIGINOSA
604130	UNDIFFERENTIATED EMBRYONIC CELL TRANSCRIPTION FACTOR 1; UTF1
604131	ALPHA-THALASSEMIA
604132	MOVED TO 300601
604133	MOVED TO 300288
604134	A DISINTEGRIN-LIKE AND METALLOPROTEASE WITH THROMBOSPONDIN TYPE 1 MOTIF, 13; ADAMTS13
604135	NUCLEAR FACTOR ERYTHROID 2-LIKE 3; NFE2L3
604136	INTERLEUKIN 24; IL24
604137	MOVED TO 192150
604138	G PROTEIN-COUPLED RECEPTOR, FAMILY C, GROUP 5, MEMBER A; GPRC5A
604139	DNAJ/HSP40 HOMOLOG, SUBFAMILY B, MEMBER 2; DNAJB2
604140	DEATH INDUCER-OBLITERATOR 1; DIDO1
604141	ADP-RIBOSYLATION FACTOR GUANINE NUCLEOTIDE EXCHANGE FACTOR 1; ARFGEF1
604142	TYRO PROTEIN TYROSINE KINASE-BINDING PROTEIN; TYROBP
604143	EXTRA SPINDLE POLES-LIKE 1; ESPL1
604144	SOLUTE CARRIER FAMILY 7 (CATIONIC AMINO ACID TRANSPORTER, y+ SYSTEM), MEMBER 9; SLC7A9
604145	CARDIOMYOPATHY, DILATED, 1G; CMD1G
604146	SYNAPTOTAGMIN 7; SYT7
604147	PTTG1 REGULATOR OF SISTER CHROMATID SEPARATION, SECURIN; PTTG1
604148	SOLUTE CARRIER FAMILY 13 (SODIUM-DEPENDENT DICARBOXYLATE TRANSPORTER), MEMBER 2; SLC13A2
604149	SARCOGLYCAN, EPSILON; SGCE
604150	POLYMERASE II, RNA, SUBUNIT J; POLR2J
604151	UBIQUITIN-CONJUGATING ENZYME E2 E3; UBE2E3
604152	ORNITHINE DECARBOXYLASE ANTIZYME 2; OAZ2
604153	NEUROMEDIN U RECEPTOR 1; NMUR1
604154	ALZHEIMER DISEASE 15; AD15
604155	LanC-LIKE 1; LANCL1
604156	SECRETED FRIZZLED-RELATED PROTEIN 1; SFRP1
604157	SECRETED FRIZZLED-RELATED PROTEIN 2; SFRP2
604158	SECRETED FRIZZLED-RELATED PROTEIN 5; SFRP5
604159	SOLUTE CARRIER FAMILY 6 (NEUROTRANSMITTER TRANSPORTER, GLYCINE), MEMBER 5; SLC6A5
604160	INTEGRIN, BETA-8; ITGB8
604161	KISS1 RECEPTOR; KISS1R
604162	MOVED TO 600816
604163	RIBOSOMAL PROTEIN L3; RPL3
604164	ONE CUT HOMEOBOX 1; ONECUT1
604165	SOLUTE CARRIER FAMILY 25 (MITOCHONDRIAL CARRIER, OXOGLUTARATE CARRIER), MEMBER 11; SLC25A11
604166	RIBOSOMAL PROTEIN L7; RPL7
604167	CCCTC-BINDING FACTOR; CTCF
604168	CONGENITAL CATARACTS, FACIAL DYSMORPHISM, AND NEUROPATHY; CCFDN
604169	LEFT VENTRICULAR NONCOMPACTION 1; LVNC1
604170	PHOSPHOLIPID SCRAMBLASE 1; PLSCR1
604171	ALY/REF EXPORT FACTOR; ALYREF
604172	CARONTE
604173	POIKILODERMA WITH NEUTROPENIA; PN
604174	RIBOSOMAL PROTEIN L15; RPL15
604175	RIBOSOMAL PROTEIN L11; RPL11
604176	SUPPRESSOR OF CYTOKINE SIGNALING 3; SOCS3
604177	RIBOSOMAL PROTEIN L8; RPL8
604178	RIBOSOMAL PROTEIN L18A; RPL18A
604179	RIBOSOMAL PROTEIN L18; RPL18
604180	RIBOSOMAL PROTEIN L24; RPL24
604181	RIBOSOMAL PROTEIN L37; RPL37
604182	RIBOSOMAL PROTEIN L38; RPL38
604183	CHOLESTEATOMA, CONGENITAL
604184	PUTATIVE NEURONAL CELL ADHESION MOLECULE; PUNC
604185	FACIAL PARESIS, HEREDITARY CONGENITAL, 2; HCFP2
604186	CHEMOKINE, CXC MOTIF, LIGAND 14; CXCL14
604187	SPASTIC PARAPLEGIA 10, AUTOSOMAL DOMINANT; SPG10
604188	SELENIUM-BINDING PROTEIN 1; SELENBP1
604189	DNAJ/HSP40 HOMOLOG, SUBFAMILY C, MEMBER 4; DNAJC4
604190	SOLUTE CARRIER FAMILY 22 (ORGANIC CATION TRANSPORTER), MEMBER 4; SLC22A4
604191	ZINC FINGER PROTEIN 263; ZNF263
604192	MOVED TO 603247
604193	SOLUTE CARRIER FAMILY 27 (FATTY ACID TRANSPORTER), MEMBER 3; SLC27A3
604194	SOLUTE CARRIER FAMILY 27 (FATTY ACID TRANSPORTER), MEMBER 4; SLC27A4
604195	MOVED TO 603314
604196	SOLUTE CARRIER FAMILY 27 (FATTY ACID TRANSPORTER), MEMBER 6; SLC27A6
604197	5,10-METHENYLTETRAHYDROFOLATE SYNTHETASE; MTHFS
604198	RAS-ASSOCIATED PROTEIN RAB11B; RAB11B
604199	RAS-ASSOCIATED PROTEIN RAB35; RAB35
604200	SIALIC ACID-BINDING IMMUNOGLOBULIN-LIKE LECTIN 5; SIGLEC5
604201	HEPATIC FIBROSIS, SEVERE, SUSCEPTIBILITY TO, DUE TO SCHISTOSOMA MANSONI INFECTION
604202	SYNAPTOSOMAL-ASSOCIATED PROTEIN, 29-KD; SNAP29
604203	SYNTAXIN 8; STX8
604204	SYNTAXIN 17; STX17
604205	COPINE I; CPNE1
604206	COPINE II; CPNE2
604207	COPINE III; CPNE3
604208	COPINE IV; CPNE4
604209	COPINE V; CPNE5
604210	CRUMBS CELL POLARITY COMPLEX COMPONENT 1; CRB1
604211	HIRSCHSPRUNG DISEASE WITH HEART DEFECTS, LARYNGEAL ANOMALIES, AND PREAXIAL POLYDACTYLY
604212	POLYADENYLATE-SPECIFIC RIBONUCLEASE; PARN
604213	CHUDLEY-MCCULLOUGH SYNDROME; CMCS
604214	KRIT1 ANKYRIN REPEAT-CONTAINING PROTEIN 1; KRIT1
604215	INHIBITOR OF GROWTH 2; ING2
604216	SOLUTE CARRIER FAMILY 17, MEMBER 4; SLC17A4
604217	SOLUTE CARRIER FAMILY 34 (SODIUM/PHOSPHATE COTRANSPORTER), MEMBER 2; SLC34A2
604218	ENCEPHALOPATHY, FAMILIAL, WITH NEUROSERPIN INCLUSION BODIES; FENIB
604219	CATARACT 9, MULTIPLE TYPES; CTRCT9
604220	ACTIN-RELATED PROTEIN 2/3 COMPLEX, SUBUNIT 1A; ARPC1A
604221	ACTIN-RELATED PROTEIN 2; ACTR2
604222	ACTIN-RELATED PROTEIN 3; ACTR3
604223	ACTIN-RELATED PROTEIN 2/3 COMPLEX, SUBUNIT 1B; ARPC1B
604224	ACTIN-RELATED PROTEIN 2/3 COMPLEX, SUBUNIT 2; ARPC2
604225	ACTIN-RELATED PROTEIN 2/3 COMPLEX, SUBUNIT 3; ARPC3
604226	ACTIN-RELATED PROTEIN 2/3 COMPLEX, SUBUNIT 4; ARPC4
604227	ACTIN-RELATED PROTEIN 2/3 COMPLEX, SUBUNIT 5; ARPC5
604228	MOVED TO 607624
604229	ANTERIOR SEGMENT DYSGENESIS 5; ASGD5
604230	ADENOSINE DEAMINASE, tRNA-SPECIFIC, 1; ADAT1
604231	PITUITARY TUMOR-TRANSFORMING GENE 2; PTTG2
604232	LEBER CONGENITAL AMAUROSIS 3; LCA3
604233	GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 1; GEFSP1
604234	INTEGRIN, BETA-LIKE 1; ITGBL1
604235	SOLUTE CARRIER FAMILY 7 (CATIONIC AMINO ACID TRANSPORTER, y+ SYSTEM), MEMBER 8; SLC7A8
604236	MOVED TO 604233
604237	CYTOKINE RECEPTOR-LIKE FACTOR 1; CRLF1
604238	SNAIL FAMILY TRANSCRIPTIONAL REPRESSOR 1; SNAI1
604239	PHOSPHOSERINE PHOSPHATASE-LIKE; PSPHL
604240	T-CELL LEUKEMIA, HOMEOBOX 2; TLX2
604241	CD2-ASSOCIATED PROTEIN; CD2AP
604242	RING FINGER PROTEIN 6; RNF6
604243	MOVED TO 300594
604244	MOVED TO 300595
604245	MOVED TO 300596
604246	MOVED TO 300597
604247	MOVED TO 300598
604248	MOVED TO 300599
604249	RETICULON 3; RTN3
604250	HEMOCHROMATOSIS, TYPE 3; HFE3
604251	CALCINEURIN-BINDING PROTEIN 1
604252	BETA-SITE AMYLOID BETA A4 PRECURSOR PROTEIN-CLEAVING ENZYME 1; BACE1
604253	CASEIN KINASE I, GAMMA-3; CSNK1G3
604254	DYSLEXIA, SUSCEPTIBILITY TO, 3; DYX3
604255	LADYBIRD HOMEOBOX 1; LBX1
604256	BASIC HELIX-LOOP-HELIX FAMILY, MEMBER E40; BHLHE40
604257	CAMERA-MARUGO-COHEN SYNDROME
604258	DLC1 RHO GTPase ACTIVATING PROTEIN; DLC1
604259	PLEXIN C1; PLXNC1
604260	SIGNAL TRANSDUCER AND ACTIVATOR OF TRANSCRIPTION 5B; STAT5B
604261	AUTOPHAGY-RELATED 5; ATG5
604262	AMYLOID BETA A4 PRECURSOR PROTEIN-BINDING, FAMILY A, MEMBER 3; APBA3
604263	PRION-LIKE PROTEIN DOPPEL; PRND
604264	CADHERIN EGF LAG SEVEN-PASS G-TYPE RECEPTOR 3; CELSR3
604265	CADHERIN EGF LAG SEVEN-PASS G-TYPE RECEPTOR 2; CELSR2
604266	MULTIPLE EPIDERMAL GROWTH FACTOR-LIKE DOMAINS 6; MEGF6
604267	MULTIPLE EPIDERMAL GROWTH FACTOR-LIKE DOMAINS 8; MEGF8
604268	MULTIPLE EPIDERMAL GROWTH FACTOR-LIKE DOMAINS 9; MEGF9
604269	FAT ATYPICAL CADHERIN 2; FAT2
604270	LOW DENSITY LIPOPROTEIN RECEPTOR-RELATED PROTEIN 4; LRP4
604271	GROWTH HORMONE INSENSITIVITY, PARTIAL; GHIP
604272	SCO CYTOCHROME c OXIDASE ASSEMBLY PROTEIN 2; SCO2
604273	MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 1; MC5DN1
604274	KILLER CELL LECTIN-LIKE RECEPTOR A1, PSEUDOGENE; KLRA1P
604275	CATENIN, DELTA-2; CTNND2
604276	PLAKOPHILIN 4; PKP4
604277	SPASTIN; SPAST
604278	RENAL TUBULAR ACIDOSIS, PROXIMAL, WITH OCULAR ABNORMALITIES AND IMPAIRED INTELLECTUAL DEVELOPMENT
604279	JUNCTION-MEDIATING AND REGULATORY PROTEIN; JMY
604280	PLEXIN A4; PLXNA4
604281	DBF4 ZINC FINGER; DBF4
604282	PLEXIN D1; PLXND1
604283	PROTEOGLYCAN 4; PRG4
604284	MOVED TO 137920
604285	ALANINE-GLYOXYLATE AMINOTRANSFERASE; AGXT
604286	MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 4; LGMDR4
604287	CARNEY TRIAD
604288	CARDIOMYOPATHY, DILATED, 1H; CMD1H
604289	RAD54 HOMOLOG B; RAD54B
604290	ACERULOPLASMINEMIA; ACEP
604291	ASCARIS LUMBRICOIDES INFECTION, SUSCEPTIBILITY TO
604292	ECTRODACTYLY, ECTODERMAL DYSPLASIA, AND CLEFT LIP/PALATE SYNDROME 3; EEC3
604293	PLEXIN B2; PLXNB2
604294	VENTRAL ANTERIOR HOMEOBOX 1; VAX1
604295	VENTRAL ANTERIOR HOMEOBOX 2; VAX2
604296	GLYOXYLATE REDUCTASE/HYDROXYPYRUVATE REDUCTASE; GRHPR
604297	SYNAPTOJANIN 1; SYNJ1
604298	SIGNAL TRANSDUCING ADAPTOR FAMILY MEMBER 1; STAP1
604299	ADAPTOR PROTEIN, PHOSPHOTYROSINE INTERACTION, PH DOMAIN, AND LEUCINE ZIPPER-CONTAINING PROTEIN 1; APPL1
604300	2-HYDROXYACYL-CoA LYASE 1; HACL1
604301	OCULOMEDIN; OCLM
604302	RHEUMATOID ARTHRITIS, SYSTEMIC JUVENILE
604303	ACTIN-LIKE 7A; ACTL7A
604304	ACTIN-LIKE 7B; ACTL7B
604305	MAJOR HISTOCOMPATIBILITY COMPLEX, CLASS II, DQ BETA-1; HLA-DQB1
604306	FAS APOPTOTIC INHIBITORY MOLECULE 2; FAIM2
604307	CATARACT 2, MULTIPLE TYPES; CTRCT2
604308	MASS SYNDROME
604309	SOLUTE CARRIER FAMILY 13 (SODIUM-DEPENDENT DICARBOXYLATE TRANSPORTER), MEMBER 4; SLC13A4
604310	BIOGENESIS OF LYSOSOME-RELATED ORGANELLES COMPLEX 1, SUBUNIT 6; BLOC1S6
604311	MEDIATOR COMPLEX SUBUNIT 1; MED1
604312	CYSTATIN 3; CST3
604313	GALACTOKINASE 1; GALK1
604314	BLEPHAROPHIMOSIS WITH FACIAL AND GENITAL ANOMALIES AND IMPAIRED INTELLECTUAL DEVELOPMENT
604315	ANEMIA, CONGENITAL HYPOPLASTIC, WITH MULTIPLE CONGENITAL ANOMALIES/MENTAL RETARDATION SYNDROME
604316	PSORIASIS 5, SUSCEPTIBILITY TO; PSORS5
604317	MICROCEPHALY 2, PRIMARY, AUTOSOMAL RECESSIVE, WITH OR WITHOUT CORTICAL MALFORMATIONS; MCPH2
604318	GTF2I REPEAT DOMAIN-CONTAINING PROTEIN 1; GTF2IRD1
604319	TERF1-INTERACTING NUCLEAR FACTOR 2; TINF2
604320	NEURONOPATHY, DISTAL HEREDITARY MOTOR, AUTOSOMAL RECESSIVE 1; HMNR1
604321	MICROCEPHALY 4, PRIMARY, AUTOSOMAL RECESSIVE; MCPH4
604322	SOLUTE CARRIER FAMILY 17 (ACIDIC SUGAR TRANSPORTER), MEMBER 5; SLC17A5
604323	ATP-BINDING CASSETTE, SUBFAMILY C, MEMBER 3; ABCC3
604324	ACNE, ADULT
604325	PROTEIN PHOSPHATASE 2, REGULATORY SUBUNIT B, BETA; PPP2R2B
604326	SPINOCEREBELLAR ATAXIA 12; SCA12
604327	BETA-1,4-GALACTOSYLTRANSFERASE 7; B4GALT7
604328	STRUCTURE-SPECIFIC RECOGNITION PROTEIN 1; SSRP1
604329	HYPERTENSION, ESSENTIAL, SUSCEPTIBILITY TO, 2
604330	GRB2-RELATED ADAPTOR PROTEIN; GRAP
604331	INTEGRATOR COMPLEX SUBUNIT 6; INTS6
604332	CYSTEINE-RICH HYDROPHOBIC DOMAIN PROTEIN 2; CHIC2
604333	WD40 REPEAT-CONTAINING PROTEIN CIAO1; CIAO1
604334	UBIQUITIN-SPECIFIC PROTEASE 6; USP6
604335	REFLEX SYMPATHETIC DYSTROPHY
604336	TRANSMEMBRANE PHOSPHATASE WITH TENSIN HOMOLOGY; TPTE
604337	CHLORIDE CHANNEL ACCESSORY 3, PSEUDOGENE; CLCA3P
604338	REMOVED FROM DATABASE
604339	REMOVED FROM DATABASE
604340	REMOVED FROM DATABASE
604341	REMOVED FROM DATABASE
604342	REMOVED FROM DATABASE
604343	REMOVED FROM DATABASE
604344	MANNOSIDASE, ALPHA, CLASS 1A, MEMBER 1; MAN1A1
604345	MANNOSIDASE, ALPHA, CLASS 1A, MEMBER 2; MAN1A2
604346	MANNOSIDASE, ALPHA, CLASS 1B, MEMBER 1; MAN1B1
604347	ZINC FINGER RANBP2-TYPE DOMAIN-CONTAINING PROTEIN 2; ZRANB2
604348	ADVANCED SLEEP PHASE SYNDROME, FAMILIAL, 1; FASPS1
604349	LAMININ, GAMMA-3; LAMC3
604350	RAS-ASSOCIATED PROTEIN RAB3D; RAB3D
604351	PHD FINGER PROTEIN 2; PHF2
604352	FEBRILE SEIZURES, FAMILIAL, 4; FEB4
604353	CYSTEINE- AND HISTIDINE-RICH DOMAIN-CONTAINING PROTEIN 1; CHORDC1
604354	NUCLEAR FMRP-INTERACTING PROTEIN 1; NUFIP1
604355	COATOMER PROTEIN COMPLEX, SUBUNIT GAMMA-2; COPG2
604356	DUANE RETRACTION SYNDROME 2; DURS2
604357	MAB21-LIKE 2; MAB21L2
604358	STROMAL ANTIGEN 1; STAG1
604359	MOVED TO 300826
604360	SPASTIC PARAPLEGIA 11, AUTOSOMAL RECESSIVE; SPG11
604361	MOVED TO 600638
604362	LIM DOMAIN ONLY 7; LMO7
604363	MYOCLONIC EPILEPSY, CONGENITAL DEAFNESS, MACULAR DYSTROPHY, AND PSYCHIATRIC DISORDERS
604364	EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 1; FFEVF1
604365	PROMININ 1; PROM1
604366	DYNEIN, AXONEMAL, INTERMEDIATE CHAIN 1; DNAI1
604367	LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 3; FPLD3
604368	GLYCOPROTEIN NMB; GPNMB
604369	SALLA DISEASE; SD
604370	BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1
604371	HUMAN ENDOGENOUS RETROVIRUS-H LONG TERMINAL REPEAT-ASSOCIATING 2; HHLA2
604372	HUMAN ENDOGENOUS RETROVIRUS-H LONG TERMINAL REPEAT-ASSOCIATING 3; HHLA3
604373	CHECKPOINT KINASE 2; CHEK2
604374	METALLOTHIONEIN-LIKE 5, TESTIS-SPECIFIC; MTL5
604375	HUMAN GROWTH FACTOR-REGULATED TYROSINE KINASE SUBSTRATE; HGS
604376	MYELIN PROTEIN ZERO-LIKE 1; MPZL1
604377	MITOCHONDRIAL COMPLEX IV DEFICIENCY, NUCLEAR TYPE 2; MC4DN2
604378	BECLIN 1; BECN1
604379	HYPOTRICHOSIS 7; HYPT7
604380	ULNAR RAY DYSGENESIS WITH POSTAXIAL POLYDACTYLY AND RENAL CYSTIC DYSPLASIA
604381	PATENT DUCTUS ARTERIOSUS AND BICUSPID AORTIC VALVE WITH HAND ANOMALIES
604382	LISSENCEPHALY, FAMILIAL, WITH CLEFT PALATE AND CEREBELLAR HYPOPLASIA
604383	GROWTH FACTOR-INDEPENDENT 1B; GFI1B
604384	ATPase, Ca(2+)-TRANSPORTING, TYPE 2C, MEMBER 1; ATP2C1
604385	SODIUM VOLTAGE-GATED CHANNEL, ALPHA SUBUNIT 11; SCN11A
604386	TRANSCRIPTIONAL REPRESSOR, GATA-BINDING 1; TRPS1
604387	NEPHRONOPHTHISIS 3; NPHP3
604388	GUANINE NUCLEOTIDE-BINDING PROTEIN, GAMMA-4; GNG4
604389	GUANINE NUCLEOTIDE-BINDING PROTEIN, GAMMA-10; GNG10
604390	GUANINE NUCLEOTIDE-BINDING PROTEIN, GAMMA-11; GNG11
604391	ATAXIA-TELANGIECTASIA-LIKE DISORDER 1; ATLD1
604392	ARYLHYDROCARBON-INTERACTING RECEPTOR PROTEIN-LIKE 1; AIPL1
604393	LEBER CONGENITAL AMAUROSIS 4; LCA4
604394	GUANINE NUCLEOTIDE-BINDING PROTEIN, ALPHA-12; GNA12
604395	DNA MISMATCH REPAIR PROTEIN MLH3; MLH3
604396	SET DOMAIN PROTEIN, BIFURCATED, 1; SETDB1
604397	GUANINE NUCLEOTIDE-BINDING PROTEIN, ALPHA-14; GNA14
604398	SECRETOGLOBIN, FAMILY 2A, MEMBER 1; SCGB2A1
604399	PROTEIN PHOSPHATASE 1, REGULATORY SUBUNIT 1B; PPP1R1B
604400	ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA, FAMILIAL, 5; ARVD5
604401	ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA, FAMILIAL, 6; ARVD6
604402	ST3 BETA-GALACTOSIDE ALPHA-2,3-SIALYLTRANSFERASE 5; ST3GAL5
604403	GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 2; GEFSP2
604404	GLYPICAN 6; GPC6
604405	SIALIC ACID-BINDING IMMUNOGLOBULIN-LIKE LECTIN 6; SIGLEC6
604406	GUANINE NUCLEOTIDE-BINDING PROTEIN, ALPHA-13; GNA13
604407	LEUCINE ZIPPER/EF-HAND-CONTAINING TRANSMEMBRANE PROTEIN 1; LETM1
604408	MOVED TO 600610
604409	GLUCOCORTICOID MODULATORY ELEMENT-BINDING PROTEIN 1; GMEB1
604410	SIALIC ACID-BINDING IMMUNOGLOBULIN-LIKE LECTIN 7; SIGLEC7
604411	INNER CENTROMERE PROTEIN; INCENP
604412	T-CELL LEUKEMIA/LYMPHOMA 6; TCL6
604413	MOVED TO 604412
604414	POLYMERASE II, RNA, SUBUNIT F; POLR2F
604415	STEAP FAMILY MEMBER 1; STEAP1
604416	PYOGENIC STERILE ARTHRITIS, PYODERMA GANGRENOSUM, AND ACNE
604417	ALF TRANSCRIPTION ELONGATION FACTOR 4; AFF4
604418	GAP JUNCTION PROTEIN, BETA-6; GJB6
604419	POLYMERASE, DNA, THETA; POLQ
604420	HEMATOPOIETICALLY EXPRESSED HOMEOBOX; HHEX
604421	PHOSDUCIN-LIKE; PDCL
604422	PANCREATIC LIPASE-RELATED PROTEIN 1; PNLIPRP1
604423	PANCREATIC LIPASE-RELATED PROTEIN 2; PNLIPRP2
604424	HOMEODOMAIN-INTERACTING PROTEIN KINASE 3; HIPK3
604425	LIM HOMEOBOX GENE 8; LHX8
604426	CYTOCHROME P450, FAMILY 4, SUBFAMILY F, POLYPEPTIDE 2; CYP4F2
604427	SODIUM VOLTAGE-GATED CHANNEL, ALPHA SUBUNIT 10; SCN10A
604428	MOVED TO 300935
604429	PROLINE-RICH GAMMA-CARBOXYGLUTAMIC ACID PROTEIN 2; PRRG2
604430	GUANINE NUCLEOTIDE-BINDING PROTEIN, GAMMA-7; GNG7
604431	POLYNEUROPATHY, LETHAL NEONATAL, AXONAL SENSORIMOTOR, AUTOSOMAL RECESSIVE
604432	SPINOCEREBELLAR ATAXIA 11; SCA11
604433	POTASSIUM CHANNEL, VOLTAGE-GATED, ISK-RELATED SUBFAMILY, MEMBER 3; KCNE3
604434	KALLIKREIN-RELATED PEPTIDASE 11; KLK11
604435	MOVED TO 164010
604436	PYRIDOXAL PHOSPHATE-BINDING PROTEIN; PLPBP
604437	SOLUTE CARRIER FAMILY 38 (AMINO ACID TRANSPORTER), MEMBER 3; SLC38A3
604438	KALLIKREIN-RELATED PEPTIDASE 7; KLK7
604439	GRB2-ASSOCIATED BINDING PROTEIN 1; GAB1
604440	CELL DEATH-INDUCING DFFA-LIKE EFFECTOR A; CIDEA
604441	CELL DEATH-INDUCING DFFA-LIKE EFFECTOR B; CIDEB
604442	MOVED TO 144700
604443	ACYL-CoA SYNTHETASE LONG CHAIN FAMILY, MEMBER 6; ACSL6
604444	BMP AND ACTIVIN MEMBRANE-BOUND INHIBITOR; BAMBI
604445	PROTEASE INHIBITOR 13; PI13
604446	PHOSPHOTRIESTERASE-RELATED PROTEIN; PTER
604447	GUANINE NUCLEOTIDE-BINDING PROTEIN, BETA-5; GNB5
604448	CYTOHESIN 1-INTERACTING PROTEIN; CYTIP
604449	PROTEASOME 26S SUBUNIT, NON-ATPase, 11; PSMD11
604450	PROTEASOME 26S SUBUNIT, NON-ATPase, 12; PSMD12
604451	BASAL CELL CARCINOMA, INFUNDIBULOCYSTIC
604452	PROTEASOME 26S SUBUNIT, NON-ATPase, 5; PSMD5
604453	NUCLEAR RECEPTOR SUBFAMILY 5, GROUP A, MEMBER 2; NR5A2
604454	WELANDER DISTAL MYOPATHY; WDM
604455	SARCOSINE DEHYDROGENASE; SARDH
604456	INTERFERON-INDUCED TRANSMEMBRANE PROTEIN 1; IFITM1
604457	NUCLEAR BODY PROTEIN SP110; SP110
604458	MOVED TO 604457
604459	INTERLEUKIN 1 RECEPTOR-ASSOCIATED KINASE 3; IRAK3
604460	FAS-ASSOCIATED FACTOR 1; FAF1
604461	HUMAN PAPILLOMAVIRUS TYPE 6A INTEGRATION SITE 1; HPV6AI1
604462	SEMAPHORIN 4C; SEMA4C
604463	CD160 ANTIGEN; CD160
604464	INTERSECTIN 2; ITSN2
604465	SH3 DOMAIN, GRB2-LIKE, 2; SH3GL2
604466	METHYLTRANSFERASE 1, tRNA METHYLGUANOSINE; METTL1
604467	MONOCYTE-TO-MACROPHAGE DIFFERENTIATION-ASSOCIATED PROTEIN; MMD
604468	MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE 6; MAP3K6
604469	EXOCYST COMPLEX COMPONENT 5; EXOC5
604470	CD2 ANTIGEN-BINDING PROTEIN 2; CD2BP2
604471	SOLUTE CARRIER FAMILY 1 (GLUTAMATE TRANSPORTER), MEMBER 7; SLC1A7
604472	TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY, MEMBER 13; TNFSF13
604473	GLUTAMATE RECEPTOR, METABOTROPIC, 1; GRM1
604474	HUMAN HERPESVIRUS TYPE 6, INTEGRATED
604475	RETICULON 4; RTN4
604476	MOVED TO 604350
604477	CHROMOBOX 3; CBX3
604478	CHROMOBOX 5; CBX5
604479	SIRTUIN 1; SIRT1
604480	SIRTUIN 2; SIRT2
604481	SIRTUIN 3; SIRT3
604482	SIRTUIN 4; SIRT4
604483	SIRTUIN 5; SIRT5
604484	NEUROPATHY, HEREDITARY MOTOR AND SENSORY, OKINAWA TYPE; HMSNO
604485	NUCLEAR RECEPTOR SUBFAMILY 2, GROUP E, MEMBER 3; NR2E3
604486	PEPTIDYL-PROLYL CIS/TRANS ISOMERASE, MITOCHONDRIAL; PPIF
604487	OTOGELIN; OTOG
604488	TITIN-CAP; TCAP
604489	ALPHA-METHYLACYL-CoA RACEMASE; AMACR
604490	SACSIN; SACS
604491	CAS-BR-M MURINE ECOTROPIC RETROVIRAL TRANSFORMING SEQUENCE B; CBLB
604492	VOLTAGE-DEPENDENT ANION CHANNEL 1; VDAC1
604493	GAP JUNCTION PROTEIN, BETA-5; GJB5
604494	INTERLEUKIN 18 RECEPTOR 1; IL18R1
604495	NUCLEAR FACTOR KAPPA-B INHIBITOR, BETA; NFKBIB
604496	NFKB INHIBITOR-INTERACTING RAS-LIKE PROTEIN 1; NKIRAS1
604497	NFKB INHIBITOR-INTERACTING RAS-LIKE PROTEIN 2; NKIRAS2
604498	AMEGAKARYOCYTIC THROMBOCYTOPENIA, CONGENITAL, 1; CAMT1
604499	HYPERLIPIDEMIA, FAMILIAL COMBINED, 2; FCHL2
604500	ZINC FINGER HIT DOMAIN-CONTAINING PROTEIN 3; ZNHIT3
604501	THYROID HORMONE RECEPTOR INTERACTOR 4; TRIP4
604502	HIGH MOBILITY GROUP NUCLEOSOMAL BINDING PROTEIN 3; HMGN3
604503	JUMONJI DOMAIN-CONTAINING PROTEIN 1C; JMJD1C
604504	THYROID HORMONE RECEPTOR INTERACTOR 10; TRIP10
604505	THYROID HORMONE RECEPTOR INTERACTOR 11; TRIP11
604506	THYROID HORMONE RECEPTOR INTERACTOR 12; TRIP12
604507	THYROID HORMONE RECEPTOR INTERACTOR 13; TRIP13
604508	COP9 SIGNALOSOME, SUBUNIT 2; COPS2
604509	INTERLEUKIN 18 RECEPTOR ACCESSORY PROTEIN; IL18RAP
604510	HYALURONOGLUCOSAMINIDASE 4; HYAL4
604511	CHROMOBOX 1; CBX1
604512	INTERLEUKIN 1 RECEPTOR-LIKE 2; IL1RL2
604513	CD84 ANTIGEN; CD84
604514	SH2 DOMAIN PROTEIN 2A; SH2D2A
604515	B-CELL LINKER PROTEIN; BLNK
604516	IMMUNOGLOBULIN SUPERFAMILY, MEMBER 2; IGSF2
604517	PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR-GAMMA, COACTIVATOR 1, ALPHA; PPARGC1A
604518	GRB2-RELATED ADAPTOR PROTEIN 2; GRAP2
604519	INFLAMMATORY BOWEL DISEASE 3; IBD3
604520	TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY, MEMBER 14; TNFSF14
604521	3-HYDROXYANTHRANILATE 3,4-DIOXYGENASE; HAAO
604522	DEFENSIN, ALPHA, 3; DEFA3
604523	CADHERIN EGF LAG SEVEN-PASS G-TYPE RECEPTOR 1; CELSR1
604524	LYMPHOCYTE ANTIGEN 75; LY75
604525	HISTAMINE RECEPTOR H3; HRH3
604526	ISOCITRATE DEHYDROGENASE 3, BETA SUBUNIT; IDH3B
604527	POTASSIUM CHANNEL, VOLTAGE-GATED, SUBFAMILY H, MEMBER 3; KCNH3
604528	POTASSIUM CHANNEL, VOLTAGE-GATED, SUBFAMILY H, MEMBER 4; KCNH4
604529	ORTHOPEDIA HOMEOBOX; OTP
604530	NATURAL CYTOTOXICITY TRIGGERING RECEPTOR 1; NCR1
604531	NATURAL CYTOTOXICITY TRIGGERING RECEPTOR 2; NCR2
604532	POLYCYSTIN 2-LIKE 1; PKD2L1
604533	INTERFERON-STIMULATED EXONUCLEASE GENE 20; ISG20
604534	CD83 ANTIGEN; CD83
604535	KINESIN FAMILY MEMBER C3; KIFC3
604536	ECTODERMAL DYSPLASIA/SKIN FRAGILITY SYNDROME; EDSFS
604537	LEBER CONGENITAL AMAUROSIS 5; LCA5
604538	KINESIN FAMILY MEMBER 2C; KIF2C
604539	A DISINTEGRIN-LIKE AND METALLOPROTEINASE WITH THROMBOSPONDIN TYPE 1 MOTIF, 2; ADAMTS2
604540	KERATIN 36, TYPE I; KRT36
604541	KERATIN 37, TYPE I; KRT37
604542	KERATIN 38, TYPE I; KRT38
604543	LIM DOMAIN-CONTAINING PROTEIN 1; LIMD1
604544	LEUCYL-tRNA SYNTHETASE 2; LARS2
604545	KARYOPHERIN ALPHA-5; KPNA5
604546	TONSOKU-LIKE DNA REPAIR PROTEIN; TONSL
604547	VAN DER WOUDE SYNDROME 1, MODIFIER OF
604548	NUCLEAR FACTOR KAPPA-B INHIBITOR, EPSILON; NFKBIE
604549	MOVED TO 172471
604550	DENSITY-REGULATED PROTEIN; DENR
604551	CHOLESTEROL 25-HYDROXYLASE; CH25H
604552	HEPATOCYTE GROWTH FACTOR ACTIVATOR; HGFAC
604553	HEAT-SHOCK FACTOR-BINDING PROTEIN 1; HSBP1
604554	HEAT-SHOCK TRANSCRIPTION FACTOR 2-BINDING PROTEIN; HSF2BP
604555	CADHERIN 10; CDH10
604556	DUAL-SPECIFICITY TYROSINE PHOSPHORYLATION-REGULATED KINASE 1B; DYRK1B
604557	ZINC FINGER PROTEIN 423; ZNF423
604558	INDUCIBLE T-CELL COSTIMULATOR; ICOS
604559	PROGRESSIVE FAMILIAL HEART BLOCK, TYPE IB; PFHB1B
604560	MOVED TO 604453
604561	ALPHA-1,3-MANNOSYL-GLYCOPROTEIN BETA-1,4-N-ACETYLGLUCOSAMINYLTRANSFERASE, ISOZYME B; MGAT4B
604562	APOPTOTIC CHROMATIN CONDENSATION INDUCER 1; ACIN1
604563	CHARCOT-MARIE-TOOTH DISEASE, TYPE 4B2; CMT4B2
604564	GLUTATHIONE S-TRANSFERASE, MICROSOMAL, 3; MGST3
604565	ALG5 DOLICHYL-PHOSPHATE BETA-GLUCOSYLTRANSFERASE; ALG5
604566	ALG6 ALPHA-1,3-GLUCOSYLTRANSFERASE; ALG6
604567	DOUBLE C2-LIKE DOMAIN-CONTAINING PROTEIN, ALPHA; DOC2A
604568	DOUBLE C2-LIKE DOMAIN-CONTAINING PROTEIN, BETA; DOC2B
604569	CONTACTIN-ASSOCIATED PROTEIN-LIKE 2; CNTNAP2
604570	SHROOM FAMILY MEMBER 3; SHROOM3
604571	BARE LYMPHOCYTE SYNDROME, TYPE I
604572	DNAJ/HSP40 HOMOLOG, SUBFAMILY B, MEMBER 1; DNAJB1
604573	ATP SYNTHASE MEMBRANE SUBUNIT 6.8PL; ATP5MPL
604574	FERRIC CHELATE REDUCTASE 1-LIKE; FRRS1L
604575	ZINC FINGER HIT DOMAIN-CONTAINING PROTEIN 2; ZNHIT2
604576	ERGOSTEROL BIOSYNTHESIS 28 HOMOLOG; ERG28
604577	BLOOD VESSEL EPICARDIAL SUBSTANCE; BVES
604578	ABSENT IN MELANOMA 2; AIM2
604579	FRIZZLED CLASS RECEPTOR 4; FZD4
604580	FIBULIN 5; FBLN5
604581	AFG3-LIKE MATRIX AAA PEPTIDASE, SUBUNIT 2; AFG3L2
604582	PALM2 AND AKAP2 FUSION GENE;  PALM2AKAP2
604583	PROGRAMMED CELL DEATH 5; PDCD5
604584	PLATELET-DERIVED GROWTH FACTOR RECEPTOR-LIKE; PDGFRL
604585	NUCLEAR BODY PROTEIN SP100; SP100
604586	SYNTAXIN-BINDING PROTEIN 5; STXBP5
604587	CALCIUM BINDING AND COILED-COIL DOMAIN PROTEIN 2; CALCOCO2
604588	NIMA-RELATED KINASE 1; NEK1
604589	BROMODOMAIN-CONTAINING PROTEIN 1; BRD1
604590	Fc FRAGMENT OF IgG RECEPTOR IIb; FCGR2B
604591	PHOSPHATIDYLETHANOLAMINE-BINDING PROTEIN 1; PEBP1
604592	T CELL IMMUNE REGULATOR 1; TCIRG1
604593	KINESIN FAMILY MEMBER 5C; KIF5C
604594	CYSTEINE-RICH PDZ DOMAIN-BINDING PROTEIN; CRIPT
604595	CHOLESTEROL LEVEL QUANTITATIVE TRAIT LOCUS 1
604596	F-BOX AND WD REPEAT DOMAIN 10B; FBXW10B
604597	GLUTAMATE RECEPTOR-INTERACTING PROTEIN 1; GRIP1
604598	OXIDATIVE STRESS-INDUCED GROWTH INHIBITOR FAMILY MEMBER 2; OSGIN2
604599	EUCHROMATIC HISTONE-LYSINE N-METHYLTRANSFERASE 2; EHMT2
604600	TRANSIENT RECEPTOR POTENTIAL CATION CHANNEL, SUBFAMILY M, MEMBER 5; TRPM5
604601	TRANSLATIONAL RELEASE FACTOR, MITOCHONDRIAL, 1; MTRF1
604602	RIBOSOME-RECYCLING FACTOR, MITOCHONDRIAL; MRRF
604603	MYOFERLIN; MYOF
604604	SOLUTE CARRIER FAMILY 30 (ZINC TRANSPORTER), MEMBER 9; SLC30A9
604605	KALIRIN; KALRN
604606	ODORANT-BINDING PROTEIN 2B; OBP2B
604607	HOMEOBOX B13; HOXB13
604608	MOVED TO 604609
604609	MUCIN 12; MUC12
604610	RECQ PROTEIN-LIKE 3; RECQL3
604611	RECQ PROTEIN-LIKE 2; RECQL2
604612	NK2 HOMEOBOX 2; NKX2-2
604613	T-BOX TRANSCRIPTION FACTOR 18; TBX18
604614	T-BOX TRANSCRIPTION FACTOR 19; TBX19
604615	EOMESODERMIN; EOMES
604616	T-BOX, BRAIN, 1; TBR1
604617	NEURAMINIDASE 3; NEU3
604618	NITRILASE 1; NIT1
604619	LEUCINE-RICH GENE, GLIOMA-INACTIVATED, 1; LGI1
604620	G PROTEIN-COUPLED RECEPTOR 65; GPR65
604621	BETA-1,4-MANNOSYL-GLYCOPROTEIN BETA-1,4-N-ACETYLGLUCOSAMINYLTRANSFERASE; MGAT3
604622	MOVED TO 606519
604623	ALPHA-1,3-MANNOSYL-GLYCOPROTEIN BETA-1,4-N-ACETYLGLUCOSAMINYLTRANSFERASE, ISOZYME A; MGAT4A
604624	HEAT-SHOCK 27-KD PROTEIN 3; HSPB3
604625	TOOTH AGENESIS, SELECTIVE, 3; STHAG3
604626	MALIC ENZYME 3; ME3
604627	INTERLEUKIN 17B; IL17B
604628	INTERLEUKIN 17C; IL17C
604629	MATRIX METALLOPROTEINASE 20; MMP20
604630	NUCLEAR RECEPTOR SUBFAMILY 0, GROUP B, MEMBER 2; NR0B2
604631	VESICLE AMINE TRANSPORT PROTEIN 1; VAT1
604632	VAC14 COMPONENT OF PIKFYVE COMPLEX; VAC14
604633	EGF-CONTAINING FIBULIN-LIKE EXTRACELLULAR MATRIX PROTEIN 2; EFEMP2
604634	TRANSGELIN 2; TAGLN2
604635	NEUREXOPHILIN 2; NXPH2
604636	NEUREXOPHILIN 3; NXPH3
604637	NEUREXOPHILIN 4; NXPH4
604638	ACTININ, ALPHA-4; ACTN4
604639	NEUREXOPHILIN 1; NXPH1
604640	T-CELL LEUKEMIA HOMEOBOX 3; TLX3
604641	MITOGEN-ACTIVATED PROTEIN KINASE 8-INTERACTING PROTEIN 1; MAPK8IP1
604642	CARBONIC ANHYDRASE X; CA10
604643	NEUROPEPTIDE FF-AMIDE PEPTIDE; NPFF
604644	CARBONIC ANHYDRASE XI; CA11
604645	PHOSPHODIESTERASE 7B, cAMP-SPECIFIC, HIGH AFFINITY; PDE7B
604646	NUCLEOPORIN, 50-KD; NUP50
604647	CALCYON; CALY
604648	T-BOX TRANSCRIPTION FACTOR 10; TBX10
604649	TUBULIN-SPECIFIC CHAPERONE D; TBCD
604650	INTERFERON-INDUCED PROTEIN WITH TETRATRICOPEPTIDE REPEATS 3; IFIT3
604651	GROWTH/DIFFERENTIATION FACTOR 7; GDF7
604652	TRANSCRIPTION FACTOR 7-LIKE 1; TCF7L1
604653	SOLUTE CARRIER FAMILY 40 (IRON-REGULATED TRANSPORTER), MEMBER 1; SLC40A1
604654	5-HYDROXYTRYPTAMINE RECEPTOR 3B; HTR3B
604655	MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE 14; MAP3K14
604656	FORMIN-LIKE 1; FMNL1
604657	TRANSMEMBRANE 4 SUPERFAMILY, MEMBER 5; TM4SF5
604658	TRANSMEMBRANE 7 SUPERFAMILY, MEMBER 1; TM7SF1
604659	ENDOGENOUS RETROVIRAL FAMILY W, MEMBER 1; ERVW1
604660	POTASSIUM CHANNEL-INTERACTING PROTEIN 1; KCNIP1
604661	POTASSIUM CHANNEL-INTERACTING PROTEIN 2; KCNIP2
604662	POTASSIUM CHANNEL-INTERACTING PROTEIN 3; KCNIP3
604663	WINGLESS-TYPE MMTV INTEGRATION SITE FAMILY, MEMBER 6; WNT6
604664	INTERFERON-GAMMA-INDUCIBLE PROTEIN 30; IFI30
604665	COP9 SIGNALOSOME, SUBUNIT 3; COPS3
604666	MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE KINASE 4; MAP4K4
604667	CALCIUM-DEPENDENT ACTIVATOR PROTEIN FOR SECRETION; CADPS
604668	ZINC FINGER PROTEIN 264; ZNF264
604669	POLYCYSTIN 2-LIKE 2; PKD2L2
604670	POLYCYSTIN AND SEA URCHIN REJ HOMOLOG-LIKE; PKDREJ
604671	JUMPING TRANSLOCATION BREAKPOINT; JTB
604672	CD209 ANTIGEN; CD209
604673	INOSITOL 1,4,5-TRIPHOSPHATE RECEPTOR ASSOCIATED 1; IRAG1
604674	HES-RELATED FAMILY bHLH TRANSCRIPTION FACTOR WITH YRPW MOTIF 2; HEY2
604675	PAIRED-RELATED HOMEOBOX GENE 2; PRRX2
604676	HLA COMPLEX P5 GENE; HCP5
604677	CERAMIDE TRANSPORTER 1; CERT1
604678	TRANSMEMBRANE 9 SUPERFAMILY, MEMBER 2; TM9SF2
604679	POLYADENYLATE-BINDING PROTEIN, CYTOPLASMIC, 1; PABPC1
604680	POLYADENYLATE-BINDING PROTEIN, CYTOPLASMIC, 3; PABPC3
604681	MOVED TO 604680
604682	INTEGRIN, ALPHA-E; ITGAE
604683	KINESIN FAMILY MEMBER 3A; KIF3A
604684	MLLT11 TRANSCRIPTION FACTOR 7 COFACTOR; MLLT11
604685	HOMEOBOX A2; HOXA2
604686	A-KINASE ANCHOR PROTEIN 13; AKAP13
604687	PROSTAGLANDIN D2 RECEPTOR; PTGDR
604688	A-KINASE ANCHOR PROTEIN 5; AKAP5
604689	A-KINASE ANCHOR PROTEIN 3; AKAP3
604690	GROWTH AND DEVELOPMENTAL RETARDATION, OCULAR PTOSIS, CARDIAC DEFECT, AND ANAL ATRESIA
604691	A-KINASE ANCHOR PROTEIN 6; AKAP6
604692	A-KINASE ANCHOR PROTEIN 8; AKAP8
604693	A-KINASE ANCHOR PROTEIN 7; AKAP7
604694	A-KINASE ANCHOR PROTEIN 10; AKAP10
604695	ADP-RIBOSYLATION FACTOR-LIKE GTPase 3; ARL3
604696	A-KINASE ANCHOR PROTEIN 11; AKAP11
604697	CHEMOKINE, CC MOTIF, LIGAND 26; CCL26
604698	A-KINASE ANCHOR PROTEIN 12; AKAP12
604699	ADP-RIBOSYLATION FACTOR-RELATED PROTEIN 1; ARFRP1
604700	TARGET OF MYB1 MEMBRANE TRAFFICKING PROTEIN; TOM1
604701	TARGET OF MYB1-LIKE 1 MEMBRANE TRAFFICKING PROTEIN; TOM1L1
604702	HMG BOX DOMAIN-CONTAINING 4; HMGXB4
604703	MOVED TO 604702
604704	BREAST CANCER ANTIESTROGEN RESISTANCE 3; BCAR3
604705	MER TYROSINE KINASE PROTOONCOGENE; MERTK
604706	MOVED TO 164015
604707	ALDO-KETO REDUCTASE FAMILY 1, MEMBER B10; AKR1B10
604708	NUCLEAR FACTOR OF ACTIVATED T CELLS 5; NFAT5
604709	T-CELL LYMPHOMA INVASION AND METASTASIS 2; TIAM2
604710	LATENT TRANSFORMING GROWTH FACTOR-BETA-BINDING PROTEIN 4; LTBP4
604711	UBIQUITIN-LIKE 3; UBL3
604712	RIBONUCLEOTIDE REDUCTASE REGULATORY TP53 INDUCIBLE SUBUNIT M2B; RRM2B
604713	C-TYPE LECTIN DOMAIN FAMILY 11, MEMBER A; CLEC11A
604714	TSPY-LIKE 1; TSPYL1
604715	ORTHOSTATIC INTOLERANCE
604716	UDP GLUCURONOSYLTRANSFERASE FAMILY 2, MEMBER A1; UGT2A1
604717	DEAFNESS, AUTOSOMAL DOMINANT 20; DFNA20
604718	TRANSCRIPTION TERMINATION FACTOR 2; TTF2
604719	SERINE/THREONINE PROTEIN KINASE 16; STK16
604720	TRANSFERRIN RECEPTOR 2; TFR2
604721	SH2 DOMAIN-CONTAINING PROTEIN 3A; SH2D3A
604722	SH2 DOMAIN-CONTAINING PROTEIN 3C; SH2D3C
604723	Ts TRANSLATION ELONGATION FACTOR, MITOCHONDRIAL; TSFM
604724	HEPARANASE; HPSE
604725	UBIQUITIN-SPECIFIC PROTEASE 2; USP2
604726	SERINE/THREONINE PROTEIN KINASE 17A; STK17A
604727	SERINE/THREONINE PROTEIN KINASE 17B; STK17B
604728	UBIQUITIN-SPECIFIC PROTEASE 3; USP3
604729	UBIQUITIN-SPECIFIC PROTEASE 21; USP21
604730	TUB-LIKE PROTEIN 3; TULP3
604731	UBIQUITIN-SPECIFIC PROTEASE 15; USP15
604732	TRANSCRIPTION FACTOR EC; TFEC
604733	TRYPTOPHANYL-tRNA SYNTHETASE 2; WARS2
604734	WD REPEAT-CONTAINING PROTEIN 1; WDR1
604735	UBIQUITIN-SPECIFIC PROTEASE 16; USP16
604736	UBIQUITIN-SPECIFIC PROTEASE 25; USP25
604737	WD REPEAT-CONTAINING PROTEIN 3; WDR3
604738	CHEMOKINE, CC MOTIF, RECEPTOR 9; CCR9
604739	RNA-BINDING MOTIF PROTEIN 39; RBM39
604740	SOLUTE CARRIER FAMILY 39 (ZINC TRANSPORTER), MEMBER 1; SLC39A1
604741	ALDO-KETO REDUCTASE FAMILY 1, MEMBER D1; AKR1D1
604742	DOUBLECORTIN-LIKE KINASE 1; DCLK1
604743	DIMETHYLARGININE DIMETHYLAMINOHYDROLASE 1; DDAH1
604744	DIMETHYLARGININE DIMETHYLAMINOHYDROLASE 2; DDAH2
604745	TRANSCRIPTION FACTOR-LIKE 5; TCFL5
604746	TESTIS-ASSOCIATED ACTIN-MODELING KINASE 2; TESK2
604747	SRY-BOX 14; SOX14
604748	SRY-BOX 13; SOX13
604749	ZINC FINGER PROTEIN 235; ZNF235
604750	ZINC FINGER PROTEIN 234; ZNF234
604751	ZINC FINGER PROTEIN 266; ZNF266
604752	ZINC FINGER PROTEIN 267; ZNF267
604753	ZINC FINGER PROTEIN 268; ZNF268
604754	ZINC FINGER PROTEIN 271, PSEUDOGENE; ZNF271P
604755	ZINC FINGER PROTEIN 272; ZNF272
604756	ZINC FINGER PROTEIN 273; ZNF273
604757	CRANIOSYNOSTOSIS 2; CRS2
604758	RELB PROTOONCOGENE, NFKB-SUBUNIT; RELB
604759	SYNAPTONEMAL COMPLEX PROTEIN 3; SYCP3
604760	ZINC FINGER PROTEIN 236; ZNF236
604761	ZINC FINGER AN1 DOMAIN-CONTAINING PROTEIN 5; ZFAND5
604762	SWITCH-ASSOCIATED PROTEIN 70
604763	RHO GUANINE NUCLEOTIDE EXCHANGE FACTOR 12; ARHGEF12
604764	ZINC FINGER AND HOMEODOMAIN PROTEIN 1; ZHX1
604765	CARDIOMYOPATHY, DILATED, 1I; CMD1I
604766	NPHS2 STOMATIN FAMILY MEMBER, PODOCIN; NPHS2
604767	DELETED IN ESOPHAGEAL CANCER 1; DEC1
604768	ZINC FINGER PROTEIN 254; ZNF254
604769	PEROXIREDOXIN 3; PRDX3
604770	ACETYL-CoA ACYLTRANSFERASE 2; ACAA2
604771	POLYCYSTIC BONE DISEASE
604772	VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 1, WITH OR WITHOUT ATRIAL DYSFUNCTION AND/OR DILATED CARDIOMYOPATHY; CPVT1
604773	ACYL-CoA DEHYDROGENASE FAMILY, MEMBER 8; ACAD8
604774	ANGIOPOIETIN-LIKE 3; ANGPTL3
604775	TRANSIENT RECEPTOR POTENTIAL CATION CHANNEL, SUBFAMILY A, MEMBER 1; TRPA1
604776	MAJOR HISTOCOMPATIBILITY COMPLEX, CLASS II, DR BETA-5; HLA-DRB5
604777	ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 5; ARCI5
604778	A DISINTEGRIN AND METALLOPROTEINASE DOMAIN 29; ADAM29
604779	A DISINTEGRIN AND METALLOPROTEINASE DOMAIN 30; ADAM30
604780	ABHYDROLASE DOMAIN-CONTAINING PROTEIN 5, LYSOPHOSPHATIDIC ACID ACYLTRANSFERASE; ABHD5
604781	MOVED TO 604777
604782	ASH2-LIKE; ASH2L
604783	CLEFT LIP AND PALATE-ASSOCIATED TRANSMEMBRANE PROTEIN 1; CLPTM1
604784	TRANSCRIPTION ELONGATION FACTOR A, 2; TCEA2
604785	CATENIN, ALPHA-LIKE, 1; CTNNAL1
604786	ADP-RIBOSYLATION FACTOR-LIKE GTPase 4A; ARL4A
604787	ADP-RIBOSYLATION FACTOR-LIKE GTPase 4C; ARL4C
604788	RUVB-LIKE AAA ATPase 2; RUVBL2
604789	INTEGRIN, ALPHA-11; ITGA11
604790	TASTE RECEPTOR, TYPE 2, MEMBER 14; TAS2R14
604791	TASTE RECEPTOR, TYPE 2, MEMBER 10; TAS2R10
604792	TASTE RECEPTOR, TYPE 2, MEMBER 13; TAS2R13
604793	TASTE RECEPTOR, TYPE 2, MEMBER 7; TAS2R7
604794	TASTE RECEPTOR, TYPE 2, MEMBER 8; TAS2R8
604795	TASTE RECEPTOR, TYPE 2, MEMBER 9; TAS2R9
604796	TASTE RECEPTOR, TYPE 2, MEMBER 1; TAS2R1
604797	APOLIPOPROTEIN B mRNA-EDITING ENZYME, CATALYTIC POLYPEPTIDE-LIKE 2; APOBEC2
604798	HOMER SCAFFOLD PROTEIN 1; HOMER1
604799	HOMER SCAFFOLD PROTEIN 2; HOMER2
604800	HOMER SCAFFOLD PROTEIN 3; HOMER3
604801	MUSCULAR DYSTROPHY, CONGENITAL, 1B; MDC1B
604802	HUNTINGTON DISEASE-LIKE 3; HDL3
604803	DOP1 LEUCINE ZIPPER-LIKE PROTEIN B; DOP1B
604804	MICROCEPHALY 3, PRIMARY, AUTOSOMAL RECESSIVE; MCPH3
604805	SPASTIC PARAPLEGIA 12, AUTOSOMAL DOMINANT; SPG12
604806	FIBRONECTIN-LIKE DOMAIN-CONTAINING LEUCINE-RICH TRANSMEMBRANE PROTEIN 1; FLRT1
604807	FIBRONECTIN-LIKE DOMAIN-CONTAINING LEUCINE-RICH TRANSMEMBRANE PROTEIN 2; FLRT2
604808	FIBRONECTIN-LIKE DOMAIN-CONTAINING LEUCINE-RICH TRANSMEMBRANE PROTEIN 3; FLRT3
604809	PANBRONCHIOLITIS, DIFFUSE
604810	LEUKOCYTE IMMUNOGLOBULIN-LIKE RECEPTOR, SUBFAMILY A, MEMBER 1; LILRA1
604811	LEUKOCYTE IMMUNOGLOBULIN-LIKE RECEPTOR, SUBFAMILY B, MEMBER 1; LILRB1
604812	LEUKOCYTE IMMUNOGLOBULIN-LIKE RECEPTOR, SUBFAMILY A, MEMBER 2; LILRA2
604813	CYTOCHROME c OXIDASE COPPER CHAPERONE COX17; COX17
604814	LEUKOCYTE IMMUNOGLOBULIN-LIKE RECEPTOR, SUBFAMILY B, MEMBER 5; LILRB5
604815	LEUKOCYTE IMMUNOGLOBULIN-LIKE RECEPTOR, SUBFAMILY B, MEMBER 2; LILRB2
604816	MOVED TO 604213
604817	CARBOHYDRATE SULFOTRANSFERASE 5; CHST5
604818	LEUKOCYTE IMMUNOGLOBULIN-LIKE RECEPTOR, SUBFAMILY A, MEMBER 3; LILRA3
604819	POLY-U-BINDING SPLICING FACTOR, 60-KD; PUF60
604820	LEUKOCYTE IMMUNOGLOBULIN-LIKE RECEPTOR, SUBFAMILY B, MEMBER 3; LILRB3
604821	LEUKOCYTE IMMUNOGLOBULIN-LIKE RECEPTOR, SUBFAMILY B, MEMBER 4; LILRB4
604822	CALPAIN 11; CAPN11
604823	BARX HOMEOBOX 2; BARX2
604824	KLOTHO; KL
604825	FASCICULATION AND ELONGATION PROTEIN ZETA 1; FEZ1
604826	FASCICULATION AND ELONGATION PROTEIN ZETA 2; FEZ2
604827	EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 7; EIG7
604828	CHEMOKINE, C MOTIF, LIGAND 2; XCL2
604829	DOWN SYNDROME CRITICAL REGION GENE 4; DSCR4
604830	MANDIBULOFACIAL DYSOSTOSIS SYNDROME, BAURU TYPE
604831	EVC CILIARY COMPLEX SUBUNIT 1; EVC
604832	CARBONIC ANHYDRASE XIV; CA14
604833	CHEMOKINE, CC MOTIF, LIGAND 27; CCL27
604834	TANK-BINDING KINASE 1; TBK1
604835	DUAL-SPECIFICITY PHOSPHATASE 12; DUSP12
604836	CHEMOKINE, CC MOTIF, RECEPTOR 4; CCR4
604837	PROSTAGLANDIN D2 RECEPTOR 2; PTGDR2
604838	G PROTEIN-COUPLED RECEPTOR 45; GPR45
604839	FK506-BINDING PROTEIN 6; FKBP6
604840	FK506-BINDING PROTEIN 8; FKBP8
604841	STICKLER SYNDROME, TYPE II; STL2
604842	SOLUTE CARRIER FAMILY 22 (EXTRANEURONAL MONOAMINE TRANSPORTER), MEMBER 3; SLC22A3
604843	SOLUTE CARRIER ORGANIC ANION TRANSPORTER FAMILY, MEMBER 1B1; SLCO1B1
604844	HEPARAN SULFATE 2-O-SULFOTRANSFERASE 1; HS2ST1
604845	PROSTATE CANCER ANTIGEN 3; PCA3
604846	HEPARAN SULFATE 6-O-SULFOTRANSFERASE 1; HS6ST1
604847	G PROTEIN-COUPLED RECEPTOR 26; GPR26
604848	MOVED TO 604849
604849	TRACE AMINE-ASSOCIATED RECEPTOR 2; TAAR2
604850	COP9 SIGNALOSOME, SUBUNIT 5; COPS5
604851	G-RICH RNA SEQUENCE-BINDING FACTOR 1; GRSF1
604852	CHEMOKINE, CXC MOTIF, LIGAND 11; CXCL11
604853	MITOCHONDRIAL RIBOSOMAL PROTEIN L28; MRPL28
604854	INDOLETHYLAMINE N-METHYLTRANSFERASE; INMT
604855	HYALURONAN METABOLISM, DEFECT IN
604856	LANGERHANS CELL HISTIOCYTOSIS
604857	SIGNAL RECOGNITION PARTICLE, 54-KD; SRP54
604858	SIGNAL RECOGNITION PARTICLE, 68-KD; SRP68
604859	LIM AND CYSTEINE-RICH DOMAINS 1; LMCD1
604860	MALT1 PARACASPASE; MALT1
604861	LARGE TUMOR SUPPRESSOR KINASE 2; LATS2
604862	CD207 ANTIGEN; CD207
604863	LECITHIN RETINOL ACYLTRANSFERASE; LRAT
604864	OSTEOARTHRITIS WITH MILD CHONDRODYSPLASIA; OSCDP
604865	KRUPPEL-LIKE FACTOR 7; KLF7
604866	PLAG1-LIKE ZINC FINGER 2; PLAGL2
604867	TASTE RECEPTOR, TYPE 2, MEMBER 16; TAS2R16
604868	TASTE RECEPTOR, TYPE 2, MEMBER 3; TAS2R3
604869	TASTE RECEPTOR, TYPE 2, MEMBER 4; TAS2R4
604870	MACROPHAGE RECEPTOR WITH COLLAGENOUS STRUCTURE; MARCO
604871	MATRIX METALLOPROTEINASE 24; MMP24
604872	PROPROTEIN CONVERTASE, SUBTILISIN/KEXIN-TYPE, 7; PCSK7
604873	MYELIN PROTEIN ZERO-LIKE 2; MPZL2
604874	KILLER CELL LECTIN-LIKE RECEPTOR, SUBFAMILY G, MEMBER 1; KLRG1
604875	MYOSIN IXA; MYO9A
604876	REGULATOR OF CALCINEURIN 2; RCAN2
604877	MAF bZIP TRANSCRIPTION FACTOR F; MAFF
604878	SOLUTE CARRIER FAMILY 12 (POTASSIUM/CHLORIDE TRANSPORTER), MEMBER 6; SLC12A6
604879	SOLUTE CARRIER FAMILY 12 (POTASSIUM/CHLORIDE TRANSPORTER), MEMBER 7; SLC12A7
604880	MOVED TO 300609
604881	RABPHILIN 3A-LIKE; RPH3AL
604882	NEUROGENIN 3; NEUROG3
604883	GENERAL TRANSCRIPTION FACTOR 3C, POLYPEPTIDE 2; GTF3C2
604884	NIMA-RELATED KINASE 6; NEK6
604885	MYB-BINDING PROTEIN 1A; MYBBP1A
604886	ENDOPLASMIC RETICULUM MEMBRANE PROTEIN COMPLEX, SUBUNIT 8; EMC8
604887	METHYLENETETRAHYDROFOLATE DEHYDROGENASE 2; MTHFD2
604888	GENERAL TRANSCRIPTION FACTOR 3C, POLYPEPTIDE 3; GTF3C3
604889	NEUROBEACHIN; NBEA
604890	GENERAL TRANSCRIPTION FACTOR 3C, POLYPEPTIDE 5; GTF3C5
604891	NCK-ASSOCIATED PROTEIN 1; NCKAP1
604892	GENERAL TRANSCRIPTION FACTOR 3C, POLYPEPTIDE 4; GTF3C4
604893	ANTISENSE IGF2R RNA, NONCODING; AIRN
604894	ONE CUT HOMEOBOX 2; ONECUT2
604895	T-BOX TRANSCRIPTION FACTOR 21; TBX21
604896	MKKS CENTROSOMAL SHUTTLING PROTEIN; MKKS
604897	PREFOLDIN 1; PFDN1
604898	PREFOLDIN 4; PFDN4
604899	PREFOLDIN 5; PFDN5
604900	DIACYLGLYCEROL O-ACYLTRANSFERASE 1; DGAT1
604901	NORTH AMERICAN INDIAN CHILDHOOD CIRRHOSIS; NAIC
604902	BRF1 SUBUNIT OF RNA POLYMERASE III TRANSCRIPTION INITIATION FACTOR; BRF1
604903	TATA BOX-BINDING PROTEIN-ASSOCIATED FACTOR 1A; TAF1A
604904	TATA BOX-BINDING PROTEIN-ASSOCIATED FACTOR 1B; TAF1B
604905	TATA BOX-BINDING PROTEIN-ASSOCIATED FACTOR 1C; TAF1C
604906	SCHIZOPHRENIA 9; SCZD9
604907	TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY, MEMBER 13B; TNFRSF13B
604908	PROTEIN PHOSPHATASE 4, REGULATORY SUBUNIT 1; PPP4R1
604909	CCR4-NOT TRANSCRIPTION COMPLEX, SUBUNIT 2; CNOT2
604910	CCR4-NOT TRANSCRIPTION COMPLEX, SUBUNIT 3; CNOT3
604911	CCR4-NOT TRANSCRIPTION COMPLEX, SUBUNIT 4; CNOT4
604912	TAF2 RNA POLYMERASE II, TATA BOX-BINDING PROTEIN-ASSOCIATED FACTOR, 150-KD; TAF2
604913	CCR4-NOT TRANSCRIPTION COMPLEX, SUBUNIT 7; CNOT7
604914	JUMONJI DOMAIN-CONTAINING PROTEIN 6; JMJD6
604915	MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE 13; MAP3K13
604916	MOVED TO 616580
604917	CCR4-NOT TRANSCRIPTION COMPLEX, SUBUNIT 1; CNOT1
604918	PICCOLO PRESYNAPTIC CYTOMATRIX PROTEIN; PCLO
604919	BECKER NEVUS SYNDROME; BNS
604920	MOVED TO 603218
604921	MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE KINASE 3; MAP4K3
604922	CORTICAL DEFECTS, WORMIAN BONES, AND DENTINOGENESIS IMPERFECTA
604923	MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE KINASE 5; MAP4K5
604924	PHOSPHORYLATED ADAPTOR FOR RNA EXPORT; PHAX
604925	RAB ACCEPTOR 1; RABAC1
604926	MOVED TO 300948
604927	C-TERMINAL DOMAIN OF RNA POLYMERASE II SUBUNIT A, PHOSPHATASE OF, SUBUNIT 1; CTDP1
604928	WOLFRAM SYNDROME 2; WFS2
604929	MOVED TO 181350
604930	NCK ADAPTOR PROTEIN 2; NCK2
604931	CORTISONE REDUCTASE DEFICIENCY 1; CORTRD1
604932	PROTEIN KINASE, cAMP-DEPENDENT CATALYTIC, INHIBITOR GAMMA; PKIG
604933	MutY DNA GLYCOSYLASE; MUTYH
604934	TUBULIN-SPECIFIC CHAPERONE E; TBCE
604935	DOUBLESEX- AND MAB3-RELATED TRANSCRIPTION FACTOR 2; DMRT2
604936	KILLER CELL IMMUNOGLOBULIN-LIKE RECEPTOR, TWO DOMAINS, LONG CYTOPLASMIC TAIL, 1; KIR2DL1
604937	KILLER CELL IMMUNOGLOBULIN-LIKE RECEPTOR, TWO DOMAINS, LONG CYTOPLASMIC TAIL, 2; KIR2DL2
604938	KILLER CELL IMMUNOGLOBULIN-LIKE RECEPTOR, TWO DOMAINS, LONG CYTOPLASMIC TAIL, 3; KIR2DL3
604939	PHOSPHOLIPASE A2 RECEPTOR 1; PLA2R1
604940	MOVED TO 601228
604941	PROTEIN PHOSPHATASE 2, REGULATORY SUBUNIT B, ALPHA; PPP2R2A
604942	SYNTAPHILIN; SNPH
604943	SOLUTE CARRIER FAMILY 26, MEMBER 5; SLC26A5
604944	PROTEIN PHOSPHATASE 2, REGULATORY SUBUNIT B-DOUBLE PRIME, ALPHA; PPP2R3A
604945	KILLER CELL IMMUNOGLOBULIN-LIKE RECEPTOR, TWO DOMAINS, LONG CYTOPLASMIC TAIL, 4; KIR2DL4
604946	KILLER CELL IMMUNOGLOBULIN-LIKE RECEPTOR, THREE DOMAINS, LONG CYTOPLASMIC TAIL, 1; KIR3DL1
604947	KILLER CELL IMMUNOGLOBULIN-LIKE RECEPTOR, THREE DOMAINS, LONG CYTOPLASMIC TAIL, 2; KIR3DL2
604948	GROWTH ARREST- AND DNA DAMAGE-INDUCIBLE GENE, BETA; GADD45B
604949	GROWTH ARREST- AND DNA DAMAGE-INDUCIBLE GENE, GAMMA; GADD45G
604950	PUTATIVE HOMEODOMAIN TRANSCRIPTION FACTOR 1; PHTF1
604951	6-PHOSPHOGLUCONOLACTONASE; PGLS
604952	KILLER CELL IMMUNOGLOBULIN-LIKE RECEPTOR, TWO DOMAINS, SHORT CYTOPLASMIC TAIL, 1; KIR2DS1
604953	KILLER CELL IMMUNOGLOBULIN-LIKE RECEPTOR, TWO DOMAINS, SHORT CYTOPLASMIC TAIL, 2; KIR2DS2
604954	KILLER CELL IMMUNOGLOBULIN-LIKE RECEPTOR, TWO DOMAINS, SHORT CYTOPLASMIC TAIL, 3; KIR2DS3
604955	KILLER CELL IMMUNOGLOBULIN-LIKE RECEPTOR, TWO DOMAINS, SHORT CYTOPLASMIC TAIL, 4; KIR2DS4
604956	KILLER CELL IMMUNOGLOBULIN-LIKE RECEPTOR, TWO DOMAINS, SHORT CYTOPLASMIC TAIL, 5; KIR2DS5
604957	MOVED TO 604946
604958	ACTIN-LIKE 6A; ACTL6A
604959	PHORBOL-12-MYRISTATE-13-ACETATE-INDUCED PROTEIN 1; PMAIP1
604960	PROTEIN KINASE C AND CASEIN KINASE SUBSTRATE IN NEURONS 2; PACSIN2
604961	PHOSPHODIESTERASE 11A; PDE11A
604962	T-CELL RECEPTOR-ASSOCIATED TRANSMEMBRANE ADAPTOR 1; TRAT1
604963	PEPTIDOGLYCAN RECOGNITION PROTEIN 1; PGLYRP1
604964	SHP2-INTERACTING TRANSMEMBRANE ADAPTOR PROTEIN 1; SIT1
604965	SERINE/THREONINE PROTEIN KINASE 4; STK4
604966	PROTOCADHERIN-ALPHA GENE CLUSTER; PCDHA@
604967	PROTOCADHERIN-BETA GENE CLUSTER; PCDHB@
604968	PROTOCADHERIN-GAMMA GENE CLUSTER; PCDHG@
604969	SRC KINASE-ASSOCIATED PHOSPHOPROTEIN 1; SKAP1
604970	AURORA KINASE B; AURKB
604971	MYOD FAMILY INHIBITOR; MDFI
604972	ORIGIN RECOGNITION COMPLEX, SUBUNIT 3; ORC3
604973	FICOLIN 3; FCN3
604974	SRY-BOX 21; SOX21
604975	SRY-BOX 5; SOX5
604976	PROTEIN KINASE, AMP-ACTIVATED, NONCATALYTIC, GAMMA-3; PRKAG3
604977	SERINE/THREONINE PROTEIN KINASE 19; STK19
604978	NUDIX HYDROLASE 21; NUDT21
604979	CLEAVAGE AND POLYADENYLATION SPECIFICITY FACTOR 6; CPSF6
604980	RAC GTPase-ACTIVATING PROTEIN 1; RACGAP1
604981	WW DOMAIN-CONTAINING BINDING PROTEIN 4; WBP4
604982	HPS1 BIOGENESIS OF LYSOSOMAL ORGANELLES COMPLEX 3, SUBUNIT 1; HPS1
604983	POLYMERASE, DNA, GAMMA-2; POLG2
604984	SERINE/THREONINE PROTEIN KINASE 24; STK24
604985	SPECTRIN, BETA, NONERYTHROCYTIC, 2; SPTBN2
604986	BRCA1-ASSOCIATED PROTEIN; BRAP
604987	C-TYPE LECTIN DOMAIN FAMILY 5, MEMBER A; CLEC5A
604988	SOLUTE CARRIER ORGANIC ANION TRANSPORTER FAMILY, MEMBER 2B1; SLCO2B1
604989	SPONDIN 1; SPON1
604990	SOLUTE CARRIER FAMILY 9, MEMBER 3, REGULATOR 1; SLC9A3R1
604991	PROSTATE ANDROGEN-REGULATED TRANSCRIPT 1; PART1
604992	SARCALUMENIN; SRL
604993	PRE-mRNA-PROCESSING FACTOR 18; PRPF18
604994	SIX HOMEOBOX 2; SIX2
604995	SOLUTE CARRIER FAMILY 22 (ORGANIC ANION TRANSPORTER), MEMBER 7; SLC22A7
604996	FXYD DOMAIN-CONTAINING ION TRANSPORT REGULATOR 3; FXYD3
604997	DOCKING PROTEIN 2; DOK2
604998	CALCIUM/CALMODULIN-DEPENDENT PROTEIN KINASE I; CAMK1
604999	SH3 AND MULTIPLE ANKYRIN REPEAT DOMAINS 1; SHANK1
605000	CORONIN 1A; CORO1A
605001	ANGIOPOIETIN-LIKE 2; ANGPTL2
605002	CORONIN 2B; CORO2B
605003	SENTRIN-SPECIFIC PROTEASE FAMILY, MEMBER 6; SENP6
605004	GLYCOGEN SYNTHASE KINASE 3-BETA; GSK3B
605005	UDP-N-ACETYL-ALPHA-D-GALACTOSAMINE:POLYPEPTIDE N-ACETYLGALACTOSAMINYLTRANSFERASE 7; GALNT7
605006	FREQUENTLY REARRANGED IN ADVANCED T-CELL LYMPHOMAS 2; FRAT2
605007	A DISINTEGRIN-LIKE AND METALLOPROTEINASE WITH THROMBOSPONDIN TYPE 1 MOTIF, 5; ADAMTS5
605008	A DISINTEGRIN-LIKE AND METALLOPROTEINASE WITH THROMBOSPONDIN TYPE 1 MOTIF, 6; ADAMTS6
605009	A DISINTEGRIN-LIKE AND METALLOPROTEINASE WITH THROMBOSPONDIN TYPE 1 MOTIF, 7; ADAMTS7
605010	SERINE PROTEASE INHIBITOR, KAZAL-TYPE, 5; SPINK5
605011	A DISINTEGRIN-LIKE AND METALLOPROTEINASE WITH THROMBOSPONDIN TYPE 1 MOTIF, 3; ADAMTS3
605012	SPT16 HOMOLOG, FACILITATES CHROMATIN REMODELING SUBUNIT; SUPT16H
605013	MICROHYDRANENCEPHALY; MHAC
605014	SYNTAXIN 11; STX11
605015	ZINC FINGER PROTEIN 214; ZNF214
605016	ZINC FINGER PROTEIN 215; ZNF215
605017	PRE-B-LYMPHOCYTE GENE 3; VPREB3
605018	CYLD LYSINE-63 DEUBIQUITINASE; CYLD
605019	HYPOBETALIPOPROTEINEMIA, FAMILIAL, 2; FHBL2
605020	VISUAL SYSTEM HOMEOBOX 1; VSX1
605021	MYOCLONIC EPILEPSY, FAMILIAL INFANTILE; FIME
605022	p21 PROTEIN-ACTIVATED KINASE 2; PAK2
605023	HYDROXYACID OXIDASE 1; HAO1
605024	SOLUTE CARRIER FAMILY 4 (SODIUM BICARBONATE COTRANSPORTER), MEMBER 8; SLC4A8
605025	INTEGRIN, ALPHA-3; ITGA3
605026	DIABETES MELLITUS, CONGENITAL AUTOIMMUNE
605027	LYMPHOMA, NON-HODGKIN, FAMILIAL
605028	LOW DENSITY LIPOPROTEIN CHOLESTEROL, MILD ELEVATION OF
605029	KILLER CELL LECTIN-LIKE RECEPTOR F1; KLRF1
605030	SERINE/THREONINE PROTEIN KINASE 3; STK3
605031	POLO-LIKE KINASE 4; PLK4
605032	COMPLEXIN 1; CPLX1
605033	COMPLEXIN 2; CPLX2
605034	TRANSLOCASE OF INNER MITOCHONDRIAL MEMBRANE 23; TIMM23
605035	WASP PROTEIN FAMILY, MEMBER 1; WASF1
605036	ZINC FINGER PROTEIN 219; ZNF219
605037	KINESIN FAMILY MEMBER 17; KIF17
605038	POSTMEIOTIC SEGREGATION INCREASED 2-LIKE 1; PMS2L1
605039	BOHRING-OPITZ SYNDROME; BOPS
605040	CLAVICULAR HYPOPLASIA, ZYGOMATIC ARCH HYPOPLASIA, AND MICROGNATHIA
605041	BROOKE-SPIEGLER SYNDROME; BRSS
605042	MEDIATOR COMPLEX SUBUNIT 23; MED23
605043	MEDIATOR COMPLEX SUBUNIT 26; MED26
605044	MEDIATOR COMPLEX SUBUNIT 27; MED27
605045	MEDIATOR COMPLEX SUBUNIT 7; MED7
605046	UBIQUILIN 1; UBQLN1
605047	INTERFERON REGULATORY FACTOR 7; IRF7
605048	INHIBITOR OF NUCLEAR FACTOR KAPPA-B KINASE, SUBUNIT EPSILON; IKBKE
605049	TWISTED GASTRULATION BMP MODULATOR 1; TWSG1
605050	MOVED TO 142750
605051	CANNABINOID RECEPTOR 2; CNR2
605052	TAR RNA-BINDING PROTEIN 1; TARBP1
605053	TAR RNA-BINDING PROTEIN 2; TARBP2
605054	SMALL EDRK-RICH FACTOR 2; SERF2
605055	ALZHEIMER DISEASE, FAMILIAL EARLY-ONSET, WITH COEXISTING AMYLOID AND PRION PATHOLOGY
605056	WASP-LIKE ACTIN NUCLEATION-PROMOTING FACTOR; WASL
605057	TRANSLOCASE OF INNER MITOCHONDRIAL MEMBRANE 17A; TIMM17A
605058	TRANSLOCASE OF INNER MITOCHONDRIAL MEMBRANE 44; TIMM44
605059	MOVED TO 123930
605060	SEDOHEPTULOKINASE; SHPK
605061	TERF2-INTERACTING PROTEIN; TERF2IP
605062	TASTE RECEPTOR, TYPE 2, MEMBER 5; TAS2R5
605063	STRESS-INDUCED PHOSPHOPROTEIN 1; STIP1
605064	KINESIN FAMILY MEMBER 23; KIF23
605065	CELL DIVISION CYCLE 37, HSP90 COCHAPERONE; CDC37
605066	TYROSINE 3-MONOOXYGENASE/TRYPTOPHAN 5-MONOOXYGENASE ACTIVATION PROTEIN, EPSILON ISOFORM; YWHAE
605067	TRICUSPID ATRESIA
605068	WASP PROTEIN FAMILY, MEMBER 3; WASF3
605069	MITOGEN-ACTIVATED PROTEIN KINASE-INTERACTING SERINE/THREONINE KINASE 2; MKNK2
605070	EARLY ENDOSOME ANTIGEN 1; EEA1
605071	REGULATOR OF G PROTEIN SIGNALING 19; RGS19
605072	GIPC PDZ DOMAIN-CONTAINING FAMILY, MEMBER 1; GIPC1
605073	TRIPARTITE MOTIF-CONTAINING PROTEIN 37; TRIM37
605074	RENAL CELL CARCINOMA, PAPILLARY, 1; RCCP1
605075	MOVED TO 605074
605076	SMALL NUCLEAR RNA-ACTIVATING PROTEIN COMPLEX, POLYPEPTIDE 2; SNAPC2
605077	DNMT1-ASSOCIATED PROTEIN 1; DNMAP1
605078	TAR DNA-BINDING PROTEIN; TARDBP
605079	SAL-LIKE 3; SALL3
605080	CYCLIC NUCLEOTIDE-GATED CHANNEL, BETA-3; CNGB3
605081	CYTOHESIN 3; CYTH3
605082	RAS ASSOCIATION DOMAIN FAMILY PROTEIN 1; RASSF1
605083	FRIZZLED-RELATED PROTEIN; FRZB
605084	MITOCHONDRIAL CALCIUM UPTAKE PROTEIN 1; MICU1
605085	TRIGGERING RECEPTOR EXPRESSED ON MYELOID CELLS 1; TREM1
605086	TRIGGERING RECEPTOR EXPRESSED ON MYELOID CELLS 2; TREM2
605087	PHOSPHATIDYLINOSITOL GLYCAN ANCHOR BIOSYNTHESIS CLASS K PROTEIN; PIGK
605088	MAJOR VAULT PROTEIN; MVP
605089	MITOCHONDRIAL RIBOSOMAL PROTEIN L40; MRPL40
605090	RETINOIC ACID RECEPTOR RESPONDER 1; RARRES1
605091	FYVE, RhoGEF, AND PH DOMAIN-CONTAINING PROTEIN 2; FGD2
605092	PHOSPHOLIPASE A AND ACYLTRANSFERASE 4; PLAAT4
605093	SH2B ADAPTOR PROTEIN 3; SH2B3
605094	STEAP2 METALLOREDUCTASE; STEAP2
605095	MOVED TO 605097
605096	ANOCTAMIN 7; ANO7
605097	SOLUTE CARRIER FAMILY 45, MEMBER 3; SLC45A3
605098	MOVED TO 604146
605099	MOVED TO 605097
605100	PROTEIN PHOSPHATASE, MAGNESIUM/MANGANESE-DEPENDENT, 1D; PPM1D
605101	TAK1-BINDING PROTEIN 2; TAB2
605102	MANNAN-BINDING LECTIN SERINE PROTEASE 2; MASP2
605103	NEUROMEDIN U; NMU
605104	RNA-BINDING FOX1 HOMOLOG 1; RBFOX1
605105	EARLY RESPONSE TO NEURAL INDUCTION GENE
605106	LYSOPHOSPHATIDIC ACID RECEPTOR 3; LPAR3
605107	ENDOTHELIAL DIFFERENTIATION-RELATED FACTOR 1; EDF1
605108	NEUROMEDIN U RECEPTOR 2; NMUR2
605109	HECT DOMAIN AND RCC1-LIKE DOMAIN 1; HERC1
605110	LYSOPHOSPHATIDIC ACID RECEPTOR 2; LPAR2
605111	SPHINGOSINE-1-PHOSPHATE RECEPTOR 2; S1PR2
605112	TROPOMODULIN 3; TMOD3
605113	ALPHA-AMINOADIPIC SEMIALDEHYDE SYNTHASE; AASS
605114	SPO11 INITIATOR OF MEIOTIC DOUBLE-STRANDED BREAKS; SPO11
605115	HYPERTENSION, EARLY-ONSET, AUTOSOMAL DOMINANT, WITH SEVERE EXACERBATION IN PREGNANCY
605116	CHOLINERGIC RECEPTOR, NEURONAL NICOTINIC, ALPHA POLYPEPTIDE 9; CHRNA9
605117	SUPPRESSOR OF CYTOKINE SIGNALING 2; SOCS2
605118	SUPPRESSOR OF CYTOKINE SIGNALING 6; SOCS6
605119	PROTEIN PHOSPHATASE, MAGNESIUM/MANGANESE-DEPENDENT, 1G; PPM1G
605120	GROWTH/DIFFERENTIATION FACTOR 2; GDF2
605121	RRN3 HOMOLOG, RNA POLYMERASE I TRANSCRIPTION FACTOR; RRN3
605122	SUV3-LIKE 1; SUPV3L1
605123	SERINE PEPTIDASE INHIBITOR, KUNITZ-TYPE, 1; SPINT1
605124	SERINE PEPTIDASE INHIBITOR, KUNITZ-TYPE, 2; SPINT2
605125	GABA-A RECEPTOR-ASSOCIATED PROTEIN; GABARAP
605126	FOUR-AND-A-HALF LIM DOMAINS 5; FHL5
605127	OPTICIN; OPTC
605128	GUANYLATE CYCLASE ACTIVATOR 1C; GUCA1C
605129	PROTEASOME ACTIVATOR SUBUNIT 3; PSME3
605130	WIEDEMANN-STEINER SYNDROME; WDSTS
605131	WW DOMAIN-CONTAINING OXIDOREDUCTASE; WWOX
605132	TLE FAMILY MEMBER 4, TRANSCRIPTIONAL COREPRESSOR; TLE4
605133	NUCLEAR CAP-BINDING PROTEIN 2; NCBP2
605134	PHOSPHATIDYLINOSITOL TRANSFER PROTEIN, CYTOPLASMIC, 1; PITPNC1
605135	MOVED TO 172100
605136	MOVED TO 604974
605137	MOVED TO 601297
605138	ORNITHINE DECARBOXYLASE ANTIZYME 3; OAZ3
605139	CHAPERONIN CONTAINING T-COMPLEX POLYPEPTIDE 1, SUBUNIT 2; CCT2
605140	CHAPERONIN CONTAINING T-COMPLEX POLYPEPTIDE 1, SUBUNIT 7; CCT7
605141	PRE-B-LYMPHOCYTE GENE 1; VPREB1
605142	CHAPERONIN CONTAINING T-COMPLEX POLYPEPTIDE 1, SUBUNIT 4; CCT4
605143	ACTIN-RELATED PROTEIN 1A; ACTR1A
605144	ACTIN-RELATED PROTEIN 1B; ACTR1B
605145	ANKH INORGANIC PYROPHOSPHATE TRANSPORT REGULATOR; ANKH
605146	SPHINGOSINE-1-PHOSPHATE RECEPTOR 5; S1PR5
605147	LEUKOCYTE CELL-DERIVED CHEMOTAXIN 1; LECT1
605148	UDP-N-ACETYL-ALPHA-D-GALACTOSAMINE:POLYPEPTIDE N-ACETYLGALACTOSAMINYLTRANSFERASE 6; GALNT6
605149	CHEMOKINE, CXC MOTIF, LIGAND 13; CXCL13
605150	MOVED TO 601297
605151	MOVED TO 604747
605152	CILIA- AND FLAGELLA-ASSOCIATED PROTEIN 45; CFAP45
605153	RECEPTOR ACTIVITY-MODIFYING PROTEIN 1; RAMP1
605154	RECEPTOR ACTIVITY-MODIFYING PROTEIN 2; RAMP2
605155	RECEPTOR ACTIVITY-MODIFYING PROTEIN 3; RAMP3
605156	MOVED TO 259600
605157	p53-RESPONSIVE GENE 1
605158	PEROXIDASIN; PXDN
605159	APOPTOSIS-INDUCING FACTOR, MITOCHONDRIA-ASSOCIATED, 2; AIFM2
605160	p53-RESPONSIVE GENE 4
605161	WAP 4-DISULFIDE CORE DOMAIN 5; WFDC5
605162	GADD45G-INTERACTING PROTEIN; GADD45GIP1
605163	CHEMOKINE, CXC MOTIF, RECEPTOR 6; CXCR6
605164	HISTONE DEACETYLASE 2; HDAC2
605165	ZINC FINGER PROTEIN 278; ZNF278
605166	HISTONE DEACETYLASE 3; HDAC3
605167	B MELANOMA ANTIGEN; BAGE
605168	FATTY ACID-BINDING PROTEIN 5; FABP5
605169	E74-LIKE ETS TRANSCRIPTION FACTOR 5; ELF5
605170	ETOPOSIDE-INDUCED 1.4 mRNA; EI24
605171	TUMOR PROTEIN p53-INDUCIBLE PROTEIN 3; TP53I3
605172	PROSTAGLANDIN E SYNTHASE; PTGES
605173	ECTODERMAL-NEURAL CORTEX 1; ENC1
605174	A DISINTEGRIN-LIKE AND METALLOPROTEINASE WITH THROMBOSPONDIN TYPE 1 MOTIF, 1; ADAMTS1
605175	A DISINTEGRIN-LIKE AND METALLOPROTEINASE WITH THROMBOSPONDIN TYPE 1 MOTIF, 8; ADAMTS8
605176	HYDROXYACID OXIDASE 2; HAO2
605177	REMOVED FROM DATABASE
605178	GROWTH ARREST-SPECIFIC 8; GAS8
605179	GAS8 ANTISENSE RNA 1, NONCODING; GAS8AS1
605180	SOLUTE CARRIER FAMILY 38 (AMINO ACID TRANSPORTER), MEMBER 2; SLC38A2
605181	TRANSMEMBRANE 7 SUPERFAMILY, MEMBER 3; TM7SF3
605182	RAS p21 PROTEIN ACTIVATOR 3; RASA3
605183	CALMODULIN-LIKE 5; CALML5
605184	POLYADENYLATE-BINDING PROTEIN-INTERACTING PROTEIN 1; PAIP1
605185	DELTA-LIKE CANONICAL NOTCH LIGAND 4; DLL4
605186	WNT INHIBITORY FACTOR 1; WIF1
605187	G PROTEIN-COUPLED RECEPTOR 27; GPR27
605188	G PROTEIN-COUPLED RECEPTOR 85; GPR85
605189	DICKKOPF WNT SIGNALING PATHWAY INHIBITOR 1; DKK1
605190	TRANSLOCATION-ASSOCIATING MEMBRANE PROTEIN 1; TRAM1
605191	BTAF1 RNA POLYMERASE II, B-TFIID TRANSCRIPTION FACTOR-ASSOCIATED, 170-KD;  BTAF1
605192	DEAFNESS, AUTOSOMAL DOMINANT 23; DFNA23
605193	DIRAS FAMILY, GTP-BINDING RAS-LIKE PROTEIN 3; DIRAS3
605194	CRYPTIC PROTEIN; CFC1
605195	MESODERM POSTERIOR BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTOR 2; MESP2
605196	COENZYME Q3, METHYLTRANSFERASE; COQ3
605197	KYNURENINASE; KYNU
605198	TERMINAL NUCLEOTIDYLTRANSFERASE 4A; TENT4A
605199	SPLICING FACTOR, PROLINE- AND GLUTAMINE-RICH; SFPQ
605200	HECT DOMAIN AND RCC1-LIKE DOMAIN 3; HERC3
605201	HIGH DENSITY LIPOPROTEIN CHOLESTEROL LEVEL QUANTITATIVE TRAIT LOCUS 14; HDLCQ14
605202	N-ACETYLNEURAMINIC ACID PHOSPHATE SYNTHASE; NANS
605203	MOVED TO 263650
605204	TORSIN 1A; TOR1A
605205	ADENYLATE CYCLASE 10; ADCY10
605206	HYPERPOLARIZATION-ACTIVATED CYCLIC NUCLEOTIDE-GATED POTASSIUM CHANNEL 4; HCN4
605207	CYTOCHROME P450, SUBFAMILY XXVIB, POLYPEPTIDE 1; CYP26B1
605208	SOLUTE CARRIER FAMILY 17 (VESICULAR GLUTAMATE COTRANSPORTER), MEMBER 7; SLC17A7
605209	CHECKPOINT PROTEIN WITH FHA AND RING FINGER DOMAINS; CHFR
605210	DISRUPTED IN SCHIZOPHRENIA 1; DISC1
605211	BARH-LIKE 1; BARHL1
605212	BARH-LIKE 2; BARHL2
605213	3-PHOSPHOINOSITIDE-DEPENDENT PROTEIN KINASE 1; PDPK1
605214	POTASSIUM CHANNEL, CALCIUM-ACTIVATED, LARGE CONDUCTANCE, SUBFAMILY M, BETA MEMBER 2; KCNMB2
605215	SRC KINASE-ASSOCIATED PHOSPHOPROTEIN 2; SKAP2
605216	RHO GUANINE NUCLEOTIDE EXCHANGE FACTOR 4; ARHGEF4
605217	SHC TRANSFORMING PROTEIN 2; SHC2
605218	SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO, 2; SLEB2
605219	DIRECT IAP-BINDING PROTEIN WITH LOW pI; DIABLO
605220	APOLIPOPROTEIN B RECEPTOR; APOBR
605221	SPLICING FACTOR, SERINE/ARGININE-RICH, 10; SRSF10
605222	POTASSIUM CHANNEL, CALCIUM-ACTIVATED, LARGE CONDUCTANCE, SUBFAMILY M, BETA MEMBER 3; KCNMB3
605223	POTASSIUM CHANNEL, CALCIUM-ACTIVATED, LARGE CONDUCTANCE, SUBFAMILY M, BETA MEMBER 4; KCNMB4
605224	RHODOPSIN HOMOLOG, RETINAL PIGMENT EPITHELIUM-DERIVED; RRH
605225	INFLAMMATORY BOWEL DISEASE 7; IBD7
605226	ARGININE-GLUTAMIC ACID DIPEPTIDE REPEATS; RERE
605227	REVERSION-INDUCING CYSTEINE-RICH PROTEIN WITH KAZAL MOTIFS; RECK
605228	COREPRESSOR INTERACTING WITH RBPJ, 1; CIR1
605229	SPASTIC PARAPLEGIA 14, AUTOSOMAL RECESSIVE; SPG14
605230	TUMOR PROTEIN p53-BINDING PROTEIN 1; TP53BP1
605231	BARDET-BIEDL SYNDROME 6; BBS6
605232	PROTEIN KINASE, LYSINE-DEFICIENT 1; WNK1
605233	DIANZANI AUTOIMMUNE LYMPHOPROLIFERATIVE DISEASE
605234	VOMERONASAL 1 RECEPTOR 1; VN1R1
605235	NUCLEOLAR PROTEIN 3; NOL3
605236	CORIN, SERINE PEPTIDASE; CORIN
605237	XENOTROPIC AND POLYTROPIC RETROVIRUS RECEPTOR; XPR1
605238	HISTAMINE N-METHYLTRANSFERASE; HNMT
605239	ATPase, H+ TRANSPORTING, LYSOSOMAL, V0 SUBUNIT A, ISOFORM 4; ATP6V0A4
605240	CHEMOKINE, CC MOTIF, LIGAND 28; CCL28
605241	LYMPHOCYTE ANTIGEN 86; LY86
605242	USH1 PROTEIN NETWORK COMPONENT HARMONIN; USH1C
605243	LYMPHOCYTE ANTIGEN 96; LY96
605244	CARNEY COMPLEX, TYPE 2; CNC2
605245	SOLUTE CARRIER FAMILY 2 (FACILITATED GLUCOSE TRANSPORTER), MEMBER 8; SLC2A8
605246	COMPLEMENT COMPONENT 3a RECEPTOR 1; C3AR1
605247	p53-INDUCED DEATH DOMAIN PROTEIN 1; PIDD1
605248	MUCOLIPIN 1; MCOLN1
605249	MOVED TO 155100
605250	ATP-BINDING CASSETTE, SUBFAMILY C, MEMBER 4; ABCC4
605251	ATP-BINDING CASSETTE, SUBFAMILY C, MEMBER 5; ABCC5
605252	POLYMERASE, DNA, IOTA; POLI
605253	NEUROPATHY, CONGENITAL HYPOMYELINATING, 1, AUTOSOMAL RECESSIVE; CHN1
605254	NICASTRIN; NCSTN
605255	ETS VARIANT TRANSCRIPTION FACTOR 7; ETV7
605256	RAD18 E3 UBIQUITIN PROTEIN LIGASE; RAD18
605257	ACTIVATION-INDUCED CYTIDINE DEAMINASE; AICDA
605258	IMMUNODEFICIENCY WITH HYPER-IgM, TYPE 2; HIGM2
605259	SPINOCEREBELLAR ATAXIA 13; SCA13
605260	MOVED TO 145900
605261	NADPH OXIDASE 4; NOX4
605262	NMYC DOWNSTREAM-REGULATED GENE 1; NDRG1
605263	SHC TRANSFORMING PROTEIN 3; SHC3
605264	SORBIN AND SH3-DOMAINS CONTAINING PROTEIN 1; SORBS1
605265	APOPTOSIS AND CASPASE ACTIVATION INHIBITOR; AVEN
605266	JUNCTOPHILIN 1; JPH1
605267	JUNCTOPHILIN 2; JPH2
605268	JUNCTOPHILIN 3; JPH3
605269	CORONIN 1C; CORO1C
605270	N-SULFOGLUCOSAMINE SULFOHYDROLASE; SGSH
605271	SERPIN PEPTIDASE INHIBITOR, CLADE A, MEMBER 10; SERPINA10
605272	NMYC DOWNSTREAM-REGULATED GENE 2; NDRG2
605273	NMYC DOWNSTREAM-REGULATED GENE 3; NDRG3
605274	MESOMELIC DYSPLASIA, SAVARIRAYAN TYPE
605275	NOONAN SYNDROME 2; NS2
605276	APOPTOSIS-ASSOCIATED TYROSINE KINASE; AATK
605277	GLUCOCORTICOID RECEPTOR DNA-BINDING FACTOR 1; GRLF1
605278	CARBOXYLESTERASE 2; CES2
605279	CARBOXYLESTERASE 3; CES3
605280	SPASTIC PARAPLEGIA 13, AUTOSOMAL DOMINANT; SPG13
605281	DEAD-BOX HELICASE 4; DDX4
605282	TEMTAMY PREAXIAL BRACHYDACTYLY SYNDROME; TPBS
605283	MAGE-LIKE 2; MAGEL2
605284	TSC COMPLEX SUBUNIT 1; TSC1
605285	NEUROPATHY, HEREDITARY MOTOR AND SENSORY, RUSSE TYPE; HMSNR
605286	CALPAIN 10; CAPN10
605287	ARGINYL AMINOPEPTIDASE-LIKE 1; RNPEPL1
605288	MOVED TO 273300
605289	SPLIT-HAND/FOOT MALFORMATION 4; SHFM4
605290	OPA1 MITOCHONDRIAL DYNAMIN-LIKE GTPase; OPA1
605291	MOVED TO 191720
605292	5-PRIME-NUCLEOTIDASE, MITOCHONDRIAL; NT5M
605293	OPTIC ATROPHY 4; OPA4
605294	CARBOHYDRATE SULFOTRANSFERASE 6; CHST6
605295	FIDGETIN; FIGN
605296	PROTEASOME ASSEMBLY CHAPERONE 1; PSMG1
605297	NEGATIVE ELONGATION FACTOR COMPLEX, MEMBER C/D; NELFCD
605298	VPS26 ENDOSOMAL PROTEIN-SORTING FACTOR C; VPS26C
605299	NUCLEAR RECEPTOR COACTIVATOR 6; NCOA6
605300	SH2B ADAPTOR PROTEIN 2; SH2B2
605301	TRANSFORMING, ACIDIC, COILED-COIL-CONTAINING PROTEIN 1; TACC1
605302	TRANSFORMING, ACIDIC, COILED-COIL-CONTAINING PROTEIN 2; TACC2
605303	TRANSFORMING, ACIDIC, COILED-COIL-CONTAINING PROTEIN 3; TACC3
605304	NEUROGLOBIN; NGB
605305	KILLER CELL IMMUNOGLOBULIN-LIKE RECEPTOR, TWO DOMAINS, LONG CYTOPLASMIC TAIL, 5A; KIR2DL5A
605306	C-TYPE LECTIN DOMAIN FAMILY 4, MEMBER A; CLEC4A
605307	ADRENOMEDULLIN RECEPTOR; ADMR
605308	ZINC FINGER PROTEIN 346; ZNF346
605309	MACROCEPHALY/AUTISM SYNDROME
605310	COILED-COIL ALPHA-HELICAL ROD PROTEIN 1; CCHCR1
605311	MOVED TO 601776
605312	GROWTH/DIFFERENTIATION FACTOR 15; GDF15
605313	RNA-BINDING MOTIF PROTEIN 8A; RBM8A
605314	HISTONE DEACETYLASE 4; HDAC4
605315	HISTONE DEACETYLASE 5; HDAC5
605316	MOVED TO 601072
605317	FORKHEAD BOX P2; FOXP2
605318	MOVED TO 600833
605319	6-PHOSPHOFRUCTO-2-KINASE/FRUCTOSE-2,6-BISPHOSPHATASE 3; PFKFB3
605320	6-PHOSPHOFRUCTO-2-KINASE/FRUCTOSE-2,6-BISPHOSPHATASE 4; PFKFB4
605321	FRONTOOCULAR SYNDROME
605322	WAP 4-DISULFIDE CORE DOMAIN 1; WFDC1
605323	C-TERMINAL DOMAIN OF RNA POLYMERASE II POLYPEPTIDE A, SMALL PHOSPHATASE OF, 1; CTDSP1
605324	AMYLOID BETA PRECURSOR PROTEIN-BINDING PROTEIN 2; APPBP2
605325	CYTOCHROME P450, SUBFAMILY IIIA, POLYPEPTIDE 5; CYP3A5
605326	TAX1-BINDING PROTEIN 1; TAX1BP1
605327	NUCLEAR FACTOR, INTERLEUKIN 3-REGULATED; NFIL3
605328	KRUPPEL-LIKE FACTOR 13; KLF13
605329	MOVED TO 605205
605330	INTERLEUKIN 22; IL22
605331	ERYTHROCYTE MEMBRANE PROTEIN BAND 4.1-LIKE 3; EPB41L3
605332	KELCH-LIKE 1; KLHL1
605333	PDS5 COHESIN-ASSOCIATED FACTOR B; PDS5B
605334	MOVED TO 300290
605335	PLECKSTRIN HOMOLOGY-LIKE DOMAIN, FAMILY A, MEMBER 1; PHLDA1
605336	COMPLEMENT FACTOR H-RELATED 3; CFHR3
605337	COMPLEMENT FACTOR H-RELATED 4; CFHR4
605338	INTERNEXIN, ALPHA; INA
605339	FMR1 AUTOSOMAL HOMOLOG 2; FXR2
605340	CYTOCHROME P450, SUBFAMILY IIIA, POLYPEPTIDE 7; CYP3A7
605341	PAIRED IMMUNOGLOBULIN-LIKE TYPE 2 RECEPTOR, ALPHA; PILRA
605342	PAIRED IMMUNOGLOBULIN-LIKE TYPE 2 RECEPTOR, BETA; PILRB
605343	FOLLISTATIN-LIKE 3; FSTL3
605344	NUCLEAR TRANSCRIPTION FACTOR Y, GAMMA; NFYC
605345	AlkB HOMOLOG 1, HISTONE H2A DIOXYGENASE; ALKBH1
605346	MOVED TO 176730
605347	PEPTIDYLARGININE DEIMINASE, TYPE IV; PADI4
605348	TRANSMEMBRANE PROTEIN 50A; TMEM50A
605349	NUCLEAR PRELAMIN A RECOGNITION FACTOR; NARF
605350	INTERLEUKIN 27 RECEPTOR, ALPHA; IL27RA
605351	FIBRINOGEN-LIKE 2; FGL2
605352	MALIGNANT FIBROUS HISTIOCYTOMA-AMPLIFIED SEQUENCE 1; MFHAS1
605353	GHRELIN; GHRL
605354	CASPASE RECRUITMENT DOMAIN-CONTAINING PROTEIN 18; CARD18
605355	NEMALINE MYOPATHY 5A, AUTOSOMAL RECESSIVE, SEVERE INFANTILE; NEM5A
605356	TYROSINE 3-MONOOXYGENASE/TRYPTOPHAN 5-MONOOXYGENASE ACTIVATION PROTEIN, GAMMA ISOFORM; YWHAG
605357	STONIN 1; STON1
605358	GENERAL TRANSCRIPTION FACTOR IIA, 1-LIKE; GTF2A1L
605359	PROLINE-RICH PROTEIN 4; PRR4
605360	COILED-COIL DOMAIN-CONTAINING PROTEIN 85B; CCDC85B
605361	SPINOCEREBELLAR ATAXIA 14; SCA14
605362	CARDIOMYOPATHY, DILATED, 1J; CMD1J
605363	GLUTAMATE DECARBOXYLASE 1; GAD1
605364	PSORIASIS 6, SUSCEPTIBILITY TO; PSORS6
605365	MOVED TO 114480
605366	OLFACTOMEDIN 1; OLFM1
605367	ELAC RIBONUCLEASE Z 2; ELAC2
605368	BCL2/ADENOVIRUS E1B 19-KD PROTEIN-INTERACTING PROTEIN 3-LIKE; BNIP3L
605369	TRANSMEMBRANE PROTEASE, SERINE 11D; TMPRSS11D
605370	RHO GTPase-ACTIVATING PROTEIN 26; ARHGAP26
605371	ADP-RIBOSYLATION FACTOR GUANINE NUCLEOTIDE EXCHANGE FACTOR 2; ARFGEF2
605372	HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN A3; HNRNPA3
605373	PHEOCHROMOCYTOMA/PARAGANGLIOMA SYNDROME 3; PPGL3
605374	MYCN, OPPOSITE STRAND; MYCNOS
605375	EPILEPSY, NOCTURNAL FRONTAL LOBE, 3; ENFL3
605376	HETEROTAXY, VISCERAL, 2, AUTOSOMAL; HTX2
605377	DYSTROPHIA MYOTONICA PROTEIN KINASE; DMPK
605378	ALADIN WD REPEAT NUCLEOPORIN; AAAS
605379	GIGAXONIN; GAN
605380	FIBROBLAST GROWTH FACTOR 23; FGF23
605381	RHESUS BLOOD GROUP, C GLYCOPROTEIN; RHCG
605382	MOVED TO 167320
605383	INTERLEUKIN 21 RECEPTOR; IL21R
605384	INTERLEUKIN 21; IL21
605385	PRENYL PROTEIN PROTEASE RCE1; RCE1
605386	MICRO RNA LET7A1; MIRLET7A1
605387	CATARACT 31, MULTIPLE TYPES; CTRCT31
605388	CEREBRAL PALSY, ATAXIC, AUTOSOMAL RECESSIVE
605389	HYPOTRICHOSIS 1; HYPT1
605390	LEUPAXIN; LPXN
605391	MULTIPLE INOSITOL POLYPHOSPHATE PHOSPHATASE 1; MINPP1
605392	FIBROBLAST GROWTH FACTOR RECEPTOR 1 ONCOGENE PARTNER; FGFR1OP
605393	LYSINE DEMETHYLASE 5B; KDM5B
605394	BTB AND CNC HOMOLOGY 2; BACH2
605395	TRANSMEMBRANE p24 TRAFFICKING PROTEIN 1; TMED1
605396	MOVED TO 604686
605397	CD226 ANTIGEN; CD226
605398	CHEMOKINE, CXC MOTIF, LIGAND 16; CXCL16
605399	NIDOGEN 2; NID2
605400	FIBROMATOSIS, GINGIVAL, WITH HYPERTRICHOSIS AND MENTAL RETARDATION
605401	IQ MOTIF-CONTAINING GTPase-ACTIVATING PROTEIN 2; IQGAP2
605402	CD274 MOLECULE; CD274
605403	TOLL-LIKE RECEPTOR 6; TLR6
605404	BCL2-RELATED OVARIAN KILLER; BOK
605405	USP6 N-TERMINAL-LIKE; USP6NL
605406	TRANSMEMBRANE p24 TRAFFICKING PROTEIN 10; TMED10
605407	SEGAWA SYNDROME, AUTOSOMAL RECESSIVE
605408	MOVED TO 159900
605409	TRANSCRIPTION ELONGATION REGULATOR 1; TCERG1
605410	POTASSIUM VOLTAGE-GATED CHANNEL, SHAL-RELATED SUBFAMILY, MEMBER 2; KCND2
605411	POTASSIUM VOLTAGE-GATED CHANNEL, SHAL-RELATED SUBFAMILY, MEMBER 3; KCND3
605412	RAB, MEMBER OF RAS ONCOGENE FAMILY-LIKE 2A; RABL2A
605413	RAB, MEMBER OF RAS ONCOGENE FAMILY-LIKE 2B; RABL2B
605414	ATP-BINDING CASSETTE, SUBFAMILY A, MEMBER 7; ABCA7
605415	DICKKOPF WNT SIGNALING PATHWAY INHIBITOR 2; DKK2
605416	DICKKOPF WNT SIGNALING PATHWAY INHIBITOR 3; DKK3
605417	DICKKOPF WNT SIGNALING PATHWAY INHIBITOR 4; DKK4
605418	DICKKOPF-LIKE 1; DKKL1
605419	SCHIZOPHRENIA 10; SCZD10
605420	ARISTALESS HOMEOBOX 4; ALX4
605421	A DISINTEGRIN-LIKE AND METALLOPROTEINASE WITH THROMBOSPONDIN TYPE 1 MOTIF, 9; ADAMTS9
605422	ZINC FINGER PROTEIN 350; ZNF350
605423	DESERT HEDGEHOG SIGNALING MOLECULE; DHH
605424	MASTERMIND-LIKE 1; MAML1
605425	GAP JUNCTION PROTEIN, BETA-4; GJB4
605426	TUMOR PROTEIN p53-REGULATED APOPTOSIS-INDUCING PROTEIN 1; TP53AIP1
605427	TRANSIENT RECEPTOR POTENTIAL CATION CHANNEL, SUBFAMILY V, MEMBER 4; TRPV4
605428	DEAFNESS, AUTOSOMAL RECESSIVE 26; DFNB26
605429	DEAFNESS, AUTOSOMAL RECESSIVE 26, MODIFIER OF; DFNB26M
605430	SPERM-ASSOCIATED ANTIGEN 9; SPAG9
605431	MITOGEN-ACTIVATED PROTEIN KINASE 8-INTERACTING PROTEIN 3; MAPK8IP3
605432	RADIOULNAR SYNOSTOSIS WITH AMEGAKARYOCYTIC THROMBOCYTOPENIA 1; RUSAT1
605433	KINESIN FAMILY MEMBER 13A; KIF13A
605434	CLASPIN; CLSPN
605435	PROTEIN KINASE D1; PRKD1
605436	SMALL NUCLEOLAR RNA, C/D BOX, 116-1; SNORD116-1
605437	PROTEIN KINASE C, ETA; PRKCH
605438	DISCS LARGE-ASSOCIATED PROTEIN 2; DLGAP2
605439	ETS HOMOLOGOUS FACTOR; EHF
605440	UBIQUILIN 4; UBQLN4
605441	ADIPOCYTE-, C1q-, AND COLLAGEN DOMAIN-CONTAINING; ADIPOQ
605442	WT1-ASSOCIATED PROTEIN; WTAP
605443	PCGEM1 PROSTATE-SPECIFIC TRANSCRIPT; PCGEM1
605444	RNA-BINDING MOTIF PROTEIN, X CHROMOSOME, LIKE 2; RBMXL2
605445	DISCS LARGE-ASSOCIATED PROTEIN 1; DLGAP1
605446	RETINITIS PIGMENTOSA GTPase REGULATOR-INTERACTING PROTEIN; RPGRIP1
605447	SMALL NUCLEOLAR RNA HOST GENE 32; SNHG32
605448	RUN DOMAIN-CONTAINING PROTEIN 3A; RUNDC3A
605449	GLUTATHIONE S-TRANSFERASE, ALPHA-3; GSTA3
605450	GLUTATHIONE S-TRANSFERASE, ALPHA-4; GSTA4
605451	p21 PROTEIN-ACTIVATED KINASE 4; PAK4
605452	ATP-BINDING CASSETTE, SUBFAMILY B, MEMBER 6; ABCB6
605453	ATP-BINDING CASSETTE, SUBFAMILY B, MEMBER 9; ABCB9
605454	ATP-BINDING CASSETTE, SUBFAMILY B, MEMBER 10; ABCB10
605455	RAS-ASSOCIATED PROTEIN RAB26; RAB26
605456	BET1 GOLGI VESICULAR MEMBRANE-TRAFFICKING PROTEIN; BET1
605457	INTERLEUKIN 22 RECEPTOR, ALPHA-1; IL22RA1
605458	INTERLEUKIN 17 RECEPTOR B; IL17RB
605459	ATP-BINDING CASSETTE, SUBFAMILY G, MEMBER 5; ABCG5
605460	ATP-BINDING CASSETTE, SUBFAMILY G, MEMBER 8; ABCG8
605461	INTERLEUKIN 17 RECEPTOR A; IL17RA
605462	BASAL CELL CARCINOMA, SUSCEPTIBILITY TO, 1; BCC1
605463	RADIATION SENSITIVITY/CHROMOSOME INSTABILITY SYNDROME, AUTOSOMAL DOMINANT
605464	ATP-BINDING CASSETTE, SUBFAMILY B, MEMBER 8; ABCB8
605465	ZINC FINGER PROTEIN 277; ZNF277
605466	SIGNAL REGULATORY PROTEIN, GAMMA; SIRPG
605467	ZINC FINGER PROTEIN 274; ZNF274
605468	CDC42 EFFECTOR PROTEIN 4; CDC42EP4
605469	LYSINE DEMETHYLASE 4C; KDM4C
605470	MATRIX METALLOPROTEINASE 26; MMP26
605471	ZINC FINGER FYVE TYPE-CONTAINING PROTEIN 1; ZFYVE1
605472	USHER SYNDROME, TYPE IIC; USH2C
605473	UBIQUILIN 3; UBQLN3
605474	TOLL-LIKE RECEPTOR 9; TLR9
605475	BAI1-ASSOCIATED PROTEIN 2; BAIAP2
605476	ARF GTPase-ACTIVATING PROTEIN WITH GTPase DOMAIN, ANKYRIN REPEAT, AND PLECKSTRIN HOMOLOGY DOMAIN 2; AGAP2
605477	RHO GUANINE NUCLEOTIDE EXCHANGE FACTOR 7; ARHGEF7
605478	SINGLE IMMUNOGLOBULIN DOMAIN-CONTAINING IL1R-RELATED PROTEIN; SIGIRR
605479	CHOLESTASIS, BENIGN RECURRENT INTRAHEPATIC, 2; BRIC2
605480	SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO, 3; SLEB3
605481	ABNORMAL SPINDLE-LIKE, MICROCEPHALY-ASSOCIATED; ASPM
605482	GLUTATHIONE S-TRANSFERASE, OMEGA-1; GSTO1
605483	DYNEIN, AXONEMAL, INTERMEDIATE CHAIN 2; DNAI2
605484	Fc FRAGMENT OF IgA AND IgM, RECEPTOR FOR; FCAMR
605485	VPS41 SUBUNIT OF HOPS COMPLEX; VPS41
605486	MOVED TO 605313
605487	cAMP-REGULATED PHOSPHOPROTEIN 19; ARPP19
605488	cAMP-REGULATED PHOSPHOPROTEIN 21; ARPP21
605489	INTRAFLAGELLAR TRANSPORT 81; IFT81
605490	LON PEPTIDASE 1, MITOCHONDRIAL; LONP1
605491	NEBULETTE; NEBL
605492	LEUCINE-RICH REPEAT PROTEIN, NEURONAL, 2; LRRN2
605493	TRIPARTITE MOTIF-CONTAINING PROTEIN 3; TRIM3
605494	INTEGRIN, BETA-3, BINDING PROTEIN OF; ITGB3BP
605495	SOLUTE CARRIER ORGANIC ANION TRANSPORTER FAMILY, MEMBER 1B3; SLCO1B3
605496	CENTROSOMAL PROTEIN 1; CEP1
605497	CARTILAGE-ASSOCIATED PROTEIN; CRTAP
605498	M-PHASE PHOSPHOPROTEIN 1; MPHOSPH1
605499	ZW10 INTERACTOR, ANTISENSE; ZWINTAS
605500	M-PHASE PHOSPHOPROTEIN 6; MPHOSPH6
605501	M-PHASE PHOSPHOPROTEIN 9; MPHOSPH9
605502	DNAJ/HSP40 HOMOLOG, SUBFAMILY C, MEMBER 2; DNAJC2
605503	M-PHASE PHOSPHOPROTEIN 10; MPHOSPH10
605504	KALLIKREIN-RELATED PEPTIDASE 9; KLK9
605505	KALLIKREIN-RELATED PEPTIDASE 13; KLK13
605506	VPS26 RETROMER COMPLEX COMPONENT A; VPS26A
605507	INTERLEUKIN 36 RECEPTOR ANTAGONIST; IL36RN
605508	INTERLEUKIN 36, BETA; IL36B
605509	INTERLEUKIN 36, ALPHA; IL36A
605510	INTERLEUKIN 37; IL37
605511	TRANSMEMBRANE PROTEASE, SERINE 3; TMPRSS3
605512	ELONGATION OF VERY LONG CHAIN FATTY ACIDS-LIKE 4; ELOVL4
605513	MELAN A; MLANA
605514	PROTOCADHERIN 15; PCDH15
605515	FORKHEAD BOX P1; FOXP1
605516	CADHERIN 23; CDH23
605517	BETA-1,4-GLUCURONYLTRANSFERASE 1; B4GAT1
605518	LIPIN 1; LPIN1
605519	LIPIN 2; LPIN2
605520	LIPIN 3; LPIN3
605521	TATA BOX-BINDING PROTEIN-LIKE PROTEIN 1; TBPL1
605522	LIMB DEVELOPMENT MEMBRANE PROTEIN 1; LMBR1
605523	TRANSDUCER OF ERBB2, 1; TOB1
605524	MOVED TO 164874
605525	CHROMATIN LICENSING AND DNA REPLICATION FACTOR 1; CDT1
605526	ALZHEIMER DISEASE 6
605527	METHIONINE ADENOSYLTRANSFERASE II, BETA; MAT2B
605528	NEURAMINIDASE 2; NEU2
605529	UPF2 REGULATOR OF NONSENSE-MEDIATED mRNA DECAY; UPF2
605530	UPF3A REGULATOR OF NONSENSE-MEDIATED mRNA DECAY; UPF3A
605531	MOVED TO 300298
605532	SMAD-SPECIFIC E3 UBIQUITIN PROTEIN LIGASE 2; SMURF2
605533	NEUREGULIN 3; NRG3
605534	HIGH MOBILITY GROUP PROTEIN 20A; HMG20A
605535	HIGH MOBILITY GROUP PROTEIN 20B; HMG20B
605536	RAB11 FAMILY-INTERACTING PROTEIN 5; RAB11FIP5
605537	ACTIVATING TRANSCRIPTION FACTOR 6; ATF6
605538	NEUROTENSIN RECEPTOR 2; NTSR2
605539	KALLIKREIN-RELATED PEPTIDASE 12; KLK12
605540	TERMINAL NUCLEOTIDYLTRANSFERASE 4B; TENT4B
605541	VAV GUANINE NUCLEOTIDE EXCHANGE FACTOR 3; VAV3
605542	INTERLEUKIN 36, GAMMA; IL36G
605543	PARKINSON DISEASE 4, AUTOSOMAL DOMINANT; PARK4
605544	FIBROMATOSIS, GINGIVAL, 2; GINGF2
605545	CD163 ANTIGEN; CD163
605546	GLYCOPROTEIN VI, PLATELET; GP6
605547	FOLLISTATIN-LIKE 1; FSTL1
605548	A DISINTEGRIN AND METALLOPROTEINASE DOMAIN 15; ADAM15
605549	CONE-ROD DYSTROPHY 8; CORD8
605550	RAS PROTEIN, DEXAMETHASONE-INDUCED, 1; RASD1
605551	NITRIC OXIDE SYNTHASE 1 (NEURONAL) ADAPTOR PROTEIN; NOS1AP
605552	ABDOMINAL OBESITY-METABOLIC SYNDROME 1; AOMS1
605553	POLY(A) POLYMERASE, ALPHA; PAPOLA
605554	CD244 ANTIGEN; CD244
605555	ARYL HYDROCARBON RECEPTOR-INTERACTING PROTEIN; AIP
605556	SOLUTE CARRIER FAMILY 4 (SODIUM BICARBONATE TRANSPORTER-LIKE), MEMBER 10; SLC4A10
605557	PR DOMAIN-CONTAINING PROTEIN 16; PRDM16
605558	FIBROBLAST GROWTH FACTOR 20; FGF20
605559	HOMEOBOX C11; HOXC11
605560	HOMEOBOX C10; HOXC10
605561	PLAKOPHILIN 3; PKP3
605562	SECRETOGLOBIN, FAMILY 2A, MEMBER 2; SCGB2A2
605563	CALCIUM-BINDING PROTEIN 1; CABP1
605564	CALCIUM- AND INTEGRIN-BINDING PROTEIN 2; CIB2
605565	RESISTIN; RETN
605566	RETICULON 4 RECEPTOR; RTN4R
605567	SIVA APOPTOSIS-INDUCING FACTOR 1; SIVA1
605568	SMAD-SPECIFIC E3 UBIQUITIN PROTEIN LIGASE 1; SMURF1
605569	G PROTEIN-COUPLED RECEPTOR 83; GPR83
605570	RAS-ASSOCIATED PROTEIN RAB11A; RAB11A
605571	PIWI-LIKE RNA-MEDIATED GENE SILENCING 1; PIWIL1
605572	ABDOMINAL OBESITY-METABOLIC SYNDROME QUANTITATIVE TRAIT LOCUS 2
605573	17-BETA HYDROXYSTEROID DEHYDROGENASE III; HSD17B3
605574	UBIQUITIN-CONJUGATING ENZYME E2 C; UBE2C
605575	STRUCTURAL MAINTENANCE OF CHROMOSOMES 4; SMC4
605576	STRUCTURAL MAINTENANCE OF CHROMOSOMES 2; SMC2
605577	RAS GUANYL NUCLEOTIDE-RELEASING PROTEIN 2; RASGRP2
605578	INTERFERON-INDUCED TRANSMEMBRANE PROTEIN 2; IFITM2
605579	INTERFERON-INDUCED TRANSMEMBRANE PROTEIN 3; IFITM3
605580	INTERLEUKIN 23-ALPHA; IL23A
605581	BETA-1,3-N-ACETYLGLUCOSYAMINYLTRANSFERASE 2; B3GNT2
605582	CARDIOMYOPATHY, DILATED, 1K; CMD1K
605583	DEAFNESS, AUTOSOMAL DOMINANT 25; DFNA25
605584	DEAH-BOX HELICASE 38; DHX38
605585	CELL DIVISION CYCLE 40; CDC40
605586	IMPORTIN 7; IPO7
605587	PROTEASE INHIBITOR 14; PI14
605588	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2B1; CMT2B1
605589	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2B2; CMT2B2
605590	SPLICING FACTOR 3B, SUBUNIT 1; SF3B1
605591	SPLICING FACTOR 3B, SUBUNIT 2; SF3B2
605592	SPLICING FACTOR 3B, SUBUNIT 3; SF3B3
605593	SPLICING FACTOR 3B, SUBUNIT 4; SF3B4
605594	DEAFNESS, AUTOSOMAL DOMINANT 39, WITH DENTINOGENESIS IMPERFECTA 1
605595	SPLICING FACTOR 3A, SUBUNIT 1; SF3A1
605596	SPLICING FACTOR 3A, SUBUNIT 3; SF3A3
605597	FORKHEAD TRANSCRIPTION FACTOR FOXL2; FOXL2
605598	TYPE 1 DIABETES MELLITUS 18; T1D18
605599	LYSOPHOSPHOLIPASE I; LYPLA1
605600	IMPORTIN 8; IPO8
605601	PROTEOGLYCAN 2; PRG2
605602	MYOZENIN 2; MYOZ2
605603	MYOZENIN 1; MYOZ1
605604	POLYADENYLATE-BINDING PROTEIN-INTERACTING PROTEIN 2; PAIP2
605605	MOVED TO 605535
605606	PSORIASIS 7, SUSCEPTIBILITY TO; PSORS7
605607	CENTROMERIC PROTEIN H; CENPH
605608	CLAUDIN 14; CLDN14
605609	OXIDATION RESISTANCE 1; OXR1
605610	POLYNUCLEOTIDE KINASE 3-PRIME PHOSPHATASE; PNKP
605611	SH3 DOMAIN-BINDING PROTEIN 4; SH3BP4
605612	SH3 DOMAIN-BINDING PROTEIN 5; SH3BP5
605613	HUNTINGTIN-INTERACTING PROTEIN 1-RELATED PROTEIN; HIP1R
605614	GCN1 ACTIVATOR OF EIF2AK4; GCN1
605615	ARIADNE RBR E3 UBIQUITIN PROTEIN LIGASE 2; ARIH2
605616	SOLUTE CARRIER FAMILY 6 (PROLINE IMINO TRANSPORTER), MEMBER 20; SLC6A20
605617	MOVED TO 220600
605618	TETRALOGY OF FALLOT SYNDROME, AUTOSOMAL RECESSIVE
605619	INTERLEUKIN 20; IL20
605620	INTERLEUKIN 20 RECEPTOR, ALPHA; IL20RA
605621	INTERLEUKIN 20 RECEPTOR, BETA; IL20RB
605622	PROTOCADHERIN 12; PCDH12
605623	MUSKELIN 1; MKLN1
605624	ARIADNE RBR E3 UBIQUITIN PROTEIN LIGASE 1; ARIH1
605625	MYELOMA OVEREXPRESSED GENE; MYEOV
605626	ENDOGENOUS RETROVIRUS GROUP K, MEMBER 6; ERVK-6
605627	CEREBROOCULONASAL SYNDROME
605628	HIV-1 TAT-INTERACTING PROTEIN 2, 30-KD; HTATIP2
605629	CITRON RHO-INTERACTING SERINE/THREONINE KINASE; CIT
605630	PHOSPHOLIPASE A2, GROUP IID; PLA2G2D
605631	NAPSIN A; NAPSA
605632	SOLUTE CARRIER FAMILY 35 (UDP-N-ACETYLGLUCOSAMINE TRANSPORTER), MEMBER 3; SLC35A3
605633	MUCIN 3B, INTESTINAL; MUC3B
605634	SOLUTE CARRIER FAMILY 35 (CMP-SIALIC ACID TRANSPORTER), MEMBER 1; SLC35A1
605635	HYPERALDOSTERONISM, FAMILIAL, TYPE II; HALD2
605636	MATERNALLY EXPRESSED GENE 3; MEG3
605637	CONGENITAL MYOPATHY 6 WITH OPHTHALMOPLEGIA; CMYP6
605638	BACULOVIRAL IAP REPEAT-CONTAINING PROTEIN 6; BIRC6
605639	SIALIC ACID-BINDING IMMUNOGLOBULIN-LIKE LECTIN 8; SIGLEC8
605640	SIALIC ACID-BINDING IMMUNOGLOBULIN-LIKE LECTIN 9; SIGLEC9
605641	SOLUTE CARRIER FAMILY 7 (CATIONIC AMINO ACID TRANSPORTER, y+ SYSTEM), MEMBER 6; SLC7A6
605642	THYROID CARCINOMA, PAPILLARY, WITH PAPILLARY RENAL NEOPLASIA
605643	KALLIKREIN-RELATED PEPTIDASE 5; KLK5
605644	KALLIKREIN-RELATED PEPTIDASE 8; KLK8
605645	RESISTIN-LIKE PROTEIN, BETA; RETNLB
605646	SOLUTE CARRIER FAMILY 26, MEMBER 4; SLC26A4
605647	F-BOX ONLY PROTEIN 6; FBXO6
605648	F-BOX ONLY PROTEIN 7; FBXO7
605649	F-BOX ONLY PROTEIN 8; FBXO8
605650	POLYMERASE, DNA, KAPPA; POLK
605651	F-BOX AND WD40 DOMAIN PROTEIN 11; FBXW11
605652	F-BOX AND LEUCINE-RICH REPEAT PROTEIN 2; FBXL2
605653	F-BOX AND LEUCINE-RICH REPEAT PROTEIN 3; FBXL3
605654	F-BOX AND LEUCINE-RICH REPEAT PROTEIN 4; FBXL4
605655	F-BOX AND LEUCINE-RICH REPEAT PROTEIN 5; FBXL5
605656	F-BOX AND LEUCINE-RICH REPEAT PROTEIN 7; FBXL7
605657	LYSINE DEMETHYLASE 2A; KDM2A
605658	INTERLEUKIN 25; IL25
605659	C-TYPE LECTIN DOMAIN FAMILY 2, MEMBER D; CLEC2D
605660	PREFOLDIN 6; PFDN6
605661	TRIPARTITE MOTIF-CONTAINING PROTEIN 13; TRIM13
605662	RAS-ASSOCIATED PROTEIN RAB36; RAB36
605663	RADIAL SPOKE HEAD 14 HOMOLOG; RSPH14
605664	KINESIN FAMILY MEMBER 20A; KIF20A
605665	MOVED TO 600582
605666	CYSTEINYL LEUKOTRIENE RECEPTOR 2; CYSLTR2
605667	RAL GUANINE NUCLEOTIDE DISSOCIATION STIMULATOR-LIKE 1; RGL1
605668	BETA-SITE AMYLOID BETA A4 PRECURSOR PROTEIN-CLEAVING ENZYME 2; BACE2
605669	PROSTATE AND BREAST CANCER OVEREXPRESSED 1; PBOV1
605670	LATE-ONSET RETINAL DEGENERATION; LORD
605671	DMX-LIKE 1; DMXL1
605672	CEREBELLAR ATAXIA AND HYPERGONADOTROPIC HYPOGONADISM
605673	B-CELL ANTIPROLIFERATION FACTOR 4; BTG4
605674	B-CELL ANTIPROLIFERATION FACTOR 3; BTG3
605675	RING FINGER PROTEIN 14; RNF14
605676	CARDIOMYOPATHY, DILATED, WITH WOOLLY HAIR AND KERATODERMA; DCWHK
605677	ACYL-CoA SYNTHETASE LONG CHAIN FAMILY, MEMBER 5; ACSL5
605678	MLX-INTERACTING PROTEIN-LIKE; MLXIPL
605679	INTERLEUKIN 26; IL26
605680	BROMODOMAIN ADJACENT TO ZINC FINGER DOMAIN, 1A; BAZ1A
605681	BROMODOMAIN ADJACENT TO ZINC FINGER DOMAIN, 1B; BAZ1B
605682	BROMODOMAIN ADJACENT TO ZINC FINGER DOMAIN, 2A; BAZ2A
605683	BROMODOMAIN ADJACENT TO ZINC FINGER DOMAIN, 2B; BAZ2B
605684	TRIPARTITE MOTIF-CONTAINING PROTEIN 34; TRIM34
605685	MOVED TO 216550
605686	CELL ADHESION MOLECULE 1; CADM1
605687	INTERLEUKIN 19; IL19
605688	COPINE VI; CPNE6
605689	COPINE VII; CPNE7
605690	BRD4-INTERACTING CHROMATIN REMODELING COMPLEX-ASSOCIATED PROTEIN; BICRA
605691	RIBOSOME BIOGENESIS FACTOR NOP53; NOP53
605692	TRANSIENT RECEPTOR POTENTIAL CATION CHANNEL, SUBFAMILY M, MEMBER 7; TRPM7
605693	RAS-ASSOCIATED PROTEIN RAB30; RAB30
605694	RAS-ASSOCIATED PROTEIN RAB31; RAB31
605695	BIOGENESIS OF LYSOSOME-RELATED ORGANELLES COMPLEX 1, SUBUNIT 4; BLOC1S4
605696	POTASSIUM CHANNEL, VOLTAGE-GATED, SUBFAMILY G, MEMBER 2; KCNG2
605697	UL16-BINDING PROTEIN 1; ULBP1
605698	UL16-BINDING PROTEIN 2; ULBP2
605699	UL16-BINDING PROTEIN 3; ULBP3
605700	TRIPARTITE MOTIF-CONTAINING PROTEIN 39; TRIM39
605701	TRIPARTITE MOTIF-CONTAINING PROTEIN 10; TRIM10
605702	LYMPHATIC VESSEL ENDOTHELIAL HYALURONAN RECEPTOR 1; LYVE1
605703	VAMP-ASSOCIATED PROTEIN A; VAPA
605704	VAMP-ASSOCIATED PROTEIN B AND C; VAPB
605705	SALT-INDUCIBLE KINASE 1; SIK1
605706	RECEPTOR-INTERACTING SERINE-THREONINE KINASE 4; RIPK4
605707	MOVED TO 604985
605708	RHO GUANINE NUCLEOTIDE EXCHANGE FACTOR 11; ARHGEF11
605709	ADP-RIBOSYLATION FACTOR-LIKE GTPase 6-INTERACTING PROTEIN 5; ARL6IP5
605710	GDNF FAMILY RECEPTOR ALPHA-3; GFRA3
605711	MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 1; MMDS1
605712	SERINE PALMITOYLTRANSFERASE, LONG-CHAIN BASE SUBUNIT 1; SPTLC1
605713	SERINE PALMITOYLTRANSFERASE, LONG-CHAIN BASE SUBUNIT 2; SPTLC2
605714	CEREBRAL AMYLOID ANGIOPATHY, APP-RELATED
605715	CD276 ANTIGEN; CD276
605716	POTASSIUM CHANNEL, VOLTAGE-GATED, SUBFAMILY H, MEMBER 5; KCNH5
605717	INDUCIBLE T-CELL COSTIMULATOR LIGAND; ICOSLG
605718	MEDIATOR COMPLEX SUBUNIT 4; MED4
605719	LINKER FOR ACTIVATION OF T CELLS FAMILY, MEMBER 2; LAT2
605720	POTASSIUM CHANNEL, SUBFAMILY K, MEMBER 4; KCNK4
605721	JUNCTION ADHESION MOLECULE 1; JAM1
605722	POTASSIUM CHANNEL, INWARDLY RECTIFYING, SUBFAMILY J, MEMBER 16; KCNJ16
605723	PROGRAMMED CELL DEATH 1 LIGAND 2; PDCD1LG2
605724	FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1
605725	PERIAXIN; PRX
605726	NEURONOPATHY, DISTAL HEREDITARY MOTOR, AUTOSOMAL RECESSIVE 2; HMNR2
605727	OTOSCLEROSIS 2; OTSC2
605728	CATARACT 25; CTRCT25
605729	AT-HOOK TRANSCRIPTION FACTOR AKNA; AKNA
605730	SPERM-ASSOCIATED ANTIGEN 6; SPAG6
605731	SPERM-ASSOCIATED ANTIGEN 8; SPAG8
605732	TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY, MEMBER 21; TNFRSF21
605733	PRELI DOMAIN-CONTAINING PROTEIN 1; PRELID1
605734	TRANSMEMBRANE PROTEIN WITH EGF-LIKE AND 2 FOLLISTATIN-LIKE DOMAINS 2; TMEFF2
605735	BLEEDING DISORDER, PLATELET-TYPE, 12; BDPLT12
605736	UBIQUITIN-ASSOCIATED AND SH3 DOMAIN-CONTAINING PROTEIN A; UBASH3A
605737	BACULOVIRAL IAP REPEAT-CONTAINING PROTEIN 7; BIRC7
605738	MICROPHTHALMIA/COLOBOMA 2; MCOPCB2
605739	KYPHOSCOLIOSIS PEPTIDASE; KY
605740	SCLEROSTIN; SOST
605741	G PROTEIN-COUPLED RECEPTOR 183; GPR183
605742	TUBULIN, ALPHA-8; TUBA8
605743	HEDGEHOG ACYLTRANSFERASE; HHAT
605744	EXOSTOSIN-LIKE GLYCOSYLTRANSFERASE 3; EXTL3
605745	CYTOCHROME b REDUCTASE 1; CYBRD1
605746	ANISOMASTIA
605747	LOW DENSITY LIPOPROTEIN RECEPTOR ADAPTOR PROTEIN 1; LDLRAP1
605748	BETA-CAROTENE OXYGENASE 1; BCO1
605749	CATARACT 26, MULTIPLE TYPES; CTRCT26
605750	EXUDATIVE VITREORETINOPATHY 3; EVR3
605751	SEIZURES, BENIGN FAMILIAL INFANTILE, 2; BFIS2
605752	HID1 DOMAIN-CONTAINING PROTEIN 1; HID1
605753	SERINE PROTEASE INHIBITOR, KAZAL-TYPE, 2; SPINK2
605754	PHOSPHATIDYLINOSITOL GLYCAN ANCHOR BIOSYNTHESIS CLASS Q PROTEIN; PIGQ
605755	DOUBLECORTIN DOMAIN-CONTAINING PROTEIN 2; DCDC2
605756	OVARIAN DYSGENESIS, HYPERGONADOTROPIC, WITH SHORT STATURE AND RECURRENT METABOLIC ACIDOSIS
605757	PELOTA mRNA SURVEILLANCE AND RIBOSOME RESCUE FACTOR; PELO
605758	ANKYRIN REPEAT- AND SOCS BOX-CONTAINING PROTEIN 1; ASB1
605759	ANKYRIN REPEAT- AND SOCS BOX-CONTAINING PROTEIN 2; ASB2
605760	ANKYRIN REPEAT- AND SOCS BOX-CONTAINING PROTEIN 3; ASB3
605761	ANKYRIN REPEAT- AND SOCS BOX-CONTAINING PROTEIN 4; ASB4
605762	MOK PROTEIN KINASE; MOK
605763	SOLUTE CARRIER FAMILY 45, MEMBER 1; SLC45A1
605764	TYROSYL-DNA PHOSPHODIESTERASE 2; TDP2
605765	DELETED IN LYMPHOCYTIC LEUKEMIA 1; DLEU1
605766	DELETED IN LYMPHOCYTIC LEUKEMIA 2; DLEU2
605767	PHOSPHOPROTEIN ASSOCIATED WITH GLYCOSPHINGOLIPID-ENRICHED MICRODOMAINS 1; PAG1
605768	DUAL ADAPTOR OF PHOSPHOTYROSINE AND 3-PHOSPHOINOSITIDES 1
605769	TRIPARTITE MOTIF-CONTAINING PROTEIN 33; TRIM33
605770	ILVB-LIKE; ILVBL
605771	COX7A2-LIKE PROTEIN; COX7A2L
605772	ESTROGEN RECEPTOR-BINDING SITE-ASSOCIATED ANTIGEN, 9; EBAG9
605773	LEUKOTRIENE B4 RECEPTOR 2; LTB4R2
605774	KELCH-LIKE 2; KLHL2
605775	KELCH-LIKE 3; KLHL3
605776	FIBRINOGEN-LIKE 1; FGL1
605777	SPHINGOMYELIN PHOSPHODIESTERASE 3, NEUTRAL MEMBRANE; SMPD3
605778	NIF3-LIKE 1; NIF3L1
605779	NAIL DISORDER, NONSYNDROMIC CONGENITAL, 7; NDNC7
605780	PR DOMAIN-CONTAINING PROTEIN 4; PRDM4
605781	RAS HOMOLOG GENE FAMILY, MEMBER D; RHOD
605782	EUKARYOTIC TRANSLATION INITIATION FACTOR 5A2; EIF5A2
605783	BCAS2 PRE-mRNA PROCESSING FACTOR; BCAS2
605784	TWEETY FAMILY MEMBER 1; TTYH1
605785	TUBULIN, GAMMA-2; TUBG2
605786	RNA-BINDING MOTIF PROTEIN, SINGLE STRAND-INTERACTING, 3; RBMS3
605787	ANKYRIN REPEAT-CONTAINING PROTEIN, FAMILY A, MEMBER 2; ANKRA2
605788	MICROTUBULE-ASSOCIATED PROTEIN, RP/EB FAMILY, MEMBER 3; MAPRE3
605789	MICROTUBULE-ASSOCIATED PROTEIN, RP/EB FAMILY, MEMBER 2; MAPRE2
605790	SERINE/THREONINE KINASE 31; STK31
605791	TESTIS-EXPRESSED GENE 12; TEX12
605792	TESTIS-EXPRESSED GENE 14; TEX14
605793	RING FINGER PROTEIN 17; RNF17
605794	MOV10-LIKE RISC COMPLEX RNA HELICASE 1; MOV10L1
605795	TESTIS-EXPRESSED GENE 15; TEX15
605796	TUDOR DOMAIN-CONTAINING PROTEIN 1; TDRD1
605797	ANKYRIN REPEAT, SAM, AND BASIC LEUCINE ZIPPER DOMAIN-CONTAINING 1; ASZ1
605798	NEURAL PROLIFERATION, DIFFERENTIATION, AND CONTROL PROTEIN 1; NPDC1
605799	AMNION-ASSOCIATED TRANSMEMBRANE PROTEIN; AMN
605800	HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN U-LIKE 1; HNRNPUL1
605801	RALA-BINDING PROTEIN 1; RALBP1
605802	ZINC FINGER E BOX-BINDING HOMEOBOX 2; ZEB2
605803	DERMATITIS, ATOPIC, 2; ATOD2
605804	DERMATITIS, ATOPIC, 3; ATOD3
605805	DERMATITIS, ATOPIC, 4; ATOD4
605806	CADHERIN 7; CDH7
605807	CADHERIN 20; CDH20
605808	BIRDSHOT CHORIORETINOPATHY
605809	MYASTHENIC SYNDROME, CONGENITAL, 4A, SLOW-CHANNEL; CMS4A
605810	MITOCHONDRIAL RIBOSOMAL PROTEIN S22; MRPS22
605811	NTF2-LIKE EXPORT FACTOR 1; NXT1
605812	DEAD-BOX HELICASE 19B; DDX19B
605813	NUCLEAR TRANSPORT FACTOR 2; NUTF2
605814	CITRULLINEMIA, TYPE II, NEONATAL-ONSET
605815	NUCLEOPORIN, 62-KD; NUP62
605816	EPSTEIN-BARR VIRUS-INDUCED GENE 3; EBI3
605817	RECEPTOR-INTERACTING SERINE/THREONINE KINASE 3; RIPK3
605818	DEAFNESS, AUTOSOMAL RECESSIVE 27; DFNB27
605819	PESCADILLO RIBOSOMAL BIOGENESIS FACTOR 1; PES1
605820	NONAKA MYOPATHY; NM
605821	ALPHA-HEMOGLOBIN STABILIZING PROTEIN; AHSP
605822	SPONDYLOOCULAR SYNDROME; SOS
605823	POPEYE DOMAIN-CONTAINING PROTEIN 2; POPDC2
605824	POPEYE DOMAIN-CONTAINING PROTEIN 3; POPDC3
605825	HEME-BINDING PROTEIN 2; HEBP2
605826	HEME-BINDING PROTEIN 1; HEBP1
605827	BASALOID FOLLICULAR HAMARTOMA SYNDROME, GENERALIZED, AUTOSOMAL DOMINANT; GBFHS
605828	TRANSMEMBRANE CHANNEL-LIKE PROTEIN 6; TMC6
605829	TRANSMEMBRANE CHANNEL-LIKE PROTEIN 8; TMC8
605830	FIBROBLAST GROWTH FACTOR RECEPTOR-LIKE 1; FGFRL1
605831	FIBROBLAST GROWTH FACTOR 22; FGF22
605832	ACETYL-CoA SYNTHETASE SHORT CHAIN FAMILY, MEMBER 2; ACSS2
605833	BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS 2; BMND2
605834	TROPOMODULIN 4; TMOD4
605835	CELL MIGRATION-INDUCING HYALURONIDASE 2; CEMIP2
605836	UNC13 HOMOLOG B; UNC13B
605837	HECT DOMAIN AND RCC1-LIKE DOMAIN 2; HERC2
605838	BABY RATTLE PELVIS DYSPLASIA
605839	MOVED TO 150800
605840	RING FINGER PROTEIN 111; RNF111
605841	NARCOLEPSY 2, SUSCEPTIBILITY TO; NRCLP2
605842	TRANSDUCIN-BETA-LIKE 2; TBL2
605843	PEROXISOMAL TRANS-2-ENOYL-CoA REDUCTASE; PECR
605844	DERMATITIS, ATOPIC, 5; ATOD5
605845	DERMATITIS, ATOPIC, 6; ATOD6
605846	B-CELL CLL/LYMPHOMA 7B; BCL7B
605847	B-CELL CLL/LYMPHOMA 7C; BCL7C
605848	CASPASE 14, APOPTOSIS-RELATED CYSTEINE PROTEASE; CASP14
605849	DIMETHYLGLYCINE DEHYDROGENASE; DMGDH
605850	DIMETHYLGLYCINE DEHYDROGENASE DEFICIENCY; DMGDHD
605851	ISOPRENYLCYSTEINE CARBOXYLMETHYLTRANSFERASE; ICMT
605852	CYTOPLASMIC LINKER-ASSOCIATED PROTEIN 1; CLASP1
605853	CYTOPLASMIC LINKER-ASSOCIATED PROTEIN 2; CLASP2
605854	BCL2-BINDING COMPONENT 3; BBC3
605855	ATPase, PHOSPHOLIPID-TRANSPORTING, 10A; ATP10A
605856	SHORT STATURE, IMPAIRED INTELLECTUAL DEVELOPMENT, CALLOSAL AGENESIS, HEMINASAL HYPOPLASIA, MICROPHTHALMIA, AND ATYPICAL CLEFTING
605857	RAS HOMOLOG GENE FAMILY, MEMBER Q; RHOQ
605858	SCRATCH FAMILY TRANSCRIPTIONAL REPRESSOR 1; SCRT1
605859	ZINC FINGER- AND BTB DOMAIN-CONTAINING PROTEIN 32; ZBTB32
605860	RCAN FAMILY MEMBER 3; RCAN3
605861	CANOPY FGF SIGNALING REGULATOR 2; CNPY2
605862	RIBITOL XYLOSYLTRANSFERASE 1; RXYLT1
605863	BETA-1,3-N-ACETYLGLUCOSAMINYLTRANSFERASE 3; B3GNT3
605864	BETA-1,3-N-ACETYLGLUCOSAMINYLTRANSFERASE 4; B3GNT4
605865	TASTE RECEPTOR TYPE 1, MEMBER 3; TAS1R3
605866	ATPase, CLASS I, TYPE 8B, MEMBER 3; ATP8B3
605867	ATPase, CLASS I, TYPE 8B, MEMBER 2; ATP8B2
605868	ATPase, PHOSPHOLIPID TRANSPORTING, 11A; ATP11A
605869	ATPase, CLASS VI, TYPE 11B; ATP11B
605870	ATPase, CLASS I, TYPE 8A, MEMBER 2; ATP8A2
605871	MOVED TO 193090
605872	C-TYPE LECTIN DOMAIN FAMILY 4, MEMBER M; CLEC4M
605873	POTASSIUM CHANNEL, SUBFAMILY K, MEMBER 10; KCNK10
605874	POTASSIUM CHANNEL, SUBFAMILY K, MEMBER 9; KCNK9
605875	WASP PROTEIN FAMILY, MEMBER 2; WASF2
605876	Fc RECEPTOR-LIKE PROTEIN 4; FCRL4
605877	Fc RECEPTOR-LIKE PROTEIN 5; FCRL5
605878	ZINC FINGER- AND BTB DOMAIN-CONTAINING PROTEIN 7A; ZBTB7A
605879	POTASSIUM CHANNEL, CALCIUM-ACTIVATED, INTERMEDIATE/SMALL CONDUCTANCE, SUBFAMILY N, MEMBER 2; KCNN2
605880	LYSINE ACETYLTRANSFERASE 6B; KAT6B
605881	SOLUTE CARRIER FAMILY 35, MEMBER C1; SLC35C1
605882	BRCA1-INTERACTING PROTEIN 1; BRIP1
605883	LYSOSOME-ASSOCIATED MEMBRANE PROTEIN 3; LAMP3
605884	DYNEIN, AXONEMAL, HEAVY CHAIN 10; DNAH10
605885	SEMAPHORIN 6A; SEMA6A
605886	COMPLEMENT COMPONENT RECEPTOR 1-LIKE; CR1L
605887	MOVED TO 300357
605888	EH DOMAIN-CONTAINING 1; EHD1
605889	PDZ AND LIM DOMAIN PROTEIN 3; PDLIM3
605890	EH DOMAIN-CONTAINING 2; EHD2
605891	EH DOMAIN-CONTAINING 3; EHD3
605892	EH DOMAIN-CONTAINING 4; EHD4
605893	CDP-DIACYLGLYCEROL-INOSITOL 3-PHOSPHATIDYLTRANSFERASE; CDIPT
605894	EP300-INTERACTING INHIBITOR OF DIFFERENTIATION 1; EID1
605895	EUKARYOTIC TRANSLATION INITIATION FACTOR 4E FAMILY, MEMBER 2; EIF4E2
605896	ENDOTHELIN-CONVERTING ENZYME-LIKE 1; ECEL1
605897	UDP-GLUCOSE:GLYCOPROTEIN GLUCOSYLTRANSFERASE 1; UGGT1
605898	UDP-GLUCOSE:GLYCOPROTEIN GLUCOSYLTRANSFERASE 2; UGGT2
605899	GLYCINE ENCEPHALOPATHY 1; GCE1
605900	PDZ AND LIM DOMAIN PROTEIN 1; PDLIM1
605901	UROCORTIN III; UCN3
605902	UROCORTIN II; UCN2
605903	PDZ AND LIM DOMAIN PROTEIN 7; PDLIM7
605904	PDZ AND LIM DOMAIN PROTEIN 5; PDLIM5
605905	DCN1 DOMAIN-CONTAINING PROTEIN 1; DCUN1D1
605906	LIM DOMAIN-BINDING 3; LDB3
605907	ALG1 CHITOBIOSYLDIPHOSPHODOLICHOL BETA-MANNOSYLTRANSFERASE; ALG1
605908	MODULATOR OF VRAC CURRENT 1; MLC1
605909	PARKINSON DISEASE 6, AUTOSOMAL RECESSIVE EARLY-ONSET; PARK6
605910	ANGIOPOIETIN-LIKE 4; ANGPTL4
605911	3-HYDROXY-3-METHYLGLUTARYL-CoA SYNTHASE-2 DEFICIENCY; HMGCS2D
605912	MATRIX, EXTRACELLULAR, PHOSPHOGLYCOPROTEIN; MEPE
605913	BLEEDING DISORDER, EAST TEXAS TYPE
605914	TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY, MEMBER 12A; TNFRSF12A
605915	TRANSDUCIN-BETA-LIKE 3; TBL3
605916	SPECTRIN, BETA, NONERYTHROCYTIC, 5; SPTBN5
605917	TPX2 MICROTUBULE NUCLEATION FACTOR; TPX2
605918	SPONDIN 2; SPON2
605919	MOVED TO 300361
605920	STAUFEN DOUBLE-STRANDED RNA-BINDING PROTEIN 2; STAU2
605921	STROMAL INTERACTION MOLECULE 1; STIM1
605922	MYOINOSITOL MONOPHOSPHATASE 2; IMPA2
605923	SRY-BOX 8; SOX8
605924	WD REPEAT-CONTAINING PROTEIN 4; WDR4
605925	PERICENTRIN; PCNT
605926	PROTEIN INTERACTING WITH C KINASE 1; PICK1
605927	MDM2-BINDING PROTEIN; MDM2BP
605928	ADP-RIBOSYLATION FACTOR-INTERACTING PROTEIN 1; ARFIP1
605929	SORTING NEXIN 2; SNX2
605930	SORTING NEXIN 3; SNX3
605931	SORTING NEXIN 4; SNX4
605932	BETAINE-HOMOCYSTEINE METHYLTRANSFERASE 2; BHMT2
605933	DENDROCYTE-EXPRESSED 7-TRANSMEMBRANE PROTEIN; DCSTAMP
605934	HOLOPROSENCEPHALY 6; HPE6
605935	ARTHROPATHY, EROSIVE
605936	BRIDGING INTEGRATOR 2; BIN2
605937	SORTING NEXIN 5; SNX5
605938	PHOSPHATIDYLINOSITOL GLYCAN ANCHOR BIOSYNTHESIS CLASS P PROTEIN; PIGP
605939	PHOSPHOLIPASE C, DELTA-4; PLCD4
605940	BRAIN-ABUNDANT SIGNAL PROTEIN, MEMBRANE-ATTACHED, 1; BASP1
605941	SPLICEOSOME-ASSOCIATED FACTOR 1, RECRUITER OF U4/U6.U5 tri-snRNP; SART1
605942	DERMATAN SULFATE EPIMERASE; DSE
605943	GLYCEROPHOSPHODIESTER PHOSPHODIESTERASE 1; GDE1
605944	LIVER FIBROCYSTIC DISEASE AND POLYDACTYLY
605945	CRUMPLED HELICES AND SMALL MOUTH
605946	METAPHYSEAL DYSPLASIA, BRAUN-TINSCHERT TYPE
605947	PHOSPHATIDYLINOSITOL GLYCAN ANCHOR BIOSYNTHESIS CLASS L PROTEIN; PIGL
605948	G PROTEIN-COUPLED RECEPTOR, FAMILY C, GROUP 5, MEMBER B; GPRC5B
605949	G PROTEIN-COUPLED RECEPTOR, FAMILY C, GROUP 5, MEMBER C; GPRC5C
605950	RAS-ASSOCIATED PROTEIN RAB33B; RAB33B
605951	DOLICHYL-PHOSPHATE MANNOSYLTRANSFERASE 3; DPM3
605952	SORTING NEXIN 9; SNX9
605953	ARF GTPase-ACTIVATING PROTEIN WITH SH3 DOMAIN, ANKYRIN REPEAT, AND PH DOMAIN 1; ASAP1
605954	FETUIN B; FETUB
605955	NK6 HOMEOBOX 2; NKX6-2
605956	NUCLEOTIDE-BINDING OLIGOMERIZATION DOMAIN PROTEIN 2; NOD2
605957	MOVED TO 600965
605958	TRAF-INTERACTING PROTEIN; TRAIP
605959	HR44 ANTIGEN
605960	EXOSOME COMPONENT 10; EXOSC10
605961	PLEIOTROPIC REGULATOR 1; PLRG1
605962	RAB9 EFFECTOR PROTEIN WITH KELCH MOTIFS; RABEPK
605963	SORTING NEXIN 17; SNX17
605964	SORTING NEXIN 15; SNX15
605965	RAS AND RAB INTERACTOR 1; RIN1
605966	HEPATOCYTE NUCLEAR FACTOR 4-GAMMA; HNF4G
605967	ACROPECTORAL SYNDROME; ACRPS
605968	RET FINGER PROTEIN-LIKE 1; RFPL1
605969	RET FINGER PROTEIN-LIKE 2; RFPL2
605970	RET FINGER PROTEIN-LIKE 3; RFPL3
605971	RET FINGER PROTEIN-LIKE 3, ANTISENSE; RFPL3S
605972	RET FINGER PROTEIN-LIKE 1, ANTISENSE; RFPL1S
605973	DDB1- AND CUL4-ASSOCIATED FACTOR 7; DCAF7
605974	SLU7 HOMOLOG, SPLICING FACTOR; SLU7
605975	SERINE/ARGININE REPETITIVE MATRIX PROTEIN 1; SRRM1
605976	ZINC FINGER- AND BTB DOMAIN-CONTAINING PROTEIN 6; ZBTB6
605977	INNER MITOCHONDRIAL MEMBRANE PEPTIDASE, SUBUNIT 2; IMMP2L
605978	VACUOLAR PROTEIN SORTING 13 HOMOLOG A; VPS13A
605979	SMALL NUCLEAR RNA-ACTIVATING PROTEIN COMPLEX, POLYPEPTIDE 5; SNAPC5
605980	NUCLEOTIDE-BINDING OLIGOMERIZATION DOMAIN PROTEIN 1; NOD1
605981	UBIQUITIN-PROTEIN LIGASE E3 COMPONENT N-RECOGNIN 1; UBR1
605982	MOVED TO 194070
605983	PROTEIN PHOSPHATASE 2, STRUCTURAL/REGULATORY SUBUNIT A, ALPHA; PPP2R1A
605984	EMBRYONIC ECTODERM DEVELOPMENT; EED
605985	MOVED TO 300408
605986	SERINE/THREONINE KINASE RECEPTOR-ASSOCIATED PROTEIN; STRAP
605987	PROTEIN INHIBITOR OF ACTIVATED STAT3; PIAS3
605988	DNA CROSS-LINK REPAIR PROTEIN 1C; DCLRE1C
605989	PROTEIN INHIBITOR OF ACTIVATED STAT4; PIAS4
605990	NEPHROLITHIASIS, URIC ACID, SUSCEPTIBILITY TO
605991	NEURONAL GUANINE NUCLEOTIDE EXCHANGE FACTOR; NGEF
605992	LIM HOMEOBOX PROTEIN 5; LHX5
605993	PYRUVATE DEHYDROGENASE PHOSPHATASE CATALYTIC SUBUNIT 1; PDP1
605994	CYTOCHROME P450, FAMILY 39, SUBFAMILY A, POLYPEPTIDE 1; CYP39A1
605995	KINESIN FAMILY MEMBER 1B; KIF1B
605996	DECAPPING EXORIBONUCLEASE; DXO
605997	PROTEIN PHOSPHATASE 2, REGULATORY SUBUNIT B, GAMMA ISOFORM; PPP2R2C
605998	HCLS1-ASSOCIATED PROTEIN X1; HAX1
605999	C-TYPE LECTIN DOMAIN FAMILY 10, MEMBER A; CLEC10A
606000	BUTYROPHILIN-LIKE PROTEIN 2; BTNL2
606001	INTERLEUKIN 32; IL32
606002	SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE, WITH AXONAL NEUROPATHY 2; SCAN2
606003	TRANSALDOLASE DEFICIENCY; TALDOD
606004	GOLGI-ASSOCIATED, GAMMA-ADAPTIN EAR-CONTAINING, ARF-BINDING PROTEIN 1; GGA1
606005	GOLGI-ASSOCIATED, GAMMA-ADAPTIN EAR-CONTAINING, ARF-BINDING PROTEIN 2; GGA2
606006	GOLGI-ASSOCIATED, GAMMA-ADAPTIN EAR-CONTAINING, ARF-BINDING PROTEIN 3; GGA3
606007	POLYMERASE III, RNA, SUBUNIT K; POLR3K
606008	NATURAL KILLER CELL GROUP 7 SEQUENCE; NKG7
606009	DOUBLE HOMEOBOX PROTEIN 4; DUX4
606010	NUCLEAR RECEPTOR-BINDING PROTEIN 1; NRBP1
606011	V-SET AND IMMUNOGLOBULIN DOMAINS-CONTAINING PROTEIN 2; VSIG2
606012	DEAFNESS, AUTOSOMAL DOMINANT 18; DFNA18
606013	F-BOX ONLY PROTEIN 5; FBXO5
606014	ARISTALESS-LIKE HOMEOBOX 3; ALX3
606015	FAS APOPTOTIC INHIBITORY MOLECULE 3; FAIM3
606016	KELCH-LIKE ECH-ASSOCIATED PROTEIN 1; KEAP1
606017	POLYMERASE II, RNA, SUBUNIT D; POLR2D
606018	EGF-LIKE REPEATS- AND DISCOIDIN I-LIKE DOMAINS-CONTAINING PROTEIN 3; EDIL3
606019	EXOSOME COMPONENT 8; EXOSC8
606020	OPA-INTERACTING PROTEIN 5; OIP5
606021	PRAME NUCLEAR RECEPTOR TRANSCRIPTIONAL REGULATOR; PRAME
606022	NUDIX HYDROLASE 9; NUDT9
606023	POLYMERASE II, RNA, SUBUNIT H; POLR2H
606024	MOVED TO 604753
606025	ZINC FINGER- AND BTB DOMAIN-CONTAINING PROTEIN 20; ZBTB20
606026	NEGATIVE ELONGATION FACTOR COMPLEX, MEMBER A; NELFA
606027	CLEAVAGE AND POLYADENYLATION SPECIFICITY FACTOR 1; CPSF1
606028	CLEAVAGE AND POLYADENYLATION SPECIFICITY FACTOR 2; CPSF2
606029	CLEAVAGE AND POLYADENYLATION SPECIFICITY FACTOR 3; CPSF3
606030	ENHANCER OF mRNA DECAPPING 4; EDC4
606031	WD REPEAT-CONTAINING PROTEIN 6; WDR6
606032	SERINE/ARGININE REPETITIVE MATRIX PROTEIN 2; SRRM2
606033	POLYMERASE II, RNA, SUBUNIT K; POLR2K
606034	RIBONUCLEASE H2, SUBUNIT A; RNASEH2A
606035	FASTING INSULIN LEVEL QUANTITATIVE TRAIT LOCUS 1; FIQTL1
606036	ARYL HYDROCARBON RECEPTOR NUCLEAR TRANSLOCATOR 2; ARNT2
606037	CD96 ANTIGEN; CD96
606038	LYMPHOCYTE ANTIGEN 6 COMPLEX, LOCUS G6D; LY6G6D
606039	HYDROXYCARBOXYLIC ACID RECEPTOR 3; HCAR3
606040	WD REPEAT-CONTAINING PROTEIN 8; WDR8
606041	SPARC-LIKE PROTEIN 1; SPARCL1
606042	MYONEURIN; MYNN
606043	ZINC FINGER PROTEIN 331; ZNF331
606044	ZINC RIBBON DOMAIN-CONTAINING PROTEIN 2; ZNRD2
606045	INTRAFLAGELLAR TRANSPORT 122; IFT122
606046	SYNTAXIN 18; STX18
606047	LEUKOCYTE IMMUNOGLOBULIN-LIKE RECEPTOR, SUBFAMILY A, MEMBER 5; LILRA5
606048	MEMBRANE-BOUND O-ACETYLTRANSFERASE DOMAIN-CONTAINING PROTEIN 7; MBOAT7
606049	ACROMEGALOID FEATURES, OVERGROWTH, CLEFT PALATE, AND HERNIA
606050	UBIQUITIN D; UBD
606051	SECRETION-REGULATING GUANINE NUCLEOTIDE EXCHANGE FACTOR; SERGEF
606052	MOVED TO 607745
606053	INTELLECTUAL DEVELOPMENTAL DISORDER WITH AUTISM AND SPEECH DELAY; IDDAS
606054	PROPIONIC ACIDEMIA
606055	PHOSPHATIDYLCHOLINE TRANSFER PROTEIN; PCTP
606056	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIb; CDG2B
606057	RAP GUANINE NUCLEOTIDE EXCHANGE FACTOR 3; RAPGEF3
606058	RAP GUANINE NUCLEOTIDE EXCHANGE FACTOR; RAPGEF4
606059	PROTEIN KINASE, cAMP-DEPENDENT CATALYTIC, INHIBITOR ALPHA; PKIA
606060	DNAJ/HSP40 HOMOLOG, SUBFAMILY C, MEMBER 12; DNAJC12
606061	T-BOX TRANSCRIPTION FACTOR 20; TBX20
606062	STRUCTURAL MAINTENANCE OF CHROMOSOMES 3; SMC3
606063	EXONUCLEASE 1; EXO1
606064	CD248 ANTIGEN; CD248
606065	ATYPICAL CHEMOKINE RECEPTOR 4; ACKR4
606066	LIM HOMEOBOX GENE 9; LHX9
606067	OTORAPLIN; OTOR
606068	RETINITIS PIGMENTOSA 28; RP28
606069	HEMOCHROMATOSIS, TYPE 4; HFE4
606070	AMYOTROPHIC LATERAL SCLEROSIS 21; ALS21
606071	HEREDITARY MOTOR AND SENSORY NEUROPATHY, TYPE IIC; HMSN2C
606072	RIPPLING MUSCLE DISEASE 2; RMD2
606073	NADPH-DEPENDENT DIFLAVIN OXIDOREDUCTASE 1; NDOR1
606074	GLOBOSIDE ALPHA-1,3-N-ACETYLGALACTOSAMINYLTRANSFERASE; GBGT1
606075	TWINKLE mtDNA HELICASE; TWNK
606076	PHOSPHATIDYLINOSITOL 3-KINASE, REGULATORY SUBUNIT 3; PIK3R3
606077	RNA-BINDING MOTIF PROTEIN 15; RBM15
606078	MYOCARDIN-RELATED TRANSCRIPTION FACTOR A; MRTFA
606079	CD163 ANTIGEN-LIKE 1; CD163L1
606080	CHITINASE, ACIDIC; CHIA
606081	TRANSLOCASE OF OUTER MITOCHONDRIAL MEMBRANE 70; TOMM70
606082	GOITER, MULTINODULAR 3; MNG3
606083	POLYBROMO 1; PBRM1
606084	CDC42 EFFECTOR PROTEIN 1; CDC42EP1
606085	TESTIS-DERIVED TRANSCRIPT; TES
606086	EUKARYOTIC TRANSLATION INITIATION FACTOR 5B; EIF5B
606087	SYNEMIN; SYNM
606088	PHOSPHOLIPASE A2, GROUP IVB; PLA2G4B
606089	BRAIN CYTOPLASMIC RNA 1; BCYRN1
606090	CARNITINE OCTANOYLTRANSFERASE; CROT
606091	SIALIC ACID-BINDING IMMUNOGLOBULIN-LIKE LECTIN 10; SIGLEC10
606092	DNAJ/HSP40 HOMOLOG, SUBFAMILY C, MEMBER 14; DNAJC14
606093	PEPTIDYL-PROLYL ISOMERASE G; PPIG
606094	SIALIC ACID-BINDING IMMUNOGLOBULIN-LIKE LECTIN 12; SIGLEC12
606095	PEPTIDYL-PROLYL ISOMERASE H; PPIH
606096	LECTIN, GALACTOSIDE-BINDING, SOLUBLE, 12
606097	PHOSPHATIDYLINOSITOL GLYCAN ANCHOR BIOSYNTHESIS CLASS N PROTEIN; PIGN
606098	SORTING NEXIN 6; SNX6
606099	LECTIN, GALACTOSIDE-BINDING, SOLUBLE, 8; LGALS8
606100	ADHESION G PROTEIN-COUPLED RECEPTOR E2; ADGRE2
606101	ADHESION G PROTEIN-COUPLED RECEPTOR E3; ADGRE3
606102	PHOSPHATIDYLINOSITOL 4-PHOSPHATE 5-KINASE, TYPE I, GAMMA; PIP5K1C
606103	SESTRIN 1; SESN1
606104	MOVED TO 124000
606105	SOLUTE CARRIER FAMILY 44, MEMBER 1; SLC44A1
606106	SOLUTE CARRIER FAMILY 44, MEMBER 2; SLC44A2
606107	SOLUTE CARRIER FAMILY 44, MEMBER 4; SLC44A4
606108	PROTEIN PHOSPHATASE, MAGNESIUM/MANGANESE-DEPENDENT, 1A; PPM1A
606109	NUDC DOMAIN-CONTAINING PROTEIN 1; NUDCD1
606110	LY6/NEUROTOXIN 1; LYNX1
606111	MELANIN-CONCENTRATING HORMONE RECEPTOR 2; MCHR2
606112	RIBONUCLEASE P/MRP SUBUNIT p14; RPP14
606113	POP7 HOMOLOG, RIBONUCLEASE P/MRP SUBUNIT; POP7
606114	POP4 HOMOLOG, RIBONUCLEASE P/MRP SUBUNIT; POP4
606115	RIBONUCLEASE P/MRP SUBUNIT p30; RPP30
606116	RIBONUCLEASE P/MRP SUBUNIT p38; RPP38
606117	RIBONUCLEASE P/MRP SUBUNIT p40; RPP40
606118	HPS3 BIOGENESIS OF LYSOSOMAL ORGANELLES COMPLEX 2, SUBUNIT 1; HPS3
606119	SECRETED LY6/PLAUR DOMAIN-CONTAINING PROTEIN 1; SLURP1
606120	MOVED TO 561010
606121	CGRP RECEPTOR COMPONENT; CRCP
606122	TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY, MEMBER 19; TNFRSF19
606123	RING FINGER PROTEIN 16; RNF16
606124	RING FINGER PROTEIN 18; RNF18
606125	TRIPARTITE MOTIF-CONTAINING PROTEIN 8; TRIM8
606126	BCL2-LIKE 14; BCL2L14
606127	MYOCARDIN; MYOCD
606128	MOVED TO 606078
606129	DIAMOND-BLACKFAN ANEMIA 2; DBA2
606130	RING FINGER PROTEIN 26; RNF26
606131	TRIPARTITE MOTIF-CONTAINING PROTEIN 63; TRIM63
606132	CDC42 EFFECTOR PROTEIN 2; CDC42EP2
606133	CDC42 EFFECTOR PROTEIN 3; CDC42EP3
606134	REV1 DNA-DIRECTED POLYMERASE; REV1
606135	KALLIKREIN-RELATED PEPTIDASE 14; KLK14
606136	RAS PROTEIN ACTIVATOR-LIKE 2; RASAL2
606137	CELL GROWTH REGULATOR WITH EF-HAND DOMAIN 1; CGREF1
606138	CELL GROWTH REGULATOR WITH RING FINGER DOMAIN 1; CGRRF1
606139	KRUPPEL-LIKE FACTOR 16; KLF16
606140	EXPORTIN 7; XPO7
606141	RAN-BINDING PROTEIN 17; RANBP17
606142	SOLUTE CARRIER FAMILY 2 (FACILITATED GLUCOSE TRANSPORTER), MEMBER 9; SLC2A9
606143	FRIZZLED CLASS RECEPTOR 3; FZD3
606144	RAS-ASSOCIATED PROTEIN RAB23; RAB23
606145	SOLUTE CARRIER FAMILY 2 (FACILITATED GLUCOSE TRANSPORTER), MEMBER 10; SLC2A10
606146	FRIZZLED CLASS RECEPTOR 8; FZD8
606147	FRIZZLED CLASS RECEPTOR 10; FZD10
606148	FATTY ACID DESATURASE 1; FADS1
606149	FATTY ACID DESATURASE 2; FADS2
606150	FATTY ACID DESATURASE 3; FADS3
606151	BBS2 GENE; BBS2
606152	SOLUTE CARRIER FAMILY 19 (THIAMINE TRANSPORTER), MEMBER 3; SLC19A3
606153	ATP SYNTHASE F1, SUBUNIT EPSILON; ATP5F1E
606154	MUCIN 16; MUC16
606155	MOVED TO 243310
606156	SENER SYNDROME
606157	PANTOTHENATE KINASE 2; PANK2
606158	BSCL2 GENE; BSCL2
606159	NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 3; NBIA3
606160	PANTOTHENATE KINASE 1; PANK1
606161	PANTOTHENATE KINASE 3; PANK3
606162	PANTOTHENATE KINASE 4; PANK4
606163	MOVED TO 300829
606164	DIAMOND-BLACKFAN ANEMIA 15 WITH MANDIBULOFACIAL DYSOSTOSIS; DBA15
606165	BOL-LIKE; BOLL
606166	MOVED TO 603100
606167	G PROTEIN-COUPLED RECEPTOR 132; GPR132
606168	DEAD-BOX HELICASE 20; DDX20
606169	MOVED TO 277410
606170	GENITOPATELLAR SYNDROME; GTPTS
606171	tRNA SERINE (ANTICODON TGA) 2-1; TRS-TGA2-1
606172	tRNA SERINE (ANTICODON TGA) 4-1; TRS-TGA4-1
606173	GRPE-LIKE 1, MITOCHONDRIAL; GRPEL1
606174	BACULUM, CONGENITAL ABSENCE OF
606175	CARNITINE ACETYLTRANSFERASE DEFICIENCY
606176	DIABETES MELLITUS, PERMANENT NEONATAL, 1; PNDM1
606177	PARS PLANITIS
606178	HEDGEHOG-INTERACTING PROTEIN; HHIP
606179	ANEURYSMAL BONE CYSTS
606180	EXOSOME COMPONENT 9; EXOSC9
606181	DEAD-BOX HELICASE 24; DDX24
606182	TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY, MEMBER 9; TNFSF9
606183	LARYNGEAL ABDUCTOR PARALYSIS WITH CEREBELLAR ATAXIA AND MOTOR NEUROPATHY
606184	A DISINTEGRIN-LIKE AND METALLOPROTEINASE WITH THROMBOSPONDIN TYPE 1 MOTIF, 12; ADAMTS12
606185	TUMOR PROTEIN p53-INDUCIBLE NUCLEAR PROTEIN 1; TP53INP1
606186	CALCYCLIN-BINDING PROTEIN; CACYBP
606187	ALZHEIMER DISEASE 7
606188	A DISINTEGRIN AND METALLOPROTEINASE DOMAIN 28; ADAM28
606189	CYSTEINE-RICH MOTOR NEURON PROTEIN 1; CRIM1
606190	MENINGIOMA, RADIATION-INDUCED
606191	FORMIN-BINDING PROTEIN 1; FNBP1
606192	BUTYROPHILIN-LIKE PROTEIN 3; BTNL3
606193	SOLUTE CARRIER FAMILY 13 (SODIUM/SULFATE SYMPORTER), MEMBER 1; SLC13A1
606194	KERATIN 23, TYPE I; KRT23
606195	IROQUOIS HOMEOBOX PROTEIN 5; IRX5
606196	IROQUOIS HOMEOBOX PROTEIN 6; IRX6
606197	IROQUOIS HOMEOBOX PROTEIN 1; IRX1
606198	IROQUOIS HOMEOBOX PROTEIN 2; IRX2
606199	IROQUOIS HOMEOBOX PROTEIN 4; IRX4
606200	BASIC HELIX-LOOP-HELIX FAMILY, MEMBER E41; BHLHE41
606201	WOLFRAMIN ER TRANSMEMBRANE GLYCOPROTEIN; WFS1
606202	SOLUTE CARRIER FAMILY 45, MEMBER 2; SLC45A2
606203	GRB2-ASSOCIATED BINDING PROTEIN 2; GAB2
606204	LYMPHOCYTE ANTIGEN 6 COMPLEX, LOCUS D; LY6D
606205	SOLUTE CARRIER FAMILY 6 (NEUROTRANSMITTER TRANSPORTER, L-PROLINE), MEMBER 7; SLC6A7
606206	METALLOTHIONEIN 4; MT4
606207	SOLUTE CARRIER FAMILY 28 (SODIUM-COUPLED NUCLEOSIDE TRANSPORTER), MEMBER 1; SLC28A1
606208	SOLUTE CARRIER FAMILY 28 (SODIUM-COUPLED NUCLEOSIDE TRANSPORTER), MEMBER 2; SLC28A2
606209	YKT6 v-SNARE HOMOLOG; YKT6
606210	SELENOPROTEIN N; SELENON
606211	SIRTUIN 6; SIRT6
606212	SIRTUIN 7; SIRT7
606213	SIGNAL SEQUENCE RECEPTOR, GAMMA; SSR3
606214	SPECTRIN, BETA, NONERYTHROCYTIC, 4; SPTBN4
606215	ATRIOVENTRICULAR SEPTAL DEFECT; AVSD
606216	METHIONINE SULFOXIDE REDUCTASE B1; MSRB1
606217	ATRIOVENTRICULAR SEPTAL DEFECT, SUSCEPTIBILITY TO, 2; AVSD2
606218	SELENOPHOSPHATE SYNTHETASE 2; SEPHS2
606219	TUMOR NECROSIS FACTOR RECEPTOR-ASSOCIATED PROTEIN 1; TRAP1
606220	INTELLECTUAL DEVELOPMENTAL DISORDER WITH SHORT STATURE, FACIAL ANOMALIES, AND SPEECH DEFECTS; IDDSFAS
606221	IKAROS FAMILY ZINC FINGER 3; IKZF3
606222	IMMUNOGLOBULIN SUPERFAMILY, MEMBER 6; IGSF6
606223	PROTEASOME 26S SUBUNIT, NON-ATPASE, 2; PSMD2
606224	5-PRIME-NUCLEOTIDASE, CYTOSOLIC IIIA; NT5C3A
606225	TASTE RECEPTOR TYPE 1, MEMBER 1; TAS1R1
606226	TASTE RECEPTOR TYPE 1, MEMBER 2; TAS1R2
606227	MEMBRANE-TYPE FRIZZLED-RELATED PROTEIN; MFRP
606228	ARGONAUTE RISC COMPONENT 1; AGO1
606229	ARGONAUTE RISC COMPONENT 2; AGO2
606230	SH3 AND MULTIPLE ANKYRIN REPEAT DOMAINS 3; SHANK3
606231	ADAPTOR PROTEIN, PHOSPHOTYROSINE INTERACTION, PH DOMAIN, AND LEUCINE ZIPPER-CONTAINING PROTEIN 2; APPL2
606232	PHELAN-MCDERMID SYNDROME; PHMDS
606233	PROKINETICIN 1; PROK1
606234	IKAROS FAMILY ZINC FINGER 2; IKZF2
606235	THIOREDOXIN REDUCTASE 3; TXNRD3
606236	ASPSCR1 TETHER FOR SLC2A4, UBX DOMAIN-CONTAINING; ASPSCR1
606237	TRANSFORMING GROWTH FACTOR-BETA RECEPTOR-ASSOCIATED PROTEIN 1; TGFBRAP1
606238	IKAROS FAMILY ZINC FINGER 5; IKZF5
606239	IKAROS FAMILY ZINC FINGER 4; IKZF4
606240	THYROID CANCER, NONMEDULLARY, 3; NMTC3
606241	DICER 1, RIBONUCLEASE III; DICER1
606242	MENTAL RETARDATION, MICROCEPHALY, GROWTH RETARDATION, JOINT CONTRACTURES, AND FACIAL DYSMORPHISM
606243	ALVEOLAR SOFT PART SARCOMA; ASPS
606244	SIGNAL-TRANSDUCING ADAPTOR MOLECULE 2; STAM2
606245	SUZ12 POLYCOMB REPRESSIVE COMPLEX 2 SUBUNIT; SUZ12
606246	JAZF ZINC FINGER 1; JAZF1
606247	STAM-BINDING PROTEIN; STAMBP
606248	QUINOLINATE PHOSPHORIBOSYLTRANSFERASE; QPRT
606249	PROTEIN KINASE, LYSINE-DEFICIENT 2; WNK2
606250	UDP-N-ACETYL-ALPHA-D-GALACTOSAMINE:POLYPEPTIDE N-ACETYLGALACTOSAMINYLTRANSFERASE 8; GALNT8
606251	UDP-N-ACETYL-ALPHA-D-GALACTOSAMINE:POLYPEPTIDE N-ACETYLGALACTOSAMINYLTRANSFERASE 9; GALNT9
606252	TIR DOMAIN-CONTAINING ADAPTOR PROTEIN; TIRAP
606253	MOVED TO 191343
606254	SELENOPROTEIN F; SELENOF
606255	STATURE AS A QUANTITATIVE TRAIT
606256	STATURE QUANTITATIVE TRAIT LOCUS 2; STQTL2
606257	STATURE QUANTITATIVE TRAIT LOCUS 3; STQTL3
606258	STATURE QUANTITATIVE TRAIT LOCUS 4; STQTL4
606259	BRMS1 TRANSCRIPTIONAL REPRESSOR AND ANOIKIS REGULATOR; BRMS1
606260	MYOTUBULARIN-RELATED PROTEIN 9; MTMR9
606261	NUDIX HYDROLASE 6; NUDT6
606262	MOVED TO 602080
606263	PAGET DISEASE OF BONE 4; PDB4
606264	C-TYPE LECTIN DOMAIN FAMILY 7, MEMBER A; CLEC7A
606265	E1A-BINDING PROTEIN, 400-KD; EP400
606266	BCL2-MODIFYING FACTOR; BMF
606267	WINGLESS-TYPE MMTV INTEGRATION SITE FAMILY, MEMBER 16; WNT16
606268	WINGLESS-TYPE MMTV INTEGRATION SITE FAMILY, MEMBER 10A; WNT10A
606269	TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY, MEMBER 13C; TNFRSF13C
606270	TOLL-LIKE RECEPTOR 10; TLR10
606271	DISRUPTED IN SCHIZOPHRENIA 2; DISC2
606272	CYSTINOSIN; CTNS
606273	EUKARYOTIC TRANSLATION INITIATION FACTOR 2B, SUBUNIT 3; EIF2B3
606274	CASEIN KINASE I, GAMMA-1; CSNK1G1
606275	MOVED TO 601172
606276	CARTILAGE ACIDIC PROTEIN 1; CRTAC1
606277	TOLL-INTERACTING PROTEIN; TOLLIP
606278	F-BOX AND WD40 DOMAIN PROTEIN 7; FBXW7
606279	ABI FAMILY MEMBER 3 BINDING PROTEIN; ABI3BP
606280	NON-SMC CONDENSIN I COMPLEX SUBUNIT G; NCAPG
606281	RAS-ASSOCIATED PROTEIN RAB38; RAB38
606282	DEAFNESS, AUTOSOMAL DOMINANT 24; DFNA24
606283	SORTILIN-RELATED VPS10 DOMAIN-CONTAINING RECEPTOR 1; SORCS1
606284	SORTILIN-RELATED VPS10 DOMAIN-CONTAINING RECEPTOR 2; SORCS2
606285	SORTILIN-RELATED VPS10 DOMAIN-CONTAINING RECEPTOR 3; SORCS3
606286	DEAD-BOX HELICASE 43; DDX43
606287	MOVED TO 605743
606288	PROTOCADHERIN-GAMMA, SUBFAMILY A, MEMBER 1; PCDHGA1
606289	PROTOCADHERIN-GAMMA, SUBFAMILY A, MEMBER 2; PCDHGA2
606290	PROTOCADHERIN-GAMMA, SUBFAMILY A, MEMBER 3; PCDHGA3
606291	PROTOCADHERIN-GAMMA, SUBFAMILY A, MEMBER 4; PCDHGA4
606292	PROTOCADHERIN-GAMMA, SUBFAMILY A, MEMBER 5; PCDHGA5
606293	PROTOCADHERIN-GAMMA, SUBFAMILY A, MEMBER 6; PCDHGA6
606294	PROTOCADHERIN-GAMMA, SUBFAMILY A, MEMBER 7; PCDHGA7
606295	PROTOCADHERIN-GAMMA, SUBFAMILY A, MEMBER 8; PCDHGA8
606296	PROTOCADHERIN-GAMMA, SUBFAMILY A, MEMBER 9; PCDHGA9
606297	PROTOCADHERIN-GAMMA, SUBFAMILY A, MEMBER 10; PCDHGA10
606298	PROTOCADHERIN-GAMMA, SUBFAMILY A, MEMBER 11; PCDHGA11
606299	PROTOCADHERIN-GAMMA, SUBFAMILY B, MEMBER 1; PCDHGB1
606300	PROTOCADHERIN-GAMMA, SUBFAMILY B, MEMBER 2; PCDHGB2
606301	PROTOCADHERIN-GAMMA, SUBFAMILY B, MEMBER 3; PCDHGB3
606302	PROTOCADHERIN-GAMMA, SUBFAMILY B, MEMBER 5; PCDHGB5
606303	PROTOCADHERIN-GAMMA, SUBFAMILY B, MEMBER 6; PCDHGB6
606304	PROTOCADHERIN-GAMMA, SUBFAMILY B, MEMBER 7; PCDHGB7
606305	PROTOCADHERIN-GAMMA, SUBFAMILY C, MEMBER 4; PCDHGC4
606306	PROTOCADHERIN-GAMMA, SUBFAMILY C, MEMBER 5; PCDHGC5
606307	PROTOCADHERIN-ALPHA 1; PCDHA1
606308	PROTOCADHERIN-ALPHA 2; PCDHA2
606309	PROTOCADHERIN-ALPHA 3; PCDHA3
606310	PROTOCADHERIN-ALPHA 4; PCDHA4
606311	PROTOCADHERIN-ALPHA 5; PCDHA5
606312	PROTOCADHERIN-ALPHA 6; PCDHA6
606313	PROTOCADHERIN-ALPHA 7; PCDHA7
606314	PROTOCADHERIN-ALPHA 8; PCDHA8
606315	PROTOCADHERIN-ALPHA 9; PCDHA9
606316	PROTOCADHERIN-ALPHA 10; PCDHA10
606317	PROTOCADHERIN-ALPHA 11; PCDHA11
606318	PROTOCADHERIN-ALPHA 12; PCDHA12
606319	PROTOCADHERIN-ALPHA 13; PCDHA13
606320	PROTOCADHERIN-ALPHA, SUBFAMILY C, MEMBER 1; PCDHAC1
606321	PROTOCADHERIN-ALPHA, SUBFAMILY C, MEMBER 2; PCDHAC2
606322	CYTOPLASMIC FMRP-INTERACTING PROTEIN 1; CYFIP1
606323	CYTOPLASMIC FMRP-INTERACTING PROTEIN 2; CYFIP2
606324	PARKINSON DISEASE 7, AUTOSOMAL RECESSIVE EARLY-ONSET; PARK7
606325	HETEROTAXY, VISCERAL, 3, AUTOSOMAL; HTX3
606326	SIX HOMEOBOX 6; SIX6
606327	PROTOCADHERIN-BETA 1; PCDHB1
606328	PROTOCADHERIN-BETA 2; PCDHB2
606329	PROTOCADHERIN-BETA 3; PCDHB3
606330	PROTOCADHERIN-BETA 4; PCDHB4
606331	PROTOCADHERIN-BETA 5; PCDHB5
606332	PROTOCADHERIN-BETA 6; PCDHB6
606333	PROTOCADHERIN-BETA 7; PCDHB7
606334	PROTOCADHERIN-BETA 8; PCDHB8
606335	PROTOCADHERIN-BETA 9; PCDHB9
606336	PROTOCADHERIN-BETA 10; PCDHB10
606337	PROTOCADHERIN-BETA 11; PCDHB11
606338	PROTOCADHERIN-BETA 12; PCDHB12
606339	PROTOCADHERIN-BETA 13; PCDHB13
606340	PROTOCADHERIN-BETA 14; PCDHB14
606341	PROTOCADHERIN-BETA 15; PCDHB15
606342	SIX HOMEOBOX 4; SIX4
606343	POLYMERASE, DNA, LAMBDA; POLL
606344	POLYMERASE, DNA, MU; POLM
606345	PROTOCADHERIN-BETA 16; PCDHB16
606346	DEAFNESS, AUTOSOMAL DOMINANT 22; DFNA22
606347	PROLINE/SERINE/THREONINE PHOSPHATASE-INTERACTING PROTEIN 1; PSTPIP1
606348	INFLAMMATORY BOWEL DISEASE 5; IBD5
606349	GAMBLING, PATHOLOGIC
606350	APRATAXIN; APTX
606351	ESPIN; ESPN
606352	ALSIN RHO GUANINE NUCLEOTIDE EXCHANGE FACTOR ALS2; ALS2
606353	PRIMARY LATERAL SCLEROSIS, JUVENILE; PLSJ
606354	MOVED TO 605317
606355	DEAD-BOX HELICASE 18; DDX18
606356	TRANSMEMBRANE PROTEIN 123; TMEM123
606357	DExD-BOX HELICASE 21; DDX21
606358	ANTERIOR GRADIENT 2, PROTEIN DISULPHIDE ISOMERASE FAMILY MEMBER; AGR2
606359	WINGLESS-TYPE MMTV INTEGRATION SITE FAMILY, MEMBER 3A; WNT3A
606360	WINGLESS-TYPE MMTV INTEGRATION SITE FAMILY, MEMBER 8A; WNT8A
606361	WINGLESS-TYPE MMTV INTEGRATION SITE FAMILY, MEMBER 5B; WNT5B
606362	ACID PHOSPHATASE 4; ACP4
606363	ABI FAMILY MEMBER 3; ABI3
606364	MOVED TO 606658
606365	GLUTAMINASE 2; GLS2
606366	RAS HOMOLOG GENE FAMILY, MEMBER U; RHOU
606367	IMMUNODEFICIENCY 41 WITH LYMPHOPROLIFERATION AND AUTOIMMUNITY; IMD41
606368	APOLIPOPROTEIN A-V; APOA5
606369	MACROCEPHALY AND EPILEPTIC ENCEPHALOPATHY
606370	THIAMINE PYROPHOSPHOKINASE; TPK1
606371	ACTIVATING TRANSCRIPTION FACTOR 7; ATF7
606372	CHOLINERGIC RECEPTOR, NEURONAL NICOTINIC, ALPHA POLYPEPTIDE 10; CHRNA10
606373	FORMIN 2; FMN2
606374	BETA-1,3-GLUCURONYLTRANSFERASE 3; B3GAT3
606375	MOVED TO 151290
606376	CARBOHYDRATE SULFOTRANSFERASE 10; CHST10
606377	DIMERIC DIHYDRODIOL DEHYDROGENASE; DHDH
606378	ST6 ALPHA-N-ACETYL-NEURAMINYL-2,3-BETA-GALACTOSYL-1,3-N-ACETYLGALACTOSAMINIDE ALPHA-2,6-SIALYLTRANSFERASE 4; ST6GALNAC4
606379	G PROTEIN-COUPLED RECEPTOR 87; GPR87
606380	PURINERGIC RECEPTOR P2Y, G PROTEIN-COUPLED, 13; P2RY13
606381	SUCCINATE RECEPTOR 1; SUCNR1
606382	MEMBRANE-ASSOCIATED GUANYLATE KINASE, WW AND PDZ DOMAINS-CONTAINING, 2; MAGI2
606383	G PROTEIN-COUPLED RECEPTOR 84; GPR84
606384	UBIQUITIN PROTEIN LIGASE NEDD4-LIKE; NEDD4L
606385	OLIGODENDROCYTE LINEAGE TRANSCRIPTION FACTOR 1; OLIG1
606386	OLIGODENDROCYTE LINEAGE TRANSCRIPTION FACTOR 2; OLIG2
606387	TOPOISOMERASE I, MITOCHONDRIAL; TOP1MT
606388	THIOESTERASE SUPERFAMILY MEMBER 4; THEM4
606389	CATION CHANNEL, SPERM-ASSOCIATED, 1; CATSPER1
606390	MOVED TO 142560
606391	MATURITY-ONSET DIABETES OF THE YOUNG; MODY
606392	MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 4; MODY4
606393	A DISINTEGRIN AND METALLOPROTEINASE DOMAIN-LIKE PROTEIN DECYSIN 1; ADAMDEC1
606394	MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 6; MODY6
606395	PROLACTIN REGULATORY ELEMENT-BINDING PROTEIN; PREB
606396	BRIDGING INTEGRATOR 3; BIN3
606397	CLARIN 1; CLRN1
606398	ACTIVATING TRANSCRIPTION FACTOR 5; ATF5
606399	CALCIUM CHANNEL, VOLTAGE-DEPENDENT, ALPHA-2/DELTA SUBUNIT 3; CACNA2D3
606400	CALPAIN 7; CAPN7
606401	CALPAIN 9; CAPN9
606402	GASTROKINE 1; GKN1
606403	CALCIUM CHANNEL, VOLTAGE-DEPENDENT, GAMMA-3 SUBUNIT; CACNG3
606404	CALCIUM CHANNEL, VOLTAGE-DEPENDENT, GAMMA-4 SUBUNIT; CACNG4
606405	CALCIUM CHANNEL, VOLTAGE-DEPENDENT, GAMMA-5 SUBUNIT; CACNG5
606406	NUCLEAR PORE COMPLEX-INTERACTING PROTEIN FAMILY, MEMBER A1; NPIPA1
606407	HYPOTONIA-CYSTINURIA SYNDROME
606408	EHLERS-DANLOS SYNDROME, CLASSIC-LIKE, 1; EDSCLL1
606409	ITCHY E3 UBIQUITIN PROTEIN LIGASE; ITCH
606410	ANTHRAX TOXIN RECEPTOR 1; ANTXR1
606411	SOLUTE CARRIER FAMILY 13 (SODIUM-DEPENDENT DICARBOXYLATE TRANSPORTER), MEMBER 3; SLC13A3
606412	BARTTIN CLCNK-TYPE ACCESSORY SUBUNIT BETA; BSND
606413	INSULIN-LIKE 5; INSL5
606414	INSULIN-LIKE 6; INSL6
606415	MOVED TO 114580
606416	NLR FAMILY, PYRIN DOMAIN-CONTAINING 3; NLRP3
606417	WD REPEAT-CONTAINING PROTEIN 11; WDR11
606418	24-DEHYDROCHOLESTEROL REDUCTASE; DHCR24
606419	PRE-mRNA-PROCESSING FACTOR 31; PRPF31
606420	ENGULFMENT AND CELL MOTILITY GENE 1; ELMO1
606421	ENGULFMENT AND CELL MOTILITY GENE 2; ELMO2
606422	ENGULFMENT AND CELL MOTILITY GENE 3; ELMO3
606423	DISRUPTED IN RENAL CARCINOMA 1; DIRC1
606424	EGL9 FAMILY HYPOXIA-INDUCIBLE FACTOR 2; EGLN2
606425	EGL9 FAMILY HYPOXIA-INDUCIBLE FACTOR 1; EGLN1
606426	EGL9 FAMILY HYPOXIA-INDUCIBLE FACTOR 3; EGLN3
606427	ZINC FINGER PROTEIN 320; ZNF320
606428	UDP-GLYCOSYLTRANSFERASE 1 FAMILY, POLYPEPTIDE A3; UGT1A3
606429	UDP-GLYCOSYLTRANSFERASE 1 FAMILY, POLYPEPTIDE A4; UGT1A4
606430	UDP-GLYCOSYLTRANSFERASE 1 FAMILY, POLYPEPTIDE A5; UGT1A5
606431	UDP-GLYCOSYLTRANSFERASE 1 FAMILY, POLYPEPTIDE A6; UGT1A6
606432	UDP-GLYCOSYLTRANSFERASE 1 FAMILY, POLYPEPTIDE A7; UGT1A7
606433	UDP-GLYCOSYLTRANSFERASE 1 FAMILY, POLYPEPTIDE A8; UGT1A8
606434	UDP-GLYCOSYLTRANSFERASE 1 FAMILY, POLYPEPTIDE A9; UGT1A9
606435	UDP-GLYCOSYLTRANSFERASE 1 FAMILY, POLYPEPTIDE A10; UGT1A10
606436	SYNAPTOTAGMIN 12; SYT12
606437	MOVED TO 121200
606438	HUNTINGTON DISEASE-LIKE 2; HDL2
606439	ATLASTIN GTPase 1; ATL1
606440	STEREOCILIN; STRC
606441	HTRA SERINE PEPTIDASE 2; HTRA2
606442	ABL INTERACTOR 2; ABI2
606443	cAMP RESPONSE ELEMENT-BINDING PROTEIN 3; CREB3
606444	CREB/ATF BASIC LEUCINE ZIPPER TRANSCRIPTION FACTOR; CREBZF
606445	PERSISTENT POLYCLONAL B-CELL LYMPHOCYTOSIS; PPBL
606446	SLAM FAMILY, MEMBER 6; SLAMF6
606447	RNA-BINDING PROTEIN S1; RNPS1
606448	THIOREDOXIN REDUCTASE 2; TXNRD2
606449	PROTEIN-TYROSINE PHOSPHATASE, TYPE 4A, 3; PTP4A3
606450	NEUROEPITHELIAL CELL TRANSFORMING GENE 1; NET1
606451	DEAFNESS, AUTOSOMAL DOMINANT 30; DFNA30
606452	ZINC FINGER, MATRIN-TYPE 3; ZMAT3
606453	LIPOPOLYSACCHARIDE-RESPONSIVE, BEIGE-LIKE ANCHOR PROTEIN; LRBA
606454	EUKARYOTIC TRANSLATION INITIATION FACTOR 2B, SUBUNIT 2; EIF2B2
606455	PROTEIN PHOSPHATASE 1, REGULATORY SUBUNIT 13B; PPP1R13B
606456	NUCLEOPHOSMIN/NUCLEOPLASMIN FAMILY, MEMBER 3; NPM3
606457	INHIBITOR OF BRUTON AGAMMAGLOBULINEMIA TYROSINE KINASE; IBTK
606458	CYSTEINE- AND SERINE-RICH NUCLEAR PROTEIN 1; CSRNP1
606459	OPIOID GROWTH FACTOR RECEPTOR; OGFR
606460	LONGEVITY 2
606461	TRIMETHYLGUANOSINE SYNTHASE 1; TGS1
606462	RAD21 COHESIN COMPLEX COMPONENT; RAD21
606463	GLUCOSIDASE, BETA, ACID; GBA
606464	HEPCIDIN ANTIMICROBIAL PEPTIDE; HAMP
606465	KRUPPEL-LIKE FACTOR 15; KLF15
606466	PML-RARA REGULATED ADAPTOR MOLECULE 1; PRAM1
606467	ALDEHYDE DEHYDROGENASE 8 FAMILY, MEMBER A1; ALDH8A1
606468	GAR1 RIBONUCLEOPROTEIN; GAR1
606469	RING FINGER PROTEIN 29; RNF29
606470	NHP2 RIBONUCLEOPROTEIN; NHP2
606471	NOP10 RIBONUCLEOPROTEIN; NOP10
606472	SS18L1 SUBUNIT OF BAF CHROMATIN REMODELING COMPLEX; SS18L1
606473	SS18-LIKE GENE 2; SS18L2
606474	RING FINGER PROTEIN 30; RNF30
606475	CD320 ANTIGEN; CD320
606476	INOSITOL 1,4,5-TRISPHOSPHATE 3-KINASE C; ITPKC
606477	SERINE RACEMASE; SRR
606478	PROTECTION OF TELOMERES 1; POT1
606479	NEUROLIGIN 2; NLGN2
606480	ZINC METALLOPROTEINASE STE24; ZMPSTE24
606481	PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE 5-PHOSPHATASE, A; PIB5PA
606482	CHARCOT-MARIE-TOOTH DISEASE, DOMINANT INTERMEDIATE B; CMTDIB
606483	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2GG; CMT2GG
606484	MYOTROPHIN; MTPN
606485	POLYMERASE II, RNA, SUBUNIT M; POLR2M
606486	CHARGED MULTIVESICULAR BODY PROTEIN 1B; CHMP1B
606487	PHOSPHOLIPASE A AND ACETYLTRANSFERASE 1; PLAAT1
606488	EXOSOME COMPONENT 7; EXOSC7
606489	EXOSOME COMPONENT 3; EXOSC3
606490	EXOSOME COMPONENT 6; EXOSC6
606491	EXOSOME COMPONENT 4; EXOSC4
606492	EXOSOME COMPONENT 5; EXOSC5
606493	EXOSOME COMPONENT 1; EXOSC1
606494	ST3 BETA-GALACTOSIDE ALPHA-2,3-SIALYLTRANSFERASE 3; ST3GAL3
606495	MAP/MICROTUBULE AFFINITY-REGULATING KINASE 4; MARK4
606496	INTERLEUKIN 17F; IL17F
606497	URIDINE DIPHOSPHATE GLYCOSYLTRANSFERASE 2 FAMILY, MEMBER B28; UGT2B28
606498	MEMBRANE-SPANNING 4-DOMAINS, SUBFAMILY A, MEMBER 3; MS4A3
606499	MEMBRANE-SPANNING 4-DOMAINS, SUBFAMILY A, MEMBER 5; MS4A5
606500	SECRETOGLOBIN, FAMILY 3A, MEMBER 1; SCGB3A1
606501	MYOTUBULARIN-RELATED PROTEIN 12; MTMR12
606502	MEMBRANE-SPANNING 4-DOMAINS, SUBFAMILY A, MEMBER 7; MS4A7
606503	SUV39H2 HISTONE LYSINE METHYLTRANSFERASE; SUV39H2
606504	CANCER SUSCEPTIBILITY CANDIDATE 3; CASC3
606505	PIN2-INTERACTING PROTEIN 1; PINX1
606506	MOVED TO 300927
606507	MOVED TO 602488
606508	Fc RECEPTOR-LIKE PROTEIN 1; FCRL1
606509	Fc RECEPTOR-LIKE PROTEIN 2; FCRL2
606510	Fc RECEPTOR-LIKE PROTEIN 3; FCRL3
606511	MAP/MICROTUBULE AFFINITY-REGULATING KINASE 1; MARK1
606512	PROTEIN KINASE C AND CASEIN KINASE SUBSTRATE IN NEURONS 1; PACSIN1
606513	PROTEIN KINASE C AND CASEIN KINASE SUBSTRATE IN NEURONS 3; PACSIN3
606514	CYTOHESIN 4; CYTH4
606515	RNA, 7SK, SMALL NUCLEAR; RN7SK
606516	MUSCLEBLIND-LIKE SPLICING REGULATOR 1; MBNL1
606517	ARYLHYDROCARBON RECEPTOR REPRESSOR; AHRR
606518	HEPATITIS A VIRUS CELLULAR RECEPTOR 1; HAVCR1
606519	PHACE ASSOCIATION
606520	MEGAKARYOCYTE AND PLATELET INHIBITORY RECEPTOR G6B; MPIG6B
606521	SOLUTE CARRIER FAMILY 25 (MITOCHONDRIAL THIAMINE PYROPHOSPHATE CARRIER), MEMBER 19; SLC25A19
606522	GROWTH/DIFFERENTIATION FACTOR 3; GDF3
606523	SLIT-ROBO RHO GTPase-ACTIVATING PROTEIN 1; SRGAP1
606524	SLIT-ROBO RHO GTPase-ACTIVATING PROTEIN 2; SRGAP2
606525	SLIT-ROBO RHO GTPase-ACTIVATING PROTEIN 3; SRGAP3
606526	MELANOPHILIN; MLPH
606527	MEGARBANE SYNDROME
606528	HOMOZYGOUS 11p15-p14 DELETION SYNDROME
606529	CRANIOSYNOSTOSIS SYNDROME, AUTOSOMAL RECESSIVE
606530	CYTOCHROME P450, SUBFAMILY XXVIIA, POLYPEPTIDE 1; CYP27A1
606531	SECRETOGLOBIN, FAMILY 3A, MEMBER 2; SCGB3A2
606532	HORMONALLY UPREGULATED NEU-ASSOCIATED KINASE; HUNK
606533	CHLORIDE INTRACELLULAR CHANNEL 3; CLIC3
606534	CYTOCHROME P450, SUBFAMILY IIIA, POLYPEPTIDE 43; CYP3A43
606535	MYC-BINDING PROTEIN; MYCBP
606536	CHLORIDE INTRACELLULAR CHANNEL 4; CLIC4
606537	MYOSIN IB; MYO1B
606538	MYOSIN IC; MYO1C
606539	MYOSIN ID; MYO1D
606540	MYOSIN VB; MYO5B
606541	MYOSIN VIIB; MYO7B
606542	HISTONE DEACETYLASE 7A; HDAC7A
606543	HISTONE DEACETYLASE 9; HDAC9
606544	MITOCHONDRIAL ELONGATION FACTOR G2; GFM2
606545	ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 3; ARCI3
606546	HYDATIDIFORM MOLE-ASSOCIATED AND IMPRINTED TRANSCRIPT; HYMAI
606547	MEMBRANE-SPANNING 4-DOMAINS, SUBFAMILY A, MEMBER 4A; MS4A4A
606548	MEMBRANE-SPANNING 4-DOMAINS, SUBFAMILY A, MEMBER 6A; MS4A6A
606549	MEMBRANE-SPANNING 4-DOMAINS, SUBFAMILY A, MEMBER 8B; MS4A8B
606550	MEMBRANE-SPANNING 4-DOMAINS, SUBFAMILY A, MEMBER 12
606551	LEUCINE ZIPPER, PUTATIVE TUMOR SUPPRESSOR 1; LZTS1
606552	EPISODIC ATAXIA, TYPE 4; EA4
606553	SOLUTE CARRIER FAMILY 9, MEMBER 3, REGULATOR 2; SLC9A3R2
606554	EPISODIC ATAXIA, TYPE 3; EA3
606555	TRIPARTITE MOTIF-CONTAINING PROTEIN 9; TRIM9
606556	TRIPARTITE MOTIF-CONTAINING PROTEIN 14; TRIM14
606557	BAF CHROMATIN REMODELING COMPLEX SUBUNIT BCL11A; BCL11A
606558	BAF CHROMATIN REMODELING COMPLEX SUBUNIT BCL11B; BCL11B
606559	TRIPARTITE MOTIF-CONTAINING PROTEIN 22; TRIM22
606560	SPERM-ASSOCIATED ANTIGEN 11B; SPAG11B
606561	SOLUTE CARRIER FAMILY 36 (PROTON/AMINO ACID SYMPORTER), MEMBER 1; SLC36A1
606562	TRANSMEMBRANE 6 SUPERFAMILY, MEMBER 1; TM6SF1
606563	TRANSMEMBRANE 6 SUPERFAMILY, MEMBER 2; TM6SF2
606564	PROSTATE TRANSMEMBRANE PROTEIN, ANDROGEN-INDUCED; PMEPA1
606565	TRANSMEMBRANE PROTEASE, SERINE 4; TMPRSS4
606566	MYOSIN LIGHT CHAIN KINASE 2; MYLK2
606567	TRANSMEMBRANE 4 SUPERFAMILY, MEMBER 4; TM4SF4
606568	LEUCINE ZIPPER TRANSCRIPTION FACTOR-LIKE 1; LZTFL1
606569	SUPPRESSOR OF ACTIN MUTATIONS 1-LIKE; SACM1L
606570	SECRETED FRIZZLED-RELATED PROTEIN 4; SFRP4
606571	LOW DENSITY LIPOPROTEIN RECEPTOR CLASS A DOMAIN-CONTAINING PROTEIN 4; LDLRAD4
606572	NADPH OXIDASE 5; NOX5
606573	FYN-RELATED SRC FAMILY TYROSINE KINASE; FRK
606574	ALBINISM, OCULOCUTANEOUS, TYPE IV; OCA4
606575	MEMBRANE PROTEIN, PALMITOYLATED 4; MPP4
606576	TAF3 RNA POLYMERASE II, TATA BOX-BINDING PROTEIN-ASSOCIATED FACTOR, 140-KD; TAF3
606577	SRC-LIKE ADAPTOR 2; SLA2
606578	AQUAPORIN 10; AQP10
606579	VITILIGO-ASSOCIATED MULTIPLE AUTOIMMUNE DISEASE SUSCEPTIBILITY 1; VAMAS1
606580	OUTER MITOCHONDRIAL MEMBRANE LIPID METABOLISM REGULATOR OPA3; OPA3
606581	POLYSUBSTANCE ABUSE, SUSCEPTIBILITY TO; PSAB
606582	DELTA-LIKE CANONICAL NOTCH LIGAND 1; DLL1
606583	PEROXIREDOXIN 5; PRDX5
606584	PROTEIN-TYROSINE PHOSPHATASE, NONRECEPTOR-TYPE, 23; PTPN23
606585	ENAMELIN; ENAM
606586	RETINOIC ACID-INDUCED 14; RAI14
606587	PROTEIN-TYROSINE PHOSPHATASE, NONRECEPTOR-TYPE, 18; PTPN18
606588	DNA METHYLTRANSFERASE 3-LIKE PROTEIN; DNMT3L
606589	SORTING NEXIN 13; SNX13
606590	NPL4 HOMOLOG, UBIQUITIN RECOGNITION FACTOR; NPLOC4
606591	MUS81 STRUCTURE-SPECIFIC ENDONUCLEASE SUBUNIT; MUS81
606592	VANIN 3; VNN3
606593	LIG4 SYNDROME
606594	SET DOMAIN-CONTAINING PROTEIN 7; SETD7
606595	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2F; CMT2F
606596	FUKUTIN-RELATED PROTEIN; FKRP
606597	PAIRED BOX GENE 3; PAX3
606598	GANGLIOSIDE-INDUCED DIFFERENTIATION-ASSOCIATED PROTEIN 1; GDAP1
606599	THIOREDOXIN-INTERACTING PROTEIN; TXNIP
606600	RAS PROTEIN-SPECIFIC GUANINE NUCLEOTIDE-RELEASING FACTOR 1; RASGRF1
606601	ENDOGENOUS RETROVIRAL SEQUENCE E, 1; ERVE1
606602	BRAIN AND ACUTE LEUKEMIA GENE, CYTOPLASMIC; BAALC
606603	EDAR-ASSOCIATED DEATH DOMAIN; EDARADD
606604	F-BOX ONLY PROTEIN 32; FBXO32
606605	ATR-INTERACTING PROTEIN; ATRIP
606606	MOVED TO 262700
606607	PROTEASOME SUBUNIT, ALPHA-TYPE, 7; PSMA7
606608	YES1-ASSOCIATED TRANSCRIPTIONAL REGULATOR; YAP1
606609	3-PRIME REPAIR EXONUCLEASE 1; TREX1
606610	NSFL1 COFACTOR; NSFL1C
606611	DEFENSIN, BETA, 103A; DEFB103A
606612	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH OR WITHOUT IMPAIRED INTELLECTUAL DEVELOPMENT), TYPE B, 5; MDDGB5
606613	HIGH DENSITY LIPOPROTEIN CHOLESTEROL LEVEL QUANTITATIVE TRAIT LOCUS 1; HDLCQ1
606614	RAS PROTEIN-SPECIFIC GUANINE NUCLEOTIDE-RELEASING FACTOR 2; RASGRF2
606615	HYPOXIA-INDUCIBLE FACTOR 1-ALPHA INHIBITOR; HIF1AN
606616	DYSLEXIA, SUSCEPTIBILITY TO, 6; DYX6
606617	MOVED TO 604169
606618	DUAL-SPECIFICITY PHOSPHATASE 14; DUSP14
606619	GLUCOSIDASE, BETA, ACID 3; GBA3
606620	SLAM FAMILY, MEMBER 8; SLAMF8
606621	INTRAFLAGELLAR TRANSPORT 57; IFT57
606622	SWI/SNF-RELATED, MATRIX-ASSOCIATED, ACTIN-DEPENDENT REGULATOR OF CHROMATIN, SUBFAMILY A-LIKE PROTEIN 1; SMARCAL1
606623	17-BETA-HYDROXYSTEROID DEHYDROGENASE VI; HSD17B6
606624	NEUROGENIN 2; NEUROG2
606625	SLAM FAMILY, MEMBER 7; SLAMF7
606626	DISHEVELLED-ASSOCIATED ACTIVATOR OF MORPHOGENESIS 1; DAAM1
606627	DISHEVELLED-ASSOCIATED ACTIVATOR OF MORPHOGENESIS 2; DAAM2
606628	GLYCINE N-METHYLTRANSFERASE; GNMT
606629	PROTEIN REGULATING SYNAPTIC MEMBRANE EXOCYTOSIS 1; RIMS1
606630	PROTEIN REGULATING SYNAPTIC MEMBRANE EXOCYTOSIS 2; RIMS2
606631	CAMURATI-ENGELMANN DISEASE, TYPE 2
606632	ODOR, MALE, WOMEN'S CHOICE OF
606633	TRANSCRIPTION FACTOR Sp7; SP7
606634	DERMCIDIN; DCD
606635	TRANSMEMBRANE PROTEASE, SERINE 15; TMPRSS15
606636	NLR FAMILY, PYRIN DOMAIN-CONTAINING 1; NLRP1
606637	PEPTIDE YY, 2; PYY2
606638	PANCREATIC POLYPEPTIDE 2; PPY2
606639	MITOCHONDRIAL ELONGATION FACTOR G1; GFM1
606640	AMYOTROPHIC LATERAL SCLEROSIS 3; ALS3
606641	BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 1; BMIQ1
606642	MOVED TO 606641
606643	BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 2; BMIQ2
606644	IMMUNOGLOBULIN SUPERFAMILY, MEMBER 8; IGSF8
606645	CENTAURIN, DELTA-1; CENTD1
606646	CENTAURIN, DELTA-2; CENTD2
606647	CENTAURIN, DELTA-3; CENTD3
606648	INTERLEUKIN 22 RECEPTOR, ALPHA-2; IL22RA2
606649	HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 ENHANCER-BINDING PROTEIN 3; HIVEP3
606650	GLUTAMATE RECEPTOR, IONOTROPIC, N-METHYL-D-ASPARTATE 3A; GRIN3A
606651	GLUTAMATE RECEPTOR, IONOTROPIC, N-METHYL-D-ASPARTATE 3B; GRIN3B
606652	HEPATITIS A VIRUS CELLULAR RECEPTOR 2; HAVCR2
606653	LEUCINE-RICH REPEAT-CONTAINING G PROTEIN-COUPLED RECEPTOR 6; LGR6
606654	RELAXIN/INSULIN-LIKE FAMILY PEPTIDE RECEPTOR 1; RXFP1
606655	RELAXIN/INSULIN-LIKE FAMILY PEPTIDE RECEPTOR 2; RXFP2
606656	MOVED TO 213600
606657	GLAUCOMA, NORMAL TENSION, SUSCEPTIBILITY TO
606658	SPINOCEREBELLAR ATAXIA 15; SCA15
606659	TRANSLOCASE OF INNER MITOCHONDRIAL MEMBRANE 8B; TIMM8B
606660	MELANOMA, UVEAL, SUSCEPTIBILITY TO, 1; UVM1
606661	MELANOMA, UVEAL, SUSCEPTIBILITY TO, 2; UVM2
606662	WAARDENBURG SYNDROME, TYPE 2C; WS2C
606663	LYSYL OXIDASE-LIKE 2; LOXL2
606664	GLYCINE N-METHYLTRANSFERASE DEFICIENCY
606665	OPSIN 4; OPN4
606666	LEUCINE-RICH REPEAT-CONTAINING G PROTEIN-COUPLED RECEPTOR 4; LGR4
606667	LEUCINE-RICH REPEAT-CONTAINING G PROTEIN-COUPLED RECEPTOR 5; LGR5
606668	INFLAMMATORY BOWEL DISEASE 8; IBD8
606669	FXYD DOMAIN-CONTAINING ION TRANSPORT REGULATOR 5; FXYD5
606670	PROTEIN PHOSPHATASE 1, REGULATORY SUBUNIT 11; PPP1R11
606671	NCK-INTERACTING PROTEIN WITH SH3 DOMAIN; NCKIPSD
606672	GLYCOPROTEIN Ib, PLATELET, ALPHA POLYPEPTIDE; GP1BA
606673	BETA-UREIDOPROPIONASE; UPB1
606674	INFLAMMATORY BOWEL DISEASE 6; IBD6
606675	INFLAMMATORY BOWEL DISEASE 4; IBD4
606676	TRANSIENT RECEPTOR POTENTIAL CATION CHANNEL, SUBFAMILY V, MEMBER 2; TRPV2
606677	C-TYPE LECTIN DOMAIN FAMILY 4, MEMBER C; CLEC4C
606678	TRANSIENT RECEPTOR POTENTIAL CATION CHANNEL, SUBFAMILY M, MEMBER 8; TRPM8
606679	TRANSIENT RECEPTOR POTENTIAL CATION CHANNEL, SUBFAMILY V, MEMBER 5; TRPV5
606680	TRANSIENT RECEPTOR POTENTIAL CATION CHANNEL, SUBFAMILY V, MEMBER 6; TRPV6
606681	NUCLEAR RECEPTOR-BINDING SET DOMAIN PROTEIN 1; NSD1
606682	HPS4 BIOGENESIS OF LYSOSOMAL ORGANELLES COMPLEX 3, SUBUNIT 2; HPS4
606683	FXYD DOMAIN-CONTAINING ION TRANSPORT REGULATOR 6; FXYD6
606684	FXYD DOMAIN-CONTAINING ION TRANSPORT REGULATOR 7; FXYD7
606685	CARDIOMYOPATHY, DILATED, 1L; CMD1L
606686	EUKARYOTIC TRANSLATION INITIATION FACTOR 2B, SUBUNIT 1; EIF2B1
606687	EUKARYOTIC TRANSLATION INITIATION FACTOR 2B, SUBUNIT 4; EIF2B4
606688	SPONGIFORM ENCEPHALOPATHY WITH NEUROPSYCHIATRIC FEATURES
606689	GLAUCOMA 1, OPEN ANGLE, B; GLC1B
606690	LYMPHANGIOLEIOMYOMATOSIS; LAM
606691	CEA CELL ADHESION MOLECULE 19; CEACAM19
606692	TNF RECEPTOR-ASSOCIATED FACTOR 7; TRAF7
606693	KUFOR-RAKEB SYNDROME; KRS
606694	NUCLEOPORIN, 155-KD; NUP155
606695	OPSIN 3; OPN3
606696	KATANIN, p60 SUBUNIT, A1; KATNA1
606697	ZINC FINGER PROTEIN ZK1
606698	SRY-BOX 30
606699	HELICASE WITH ZINC FINGER DOMAIN; HELZ
606700	MIDNOLIN; MIDN
606701	DORSAL ROOT GANGLIA HOMEOBOX; DRGX
606702	PKHD1 CILIARY IPT DOMAIN-CONTAINING FIBROCYSTIN/POLYDUCTIN; PKHD1
606703	DYSKINESIA WITH OROFACIAL INVOLVEMENT, AUTOSOMAL DOMINANT; DSKOD
606704	G PROTEIN-COUPLED RECEPTOR 75; GPR75
606705	DEAFNESS, AUTOSOMAL DOMINANT 36; DFNA36
606706	TRANSMEMBRANE CHANNEL-LIKE PROTEIN 1; TMC1
606707	TRANSMEMBRANE CHANNEL-LIKE PROTEIN 2; TMC2
606708	SPLIT-HAND/FOOT MALFORMATION 5; SHFM5
606709	PROTEASE, SERINE, 12; PRSS12
606710	LHFPL TETRASPAN SUBFAMILY, MEMBER 6; LHFPL6
606711	SPECIFIC LANGUAGE IMPAIRMENT 1; SLI1
606712	SPECIFIC LANGUAGE IMPAIRMENT 2; SLI2
606713	VAN DER WOUDE SYNDROME 2; VWS2
606714	PROLINE-RICH NUCLEAR RECEPTOR COACTIVATOR 1; PNRC1
606715	ACID-SENSING ION CHANNEL, SUBUNIT 4; ASIC4
606716	N-ACETYLTRANSFERASE 8; NAT8
606717	XIAP-ASSOCIATED FACTOR 1; XAF1
606718	SOLUTE CARRIER FAMILY 26 (SULFATE TRANSPORTER), MEMBER 2; SLC26A2
606719	MELANOMA-PANCREATIC CANCER SYNDROME
606720	ENDONUCLEASE, POLY(U)-SPECIFIC; ENDOU
606721	LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 7; FPLD7
606722	NEUROCALCIN, DELTA; NCALD
606723	MITOGEN-ACTIVATED PROTEIN KINASE-ACTIVATED PROTEIN KINASE 5; MAPKAPK5
606724	MITOGEN-ACTIVATED PROTEIN KINASE-INTERACTING SERINE/THREONINE KINASE 1; MKNK1
606725	CLN6 TRANSMEMBRANE ER PROTEIN; CLN6
606726	SOLUTE CARRIER FAMILY 12 (POTASSIUM/CHLORIDE TRANSPORTER), MEMBER 5; SLC12A5
606727	NK2 HOMEOBOX 3; NKX2-3
606728	CAVEOLAE-ASSOCIATED PROTEIN 2; CAVIN2
606729	OXYSTEROL-BINDING PROTEIN 2; OSBP2
606730	OXYSTEROL-BINDING PROTEIN-LIKE PROTEIN 1A; OSBPL1A
606731	OXYSTEROL-BINDING PROTEIN-LIKE PROTEIN 2; OSBPL2
606732	OXYSTEROL-BINDING PROTEIN-LIKE PROTEIN 3; OSBPL3
606733	OXYSTEROL-BINDING PROTEIN-LIKE PROTEIN 5; OSBPL5
606734	OXYSTEROL-BINDING PROTEIN-LIKE PROTEIN 6; OSBPL6
606735	OXYSTEROL-BINDING PROTEIN-LIKE PROTEIN 7; OSBPL7
606736	OXYSTEROL-BINDING PROTEIN-LIKE PROTEIN 8; OSBPL8
606737	OXYSTEROL-BINDING PROTEIN-LIKE PROTEIN 9; OSBPL9
606738	OXYSTEROL-BINDING PROTEIN-LIKE PROTEIN 10; OSBPL10
606739	OXYSTEROL-BINDING PROTEIN-LIKE PROTEIN 11; OSBPL11
606740	ZINC FINGER PROTEIN 180; ZNF180
606741	ZINC FINGER PROTEIN 181; ZNF181
606742	TOLLOID-LIKE 1; TLL1
606743	TOLLOID-LIKE 2; TLL2
606744	SECKEL SYNDROME 2; SCKL2
606745	PAR3 FAMILY CELL POLARITY REGULATOR; PARD3
606746	MYELOID-DERIVED GROWTH FACTOR; MYDGF
606747	VASCULAR ENDOTHELIAL ZINC FINGER 1; VEZF1
606748	COACTOSIN-LIKE PROTEIN 1; COTL1
606749	TUBULOINTERSTITIAL NEPHRITIS ANTIGEN; TINAG
606750	Z-DNA BINDING PROTEIN 1; ZBP1
606751	TRANSMEMBRANE PROTEASE, SERINE 5; TMPRSS5
606752	ACUTE HEMORRHAGIC LEUKOENCEPHALITIS
606753	TETRATRICOPEPTIDE REPEAT DOMAIN-CONTAINING PROTEIN 4; TTC4
606754	SAM DOMAIN- AND HD DOMAIN-CONTAINING PROTEIN 1; SAMHD1
606755	PEPTIDYLARGININE DEIMINASE, TYPE III; PADI3
606756	17-BETA-HYDROXYSTEROID DEHYDROGENASE VII; HSD17B7
606757	SOLUTE CARRIER FAMILY 4 (SODIUM BICARBONATE COTRANSPORTER), MEMBER 5; SLC4A5
606758	DUAL OXIDASE 1; DUOX1
606759	DUAL OXIDASE 2; DUOX2
606760	MOVED TO 603977
606761	MALONYL-CoA DECARBOXYLASE; MLYCD
606762	HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 6; HHF6
606763	CILIARY DYSKINESIA, PRIMARY, 2; CILD2
606764	GASTROINTESTINAL STROMAL TUMOR; GIST
606765	THYROID PEROXIDASE; TPO
606766	SPERMATOGENIC FAILURE 3; SPGF3
606767	POTASSIUM CHANNEL, VOLTAGE-GATED, SUBFAMILY G, MEMBER 3; KCNG3
606768	MYOPATHY, DISTAL, WITH ANTERIOR TIBIAL ONSET; DMAT
606769	HELICASE, POLQ-LIKE; HELQ
606770	ADIPONECTIN, SERUM LEVEL OF, QUANTITATIVE TRAIT LOCUS 2; ADIPQTL2
606771	ADIPONECTIN, SERUM LEVEL OF, QUANTITATIVE TRAIT LOCUS 3; ADIPQTL3
606772	IMPAIRED INTELLECTUAL DEVELOPMENT, OBESITY, MANDIBULAR PROGNATHISM, AND EYE AND SKIN ANOMALIES
606773	HEMIFACIAL MYOHYPERPLASIA; HFMH
606774	MYOINOSITOL OXYGENASE; MIOX
606775	CHONDROITIN SULFATE PROTEOGLYCAN 5; CSPG5
606776	TRANSGLUTAMINASE 7; TGM7
606777	GLUT1 DEFICIENCY SYNDROME 1; GLUT1DS1
606778	SLINGSHOT PROTEIN PHOSPHATASE 1; SSH1
606779	SLINGSHOT PROTEIN PHOSPHATASE 2; SSH2
606780	SLINGSHOT PROTEIN PHOSPHATASE 3; SSH3
606781	TRANSKETOLASE; TKT
606782	C-TYPE LECTIN DOMAIN FAMILY 1, MEMBER A; CLEC1A
606783	C-TYPE LECTIN DOMAIN FAMILY 1, MEMBER B; CLEC1B
606784	GLYCOGEN SYNTHASE KINASE 3-ALPHA; GSK3A
606785	CRIGLER-NAJJAR SYNDROME, TYPE II
606786	CD300C ANTIGEN; CD300C
606787	PERIPHERAL ARTERIAL OCCLUSIVE DISEASE 1
606788	ANOREXIA NERVOSA, SUSCEPTIBILITY TO; ANON
606789	FETAL HEMOGLOBIN QUANTITATIVE TRAIT LOCUS 4; HBFQTL4
606790	CD300A ANTIGEN; CD300A
606791	TRANSMEMBRANE PHOSPHOINOSITIDE 3-PHOSPHATASE AND TENSIN HOMOLOG 2; TPTE2
606792	HISTAMINE RECEPTOR H4; HRH4
606793	AMINOPEPTIDASE, PUROMYCIN-SENSITIVE; NPEPPS
606794	SOLUTE CARRIER FAMILY 25 (MITOCHONDRIAL CARRIER), MEMBER 10; SLC25A10
606795	SOLUTE CARRIER FAMILY 25 (MITOCHONDRIAL CARRIER), MEMBER 17; SLC25A17
606796	SUPPRESSION OF TUMORIGENICITY 13; ST13
606797	ST14 TRANSMEMBRANE SERINE PROTEASE MATRIPTASE; ST14
606798	BLEPHAROSPASM, BENIGN ESSENTIAL, SUSCEPTIBILITY TO
606799	STROKE, SUSCEPTIBILITY TO, 1
606800	GLUCOSIDASE, ALPHA, ACID; GAA
606801	MACROPHAGE ERYTHROBLAST ATTACHER; MAEA
606802	SPIB TRANSCRIPTION FACTOR; SPIB
606803	ACYL-CoA THIOESTERASE 11; ACOT11
606804	GOLGI MEMBRANE PROTEIN 1; GOLM1
606805	GOLGI INTEGRAL MEMBRANE PROTEIN 4; GOLIM4
606806	FORMIMINOTRANSFERASE CYCLODEAMINASE; FTCD
606807	INTERLEUKIN 17 RECEPTOR D; IL17RD
606808	MYOSIN IIIA; MYO3A
606809	ACYL-CoA-BINDING DOMAIN-CONTAINING PROTEIN 3; ACBD3
606810	PROLINE DEHYDROGENASE 1; PRODH
606811	ALDEHYDE DEHYDROGENASE, FAMILY 4, SUBFAMILY A, MEMBER 1; ALDH4A1
606812	FUMARASE DEFICIENCY; FMRD
606813	SOLUTE CARRIER FAMILY 2i (FACILITATED GLUCOSE TRANSPORTER), MEMBER 6; SLC2A6
606814	PROTEOGLYCAN 3; PRG3
606815	CBP/P300-INTERACTING TRANSACTIVATOR, WITH GLU/ASP-RICH CARBOXY TERMINAL DOMAIN, 4; CITED4
606816	SID1 TRANSMEMBRANE FAMILY, MEMBER 1; SIDT1
606817	PRE-T-CELL RECEPTOR, ALPHA-CHAIN PRECURSOR; PTCRA
606818	DIPEPTIDYL PEPTIDASE III; DPP3
606819	DIPEPTIDYL PEPTIDASE VIII; DPP8
606820	GLUTAREDOXIN 2; GLRX2
606821	COMPONENT OF OLIGOMERIC GOLGI COMPLEX 5; COG5
606822	PROTEIN O-MANNOSE BETA-1,2-N-ACETYLGLUCOSAMINYLTRANSFERASE; POMGNT1
606823	ADHESION G PROTEIN-COUPLED RECEPTOR A2; ADGRA2
606824	GLUCOSE/GALACTOSE MALABSORPTION; GGM
606825	TENSIN 3; TNS3
606826	PLEXIN DOMAIN-CONTAINING PROTEIN 1; PLXDC1
606827	PLEXIN DOMAIN-CONTAINING PROTEIN 2; PLXDC2
606828	N-ACETYLGLUCOSAMINE KINASE; NAGK
606829	FRATAXIN; FXN
606830	ATP/GTP-BINDING PROTEIN 1; AGTPBP1
606831	NLR FAMILY, CASPASE RECRUITMENT DOMAIN-CONTAINING 4; NLRC4
606832	ENDOPLASMIC RETICULUM AMINOPEPTIDASE 1; ERAP1
606833	LYSINE-SPECIFIC METHYLTRANSFERASE 2C; KMT2C
606834	LYSINE-SPECIFIC METHYLTRANSFERASE 2B; KMT2B
606835	DIGITAL ARTHROPATHY-BRACHYDACTYLY, FAMILIAL; FDAB
606836	GLUCOSAMINYL (N-ACETYL) TRANSFERASE 3, MUCIN-TYPE; GCNT3
606837	RB1-INDUCIBLE COILED-COIL 1; RB1CC1
606838	PYD AND CARD DOMAIN-CONTAINING PROTEIN; PYCARD
606839	CADHERIN-RELATED FAMILY, MEMBER 5; CDHR5
606840	PARASOMNIA, SLEEP BRUXISM TYPE; PSMNSB
606841	DEATH EFFECTOR DOMAIN-CONTAINING PROTEIN; DEDD
606842	CARDIONEUROMYOPATHY WITH HYALINE MASSES AND NEMALINE RODS
606843	IMMUNODEFICIENCY WITH HYPER-IgM, TYPE 3; HIGM3
606844	ALMS1 CENTROSOME AND BASAL BODY ASSOCIATED PROTEIN; ALMS1
606845	GOLGI-ASSOCIATED PDZ AND COILED-COIL DOMAINS-CONTAINING PROTEIN; GOPC
606846	SET AND MYND DOMAIN-CONTAINING PROTEIN 1; SMYD1
606847	TREACLE RIBOSOME BIOGENESIS FACTOR 1; TCOF1
606848	NIMA-RELATED KINASE 7; NEK7
606849	UBIQUITIN-LIKE 5; UBL5
606850	MIPOL1 GENE; MIPOL1
606851	CREE MENTAL RETARDATION SYNDROME
606852	PARKINSON DISEASE 10; PARK10
606853	ATPase, H+ TRANSPORTING, LYSOSOMAL, 13-KD, V1 SUBUNIT G, ISOFORM 2; ATP6V1G2
606854	CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 14A (BILATERAL FRONTOPARIETAL); CDCBM14A
606855	RELAXIN 3; RLN3
606856	PANCREATIC CANCER, SUSCEPTIBILITY TO, 1
606857	GLUTAMATE-CYSTEINE LIGASE, CATALYTIC SUBUNIT; GCLC
606858	MOVED TO 251200
606859	MOVED TO 270700
606860	COMPLEMENT COMPONENT 1 INHIBITOR; C1NH
606861	PROSTATE- AND TESTIS-EXPRESSED GENE; PATE
606862	OSTEOCLAST-ASSOCIATED RECEPTOR; OSCAR
606863	THYMOCYTE SELECTION-ASSOCIATED HIGH MOBILITY GROUP BOX; TOX
606864	PARAGANGLIOMA AND GASTRIC STROMAL SARCOMA
606865	FUCOSYLTRANSFERASE 9; FUT9
606866	MITOCHONDRIAL RIBOSOMAL PROTEIN L49; MRPL49
606867	GOLGI REASSEMBLY STACKING PROTEIN 1; GORASP1
606868	HOMEODOMAIN-INTERACTING PROTEIN KINASE 2; HIPK2
606869	HEXOSAMINIDASE A; HEXA
606870	JUNCTIONAL ADHESION MOLECULE 2; JAM2
606871	JUNCTIONAL ADHESION MOLECULE 3; JAM3
606872	CAS-BR-M MURINE ECTOPIC RETROVIRAL TRANSFORMING SEQUENCE LIKE-1; CBLL1
606873	HEXOSAMINIDASE B; HEXB
606874	HIRSCHSPRUNG DISEASE, SUSCEPTIBILITY TO, 6; HSCR6
606875	HIRSCHSPRUNG DISEASE, SUSCEPTIBILITY TO, 7; HSCR7
606876	PHOSPHATIDYLINOSITOL TRANSFER PROTEIN, BETA; PITPNB
606877	ACIDIC LEUCINE-RICH NUCLEAR PHOSPHOPROTEIN 32 FAMILY, MEMBER C; ANP32C
606878	ACIDIC LEUCINE-RICH NUCLEAR PHOSPHOPROTEIN 32 FAMILY, MEMBER D; ANP32D
606879	PHOSPHOGLYCERATE DEHYDROGENASE; PHGDH
606880	CASPASE 8-ASSOCIATED PROTEIN 2; CASP8AP2
606881	FORMIN HOMOLOGY-2 DOMAIN-CONTAINING PROTEIN 1; FHOD1
606882	ATPase, Cu(2+)-TRANSPORTING, BETA POLYPEPTIDE; ATP7B
606883	INTERLEUKIN 1 RECEPTOR-ASSOCIATED KINASE 4; IRAK4
606884	RNA-BINDING MOTIF PROTEIN 5; RBM5
606885	ACYL-CoA DEHYDROGENASE, SHORT-CHAIN; ACADS
606886	RNA-BINDING MOTIF PROTEIN 6; RBM6
606887	SULFITE OXIDASE; SUOX
606888	CHOLINERGIC RECEPTOR, NEURONAL NICOTINIC, ALPHA POLYPEPTIDE 6; CHRNA6
606889	ALZHEIMER DISEASE 4; AD4
606890	GALACTOSYLCERAMIDASE; GALC
606891	Fc RECEPTOR-LIKE PROTEIN A; FCRLA
606892	SYNTAXIN 12; STX12
606893	VASCULAR MALFORMATION, PRIMARY INTRAOSSEOUS; VMPI
606894	DUODENOJEJUNAL ATRESIA WITH VOLVULUS, ABSENT DORSAL MESENTERY, AND ABSENT SUPERIOR MESENTERIC ARTERY
606895	SYMPHALANGISM, DISTAL, WITH MICRODONTIA, DENTAL PULP STONES, AND NARROWED ZYGOMATIC ARCH
606896	DYSLEXIA, SUSCEPTIBILITY TO, 5; DYX5
606897	LYSOSOMAL TRAFFICKING REGULATOR; LYST
606898	CALCIUM CHANNEL, VOLTAGE-DEPENDENT, GAMMA-6 SUBUNIT; CACNG6
606899	CALCIUM CHANNEL, VOLTAGE-DEPENDENT, GAMMA-7 SUBUNIT; CACNG7
606900	CALCIUM CHANNEL, VOLTAGE-DEPENDENT, GAMMA-8 SUBUNIT; CACNG8
606901	MOVED TO 604754
606902	PYGOPUS FAMILY PHD FINGER 1; PYGO1
606903	PYGOPUS FAMILY PHD FINGER 2; PYGO2
606904	MOVED TO 254770
606905	PHOSPHATIDYLINOSITOL 3,4,5-TRISPHOSPHATE-DEPENDENT RAC EXCHANGER 1; PREX1
606906	MITOCHONDRIAL RIBOSOMAL RNA METHYLTRANSFERASE 2; MRM2
606907	APOLIPOPROTEIN M; APOM
606908	ADP-RIBOSYLATION FACTOR GTPase-ACTIVATING PROTEIN 2; ARFGAP2
606909	VESICLE-ASSOCIATED MEMBRANE PROTEIN 4; VAMP4
606910	BCL2-LIKE 10; BCL2L10
606911	SECRETORY CARRIER MEMBRANE PROTEIN 1; SCAMP1
606912	SECRETORY CARRIER MEMBRANE PROTEIN 2; SCAMP2
606913	SECRETORY CARRIER MEMBRANE PROTEIN 3; SCAMP3
606914	PROTEIN KINASE, cAMP-DEPENDENT CATALYTIC, INHIBITOR BETA; PKIB
606915	G PROTEIN-COUPLED RECEPTOR 63; GPR63
606916	G PROTEIN-COUPLED RECEPTOR 61; GPR61
606917	G PROTEIN-COUPLED RECEPTOR 62; GPR62
606918	GOLGIN A5; GOLGA5
606919	CERAMIDE SYNTHASE 1; CERS1
606920	CERAMIDE SYNTHASE 2; CERS2
606921	G PROTEIN-COUPLED RECEPTOR 78; GPR78
606922	OXOGLUTARATE RECEPTOR 1; OXGR1
606923	HYDROXYCARBOXYLIC ACID RECEPTOR 1; HCAR1
606924	MOVED TO 300748
606925	PYROGLUTAMYLATED RF-AMIDE PEPTIDE RECEPTOR; QRFPR
606926	LYSOPHOSPHATIDIC ACID RECEPTOR 5; LPAR5
606927	TRACE AMINE-ASSOCIATED RECEPTOR 8; TAAR8
606928	BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS 3; BMND3
606929	THO COMPLEX, SUBUNIT 3; THOC3
606930	THO COMPLEX, SUBUNIT 1; THOC1
606931	MOVED TO 601501
606932	VPS29 RETROMER COMPLEX COMPONENT; VPS29
606933	TYROSINASE; TYR
606934	NADH DEHYDROGENASE (UBIQUINONE) COMPLEX I, ASSEMBLY FACTOR 1; NDUFAF1
606935	RNA-BINDING MOTIF PROTEIN 17; RBM17
606936	TRANSIENT RECEPTOR POTENTIAL CATION CHANNEL, SUBFAMILY M, MEMBER 4; TRPM4
606937	MOVED TO 251300
606938	UROPORPHYRINOGEN III SYNTHASE; UROS
606939	ATPase, H+ TRANSPORTING, LYSOSOMAL, 56/58-KD, V1 SUBUNIT B, ISOFORM 2; ATP6V1B2
606940	ZINC FINGER HOMEOBOX 4; ZFHX4
606941	ALG9 ALPHA-1,2-MANNOSYLTRANSFERASE; ALG9
606942	COATOMER PROTEIN COMPLEX, SUBUNIT EPSILON; COPE
606943	USHER SYNDROME, TYPE IG; USH1G
606944	ERBB2 INTERACTING PROTEIN; ERBIN
606945	LOW DENSITY LIPOPROTEIN RECEPTOR; LDLR
606946	ANAPHASE-PROMOTING COMPLEX, SUBUNIT 2; ANAPC2
606947	ANAPHASE-PROMOTING COMPLEX, SUBUNIT 4; ANAPC4
606948	ANAPHASE-PROMOTING COMPLEX, SUBUNIT 5; ANAPC5
606949	ANAPHASE-PROMOTING COMPLEX, SUBUNIT 7; ANAPC7
606950	THYROTROPIN-RELEASING HORMONE-DEGRADING ECTOENZYME; TRHDE
606951	INTERFERON-INDUCED HELICASE C DOMAIN-CONTAINING PROTEIN 1; IFIH1
606952	ALBINISM, OCULOCUTANEOUS, TYPE IB; OCA1B
606953	UDP-GALACTOSE-4-EPIMERASE; GALE
606954	ZINC FINGER PROTEIN 253; ZNF253
606955	MOVED TO 194555
606956	ZINC FINGER PROTEIN 256; ZNF256
606957	ZINC FINGER PROTEIN 257; ZNF257
606958	PROTEIN ASSOCIATED WITH LIN7 1, MAGUK p55 FAMILY MEMBER; PALS1
606959	PROTEIN ASSOCIATED WITH LIN7 2, MAGUK p55 FAMILY MEMBER; PALS2
606960	INSULINOMA TUMOR SUPPRESSOR GENE LOCUS
606961	WW DOMAIN-BINDING PROTEIN 1; WBP1
606962	WW DOMAIN-BINDING PROTEIN 2; WBP2
606963	PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; COPD
606964	SERINE/THREONINE PROTEIN KINASE 38; STK38
606965	FAS-ACTIVATED SERINE/THREONINE KINASE; FASTK
606966	NEPHRONOPHTHISIS 4; NPHP4
606967	LECITHIN:CHOLESTEROL ACYLTRANSFERASE; LCAT
606968	EUKARYOTIC ELONGATION FACTOR 2 KINASE; EEF2K
606969	GEM NUCLEAR ORGANELLE-ASSOCIATED PROTEIN 4; GEMIN4
606970	MOVED TO 600669
606971	MOVED TO 607631
606972	EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 2; EIG2
606973	COMPONENT OF OLIGOMERIC GOLGI COMPLEX 1; COG1
606974	COMPONENT OF OLIGOMERIC GOLGI COMPLEX 2; COG2
606975	COMPONENT OF OLIGOMERIC GOLGI COMPLEX 3; COG3
606976	COMPONENT OF OLIGOMERIC GOLGI COMPLEX 4; COG4
606977	COMPONENT OF OLIGOMERIC GOLGI COMPLEX 6; COG6
606978	COMPONENT OF OLIGOMERIC GOLGI COMPLEX 7; COG7
606979	COMPONENT OF OLIGOMERIC GOLGI COMPLEX 8; COG8
606980	COENZYME Q8A; COQ8A
606981	GUANINE NUCLEOTIDE-BINDING PROTEIN, GAMMA-2; GNG2
606982	GERANYLGERANYL DIPHOSPHATE SYNTHASE 1; GGPS1
606983	DIACYLGLYCEROL O-ACYLTRANSFERASE 2; DGAT2
606984	HYPERRENINEMIC HYPOALDOSTERONISM, FAMILIAL, 2
606985	ELONGATOR ACETYLTRANSFERASE COMPLEX, SUBUNIT 4; ELP4
606986	MOVED TO 600716
606987	G PROTEIN-COUPLED RECEPTOR KINASE 7; GRK7
606988	CALCINEURIN-LIKE EF-HAND PROTEIN 1; CHP1
606989	MYELOPEROXIDASE; MPO
606990	COATOMER PROTEIN COMPLEX, SUBUNIT BETA-2; COPB2
606991	INOSITOL HEXAPHOSPHATE KINASE 1; IP6K1
606992	INOSITOL HEXAPHOSPHATE KINASE 2; IP6K2
606993	INOSITOL HEXAPHOSPHATE KINASE 3; IP6K3
606994	TYROSINE KINASE, NONRECEPTOR, 2; TNK2
606995	SENIOR-LOKEN SYNDROME 3; SLSN3
606996	SENIOR-LOKEN SYNDROME 4; SLSN4
606997	C1D NUCLEAR RECEPTOR COREPRESSOR; C1D
606998	FLOTILLIN 1; FLOT1
606999	GALACTOSE-1-PHOSPHATE URIDYLYLTRANSFERASE; GALT
607000	MEDIATOR COMPLEX SUBUNIT 24; MED24
607001	EUCHROMATIC HISTONE METHYLTRANSFERASE 1; EHMT1
607002	PROKINETICIN 2; PROK2
607003	THYMIC STROMAL LYMPHOPOIETIN; TSLP
607004	BRACHYDACTYLY, TYPE A1, B; BDA1B
607005	GEM NUCLEAR ORGANELLE-ASSOCIATED PROTEIN 5; GEMIN5
607006	GEM NUCLEAR ORGANELLE-ASSOCIATED PROTEIN 6; GEMIN6
607007	SNAP-ASSOCIATED PROTEIN; SNAPIN
607008	ACYL-CoA DEHYDROGENASE, MEDIUM-CHAIN; ACADM
607009	TRANSIENT RECEPTOR POTENTIAL CATION CHANNEL, SUBFAMILY M, MEMBER 6; TRPM6
607010	DECAPPING mRNA 1A; DCP1A
607011	UBIQUITIN-SPECIFIC PROTEASE 17; USP17
607012	B-DOUBLE PRIME 1, SUBUNIT OF RNA POLYMERASE III TRANSCRIPTION INITIATION FACTOR IIIB; BDP1
607013	BRF2 SUBUNIT OF RNA POLYMERASE III TRANSCRIPTION INITIATION FACTOR; BRF2
607014	HURLER SYNDROME
607015	HURLER-SCHEIE SYNDROME
607016	SCHEIE SYNDROME
607017	DEAFNESS, AUTOSOMAL DOMINANT 21; DFNA21
607018	ADHESION G PROTEIN-COUPLED RECEPTOR L2; ADGRL2
607019	RAS ASSOCIATION DOMAIN FAMILY PROTEIN 3; RASSF3
607020	RAS ASSOCIATION DOMAIN FAMILY PROTEIN 5; RASSF5
607021	SEZ6-LIKE PROTEIN; SEZ6L
607022	CCCTC-BINDING FACTOR-LIKE PROTEIN; CTCFL
607023	POLO-LIKE KINASE 2; PLK2
607024	DEBRANCHING RNA LARIATS 1; DBR1
607025	MATERNAL EMBRYONIC LEUCINE ZIPPER KINASE; MELK
607026	NEURON NAVIGATOR 2; NAV2
607027	ATPase, H+ TRANSPORTING, LYSOSOMAL, 70-KD, VI SUBUNIT A; ATP6V1A
607028	ATPase, H+ TRANSPORTING, LYSOSOMAL, 38-KD, V0 SUBUNIT D, ISOFORM 1; ATP6V0D1
607029	VESICLE-ASSOCIATED MEMBRANE PROTEIN 5; VAMP5
607030	GRANCALCIN; GCA
607031	LIPOIC ACID SYNTHASE; LIAS
607032	SMG1 NONSENSE-MEDIATED mRNA DECAY-ASSOCIATED PI3K-RELATED KINASE; SMG1
607033	TRANSCRIPTION FACTOR B1, MITOCHONDRIAL; TFB1M
607034	MOVED TO 135700
607035	SUFU NEGATIVE REGULATOR OF HEDGEHOG SIGNALING; SUFU
607036	ISOVALERYL-CoA DEHYDROGENASE; IVD
607037	ENOYL-CoA HYDRATASE/3-HYDROXYACYL CoA DEHYDROGENASE; EHHADH
607038	OTOANCORIN; OTOA
607039	DEAFNESS, AUTOSOMAL RECESSIVE 22; DFNB22
607040	ATP-BINDING CASSETTE, SUBFAMILY C, MEMBER 11; ABCC11
607041	ATP-BINDING CASSETTE, SUBFAMILY C, MEMBER 12; ABCC12
607042	CLN3 LYSOSOMAL/ENDOSOMAL TRANSMEMBRANE PROTEIN, BATTENIN; CLN3
607043	TRAF3-INTERACTING PROTEIN 2; TRAF3IP2
607044	T-BOX 24
607045	RHABDOMYOSARCOMA 2-ASSOCIATED TRANSCRIPT; RMST
607046	TRANSLOCASE OF OUTER MITOCHONDRIAL MEMBRANE 22; TOMM22
607047	ATAXIN 3; ATXN3
607048	START DOMAIN-CONTAINING PROTEIN 3; STARD3
607049	START DOMAIN-CONTAINING PROTEIN 4; STARD4
607050	START DOMAIN-CONTAINING PROTEIN 5; STARD5
607051	START DOMAIN-CONTAINING PROTEIN 6; STARD6
607052	TUMOR SUPPRESSOR CANDIDATE 2; TUSC2
607053	HIGH DENSITY LIPOPROTEIN CHOLESTEROL LEVEL QUANTITATIVE TRAIT LOCUS 2; HDLCQ2
607054	PLECKSTRIN HOMOLOGY-LIKE DOMAIN, FAMILY A, MEMBER 3; PHLDA3
607055	TRANSCRIPTION FACTOR B2, MITOCHONDRIAL; TFB2M
607056	INTERPHOTORECEPTOR MATRIX PROTEOGLYCAN 2; IMPG2
607057	UBIQUITIN-SPECIFIC PROTEASE 18; USP18
607058	GAP JUNCTION PROTEIN, DELTA-2; GJD2
607059	SOLUTE CARRIER FAMILY 39 (ZINC TRANSPORTER), MEMBER 4; SLC39A4
607060	PARKINSON DISEASE 8, AUTOSOMAL DOMINANT; PARK8
607061	PROSTAGLANDIN E SYNTHASE 3; PTGES3
607062	FK506-BINDING PROTEIN 7; FKBP7
607063	FK506-BINDING PROTEIN 10; FKBP10
607064	PROCOLLAGEN C-ENDOPEPTIDASE ENHANCER 2; PCOLCE2
607065	GLUTAMINYL-PEPTIDE CYCLOTRANSFERASE; QPCT
607066	TRANSIENT RECEPTOR POTENTIAL CATION CHANNEL, SUBFAMILY V, MEMBER 3; TRPV3
607067	SAITOHIN; STH
607068	CYTOCHROME b561 DOMAIN-CONTAINING PROTEIN 2; CYB561D2
607069	TRANSMEMBRANE PROTEIN 115; TMEM115
607070	ZINC FINGER MYND DOMAIN-CONTAINING PROTEIN 10; ZMYND10
607071	HYALURONOGLUCOSAMINIDASE 1; HYAL1
607072	NPR2-LIKE PROTEIN, GATOR1 COMPLEX SUBUNIT; NPRL2
607073	N-ALPHA-ACETYLTRANSFERASE 80, NatH CATALYTIC SUBUNIT; NAA80
607074	PROTEIN KINASE D2; PRKD2
607075	PDGFA-ASSOCIATED PROTEIN 1; PDAP1
607076	PROTEASE INHIBITOR 15; PI15
607077	PROTEIN KINASE C, NU; PRKCN
607078	EPIPHYSEAL DYSPLASIA, MULTIPLE, 5; EDM5
607079	RHESUS BLOOD GROUP, B GLYCOPROTEIN; RHBG
607080	46,XY GONADAL DYSGENESIS WITH MINIFASCICULAR NEUROPATHY; GDMN
607081	TAP-BINDING PROTEIN-LIKE; TAPBPL
607082	CALCIUM CHANNEL, VOLTAGE-DEPENDENT, ALPHA-2/DELTA SUBUNIT 2; CACNA2D2
607083	NUCLEAR RECEPTOR-BINDING SET DOMAIN PROTEIN 3; NSD3
607084	DEAFNESS, AUTOSOMAL RECESSIVE 31; DFNB31
607085	MYASTHENIA GRAVIS WITH THYMUS HYPERPLASIA
607086	AORTIC ANEURYSM, FAMILIAL THORACIC 1; AAT1
607087	AORTIC ANEURYSM, FAMILIAL THORACIC 2; AAT2
607088	NEURONOPATHY, DISTAL HEREDITARY MOTOR, AUTOSOMAL RECESSIVE 3; HMNR3
607089	CYCLIN D-TYPE-BINDING PROTEIN 1; CCNDBP1
607090	SYF2 PRE-mRNA SPLICING FACTOR; SYF2
607091	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IId; CDG2D
607092	SPHINGOSINE KINASE 2; SPHK2
607093	5,10-METHYLENETETRAHYDROFOLATE REDUCTASE; MTHFR
607094	SUPPRESSOR OF CYTOKINE SIGNALING 5; SOCS5
607095	ANAUXETIC DYSPLASIA 1; ANXD1
607096	SOLUTE CARRIER FAMILY 22 (URATE TRANSPORTER), MEMBER 12; SLC22A12
607097	SOLUTE CARRIER FAMILY 22 (ORGANIC ANION/CATION TRANSPORTER), MEMBER 11
607098	ENOLASE ALPHA, LUNG-SPECIFIC; ENO1B
607099	HISTONE H4 TRANSCRIPTION FACTOR; HINFP
607100	NEPHROCYSTIN 1; NPHP1
607101	DEAFNESS, AUTOSOMAL RECESSIVE 30; DFNB30
607102	WT1 TRANSCRIPTION FACTOR; WT1
607103	ARGINYLTRANSFERASE 1; ATE1
607104	TANKYRASE 1-BINDING PROTEIN 1; TNKS1BP1
607105	NADPH OXIDASE 3; NOX3
607106	MINOR HISTOCOMPATIBILITY 13; HM13
607107	NASOPHARYNGEAL CARCINOMA
607108	PAIRED BOX GENE 6; PAX6
607109	APOLIPOPROTEIN B mRNA-EDITING ENZYME, CATALYTIC POLYPEPTIDE-LIKE 3A; APOBEC3A
607110	APOLIPOPROTEIN B mRNA-EDITING ENZYME, CATALYTIC POLYPEPTIDE-LIKE 3B; APOBEC3B
607111	SPARTIN; SPART
607112	F-BOX ONLY PROTEIN 2; FBXO2
607113	APOLIPOPROTEIN B mRNA-EDITING ENZYME, CATALYTIC POLYPEPTIDE-LIKE 3G; APOBEC3G
607114	A DISINTEGRIN AND METALLOPROTEINASE DOMAIN 33; ADAM33
607115	CINCA SYNDROME; CINCA
607116	ALZHEIMER DISEASE 8
607117	MICROCEPHALIN 1; MCPH1
607118	MITOCHONDRIAL RIBOSOMAL PROTEIN L3; MRPL3
607119	RING FINGER PROTEIN 19A, RBR E3 UBIQUITIN PROTEIN LIGASE; RNF19A
607120	PHOSPHOLIPASE C, BETA-1; PLCB1
607121	MOVED TO 605569
607122	PROKINETICIN RECEPTOR 1; PROKR1
607123	PROKINETICIN RECEPTOR 2; PROKR2
607124	PHOSPHOLIPID PHOSPHATASE 1; PLPP1
607125	PHOSPHOLIPID PHOSPHATASE 3; PLPP3
607126	PHOSPHOLIPID PHOSPHATASE 2; PLPP2
607127	ELKS/RAB6-INTERACTING/CAST FAMILY, MEMBER 1; ERC1
607128	TANKYRASE 2; TNKS2
607129	MICROTUBULE-ASSOCIATED MONOOXYGENASE, CALPONIN AND LIM DOMAINS-CONTAINING, 1; MICAL1
607130	REGULATORY ASSOCIATED PROTEIN OF MTOR; RPTOR
607131	AL-GAZALI-BAKALINOVA SYNDROME; AGBK
607132	LARYNGEAL ATRESIA, ENCEPHALOCELE, AND LIMB DEFORMITIES
607133	MOVED TO 601547
607134	SPECIFIC LANGUAGE IMPAIRMENT 3; SLI3
607135	CREATININE CLEARANCE QUANTITATIVE TRAIT LOCUS
607136	SPINOCEREBELLAR ATAXIA 17; SCA17
607137	HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN D-LIKE PROTEIN; HNRNPDL
607138	cAMP RESPONSE ELEMENT-BINDING PROTEIN 3-LIKE 4; CREB3L4
607139	FANCA GENE; FANCA
607140	ANGIOID STREAKS
607141	GLIOMA PATHOGENESIS-RELATED PROTEIN 2; GLIPR2
607142	MOVED TO 602617
607143	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ig; CDG1G
607144	ALG12 ALPHA-1,6-MANNOSYLTRANSFERASE; ALG12
607145	DYSTROBREVIN-BINDING PROTEIN 1; DTNBP1
607146	PDZ DOMAIN-CONTAINING 3; PDZD3
607147	NECTIN CELL ADHESION MOLECULE 3; NECTIN3
607148	MOVED TO 300417
607149	RNA EXONUCLEASE 2; REXO2
607150	FEV TRANSCRIPTION FACTOR, ETS FAMILY MEMBER; FEV
607151	MOYAMOYA DISEASE 2; MYMY2
607152	SPASTIC PARAPLEGIA 19, AUTOSOMAL DOMINANT; SPG19
607153	INTEGRIN, BETA-1, BINDING PROTEIN OF, 1; ITGB1BP1
607154	ALLERGIC RHINITIS
607155	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 5; MDDGC5
607156	ST3 BETA-GALACTOSIDE ALPHA-2,3-SIALYLTRANSFERASE 6; ST3GAL6
607157	SIALIC ACID-BINDING IMMUNOGLOBULIN-LIKE LECTIN 11; SIGLEC11
607158	VENT HOMEOBOX; VENTX
607159	ZINC FINGER MIZ-DOMAIN CONTAINING 1; ZMIZ1
607160	ATPase, H+ TRANSPORTING, LYSOSOMAL, 14-KD, V1 SUBUNIT F; ATP6V1F
607161	MULTIPLE CONGENITAL ANOMALIES SYNDROME WITH CLOVERLEAF SKULL
607162	ST8 ALPHA-N-ACETYL-NEURAMINIDE ALPHA-2,8-SIALYLTRANSFERASE 5; ST8SIA5
607163	LYSYL OXIDASE-LIKE 3; LOXL3
607164	LADYBIRD HOMEOBOX 2; LBX2
607165	SERINE INCORPORATOR 3; SERINC3
607166	TESTIS-SPECIFIC PROTEIN 10; TSGA10
607167	DYNEIN, LIGHT CHAIN, ROADBLOCK TYPE, 1; DYNLRB1
607168	DYNEIN, LIGHT CHAIN, ROADBLOCK TYPE, 2; DYNLRB2
607169	PROTEASE, SERINE, 16; PRSS16
607170	CYSTEINE-RICH PROTEIN WITH EGF-LIKE DOMAINS 1; CRELD1
607171	CYSTEINE-RICH PROTEIN WITH EGF-LIKE DOMAINS 2
607172	SERINE/THREONINE KINASE 11-INTERACTING PROTEIN; STK11IP
607173	PROTEASOME 26S SUBUNIT, NON-ATPase, 14; PSMD14
607174	MENINGIOMA, FAMILIAL, SUSCEPTIBILITY TO
607175	DUAL-SPECIFICITY PHOSPHATASE 16; DUSP16
607176	CALNEURON 1; CALN1
607177	IMMEDIATE-EARLY RESPONSE GENE 5; IER5
607178	PDZK1-INTERACTING PROTEIN 1; PDZK1IP1
607179	RNA-BINDING MOTIF PROTEIN 12; RBM12
607180	LEUCINE-RICH REPEAT-CONTAINING PROTEIN 2; LRRC2
607181	RECEPTOR-TRANSPORTING PROTEIN 3; RTP3
607182	FYVE AND COILED-COIL DOMAIN CONTAINING 1; FYCO1
607183	SEC24-RELATED GENE FAMILY, MEMBER A; SEC24A
607184	SEC24-RELATED GENE FAMILY, MEMBER B; SEC24B
607185	SEC24-RELATED GENE FAMILY, MEMBER C; SEC24C
607186	SEC24-RELATED GENE FAMILY, MEMBER D; SEC24D
607187	ST3 BETA-GALACTOSIDE ALPHA-2,3-SIALYLTRANSFERASE 1; ST3GAL1
607188	ST3 BETA-GALACTOSIDE ALPHA-2,3-SIALYLTRANSFERASE 2; ST3GAL2
607189	REGULATOR OF G PROTEIN SIGNALING 8; RGS8
607190	REGULATOR OF G PROTEIN SIGNALING 13; RGS13
607191	REGULATOR OF G PROTEIN SIGNALING 17; RGS17
607192	REGULATOR OF G PROTEIN SIGNALING 18; RGS18
607193	REGULATOR OF G PROTEIN SIGNALING 20; RGS20
607194	PANCREAS TRANSCRIPTION FACTOR 1, ALPHA SUBUNIT; PTF1A
607195	MOVED TO 128230
607196	MICROCEPHALY, AMISH TYPE; MCPHA
607197	DEAFNESS, AUTOSOMAL RECESSIVE
607198	TYROSYL-DNA PHOSPHODIESTERASE 1; TDP1
607199	INTERFERON REGULATORY FACTOR 6; IRF6
607200	THYROID DYSHORMONOGENESIS 6; TDH6
607201	HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN R; HNRNPR
607202	CELIAC DISEASE, SUSCEPTIBILITY TO, 5; CELIAC5
607203	SALVADOR FAMILY, WW DOMAIN-CONTAINING PROTEIN 1; SAV1
607204	PUMILIO RNA BINDING FAMILY MEMBER 1; PUM1
607205	PUMILIO RNA BINDING FAMILY MEMBER 2; PUM2
607206	ARACHIDONATE LIPOXYGENASE 3; ALOXE3
607207	STIP1 HOMOLOGOUS AND U BOX-CONTAINING PROTEIN 1; STUB1
607208	DRAVET SYNDROME; DRVT
607209	CASPASE RECRUITMENT DOMAIN-CONTAINING PROTEIN 10; CARD10
607210	CASPASE RECRUITMENT DOMAIN-CONTAINING PROTEIN 11; CARD11
607211	CASPASE RECRUITMENT DOMAIN-CONTAINING PROTEIN 14; CARD14
607212	CASPASE RECRUITMENT DOMAIN-CONTAINING PROTEIN 9; CARD9
607213	ORIGIN RECOGNITION COMPLEX, SUBUNIT 6; ORC6
607214	ANONYCHIA, TOTAL, WITH MICROCEPHALY
607215	NEPHROCYSTIN 4; NPHP4
607216	SIDEKICK CELL ADHESION MOLECULE 1; SDK1
607217	SIDEKICK CELL ADHESION MOLECULE 2; SDK2
607218	INTERFERON REGULATORY FACTOR 5; IRF5
607219	CONTACTIN 5; CNTN5
607220	CONTACTIN 6; CNTN6
607221	EPILEPSY, PARTIAL, WITH PERICENTRAL SPIKES; PEPS
607222	F-BOX ONLY PROTEIN 18; FBXO18
607223	SPARC-RELATED MODULAR CALCIUM-BINDING PROTEIN 2; SMOC2
607224	ORAL CANCER OVEREXPRESSED GENE 1; ORAOV1
607225	SPASTIC PARALYSIS, INFANTILE-ONSET ASCENDING; IAHSP
607226	HISTONE DEACETYLASE 11; HDAC11
607227	MAS-RELATED G PROTEIN-COUPLED RECEPTOR FAMILY, MEMBER X1; MRGPRX1
607228	MAS-RELATED G PROTEIN-COUPLED RECEPTOR FAMILY, MEMBER X2; MRGPRX2
607229	MAS-RELATED G PROTEIN-COUPLED RECEPTOR FAMILY, MEMBER X3; MRGPRX3
607230	MAS-RELATED G PROTEIN-COUPLED RECEPTOR FAMILY, MEMBER X4; MRGPRX4
607231	MAS-RELATED G PROTEIN-COUPLED RECEPTOR FAMILY, MEMBER D; MRGPRD
607232	MAS-RELATED G PROTEIN-COUPLED RECEPTOR FAMILY, MEMBER E; MRGPRE
607233	MAS-RELATED G PROTEIN-COUPLED RECEPTOR FAMILY, MEMBER F; MRGPRF
607234	MAS-RELATED G PROTEIN-COUPLED RECEPTOR FAMILY, MEMBER G; MRGPRG
607235	MAS1 ONCOGENE-LIKE; MAS1L
607236	MOVED TO 234200
607237	TRANSMEMBRANE INNER EAR-EXPRESSED GENE; TMIE
607238	COMM DOMAIN-CONTAINING PROTEIN 1; COMMD1
607239	DEAFNESS, AUTOSOMAL RECESSIVE 33; DFNB33
607240	LYSINE METHYLTRANSFERASE 5A; KMT5A
607241	FOLLICULAR DENDRITIC CELL SECRETED PROTEIN; FDCSP
607242	ADAPTOR-RELATED PROTEIN COMPLEX 2, ALPHA-2 SUBUNIT; AP2A2
607243	ADAPTOR-RELATED PROTEIN COMPLEX 4, SIGMA-1 SUBUNIT; AP4S1
607244	ADAPTOR-RELATED PROTEIN COMPLEX 4, EPSILON-1 SUBUNIT; AP4E1
607245	ADAPTOR-RELATED PROTEIN COMPLEX 4, BETA-1 SUBUNIT; AP4B1
607246	ADAPTOR-RELATED PROTEIN COMPLEX 3, DELTA-1 SUBUNIT; AP3D1
607247	CHONDROLECTIN; CHODL
607248	GLIOMA SUSCEPTIBILITY 4; GLM4
607249	CATION CHANNEL, SPERM-ASSOCIATED, 2; CATSPER2
607250	SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE, WITH AXONAL NEUROPATHY 1; SCAN1
607251	TRANSLOCASE OF INNER MITOCHONDRIAL MEMBRANE 22; TIMM22
607252	APOLIPOPROTEIN L2; APOL2
607253	APOLIPOPROTEIN L3; APOL3
607254	APOLIPOPROTEIN L4; APOL4
607255	APOLIPOPROTEIN L5; APOL5
607256	APOLIPOPROTEIN L6; APOL6
607257	SRY-BOX 6; SOX6
607258	HYPERCALCIURIA, ABSORPTIVE, 1
607259	SPASTIC PARAPLEGIA 7, AUTOSOMAL RECESSIVE; SPG7
607260	PLACENTAL PROTEIN 13-LIKE PROTEIN
607261	EVC CILIARY COMPLEX SUBUNIT 2; EVC2
607262	EPSIN 1; EPN1
607263	EPSIN 2; EPN2
607264	EPSIN 3; EPN3
607265	CLATHRIN INTERACTOR 1; CLINT1
607266	MOVED TO 608048
607267	POLYMERASE, DNA, EPSILON-3; POLE3
607268	CHROMATIN ACCESSIBILITY COMPLEX, SUBUNIT 1; CHRAC1
607269	POLYMERASE, DNA, EPSILON-4; POLE4
607270	ACTIVATOR OF TRANSCRIPTION AND DEVELOPMENTAL REGULATOR AUTS2; AUTS2
607271	CASPASE 8 DEFICIENCY
607272	NDC80 KINETOCHORE COMPLEX COMPONENT; NDC80
607273	FOLLICULIN; FLCN
607274	UBIQUITIN-SPECIFIC PROTEASE 14; USP14
607275	HOP HOMEOBOX; HOPX
607276	RESTING HEART RATE, VARIATION IN
607277	ASTHMA-RELATED TRAITS, SUSCEPTIBILITY TO, 1
607278	OSTEOFIBROUS DYSPLASIA, SUSCEPTIBILITY TO; OSFD
607279	SYSTEMIC LUPUS ERYTHEMATOSUS WITH HEMOLYTIC ANEMIA, SUSCEPTIBILITY TO, 1; SLEH1
607280	CONTACTIN 4; CNTN4
607281	LSM1 HOMOLOG, mRNA DEGRADATION-ASSOCIATED; LSM1
607282	LSM2 PROTEIN; LSM2
607283	LSM3 PROTEIN; LSM3
607284	LSM4 PROTEIN; LSM4
607285	LSM5 PROTEIN; LSM5
607286	LSM6 PROTEIN; LSM6
607287	LSM7 PROTEIN; LSM7
607288	LSM8 PROTEIN; LSM8
607289	BIOGENESIS OF LYSOSOME-RELATED ORGANELLES COMPLEX 1, SUBUNIT 5; BLOC1S5
607290	SHISA FAMILY, MEMBER 5; SHISA5
607291	SYNERGIN, GAMMA; SYNRG
607292	SEMAPHORIN 4A; SEMA4A
607293	CHLORIDE INTRACELLULAR CHANNEL 5; CLIC5
607294	TRANSFORMING GROWTH FACTOR-BETA-INDUCED FACTOR 2; TGIF2
607295	MYOSIN XVIIIB; MYO18B
607296	ATPase, H+ TRANSPORTING, LYSOSOMAL, 13-KD, V1 SUBUNIT G, ISOFORM 1; ATP6V1G1
607297	NERVE INJURY-INDUCED PROTEIN 2; NINJ2
607298	GUANINE NUCLEOTIDE-BINDING PROTEIN, GAMMA-13; GNG13
607299	DELTA- AND NOTCH-LIKE EPIDERMAL GROWTH FACTOR-RELATED RECEPTOR; DNER
607300	PRE-mRNA-PROCESSING FACTOR 8; PRPF8
607301	PRE-mRNA PROCESSING FACTOR 3; PRPF3
607302	MOVED TO 116960
607303	MORTALITY FACTOR 4-LIKE PROTEIN 1; MORF4L1
607304	CATARACT 27; CTRCT27
607305	MDS2 GENE
607306	STEROID 5-ALPHA-REDUCTASE 2; SRD5A2
607307	FILAMIN A-INTERACTING PROTEIN 1; FILIP1
607308	MAMMOGRAPHIC DENSITY
607309	ADAPTOR-RELATED PROTEIN COMPLEX 1, MU-2 SUBUNIT; AP1M2
607310	A DISINTEGRIN AND METALLOPROTEINASE DOMAIN 7; ADAM7
607311	PROGESTERONE RECEPTOR; PGR
607312	ZINC FINGER CCCH DOMAIN-CONTAINING ANTIVIRAL PROTEIN 1; ZC3HAV1
607313	GAZE PALSY, FAMILIAL HORIZONTAL, WITH PROGRESSIVE SCOLIOSIS 1; HGPPS1
607314	CALCIUM-BINDING PROTEIN 2; CABP2
607315	CALCIUM-BINDING PROTEIN 5; CABP5
607316	MOVED TO 607315
607317	SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 4; SCAR4
607318	LYSYL OXIDASE-LIKE 4; LOXL4
607319	SCM-LIKE PROTEIN WITH 4 MBT DOMAINS 1; SFMBT1
607320	RAS GUANYL NUCLEOTIDE-RELEASING PROTEIN 4; RASGRP4
607321	ATPase, Na+/K+ TRANSPORTING, ALPHA-4 POLYPEPTIDE; ATP1A4
607322	MOVED TO 143470
607323	DUANE-RADIAL RAY SYNDROME; DRRS
607324	POLYDACTYLY, POSTAXIAL, TYPE A3; PAPA3
607325	DEDICATOR OF CYTOKINESIS 9; DOCK9
607326	SMITH-MCCORT DYSPLASIA 1; SMC1
607327	MUSCLEBLIND-LIKE SPLICING REGULATOR 2; MBNL2
607328	HEXAMETHYLENE BIS ACETAMIDE-INDUCIBLE PROTEIN 1; HEXIM1
607329	HYPERTENSION, ESSENTIAL, SUSCEPTIBILITY TO, 3
607330	LATHOSTEROLOSIS; LATHOS
607331	RP9 PRE-mRNA SPLICING FACTOR; RP9
607332	NEURONAL REGENERATION-RELATED PROTEIN; NREP
607333	STE20-RELATED KINASE ADAPTOR BETA; STRADB
607334	TRAFFICKING PROTEIN, KINESIN-BINDING 2; TRAK2
607335	BESTROPHIN 2; BEST2
607336	BESTROPHIN 4; BEST4
607337	BESTROPHIN 3; BEST3
607338	LEPTIN RECEPTOR OVERLAPPING TRANSCRIPT-LIKE 1; LEPROTL1
607339	CORONARY HEART DISEASE, SUSCEPTIBILITY TO, 1
607340	GAMMA-AMINOBUTYRIC ACID B RECEPTOR 2; GABBR2
607341	FOCAL CORTICAL DYSPLASIA, TYPE II; FCORD2
607342	CYTOPLASMIC POLYADENYLATION ELEMENT-BINDING PROTEIN 1; CPEB1
607343	SAL-LIKE 4; SALL4
607344	TUBULIN, DELTA-1; TUBD1
607345	TUBULIN, EPSILON-1; TUBE1
607346	SPINOCEREBELLAR ATAXIA 19; SCA19
607347	ALPHA KINASE 1; ALPK1
607348	HES FAMILY bHLH TRANSCRIPTION FACTOR 5; HES5
607349	TALIN 2; TLN2
607350	KINESIN FAMILY MEMBER 13B; KIF13B
607351	RHO-RELATED BTB DOMAIN-CONTAINING PROTEIN 1; RHOBTB1
607352	RHO-RELATED BTB DOMAIN-CONTAINING PROTEIN 2; RHOBTB2
607353	RHO-RELATED BTB DOMAIN-CONTAINING PROTEIN 3; RHOBTB3
607354	SCOLIOSIS, ISOLATED, SUSCEPTIBILITY TO, 2; IS2
607355	ARGONAUTE RISC COMPONENT 3; AGO3
607356	ARGONAUTE RISC COMPONENT 4; AGO4
607357	POTASSIUM CHANNEL, VOLTAGE-GATED, KQT-LIKE SUBFAMILY, MEMBER 5; KCNQ5
607358	AUTOIMMUNE REGULATOR; AIRE
607359	CELL DIVISION CYCLE AND APOPTOSIS REGULATOR 2; CCAR2
607360	LACRITIN; LACRT
607361	MECKEL SYNDROME, TYPE 3; MKS3
607362	RGM DOMAIN FAMILY, MEMBER A; RGMA
607363	KINETOCHORE-ASSOCIATED PROTEIN 1; KNTC1
607364	BARTTER SYNDROME, TYPE 3; BARTS3
607365	LIPASE H; LIPH
607366	POTASSIUM CHANNEL, SUBFAMILY K, MEMBER 12; KCNK12
607367	POTASSIUM CHANNEL, SUBFAMILY K, MEMBER 13; KCNK13
607368	POTASSIUM CHANNEL, SUBFAMILY K, MEMBER 15; KCNK15
607369	POTASSIUM CHANNEL, SUBFAMILY K, MEMBER 16; KCNK16
607370	POTASSIUM CHANNEL, SUBFAMILY K, MEMBER 17; KCNK17
607371	DYSTONIA-DEAFNESS SYNDROME 1; DDS1
607372	MEDIATOR COMPLEX SUBUNIT 15; MED15
607373	AUTISM, SUSCEPTIBILITY TO, 8; AUTS8
607374	PRKR INHIBITOR, REPRESSOR OF; PRKRIR
607375	DOT1-LIKE; DOT1L
607376	DYNACTIN 2; DCTN2
607377	LENS EPITHELIAL PROTEIN; LENEP
607378	SERPINE1 mRNA-BINDING PROTEIN 1; SERBP1
607379	NF2, MOESIN-EZRIN-RADIXIN-LIKE (MERLIN) TUMOR SUPPRESSOR; NF2
607380	TNF RECEPTOR-ASSOCIATED FACTOR 3-INTERACTING PROTEIN 1; TRAF3IP1
607381	TRANSLOCASE OF INNER MITOCHONDRIAL MEMBRANE 50; TIMM50
607382	CAP-GLY DOMAIN-CONTAINING LINKER PROTEIN 3; CLIP3
607383	TRANSLOCASE OF INNER MITOCHONDRIAL MEMBRANE 13; TIMM13
607384	TRANSLOCASE OF INNER MITOCHONDRIAL MEMBRANE 9; TIMM9
607385	UDP-N-ACETYLGLUCOSAMINE:ALPHA-1,3-D-MANNOSIDE BETA-1,4-N-ACETYLGLUCOSAMINYLTRANSFERASE IV
607386	INTRAFLAGELLAR TRANSPORT 172; IFT172
607387	DYNACTIN 3; DCTN3
607388	TRANSLOCASE OF INNER MITOCHONDRIAL MEMBRANE 10B; TIMM10B
607389	SINGLE-STRANDED DNA-BINDING PROTEIN 2; SSBP2
607390	SINGLE-STRANDED DNA-BINDING PROTEIN 3; SSBP3
607391	SINGLE-STRANDED DNA-BINDING PROTEIN 4; SSBP4
607392	WW DOMAIN-CONTAINING TRANSCRIPTION REGULATOR 1; WWTR1
607393	CELL DIVISION CYCLE 73; CDC73
607394	POU DOMAIN, CLASS 2, TRANSCRIPTION FACTOR 3; POU2F3
607395	STREPTOCOCCUS, GROUP A, SEVERITY OF INFECTION BY
607396	TRANSDUCER OF ERBB2, 2; TOB2
607397	MELANOCORTIN 2 RECEPTOR; MC2R
607398	GLUCOCORTICOID DEFICIENCY 2; GCCD2
607399	MUCOLIPIN 2; MCOLN2
607400	MUCOLIPIN 3; MCOLN3
607401	INTERFERON, LAMBDA-2; IFNL2
607402	INTERFERON, LAMBDA-3; IFNL3
607403	INTERFERON, LAMBDA-1; IFNL1
607404	INTERFERON-LAMBDA RECEPTOR 1; IFNLR1
607405	TRACE AMINE-ASSOCIATED RECEPTOR 5; TAAR5
607406	STARCH-BINDING DOMAIN-CONTAINING PROTEIN 1; STBD1
607407	EARLY B-CELL FACTOR 3; EBF3
607408	D-AMINO ACID OXIDASE ACTIVATOR; DAOA
607409	NEURITIN 1; NRN1
607410	DIENCEPHALON/MESENCEPHALON HOMEOBOX 1; DMBX1
607411	PATENT DUCTUS ARTERIOSUS 1; PDA1
607412	BPI FOLD-CONTAINING PROTEIN, FAMILY A, MEMBER 1; BPIFA1
607413	ALZHEIMER DISEASE NEURONAL THREAD PROTEIN
607414	FEZ FAMILY ZINC FINGER PROTEIN 2; FEZF2
607415	DAOA ANTISENSE RNA; DAOAAS
607416	CELL ADHESION MOLECULE L1-LIKE; CHL1
607417	INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 2; MRT2
607418	GRIP AND COILED-COIL DOMAINS-CONTAINING PROTEIN 1; GCC1
607419	GEM NUCLEAR ORGANELLE-ASSOCIATED PROTEIN 7; GEMIN7
607420	GABA-A RECEPTOR-ASSOCIATED PROTEIN-LIKE PROTEIN 1; GABARAPL1
607421	NME/NM23 FAMILY, MEMBER 8; NME8
607422	GLYCINE C-ACETYLTRANSFERASE; GCAT
607423	PROTEIN O-MANNOSYLTRANSFERASE 1; POMT1
607424	GLYCINE N-ACYLTRANSFERASE; GLYAT
607425	GAP JUNCTION PROTEIN, DELTA-3; GJD3
607426	COENZYME Q10 DEFICIENCY, PRIMARY, 1; COQ10D1
607427	ENOLASE SUPERFAMILY MEMBER 1; ENOSF1
607428	KIRRE-LIKE NEPHRIN FAMILY ADHESION MOLECULE 1; KIRREL1
607429	PRENYL DIPHOSPHATE SYNTHASE, SUBUNIT 1; PDSS1
607430	DAZ-ASSOCIATED PROTEIN 1; DAZAP1
607431	DAZ-ASSOCIATED PROTEIN 2; DAZAP2
607432	LISSENCEPHALY 1; LIS1
607433	TWINFILIN ACTIN-BINDING PROTEIN 2; TWF2
607434	GTP-BINDING PROTEIN 2; GTPBP2
607435	ERA G-PROTEIN-LIKE 1; ERAL1
607436	POLY(A) POLYMERASE, BETA; PAPOLB
607437	G PROTEIN-COUPLED RECEPTOR, FAMILY C, GROUP 5, MEMBER D; GPRC5D
607438	MOVED TO 138210
607439	PROTEIN O-MANNOSYLTRANSFERASE 2; POMT2
607440	FUKUTIN; FKTN
607441	EPITHELIAL STROMAL INTERACTION 1; EPSTI1
607442	ECHINODERM MICROTUBULE-ASSOCIATED PROTEIN-LIKE 4; EML4
607443	EPIDIDYMAL SPERM BINDING PROTEIN 1; ELSPBP1
607444	SBDS RIBOSOME MATURATION FACTOR; SBDS
607445	EUKARYOTIC TRANSLATION INITIATION FACTOR 4E NUCLEAR IMPORT FACTOR 1; EIF4ENIF1
607446	BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 3; BMIQ3
607447	BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 4; BMIQ4
607448	NEUROPEPTIDE FF RECEPTOR 1; NPFFR1
607449	NEUROPEPTIDE FF RECEPTOR 2; NPFFR2
607450	ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA, FAMILIAL, 8; ARVD8
607451	GLUCOCORTICOID MODULATORY ELEMENT-BINDING PROTEIN 2; GMEB2
607452	GABA-A RECEPTOR-ASSOCIATED PROTEIN-LIKE PROTEIN 2; GABARAPL2
607453	DEAFNESS, AUTOSOMAL DOMINANT 44; DFNA44
607454	SPINOCEREBELLAR ATAXIA 21; SCA21
607455	ZINC FINGER AN1 DOMAIN-CONTAINING PROTEIN 3; ZFAND3
607456	UTP4 SMALL SUBUNIT PROCESSOME COMPONENT; UTP4
607457	GIL BLOOD GROUP
607458	SPINOCEREBELLAR ATAXIA 18; SCA18
607459	SENSORY ATAXIC NEUROPATHY, DYSARTHRIA, AND OPHTHALMOPARESIS; SANDO
607460	PHOSPHATIDYLSERINE-SPECIFIC PHOSPHOLIPASE A1-ALPHA; PLA1A
607461	DYMECLIN; DYM
607462	ATROPHIN 1; ATN1
607463	PROTEIN PHOSPHATASE 1, REGULATORY SUBUNIT 13-LIKE; PPP1R13L
607464	THYROID CARCINOMA, HURTHLE CELL
607465	CODANIN 1; CDAN1
607466	RAS-ASSOCIATED PROTEIN RAB2B; RAB2B
607467	C-TYPE LECTIN-LIKE 1; CLECL1
607468	G PROTEIN-COUPLED RECEPTOR 88; GPR88
607469	N-ACYLETHANOLAMINE ACID AMIDASE; NAAA
607470	BCAS3 MICROTUBULE-ASSOCIATED CELL MIGRATION FACTOR; BCAS3
607471	BREAST CARCINOMA AMPLIFIED SEQUENCE 4; BCAS4
607472	MITOCHONDRIAL ESCAPE 1-LIKE 1; YME1L1
607473	VITAMIN K-DEPENDENT CLOTTING FACTORS, COMBINED DEFICIENCY OF, 2; VKCFD2
607474	HOMOGENTISATE 1,2-DIOXYGENASE; HGD
607475	BOTHNIA RETINAL DYSTROPHY
607476	NEWFOUNDLAND ROD-CONE DYSTROPHY; NFRCD
607477	G2- AND S-PHASE EXPRESSED GENE 1; GTSE1
607478	TRYPTOPHAN HYDROXYLASE 2; TPH2
607479	APC DOWNREGULATED 1; APCDD1
607480	MOVED TO 300424
607481	METABOLISM OF COBALAMIN ASSOCIATED A; MMAA
607482	CARDIOMYOPATHY, DILATED, 1M; CMD1M
607483	BASAL GANGLIA DISEASE, BIOTIN-THIAMINE RESPONSIVE; BBTGD
607484	PAR6 FAMILY CELL POLARITY REGULATOR ALPHA; PARD6A
607485	FRONTOTEMPORAL LOBAR DEGENERATION WITH TDP43 INCLUSIONS, GRN-RELATED
607486	KNOPS BLOOD GROUP SYSTEM; KN
607487	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 25; CMH25
607488	DYSTONIA 15, MYOCLONIC; DYT15
607489	CULLIN 9; CUL9
607490	LACTATE DEHYDROGENASE D; LDHD
607491	PROTEIN O-FUCOSYLTRANSFERASE 1; POFUT1
607492	PHOSPHOFURIN ACIDIC CLUSTER SORTING PROTEIN 1; PACS1
607493	INHIBITOR OF GROWTH 3; ING3
607494	INOSITOL POLYPHOSPHATE-4-PHOSPHATASE, TYPE II, 105-KD; INPP4B
607495	MOVED TO 607138
607496	NITRIC OXIDE SYNTHASE TRAFFICKER; NOSTRIN
607497	BETA-1,3-GLUCURONYLTRANSFERASE 2; B3GAT2
607498	MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 3
607499	BULIMIA NERVOSA, SUSCEPTIBILITY TO; BULN
607500	MOVED TO 146390
607501	MIGRAINE WITHOUT AURA, SUSCEPTIBILITY TO, 4
607502	DISPATCHED RND TRANSPORTER FAMILY, MEMBER 1; DISP1
607503	DISPATCHED RND TRANSPORTER FAMILY, MEMBER 2; DISP2
607504	HEADACHE ASSOCIATED WITH SEXUAL ACTIVITY; HSA
607505	PAS DOMAIN-CONTAINING SERINE/THREONINE KINASE; PASK
607506	A DISINTEGRIN-LIKE AND METALLOPROTEINASE WITH THROMBOSPONDIN TYPE 1 MOTIF, 14; ADAMTS14
607507	PSORIATIC ARTHRITIS, SUSCEPTIBILITY TO
607508	MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 5
607509	A DISINTEGRIN-LIKE AND METALLOPROTEINASE WITH THROMBOSPONDIN TYPE 1 MOTIF, 15; ADAMTS15
607510	A DISINTEGRIN-LIKE AND METALLOPROTEINASE WITH THROMBOSPONDIN TYPE 1 MOTIF, 16; ADAMTS16
607511	A DISINTEGRIN-LIKE AND METALLOPROTEINASE WITH THROMBOSPONDIN TYPE 1 MOTIF, 17; ADAMTS17
607512	A DISINTEGRIN-LIKE AND METALLOPROTEINASE WITH THROMBOSPONDIN TYPE 1 MOTIF, 18; ADAMTS18
607513	A DISINTEGRIN-LIKE AND METALLOPROTEINASE WITH THROMBOSPONDIN TYPE 1 MOTIF, 19; ADAMTS19
607514	BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 10; BMIQ10
607515	PLACENTA-SPECIFIC GENE 8; PLAC8
607516	MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 6
607517	LEUKOCYTE IMMUNOGLOBULIN-LIKE RECEPTOR, SUBFAMILY A, MEMBER 4; LILRA4
607518	MONOCYTE AND PLASMACYTOID ACTIVATED MOLECULE
607519	POLY(ADP-RIBOSE) POLYMERASE FAMILY, MEMBER 4; PARP4
607520	ZYGOTE ARREST 1; ZAR1
607521	HPS5 BIOGENESIS OF LYSOSOMAL ORGANELLES COMPLEX 2, SUBUNIT 2; HPS5
607522	HPS6 BIOGENESIS OF LYSOSOMAL ORGANELLES COMPLEX 2, SUBUNIT 3; HPS6
607523	NAIL DISORDER, NONSYNDROMIC CONGENITAL, 8; NDNC8
607524	RING FINGER PROTEIN 39; RNF39
607525	POLYMERASE I, RNA, SUBUNIT H; POLR1H
607526	RIBOSOMAL PROTEIN L27; RPL27
607527	POLYPYRIMIDINE TRACT BINDING PROTEIN 3; PTBP3
607528	ROUNDABOUT GUIDANCE RECEPTOR 4; ROBO4
607529	SERYL-tRNA SYNTHETASE 1; SARS1
607530	HOMEOBOX A11, ANTISENSE; HOXA11AS
607531	KRUPPEL-LIKE FACTOR 12; KLF12
607532	PROGESTERONE-INDUCED BLOCKING FACTOR 1; PIBF1
607533	DIS3 HOMOLOG, EXOSOME ENDORIBONUCLEASE AND 3-PRIME-5-PRIME EXORIBONUCLEASE; DIS3
607534	YY1-ASSOCIATED FACTOR 2; YAF2
607535	RING1- AND YY1-BINDING PROTEIN; RYBP
607536	CREB-REGULATED TRANSCRIPTION COACTIVATOR 1; CRTC1
607537	MASTERMIND-LIKE 2; MAML2
607538	NUDE NEURODEVELOPMENT PROTEIN 1-LIKE 1; NDEL1
607539	CAMPTOSYNPOLYDACTYLY, COMPLEX; CCSPD
607540	SECRETORY DIARRHEA, MYOPATHY, AND DEAFNESS
607541	CORNEAL DYSTROPHY, AVELLINO TYPE; CDA
607542	POTASSIUM CHANNEL, VOLTAGE-GATED, KQT-LIKE SUBFAMILY, MEMBER 1; KCNQ1
607543	SPONDYLOMETAPHYSEAL DYSPLASIA WITH BOWED FOREARMS AND FACIAL DYSMORPHISM
607544	LEUCINE-RICH PPR MOTIF-CONTAINING PROTEIN; LRPPRC
607545	METHYLSTEROL MONOOXYGENASE 1; MSMO1
607546	CD200 RECEPTOR 1; CD200R1
607547	RIBOSOMAL PROTEIN L39-LIKE; RPL39L
607548	RADIAL SPOKE HEAD 6 HOMOLOG A; RSPH6A
607549	POTE ANKYRIN DOMAIN FAMILY, MEMBER D; POTED
607550	SOLUTE CARRIER FAMILY 16 (MONOCARBOXYLIC ACID TRANSPORTER), MEMBER 10; SLC16A10
607551	STROMAL CELL-DERIVED FACTOR 2-LIKE 1; SDF2L1
607552	MOVED TO 255320
607553	EPIPLAKIN 1; EPPK1
607554	ATRIAL FIBRILLATION, FAMILIAL, 3; ATFB3
607555	TORSIN 3A; TOR3A
607556	TWIST FAMILY bHLH TRANSCRIPTION FACTOR 2; TWIST2
607557	SOLUTE CARRIER FAMILY 17 (VESICULAR GLUTAMATE COTRANSPORTER), MEMBER 8; SLC17A8
607558	SEC14-LIKE LIPID-BINDING PROTEIN 2; SEC14L2
607559	MAHOGUNIN, RING FINGER 1; MGRN1
607560	RHO GUANINE NUCLEOTIDE EXCHANGE FACTOR 2; ARHGEF2
607561	MOVED TO 210720
607562	INTERLEUKIN 23 RECEPTOR; IL23R
607563	SOLUTE CARRIER FAMILY 17 (VESICULAR GLUTAMATE COTRANSPORTER), MEMBER 6; SLC17A6
607564	TRIPARTITE MOTIF-CONTAINING PROTEIN 6; TRIM6
607565	SPASTIC PARAPLEGIA, ATAXIA, AND MENTAL RETARDATION
607566	EPM2A GLUCAN PHOSPHATASE, LAFORIN; EPM2A
607567	OLFACTOMEDIN 3; OLFM3
607568	METABOLISM OF COBALAMIN ASSOCIATED B; MMAB
607569	MOVED TO 603689
607570	DEAH-BOX HELICASE 40; DHX40
607571	SOLUTE CARRIER FAMILY 25 (MITOCHONDRIAL OXODICARBOXYLATE CARRIER), MEMBER 21; SLC25A21
607572	LEPROSY, SUSCEPTIBILITY TO, 2; LPRS2
607573	MICROTUBULE-ASSOCIATED PROTEIN 1S; MAP1S
607574	ARYLSULFATASE A; ARSA
607575	ADENOSINE DEAMINASE 2; ADA2
607576	CECR2 HISTONE ACETYL-LYSINE READER; CECR2
607577	ECTONUCLEOSIDE TRIPHOSPHATE DIPHOSPHOHYDROLASE 4; ENTPD4
607578	BREATH-HOLDING SPELLS
607579	SOLUTE CARRIER FAMILY 22 (ORGANIC ANION/CATION TRANSPORTER), MEMBER 9; SLC22A9
607580	SOLUTE CARRIER FAMILY 22 (ORGANIC ANION/CATION TRANSPORTER), MEMBER 10; SLC22A10
607581	SOLUTE CARRIER FAMILY 22 (ORGANIC ANION TRANSPORTER), MEMBER 8; SLC22A8
607582	SOLUTE CARRIER FAMILY 22 (ORGANIC ANION TRANSPORTER), MEMBER 6; SLC22A6
607583	PEROXISOME BIOGENESIS FACTOR 11G; PEX11G
607584	SPASTIC PARAPLEGIA 24, AUTOSOMAL RECESSIVE; SPG24
607585	ATM SERINE/THREONINE KINASE; ATM
607586	CALCIUM RESPONSE FACTOR; CARF
607587	INTERLEUKIN 17D; IL17D
607588	PEPTIDYL-PROLYL ISOMERASE-LIKE 2; PPIL2
607589	SERUM/GLUCOCORTICOID-REGULATED KINASE 2; SGK2
607590	BBS7 GENE; BBS7
607591	SERUM/GLUCOCORTICOID-REGULATED KINASE 3; SGK3
607592	PROSTATE CANCER AGGRESSIVENESS QUANTITATIVE TRAIT LOCUS ON CHROMOSOME 19
607593	MEDIATOR OF DNA DAMAGE CHECKPOINT PROTEIN 1; MDC1
607594	IMMUNODEFICIENCY, COMMON VARIABLE, 1; CVID1
607595	MOVED TO 175780
607596	PONTOCEREBELLAR HYPOPLASIA, TYPE 1A; PCH1A
607597	MICROPHTHALMIA WITH CYST, BILATERAL FACIAL CLEFTS, AND LIMB ANOMALIES
607598	LETHAL CONGENITAL CONTRACTURE SYNDROME 2; LCCS2
607599	RETINOL DEHYDROGENASE 10; RDH10
607600	EPIDERMOLYSIS BULLOSA SIMPLEX SUPERFICIALIS; EBSS
607601	TIR DOMAIN-CONTAINING ADAPTOR MOLECULE 1; TICAM1
607602	ICHTHYOSIS, ANNULAR EPIDERMOLYTIC, 1; AEI1
607603	POTASSIUM CHANNEL, VOLTAGE-GATED, SUBFAMILY G, MEMBER 4; KCNG4
607604	POTASSIUM CHANNEL, VOLTAGE-GATED, SUBFAMILY V, MEMBER 2; KCNV2
607605	GLUTATHIONE S-TRANSFERASE, ALPHA-5; GSTA5
607606	KERATIN 9, TYPE I; KRT9
607607	NUCLEOPORIN, 54-KD; NUP54
607608	SPHINGOMYELIN PHOSPHODIESTERASE 1, ACID LYSOSOMAL; SMPD1
607609	PEPTIDYL-PROLYL ISOMERASE-LIKE 4; PPIL4
607610	PHOSPHOLIPID SCRAMBLASE 2; PLSCR2
607611	PHOSPHOLIPID SCRAMBLASE 3; PLSCR3
607612	PHOSPHOLIPID SCRAMBLASE 4; PLSCR4
607613	NUCLEOPORIN, 133-KD; NUP133
607614	NUCLEOPORIN, 160-KD; NUP160
607615	NUCLEOPORIN, 58-KD; NUP58
607616	NIEMANN-PICK DISEASE, TYPE B
607617	NUCLEOPORIN, 107-KD; NUP107
607618	DEAD-BOX HELICASE 28; DDX28
607619	FERM DOMAIN-CONTAINING PROTEIN 3; FRMD3
607620	COLLECTIN 10; COLEC10
607621	COLLECTIN 12; COLEC12
607622	PHOSPHOMEVALONATE KINASE; PMVK
607623	NPC INTRACELLULAR CHOLESTEROL TRANSPORTER 1; NPC1
607624	GRISCELLI SYNDROME, TYPE 2; GS2
607625	NIEMANN-PICK DISEASE, TYPE C2; NPC2
607626	ICHTHYOSIS, LEUKOCYTE VACUOLES, ALOPECIA, AND SCLEROSING CHOLANGITIS; ILVASC
607627	BPI FOLD-CONTAINING PROTEIN, FAMILY A, MEMBER 4, PSEUDOGENE; BPIFA4P
607628	EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 11; EIG11
607629	APH1 HOMOLOG A, GAMMA SECRETASE SUBUNIT; APH1A
607630	APH1 HOMOLOG B, GAMMA-SECRETASE SUBUNIT; APH1B
607631	EPILEPSY, JUVENILE ABSENCE, SUSCEPTIBILITY TO, 1; EJA1
607632	PRESENILIN ENHANCER, GAMMA-SECRETASE SUBUNIT; PSENEN
607633	XANTHINE DEHYDROGENASE; XDH
607634	OSTEOPETROSIS, AUTOSOMAL DOMINANT 1; OPTA1
607635	CARBOXYPEPTIDASE A4; CPA4
607636	MOVED TO 144750
607637	EMX2 OPPOSITE STRAND/ANTISENSE RNA; EMX2OS
607638	DEOXYCYTIDYLATE DEAMINASE; DCTD
607639	SCAVENGER RECEPTOR CYSTEINE-RICH FAMILY MEMBER WITH 4 DOMAINS; SSC4D
607640	ATAXIN 7; ATXN7
607641	NEURONOPATHY, DISTAL HEREDITARY MOTOR, AUTOSOMAL DOMINANT 14; HMND14
607642	RETINOIC ACID-INDUCED GENE 1; RAI1
607643	FASCIN ACTIN-BUNDLING PROTEIN 2, RETINAL; FSCN2
607644	CANDIDIASIS, FAMILIAL, 3; CANDF3
607645	NEURONAL VESICLE TRAFFICKING-ASSOCIATED PROTEIN 1; NSG1
607646	ZINC FINGER- AND BTB DOMAIN-CONTAINING PROTEIN 7B; ZBTB7B
607647	PLASMALEMMA VESICLE-ASSOCIATED PROTEIN; PLVAP
607648	SERINE/THREONINE PROTEIN KINASE 39; STK39
607649	OSTEOPETROSIS-ASSOCIATED TRANSMEMBRANE PROTEIN 1; OSTM1
607650	DEFENSIN, BETA, 118; DEFB118
607651	PLECKSTRIN HOMOLOGY DOMAIN-CONTAINING PROTEIN, FAMILY B, MEMBER 1; PLEKHB1
607652	SERINE/THREONINE PROTEIN KINASE 36; STK36
607653	RAS HOMOLOG GENE FAMILY, MEMBER J; RHOJ
607654	KERATOSIS PALMOPLANTARIS STRIATA III; PPKS3
607655	MOVED TO 605676
607656	CURLY HAIR-ACRAL KERATODERMA-CARIES SYNDROME
607657	CYSTATHIONINE GAMMA-LYASE; CTH
607658	HYPOTRICHOSIS-OSTEOLYSIS-PERIODONTITIS-PALMOPLANTAR KERATODERMA SYNDROME
607659	ELL-ASSOCIATED FACTOR 2; EAF2
607660	TESTIS-SPECIFIC SERINE/THREONINE KINASE 3; TSSK3
607661	MOVED TO 602281
607662	SPERMATOGENESIS-ASSOCIATED PROTEIN 2; SPATA2
607663	DEAD-BOX HELICASE 25; DDX25
607664	N-ACETYLGLUCOSAMINE-6-SULFATASE; GNS
607665	TUBULOINTERSTITIAL NEPHRITIS WITH UVEITIS; TINU
607666	ANGIOPOIETIN-LIKE 5; ANGPTL5
607667	CATENIN, ALPHA-3; CTNNA3
607668	ADP-RIBOSYLATION FACTOR-LIKE GTPase 6-INTERACTING PROTEIN 4; ARL6IP4
607669	ADP-RIBOSYLATION FACTOR-LIKE GTPase 6-INTERACTING PROTEIN 1; ARL6IP1
607670	SERINE/THREONINE PROTEIN KINASE 33; STK33
607671	DYSTONIA 13, TORSION, AUTOSOMAL DOMINANT; DYT13
607672	CARDIOTROPHIN-LIKE CYTOKINE FACTOR 1; CLCF1
607673	ENDOPLASMIC RETICULUM DEGRADATION-ENHANCING ALPHA-MANNOSIDASE-LIKE PROTEIN 1; EDEM1
607674	CATARACT, CONGENITAL, WITH MENTAL IMPAIRMENT AND DENTATE GYRUS ATROPHY
607675	REST COREPRESSOR; RCOR
607676	IMMUNODEFICIENCY 67; IMD67
607677	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2I; CMT2I
607678	CHARCOT-MARIE-TOOTH DISEASE, DEMYELINATING, TYPE 1D; CMT1D
607679	DEDICATOR OF CYTOKINESIS 4; DOCK4
607680	ZINC FINGER PROTEIN 363; ZNF363
607681	FEBRILE SEIZURES, FAMILIAL, 8; FEB8
607682	EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 9; EIG9
607683	DEAFNESS, AUTOSOMAL DOMINANT 52; DFNA52
607684	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2E; CMT2E
607685	HYPEREOSINOPHILIC SYNDROME, IDIOPATHIC; HES
607686	FIP1-LIKE 1; FIP1L1
607687	HIGH DENSITY LIPOPROTEIN CHOLESTEROL LEVEL QUANTITATIVE TRAIT LOCUS 3
607688	PARKINSON DISEASE 11, AUTOSOMAL DOMINANT, SUSCEPTIBILITY TO; PARK11
607689	MOVED TO 246700
607690	SECRETION-ASSOCIATED RAS-RELATED GTPase 1B; SAR1B
607691	SECRETION-ASSOCIATED RAS-RELATED GTPase 1A; SAR1A
607692	MOVED TO 248800 AND 246700
607693	SELENOCYSTEINE INSERTION SEQUENCE-BINDING PROTEIN 2; SECISBP2
607694	LEUKODYSTROPHY, HYPOMYELINATING, 7, WITH OR WITHOUT OLIGODONTIA AND/OR HYPOGONADOTROPIC HYPOGONADISM; HLD7
607695	EUKARYOTIC ELONGATION FACTOR, SELENOCYSTEINE-tRNA-SPECIFIC; EEFSEC
607696	USH1 PROTEIN NETWORK COMPONENT SANS; USH1G
607697	SET-BINDING FACTOR 2; SBF2
607698	LIGAND-DEPENDENT NUCLEAR RECEPTOR COREPRESSOR; LCOR
607699	RING FINGER PROTEIN 20; RNF20
607700	RING FINGER PROTEIN 40; RNF40
607701	KELCH-LIKE 41; KLHL41
607702	TRANSCRIPTIONAL AND IMMUNE RESPONSE REGULATOR; TCIM
607703	NUCLEOPORIN, 210-KD; NUP210
607704	KN MOTIF- AND ANKYRIN REPEAT DOMAIN-CONTAINING PROTEIN 1; KANK1
607705	PROTEASOME ACTIVATOR SUBUNIT 4; PSME4
607706	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, WITH VOCAL CORD PARESIS, AUTOSOMAL RECESSIVE
607707	CALCIUM/CALMODULIN-DEPENDENT PROTEIN KINASE II-BETA; CAMK2B
607708	CALCIUM/CALMODULIN-DEPENDENT PROTEIN KINASE II-DELTA; CAMK2D
607709	TIGHT JUNCTION PROTEIN 2; TJP2
607710	ENDOSOMAL TRANSMEMBRANE EPSIN INTERACTOR 1; ENTREP1
607711	DISCO-INTERACTING PROTEIN 2 HOMOLOG A; DIP2A
607712	HYPERMETHYLATED IN CANCER 2; HIC2
607713	KILLER-SPECIFIC SECRETORY PROTEIN, 37-KD
607714	TNFAIP3-INTERACTING PROTEIN 1; TNIP1
607715	TSC22 DOMAIN FAMILY, MEMBER 1; TSC22D1
607716	SYNAPTOTAGMIN 13; SYT13
607717	TENSIN 2; TNS2
607718	SYNAPTOTAGMIN 6; SYT6
607719	SYNAPTOTAGMIN 8; SYT8
607720	TRANSLIN-ASSOCIATED FACTOR X-INTERACTING PROTEIN 1; TSNAXIP1
607721	NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR 1; NSLH1
607722	ENDOPLASMIC RETICULUM MEMBRANE PROTEIN COMPLEX, SUBUNIT 2; EMC2
607723	SAD1 AND UNC84 DOMAIN-CONTAINING PROTEIN 1; SUN1
607724	CALCYPHOSINE 2; CAPS2
607725	POLY(ADP-RIBOSE) POLYMERASE 2; PARP2
607726	POLY(ADP-RIBOSE) POLYMERASE FAMILY, MEMBER 3; PARP3
607727	CULLIN-ASSOCIATED NEDDYLATION-DISSOCIATED PROTEIN 1; CAND1
607728	POROKERATOSIS 4, DISSEMINATED SUPERFICIAL ACTINIC TYPE; POROK4
607729	DNA DAMAGE-INDUCIBLE TRANSCRIPT 4; DDIT4
607730	DNA DAMAGE-INDUCIBLE TRANSCRIPT 4-LIKE; DDIT4L
607731	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2H; CMT2H
607732	STERILE ALPHA AND TIR MOTIFS-CONTAINING PROTEIN 1; SARM1
607733	SCRIBBLE PLANAR CELL POLARITY PROTEIN; SCRIB
607734	CHARCOT-MARIE-TOOTH DISEASE, DEMYELINATING, TYPE 1F; CMT1F
607735	PROGESTERONE RECEPTOR MEMBRANE COMPONENT 2; PGRMC2
607736	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2J; CMT2J
607737	FIBROBLAST GROWTH FACTOR-BINDING PROTEIN 1; FGFBP1
607738	POTASSIUM CHANNEL, VOLTAGE-GATED, SHAB-RELATED SUBFAMILY, MEMBER 2; KCNB2
607739	MOVED TO 604563
607740	UBIQUITIN-SPECIFIC PROTEASE 32; USP32
607741	TBC1 DOMAIN FAMILY, MEMBER 3; TBC1D3
607742	KERATIN 24, TYPE I; KRT24
607743	FIBROBLAST GROWTH FACTOR RECEPTOR SUBSTRATE 2; FRS2
607744	FIBROBLAST GROWTH FACTOR RECEPTOR SUBSTRATE 3; FRS3
607745	SEIZURES, BENIGN FAMILIAL INFANTILE, 3; BFIS3
607746	FERM DOMAIN-CONTAINING KINDLIN 2; FERMT2
607747	FILAMIN-BINDING LIM PROTEIN 1; FBLIM1
607748	HYPERCHOLANEMIA, FAMILIAL 1; FHCA1
607749	CELL DIVISION CYCLE-ASSOCIATED PROTEIN 3; CDCA3
607750	APOLIPOPROTEIN B mRNA-EDITING ENZYME, CATALYTIC POLYPEPTIDE-LIKE 3C; APOBEC3C
607751	TASTE RECEPTOR, TYPE 2, MEMBER 38; TAS2R38
607752	CYCLIN O; CCNO
607753	SINGLE-STRAND-SELECTIVE MONOFUNCTIONAL URACIL-DNA GLYCOSYLASE 1; SMUG1
607754	MAKORIN 1; MKRN1
607755	MITOGEN-ACTIVATED PROTEIN KINASE 8-INTERACTING PROTEIN 2; MAPK8IP2
607756	ALPHA-AMINOADIPATE SEMIALDEHYDE DEHYDROGENASE-PHOSPHOPANTETHEINYL TRANSFERASE; AASDHPPT
607757	CHIBBY FAMILY, MEMBER 1, BETA-CATENIN ANTAGONIST; CBY1
607758	CATENIN, BETA-INTERACTING PROTEIN 1; CTNNBIP1
607759	INTEGRIN, ALPHA-2B; ITGA2B
607760	DNA TOPOISOMERASE II-BINDING PROTEIN 1; TOPBP1
607761	KIRRE-LIKE NEPHRIN FAMILY ADHESION MOLECULE 3; KIRREL3
607762	KIRRE-LIKE NEPHRIN FAMILY ADHESION MOLECULE 2; KIRREL2
607763	CENTAURIN, BETA-1; CENTB1
607764	3-BETA-HYDROXY-DELTA-5-C27-STEROID OXIDOREDUCTASE; HSD3B7
607765	BILE ACID SYNTHESIS DEFECT, CONGENITAL, 1; CBAS1
607766	CENTAURIN, BETA-2; CENTB2
607767	SESTRIN 2; SESN2
607768	SESTRIN 3; SESN3
607769	PLECKSTRIN HOMOLOGY DOMAIN-CONTAINING PROTEIN, FAMILY A, MEMBER 4; PLEKHA4
607770	PLECKSTRIN HOMOLOGY DOMAIN-CONTAINING PROTEIN, FAMILY A, MEMBER 5; PLEKHA5
607771	PLECKSTRIN HOMOLOGY DOMAIN-CONTAINING PROTEIN, FAMILY A, MEMBER 6; PLEKHA6
607772	PLECKSTRIN HOMOLOGY DOMAIN-CONTAINING PROTEIN, FAMILY A, MEMBER 1; PLEKHA1
607773	PLECKSTRIN HOMOLOGY DOMAIN-CONTAINING PROTEIN, FAMILY A, MEMBER 2; PLEKHA2
607774	PLECKSTRIN HOMOLOGY DOMAIN-CONTAINING PROTEIN, FAMILY A, MEMBER 3; PLEKHA3
607775	POTASSIUM CHANNEL, VOLTAGE-GATED, ISK-RELATED SUBFAMILY, MEMBER 4; KCNE4
607776	SIN3 TRANSCRIPTION REGULATOR FAMILY MEMBER A; SIN3A
607777	SIN3 TRANSCRIPTION REGULATOR FAMILY MEMBER B; SIN3B
607778	ACROCAPITOFEMORAL DYSPLASIA; ACFD
607779	PROGESTIN AND ADIPOQ RECEPTOR FAMILY, MEMBER 7; PAQR7
607780	PROGESTIN AND ADIPOQ RECEPTOR FAMILY, MEMBER 8; PAQR8
607781	PROGESTIN AND ADIPOQ RECEPTOR FAMILY, MEMBER 5; PAQR5
607782	LUC7-LIKE; LUC7L
607783	MESODERM DEVELOPMENT LRP CHAPERONE; MESD
607784	ATP-BINDING CASSETTE, SUBFAMILY G, MEMBER 4; ABCG4
607785	JUVENILE MYELOMONOCYTIC LEUKEMIA; JMML
607786	PROPROTEIN CONVERTASE, SUBTILISIN/KEXIN-TYPE, 9; PCSK9
607787	G PROTEIN-COUPLED RECEPTOR 180; GPR180
607788	MULTIPLE COAGULATION FACTOR DEFICIENCY PROTEIN 2; MCFD2
607789	PHD FINGER PROTEIN 3; PHF3
607790	TET METHYLCYTOSINE DIOXYGENASE 1; TET1
607791	CHARCOT-MARIE-TOOTH DISEASE, DOMINANT INTERMEDIATE D; CMTDID
607792	GERMINAL CENTER-ASSOCIATED, SIGNALING AND MOTILITY; GCSAM
607793	PETER PAN, DROSOPHILA, HOMOLOG OF; PPAN
607794	MEST INTRONIC TRANSCRIPT 1; MESTIT1
607795	PRE-mRNA-PROCESSING FACTOR 4; PRPF4
607796	PHD FINGER PROTEIN 11; PHF11
607797	SMALL NUCLEAR RIBONUCLEOPROTEIN, 40-KD; SNRNP40
607798	TATA BOX-BINDING PROTEIN-ASSOCIATED FACTOR 1-LIKE; TAF1L
607799	ZINC FINGER DHHC DOMAIN-CONTAINING PROTEIN 17; ZDHHC17
607800	ATP-BINDING CASSETTE, SUBFAMILY A, MEMBER 12; ABCA12
607801	MOVED TO 606072
607802	CYCLIN M1; CNNM1
607803	CYCLIN M2; CNNM2
607804	CYCLIN M3; CNNM3
607805	CYCLIN M4; CNNM4
607806	OTOPETRIN 1; OTOP1
607807	ATP-BINDING CASSETTE, SUBFAMILY A, MEMBER 13; ABCA13
607808	NK2 HOMEOBOX 4; NKX2-4
607809	ACETYL-CoA ACETYLTRANSFERASE 1; ACAT1
607810	RADICAL S-ADENOSYL METHIONINE DOMAIN-CONTAINING PROTEIN 2; RSAD2
607811	p21-ACTIVATED KINASE- AND PHOSPHOLIPASE C-INTERACTING PROTEIN 1; PAK1IP1
607812	CRANIOLENTICULOSUTURAL DYSPLASIA; CLSD
607813	PHOSPHOLIPID PHOSPHATASE-RELATED PROTEIN 4; PLPPR4
607814	REGULATOR OF G PROTEIN SIGNALING 9-BINDING PROTEIN; RGS9BP
607815	ANKYRIN REPEAT AND STERILE ALPHA MOTIF DOMAINS-CONTAINING PROTEIN 1B; ANKS1B
607816	POLYCOMB GROUP RING FINGER PROTEIN 6; PCGF6
607817	VACUOLAR PROTEIN SORTING 13 HOMOLOG B; VPS13B
607818	ZINC FINGER PROTEIN 365; ZNF365
607819	SOLUTE CARRIER FAMILY 30 (ZINC TRANSPORTER), MEMBER 5; SLC30A5
607820	HOOK MICROTUBULE TETHERING PROTEIN 1; HOOK1
607821	DEAFNESS, AUTOSOMAL RECESSIVE 37; DFNB37
607822	ALZHEIMER DISEASE 3; AD3
607823	HYPOTRICHOSIS-LYMPHEDEMA-TELANGIECTASIA SYNDROME; HLTS
607824	HOOK MICROTUBULE TETHERING PROTEIN 2; HOOK2
607825	HOOK MICROTUBULE TETHERING PROTEIN 3; HOOK3
607826	ADENOSYLHOMOCYSTEINASE-LIKE 1; AHCYL1
607827	OTOPETRIN 2; OTOP2
607828	OTOPETRIN 3; OTOP3
607829	MITRAL VALVE PROLAPSE 2; MVP2
607830	FRASER EXTRACELLULAR MATRIX COMPLEX SUBUNIT 1; FRAS1
607831	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2K; CMT2K
607832	FOCAL SEGMENTAL GLOMERULOSCLEROSIS 3, SUSCEPTIBILITY TO; FSGS3
607833	TACHYKININ 4; TAC4
607834	ANXIETY
607835	SPLICING FACTOR 3B, SUBUNIT 6; SF3B6
607836	AUTOIMMUNE DISEASE, SUSCEPTIBILITY TO, 1; AIS1
607837	CLN8 TRANSMEMBRANE ER AND ERGIC PROTEIN; CLN8
607838	N-ACETYLGLUCOSAMINE-1-PHOSPHOTRANSFERASE, GAMMA SUBUNIT; GNPTG
607839	GLYCOGEN BRANCHING ENZYME; GBE1
607840	N-ACETYLGLUCOSAMINE-1-PHOSPHOTRANSFERASE, ALPHA/BETA SUBUNITS; GNPTAB
607841	DEAFNESS, AUTOSOMAL DOMINANT 48; DFNA48
607842	AURAL ATRESIA, CONGENITAL; CAA
607843	PKHD1-LIKE 1; PKHD1L1
607844	LEM DOMAIN-CONTAINING PROTEIN 3; LEMD3
607845	EXPORTIN 5; XPO5
607846	METHYLTRANSFERASE 2B, METHYLCYTIDINE; METTL2B
607847	NEUTROPENIA, NONIMMUNE CHRONIC IDIOPATHIC, OF ADULTS
607848	RAB-INTERACTING LYSOSOMAL PROTEIN; RILP
607849	RETINOL DEHYDROGENASE 11; RDH11
607850	OSTEOARTHRITIS SUSCEPTIBILITY 3; OS3
607851	NKD INHIBITOR OF WNT SIGNALING PATHWAY 1; NKD1
607852	NKD INHIBITOR OF WNT SIGNALING PATHWAY 2; NKD2
607853	PANIC DISORDER 2; PAND2
607854	BESTROPHIN 1; BEST1
607855	MUSCULAR DYSTROPHY, CONGENITAL MEROSIN-DEFICIENT, 1A; MDC1A
607856	CINGULIN-LIKE 1; CGNL1
607857	PSORIASIS 9, SUSCEPTIBILITY TO; PSORS9
607858	PRESENILIN-ASSOCIATED RHOMBOID-LIKE PROTEIN; PARL
607859	ANGIOMA, TUFTED
607860	YY1 ASSOCIATED PROTEIN 1; YY1AP1
607861	DAPPER, ANTAGONIST OF BETA-CATENIN, 1; DACT1
607862	DIRAS FAMILY, GTP-BINDING RAS-LIKE PROTEIN 1; DIRAS1
607863	DIRAS FAMILY, GTP-BINDING RAS-LIKE PROTEIN 2; DIRAS2
607864	CAUDAL DUPLICATION ANOMALY
607865	SET DOMAIN PROTEIN, BIFURCATED, 2; SETDB2
607866	SPRY DOMAIN-CONTAINING PROTEIN 7; SPRYD7
607867	RCC1 DOMAIN- AND BTB DOMAIN-CONTAINING PROTEIN 1; RCBTB1
607868	TRIPARTITE MOTIF-CONTAINING PROTEIN 11; TRIM11
607869	UNC5 NETRIN RECEPTOR A; UNC5A
607870	UNC5 NETRIN RECEPTOR B; UNC5B
607871	F-BOX ONLY PROTEIN 11; FBXO11
607872	CHROMOSOME 1p36 DELETION SYNDROME, DISTAL
607873	SCAVENGER RECEPTOR CLASS F, MEMBER 1; SCARF1
607874	ZINC FINGER PROTEIN 444; ZNF444
607875	INOSITOL POLYPHOSPHATE-5-PHOSPHATASE K; INPP5K
607876	EPILEPSY, FAMILIAL ADULT MYOCLONIC, 2; FAME2
607877	OTOSPIRALIN
607878	NICOTINAMIDE NUCLEOTIDE TRANSHYDROGENASE; NNT
607879	EXOCYST COMPLEX COMPONENT 1; EXOC1
607880	EXOCYST COMPLEX COMPONENT 6B; EXOC6B
607881	SIGNAL-TRANSDUCING ADAPTOR PROTEIN 2
607882	SOLUTE CARRIER FAMILY 52 (RIBOFLAVIN TRANSPORTER), MEMBER 2; SLC52A2
607883	SOLUTE CARRIER FAMILY 52 (RIBOFLAVIN TRANSPORTER), MEMBER 1; SLC52A1
607884	CKLF-LIKE MARVEL TRANSMEMBRANE DOMAIN-CONTAINING 1; CMTM1
607885	CKLF-LIKE MARVEL TRANSMEMBRANE DOMAIN-CONTAINING 2; CMTM2
607886	CKLF-LIKE MARVEL TRANSMEMBRANE DOMAIN-CONTAINING 3; CMTM3
607887	CKLF-LIKE MARVEL TRANSMEMBRANE DOMAIN-CONTAINING 4; CMTM4
607888	CKLF-LIKE MARVEL TRANSMEMBRANE DOMAIN-CONTAINING 5; CMTM5
607889	CKLF-LIKE MARVEL TRANSMEMBRANE DOMAIN-CONTAINING 6; CMTM6
607890	CKLF-LIKE MARVEL TRANSMEMBRANE DOMAIN-CONTAINING 7; CMTM7
607891	CKLF-LIKE MARVEL TRANSMEMBRANE DOMAIN-CONTAINING 8; CMTM8
607892	DESMOGLEIN 4; DSG4
607893	OVARIAN CANCER, SUSCEPTIBILITY TO, 1; OVCAS1
607894	POLYCYSTIN 1-LIKE 2; PKD1L2
607895	POLYCYSTIN 1-LIKE 3; PKD1L3
607896	OVCA2 SERINE HYDROLASE DOMAIN-CONTAINING PROTEIN; OVCA2
607897	MUSASHI RNA BINDING PROTEIN 2; MSI2
607898	TRIBBLES PSEUDOKINASE 3; TRIB3
607899	WT1 ANTISENSE RNA; WT1AS
607900	FERM DOMAIN-CONTAINING KINDLIN 1; FERMT1
607901	FERM DOMAIN-CONTAINING KINDLIN 3; FERMT3
607902	SNURPORTIN 1; SNUPN
607903	HYPOTRICHOSIS 6; HYPT6
607904	CALCIUM CHANNEL, VOLTAGE-DEPENDENT, T TYPE, ALPHA-1H SUBUNIT; CACNA1H
607905	ALG2 ALPHA-1,3/1,6-MANNOSYLTRANSFERASE; ALG2
607906	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ii; CDG1I
607907	DERMATOFIBROSARCOMA PROTUBERANS; DFSP
607908	LIM ZINC FINGER DOMAIN-CONTAINING PROTEIN 2; LIMS2
607909	ANTIZYME INHIBITOR 1; AZIN1
607910	KINESIN FAMILY MEMBER 9; KIF9
607911	EPM2A-INTERACTING PROTEIN 1; EPM2AIP1
607912	SELENOPROTEIN T; SELENOT
607913	GLUTATHIONE PEROXIDASE 6; GPX6
607914	SELENOPROTEIN H; SELENOH
607915	SELENOPROTEIN I; SELENOI
607916	SELENOPROTEIN K; SELENOK
607917	SELENOPROTEIN O; SELENOO
607918	SELENOPROTEIN S; SELENOS
607919	SELENOPROTEIN V; SELENOV
607920	MOVED TO 159001
607921	RETINITIS PIGMENTOSA 30; RP30
607922	ALPHA-1,4-GALACTOSYLTRANSFERASE; A4GALT
607923	SYNAPTOSOMAL-ASSOCIATED PROTEIN, 91-KD; SNAP91
607924	METASTASIS-ASSOCIATED LUNG ADENOCARCINOMA TRANSCRIPT 1; MALAT1
607925	B- AND T-LYMPHOCYTE ATTENUATOR; BTLA
607926	HOST CELL FACTOR C2; HCFC2
607927	ANKYRIN REPEATS- AND FYVE DOMAIN-CONTAINING PROTEIN 1; ANKFY1
607928	WHIRLIN; WHRN
607929	CCM2 SCAFFOLD PROTEIN; CCM2
607930	CYTOKINE-LIKE PROTEIN 1; CYTL1
607931	ATAXIN 2-LIKE; ATXN2L
607932	MICROPHTHALMIA, SYNDROMIC 6; MCOPS6
607933	SOLUTE CARRIER FAMILY 7 (CATIONIC AMINO ACID TRANSPORTER, y+ SYSTEM), MEMBER 11; SLC7A11
607934	PEPTIDYLARGININE DEIMINASE, TYPE I; PADI1
607935	PEPTIDYLARGININE DEIMINASE, TYPE II; PADI2
607936	PEELING SKIN SYNDROME 4; PSS4
607937	NANOG HOMEOBOX; NANOG
607938	NEUROTRIMIN; NTM
607939	SULFATASE-MODIFYING FACTOR 1; SUMF1
607940	SULFATASE-MODIFYING FACTOR 2; SUMF2
607941	ATRIAL SEPTAL DEFECT 2; ASD2
607942	PHOSPHOINOSITIDE 3-KINASE ADAPTOR PROTEIN 1; PIK3AP1
607943	RAS p21 PROTEIN ACTIVATOR 4; RASA4
607944	SPONDYLOENCHONDRODYSPLASIA WITH IMMUNE DYSREGULATION; SPENCDI
607945	ADIPONECTIN RECEPTOR 1; ADIPOR1
607946	ADIPONECTIN RECEPTOR 2; ADIPOR2
607947	POTASSIUM CHANNEL REGULATOR; KCNRG
607948	MYCOBACTERIUM TUBERCULOSIS, SUSCEPTIBILITY TO
607949	MYCOBACTERIUM TUBERCULOSIS, SUSCEPTIBILITY TO, 1
607950	TESTIS-SPECIFIC PROTEASE 50
607951	CENTROSOMAL PROTEIN, 57-KD; CEP57
607952	SOLUTE CARRIER FAMILY 6 (NEUROTRANSMITTER TRANSPORTER, GABA), MEMBER 11; SLC6A11
607953	TRANSGELIN 3; TAGLN3
607954	RAN GUANINE NUCLEOTIDE RELEASE FACTOR; RANGRF
607955	SAM- AND SH3 DOMAIN-CONTAINING PROTEIN 1; SASH1
607956	MEDIATOR COMPLEX SUBUNIT 8; MED8
607957	CALCIUM/CALMODULIN-DEPENDENT PROTEIN KINASE I-DELTA; CAMK1D
607958	SYNTAXIN-BINDING PROTEIN 6; STXBP6
607959	SOLUTE CARRIER FAMILY 7 (CATIONIC AMINO ACID TRANSPORTER, y+ SYSTEM), MEMBER 10; SLC7A10
607960	DEAH-BOX HELICASE 32, PUTATIVE; DHX32
607961	SEMAPHORIN 7A; SEMA7A
607962	MICRO RNA 23A; MIR23A
607963	METHYL-CpG BINDING DOMAIN PROTEIN 3-LIKE 1; MBD3L1
607964	METHYL-CpG BINDING DOMAIN PROTEIN 3-LIKE 2; MBD3L2
607965	SYSTEMIC LUPUS ERYTHEMATOSUS WITH NEPHRITIS, SUSCEPTIBILITY TO, 1; SLEN1
607966	SYSTEMIC LUPUS ERYTHEMATOSUS WITH NEPHRITIS, SUSCEPTIBILITY TO, 2; SLEN2
607967	SYSTEMIC LUPUS ERYTHEMATOSUS WITH NEPHRITIS, SUSCEPTIBILITY TO, 3; SLEN3
607968	PARATHYROID HORMONE-RESPONSIVE B1 GENE
607969	CDC-LIKE KINASE 4; CLK4
607970	G PROTEIN-COUPLED RECEPTOR 135; GPR135
607971	SOLUTE CARRIER FAMILY 6 (NEUROTRANSMITTER TRANSPORTER), MEMBER 15; SLC6A15
607972	SOLUTE CARRIER FAMILY 6 (NEUROTRANSMITTER TRANSPORTER), MEMBER 16; SLC6A16
607973	NEUROPILIN- AND TOLLOID-LIKE 1; NETO1
607974	NEUROPILIN- AND TOLLOID-LIKE 2; NETO2
607975	OXIDATIVE STRESS-INDUCED GROWTH INHIBITOR 1; OSGIN1
607976	CYTOCHROME c OXIDASE, SUBUNIT 4I2; COX4I2
607977	HDC HOMOLOG, CELL CYCLE REGULATOR; HECA
607978	SAM DOMAIN, SH3 DOMAIN, AND NUCLEAR LOCALIZATION SIGNALS 1; SAMSN1
607979	SERINE HYDROLASE-LIKE, PSEUDOGENE; SERHL
607980	TRANSLOCASE OF OUTER MITOCHONDRIAL MEMBRANE 7; TOMM7
607981	NEGATIVE REGULATOR OF UBIQUITIN-LIKE PROTEINS 1; NUB1
607982	SCY1-LIKE 1; SCYL1
607983	GOLGIN, RAB6-INTERACTING; GORAB
607984	SPROUTY RTK SIGNALING ANTAGONIST 4; SPRY4
607985	N-ACETYLGLUCOSAMINE-1-PHOSPHODIESTER ALPHA-N-ACETYLGLUCOSAMINIDASE; NAGPA
607986	S100 CALCIUM-BINDING PROTEIN A14; S100A14
607987	DNAJ/HSP40 HOMOLOG, SUBFAMILY C, MEMBER 10; DNAJC10
607988	SPARC/OSTEONECTIN, CWCV, AND KAZAL-LIKE DOMAINS PROTEOGLYCAN 2; SPOCK2
607989	SPARC/OSTEONECTIN, CWCV, AND KAZAL-LIKE DOMAINS PROTEOGLYCAN 3; SPOCK3
607990	UBIQUITIN-LIKE PROTEIN CONTAINING PHD AND RING FINGER DOMAINS 1; UHRF1
607991	SOLUTE CARRIER FAMILY 8 (SODIUM-CALCIUM EXCHANGER), MEMBER A3; SLC8A3
607992	SURP AND G-PATCH DOMAINS-CONTAINING PROTEIN 1; SUGP1
607993	SURP AND G-PATCH DOMAINS-CONTAINING PROTEIN 2; SUGP2
607994	5-PRIME,3-PRIME-EXORIBONUCLEASE 1; XRN1
607995	UNC93 HOMOLOG A; UNC93A
607996	PREPRONEUROPEPTIDE B
607997	NEUROPEPTIDE W; NPW
607998	TRIPEPTIDYL PEPTIDASE I; TPP1
607999	ASH1-LIKE HISTONE LYSINE METHYLTRANSFERASE; ASH1L
608000	N-ALPHA-ACETYLTRANSFERASE 15, NatA AUXILIARY SUBUNIT; NAA15
608001	MOVED TO 602132
608002	NEPHROCYSTIN 3; NPHP3
608003	HOMEODOMAIN-INTERACTING PROTEIN KINASE 1; HIPK1
608004	NUCLEAR FACTOR KAPPA-B INHIBITOR, ZETA; NFKBIZ
608005	SIL1 NUCLEOTIDE EXCHANGE FACTOR; SIL1
608006	LEIOMODIN 2; LMOD2
608007	PLECKSTRIN 2; PLEK2
608008	ANNEXIN A10; ANXA10
608009	ADENYLATE KINASE 5; AK5
608010	NPC1-LIKE INTRACELLULAR CHOLESTEROL TRANSPORTER 1; NPC1L1
608011	GUANINE NUCLEOTIDE-BINDING PROTEIN-LIKE 3; GNL3
608012	PROTEIN DISULFIDE ISOMERASE, FAMILY A, MEMBER 2; PDIA2
608013	GAUCHER DISEASE, PERINATAL LETHAL
608014	HEAT-SHOCK 22-KD PROTEIN 8; HSPB8
608015	TSUKUSHIN; TSKU
608016	CYTOCHROME c OXIDASE ASSEMBLY FACTOR 4 HOMOLOG; COA4
608017	FAMILY WITH SEQUENCE SIMILARITY 162, MEMBER A; FAM162A
608018	PROTEASE, SERINE, 27; PRSS27
608019	TNFAIP3-INTERACTING PROTEIN 3; TNIP3
608020	NUCLEOBINDIN 2; NUCB2
608021	WAP, FOLLISTATIN, IMMUNOGLOBULIN, KUNITZ, AND NTR DOMAINS-CONTAINING PROTEIN 1; WFIKKN1
608022	DIAPHANOSPONDYLODYSOSTOSIS
608023	DEAD-BOX HELICASE 56; DDX56
608024	ENOYL-CoA DELTA ISOMERASE 2; ECI2
608025	NBAS SUBUNIT OF NRZ TETHERING COMPLEX; NBAS
608026	HYPERTENSIVE NEPHROPATHY; HNP1
608027	PONTOCEREBELLAR HYPOPLASIA, TYPE 3; PCH3
608028	THAI SYMPHALANGISM SYNDROME
608029	SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 6; SCAR6
608030	AMYOTROPHIC LATERAL SCLEROSIS 6 WITH OR WITHOUT FRONTOTEMPORAL DEMENTIA; ALS6
608031	AMYOTROPHIC LATERAL SCLEROSIS 7; ALS7
608032	MOVED TO 127500
608033	ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED, SUSCEPTIBILITY TO, 3; IIAE3
608034	ASPARTOACYLASE; ASPA
608035	MELANOMA, CUTANEOUS MALIGNANT, SUSCEPTIBILITY TO, 4; CMM4
608036	TYPE 2 DIABETES MELLITUS 4; T2D4
608037	CHONDROITIN POLYMERIZING FACTOR 2; CHPF2
608038	p21 PROTEIN-ACTIVATED KINASE 5; PAK5
608039	SPERMATOGENESIS-ASSOCIATED PROTEIN 9; SPATA9
608040	INTRAFLAGELLAR TRANSPORT 74; IFT74
608041	ANTHRAX TOXIN RECEPTOR 2; ANTXR2
608042	SYNAPTOTAGMIN-LIKE 1; SYTL1
608043	UDP-N-ACETYL-ALPHA-D-GALACTOSAMINE:POLYPEPTIDE N-ACETYLGALACTOSAMINYLTRANSFERASE 10; GALNT10
608044	SOLUTE CARRIER FAMILY 5 (IODIDE TRANSPORTER), MEMBER 8; SLC5A8
608045	REPRESSOR OF TELOMERASE EXPRESSION 1
608046	SYNOVIAL APOPTOSIS INHIBITOR 1; SYVN1
608047	UBIQUITIN-PROTEIN LIGASE E3B; UBE3B
608048	SNF2, LINKER HISTONE, PHD FINGER, RING FINGER, AND HELICASE DOMAINS-CONTAINING PROTEIN; SHPRH
608049	AUTISM, SUSCEPTIBILITY TO, 3; AUTS3
608050	TORSIN 1B; TOR1B
608051	MACULAR DYSTROPHY, RETINAL, 2; MCDR2
608052	TORSIN 2A; TOR2A
608053	ELECTRON TRANSFER FLAVOPROTEIN, ALPHA POLYPEPTIDE; ETFA
608054	CYTOCHROME P450, SUBFAMILY IIA, POLYPEPTIDE 7; CYP2A7
608055	CYTOCHROME P450, SUBFAMILY IIA, POLYPEPTIDE 13; CYP2A13
608056	MOVED TO 151660
608057	DEOXYRIBONUCLEASE II BETA; DNASE2B
608058	GLUCOSE-6-PHOSPHATASE, CATALYTIC, 2; G6PC2
608059	HES FAMILY bHLH TRANSCRIPTION FACTOR 7; HES7
608060	HES FAMILY bHLH TRANSCRIPTION FACTOR 4; HES4
608061	TRANSLOCASE OF OUTER MITOCHONDRIAL MEMBRANE 40; TOMM40
608062	DOUBLECORTIN DOMAIN-CONTAINING PROTEIN 1; DCDC1
608063	BILE AND PANCREATIC DUCTS, COMPLETE ABSENCE OF
608064	KELCH-LIKE 5; KLHL5
608065	SOLUTE CARRIER FAMILY 38 (AMINO ACID TRANSPORTER), MEMBER 4; SLC38A4
608066	SCAFFOLD ATTACHMENT FACTOR B2; SAFB2
608067	RING FINGER AND WD REPEAT DOMAINS-CONTAINING PROTEIN 2; RFWD2
608068	NEUTROPHILIC DERMATOSIS, ACUTE FEBRILE; AFND
608069	ERBB RECEPTOR FEEDBACK INHIBITOR 1; ERRFI1
608070	HOMOCYSTEINE- AND ENDOPLASMIC RETICULUM STRESS-INDUCIBLE PROTEIN, UBIQUITIN-LIKE DOMAIN-CONTAINING, 1; HERPUD1
608071	F-BOX AND WD40 DOMAIN PROTEIN 4; FBXW4
608072	NHL REPEAT-CONTAINING PROTEIN 1; NHLRC1
608073	NUCLEOPHOSMIN/NUCLEOPLASMIN FAMILY, MEMBER 2; NPM2
608074	PROGRAMMED CELL DEATH 6-INTERACTING PROTEIN; PDCD6IP
608075	PHOSPHOLIPASE C, ZETA-1; PLCZ1
608076	TYROSINE KINASE, NONRECEPTOR, 1; TNK1
608077	PURINERGIC RECEPTOR P2X-LIKE 1; P2RXL1
608078	SCHIZOPHRENIA 11
608079	ELAC RIBONUCLEASE Z 1; ELAC1
608080	MAESTRO; MRO
608081	SYNAPTOTAGMIN 15; SYT15
608082	YIPPEE-LIKE 1; YPEL1
608083	APOLIPOPROTEIN C-II; APOC2
608084	GTPase, IMAP FAMILY, MEMBER 1; GIMAP1
608085	GTPase, IMAP FAMILY, MEMBER 2; GIMAP2
608086	GTPase, IMAP FAMILY, MEMBER 5; GIMAP5
608087	GTPase, IMAP FAMILY, MEMBER 4; GIMAP4
608088	NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE I, WITH COUGH AND GASTROESOPHAGEAL REFLUX
608089	ENDOMETRIAL CANCER
608090	MLX-INTERACTING PROTEIN; MLXIP
608091	JOUBERT SYNDROME 2; JBTS2
608092	PALLADIN, CYTOSKELETAL-ASSOCIATED PROTEIN; PALLD
608093	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ij; CDG1J
608094	SOLUTE CARRIER FAMILY 37 (SUGAR-PHOSPHATE TRANSPORTER), MEMBER 1; SLC37A1
608095	SODIUM CHANNEL MODIFIER 1; SCNM1
608096	EPILEPSY, FAMILIAL TEMPORAL LOBE, 2; ETL2
608097	PERIVENTRICULAR HETEROTOPIA WITH MICROCEPHALY, AUTOSOMAL RECESSIVE; ARPHM
608098	PERIVENTRICULAR NODULAR HETEROTOPIA 3; PVNH3
608099	MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 3; LGMDR3
608100	NFU1 IRON-SULFUR CLUSTER SCAFFOLD; NFU1
608101	SPERMATID-SPECIFIC LINKER HISTONE H1-LIKE PROTEIN
608102	CLN5 INTRACELLULAR TRAFFICKING PROTEIN; CLN5
608103	ALG8 ALPHA-1,3-GLUCOSYLTRANSFERASE; ALG8
608104	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ih; CDG1H
608105	EPILEPSY, ROLANDIC, WITH PAROXYSMAL EXERCISE-INDUCED DYSTONIA AND WRITER'S CRAMP; EPRPDC
608106	IMMUNODEFICIENCY WITH HYPER-IgM, TYPE 5; HIGM5
608107	MEFV INNATE IMMUNITY REGULATOR, PYRIN; MEFV
608108	CRANIOFACIAL DEVELOPMENT PROTEIN 1; CFDP1
608109	PSEUDOURIDINE SYNTHASE 1; PUS1
608110	p21 PROTEIN-ACTIVATED KINASE 6; PAK6
608111	FANCL GENE; FANCL
608112	TRAFFICKING PROTEIN, KINESIN-BINDING 1; TRAK1
608113	SARCOGLYCAN, ZETA; SGCZ
608114	CENTAURIN, ALPHA-1; CENTA1
608115	OVARIAN HYPERSTIMULATION SYNDROME; OHSS
608116	HEDGEHOG ACYLTRANSFERASE-LIKE PROTEIN; HHATL
608117	PHOSPHODIESTERASE 4D-INTERACTING PROTEIN; PDE4DIP
608118	ZINC DEFICIENCY, TRANSIENT NEONATAL; TNZD
608119	HOMEODOMAIN LEUCINE ZIPPER-CONTAINING FACTOR
608120	PARVIN, ALPHA; PARVA
608121	PARVIN, BETA; PARVB
608122	PARVIN, GAMMA; PARVG
608123	ACYL-CoA THIOESTERASE 8; ACOT8
608124	XYLOSYLTRANSFERASE 1; XYLT1
608125	XYLOSYLTRANSFERASE 2; XYLT2
608126	WD REPEAT AND HMG-BOX DNA-BINDING PROTEIN 1; WDHD1
608127	PRE-B-CELL LEUKEMIA TRANSCRIPTION FACTOR 4; PBX4
608128	MOVED TO 604605
608129	UBIQUITIN-ASSOCIATED DOMAIN-CONTAINING PROTEIN 1; UBAC1
608130	NUAK FAMILY, SNF1-LIKE KINASE, 1; NUAK1
608131	NUAK FAMILY, SNF1-LIKE KINASE, 2; NUAK2
608132	TETRATRICOPEPTIDE REPEAT DOMAIN-CONTAINING PROTEIN 8; TTC8
608133	RETINITIS PIGMENTOSA 7; RP7
608134	PARALEMMIN; PALM
608135	ASPORIN; ASPN
608136	RHO GUANINE NUCLEOTIDE EXCHANGE FACTOR 10; ARHGEF10
608137	NMDA RECEPTOR SYNAPTONUCLEAR SIGNALING AND NEURONAL MIGRATION FACTOR; NSMF
608138	PROGRAMMED CELL DEATH 7; PDCD7
608139	CENTROMERE PROTEIN V; CENPV
608140	NUCLEOPORIN, 35-KD; NUP35
608141	NUCLEOPORIN, 43-KD; NUP43
608142	HSCB MITOCHONDRIAL IRON-SULFUR CLUSTER COCHAPERONE; HSCB
608143	1-ACYLGLYCEROL-3-PHOSPHATE O-ACYLTRANSFERASE 6; AGPAT6
608144	SAM POINTED DOMAIN-CONTAINING ETS TRANSCRIPTION FACTOR; SPDEF
608145	NIPA MAGNESIUM TRANSPORTER 1; NIPA1
608146	NIPA MAGNESIUM TRANSPORTER 2; NIPA2
608147	TUBULIN-GAMMA COMPLEX-ASSOCIATED PROTEIN 5; TUBGCP5
608148	SPECIAL AT-RICH SEQUENCE-BINDING PROTEIN 2; SATB2
608149	KAGAMI-OGATA SYNDROME
608150	PERIPHILIN 1; PPHLN1
608151	WD REPEAT-CONTAINING PROTEIN 19; WDR19
608152	PROSTAGLANDIN E SYNTHASE 2; PTGES2
608153	PROTEIN PHOSPHATASE 1, REGULATORY SUBUNIT 14A; PPP1R14A
608154	LIPODYSTROPHY, GENERALIZED, WITH MENTAL RETARDATION, DEAFNESS, SHORT STATURE, AND SLENDER BONES
608155	SYNAPTOPODIN; SYNPO
608156	NABLUS MASK-LIKE FACIAL SYNDROME; NMLFS
608157	SOLUTE CARRIER FAMILY 25 (MITOCHONDRIAL CARRIER, ORNITHINE TRANSPORTER), MEMBER 2; SLC25A2
608158	CoQ-RESPONSIVE OXPHOS DEFICIENCY
608159	PROTEASE, SERINE, 21; PRSS21
608160	SRY-BOX 9; SOX9
608161	MACULAR DYSTROPHY, VITELLIFORM, 3; VMD3
608162	V-SET DOMAIN-CONTAINING T-CELL ACTIVATION INHIBITOR 1; VTCN1
608163	EXOCYST COMPLEX COMPONENT 7; EXOC7
608164	POTASSIUM CHANNEL, VOLTAGE-GATED, SUBFAMILY V, MEMBER 1; KCNV1
608165	PTB DOMAIN-CONTAINING ENGULFMENT ADAPTOR PROTEIN 1; GULP1
608166	SEMAPHORIN 3E; SEMA3E
608167	POTASSIUM CHANNEL, SUBFAMILY T, MEMBER 1; KCNT1
608168	POTASSIUM CHANNEL, VOLTAGE-GATED, SUBFAMILY H, MEMBER 6; KCNH6
608169	POTASSIUM CHANNEL, VOLTAGE-GATED, SUBFAMILY H, MEMBER 7; KCNH7
608170	DEAD-BOX HELICASE 41; DDX41
608171	CALCIUM CHANNEL, VOLTAGE-DEPENDENT, ALPHA-2/DELTA SUBUNIT 4; CACNA2D4
608172	DEHYDRODOLICHYL DIPHOSPHATE SYNTHASE; DHDDS
608173	AUTOIMMUNE THYROID DISEASE, SUSCEPTIBILITY TO, 1
608174	AUTOIMMUNE THYROID DISEASE, SUSCEPTIBILITY TO, 2
608175	AUTOIMMUNE THYROID DISEASE, SUSCEPTIBILITY TO, 3; AITD3
608176	AUTOIMMUNE THYROID DISEASE, SUSCEPTIBILITY TO, 4
608177	EXOSTOSIN GLYCOSYLTRANSFERASE 1; EXT1
608178	LEUCINE ZIPPER PROTEIN 2; LUZP2
608179	CAYTAXIN; ATCAY
608180	SYNPOLYDACTYLY 2; SPD2
608181	ACIDIC CLUSTER PROTEIN, 33-KD; ACP33
608182	POTASSIUM CHANNEL-INTERACTING PROTEIN 4
608183	CHONDROITIN SULFATE SYNTHASE 1; CHSY1
608184	IMMUNODEFICIENCY WITH HYPER-IgM, TYPE 4; HIGM4
608185	EXOCYST COMPLEX COMPONENT 4; EXOC4
608186	EXOCYST COMPLEX COMPONENT 3; EXOC3
608187	MINICHROMOSOME MAINTENANCE COMPLEX COMPONENT 8; MCM8
608188	CARDIOLIPIN SYNTHASE 1; CRLS1
608189	TROPICAL CALCIFIC PANCREATITIS
608190	N-ACETYLTRANSFERASE 8B; NAT8B
608191	RB-ASSOCIATED KRAB ZINC FINGER; RBAK
608192	SCY1-LIKE PROTEIN 3; SCYL3
608193	REC8 MEIOTIC RECOMBINATION PROTEIN; REC8
608194	CONE-ROD DYSTROPHY 13; CORD13
608195	LEUCINE-RICH REPEAT-CONTAINING PROTEIN 1; LRRC1
608196	WERNER HELICASE-INTERACTING PROTEIN 1; WRNIP1
608197	PEPTIDOGLYCAN RECOGNITION PROTEIN 3; PGLYRP3
608198	PEPTIDOGLYCAN RECOGNITION PROTEIN 4; PGLYRP4
608199	PEPTIDOGLYCAN RECOGNITION PROTEIN 2; PGLYRP2
608200	CDK5 REGULATORY SUBUNIT-ASSOCIATED PROTEIN 1; CDK5RAP1
608201	CDK5 REGULATORY SUBUNIT-ASSOCIATED PROTEIN 2; CDK5RAP2
608202	CDK5 REGULATORY SUBUNIT-ASSOCIATED PROTEIN 3; CDK5RAP3
608203	IMMUNODEFICIENCY 73A WITH DEFECTIVE NEUTROPHIL CHEMOTAXIS AND LEUKOCYTOSIS; IMD73A
608204	UNC93 HOMOLOG B1, TLR SIGNALING REGULATOR; UNC93B1
608205	MITOCHONDRIAL TRANS-2-ENOYL-CoA REDUCTASE; MECR
608206	SH3 DOMAIN AND TETRATRICOPEPTIDE REPEAT DOMAIN 2; SH3TC2
608207	KALA-AZAR, SUSCEPTIBILITY TO, 1; KAZA1
608208	MEMBRANE-ASSOCIATED RING-CH FINGER PROTEIN 4; MARCHF4
608209	DIPEPTIDYL PEPTIDASE X; DPP10
608210	EXOSTOSIN GLYCOSYLTRANSFERASE 2; EXT2
608211	KIDNEY-ASSOCIATED ANTIGEN 1; KAAG1
608212	IMMUNITY-RELATED GTPase FAMILY, M; IRGM
608213	CELL CYCLE EXIT AND NEURONAL DIFFERENTIATION 1; CEND1
608214	SODIUM VOLTAGE-GATED CHANNEL, BETA SUBUNIT 3; SCN3B
608215	LIM HOMEOBOX GENE 6; LHX6
608216	COMM DOMAIN-CONTAINING PROTEIN 5; COMMD5
608217	SEIZURES, BENIGN FAMILIAL NEONATAL, 3; BFNS3
608218	KERATIN 20, TYPE I; KRT20
608219	DEAFNESS, AUTOSOMAL RECESSIVE 38; DFNB38
608220	SPASTIC PARAPLEGIA 25, AUTOSOMAL RECESSIVE; SPG25
608221	MICROTUBULE-ASSOCIATED SERINE/THREONINE KINASE-LIKE; MASTL
608222	ADENYLOSUCCINATE LYASE; ADSL
608223	ASPIRIN RESISTANCE
608224	DEAFNESS, AUTOSOMAL DOMINANT 41; DFNA41
608225	UDP-N-ACETYL-ALPHA-D-GALACTOSAMINE:POLYPEPTIDE N-ACETYLGALACTOSAMINYLTRANSFERASE 14; GALNT14
608226	NANOS C2HC-TYPE ZINC FINGER 1; NANOS1
608227	CRANIOFACIAL ABNORMALITIES, CATARACTS, CONGENITAL HEART DISEASE, SACRAL NEURAL TUBE DEFECTS, AND GROWTH AND DEVELOPMENTAL RETARDATION
608228	NANOS C2HC-TYPE ZINC FINGER 2; NANOS2
608229	NANOS C2HC-TYPE ZINC FINGER 3; NANOS3
608230	CALCIUM CHANNEL, VOLTAGE-DEPENDENT, T TYPE, ALPHA-1I SUBUNIT; CACNA1I
608231	RAS ASSOCIATION DOMAIN FAMILY, MEMBER 8; RASSF8
608232	LEUKEMIA, CHRONIC MYELOID; CML
608233	HERMANSKY-PUDLAK SYNDROME 2; HPS2
608234	GALACTOSE-3-O-SULFOTRANSFERASE 3; GAL3ST3
608235	GALACTOSE-3-O-SULFOTRANSFERASE 4; GAL3ST4
608236	SLOWED NERVE CONDUCTION VELOCITY, AUTOSOMAL DOMINANT; SNCV
608237	GALACTOSE-3-O-SULFOTRANSFERASE 2; GAL3ST2
608238	SIGNAL PEPTIDE PEPTIDASE-LIKE 2A; SPPL2A
608239	SIGNAL PEPTIDE PEPTIDASE-LIKE 2B
608240	SIGNAL PEPTIDE PEPTIDASE-LIKE 3; SPPL3
608241	SMAD NUCLEAR INTERACTING PROTEIN 1; SNIP1
608242	HECT DOMAIN AND RCC1-LIKE DOMAIN 5; HERC5
608243	NSE3 HOMOLOG, SMC5-SMC6 COMPLEX COMPONENT; NSMCE3
608244	OTOSCLEROSIS 3; OTSC3
608245	KERATIN 71, TYPE II; KRT71
608246	KERATIN 72, TYPE II; KRT72
608247	KERATIN 73, TYPE II; KRT73
608248	KERATIN 74, TYPE II; KRT74
608249	CYCLIN B1 INTERACTING PROTEIN 1; CCNB1IP1
608250	SDS3 HOMOLOG, SIN3A COREPRESSOR COMPLEX COMPONENT; SUDS3
608251	PHOBIA, SPECIFIC
608252	ACTIN FILAMENT-ASSOCIATED PROTEIN 1; AFAP1
608253	TESTIS-SPECIFIC KINASE SUBSTRATE; TSKS
608254	PAX TRANSCRIPTION ACTIVATION DOMAIN-INTERACTING PROTEIN 1; PAXIP1
608255	TRAF3-INTERACTING PROTEIN 3; TRAF3IP3
608256	SODIUM VOLTAGE-GATED CHANNEL, BETA SUBUNIT 4; SCN4B
608257	MANDIBULOFACIAL DYSOSTOSIS WITH PTOSIS, AUTOSOMAL DOMINANT
608258	DIPEPTIDYL PEPTIDASE IX; DPP9
608259	INSULIN-LIKE GROWTH FACTOR 2 mRNA-BINDING PROTEIN 3; IGF2BP3
608260	POTASSIUM CHANNEL, VOLTAGE-GATED, SUBFAMILY H, MEMBER 8; KCNH8
608261	SENTRIN-SPECIFIC PROTEASE FAMILY, MEMBER 2; SENP2
608262	DISRUPTED IN RENAL CARCINOMA 3; DIRC3
608263	HEAT-SHOCK 27-KD PROTEIN-ASSOCIATED PROTEIN 1; HSPBAP1
608264	DEAFNESS, AUTOSOMAL RECESSIVE 40; DFNB40
608265	DEAFNESS, AUTOSOMAL RECESSIVE 39; DFNB39
608266	PARATHYROID CARCINOMA
608267	RAS-RELATED GTP-BINDING PROTEIN C; RRAGC
608268	RAS-RELATED GTP-BINDING PROTEIN D; RRAGD
608269	SOLUTE CARRIER FAMILY 28 (SODIUM-COUPLED NUCLEOSIDE TRANSPORTER), MEMBER 3; SLC28A3
608270	THREONINE ASPARTASE 1; TASP1
608271	MICROTUBULE-ACTIN CROSS-LINKING FACTOR 1; MACF1
608272	NEURAMINIDASE 1; NEU1
608273	INTERLEUKIN 27; IL27
608274	PROTEIN ARGININE METHYLTRANSFERASE 6; PRMT6
608275	SOLUTE CARRIER FAMILY 22 (ORGANIC CATION TRANSPORTER), MEMBER 15; SLC22A15
608276	SOLUTE CARRIER FAMILY 22 (ORGANIC CATION TRANSPORTER), MEMBER 16; SLC22A16
608277	CARBOHYDRATE SULFOTRANSFERASE 15; CHST15
608278	GROWTH FAILURE, MICROCEPHALY, MENTAL RETARDATION, CATARACTS, LARGE JOINT CONTRACTURES, OSTEOPOROSIS, CORTICAL DYSPLASIA, AND CEREBELLAR ATROPHY
608279	CRANIOSYNOSTOSIS WITH OCULAR ABNORMALITIES AND HALLUCAL DEFECTS
608280	GROWTH ARREST-SPECIFIC 5; GAS5
608281	SCIMITAR ANOMALY, MULTIPLE CARDIAC MALFORMATIONS, AND CRANIOFACIAL AND CENTRAL NERVOUS SYSTEM ABNORMALITIES
608282	TRACE AMINE-ASSOCIATED RECEPTOR 9; TAAR9
608283	KINESIN FAMILY MEMBER 21A; KIF21A
608284	INTRAMEMBRANE PROTEASE 5
608285	NAD SYNTHETASE 1; NADSYN1
608286	PROTOCADHERIN 10; PCDH10
608287	PROTOCADHERIN 18; PCDH18
608288	INSULIN-LIKE GROWTH FACTOR 2 mRNA-BINDING PROTEIN 1; IGF2BP1
608289	INSULIN-LIKE GROWTH FACTOR 2 mRNA-BINDING PROTEIN 2; IGF2BP2
608290	LELIS SYNDROME
608291	TUBULIN-TYROSINE LIGASE; TTL
608292	STOMATIN-LIKE PROTEIN 2; STOML2
608293	RHO GTPase-ACTIVATING PROTEIN 17; ARHGAP17
608294	NME/NM23 NUCLEOSIDE DIPHOSPHATE KINASE 6; NME6
608295	FAMILY WITH SEQUENCE SIMILARITY 107, MEMBER A; FAM107A
608296	FIBROBLAST GROWTH FACTOR, ACIDIC, INTRACELLULAR BINDING PROTEIN; FIBP
608297	REMOVED FROM DATABASE
608298	COILED-COIL DOMAIN-CONTAINING PROTEIN 80; CCDS80
608299	RING FINGER PROTEIN 34; RNF34
608300	N-ACETYLGLUTAMATE SYNTHASE; NAGS
608301	LEUCINE-RICH GENE, GLIOMA-INACTIVATED, 2; LGI2
608302	LEUCINE-RICH GENE, GLIOMA-INACTIVATED, 3; LGI3
608303	LEUCINE-RICH GENE, GLIOMA-INACTIVATED, 4; LGI4
608304	CANCER/TESTIS ANTIGEN 3; CTAG3
608305	SOLUTE CARRIER FAMILY 13 (SODIUM-DEPENDENT CITRATE TRANSPORTER), MEMBER 5; SLC13A5
608306	TRANSCRIPTION FACTOR Sp8; SP8
608307	CARBAMOYL PHOSPHATE SYNTHETASE I; CPS1
608308	ANKYRIN REPEAT AND BTB/POZ DOMAIN CONTAINING 1; ABTB1
608309	PTEN-INDUCED KINASE 1; PINK1
608310	ARGININOSUCCINATE LYASE; ASL
608311	GLUTAMATE RECEPTOR, IONOTROPIC, N-METHYL D-ASPARTATE-LIKE 1B; GRINL1B
608312	POLYMERASE I, RNA, SUBUNIT F; POLR1F
608313	ARGINASE 1; ARG1
608314	SEPTIN 3; SEPT3
608315	ELL-ASSOCIATED FACTOR 1; EAF1
608316	CORONARY HEART DISEASE, SUSCEPTIBILITY TO, 2
608317	GRAINYHEAD-LIKE 3; GRHL3
608318	CORONARY HEART DISEASE, SUSCEPTIBILITY TO, 4
608319	MOVED TO 605097
608320	CORONARY ARTERY DISEASE, AUTOSOMAL DOMINANT, 1; ADCAD1
608321	TIR DOMAIN-CONTAINING ADAPTOR MOLECULE 2; TICAM2
608322	KINESIN FAMILY MEMBER 21B; KIF21B
608323	CHARCOT-MARIE-TOOTH DISEASE, DOMINANT INTERMEDIATE C; CMTDIC
608324	SMALL INTEGRAL MEMBRANE PROTEIN 3; SMIM3
608325	PHD FINGER PROTEIN 21A; PHF21A
608326	STOMATIN-LIKE PROTEIN 1; STOML1
608327	STOMATIN-LIKE PROTEIN 3; STOML3
608328	WEILL-MARCHESANI SYNDROME 2; WMS2
608329	MYELIN REGULATORY FACTOR; MYRF
608330	PRE-mRNA-PROCESSING FACTOR 19; PRPF19
608331	SOLUTE CARRIER FAMILY 36 (PROTON/AMINO ACID SYMPORTER), MEMBER 2; SLC36A2
608332	SOLUTE CARRIER FAMILY 36 (PROTON/AMINO ACID SYMPORTER), MEMBER 3; SLC36A3
608333	DOCKING PROTEIN 4; DOK4
608334	DOCKING PROTEIN 5; DOK5
608335	PLECKSTRIN HOMOLOGY DOMAIN-CONTAINING PROTEIN, FAMILY O, MEMBER 1; PLEKHO1
608336	TRANSMEMBRANE PROTEIN, ADIPOCYTE ASSOCIATED 1; TPRA1
608337	OTU DOMAIN-CONTAINING UBIQUITIN ALDEHYDE-BINDING PROTEIN 1; OTUB1
608338	OTU DOMAIN-CONTAINING UBIQUITIN ALDEHYDE-BINDING PROTEIN 2; OTUB2
608339	SYNTAXIN-BINDING PROTEIN 3; STXBP3
608340	CHARCOT-MARIE-TOOTH DISEASE, RECESSIVE INTERMEDIATE A; CMTRIA
608341	CYTOCHROME b5 REDUCTASE 1; CYB5R1
608342	CYTOCHROME b5 REDUCTASE 2; CYB5R2
608343	CYTOCHROME b5 REDUCTASE 4; CYB5R4
608344	HEAT-SHOCK 27-KD PROTEIN 9; HSPB9
608345	NYSTAGMUS 3, CONGENITAL, AUTOSOMAL DOMINANT; NYS3
608346	MOVED TO 236670
608347	DICARBONYL/L-XYLULOSE REDUCTASE; DCXR
608348	BRANCHED-CHAIN KETO ACID DEHYDROGENASE E1, ALPHA POLYPEPTIDE; BCKDHA
608349	HEMATOPOIETIC SH2 DOMAIN-CONTAINING PROTEIN; HSH2D
608350	ENDOMUCIN; EMCN
608351	IMMUNOGLOBULIN SUPERFAMILY, MEMBER 11; IGSF11
608352	ACROSIN-BINDING PROTEIN; ACRBP
608353	ANTIZYME INHIBITOR 2; AZIN2
608354	CAPILLARY MALFORMATION-ARTERIOVENOUS MALFORMATION 1; CMAVM1
608355	MOVED TO 608354
608356	OUTER DENSE FIBER OF SPERM TAILS 3; ODF3
608357	SULFOTRANSFERASE FAMILY 1C, MEMBER 4; SULT1C4
608358	CONGENITAL MYOPATHY 7A, MYOSIN STORAGE, AUTOSOMAL DOMINANT; CMYP7A
608359	SULFOTRANSFERASE FAMILY 4A, MEMBER 1; SULT4A1
608360	LEUCINE-RICH REPEAT-CONTAINING PROTEIN 8A; LRRC8A
608361	SPONDYLOEPIPHYSEAL DYSPLASIA, KIMBERLEY TYPE; SEDK
608362	STATHMIN-LIKE 3; STMN3
608363	CHROMOSOME 22q11.2 DUPLICATION SYNDROME
608364	LIM DOMAIN AND ACTIN-BINDING PROTEIN 1; LIMA1
608365	T-COMPLEX PROTEIN 10-LIKE; TCP10L
608366	CELL MIGRATION-INDUCING HYALURONIDASE 1; CEMIP
608367	MYOPIA 17, AUTOSOMAL DOMINANT; MYP17
608368	RAD9 CHECKPOINT CLAMP COMPONENT B; RAD9B
608369	UDP-N-ACETYL-ALPHA-D-GALACTOSAMINE:POLYPEPTIDE N-ACETYLGALACTOSAMINYLTRANSFERASE 13; GALNT13
608370	STEAROYL-CoA DESATURASE 5; SCD5
608371	OROFACIAL CLEFT 4; OFC4
608372	DEAFNESS, AUTOSOMAL DOMINANT 49; DFNA49
608373	SYNAPTOGYRIN 4; SYNGR4
608374	HEMOJUVELIN BMP CORECEPTOR; HJV
608375	DNAJ/HSP40 HOMOLOG, SUBFAMILY C, MEMBER 6; DNAJC6
608376	DNAJ/HSP40 HOMOLOG, SUBFAMILY B, MEMBER 12; DNAJB12
608377	ADP-RIBOSYLATION FACTOR GTPase-ACTIVATING PROTEIN 1; ARFGAP1
608378	NUCLEAR EXPORT MEDIATOR FACTOR; NEMF
608379	CHEMOKINE, CC MOTIF, RECEPTOR-LIKE PROTEIN 2; CCRL2
608380	RETINITIS PIGMENTOSA 26; RP26
608381	CERAMIDE KINASE-LIKE; CERKL
608382	DNAJ/HSP40 HOMOLOG, SUBFAMILY A, MEMBER 3; DNAJA3
608383	DIHYDROPYRIMIDINASE-LIKE 5; DPYSL5
608384	GASDERMIN C; GSDMC
608385	TENSIN 4; TNS4
608386	PARATHYROID HORMONE 2; PTH2
608387	ZINC FINGER PROTEIN 213; ZNF213
608388	ECSIT SIGNALING INTEGRATOR; ECSIT
608389	BRANCHIOOTIC SYNDROME 3; BOS3
608390	MYOTONIA, POTASSIUM-AGGRAVATED
608391	AUTOIMMUNE DISEASE, SUSCEPTIBILITY TO, 2; AIS2
608392	AUTOIMMUNE DISEASE, SUSCEPTIBILITY TO, 3; AIS3
608393	MICROCEPHALY 6, PRIMARY, AUTOSOMAL RECESSIVE; MCPH6
608394	DEAFNESS, AUTOSOMAL DOMINANT 43; DFNA43
608395	MOVED TO 610217
608396	SOLUTE CARRIER FAMILY 9 (SODIUM/HYDROGEN EXCHANGER), MEMBER 9; SLC9A9
608397	CUB AND SUSHI MULTIPLE DOMAINS 1; CSMD1
608398	CUB AND SUSHI MULTIPLE DOMAINS 2; CSMD2
608399	CUB AND SUSHI MULTIPLE DOMAINS 3; CSMD3
608400	USHERIN; USH2A
608401	MEMBRANE-SPANNING 4-DOMAINS, SUBFAMILY A, MEMBER 4E; MS4A4E
608402	MEMBRANE-SPANNING 4-DOMAINS, SUBFAMILY A, MEMBER 6E; MS4A6E
608403	MEMBRANE-SPANNING 4-DOMAINS, SUBFAMILY A, MEMBER 10; MS4A10
608404	PLATELET GLYCOPROTEIN IV DEFICIENCY
608405	1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYNTHASE; ACCS
608406	VATER-LIKE DEFECTS WITH PULMONARY HYPERTENSION, LARYNGEAL WEBS, AND GROWTH DEFICIENCY
608407	DIHYDROPYRIMIDINASE-LIKE 4; DPYSL4
608408	DEVELOPMENTAL PLURIPOTENCY-ASSOCIATED GENE 3; DPPA3
608409	CHROMOSOME 15 OPEN READING FRAME 48; C15ORF48
608410	BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 7; BMIQ7
608411	EXPORTIN 6; XPO6
608412	GC-RICH PROMOTER-BINDING PROTEIN 1; GPBP1
608413	UBIQUITIN-PROTEIN LIGASE E3 COMPONENT N-RECOGNIN 5; UBR5
608414	PHOSPHOLIPASE C, EPSILON-1; PLCE1
608415	PROLONGED ELECTRORETINAL RESPONSE SUPPRESSION 1; PERRS1
608416	MATRIX METALLOPROTEINASE 21; MMP21
608417	MATRIX METALLOPROTEINASE 28; MMP28
608418	SEPTIN 8; SEPT8
608419	METHYLMALONYL-CoA EPIMERASE; MCEE
608420	PANNEXIN 1; PANX1
608421	PANNEXIN 2; PANX2
608422	PANNEXIN 3; PANX3
608423	MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL DOMINANT 2; LGMDD2
608424	MUCIN 17; MUC17
608425	FRUCTOSAMINE 3-KINASE
608426	MAKORIN 2; MKRN2
608427	PARKIN COREGULATED GENE; PACRG
608428	CYTOCHROME P450, SUBFAMILY XXVIC, POLYPEPTIDE 1; CYP26C1
608429	CARBOHYDRATE SULFOTRANSFERASE 14; CHST14
608430	TRPC4-ASSOCIATED PROTEIN; TRPC4AP
608431	G3BP STRESS GRANULE ASSEMBLY FACTOR 1; G3BP1
608432	CRANIOSYNOSTOSIS, CALCIFICATION OF BASAL GANGLIA, AND FACIAL DYSMORPHISM
608433	ZINC FINGER- AND BTB DOMAIN-CONTAINING PROTEIN 18; ZBTB18
608434	GIT ArfGAP 1; GIT1
608435	MUSCLE RAS VIRAL ONCOGENE HOMOLOG; MRAS
608436	SULFOTRANSFERASE FAMILY 1B, MEMBER 1; SULT1B1
608437	SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO, 4; SLEB4
608438	TOUSLED-LIKE KINASE 1; TLK1
608439	TOUSLED-LIKE KINASE 2; TLK2
608440	LACTAMASE, BETA; LACTB
608441	SPECTRIN REPEAT-CONTAINING NUCLEAR ENVELOPE PROTEIN 1; SYNE1
608442	SPECTRIN REPEAT-CONTAINING NUCLEAR ENVELOPE PROTEIN 2; SYNE2
608443	INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 3; MRT3
608444	LYSINE-SPECIFIC METHYLTRANSFERASE 2E; KMT2E
608445	SPEECH-SOUND DISORDER
608446	MYOCARDIAL INFARCTION, SUSCEPTIBILITY TO
608447	CAROTID INTIMAL MEDIAL THICKNESS 2
608448	INFLAMMATORY BOWEL DISEASE 9; IBD9
608449	POLYPYRIMIDINE TRACT-BINDING PROTEIN 2; PTBP2
608450	B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA-EXPRESSED GENE; BLACE
608451	ETHE1 PERSULFIDE DIOXYGENASE; ETHE1
608452	PLATELET-DERIVED GROWTH FACTOR C; PDGFC
608453	CAS-BR-M MURINE ECOTROPIC RETROVIRAL TRANSFORMING SEQUENCE C; CBLC
608454	MOVED TO 267750
608455	GLYCOGEN PHOSPHORYLASE, MUSCLE; PYGM
608456	FAMILIAL ADENOMATOUS POLYPOSIS 2; FAP2
608457	CHROMOBOX 7; CBX7
608458	NEUROCHONDRIN; NCDN
608459	CYCLIN-DEPENDENT KINASE-LIKE 3; CDKL3
608460	ZINC FINGER PROTEIN 276; ZFP276
608461	COLLAGEN, TYPE XXVII, ALPHA-1; COL27A1
608462	HIRSCHSPRUNG DISEASE, SUSCEPTIBILITY TO, 8; HSCR8
608463	APOPTOSIS-ANTAGONIZING TRANSCRIPTION FACTOR; AATF
608464	ANGIOGENIC FACTOR WITH G-PATCH AND FHA DOMAINS 1; AGGF1
608465	SENATAXIN; SETX
608466	ACTIVATOR OF HEAT-SHOCK 90-KD PROTEIN ATPase 1; AHSA1
608467	STONIN 2; STON2
608468	CARBON CATABOLITE REPRESSION 4-LIKE; CCRN4L
608469	DEAD-BOX HELICASE 17; DDX17
608470	CORNEAL DYSTROPHY, REIS-BUCKLERS TYPE; CDRB
608471	CORNEAL DYSTROPHY, LATTICE TYPE IIIA; CDL3A
608472	ST6 BETA-GALACTOSAMIDE ALPHA-2,6-SIALYLTRANSFERASE 2; ST6GAL2
608473	ANAPHASE-PROMOTING COMPLEX, SUBUNIT 1; ANAPC1
608474	MYOPIA 5, AUTOSOMAL DOMINANT; MYP5
608475	3-HYDROXYISOBUTYRATE DEHYDROGENASE; HIBADH
608476	TBK1-BINDING PROTEIN 1; TBKBP1
608477	ALDO-KETO REDUCTASE FAMILY 7, MEMBER A3; AKR7A3
608478	ALDO-KETO REDUCTASE FAMILY 7, MEMBER A4
608479	SOLUTE CARRIER FAMILY 26 (SULFATE TRANSPORTER), MEMBER 7; SLC26A7
608480	SOLUTE CARRIER FAMILY 26 (SULFATE TRANSPORTER), MEMBER 8; SLC26A8
608481	SOLUTE CARRIER FAMILY 26 (SULFATE TRANSPORTER), MEMBER 9; SLC26A9
608482	MATRIX METALLOPROTEINASE 25; MMP25
608483	AKT-INTERACTING PROTEIN; AKTIP
608484	CONGENITAL CORNEAL OPACITIES, CORNEA GUTTATA, AND CORECTOPIA
608485	TRANSLOCATION-ASSOCIATED MEMBRANE PROTEIN 2; TRAM2
608486	MTTS I-BAR DOMAIN-CONTAINING PROTEIN 1; MTSS1
608487	TRIPARTITE MOTIF-CONTAINING PROTEIN 5; TRIM5
608488	SPARC-RELATED MODULAR CALCIUM-BINDING 1; SMOC1
608489	STROMAL ANTIGEN 3; STAG3
608490	SOLUTE CARRIER FAMILY 38 (AMINO ACID TRANSPORTER), MEMBER 1; SLC38A1
608491	CYCLIN D-BINDING MYB-LIKE TRANSCRIPTION FACTOR 1; DMTF1
608492	OLFACTORY RECEPTOR, FAMILY 5, SUBFAMILY F, MEMBER 1; OR5F1
608493	OLFACTORY RECEPTOR, FAMILY 10, SUBFAMILY A, MEMBER 1; OR10A1
608494	OLFACTORY RECEPTOR, FAMILY 2, SUBFAMILY D, MEMBER 2; OR2D2
608495	OLFACTORY RECEPTOR, FAMILY 6, SUBFAMILY A, MEMBER 2; OR6A2
608496	OLFACTORY RECEPTOR, FAMILY 5, SUBFAMILY I, MEMBER 1; OR5I1
608497	OLFACTORY RECEPTOR, FAMILY 2, SUBFAMILY F, MEMBER 1; OR2F1
608498	ZONA PELLUCIDA-BINDING PROTEIN; ZPBP
608499	ZONA PELLUCIDA-BINDING PROTEIN 2; ZPBP2
608500	PRICKLE PLANAR CELL POLARITY PROTEIN 1; PRICKLE1
608501	PRICKLE, PLANAR CELL POLARITY PROTEIN 2; PRICKLE2
608502	POLY(rC)-BINDING PROTEIN 3; PCBP3
608503	POLY(rC)-BINDING PROTEIN 4; PCBP4
608504	RHO GUANINE NUCLEOTIDE EXCHANGE FACTOR 15; ARHGEF15
608505	MOVED TO 225750
608506	MITOFUSIN 1; MFN1
608507	MITOFUSIN 2; MFN2
608508	CYTOCHROME b(-245), ALPHA SUBUNIT; CYBA
608509	ALOPECIA UNIVERSALIS CONGENITA, XY GONADAL DYSGENESIS, AND LARYNGOMALACIA
608510	SH2 DOMAIN-CONTAINING 1B; SH2D1B
608511	PHYTANOYL-CoA HYDROXYLASE-INTERACTING PROTEIN; PHYHIP
608512	NEUTROPHIL CYTOSOLIC FACTOR 1; NCF1
608513	RIBONUCLEASE P, RNA COMPONENT H1; RPPH1
608514	ANDROGEN-INDUCED GENE 1; AIG1
608515	NEUTROPHIL CYTOSOLIC FACTOR 2; NCF2
608516	MAJOR DEPRESSIVE DISORDER; MDD
608517	MYOPALLADIN; MYPN
608518	OROFACIODIGITAL SYNDROME VII; OFD7
608519	F-BOX ONLY PROTEIN 16; FBXO16
608520	MAJOR DEPRESSIVE DISORDER 1
608521	LATE ENDOSOMAL/LYSOSOMAL ADAPTOR, MITOGEN-ACTIVATED PROTEIN KINASE AND MAMMALIAN TARGET OF RAPAMYCIN ACTIVATOR 5; LAMTOR5
608522	HEPATITIS B VIRUS X-ASSOCIATED PROTEIN; HBXAP
608523	DIO3, OPPOSITE STRAND; DIO3OS
608524	INHIBITOR OF GROWTH 4; ING4
608525	INHIBITOR OF GROWTH 5; ING5
608526	PERIODONTITIS, AGGRESSIVE, 2
608527	NEURAMINIDASE 4; NEU4
608528	PHOSPHATIDYLINOSITOL GLYCAN ANCHOR BIOSYNTHESIS CLASS U PROTEIN; PIGU
608529	FIBRILLIN 3; FBN3
608530	BTB/POZ DOMAIN-CONTAINING PROTEIN 1; BTBD1
608531	BTB/POZ DOMAIN-CONTAINING PROTEIN 2; BTBD2
608532	NON-SMC CONDENSIN II COMPLEX SUBUNIT G2; NCAPG2
608533	F-BOX ONLY PROTEIN 38; FBXO38
608534	ACTIN-RELATED PROTEIN M1
608535	ACTIN-RELATED PROTEIN T2; ACTRT2
608536	GTP-BINDING PROTEIN 3; GTPBP3
608537	VON HIPPEL-LINDAU TUMOR SUPPRESSOR; VHL
608538	AT-RICH INTERACTION DOMAIN-CONTAINING PROTEIN 5B; ARID5B
608539	GLIS FAMILY ZINC FINGER PROTEIN 2; GLIS2
608540	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ik; CDG1K
608541	RHO GTPase INVOLVED IN BETA-CATENIN, N-CADHERIN, AND NMDA RECEPTOR SIGNALING
608542	ANEURYSM, INTRACRANIAL BERRY, 2; ANIB2
608543	SCHIZOPHRENIA 12
608544	HISTONE DEACETYLASE 10; HDAC10
608545	LARSEN-LIKE SYNDROME
608546	EUKARYOTIC TRANSLATION INITIATION FACTOR 4A, ISOFORM 3; EIF4A3
608547	VITAMIN K EPOXIDE REDUCTASE COMPLEX, SUBUNIT 1; VKORC1
608548	HEMICENTIN; HMCN1
608549	VPS11 CORE SUBUNIT OF CORVET AND HOPS COMPLEXES; VPS11
608550	VPS16 CORE SUBUNIT OF CORVET AND HOPS COMPLEXES; VPS16
608551	VPS18 CORE SUBUNIT OF CORVET AND HOPS COMPLEXES; VPS18
608552	VPS33B LATE ENDOSOME AND LYSOSOME ASSOCIATED; VPS33B
608553	LEBER CONGENITAL AMAUROSIS 9; LCA9
608554	NEURONAL PAS DOMAIN PROTEIN 4; NPAS4
608555	METAXIN 2; MTX2
608556	LEGIONNAIRE DISEASE, SUSCEPTIBILITY TO
608557	MYOCARDIAL INFARCTION, SUSCEPTIBILITY TO, 2
608558	BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 5; BMIQ5
608559	BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 6; BMIQ6
608560	STABILIN 1; STAB1
608561	STABILIN 2; STAB2
608562	POLYDACTYLY, POSTAXIAL, TYPE A4
608563	MOVED TO 204650
608564	GIT ArfGAP 2; GIT2
608565	DEAFNESS, AUTOSOMAL RECESSIVE 35; DFNB35
608566	MUCIN 15, TRANSMEMBRANE; MUC15
608567	SICK SINUS SYNDROME 1; SSS1
608568	MYOSIN, HEAVY CHAIN 14, NONMUSCLE; MYH14
608569	CARDIOMYOPATHY, DILATED, 1O; CMD1O
608570	AHNAK NUCLEOPROTEIN 2; AHNAK2
608571	ULNAR/FIBULAR RAY DEFECT AND BRACHYDACTYLY
608572	BURN-MCKEOWN SYNDROME; BMKS
608573	MOVED TO 605096
608574	EMSY TRANSCRIPTIONAL REPRESSOR, BRCA2 INTERACTING; EMSY
608575	RETINOL DEHYDROGENASE 8; RDH8
608576	GRAINYHEAD-LIKE 2; GRHL2
608577	CHURCHILL DOMAIN-CONTAINING 1; CHURC1
608578	MOVED TO 243310
608579	SEVERE CUTANEOUS ADVERSE REACTION, SUSCEPTIBILITY TO
608580	MYOSIN, HEAVY CHAIN 16, SKELETAL MUSCLE, PSEUDOGENE; MYH16
608581	RP1-LIKE PROTEIN 1; RP1L1
608582	EPIDERMAL GROWTH FACTOR-LIKE 7; EGFL7
608583	ATRIAL FIBRILLATION, FAMILIAL, 1; ATFB1
608584	ASTHMA-RELATED TRAITS, SUSCEPTIBILITY TO, 2
608585	BRACHIAL PALSY, FAMILIAL CONGENITAL
608586	KERATOCONUS 3; KTCN3
608587	GH3 DOMAIN-CONTAINING PROTEIN; GHDC
608588	DExH-BOX HELICASE 58; DHX58
608589	SLAM FAMILY, MEMBER 9; SLAMF9
608590	MOVED TO 608358
608591	MOVED TO 614436
608592	CTD SMALL PHOSPHATASE-LIKE; CTDSPL
608593	COMPLEMENT FACTOR H-RELATED 5; CFHR5
608594	LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 1; CGL1
608595	NEUROPEPTIDE S RECEPTOR 1; NPSR1
608596	NPSR1 ANTISENSE RNA 1; NPSRAS1
608597	NEURALIZED E3 UBIQUITIN PROTEIN LIGASE 2; NEURL2
608598	CANCER SUSCEPTIBILITY CANDIDATE 2; CASC2
608599	RAB11 FAMILY-INTERACTING PROTEIN 2; RAB11FIP2
608600	LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 1; FPLD1
608601	FIBROSIN 1; FBS1
608602	NUCLEAR BODY PROTEIN SP140; SP140
608603	GLIOMEDIN; GLDN
608604	RETINOL-BINDING PROTEIN 7; RBP7
608605	OLIGOSACCHARYLTRANSFERASE COMPLEX, CATALYTIC SUBUNIT STT3B; STT3B
608606	BASIC HELIX-LOOP-HELIX FAMILY, MEMBER A15; BHLHA15
608607	NEUROBLASTOMA BREAKPOINT FAMILY, MEMBER 12; NBPF12
608608	PEPTIDYL-PROLYL ISOMERASE A-LIKE PROTEIN 4E; PPIAL4E
608609	CHROMOSOME 1 OPEN READING FRAME 152; C1ORF152
608610	PROGRAMMED CELL DEATH 4; PDCD4
608611	RIBOSE 5-PHOSPHATE ISOMERASE DEFICIENCY; RPIAD
608612	MANDIBULOACRAL DYSPLASIA WITH TYPE B LIPODYSTROPHY; MADB
608613	TRANSCRIPTION FACTOR Sp6; SP6
608614	CYTOCHROME P450, FAMILY 4, SUBFAMILY V, POLYPEPTIDE 2; CYP4V2
608615	OLIGODONTIA-COLORECTAL CANCER SYNDROME; ODCRCS
608616	OBSCURIN; OBSCN
608617	FAMILY WITH SEQUENCE SIMILARITY 3, MEMBER B; FAM3B
608618	FAMILY WITH SEQUENCE SIMILARITY 3, MEMBER C; FAM3C
608619	FAMILY WITH SEQUENCE SIMILARITY 3, MEMBER D; FAM3D
608620	MOVED TO 605232
608621	SPERM AUTOANTIGENIC PROTEIN 17; SPA17
608622	HYPERTENSION, DIASTOLIC, RESISTANCE TO
608623	MOVED TO 276300
608624	MIDFACE HYPOPLASIA, OBESITY, DEVELOPMENTAL DELAY, AND NEONATAL HYPOTONIA
608625	PEPTIDYL-tRNA HYDROLASE 2; PTRH2
608626	STE20-RELATED KINASE ADAPTOR ALPHA; STRADA
608627	AMYOTROPHIC LATERAL SCLEROSIS 8; ALS8
608628	TRANSDUCIN-BETA-LIKE 1 RECEPTOR 1; TBL1XR1
608629	JOUBERT SYNDROME 3; JBTS3
608630	ROUNDABOUT GUIDANCE RECEPTOR 3; ROBO3
608631	ASPERGER SYNDROME, SUSCEPTIBILITY TO, 2; ASPG2
608632	MICRO RNA 196A1; MIR196A1
608633	CASPASE 12, APOPTOSIS-RELATED CYSTEINE PROTEASE; CASP12
608634	NEURONOPATHY, DISTAL HEREDITARY MOTOR, AUTOSOMAL DOMINANT 3; HMND3
608635	ARFGAP WITH DUAL PLECKSTRIN HOMOLOGY DOMAINS 2; ADAP2
608636	CHROMOSOME 15q11-q13 DUPLICATION SYNDROME
608637	MOVED TO 143095
608638	ASPERGER SYNDROME, SUSCEPTIBILITY TO, 1; ASPG1
608639	PLECKSTRIN HOMOLOGY DOMAIN-CONTAINING PROTEIN, FAMILY A, MEMBER 8; PLEKHA8
608640	ZINC FINGER PROTEIN 461; ZNF461
608641	DEAFNESS, AUTOSOMAL DOMINANT 28; DFNA28
608642	ZINC-BINDING ALCOHOL DEHYDROGENASE DOMAIN-CONTAINING PROTEIN 1; ZADH1
608643	AROMATIC L-AMINO ACID DECARBOXYLASE DEFICIENCY; AADCD
608644	CILIARY DYSKINESIA, PRIMARY, 3; CILD3
608645	DEAFNESS, AUTOSOMAL DOMINANT 31; DFNA31
608646	CILIARY DYSKINESIA, PRIMARY, 4; CILD4
608647	CILIARY DYSKINESIA, PRIMARY, 5; CILD5
608648	SEC63 HOMOLOG, PROTEIN TRANSLOCATION REGULATOR; SEC63
608649	ICHTHYOSIS PREMATURITY SYNDROME; IPS
608650	UNC51-LIKE AUTOPHAGY-ACTIVATING KINASE 2; ULK2
608651	ARF GTPase-ACTIVATING PROTEIN WITH GTPase DOMAIN, ANKYRIN REPEAT, AND PLECKSTRIN HOMOLOGY DOMAIN 1; AGAP1
608652	DEAFNESS, AUTOSOMAL DOMINANT 47; DFNA47
608653	DEAFNESS, AUTOSOMAL RECESSIVE 32, WITH OR WITHOUT IMMOTILE SPERM; DFNB32
608654	NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE V; HSAN5
608655	GAP JUNCTION PROTEIN, GAMMA-1; GJC1
608656	PROSTATE CANCER, HEREDITARY, 3
608657	JUN DIMERIZATION PROTEIN 2; JDP2
608658	PROSTATE CANCER, HEREDITARY, 4
608659	SENTRIN-SPECIFIC PROTEASE FAMILY, MEMBER 8; SENP8
608660	INSULIN-INDUCED GENE 2; INSIG2
608661	PODOCAN; PODN
608662	ANOCTAMIN 5; ANO5
608663	ANOCTAMIN 6; ANO6
608664	MOVED TO 210600
608665	PSMC3-INTERACTING PROTEIN; PSMC3IP
608666	PEROXISOME BIOGENESIS FACTOR 26; PEX26
608667	NIPPED-B-LIKE; NIPBL
608668	ZINC FINGER MYND DOMAIN-CONTAINING PROTEIN 11; ZMYND11
608669	BASONUCLIN 2; BNC2
608670	ROBIN SEQUENCE WITH DISTINCTIVE FACIAL APPEARANCE AND BRACHYDACTYLY
608671	DAZ-INTERACTING ZINC FINGER PROTEIN 1; DZIP1
608672	DAZ-INTERACTING ZINC FINGER PROTEIN 3; DZIP3
608673	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2L; CMT2L
608674	SH3 DOMAIN PROTEIN 19
608675	FUCOSE KINASE; FCSK
608676	TAXILIN, ALPHA; TXLNA
608677	MINDBOMB E3 UBIQUITIN PROTEIN LIGASE 1; MIB1
608678	INTERLEUKIN 33; IL33
608679	TP53-REGULATING KINASE; TP53RK
608680	TP53RK-BINDING PROTEIN; TPRKB
608681	SPONDYLOCOSTAL DYSOSTOSIS 2, AUTOSOMAL RECESSIVE; SCDO2
608682	ADRENOMEDULLIN 2; ADM2
608683	CYSTATIN 8; CST8
608684	NINEIN; NIN
608685	STRUCTURAL MAINTENANCE OF CHROMOSOMES 1B; SMC1B
608686	RAB3A-INTERACTING PROTEIN; RAB3IP
608687	SPINOCEREBELLAR ATAXIA 20; SCA20
608688	AICA-RIBOSIDURIA DUE TO ATIC DEFICIENCY
608689	MESODERM POSTERIOR BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTOR 1; MESP1
608690	SSX2-INTERACTING PROTEIN; SSX2IP
608691	MAJOR DEPRESSIVE DISORDER 2
608692	BASIC LEUCINE ZIPPER NUCLEAR FACTOR 1; BLZF1
608693	GOLGI REASSEMBLY STACKING PROTEIN 2; GORASP2
608694	ZINC FINGER PROTEIN 622; ZNF622
608695	GLAUCOMA 1, OPEN ANGLE, J; GLC1J
608696	GLAUCOMA 1, OPEN ANGLE, K; GLC1K
608697	FOLLICULOGENESIS-SPECIFIC bHLH TRANSCRIPTION FACTOR; FIGLA
608698	DISCOIDIN, CUB, AND LCCL DOMAIN-CONTAINING PROTEIN 2; DCBLD2
608699	BONE MORPHOGENETIC PROTEIN-BINDING ENDOTHELIAL REGULATOR PROTEIN; BMPER
608700	NICOTINAMIDE NUCLEOTIDE ADENYLYLTRANSFERASE 1; NMNAT1
608701	NICOTINAMIDE NUCLEOTIDE ADENYLYLTRANSFERASE 2; NMNAT2
608702	NICOTINAMIDE NUCLEOTIDE ADENYLYLTRANSFERASE 3; NMNAT3
608703	SPINOCEREBELLAR ATAXIA 25; SCA25
608704	NICOTINAMIDE RIBOSIDE KINASE 1; NMRK1
608705	INTEGRIN, BETA-1, BINDING PROTEIN OF, 3; ITGB1BP3
608706	DYNEIN, AXONEMAL, ASSEMBLY FACTOR 4; DNAAF4
608707	CELL ADHESION MOLECULE-RELATED/DOWNREGULATED BY ONCOGENES; CDON
608708	BROTHER OF CDON; BOC
608709	LIPODYSTROPHY, PARTIAL, ACQUIRED, SUSCEPTIBILITY TO; APLD
608710	GRANULOMATOSIS WITH POLYANGIITIS; GPA
608711	CTD SMALL PHOSPHATASE 2; CTDSP2
608712	PROTEIN-TYROSINE PHOSPHATASE, RECEPTOR-TYPE, T; PTPRT
608713	CYTOCHROME P450, SUBFAMILY IIR, POLYPEPTIDE 1; CYP2R1
608714	SYNTROPHIN, GAMMA-1; SNTG1
608715	SYNTROPHIN, GAMMA-2; SNTG2
608716	MICROCEPHALY 5, PRIMARY, AUTOSOMAL RECESSIVE; MCPH5
608717	LECTIN, GALACTOSIDE-BINDING, SOLUBLE, 13; LGALS13
608718	KERATIN-ASSOCIATED PROTEIN 13-1; KRTAP13-1
608719	TR4-ASSOCIATED PROTEIN, 16-KD
608720	NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, ADULT-ONSET, WITH ANOSMIA
608721	CALCIUM/CALMODULIN-DEPENDENT PROTEIN KINASE II INHIBITOR 2; CAMK2N2
608722	CAPPING PROTEIN, ALPHA-3; CAPZA3
608723	PHOSPHATASE AND ACTIN REGULATOR 1; PHACTR1
608724	PHOSPHATASE AND ACTIN REGULATOR 2; PHACTR2
608725	PHOSPHATASE AND ACTIN REGULATOR 3; PHACTR3
608726	PHOSPHATASE AND ACTIN REGULATOR 4; PHACTR4
608727	DET1 PARTNER OF COP1 E3 UBIQUITIN LIGASE; DET1
608728	SPONDYLOEPIMETAPHYSEAL DYSPLASIA, BOROCHOWITZ-CORMIER-DAIRE TYPE; SEMDBCD
608729	ANGIOTENSIN II RECEPTOR-ASSOCIATED PROTEIN; AGTRAP
608730	SOLUTE CARRIER FAMILY 39 (ZINC TRANSPORTER), MEMBER 5; SLC39A5
608731	SOLUTE CARRIER FAMILY 39 (ZINC TRANSPORTER), MEMBER 6; SLC39A6
608732	SOLUTE CARRIER FAMILY 39 (ZINC TRANSPORTER), MEMBER 8; SLC39A8
608733	SOLUTE CARRIER FAMILY 39 (ZINC TRANSPORTER), MEMBER 10; SLC39A10
608734	SOLUTE CARRIER FAMILY 39 (ZINC TRANSPORTER), MEMBER 12; SLC39A12
608735	SOLUTE CARRIER FAMILY 39 (ZINC TRANSPORTER), MEMBER 13; SLC39A13
608736	SOLUTE CARRIER FAMILY 39 (ZINC TRANSPORTER), MEMBER 14; SLC39A14
608737	RAB11 FAMILY-INTERACTING PROTEIN 1; RAB11FIP1
608738	RAB11 FAMILY-INTERACTING PROTEIN 3; RAB11FIP3
608739	EXORIBONUCLEASE 1; ERI1
608740	NFAT ACTIVATING PROTEIN WITH ITAM MOTIF 1; NFAM1
608741	SYNAPTOTAGMIN 11; SYT11
608742	HYPERTENSION, ESSENTIAL, SUSCEPTIBILITY TO, 4
608743	JUNCTIONAL SARCOPLASMIC RETICULUM PROTEIN 1; JSRP1
608744	SOLUTE CARRIER FAMILY 25 (MITOCHONDRIAL CARRIER, PHOSPHATE CARRIER), MEMBER 24; SLC25A24
608745	SOLUTE CARRIER FAMILY 25 (MITOCHONDRIAL CARRIER, PHOSPHATE CARRIER), MEMBER 25; SLC25A25
608746	SOLUTE CARRIER FAMILY 25 (MITOCHONDRIAL CARRIER, PHOSPHATE CARRIER), MEMBER 23; SLC25A23
608747	INSULIN-LIKE GROWTH FACTOR I DEFICIENCY; IGF1D
608748	BONE MORPHOGENETIC PROTEIN 10; BMP10
608749	BROMODOMAIN-CONTAINING PROTEIN 4; BRD4
608750	ALG3 ALPHA-1,3-MANNOSYLTRANSFERASE; ALG3
608751	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 8; CMH8
608752	C1q- AND TUMOR NECROSIS FACTOR-RELATED PROTEIN 5; C1QTNF5
608753	tRNA SPLICING ENDONUCLEASE, SUBUNIT 2; TSEN2
608754	tRNA SPLICING ENDONUCLEASE, SUBUNIT 34; TSEN34
608755	tRNA SPLICING ENDONUCLEASE, SUBUNIT 54; TSEN54
608756	tRNA SPLICING ENDONUCLEASE, SUBUNIT 15; TSEN15
608757	CLEAVAGE FACTOR POLYNUCLEOTIDE KINASE SUBUNIT 1; CLP1
608758	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 10; CMH10
608759	CYTOGLOBIN; CYGB
608760	AUTOPHAGY-RELATED 7; ATG7
608761	SOLUTE CARRIER FAMILY 5 (CHOLINE TRANSPORTER), MEMBER 7; SLC5A7
608762	EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 3; EIG3
608763	EHLERS-DANLOS SYNDROME, BEASLEY-COHEN TYPE
608764	NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; NAMPT
608765	SCOLIOSIS, ISOLATED, SUSCEPTIBILITY TO, 3; IS3
608766	LOW DENSITY LIPOPROTEIN RECEPTOR-RELATED PROTEIN 1B; LRP1B
608767	FEM1 HOMOLOG C; FEM1C
608768	SPINOCEREBELLAR ATAXIA 8; SCA8
608769	PYRUVATE DEHYDROGENASE COMPLEX, COMPONENT X; PDHX
608770	DIHYDROLIPOAMIDE S-ACETYLTRANSFERASE; DLAT
608771	MEDIATOR COMPLEX SUBUNIT 13-LIKE; MED13L
608772	INVASION INHIBITORY PROTEIN, 45-KD
608773	TUBULIN POLYMERIZATION-PROMOTING PROTEIN; TPPP
608774	ANKYRIN REPEAT- AND KINASE DOMAIN-CONTAINING PROTEIN 1; ANKK1
608775	HAUS AUGMIN-LIKE COMPLEX, SUBUNIT 1; HAUS1
608776	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Il; CDG1L
608777	PERIOSTIN; POSTN
608778	KELCH-LIKE 10; KLHL10
608779	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIe; CDG2E
608780	GENERAL TRANSCRIPTION FACTOR IIH, POLYPEPTIDE 5; GTF2H5
608781	ASPERGER SYNDROME, SUSCEPTIBILITY TO, 3; ASPG3
608782	PYRUVATE DEHYDROGENASE PHOSPHATASE DEFICIENCY; PDHPD
608783	SET AND MYND DOMAIN-CONTAINING PROTEIN 3; SMYD3
608784	ZINC FINGER DHHC DOMAIN-CONTAINING PROTEIN 8; ZDHHC8
608785	HTRA SERINE PEPTIDASE 3; HTRA3
608786	PYRUVATE CARBOXYLASE; PC
608787	OTOSCLEROSIS 5; OTSC5
608788	SUPPRESSOR OF CYTOKINE SIGNALING 7; SOCS7
608789	NCK-ASSOCIATED PROTEIN 5; NCKAP5
608790	TRANSCRIPTIONAL ADAPTOR 2B; TADA2B
608791	NUCLEOREDOXIN-LIKE PROTEIN 1; NXNL1
608792	GIPC PDZ DOMAIN-CONTAINING FAMILY, MEMBER 3; GIPC3
608793	SPERM ANTIGEN WITH CALPONIN HOMOLOGY AND COILED-COIL DOMAINS 1; SPECC1
608794	PHOSPHATIDYLINOSITOL TRANSFER PROTEIN, MEMBRANE-ASSOCIATED, 1; PITPNM1
608795	PHOSPHOLIPASE C, DELTA-3; PLCD3
608796	MOYAMOYA DISEASE 3; MYMY3
608797	MEIOTIC DOUBLE-STRANDED BREAK FORMATION PROTEIN 1; MEI1
608798	GASDERMIN E; GSDME
608799	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ie; CDG1E
608800	SUDDEN INFANT DEATH WITH DYSGENESIS OF THE TESTES SYNDROME; SIDDT
608801	GLUTARYL-CoA DEHYDROGENASE; GCDH
608802	L3MBTL HISTONE METHYL-LYSINE-BINDING PROTEIN 1; L3MBTL1
608803	GAP JUNCTION PROTEIN, GAMMA-2; GJC2
608804	LEUKODYSTROPHY, HYPOMYELINATING, 2; HLD2
608805	AVASCULAR NECROSIS OF FEMORAL HEAD, PRIMARY, 1; ANFH1
608806	N-ACETYLATED ALPHA-LINKED ACIDIC DIPEPTIDASE-LIKE 2; NAALADL2
608807	MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 10; LGMDR10
608808	TRANSPOSITION OF THE GREAT ARTERIES, DEXTRO-LOOPED; DTGA
608809	LEUKOENCEPHALOPATHY, ARTHRITIS, COLITIS, AND HYPOGAMMAGLOBULINEMA; LACH
608810	MYOPATHY, MYOFIBRILLAR, 2; MFM2
608811	METAPHYSEAL UNDERMODELING, SPONDYLAR DYSPLASIA, AND OVERGROWTH
608812	COLORECTAL CANCER, SUSCEPTIBILITY TO, 1; CRCS1
608813	DER1-LIKE DOMAIN FAMILY, MEMBER 1; DERL1
608814	LATERAL SEMICIRCULAR CANAL MALFORMATION, FAMILIAL, WITH EXTERNAL AND MIDDLE EAR ABNORMALITIES
608815	EF-HAND DOMAIN (C-TERMINAL)-CONTAINING PROTEIN 1; EFHC1
608816	MYOCLONIC EPILEPSY, JUVENILE, SUSCEPTIBILITY TO, 3; EJM3
608817	LEUCINE-RICH REPEAT-CONTAINING PROTEIN 4C; LRRC4C
608818	NETRIN G1; NTNG1
608819	KERATIN-ASSOCIATED PROTEIN 1-1; KRTAP1-1
608820	KERATIN-ASSOCIATED PROTEIN 1-3; KRTAP1-3
608821	KERATIN-ASSOCIATED PROTEIN 1-4; KRTAP1-4
608822	KERATIN-ASSOCIATED PROTEIN 1-5; KRTAP1-5
608823	CHORIONIC GONADOTROPIN, BETA POLYPEPTIDE 1; CGB1
608824	CHORIONIC GONADOTROPIN, BETA POLYPEPTIDE 2; CGB2
608825	CHORIONIC GONADOTROPIN, BETA POLYPEPTIDE 5; CGB5
608826	CHORIONIC GONADOTROPIN, BETA POLYPEPTIDE 7; CGB7
608827	CHORIONIC GONADOTROPIN, BETA POLYPEPTIDE 8; CGB8
608828	DROSHA RIBONUCLEASE III; DROSHA
608829	SMALL UBIQUITIN-LIKE MODIFIER 4; SUMO4
608830	RETINOL DEHYDROGENASE 12; RDH12
608831	RESTLESS LEGS SYNDROME, SUSCEPTIBILITY TO, 2; RLS2
608832	GREMLIN 2, DAN FAMILY BMP ANTAGONIST; GREM2
608833	REGULATOR OF TELOMERE ELONGATION HELICASE 1; RTEL1
608834	cAMP RESPONSE ELEMENT-BINDING PROTEIN 3-LIKE 2; CREB3L2
608835	ATP-BINDING CASSETTE, SUBFAMILY C, MEMBER 13; ABCC13
608836	CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, LETHAL NEONATAL
608837	CARNEY COMPLEX VARIANT
608838	VITAMIN K EPOXIDE REDUCTASE COMPLEX, SUBUNIT 1-LIKE 1; VKORC1L1
608839	CALPAIN 12; CAPN12
608840	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH IMPAIRED INTELLECTUAL DEVELOPMENT), TYPE B, 6; MDDGB6
608841	COMPLEMENT COMPONENT 3- AND PREGNANCY ZONE PROTEIN-LIKE ALPHA-2-MACROGLOBULIN DOMAIN-CONTAINING PROTEIN 8; CPAMD8
608842	COILED-COIL-HELIX-COILED-COIL-HELIX DOMAIN-CONTAINING PROTEIN 1; CHCHD1
608843	VASORIN
608844	NEI-LIKE DNA GLYCOSYLASE 1; NEIL1
608845	ADP-RIBOSYLATION FACTOR-LIKE GTPase 6; ARL6
608846	CARNITINE PALMITOYLTRANSFERASE IC; CPT1C
608847	FERRITIN, MITOCHONDRIAL; FTMT
608848	FORMIN-BINDING PROTEIN 1-LIKE; FNBP1L
608849	U2AF HOMOLOGY MOTIF KINASE 1; UHMK1
608850	MACULAR DYSTROPHY, RETINAL, 3; MCDR3
608851	5-PRIME,3-PRIME-EXORIBONUCLEASE 2; XRN2
608852	PULMONARY FUNCTION
608853	BH3-LIKE MOTIF-CONTAINING CELL DEATH INDUCER; BLID
608854	OXIDORED-NITRO DOMAIN-CONTAINING PROTEIN 1
608855	TWEETY FAMILY MEMBER 2; TTYH2
608856	CUTANEOUS T-CELL LYMPHOMA-ASSOCIATED ANTIGEN 1; CTAGE1
608857	CUTANEOUS T-CELL LYMPHOMA-ASSOCIATED ANTIGEN 3; CTAGE3
608858	FIBROBLAST GROWTH FACTOR RECEPTOR 1 ONCOGENE PARTNER 2; FGFR1OP2
608859	CD109 ANTIGEN; CD109
608860	ASTACIN-LIKE METALLOENDOPEPTIDASE; ASTL
608861	ATPase, H+ TRANSPORTING, LYSOSOMAL, 50/57-KD, V1 SUBUNIT H; ATP6V1H
608862	NAD(P)HX EPIMERASE; NAXE
608863	PODOPLANIN; PDPN
608864	OROFACIAL CLEFT 6, SUSCEPTIBILITY TO; OFC6
608865	URB1 RIBOSOME BIOGENESIS 1, S. CEREVISIAE, HOMOLOG OF; URB1
608866	FRA10A-ASSOCIATED CGG REPEAT 1; FRA10AC1
608867	DUAL-SPECIFICITY PHOSPHATASE 10; DUSP10
608868	LEUCINE-RICH REPEATS- AND IMMUNOGLOBULIN-LIKE DOMAINS-CONTAINING PROTEIN 1; LRIG1
608869	LEUCINE-RICH REPEATS- AND IMMUNOGLOBULIN-LIKE DOMAINS-CONTAINING PROTEIN 2; LRIG2
608870	LEUCINE-RICH REPEATS- AND IMMUNOGLOBULIN-LIKE DOMAINS-CONTAINING PROTEIN 3; LRIG3
608871	NIPSNAP HOMOLOG 3A; NIPSNAP3A
608872	NIPSNAP HOMOLOG 3B; NIPSNAP3B
608873	SEMAPHORIN 6B; SEMA6B
608874	OROFACIAL CLEFT 5; OFC5
608875	GENE EXPRESSION, VARIATION IN, QUANTITATIVE TRAIT LOCUS ON CHROMOSOME 14
608876	PCF11 CLEAVAGE AND POLYADENYLATION FACTOR SUBUNIT; PCF11
608877	VACUOLAR PROTEIN SORTING 13 HOMOLOG D; VPS13D
608878	GENE EXPRESSION, VARIATION IN, QUANTITATIVE TRAIT LOCUS ON CHROMOSOME 20
608879	VACUOLAR PROTEIN SORTING 13 HOMOLOG C; VPS13C
608880	ZINC FINGER FYVE DOMAIN-CONTAINING PROTEIN 16; ZFYVE16
608881	MICROTUBULE-ASSOCIATED MONOOXYGENASE, CALPONIN AND LIM DOMAINS-CONTAINING, 2; MICAL2
608882	MICROTUBULE-ASSOCIATED MONOOXYGENASE, CALPONIN AND LIM DOMAINS-CONTAINING, 3; MICAL3
608883	MOVED TO 137030
608884	RAL GTPase-ACTIVATING PROTEIN, CATALYTIC SUBUNIT ALPHA-1; RALGAPA1
608885	STOMATIN-DEFICIENT CRYOHYDROCYTOSIS WITH NEUROLOGIC DEFECTS; SDCHCN
608886	PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR-GAMMA, COACTIVATOR 1, BETA; PPARGC1B
608887	PURINE-RICH ELEMENT-BINDING PROTEIN B; PURB
608888	RNA-BINDING MOTIF PROTEIN 45; RBM45
608889	AMINOCARBOXYMUCONATE SEMIALDEHYDE DECARBOXYLASE; ACMSD
608890	MOVED TO 193510
608891	ODD-SKIPPED-RELATED TRANSCRIPTION FACTOR 1; OSR1
608892	CHROMODOMAIN HELICASE DNA-BINDING PROTEIN 7; CHD7
608893	SOLUTE CARRIER FAMILY 6 (NEUROTRANSMITTER TRANSPORTER), MEMBER 19; SLC6A19
608894	ABELSON HELPER INTEGRATION SITE 1; AHI1
608895	MACULAR DEGENERATION, AGE-RELATED, 3; ARMD3
608896	SARCOGLYCAN, GAMMA; SGCG
608897	UNC13 HOMOLOG D; UNC13D
608898	HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 3; FHL3
608899	GTF2I REPEAT DOMAIN-CONTAINING PROTEIN 2, ALPHA
608900	GTF2I REPEAT DOMAIN-CONTAINING PROTEIN 2, BETA
608901	CORONARY HEART DISEASE, SUSCEPTIBILITY TO, 5
608902	DRUG METABOLISM, POOR, CYP2D6-RELATED
608903	ATTENTION DEFICIT-HYPERACTIVITY DISORDER, SUSCEPTIBILITY TO, 1
608904	ATTENTION DEFICIT-HYPERACTIVITY DISORDER, SUSCEPTIBILITY TO, 2
608905	ATTENTION DEFICIT-HYPERACTIVITY DISORDER, SUSCEPTIBILITY TO, 3
608906	ATTENTION DEFICIT-HYPERACTIVITY DISORDER, SUSCEPTIBILITY TO, 4
608907	ALZHEIMER DISEASE 9, SUSCEPTIBILITY TO; AD9
608908	MYOPIA 6; MYP6
608909	ADP-RIBOSYLATION FACTOR-LIKE GTPase 5B; ARL5B
608910	CUTANEOUS T-CELL LYMPHOMA-ASSOCIATED ANTIGEN 4; CTAGE4
608911	CHOANAL ATRESIA, POSTERIOR; PCA
608912	POTE ANKYRIN DOMAIN FAMILY, MEMBER B; POTEB
608913	POTE ANKYRIN DOMAIN FAMILY, MEMBER H; POTEH
608914	POTE ANKYRIN DOMAIN FAMILY, MEMBER E; POTEE
608915	POTE ANKYRIN DOMAIN FAMILY, MEMBER A; POTEA
608916	POTE ANKYRIN DOMAIN FAMILY, MEMBER G; POTEG
608917	ATP SYNTHASE, MITOCHONDRIAL F1 COMPLEX, ASSEMBLY FACTOR 1; ATPAF1
608918	ATP SYNTHASE, MITOCHONDRIAL F1 COMPLEX, ASSEMBLY FACTOR 2; ATPAF2
608919	TWEETY FAMILY MEMBER 3; TTYH3
608920	PHOSPHATIDYLINOSITOL TRANSFER PROTEIN, MEMBRANE-ASSOCIATED, 2; PITPNM2
608921	PHOSPHATIDYLINOSITOL TRANSFER PROTEIN, MEMBRANE-ASSOCIATED, 3; PITPNM3
608922	ADP-RIBOSYLATION FACTOR-LIKE GTPase 13B; ARL13B
608923	TRACE AMINE-ASSOCIATED RECEPTOR 6; TAAR6
608924	FORKHEAD BOX P4; FOXP4
608925	MULTIMERIN 2; MMRN2
608926	EMI DOMAIN-CONTAINING PROTEIN 1; EMID1
608927	EMI DOMAIN-CONTAINING PROTEIN 2; EMID2
608928	ELASTIN MICROFIBRIL INTERFACER 2; EMILIN2
608929	ELASTIN MICROFIBRIL INTERFACER 3; EMILIN3
608930	MYASTHENIC SYNDROME, CONGENITAL, 1B, FAST-CHANNEL; CMS1B
608931	MYASTHENIC SYNDROME, CONGENITAL, 4C, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY; CMS4C
608932	KERATOCONUS 2; KTCN2
608933	ENDONUCLEASE VIII-LIKE 2; NEIL2
608934	ENDONUCLEASE VIII-LIKE 3; NEIL3
608935	LUNG CANCER SUSCEPTIBILITY 1; LNCR1
608936	OPIORPHIN PREPROPEPTIDE; OPRPN
608937	SH2B ADAPTOR PROTEIN 1; SH2B1
608938	RIBOSOMAL PROTEIN S6 KINASE B1; RPS6KB1
608939	RIBOSOMAL PROTEIN S6 KINASE B2; RPS6KB2
608940	SPONDYLOMETAPHYSEAL DYSPLASIA WITH CONE-ROD DYSTROPHY; SMDCRD
608941	GUANINE NUCLEOTIDE-BINDING PROTEIN, GAMMA-3; GNG3
608942	DYNEIN, LIGHT CHAIN, LC8 TYPE, 2; DYNLL2
608943	CYTOKINE-INDUCED APOPTOSIS INHIBITOR 1; CIAPIN1
608944	FRAS1-RELATED EXTRACELLULAR MATRIX PROTEIN 1; FREM1
608945	FRAS1-RELATED EXTRACELLULAR MATRIX PROTEIN 2; FREM2
608946	FRAS1-RELATED EXTRACELLULAR MATRIX PROTEIN 3
608947	POTASSIUM CHANNEL TETRAMERIZATION DOMAIN-CONTAINING PROTEIN 13; KCTD13
608948	ZIC FAMILY, MEMBER 4; ZIC4
608949	GLYCOLIPID TRANSFER PROTEIN; GLTP
608950	MAGI2 INTRONIC TRANSCRIPT; MAGI2IT
608951	CCR4-NOT TRANSCRIPTION COMPLEX, SUBUNIT 6; CNOT6
608952	REPLICATION TIMING REGULATORY FACTOR 1; RIF1
608953	TEKTIN 2; TEKT2
608954	MON1 HOMOLOG B, SECRETORY TRAFFICKING-ASSOCIATED; MON1B
608955	TUBULIN TYROSINE LIGASE-LIKE 1; TTLL1
608956	SOLUTE CARRIER FAMILY 46, MEMBER 2; SLC46A2
608957	IMMUNODEFICIENCY 116; IMD116
608958	ADENOSINE DEAMINASE; ADA
608959	DIPHTHAMIDE BIOSYNTHESIS PROTEIN 3; DPH3
608960	ADP-RIBOSYLATION FACTOR-LIKE GTPase 5A; ARL5A
608961	TRANSIENT RECEPTOR POTENTIAL CATION CHANNEL, SUBFAMILY M, MEMBER 3; TRPM3
608962	RHOMBOID-LIKE 2; RHBDL2
608963	NUT MIDLINE CARCINOMA FAMILY MEMBER 1; NUTM1
608964	TATA BOX-BINDING PROTEIN-LIKE PROTEIN 2; TBPL2
608965	CALCIUM-BINDING PROTEIN 4; CABP4
608966	DAPPER, ANTAGONIST OF BETA-CATENIN, 2; DACT2
608967	MOVED TO 609192
608968	MAF bZIP TRANSCRIPTION FACTOR B; MAFB
608969	UTP14C SMALL SUBUNIT PROCESSOME COMPONENT; UTP14C
608970	MACULAR DYSTROPHY, PATTERNED, 2; MDPT2
608971	IMMUNODEFICIENCY 104; IMD104
608972	CREB-REGULATED TRANSCRIPTION COACTIVATOR 2; CRTC2
608973	SALT-INDUCIBLE KINASE 2; SIK2
608974	COMPLEMENT COMPONENT C1r-LIKE PROTEIN; C1RL
608975	PAR6 FAMILY CELL POLARITY REGULATOR BETA; PARD6B
608976	PAR6 FAMILY CELL POLARITY REGULATOR GAMMA; PARD6G
608977	DNAJ/HSP40 HOMOLOG, SUBFAMILY C, MEMBER 19; DNAJC19
608978	MEACHAM SYNDROME
608979	PROTEIN PHOSPHATASE, MAGNESIUM/MANGANESE-DEPENDENT, 1M; PPM1M
608980	BIFID NOSE WITH OR WITHOUT ANORECTAL AND RENAL ANOMALIES; BNAR
608981	ACTIVIN A RECEPTOR, TYPE IC; ACVR1C
608982	STATURE QUANTITATIVE TRAIT LOCUS 5; STQTL5
608983	MOVED TO 115700
608984	ATAXIA, SENSORY, 1, AUTOSOMAL DOMINANT; SNAX1
608985	RING FINGER PROTEIN 2; RNF2
608986	CREB-REGULATED TRANSCRIPTION COACTIVATOR 3; CRTC3
608987	PROCOLLAGEN-PROLINE, 2-OXOGLUTARATE-4-DIOXYGENASE, ALPHA SUBUNIT, ISOFORM 3; P4HA3
608988	ATRIAL FIBRILLATION, FAMILIAL, 2; ATFB2
608989	RETINAL DEHYDROGENASE, EPIDERMAL, 2
608990	A DISINTEGRIN-LIKE AND METALLOPROTEINASE WITH THROMBOSPONDIN TYPE 1 MOTIF, 10; ADAMTS10
608991	MASTERMIND-LIKE 3; MAML3
608992	BCL6B TRANSCRIPTION REPRESSOR; BCL6B
608993	APOLIPOPROTEIN B mRNA-EDITING ENZYME, CATALYTIC POLYPEPTIDE-LIKE 3F; APOBEC3F
608994	ANKYRIN REPEAT AND STERILE ALPHA MOTIF DOMAINS-CONTAINING PROTEIN 1A; ANKS1A
608995	DYSLEXIA, SUSCEPTIBILITY TO, 8; DYX8
608996	PREMATURE OVARIAN FAILURE 3; POF3
608997	MOVED TO 300512
608998	EARP COMPLEX AND GARP COMPLEX INTERACTING PROTEIN 1; EIPR1
608999	TUMOR-SUPPRESSING SUBTRANSFERABLE FRAGMENT CANDIDATE GENE 2; TSSC2
609000	MONOOXYGENASE, DBH-LIKE, 1; MOXD1
609001	PHOSPHATIDYLINOSITOL 3-KINASE, CLASS 2, GAMMA; PIK3C2G
609002	TEKTIN 1; TEKT1
609003	FISSION, MITOCHONDRIAL 1; FIS1
609004	B-CELL CLL/LYMPHOMA 9-LIKE; BCL9L
609005	WD REPEAT-CONTAINING PROTEIN 17; WDR17
609006	DEAFNESS, AUTOSOMAL RECESSIVE 36, WITH OR WITHOUT VESTIBULAR INVOLVEMENT; DFNB36
609007	LEUCINE-RICH REPEAT KINASE 2; LRRK2
609008	MARFANOID HABITUS WITH SITUS INVERSUS
609009	TYROSINE 3-MONOOXYGENASE/TRYPTOPHAN 5-MONOOXYGENASE ACTIVATION PROTEIN, THETA ISOFORM; YWHAQ
609010	3-METHYLCROTONYL-CoA CARBOXYLASE 1; MCCC1
609011	VASOHIBIN 1; VASH1
609012	WD REPEAT-CONTAINING PROTEIN 5; WDR5
609013	SOLUTE CARRIER ORGANIC ANION TRANSPORTER FAMILY, MEMBER 4C1; SLCO4C1
609014	3-METHYLCROTONYL-CoA CARBOXYLASE 2; MCCC2
609015	MITOCHONDRIAL TRIFUNCTIONAL PROTEIN DEFICIENCY 1; MTPD1
609016	LONG-CHAIN 3-HYDROXYACYL-CoA DEHYDROGENASE DEFICIENCY
609017	ERYTHROBLAST MEMBRANE-ASSOCIATED PROTEIN; ERMAP
609018	HOLOCARBOXYLASE SYNTHETASE; HLCS
609019	BIOTINIDASE; BTD
609020	FOLATE HYDROLASE 1B; FOLH1B
609021	PERIPHERAL CONE DYSTROPHY
609022	RAPAMYCIN-INSENSITIVE COMPANION OF MTOR; RICTOR
609023	PNKD METALLO-BETA-LACTAMASE DOMAIN-CONTAINING PROTEIN; PNKD
609024	KDEL ENDOPLASMIC RETICULUM PROTEIN RETENTION RECEPTOR 2; KDELR2
609025	KERATIN 75, TYPE II; KRT75
609026	CATARACT 28; CTRCT28
609027	BLOOD GROUP, INDIAN SYSTEM; IN
609028	TRAF-INTERACTING PROTEIN WITH FORKHEAD-ASSOCIATED DOMAIN; TIFA
609029	EMANUEL SYNDROME
609030	DGCR8 MICROPROCESSOR COMPLEX SUBUNIT; DGCR8
609031	EPIDIDYMAL PROTEASE INHIBITOR; EPPIN
609032	FSHD REGION GENE 2; FRG2
609033	POSTERIOR COLUMN ATAXIA WITH RETINITIS PIGMENTOSA; AXPC1
609034	HES-RELATED bHLH TRANSCRIPTION FACTOR WITH YRPW MOTIF-LIKE PROTEIN; HEYL
609035	RAS ASSOCIATION AND PLECKSTRIN HOMOLOGY DOMAINS-CONTAINING PROTEIN 1; RAPH1
609036	APBB1-INTERACTING PROTEIN; APBB1IP
609037	MENTAL RETARDATION WITH OPTIC ATROPHY, FACIAL DYSMORPHISM, MICROCEPHALY, AND SHORT STATURE
609038	RHO FAMILY GTPase 1; RND1
609039	NARCOLEPSY 3; NRCLP3
609040	ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA, FAMILIAL, 9; ARVD9
609041	SPASTIC PARAPLEGIA 27, AUTOSOMAL RECESSIVE; SPG27
609042	OPSIN 5; OPN5
609043	RELAXIN/INSULIN-LIKE FAMILY PEPTIDE RECEPTOR 4; RXFP4
609044	FREE FATTY ACID RECEPTOR 4; FFAR4
609045	G PROTEIN-COUPLED RECEPTOR 141; GPR141
609046	G PROTEIN-COUPLED RECEPTOR 142; GPR142
609047	SKELETAL DYSPLASIA, RHIZOMELIC, WITH RETINITIS PIGMENTOSA
609048	MELANOMA, CUTANEOUS MALIGNANT, SUSCEPTIBILITY TO, 3; CMM3
609049	PIERSON SYNDROME; PIERS
609050	METASTASIS-ASSOCIATED GENE 3; MTA3
609051	CASPASE RECRUITMENT DOMAIN-CONTAINING PROTEIN 8; CARD8
609052	SPONDYLOMETAPHYSEAL DYSPLASIA, TYPE A4; SMDA4
609053	FANCONI ANEMIA, COMPLEMENTATION GROUP I; FANCI
609054	FANCONI ANEMIA, COMPLEMENTATION GROUP J; FANCJ
609055	CEROID LIPOFUSCINOSIS, NEURONAL, 9; CLN9
609056	SALT AND PEPPER DEVELOPMENTAL REGRESSION SYNDROME; SPDRS
609057	EPIDERMOLYSIS BULLOSA SIMPLEX 7, WITH NEPHROPATHY AND DEAFNESS; EBS7
609058	METHYLMALONYL-CoA MUTASE; MMUT
609059	PATATIN-LIKE PHOSPHOLIPASE DOMAIN-CONTAINING PROTEIN 2; PNPLA2
609060	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 1; COXPD1
609061	ENAH ACTIN REGULATOR; ENAH
609062	POU DOMAIN, CLASS 6, TRANSCRIPTION FACTOR 2; POU6F2
609063	THIOREDOXIN 2; TXN2
609064	CARNOSINE DIPEPTIDASE 1; CNDP1
609065	MOVED TO 605714
609066	AJUBA LIM PROTEIN; AJUBA
609067	SCLERAXIS bHLH TRANSCRIPTION FACTOR; SCX
609068	DAN DOMAIN FAMILY, MEMBER 5; DAND5
609069	PANCREATIC AND CEREBELLAR AGENESIS; PACA
609070	HEMOGLOBIN, HIGH ALTITUDE ADAPTATION; HALAH
609071	F-BOX AND WD40 DOMAIN PROTEIN 2; FBXW2
609072	F-BOX AND WD40 DOMAIN PROTEIN 5; FBXW5
609073	F-BOX AND WD40 DOMAIN PROTEIN 8; FBXW8
609074	F-BOX AND WD40 DOMAIN PROTEIN 9; FBXW9
609075	F-BOX AND WD40 DOMAIN PROTEIN 12; FBXW12
609076	F-BOX AND LEUCINE-RICH REPEAT PROTEIN 6; FBXL6
609077	F-BOX AND LEUCINE-RICH REPEAT PROTEIN 8; FBXL8
609078	LYSINE DEMETHYLASE 2B; KDM2B
609079	F-BOX AND LEUCINE-RICH REPEAT PROTEIN 12; FBXL12
609080	F-BOX AND LEUCINE-RICH REPEAT PROTEIN 13; FBXL13
609081	F-BOX AND LEUCINE-RICH REPEAT PROTEIN 14; FBXL14
609082	F-BOX AND LEUCINE-RICH REPEAT PROTEIN 16; FBXL16
609083	F-BOX AND LEUCINE-RICH REPEAT PROTEIN 17; FBXL17
609084	F-BOX AND LEUCINE-RICH REPEAT PROTEIN 18; FBXL18
609085	F-BOX AND LEUCINE-RICH REPEAT PROTEIN 19; FBXL19
609086	F-BOX AND LEUCINE-RICH REPEAT PROTEIN 20; FBXL20
609087	F-BOX AND LEUCINE-RICH REPEAT PROTEIN 21; FBXL21
609088	F-BOX AND LEUCINE-RICH REPEAT PROTEIN 22; FBXL22
609089	F-BOX ONLY PROTEIN 3; FBXO3
609090	F-BOX ONLY PROTEIN 4; FBXO4
609091	F-BOX ONLY PROTEIN 9; FBXO9
609092	F-BOX ONLY PROTEIN 10; FBXO10
609093	F-BOX ONLY PROTEIN 15; FBXO15
609094	F-BOX ONLY PROTEIN 17; FBXO17
609095	F-BOX ONLY PROTEIN 21; FBXO21
609096	F-BOX ONLY PROTEIN 22; FBXO22
609097	F-BOX ONLY PROTEIN 24; FBXO24
609098	F-BOX ONLY PROTEIN 25; FBXO25
609099	F-BOX ONLY PROTEIN 27; FBXO27
609100	F-BOX ONLY PROTEIN 28; FBXO28
609101	F-BOX ONLY PROTEIN 30; FBXO30
609102	F-BOX ONLY PROTEIN 31; FBXO31
609103	F-BOX ONLY PROTEIN 33; FBXO33
609104	F-BOX ONLY PROTEIN 34; FBXO34
609105	F-BOX ONLY PROTEIN 36; FBXO36
609106	F-BOX ONLY PROTEIN 39; FBXO39
609107	F-BOX ONLY PROTEIN 40; FBXO40
609108	F-BOX ONLY PROTEIN 41; FBXO41
609109	F-BOX ONLY PROTEIN 42; FBXO42
609110	F-BOX ONLY PROTEIN 43; FBXO43
609111	F-BOX ONLY PROTEIN 44; FBXO44
609112	F-BOX ONLY PROTEIN 45; FBXO45
609113	TELOMERE LENGTH, MEAN LEUKOCYTE; LTL
609114	DESTRIN; DSTN
609115	MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL DOMINANT 3; LGMDD3
609116	RESPIRATORY RHYTHMICITY IN SLEEP
609117	F-BOX ONLY PROTEIN 46; FBXO46
609118	PROGRAMMED CELL DEATH 10; PDCD10
609119	THAP DOMAIN-CONTAINING PROTEIN 11; THAP11
609120	CATION CHANNEL, SPERM-ASSOCIATED, 3; CATSPER3
609121	CATION CHANNEL, SPERM-ASSOCIATED, 4; CATSPER4
609122	ANEURYSM, INTRACRANIAL BERRY, 3; ANIB3
609123	ATPase, CLASS I, TYPE 8B, MEMBER 4; ATP8B4
609124	ZINC FINGER PROTEIN 385A; ZNF385A
609125	MOTILE SPERM DOMAIN-CONTAINING PROTEIN 3; MOSPD3
609126	ATPase, CLASS II, TYPE 9A; ATP9A
609127	MOVED TO 300516
609128	ARTHROGRYPOSIS, DISTAL, TYPE 4; DA4
609129	AUDITORY NEUROPATHY, AUTOSOMAL DOMINANT 1; AUNA1
609130	CENTROMERIC PROTEIN S; CENPS
609131	CLAUDIN 7; CLDN7
609132	LYSINE DEMETHYLASE 1A; KDM1A
609133	FLT3-INTERACTING ZINC FINGER PROTEIN 1; FIZ1
609134	UBIQUITIN-PROTEIN LIGASE E3 COMPONENT N-RECOGNIN 2; UBR2
609135	APLASTIC ANEMIA
609136	PERIPHERAL DEMYELINATING NEUROPATHY, CENTRAL DYSMYELINATION, WAARDENBURG SYNDROME, AND HIRSCHSPRUNG DISEASE; PCWH
609137	RECEPTOR-TRANSPORTING PROTEIN 1; RTP1
609138	RECEPTOR-TRANSPORTING PROTEIN 2; RTP2
609139	RECEPTOR EXPRESSION-ENHANCING PROTEIN 1; REEP1
609140	CORNEAL DYSTROPHY, POSTERIOR POLYMORPHOUS, 2; PPCD2
609141	CORNEAL DYSTROPHY, POSTERIOR POLYMORPHOUS, 3; PPCD3
609142	CEA CELL ADHESION MOLECULE 3; CEACAM3
609143	MOVED TO 607278
609144	FLVCR HEME TRANSPORTER 1; FLVCR1
609145	NEUROFASCIN; NFASC
609146	RIC8 GUANINE NUCLEOTIDE EXCHANGE FACTOR A; RIC8A
609147	RIC8 GUANINE NUCLEOTIDE EXCHANGE FACTOR B; RIC8B
609148	MALARIA, MILD, SUSCEPTIBILITY TO
609149	SOLUTE CARRIER FAMILY 29 (MONOAMINE TRANSPORTER), MEMBER 4; SLC29A4
609150	CXXC FINGER PROTEIN 1; CXXC1
609151	UBX DOMAIN PROTEIN 11; UBXN11
609152	HYPERTHYROIDISM, NONAUTOIMMUNE
609153	PSEUDOHYPERKALEMIA, FAMILIAL, 2, DUE TO RED CELL LEAK; PSHK2
609154	ACHAETE-SCUTE FAMILY bHLH TRANSCRIPTION FACTOR 3; ASCL3
609155	ACHAETE-SCUTE FAMILY bHLH TRANSCRIPTION FACTOR 4; ASCL4
609156	NICALIN; NCLN
609157	NODAL MODULATOR 1; NOMO1
609158	NODAL MODULATOR 2; NOMO2
609159	NODAL MODULATOR 3; NOMO3
609160	MOVED TO 601419
609161	STRIATAL DEGENERATION, AUTOSOMAL DOMINANT 1; ADSD1
609162	CZECH DYSPLASIA
609163	HYDROXYCARBOXYLIC ACID RECEPTOR 2; HCAR2
609164	UMBILICUS, FAMILIAL FLAT
609165	ICHTHYOSIS WITH CONFETTI; IWC
609166	BRANCHIOGENIC-DEAFNESS SYNDROME
609167	MOVED TO 604379
609168	SHUGOSHIN-LIKE 1; SGOL1
609169	GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE, SPERMATOGENIC; GAPDHS
609170	THIOREDOXIN DOMAIN-CONTAINING PROTEIN 4; TXNDC4
609171	CDC42 EFFECTOR PROTEIN 5; CDC42EP5
609172	PROTEIN PHOSPHATASE 1, REGULATORY SUBUNIT 16A; PPP1R16A
609173	KINETOCHORE SCAFFOLD 1; KNL1
609174	NSL1, MIS12 KINETOCHORE COMPLEX COMPONENT; NSL1
609175	DSN1, MIS12 KINETOCHORE COMPLEX COMPONENT; DSN1
609176	POLYAMINE-MODULATED FACTOR 1; PMF1
609177	ZW10 INTERACTING KINETOCHORE PROTEIN; ZWINT
609178	MIS12 KINETOCHORE COMPLEX COMPONENT; MIS12
609179	MIGRAINE WITH AURA, SUSCEPTIBILITY TO, 7
609180	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE If; CDG1F
609181	DUAL-SPECIFICITY TYROSINE PHOSPHORYLATION-REGULATED KINASE 4; DYRK4
609182	SOLUTE CARRIER FAMILY 35, MEMBER D2; SLC35D2
609183	AURORA KINASE A-INTERACTING PROTEIN 1; AURKAIP1
609184	KINESIN FAMILY MEMBER 4B; KIF4B
609185	ZINC FINGER AND HOMEODOMAIN PROTEIN 2; ZHX2
609186	D-2-HYDROXYGLUTARATE DEHYDROGENASE; D2HGDH
609187	SUCCINYL-CoA:GLUTARATE-CoA TRANSFERASE; SUGCT
609188	M-PHASE-SPECIFIC PLK1-INTERACTING PROTEIN; MPLKIP
609189	ANTI-SILENCING FUNCTION 1A HISTONE CHAPERONE; ASF1A
609190	ANTI-SILENCING FUNCTION 1B HISTONE CHAPERONE; ASF1B
609191	PROTEIN KINASE A-INTERACTING PROTEIN 1; AKIP1
609192	LOEYS-DIETZ SYNDROME 1; LDS1
609193	LEUCINE-RICH REPEAT PROTEIN 1; LRR1
609194	CDK5 AND ABL ENZYME SUBSTRATE 1; CABLES1
609195	SPASTIC PARAPLEGIA 26, AUTOSOMAL RECESSIVE; SPG26
609196	MELANOCORTIN 2 RECEPTOR ACCESSORY PROTEIN; MRAP
609197	GLUCOCORTICOID DEFICIENCY 3; GCCD3
609198	ADAMTS-LIKE PROTEIN 1; ADAMTSL1
609199	ADAMTS-LIKE PROTEIN 3; ADAMTSL3
609200	MYOPATHY, MYOFIBRILLAR, 3; MFM3
609201	UBIQUITIN-ASSOCIATED AND SH3 DOMAIN-CONTAINING PROTEIN B; UBASH3B
609202	SECRETAGOGIN; SCGN
609203	CLAUDIN 23; CLDN23
609204	MITOCHONDRIAL RIBOSOMAL PROTEIN S16: MRPS16
609205	DAB2-INTERACTING PROTEIN; DAB2IP
609206	EUKARYOTIC TRANSLATION ELONGATION FACTOR 1, EPSILON-1; EEF1E1
609207	MELANOREGULIN; MREG
609208	KAZAL-TYPE SERINE PEPTIDASE INHIBITOR DOMAIN 1; KAZALD1
609209	INFLUENZA VIRUS NS1A-BINDING PROTEIN; IVNS1ABP
609210	CLAUDIN 18; CLDN18
609211	MYOSIN, LIGHT CHAIN 12B, REGULATORY; MYL12B
609212	ASPARAGINASE-LIKE PROTEIN 1; ASRGL1
609213	SEC61 TRANSLOCON, ALPHA-1 SUBUNIT; SEC61A1
609214	SEC61 TRANSLOCON, BETA SUBUNIT; SEC61B
609215	SEC61 TRANSLOCON, GAMMA SUBUNIT; SEC61G
609216	SPIRE-TYPE ACTIN NUCLEATION FACTOR 1; SPIRE1
609217	SPIRE-TYPE ACTIN NUCLEATION FACTOR 2; SPIRE2
609218	FOVEAL HYPOPLASIA 2; FVH2
609219	NUDIX HYDROLASE 14; NUDT14
609220	BRUCK SYNDROME 2; BRKS2
609221	N-ACETYLTRANSFERASE 10; NAT10
609222	DANDY-WALKER MALFORMATION WITH OCCIPITAL CEPHALOCELE, AUTOSOMAL DOMINANT; ADDWOC
609223	SPONDYLOEPIPHYSEAL DYSPLASIA TARDA, AUTOSOMAL RECESSIVE, LEROY-SPRANGER TYPE
609224	WD40 REPEAT PROTEIN INTERACTING WITH PHOSPHOINOSITIDES 1; WIPI1
609225	WD40 REPEAT PROTEIN INTERACTING WITH PHOSPHOINOSITIDES 2; WIPI2
609226	WD REPEAT-CONTAINING PROTEIN 45B; WDR45B
609227	GRISCELLI SYNDROME, TYPE 3; GS3
609228	NUDIX HYDROLASE 3; NUDT3
609229	NUDIX HYDROLASE 4; NUDT4
609230	NUDIX HYDROLASE 5; NUDT5
609231	NUDIX HYDROLASE 7; NUDT7
609232	NUDIX HYDROLASE 12; NUDT12
609233	NUDIX HYDROLASE 13; NUDT13
609234	EUKARYOTIC TRANSLATION INITIATION FACTOR 2A; EIF2A
609235	BR SERINE/THREONINE KINASE 1; BRSK1
609236	BR SERINE/THREONINE KINASE 2; BRSK2
609237	IQ MOTIF-CONTAINING PROTEIN B1; IQCB1
609238	RAB GTPase-ACTIVATING PROTEIN 1-LIKE; RABGAP1L
609239	LYSOPHOSPHATIDIC ACID RECEPTOR 6; LPAR6
609240	HISTONE H3-ASSOCIATED PROTEIN KINASE; HASPIN
609241	SCHINDLER DISEASE, TYPE I
609242	KANZAKI DISEASE
609243	RETINOIC ACID EARLY TRANSCRIPT 1E; RAET1E
609244	RETINOIC ACID EARLY TRANSCRIPT 1G; RAET1G
609245	G PROTEIN SIGNALING MODULATOR 2; GPSM2
609246	PYRIDOXAL PHOSPHATASE; PDXP
609247	RING FINGER PROTEIN 13; RNF13
609248	HECT DOMAIN AND RCC1-LIKE DOMAIN 4; HERC4
609249	HECT DOMAIN AND RCC1-LIKE DOMAIN 6; HERC6
609250	HYPOTRICHOSIS, PROGRESSIVE PATTERNED SCALP, WITH WIRY HAIR, ONYCHOLYSIS, AND CLEFT LIP/PALATE
609251	Fc RECEPTOR-LIKE PROTEIN B; FCRLB
609252	LIPASE I; LIPI
609253	FEBRILE SEIZURES, FAMILIAL, 6; FEB6
609254	SENIOR-LOKEN SYNDROME 5; SLSN5
609255	FEBRILE SEIZURES, FAMILIAL, 5; FEB5
609256	MYOPIA 7; MYP7
609257	MYOPIA 8; MYP8
609258	MYOPIA 9; MYP9
609259	MYOPIA 10; MYP10
609260	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, AUTOSOMAL DOMINANT, TYPE 2A2A; CMT2A2A
609261	STUTTERING, FAMILIAL PERSISTENT, 2; STUT2
609262	CEREBLON; CRBN
609263	SEH1-LIKE PROTEIN; SEH1L
609264	NUCLEOPORIN, 37-KD; NUP37
609265	TUMOR PREDISPOSITION SYNDROME 4; TPDS4
609266	MOVED TO 151623
609267	MELANOMA ANTIGEN, FAMILY F, 1; MAGEF1
609268	SPLICING REGULATORY PROTEIN, GLUTAMINE/LYSINE-RICH, 1; SREK1
609269	KIAA0319 GENE; KIAA0319
609270	SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 7; SCAR7
609271	KERATOCONUS 4; KTCN4
609272	TRYPTASE, DELTA-1; TPSD1
609273	NEMALINE MYOPATHY 6; NEM6
609274	NASCENT POLYPEPTIDE-ASSOCIATED COMPLEX, ALPHA POLYPEPTIDE, 2; NACA2
609275	RAB3 GTPase-ACTIVATING PROTEIN, NONCATALYTIC SUBUNIT; RAB3GAP2
609276	NON-SMC CONDENSIN II COMPLEX SUBUNIT D3; NCAPD3
609277	MOLYBDENUM COFACTOR SYNTHESIS 3; MOCS3
609278	IZUMO SPERM-EGG FUSION PROTEIN 1; IZUMO1
609279	CENTROMERIC PROTEIN J; CENPJ
609280	EUKARYOTIC TRANSLATION INITIATION FACTOR 2-ALPHA KINASE 4; EIF2AK4
609281	MOB KINASE ACTIVATOR 1A; MOB1A
609282	MOB KINASE ACTIVATOR 1B; MOB1B
609283	PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 2; PEOA2
609284	CONGENITAL MYOPATHY 4B, AUTOSOMAL RECESSIVE; CMYP4B
609285	CONGENITAL MYOPATHY 23; CMYP23
609286	PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 3; PEOA3
609287	SH3 DOMAIN, GRB2-LIKE, ENDOPHILIN B1; SH3GLB1
609288	SH3 DOMAIN, GRB2-LIKE, ENDOPHILIN B2; SH3GLB2
609289	SYNCOPE, FAMILIAL VASOVAGAL; VVS
609290	ADENYLATE KINASE 3; AK3
609291	SPROUTY-RELATED EVH1 DOMAIN-CONTAINING PROTEIN 1; SPRED1
609292	SPROUTY-RELATED EVH1 DOMAIN-CONTAINING PROTEIN 2; SPRED2
609293	SPROUTY-RELATED EVH1 DOMAIN-CONTAINING PROTEIN 3; SPRED3
609294	SEMAPHORIN 6C; SEMA6C
609295	SEMAPHORIN 6D; SEMA6D
609296	B-CELL IMMUNODEFICIENCY, DISTAL LIMB ANOMALIES, AND UROGENITAL MALFORMATIONS; BILU
609297	SEMAPHORIN 5A; SEMA5A
609298	SEMAPHORIN 5B; SEMA5B
609299	PROSTATE CANCER, HEREDITARY, 5; HPC5
609300	CYTOCHROME P450, FAMILY 17, SUBFAMILY A, POLYPEPTIDE 1; CYP17A1
609301	p53 EFFECTOR RELATED TO PMP22; PERP
609302	SOLUTE CARRIER FAMILY 25 (MITOCHONDRIAL CARRIER, GLUTAMATE), MEMBER 22; SLC25A22
609303	SOLUTE CARRIER FAMILY 25 (MITOCHONDRIAL CARRIER, GLUTAMATE), MEMBER 18; SLC25A18
609304	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 3; DEE3
609305	LATEXIN; LXN
609306	SPINOCEREBELLAR ATAXIA 26; SCA26
609307	MOVED TO 193003
609308	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 1; MDDGC1
609309	MutS HOMOLOG 2; MSH2
609310	LYNCH SYNDROME 2; LYNCH2
609311	CHARCOT-MARIE-TOOTH DISEASE, TYPE 4H; CMT4H
609312	DOPAMINE BETA-HYDROXYLASE, PLASMA; DBH
609313	MEDNIK SYNDROME; MEDNIK
609314	RADIAL SPOKE HEAD COMPONENT 1; RSPH1
609315	TRIPARTITE MOTIF-CONTAINING PROTEIN 7; TRIM7
609316	TRIPARTITE MOTIF-CONTAINING PROTEIN 31; TRIM31
609317	TRIPARTITE MOTIF-CONTAINING PROTEIN 36; TRIM36
609318	TRIPARTITE MOTIF-CONTAINING PROTEIN 45; TRIM45
609319	HEMATOCRIT/HEMOGLOBIN QUANTITATIVE TRAIT LOCUS 1; HCHGQ1
609320	HEMATOCRIT/HEMOGLOBIN QUANTITATIVE TRAIT LOCUS 2; HCHGQ2
609321	SAS6 CENTRIOLAR ASSEMBLY PROTEIN; SASS6
609322	RHABDOID TUMOR PREDISPOSITION SYNDROME 1; RTPS1
609323	OLIGODENDROCYTE LINEAGE TRANSCRIPTION FACTOR 3; OLIG3
609324	EPIPHYSEAL DYSPLASIA, MULTIPLE, WITH SEVERE PROXIMAL FEMORAL DYSPLASIA
609325	EPIPHYSEAL DYSPLASIA, MULTIPLE, WITH MINIEPIPHYSES
609326	MICRO RNA 1-1; MIR1-1
609327	MICRO RNA 124-1; MIR124-1
609328	URIDINE/CYTIDINE KINASE 1; UCK1
609329	URIDINE/CYTIDINE KINASE 2; UCK2
609330	ONCOPROTEIN-INDUCED TRANSCRIPT 3; OIT3
609331	BASIC HELIX-LOOP-HELIX FAMILY, MEMBER E23; BHLHE23
609332	TETRATRICOPEPTIDE REPEAT DOMAIN-CONTAINING PROTEIN 7A; TTC7A
609333	TRACE AMINE-ASSOCIATED RECEPTOR 1; TAAR1
609334	CHROMOSOME 18 PERICENTRIC INVERSION
609335	ODR4 GPCR LOCALIZATION FACTOR HOMOLOG; ODR4
609336	ANGIOPOIETIN-LIKE 6; ANGPTL6
609337	MICRO RNA 155; MIR155
609338	CAROTID INTIMAL MEDIAL THICKNESS 1
609339	MOVED TO 265000
609340	SPASTIC PARAPLEGIA 28, AUTOSOMAL RECESSIVE; SPG28
609341	TRYPTASE, GAMMA-1; TPSG1
609342	COBALAMIN-BINDING INTRINSIC FACTOR; CBLIF
609343	PROTEASE, SERINE, 22; PRSS22
609344	KIELIN/CHORDIN-LIKE PROTEIN
609345	CEREBRORENODIGITAL SYNDROME WITH LIMB MALFORMATIONS AND TRIRADIATE ACETABULA
609346	RECEPTOR EXPRESSION-ENHANCING PROTEIN 6; REEP6
609347	RECEPTOR EXPRESSION-ENHANCING PROTEIN 2; REEP2
609348	RECEPTOR EXPRESSION-ENHANCING PROTEIN 3; REEP3
609349	RECEPTOR EXPRESSION-ENHANCING PROTEIN 4; REEP4
609350	RECEPTOR-TRANSPORTING PROTEIN 4; RTP4
609351	ADP-RIBOSYLATION FACTOR-LIKE GTPase 11; ARL11
609352	EPIDERMOLYSIS BULLOSA SIMPLEX 2E, WITH MIGRATORY CIRCINATE ERYTHEMA; EBS2E
609353	ESTABLISHMENT OF SISTER CHROMATID COHESION N-ACETYLTRANSFERASE 2; ESCO2
609354	BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS 5; BMND5
609355	MICRO RNA 32; MIR32
609356	NUCLEAR FMRP-INTERACTING PROTEIN 2; NUFIP2
609357	MINICHROMOSOME MAINTENANCE COMPLEX COMPONENT 10; MCM10
609358	ETS VARIANT TRANSCRIPTION FACTOR 2; ETV2
609359	HS1-BINDING PROTEIN 3; HS1BP3
609360	RENALASE; RNLS
609361	MOB FAMILY, MEMBER 4; MOB4
609362	LYSOPHOSPHOLIPASE 3; LYPLA3
609363	COLLOID CYSTS OF THIRD VENTRICLE
609364	NLR FAMILY, PYRIN DOMAIN-CONTAINING 2; NLRP2
609365	GUANINE NUCLEOTIDE-BINDING PROTEIN-LIKE 2; GNL2
609366	CTR9 HOMOLOG, PAF1/RNA POLYMERASE II COMPLEX COMPONENT; CTR9
609367	KINESIN FAMILY BINDING PROTEIN; KIFBP
609368	ATLASTIN GTPase 2; ATL2
609369	ATLASTIN GTPase 3; ATL3
609370	SERINE/THREONINE KINASE 35; STK35
609371	FAMILY WITH SEQUENCE SIMILARITY 13, MEMBER B; FAM13B
609372	FAMILY WITH SEQUENCE SIMILARITY 53, MEMBER C; FAM53C
609373	LYSINE DEMETHYLASE 3B; KDM3B
609374	CELL DIVISION CYCLE-ASSOCIATED PROTEIN 5; CDCA5
609375	LIN9 DREAM MUVB CORE COMPLEX COMPONENT; LIN9
609376	CATARACT 35; CTRCT35
609377	ACD SHELTERIN COMPLEX SUBUNIT AND TELOMERASE RECRUITMENT FACTOR; ACD
609378	AUTISM, SUSCEPTIBILITY TO, 6; AUTS6
609379	LIPOCALIN 6; LCN6
609380	LEISHMANOLYSIN-LIKE; LMLN
609381	SYNTAXIN-BINDING PROTEIN 5-LIKE; STXBP5L
609382	IMMEDIATE-EARLY RESPONSE 3-INTERACTING PROTEIN 1; IER3IP1
609383	NIPA-LIKE DOMAIN-CONTAINING PROTEIN 4; NIPAL4
609384	FIBROSIS OF EXTRAOCULAR MUSCLES, CONGENITAL, 3C; CFEOM3C
609385	DND MICRO RNA-MEDIATED REPRESSION INHIBITOR 1; DND1
609386	STRUCTURAL MAINTENANCE OF CHROMOSOMES 5; SMC5
609387	STRUCTURAL MAINTENANCE OF CHROMOSOMES 6; SMC6
609388	METHYLTRANSFERASE-LIKE 9; METTL9
609389	INOSITOL POLYPHOSPHATE 5-PHOSPHATASE F; INPP5F
609390	FIG4 PHOSPHOINOSITIDE 5-PHOSPHATASE; FIG4
609391	TRANSCRIPTION FACTOR Sp5; SP5
609392	KRUPPEL-LIKE FACTOR 3; KLF3
609393	KRUPPEL-LIKE FACTOR 14; KLF14
609394	SPC24, NDC80 KINETOCHORE COMPLEX COMPONENT; SPC24
609395	SPC25, NDC80 KINETOCHORE COMPLEX COMPONENT; SPC25
609396	PH DOMAIN AND LEUCINE-RICH REPEAT PROTEIN PHOSPHATASE 1; PHLPP1
609397	STORKHEAD BOX 1; STOX1
609398	ATPase, H+ TRANSPORTING, LYSOSOMAL, 34-KD, V1 SUBUNIT D; ATP6V1D
609399	SPERM EQUATORIAL SEGMENT PROTEIN 1; SPESP1
609400	AUTOIMMUNE DISEASE, SUSCEPTIBILITY TO, 4; AIS4
609401	HEPARAN SULFATE 6-O-SULFOTRANSFERASE 3; HS6ST3
609402	PREECLAMPSIA/ECLAMPSIA 2; PEE2
609403	PREECLAMPSIA/ECLAMPSIA 3; PEE3
609404	PREECLAMPSIA/ECLAMPSIA 4; PEE4
609405	RHO GTPase-ACTIVATING PROTEIN 8; ARHGAP8
609406	PROLINE-RICH PROTEIN 5; PRR5
609407	HEPARAN SULFATE-GLUCOSAMINE 3-SULFOTRANSFERASE 5; HS3ST5
609408	HOLOPROSENCEPHALY 8; HPE8
609409	HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN A0; HNRNPA0
609410	SYNAPTOJANIN 2; SYNJ2
609411	SYNAPTOJANIN 2-BINDING PROTEIN; SYNJ2BP
609412	ERCC EXCISION REPAIR 8, CSA UBIQUITIN LIGASE COMPLEX SUBUNIT; ERCC8
609413	ERCC EXCISION REPAIR 6, CHROMATIN REMODELING FACTOR; ERCC6
609414	PHOSPHOINOSITIDE KINASE, FYVE FINGER-CONTAINING; PIKFYVE
609415	MICRO RNA 17 HOST GENE; MIR17HG
609416	MICRO RNA 17; MIR17
609417	MICRO RNA 18A; MIR18A
609418	MICRO RNA 19A; MIR19A
609419	MICRO RNA 19B1; MIR19B1
609420	MICRO RNA 20A; MIR20A
609421	MOVED TO 609416
609422	MICRO RNA 92A1; MIR92A1
609423	HUMAN IMMUNODEFICIENCY VIRUS TYPE 1, SUSCEPTIBILITY TO
609424	RING FINGER AND CCCH-TYPE ZINC FINGER DOMAINS-CONTAINING 1; RC3H1
609425	CHROMOSOME 3q29 DELETION SYNDROME
609426	MISSHAPEN/NIK-RELATED KINASE 1; MINK1
609427	LHFPL TETRASPAN SUBFAMILY, MEMBER 5; LHFPL5
609428	TUKEL SYNDROME
609429	FORKHEAD BOX N4; FOXN4
609430	NEURONAL PAS DOMAIN PROTEIN 3; NPAS3
609431	MAP3K12-BINDING INHIBITORY PROTEIN; MBIP
609432	SYNDACTYLY, MESOAXIAL SYNOSTOTIC, WITH PHALANGEAL REDUCTION; MSSD
609433	UBIQUITIN INTERACTION MOTIF-CONTAINING PROTEIN 1; UIMC1
609434	LUC7-LIKE 3 PRE-mRNA SPLICING FACTOR; LUC7L3
609435	NADH-UBIQUINONE OXIDOREDUCTASE SUBUNIT A13; NDUFA13
609436	FIBROBLAST GROWTH FACTOR 21; FGF21
609437	SERINE/THREONINE PROTEIN KINASE 40; STK40
609438	MENTAL RETARDATION, KERATOCONUS, FEBRILE SEIZURES, AND SINOATRIAL BLOCK
609439	DEAFNESS, AUTOSOMAL RECESSIVE 48; DFNB48
609440	UTP11-LIKE PROTEIN; UTP11L
609441	ACROMESOMELIC DYSPLASIA 3; AMD3
609442	VALPROATE EMBRYOPATHY, SUSCEPTIBILITY TO
609443	CHYMOTRYPSIN-LIKE ELASTASE FAMILY, MEMBER 2A; CELA2A
609444	CHYMOTRYPSIN-LIKE ELASTASE FAMILY, MEMBER 2B; CELA2B
609445	RELAXIN/INSULIN-LIKE FAMILY PEPTIDE RECEPTOR 3; RXFP3
609446	PAROXYSMAL NONKINESIGENIC DYSKINESIA, 3, WITH OR WITHOUT GENERALIZED EPILEPSY; PNKD3
609447	MARGINAL ZONE B AND B1 CELL-SPECIFIC PROTEIN; MZB1
609448	THIOREDOXIN DOMAIN-CONTAINING PROTEIN 12; TXNDC12
609449	NUDE NEURODEVELOPMENT PROTEIN 1; NDE1
609450	MAX DIMERIZATION PROTEIN 3; MXD3
609451	ZFP90 ZINC FINGER PROTEIN; ZFP90
609452	MYOPATHY, MYOFIBRILLAR, 4; MFM4
609453	GOLGIN A7; GOLGA7
609454	SUPRANUCLEAR PALSY, PROGRESSIVE, 2; PSNP2
609455	PROLINE-, GLUTAMIC ACID-, AND LEUCINE-RICH PROTEIN 1; PELP1
609456	MOVED TO 254300
609457	HISTIDINE AMMONIA-LYASE; HAL
609458	MANNOSIDASE, ALPHA, CLASS 2B, MEMBER 1; MAN2B1
609459	DIGEORGE SYNDROME CRITICAL REGION GENE 6-LIKE; DGCR6L
609460	GOLDBERG-SHPRINTZEN SYNDROME; GOSHS
609461	TRIBBLES PSEUDOKINASE 1; TRIB1
609462	TRIBBLES PSEUDOKINASE 2; TRIB2
609463	MYOCARDIN-RELATED TRANSCRIPTION FACTOR B; MRTFB
609464	MOVED TO 186580
609465	AL-GAZALI SYNDROME; ALGAZ
609466	CLEFT PALATE, MIDFACIAL HYPOPLASIA, TRIANGULAR FACIES, AND SENSORINEURAL HEARING LOSS
609467	CHEMOKINE, CC MOTIF, LIGAND 3, PSEUDOGENE 1; CCL3P1
609468	CHEMOKINE, CC MOTIF, LIGAND 3-LIKE 3; CCL3L3
609469	NEPHROPATHY, PROGRESSIVE, WITH DEAFNESS
609470	LEFT VENTRICULAR NONCOMPACTION 2; LVNC2
609471	GLUCOSIDASE, BETA, ACID 2; GBA2
609472	CYCLIC NUCLEOTIDE-GATED CHANNEL, ALPHA-4; CNGA4
609473	CINGULIN; CGN
609474	NEURONAL PENTRAXIN RECEPTOR; NPTXR
609475	A-KINASE ANCHOR PROTEIN 8-LIKE PROTEIN; AKAP8L
609476	NEMO-LIKE KINASE; NLK
609477	SINGLE-PASS MEMBRANE PROTEIN WITH COILED-COIL DOMAINS 4; SMCO4
609478	ST8 ALPHA-N-ACETYL-NEURAMINIDE ALPHA-2,8-SIALYLTRANSFERASE 3; ST8SIA3
609479	MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE 20; MAP3K20
609480	MOVED TO 194521
609481	ISL2 TRANSCRIPTION FACTOR, LIM/HOMEODOMAIN; ISL2
609482	ANTERIOR GRADIENT 3, PROTEIN DISULPHIDE ISOMERASE FAMILY MEMBER; AGR3
609483	FAMILY WITH SEQUENCE SIMILARITY 84, MEMBER B; FAM84B
609484	LY6/PLAUR DOMAIN-CONTAINING PROTEIN 3; LYPD3
609485	MODULATOR OF APOPTOSIS 1; MOAP1
609486	E2F-ASSOCIATED PHOSPHOPROTEIN; EAPP
609487	MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE 2; MAP3K2
609488	CANCER/TESTIS ANTIGEN KM-HN-1
609489	MANNOSIDASE, BETA A, LYSOSOMAL; MANBA
609490	INHIBITORY CASPASE RECRUITMENT DOMAIN PROTEIN
609491	G PROTEIN SIGNALING MODULATOR 1; GPSM1
609492	RAS ASSOCIATION DOMAIN FAMILY PROTEIN 2; RASSF2
609493	SLC2A4 REGULATOR; SLC2A4RG
609494	ZINC FINGER PROTEIN 395; ZNF395
609495	GAMETOGENETIN-BINDING PROTEIN 1; GGNBP1
609496	MOVED TO 609814
609497	ENDOPLASMIC RETICULUM AMINOPEPTIDASE 2; ERAP2
609498	F-BOX ONLY PROTEIN 47
609499	MCF.2 CELL LINE-DERIVED TRANSFORMING SEQUENCE-LIKE; MCF2L
609500	MYOPATHY, AUTOPHAGIC VACUOLAR, INFANTILE-ONSET
609501	TUDOR AND KH DOMAINS-CONTAINING PROTEIN; TDRKH
609502	CADHERIN-RELATED FAMILY, MEMBER 1; CDHR1
609503	SPERM MICROTUBULE-ASSOCIATED PROTEIN 2; SPMAP2
609504	MICROSPHERULE PROTEIN 1; MCRS1
609505	TRIPARTITE MOTIF-CONTAINING PROTEIN 16; TRIM16
609506	CYTOCHROME P450, SUBFAMILY XXVIIB, POLYPEPTIDE 1; CYP27B1
609507	TOPOISOMERASE I-BINDING ARGININE/SERINE-RICH PROTEIN; TOPORS
609508	STICKLER SYNDROME, TYPE I, NONSYNDROMIC OCULAR
609509	INTERLEUKIN 31; IL31
609510	INTERLEUKIN 31 RECEPTOR A; IL31RA
609511	RABENOSYN, RAB EFFECTOR; RBSN
609512	CHARGED MULTIVESICULAR BODY PROTEIN 2B; CHMP2B
609513	NEUROPEPTIDE S
609514	TATA BOX-BINDING PROTEIN-ASSOCIATED FACTOR 8; TAF8
609515	IRIDOGONIODYSGENESIS AND SKELETAL ANOMALIES
609516	ZINC FINGER PROTEIN 382; ZNF382
609517	TGFB1-INDUCED ANTIAPOPTOTIC FACTOR 1; TIAF1
609518	THAP DOMAIN-CONTAINING PROTEIN 7; THAP7
609519	TCF3 FUSION PARTNER; TFPT
609520	THAP DOMAIN-CONTAINING PROTEIN 1; THAP1
609521	SOLUTE CARRIER FAMILY 30 (ZINC TRANSPORTER), MEMBER 1; SLC30A1
609522	ELONGIN A2; ELOA2
609523	ALDEHYDE DEHYDROGENASE, FAMILY 3, SUBFAMILY A, MEMBER 2; ALDH3A2
609524	MYOPATHY, MYOFIBRILLAR, 5; MFM5
609525	METHYLTRANSFERASE 8, METHYLCYTIDINE; METTL8
609526	PLECKSTRIN HOMOLOGY DOMAIN- AND RhoGEF DOMAIN-CONTAINING PROTEIN G4; PLEKHG4
609527	RAP GUANINE NUCLEOTIDE EXCHANGE FACTOR 5; RAPGEF5
609528	CEREBRAL DYSGENESIS, NEUROPATHY, ICHTHYOSIS, AND PALMOPLANTAR KERATODERMA SYNDROME; CEDNIK
609529	IMMUNOGLOBULIN A DEFICIENCY 2; IGAD2
609530	RAP GUANINE NUCLEOTIDE EXCHANGE FACTOR 2; RAPGEF2
609531	RAS GUANYL NUCLEOTIDE-RELEASING PROTEIN 3; RASGRP3
609532	HEPATITIS C VIRUS, SUSCEPTIBILITY TO
609533	DEAFNESS, AUTOSOMAL RECESSIVE 23; DFNB23
609534	ATPase FAMILY, AAA DOMAIN-CONTAINING, MEMBER 5; ATAD5
609535	DRUG METABOLISM, POOR, CYP2C19-RELATED
609536	COMPLEMENT COMPONENT 5 DEFICIENCY; C5D
609537	LIPOMYELOMENINGOCELE
609538	PROTEIN-TYROSINE PHOSPHATASE, MITOCHONDRIAL, 1; PTPMT1
609539	AT-RICH INTERACTION DOMAIN-CONTAINING PROTEIN 2; ARID2
609540	SKI8 SUBUNIT OF SUPERKILLER COMPLEX; SKIC8
609541	SPASTIC PARAPLEGIA, OPTIC ATROPHY, AND NEUROPATHY; SPOAN
609542	ATPase, CLASS I, TYPE 8A, MEMBER 1; ATP8A1
609543	LONG INTERGENIC NONCODING RNA 293; LINC00293
609544	CENTRIOLAR COILED-COIL PROTEIN, 110-KD; CCP110
609545	OMPHALOCELE, DIAPHRAGMATIC HERNIA, AND RADIAL RAY DEFECTS
609546	UBIQUITIN-SPECIFIC PROTEASE 29; USP29
609547	MOVED TO 131200
609548	LECTIN, MANNOSE-BINDING 1-LIKE; LMAN1L
609549	NANOPHTHALMOS 2; NNO2
609550	ZINC FINGER PROTEIN 330; ZNF330
609551	LECTIN, MANNOSE-BINDING 2; LMAN2
609552	LECTIN, MANNOSE-BINDING 2-LIKE; LMAN2L
609553	RETBINDIN
609554	INTEGRAL MEMBRANE PROTEIN 2C; ITM2C
609555	CARBOXYPEPTIDASE X, M14 FAMILY, MEMBER 1; CPXM1
609556	ATPase 13A4; ATP13A4
609557	PROLYL ENDOPEPTIDASE-LIKE; PREPL
609558	PROSTATE CANCER, HEREDITARY, 6
609559	CALMODULIN LYSINE N-METHYLTRANSFERASE; CAMKMT
609560	MITOCHONDRIAL DNA DEPLETION SYNDROME 2 (MYOPATHIC TYPE); MTDPS2
609561	CARBOXYPEPTIDASE A5; CPA5
609562	CARBOXYPEPTIDASE A6; CPA6
609563	CARBOXYPEPTIDASE O; CPO
609564	POLY(ADP-RIBOSE) POLYMERASE FAMILY, MEMBER 10; PARP10
609565	MAST CELL-EXPRESSED MEMBRANE PROTEIN 1
609566	PARIETAL FORAMINA 3; PFM3
609567	PATATIN-LIKE PHOSPHOLIPASE DOMAIN-CONTAINING PROTEIN 3; PNPLA3
609568	RHO GTPase-ACTIVATING PROTEIN 20; ARHGAP20
609569	MOVED TO 132100
609570	MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 8
609571	ZINC FINGER PROTEIN 699; ZNF699
609572	PHOTOPAROXYSMAL RESPONSE 2; PPR2
609573	PHOTOPAROXYSMAL RESPONSE 3; PPR3
609574	17-BETA-HYDROXYSTEROID DEHYDROGENASE XII; HSD17B12
609575	ACYL-CoA DEHYDROGENASE, VERY LONG-CHAIN; ACADVL
609576	ACYL-CoA DEHYDROGENASE, LONG-CHAIN; ACADL
609577	CULLIN 7; CUL7
609578	CARDIOMYOPATHY, FAMILIAL RESTRICTIVE, 2; RCM2
609579	SCAPHOCEPHALY, MAXILLARY RETRUSION, AND IMPAIRED INTELLECTUAL DEVELOPMENT
609580	NINEIN-LIKE PROTEIN; NINL
609581	MOVED TO 130720
609582	MICRO RNA 122A; MIR122A
609583	JOUBERT SYNDROME 4; JBTS4
609584	L-2-HYDROXYGLUTARATE DEHYDROGENASE; L2HGDH
609585	COMPLEXIN 3; CPLX3
609586	COMPLEXIN 4; CPLX4
609587	REGULATOR OF CHROMOSOME CONDENSATION 2; RCC2
609588	GLUTAREDOXIN 5; GLRX5
609589	MICROTUBULE-ASSOCIATED SCAFFOLD PROTEIN 1; MTUS1
609590	QKI, KH DOMAIN-CONTAINING RNA-BINDING PROTEIN; QKI
609591	RIC-LIKE PROTEIN WITHOUT CAAX MOTIF 1; RIT1
609592	RIC-LIKE PROTEIN WITHOUT CAAX MOTIF 2; RIT2
609593	CAPPING PROTEIN REGULATOR AND MYOSIN 1 LINKER 1; CARMIL1
609594	VENTRICULAR ZONE-EXPRESSED PH DOMAIN-CONTAINING PROTEIN, ZEBRAFISH, HOMOLOG OF, 1; VEPH1
609595	R-SPONDIN 1; RSPO1
609596	EUKARYOTIC TRANSLATION INITIATION FACTOR 3, SUBUNIT K; EIF3K
609597	PARIETAL FORAMINA 2; PFM2
609598	ZINC FINGER AND HOMEODOMAIN PROTEIN 3; ZHX3
609599	ANKYRIN REPEAT DOMAIN-CONTAINING PROTEIN 1; ANKRD1
609600	ZINC FINGER PROTEIN 396; ZNF396
609601	ZINC FINGER PROTEIN 397; ZNF397
609602	KRUPPEL-LIKE FACTOR 17; KLF17
609603	CRYSTALLIN, GAMMA-N; CRYGN
609604	MICROTUBULE-ASSOCIATED PROTEIN 1, LIGHT CHAIN 3, BETA; MAP1LC3B
609605	MICROTUBULE-ASSOCIATED PROTEIN 1, LIGHT CHAIN 3, GAMMA; MAP1LC3C
609606	AUTOPHAGY-RELATED 3; ATG3
609607	NECTIN CELL ADHESION MOLECULE 4; NECTIN4
609608	AUTOPHAGY-RELATED 12; ATG12
609609	MOVED TO 231530
609610	TUBULIN-GAMMA COMPLEX-ASSOCIATED PROTEIN 4; TUBGCP4
609611	ACIDIC LEUCINE-RICH NUCLEAR PHOSPHOPROTEIN 32 FAMILY, MEMBER E; ANP32E
609612	FIBROSIS OF EXTRAOCULAR MUSCLES, CONGENITAL, WITH SYNERGISTIC DIVERGENCE
609613	PLECKSTRIN HOMOLOGY DOMAIN-CONTAINING PROTEIN, FAMILY M, MEMBER 2; PLEKHM2
609614	RNA EXONUCLEASE 1 HOMOLOG; REXO1
609615	QUEUINE tRNA-RIBOSYLTRANSFERASE 1; QTRT1
609616	SPONDYLOMEGAEPIPHYSEAL DYSPLASIA WITH UPPER LIMB MESOMELIA, PUNCTATE CALCIFICATIONS, AND DEAFNESS
609617	SOLUTE CARRIER FAMILY 30 (ZINC TRANSPORTER), MEMBER 2; SLC30A2
609618	NONCODING REPRESSOR OF NFAT; NRON
609619	GOLGIN A8 FAMILY, MEMBER B; GOLGA8B
609620	SHORT QT SYNDROME 1; SQT1
609621	SHORT QT SYNDROME 2; SQT2
609622	SHORT QT SYNDROME 3; SQT3
609623	RAS-INTERACTING PROTEIN 1; RASIP1
609624	MITOCHONDRIAL COILED-COIL DOMAIN 1; MCCD1
609625	CHROMOSOME 10q26 DELETION SYNDROME
609626	MAM DOMAIN-CONTAINING GLYCOSYLPHOSPHATIDYLINOSITOL ANCHOR 1; MDGA1
609627	TASTE RECEPTOR, TYPE 2, MEMBER 50; TAS2R50
609628	MAJEED SYNDROME; MJDS
609629	VISCERAL NEUROPATHY, FAMILIAL, 3, AUTOSOMAL DOMINANT; VSCN3
609630	LEUKEMIA, CHRONIC LYMPHOCYTIC, SUSCEPTIBILITY TO, 1
609631	DExD/H-BOX HELICASE 58; DDX58
609632	GLYCEROPHOSPHODIESTER PHOSPHODIESTERASE DOMAIN-CONTAINING PROTEIN 5; GDPD5
609633	MAJOR AFFECTIVE DISORDER 3; MAFD3
609634	MIGRAINE, FAMILIAL HEMIPLEGIC, 3; FHM3
609635	TRANSCRIPTION FACTOR 23; TCF23
609636	ALZHEIMER DISEASE 10
609637	HOLOPROSENCEPHALY 5; HPE5
609638	EPIDERMOLYSIS BULLOSA, LETHAL ACANTHOLYTIC; EBLA
609639	HEMOGLOBIN MU
609640	FRIAS SYNDROME
609641	EUKARYOTIC TRANSLATION INITIATION FACTOR 3, SUBUNIT M; EIF3M
609642	T-CELL ANTIGEN RECEPTOR, GAMMA SUBUNIT, ALTERNATE READING FRAME PROTEIN
609643	NGUYEN SYNDROME
609644	FANCM GENE; FANCM
609645	NLR FAMILY, PYRIN DOMAIN-CONTAINING 4; NLRP4
609646	DEAFNESS, AUTOSOMAL RECESSIVE 42; DFNB42
609647	DEAFNESS, AUTOSOMAL RECESSIVE 46; DFNB46
609648	NLR FAMILY, PYRIN DOMAIN-CONTAINING 12; NLRP12
609649	TRICHILEMMAL CYST 1; TRICY1
609650	NLR FAMILY, PYRIN DOMAIN-CONTAINING 6; NLRP6
609651	GLYCOPROTEIN HORMONE, ALPHA-2; GPHA2
609652	GLYCOPROTEIN HORMONE, BETA-5; GPHB5
609653	NADH DEHYDROGENASE (UBIQUINONE) COMPLEX I, ASSEMBLY FACTOR 2; NDUFAF2
609654	SHORT STATURE AND FACIOAURICULOTHORACIC MALFORMATIONS
609655	TALO-PATELLO-SCAPHOID OSTEOLYSIS, SYNOVITIS, AND SHORT FOURTH METACARPALS
609656	BONE SIZE QUANTITATIVE TRAIT LOCUS 1
609657	BONE SIZE QUANTITATIVE TRAIT LOCUS 2
609658	NLR FAMILY, PYRIN DOMAIN-CONTAINING 5; NLRP5
609659	NLR FAMILY, PYRIN DOMAIN-CONTAINING 8; NLRP8
609660	NLR FAMILY, PYRIN DOMAIN-CONTAINING 13; NLRP13
609661	NLR FAMILY, PYRIN DOMAIN-CONTAINING 7; NLRP7
609662	NLR FAMILY, PYRIN DOMAIN-CONTAINING 10; NLRP10
609663	NLR FAMILY, PYRIN DOMAIN-CONTAINING 9; NLRP9
609664	NLR FAMILY, PYRIN DOMAIN-CONTAINING 11; NLRP11
609665	NLR FAMILY, PYRIN DOMAIN-CONTAINING 14; NLRP14
609666	TWO-PORE SEGMENT CHANNEL 1; TPCN1
609667	T-CELL ACTIVATION GTPase-ACTIVATING PROTEIN; TAGAP
609668	PROTEIN PHOSPHATASE TARGETING COQ7; PPTC7
609669	WD REPEAT-CONTAINING PROTEIN 36; WDR36
609670	MIGRAINE WITH AURA, SUSCEPTIBILITY TO, 9
609671	STEAP3 METALLOREDUCTASE; STEAP3
609672	EXOCYST COMPLEX COMPONENT 6; EXOC6
609673	PLATELET-DERIVED GROWTH FACTOR D; PDGFD
609674	ESTABLISHMENT OF SISTER CHROMATID COHESION N-ACEYTLTRANSFERASE 1; ESCO1
609675	SCLEROSTIN DOMAIN-CONTAINING PROTEIN 1; SOSTDC1
609676	MITOCHONDRIAL ANTIVIRAL SIGNALING PROTEIN; MAVS
609677	OS9 ENDOPLASMIC RETICULUM LECTIN; OS9
609678	SLIT- AND NTRK-LIKE FAMILY, MEMBER 1; SLITRK1
609679	SLIT- AND NTRK-LIKE FAMILY, MEMBER 3; SLITRK3
609680	SLIT- AND NTRK-LIKE FAMILY, MEMBER 5; SLITRK5
609681	SLIT- AND NTRK-LIKE FAMILY, MEMBER 6; SLITRK6
609682	DNA CROSS-LINK REPAIR PROTEIN 1A; DCLRE1A
609683	DNA CROSS-LINK REPAIR PROTEIN 1B; DCLRE1B
609684	MAL PROTEOLIPID PROTEIN 2; MAL2
609685	CELL DIVISION CYCLE-ASSOCIATED PROTEIN 7-LIKE; CDCA7L
609686	CITRATE LYASE BETA-LIKE; CLYBL
609687	MICRO RNA 196A2; MIR196A2
609688	MICRO RNA 196B; MIR196B
609689	CENTROSOMAL PROTEIN, 250-KD; CEP250
609690	PHENYLALANINE-tRNA SYNTHETASE, BETA SUBUNIT; FARSB
609691	FORMIN HOMOLOGY-2 DOMAIN-CONTAINING PROTEIN 3; FHOD3
609692	WAS/WASL-INTERACTING PROTEIN FAMILY, MEMBER 2; WIPF2
609693	VON WILLEBRAND FACTOR A DOMAIN-CONTAINING PROTEIN 7; VWA7
609694	GEM-INTERACTING PROTEIN; GMIP
609695	4-HYDROXYPHENYLPYRUVATE DIOXYGENASE; HPD
609696	AT-RICH INTERACTION DOMAIN-CONTAINING PROTEIN 4B; ARID4B
609697	SIN3A-ASSOCIATED PROTEIN, 130-KD; SAP130
609698	THYROID HORMONE METABOLISM, ABNORMAL, 1; THMA1
609699	MONOGLYCERIDE LIPASE; MGLL
609700	RAB GUANINE NUCLEOTIDE EXCHANGE FACTOR 1; RABGEF1
609701	N-ACETYLGLUCOSAMINIDASE, ALPHA-; NAGLU
609702	PROTEASOME ASSEMBLY CHAPERONE 2; PSMG2
609703	MICRO RNA 15A; MIR15A
609704	MICRO RNA 16-1; MIR16-1
609705	MICRO RNA 24-1; MIR24-1
609706	DEAFNESS, AUTOSOMAL RECESSIVE 53; DFNB53
609707	DIHYDROURIDINE SYNTHASE 2-LIKE; DUS2L
609708	LIPOPROTEIN LIPASE; LPL
609709	GLYCOSYLTRANSFERASE-LIKE 1B; GYLTL1B
609710	DENDRITIC CELL-ASSOCIATED NUCLEAR PROTEIN 1; DCANP1
609711	UBIQUINOL-CYTOCHROME C REDUCTASE, COMPLEX III SUBUNIT XI; UQCR11
609712	PYRUVATE KINASE, LIVER AND RED BLOOD CELL; PKLR
609713	HUS1 CHECKPOINT CLAMP COMPONENT B; HUS1B
609714	TRIGGERING RECEPTOR EXPRESSED ON MYELOID CELLS-LIKE PROTEIN 1; TREML1
609715	TRIGGERING RECEPTOR EXPRESSED ON MYELOID CELLS-LIKE PROTEIN 2; TREML2
609716	TRIGGERING RECEPTOR EXPRESSED ON MYELOID CELLS-LIKE PROTEIN 3; TREML3
609717	PROSTATE CANCER-ASSOCIATED TRANSCRIPT 4; PCAT4
609718	LHFPL TETRASPAN SUBFAMILY, MEMBER 2; LHFPL2
609719	LHFPL TETRASPAN SUBFAMILY, MEMBER 3; LHFPL3
609720	CRUMBS CELL POLARITY COMPLEX COMPONENT 2; CRB2
609721	POLYCYSTIN 1-LIKE 1; PKD1L1
609722	PDZ AND LIM DOMAIN PROTEIN 2; PDLIM2
609723	YIPPEE-LIKE 2; YPEL2
609724	YIPPEE-LIKE 3; YPEL3
609725	YIPPEE-LIKE 4; YPEL4
609726	YIPPEE-LIKE 5; YPEL5
609727	SPASTIC PARAPLEGIA 29, AUTOSOMAL DOMINANT; SPG29
609728	METHIONYL-tRNA SYNTHETASE 2; MARS2
609729	PDZ DOMAIN-CONTAINING RING FINGER PROTEIN 3; PDZRN3
609730	PDZ DOMAIN-CONTAINING RING FINGER PROTEIN 4; PDZRN4
609731	CYSTATIN 11; CST11
609732	LIGAND OF NUMB PROTEIN X1; LNX1
609733	LIGAND OF NUMB PROTEIN X2; LNX2
609734	OBESITY, EARLY-ONSET, WITH ADRENAL INSUFFICIENCY AND RED HAIR; OBAIRH
609735	RING FINGER AND FYVE-LIKE DOMAIN CONTAINING 1; RFFL
609736	COILED-COIL DOMAIN-CONTAINING PROTEIN 88A; CCDC88A
609737	CRUMBS CELL POLARITY COMPLEX COMPONENT 3; CRB3
609738	IMMUNOGLOBULIN SUPERFAMILY, MEMBER 9; IGSF9
609739	IMMUNOGLOBULIN-LIKE DOMAIN-CONTAINING RECEPTOR 1; ILDR1
609740	PHD FINGER PROTEIN 19; PHF19
609741	CATARACT 22, MULTIPLE TYPES; CTRCT22
609742	INTERLEUKIN 4-INDUCED GENE 1; IL4I1
609743	CELL ADHESION MOLECULE 3; CADM3
609744	CELL ADHESION MOLECULE 4; CADM4
609745	GLAUCOMA 1, OPEN ANGLE, I; GLC1I
609746	RHO GTPase-ACTIVATING PROTEIN 10; ARHGAP10
609747	ACTIN-BINDING RHO-ACTIVATING PROTEIN; ABRA
609748	UBIQUITIN-LIKE 7; UBL7
609749	UDP-GLUCURONATE DECARBOXYLASE 1; UXS1
609750	EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 4; EIG4
609751	ACYL-CoA OXIDASE 1, PALMITOYL; ACOX1
609752	NUCLEAR RECEPTOR COACTIVATOR 7; NCOA7
609753	CELIAC DISEASE, SUSCEPTIBILITY TO, 4; CELIAC4
609754	CELIAC DISEASE, SUSCEPTIBILITY TO, 2; CELIAC2
609755	CELIAC DISEASE, SUSCEPTIBILITY TO, 3; CELIAC3
609756	CHRNA7/FAM7A FUSION GENE; CHRFAM7A
609757	WILLIAMS-BEUREN REGION DUPLICATION SYNDROME
609758	Na+/K+ TRANSPORTING ATPase-INTERACTING 2; NKAIN2
609759	PR DOMAIN-CONTAINING PROTEIN 7; PRDM7
609760	PR DOMAIN-CONTAINING PROTEIN 9; PRDM9
609761	TRIO- AND F-ACTIN-BINDING PROTEIN; TRIOBP
609762	BIOGENESIS OF LYSOSOME-RELATED ORGANELLES COMPLEX 1, SUBUNIT 3; BLOC1S3
609763	PHOSPHATIDYLINOSITOL 4-KINASE, TYPE 2, ALPHA; PI4K2A
609764	LYSINE DEMETHYLASE 4A; KDM4A
609765	LYSINE DEMETHYLASE 4B; KDM4B
609766	LYSINE DEMETHYLASE 4D; KDM4D
609767	SOLUTE CARRIER FAMILY 25 (MITOCHONDRIAL CARRIER), MEMBER 28; SLC25A28
609768	BIOGENESIS OF LYSOSOME-RELATED ORGANELLES COMPLEX 1, SUBUNIT 2; BLOC1S2
609769	SHORT CHAIN DEHYDROGENASE/REDUCTASE FAMILY 9C, MEMBER 7; SDR9C7
609770	JUNCTIONAL ADHESION MOLECULE-LIKE; JAML
609771	UBINUCLEIN 1; UBN1
609772	CORTACTIN-BINDING PROTEIN 2; CTTNBP2
609773	EP300-INTERACTING INHIBITOR OF DIFFERENTIATION 2; EID2
609774	APOPTOSIS INHIBITOR 5; API5
609775	YIP1 DOMAIN FAMILY, MEMBER 3; YIPF3
609776	PROLINE-RICH ACIDIC PROTEIN 1; PRAP1
609777	XIN ACTIN-BINDING REPEAT-CONTAINING PROTEIN 1; XIRP1
609778	XIN ACTIN-BINDING REPEAT-CONTAINING PROTEIN 2; XIRP2
609779	NIMA-RELATED KINASE 11; NEK11
609780	CARBOXYPEPTIDASE, VITELLOGENIC-LIKE; CPVL
609781	MOVED TO 100070
609782	AORTIC ANEURYSM, FAMILIAL ABDOMINAL, 2; AAA2
609783	INTER-ALPHA-TRYPSIN INHIBITOR, HEAVY CHAIN 5; ITIH5
609784	UPSTREAM BINDING PROTEIN 1; UBP1
609785	TRANSCRIPTION FACTOR CP2-LIKE 1; TFCP2L1
609786	GRAINYHEAD-LIKE 1; GRHL1
609787	UBIQUITIN-ASSOCIATED PROTEIN 1; UBAP1
609788	X-RAY RADIATION RESISTANCE-ASSOCIATED 1; XRRA1
609789	AQUAPORIN 12A; AQP12A
609790	ALZHEIMER DISEASE 11
609791	LEUCINE-RICH REPEAT- AND Ig DOMAIN-CONTAINING NOGO RECEPTOR-INTERACTING PROTEIN 1; LINGO1
609792	LEUCINE-RICH REPEAT- AND Ig DOMAIN-CONTAINING NOGO RECEPTOR-INTERACTING PROTEIN 3; LINGO3
609793	LEUCINE-RICH REPEAT- AND Ig DOMAIN-CONTAINING NOGO RECEPTOR-INTERACTING PROTEIN 2; LINGO2
609794	LEUCINE-RICH REPEAT- AND Ig DOMAIN-CONTAINING NOGO RECEPTOR-INTERACTING PROTEIN 4; LINGO4
609795	PYROGLUTAMYLATED RF-AMIDE PEPTIDE PRECURSOR PROTEIN; QRFP
609796	PEELING SKIN SYNDROME 2; PSS2
609797	BICD CARGO ADAPTOR 2; BICD2
609798	NIMA-RELATED KINASE 9; NEK9
609799	NIMA-RELATED KINASE 8; NEK8
609800	GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 4; GEFSP4
609801	CD300E ANTIGEN; CD300E
609802	SOLUTE CARRIER FAMILY 24 (SODIUM/POTASSIUM/CALCIUM EXCHANGER), MEMBER 5; SLC24A5
609803	ANKYRIN AND ARMADILLO REPEATS-CONTAINING PROTEIN; ANKAR
609804	CILIA- AND FLAGELLA-ASSOCIATED PROTEIN 52; CFAP52
609805	SPERMATOGENESIS-ASSOCIATED PROTEIN 19; SPATA19
609806	HYDROXYMETHYLBILANE SYNTHASE; HMBS
609807	CD300 ANTIGEN-LIKE FAMILY, MEMBER F; CD300LF
609808	HAMARTOMA, PRECALCANEAL CONGENITAL FIBROLIPOMATOUS
609809	LCK-INTERACTING TRANSMEMBRANE ADAPTOR 1; LIME1
609810	PATERNALLY EXPRESSED GENE 10; PEG10
609811	CYTOCHROME C OXIDASE, SUBUNIT 7B2; COX7B2
609812	MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 8, WITH EXOCRINE DYSFUNCTION; MODY8
609813	SPONDYLOCOSTAL DYSOSTOSIS 3, AUTOSOMAL RECESSIVE; SCDO3
609814	COMPLEMENT FACTOR H DEFICIENCY; CFHD
609815	ZYGODACTYLY 1
609816	NEUROBEACHIN-LIKE 1; NBEAL1
609817	VASCULITIS, LYMPHOCYTIC, CUTANEOUS SMALL VESSEL
609818	UBIQUITIN-SPECIFIC PROTEIN 10; USP10
609819	PRAC1 SMALL NUCLEAR PROTEIN; PRAC1
609820	ERYTHROCYTOSIS, FAMILIAL, 3; ECYT3
609821	BLEEDING DISORDER, PLATELET-TYPE, 8; BDPLT8
609822	STATURE QUANTITATIVE TRAIT LOCUS 7; STQTL7
609823	DEAFNESS, AUTOSOMAL RECESSIVE 28; DFNB28
609824	HORMA DOMAIN-CONTAINING PROTEIN 1; HORMAD1
609825	COENZYME Q2, POLYPRENYLTRANSFERASE; COQ2
609826	SOLUTE CARRIER FAMILY 34 (SODIUM/PHOSPHATE COTRANSPORTER), MEMBER 3; SLC34A3
609827	PELLINO E3 UBIQUITIN PROTEIN LIGASE 3; PELI3
609828	FIBRONECTIN TYPE III AND SPRY DOMAINS-CONTAINING PROTEIN 1; FSD1
609829	FSD1 N-TERMINUS-LIKE PROTEIN; FSD1NL
609830	REMOVED FROM DATABASE
609831	METABOLISM OF COBALAMIN ASSOCIATED C; MMACHC
609832	SOLUTE CARRIER FAMILY 47, MEMBER 1; SLC47A1
609833	SOLUTE CARRIER FAMILY 47, MEMBER 2; SLC47A2
609834	SET AND MARINER TRANSPOSASE DOMAINS-CONTAINING PROTEIN; SETMAR
609835	MYCBP-ASSOCIATED PROTEIN; MYCBPAP
609836	PTERIN-4-ALPHA-CARBINOLAMINE DEHYDRATASE 2; PCBD2
609837	SMALL NUCLEOLAR RNA, C/D BOX, 115-1; SNORD115-1
609838	SOLUTE CARRIER FAMILY 24 (SODIUM/POTASSIUM/CALCIUM EXCHANGER), MEMBER 2; SLC24A2
609839	SOLUTE CARRIER FAMILY 24 (SODIUM/POTASSIUM/CALCIUM EXCHANGER), MEMBER 3; SLC24A3
609840	SOLUTE CARRIER FAMILY 24 (SODIUM/POTASSIUM/CALCIUM EXCHANGER), MEMBER 4; SLC24A4
609841	SOLUTE CARRIER FAMILY 8 (SODIUM/LITHIUM/CALCIUM EXCHANGER), MEMBER B1; SLC8B1
609842	ENHANCER OF mRNA DECAPPING 3; EDC3
609843	DECAPPING mRNA 1B; DCP1B
609844	DECAPPING mRNA 2; DCP2
609845	SUCRASE-ISOMALTASE; SI
609846	REGENERATING ISLET-DERIVED FAMILY, MEMBER 4; REG4
609847	NOTUM, PALMITOLEOYL-PROTEIN CARBOXYLESTERASE; NOTUM
609848	POTASSIUM CHANNEL TETRAMERIZATION DOMAIN-CONTAINING PROTEIN 11; KCTD11
609849	CORONIN 1B; CORO1B
609850	TBC1 DOMAIN FAMILY, MEMBER 1; TBC1D1
609851	INOSITOL POLYPHOSPHATE MULTIKINASE; IPMK
609852	MIX1 HOMEOBOX-LIKE PROTEIN 1; MIXL1
609853	PHOSPHOPANTOTHENOYLCYSTEINE SYNTHETASE; PPCS
609854	PHOSPHOPANTOTHENOYLCYSTEINE DECARBOXYLASE; PPCDC
609855	COENZYME A SYNTHASE; COASY
609856	SPERMATOGENESIS-ASSOCIATED PROTEIN 16; SPATA16
609857	DYSTROPHIA MYOTONICA WD REPEAT-CONTAINING PROTEIN; DMWD
609858	ETHANOLAMINE KINASE 1; ETNK1
609859	ETHANOLAMINE KINASE 2; ETNK2
609860	DAD1-RELATED GENE
609861	I-KAPPA-B KINASE-INTERACTING PROTEIN; IKBIP
609862	TRANSMEMBRANE PROTEASE, SERINE 6; TMPRSS6
609863	TECTONIC FAMILY, MEMBER 1; TCTN1
609864	PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE 4-PHOSPHATASE, TYPE II; PIP4P2
609865	PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE 4-PHOSPHATASE, TYPE I; PIP4P1
609866	START DOMAIN-CONTAINING PROTEIN 13; STARD13
609867	UBIQUITIN-LIKE DOMAIN-CONTAINING CTD PHOSPHATASE 1; UBLCP1
609868	SPERMATOGENESIS-ASSOCIATED PROTEIN 7; SPATA7
609869	SPERMATOGENESIS-ASSOCIATED PROTEIN 12; SPATA12
609870	RHO GTPase-ACTIVATING PROTEIN 21; ARHGAP21
609871	TBC1 DOMAIN FAMILY, MEMBER 2; TBC1D2
609872	WAP 4-DISULFIDE CORE DOMAIN 12; WFDC12
609873	INTELECTIN 1; ITLN1
609874	INTELECTIN 2; ITLN2
609875	ATONAL bHLH TRANSCRIPTION FACTOR 7; ATOH7
609876	BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS 6; BMND6
609877	CRYSTALLIN, LAMBDA-1; CRYL1
609878	MEDIATOR COMPLEX SUBUNIT 9; MED9
609879	SPERMATOGENESIS-ASSOCIATED PROTEIN 4; SPATA4
609880	LYSINE ACETYLTRANSFERASE 7; KAT7
609881	RNA POLYMERASE II, SUBUNIT J2; POLR2J2
609882	METAL-REGULATORY TRANSCRIPTION FACTOR 2; MTF2
609883	MKS TRANSITION ZONE COMPLEX SUBUNIT 1; MKS1
609884	TRANSMEMBRANE PROTEIN 67; TMEM67
609885	ELONGATION FACTOR, RNA POLYMERASE II, 3; ELL3
609886	MOVED TO 162000 AND 137920
609887	GLAUCOMA 1, OPEN ANGLE, G; GLC1G
609888	LEPROSY, SUSCEPTIBILITY TO, 1; LPRS1
609889	ALPHA/BETA T-CELL LYMPHOPENIA WITH GAMMA/DELTA T-CELL EXPANSION, SEVERE CYTOMEGALOVIRUS INFECTION, AND AUTOIMMUNITY
609890	UBIQUITIN PROTEIN LIGASE E3 COMPONENT N-RECOGNIN 4; UBR4
609891	RIPPLY TRANSCRIPTIONAL REPRESSOR 2; RIPPLY2
609892	RIPPLY TRANSCRIPTIONAL REPRESSOR 3; RIPPLY3
609893	HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 3; CHNG3
609894	UNC13 HOMOLOG A; UNC13A
609895	CASTOR ZINC FINGER PROTEIN 1; CASZ1
609896	EUKARYOTIC TRANSLATION INITIATION FACTOR 4E FAMILY, MEMBER 3; EIF4E3
609897	EPIDERMAL GROWTH FACTOR-LIKE 8; EGFL8
609898	KRINGLE DOMAIN-CONTAINING TRANSMEMBRANE PROTEIN 1; KREMEN1
609899	KRINGLE DOMAIN-CONTAINING TRANSMEMBRANE PROTEIN 2; KREMEN2
609900	APOLIPOPROTEIN B mRNA-EDITING ENZYME, CATALYTIC POLYPEPTIDE-LIKE 3D; APOBEC3D
609901	ANKYRIN REPEAT AND STERILE ALPHA MOTIF DOMAINS-CONTAINING PROTEIN 4B; ANKS4B
609902	MOVED TO 603317
609903	SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO, 5; SLEB5
609904	HISTONE GENE CLUSTER 1, H2B HISTONE FAMILY, MEMBER A; HIST1H2BA
609905	MYOSIN LIGHT CHAIN 9, REGULATORY; MYL9
609906	EMBRYONAL FYN-ASSOCIATED SUBSTRATE; EFS
609907	SEMAPHORIN 3D; SEMA3D
609908	APOLIPOPROTEIN B mRNA-EDITING ENZYME, CATALYTIC POLYPEPTIDE-LIKE 4; APOBEC4
609909	CARDIOMYOPATHY, DILATED, 1P; CMD1P
609910	CILIA- AND FLAGELLA-ASSOCIATED PROTEIN 91; CFAP91
609911	HEPATOCELLULAR CARCINOMA-DOWNREGULATED MITOCHONDRIAL CARRIER PROTEIN
609912	LYSINE ACETYLTRANSFERASE 8; KAT8
609913	RETINITIS PIGMENTOSA 32; RP32
609914	AQUAPORIN 11; AQP11
609915	CARDIOMYOPATHY, DILATED, 1Q; CMD1Q
609916	5-AZACYTIDINE-INDUCED PROTEIN 2; AZI2
609917	PRION PROTEIN-INTERACTING PROTEIN; PRNPIP
609918	GALLBLADDER DISEASE 2; GBD2
609919	GALLBLADDER DISEASE 3; GBD3
609920	CADHERIN 22; CDH22
609921	LOW DENSITY LIPOPROTEIN RECEPTOR-RELATED PROTEIN 10; LRP10
609922	EH DOMAIN-BINDING PROTEIN 1; EHBP1
609923	RETINITIS PIGMENTOSA 31; RP31
609924	AMINOACYLASE 1 DEFICIENCY; ACY1D
609925	DIPEPTIDASE 2; DPEP2
609926	DIPEPTIDASE 3; DPEP3
609927	VPS37A SUBUNIT OF ESCRIT-I; VPS37A
609928	MYOSIN, HEAVY CHAIN 7B, CARDIAC MUSCLE, BETA; MYH7B
609929	MYOSIN, HEAVY CHAIN 15; MYH15
609930	MYOSIN, LIGHT CHAIN 6B, ALKALI, SMOOTH MUSCLE AND NONMUSCLE, SLOW; MYL6B
609931	MYOSIN LIGHT CHAIN 6, ALKALI, SMOOTH MUSCLE AND NONMUSCLE; MYL6
609932	SPERM ACROSOME-ASSOCIATED PROTEIN 4; SPACA4
609933	REGENERATING ISLET-DERIVED 3-GAMMA; REG3G
609934	EARLY B-CELL FACTOR 2; EBF2
609935	EARLY B-CELL FACTOR 4; EBF4
609936	SPINDLIN 1; SPIN1
609937	CELL DIVISION CYCLE-ASSOCIATED PROTEIN 7; CDCA7
609938	CELL ADHESION MOLECULE 2; CADM2
609939	SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO, 6; SLEB6
609940	MOVED TO 112250
609941	DEAFNESS, AUTOSOMAL RECESSIVE 51; DFNB51
609942	NOONAN SYNDROME 3; NS3
609943	MOVED TO 135900
609944	ECTODERMAL DYSPLASIA, SENSORINEURAL HEARING LOSS, AND DISTINCTIVE FACIAL FEATURES
609945	BRACHYPHALANGY, POLYDACTYLY, AND TIBIAL APLASIA/HYPOPLASIA
609946	DEAFNESS, AUTOSOMAL RECESSIVE 47; DFNB47
609947	PROTEIN ONLY RNASE P CATALYTIC SUBUNIT; PRORP
609948	RING FINGER PROTEIN 216; RNF216
609949	COMPLEMENT COMPONENT 5a RECEPTOR 2; C5AR2
609950	RIBONUCLEOPROTEIN, PTB-BINDING 1; RAVER1
609951	ZINC FINGER PROTEIN 384; ZNF384
609952	DEAFNESS, AUTOSOMAL RECESSIVE 55; DFNB55
609953	RIBONUCLEOPROTEIN, PTB-BINDING 2; RAVER2
609954	ASPERGER SYNDROME, SUSCEPTIBILITY TO, 4; ASPG4
609955	FIBROMATOSIS, GINGIVAL, 3; GINGF3
609956	RAS-ASSOCIATED PROTEIN RAB37; RAB37
609957	PROTEIN PHOSPHATASE, MAGNESIUM/MANGANESE-DEPENDENT, 1J; PPM1J
609958	ASTHMA-RELATED TRAITS, SUSCEPTIBILITY TO, 3
609959	MYELOID-ASSOCIATED DIFFERENTIATION MARKER; MYADM
609960	PUMILIO RNA-BINDING FAMILY, MEMBER 3; PUM3
609961	MINOR HISTOCOMPATIBILITY ANTIGEN HB-1; HMHB1
609962	C-TYPE LECTIN DOMAIN FAMILY 4, MEMBER E; CLEC4E
609963	CHONDROITIN SULFATE SYNTHASE 3; CHSY3
609964	C-TYPE LECTIN DOMAIN FAMILY 4, MEMBER D; CLEC4D
609965	DEAFNESS, AUTOSOMAL DOMINANT 53; DFNA53
609966	GAMETOGENETIN; GGN
609967	B-CELL NOVEL PROTEIN 1
609968	HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 5; HHF5
609969	SUPRABASIN
609970	HES FAMILY bHLH TRANSCRIPTION FACTOR 2; HES2
609971	HES FAMILY bHLH TRANSCRIPTION FACTOR 3; HES3
609972	ACYL-CoA THIOESTERASE 2; ACOT2
609973	HYPERPOLARIZATION-ACTIVATED CYCLIC NUCLEOTIDE-GATED POTASSIUM CHANNEL 3; HCN3
609974	CADHERIN 9; CDH9
609975	HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 4; HHF4
609976	HYPOXIA-INDUCIBLE FACTOR 3, ALPHA SUBUNIT; HIF3A
609977	CELL DIVISION CYCLE-ASSOCIATED PROTEIN 8; CDCA8
609978	CALCIUM-DEPENDENT ACTIVATOR PROTEIN FOR SECRETION 2; CADPS2
609979	VESTIGIAL-LIKE 2; VGLL2
609980	VESTIGIAL-LIKE 3; VGLL3
609981	IMMUNODEFICIENCY 54; IMD54
609982	VACUOLAR PROTEIN SORTING 4 HOMOLOG A; VPS4A
609983	VACUOLAR PROTEIN SORTING 4 HOMOLOG B; VPS4B
609984	ZWILCH KINETOCHORE PROTEIN; ZWILCH
609985	PANIC DISORDER 3; PAND3
609986	CASPASE RECRUITMENT DOMAIN-CONTAINING PROTEIN 6; CARD6
609987	STIMULATED BY RETINOIC ACID 8; STRA8
609988	PYROPHOSPHATASE, INORGANIC, 2; PPA2
609989	METAPHYSEAL CHONDRODYSPLASIA WITH CONE-SHAPED EPIPHYSES, NORMAL HAIR, AND NORMAL HANDS
609990	TRICHOSCYPHODYSPLASIA
609991	FIBRONECTIN TYPE III DOMAIN-CONTAINING PROTEIN 1; FNDC1
609992	POP5 HOMOLOG, RIBONUCLEASE P/MRP SUBUNIT; POP5
609993	OSTEOSCLEROSIS WITH ICHTHYOSIS AND PREMATURE OVARIAN FAILURE
609994	MYOPIA 11, AUTOSOMAL DOMINANT; MYP11
609995	MYOPIA 12, AUTOSOMAL DOMINANT; MYP12
609996	COLLAGEN, TYPE XXVIII, ALPHA-1; COL28A1
609997	HISTIDINE TRIAD NUCLEOTIDE-BINDING PROTEIN 2; HINT2
609998	HISTIDINE TRIAD NUCLEOTIDE-BINDING PROTEIN 3; HINT3
609999	SYNAPSE DIFFERENTIATION-INDUCED GENE 1-LIKE; SYNDIG1L
610000	CENTROSOMAL PROTEIN, 55-KD; CEP55
610001	ARTHROGRYPOSIS MULTIPLEX WITH DEAFNESS, INGUINAL HERNIAS, AND EARLY DEATH
610002	COLLAGEN, TYPE XXI, ALPHA-1; COL21A1
610003	CEROID LIPOFUSCINOSIS, NEURONAL, 8, NORTHERN EPILEPSY VARIANT
610004	COLLAGEN, TYPE XXV, ALPHA-1; COL25A1
610005	TRAF2- AND NCK-INTERACTING KINASE; TNIK
610006	2-METHYLBUTYRYL-CoA DEHYDROGENASE DEFICIENCY
610007	LIMB REGION 1 HOMOLOG-LIKE; LMBR1L
610008	ARYLSULFATASE G; ARSG
610009	ARYLSULFATASE I; ARSI
610010	ARYLSULFATASE J; ARSJ
610011	ARYLSULFATASE K; ARSK
610012	SULFATASE 1; SULF1
610013	SULFATASE 2; SULF2
610014	TM2 DOMAIN-CONTAINING PROTEIN 3; TM2D3
610015	GLUTAMINE DEFICIENCY, CONGENITAL
610016	MICRO RNA 132; MIR132
610017	MULTIPLE SYNOSTOSES SYNDROME 2; SYNS2
610018	RHO GUANINE NUCLEOTIDE EXCHANGE FACTOR 40; ARHGEF40
610019	CATARACT 18; CTRCT18
610020	TBC1 DOMAIN FAMILY, MEMBER 10A; TBC1D10A
610021	HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 7; HHF7
610022	MYOSIN VC; MYO5C
610023	BRACHYDACTYLY, COLOBOMA, AND ANTERIOR SEGMENT DYSGENESIS
610024	RETINAL CONE DYSTROPHY 3A; RCD3A
610025	COLLAGEN, TYPE XXIV, ALPHA-1; COL24A1
610026	COLLAGEN, TYPE XXII, ALPHA-1; COL22A1
610027	VPS26 RETROMER COMPLEX COMPONENT B; VPS26B
610028	POLY(ADP-RIBOSE) POLYMERASE FAMILY, MEMBER 14; PARP14
610029	VOLTAGE-DEPENDENT ANION CHANNEL 3; VDAC3
610030	VOLTAGE-DEPENDENT ANION CHANNEL 1 PSEUDOGENE 4; VDAC1P4
610031	CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 7; CDCBM7
610032	TRANSPORTIN 3; TNPO3
610033	PENTA-EF-HAND DOMAIN-CONTAINING PROTEIN 1; PEF1
610034	VPS33A CORE SUBUNIT OF CORVET AND HOPS COMPLEXES; VPS33A
610035	VACUOLAR PROTEIN SORTING 45 HOMOLOG; VPS45
610036	CLAUDIN 19; CLDN19
610037	VPS37B SUBUNIT OF ESCRT-I; VPS37B
610038	VPS37C SUBUNIT OF ESCRT-I; VPS37C
610039	VPS37D SUBUNIT OF ESCRT-I; VPS37D
610040	MYOSIN IIIB; MYO3B
610041	NEDD4 FAMILY-INTERACTING PROTEIN 2; NDFIP2
610042	PITT-HOPKINS-LIKE SYNDROME 1; PTHSL1
610043	COLLAGEN, TYPE XXIII, ALPHA-1; COL23A1
610044	POTASSIUM CHANNEL, SUBFAMILY T, MEMBER 2; KCNT2
610045	ALDEHYDE DEHYDROGENASE 5 FAMILY, MEMBER A1; ALDH5A1
610046	LAEVERIN; LVRN
610047	CANOPY FGF SIGNALING REGULATOR 4; CNPY4
610048	CORNEAL DYSTROPHY, CONGENITAL STROMAL; CSCD
610049	SAP DOMAIN-CONTAINING RIBONUCLEOPROTEIN; SARNP
610050	TRANSMEMBRANE PROTEASE, SERINE 13; TMPRSS13
610051	CHARGED MULTIVESICULAR BODY PROTEIN 4A; CHMP4A
610052	CHARGED MULTIVESICULAR BODY PROTEIN 3; CHMP3
610053	TUBULIN-GAMMA COMPLEX-ASSOCIATED PROTEIN 6; TUBGCP6
610054	MACRO H2A.1 HISTONE; MACROH2A1
610055	COILED-COIL AND C2 DOMAINS-CONTAINING PROTEIN 1A; CC2D1A
610056	SPERM-ASSOCIATED ANTIGEN 7; SPAG7
610057	TRANS-2,3-ENOYL-CoA REDUCTASE; TECR
610058	TUBULIN-SPECIFIC CHAPERONE A; TBCA
610059	MITOCHONDRIAL RIBOSOMAL PROTEIN L33; MRPL33
610060	POLYMERASE I, RNA, SUBUNIT C; POLR1C
610061	DYNEIN, AXONEMAL, HEAVY CHAIN 7; DNAH7
610062	DYNEIN, AXONEMAL, LIGHT CHAIN 1; DNAL1
610063	DYNEIN, AXONEMAL, HEAVY CHAIN 17; DNAH17
610064	OPIOID DEPENDENCE, SUSCEPTIBILITY TO, 1
610065	SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO, 7; SLEB7
610066	SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO, 8; SLEB8
610067	MYOSIN XVIIIA; MYO18A
610068	SOLUTE CARRIER FAMILY 26 (ANION TRANSPORTER), MEMBER 6: SLC26A6
610069	POLYPOSIS SYNDROME, HEREDITARY MIXED, 2; HMPS2
610070	ASTER-ASSOCIATED PROTEIN
610071	HYPERPARATHYROIDISM 3; HRPT3
610072	ERMIN; ERMN
610073	ORM1-LIKE PROTEIN 1; ORMDL1
610074	ORM1-LIKE PROTEIN 2; ORMDL2
610075	ORM1-LIKE PROTEIN 3; ORMDL3
610076	CYCLIN-DEPENDENT KINASE 20; CDK20
610077	REGULATOR OF CELL CYCLE; RGCC
610078	MORC FAMILY CW-TYPE ZINC FINGER PROTEIN 3; MORC3
610079	SIALIC ACID ACETYLESTERASE; SIAE
610080	TM2 DOMAIN-CONTAINING PROTEIN 1; TM2D1
610081	TM2 DOMAIN-CONTAINING PROTEIN 2; TM2D2
610082	MYOSIN REGULATORY LIGHT CHAIN-INTERACTING PROTEIN; MYLIP
610083	TENEURIN TRANSMEMBRANE PROTEIN 3; TENM3
610084	TENEURIN TRANSMEMBRANE PROTEIN 4; TENM4
610085	FAMILY WITH SEQUENCE SIMILARITY 167, MEMBER A; FAM167A
610086	PROTEIN ARGININE METHYLTRANSFERASE 8; PRMT8
610087	PROTEIN ARGININE METHYLTRANSFERASE 7; PRMT7
610088	OLFACTOMEDIN-LIKE 3; OLFML3
610089	RAD50-INTERACTING PROTEIN 1; RINT1
610090	PYRIDOXAMINE 5-PRIME-PHOSPHATE OXIDASE DEFICIENCY; PNPOD
610091	WD REPEAT- AND SOCS BOX-CONTAINING PROTEIN 1; WSB1
610092	MICROPHTHALMIA/COLOBOMA 3; MCOPCB3
610093	MICROPHTHALMIA, ISOLATED 2; MCOP2
610094	DEF6 GUANINE NUCLEOTIDE EXCHANGE FACTOR; DEF6
610095	KILLER CELL IMMUNOGLOBULIN-LIKE RECEPTOR, THREE DOMAINS, LONG CYTOPLASMIC TAIL, 3; KIR3DL3
610096	T-CELL IMMUNOGLOBULIN AND MUCIN DOMAINS-CONTAINING PROTEIN 4; TIMD4
610097	OUTER DENSE FIBER OF SPERM TAILS 4; ODF4
610098	MINICHROMOSOME MAINTENANCE COMPLEX COMPONENT 9; MCM9
610099	MYOPATHY, DISTAL, 3; MPD3
610100	GIANT AXONAL NEUROPATHY 2, AUTOSOMAL DOMINANT; GAN2
610101	CUTC COPPER TRANSPORTER; CUTC
610102	COMPLEMENT COMPONENT 7 DEFICIENCY; C7D
610103	S100 CALCIUM-BINDING PROTEIN, ZETA; S100Z
610104	MICRO RNA 125B1; MIR125B1
610105	MICRO RNA 125B2; MIR125B2
610106	DREBRIN-LIKE; DBNL
610107	O-SIALOGLYCOPROTEIN ENDOPEPTIDASE; OSGEP
610108	ANOCTAMIN 1, CALCIUM-ACTIVATED CHLORIDE CHANNEL; ANO1
610109	ANOCTAMIN 2; ANO2
610110	ANOCTAMIN 3; ANO3
610111	ANOCTAMIN 4; ANO4
610112	C-MAF-INDUCING PROTEIN; CMIP
610113	ADAMTS-LIKE 4; ADAMTSL4
610114	STATURE QUANTITATIVE TRAIT LOCUS 8; STQTL8
610115	TRANSMEMBRANE PROTEIN 48; TMEM48
610116	PURINERGIC RECEPTOR P2Y, G PROTEIN-COUPLED, 14; P2RY14
610117	SOLUTE CARRIER FAMILY 26 (SULFATE TRANSPORTER), MEMBER 11; SLC26A11
610118	G PROTEIN-COUPLED RECEPTOR 33; GPR33
610119	TENEURIN TRANSMEMBRANE PROTEIN 2; TENM2
610120	TETRASPANIN 33; TSPAN33
610121	5-HYDROXYTRYPTAMINE RECEPTOR 3C; HTR3C
610122	5-HYDROXYTRYPTAMINE RECEPTOR 3D; HTR3D
610123	5-HYDROXYTRYPTAMINE RECEPTOR 3E; HTR3E
610124	CARBOHYDRATE SULFOTRANSFERASE 13; CHST13
610125	MICROPHTHALMIA, SYNDROMIC 5; MCOPS5
610126	MOVED TO 607932
610127	CEROID LIPOFUSCINOSIS, NEURONAL, 10; CLN10
610128	CARBOHYDRATE SULFOTRANSFERASE 11; CHST11
610129	CARBOHYDRATE SULFOTRANSFERASE 12; CHST12
610130	SOLUTE CARRIER FAMILY 26 (SULFATE TRANSPORTER), MEMBER 1; SLC26A1
610131	PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 4; PEOA4
610132	VANGL PLANAR CELL POLARITY PROTEIN 1; VANGL1
610133	ST6 ALPHA-N-ACETYL-NEURAMINYL-2,3-BETA-GALACTOSYL-1,3-N-ACETYLGALACTOSAMINIDE ALPHA-2,6-SIALYLTRANSFERASE 3; ST6GALNAC3
610134	ST6 ALPHA-N-ACETYL-NEURAMINYL-2,3-BETA-GALACTOSYL-1,3-N-ACETYLGALACTOSAMINIDE ALPHA-2,6-SIALYLTRANSFERASE 5; ST6GALNAC5
610135	ST6 ALPHA-N-ACETYL-NEURAMINYL-2,3-BETA-GALACTOSYL-1,3-N-ACETYLGALACTOSAMINIDE ALPHA-2,6-SIALYLTRANSFERASE 6; ST6GALNAC6
610136	DEVRIENDT SYNDROME
610137	ST6 ALPHA-N-ACETYL-NEURAMINYL-2,3-BETA-GALACTOSYL-1,3-N-ACETYLGALACTOSAMINIDE ALPHA-2,6-SIALYLTRANSFERASE 2; ST6GALNAC2
610138	ST6 ALPHA-N-ACETYL-NEURAMINYL-2,3-BETA-GALACTOSYL-1,3-N-ACETYLGALACTOSAMINIDE ALPHA-2,6-SIALYLTRANSFERASE 1; ST6GALNAC1
610139	ST8 ALPHA-N-ACETYL-NEURAMINIDE ALPHA-2,8-SIALYLTRANSFERASE 6; ST8SIA6
610140	HEART-HAND SYNDROME, SLOVENIAN TYPE
610141	QT INTERVAL, VARIATION IN
610142	CENTROSOMAL PROTEIN, 290-KD; CEP290
610143	DEAFNESS, AUTOSOMAL RECESSIVE 62; DFNB62
610144	TBC1 DOMAIN FAMILY, MEMBER 3B; TBC1D3B
610145	ENDOTHELIN-CONVERTING ENZYME 2; ECE2
610146	INSULIN-LIKE GROWTH FACTOR II, ANTISENSE; IGF2AS
610147	G PROTEIN-COUPLED BILE ACID RECEPTOR 1; GPBAR1
610148	BBS10 GENE; BBS10
610149	MACULAR DEGENERATION, AGE-RELATED, 7; ARMD7
610150	CHAPERONIN CONTAINING T-COMPLEX POLYPEPTIDE 1, SUBUNIT 5; CCT5
610151	METHIONYL AMINOPEPTIDASE 1; METAP1
610152	CENTROMERIC PROTEIN M; CENPM
610153	DEAFNESS, AUTOSOMAL RECESSIVE 49; DFNB49
610154	DEAFNESS, AUTOSOMAL RECESSIVE 44; DFNB44
610155	TYPE 1 DIABETES MELLITUS 19; T1D19
610156	IMPAIRED INTELLECTUAL DEVELOPMENT, TRUNCAL OBESITY, RETINAL DYSTROPHY, AND MICROPENIS SYNDROME; MORMS
610157	HEAT-SHOCK RNA 1
610158	CORNEAL DYSTROPHY, FUCHS ENDOTHELIAL, 2; FECD2
610159	ZINC FINGER PROTEIN 366; ZNF366
610160	ZINC FINGER PROTEIN 367; ZNF367
610161	TRANSCRIPTION FACTOR AP2-DELTA; TFAP2D
610162	COILED-COIL DOMAIN-CONTAINING PROTEIN 28B; CCDC28B
610163	IMMUNODEFICIENCY 25; IMD25
610164	MICRO RNA 134; MIRN134
610165	GLYCOSYLTRANSFERASE-LIKE DOMAIN-CONTAINING PROTEIN 1; GTDC1
610166	IQ MOTIF- AND SEC7 DOMAIN-CONTAINING PROTEIN 1; IQSEC1
610167	PHOSPHOHISTIDINE PHOSPHATASE 1; PHPT1
610168	LOEYS-DIETZ SYNDROME 2; LDS2
610169	INO80 COMPLEX, ATPase SUBUNIT; INO80
610170	KYPHOSCOLIOSIS 1; KYPSC1
610171	CALMODULIN-LIKE 6; CALML6
610172	SPERM FLAGELLAR PROTEIN 2; SPEF2
610173	MICRO RNA 10A; MIR10A
610174	UBIQUITIN DOMAIN-CONTAINING PROTEIN 2; UBTD2
610175	MICRO RNA 130A; MIR130A
610176	SECRETOGLOBIN, FAMILY 1C, MEMBER 1; SCGB1C1
610177	APOPTOSIS-ENHANCING NUCLEASE; AEN
610178	KIAA0586 GENE; KIAA0586
610179	PHOSPHOLIPASE B1; PLB1
610180	OSTEOCLAST-STIMULATING FACTOR 1; OSTF1
610181	AICARDI-GOUTIERES SYNDROME 2; AGS2
610182	PALMDELPHIN; PALMD
610183	ZINC FINGER AN1 DOMAIN-CONTAINING PROTEIN 6; ZFAND6
610184	MONOACYLGLYCEROL O-ACYLTRANSFERASE 3; MOGAT3
610185	CEREBELLAR ATAXIA, IMPAIRED INTELLECTUAL DEVELOPMENT, AND DYSEQUILIBRIUM SYNDROME 2; CAMRQ2
610186	UBIQUITIN-SPECIFIC PEPTIDASE 17-LIKE FAMILY MEMBER 2; USP17L2
610187	DIAPHRAGMATIC HERNIA 3; DIH3
610188	JOUBERT SYNDROME 5; JBTS5
610189	SENIOR-LOKEN SYNDROME 6; SLSN6
610190	CARBOHYDRATE SULFOTRANSFERASE 8; CHST8
610191	CARBOHYDRATE SULFOTRANSFERASE 9; CHST9
610192	GLIS FAMILY ZINC FINGER PROTEIN 3; GLIS3
610193	ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA, FAMILIAL, 10; ARVD10
610194	BETA-1,3-N-ACETYLGALACTOSAMINYLTRANSFERASE 2; B3GALNT2
610195	PTOV1 EXTENDED AT-HOOK-CONTAINING ADAPTOR PROTEIN; PTOV1
610196	ELMO/CED12 DOMAIN-CONTAINING PROTEIN 2; ELMOD2
610197	MEDIATOR COMPLEX SUBUNIT 25; MED25
610198	3-METHYLGLUTACONIC ACIDURIA, TYPE V; MGCA5
610199	DIABETES MELLITUS, NEONATAL, WITH CONGENITAL HYPOTHYROIDISM; NDH
610200	MITOCHONDRIAL RIBOSOMAL PROTEIN L13; MRPL13
610201	CENTROSOMAL PROTEIN, 162-KD; CEP162
610202	CATARACT 21, MULTIPLE TYPES; CTRCT21
610203	CYSTEINE-RICH INHIBITOR OF PAK1; CRIPAK
610204	PONTOCEREBELLAR HYPOPLASIA, TYPE 5; PCH5
610205	ALAGILLE SYNDROME 2; ALGS2
610206	SOLUTE CARRIER FAMILY 4 (SODIUM BORATE COTRANSPORTER), MEMBER 11; SLC4A11
610207	SOLUTE CARRIER FAMILY 4 (ANION EXCHANGER), MEMBER 9; SLC4A9
610208	MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 10
610209	MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 11
610210	MAF1 HOMOLOG, NEGATIVE REGULATOR OF RNA POLYMERASE III; MAF1
610211	SRA STEM LOOP-INTERACTING RNA-BINDING PROTEIN; SLIRP
610212	DEAFNESS, AUTOSOMAL RECESSIVE 66; DFNB66
610213	ANEURYSM, INTRACRANIAL BERRY, 4; ANIB4
610214	ENDOPLASMIC RETICULUM DEGRADATION-ENHANCING ALPHA-MANNOSIDASE-LIKE PROTEIN 3; EDEM3
610215	RHO GUANINE NUCLEOTIDE EXCHANGE FACTOR 25; ARHGEF25
610216	ANOCTAMIN 8; ANO8
610217	NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 2B; NBIA2B
610218	SAP30-BINDING PROTEIN; SAP30BP
610219	PEJVAKIN; PJVK
610220	DEAFNESS, AUTOSOMAL RECESSIVE 59; DFNB59
610221	AKT1 SUBSTRATE 1, PROLINE-RICH; AKT1S1
610222	RAS AND RAB INTERACTOR 2; RIN2
610223	RAS AND RAB INTERACTOR 3; RIN3
610224	SPERMATOGENESIS- AND OOGENESIS-SPECIFIC BASIC HELIX-LOOP-HELIX PROTEIN 1; SOHLH1
610225	RIBOSOMAL PROTEIN S19 BINDING PROTEIN 1; RPS19BP1
610226	ZINC FINGER PROTEIN 750; ZNF750
610227	SEBORRHEA-LIKE DERMATITIS WITH PSORIASIFORM ELEMENTS
610228	CALPAIN 13; CAPN13
610229	CALPAIN 14; CAPN14
610230	tRNA 5-METHYLAMINOMETHYL-2-THIOURIDYLATE METHYLTRANSFERASE; TRMU
610231	POLYCOMB GROUP RING FINGER PROTEIN 1; PCGF1
610232	ATPase 13A3; ATP13A3
610233	MOVED TO 211900
610234	SYNPOLYDACTYLY 3; SPD3
610235	MITOCHONDRIAL FISSION PROCESS 1; MTFP1
610236	LUNAPARK; LNPK
610237	MEDIATOR COMPLEX SUBUNIT 30; MED30
610238	SOLUTE CARRIER FAMILY 5 (SODIUM/GLUCOSE COTRANSPORTER), MEMBER 11; SLC5A11
610239	HIGH DENSITY LIPOPROTEIN CHOLESTEROL LEVEL QUANTITATIVE TRAIT LOCUS 4
610240	LHFPL TETRASPAN SUBFAMILY, MEMBER 4; LHFPL4
610241	RING FINGER PROTEIN 32; RNF32
610242	CHROMOSOME 7 OPEN READING FRAME 13; C7ORF13
610243	ZINC FINGER FYVE DOMAIN-CONTAINING PROTEIN 27; ZFYVE27
610244	SPASTIC PARAPLEGIA 33, AUTOSOMAL DOMINANT; SPG33
610245	SPINOCEREBELLAR ATAXIA 23; SCA23
610246	SPINOCEREBELLAR ATAXIA 28; SCA28
610247	ESOPHAGITIS, EOSINOPHILIC, 1; EOE1
610248	DEAFNESS, AUTOSOMAL RECESSIVE 65; DFNB65
610249	PROTEIN O-FUCOSYLTRANSFERASE 2; POFUT2
610250	SPASTIC PARAPLEGIA 31, AUTOSOMAL DOMINANT; SPG31
610251	ALCOHOL SENSITIVITY, ACUTE
610252	MICRO RNA 1-2; MIR1-2
610253	KLEEFSTRA SYNDROME 1; KLEFS1
610254	MICRO RNA 133A1; MIR133A1
610255	MICRO RNA 133A2; MIR133A2
610256	ANTERIOR SEGMENT DYSGENESIS 2; ASGD2
610257	SEC31 HOMOLOG A, COPII COAT COMPLEX COMPONENT; SEC31A
610258	SEC31 HOMOLOG B, COPII COAT COMPLEX COMPONENT; SEC31B
610259	LONG INTERGENIC NONCODING RNA 163; LINC00163
610260	PYLORIC STENOSIS, INFANTILE HYPERTROPHIC, 2; IHPS2
610261	HYPERTENSION, ESSENTIAL, SUSCEPTIBILITY TO, 5
610262	HYPERTENSION, ESSENTIAL, SUSCEPTIBILITY TO, 6
610263	DNAJ/HSP40 HOMOLOG, SUBFAMILY B, MEMBER 13; DNAJB13
610264	TESTIS-PROSTATE-PLACENTA-EXPRESSED PROTEIN; TEPP
610265	DEAFNESS, AUTOSOMAL RECESSIVE 67; DFNB67
610266	TAO KINASE 1; TAOK1
610267	METHIONINE AMINOPEPTIDASE 1D; METAP1D
610268	MONOACYLGLYCEROL O-ACYLTRANSFERASE 1; MOGAT1
610269	MOVED TO 607499 AND 606788
610270	MONOACYLGLYCEROL O-ACYLTRANSFERASE 2; MOGAT2
610271	PHOSPHATIDYLINOSITOL GLYCAN ANCHOR BIOSYNTHESIS CLASS S PROTEIN; PIGS
610272	PHOSPHATIDYLINOSITOL GLYCAN ANCHOR BIOSYNTHESIS CLASS T PROTEIN; PIGT
610273	PHOSPHATIDYLINOSITOL GLYCAN ANCHOR BIOSYNTHESIS CLASS M PROTEIN; PIGM
610274	PHOSPHATIDYLINOSITOL GLYCAN ANCHOR BIOSYNTHESIS CLASS V PROTEIN; PIGV
610275	PHOSPHATIDYLINOSITOL GLYCAN ANCHOR BIOSYNTHESIS CLASS W PROTEIN; PIGW
610276	PHOSPHATIDYLINOSITOL GLYCAN ANCHOR BIOSYNTHESIS CLASS X PROTEIN; PIGX
610277	ORAI CALCIUM RELEASE-ACTIVATED CALCIUM MODULATOR 1; ORAI1
610278	PLATELET ENDOTHELIAL AGGREGATION RECEPTOR 1
610279	PACHYGYRIA, FRONTOTEMPORAL
610280	OSTEOCRIN; OSTN
610281	ZINC FINGER PROTEIN 62; ZFP62
610282	RETINITIS PIGMENTOSA 35; RP35
610283	CONE-ROD DYSTROPHY 10; CORD10
610284	LIPOYLTRANSFERASE 1; LIPT1
610285	DOWNSTREAM OF TYROSINE KINASE 7; DOK7
610286	LEUCINE CARBOXYL METHYLTRANSFERASE 1; LCMT1
610287	F-BOX AND LEUCINE-RICH REPEAT PROTEIN 15; FBXL15
610288	GOLGIN A6 FAMILY, MEMBER A; GOLGA6A
610289	3-OXOACID CoA TRANSFERASE 2; OXCT2
610290	UDP-N-ACETYL-ALPHA-D-GALACTOSAMINE:POLYPEPTIDE N-ACETYLGALACTOSAMINYLTRANSFERASE 12; GALNT12
610291	SYNAPTIC VESICLE GLYCOPROTEIN 2C; SV2C
610292	B-CELL SCAFFOLD PROTEIN WITH ANKYRIN REPEATS 1; BANK1
610293	GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 1; GPIBD1
610294	INTELLIGENCE QUANTITATIVE TRAIT LOCUS 2
610295	INTELLIGENCE QUANTITATIVE TRAIT LOCUS 3
610296	NUDC DOMAIN-CONTAINING PROTEIN 3; NUDCD3
610297	PARKINSON DISEASE 13, AUTOSOMAL DOMINANT, SUSCEPTIBILITY TO; PARK13
610298	PLECKSTRIN HOMOLOGY-LIKE DOMAIN, FAMILY B, MEMBER 2; PHLDB2
610299	SOLUTE CARRIER FAMILY 6 (NEUROTRANSMITTER TRANSPORTER), MEMBER 17; SLC6A17
610300	SOLUTE CARRIER FAMILY 6 (NEUROTRANSMITTER TRANSPORTER), MEMBER 18; SLC6A18
610301	TRANSMEMBRANE PROTEIN 57; TMEM57
610302	ENDOPLASMIC RETICULUM DEGRADATION-ENHANCING ALPHA-MANNOSIDASE-LIKE PROTEIN 2; EDEM2
610303	MAF bZIP TRANSCRIPTION FACTOR A; MAFA
610304	DER1-LIKE DOMAIN FAMILY, MEMBER 2; DERL2
610305	DER1-LIKE DOMAIN FAMILY, MEMBER 3; DERL3
610306	NEPHRONECTIN; NPNT
610307	CERAMIDE KINASE; CERK
610308	BETA-3-GLUCOSYLTRANSFERASE; B3GLCT
610309	UBIQUITIN-CONJUGATING ENZYME E2 S; UBE2S
610310	MGAT4 FAMILY, MEMBER D; MGAT4D
610311	MEDIATOR COMPLEX SUBUNIT 28; MED28
610312	PIWI-LIKE RNA-MEDIATED GENE SILENCING 2; PIWIL2
610313	CRISPONI/COLD-INDUCED SWEATING SYNDROME 2; CISS2
610314	PIWI-LIKE RNA-MEDIATED GENE SILENCING 3: PIWIL3
610315	PIWI-LIKE RNA-MEDIATED GENE SILENCING 4; PIWIL4
610316	POLYRIBONUCLEOTIDE NUCLEOTIDYLTRANSFERASE 1; PNPT1
610317	CORDON-BLEU WH2 REPEAT PROTEIN; COBL
610318	COBL-LIKE PROTEIN 1: COBLL1
610319	RHIZOMELIC DYSPLASIA, SCOLIOSIS, AND RETINITIS PIGMENTOSA
610320	MYOPIA 14; MYP14
610321	PROSTATE CANCER, HEREDITARY, 7; HPC7
610322	TRANSCRIPTIONAL REGULATING FACTOR 1; TRERF1
610323	METADHERIN; MTDH
610324	3-OXOACYL-ACP SYNTHASE, MITOCHONDRIAL; OXSM
610325	NUCLEAR DISTRIBUTION C, DYNEIN COMPLEX REGULATOR; NUDC
610326	RIBONUCLEASE H2, SUBUNIT B; RNASEH2B
610327	RUN AND FYVE DOMAINS-CONTAINING PROTEIN 1; RUFY1
610328	RUN AND FYVE DOMAINS-CONTAINING PROTEIN 2; RUFY2
610329	AICARDI-GOUTIERES SYNDROME 3; AGS3
610330	RIBONUCLEASE H2, SUBUNIT C; RNASEH2C
610331	HES FAMILY bHLH TRANSCRIPTION FACTOR 6; HES6
610332	MOVED TO 608572
610333	AICARDI-GOUTIERES SYNDROME 4; AGS4
610334	TRANSMEMBRANE PROTEIN 176A; TMEM176A
610335	PHD FINGER PROTEIN 20; PHF20
610336	C2 CALCIUM-DEPENDENT DOMAIN-CONTAINING PROTEIN 4C; C2CD4C
610337	UPREGULATOR OF CELL PROLIFERATION; URGCP
610338	RIGHT PULMONARY ARTERY, ANOMALOUS ORIGIN OF, FAMILIAL
610339	PROLYL 3-HYDROXYLASE 1; P3H1
610340	ERYTHROCYTE MEMBRANE PROTEIN BAND 4.1-LIKE 4B; EPB41L4B
610341	PROLYL 3-HYDROXYLASE 2; P3H2
610342	PROLYL 3-HYDROXYLASE 3; P3H3
610343	C2 CALCIUM-DEPENDENT DOMAIN-CONTAINING PROTEIN 4A; C2CD4A
610344	C2 CALCIUM-DEPENDENT DOMAIN-CONTAINING PROTEIN 4B; C2CD4B
610345	ACYLGLYCEROL KINASE; AGK
610346	CELL DIVISION CYCLE 37-LIKE 1; CDC37L1
610347	REGULATION OF NUCLEAR PRE-mRNA DOMAIN-CONTAINING PROTEIN 1A; RPRD1A
610348	SMC5-SMC6 COMPLEX LOCALIZATION FACTOR 2; SLF2
610349	MEF2-ACTIVATING SAP TRANSCRIPTIONAL REGULATOR; MAMSTR
610350	LINES HOMOLOG 1; LINS1
610351	PROTEIN PHOSPHATASE 4, REGULATORY SUBUNIT 3, ALPHA; PPP4R3A
610352	PROTEIN PHOSPHATASE 4, REGULATORY SUBUNIT 3, BETA; PPP4R3B
610353	EPILEPSY, NOCTURNAL FRONTAL LOBE, 4; ENFL4
610354	RIC1 HOMOLOG, RAB6A GEF COMPLEX PARTNER 1; RIC1
610355	PARTNER AND LOCALIZER OF BRCA2; PALB2
610356	RETINAL CONE DYSTROPHY 3B; RCD3B
610357	SPASTIC PARAPLEGIA 30, AUTOSOMAL DOMINANT; SPG30
610358	SIGNAL PEPTIDASE COMPLEX, SUBUNIT 1; SPCS1
610359	RETINITIS PIGMENTOSA 33; RP33
610360	MUCIN 20, CELL SURFACE-ASSOCIATED; MUC20
610361	OROFACIAL CLEFT 9; OFC9
610362	RETINA AND ANTERIOR NEURAL FOLD HOMEOBOX 2; RAX2
610363	PEPTIDYLARGININE DEIMINASE, TYPE VI; PADI6
610364	TRANSMEMBRANE BAX INHIBITOR MOTIF-CONTAINING PROTEIN 1; TMBIM1
610365	C1q- AND TUMOR NECROSIS FACTOR-RELATED PROTEIN 1; C1QTNF1
610366	ADAPTOR-RELATED PROTEIN COMPLEX 3, MU-1 SUBUNIT; AP3M1
610367	SOLUTE CARRIER FAMILY 2 (FACILITATED GLUCOSE TRANSPORTER), MEMBER 11; SLC2A11
610368	LEUCINE-RICH REPEATS- AND CALPONIN HOMOLOGY DOMAIN-CONTAINING PROTEIN 1; LRCH1
610369	HEAT-SHOCK 70-KD PROTEIN 14; HSPA14
610370	DIARRHEA 4, MALABSORPTIVE, CONGENITAL; DIAR4
610371	SOLUTE CARRIER FAMILY 2 (FACILITATED GLUCOSE TRANSPORTER), MEMBER 7; SLC2A7
610372	SOLUTE CARRIER FAMILY 2 (FACILITATED GLUCOSE TRANSPORTER), MEMBER 12; SLC2A12
610373	DExD-BOX HELICASE 50; DDX50
610374	DIABETES MELLITUS, TRANSIENT NEONATAL, 2; TNDM2
610375	CAPRIN FAMILY, MEMBER 2; CAPRIN2
610376	ATYPICAL CHEMOKINE RECEPTOR 3; ACKR3
610377	MEVALONIC ACIDURIA; MEVA
610378	GLIS FAMILY ZINC FINGER PROTEIN 1; GLIS1
610379	WEST NILE VIRUS, SUSCEPTIBILITY TO
610380	MOVED TO 610168
610381	CONE-ROD DYSTROPHY 11; CORD11
610382	PROSOPAGNOSIA, HEREDITARY
610383	RAS ASSOCIATION DOMAIN FAMILY, MEMBER 9; RASSF9
610384	HECT, C2, AND WW DOMAINS-CONTAINING E3 UBIQUITIN-PROTEIN LIGASE 1; HECW1
610385	LR8 PROTEIN; LR8
610386	BTB/POZ DOMAIN-CONTAINING PROTEIN 7; BTBD7
610387	SOLUTE CARRIER FAMILY 25 (MITOCHONDRIAL IRON CARRIER), MEMBER 37; SLC25A37
610388	RRAD- AND GEM-LIKE GTPase 1; REM1
610389	LATE ENDOSOMAL/LYSOSOMAL ADAPTOR, MAPK AND MTOR ACTIVATOR 2; LAMTOR2
610390	MACROPHAGE EXPRESSED GENE 1; MPEG1
610391	PHOSPHOLIPID PHOSPHATASE-RELATED PROTEIN 3; PLPPR3
610392	MYC-BINDING PROTEIN 2; MYCBP2
610393	GON4-LIKE PROTEIN; GON4L
610394	GLIPR1-LIKE PROTEIN 2; GLIPR1L2
610395	GLIPR1-LIKE PROTEIN 1; GLIPR1L1
610396	TRAFFICKING PROTEIN PARTICLE COMPLEX, SUBUNIT 6A; TRAPPC6A
610397	TRAFFICKING PROTEIN PARTICLE COMPLEX, SUBUNIT 6B; TRAPPC6B
610398	SAP30-LIKE PROTEIN; SAP30L
610399	TRANSMEMBRANE PROTEASE, SERINE 11E; TMPRSS11E
610400	MONO-ADP RIBOSYLHYDROLASE 1; MACROD1
610401	NETRIN 4; NTN4
610402	MOVED TO 609122 AND 300870
610403	CULLIN-ASSOCIATED NEDDYLATION-DISSOCIATED 2; CAND2
610404	RECQ-MEDIATED GENOME INSTABILITY 1; RMI1
610405	CHONDROITIN POLYMERIZING FACTOR; CHPF
610406	tRNA ARGININE (ANTICODON TCT) 2-1; TRR-TCT2-1
610407	tRNA GLYCINE (ANTICODON GCC) 2-6; TRG-GCC2-6
610408	SOLUTE CARRIER FAMILY 15 (OLIGOPEPTIDE TRANSPORTER), MEMBER 3; SLC15A3
610409	SOLUTE CARRIER FAMILY 16 (MONOCARBOXYLIC ACID TRANSPORTER), MEMBER 8; SLC16A8
610410	SHORT-CHAIN DEHYDROGENASE/REDUCTASE FAMILY, MEMBER 1; DHRS1
610411	IMPORTIN 13; IPO13
610412	SERINE PALMITOYLTRANSFERASE, SMALL SUBUNIT, B; SPTSSB
610413	INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN-LIKE 1; IGFBPL1
610414	NEUROBLASTOMA BREAKPOINT FAMILY, MEMBER 15; NBPF15
610415	SYNTAXIN-BINDING PROTEIN 4; STXBP4
610416	SCAN DOMAIN-CONTAINING 1; SCAND1
610417	SCAN DOMAIN-CONTAINING 2; SCAND2
610418	WD REPEAT- AND FYVE DOMAIN-CONTAINING PROTEIN 2; WDFY2
610419	DEAFNESS, AUTOSOMAL RECESSIVE 68; DFNB68
610420	PREAURICULAR TAG, ISOLATED, AUTOSOMAL DOMINANT, 1
610421	KH DOMAIN-CONTAINING, RNA-BINDING, SIGNAL TRANSDUCTION-ASSOCIATED PROTEIN 3; KHDRBS3
610422	ALOPECIA-INTELLECTUAL DISABILITY SYNDROME 2; APMR2
610423	PHOSPHOFURIN ACIDIC CLUSTER SORTING PROTEIN 2; PACS2
610424	HEPATITIS B VIRUS, SUSCEPTIBILITY TO
610425	CATARACT 23, MULTIPLE TYPES; CTRCT23
610426	MOVED TO 610425
610427	CONE-ROD SYNAPTIC DISORDER, CONGENITAL NONPROGRESSIVE; CRSD
610428	CYTOCHROME c OXIDASE ASSEMBLY FACTOR COX18; COX18
610429	CYTOCHROME c OXIDASE ASSEMBLY FACTOR COX19; COX19
610430	MACROGLOBULINEMIA, WALDENSTROM, SUSCEPTIBILITY TO, 2; WM2
610431	RING FINGER PROTEIN 167; RNF167
610432	RING FINGER PROTEIN 125; RNF125
610433	LYMPHOCYTE ANTIGEN 6 COMPLEX, LOCUS G5B; LY6G5B
610434	LYMPHOCYTE ANTIGEN 6 COMPLEX, LOCUS G5C; LY6G5C
610435	LYMPHOCYTE ANTIGEN 6 COMPLEX, LOCUS G6C; LY6G6C
610436	ROTATIN; RTTN
610437	LYMPHOCYTE ANTIGEN 6 FAMILY, MEMBER G6E, PSEUDOGENE; LY6G6E
610438	RESTLESS LEGS SYNDROME, SUSCEPTIBILITY TO, 3; RLS3
610439	RESTLESS LEGS SYNDROME, SUSCEPTIBILITY TO, 4; RLS4
610440	SMALL G PROTEIN SIGNALING MODULATOR 3; SGSM3
610441	TESTICULAR MICROLITHIASIS
610442	SPONDYLOEPIMETAPHYSEAL DYSPLASIA, GENEVIEVE TYPE; SEMDG
610443	KOOLEN-DE VRIES SYNDROME; KDVS
610444	NIGHT BLINDNESS, CONGENITAL STATIONARY, AUTOSOMAL DOMINANT 3; CSNBAD3
610445	NIGHT BLINDNESS, CONGENITAL STATIONARY, AUTOSOMAL DOMINANT 1; CSNBAD1
610446	BURULI ULCER, SUSCEPTIBILITY TO
610447	SHADOW OF PRION PROTEIN; SPRN
610448	CHILBLAIN LUPUS 1; CHBL1
610449	MITOCHONDRIAL CARRIER HOMOLOG 1; MTCH1
610450	LY6/PLAUR DOMAIN-CONTAINING PROTEIN 1; LYPD1
610451	LEUCINE-RICH REPEAT-CONTAINING PROTEIN 35; LRRC35
610452	MUTAGEN SENSITIVITY
610453	HEPARAN-ALPHA-GLUCOSAMINIDE N-ACETYLTRANSFERASE; HGSNAT
610454	LEUCINE ZIPPER, PUTATIVE TUMOR SUPPRESSOR 2; LZTS2
610455	TUMORAL CALCINOSIS, NORMOPHOSPHATEMIC, FAMILIAL; NFTC
610456	STERILE ALPHA MOTIF DOMAIN-CONTAINING PROTEIN 9; SAMD9
610457	SPHINGOMYELIN PHOSPHODIESTERASE 4, NEUTRAL MEMBRANE; SMPD4
610458	LEUCINE ZIPPER AND CTNNBIP1 DOMAINS-CONTAINING PROTEIN; LZIC
610459	PROLINE-RICH PROTEIN 13; PRR13
610460	THIOPURINES, POOR METABOLISM OF, 1; THPM1
610461	RETICULON 4 RECEPTOR-LIKE 1; RTN4RL1
610462	RETICULON 4 RECEPTOR-LIKE 2; RTN4RL2
610463	NUS1 DEHYDRODOLICHYL DIPHOSPHATE SYNTHASE SUBUNIT; NUS1
610464	G PROTEIN-COUPLED RECEPTOR 156; GPR156
610465	ACYL-CoA SYNTHETASE FAMILY, MEMBER 2; ACSF2
610466	LIMB AND CNS EXPRESSED 1; LIX1
610467	3-HYDROXYACYL-CoA DEHYDRATASE 1; HACD1
610468	INTERFERON-INDUCED PROTEIN 44; IFI44
610469	ADAPTOR-RELATED PROTEIN COMPLEX 3, MU-2 SUBUNIT; AP3M2
610470	TRANSFER RNA PHOSPHOTRANSFERASE 1; TRPT1
610471	VASOHIBIN 2; VASH2
610472	ACYLTRANSFERASE-LIKE 2; AYTL2
610473	LYSOPHOSPHATIDYLGLYCEROL ACYLTRANSFERASE 1; LPGAT1
610474	CAMPTODACTYLY, TALL STATURE, AND HEARING LOSS SYNDROME; CATSHLS
610475	PIGMENTED NODULAR ADRENOCORTICAL DISEASE, PRIMARY, 2; PPNAD2
610476	ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA, FAMILIAL, 11; ARVD11
610477	TRANSMEMBRANE PROTEASE, SERINE 9; TMPRSS9
610478	RETINAL CONE DYSTROPHY 4; RCD4
610479	SERUM RESPONSE FACTOR BINDING PROTEIN 1; SRFBP1
610480	LEM DOMAIN-CONTAINING PROTEIN 1; LEMD1
610481	SRC HOMOLOGY 2 DOMAIN-CONTAINING TRANSFORMING PROTEIN D; SHD
610482	SH2 DOMAIN-CONTAINING PROTEIN E; SHE
610483	AGAMMAGLOBULINEMIA, MICROCEPHALY, AND SEVERE DERMATITIS
610484	PROLINE-RICH SYNAPSE-ASSOCIATED PROTEIN-INTERACTING PROTEIN 1
610485	LONG INTERGENIC NONCODING RNA 312; LINC00312
610486	LEUCINE-RICH REPEAT-CONTAINING PROTEIN 4; LRRC4
610487	KH DOMAIN-CONTAINING, RNA-BINDING, SIGNAL TRANSDUCTION-ASSOCIATED PROTEIN 2; KHDRBS2
610488	TETRATRICOPEPTIDE REPEAT DOMAIN-CONTAINING PROTEIN 9; TTC9
610489	PIGMENTED NODULAR ADRENOCORTICAL DISEASE, PRIMARY, 1; PPNAD1
610490	PURPLE ACID PHOSPHATASE, LONG FORM
610491	SLAIN MOTIF FAMILY, MEMBER 1; SLAIN1
610492	SLAIN MOTIF FAMILY, MEMBER 2; SLAIN2
610493	DIX DOMAIN-CONTAINING PROTEIN 1; DIXDC1
610494	DDB1- AND CUL4-ASSOCIATED FACTOR 6; DCAF6
610495	INTERMEDIATE FILAMENT FAMILY ORPHAN 1; IFFO1
610496	RHO GTPase-ACTIVATING PROTEIN 29; ARHGAP29
610497	BRAIN AND REPRODUCTIVE ORGAN-EXPRESSED PROTEIN; BRE
610498	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 2; COXPD2
610499	RAP GUANINE NUCLEOTIDE EXCHANGE FACTOR 6; RAPGEF6
610500	ANKYRIN REPEAT AND KH DOMAIN-CONTAINING PROTEIN 1; ANKHD1
610501	NEUROBLASTOMA BREAKPOINT FAMILY, MEMBER 1; NBPF1
610502	RETICULON 4-INTERACTING PROTEIN 1; RTN4IP1
610503	CELL DEATH-INDUCING p53 TARGET 1; CDIP1
610504	PRETERM PREMATURE RUPTURE OF THE MEMBRANES; PPROM
610505	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 3; COXPD3
610506	PAF1 HOMOLOG, PAF1/RNA POLYMERASE II COMPLEX COMPONENT; PAF1
610507	LEO1 HOMOLOG, PAF1/RNA POLYMERASE II COMPLEX COMPONENT; LEO1
610508	MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 7; MODY7
610509	RIC3 ACETYLCHOLINE RECEPTOR CHAPERONE; RIC3
610510	AURORA BOREALIS; BORA
610511	SEC23 HOMOLOG A, COAT COMPLEX II COMPONENT; SEC23A
610512	SEC23 HOMOLOG B, COAT COMPLEX II COMPONENT; SEC23B
610513	ATPase 13A2; ATP13A2
610514	PHD FINGER PROTEIN 17; PHF17
610515	PHD FINGER PROTEIN 15; PHF15
610516	GLYCERATE KINASE; GLYCTK
610517	CONTACTIN-ASSOCIATED PROTEIN-LIKE 3; CNTNAP3
610518	CONTACTIN-ASSOCIATED PROTEIN-LIKE 4; CNTNAP4
610519	CONTACTIN-ASSOCIATED PROTEIN-LIKE 5; CNTNAP5
610520	CD300 ANTIGEN-LIKE FAMILY, MEMBER G; CD300LG
610521	POTASSIUM CHANNEL TETRAMERIZATION DOMAIN-CONTAINING PROTEIN 12; KCTD12
610522	COORDINATED EXPRESSION TO IRXA2
610523	CENTROSOMAL PROTEIN, 41-KD; CEP41
610524	ENDOGENOUS RETROVIRUS GROUP FRD, MEMBER 1; ERVFRD1
610525	5-PRIME-NUCLEOTIDASE, CYTOSOLIC, IA; NT5C1A
610526	5-PRIME-NUCLEOTIDASE, CYTOSOLIC, IB; NT5C1B
610527	THIOREDOXIN DOMAIN-CONTAINING PROTEIN 1; TXNDC1
610528	CHROMODOMAIN HELICASE DNA-BINDING PROTEIN 8; CHD8
610529	TUMOR SUPPRESSOR CANDIDATE 1; TUSC1
610530	TRIPARTITE MOTIF-CONTAINING PROTEIN 41; TRIM41
610531	HYCCIN, PI4KA LIPID KINASE COMPLEX, SUBUNIT 1; HYCC1
610532	LEUKODYSTROPHY, HYPOMYELINATING, 5; HLD5
610533	WW AND C2 DOMAINS-CONTAINING PROTEIN 1; WWC1
610534	DECAPPING ENZYME, SCAVENGER; DCPS
610535	GLAUCOMA 1, OPEN ANGLE, M; GLC1M
610536	MANDIBULOFACIAL DYSOSTOSIS, GUION-ALMEIDA TYPE; MFDGA
610537	DIPEPTIDYL PEPTIDASE VII; DPP7
610538	UBIQUITIN-CONJUGATING ENZYME E2 T; UBE2T
610539	GAUCHER DISEASE, ATYPICAL, DUE TO SAPOSIN C DEFICIENCY; GDSAPC
610540	GNAS COMPLEX LOCUS, ANTISENSE TRANSCRIPT 1; GNASAS1
610541	PROTEIN PHOSPHATASE 1, REGULATORY SUBUNIT 3B; PPP1R3B
610542	MYASTHENIC SYNDROME, CONGENITAL, 12; CMS12
610543	CHROMOSOME 16p13.3 DELETION SYNDROME, PROXIMAL
610544	IGF-LIKE FAMILY MEMBER 1; IGFL1
610545	IGF-LIKE FAMILY MEMBER 2; IGFL2
610546	IGF-LIKE FAMILY MEMBER 3; IGFL3
610547	IGF-LIKE FAMILY MEMBER 4; IGFL4
610548	AQUARIUS INTRON-BINDING SPLICEOSOMAL FACTOR; AQR
610549	DIABETES MELLITUS, INSULIN-RESISTANT, WITH ACANTHOSIS NIGRICANS
610550	METHIONINE ADENOSYLTRANSFERASE I, ALPHA; MAT1A
610551	ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED (HERPES-SPECIFIC), SUSCEPTIBILITY TO, 1; IIAE1
610552	UBIQUITIN-LIKE MODIFIER-ACTIVATING ENZYME 5; UBA5
610553	UBIQUITIN-FOLD MODIFIER 1; UFM1
610554	UBIQUITIN-FOLD MODIFIER-CONJUGATING ENZYME 1; UFC1
610555	CORE 1 SYNTHASE, GLYCOPROTEIN-N-ACETYLGALACTOSAMINE 3-BETA-GALACTOSYLTRANSFERASE, 1; C1GALT1
610556	HIGHLY ACCELERATED REGION GENE 1A; HAR1A
610557	HIGHLY ACCELERATED REGION GENE 1B; HAR1B
610558	MITOGEN-ACTIVATED PROTEIN KINASE-ASSOCIATED PROTEIN 1; MAPKAP1
610559	RAS ASSOCIATION DOMAIN FAMILY, MEMBER 4; RASSF4
610560	PROTEASE, SERINE, 36; PRSS36
610561	PROTEASE, SERINE, 53; PRSS53
610562	ZINC FINGER CCCH DOMAIN-CONTAINING PROTEIN 12A; ZC3H12A
610563	KARYOPHERIN ALPHA-6; KPNA6
610564	PRENYL DIPHOSPHATE SYNTHASE, SUBUNIT 2; PDSS2
610565	DYNEIN, AXONEMAL, LIGHT CHAIN 4; DNAL4
610566	MICRO RNA 146A; MIR146A
610567	MICRO RNA 146B; MIR146B
610568	ZINC FINGER PROTEIN 687; ZNF687
610569	UBIQUITIN-SPECIFIC PROTEASE 24; USP24
610570	UBIQUITIN-SPECIFIC PROTEASE 40; USP40
610571	FK506-BINDING PROTEIN 11; FKBP11
610572	MARVEL DOMAIN-CONTAINING PROTEIN 2; MARVELD2
610573	R-SPONDIN 4; RSPO4
610574	R-SPONDIN 3; RSPO3
610575	R-SPONDIN 2; RSPO2
610576	RHO GTPase-ACTIVATING PROTEIN 9; ARHGAP9
610577	RHO GTPase-ACTIVATING PROTEIN 12; ARHGAP12
610578	RHO GTPase-ACTIVATING PROTEIN 15; ARHGAP15
610579	RCSD DOMAIN-CONTAINING PROTEIN 1; RCSD1
610580	ONCOGENE PIM3; PIM3
610581	COATOMER PROTEIN COMPLEX, SUBUNIT GAMMA-2, INTRONIC TRANSCRIPT 1; COPG2IT1
610582	DIABETES MELLITUS, TRANSIENT NEONATAL, 3
610583	ANKYRIN REPEAT DOMAIN-CONTAINING PROTEIN 6; ANKRD6
610584	TRIPARTITE MOTIF-CONTAINING PROTEIN 67; TRIM67
610585	RHO GTPase-ACTIVATING PROTEIN 22; ARHGAP22
610586	RHO GTPase-ACTIVATING PROTEIN 24; ARHGAP24
610587	RHO GTPase-ACTIVATING PROTEIN 25; ARHGAP25
610588	DENDRIN; DDN
610589	RHO GTPase-ACTIVATING PROTEIN 11A; ARHGAP11A
610590	RHO GTPase-ACTIVATING PROTEIN 23; ARHGAP23
610591	RHO GTPase-ACTIVATING PROTEIN 27; ARHGAP27
610592	RHO GTPase-ACTIVATING PROTEIN 28; ARHGAP28
610593	MAP6 DOMAIN-CONTAINING PROTEIN 1; MAP6D1
610594	FOLLICULIN-INTERACTING PROTEIN 1; FNIP1
610595	FLAVIN ADENINE DINUCLEOTIDE SYNTHETASE 1; FLAD1
610596	BLOCK OF PROLIFERATION 1; BOP1
610597	GLUTAMATE-RICH WD REPEAT-CONTAINING PROTEIN 1; GRWD1
610598	PHOTORECEPTOR DISC COMPONENT; PRCD
610599	RETINITIS PIGMENTOSA 36; RP36
610600	CORTICOSTERONE METHYLOXIDASE TYPE II DEFICIENCY
610601	KALLIKREIN-RELATED PEPTIDASE 15; KLK15
610602	AlkB HOMOLOG 2, ALPHA-KETOGLUTARATE-DEPENDENT DIOXYGENASE; ALKBH2
610603	AlkB HOMOLOG 3, ALPHA-KETOGLUTARATE-DEPENDENT DIOXYGENASE; ALKBH3
610604	KILLER CELL IMMUNOGLOBULIN-LIKE RECEPTOR, THREE DOMAINS, PSEUDOGENE 1; KIR3DP1
610605	CYTOPLASMIC POLYADENYLATION ELEMENT-BINDING PROTEIN 2; CPEB2
610606	CYTOPLASMIC POLYADENYLATION ELEMENT-BINDING PROTEIN 3; CPEB3
610607	CYTOPLASMIC POLYADENYLATION ELEMENT-BINDING PROTEIN 4; CPEB4
610608	GINS COMPLEX SUBUNIT 1; GINS1
610609	GINS COMPLEX SUBUNIT 2; GINS2
610610	GINS COMPLEX SUBUNIT 3; GINS3
610611	GINS COMPLEX SUBUNIT 4; GINS4
610612	LEBER CONGENITAL AMAUROSIS 12; LCA12
610613	CYTOCHROME P450, SUBFAMILY XIB, POLYPEPTIDE 1; CYP11B1
610614	TRANSFORMING GROWTH FACTOR-BETA REGULATOR 1; TBRG1
610615	RAB, MEMBER RAS ONCOGENE FAMILY-LIKE 6; RABL6
610616	ANKYRIN REPEAT DOMAIN-CONTAINING PROTEIN 12; ANKRD12
610617	DENTICLELESS E3 UBIQUITIN PROTEIN LIGASE HOMOLOG; DTL
610618	ANGIOEDEMA, HEREDITARY, 3; HAE3
610619	COAGULATION FACTOR XII; F12
610620	ADP-RIBOSYLHYDROLASE-LIKE 1; ADPRHL1
610621	INTURNED PLANAR CELL POLARITY PROTEIN; INTU
610622	FUZZY PLANAR CELL POLARITY PROTEIN; FUZ
610623	CATARACT 11, MULTIPLE TYPES; CTRCT11
610624	ADP-RIBOSYLHYDROLASE-LIKE 2; ADPRHL2
610625	ADP-RIBOSYLTRANSFERASE 5; ART5
610626	PHOSPHOLIPID PHOSPHATASE 5; PLPP5
610627	ALPHA-2-MACROGLOBULIN-LIKE 1; A2ML1
610628	HYPOGONADOTROPIC HYPOGONADISM 4 WITH OR WITHOUT ANOSMIA; HH4
610629	DIAMOND-BLACKFAN ANEMIA 3; DBA3
610630	PROTEIN TYROSINE PHOSPHATASE, NONRECEPTOR-TYPE, 20; PTPN20
610631	MOVED TO 610630
610632	MITOCHONDRIAL CALCIUM UPTAKE PROTEIN 2; MICU2
610633	MITOCHONDRIAL CALCIUM UPTAKE PROTEIN 3; MICU3
610634	MOVED TO 115650
610635	COLLAGEN TRIPLE-HELIX REPEAT-CONTAINING PROTEIN 1; CTHRC1
610636	MICRO RNA 27B; MIR27B
610637	MEMBRANE-ASSOCIATED RING-CH FINGER PROTEIN 5; MARCHF5
610638	IMMUNOGLOBULIN SUPERFAMILY, MEMBER 5; IGSF5
610639	GRID2-INTERACTING PROTEIN 1; GRID2IP1
610640	YTH N6-METHYLADENOSINE RNA-BINDING PROTEIN 2; YTHDF2
610641	TERMINAL URIDYLYL TRANSFERASE 1, U6 snRNA-SPECIFIC; TUT1
610642	ENDOPLASMIC RETICULUM PROTEIN, 27-KD; ERP27
610643	CELL PROLIFERATION-REGULATING INHIBITOR OF PROTEIN PHOSPHATASE 2A; CIP2A
610644	PALMOPLANTAR HYPERKERATOSIS WITH SQUAMOUS CELL CARCINOMA OF SKIN AND 46,XX SEX REVERSAL
610645	CALCIUM- AND INTEGRIN-BINDING PROTEIN 3; CIB3
610646	CALCIUM- AND INTEGRIN-BINDING PROTEIN 4; CIB4
610647	N-ACETYLTRANSFERASE 8-LIKE; NAT8L
610648	CUT-LIKE HOMEOBOX 2; CUX2
610649	BONE SIZE QUANTITATIVE TRAIT LOCUS 3
610650	ADHESION-REGULATING MOLECULE 1; ADRM1
610651	XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP B; XPB
610652	PHOSPHODIESTERASE 10A; PDE10A
610653	RIBOSOMAL RNA-PROCESSING 1; RRP1
610654	RIBOSOMAL RNA-PROCESSING 1B; RRP1B
610655	TELANGIECTASIA, HEREDITARY HEMORRHAGIC, TYPE 4; HHT4
610656	CYSTEINE CONJUGATE BETA-LYASE 2; CCBL2
610657	WASH COMPLEX, SUBUNIT 5; WASHC5
610658	TRIPARTITE MOTIF-CONTAINING PROTEIN 29; TRIM29
610659	GLUTAMATE RECEPTOR, IONOTROPIC, DELTA 1; GRID1
610660	GLYOXYLATE REDUCTASE 1 HOMOLOG; GLYR1
610661	N-GLYCANASE 1; NGLY1
610662	PHOSPHATIDYLINOSITOL GLYCAN ANCHOR BIOSYNTHESIS CLASS Y PROTEIN; PIGY
610663	SET AND MYND DOMAIN-CONTAINING PROTEIN 2; SMYD2
610664	BRIDGE-LIKE LIPID TRANSFER PROTEIN FAMILY, MEMBER 2; BLTP2
610665	Fc FRAGMENT OF IgG RECEPTOR IIIb; FCGR3B
610666	NEURENSIN 2; NRSN2
610667	UBIQUITIN CARBOXYL-TERMINAL HYDROLASE L5; UCHL5
610668	INSC SPINDLE ORIENTATION ADAPTOR PROTEIN; INSC
610669	TNFAIP3-INTERACTING PROTEIN 2; TNIP2
610670	CYTOCHROME P450, FAMILY 2, SUBFAMILY U, POLYPEPTIDE 1; CYP2U1
610671	ZINC FINGER PROTEIN 628; ZNF628
610672	NUCLEUS ACCUMBENS-ASSOCIATED PROTEIN 1, BEN AND BTB/POZ DOMAINS-CONTAINING; NACC1
610673	NUCLEAR APOPTOSIS-INDUCING FACTOR 1; NAIF1
610674	SPERM FLAGELLAR PROTEIN 1; SPEF1
610675	UNCONVENTIONAL SNARE IN THE ER 1; USE1
610676	AUTISM, SUSCEPTIBILITY TO, 7; AUTS7
610677	LSM14A mRNA PROCESSING BODY ASSEMBLY FACTOR; LSM14A
610678	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 4; COXPD4
610679	CYCLIN-DEPENDENT KINASE 14; CDK14
610680	HOLOPROSENCEPHALY, RECURRENT INFECTIONS, AND MONOCYTOSIS
610681	PHOSPHOFRUCTOKINASE, MUSCLE TYPE; PFKM
610682	OSTEOGENESIS IMPERFECTA, TYPE VII; OI7
610683	BBS12 GENE; BBS12
610684	C-TERMINAL DOMAIN NUCLEAR ENVELOPE PHOSPHATASE 1; CTDNEP1
610685	SPLIT-HAND/FOOT MALFORMATION WITH LONG BONE DEFICIENCY 2; SHFLD2
610686	UBX DOMAIN PROTEIN 2B; UBXN2B
610687	NEMALINE MYOPATHY 7; NEM7
610688	JOUBERT SYNDROME 6; JBTS6
610689	DIPLA1, ANTISENSE
610690	3-HYDROXYISOBUTYRYL-CoA HYDROLASE; HIBCH
610691	PRUNE HOMOLOG 2 WITH BCH DOMAIN; PRUNE2
610692	HEAT-SHOCK 27-KD PROTEIN 7; HSPB7
610693	HYLS1 CENTRIOLAR AND CILIOGENESIS-ASSOCIATED PROTEIN; HYLS1
610694	PYROGLUTAMYL PEPTIDASE I; PGPEP1
610695	HEAT-SHOCK 27-KD PROTEIN 6; HSPB6
610696	PCNA-ASSOCIATED FACTOR, 15-KD
610697	PDZ DOMAIN-CONTAINING 2; PDZD2
610698	MACULAR DEGENERATION, AGE-RELATED, 4; ARMD4
610699	ZINC FINGER AN1 DOMAIN-CONTAINING PROTEIN 2A; ZFAND2A
610700	HTRA SERINE PEPTIDASE 4; HTRA4
610701	HEAT-SHOCK 70-KD PROTEIN 12A; HSPA12A
610702	HEAT-SHOCK 70-KD PROTEIN 12B; HSPA12B
610703	HEAT-SHOCK 105/110-KD PROTEIN 1; HSPH1
610704	PROHIBITIN 2; PHB2
610705	CD300 ANTIGEN-LIKE FAMILY, MEMBER B; CD300LB
610706	DEAFNESS, CONGENITAL, WITH INNER EAR AGENESIS, MICROTIA, AND MICRODONTIA
610707	PSORIASIS 8, SUSCEPTIBILITY TO; PSORS8
610708	OPTIC ATROPHY 5; OPA5
610709	TESTIS-SPECIFIC SERINE/THREONINE KINASE 1; TSSK1
610710	TESTIS-SPECIFIC SERINE/THREONINE KINASE 2; TSSK2
610711	TESTIS-SPECIFIC SERINE/THREONINE KINASE 4; TSSK4
610712	TESTIS-SPECIFIC SERINE/THREONINE KINASE 6; TSSK6
610713	BRACHYDACTYLY-SYNDACTYLY SYNDROME; BDSD
610714	PROTEIN KINASE N3; PKN3
610715	HEMOGEN; HEMGN
610716	TIMELESS-INTERACTING PROTEIN; TIPIN
610717	NEUTRAL LIPID STORAGE DISEASE WITH MYOPATHY; NLSDM
610718	MICRO RNA 195; MIR195
610719	MICRO RNA 199A1; MIR199A1
610720	MICRO RNA 199A2; MIR199A2
610721	MICRO RNA 214; MIR214
610722	MOVED TO 607962
610723	MICRO RNA 23B; MIR23B
610724	MICRO RNA 24-2; MIR24-2
610725	NEPHROTIC SYNDROME, TYPE 3; NPHS3
610726	TRUB PSEUDOURIDINE SYNTHASE FAMILY MEMBER 1; TRUB1
610727	TRUB PSEUDOURIDINE SYNTHASE FAMILY MEMBER 2; TRUB2
610728	SPHINGOMYELIN PHOSPHODIESTERASE, ACID-LIKE, 3A; SMPDL3A
610729	WD REPEAT-CONTAINING PROTEIN 92; WDR92
610730	CHAPERONIN-CONTAINING T-COMPLEX POLYPEPTIDE 1, SUBUNIT 6B; CCT6B
610731	ANKYRIN REPEAT DOMAIN-CONTAINING PROTEIN 7; ANKRD7
610732	TETRATRICOPEPTIDE REPEAT DOMAIN-CONTAINING PROTEIN 12; TTC12
610733	NOONAN SYNDROME 4; NS4
610734	ANKYRIN REPEAT DOMAIN-CONTAINING PROTEIN 2; ANKRD2
610735	MYOZENIN 3; MYOZ3
610736	ANKYRIN REPEAT DOMAIN-CONTAINING PROTEIN 23; ANKRD23
610737	KINASE SUPPRESSOR OF RAS 2; KSR2
610738	NEUTROPENIA, SEVERE CONGENITAL, 3, AUTOSOMAL RECESSIVE; SCN3
610739	TRINUCLEOTIDE REPEAT-CONTAINING GENE 6A; TNRC6A
610740	TRINUCLEOTIDE REPEAT-CONTAINING GENE 6B; TNRC6B
610741	TRINUCLEOTIDE REPEAT-CONTAINING GENE 6C; TNRC6C
610742	MOV10 RISC COMPLEX RNA HELICASE ; MOV10
610743	SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 8; SCAR8
610744	IRIS PATTERN
610745	STIMULATED BY RETINOIC ACID 6; STRA6
610746	DOLICHOL KINASE; DOLK
610747	STERILE ALPHA MOTIF DOMAIN-CONTAINING PROTEIN 4A; SAMD4A
610748	UBIQUITIN-SPECIFIC PROTEASE 28; USP28
610749	KELCH-LIKE 31; KLHL31
610750	ZINC FINGER CCHC DOMAIN- AND RNA-BINDING MOTIF-CONTAINING PROTEIN 1; ZCRB1
610751	PHOSPHORIBOSYL TRANSFERASE DOMAIN-CONTAINING PROTEIN 1; PRTFDC1
610752	URONYL 2-SULFOTRANSFERASE; UST
610753	ALOPECIA AREATA 2; AA2
610754	WAPL COHESIN RELEASE FACTOR; WAPL
610755	MULTIPLE ENDOCRINE NEOPLASIA, TYPE IV; MEN4
610756	CEREBROOCULOFACIOSKELETAL SYNDROME 2; COFS2
610757	CHEMOKINE, CC MOTIF, LIGAND 4-LIKE 2; CCL4L2
610758	CEREBROOCULOFACIOSKELETAL SYNDROME 4; COFS4
610759	CORNELIA DE LANGE SYNDROME 3 WITH OR WITHOUT MIDLINE BRAIN DEFECTS; CDLS3
610760	CHOLESTEROL LEVEL QUANTITATIVE TRAIT LOCUS 2
610761	HIGH DENSITY LIPOPROTEIN CHOLESTEROL LEVEL QUANTITATIVE TRAIT LOCUS 5
610762	HIGH DENSITY LIPOPROTEIN CHOLESTEROL LEVEL QUANTITATIVE TRAIT LOCUS 6; HDLCQ6
610763	N-ACETYLNEURAMINIC ACID PHOSPHATASE; NANP
610764	TSPO-ASSOCIATED PROTEIN 1; TSPOAP1
610765	MOVED TO 602400
610766	MEIOSIS-SPECIFIC NUCLEAR STRUCTURAL PROTEIN 1; MNS1
610767	AUTOPHAGY 16-LIKE 1; ATG16L1
610768	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Im; CDG1M
610769	NOC3-LIKE DNA REPLICATION REGULATOR; NOC3L
610770	NOC2-LIKE NUCLEOLAR-ASSOCIATED TRANSCRIPTIONAL REPRESSOR; NOC2L
610771	CHROMODOMAIN HELICASE DNA-BINDING PROTEIN 5; CHD5
610772	NK6 HOMEOBOX 3; NKX6-3
610773	MITOCHONDRIAL PHOSPHATE CARRIER DEFICIENCY; MPCD
610774	CANOPY FGF SIGNALING REGULATOR 3; CNPY3
610775	TP53-INDUCED GLYCOLYSIS AND APOPTOSIS REGULATOR; TIGAR
610776	DAMAGE-REGULATED AUTOPHAGY MODULATOR 1; DRAM1
610777	NEUROGUIDIN; NGDN
610778	GUANINE NUCLEOTIDE-BINDING PROTEIN, BETA-1-LIKE; GNB1L
610779	NUCLEOTIDE-BINDING PROTEIN 2; NUBP2
610780	LARGE 60S SUBUNIT NUCLEAR EXPORT GTPase 1; LSG1
610781	GUANOSINE MONOPHOSPHATE REDUCTASE 2; GMPR2
610782	MICRO RNA 29A; MIR29A
610783	MICRO RNA 29B1; MIR29B1
610784	MICRO RNA 29C; MIR29C
610785	PDLIM1-INTERACTING KINASE 1-LIKE; PDIK1L
610786	SRC KINASE SIGNALING INHIBITOR 1; SRCIN1
610787	PRAC2 SMALL NUCLEAR PROTEIN; PRAC2
610788	SOLUTE CARRIER FAMILY 35 (3-PRIME-PHOSPHOADENOSINE 5-PRIME-PHOSPHOSULFATE TRANSPORTER), MEMBER B2; SLC35B2
610789	p53 AND DNA DAMAGE-REGULATED 1; PDRG1
610790	SOLUTE CARRIER FAMILY 35, MEMBER B1; SLC35B1
610791	SOLUTE CARRIER FAMILY 43 (L-TYPE AMINO ACID TRANSPORTER), MEMBER 2; SLC43A2
610792	SOLUTE CARRIER FAMILY 22, MEMBER 25; SLC22A25
610793	SOLUTE CARRIER FAMILY 25 (MITOCHONDRIAL CARRIER, KIDNEY), MEMBER 30; SLC25A30
610794	ZINC FINGER PROTEIN 323; ZNF323
610795	SORBIN AND SH3 DOMAINS-CONTAINING PROTEIN 3; SORBS3
610796	SOLUTE CARRIER FAMILY 25 (MITOCHONDRIAL CARRIER, ADENINE NUCLEOTIDE TRANSLOCATOR), MEMBER 31; SLC25A31
610797	EPIPHYSEAL DYSPLASIA, BAUMANN TYPE
610798	IMMUNODEFICIENCY DUE TO DEFECT IN MAPBP-INTERACTING PROTEIN
610799	MOVED TO 607676
610800	AUTOPHAGY-RELATED 10; ATG10
610801	SOLUTE CARRIER FAMILY 41 (MAGNESIUM TRANSPORTER), MEMBER 1; SLC41A1
610802	SOLUTE CARRIER FAMILY 41, MEMBER 2; SLC41A2
610803	SOLUTE CARRIER FAMILY 41, MEMBER 3; SLC41A3
610804	SOLUTE CARRIER FAMILY 35 (UDP-GLUCURONIC ACID/UDP-N-ACETYLGALACTOSAMINE DUAL TRANSPORTER), MEMBER D1; SLC35D1
610805	CONGENITAL ANOMALIES OF KIDNEY AND URINARY TRACT 1; CAKUT1
610806	TBC1 DOMAIN FAMILY, MEMBER 3C; TBC1D3C
610807	TBC1 DOMAIN FAMILY, MEMBER 3D; TBC1D3D
610808	TBC1 DOMAIN FAMILY, MEMBER 3E; TBC1D3E
610809	TBC1 DOMAIN FAMILY, MEMBER 3F; TBC1D3F
610810	TBC1 DOMAIN FAMILY, MEMBER 3G; TBC1D3G
610811	TBC1 DOMAIN FAMILY, MEMBER 3H; TBC1D3H
610812	HYDIN AXONEMAL CENTRAL PAIR APPARATUS PROTEIN; HYDIN
610813	HYDIN AXONEMAL CENTRAL PAIR APPARATUS PROTEIN 2; HYDIN2
610814	MOVED TO 601186
610815	MOVED TO 138480
610816	SOLUTE CARRIER FAMILY 25 (MITOCHONDRIAL CARRIER, PYRIMIDINE NUCLEOTIDE TRANSPORTER), MEMBER 33; SLC25A33
610817	SOLUTE CARRIER FAMILY 25, MEMBER 34; SLC25A34
610818	SOLUTE CARRIER FAMILY 25, MEMBER 35; SLC25A35
610819	SOLUTE CARRIER FAMILY 25, MEMBER 38; SLC25A38
610820	SOLUTE CARRIER FAMILY 25, MEMBER 39; SLC25A39
610821	SOLUTE CARRIER FAMILY 25, MEMBER 40; SLC25A40
610822	SOLUTE CARRIER FAMILY 25, MEMBER 41; SLC25A41
610823	SOLUTE CARRIER FAMILY 25, MEMBER 42; SLC25A42
610824	SOLUTE CARRIER FAMILY 25, MEMBER 44; SLC25A44
610825	SOLUTE CARRIER FAMILY 25, MEMBER 45; SLC25A45
610826	SOLUTE CARRIER FAMILY 25, MEMBER 46; SLC25A46
610827	ZINC FINGER PROTEIN 335; ZNF335
610828	HOLOPROSENCEPHALY 7; HPE7
610829	HOLOPROSENCEPHALY 9; HPE9
610830	POLYOSTEOLYSIS-HYPEROSTOSIS SYNDROME
610831	TBC1 DOMAIN FAMILY, MEMBER 10C; TBC1D10C
610832	FANCONI ANEMIA, COMPLEMENTATION GROUP N; FANCN
610833	N-ALPHA-ACETYLTRANSFERASE 20, NatB CATALYTIC SUBUNIT; NAA20
610834	N-ALPHA-ACETYLTRANSFERASE 50, NatE CATALYTIC SUBUNIT; NAA50
610835	NMDA RECEPTOR-REGULATED 2; NARG2
610836	AUTISM, SUSCEPTIBILITY TO, 11; AUTS11
610837	BCL2-LIKE 12; BCL2L12
610838	AUTISM, SUSCEPTIBILITY TO, 12; AUTS12
610839	OSTEOARTHRITIS SUSCEPTIBILITY 4; OS4
610840	MITRAL VALVE PROLAPSE 3; MVP3
610841	STROMAL INTERACTION MOLECULE 2; STIM2
610842	PSEUDOXANTHOMA ELASTICUM-LIKE DISORDER WITH MULTIPLE COAGULATION FACTOR DEFICIENCY
610843	UBIQUINOL-CYTOCHROME C REDUCTASE, COMPLEX III SUBUNIT X; UQCR10
610844	SPG11 VESICLE TRAFFICKING ASSOCIATED, SPATACSIN; SPG11
610845	SOLUTE CARRIER FAMILY 35 (3-PRIME-PHOSPHOADENOSINE 5-PRIME-PHOSPHOSULFATE TRANSPORTER), MEMBER B3; SLC35B3
610846	LEUCINE-RICH REPEAT-CONTAINING PROTEIN 10; LRRC10
610847	ZINC FINGER PROTEIN 322; ZNF322
610848	RAB15 EFFECTOR PROTEIN; REP15
610849	TUBULIN TYROSINE LIGASE-LIKE 6; TTLL6
610850	XPA-BINDING PROTEIN 2; XAB2
610851	ADAPTOR-RELATED PROTEIN COMPLEX 1-ASSOCIATED REGULATORY PROTEIN; AP1AR
610852	CILIARY DYSKINESIA, PRIMARY, 6; CILD6
610853	AT-HOOK-CONTAINING TRANSCRIPTION FACTOR 1; AHCTF1
610854	MOVED TO 610682
610855	ANKYRIN REPEAT DOMAIN-CONTAINING PROTEIN 26; ANKRD26
610856	ANKYRIN REPEAT DOMAIN-CONTAINING PROTEIN 30A; ANKRD30A
610857	MUCIN-LIKE 1; MUCL1
610858	RNA TRANSCRIPTION, TRANSLATION, AND TRANSPORT FACTOR; RTRAF
610859	CAPPING PROTEIN REGULATOR AND MYOSIN 1 LINKER 2; CARMIL2
610860	AMYLO-1,6-GLUCOSIDASE, 4-ALPHA-GLUCANOTRANSFERASE; AGL
610861	SPECTRIN REPEAT-CONTAINING NUCLEAR ENVELOPE PROTEIN 3; SYNE3
610862	DELTA(4)-DESATURASE, SPHINGOLIPID, 2; DEGS2
610863	GUANINE NUCLEOTIDE-BINDING PROTEIN, BETA-4; GNB4
610864	FLVCR1 DIVERGENT TRANSCRIPT; FLVCR1-DT
610865	FLVCR HEME TRANSPORTER 2; FLVCR2
610866	URIDINE/CYTIDINE KINASE-LIKE 1; UCKL1
610867	LEUCINE-RICH REPEAT TRANSMEMBRANE PROTEIN 1: LRRTM1
610868	LEUCINE-RICH REPEAT TRANSMEMBRANE PROTEIN 2; LRRTM2
610869	LEUCINE-RICH REPEAT TRANSMEMBRANE PROTEIN 3; LRRTM3
610870	LEUCINE-RICH REPEAT TRANSMEMBRANE PROTEIN 4; LRRTM4
610871	SAKODA COMPLEX
610872	IBR DOMAIN-CONTAINING PROTEIN 3; IBRDC3
610873	MENARCHE, AGE AT, QUANTITATIVE TRAIT LOCUS 1; MENAQ1
610874	SPERMATOGENESIS AND CENTRIOLE-ASSOCIATED 1; SPATC1
610875	SAPS DOMAIN FAMILY, MEMBER 1; SAPS1
610876	HECT DOMAIN- AND ANKYRIN REPEAT-CONTAINING E3 UBIQUITIN PROTEIN LIGASE 1; HACE1
610877	SAPS DOMAIN FAMILY, MEMBER 2; SAPS2
610878	VESICOURETERAL REFLUX 2; VUR2
610879	SAPS DOMAIN FAMILY, MEMBER 3; SAPS3
610880	CHROMOSOME 11 OPEN READING FRAME 24; C11ORF24
610881	LYSINE METHYLTRANSFERASE 5B; KMT5B
610882	SJOGREN SYNDROME NUCLEAR AUTOANTIGEN 1; SSNA1
610883	POTOCKI-LUPSKI SYNDROME; PTLS
610884	FA CORE COMPLEX-ASSOCIATED PROTEIN 24; FAAP24
610885	ESSENTIAL MEIOTIC STRUCTURE-SPECIFIC ENDONUCLEASE 1; EME1
610886	ESSENTIAL MEIOTIC STRUCTURE-SPECIFIC ENDONUCLEASE 2; EME2
610887	POLYMERASE, DNA, NU; POLN
610888	GASTRIC CANCER-RELATED GENE 224
610889	IMPORTIN 11; IPO11
610890	REGULATOR OF G PROTEIN SIGNALING 7-BINDING PROTEIN; RGS7BP
610891	FAMILY WITH SEQUENCE SIMILARITY 102, MEMBER A; FAM102A
610892	SYNAPTOTAGMIN 14-LIKE PROTEIN; SYT14L
610893	CHARGED MULTIVESICULAR BODY PROTEIN 2A; CHMP2A
610894	NEUREGULIN 4; NRG4
610895	WAP, FOLLISTATIN, IMMUNOGLOBULIN, KUNITZ, AND NTR DOMAINS-CONTAINING PROTEIN 2; WFIKKN2
610896	BRANCHIOOTORENAL SYNDROME 2; BOR2
610897	CHARGED MULTIVESICULAR BODY PROTEIN 4B; CHMP4B
610898	SUPRANUCLEAR PALSY, PROGRESSIVE, 3; PSNP3
610899	CHARGED MULTIVESICULAR BODY PROTEIN 4C; CHMP4C
610900	CHARGED MULTIVESICULAR BODY PROTEIN 5; CHMP5
610901	CHARGED MULTIVESICULAR BODY PROTEIN 6; CHMP6
610902	VESSICLE TRAFFICKING 1; VTA1
610903	VACUOLAR PROTEIN SORTING 36 HOMOLOG; VPS36
610904	SNF8 SUBUNIT OF ESCRIT-II; SNF8
610905	MOVED TO 225750
610906	ASTHMA-RELATED TRAITS, SUSCEPTIBILITY TO, 4
610907	VACUOLAR PROTEIN SORTING 25 HOMOLOG; VPS25
610908	AUTISM, SUSCEPTIBILITY TO, 13; AUTS13
610909	MINICHROMOSOME MAINTENANCE COMPLEX-BINDING PROTEIN; MCMBP
610910	PULMONARY ALVEOLAR PROTEINOSIS, ACQUIRED
610911	RHO GTPase-ACTIVATING PROTEIN 31; ARHGAP31
610912	AMELOTIN; AMTN
610913	SURFACTANT METABOLISM DYSFUNCTION, PULMONARY, 2; SMDP2
610914	ECTO-NOX DISULFIDE-THIOL EXCHANGER 1; ENOX1
610915	OSTEOGENESIS IMPERFECTA, TYPE VIII; OI8
610916	NOP2/SUN RNA METHYLTRANSFERASE FAMILY, MEMBER 2; NSUN2
610917	RAS-ASSOCIATED PROTEIN 34; RAB34
610918	SELENOPROTEIN M; SELENOM
610919	GTP-BINDING PROTEIN 5; GTPBP5
610920	GTP-BINDING PROTEIN 10; GTPBP10
610921	SURFACTANT METABOLISM DYSFUNCTION, PULMONARY, 3; SMDP3
610922	NUCLEAR PORE ASSOCIATED PROTEIN 1; NPAP1
610923	SOLUTE CARRIER FAMILY 35 (UDP-XYLOSE/UDP-N-ACETYLGLUCOSAMINE TRANSPORTER), MEMBER B4; SLC35B4
610924	RANBP-TYPE AND C3HC4-TYPE ZINC FINGER-CONTAINING 1; RBCK1
610925	INTERLEUKIN 17 RECEPTOR C; IL17RC
610926	TOOTH AGENESIS, SELECTIVE, 5; STHAG5
610927	SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO, 9; SLEB9
610928	SRY-BOX 17; SOX17
610929	ORAI CALCIUM RELEASE-ACTIVATED CALCIUM MODULATOR 2; ORAI2
610930	ORAI CALCIUM RELEASE-ACTIVATED CALCIUM MODULATOR 3; ORAI3
610931	ZINC FINGER GENE IN AUTOIMMUNE THYROID DISEASE 1; ZFAT1
610932	TWINFILIN ACTIN-BINDING PROTEIN 1; TWF1
610933	LEUCINE-RICH REPEAT- AND STERILE ALPHA MOTIF-CONTAINING 1; LRSAM1
610934	NOBOX OOGENESIS HOMEOBOX; NOBOX
610935	ZINC-ACTIVATED ION CHANNEL; ZACN
610936	PHOSPHOSERINE AMINOTRANSFERASE 1; PSAT1
610937	RPGRIP1-LIKE; RPGRIP1L
610938	CORONARY HEART DISEASE, SUSCEPTIBILITY TO, 7; CHDS7
610939	MICRO RNA 192; MIR192
610940	MICRO RNA 194-1; MIR194-1
610941	MICRO RNA 194-2; MIR194-2
610942	MICRO RNA 204; MIR204
610943	MICRO RNA 215; MIR215
610944	MICRO RNA 216; MIR216
610945	MICRO RNA 296; MIR296
610946	MICRO RNA 133B; MIR133B
610947	CORONARY ARTERY DISEASE, AUTOSOMAL DOMINANT 2; ADCAD2
610948	HYPERTENSION, ESSENTIAL, SUSCEPTIBILITY TO, 7
610949	SYNAPTOTAGMIN 14; SYT14
610950	SYNAPTOTAGMIN 16; SYT16
610951	CEROID LIPOFUSCINOSIS, NEURONAL, 7; CLN7
610952	CROOKED NECK PRE-mRNA SPLICING FACTOR-LIKE 1; CRNKL1
610953	PIF1 5-PRIME-TO-3-PRIME DNA HELICASE; PIF1
610954	PITT-HOPKINS SYNDROME; PTHS
610955	TRAFFICKING PROTEIN PARTICLE COMPLEX, SUBUNIT 3; TRAPPC3
610956	ASPARTYL-tRNA SYNTHETASE 2; DARS2
610957	TYROSYL-tRNA SYNTHETASE 2; YARS2
610958	1-ACYLGLYCEROL-3-PHOSPHATE O-ACYLTRANSFERASE 9; AGPAT9
610959	MICRO RNA 376A1; MIR376A1
610960	MICRO RNA 376A2; MIR376A2
610961	MICRO RNA 376B; MIR376B
610962	SMG5 NONSENSE-MEDIATED mRNA DECAY FACTOR; SMG5
610963	SMG6 NONSENSE-MEDIATED mRNA DECAY FACTOR; SMG6
610964	SMG7 NONSENSE-MEDIATED mRNA DECAY FACTOR; SMG7
610965	XFE PROGEROID SYNDROME; XFEPS
610966	FTO ALPHA-KETOGLUTARATE-DEPENDENT DIOXYGENASE; FTO
610967	OSTEOGENESIS IMPERFECTA, TYPE V; OI5
610968	OSTEOGENESIS IMPERFECTA, TYPE XI; OI11
610969	TRAFFICKING PROTEIN PARTICLE COMPLEX, SUBUNIT 1; TRAPPC1
610970	TRAFFICKING PROTEIN PARTICLE COMPLEX 2-LIKE; TRAPPC2L
610971	TRAFFICKING PROTEIN PARTICLE COMPLEX, SUBUNIT 4; TRAPPC4
610972	ADHERENS JUNCTION-ASSOCIATED PROTEIN 1; AJAP1
610973	MEMBRANE PROTEIN, PALMITOYLATED 7; MPP7
610974	ZINC FINGER PROTEIN 521; ZNF521
610975	SKIN-, EMBRYO-, BRAIN-, AND OOCYTE-SPECIFIC HOMEOBOX
610976	APOLIPOPROTEIN B mRNA EDITING ENZYME, CATALYTIC POLYPEPTIDE-LIKE 3H; APOBEC3H
610977	TETRACYCLINE TRANSPORTER-LIKE PROTEIN
610978	CHOREOATHETOSIS AND CONGENITAL HYPOTHYROIDISM WITH OR WITHOUT PULMONARY DYSFUNCTION; CAHTP
610979	DIPHOSPHOINOSITOL PENTAKISPHOSPHATE KINASE 1; PPIP5K1
610980	KCNQ1 DOWNSTREAM NEIGHBOR; KCNQ1DN
610981	WWBP2 N-TERMINAL-LIKE PROTEIN; WBP2NL
610982	INVERTED FORMIN 2; INF2
610983	MICRO RNA 376C; MIR376C
610984	COMPLEMENT FACTOR I DEFICIENCY; CFID
610985	UBIQUITIN E2 VARIANT AND LACTATE/MALATE DEHYDROGENASE DOMAINS-CONTAINING PROTEIN; UEVLD
610986	LEUCINE-RICH REPEAT KINASE 1; LRRK1
610987	N-ACYLSPHINGOSINE AMIDOHYDROLASE 2B; ASAH2B
610988	LEPROSY, SUSCEPTIBILITY TO, 4; LPRS4
610989	LEMUR TYROSINE KINASE 2; LMTK2
610990	PROTEIN PHOSPHATASE 1 REGULATORY SUBUNIT 18; PPP1R18
610991	OBSCURIN-LIKE 1; OBSL1
610992	PHOSPHOSERINE AMINOTRANSFERASE DEFICIENCY; PSATD
610993	UBIQUITIN-SPECIFIC PROTEASE 44; USP44
610994	TRANSMEMBRANE PROTEIN 189; TMEM189
610995	PRENYLCYSTEINE OXIDASE 1; PCYOX1
610996	D-AMINOACYL-tRNA DEACYLASE 1; DTD1
610997	PROSTATE CANCER, HEREDITARY, 9; HPC9
610998	METEORIN; METRN
610999	ENHANCER OF POLYCOMB HOMOLOG 1; EPC1
611000	ENHANCER OF POLYCOMB HOMOLOG 2; EPC2
611001	MYST/ESA1-ASSOCIATED FACTOR 6; MEAF6
611002	TRANSMEMBRANE PROTEIN 204; TMEM204
611003	SMOKING AS A QUANTITATIVE TRAIT LOCUS 1; SQTL1
611004	SMOKING AS A QUANTITATIVE TRAIT LOCUS 2; SQTL2
611005	MEX3 RNA-BINDING FAMILY MEMBER C; MEX3C
611006	IRON-SULFUR CLUSTER ASSEMBLY 1; ISCA1
611007	MEX3 RNA-BINDING FAMILY MEMBER A; MEX3A
611008	MEX3 RNA-BINDING FAMILY MEMBER B; MEX3B
611009	MEX3 RNA-BINDING FAMILY MEMBER D; MEX3D
611010	FIBROMATOSIS, GINGIVAL, 4; GINGF4
611011	TRANSMEMBRANE PROTEIN 259; TMEM259
611012	REGULATOR OF G PROTEIN SIGNALING-LIKE 1; RGSL1
611013	REGULATOR OF G PROTEIN SIGNALING-LIKE 2; RGSL2
611014	HYPERTENSION, ESSENTIAL, SUSCEPTIBILITY TO, 8; HYT8
611015	AUTISM, SUSCEPTIBILITY TO, 9; AUTS9
611016	AUTISM, SUSCEPTIBILITY TO, 10; AUTS10
611017	TRYPSIN DOMAIN-CONTAINING PROTEIN 1; TYSND1
611018	POLYADENYLATE-BINDING PROTEIN-INTERACTING PROTEIN 2B; PAIP2B
611019	ATPase, H+ TRANSPORTING, LYSOSOMAL, 9-KD, V0 SUBUNIT E2; ATP6V0E2
611020	MICRO RNA 21; MIR21
611021	NMD3 RIBOSOME EXPORT ADAPTOR; NMD3
611022	DEAFNESS, AUTOSOMAL RECESSIVE 24; DFNB24
611023	tRNA METHYLTRANSFERASE 5; TRMT5
611024	ZINC FINGER PROTEIN 667; ZNF667
611025	ENKURIN, TRPC CHANNEL-INTERACTING PROTEIN; ENKUR
611026	FATTY ACID 2-HYDROXYLASE; FA2H
611027	SHC-BINDING AND SPINDLE-ASSOCIATED PROTEIN 1; SHCBP1
611028	TRANSMEMBRANE PROTEIN 30A; TMEM30A
611029	TRANSMEMBRANE PROTEIN 30B; TMEM30B
611030	TRANSMEMBRANE PROTEIN 30C; TMEM30C
611031	EPISODIC KINESIGENIC DYSKINESIA 2; EKD2
611032	SPERMATOGENESIS-ASSOCIATED PROTEIN 17; SPATA17
611033	CHROMOSOME 11 OPEN READING FRAME 21; C11ORF21
611034	SOLUTE CARRIER FAMILY 17 (ORGANIC ANION TRANSPORTER), MEMBER 3; SLC17A3
611035	APRATAXIN- AND PNKP-LIKE FACTOR; APLF
611036	SOLUTE CARRIER FAMILY 2 (FACILITATED GLUCOSE TRANSPORTER), MEMBER 13; SLC2A13
611037	SOLUTE CARRIER FAMILY 25 (MITOCHONDRIAL CARRIER, PHOSPHATE CARRIER), MEMBER 26; SLC25A26
611038	MICROPHTHALMIA, SYNDROMIC 16; MCOPS16
611039	SOLUTE CARRIER FAMILY 2 (FACILITATED GLUCOSE TRANSPORTER), MEMBER 14; SLC2A14
611040	MICROPHTHALMIA, ISOLATED 5; MCOP5
611041	TRIPARTITE MOTIF-CONTAINING PROTEIN 47; TRIM47
611042	LATE CORNIFIED ENVELOPE-LIKE PROLINE-RICH 1; LELP1
611043	LIN28 HOMOLOG A; LIN28A
611044	LIN28 HOMOLOG B; LIN28B
611045	GLUCOSE-6-PHOSPHATASE, CATALYTIC, 3; G6PC3
611046	MYCOBACTERIUM TUBERCULOSIS, SUSCEPTIBILITY TO, 2
611047	RETINOIC ACID EARLY TRANSCRIPT 1L; RAET1L
611048	PROTEIN PHOSPHATASE 1, REGULATORY SUBUNIT 15A; PPP1R15A
611049	SOLUTE CARRIER FAMILY 17, MEMBER 2; SLC17A2
611050	LEUCINE ZIPPER PROTEIN 6; LUZP6
611051	COILED-COIL DOMAIN-CONTAINING PROTEIN 50; CCDC50
611052	SET DOMAIN-CONTAINING PROTEIN 1A; SETD1A
611053	RUN DOMAIN AND SH3 DOMAIN-CONTAINING PROTEIN 2; RUSC2
611054	PTPRF-INTERACTING PROTEIN ALPHA-1; PPFIA1
611055	SET DOMAIN-CONTAINING PROTEIN 1B; SETD1B
611056	SELENOCYSTEINE LYASE; SCLY
611057	MOVED TO 603989
611058	PEROXISOME BIOGENESIS FACTOR 5-LIKE; PEX5L
611059	WD REPEAT-CONTAINING PROTEIN 82; WDR82
611060	SET-BINDING PROTEIN 1; SETBP1
611061	FAMILY WITH SEQUENCE SIMILARITY 20, MEMBER C; FAM20C
611062	FAMILY WITH SEQUENCE SIMILARITY 20, MEMBER A; FAM20A
611063	FAM20B GLYCOSAMINOGLYCAN XYLOSYLKINASE; FAM20B
611064	ASTHMA-RELATED TRAITS, SUSCEPTIBILITY TO, 5
611065	PROTEIN PHOSPHATASE, MAGNESIUM/MANGANESE-DEPENDENT, 1K; PPM1K
611066	PH DOMAIN AND LEUCINE-RICH REPEAT PROTEIN PHOSPHATASE-LIKE; PHLPPL
611067	NEURONOPATHY, DISTAL HEREDITARY MOTOR, AUTOSOMAL RECESSIVE 4; HMNR4
611068	SMALL NUCLEOLAR RNA, C/D BOX, 43; SNORD43
611069	RNA, U86 SMALL NUCLEOLAR
611070	SMALL NUCLEOLAR RNA, C/D BOX, 83A; SNORD83A
611071	SMALL NUCLEOLAR RNA, C/D BOX, 83B; SNORD83B
611072	DNAJ/HSP40 HOMOLOG, SUBFAMILY C, MEMBER 24; DNAJC24
611073	ALZHEIMER DISEASE 12
611074	BRAIN-SPECIFIC HOMEOBOX; BSX
611075	DIPHTHAMIDE BIOSYNTHESIS PROTEIN 5; DPH5
611076	5-PRIME-NUCLEOTIDASE DOMAIN-CONTAINING PROTEIN 3; NT5DC3
611077	COILED-COIL-HELIX-COILED-COIL-HELIX DOMAIN-CONTAINING PROTEIN 4; CHCHD4
611078	COBALAMIN SYNTHETASE W DOMAIN-CONTAINING PROTEIN 1; CBWD1
611079	COBALAMIN SYNTHETASE W DOMAIN-CONTAINING PROTEIN 2; CBWD2
611080	COBALAMIN SYNTHETASE W DOMAIN-CONTAINING PROTEIN 3; CBWD3
611081	INFLAMMATORY BOWEL DISEASE (CROHN DISEASE) 10; IBD10
611082	MIAT GENE; MIAT
611083	ALCOHOL DEHYDROGENASE, IRON-CONTAINING, 1; ADHFE1
611084	FORKHEAD BOX D4-LIKE 1; FOXD4L1
611085	FORKHEAD BOX D4-LIKE 4; FOXD4L4
611086	FORKHEAD BOX D4-LIKE 3; FOXD4L3
611087	POLYHYDRAMNIOS, MEGALENCEPHALY, AND SYMPTOMATIC EPILEPSY; PMSE
611088	COILED-COIL DOMAIN-CONTAINING PROTEIN 65; CCDC65
611089	MYOTUBULARIN-RELATED PROTEIN 14; MTMR14
611090	INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 12; MRT12
611091	INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 5; MRT5
611092	INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 6; MRT6
611093	INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 7; MRT7
611094	MOVED TO 614300
611095	INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 9; MRT9
611096	INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 10; MRT10
611097	INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 11; MRT11
611098	STEAP4 METALLOREDUCTASE; STEAP4
611099	PROTEIN DISULFIDE ISOMERASE, FAMILY A, MEMBER 6; PDIA6
611100	PROSTATE CANCER, HEREDITARY, 10; HPC10
611101	PLECKSTRIN HOMOLOGY DOMAIN- AND RhoGEF DOMAIN-CONTAINING PROTEIN G5; PLEKHG5
611102	DEAFNESS-INFERTILITY SYNDROME; DIS
611103	ACYL-CoA DEHYDROGENASE FAMILY, MEMBER 9; ACAD9
611104	FYVE, RhoGEF, AND PH DOMAIN-CONTAINING PROTEIN 4; FGD4
611105	LEUKOENCEPHALOPATHY WITH BRAINSTEM AND SPINAL CORD INVOLVEMENT AND LACTATE ELEVATION; LBSL
611106	ZINC FINGER CCCH DOMAIN-CONTAINING PROTEIN 12D; ZC3H12D
611107	INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 4; MRT4
611108	VON WILLEBRAND FACTOR C DOMAIN-CONTAINING PROTEIN 2; VWC2
611109	CINNAMON ODOR, PLEASANTNESS OF
611110	MAP3K7 C-TERMINAL-LIKE PROTEIN; MAP3K7CL
611111	DEVELOPMENTAL PLURIPOTENCY-ASSOCIATED GENE 5; DPPA5
611112	DAPPER, ANTAGONIST OF BETA-CATENIN, 3; DACT3
611113	CEMENTUM PROTEIN 1; CEMP1
611114	MICRO RNA 150; MIR150
611115	VON WILLEBRAND FACTOR C AND EGF DOMAIN-CONTAINING PROTEIN; VWCE
611116	MICRO RNA 208A; MIR208A
611117	PROTEIN PHOSPHATASE METHYLESTERASE 1; PPME1
611118	NUCLEAR PRELAMIN A RECOGNITION FACTOR-LIKE; NARFL
611119	KELCH-LIKE 7; KLHL7
611120	SERINE PALMITOYLTRANSFERASE, LONG-CHAIN BASE SUBUNIT 3; SPTLC3
611121	CALMIN; CLMN
611122	ANKYRIN REPEAT DOMAIN-CONTAINING PROTEIN 28; ANKRD28
611123	EPHRIN RECEPTOR EphA10; EPHA10
611124	MAJOR FACILITATOR SUPERFAMILY DOMAIN-CONTAINING PROTEIN 8; MFSD8
611125	DERMATAN SULFATE EPIMERASE-LIKE; DSEL
611126	MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 20; MC1DN20
611127	UBIQUITIN-LIKE 4B; UBL4B
611128	MAM DOMAIN-CONTAINING GLYCOSYLPHOSPHATIDYLINOSITOL ANCHOR 2; MDGA2
611129	WW DOMAIN-BINDING PROTEIN 1-LIKE; WBP1L
611130	CHARGED MULTIVESICULAR BODY PROTEIN 7; CHMP7
611131	RETINITIS PIGMENTOSA 37; RP37
611132	RIBOKINASE; RBKS
611133	SMALL NUCLEOLAR RNA, C/D BOX, 82; SNORD82
611134	MECKEL SYNDROME, TYPE 4; MKS4
611135	KLOTHO, BETA; KLB
611136	EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 13; EIG13
611137	PROTEASOME SUBUNIT, BETA-TYPE, 11; PSMB11
611138	SPERMATID PERINUCLEAR RNA-BINDING PROTEIN; STRBP
611139	CORONARY HEART DISEASE, SUSCEPTIBILITY TO, 8; CHDS8
611140	TELOMERE MAINTENANCE 2; TELO2
611141	MINDBOMB E3 UBIQUITIN PROTEIN LIGASE 2; MIB2
611142	CYTOSKELETON-ASSOCIATED PROTEIN 5; CKAP5
611143	ABRAXAS 1, BRCA1 A COMPLEX SUBUNIT; ABRAXAS1
611144	ABRAXAS 2, BRISC COMPLEX SUBUNIT; ABRAXAS2
611145	SOLUTE CARRIER FAMILY 30 (ZINC TRANSPORTER), MEMBER 8; SLC30A8
611146	SOLUTE CARRIER FAMILY 30 (ZINC TRANSPORTER), MEMBER 10; SLC30A10
611147	PAROXYSMAL NONKINESIGENIC DYSKINESIA 2; PNKD2
611148	SOLUTE CARRIER FAMILY 30 (ZINC TRANSPORTER), MEMBER 6; SLC30A6
611149	SOLUTE CARRIER FAMILY 30 (ZINC TRANSPORTER), MEMBER 7; SLC30A7
611150	ATAXIN 10; ATXN10
611151	tRNA METHYLTRANSFERASE 2 HOMOLOG A; TRMT2A
611152	ALZHEIMER DISEASE 13; AD13
611153	XPA, DNA DAMAGE RECOGNITION AND REPAIR FACTOR; XPA
611154	ALZHEIMER DISEASE 14; AD14
611155	MOVED TO 604154
611156	ENDOPLASMIC RETICULUM METALLOPEPTIDASE 1; ERMP1
611157	MRG/MORF4L-BINDING PROTEIN; MRGBP
611158	KERATIN 77, TYPE II; KRT77
611159	KERATIN 78, TYPE II; KRT78
611160	KERATIN 79, TYPE II; KRT79
611161	KERATIN 80, TYPE II; KRT80
611162	MALARIA, SUSCEPTIBILITY TO
611163	TOX HIGH MOBILITY GROUP BOX FAMILY MEMBER 2; TOX2
611164	ARGININE-FIFTY HOMEOBOX; ARGFX
611165	DIVERGENT-PAIRED RELATED HOMEOBOX; DPRX
611166	TETRAPEPTIDE REPEAT HOMEOBOX 1; TPRX1
611167	TETRAPEPTIDE REPEAT HOMEOBOX-LIKE; TPRXL
611168	DOUBLE HOMEOBOX A; DUXA
611169	CATION CHANNEL, SPERM-ASSOCIATED, AUXILIARY SUBUNIT BETA; CATSPERB
611170	STERILE ALPHA MOTIF DOMAIN-CONTAINING PROTEIN 9-LIKE; SAMD9L
611171	SHOOTIN1; SHTN1
611172	MICRO RNA 34A; MIR34A
611173	MICRO RNA 375; MIR375
611174	HAMAMY SYNDROME; HMMS
611175	OBG-LIKE ATPase 1; OLA1
611176	JNK/MAPK8-ASSOCIATED MEMBRANE PROTEIN; JKAMP
611177	INTRAFLAGELLAR TRANSPORT 80; IFT80
611178	GALANIN-LIKE PEPTIDE; GALP
611179	SHROOM FAMILY MEMBER 1; SHROOM1
611180	NEGATIVE ELONGATION FACTOR COMPLEX, MEMBER B; NELFB
611181	ACYL-CoA DEHYDROGENASE FAMILY, MEMBER 10; ACAD10
611182	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIh; CDG2H
611183	BRICK1, SCAR/WAVE ACTIN-NUCLEATING COMPLEX SUBUNIT; BRK1
611184	PIEZO-TYPE MECHANOSENSITIVE ION CHANNEL COMPONENT 1; PIEZO1
611185	RESTLESS LEGS SYNDROME, SUSCEPTIBILITY TO, 6; RLS6
611186	MICRO RNA 9-1; MIR9-1
611187	MICRO RNA 9-2; MIR9-2
611188	MICRO RNA 9-3; MIR9-3
611189	MICRO RNA 197; MIR197
611190	MICRO RNA 346; MIR346
611191	MICRO RNA 125A; MIR125A
611192	ANKYRIN REPEAT DOMAIN-CONTAINING PROTEIN 11; ANKRD11
611193	RIBOSOMAL RNA-PROCESSING 15 HOMOLOG; RRP15
611194	RUN AND FYVE DOMAINS-CONTAINING PROTEIN 3; RUFY3
611195	JANUS KINASE AND MICROTUBULE-INTERACTING PROTEIN 1; JAKMIP1
611196	ZINC FINGER MIZ-DOMAIN CONTAINING 2; ZMIZ2
611197	JANUS KINASE AND MICROTUBULE-INTERACTING PROTEIN 2; JAKMIP2
611198	JANUS KINASE AND MICROTUBULE-INTERACTING PROTEIN 3; JAKMIP3
611199	DNTT-INTERACTING PROTEIN 2; DNTTIP2
611200	TUDOR DOMAIN-CONTAINING PROTEIN 6; TDRD6
611201	KELCH-LIKE 9; KLHL9
611202	N-ACYLSPHINGOSINE AMIDOHYDROLASE 2; ASAH2
611203	DNAJ/HSP40 HOMOLOG, SUBFAMILY C, MEMBER 5; DNAJC5
611204	COILED-COIL DOMAIN-CONTAINING PROTEIN 88C; CCDC88C
611205	COILED-COIL DOMAIN-CONTAINING PROTEIN 88B; CCDC88B
611206	DNAJ/HSP40 HOMOLOG, SUBFAMILY C, MEMBER 9; DNAJC9
611207	DNAJ/HSP40 HOMOLOG, SUBFAMILY C, MEMBER 1; DNAJC1
611208	HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN L-LIKE; HNRNPLL
611209	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIg; CDG2G
611210	PDZ-BINDING KINASE; PBK
611211	RECEPTOR EXPRESSED IN LYMPHOID TISSUES; RELT
611212	RELT-LIKE 1; RELL1
611213	RELT-LIKE 2; RELL2
611214	TSR1 RIBOSOME MATURATION FACTOR; TSR1
611215	PRADER-WILLI REGION NONCODING RNA 1; PWRN1
611216	UBX DOMAIN PROTEIN 4; UBXN4
611217	PRADER-WILLI REGION NONCODING RNA 2; PWRN2
611218	GASDERMIN A; GSDMA
611219	UNC45 MYOSIN CHAPERONE A; UNC45A
611220	UNC45 MYOSIN CHAPERONE B; UNC45B
611221	GASDERMIN B; GSDMB
611222	MICROPHTHALMIA, SYNDROMIC 10; MCOPS10
611223	AKT SERINE/THREONINE KINASE 3; AKT3
611224	SUCCINATE-CoA LIGASE, ALPHA SUBUNIT; SUCLG1
611225	SPASTIC PARAPLEGIA 18B, AUTOSOMAL RECESSIVE; SPG18B
611226	ARMADILLO REPEAT-CONTAINING PROTEIN 3; ARMC3
611227	HYDROGEN VOLTAGE-GATED CHANNEL 1; HVCN1
611228	CHARCOT-MARIE-TOOTH DISEASE, TYPE 4J; CMT4J
611229	ENDOPLASMIC RETICULUM LECTIN 1; ERLEC1
611230	NON-SMC CONDENSIN II COMPLEX SUBUNIT H2; NCAPH2
611231	CLAUDIN 8; CLDN8
611232	CLAUDIN 12; CLDN12
611233	ARGININE-RICH PROTEIN MUTATED IN EARLY STAGE TUMORS-LIKE 1; ARMETL1
611234	FAMILY WITH SEQUENCE SIMILARITY 84, MEMBER A; FAM84A
611235	TRANSMEMBRANE PROTEIN 38A; TMEM38A
611236	TRANSMEMBRANE PROTEIN 38B; TMEM38B
611237	BTB/POZ DOMAIN-CONTAINING PROTEIN 9; BTBD9
611238	COILED-COIL-HELIX-COILED-COIL-HELIX DOMAIN-CONTAINING PROTEIN 7; CHCHD7
611239	GPRIN FAMILY, MEMBER 1; GPRIN1
611240	GPRIN FAMILY, MEMBER 2; GPRIN2
611241	GPRIN FAMILY, MEMBER 3; GPRIN3
611242	RESTLESS LEGS SYNDROME, SUSCEPTIBILITY TO, 5; RLS5
611243	tRNA YW-SYNTHESIZING PROTEIN 1 HOMOLOG; TYW1
611244	tRNA METHYLTRANSFERASE 12 HOMOLOG; TRMT12
611245	tRNA YW-SYNTHESIZING PROTEIN 3 HOMOLOG; TYW3
611246	LEUCINE CARBOXYL METHYLTRANSFERASE 2; LCMT2
611247	MAJOR AFFECTIVE DISORDER 4; MAFD4
611248	KELCH DOMAIN-CONTAINING PROTEIN 3; KLHDC3
611249	MICRO RNA LET7B; MIRLET7B
611250	MICRO RNA LET7E; MIRLET7E
611251	DISPATCHED RND TRANSPORTER FAMILY, MEMBER 3; DISP3
611252	SPASTIC PARAPLEGIA 32, AUTOSOMAL RECESSIVE; SPG32
611253	KINESIN FAMILY MEMBER 27; KIF27
611254	KINESIN FAMILY MEMBER 7; KIF7
611255	NADPH OXIDASE ACTIVATOR 1; NOXA1
611256	NADPH OXIDASE ORGANIZER 1; NOXO1
611257	TRANSMEMBRANE PROTEIN 132D; TMEM132D
611258	TUDOR DOMAIN-CONTAINING PROTEIN 7; TDRD7
611259	CDK5 REGULATORY SUBUNIT-ASSOCIATED PROTEIN 1-LIKE 1; CDKAL1
611260	THREONINE SYNTHASE-LIKE 1; THNSL1
611261	THREONINE SYNTHASE-LIKE 2; THNSL2
611262	DEOXYHYPUSINE HYDROXYLASE; DOHH
611263	SHORT-RIB THORACIC DYSPLASIA 2 WITH OR WITHOUT POLYDACTYLY; SRTD2
611264	CENTROMERIC PROTEIN W; CENPW
611265	PEROXISOMAL PROLIFERATOR-ACTIVATED RECEPTOR ALPHA-INTERACTING COFACTOR COMPLEX, 285-KD SUBUNIT
611266	POTE ANKYRIN DOMAIN FAMILY, MEMBER K, PSEUDOGENE; POTEKP
611267	OLFACTORY RECEPTOR, FAMILY 51, SUBFAMILY E, MEMBER 1; OR51E1
611268	OLFACTORY RECEPTOR, FAMILY 51, SUBFAMILY E, MEMBER 2; OR51E2
611269	NUCLEOLAR PROTEIN WITH MIF4G DOMAIN 1; NOM1
611270	NSF ATTACHMENT PROTEIN BETA; NAPB
611271	KINESIN FAMILY MEMBER 18A; KIF18A
611272	ZINC FINGER PROTEIN WITH KRAB AND SCAN DOMAINS 5; ZKSCAN5
611273	SKI FAMILY TRANSCRIPTIONAL COREPRESSOR 1; SKOR1
611274	GLAUCOMA 1, OPEN ANGLE, N; GLC1N
611275	BCL2/ADENOVIRUS E1B 19-KD PROTEIN-INTERACTING PROTEIN 2-LIKE; BNIPL
611276	GLAUCOMA 1, OPEN ANGLE, H; GLC1H
611277	MOVED TO 607681
611278	KINESIN FAMILY MEMBER 12; KIF12
611279	KINESIN FAMILY MEMBER 14; KIF14
611280	KELCH DOMAIN-CONTAINING PROTEIN 2; KLHDC2
611281	KELCH DOMAIN-CONTAINING PROTEIN 1; KLHDC1
611282	DYNAMIN-BINDING PROTEIN; DNMBP
611283	ISOBUTYRYL-CoA DEHYDROGENASE DEFICIENCY; IBDD
611284	DYSTONIA, FOCAL, TASK-SPECIFIC; FTSD
611285	POTASSIUM CHANNEL TETRAMERIZATION DOMAIN-CONTAINING PROTEIN 5; KCTD5
611286	RNA TERMINAL PHOSPHATE CYCLASE DOMAIN-CONTAINING PROTEIN 1; RTCD1
611287	CORNICHON FAMILY AMPA RECEPTOR AUXILIARY PROTEIN 1; CNIH1
611288	CORNICHON FAMILY AMPA RECEPTOR AUXILIARY PROTEIN 2; CNIH2
611289	LEUCINE-RICH ALPHA-2-GLYCOPROTEIN 1; LRG1
611290	NONHOMOLOGOUS END-JOINING FACTOR 1; NHEJ1
611291	SEVERE COMBINED IMMUNODEFICIENCY WITH MICROCEPHALY, GROWTH RETARDATION, AND SENSITIVITY TO IONIZING RADIATION
611292	CLAVESIN 1; CLVS1
611293	COILED-COIL DOMAIN-CONTAINING PROTEIN 86; CCDC86
611294	ONE CUT HOMEOBOX 3; ONECUT3
611295	KELCH-LIKE 24; KLHL24
611296	ANNEXIN A2 RECEPTOR; ANXA2R
611297	ODD-SKIPPED-RELATED TRANSCRIPTION FACTOR 2; OSR2
611298	ENDOSOME-LYSOSOME-ASSOCIATED APOPTOSIS AND AUTOPHAGY REGULATOR 1; ELAPOR1
611299	G2/M PHASE-SPECIFIC E3 UBIQUITIN LIGASE; G2E3
611300	La RIBONUCLEOPROTEIN 6, TRANSLATIONAL REGULATOR; LARP6
611301	FANCONI ANEMIA-ASSOCIATED PROTEIN, 100-KD SUBUNIT; FAAP100
611302	SPASTIC ATAXIA 2, AUTOSOMAL RECESSIVE; SPAX2
611303	C-TYPE LECTIN DOMAIN FAMILY 16, MEMBER A; CLEC16A
611304	TRANSMEMBRANE PROTEIN 159; TMEM159
611305	ACTIN-BINDING LIM PROTEIN FAMILY, MEMBER 3; ABLIM3
611306	SCAVENGER RECEPTOR CLASS A, MEMBER 5; SCARA5
611307	MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 12; LGMDR12
611308	PERSISTENT HYPERPLASTIC PRIMARY VITREOUS, AUTOSOMAL DOMINANT; PHPVAD
611309	DEPP1 AUTOPHAGY REGULATOR; DEPP1
611310	PHOSPHOSERYL-tRNA KINASE; PSTK
611311	MOVED TO 221900
611312	CORNULIN; CRNN
611313	ARMS2 GENE; ARMS2
611314	HIGH MOBILITY GROUP NUCLEOSOMAL BINDING PROTEIN 2 PSEUDOGENE 46; HMGN2P46
611315	ZINC FINGER- AND SCAN DOMAIN-CONTAINING PROTEIN 20; ZSCAN20
611316	SOLUTE CARRIER FAMILY 12 (SODIUM/POTASSIUM/CHLORIDE TRANSPORTER), MEMBER 8; SLC12A8
611317	PHOSPHATIDYLINOSITOL 3-KINASE, REGULATORY SUBUNIT 5; PIK3R5
611318	MEDIATOR COMPLEX SUBUNIT 12-LIKE; MED12L
611319	INTERFERON-ALPHA-INDUCIBLE PROTEIN 27-LIKE 2; IFI27L2
611320	INTERFERON-ALPHA-INDUCIBLE PROTEIN 27-LIKE 1; IFI27L1
611321	CALSYNTENIN 1; CLSTN1
611322	DNAJ/HSP40 HOMOLOG, SUBFAMILY A, MEMBER 2; DNAJA2
611323	CALSYNTENIN 2; CLSTN2
611324	CALSYNTENIN 3; CLSTN3
611325	TRANSFORMING GROWTH FACTOR-BETA REGULATOR 4; TBRG4
611326	CELL CYCLE PROGRESSION 1; CCPG1
611327	DNAJ/HSP40 HOMOLOG, SUBFAMILY B, MEMBER 4; DNAJB4
611328	DNAJ/HSP40 HOMOLOG, SUBFAMILY B, MEMBER 5; DNAJB5
611329	SMALL CAJAL BODY-SPECIFIC RNA 18; SCARNA18
611330	SMALL NUCLEOLAR RNA, H/ACA BOX, 12; SNORA12
611331	SMALL NUCLEOLAR RNA, H/ACA BOX, 74B; SNORA74B
611332	DNAJ/HSP40 HOMOLOG, SUBFAMILY B, MEMBER 6; DNAJB6
611333	SMALL NUCLEOLAR RNA, H/ACA BOX, 3B; SNORA3B
611334	SMALL NUCLEOLAR RNA, H/ACA BOX, 81; SNORA81
611335	SMALL NUCLEOLAR RNA, H/ACA BOX, 5C; SNORA5C
611336	DNAJ/HSP40 HOMOLOG, SUBFAMILY B, MEMBER 7; DNAJB7
611337	DNAJ/HSP40 HOMOLOG, SUBFAMILY B, MEMBER 8; DNAJB8
611338	AUTOPHAGY-RELATED 4B CYSTEINE PEPTIDASE; ATG4B
611339	AUTOPHAGY-RELATED 4C CYSTEINE PEPTIDASE; ATG4C
611340	AUTOPHAGY-RELATED 4D CYSTEINE PEPTIDASE; ATG4D
611341	DNAJ/HSP40 HOMOLOG, SUBFAMILY B, MEMBER 11; DNAJB11
611342	CHROMOSOME 9 OPEN READING FRAME 64; C9ORF64
611343	IDNK GLUCONOKINASE; IDNK
611344	RAS AND EF-HAND DOMAINS-CONTAINING PROTEIN; RASEF
611345	INTEGRATOR COMPLEX SUBUNIT 1; INTS1
611346	INTEGRATOR COMPLEX SUBUNIT 2; INTS2
611347	INTEGRATOR COMPLEX SUBUNIT 3; INTS3
611348	INTEGRATOR COMPLEX SUBUNIT 4; INTS4
611349	INTEGRATOR COMPLEX SUBUNIT 5; INTS5
611350	INTEGRATOR COMPLEX SUBUNIT 7; INTS7
611351	INTEGRATOR COMPLEX SUBUNIT 8; INTS8
611352	INTEGRATOR COMPLEX SUBUNIT 9; INTS9
611353	INTEGRATOR COMPLEX SUBUNIT 10; INTS10
611354	INTEGRATOR COMPLEX SUBUNIT 11; INTS11
611355	INTEGRATOR COMPLEX SUBUNIT 12; INTS12
611356	G KINASE-ANCHORING PROTEIN 1; GKAP1
611357	TERMINAL NUCLEOTIDYLTRANSFERASE 5A; TENT5A
611358	RING FINGER PROTEIN 135; RNF135
611359	ACTIVATING MOLECULE IN BECLIN 1-REGULATED AUTOPHAGY; AMBRA1
611360	FANCI GENE; FANCI
611361	UBIQUITIN-LIKE MODIFIER-ACTIVATING ENZYME 6; UBA6
611362	UBIQUITIN-CONJUGATING ENZYME E2 Z; UBE2Z
611363	ATRIAL SEPTAL DEFECT 4; ASD4
611364	MYOCLONIC EPILEPSY, JUVENILE, SUSCEPTIBILITY TO, 4; EJM4
611365	TRANSMEMBRANE PROTEIN 183B; TMEM183B
611366	MYG1 EXONUCLEASE; MYG1
611367	ASPARTYL AMINOPEPTIDASE; DNPEP
611368	MAELSTROM SPERMATOGENIC TRANSPOSON SILENCER; MAEL
611369	LETHAL CONGENITAL CONTRACTURE SYNDROME 3; LCCS3
611370	FGGY CARBOHYDRATE KINASE DOMAIN-CONTAINING PROTEIN; FGGY
611371	ZINC FINGER PROTEIN 653; ZNF653
611372	SMALL ADP-RIBOSYLATION FACTOR GTPase-ACTIVATING PROTEIN 1; SMAP1
611373	LIVER-EXPRESSED ANTIMICROBIAL PEPTIDE 2; LEAP2
611374	MICRO RNA 34B; MIR34B
611375	MICRO RNA 34C; MIR34C
611376	MUNGAN SYNDROME; MGS
611377	BRACHYDACTYLY, TYPE B2; BDB2
611378	MACULAR DEGENERATION, AGE-RELATED, 9; ARMD9
611379	DISCO-INTERACTING PROTEIN 2 HOMOLOG B; DIP2B
611380	DISCO-INTERACTING PROTEIN 2 HOMOLOG C; DIP2C
611381	KALA-AZAR, SUSCEPTIBILITY TO, 2; KAZA2
611382	KALA-AZAR, SUSCEPTIBILITY TO, 3; KAZA3
611383	USHER SYNDROME, TYPE IID; USH2D
611384	PLASMODIUM FALCIPARUM FEVER EPISODES QUANTITATIVE TRAIT LOCUS 1
611385	MOVED TO 176846
611386	ACTIVITY-DEPENDENT NEUROPROTECTOR HOMEOBOX; ADNP
611387	CXC CHEMOKINE LIGAND 17; CXCL17
611388	DEOXYNUCLEOTIDYLTRANSFERASE, TERMINAL, INTERACTING PROTEIN 1; DNTTIP1
611389	PRICKLE PLANAR CELL POLARITY PROTEIN 4; PRICKLE4
611390	SPASTIC ATAXIA 3, AUTOSOMAL RECESSIVE; SPAX3
611391	CATARACT 33, MULTIPLE TYPES; CTRCT33
611392	2-AMINOETHANETHIOL DIOXYGENASE; ADO
611393	FAMILY WITH SEQUENCE SIMILARITY 110, MEMBER A; FAM110A
611394	FAMILY WITH SEQUENCE SIMILARITY 110, MEMBER B; FAM110B
611395	FAMILY WITH SEQUENCE SIMILARITY 110, MEMBER C; FAM110C
611396	ADIPOGENIN; ADIG
611397	TETRATRICOPEPTIDE REPEAT-, ANKYRIN REPEAT-, AND COILED-COIL-CONTAINING PROTEIN 1; TANC1
611398	GROWTH ARREST-SPECIFIC 2-LIKE 2; GAS2L2
611399	SODIUM CHANNEL AND CLATHRIN LINKER 1; SCLT1
611400	HOX TRANSCRIPT ANTISENSE RNA, NONCODING; HOTAIR
611401	CHROMOSOME 6 OPEN READING FRAME 15; C6ORF15
611402	DOCKING PROTEIN 6; DOK6
611403	ASTHMA-RELATED TRAITS, SUSCEPTIBILITY TO, 6
611404	LYMPHOCYTE ANTIGEN 6 FAMILY, MEMBER G6F; LY6G6F
611405	RNA TERMINAL PHOSPHATE CYCLASE-LIKE 1; RCL1
611406	DYNEIN, CYTOPLASMIC 1, LIGHT INTERMEDIATE CHAIN 2; DYNC1LI2
611407	CARDIOMYOPATHY, DILATED, 1W; CMD1W
611408	LEBERILIN LCA5; LCA5
611409	OCA2 MELANOSOMAL TRANSMEMBRANE PROTEIN; OCA2
611410	RHO FAMILY-INTERACTING CELL POLARIZATION REGULATOR 2; RIPOR2
611411	CALCIUM/CALMODULIN-DEPENDENT PROTEIN KINASE KINASE 1, ALPHA; CAMKK1
611412	N-ACETYLNEURAMINATE PYRUVATE LYASE; NPL
611413	DISCS LARGE-ASSOCIATED PROTEIN 3; DLGAP3
611414	CALRETICULIN 3; CALR3
611415	POLYMERASE (DNA-DIRECTED), DELTA 3, ACCESSORY SUBUNIT; POLD3
611416	TOX HIGH MOBILITY GROUP BOX FAMILY MEMBER 3; TOX3
611417	SMALL G PROTEIN SIGNALING MODULATOR 1; SGSM1
611418	SMALL G PROTEIN SIGNALING MODULATOR 2; SGSM2
611419	SMALL INTEGRAL MEMBRANE PROTEIN 29; SMIM29
611420	CDKN1A-INTERACTING ZINC FINGER PROTEIN 1; CIZ1
611421	SNF2-RELATED CBP ACTIVATOR PROTEIN; SRCAP
611422	MEIOTIC NUCLEAR DIVISIONS 1; MND1
611423	CENTROSOMAL PROTEIN, 135-KD; CEP135
611424	ZINC FINGER MYND DOMAIN-CONTAINING PROTEIN 19; ZMYND19
611425	CENTROBIN, CENTRIOLE DUPLICATION AND SPINDLE ASSEMBLY PROTEIN; CNTROB
611426	TENTED EYEBROWS
611427	METHYLENETETRAHYDROFOLATE DEHYDROGENASE 1-LIKE, NADP(+)-DEPENDENT; MTHFD1L
611428	DOWNSTREAM NEIGHBOR OF SON; DONSON
611429	APRG1 TUMOR SUPPRESSOR CANDIDATE; APRG1
611430	TETRATRICOPEPTIDE REPEAT DOMAIN-CONTAINING PROTEIN 21A; TTC21A
611431	LEGIUS SYNDROME; LGSS
611432	DEDICATOR OF CYTOKINESIS 8; DOCK8
611433	SERINE/THREONINE/TYROSINE KINASE 1; STYK1
611434	CYTOKINE-DEPENDENT HEMATOPOIETIC CELL LINKER; CLNK
611435	DOCKING PROTEIN 3; DOK3
611436	CARBONIC ANHYDRASE XIII; CA13
611437	DUAL-SPECIFICITY PHOSPHATASE 19; DUSP19
611438	TAXILIN, BETA; TXLNB
611439	ZINC FINGER- AND BTB DOMAIN-CONTAINING PROTEIN 22; ZBTB22
611440	WD REPEAT-CONTAINING PROTEIN 46; WDR46
611441	DOUBLE HOMEOBOX PROTEIN 1; DUX1
611442	DOUBLE HOMEOBOX PROTEIN 2; DUX2
611443	DOUBLE HOMEOBOX PROTEIN 3; DUX3
611444	DOUBLE HOMEOBOX PROTEIN 5; DUX5
611445	DYNAMIN 3; DNM3
611446	DUAL-SPECIFICITY PHOSPHATASE 18; DUSP18
611447	Y BOX-BINDING PROTEIN 2; YBX2
611448	BMS1 RIBOSOME BIOGENESIS FACTOR; BMS1
611449	EXPORTIN 4; XPO4
611450	PXK DOMAIN-CONTAINING SERINE/THREONINE KINASE; PXK
611451	DEAFNESS, AUTOSOMAL RECESSIVE 63; DFNB63
611452	MOVED TO 278150
611453	DYSBINDIN DOMAIN-CONTAINING PROTEIN 2; DBNDD2
611454	MOVED TO 105550
611455	KINOCILIN; KNCN
611456	TREMOR, HEREDITARY ESSENTIAL, 3; ETM3
611457	FORKHEAD BOX O6; FOXO6
611458	GALACTOSIDASE, BETA-1; GLB1
611459	SOLUTE CARRIER FAMILY 10 (SODIUM/BILE ACID COTRANSPORTER FAMILY), MEMBER 7; SLC10A7
611460	TUMOR PROTEIN p63-REGULATED PROTEIN 1-LIKE; TPRG1L
611461	SOLUTE CARRIER FAMILY 22 (ORGANIC CATION TRANSPORTER), MEMBER 17; SLC22A17
611462	PHOSPHATIDYLINOSITOL 3-KINASE, REGULATORY SUBUNIT 6; PIK3R6
611463	SPERMIDINE/SPERMINE N(1)-ACETYLTRANSFERASE 2; SAT2
611464	MON1 HOMOLOG A, SECRETORY TRAFFICKING-ASSOCIATED; MON1A
611465	GALLBLADDER DISEASE 4; GBD4
611466	PLECKSTRIN HOMOLOGY DOMAIN-CONTAINING PROTEIN, FAMILY M, MEMBER 1; PLEKHM1
611467	GUANYLATE-BINDING PROTEIN 5: GBP5
611468	BDNF ANTISENSE RNA; BDNFAS
611469	COLORECTAL CANCER, SUSCEPTIBILITY TO, 2; CRCS2
611470	GLUTAMATE-AMMONIA LIGASE (GLUTAMINE SYNTHETASE) DOMAIN-CONTAINING 1; GLULD1
611471	ACID PHOSPHATASE 6, LYSOPHOSPHATIDE; ACP6
611472	METHYL-CpG-BINDING DOMAIN PROTEIN 5; MBD5
611473	EMBRYONIC STEM CELL-RELATED PROTEIN; ESRG
611474	PHOSPHOLIPASE A AND ACYLTRANSFERASE 5; PLAAT5
611475	RNA POLYMERASE II-ASSOCIATED PROTEIN 1; RPAP1
611476	RNA POLYMERASE II-ASSOCIATED PROTEIN 2; RPAP2
611477	RNA POLYMERASE II-ASSOCIATED PROTEIN 3; RPAP3
611478	METHYLPHOSPHATE CAPPING ENZYME; MEPCE
611479	XPA-BINDING PROTEIN 1; XAB1
611480	PIH1 DOMAIN-CONTAINING PROTEIN 1; PIH1D1
611481	UFM1-SPECIFIC PEPTIDASE 1; UFSP1
611482	UFM1-SPECIFIC PEPTIDASE 2; UFSP2
611483	YIP1 DOMAIN FAMILY, MEMBER 5; YIPF5
611484	YIP1-INTERACTING FACTOR HOMOLOG A, MEMBRANE-TRAFFICKING PROTEIN; YIF1A
611485	CYTOCHROME P450, FAMILY 4, SUBFAMILY F, POLYPEPTIDE 12; CYP4F12
611486	SYNAPTONEMAL COMPLEX CENTRAL ELEMENT PROTEIN 1; SYCE1
611487	SYNAPTONEMAL COMPLEX CENTRAL ELEMENT PROTEIN 2; SYCE2
611488	MACULAR DEGENERATION, AGE-RELATED, 10; ARMD10
611489	CORTICOSTEROID-BINDING GLOBULIN DEFICIENCY
611490	OSTEOPETROSIS,  AUTOSOMAL RECESSIVE 4; OPTB4
611491	RAS ASSOCIATION AND DILUTE DOMAINS PROTEIN; RADIL
611492	CARBONIC ANHYDRASE II; CA2
611493	ATRIAL FIBRILLATION, FAMILIAL, 4; ATFB4
611494	ATRIAL FIBRILLATION, FAMILIAL, 5; ATFB5
611495	CYTOCHROME P450, FAMILY 4, SUBFAMILY F, POLYPEPTIDE 22; CYP4F22
611496	GATA-BINDING PROTEIN 5; GATA5
611497	OSTEOPETROSIS, AUTOSOMAL RECESSIVE 6; OPTB6
611498	NEPHRONOPHTHISIS 7; NPHP7
611499	BETA-GLUCURONIDASE; GUSB
611500	MICRO RNA 219-1; MIR219-1
611501	CALMODULIN-BINDING TRANSCRIPTION ACTIVATOR 1; CAMTA1
611502	CENTROMERIC PROTEIN K; CENPK
611503	CENTROMERIC PROTEIN L; CENPL
611504	CENTROMERIC PROTEIN O; CENPO
611505	CENTROMERIC PROTEIN P; CENPP
611506	CENTROMERIC PROTEIN Q; CENPQ
611507	CDGSH IRON SULFUR DOMAIN PROTEIN 2; CISD2
611508	CALMODULIN-BINDING TRANSCRIPTION ACTIVATOR 2; CAMTA2
611509	CENTROMERIC PROTEIN N; CENPN
611510	CENTROMERIC PROTEIN T; CENPT
611511	MLF1-INTERACTING PROTEIN; MLF1IP
611512	LYSINE DEMETHYLASE 3A; KDM3A
611513	NEUROGENIC DIFFERENTIATION 6; NEUROD6
611514	WNT LIGAND SECRETION MEDIATOR; WLS
611515	FEBRILE SEIZURES, FAMILIAL, 7; FEB7
611516	NICOLIN 1; NICN1
611517	CYTOCHROME P450, FAMILY 4, SUBFAMILY F, POLYPEPTIDE 11; CYP4F11
611518	DEDICATOR OF CYTOKINESIS 10; DOCK10
611519	POLYMERASE DELTA-INTERACTING PROTEIN 2; POLDIP2
611520	POLYMERASE DELTA-INTERACTING PROTEIN 3; POLDIP3
611521	IMMUNODEFICIENCY 35; IMD35
611522	INTRAOCULAR PRESSURE QUANTITATIVE TRAIT LOCUS; IOPQTL
611523	PONTOCEREBELLAR HYPOPLASIA, TYPE 6; PCH6
611524	ARGINYL-tRNA SYNTHETASE 2; RARS2
611525	POLYMERASE (DNA-DIRECTED), DELTA 4; POLD4
611526	NOP14 NUCLEOLAR PROTEIN; NOP14
611527	Na+/H+ EXCHANGER DOMAIN-CONTAINING PROTEIN 1; NHEDC1
611528	ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA, FAMILIAL, 12; ARVD12
611529	CYTOCHROME P450, FAMILY 2, SUBFAMILY S, POLYPEPTIDE 1; CYP2S1
611530	NEUROLYSIN; NLN
611531	EMG1 N1-SPECIFIC PSEUDOURIDINE METHYLTRANSFERASE; EMG1
611532	NUCLEOLAR PROTEIN 6; NOL6
611533	NUCLEOLAR PROTEIN 7; NOL7
611534	NUCLEOLAR PROTEIN 8; NOL8
611535	MAJOR AFFECTIVE DISORDER 5; MAFD5
611536	MAJOR AFFECTIVE DISORDER 6; MAFD6
611537	CATENIN, BETA-LIKE, 1; CTNNBL1
611538	OLFACTORY RECEPTOR, FAMILY 7, SUBFAMILY D, MEMBER 4; OR7D4
611539	FORKHEAD BOX D3; FOXD3
611540	SH3-DOMAIN GRB2-LIKE (ENDOPHILIN)-INTERACTING PROTEIN 1; SGIP1
611541	SORTING NEXIN 27; SNX27
611542	ARYLSULFATASE B; ARSB
611543	CAVITARY OPTIC DISC ANOMALIES; CODA
611544	CATARACT 17, MULTIPLE TYPES; CTRCT17
611545	CYTOCHROME P450, FAMILY 4, SUBFAMILY F, POLYPEPTIDE 8; CYP4F8
611546	ELONGATION OF VERY LONG CHAIN FATTY ACIDS-LIKE 6; ELOVL6
611547	STATURE QUANTITATIVE TRAIT LOCUS 9; STQTL9
611548	PREMATURE OVARIAN FAILURE 5; POF5
611549	SODIUM LEAK CHANNEL, NONSELECTIVE; NALCN
611550	NATURAL CYTOTOXICITY TRIGGERING RECEPTOR 3; NCR3
611551	FIBULIN 7; FBLN7
611552	NICOTINATE PHOSPHORIBOSYLTRANSFERASE; NAPRT
611553	NOONAN SYNDROME 5; NS5
611554	LEOPARD SYNDROME 2; LPRD2
611555	RENAL TUBULAR ACIDOSIS, DISTAL, WITH NEPHROCALCINOSIS, SHORT STATURE, IMPAIRED INTELLECTUAL DEVELOPMENT, AND DISTINCTIVE FACIES
611556	GLYCOGEN STORAGE DISEASE 0, MUSCLE; GSD0B
611557	UROPLAKIN 1A; UPK1A
611558	UROPLAKIN 2; UPK2
611559	UROPLAKIN 3A; UPK3A
611560	JOUBERT SYNDROME 7; JBTS7
611561	MECKEL SYNDROME, TYPE 5; MKS5
611562	SEPTIN 12; SEPT12
611563	SEPTIN 13; SEPT13
611564	BTG3-ASSOCIATED NUCLEAR PROTEIN; BANP
611565	BRIDGE-LIKE LIPID TRANSFER PROTEIN FAMILY, MEMBER 1; BLTP1
611566	PHOSPHORIBOSYLPYROPHOSPHATE SYNTHETASE 1-LIKE 1; PRPS1L1
611567	MONO-ADP RIBOSYLHYDROLASE 2; MACROD2
611568	SYNTABULIN; SYBU
611569	CYTOSKELETON-ASSOCIATED PROTEIN 2; CKAP2
611570	FRUCTOSE-1,6-BISPHOSPHATASE 1; FBP1
611571	OTOSCLEROSIS 4; OTSC4
611572	OTOSCLEROSIS 7; OTSC7
611573	SPHINGOMYELIN SYNTHASE 1; SGMS1
611574	SPHINGOMYELIN SYNTHASE 2; SGMS2
611575	STERILE ALPHA MOTIF DOMAIN-CONTAINING PROTEIN 8; SAMD8
611576	MICRO RNA 10B; MIR10B
611577	LYSINE DEMETHYLASE 6B; KDM6B
611578	FERRIC CHELATE REDUCTASE 1; FRRS1
611579	TRANSMEMBRANE PROTEIN 114; TMEM114
611580	EPIDIDYMAL PROTEIN 3A; EDDM3A
611581	MOVED TO 601067
611582	FAMILY WITH SEQUENCE SIMILARITY 12, MEMBER B; FAM12B
611583	AT-RICH INTERACTION DOMAIN-CONTAINING PROTEIN 5A; ARID5A
611584	WAARDENBURG SYNDROME, TYPE 2E; WS2E
611585	TESCALCIN; TESC
611586	COMPLEMENT COMPONENT 1, q SUBCOMPONENT-LIKE 1; C1QL1
611587	RHO GTPase-ACTIVATING PROTEIN 19; ARHGAP19
611588	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 4; MDDGC4
611589	PATATIN-LIKE PHOSPHOLIPASE DOMAIN-CONTAINING PROTEIN 5; PNPLA5
611590	RENAL TUBULAR ACIDOSIS, DISTAL, 4, WITH HEMOLYTIC ANEMIA; DRTA4
611591	PRO-PLATELET BASIC PROTEIN PSEUDOGENE 2; PPBPP2
611592	PHENYLALANYL-tRNA SYNTHETASE 2, MITOCHONDRIAL; FARS2
611593	SUBMAXILLARY GLAND ANDROGEN-REGULATED PROTEIN 3B; SMR3B
611594	UBIQUITIN-SPECIFIC PROTEASE 39; USP39
611595	THIOREDOXIN-LIKE 4A; TXNL4A
611596	SHORT-CHAIN DEHYDROGENASE/REDUCTASE FAMILY, MEMBER 4; DHRS4
611597	CATARACT 12, MULTIPLE TYPES; CTRCT12
611598	CELIAC DISEASE, SUSCEPTIBILITY TO, 6; CELIAC6
611599	MICRO RNA 206; MIR206
611600	PROTEIN REGULATING SYNAPTIC MEMBRANE EXOCYTOSIS 3; RIMS3
611601	PROTEIN REGULATING SYNAPTIC MEMBRANE EXOCYTOSIS 4; RIMS4
611602	RIMS-BINDING PROTEIN 2; RIMBP2
611603	LISSENCEPHALY 3; LIS3
611604	ENDOPLASMIC RETICULUM LIPID RAFT-ASSOCIATED PROTEIN 1; ERLIN1
611605	ENDOPLASMIC RETICULUM LIPID RAFT-ASSOCIATED PROTEIN 2; ERLIN2
611606	MICRO RNA 96; MIR96
611607	MICRO RNA 182; MIR182
611608	MICRO RNA 183; MIR183
611609	SIPA1-LIKE PROTEIN 2; SIPA1L2
611610	PHOSPHOGLUCOMUTASE 2-LIKE 1; PGM2L1
611611	S-PHASE CYCLIN A-ASSOCIATED PROTEIN IN THE ENDOPLASMIC RETICULUM; SCAPER
611612	THIAMINE TRIPHOSPHATASE; THTPA
611613	PROTEIN O-GLUCOSYLTRANSFERASE 2; POGLUT2
611614	UTP3 SMALL SUBUNIT PROCESSOME COMPONENT; UTP3
611615	CARDIOMYOPATHY, DILATED, 1X; CMD1X
611616	NAD KINASE; NADK
611617	EF-HAND DOMAIN FAMILY, MEMBER D1; EFHD1
611618	MOVED TO 248370
611619	MICRO RNA 877; MIR877
611620	MICRO RNA 1224; MIR1224
611621	MICRO RNA 1225; MIR1225
611622	IQ MOTIF-CONTAINING PROTEIN J; IQCJ
611623	NECAP ENDOCYTOSIS-ASSOCIATED PROTEIN 1; NECAP1
611624	NECAP ENDOCYTOSIS-ASSOCIATED PROTEIN 2; NECAP2
611625	GID COMPLEX, SUBUNIT 8; GID8
611626	M-PHASE PHOSPHOPROTEIN 8; MPHOSPH8
611627	TLC DOMAIN-CONTAINING PROTEIN 3A; TLCD3A
611628	NEURON NAVIGATOR 1; NAV1
611629	NEURON NAVIGATOR 3; NAV3
611630	EPILEPSY, FAMILIAL TEMPORAL LOBE, 3; ETL3
611631	EPILEPSY, FAMILIAL TEMPORAL LOBE, 4; ETL4
611632	UbiA PRENYLTRANSFERASE DOMAIN-CONTAINING PROTEIN 1; UBIAD1
611633	RTF1 HOMOLOG, PAF1/RNA POLYMERASE II COMPLEX COMPONENT; RTF1
611634	FEBRILE SEIZURES, FAMILIAL, 9; FEB9
611635	NEUROGENIC DIFFERENTIATION 4; NEUROD4
611636	N-ACETYLATED ALPHA-LINKED ACIDIC DIPEPTIDASE 2; NAALAD2
611637	PRIMARY LATERAL SCLEROSIS, ADULT, 1; PLSA1
611638	MICROPHTHALMIA/COLOBOMA 5; MCOPCB5
611639	ZINC FINGER GATA-LIKE PROTEIN 1; ZGLP1
611640	FIBRONECTIN TYPE III AND ANKYRIN REPEAT DOMAINS 1; FANK1
611641	CANCER SUSCEPTIBILITY GENE HEPN1; HEPN1
611642	HEPATOCYTE CELL ADHESION MOLECULE; HEPACAM
611643	ZINC FINGER PROTEIN WITH KRAB AND SCAN DOMAINS 4; ZKSCAN4
611644	HIRSCHSPRUNG DISEASE, SUSCEPTIBILITY TO, 9; HSCR9
611645	CXXC FINGER PROTEIN 4; CXXC4
611646	SPHK1-INTERACTING PROTEIN; SPHKAP
611647	ARV1 HOMOLOG, FATTY ACID HOMEOSTASIS MODULATOR; ARV1
611648	DIPHOSPHOINOSITOL PENTAKISPHOSPHATE KINASE 2; PPIP5K2
611649	MINDY LYSINE-48 DEUBIQUITINASE 3; MINDY3
611650	PERIPAPILLARY ATROPHY, BETA TYPE; PPAB
611651	PHOSPHOLIPASE A2, GROUP III; PLA2G3
611652	PHOSPHOLIPASE A2, GROUP XIIA; PLA2G12A
611653	PHOSPHOLIPASE A2, GROUP XIIB; PLA2G12B
611654	CENTROSOME SPINDLE POLE-ASSOCIATED PROTEIN 1; CSPP1
611655	POST-GPI ATTACHMENT TO PROTEINS 1; PGAP1
611656	SUPPRESSOR OF IKBKE 1; SIKE1
611657	SPRY DOMAIN- AND SOCS BOX-CONTAINING 1; SPSB1
611658	SPRY DOMAIN- AND SOCS BOX-CONTAINING 2; SPSB2
611659	SPRY DOMAIN- AND SOCS BOX-CONTAINING 3; SPSB3
611660	SPRY DOMAIN- AND SOCS BOX-CONTAINING 4; SPSB4
611661	DBF4 ZINC FINGER B; DBF4B
611662	EOSINOPHIL GRANULE ONTOGENY TRANSCRIPT, NONCODING; EGOT
611663	TBC1 DOMAIN FAMILY, MEMBER 20; TBC1D20
611664	SKIN/HAIR/EYE PIGMENTATION, VARIATION IN, 7; SHEP7
611665	DEAD-BOX HELICASE 54; DDX54
611666	PHOSPHOLIPID PHOSPHATASE 6; PLPP6
611667	SPERMATOGENESIS-ASSOCIATED SERINE-RICH PROTEIN 2; SPATS2
611668	CORONIN 7; CORO7
611669	tRNA METHYLTRANSFERASE 1; TRMT1
611670	INOSITOL-3-PHOSPHATE SYNTHASE 1; ISYNA1
611671	PHOSPHATIDYLINOSITOL GLYCAN ANCHOR BIOSYNTHESIS CLASS Z PROTEIN; PIGZ
611672	SOLUTE CARRIER FAMILY 46 (FOLATE TRANSPORTER), MEMBER 1; SLC46A1
611673	tRNA METHYLTRANSFERASE 1-LIKE; TRMT1L
611674	X KELL BLOOD GROUP PRECURSOR-RELATED FAMILY, MEMBER 3; XKR3
611675	KIAA0513 GENE; KIAA0513
611676	PHOSDUCIN-LIKE 2; PDCL2
611677	OLFACTORY RECEPTOR, FAMILY 13, SUBFAMILY G, MEMBER 1; OR13G1
611678	PHOSDUCIN-LIKE 3; PDCL3
611679	F-BOX AND WD40 DOMAIN PROTEIN 10; FBXW10
611680	CHROMOSOME 1 OPEN READING FRAME 116; C1ORF116
611681	A DISINTEGRIN-LIKE AND METALLOPROTEINASE WITH THROMBOSPONDIN TYPE 1 MOTIF, 20; ADAMTS20
611682	LIPOPROTEIN(a)-LIKE 2; LPAL2
611683	FRUCTOSAMINE 3-KINASE-RELATED PROTEIN
611684	SPLICEOSOME-ASSOCIATED FACTOR 3, U4/U6 RECYCLING PROTEIN; SART3
611685	RING FINGER PROTEIN 8; RNF8
611686	CAS1 DOMAIN-CONTAINING PROTEIN 1; CASD1
611687	KHDC3-LIKE PROTEIN, SUBCORTICAL MATERNAL COMPLEX MEMBER; KHDC3L
611688	KH DOMAIN-CONTAINING PROTEIN 1; KHDC1
611689	OOCYTE-EXPRESSED PROTEIN; OOEP
611690	PROLINE-RICH GAMMA-CARBOXYGLUTAMIC ACID PROTEIN 4; PRRG4
611691	SUSHI, VON WILLEBRAND FACTOR TYPE A, EGF, AND PENTRAXIN DOMAINS-CONTAINING 1; SVEP1
611692	ZINC FINGER- AND BTB DOMAIN-CONTAINING PROTEIN 34; ZBTB34
611693	COXSACKIEVIRUS- AND ADENOVIRUS RECEPTOR-LIKE MEMBRANE PROTEIN; CLMP
611694	DYSTONIA WITH CEREBELLAR ATROPHY; DYTCA
611695	TAU TUBULIN KINASE 2; TTBK2
611696	SOLUTE CARRIER FAMILY 22, MEMBER 20; SLC22A20
611697	SOLUTE CARRIER FAMILY 22, MEMBER 23; SLC22A23
611698	SOLUTE CARRIER FAMILY 22, MEMBER 24; SLC22A24
611699	SV2-RELATED PROTEIN; SVOP
611700	SV2-RELATED PROTEIN-LIKE; SVOPL
611701	SPHINGOLIPID TRANSPORTER 3; SPNS3
611702	SPONDYLOMETAPHYSEAL DYSPLASIA, EAST AFRICAN TYPE
611703	ZINC FINGER PROTEIN 436; ZNF436
611704	TRANSMEMBRANE PROTEASE, SERINE 11A; TMPRSS11A
611705	CONGENITAL MYOPATHY 5 WITH CARDIOMYOPATHY; CMYP5
611706	MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 12; MGR12
611707	MYELIN PROTEIN ZERO-LIKE 3; MPZL3
611708	MICRO RNA 431; MIR431
611709	MICRO RNA 127; MIR127
611710	MICRO RNA 136; MIR136
611711	MICRO RNA 433; MIR433
611712	HOMEODOMAIN-INTERACTING PROTEIN KINASE 4; HIPK4
611713	DYNEIN, LIGHT CHAIN, TCTEX-TYPE 4; DYNLT4
611714	GTPase-ACTIVATING PROTEIN AND VPS9 DOMAINS 1; GAPVD1
611715	STEROID 5-ALPHA-REDUCTASE 3; SRD5A3
611716	ATPase, H+ TRANSPORTING, LYSOSOMAL, V0 SUBUNIT A2; ATP6V0A2
611717	SPONDYLOEPIPHYSEAL DYSPLASIA-BRACHYDACTYLY AND DISTINCTIVE SPEECH
611718	HYPOMAGNESEMIA 4, RENAL; HOMG4
611719	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 5; COXPD5
611720	INTERFERON REGULATORY FACTOR 2-BINDING PROTEIN LIKE; IRF2BPL
611721	COMBINED SAPOSIN DEFICIENCY; PSAPD
611722	KRABBE DISEASE, ATYPICAL, DUE TO SAPOSIN A DEFICIENCY; KRBSAPA
611723	CHROMOSOME 21 OPEN READING FRAME 24; C21ORF24
611724	SKIN/HAIR/EYE PIGMENTATION, VARIATION IN, 8; SHEP8
611725	POTASSIUM CHANNEL TETRAMERIZATION DOMAIN-CONTAINING PROTEIN 7; KCTD7
611726	EPILEPSY, PROGRESSIVE MYOCLONIC, 3, WITH OR WITHOUT INTRACELLULAR INCLUSIONS; EPM3
611727	FAMILY WITH SEQUENCE SIMILARITY 163, MEMBER A; FAM163A
611728	PROLINE-RICH PROTEIN 5-LIKE; PRR5L
611729	KINESIN LIGHT CHAIN 2; KLC2
611730	ERYTHROCYTE MEMBRANE PROTEIN BAND 4.1-LIKE 5; EPB41L5
611731	APC REGULATOR OF WNT SIGNALING PATHWAY; APC
611732	MEMBRANE-BOUND O-ACETYLTRANSFERASE DOMAIN-CONTAINING PROTEIN 1; MBOAT1
611733	DAUWERSE-PETERS SYNDROME
611734	WD REPEAT-CONTAINING PROTEIN 77; WDR77
611735	CUB DOMAIN-CONTAINING PROTEIN 1; CDCP1
611736	GREB1 PROTEIN
611737	SEPTIN 10; SEPT10
611738	BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS 7; BMND7
611739	BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS 8; BMND8
611740	BETA-CAROTENE OXYGENASE 2; BCO2
611741	ACID-SENSING ION CHANNEL, SUBUNIT 3; ASIC3
611742	SKIN/HAIR/EYE PIGMENTATION, VARIATION IN, 9; SHEP9
611743	PLECKSTRIN HOMOLOGY DOMAIN- AND RhoGEF DOMAIN-CONTAINING PROTEIN G6; PLEKHG6
611744	OTU DOMAIN-CONTAINING PROTEIN 4; OTUD4
611745	VCP/p47 COMPLEX-INTERACTING PROTEIN 1;   VCPIP1
611746	SIGNAL PEPTIDE-, CUB DOMAIN-, AND EGF-LIKE DOMAINS-CONTAINING PROTEIN 1; SCUBE1
611747	SIGNAL PEPTIDE-, CUB DOMAIN-, AND EGF-LIKE DOMAINS-CONTAINING PROTEIN 2; SCUBE2
611748	OTU DOMAIN-CONTAINING PROTEIN 7B; OTUD7B
611749	ZINC FINGER RANBP2-TYPE DOMAIN-CONTAINING PROTEIN 1; ZRANB1
611750	SYNCOILIN 1; SYNC1
611751	THUMP DOMAIN-CONTAINING PROTEIN 2; THUMPD2
611752	ECRG4 AUGURIN PRECURSOR; ECRG4
611753	VACUOLE MEMBRANE PROTEIN 1; VMP1
611754	ALPHA-AMINOADIPATE AMINOTRANSFERASE; AADAT
611755	LEBER CONGENITAL AMAUROSIS 10; LCA10
611756	RHOPHILIN ASSOCIATED TAIL PROTEIN 1-LIKE; ROPN1L
611757	RHOPHILIN-ASSOCIATED TAIL PROTEIN 1; ROPN1
611758	OTU DOMAIN-CONTAINING PROTEIN 3; OTUD3
611759	STARD3 N-TERMINAL-LIKE; STARD3NL
611760	PROTOCADHERIN 17; PCDH17
611761	LIPASE MATURATION FACTOR 1; LMF1
611762	FAMILIAL COLD AUTOINFLAMMATORY SYNDROME 2; FCAS2
611763	LBH REGULATOR OF WNT SIGNALING PATHWAY; LBH
611764	CORNIFELIN; CNFN
611765	ASPARTIC PEPTIDASE, RETROVIRAL-LIKE 1; ASPRV1
611766	MITOCHONDRIAL METHIONYL-tRNA FORMYLTRANSFERASE; MTFMT
611767	MICRO RNA 126; MIR126
611768	MICRO RNA 335; MIR335
611769	MICRO RNA 128-2; MIR128-2
611770	NK2 HOMEOBOX 6; NKX2-6
611771	LIPOPROTEIN GLOMERULOPATHY; LPG
611772	NUF2 COMPONENT OF NDC80 KINETOCHORE COMPLEX; NUF2
611773	ANGIOPATHY, HEREDITARY, WITH NEPHROPATHY, ANEURYSMS, AND MUSCLE CRAMPS; HANAC
611774	MICRO RNA 128-1; MIR128-1
611775	KAWASAKI DISEASE
611776	NADH DEHYDROGENASE (UBIQUINONE) COMPLEX I, ASSEMBLY FACTOR 4; NDUFAF4
611777	BRUGADA SYNDROME 2; BRGDA2
611778	GLYCEROL-3-PHOSPHATE DEHYDROGENASE 1-LIKE; GPD1L
611779	FIBROUS SHEATH CABYR-BINDING PROTEIN; FSCB
611780	PHD AND RING FINGER DOMAIN-CONTAINING PROTEIN 1; PHRF1
611781	PR DOMAIN-CONTAINING PROTEIN 14; PRDM14
611782	DOWN SYNDROME CELL ADHESION MOLECULE-LIKE 1; DSCAML1
611783	ERYTHROCYTOSIS, FAMILIAL, 4; ECYT4
611784	GENERAL TRANSCRIPTION FACTOR 3C, POLYPEPTIDE 6; GTF3C6
611785	ATP-BINDING CASSETTE, SUBFAMILY B, MEMBER 5; ABCB5
611786	MEDIATOR OF CELL MOTILITY 1; MEMO1
611787	CYTIDINE MONOPHOSPHATE (UMP-CMP) KINASE 2, MITOCHONDRIAL; CMPK2
611788	AORTIC ANEURYSM, FAMILIAL THORACIC 6; AAT6
611789	NA+/H+ EXCHANGER DOMAIN-CONTAINING PROTEIN 2; NHEDC2
611790	MYOSIN VIIA- AND RAB-INTERACTING PROTEIN; MYRIP
611791	PATCHED DOMAIN-CONTAINING PROTEIN 3; PTCHD3
611792	ZINC FINGER CCHC DOMAIN-CONTAINING PROTEIN 4; ZCCHC4
611793	LSM12, S. CEREVISIAE, HOMOLOG OF; LSM12
611794	MICRO RNA 369; MIR369
611795	MICRO RNA 145; MIR145
611796	SECRETOGRANIN III; SCG3
611797	UBIQUINOL-CYTOCHROME C REDUCTASE COMPLEX ASSEMBLY FACTOR 1; UQCC1
611798	EFR3 HOMOLOG A; EFR3A
611799	LIGAND-DEPENDENT NUCLEAR RECEPTOR COREPRESSOR-LIKE PROTEIN; LCORL
611800	THADA ARMADILLO REPEAT-CONTAINING PROTEIN; THADA
611801	POST-GPI ATTACHMENT TO PROTEINS 3; PGAP3
611802	MIGRATION AND INVASION ENHANCER 1; MIEN1
611803	INTEGRIN-ALPHA FG-GAP REPEAT-CONTAINING PROTEIN 1; ITFG1
611804	ELLIPTOCYTOSIS 1; EL1
611805	ELONGATION OF VERY LONG CHAIN FATTY ACIDS-LIKE 5; ELOVL5
611806	ARSENIC (+3 OXIDATION STATE) METHYLTRANSFERASE; AS3MT
611807	TIP41-LIKE PROTEIN; TIPRL
611808	TREMOR, HEREDITARY ESSENTIAL, AND IDIOPATHIC NORMAL PRESSURE HYDROCEPHALUS; ETINPH
611809	BESTROPHINOPATHY, AUTOSOMAL RECESSIVE; ARB
611810	USH1C-BINDING PROTEIN 1; USHBP1
611811	ZINC FINGER PROTEIN 333; ZNF333
611812	46,XX SEX REVERSAL WITH DYSGENESIS OF KIDNEYS, ADRENALS, AND LUNGS; SERKAL
611813	ELONGATION OF VERY LONG CHAIN FATTY ACIDS-LIKE 1; ELOVL1
611814	ELONGATION OF VERY LONG CHAIN FATTY ACIDS-LIKE 2; ELOVL2
611815	ELONGATION OF VERY LONG CHAIN FATTY ACIDS-LIKE 3; ELOVL3
611816	TEMPLE-BARAITSER SYNDROME; TMBTS
611817	KILLER CELL LECTIN-LIKE RECEPTOR, SUBFAMILY K, MEMBER 1; KLRK1
611818	LONG QT SYNDROME 9; LQT9
611819	LONG QT SYNDROME 10; LQT10
611820	LONG QT SYNDROME 11; LQT11
611821	MITOCHONDRIAL RIBOSOMAL PROTEIN L1; MRPL1
611822	MITOCHONDRIAL RIBOSOMAL PROTEIN L2; MRPL2
611823	MITOCHONDRIAL RIBOSOMAL PROTEIN L4; MRPL4
611824	MITOCHONDRIAL RIBOSOMAL PROTEIN L9; MRPL9
611825	MITOCHONDRIAL RIBOSOMAL PROTEIN L10; MRPL10
611826	MITOCHONDRIAL RIBOSOMAL PROTEIN L11; MRPL11
611827	MITOCHONDRIAL RIBOSOMAL PROTEIN L14; MRPL14
611828	MITOCHONDRIAL RIBOSOMAL PROTEIN L15; MRPL15
611829	MITOCHONDRIAL RIBOSOMAL PROTEIN L16; MRPL16
611830	MITOCHONDRIAL RIBOSOMAL PROTEIN L17; MRPL17
611831	MITOCHONDRIAL RIBOSOMAL PROTEIN L18; MRPL18
611832	MITOCHONDRIAL RIBOSOMAL PROTEIN L19; MRPL19
611833	MITOCHONDRIAL RIBOSOMAL PROTEIN L20; MRPL20
611834	MITOCHONDRIAL RIBOSOMAL PROTEIN L21; MRPL21
611835	MITOCHONDRIAL RIBOSOMAL PROTEIN L22; MRPL22
611836	MITOCHONDRIAL RIBOSOMAL PROTEIN L24; MRPL24
611837	MITOCHONDRIAL RIBOSOMAL PROTEIN L27; MRPL27
611838	MITOCHONDRIAL RIBOSOMAL PROTEIN L30; MRPL30
611839	MITOCHONDRIAL RIBOSOMAL PROTEIN L32; MRPL32
611840	MITOCHONDRIAL RIBOSOMAL PROTEIN L34; MRPL34
611841	MITOCHONDRIAL RIBOSOMAL PROTEIN L35; MRPL35
611842	MITOCHONDRIAL RIBOSOMAL PROTEIN L36; MRPL36
611843	MITOCHONDRIAL RIBOSOMAL PROTEIN L37; MRPL37
611844	MITOCHONDRIAL RIBOSOMAL PROTEIN L38; MRPL38
611845	MITOCHONDRIAL RIBOSOMAL PROTEIN L39; MRPL39
611846	MITOCHONDRIAL RIBOSOMAL PROTEIN L41; MRPL41
611847	MITOCHONDRIAL RIBOSOMAL PROTEIN L42; MRPL42
611848	MITOCHONDRIAL RIBOSOMAL PROTEIN L43; MRPL43
611849	MITOCHONDRIAL RIBOSOMAL PROTEIN L44; MRPL44
611850	MITOCHONDRIAL RIBOSOMAL PROTEIN L45; MRPL45
611851	MITOCHONDRIAL RIBOSOMAL PROTEIN L46; MRPL46
611852	MITOCHONDRIAL RIBOSOMAL PROTEIN L47; MRPL47
611853	MITOCHONDRIAL RIBOSOMAL PROTEIN L48; MRPL48
611854	MITOCHONDRIAL RIBOSOMAL PROTEIN L50; MRPL50
611855	MITOCHONDRIAL RIBOSOMAL PROTEIN L51; MRPL51
611856	MITOCHONDRIAL RIBOSOMAL PROTEIN L52; MRPL52
611857	MITOCHONDRIAL RIBOSOMAL PROTEIN L53; MRPL53
611858	MITOCHONDRIAL RIBOSOMAL PROTEIN L54; MRPL54
611859	MITOCHONDRIAL RIBOSOMAL PROTEIN L55; MRPL55
611860	MOVED TO 210720
611861	ADP-DEPENDENT GLUCOKINASE; ADPGK
611862	WHITE BLOOD CELL COUNT QUANTITATIVE TRAIT LOCUS 1; WBCQ1
611863	MICROTIA WITH NASOLACRIMAL DUCT IMPERFORATION AND EYE COLOBOMA
611864	ARMADILLO REPEAT-CONTAINING 10; ARMC10
611865	L3MBTL HISTONE METHYL-LYSINE-BINDING PROTEIN 2; L3MBTL2
611866	RETINOL-BINDING PROTEIN 5; RBP5
611867	CHROMOSOME 22q11.2 DELETION SYNDROME, DISTAL
611868	PROSTATE CANCER, HEREDITARY, 12; HPC12
611869	RABAPTIN, RAB GTPase-BINDING EFFECTOR PROTEIN 2; RABEP2
611870	CENTLEIN; CNTLN
611871	REGULATOR OF MICROTUBULE DYNAMICS 1; RMDN1
611872	REGULATOR OF MICROTUBULE DYNAMICS 2; RMDN2
611873	REGULATOR OF MICROTUBULE DYNAMICS 3; RMDN3
611874	NEURON-DERIVED NEUROTROPHIC FACTOR; NENF
611875	BRUGADA SYNDROME 3; BRGDA3
611876	BRUGADA SYNDROME 4; BRGDA4
611877	BAI1-ASSOCIATED PROTEIN 2-LIKE 1; BAIAP2L1
611878	CARDIOMYOPATHY, DILATED, 1Y; CMD1Y
611879	CARDIOMYOPATHY, DILATED, 1Z; CMD1Z
611880	CARDIOMYOPATHY, DILATED, 2A; CMD2A
611881	GLYCOGEN STORAGE DISEASE XII; GSD12
611882	PROLINE-RICH NUCLEAR RECEPTOR COACTIVATOR 2; PNRC2
611883	BRCA2- AND CDKN1A-INTERACTING PROTEIN; BCCIP
611884	CILIARY DYSKINESIA, PRIMARY, 7; CILD7
611885	SHANK-ASSOCIATED RH DOMAIN INTERACTOR; SHARPIN
611886	MESOMELIC DYSPLASIA, CAMERA TYPE
611887	UROPLAKIN 3B; UPK3B
611888	ETS2 REPRESSOR FACTOR; ERF
611889	S100P-BINDING PROTEIN; S100PBP
611890	CONGENITAL ARTHROGRYPOSIS WITH ANTERIOR HORN CELL DISEASE; CAAHD
611891	AORTIC ANEURYSM, FAMILIAL ABDOMINAL, 3; AAA3
611892	ANEURYSM, INTRACRANIAL BERRY, 6; ANIB6
611893	PLECKSTRIN HOMOLOGY DOMAIN- AND RhoGEF DOMAIN-CONTAINING PROTEIN G2; PLEKHG2
611894	MICRO RNA 140; MIR140
611895	AMYOTROPHIC LATERAL SCLEROSIS 9; ALS9
611896	RETROTRANSPOSON-LIKE GENE 1; RTL1
611897	NANOPHTHALMOS 3; NNO3
611898	ENDO-BETA-N-ACETYLGLUCOSAMINIDASE; ENGASE
611899	MICRO RNA 203A; MIR203A
611900	METALLOPHOSPHOESTERASE 1; MPPE1
611901	VON WILLEBRAND FACTOR A DOMAIN-CONTAINING PROTEIN 1; VWA1
611902	COILED-COIL DOMAIN-CONTAINING PROTEIN 136; CCDC136
611903	ZINC FINGER PROTEIN 649; ZNF649
611904	PLACENTA-EXPRESSED TRANSCRIPT 1; PLET1
611905	FIBRONECTIN TYPE III DOMAIN-CONTAINING PROTEIN 4; FNDC4
611906	FIBRONECTIN TYPE III DOMAIN-CONTAINING PROTEIN 5; FNDC5
611907	EPISODIC ATAXIA, TYPE 7; EA7
611908	RFT1 HOMOLOG; RFT1
611909	FIBRONECTIN TYPE III DOMAIN-CONTAINING PROTEIN 3B; FNDC3B
611910	SOLUTE CARRIER FAMILY 16 (MONOCARBOXYLIC ACID TRANSPORTER), MEMBER 12; SLC16A12
611911	IRON-SULFUR CLUSTER ASSEMBLY ENZYME; ISCU
611912	NUCLEAR CASEIN KINASE AND CYCLIN-DEPENDENT KINASE SUBSTRATE 1; NUCKS1
611913	CHROMOSOME 16p11.2 DELETION SYNDROME, 593-KB
611914	TSC22 DOMAIN FAMILY, MEMBER 4; TSC22D4
611915	VESICULAR, OVEREXPRESSED IN CANCER, PROSURVIVAL PROTEIN 1; VOPP1
611916	COLLAGEN, TYPE VI, ALPHA-5; COL6A5
611917	LYSINE DEMETHYLASE 8; KDM8
611918	MOVED TO 601869
611919	RIBOSOMAL OXYGENASE 1; RIOX1
611920	C-REACTIVE PROTEIN, SERUM LEVEL OF, QUANTITATIVE TRAIT LOCUS 1; CRPQTL1
611921	GAP JUNCTION PROTEIN, BETA-7; GJB7
611922	GAP JUNCTION PROTEIN, DELTA-4; GJD4
611923	GAP JUNCTION PROTEIN, ALPHA-9; GJA9
611924	GAP JUNCTION PROTEIN, ALPHA-10; GJA10
611925	GAP JUNCTION PROTEIN, GAMMA-3; GJC3
611926	IMMUNODEFICIENCY, OVARIAN DYSGENESIS, AND PULMONARY FIBROSIS
611927	FAMILY WITH SEQUENCE SIMILARITY 83, MEMBER H; FAM83H
611928	PROSTATE CANCER, HEREDITARY, 13; HPC13
611929	CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE III
611930	INTERFERON-STIMULATED EXONUCLEASE GENE 20-KD-LIKE 2; ISG20L2
611931	PROTEIN PHOSPHATASE, MAGNESIUM/MANGANESE-DEPENDENT, 1L; PPM1L
611932	CDGSH IRON SULFUR DOMAIN PROTEIN 1; CISD1
611933	CDGSH IRON SULFUR DOMAIN PROTEIN 3; CISD3
611934	EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 5; EIG5
611935	METABOLISM OF COBALAMIN ASSOCIATED D; MMADHC
611936	CHROMOSOME 3q29 DUPLICATION SYNDROME
611937	IMMUNOGLOBULIN HEAVY CHAIN DIVERSITY GENE 3-3; IGHD3-3
611938	VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 2; CPVT2
611939	IMMUNOGLOBULIN HEAVY CHAIN VARIABLE GENE 3-23; IGHV3-23
611940	MEMBRANE-BOUND O-ACETYLTRANSFERASE DOMAIN-CONTAINING PROTEIN 4; MBOAT4
611941	ATPase FAMILY, AAA DOMAIN-CONTAINING, MEMBER 2; ATAD2
611942	EPILEPSY, CHILDHOOD ABSENCE, SUSCEPTIBILITY TO, 6; ECA6
611943	RIDDLE SYNDROME; RIDL
611944	LYMPHATIC MALFORMATION 2; LMPHM2
611945	SPASTIC PARAPLEGIA 37, AUTOSOMAL DOMINANT; SPG37
611946	UBX DOMAIN PROTEIN 6; UBXN6
611947	NLR FAMILY MEMBER X1; NLRX1
611948	MOVED TO 267750
611949	MEMBRANE-BOUND O-ACYLTRANSFERASE DOMAIN-CONTAINING PROTEIN 2; MBOAT2
611950	LYSOPHOSPHATIDYLCHOLINE ACYLTRANSFERASE 3; LPCAT3
611951	B9 DOMAIN-CONTAINING PROTEIN 2; B9D2
611952	VPS28 SUBUNIT OF ESCRT-I; VPS28
611953	MACULAR DEGENERATION, AGE-RELATED, 11; ARMD11
611954	MICRO RNA 373; MIR373
611955	PROSTATE CANCER, HEREDITARY, 11; HPC11
611956	CHROMOSOME 3 OPEN READING FRAME 52; C3ORF52
611957	MICRO RNA 378; MIRN378
611958	PROSTATE CANCER, HEREDITARY, 14; HPC14
611959	PROSTATE CANCER, HEREDITARY, 15; HPC15
611960	ASTHMA-RELATED TRAITS, SUSCEPTIBILITY TO, 7; ASRT7
611961	STEVENSON-CAREY SYNDROME
611962	HUNTER-MACDONALD SYNDROME
611963	ACYL-CoA THIOESTERASE 7-LIKE
611964	CYTOCHROME b5, TYPE B (OUTER MITOCHONDRIAL MEMBRANE); CYB5B
611965	THO COMPLEX, SUBUNIT 7; THOC7
611966	TRAFFICKING PROTEIN PARTICLE COMPLEX, SUBUNIT 9; TRAPPC9
611967	KELCH-LIKE 8; KLHL8
611968	CLEAVAGE STIMULATION FACTOR, 3-PRIME PRE-RNA, SUBUNIT 2, 64-KD, TAU VARIANT; CSTF2T
611969	MOB KINASE ACTIVATOR 2; MOB2
611970	NUCLEOLAR PROTEIN INTERACTING WITH THE FHA DOMAIN OF MKI67; NIFK
611971	MITOCHONDRIAL RIBOSOMAL PROTEIN S2; MRPS2
611972	MITOCHONDRIAL RIBOSOMAL PROTEIN S5; MRPS5
611973	MITOCHONDRIAL RIBOSOMAL PROTEIN S6; MRPS6
611974	MITOCHONDRIAL RIBOSOMAL PROTEIN S7; MRPS7
611975	MITOCHONDRIAL RIBOSOMAL PROTEIN S9; MRPS9
611976	MITOCHONDRIAL RIBOSOMAL PROTEIN S10; MRPS10
611977	MITOCHONDRIAL RIBOSOMAL PROTEIN S11; MRPS11
611978	MITOCHONDRIAL RIBOSOMAL PROTEIN S14; MRPS14
611979	MITOCHONDRIAL RIBOSOMAL PROTEIN S15; MRPS15
611980	MITOCHONDRIAL RIBOSOMAL PROTEIN S17; MRPS17
611981	MITOCHONDRIAL RIBOSOMAL PROTEIN S18A; MRPS18A
611982	MITOCHONDRIAL RIBOSOMAL PROTEIN S18B; MRPS18B
611983	MITOCHONDRIAL RIBOSOMAL PROTEIN S18C; MRPS18C
611984	MITOCHONDRIAL RIBOSOMAL PROTEIN S21; MRPS21
611985	MITOCHONDRIAL RIBOSOMAL PROTEIN S23; MRPS23
611986	MITOCHONDRIAL RIBOSOMAL PROTEIN S24; MRPS24
611987	MITOCHONDRIAL RIBOSOMAL PROTEIN S25; MRPS25
611988	MITOCHONDRIAL RIBOSOMAL PROTEIN S26; MRPS26
611989	MITOCHONDRIAL RIBOSOMAL PROTEIN S27; MRPS27
611990	MITOCHONDRIAL RIBOSOMAL PROTEIN S28; MRPS28
611991	MITOCHONDRIAL RIBOSOMAL PROTEIN S30; MRPS30
611992	MITOCHONDRIAL RIBOSOMAL PROTEIN S31; MRPS31
611993	MITOCHONDRIAL RIBOSOMAL PROTEIN S33; MRPS33
611994	MITOCHONDRIAL RIBOSOMAL PROTEIN S34; MRPS34
611995	MITOCHONDRIAL RIBOSOMAL PROTEIN S35; MRPS35
611996	MITOCHONDRIAL RIBOSOMAL PROTEIN S36; MRPS36
611997	MITOCHONDRIAL RIBOSOMAL PROTEIN 63; MRP63
611998	cAMP RESPONSE ELEMENT-BINDING PROTEIN 3-LIKE 3; CREB3L3
611999	RAB11 FAMILY-INTERACTING PROTEIN 4; RAB11FIP4
612000	TRIPARTITE MOTIF-CONTAINING PROTEIN 66; TRIM66
612001	CHROMOSOME 15q13.3 DELETION SYNDROME
612002	DEP DOMAIN-CONTAINING PROTEIN 1; DEPDC1
612003	GRB10-INTERACTING GYF PROTEIN 2; GIGYF2
612004	THROMBOCYTOPENIA 4; THC4
612005	CELIAC DISEASE, SUSCEPTIBILITY TO, 7; CELIAC7
612006	CELIAC DISEASE, SUSCEPTIBILITY TO, 8; CELIAC8
612007	CELIAC DISEASE, SUSCEPTIBILITY TO, 9; CELIAC9
612008	CELIAC DISEASE, SUSCEPTIBILITY TO, 10; CELIAC10
612009	CELIAC DISEASE, SUSCEPTIBILITY TO, 11; CELIAC11
612010	CELIAC DISEASE, SUSCEPTIBILITY TO, 12; CELIAC12
612011	CELIAC DISEASE, SUSCEPTIBILITY TO, 13; CELIAC13
612012	ZINC FINGER FYVE DOMAIN-CONTAINING PROTEIN 26; ZFYVE26
612013	COILED-COIL AND C2 DOMAINS-CONTAINING PROTEIN 2A; CC2D2A
612014	TETRATRICOPEPTIDE REPEAT DOMAIN-CONTAINING PROTEIN 21B; TTC21B
612015	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE In; CDG1N
612016	COENZYME Q10 DEFICIENCY, PRIMARY, 4; COQ10D4
612017	PYLORIC STENOSIS, INFANTILE HYPERTROPHIC, 3; IHPS3
612018	CATARACT 47; CTRCT47
612019	INTESTINE-SPECIFIC HOMEOBOX; ISX
612020	SPASTIC PARAPLEGIA 39, AUTOSOMAL RECESSIVE; SPG39
612021	OTU DOMAIN-CONTAINING PROTEIN 6B; OTUD6B
612022	OTU DOMAIN-CONTAINING PROTEIN 1; OTUD1
612023	YOD1 DEUBIQUITINASE; YOD1
612024	OTU DOMAIN-CONTAINING PROTEIN 7A; OTUD7A
612025	IODOTYROSINE DEIODINASE; IYD
612026	La RIBONUCLEOPROTEIN 7, TRANSCRIPTIONAL REGULATOR; LARP7
612027	TRAFFICKING REGULATOR AND SCAFFOLD PROTEIN TAMALIN; TAMALIN
612028	FAT STORAGE-INDUCING TRANSMEMBRANE PROTEIN 1; FITM1
612029	FAT STORAGE-INDUCING TRANSMEMBRANE PROTEIN 2; FITM2
612030	CORONARY HEART DISEASE, SUSCEPTIBILITY TO, 9; CHDS9
612031	INHIBIN, BETA E; INHBE
612032	DPY30 HISTONE METHYLTRANSFERASE COMPLEX REGULATORY SUBUNIT; DPY30
612033	PAXIP1-ASSOCIATED GLUTAMATE-RICH PROTEIN 1; PAGR1
612034	APC2 REGULATOR OF WNT SIGNALING PATHWAY 2; APC2
612035	ALANYL-tRNA SYNTHETASE 2; AARS2
612036	PROLYL-tRNA SYNTHETASE 2; PARS2
612037	MITOCHONDRIAL UBIQUITIN LIGASE ACTIVATOR OF NFKB 1; MUL1
612038	TRANSMEMBRANE p24 TRAFFICKING PROTEIN 4; TMED4
612039	1-ACYLGLYCEROL-3-PHOSPHATE O-ACYLTRANSFERASE 7; AGPAT7
612040	LYSOPHOSPHATIDYLCHOLINE ACYLTRANSFERASE 2; LPCAT2
612041	RING FINGER PROTEIN 212; RNF212
612042	RECOMBINATION RATE QUANTITATIVE TRAIT LOCUS 1; RRQTL1
612043	MICRO RNA 371A; MIR371A
612044	MICRO RNA 372; MIRN372
612045	C1q- AND TUMOR NECROSIS FACTOR-RELATED PROTEIN 3; C1QTNF3
612046	E2F TRANSCRIPTION FACTOR 7; E2F7
612047	E2F TRANSCRIPTION FACTOR 8; E2F8
612048	TRANSMEMBRANE PROTEIN 43; TMEM43
612049	RIBOSOMAL OXYGENASE 2; RIOX2
612050	NEDD4 FAMILY-INTERACTING PROTEIN 1; NDFIP1
612051	BRAIN-EXPRESSED, ASSOCIATED WITH NEDD4, 1; BEAN1
612052	SMOKING AS A QUANTITATIVE TRAIT LOCUS 3; SQTL3
612053	ZINC FINGER PROTEIN 36-LIKE 2; ZFP36L2
612054	CCR4-NOT TRANSCRIPTION COMPLEX, SUBUNIT 9; CNOT9
612055	RIBOSOMAL PROTEIN S27-LIKE; RPS27L
612056	GUIDED ENTRY OF TAIL-ANCHORED PROTEINS FACTOR 4; GET4
612057	SUPPRESSOR APC DOMAIN-CONTAINING PROTEIN 2; SAPCD2
612058	SAMM50 SORTING AND ASSEMBLY MACHINERY COMPONENT; SAMM50
612059	La RIBONUCLEOPROTEIN 1, TRANSLATIONAL REGULATOR; LARP1
612060	ZINC FINGER AND RING FINGER PROTEIN 1; ZNRF1
612061	ZINC FINGER AND RING FINGER PROTEIN 2; ZNRF2
612062	ZINC FINGER AND RING FINGER PROTEIN 3; ZNRF3
612063	ZINC FINGER AND RING FINGER PROTEIN 4; ZNRF4
612064	GRB10-INTERACTING GYF PROTEIN 1; GIGYF1
612065	POLY(ADP-RIBOSE) POLYMERASE FAMILY, MEMBER 9; PARP9
612066	POLY(ADP-RIBOSE) POLYMERASE FAMILY, MEMBER 15; PARP15
612067	DYSTONIA 16; DYT16
612068	PHOSPHOINOSITIDE-INTERACTING REGULATOR OF TRANSIENT RECEPTOR POTENTIAL CHANNELS; PIRT
612069	AMYOTROPHIC LATERAL SCLEROSIS 10 WITH OR WITHOUT FRONTOTEMPORAL DEMENTIA; ALS10
612070	MICRO RNA 144; MIRN144
612071	MICRO RNA 451; MIRN451
612072	MIF4G DOMAIN-CONTAINING PROTEIN; MIF4GD
612073	MITOCHONDRIAL DNA DEPLETION SYNDROME 5 (ENCEPHALOMYOPATHIC WITH OR WITHOUT METHYLMALONIC ACIDURIA); MTDPS5
612074	RNA-BINDING MOTIF PROTEIN 28; RBM28
612075	MITOCHONDRIAL DNA DEPLETION SYNDROME 8A (ENCEPHALOMYOPATHIC TYPE WITH RENAL TUBULOPATHY); MTDPS8A
612076	HYPOURICEMIA, RENAL, 2; RHUC2
612077	MICRO RNA 22; MIR22
612078	ZINC FINGER PROTEIN 469; ZNF469
612079	ALOPECIA, NEUROLOGIC DEFECTS, AND ENDOCRINOPATHY SYNDROME; ANES
612080	UBIQUINOL-CYTOCHROME c REDUCTASE, COMPLEX III SUBUNIT VII; UQCRQ
612081	INTERLEUKIN 34; IL34
612082	CAPICUA TRANSCRIPTIONAL REPRESSOR; CIC
612083	MUSCLE STRENGTH QUANTITATIVE TRAIT LOCUS 1
612084	SOLUTE CARRIER FAMILY 51, SUBUNIT ALPHA; SLC51A
612085	SOLUTE CARRIER FAMILY 51, SUBUNIT BETA; SLC51B
612086	MINOR HISTOCOMPATIBILITY ANTIGEN, SERPIN DOMAIN-CONTAINING; HMSD
612087	C-TYPE LECTIN DOMAIN FAMILY 2, MEMBER A; CLEC2A
612088	C-TYPE LECTIN DOMAIN FAMILY 12, MEMBER A; CLEC12A
612089	HYPOPHOSPHATEMIC RICKETS AND HYPERPARATHYROIDISM
612090	MICRO RNA 200A; MIR200A
612091	MICRO RNA 200B; MIRN200B
612092	MICRO RNA 200C; MIR200C
612093	MICRO RNA 141; MIR141
612094	MICRO RNA 429; MIRN429
612095	RETINITIS PIGMENTOSA 41; RP41
612096	OTOSCLEROSIS 8; OTSC8
612097	DEAFNESS, UNILATERAL, WITH DELAYED ENDOLYMPHATIC HYDROPS
612098	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 11; CMH11
612099	TRICHOEPITHELIOMA, MULTIPLE FAMILIAL, 2
612100	AUTISM, SUSCEPTIBILITY TO, 15; AUTS15
612101	PHOSPHATIDYLINOSITOL 4-KINASE, TYPE 2, BETA; PI4K2B
612102	MICRO RNA LET7G; MIRNLET7G
612103	OLIGONUCLEOTIDE/OLIGOSACCHARIDE-BINDING FOLD-CONTAINING PROTEIN 2A; OBFC2A
612104	OLIGONUCLEOTIDE/OLIGOSACCHARIDE-BINDING FOLD-CONTAINING PROTEIN 2B; OBFC2B
612105	KILLIN; KLLN
612106	ZINC FINGER- AND BTB DOMAIN-CONTAINING PROTEIN 40; ZBTB40
612107	SOLUTE CARRIER FAMILY 17 (VESICULAR NUCLEOTIDE TRANSPORTER), MEMBER 9; SLC17A9
612108	FASTING PLASMA GLUCOSE LEVEL QUANTITATIVE TRAIT LOCUS 1; FGQTL1
612109	OCULOAURICULAR SYNDROME; OCACS
612110	BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS 9; BMND9
612111	TUMOR NECROSIS FACTOR-ALPHA-INDUCED PROTEIN 8; TNFAIP8
612112	TUMOR NECROSIS FACTOR-ALPHA-INDUCED PROTEIN 8-LIKE 2; TNFAIP8L2
612113	BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS 10; BMND10
612114	BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS 11; BMND11
612115	RHO GUANINE NUCLEOTIDE EXCHANGE FACTOR 3; ARHGEF3
612116	UBIQUITIN-SPECIFIC PROTEASE 22; USP22
612117	MICRO RNA 143; MIR143
612118	IQ MOTIF- AND SEC7 DOMAIN-CONTAINING PROTEIN 3; IQSEC3
612119	TREHALASE DEFICIENCY
612120	CELL DEATH-INDUCING DFFA-LIKE EFFECTOR C; CIDEC
612121	PATATIN-LIKE PHOSPHOLIPASE DOMAIN-CONTAINING PROTEIN 1; PNPLA1
612122	PATATIN-LIKE PHOSPHOLIPASE DOMAIN-CONTAINING PROTEIN 7; PNPLA7
612123	PATATIN-LIKE PHOSPHOLIPASE DOMAIN-CONTAINING PROTEIN 8; PNPLA8
612124	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 12; CMH12
612125	SERTA DOMAIN-CONTAINING PROTEIN 3; SERTAD3
612126	GLUT1 DEFICIENCY SYNDROME 2; GLUT1DS2
612127	17-BETA-HYDROXYSTEROID DEHYDROGENASE XIII; HSD17B13
612128	RAS-LIKE, FAMILY 10, MEMBER B; RASL10B
612129	INDOLEAMINE 2,3-DIOXYGENASE 2; IDO2
612130	GENE AMPLIFIED IN ESOPHAGEAL CANCER 1; GAEC1
612131	SHORT-CHAIN DEHYDROGENASE/REDUCTASE FAMILY, MEMBER 9; DHRS9
612132	ECTODERMAL DYSPLASIA AND IMMUNODEFICIENCY 2; EDAID2
612133	TRANSCRIPTION FACTOR NFE4; NFE4
612134	GLUCURONIC ACID EPIMERASE; GLCE
612135	CALCIUM-BINDING TYROSINE PHOSPHORYLATION-REGULATED PROTEIN; CABYR
612136	ENOYL COENZYME A HYDRATASE DOMAIN-CONTAINING PROTEIN 1; ECHDC1
612137	RING FINGER PROTEIN 146; RNF146
612138	EPIDERMOLYSIS BULLOSA SIMPLEX 5C, WITH PYLORIC ATRESIA; EBS5C
612139	PHOSPHATIDYLINOSITOL 3,4,5-TRISPHOSPHATE-DEPENDENT RAC EXCHANGER 2; PREX2
612140	SEPTIN 14; SEPT14
612141	ERYTHROCYTE MEMBRANE PROTEIN BAND 4.1-LIKE 4A; EPB41L4A
612142	MICRO RNA LET7A2; MIRLET7A2
612143	MICRO RNA LET7A3; MIRNLET7A3
612144	MICRO RNA LET7C; MIRLET7C
612145	MICRO RNA LET7D; MIRNLET7D
612146	MICRO RNA LET7F1; MIRLET7F1
612147	MYOSIN LIGHT CHAIN KINASE 3; MYLK3
612148	MICRO RNA LET7I; MIRNLET7I
612149	RNA-BINDING FOX1 HOMOLOG 2; RBFOX2
612150	MICRO RNA 25; MIR25
612151	MICRO RNA 26A1; MIR26A1
612152	MICRO RNA 26B; MIR26B
612153	MICRO RNA 27A; MIR27A
612154	MICRO RNA 28; MIR28
612155	MICRO RNA 31; MIR31
612156	MICRO RNA 33A; MIR33A
612157	SENTRIN-SPECIFIC PROTEASE FAMILY, MEMBER 1; SENP1
612158	CARDIOMYOPATHY, DILATED, 1AA, WITH OR WITHOUT LEFT VENTRICULAR NONCOMPACTION; CMD1AA
612159	RABPHILIN 3A; RPH3A
612160	HISTIOCYTOMA, ANGIOMATOID FIBROUS
612161	ANEURYSM, INTRACRANIAL BERRY, 7; ANIB7
612162	ANEURYSM, INTRACRANIAL BERRY, 8; ANIB8
612163	TWO-PORE SEGMENT CHANNEL 2; TPCN2
612164	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 4; DEE4
612165	RETINITIS PIGMENTOSA 29; RP29
612166	SOLUTE CARRIER FAMILY 39 (ZINC TRANSPORTER), MEMBER 2; SLC39A2
612167	WD REPEAT-CONTAINING PROTEIN 48; WDR48
612168	SOLUTE CARRIER FAMILY 39 (ZINC TRANSPORTER), MEMBER 3; SLC39A3
612169	Fc FRAGMENT OF IgG RECEPTOR IIc; FCGR2C
612170	MUCIN 19, OLIGOMERIC; MUC19
612171	REPRIMO; RPRM
612172	DEAD-BOX HELICASE 23; DDX23
612173	SPERM-ASSOCIATED ANTIGEN 16; SPAG16
612174	CALCIUM-BINDING PROTEIN 39; CAB39
612175	CALCIUM-BINDING PROTEIN 39-LIKE PROTEIN; CAB39L
612176	MYB-LIKE, SWIRM, AND MPN DOMAINS-CONTAINING PROTEIN 1; MYSM1
612177	RNA, 7SL, CYTOPLASMIC 1; RN7SL1
612178	HEN METHYLTRANSFERASE 1; HENMT1
612179	RNA, 7SL, CYTOPLASMIC 2; RN7SL2
612180	RNA, 7SL, CYTOPLASMIC 3; RN7SL3
612181	MUCIN 13, CELL SURFACE-ASSOCIATED; MUC13
612182	N-ACETYLTRANSFERASE 2; NAT2
612183	G PROTEIN-COUPLED RECEPTOR 176; GPR176
612184	CASK-INTERACTING PROTEIN 1; CASKIN1
612185	CASK-INTERACTING PROTEIN 2; CASKIN2
612186	DMX-LIKE 2; DMXL2
612187	SOLUTE CARRIER FAMILY 48 (HEME TRANSPORTER), MEMBER 1; SLC48A1
612188	VPS39 SUBUNIT OF HOPS COMPLEX; VPS39
612189	PHENAZINE BIOSYNTHESIS-LIKE PROTEIN DOMAIN-CONTAINING PROTEIN; PBLD
612190	MTOR-ASSOCIATED PROTEIN LST8; MLST8
612191	MICROSEMINOPROTEIN, PROSTATE-ASSOCIATED; MSMP
612192	ZFP57 ZINC FINGER PROTEIN; ZFP57
612193	CARDIOMYOPATHY-ASSOCIATED PROTEIN 5; CMYA5
612194	RAS-RELATED GTP-BINDING PROTEIN A; RRAGA
612195	ABHYDROLASE DOMAIN-CONTAINING PROTEIN 1; ABHD1
612196	ABHYDROLASE DOMAIN-CONTAINING PROTEIN 2, ACYLGLYCEROL LIPASE; ABHD2
612197	ABHYDROLASE DOMAIN-CONTAINING PROTEIN 3, PHOSPHOLIPASE; ABHD3
612198	DIASTASIS RECTI AND WEAKNESS OF THE LINEA ALBA
612199	CEREBRORETINAL MICROANGIOPATHY WITH CALCIFICATIONS AND CYSTS 1; CRMCC1
612200	DIVERGENT PROTEIN KINASE DOMAIN 2A; DIPK2A
612201	ATRIAL FIBRILLATION, FAMILIAL, 6; ATFB6
612202	SRY-BOX 7; SOX7
612203	NUCLEOSOME ASSEMBLY PROTEIN 1-LIKE 5; NAP1L5
612204	AUTOPHAGY-RELATED 9A; ATG9A
612205	AUTOPHAGY-RELATED 9B; ATG9B
612206	FOUR-JOINTED BOX KINASE 1; FJX1
612207	GOLGI PHOSPHOPROTEIN 3; GOLPH3
612208	GOLGI PHOSPHOPROTEIN 3-LIKE; GOLPH3L
612209	MESOGENIN 1; MSGN1
612210	HEPATOCELLULAR CARCINOMA-UPREGULATED LONG NONCODING RNA; HULC
612211	TUMOR SUPPRESSOR CANDIDATE 5; TUSC5
612212	PLASMINOGEN-LIKE A; PLGLA
612213	BINDER OF SPERM PROTEIN HOMOLOG 1; BSPH1
612214	RAL GUANINE NUCLEOTIDE DISSOCIATION STIMULATOR-LIKE 4; RGL4
612215	SMALL NUCLEOLAR RNA HOST GENE 6; SNHG6
612216	SMALL NUCLEOLAR RNA, C/D BOX, 87; SNORD87
612217	INFLAMMATION AND LIPID REGULATOR WITH UBA-LIKE AND NBR1-LIKE DOMAINS; ILRUN
612218	ZINC FINGER- AND BTB DOMAIN-CONTAINING PROTEIN 38; ZBTB38
612219	EWING SARCOMA; ES
612220	BETA-1,4-N-ACETYLGALACTOSAMINYLTRANSFERASE 3; B4GALNT3
612221	STATURE QUANTITATIVE TRAIT LOCUS 10; STQTL10
612222	GALACTOSAMINE-6-SULFATE SULFATASE; GALNS
612223	STATURE QUANTITATIVE TRAIT LOCUS 11; STQTL11
612224	STATURE QUANTITATIVE TRAIT LOCUS 12; STQTL12
612225	MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 9; MODY9
612226	STATURE QUANTITATIVE TRAIT LOCUS 13; STQTL13
612227	DIABETES MELLITUS, KETOSIS-PRONE; KPD
612228	STATURE QUANTITATIVE TRAIT LOCUS 14; STQTL14
612229	COLORECTAL CANCER, SUSCEPTIBILITY TO, 3; CRCS3
612230	COLORECTAL CANCER, SUSCEPTIBILITY TO, 5; CRCS5
612231	COLORECTAL CANCER, SUSCEPTIBILITY TO, 6; CRCS6
612232	COLORECTAL CANCER, SUSCEPTIBILITY TO, 7; CRCS7
612233	LEUKODYSTROPHY, HYPOMYELINATING, 4; HLD4
612234	CALCIUM HOMEOSTASIS MODULATOR 1; CALHM1
612235	CALCIUM HOMEOSTASIS MODULATOR 2; CALHM2
612236	ENDOPLASMIC RETICULUM-GOLGI INTERMEDIATE COMPARTMENT PROTEIN 2; ERGIC2
612237	CHONDROSARCOMA, EXTRASKELETAL MYXOID
612238	SCOLIOSIS, ISOLATED, SUSCEPTIBILITY TO, 4; IS4
612239	SCOLIOSIS, ISOLATED, SUSCEPTIBILITY TO, 5; IS5
612240	ATRIAL FIBRILLATION, FAMILIAL, 7; ATFB7
612241	INFLAMMATORY BOWEL DISEASE 12; IBD12
612242	CHROMOSOME 10q22.3-q23.2 DELETION SYNDROME
612243	ADHESION G PROTEIN-COUPLED RECEPTOR G6; ADGRG6
612244	INFLAMMATORY BOWEL DISEASE 13; IBD13
612245	INFLAMMATORY BOWEL DISEASE 14; IBD14
612246	CD302 ANTIGEN; CD302
612247	CROUZON SYNDROME WITH ACANTHOSIS NIGRICANS; CAN
612248	ZINC FINGER PROTEIN 627; ZNF627
612249	THROMBOSPONDIN TYPE-1 DOMAIN-CONTAINING PROTEIN 7A; THSD7A
612250	G PROTEIN-COUPLED RECEPTOR 161: GPR161
612251	SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO, 10; SLEB10
612252	C-TYPE LECTIN DOMAIN FAMILY 9, MEMBER A; CLEC9A
612253	SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO, 11; SLEB11
612254	SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO, 12; SLEB12
612255	INFLAMMATORY BOWEL DISEASE 15; IBD15
612256	MICROTUBULE-ASSOCIATED SERINE/THREONINE KINASE 1; MAST1
612257	MICROTUBULE-ASSOCIATED SERINE/THREONINE KINASE 2; MAST2
612258	MICROTUBULE-ASSOCIATED SERINE/THREONINE KINASE 3; MAST3
612259	INFLAMMATORY BOWEL DISEASE 16; IBD16
612260	IMMUNODEFICIENCY 68; IMD68
612261	INFLAMMATORY BOWEL DISEASE 17; IBD17
612262	INFLAMMATORY BOWEL DISEASE 18; IBD18
612263	MELANOMA, CUTANEOUS MALIGNANT, SUSCEPTIBILITY TO, 7; CMM7
612264	MANNOSE RECEPTOR, C-TYPE, 2; MRC2
612265	FAMILY WITH SEQUENCE SIMILARITY 120, MEMBER A; FAM120A
612266	FAMILY WITH SEQUENCE SIMILARITY 120, MEMBER B; FAM120B
612267	SKIN/HAIR/EYE PIGMENTATION, VARIATION IN, 10; SHEP10
612268	TUBULIN TYROSINE LIGASE-LIKE 5; TTLL5
612269	EPILEPSY, CHILDHOOD ABSENCE, SUSCEPTIBILITY TO, 5; ECA5
612270	CELL DIVISION CYCLE-ASSOCIATED PROTEIN 4; CDCA4
612271	SKIN/HAIR/EYE PIGMENTATION, VARIATION IN, 11; SHEP11
612272	MOVED TO 608644
612273	MOVED TO 611884
612274	CILIARY DYSKINESIA, PRIMARY, 8; CILD8
612275	GAMETOGENETIN-BINDING PROTEIN 2; GGNBP2
612276	YRDC DOMAIN-CONTAINING PROTEIN; YRDC
612277	ADAMTS-LIKE PROTEIN 2; ADAMTSL2
612278	INFLAMMATORY BOWEL DISEASE (CROHN DISEASE) 19; IBD19
612279	GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 6; GEFSP6
612280	FUCOSIDASE, ALPHA-L, 1; FUCA1
612281	ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 6; ARCI6
612282	ZINC FINGER PROTEIN 804A; ZNF804A
612283	PROTEIN C; PROC
612284	MECKEL SYNDROME, TYPE 6; MKS6
612285	JOUBERT SYNDROME 9; JBTS9
612286	NEPHROLITHIASIS/OSTEOPOROSIS, HYPOPHOSPHATEMIC, 1; NPHLOP1
612287	NEPHROLITHIASIS/OSTEOPOROSIS, HYPOPHOSPHATEMIC, 2; NPHLOP2
612288	INFLAMMATORY BOWEL DISEASE 20; IBD20
612289	FONTAINE PROGEROID SYNDROME; FPS
612290	MICROTIA, HEARING IMPAIRMENT, AND CLEFT PALATE
612291	JOUBERT SYNDROME 8; JBTS8
612292	BIRK-BAREL SYNDROME; BIBARS
612293	POROKERATOSIS 5, DISSEMINATED SUPERFICIAL ACTINIC TYPE; POROK5
612294	DEP DOMAIN-CONTAINING PROTEIN 7; DEPDC7
612295	ADP-RIBOSYLATION FACTOR-LIKE GTPase 14 EFFECTOR PROTEIN; ARL14EP
612296	LONG INTERGENIC NONCODING RNA 294; LINC00294
612297	CHROMOSOME 11 OPEN READING FRAME 41; C11ORF41
612298	TRIPARTITE MOTIF-CONTAINING PROTEIN 44; TRIM44
612299	COMM DOMAIN-CONTAINING PROTEIN 9; COMMD9
612300	HEMOLYTIC ANEMIA, CD59-MEDIATED, WITH OR WITHOUT IMMUNE-MEDIATED POLYNEUROPATHY; HACD59
612301	OSTEOPETROSIS, AUTOSOMAL RECESSIVE 7; OPTB7
612302	ADHESION G PROTEIN-COUPLED RECEPTOR A1; ADGRA1
612303	ADHESION G PROTEIN-COUPLED RECEPTOR A3; ADGRA3
612304	THROMBOPHILIA DUE TO PROTEIN C DEFICIENCY, AUTOSOMAL RECESSIVE; THPH4
612305	ADHESION G PROTEIN-COUPLED RECEPTOR E4, PSEUDOGENE; ADGRE4P
612306	THYROID-STIMULATING HORMONE LEVEL QUANTITATIVE TRAIT LOCUS 1; TSHQTL1
612307	ADHESION G PROTEIN-COUPLED RECEPTOR G7; ADGRG7
612308	ZINC FINGER AND BTB DOMAIN-CONTAINING 4; ZBTB4
612309	COAGULATION FACTOR V; F5
612310	PREMATURE OVARIAN FAILURE 6; POF6
612311	ATTENTION DEFICIT-HYPERACTIVITY DISORDER, SUSCEPTIBILITY TO, 5
612312	ATTENTION DEFICIT-HYPERACTIVITY DISORDER, SUSCEPTIBILITY TO, 6
612313	GLASS SYNDROME; GLASS
612314	GLUTATHIONE S-TRANSFERASE, OMEGA-2; GSTO2
612315	KERATIN 6C, TYPE II; KRT6C
612316	ATPase FAMILY, AAA DOMAIN-CONTAINING, MEMBER 3A; ATAD3A
612317	ATPase FAMILY, AAA DOMAIN-CONTAINING, MEMBER 3B; ATAD3B
612318	PSEUDOFOLLICULITIS BARBAE
612319	SPASTIC PARAPLEGIA 35, AUTOSOMAL RECESSIVE, WITH OR WITHOUT NEURODEGENERATION; SPG35
612320	CUB DOMAIN-CONTAINING PROTEIN 2; CDCP2
612321	MOVED TO 608062
612322	FAST KINASE DOMAINS 2; FASTKD2
612323	INNER MITOCHONDRIAL MEMBRANE PEPTIDASE, SUBUNIT 1; IMMP1L
612324	COILED-COIL DOMAIN-CONTAINING PROTEIN 34; CCDC34
612325	INTESTINAL CELL KINASE; ICK
612326	TRANSCRIPTION FACTOR 25; TCF25
612327	MANNOSIDASE, ENDO-ALPHA; MANEA
612328	COILED-COIL DOMAIN-CONTAINING PROTEIN 73: CCDC73
612329	MICRO RNA 30A; MIR30A
612330	MICRO RNA 610; MIRN610
612331	LIN7 HOMOLOG B, CRUMBS CELL POLARITY COMPLEX COMPONENT; LIN7B
612332	LIN7 HOMOLOG C, CRUMBS CELL POLARITY COMPLEX COMPONENT; LIN7C
612333	PROGRAMMED CELL DEATH 11; PDCD11
612334	N-ACYL PHOSPHATIDYLETHANOLAMINE-HYDROLYZING PHOSPHOLIPASE D; NAPEPLD
612335	SPASTIC PARAPLEGIA 38, AUTOSOMAL DOMINANT; SPG38
612336	THROMBOPHILIA DUE TO PROTEIN S DEFICIENCY, AUTOSOMAL DOMINANT; THPH5
612337	INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 22; MRD22
612338	GAMMA-GLUTAMYLTRANSFERASE, LIGHT CHAIN 1; GGTLC1
612339	GAMMA-GLUTAMYLTRANSFERASE, LIGHT CHAIN 2; GGTLC2
612340	GAMMA-GLUTAMYLTRANSFERASE, LIGHT CHAIN 3; GGTLC3
612341	GAMMA-GLUTAMYLTRANSFERASE 6; GGT6
612342	GAMMA-GLUTAMYLTRANSFERASE 7; GGT7
612343	MUSICAL APTITUDE QUANTITATIVE TRAIT LOCUS
612344	ZINC FINGER PROTEIN 385B; ZNF385B
612345	CHROMOSOME 2q31.2 DELETION SYNDROME
612346	GAMMA-GLUTAMYLTRANSFERASE 1; GGT1
612347	JERVELL AND LANGE-NIELSEN SYNDROME 2; JLNS2
612348	THROMBOPHILIA, FAMILIAL, DUE TO DECREASED RELEASE OF TISSUE PLASMINOGEN ACTIVATOR; THPH9
612349	PHENYLALANINE HYDROXYLASE; PAH
612350	EHLERS-DANLOS SYNDROME, SPONDYLODYSPLASTIC TYPE, 3; EDSSPD3
612351	FORKHEAD BOX I3; FOXI3
612352	STAM-BINDING PROTEIN-LIKE 1; STAMBPL1
612353	POROKERATOSIS 6, MULTIPLE TYPES; POROK6
612354	INFLAMMATORY BOWEL DISEASE 21; IBD21
612355	MOVED TO 608881
612356	HEPARIN COFACTOR II DEFICIENCY
612357	MAJOR AFFECTIVE DISORDER 8; MAFD8
612358	KININOGEN 1; KNG1
612359	MOVED TO 158350
612360	NADH DEHYDROGENASE (UBIQUINONE) COMPLEX I, ASSEMBLY FACTOR 5; NDUFAF5
612361	SCHIZOPHRENIA 14
612362	BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 12; BMIQ12
612363	ALANINE AMINOTRANSFERASE, PLASMA LEVEL OF, QUANTITATIVE TRAIT LOCUS 1
612364	ALANINE AMINOTRANSFERASE, PLASMA LEVEL OF, QUANTITATIVE TRAIT LOCUS 2
612365	GAMMA GLUTAMYLTRANSFERASE, PLASMA LEVEL OF, QUANTITATIVE TRAIT LOCUS 1
612366	GAMMA GLUTAMYLTRANSFERASE, PLASMA LEVEL OF, QUANTITATIVE TRAIT LOCUS 2
612367	ALKALINE PHOSPHATASE, PLASMA LEVEL OF, QUANTITATIVE TRAIT LOCUS 2
612368	ALKALINE PHOSPHATASE, PLASMA LEVEL OF, QUANTITATIVE TRAIT LOCUS 3
612369	ALKALINE PHOSPHATASE, PLASMA LEVEL OF, QUANTITATIVE TRAIT LOCUS 4
612370	HYPOGONADOTROPIC HYPOGONADISM 5 WITH OR WITHOUT ANOSMIA; HH5
612371	MAJOR AFFECTIVE DISORDER 7; MAFD7
612372	MAJOR AFFECTIVE DISORDER 9; MAFD9
612373	SOLUTE CARRIER FAMILY 29 (NUCLEOSIDE TRANSPORTER), MEMBER 3: SLC29A3
612374	STIMULATOR OF INTERFERON RESPONSE cGAMP INTERACTOR 1; STING1
612375	AXIN INTERACTOR, DORSALIZATION-ASSOCIATED; AIDA
612376	ACUTE PROMYELOCYTIC LEUKEMIA; APL
612377	COMM DOMAIN-CONTAINING PROTEIN 6; COMMD6
612378	SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO, 13; SLEB13
612379	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Iq; CDG1Q
612380	INFLAMMATORY BOWEL DISEASE 22; IBD22
612381	INFLAMMATORY BOWEL DISEASE 23; IBD23
612382	MEDIATOR COMPLEX SUBUNIT 10; MED10
612383	MEDIATOR COMPLEX SUBUNIT 11; MED11
612384	MEDIATOR COMPLEX SUBUNIT 18; MED18
612385	MEDIATOR COMPLEX SUBUNIT 19; MED19
612386	FERROCHELATASE; FECH
612387	SARCOIDOSIS, SUSCEPTIBILITY TO, 2; SS2
612388	SARCOIDOSIS, SUSCEPTIBILITY TO, 3; SS3
612389	PONTOCEREBELLAR HYPOPLASIA, TYPE 2B; PCH2B
612390	PONTOCEREBELLAR HYPOPLASIA, TYPE 2C; PCH2C
612391	MOVED TO 602782
612392	NADH DEHYDROGENASE (UBIQUINONE) COMPLEX I, ASSEMBLY FACTOR 6; NDUFAF6
612393	WAS PROTEIN HOMOLOG ASSOCIATED WITH ACTIN, GOLGI MEMBRANES, AND MICROTUBULES; WHAMM
612394	BONE FRAGILITY WITH CONTRACTURES, ARTERIAL RUPTURE, AND DEAFNESS; BCARD
612395	CHOLINE KINASE, BETA; CHKB
612396	ALLANTOICASE; ALLC
612397	COLLAGEN, TYPE VI, ALPHA-4, PSEUDOGENE 1; COL6A4P1
612398	RAB-ASSOCIATED PROTEIN RAB21; RAB21
612399	TLE FAMILY MEMBER 6, SUBCORTICAL MATERNAL COMPLEX MEMBER; TLE6
612400	OSTEOARTHRITIS SUSCEPTIBILITY 5; OS5
612401	OSTEOARTHRITIS SUSCEPTIBILITY 6; OS6
612402	ALS2 C-TERMINAL-LIKE PROTEIN; ALS2CL
612403	RAS-LIKE, FAMILY 11, MEMBER A; RASL11A
612404	RAS-LIKE, FAMILY 11, MEMBER B; RASL11B
612405	ADP-RIBOSYLATION FACTOR-LIKE GTPase 9; ARL9
612406	DYSTONIA 17, TORSION, AUTOSOMAL RECESSIVE; DYT17
612407	REGULATOR OF G PROTEIN SIGNALING 21; RGS21
612408	PARASPECKLE COMPONENT 1; PSPC1
612409	RNA-BINDING MOTIF PROTEIN 14; RBM14
612410	PSORIASIS 10, SUSCEPTIBILITY TO; PSORS10
612411	FAT ATYPICAL CADHERIN 4; FAT4
612412	SPERMATOGENESIS AND CENTRIOLE-ASSOCIATED PROTEIN 1-LIKE; SPATC1L
612413	RNA-BINDING MOTIF PROTEIN 7; RBM7
612414	LEUCINE-RICH TRANSMEMBRANE O-METHYLTRANSFERASE; LRTOMT
612415	RAS-ASSOCIATED PROTEIN 24; RAB24
612416	FACTOR XI DEFICIENCY
612417	NARCOLEPSY 4, SUSCEPTIBILITY TO; NRCLP4
612418	TRANSMEMBRANE PROTEIN 70; TMEM70
612419	CARTILAGE INTERMEDIATE LAYER PROTEIN 2; CILP2
612420	ACTIN FILAMENT-ASSOCIATED PROTEIN 1-LIKE PROTEIN 2; AFAP1L2
612421	ALOPECIA, ANDROGENETIC, 3; AGA3
612422	CARDIOMYOPATHY, FAMILIAL RESTRICTIVE, 3; RCM3
612423	PREKALLIKREIN DEFICIENCY; PKKD
612424	EYES SHUT HOMOLOG; EYS
612425	SHUGOSHIN-LIKE 2; SGOL2
612426	RECQ-MEDIATED GENOME INSTABILITY 2; RMI2
612427	RNA-BINDING MOTIF PROTEIN 25; RBM25
612428	RNA-BINDING MOTIF PROTEIN 38; RBM38
612429	ZINC FINGER PROTEIN 300; ZNF300
612430	RNA-BINDING MOTIF PROTEIN 22; RBM22
612431	DEAFNESS, AUTOSOMAL DOMINANT 27; DFNA27
612432	WAS/WASL-INTERACTING PROTEIN FAMILY, MEMBER 3; WIPF3
612433	DEAFNESS, AUTOSOMAL RECESSIVE 45; DFNB45
612434	CYSTEINE-RICH SECRETORY PROTEIN, LCCL DOMAIN-CONTAINING, 2; CRISPLD2
612435	SOLUTE CARRIER ORGANIC ANION TRANSPORTER FAMILY, MEMBER 3A1; SLCO3A1
612436	SOLUTE CARRIER ORGANIC ANION TRANSPORTER FAMILY, MEMBER 4A1; SLCO4A1
612437	EPILEPSY, PROGRESSIVE MYOCLONIC, 1B; EPM1B
612438	LEUKODYSTROPHY, HYPOMYELINATING, 6; HLD6
612439	ADP-RIBOSYLATION FACTOR GTPase-ACTIVATING PROTEIN 3; ARFGAP3
612440	MOVED TO 607694
612441	ALPHA-1,6-MANNOSYL-GLYCOPROTEIN BETA-1,6-N-ACETYLGLUCOSAMINYLTRANSFERASE, ISOZYME B; MGAT5B
612442	SEC22 HOMOLOG A, VESICLE TRAFFICKING PROTEIN; SEC22A
612443	MOVED TO 612319
612444	CILIARY DYSKINESIA, PRIMARY, 9; CILD9
612445	SCOLIOSIS, ARACHNODACTYLY, AND BLINDNESS
612446	COMPLEMENT COMPONENT 6 DEFICIENCY; C6D
612447	SKELETAL DEFECTS, GENITAL HYPOPLASIA, AND IMPAIRED INTELLECTUAL DEVELOPMENT
612448	AGE-RELATED HEARING IMPAIRMENT 1; ARHI1
612449	GEN1 HOLLIDAY JUNCTION 5-PRIME FLAP ENDONUCLEASE; GEN1
612450	HBS1-LIKE PROTEIN; HBS1L
612451	RING FINGER PROTEIN 114; RNF114
612452	KAT8 REGULATORY NSL COMPLEX, SUBUNIT 1; KANSL1
612453	MULTIPLE EPIDERMAL GROWTH FACTOR-LIKE DOMAINS 10; MEGF10
612454	MULTIPLE EPIDERMAL GROWTH FACTOR-LIKE DOMAINS 11; MEGF11
612455	SOLUTE CARRIER FAMILY 5 (SODIUM/GLUCOSE COTRANSPORTER), MEMBER 12; SLC5A12
612456	APOLIPOPROTEIN L DOMAIN-CONTAINING 1; APOLD1
612457	AT-RICH INTERACTION DOMAIN-CONTAINING PROTEIN 3B; ARID3B
612458	ACTIN-LIKE 6B; ACTL6B
612459	BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 13; BMIQ13
612460	BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 14; BMIQ14
612461	ACTIVITY-REGULATED CYTOSKELETON-ASSOCIATED PROTEIN; ARC
612462	PSEUDOHYPOPARATHYROIDISM, TYPE IC; PHP1C
612463	PSEUDOPSEUDOHYPOPARATHYROIDISM; PPHP
612464	ARRESTIN DOMAIN-CONTAINING PROTEIN 3; ARRDC3
612465	TBC1 DOMAIN FAMILY, MEMBER 4; TBC1D4
612466	GUANYLATE-BINDING PROTEIN 4; GBP4
612467	GUANYLATE-BINDING PROTEIN 6; GBP6
612468	GUANYLATE-BINDING PROTEIN 7; GBP7
612469	WAGRO SYNDROME; WAGRO
612470	BASIC LEUCINE ZIPPER TRANSCRIPTION FACTOR, ATF-LIKE 3; BATF3
612471	ALANINE-GLYOXYLATE AMINOTRANSFERASE 2; AGXT2
612472	METHYLTRANSFERASE 3, N6-ADENOSINE-METHYLTRANSFERASE COMPLEX CATALYTIC SUBUNIT; METTL3
612473	PHOSPHATIDYLETHANOLAMINE-BINDING PROTEIN 4; PEBP4
612474	CHROMOSOME 1q21.1 DELETION SYNDROME, 1.35-MB
612475	CHROMOSOME 1q21.1 DUPLICATION SYNDROME
612476	BASIC LEUCINE ZIPPER TRANSCRIPTION FACTOR, ATF-LIKE; BATF
612477	IQ MOTIF-CONTAINING PROTEIN G; IQCG
612478	N-TERMINAL EF-HAND CALCIUM-BINDING PROTEIN 3; NECAB3
612479	MOVED TO 603075 AND 603029
612480	TCDD-INDUCIBLE POLY(ADP-RIBOSE) POLYMERASE; TIPARP
612481	POLY(ADP-RIBOSE) POLYMERASE FAMILY, MEMBER 12; PARP12
612482	RING FINGER PROTEIN 43; RNF43
612483	FAT ATYPICAL CADHERIN 3; FAT3
612484	RIBONUCLEASE, RNase A FAMILY, 7; RNASE7
612485	RIBONUCLEASE, RNase A FAMILY, 8; RNASE8
612486	DACHSOUS CADHERIN-RELATED 2; DCHS2
612487	RING FINGER PROTEIN 31; RNF31
612488	RING FINGER PROTEIN 38; RNF38
612489	RING FINGER PROTEIN 24; RNF24
612490	RING FINGER PROTEIN 181; RNF181
612491	APAF1-INTERACTING PROTEIN; APIP
612492	UBIQUITIN-SPECIFIC PROTEASE 30; USP30
612493	CANOPY FGF SIGNALING REGULATOR 1; CNPY1
612494	RHO GUANINE NUCLEOTIDE EXCHANGE FACTOR 10-LIKE; ARHGEF10L
612495	UBIQUITIN-PROTEIN LIGASE E3D; UBE3D
612496	RHO GUANINE NUCLEOTIDE EXCHANGE FACTOR 19; ARHGEF19
612497	TRANSFORMING GROWTH FACTOR-BETA-INDUCIBLE NUCLEAR PROTEIN 1
612498	ADENYLOSUCCINATE SYNTHASE 1; ADSS1
612499	DIMT1 rRNA METHYLTRANSFERASE AND RIBOSOME MATURATION FACTOR; DIMT1
612500	DExD-BOX HELICASE 52; DDX52
612501	UBIQUITIN-CONJUGATING ENZYME E2 Q2; UBE2Q2
612502	COLLECTIN 11; COLEC11
612503	ATP-BINDING CASSETTE, SUBFAMILY A, MEMBER 5; ABCA5
612504	ATP-BINDING CASSETTE, SUBFAMILY A, MEMBER 6; ABCA6
612505	ATP-BINDING CASSETTE, SUBFAMILY A, MEMBER 8; ABCA8
612506	UBIQUITIN-CONJUGATING ENZYME E2 R2; UBE2R2
612507	ATP-BINDING CASSETTE, SUBFAMILY A, MEMBER 9; ABCA9
612508	ATP-BINDING CASSETTE, SUBFAMILY A, MEMBER 10; ABCA10
612509	ATP-BINDING CASSETTE, SUBFAMILY C, MEMBER 10; ABCC10
612510	ATP-BINDING CASSETTE, SUBFAMILY F, MEMBER 2; ABCF2
612511	MICRO RNA 101-1; MIRN101-1
612512	MICRO RNA 101-2; MIRN101-2
612513	CHROMOSOME 2p16.1-p15 DELETION SYNDROME
612514	SPECIFIC LANGUAGE IMPAIRMENT 4; SLI4
612515	DDB1- AND CUL4-ASSOCIATED FACTOR 17; DCAF17
612516	UVEAL AUTOANTIGEN WITH COILED-COIL DOMAINS AND ANKYRIN REPEATS; UACA
612517	DYNEIN, AXONEMAL, ASSEMBLY FACTOR 2; DNAAF2
612518	CILIARY DYSKINESIA, PRIMARY, 10; CILD10
612519	SOLUTE CARRIER FAMILY 35, MEMBER D3; SLC35D3
612520	TYPE 1 DIABETES MELLITUS 20; T1D20
612521	TYPE 1 DIABETES MELLITUS 21; T1D21
612522	TYPE 1 DIABETES MELLITUS 22; T1D22
612523	IQ MOTIF-CONTAINING PROTEIN H: IQCH
612524	RIBONUCLEASE P/MRP SUBUNIT p21; RPP21
612525	PYLORIC STENOSIS, INFANTILE HYPERTROPHIC, 5; IHPS5
612526	LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 3; CGL3
612527	DIAMOND-BLACKFAN ANEMIA 4; DBA4
612528	DIAMOND-BLACKFAN ANEMIA 5; DBA5
612529	AMELOGENESIS IMPERFECTA, HYPOMATURATION TYPE, IIA2; AI2A2
612530	CHROMOSOME 1q41-q42 DELETION SYNDROME
612531	THAP DOMAIN-CONTAINING PROTEIN 2; THAP2
612532	THAP DOMAIN-CONTAINING PROTEIN 3; THAP3
612533	THAP DOMAIN-CONTAINING PROTEIN 4; THAP4
612534	THAP DOMAIN-CONTAINING PROTEIN 5; THAP5
612535	THAP DOMAIN-CONTAINING PROTEIN 6; THAP6
612536	THAP DOMAIN-CONTAINING PROTEIN 8; THAP8
612537	THAP DOMAIN-CONTAINING PROTEIN 9; THAP9
612538	THAP DOMAIN-CONTAINING PROTEIN 10; THAP10
612539	SPASTIC PARAPLEGIA 42, AUTOSOMAL DOMINANT; SPG42
612540	CONGENITAL MYOPATHY 12; CMYP12
612541	NEUTROPENIA, SEVERE CONGENITAL, 4, AUTOSOMAL RECESSIVE; SCN4
612542	VITAMIN B12 PLASMA LEVEL QUANTITATIVE TRAIT LOCUS 1; B12QTL1
612543	UBIQUITIN-SPECIFIC PROTEASE 36; USP36
612544	ACTIN-BINDING LIM PROTEIN FAMILY, MEMBER 2; ABLIM2
612545	WILLIAMS-BEUREN SYNDROME CHROMOSOME REGION 26; WBSCR26
612546	METHYLTRANSFERASE-LIKE 27; METTL27
612547	TRANSMEMBRANE PROTEIN 270; TMEM270
612548	TRIPARTITE MOTIF-CONTAINING PROTEIN 50; TRIM50
612549	TRIPARTITE MOTIF-CONTAINING PROTEIN 73; TRIM73
612550	TRIPARTITE MOTIF-CONTAINING PROTEIN 74; TRIM74
612551	FOCAL SEGMENTAL GLOMERULOSCLEROSIS 4, SUSCEPTIBILITY TO; FSGS4
612552	ZINC FINGER BED DOMAIN-CONTAINING PROTEIN 4; ZBED4
612553	MICRO RNA 370; MIR370
612554	MYOPIA 16, AUTOSOMAL DOMINANT; MYP16
612555	BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2
612556	ADIPONECTIN DEFICIENCY; ADPOD
612557	LEUKEMIA, CHRONIC LYMPHOCYTIC, SUSCEPTIBILITY TO, 3
612558	LEUKEMIA, CHRONIC LYMPHOCYTIC, SUSCEPTIBILITY TO, 4
612559	LEUKEMIA, CHRONIC LYMPHOCYTIC, SUSCEPTIBILITY TO, 5
612560	BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS 12; BMND12
612561	DIAMOND-BLACKFAN ANEMIA 6; DBA6
612562	DIAMOND-BLACKFAN ANEMIA 7; DBA7
612563	DIAMOND-BLACKFAN ANEMIA 8; DBA8
612564	THIOREDOXIN DOMAIN-CONTAINING PROTEIN 9; TXNDC9
612565	RAS-ASSOCIATED PROTEIN RAB1B; RAB1B
612566	INFLAMMATORY BOWEL DISEASE 24; IBD24
612567	INFLAMMATORY BOWEL DISEASE 25, AUTOSOMAL RECESSIVE; IBD25
612568	SPIC TRANSCRIPTION FACTOR; SPIC
612569	CELL DIVISION CYCLE AND APOPTOSIS REGULATOR 1; CCAR1
612570	FIBRILLIN 2; FBN2
612571	LUNG CANCER SUSCEPTIBILITY 3; LNCR3
612572	RETINITIS PIGMENTOSA 46; RP46
612573	MEAN PLATELET VOLUME/COUNT QUANTITATIVE TRAIT LOCUS 1; MPVCQTL1
612574	MEAN PLATELET VOLUME/COUNT QUANTITATIVE TRAIT LOCUS 2; MPVCQTL2
612575	MEAN PLATELET VOLUME/COUNT QUANTITATIVE TRAIT LOCUS 3; MPVCQTL3
612576	CHROMOSOME 17p13.3, TELOMERIC, DUPLICATION SYNDROME
612577	AMYOTROPHIC LATERAL SCLEROSIS 11; ALS11
612578	STATURE QUANTITATIVE TRAIT LOCUS 15; STQTL15
612579	STATURE QUANTITATIVE TRAIT LOCUS 16; STQTL16
612580	INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 3; MRD3
612581	INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 4; MRD4
612582	CHROMOSOME 6pter-p24 DELETION SYNDROME
612583	SPHINGOLIPID TRANSPORTER 1; SPNS1
612584	SPHINGOLIPID TRANSPORTER 2; SPNS2
612585	CLPTM1-LIKE PROTEIN; CLPTM1L
612586	ANEURYSM, INTRACRANIAL BERRY, 9; ANIB9
612587	ANEURYSM, INTRACRANIAL BERRY, 10; ANIB10
612588	BCL2-ASSOCIATED TRANSCRIPTION FACTOR 1; BCLAF1
612589	COLORECTAL CANCER, SUSCEPTIBILITY TO, 8; CRCS8
612590	COLORECTAL CANCER, SUSCEPTIBILITY TO, 9; CRCS9
612591	COLORECTAL CANCER, SUSCEPTIBILITY TO, 10; CRCS10
612592	COLORECTAL CANCER, SUSCEPTIBILITY TO, 11; CRCS11
612593	LUNG CANCER SUSCEPTIBILITY 4; LNCR4
612594	MULTIPLE SCLEROSIS, SUSCEPTIBILITY TO, 2; MS2
612595	MULTIPLE SCLEROSIS, SUSCEPTIBILITY TO, 3; MS3
612596	MULTIPLE SCLEROSIS, SUSCEPTIBILITY TO, 4; MS4
612597	CYTOTOXIC AND REGULATORY T-CELL MOLECULE; CRTAM
612598	RING FINGER PROTEIN 11; RNF11
612599	PSORIASIS 11, SUSCEPTIBILITY TO; PSORS11
612600	RNA METHYLTRANSFERASE-LIKE 1; RNMTL1
612601	RET FINGER PROTEIN-LIKE 4A; RFPL4A
612602	RNA-BINDING MOTIF PROTEIN 15B; RBM15B
612603	LATE CORNIFIED ENVELOPE PROTEIN 1A; LCE1A
612604	LATE CORNIFIED ENVELOPE PROTEIN 1B; LCE1B
612605	LATE CORNIFIED ENVELOPE 1C; LCE1C
612606	LATE CORNIFIED ENVELOPE PROTEIN 1D; LCE1D
612607	LATE CORNIFIED ENVELOPE PROTEIN 1E; LCE1E
612608	LATE CORNIFIED ENVELOPE PROTEIN 1F; LCE1F
612609	LATE CORNIFIED ENVELOPE PROTEIN 2A; LCE2A
612610	LATE CORNIFIED ENVELOPE PROTEIN 2B; LCE2B
612611	LATE CORNIFIED ENVELOPE PROTEIN 2C; LCE2C
612612	LATE CORNIFIED ENVELOPE PROTEIN 2D; LCE2D
612613	LATE CORNIFIED ENVELOPE PROTEIN 3A; LCE3A
612614	LATE CORNIFIED ENVELOPE PROTEIN 3B; LCE3B
612615	LATE CORNIFIED ENVELOPE PROTEIN 3C; LCE3C
612616	LATE CORNIFIED ENVELOPE PROTEIN 3D; LCE3D
612617	LATE CORNIFIED ENVELOPE PROTEIN 3E; LCE3E
612618	LATE CORNIFIED ENVELOPE PROTEIN 4A; LCE4A
612619	LATE CORNIFIED ENVELOPE PROTEIN 5A; LCE5A
612620	RAS ASSOCIATION DOMAIN FAMILY, MEMBER 6; RASSF6
612621	INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 5; MRD5
612622	TYPE 1 DIABETES MELLITUS 23; T1D23
612623	MICROVASCULAR COMPLICATIONS OF DIABETES, SUSCEPTIBILITY TO, 2; MVCD2
612624	MICROVASCULAR COMPLICATIONS OF DIABETES, SUSCEPTIBILITY TO, 3; MVCD3
612625	LMBR1 DOMAIN-CONTAINING PROTEIN 1: LMBRD1
612626	CHROMOSOME 15q26-qter DELETION SYNDROME
612627	SEIZURES, BENIGN FAMILIAL INFANTILE, 4; BFIS4
612628	MICROVASCULAR COMPLICATIONS OF DIABETES, SUSCEPTIBILITY TO, 4; MVCD4
612629	ADIPONECTIN, SERUM LEVEL OF, QUANTITATIVE TRAIT LOCUS 4; ADIPQTL4
612630	HAIR MORPHOLOGY 1; HRM1
612631	ADENYLATE KINASE DEFICIENCY, HEMOLYTIC ANEMIA DUE TO
612632	USHER SYNDROME, TYPE IH; USH1H
612633	MICROVASCULAR COMPLICATIONS OF DIABETES, SUSCEPTIBILITY TO, 5; MVCD5
612634	MICROVASCULAR COMPLICATIONS OF DIABETES, SUSCEPTIBILITY TO, 6; MVCD6
612635	MICROVASCULAR COMPLICATIONS OF DIABETES, SUSCEPTIBILITY TO, 7; MVCD7
612636	UNC80 HOMOLOG, NALCN CHANNEL COMPLEX SUBUNIT; UNC80
612637	FEBRILE SEIZURES, FAMILIAL, 10; FEB10
612638	NADH-UBIQUINONE OXIDOREDUCTASE SUBUNIT A11; NDUFA11
612639	INFLAMMATORY BOWEL DISEASE 26; IBD26
612640	THYMUS, BRAIN, AND TESTES ASSOCIATED; TBATA
612641	ANKYRIN 1; ANK1
612642	DEAFNESS, AUTOSOMAL DOMINANT 59; DFNA59
612643	DEAFNESS, AUTOSOMAL DOMINANT 3B; DFNA3B
612644	DEAFNESS, AUTOSOMAL DOMINANT 2B; DFNA2B
612645	DEAFNESS, AUTOSOMAL RECESSIVE 1B; DFNB1B
612646	MET TRANSCRIPTIONAL REGULATOR MACC1; MACC1
612647	RADIAL SPOKE HEAD COMPONENT 4A; RSPH4A
612648	RADIAL SPOKE HEAD COMPONENT 9; RSPH9
612649	CILIARY DYSKINESIA, PRIMARY, 11; CILD11
612650	CILIARY DYSKINESIA, PRIMARY, 12; CILD12
612651	ENDOCRINE-CEREBROOSTEODYSPLASIA; ECO
612652	MOVED TO 219150
612653	SPHEROCYTOSIS, TYPE 4; SPH4
612654	TRICHOPLEIN; TCHP
612655	TBC1 DOMAIN FAMILY, MEMBER 7; TBC1D7
612656	EPISODIC ATAXIA, TYPE 6; EA6
612657	CONE-ROD DYSTROPHY 12; CORD12
612658	TIGHT JUNCTION-ASSOCIATED PROTEIN 1; TJAP1
612659	REGULATORY FACTOR X, 6; RFX6
612660	REGULATORY FACTOR X, 7; RFX7
612661	WD REPEAT-CONTAINING PROTEIN ANTISENSE TO TP53; WRAP53
612662	TBC1 DOMAIN FAMILY, MEMBER 15; TBC1D15
612663	TRAF-INTERACTING PROTEIN WITH FORKHEAD-ASSOCIATED DOMAIN, FAMILY MEMBER B; TIFAB
612664	RAS-LIKE AND ESTROGEN-REGULATED GROWTH INHIBITOR; RERG
612665	TESTIS-EXPRESSED GENE 101; TEX101
612666	DUAL SERINE/THREONINE AND TYROSINE PROTEIN KINASE; DSTYK
612667	HOLLIDAY JUNCTION RECOGNITION PROTEIN; HJURP
612668	TASTE RECEPTOR, TYPE 2, MEMBER 43; TAS2R43
612669	TASTE RECEPTOR, TYPE 2, MEMBER 31; TAS2R31
612670	MOVED TO 138900
612671	URIC ACID CONCENTRATION, SERUM, QUANTITATIVE TRAIT LOCUS 4; UAQTL4
612672	RAS-ASSOCIATED PROTEIN RAB10; RAB10
612673	RAS-ASSOCIATED PROTEIN RAB14; RAB14
612674	POLYNEUROPATHY, HEARING LOSS, ATAXIA, RETINITIS PIGMENTOSA, AND CATARACT; PHARC
612675	SMALL CAJAL BODY-SPECIFIC RNA 15; SCARNA15
612676	QUINOID DIHYDROPTERIDINE REDUCTASE; QDPR
612677	PYRIN AND HIN DOMAIN FAMILY, MEMBER 1; PYHIN1
612678	CUGBP- AND ELAV-LIKE FAMILY, MEMBER 3; CELF3
612679	CUGBP- AND ELAV-LIKE FAMILY, MEMBER 4; CELF4
612680	CUGBP- AND ELAV-LIKE FAMILY, MEMBER 5; CELF5
612681	CUGBP- AND ELAV-LIKE FAMILY, MEMBER 6; CELF6
612682	DORSAL INHIBITORY AXON GUIDANCE PROTEIN; DRAXIN
612683	TEKTIN 3; TEKT3
612684	ISTHMIN 2; ISM2
612685	CALMODULIN-REGULATED SPECTRIN-ASSOCIATED PROTEIN 3; CAMSAP3
612686	PLECKSTRIN HOMOLOGY DOMAIN-CONTAINING PROTEIN, FAMILY A, MEMBER 7; PLEKHA7
612687	RGM DOMAIN FAMILY, MEMBER B; RGMB
612688	RING FINGER PROTEIN 168; RNF168
612689	TIGHT JUNCTION PROTEIN 3; TJP3
612690	SPHEROCYTOSIS, TYPE 5; SPH5
612691	POLYMICROGYRIA, BILATERAL TEMPOROOCCIPITAL; BTOP
612692	AGAMMAGLOBULINEMIA 6, AUTOSOMAL RECESSIVE; AGM6
612693	UBIQUITIN-RELATED MODIFIER 1; URM1
612694	CYTOSOLIC THIOURIDYLASE, SUBUNIT 1; CTU1
612695	VAULT RNA 1-1; VTRNA1-1
612696	VAULT RNA 1-2; VTRNA1-2
612697	VAULT RNA 1-3; VTRNA1-3
612698	MICRO RNA 187; MIR187
612699	RIMS-BINDING PROTEIN 3; RIMBP3
612700	RIMS-BINDING PROTEIN 3B; RIMBP3B
612701	RIMS-BINDING PROTEIN 3C; RIMBP3C
612702	HYPOGONADOTROPIC HYPOGONADISM 6 WITH OR WITHOUT ANOSMIA; HH6
612703	MICROCEPHALY 7, PRIMARY, AUTOSOMAL RECESSIVE; MCPH7
612704	RANBP2-LIKE AND GRIP DOMAIN-CONTAINING PROTEIN 1; RGPD1
612705	RANBP2-LIKE AND GRIP DOMAIN-CONTAINING PROTEIN 2; RGPD2
612706	RANBP2-LIKE AND GRIP DOMAIN-CONTAINING PROTEIN 3; RGPD3
612707	RANBP2-LIKE AND GRIP DOMAIN-CONTAINING PROTEIN 4; RGPD4
612708	RANBP2-LIKE AND GRIP DOMAIN-CONTAINING PROTEIN 5; RGPD5
612709	RANBP2-LIKE AND GRIP DOMAIN-CONTAINING PROTEIN 6; RGPD6
612710	RANBP2-LIKE AND GRIP DOMAIN-CONTAINING PROTEIN 7; RGPD7
612711	GRIP AND COILED-COIL DOMAIN-CONTAINING PROTEIN 2; GCC2
612712	LEBER CONGENITAL AMAUROSIS 13; LCA13
612713	KAHRIZI SYNDROME; KHRZ
612714	EXOCRINE PANCREATIC INSUFFICIENCY, DYSERYTHROPOIETIC ANEMIA, AND CALVARIAL HYPEROSTOSIS
612715	DYSCHROMATOSIS UNIVERSALIS HEREDITARIA 2; DUH2
612716	DYSTONIA, DOPA-RESPONSIVE, DUE TO SEPIAPTERIN REDUCTASE DEFICIENCY
612717	MYOPIA 15, AUTOSOMAL DOMINANT; MYP15
612718	CEREBRAL CREATINE DEFICIENCY SYNDROME 3; CCDS3
612719	6-PYRUVOYL-TETRAHYDROPTERIN SYNTHASE; PTS
612720	DExH-BOX HELICASE; DHX29
612721	REGULATED ENDOCRINE-SPECIFIC PROTEIN 18
612722	ELONGATOR ACETYLTRANSFERASE COMPLEX, SUBUNIT 3; ELP3
612723	PLECKSTRIN HOMOLOGY DOMAIN-CONTAINING PROTEIN, FAMILY H, MEMBER 2; PLEKHH2
612724	ALDOLASE B, FRUCTOSE-BISPHOSPHATE; ALDOB
612725	PROTEIN PHOSPHATASE 6, CATALYTIC SUBUNIT; PPP6C
612726	MOVED TO 301068
612727	BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS 13; BMND13
612728	BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS 14; BMND14
612729	LEAN BODY MASS QUANTITATIVE TRAIT LOCUS 1; LBMQTL1
612730	SOLUTE CARRIER FAMILY 9 (SODIUM/HYDROGEN EXCHANGER), MEMBER 8; SLC9A8
612731	FACIOCARDIOMELIC SYNDROME
612732	COPROPORPHYRINOGEN OXIDASE; CPOX
612733	THO COMPLEX, SUBUNIT 5; THOC5
612734	TLX1 NEIGHBOR; TLX1NB
612735	MAJOR HISTOCOMPATIBILITY COMPLEX, CLASS II, DR BETA-3; HLA-DRB3
612736	CEREBRAL CREATINE DEFICIENCY SYNDROME 2; CCDS2
612737	STATURE QUANTITATIVE TRAIT LOCUS 17; STQTL17
612738	SOLUTE CARRIER FAMILY 9, MEMBER 10; SLC9A10
612739	SPERM ACROSOME-ASSOCIATED PROTEIN 1; SPACA1
612740	PORPHYRIA, ACUTE HEPATIC
612741	SNAIL FAMILY TRANSCRIPTIONAL REPRESSOR 3; SNAI3
612742	MICRO RNA 181A1; MIR181A1
612743	MICRO RNA 181A2; MIR181A2
612744	MICRO RNA 181B1; MIR181B1
612745	MICRO RNA 181B2; MIR181B2
612746	MICRO RNA 181C; MIR181C
612747	TUFTELIN-INTERACTING PROTEIN 11; TFIP11
612748	LYSOZYME-LIKE 2; LYZL2
612749	SPERM ACROSOME-ASSOCIATED PROTEIN 3; SPACA3
612750	LYSOZYME-LIKE 4; LYZL4
612751	LYSOZYME-LIKE 6; LYZL6
612752	CXXC FINGER PROTEIN 5; CXXC5
612753	COLLAGEN AND CALCIUM-BINDING EGF DOMAIN-CONTAINING PROTEIN 1; CCBE1
612754	GLUTAREDOXIN 3; GLRX3
612755	N-ALPHA-ACETYLTRANSFERASE 25, NatB AUXILIARY SUBUNIT; NAA25
612756	TESTICULAR CELL ADHESION MOLECULE 1; TCAM1
612757	GLYCOSYLPHOSPHATIDYLINOSITOL-ANCHORED HIGH DENSITY LIPOPROTEIN-BINDING PROTEIN 1; GPIHBP1
612758	TRANSMEMBRANE ANTERIOR POSTERIOR TRANSFORMATION 1; TAPT1
612759	SYNESTHESIA
612760	SNF-RELATED KINASE; SNRK
612761	SWI/SNF-RELATED, MATRIX-ASSOCIATED ACTIN-DEPENDENT REGULATOR OF CHROMATIN, SUBFAMILY A, DEAD/H BOX-CONTAINING, 1; SMARCAD1
612762	SPTY7-LIKE, STAGA COMPLEX SUBUNIT GAMMA; SUPT7L
612763	TRANSCRIPTIONAL ADAPTOR 1-LIKE; TADA1L
612764	ISY1 SPLICING FACTOR HOMOLOG; ISY1
612765	SFI1 CENTRIN-BINDING PROTEIN; SFI1
612766	BRISC AND BRCA1 A COMPLEX, MEMBER 1; BABAM1
612767	DEAH-BOX HELICASE 36; DHX36
612768	FOLLICULIN-INTERACTING PROTEIN 2; FNIP2
612769	NONCODING NUCLEAR-ENRICHED ABUNDANT TRANSCRIPT 1; NEAT1
612770	PHOSPHATIDYLSERINE DECARBOXYLASE; PISD
612771	DUAL OXIDASE MATURATION FACTOR 1; DUOXA1
612772	DUAL OXIDASE MATURATION FACTOR 2; DUOXA2
612773	BASAL CELL ADHESION MOLECULE; BCAM
612774	TASTE RECEPTOR, TYPE 2, MEMBER 46; TAS2R46
612775	CONE-ROD DYSTROPHY 9; CORD9
612776	HYPOGLOSSIA WITH SITUS INVERSUS
612777	HYPOTONIA, SEIZURES, AND PRECOCIOUS PUBERTY
612778	SET DOMAIN-CONTAINING PROTEIN 2; SETD2
612779	DIHYDROPYRIMIDINE DEHYDROGENASE; DPYD
612780	SEIZURES, SENSORINEURAL DEAFNESS, ATAXIA, IMPAIRED INTELLECTUAL DEVELOPMENT, AND ELECTROLYTE IMBALANCE; SESAMES
612781	ISOLATED GROWTH HORMONE DEFICIENCY, TYPE IB; IGHD1B
612782	IMMUNODEFICIENCY 9; IMD9
612783	IMMUNODEFICIENCY 10; IMD10
612784	HUNTINGTIN-INTERACTING PROTEIN K
612785	MEGARBANE-JALKH SYNDROME
612786	CYCLIN Y; CCNY
612787	PSEUDOURIDYLATE SYNTHASE 10; PUS10
612788	FORKHEAD BOX Q1; FOXQ1
612789	DEAFNESS, AUTOSOMAL RECESSIVE 71; DFNB71
612790	RHO GUANINE NUCLEOTIDE EXCHANGE FACTOR 28; ARHGEF28
612791	ZINC FINGER PROTEIN WITH KRAB AND SCAN DOMAINS 3; ZKSCAN3
612792	PHOSPHATIDYLSERINE SYNTHASE 1; PTDSS1
612793	PHOSPHATIDYLSERINE SYNTHASE 2; PTDSS2
612794	ATRIAL SEPTAL DEFECT 5; ASD5
612795	POLYUNSATURATED FATTY ACIDS PLASMA LEVEL QUANTITATIVE TRAIT LOCUS 1; PUFAQTL1
612796	INFLAMMATORY BOWEL DISEASE 27; IBD27
612797	HIGH DENSITY LIPOPROTEIN CHOLESTEROL LEVEL QUANTITATIVE TRAIT LOCUS 12; HDLCQ12
612798	QUESTION MARK EARS, ISOLATED; QME
612799	GLUTAMYL-tRNA SYNTHETASE 2, MITOCHONDRIAL; EARS2
612800	CYSTEINYL-tRNA SYNTHETASE 2; CARS2
612801	ISOLEUCYL-tRNA SYNTHETASE 2; IARS2
612802	VALYL-tRNA SYNTHETASE 2; VARS2
612803	ASPARAGINYL-tRNA SYNTHETASE 2; NARS2
612804	SERYL-tRNA SYNTHETASE 2; SARS2
612805	THREONYL-tRNA SYNTHETASE 2; TARS2
612806	G PROTEIN-COUPLED RECEPTOR 89B; GPR89B
612807	LEUCINE-RICH REPEAT AND FIBRONECTIN TYPE III DOMAIN-CONTAINING PROTEIN 1; LRFN1
612808	LEUCINE-RICH REPEAT AND FIBRONECTIN TYPE III DOMAIN-CONTAINING PROTEIN 2; LRFN2
612809	LEUCINE-RICH REPEAT AND FIBRONECTIN TYPE III DOMAIN-CONTAINING PROTEIN 3; LRFN3
612810	LEUCINE-RICH REPEAT AND FIBRONECTIN TYPE III DOMAIN-CONTAINING PROTEIN 4; LRFN4
612811	LEUCINE-RICH REPEAT AND FIBRONECTIN TYPE III DOMAIN-CONTAINING PROTEIN 5; LRFN5
612812	PROFILIN 3; PFN3
612813	SPONDYLOEPIMETAPHYSEAL DYSPLASIA, AGGRECAN TYPE; SEMDAG
612814	SPERMATOGENESIS-ASSOCIATED PROTEIN 18; SPATA18
612815	ZINC FINGER DHHC DOMAIN-CONTAINING PROTEIN 13; ZDHHC13
612816	UTP18 SMALL SUBUNIT PROCESSOME COMPONENT; UTP18
612817	KRR1 SMALL SUBUNITPROCESSOME COMPONENT HOMOLOG; KRR1
612818	NUCLEOLAR AND SPINDLE-ASSOCIATED PROTEIN 1; NUSAP1
612819	NUCLEOLAR COMPLEX-ASSOCIATED PROTEIN 4 HOMOLOG; NOC4L
612820	NEUROPLASTIN; NPTN
612821	G PROTEIN-COUPLED RECEPTOR 89A; GPR89A
612822	UTP20 SMALL SUBUNIT PROCESSOME COMPONENT; UTP20
612823	TATA BOX-BINDING PROTEIN-ASSOCIATED FACTOR 1D; TAF1D
612824	SEC14-LIKE LIPID-BINDING PROTEIN 3; SEC14L3
612825	SEC14-LIKE LIPID-BINDING PROTEIN 4; SEC14L4
612826	SPHINGOSINE-1-PHOSPHATE PHOSPHATASE 1; SGPP1
612827	SPHINGOSINE-1-PHOSPHATE PHOSPHATASE 2; SGPP2
612828	CCAAT/ENHANCER-BINDING PROTEIN, ZETA; CEBPZ
612829	RAS-ASSOCIATED PROTEIN RAB3C; RAB3C
612830	SHORT-CHAIN DEHYDROGENASE/REDUCTASE FAMILY, MEMBER 3; DHRS3
612831	17-BETA-HYDROXYSTEROID DEHYDROGENASE XI; HSD17B11
612832	17-BETA-HYDROXYSTEROID DEHYDROGENASE XIV; HSD17B14
612833	SHORT-CHAIN DEHYDROGENASE/REDUCTASE FAMILY, MEMBER 7; DHRS7
612834	PLECKSTRIN HOMOLOGY-LIKE DOMAIN, FAMILY B, MEMBER 1; PHLDB1
612835	PHOSPHOLIPASE C, ETA-1; PLCH1
612836	PHOSPHOLIPASE C, ETA-2; PLCH2
612837	COENZYME 9; COQ9
612838	BRUGADA SYNDROME 5; BRGDA5
612839	TET METHYLCYTOSINE DIOXYGENASE 2; TET2
612840	LEUKOCYTE ADHESION DEFICIENCY, TYPE III; LAD3
612841	HYPOTRICHOSIS 5; HYPT5
612842	RASD FAMILY, MEMBER 2; RASD2
612843	KERATOSIS FOLLICULARIS SPINULOSA DECALVANS, AUTOSOMAL DOMINANT; KFSD
612844	SENTRIN-SPECIFIC PROTEASE FAMILY, MEMBER 3; SENP3
612845	SENTRIN-SPECIFIC PROTEASE FAMILY, MEMBER 5; SENP5
612846	SENTRIN-SPECIFIC PROTEASE FAMILY, MEMBER 7; SENP7
612847	BRACHYOLMIA TYPE 4 WITH MILD EPIPHYSEAL AND METAPHYSEAL CHANGES; BCYM4
612848	SUCCINATE DEHYDROGENASE COMPLEX ASSEMBLY FACTOR 1; SDHAF1
612849	UBIQUITIN-SPECIFIC PEPTIDASE 46; USP46
612850	TUBULIN, BETA-2B; TUBB2B
612851	NARCOLEPSY 5, SUSCEPTIBILITY TO; NRCLP5
612852	CHRONIC RECURRENT MULTIFOCAL OSTEOMYELITIS 2, WITH PERIOSTITIS AND PUSTULOSIS; CRMO2
612853	RESTLESS LEGS SYNDROME, SUSCEPTIBILITY TO, 7; RLS7
612854	SEC16 HOMOLOG A, ENDOPLASMIC RETICULUM EXPORT FACTOR; SEC16A
612855	SEC16 HOMOLOG B, ENDOPLASMIC RETICULUM EXPORT FACTOR; SEC16B
612856	ASTROTACTIN 2; ASTN2
612857	PLACENTA-SPECIFIC GENE 9; PLAC9
612858	OROFACIAL CLEFT 12; OFC12
612859	T-CELL IMMUNORECEPTOR WITH IMMUNOGLOBULIN AND ITIM DOMAINS; TIGIT
612860	QUIESCIN Q6 SULFHYDRYL OXIDASE 2; QSOX2
612861	NOP16 NUCLEOLAR PROTEIN; NOP16
612862	PULMONARY HYPERTENSION, CHRONIC THROMBOEMBOLIC, WITHOUT DEEP VEIN THROMBOSIS, SUSCEPTIBILITY TO
612863	CHROMOSOME 6q24-q25 DELETION SYNDROME
612864	PHOSPHOLIPASE A2, GROUP IVD; PLA2G4D
612865	PHOSPHATIDYLINOSITOL 4-PHOSPHATE-5-KINASE-LIKE 1; PIP5KL1
612866	ALG14 UDP-N-ACETYLGLUCOSAMINYLTRANSFERASE SUBUNIT; ALG14
612867	CORNEAL DYSTROPHY, SUBEPITHELIAL MUCINOUS; SMCD
612868	CORNEAL DYSTROPHY, POSTERIOR AMORPHOUS; PACD
612869	ATTRACTIN-LIKE 1; ATRNL1
612870	PLECKSTRIN HOMOLOGY DOMAIN-INTERACTING PROTEIN; PHIP
612871	Na+/K+ TRANSPORTING ATPase-INTERACTING 1; NKAIN1
612872	Na+/K+ TRANSPORTING ATPase-INTERACTING 3; NKAIN3
612873	Na+/K+ TRANSPORTING ATPase-INTERACTING 4; NKAIN4
612874	ERYTHROCYTE AMP DEAMINASE DEFICIENCY
612875	GONADOTROPIN-RELEASING HORMONE RECEPTOR 2; GNRHR2
612876	SPINOCEREBELLAR ATAXIA 9; SCA9
612877	CARDIOMYOPATHY, DILATED, 1BB; CMD1BB
612878	EXOPHILIN 5; EXPH5
612879	MAM DOMAIN-CONTAINING PROTEIN 2; MAMDC2
612880	SYNAPTOTAGMIN-LIKE 2; SYTL2
612881	CHROMOSOME 5q14.3 DELETION SYNDROME, DISTAL
612882	MENARCHE, AGE AT, QUANTITATIVE TRAIT LOCUS 2; MENAQ2
612883	MENARCHE, AGE AT, QUANTITATIVE TRAIT LOCUS 3; MENAQ3
612884	MENOPAUSE, NATURAL, AGE AT, QUANTITATIVE TRAIT LOCUS 2; MENOQ2
612885	PREMATURE OVARIAN FAILURE 10; POF10
612886	MENOPAUSE, NATURAL, AGE AT, QUANTITATIVE TRAIT LOCUS 4; MENOQ4
612887	SEPTIN 11; SEPT11
612888	LEUCINE-RICH REPEAT-CONTAINING PROTEIN 8B; LRRC8B
612889	LEUCINE-RICH REPEAT-CONTAINING PROTEIN 8C; LRRC8C
612890	LEUCINE-RICH REPEAT-CONTAINING PROTEIN 8D; LRRC8D
612891	LEUCINE-RICH REPEAT-CONTAINING PROTEIN 8E; LRRC8E
612892	STATURE QUANTITATIVE TRAIT LOCUS 18; STQTL18
612893	STATURE QUANTITATIVE TRAIT LOCUS 19; STQTL19
612894	STATURE QUANTITATIVE TRAIT LOCUS 20; STQTL20
612895	NUCLEOREDOXIN; NXN
612896	RAD52 MOTIF-CONTAINING PROTEIN 1; RDM1
612897	SEPTIN 1; SEPT1
612898	COENZYME Q4; COQ4
612899	EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 8; EIG8
612900	CEREBRAL PALSY, SPASTIC QUADRIPLEGIC, 2; CPSQ2
612901	TUBULIN, BETA-1; TUBB1
612902	LIPOCALIN 8; LCN8
612903	LIPOCALIN 9; LCN9
612904	LIPOCALIN 10; LCN10
612905	LIPOCALIN 12; LCN12
612906	RAS-ASSOCIATED PROTEIN RAB32; RAB32
612907	tRNA NUCLEOTIDYLTRANSFERASE, CCA-ADDING, 1; TRNT1
612908	KERATOSIS PALMOPLANTARIS STRIATA II; PPKS2
612909	RAS-ASSOCIATED PROTEIN RAB6C; RAB6C
612910	PHD FINGER PROTEIN 23; PHF23
612911	NADH DEHYDROGENASE (UBIQUINONE) COMPLEX I, ASSEMBLY FACTOR 3; NDUFAF3
612912	TRANSMEMBRANE PROTEIN 97; TMEM97
612913	OROFACIODIGITAL SYNDROME XI; OFD11
612914	MEDIATOR COMPLEX SUBUNIT 29; MED29
612915	MEDIATOR COMPLEX SUBUNIT 20; MED20
612916	ZECHI-CEIDE SYNDROME
612917	GIACHETI SYNDROME
612918	CONGENITAL LIPOMATOUS OVERGROWTH, VASCULAR MALFORMATIONS, AND EPIDERMAL NEVI
612919	LanC-LIKE 2; LANCL2
612920	THROMBOSPONDIN-TYPE LAMININ G DOMAIN AND EAR REPEATS; TSPEAR
612921	THREE M SYNDROME 2; 3M2
612922	HEMOLYTIC UREMIC SYNDROME, ATYPICAL, SUSCEPTIBILITY TO, 2; AHUS2
612923	HEMOLYTIC UREMIC SYNDROME, ATYPICAL, SUSCEPTIBILITY TO, 3; AHUS3
612924	HEMOLYTIC UREMIC SYNDROME, ATYPICAL, SUSCEPTIBILITY TO, 4; AHUS4
612925	HEMOLYTIC UREMIC SYNDROME, ATYPICAL, SUSCEPTIBILITY TO, 5; AHUS5
612926	HEMOLYTIC UREMIC SYNDROME, ATYPICAL, SUSCEPTIBILITY TO, 6; AHUS6
612927	AVL9 CELL MIGRATION-ASSOCIATED PROTEIN; AVL9
612928	ISOCHORISMATASE DOMAIN-CONTAINING 2; ISOC2
612929	MYCOBACTERIUM TUBERCULOSIS, SUSCEPTIBILITY TO, 3
612930	PHOSPHOTYROSINE INTERACTION DOMAIN-CONTAINING 1; PID1
612931	PHOSPHOGLYCERATE MUTASE 2; PGAM2
612932	GLYCOGEN STORAGE DISEASE XIII; GSD13
612933	GLYCOGEN STORAGE DISEASE XI; GSD11
612934	MOVED TO 614921
612935	MYOSIN PHOSPHATASE RHO-INTERACTING PROTEIN; MPRIP
612936	SPASTIC PARAPLEGIA 50, AUTOSOMAL RECESSIVE; SPG50
612937	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 15; MDDGC15
612938	GROWTH RETARDATION, DEVELOPMENTAL DELAY, AND FACIAL DYSMORPHISM; GDFD
612939	HEAT-SHOCK 70-KD PROTEIN-BINDING PROTEIN 1; HSPBP1
612940	CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIB; ARCL2B
612941	PRE-mRNA-PROCESSING FACTOR 40 HOMOLOG A; PRPF40A
612942	RAS-ASSOCIATED PROTEIN RAB25; RAB25
612943	RETINITIS PIGMENTOSA 42; RP42
612944	RIBONUCLEASE T2; RNASET2
612945	RAS-ASSOCIATED PROTEIN RAB4B; RAB4B
612946	HADZISELIMOVIC SYNDROME
612947	MICROCEPHALY, GROWTH RETARDATION, CATARACT, HEARING LOSS, AND UNUSUAL APPEARANCE
612948	STARGARDT MACULAR DEGENERATION, ABSENT OR HYPOPLASTIC CORPUS CALLOSUM, MENTAL RETARDATION, AND DYSMORPHIC FACIAL FEATURES
612949	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 39 WITH LEUKODYSTROPHY; DEE39
612950	PSORIASIS 12, SUSCEPTIBILITY TO; PSORS12
612951	LEUKOENCEPHALOPATHY, CYSTIC, WITHOUT MEGALENCEPHALY
612952	AICARDI-GOUTIERES SYNDROME 5; AGS5
612953	PARKINSON DISEASE 14, AUTOSOMAL RECESSIVE; PARK14
612954	MYOPATHY, MYOFIBRILLAR, 6; MFM6
612955	LONG QT SYNDROME 12; LQT12
612956	VENTRICULAR FIBRILLATION, PAROXYSMAL FAMILIAL, 2; VF2
612957	VITAMIN B6 PLASMA LEVEL QUANTITATIVE TRAIT LOCUS 1; B6QTL1
612958	TRANSLATIONAL ACTIVATOR OF MITOCHONDRIALLY ENCODED CYTOCHROME c OXIDASE SUBUNIT I; TACO1
612959	EPITHELIAL SPLICING REGULATORY PROTEIN 1; ESRP1
612960	EPITHELIAL SPLICING REGULATORY PROTEIN 2; ESRP2
612961	MULTIPLE SYNOSTOSES SYNDROME 3; SYNS3
612962	DYNACTIN 5; DCTN5
612963	DYNACTIN 6; DCTN6
612964	PREMATURE OVARIAN FAILURE 7; POF7
612965	46,XY SEX REVERSAL 3; SRXY3
612966	RAS-ASSOCIATED PROTEIN RAB22A; RAB22A
612967	BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 15; BMIQ15
612968	CATARACT 34, MULTIPLE TYPES; CTRCT34
612969	TIGGER TRANSPOSABLE ELEMENT-DERIVED GENE 7; TIGD7
612970	NEUROBLASTOMA BREAKPOINT FAMILY, MEMBER 17, PSEUDOGENE; NBPF17P
612971	PDZ DOMAIN-CONTAINING 7; PDZD7
612972	TIGGER TRANSPOSABLE ELEMENT-DERIVED GENE 1; TIGD1
612973	TIGGER TRANSPOSABLE ELEMENT-DERIVED GENE 2; TIGD2
612974	DEP DOMAIN-CONTAINING PROTEIN 6; DEPDC6
612975	SHORT SLEEP, FAMILIAL NATURAL, 1; FNSS1
612976	AGE-RELATED HEARING IMPAIRMENT 2; ARHI2
612977	DCN1 DOMAIN-CONTAINING PROTEIN 4; DCUN1D4
612978	PRECEREBELLIN 3; CBLN3
612979	SYS1 GOLGI TRAFFICKING PROTEIN; SYS1
612980	IMP U3 SMALL NUCLEOLAR RIBONUCLEAR PROTEIN 3; IMP3
612981	IMP U3 SMALL NUCLEOLAR RIBONUCLEAR PROTEIN 4; IMP4
612982	MICRO RNA 210; MIR210
612983	MICRO RNA 106B; MIR106B
612984	MICRO RNA 93; MIR93
612985	IROQUOIS HOMEOBOX PROTEIN 3; IRX3
612986	EP300-INTERACTING INHIBITOR OF DIFFERENTIATION 3; EID3
612987	NSE4 HOMOLOG A, SMC5-SMC6 COMPLEX COMPONENT; NSMCE4A
612988	TRANSMEMBRANE PROTEIN 126A; TMEM126A
612989	OPTIC ATROPHY 7 WITH OR WITHOUT AUDITORY NEUROPATHY; OPA7
612990	ASXL TRANSCRIPTIONAL REGULATOR 1; ASXL1
612991	ASXL TRANSCRIPTIONAL REGULATOR 2; ASXL2
612992	NEUROBLASTOMA BREAKPOINT FAMILY, MEMBER 3; NBPF3
612993	FILAMIN A-INTERACTING PROTEIN 1-LIKE; FILIP1L
612994	RAS-ASSOCIATED PROTEIN 28; RAB28
612995	tRNA VALINE (ANTICODON CAC) 1-2; TRV-CAC1-2
612996	tRNA LYSINE (ANTICODON CTT) 2-3; TRK-CTT2-3
612997	SPERMATOGENIC FAILURE 7; SPGF7
612998	EMERY-DREIFUSS MUSCULAR DYSTROPHY 4, AUTOSOMAL DOMINANT; EDMD4
612999	EMERY-DREIFUSS MUSCULAR DYSTROPHY 5, AUTOSOMAL DOMINANT; EDMD5
613000	PALMOPLANTAR KERATODERMA, NONEPIDERMOLYTIC, FOCAL 1; FNEPPK1
613001	ENCEPHALOCRANIOCUTANEOUS LIPOMATOSIS; ECCL
613002	IMMUNODEFICIENCY 83, SUSCEPTIBILITY TO VIRAL INFECTIONS; IMD83
613003	ATTENTION DEFICIT-HYPERACTIVITY DISORDER, SUSCEPTIBILITY TO, 7; ADHD7
613004	HUNTINGTIN; HTT
613005	SANTOS SYNDROME
613006	TYPE 1 DIABETES MELLITUS 24; T1D24
613007	BILIARY CIRRHOSIS, PRIMARY, 2; PBC2
613008	BILIARY CIRRHOSIS, PRIMARY, 3; PBC3
613009	O-PHOSPHOSERINE tRNA-SELENOCYSTEINE tRNA SYNTHASE; SEPSECS
613010	RIBOFLAVIN KINASE; RFK
613011	LYMPHOPROLIFERATIVE SYNDROME 1; LPFS1
613012	UROCANASE DOMAIN-CONTAINING PROTEIN 1; UROC1
613013	NEUROBLASTOMA, SUSCEPTIBILITY TO, 2; NBLST2
613014	NEUROBLASTOMA, SUSCEPTIBILITY TO, 3; NBLST3
613015	NEUROBLASTOMA, SUSCEPTIBILITY TO, 4; NBLST4
613016	NEUROBLASTOMA, SUSCEPTIBILITY TO, 5; NBLST5
613017	NEUROBLASTOMA, SUSCEPTIBILITY TO, 6; NBLST6
613018	TYROSINE AMINOTRANSFERASE; TAT
613019	SUCCINATE DEHYDROGENASE COMPLEX ASSEMBLY FACTOR 2; SDHAF2
613020	MOVED TO 116600
613021	BRONCHIECTASIS WITH OR WITHOUT ELEVATED SWEAT CHLORIDE 2; BESC2
613022	OXOGLUTARATE DEHYDROGENASE; OGDH
613023	CENTROSOMAL PROTEIN, 170-KD; CEP170
613024	FOLLICULAR LYMPHOMA, SUSCEPTIBILITY TO, 1; FL1
613025	SCHIZOPHRENIA 13; SCZD13
613026	CHROMOSOME 19q13.11 DELETION SYNDROME, DISTAL
613027	GLYCOGEN STORAGE DISEASE IXc; GSD9C
613028	GLIOMA SUSCEPTIBILITY 2; GLM2
613029	GLIOMA SUSCEPTIBILITY 3; GLM3
613030	GLIOMA SUSCEPTIBILITY 5; GLM5
613031	GLIOMA SUSCEPTIBILITY 6; GLM6
613032	GLIOMA SUSCEPTIBILITY 7; GLM7
613033	GLIOMA SUSCEPTIBILITY 8; GLM8
613034	MOVED TO 612541
613035	HEARING LOSS, NOISE-INDUCED, SUSCEPTIBILITY TO; NIHL
613036	PEPTIDASE, MITOCHONDRIAL PROCESSING, ALPHA; PMPCA
613037	INOSITOL POLYPHOSPHATE-5-PHOSPHATASE, 72-KD; INPP5E
613038	PITUITARY HORMONE DEFICIENCY, COMBINED OR ISOLATED, 1; CPHD1
613039	CHROMODOMAIN HELICASE DNA-BINDING PROTEIN 1-LIKE; CHD1L
613040	CCDC26 LONG NONCODING RNA; CCDC26
613041	FAMILY WITH SEQUENCE SIMILARITY 90, MEMBER A1; FAM90A1
613042	FAMILY WITH SEQUENCE SIMILARITY 90, MEMBER A3; FAM90A3
613043	FAMILY WITH SEQUENCE SIMILARITY 90, MEMBER A5; FAM90A5
613044	FAMILY WITH SEQUENCE SIMILARITY 90, MEMBER A7; FAM90A7
613045	FAMILY WITH SEQUENCE SIMILARITY 90, MEMBER A8; FAM90A8
613046	FAMILY WITH SEQUENCE SIMILARITY 90, MEMBER A9; FAM90A9
613047	FAMILY WITH SEQUENCE SIMILARITY 90, MEMBER A10; FAM90A10
613048	FAMILY WITH SEQUENCE SIMILARITY 90, MEMBER A12; FAM90A12
613049	FAMILY WITH SEQUENCE SIMILARITY 90, MEMBER A13; FAM90A13
613050	FAMILY WITH SEQUENCE SIMILARITY 90, MEMBER A14; FAM90A14
613051	FAMILY WITH SEQUENCE SIMILARITY 90, MEMBER A15; FAM90A15
613052	FAMILY WITH SEQUENCE SIMILARITY 90, MEMBER A18; FAM90A18
613053	FAMILY WITH SEQUENCE SIMILARITY 90, MEMBER A19; FAM90A19
613054	FAMILY WITH SEQUENCE SIMILARITY 90, MEMBER A20; FAM90A20
613055	ATRIAL FIBRILLATION, FAMILIAL, 8; ATFB8
613056	LUC7-LIKE 2 PRE-mRNA SPLICING FACTOR; LUC7L2
613057	MICRO RNA 26A2; MIR26A2
613058	BASAL CELL CARCINOMA, SUSCEPTIBILITY TO, 2; BCC2
613059	BASAL CELL CARCINOMA, SUSCEPTIBILITY TO, 3; BCC3
613060	EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 10; EIG10
613061	BASAL CELL CARCINOMA, SUSCEPTIBILITY TO, 4; BCC4
613062	BASAL CELL CARCINOMA, SUSCEPTIBILITY TO, 5; BCC5
613063	BASAL CELL CARCINOMA, SUSCEPTIBILITY TO, 6; BCC6
613064	DERMATITIS, ATOPIC, 7; ATOD7
613065	LEUKEMIA, ACUTE LYMPHOBLASTIC; ALL
613066	PBX/KNOTTED 1 HOMEOBOX 2; PKNOX2
613067	LEUKEMIA, ACUTE LYMPHOBLASTIC, SUSCEPTIBILITY TO, 2; ALL2
613068	NEURODEGENERATION DUE TO CEREBRAL FOLATE TRANSPORT DEFICIENCY; NCFTD
613069	PHD FINGER PROTEIN 10; PHF10
613070	LIVER FAILURE, INFANTILE, TRANSIENT; LFIT
613071	BRONCHIECTASIS WITH OR WITHOUT ELEVATED SWEAT CHLORIDE 3; BESC3
613072	LIPOXYGENASE HOMOLOGY DOMAIN-CONTAINING 1; LOXHD1
613073	METAPHYSEAL ANADYSPLASIA 2; MANDP2
613074	DEAFNESS, AUTOSOMAL DOMINANT 50; DFNA50
613075	MACS SYNDROME
613076	MYOPATHY, MITOCHONDRIAL PROGRESSIVE, WITH CONGENITAL CATARACT AND DEVELOPMENTAL DELAY; MPMCD
613077	PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 5; PEOA5
613078	NIJMEGEN BREAKAGE SYNDROME-LIKE DISORDER; NBSLD
613079	DEAFNESS, AUTOSOMAL RECESSIVE 77; DFNB77
613080	46,XY SEX REVERSAL 5; SRXY5
613081	LYSINE DEMETHYLASE 1B; KDM1B
613082	ATPase, Ca(2+)-TRANSPORTING, TYPE 2C, MEMBER 2; ATP2C2
613083	LISTERIN E3 UBIQUITIN PROTEIN LIGASE 1; LTN1
613084	MYELIN TRANSCRIPTION FACTOR 1-LIKE; MYT1L
613085	GLAUCOMA 3, PRIMARY CONGENITAL, C; GLC3C
613086	GLAUCOMA 3, PRIMARY CONGENITAL, D; GLC3D
613087	ATRIAL SEPTAL DEFECT 6; ASD6
613088	PELVIC ORGAN PROLAPSE, SUSCEPTIBILITY TO, 2
613089	CAPILLARY MALFORMATION OF THE LOWER LIP, LYMPHATIC MALFORMATION OF FACE AND NECK, ASYMMETRY OF FACE AND LIMBS, AND PARTIAL/GENERALIZED OVERGROWTH
613090	BARTTER SYNDROME, TYPE 4B, NEONATAL, WITH SENSORINEURAL DEAFNESS; BARTS4B
613091	SHORT-RIB THORACIC DYSPLASIA 3 WITH OR WITHOUT POLYDACTYLY; SRTD3
613092	TUBULOINTERSTITIAL KIDNEY DISEASE, AUTOSOMAL DOMINANT, 4; ADTKD4
613093	CONE DYSTROPHY 4; COD4
613094	MICROPHTHALMIA, ISOLATED 4; MCOP4
613095	POLYCYSTIC KIDNEY DISEASE 2 WITH OR WITHOUT POLYCYSTIC LIVER DISEASE; PKD2
613096	SPASTIC PARAPLEGIA 36, AUTOSOMAL DOMINANT; SPG36
613097	MOVED TO 601216
613098	INCREASED ANALGESIA FROM KAPPA-OPIOID RECEPTOR AGONIST, FEMALE-SPECIFIC
613099	MELANOMA, CUTANEOUS MALIGNANT, SUSCEPTIBILITY TO, 5; CMM5
613100	GLAUCOMA 1, OPEN ANGLE, O; GLC1O
613101	HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 5, WITH OR WITHOUT MICROVILLUS INCLUSION DISEASE; FHL5
613102	HYPOTRICHOSIS AND RECURRENT SKIN VESICLES; HYPTSV
613103	SERINE/ARGININE REPETITIVE MATRIX PROTEIN 4; SRRM4
613104	CALCIUM CHANNEL FLOWER-DOMAIN CONTAINING PROTEIN 1; CACFD1
613105	CHOROIDAL DYSTROPHY, CENTRAL AREOLAR 2; CACD2
613106	VERTIGO, BENIGN RECURRENT, 2; BRV2
613107	NEUTROPENIA, SEVERE CONGENITAL, 2, AUTOSOMAL DOMINANT; SCN2
613108	CANDIDIASIS, FAMILIAL, 4; CANDF4
613109	GM2 ACTIVATOR; GM2A
613110	BLADDER CANCER-ASSOCIATED PROTEIN; BLCAP
613111	CATHEPSIN A; CTSA
613112	MACROTHROMBOCYTOPENIA, ISOLATED, 1, AUTOSOMAL DOMINANT; MACTHC1
613113	NEUROFIBROMIN 1; NF1
613114	RETICULOPHAGY REGULATOR 1; RETREG1
613115	NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE IIB; HSAN2B
613116	THROMBOPHILIA DUE TO HISTIDINE-RICH GLYCOPROTEIN DEFICIENCY; THPH11
613117	SMALL NUCLEOLAR RNA, C/D BOX, 50A; SNORD50A
613118	ANTITHROMBIN III DEFICIENCY; AT3D
613119	BRUGADA SYNDROME 6; BRGDA6
613120	BRUGADA SYNDROME 7; BRGDA7
613121	NEXILIN F-ACTIN-BINDING PROTEIN; NEXN
613122	CARDIOMYOPATHY, DILATED, 1CC; CMD1CC
613123	BRUGADA SYNDROME 8; BRGDA8
613124	HYDROPS FETALIS, NONIMMUNE, WITH GRACILE BONES AND DYSMORPHISM
613125	NUCLEAR RECEPTOR-INTERACTING PROTEIN 3; NRIP3
613126	PROLINE/SERINE-RICH COILED-COIL PROTEIN 1; PSRC1
613127	CHORDIN-LIKE 2; CHRDL2
613128	STN1, CST COMPLEX SUBUNIT; STN1
613129	CONSERVED TELOMERE MAINTENANCE COMPONENT 1; CTC1
613130	TEN1, CST COMPLEX SUBUNIT; TEN1
613131	MICRO RNA 449A; MIR449A
613132	MICRO RNA 449B; MIR449B
613133	TETRASPANIN 2; TSPAN2
613134	TETRASPANIN 3; TSPAN3
613135	PARKINSONISM-DYSTONIA 1, INFANTILE-ONSET; PKDYS1
613136	TETRASPANIN 5; TSPAN5
613137	TETRASPANIN 9; TSPAN9
613138	TETRASPANIN 12; TSPAN12
613139	TETRASPANIN 13; TSPAN13
613140	TETRASPANIN 15; TSPAN15
613141	DELTEX E3 UBIQUITIN LIGASE 2; DTX2
613142	DELTEX E3 UBIQUITIN LIGASE 3; DTX3
613143	DELTEX E3 UBIQUITIN LIGASE 3L; DTX3L
613144	CHOROIDAL DYSTROPHY, CENTRAL AREOLAR, 3; CACD3
613145	SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO, 14; SLEB14
613146	MICRO RNA 184; MIR184
613147	MICRO RNA 205; MIR205
613148	INFLAMMATORY BOWEL DISEASE 28, AUTOSOMAL RECESSIVE; IBD28
613149	CDKN2B ANTISENSE RNA; CDKN2BAS
613150	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 2; MDDGA2
613151	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH IMPAIRED INTELLECTUAL DEVELOPMENT), TYPE B, 3; MDDGB3
613152	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITHOUT IMPAIRED INTELLECTUAL DEVELOPMENT), TYPE B, 4; MDDGB4
613153	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 5; MDDGA5
613154	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 6; MDDGA6
613155	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH IMPAIRED INTELLECTUAL DEVELOPMENT), TYPE B, 1; MDDGB1
613156	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH IMPAIRED INTELLECTUAL DEVELOPMENT), TYPE B, 2; MDDGB2
613157	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 3; MDDGC3
613158	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 2; MDDGC2
613159	NEPHRONOPHTHISIS-LIKE NEPHROPATHY 1; NPHPL1
613160	VON WILLEBRAND FACTOR; VWF
613161	BETA-UREIDOPROPIONASE DEFICIENCY; UPB1D
613162	SPASTIC PARAPLEGIA 45, AUTOSOMAL RECESSIVE; SPG45
613163	GABA-TRANSAMINASE DEFICIENCY
613164	PARKINSON DISEASE 16; PARK16
613165	CALCIUM-ACTIVATED NUCLEOTIDASE 1; CANT1
613166	DOUBLECORTIN-LIKE KINASE 2; DCLK2
613167	DOUBLECORTIN-LIKE KINASE 3; DCLK3
613168	SERPIN PEPTIDASE INHIBITOR, CLADE F, MEMBER 2; SERPINF2
613169	KELCH DOMAIN-CONTAINING PROTEIN 8B; KLHDC8B
613170	TETRASPANIN 1; TSPAN1
613171	RNA-BINDING MOTIF PROTEIN 20; RBM20
613172	CARDIOMYOPATHY, DILATED, 1DD; CMD1DD
613173	NEURONAL GROWTH REGULATOR 1; NEGR1
613174	CHROMOSOME 5p13 DUPLICATION SYNDROME
613175	SMG8 NONSENSE-MEDIATED mRNA DECAY FACTOR; SMG8
613176	SMG9 NONSENSE-MEDIATED mRNA DECAY FACTOR; SMG9
613177	CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IC; ARCL1C
613178	CAP-BINDING COMPLEX-DEPENDENT TRANSLATION INITIATION FACTOR; CTIF
613179	PURINE NUCLEOSIDE PHOSPHORYLASE DEFICIENCY
613180	MOVED TO 609528
613181	BOLA FAMILY MEMBER 1; BOLA1
613182	BOLA FAMILY MEMBER 2; BOLA2
613183	BOLA FAMILY MEMBER 3; BOLA3
613184	TRIPARTITE MOTIF-CONTAINING PROTEIN 68; TRIM68
613185	MICRO RNA 95; MIR95
613186	MICRO RNA 100; MIR100
613187	MICRO RNA 103-1; MIR103-1
613188	MICRO RNA 103-2; MIR103-2
613189	MICRO RNA 107; MIR107
613190	DYNEIN, AXONEMAL, ASSEMBLY FACTOR 1; DNAAF1
613191	DUAL-SPECIFICITY PHOSPHATASE 13; DUSP13
613192	INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 13; MRT13
613193	CILIARY DYSKINESIA, PRIMARY, 13; CILD13
613194	RETINITIS PIGMENTOSA 50; RP50
613195	WEILL-MARCHESANI SYNDROME 4; WMS4
613196	ETAA1 ACTIVATOR OF ATR KINASE; ETAA1
613197	TRAF-TYPE ZINC FINGER DOMAIN-CONTAINING 1; TRAFD1
613198	LYSINE METHYLTRANSFERASE 5C; KMT5C
613199	TAO KINASE 2; TAOK2
613200	PDS5 COHESIN-ASSOCIATED FACTOR A; PDS5A
613201	CHROMOSOME TRANSMISSION FIDELITY FACTOR 18; CHTF18
613202	CHROMOSOME TRANSMISSION FIDELITY FACTOR 8; CHTF8
613203	DNA REPLICATION AND SISTER CHROMATID COHESION 1; DSCC1
613204	MUSCULAR DYSTROPHY, CONGENITAL, DUE TO INTEGRIN ALPHA-7 DEFICIENCY
613205	MUSCULAR DYSTROPHY, CONGENITAL, LMNA-RELATED
613206	SPASTIC PARAPLEGIA 44, AUTOSOMAL RECESSIVE; SPG44
613207	ASTHMA-RELATED TRAITS, SUSCEPTIBILITY TO, 8; ASRT8
613208	XPC COMPLEX SUBUNIT, DNA DAMAGE RECOGNITION AND REPAIR FACTOR; XPC
613209	TRANSMEMBRANE PROTEIN 181; TMEM181
613210	DIPHTHAMIDE BIOSYNTHESIS PROTEIN 7; DPH7
613211	AMELOGENESIS IMPERFECTA, HYPOMATURATION TYPE, IIA3; AI2A3
613212	ALANYL-tRNA SYNTHETASE DOMAIN-CONTAINING 1; AARSD1
613213	CYTOCHROME b5 REDUCTASE 3; CYB5R3
613214	WD REPEAT-CONTAINING PROTEIN 72; WDR72
613215	CHROMOSOME 17p13.3, CENTROMERIC, DUPLICATION SYNDROME
613216	NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1C; CSNB1C
613217	DIARRHEA 5, WITH TUFTING ENTEROPATHY, CONGENITAL; DIAR5
613218	CYTOCHROME b5, TYPE A (MICROSOMAL); CYB5A
613219	FASTING PLASMA GLUCOSE LEVEL QUANTITATIVE TRAIT LOCUS 2; FGQTL2
613220	TRANSMEMBRANE PROTEIN 18; TMEM18
613221	MITOCHONDRIAL CARRIER HOMOLOG 2; MTCH2
613222	GLUCOSAMINE-6-PHOSPHATE DEAMINASE 2; GNPDA2
613223	LEPROSY, SUSCEPTIBILITY TO, 5; LPRS5
613224	NOONAN SYNDROME 6; NS6
613225	FACTOR XIII, A SUBUNIT, DEFICIENCY OF
613226	ZINC FINGER PROTEIN 296; ZNF296
613227	CEREBELLAR ATAXIA, IMPAIRED INTELLECTUAL DEVELOPMENT, AND DYSEQUILIBRIUM SYNDROME 3; CAMRQ3
613228	ASPARTYLGLUCOSAMINIDASE; AGA
613229	TRICHOTILLOMANIA; TTM
613230	PEPTIDASE D; PEPD
613231	KINESIN FAMILY MEMBER 26A; KIF26A
613232	RNA-BINDING MOTIF PROTEIN 42; RBM42
613233	FASTING PLASMA GLUCOSE LEVEL QUANTITATIVE TRAIT LOCUS 3; FGQTL3
613234	NEUTRAL CHOLESTEROL ESTER HYDROLASE 1; NCEH1
613235	FACTOR XIII, B SUBUNIT, DEFICIENCY OF
613236	POTASSIUM CHANNEL, INWARDLY RECTIFYING, SUBFAMILY J, MEMBER 18; KCNJ18
613237	FOCAL SEGMENTAL GLOMERULOSCLEROSIS 5; FSGS5
613238	SPONDYLOARTHROPATHY, SUSCEPTIBILITY TO, 3; SPDA3
613239	THYROTOXIC PERIODIC PARALYSIS, SUSCEPTIBILITY TO, 2; TTPP2
613240	PROTEIN PHOSPHATASE 1, REGULATORY SUBUNIT 1C; PPP1R1C
613241	PSEUDOPILI ANNULATI
613242	PROTEIN PHOSPHATASE 1, REGULATORY SUBUNIT 14C; PPP1R14C
613243	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 13; CMH13
613244	LYNCH SYNDROME 8; LYNCH8
613245	PROTEIN PHOSPHATASE 1, REGULATORY SUBUNIT 12C; PPP1R12C
613246	PROTEIN PHOSPHATASE 1, REGULATORY SUBUNIT 1A; PPP1R1A
613247	PERILIPIN 4; PLIN4
613248	PERILIPIN 5; PLIN5
613249	ENDOGENOUS BORNA-LIKE N ELEMENT-CONTAINING PROTEIN 1; EBLN1
613250	ENDOGENOUS BORNA-LIKE N ELEMENT-CONTAINING PROTEIN 2; EBLN2
613251	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 14; CMH14
613252	CARDIOMYOPATHY, DILATED, 1EE; CMD1EE
613253	MOVED TO 603046
613254	TUBEROUS SCLEROSIS 2; TSC2
613255	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 15; CMH15
613256	PROTEIN PHOSPHATASE 1, REGULATORY SUBUNIT 14D; PPP1R14D
613257	PROTEIN PHOSPHATASE 1, REGULATORY SUBUNIT 15B; PPP1R15B
613258	CHROMOSOME 18 OPEN READING FRAME 54; C18ORF54
613259	REPETIN; RPTN
613260	KERATINOCYTE PROLINE-RICH PROTEIN; KPRP
613261	PROTOGENIN; PRTG
613262	RIBOSOMAL PROTEIN L24 DOMAIN-CONTAINING PROTEIN 1; RSL24D1
613263	SMALL NUCLEOLAR RNA HOST GENE 5; SNHG5
613264	SMALL NUCLEOLAR RNA, C/D BOX; SNORD50B
613265	WAARDENBURG SYNDROME, TYPE 4B; WS4B
613266	WAARDENBURG SYNDROME, TYPE 4C; WS4C
613267	CORNEAL DYSTROPHY, FUCHS ENDOTHELIAL, 3; FECD3
613268	CORNEAL DYSTROPHY, FUCHS ENDOTHELIAL, 4; FECD4
613269	CORNEAL DYSTROPHY, FUCHS ENDOTHELIAL, 5; FECD5
613270	CORNEAL DYSTROPHY, FUCHS ENDOTHELIAL, 6; FECD6
613271	CORNEAL DYSTROPHY, FUCHS ENDOTHELIAL, 7; FECD7
613272	POTASSIUM CHANNEL TETRAMERIZATION DOMAIN-CONTAINING PROTEIN 3; KCTD3
613273	INST3- AND NABP-INTERACTING PROTEIN; INIP
613274	MOLYBDENUM COFACTOR SULFURASE; MOCOS
613275	PROTEIN PHOSPHATASE 1, REGULATORY SUBUNIT 16B; PPP1R16B
613276	U6 SMALL NUCLEAR RNA BIOGENESIS PHOSPHODIESTERASE 1; USB1
613277	TRANSMEMBRANE PROTEIN 216; TMEM216
613278	SLX4 STRUCTURE-SPECIFIC ENDONUCLEASE SUBUNIT; SLX4
613279	ZINC FINGER CCCH DOMAIN-CONTAINING PROTEIN 14: ZC3H14
613280	HYPERMANGANESEMIA WITH DYSTONIA 1; HMNDYT1
613281	SORTING NEXIN 20; SNX20
613282	FATTY LIVER DISEASE, SUSCEPTIBILITY TO, 1; FLD1
613283	GLUTAREDOXIN, CYSTEINE-RICH, 1; GRXCR1
613284	HEMATOCRIT/HEMOGLOBIN QUANTITATIVE TRAIT LOCUS 3; HCHGQ3
613285	DEAFNESS, AUTOSOMAL RECESSIVE 25; DFNB25
613286	CARDIOMYOPATHY, DILATED, 1FF; CMD1FF
613287	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2N; CMT2N
613288	TRIPARTITE MOTIF-CONTAINING PROTEIN 72; TRIM72
613289	ATAXIN 8; ATXN8
613290	HEARING LOSS, CISPLATIN-INDUCED, SUSCEPTIBILITY TO; CIHL
613291	BILE ACID MALABSORPTION, PRIMARY, 1; PBAM1
613292	DENN/MADD DOMAIN-CONTAINING PROTEIN 1B; DENND1B
613293	SH3 AND PX DOMAINS-CONTAINING PROTEIN 2B; SH3PXD2B
613294	SUMO1-ACTIVATING ENZYME, SUBUNIT 1; SAE1
613295	UBIQUITIN-LIKE MODIFIER-ACTIVATING ENZYME 2; UBA2
613296	LYSOSOME-ASSOCIATED PROTEIN, TRANSMEMBRANE 4, BETA; LAPTM4B
613297	MEMBRANE-ASSOCIATED RING-CH FINGER PROTEIN 6; MARCHF6
613298	TOPBP1-INTERACTING CHECKPOINT AND REPLICATION REGULATOR; TICRR
613299	FAMILY WITH SEQUENCE SIMILARITY 13, MEMBER A; FAM13A
613300	FAM13A OPPOSITE STRAND; FAM13AOS
613301	FEZ FAMILY ZINC FINGER PROTEIN 1; FEZF1
613302	AlkB HOMOLOG 4, LYSINE DEMETHYLASE; ALKBH4
613303	AlkB HOMOLOG 5, RNA DEMETHYLASE; ALKBH5
613304	AlkB HOMOLOG 6; ALKBH6
613305	AlkB HOMOLOG 7; ALKBH7
613306	AlkB HOMOLOG 8, tRNA METHYLTRANSFERASE; ALKBH8
613307	DEAFNESS, AUTOSOMAL RECESSIVE 79; DFNB79
613308	DIAMOND-BLACKFAN ANEMIA 9; DBA9
613309	DIAMOND-BLACKFAN ANEMIA 10; DBA10
613310	EXUDATIVE VITREORETINOPATHY 5; EVR5
613311	LYR MOTIF-CONTAINING PROTEIN 4; LYRM4
613312	HYPOPHOSPHATEMIC RICKETS, AUTOSOMAL RECESSIVE, 2; ARHR2
613313	HEMOCHROMATOSIS, TYPE 2B; HFE2B
613314	RIBOSOMAL PROTEIN L37A; RPL37A
613315	RIBOSOMAL PROTEIN L41; RPL41
613316	WD REPEAT- AND FYVE DOMAIN-CONTAINING PROTEIN 4; WDFY4
613317	DDB1- AND CUL4-ASSOCIATED FACTOR 11; DCAF11
613318	MIYOSHI MUSCULAR DYSTROPHY 2; MMD2
613319	MIYOSHI MUSCULAR DYSTROPHY 3; MMD3
613320	SPONDYLOMETAPHYSEAL DYSPLASIA, MEGARBANE-DAGHER-MELKI TYPE; SMDMDM
613321	GLUCOSIDE XYLOSYLTRANSFERASE 1; GXYLT1
613322	GLUCOSIDE XYLOSYLTRANSFERASE 2; GXYLT2
613323	FERM AND PDZ DOMAINS-CONTAINING PROTEIN 2; FRMPD2
613324	SPERMATOGENESIS-ASSOCIATED PROTEIN 13; SPATA13
613325	RHABDOID TUMOR PREDISPOSITION SYNDROME 2; RTPS2
613326	DIHYDROPYRIMIDINASE; DPYS
613327	LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 4; CGL4
613328	ROIFMAN-CHITAYAT SYNDROME; ROCHIS
613329	PLASMINOGEN ACTIVATOR INHIBITOR-1 DEFICIENCY
613330	SPONDYLO-MEGAEPIPHYSEAL-METAPHYSEAL DYSPLASIA; SMMD
613331	MEMBRANE-ASSOCIATED RING-CH FINGER PROTEIN 1; MARCHF1
613332	MEMBRANE-ASSOCIATED RING-CH FINGER PROTEIN 2; MARCHF2
613333	MEMBRANE-ASSOCIATED RING-CH FINGER PROTEIN 3; MARCHF3
613334	MEMBRANE-ASSOCIATED RING-CH FINGER PROTEIN 7; MARCHF7
613335	MEMBRANE-ASSOCIATED RING-CH FINGER PROTEIN 8; MARCHF8
613336	MEMBRANE-ASSOCIATED RING-CH FINGER PROTEIN 9; MARCHF9
613337	MEMBRANE-ASSOCIATED RING-CH FINGER PROTEIN 10; MARCHF10
613338	MEMBRANE-ASSOCIATED RING-CH FINGER PROTEIN 11; MARCHF11
613339	EPILEPSY, HOT WATER, 1; HWE1
613340	EPILEPSY, HOT WATER, 2; HWE2
613341	LEBER CONGENITAL AMAUROSIS 14; LCA14
613342	MSELENI JOINT DISEASE
613343	HANDIGODU JOINT DISEASE
613344	KIAA1549 GENE; KIAA1549
613345	HYPOKALEMIC PERIODIC PARALYSIS, TYPE 2; HOKPP2
613346	SHISA FAMILY, MEMBER 9; SHISA9
613347	PANCREATIC CANCER, SUSCEPTIBILITY TO, 2
613348	PANCREATIC CANCER, SUSCEPTIBILITY TO, 3
613349	ORNITHINE AMINOTRANSFERASE; OAT
613350	SOLUTE CARRIER FAMILY 52 (RIBOFLAVIN TRANSPORTER), MEMBER 3; SLC52A3
613351	RHO GTPase-ACTIVATING PROTEIN 18; ARHGAP18
613352	ARGININE/SERINE-RICH COILED-COIL PROTEIN 1; RSRC1
613353	MONONEUROPATHY OF THE MEDIAN NERVE, MILD; MNMN
613354	TAPERIN; TPRN
613355	CHROMOSOME 17q23.1-q23.2 DELETION SYNDROME
613356	TLR4 INTERACTOR WITH LEUCINE-RICH REPEATS; TRIL
613357	FIBRINOGEN C DOMAIN-CONTAINING PROTEIN 1; FIBCD1
613358	ALDEHYDE DEHYDROGENASE 16 FAMILY, MEMBER A1; ALDH16A1
613359	LY6/PLAUR DOMAIN-CONTAINING PROTEIN 6; LYPD6
613360	DAMAGE-REGULATED AUTOPHAGY MODULATOR 2; DRAM2
613361	SOLUTE CARRIER FAMILY 18, MEMBER B1; SLC18B1
613362	CDK2-INTERACTING PROTEIN; CINP
613363	WD REPEAT-CONTAINING PROTEIN 34; WDR34
613364	SPASTIC PARAPLEGIA 41, AUTOSOMAL DOMINANT; SPG41
613365	SOLUTE CARRIER ORGANIC ANION TRANSPORTER FAMILY, MEMBER 6A1; SLCO6A1
613366	SOLUTE CARRIER FAMILY 10 (SODIUM/BILE ACID COTRANSPORTER FAMILY), MEMBER 6; SLC10A6
613367	LIN54, C. ELEGANS, HOMOLOG OF; LIN54
613368	CARNOSINE SYNTHASE 1; CARNS1
613369	DEAD-BOX HELICASE 42; DDX42
613370	MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 10; MODY10
613371	SPINOCEREBELLAR ATAXIA 30; SCA30
613372	UFM1-SPECIFIC LIGASE 1; UFL1
613373	YEATS DOMAIN-CONTAINING PROTEIN 2; YEATS2
613374	COILED-COIL DOMAIN-CONTAINING PROTEIN 101; CCDC101
613375	MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 11; MODY11
613376	NEURONOPATHY, DISTAL HEREDITARY MOTOR, AUTOSOMAL DOMINANT 4; HMND4
613377	SH3 DOMAIN-CONTAINING RING FINGER PROTEIN 2; SH3RF2
613378	AIG2-LIKE DOMAIN-CONTAINING PROTEIN 1; A2LD1
613379	CARBOXYMETHYLENEBUTENOLIDASE-LIKE PROTEIN; CMBL
613380	H6 FAMILY HOMEOBOX 3; HMX3
613381	CYSTATHIONINE BETA-SYNTHASE; CBS
613382	BRACHYDACTYLY, TYPE E2; BDE2
613383	ANKYRIN REPEAT DOMAIN-CONTAINING PROTEIN 54; ANKRD54
613384	CYCLIN L1; CCNL1
613385	AUTOIMMUNE DISEASE, MULTISYSTEM, WITH FACIAL DYSMORPHISM; ADMFD
613386	PROTEASOME MATURATION PROTEIN; POMP
613387	FATTY LIVER DISEASE, SUSCEPTIBILITY TO, 2; FLD2
613388	FANCONI RENOTUBULAR SYNDROME 2; FRTS2
613389	SOLUTE CARRIER ORGANIC ANION TRANSPORTER FAMILY, MEMBER 1C1; SLCO1C1
613390	FANCONI ANEMIA, COMPLEMENTATION GROUP O; FANCO
613391	DEAFNESS, AUTOSOMAL RECESSIVE 84A; DFNB84A
613392	DEAFNESS, AUTOSOMAL RECESSIVE 85; DFNB85
613393	BIRBECK GRANULE DEFICIENCY
613394	MICRO RNA 138-1; MIR138-1
613395	MICRO RNA 138-2; MIR138-2
613396	DOWN SYNDROME CRITICAL REGION GENE 8; DSCR8
613397	ADVILLIN; AVIL
613398	WARSAW BREAKAGE SYNDROME; WABS
613399	BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 3; BROVCA3
613400	ACIREDUCTONE DIOXYGENASE 1; ADI1
613401	VPS33B-INTERACTING PROTEIN, APICAL-BASOLATERAL POLARITY REGULATOR, SPE39 HOMOLOG; VIPAS39
613402	MICROCEPHALY, SEIZURES, AND DEVELOPMENTAL DELAY; MCSZ
613403	TRANSMEMBRANE PROTEIN 127; TMEM127
613404	ARTHROGRYPOSIS, RENAL DYSFUNCTION, AND CHOLESTASIS 2; ARCS2
613405	MICRO RNA 2861; MIR2861
613406	WITTEVEEN-KOLK SYNDROME; WITKOS
613407	LEPROSY, SUSCEPTIBILITY TO, 6; LPRS6
613408	COILED-COIL DOMAIN-CONTAINING PROTEIN 122; CCDC122
613409	LACCASE (MULTICOPPER REDUCTASE) DOMAIN-CONTAINING PROTEIN 1; LACC1
613410	AUTISM, SUSCEPTIBILITY TO, 16; AUTS16
613411	OGUCHI DISEASE 2
613412	ESOPHAGITIS, EOSINOPHILIC, 2; EOE2
613413	TRANSMEMBRANE PROTEIN 106B; TMEM106B
613414	INTERLEUKIN 17 RECEPTOR E-LIKE; IL17REL
613415	CREATINE KINASE, MITOCHONDRIAL 1A; CKMT1A
613416	SCINDERIN; SCIN
613417	FAMILY WITH SEQUENCE SIMILARITY 48, MEMBER A; FAM48A
613418	BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS 15; BMND15
613419	ZINC FINGER- AND SCAN DOMAIN-CONTAINING PROTEIN 4; ZSCAN4
613420	POTASSIUM CHANNEL TETRAMERIZATION DOMAIN-CONTAINING PROTEIN 1; KCTD1
613421	POTASSIUM CHANNEL TETRAMERIZATION DOMAIN-CONTAINING PROTEIN 10; KCTD10
613422	POTASSIUM CHANNEL TETRAMERIZATION DOMAIN-CONTAINING PROTEIN 2; KCTD2
613423	POTASSIUM CHANNEL TETRAMERIZATION DOMAIN-CONTAINING PROTEIN 16; KCTD16
613424	CARDIOMYOPATHY, DILATED, 1R; CMD1R
613425	PHOTORECEPTOR CILIUM ACTIN REGULATOR; PCARE
613426	CARDIOMYOPATHY, DILATED, 1S; CMD1S
613427	ANAPHASE-PROMOTING COMPLEX, SUBUNIT 16; ANAPC16
613428	RETINITIS PIGMENTOSA 54; RP54
613429	HAUS AUGMIN-LIKE COMPLEX, SUBUNIT 2; HAUS2
613430	HAUS AUGMIN-LIKE COMPLEX, SUBUNIT 3; HAUS3
613431	HAUS AUGMIN-LIKE COMPLEX, SUBUNIT 4; HAUS4
613432	HAUS AUGMIN-LIKE COMPLEX, SUBUNIT 5; HAUS5
613433	HAUS AUGMIN-LIKE COMPLEX, SUBUNIT 6; HAUS6
613434	HAUS AUGMIN-LIKE COMPLEX, SUBUNIT 8; HAUS8
613435	AMYOTROPHIC LATERAL SCLEROSIS 12 WITH OR WITHOUT FRONTOTEMPORAL DEMENTIA; ALS12
613436	AUTISM, SUSCEPTIBILITY TO, 17; AUTS17
613437	FCH DOMAIN ONLY PROTEIN 1; FCHO1
613438	FCH DOMAIN ONLY PROTEIN 2; FCHO2
613439	CONSORTIN; CNST
613440	STATURE QUANTITATIVE TRAIT LOCUS 21; STQTL21
613441	TRANSCOBALAMIN II; TCN2
613442	PENTRAXIN 4; PTX4
613443	NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, STEREOTYPIC HAND MOVEMENTS, AND IMPAIRED LANGUAGE; NEDHSIL
613444	CHROMOSOME 16p11.2 DELETION SYNDROME, 220-KB
613445	MOVED TO 600642
613446	CENTROSOMAL PROTEIN, 120-KD; CEP120
613447	SPINDLE- AND CENTRIOLE-ASSOCIATED PROTEIN 1; SPICE1
613448	MITOTIC SPINDLE ORGANIZING PROTEIN 1; MZT1
613449	FAMILY WITH SEQUENCE SIMILARITY 128, MEMBER A; FAM128A
613450	MITOTIC SPINDLE-ORGANIZING PROTEIN 2B; MZT2B
613451	FRONTONASAL DYSPLASIA 2; FND2
613452	CATION CHANNEL, SPERM-ASSOCIATED, AUXILIARY SUBUNIT GAMMA; CATSPERG
613453	DEAFNESS, AUTOSOMAL RECESSIVE 91; DFNB91
613454	RETT SYNDROME, CONGENITAL VARIANT
613455	MIA SH3 DOMAIN ER EXPORT FACTOR 3; MIA3
613456	FRONTONASAL DYSPLASIA 3; FND3
613457	CHROMOSOME 14q11-q22 DELETION SYNDROME
613458	CHROMOSOME 16p13.3 DUPLICATION SYNDROME
613459	BIRTH WEIGHT QUANTITATIVE TRAIT LOCUS 2; BWQTL2
613460	FASTING PLASMA GLUCOSE LEVEL QUANTITATIVE TRAIT LOCUS 6; FGQTL6
613461	LEPTIN RECEPTOR OVERLAPPING TRANSCRIPT; LEPROT
613462	FASTING PLASMA GLUCOSE LEVEL QUANTITATIVE TRAIT LOCUS 4; FGQTL4
613463	FASTING PLASMA GLUCOSE LEVEL QUANTITATIVE TRAIT LOCUS 5; FGQTL5
613464	RETINITIS PIGMENTOSA 51; RP51
613465	NME/NM23 FAMILY, MEMBER 7; NME7
613466	PREFOLDIN 2; PFDN2
613467	ZINC FINGER CCHC DOMAIN-CONTAINING PROTEIN 6; ZCCHC6
613468	N-ACYLSPHINGOSINE AMIDOHYDROLASE 1; ASAH1
613469	HEPARANASE 2; HPSE2
613470	HEMOLYTIC ANEMIA, NONSPHEROCYTIC, DUE TO GLUCOSE PHOSPHATE ISOMERASE DEFICIENCY
613471	REYNOLDS SYNDROME
613472	UNC51-LIKE KINASE 3; ULK3
613473	WD REPEAT-CONTAINING PROTEIN 7; WDR7
613474	ZINC FINGER AN1 DOMAIN-CONTAINING PROTEIN 2B; ZFAND2B
613475	RIBOSOMAL RNA-PROCESSING 36; RRP36
613476	MAJOR FACILITATOR SUPERFAMILY DOMAIN-CONTAINING PROTEIN 6; MFSD6
613477	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 5; DEE5
613478	COILED-COIL DOMAIN-CONTAINING PROTEIN 106; CCDC106
613479	CENTROSOMAL PROTEIN 131; CEP131
613480	LYMPHATIC MALFORMATION 3; LMPHM3
613481	COILED-COIL DOMAIN-CONTAINING PROTEIN 62: CCDC62
613482	CYCLIN L2; CCNL2
613483	BASIC HELIX-LOOP-HELIX FAMILY, MEMBER E22; BHLHE22
613484	SPEN FAMILY TRANSCRIPTIONAL REPRESSOR; SPEN
613485	LONG QT SYNDROME 13; LQT13
613486	MICRO RNA 33B; MIR33B
613487	MICRO RNA 212; MIR212
613488	MYXOID LIPOSARCOMA
613489	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIj; CDG2J
613490	ALPHA-1-ANTITRYPSIN DEFICIENCY; A1ATD
613491	ALKALINE CERAMIDASE 1; ACER1
613492	ALKALINE CERAMIDASE 2; ACER2
613493	IMMUNODEFICIENCY, COMMON VARIABLE, 3; CVID3
613494	IMMUNODEFICIENCY, COMMON VARIABLE, 4; CVID4
613495	IMMUNODEFICIENCY, COMMON VARIABLE, 5; CVID5
613496	IMMUNODEFICIENCY, COMMON VARIABLE, 6; CVID6
613497	LIPASE A, LYSOSOMAL ACID; LIPA
613498	SEX HORMONE-BINDING GLOBULIN CIRCULATING LEVEL QUANTITATIVE TRAIT LOCUS; SXGQTL1
613499	HISTONE GENE CLUSTER 1, H2A HISTONE FAMILY, MEMBER A; HIST1H2AA
613500	AGAMMAGLOBULINEMIA 2, AUTOSOMAL RECESSIVE; AGM2
613501	AGAMMAGLOBULINEMIA 3, AUTOSOMAL RECESSIVE; AGM3
613502	AGAMMAGLOBULINEMIA 4, AUTOSOMAL RECESSIVE; AGM4
613503	MAJOR HISTOCOMPATIBILITY COMPLEX, CLASS II, DQ ALPHA-2; HLA-DQA2
613504	ZINC FINGER FYVE DOMAIN-CONTAINING PROTEIN 21; ZFYVE21
613505	LEUCINE-RICH REPEAT-CONTAINING PROTEIN 26; LRRC26
613506	AGAMMAGLOBULINEMIA 5, AUTOSOMAL DOMINANT; AGM5
613507	GLYCOGEN STORAGE DISEASE XV; GSD15
613508	SODIUM SERUM LEVEL QUANTITATIVE TRAIT LOCUS 1; SSQTL1
613509	CHROMOSOME 4q21 DELETION SYNDROME
613510	LATE ENDOSOMAL/LYSOSOMAL ADAPTOR, MITOGEN-ACTIVATED PROTEIN KINASE AND MAMMALIAN TARGET OF RAPAMYCIN ACTIVATOR 1; LAMTOR1
613511	SERINE PROTEASE INHIBITOR, KAZAL-TYPE, 9; SPINK9
613512	ZINC FINGER BED DOMAIN-CONTAINING PROTEIN 6; ZBED6
613513	ZINC FINGER CCCH DOMAIN-CONTAINING PROTEIN 11A; ZC3H11A
613514	ZONA PELLUCIDA GLYCOPROTEIN 4; ZP4
613515	AUTOPHAGY-RELATED 14; ATG14
613516	RUN DOMAIN- AND CYSTEINE-RICH DOMAIN-CONTAINING BECLIN-1-INTERACTING PROTEIN; RUBCN
613517	MICROPHTHALMIA, ISOLATED 6; MCOP6
613518	DERMATITIS, ATOPIC, 8; ATOD8
613519	DERMATITIS, ATOPIC, 9; ATOD9
613520	FYVE, RhoGEF, AND PH DOMAIN-CONTAINING PROTEIN 6; FGD6
613521	UROPORPHYRINOGEN DECARBOXYLASE; UROD
613522	OPSIN 1, SHORT-WAVE-SENSITIVE; OPN1SW
613523	CHROMOSOME 8p11 MYELOPROLIFERATIVE SYNDROME
613524	SHH SIGNALING AND CILIOGENESIS REGULATOR SDCCAG8; SDCCAG8
613525	SEEK1 GENE
613526	SPR1 GENE
613527	DNAJ/HSP40 HOMOLOG, SUBFAMILY C, MEMBER 27; DNAJC27
613528	SYNAPTOTAGMIN 9; SYT9
613529	CENTROSOMAL PROTEIN, 152-KD; CEP152
613530	MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 1H; LGMD1H
613531	PHOSPHATASE AND TENSIN HOMOLOG PSEUDOGENE; PTENP1
613532	RAS-ASSOCIATED PROTEIN RAB8B; RAB8B
613533	CHROMOSOME 17q21.31 DUPLICATION SYNDROME
613534	FANCD2/FANCI-ASSOCIATED NUCLEASE 1; FAN1
613535	KIAA0319-LIKE; KIAA0319L
613536	LEUCINE-, GLUTAMATE-, AND LYSINE-RICH PROTEIN 1; LEKR1
613537	NLR FAMILY, CASPASE RECRUITMENT DOMAIN-CONTAINING 5; NLRC5
613538	FEM1 HOMOLOG A; FEM1A
613539	FEM1 HOMOLOG B; FEM1B
613540	SERINE PALMITOYLTRANSFERASE, SMALL SUBUNIT, A; SPTSSA
613541	MITOCHONDRIAL TRANSLATION RELEASE FACTOR IN RESCUE; MTRFR
613542	MITOCHONDRIAL TRANSLATIONAL RELEASE FACTOR 1-LIKE; MTRF1L
613543	SOLUTE CARRIER ORGANIC ANION TRANSPORTER FAMILY, MEMBER 5A1; SLCO5A1
613544	CHROMOSOME 6q11-q14 DELETION SYNDROME
613545	MACROSTOMIA, ISOLATED
613546	AROMATASE DEFICIENCY
613547	STATURE QUANTITATIVE TRAIT LOCUS 22; STQTL22
613548	STATURE QUANTITATIVE TRAIT LOCUS 23; STQTL23
613549	STATURE QUANTITATIVE TRAIT LOCUS 24; STQTL24
613550	NEPHRONOPHTHISIS 11; NPHP11
613551	AUTOIMMUNE DISEASE, SUSCEPTIBILITY TO, 6; AIS6
613552	GAMMA-SECRETASE-ACTIVATING PROTEIN; GSAP
613553	X-PROLYL AMINOPEPTIDASE 3; XPNPEP3
613554	VON WILLEBRAND DISEASE, TYPE 2; VWD2
613555	TET METHYLCYTOSINE DIOXYGENASE 3; TET3
613556	MICRO RNA 659; MIR659
613557	MOVED TO 604213
613558	DEAFNESS, AUTOSOMAL DOMINANT 51; DFNA51
613559	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 7; COXPD7
613560	N-TERMINAL X-PRO-LYS N-METHYLTRANSFERASE 1; NTMT1
613561	MYOPATHY, LACTIC ACIDOSIS, AND SIDEROBLASTIC ANEMIA 2; MLASA2
613562	Fc RECEPTOR-LIKE PROTEIN 6; FCRL6
613563	NOONAN SYNDROME-LIKE DISORDER WITH OR WITHOUT JUVENILE MYELOMONOCYTIC LEUKEMIA; NSLL
613564	CHROMOSOME 2p12-p11.2 DELETION SYNDROME
613565	UBIQUITINATION FACTOR E4B; UBE4B
613566	FETAL HEMOGLOBIN QUANTITATIVE TRAIT LOCUS 6; HBFQTL6
613567	ZINC FINGER, MYM-TYPE 6; ZMYM6
613568	ZINC FINGER, MYM-TYPE 4; ZMYM4
613569	SAD1 AND UNC84 DOMAIN-CONTAINING PROTEIN 2; SUN2
613570	LIPID DROPLET ASSOCIATED HYDROLASE; LDAH
613571	DISORDERED STEROIDOGENESIS DUE TO CYTOCHROME P450 OXIDOREDUCTASE DEFICIENCY
613572	G PROTEIN-COUPLED RECEPTOR, FAMILY C, GROUP 6, MEMBER A; GPRC6A
613573	ECTODERMAL DYSPLASIA-SYNDACTYLY SYNDROME 1; EDSS1
613574	TETRATRICOPEPTIDE REPEAT DOMAIN-CONTAINING PROTEIN 39B; TTC39B
613575	RETINITIS PIGMENTOSA 55; RP55
613576	ECTODERMAL DYSPLASIA-SYNDACTYLY SYNDROME 2; EDSS2
613577	TBC1 DOMAIN FAMILY, MEMBER 24; TBC1D24
613578	PROTEASE, SERINE, 3; PRSS3
613579	C-TYPE LECTIN DOMAIN FAMILY 6, MEMBER A; CLEC6A
613580	WD REPEAT-CONTAINING PLANAR CELL POLARITY EFFECTOR; WDPCP
613581	RETINITIS PIGMENTOSA 56; RP56
613582	RETINITIS PIGMENTOSA 57; RP57
613583	WD REPEAT-CONTAINING PROTEIN 62; WDR62
613584	ALDEHYDE DEHYDROGENASE 1 FAMILY, MEMBER L2; ALDH1L2
613585	TRANSMEMBRANE PROTEIN 147; TMEM147
613586	NIN1-BINDING PROTEIN 1 HOMOLOG; NOB1
613587	OCCULT MACULAR DYSTROPHY; OCMD
613588	C-TYPE LECTIN DOMAIN FAMILY 3, MEMBER A; CLEC3A
613589	LOW DENSITY LIPOPROTEIN CHOLESTEROL LEVEL QUANTITATIVE TRAIT LOCUS 6; LDLCQ6
613590	BUTYROPHILIN, SUBFAMILY 2, MEMBER A1; BTN2A1
613591	BUTYROPHILIN, SUBFAMILY 2, MEMBER A2; BTN2A2
613592	BUTYROPHILIN, SUBFAMILY 2, MEMBER A3; BTN2A3
613593	BUTYROPHILIN, SUBFAMILY 3, MEMBER A1; BTN3A1
613594	BUTYROPHILIN, SUBFAMILY 3, MEMBER A2; BTN3A2
613595	BUTYROPHILIN, SUBFAMILY 3, MEMBER A3; BTN3A3
613596	FAMILY WITH SEQUENCE SIMILARITY 161, MEMBER A; FAM161A
613597	4-HYDROXY-2-OXOGLUTARATE ALDOLASE 1; HOGA1
613598	ZINC FINGER PROTEIN 513; ZNF513
613599	ABHYDROLASE DOMAIN-CONTAINING PROTEIN 12, LYSOPHOSPHOLIPASE; ABHD12
613600	TORSADE DE POINTES, SHORT-COUPLED VARIANT
613601	EARLY REPOLARIZATION ASSOCIATED WITH VENTRICULAR FIBRILLATION
613602	WD REPEAT-CONTAINING PROTEIN 35; WDR35
613603	CHROMOSOME 4q32.1-q32.2 TRIPLICATION SYNDROME
613604	CHROMOSOME 16p12.2-p11.2 DELETION SYNDROME, 7.1- TO 8.7-MB
613605	BBS PROTEIN COMPLEX-INTERACTING PROTEIN 1; BBIP1
613606	FORSYTHE-WAKELING SYNDROME; FWS
613607	THYMOCYTE SELECTION-ASSOCIATED PROTEIN; THEMIS
613608	EPILEPSY, FAMILIAL ADULT MYOCLONIC, 3; FAME3
613609	HOMEOSTATIC IRON REGULATOR; HFE
613610	CRANIOECTODERMAL DYSPLASIA 2; CED2
613611	CHOANAL ATRESIA AND LYMPHEDEMA; CATLPH
613612	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIi; CDG2I
613613	MICRO RNA 208B; MIR208B
613614	MICRO RNA 499; MIR499
613615	SENIOR-LOKEN SYNDROME 7; SLSN7
613616	HYPEROXALURIA, PRIMARY, TYPE III; HP3
613617	RETINITIS PIGMENTOSA 58; RP58
613618	CHROMOSOME 17q23.1-q23.2 DUPLICATION SYNDROME
613619	SCAVENGER RECEPTOR CLASS F, MEMBER 2; SCARF2
613620	TBC1 DOMAIN FAMILY, MEMBER 10B; TBC1D10B
613621	NUCLEOTIDE-BINDING PROTEIN-LIKE PROTEIN; NUBPL
613622	FAD-DEPENDENT OXIDOREDUCTASE DOMAIN-CONTAINING PROTEIN 1; FOXRED1
613623	AGENESIS OF THE CORPUS CALLOSUM AND CONGENITAL LYMPHEDEMA
613624	ZINC FINGER PROTEIN 592; ZNF592
613625	FACTOR V AND FACTOR VIII, COMBINED DEFICIENCY OF, 2; F5F8D2
613626	MOVED TO 255500
613627	BRACHYDACTYLY, TYPE A1, WITH SHORT STATURE, SCOLIOSIS, MICROCEPHALY, PTOSIS, HEARING LOSS, AND MENTAL RETARDATION
613628	ODONTOID HYPOPLASIA
613629	PIEZO-TYPE MECHANOSENSITIVE ION CHANNEL COMPONENT 2; PIEZO2
613630	FETAL ENCASEMENT SYNDROME
613631	WASH COMPLEX, SUBUNIT 2C; WASHC2C
613632	WASH COMPLEX, SUBUNIT 1; WASHC1
613633	DENN/MADD DOMAIN-CONTAINING PROTEIN 1A; DENND1A
613634	DENN/MADD DOMAIN-CONTAINING PROTEIN 1C; DENND1C
613635	EUKARYOTIC TRANSLATION INITIATION FACTOR 2-ALPHA KINASE 1; EIF2AK1
613636	TUBERCULIN SKIN TEST REACTIVITY, ABSENCE OF
613637	TUBERCULIN SKIN TEST REACTIVITY QUANTITATIVE TRAIT LOCUS
613638	CHROMOSOME 19p13.13 DELETION SYNDROME
613639	ADHESION G PROTEIN-COUPLED RECEPTOR D1; ADGRD1
613640	NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE IC; HSAN1C
613641	CHARCOT-MARIE-TOOTH DISEASE, RECESSIVE INTERMEDIATE B; CMTRIB
613642	CARDIOMYOPATHY, DILATED, 1GG; CMD1GG
613643	PARKINSON DISEASE 5, AUTOSOMAL DOMINANT, SUSCEPTIBILITY TO; PARK5
613644	ACTIVATING TRANSCRIPTION FACTOR 7-INTERACTING PROTEIN; ATF7IP
613645	ACTIVATING TRANSCRIPTION FACTOR 7-INTERACTING PROTEIN 2; ATF7IP2
613646	METHYLMALONIC ACIDURIA, TRANSIENT, DUE TO TRANSCOBALAMIN RECEPTOR DEFECT
613647	SPASTIC PARAPLEGIA 48, AUTOSOMAL RECESSIVE; SPG48
613648	MATERNALLY EXPRESSED GENE 8; MEG8
613649	SMALL NUCLEOLAR RNA, C/D BOX, 112; SNORD112
613650	SMALL NUCLEOLAR RNA, C/D BOX, 113-1; SNORD113-1
613651	SMALL NUCLEOLAR RNA, C/D BOX, 114-1; SNORD114-1
613652	C1q DEFICIENCY 1; C1QD1
613653	ADAPTOR-RELATED PROTEIN COMPLEX 5, ZETA-1 SUBUNIT; AP5Z1
613654	MICRO RNA 380; MIR380
613655	POTASSIUM CHANNEL, SUBFAMILY K, MEMBER 18; KCNK18
613656	MIGRAINE WITH AURA, SUSCEPTIBILITY TO, 13; MGR13
613657	D-2-HYDROXYGLUTARIC ACIDURIA 2; D2HGA2
613658	RAJAB INTERSTITIAL LUNG DISEASE WITH BRAIN CALCIFICATIONS 1; RILDBC1
613659	GASTRIC CANCER
613660	CONE-ROD DYSTROPHY 15; CORD15
613661	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ip; CDG1P
613662	MITOCHONDRIAL DNA DEPLETION SYNDROME 4B (MNGIE TYPE); MTDPS4B
613663	SHQ1, H/ACA RIBONUCLEOPROTEIN ASSEMBLY FACTOR; SHQ1
613664	SMOOTHELIN-LIKE 1; SMTNL1
613665	ATYPICAL CHEMOKINE RECEPTOR 1; ACKR1
613666	ALG11 ALPHA-1,2-MANNOSYLTRANSFERASE; ALG11
613667	SINE OCULIS-BINDING PROTEIN HOMOLOG; SOBP
613668	MICROCEPHALY, POSTNATAL PROGRESSIVE, WITH SEIZURES AND BRAIN ATROPHY
613669	MITOCHONDRIAL POLY(A) POLYMERASE; MTPAP
613670	INTELLECTUAL DEVELOPMENTAL DISORDER WITH LANGUAGE IMPAIRMENT AND WITH OR WITHOUT AUTISTIC FEATURES
613671	IMPAIRED INTELLECTUAL DEVELOPMENT, ANTERIOR MAXILLARY PROTRUSION, AND STRABISMUS; MRAMS
613672	SPASTIC ATAXIA 4, AUTOSOMAL RECESSIVE; SPAX4
613673	ANEMIA, CONGENITAL DYSERYTHROPOIETIC, TYPE IV; CDAN4
613674	VESICOURETERAL REFLUX 3; VUR3
613675	CHROMOSOME 17q11.2 DELETION SYNDROME, 1.4-MB
613676	SECKEL SYNDROME 4; SCKL4
613677	HYPERALDOSTERONISM, FAMILIAL, TYPE III; HALD3
613678	BRACHYOLMIA TYPE 2; BCYM2
613679	PROTHROMBIN DEFICIENCY, CONGENITAL
613680	BEAULIEU-BOYCOTT-INNES SYNDROME; BBIS
613681	CHROMOSOME 2q31.1 DUPLICATION SYNDROME
613682	MICRO RNA 130B; MIR130B
613683	SOLUTE CARRIER FAMILY 50 (SUGAR TRANSPORTER), MEMBER 1; SLC50A1
613684	RUBINSTEIN-TAYBI SYNDROME 2; RSTS2
613685	DEAFNESS, AUTOSOMAL RECESSIVE 83; DFNB83
613686	SPONDYLOCOSTAL DYSOSTOSIS 4, AUTOSOMAL RECESSIVE; SCDO4
613687	PARP1-BINDING PROTEIN; PARPBP
613688	LONG QT SYNDROME 2; LQT2
613689	MAMMARY-DIGITAL-NAIL SYNDROME; MDNS
613690	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 7; CMH7
613691	GRAM DOMAIN-CONTAINING PROTEIN 4; GRAMD4
613692	TERMINAL URIDYLYL TRANSFERASE 4; TUT4
613693	LONG QT SYNDROME 6; LQT6
613694	CARDIOMYOPATHY, DILATED, 1U; CMD1U
613695	LONG QT SYNDROME 5; LQT5
613696	UPSTREAM BINDING TRANSCRIPTION FACTOR (RNA POLYMERASE I)-LIKE 1; UBTFL1
613697	CARDIOMYOPATHY, DILATED, 1V; CMD1V
613698	SOLUTE CARRIER FAMILY 25 (CARNITINE/ACYLCARNITINE TRANSLOCASE), MEMBER 20; SLC25A20
613699	GLYCOSYLTRANSFERASE 6 DOMAIN-CONTAINING 1; GLT6D1
613700	SUPERNUMERARY DER(22)t(8;22) SYNDROME
613701	MICRO RNA 328; MIR328
613702	KLIPPEL-FEIL SYNDROME 3, AUTOSOMAL DOMINANT; KFS3
613703	MICROPHTHALMIA/COLOBOMA 6; MCOPCB6
613704	MICROPHTHALMIA, ISOLATED 7; MCOP7
613705	OROFACIAL CLEFT 10; OFC10
613706	NOONAN SYNDROME 7; NS7
613707	LEOPARD SYNDROME 3; LPRD3
613708	NEUROPATHY, HEREDITARY SENSORY, TYPE ID; HSN1D
613709	EUKARYOTIC TRANSLATION INITIATION FACTOR 2D; EIF2D
613710	THIAMINE METABOLISM DYSFUNCTION SYNDROME 4 (BILATERAL STRIATAL DEGENERATION AND PROGRESSIVE POLYNEUROPATHY TYPE); THMD4
613711	HIRSCHSPRUNG DISEASE, SUSCEPTIBILITY TO, 3; HSCR3
613712	HIRSCHSPRUNG DISEASE, SUSCEPTIBILITY TO, 4; HSCR4
613713	PCI DOMAIN-CONTAINING PROTEIN 2; PCID2
613714	NATURAL KILLER CELL CYTOTOXICITY RECEPTOR 3 LIGAND 1; NCR3LG1
613715	POLYMERASE I, RNA, SUBUNIT D; POLR1D
613716	MICRO RNA 661; MIR661
613717	TREACHER COLLINS SYNDROME 2; TCS2
613718	DEAFNESS, AUTOSOMAL RECESSIVE 74; DFNB74
613719	METHIONINE SULFOXIDE REDUCTASE B3; MSRB3
613720	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 7; DEE7
613721	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 11; DEE11
613722	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 12; DEE12
613723	MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 17; LGMDR17
613724	LEUKOENCEPHALOPATHY WITH DYSTONIA AND MOTOR NEUROPATHY; LKDMN
613725	SOLUTE CARRIER FAMILY 25, MEMBER 17; SLC25A27
613726	ANOCTAMIN 10; ANO10
613727	KELCH REPEAT- AND BTB/POZ DOMAIN-CONTAINING PROTEIN 13; KBTBD13
613728	SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 10; SCAR10
613729	CHROMOSOME 7q11.23 DELETION SYNDROME, DISTAL, 1.2-MB
613730	HEMORRHAGIC DESTRUCTION OF THE BRAIN, SUBEPENDYMAL CALCIFICATION, AND CATARACTS; HDBSCC
613731	RETINITIS PIGMENTOSA 4; RP4
613732	MOVED TO 256040
613733	MENIN 1 ; MEN1
613734	COILED-COIL DOMAIN-CONTAINING PROTEIN 115; CCDC115
613735	BRAIN MALFORMATIONS WITH OR WITHOUT URINARY TRACT DEFECTS; BRMUTD
613736	ACNE INVERSA, FAMILIAL, 2, WITH OR WITHOUT DOWLING-DEGOS DISEASE; ACNINV2
613737	ACNE INVERSA, FAMILIAL, 3; ACNINV3
613738	ALKYLGLYCEROL MONOOXYGENASE; AGMO
613739	THYMOCYTE NUCLEAR PROTEIN 1; THYN1
613740	MOVED TO 115200
613741	GLYCOGEN PHOSPHORYLASE, LIVER; PYGL
613742	GLUCOSE-6-PHOSPHATASE, CATALYTIC; G6PC
613743	ADRENAL INSUFFICIENCY, CONGENITAL, WITH 46,XY SEX REVERSAL, PARTIAL OR COMPLETE
613744	SPASTIC PARAPLEGIA 51, AUTOSOMAL RECESSIVE; SPG51
613745	ANAPHASE-PROMOTING COMPLEX, SUBUNIT 10; ANAPC10
613746	BREAST CANCER ANTIESTROGEN RESISTANCE 4; BCAR4
613747	KINESIN FAMILY MEMBER 24; KIF24
613748	COILED-COIL-HELIX-COILED-COIL-HELIX DOMAIN-CONTAINING PROTEIN 3; CHCHD3
613749	ZINC FINGER PROTEIN 260; ZNF260
613750	RETINITIS PIGMENTOSA 27; RP27
613751	HETEROTAXY, VISCERAL, 4, AUTOSOMAL; HTX4
613752	HYPERMETHIONINEMIA WITH S-ADENOSYLHOMOCYSTEINE HYDROLASE DEFICIENCY
613753	MICRO RNA 211; MIR211
613754	RING FINGER PROTEIN 187; RNF187
613755	MICRO RNA 326; MIR326
613756	RETINITIS PIGMENTOSA 49; RP49
613757	MACULAR DEGENERATION, AGE-RELATED, 6; ARMD6
613758	RETINITIS PIGMENTOSA 47; RP47
613759	IMMUNODEFICIENCY 90 WITH ENCEPHALOPATHY, FUNCTIONAL HYPOSPLENIA, AND HEPATIC DYSFUNCTION; IMD90
613760	SOLUTE CARRIER FAMILY 36, MEMBER 4; SLC36A4
613761	MACULAR DEGENERATION, AGE-RELATED, 5; ARMD5
613762	46,XY SEX REVERSAL 6; SRXY6
613763	CATARACT 16, MULTIPLE TYPES; CTRCT16
613764	SECRETORY CARRIER MEMBRANE PROTEIN 4; SCAMP4
613765	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 9; CMH9
613766	SECRETORY CARRIER MEMBRANE PROTEIN 5; SCAMP5
613767	RETINITIS PIGMENTOSA 45; RP45
613768	RING FINGER PROTEIN 213; RNF213
613769	RETINITIS PIGMENTOSA 44; RP44
613770	PLACENTA-SPECIFIC GENE 4; PLAC4
613771	TRANSMEMBRANE PROTEIN 205; TMEM205
613772	KELCH-LIKE 14; KLHL14
613773	IMMUNOGLOBULIN SUPERFAMILY, MEMBER 9B; IGSF9B
613774	CALMODULIN-REGULATED SPECTRIN-ASSOCIATED PROTEIN 1; CAMSAP1
613775	CALMODULIN-REGULATED SPECTRIN-ASSOCIATED PROTEIN 2; CAMSAP2
613776	CHROMOSOME 17p13.1 DELETION SYNDROME
613777	FAD-DEPENDENT OXIDOREDUCTASE DOMAIN-CONTAINING PROTEIN 2; FOXRED2
613778	MACULAR DEGENERATION, AGE-RELATED, 8; ARMD8
613779	COMPLEMENT COMPONENT 3 DEFICIENCY, AUTOSOMAL RECESSIVE; C3D
613780	AORTIC ANEURYSM, FAMILIAL THORACIC 7; AAT7
613781	COILED-COIL DOMAIN-CONTAINING PROTEIN 125; CCDC125
613782	METHIONINE SULFOXIDE REDUCTASE B2; MSRB2
613783	COMPLEMENT COMPONENT C1s DEFICIENCY; C1SD
613784	MACULAR DEGENERATION, AGE-RELATED, 12; ARMD12
613785	COMPLEMENT COMPONENT 1, r SUBCOMPONENT; C1R
613786	MICRO RNA 148A; MIR148A
613787	MICRO RNA 148B; MIR148B
613788	MICRO RNA 152; MIR152
613789	COMPLEMENT COMPONENT 8 DEFICIENCY, TYPE II; C8D2
613790	COMPLEMENT COMPONENT 8 DEFICIENCY, TYPE I; C8D1
613791	MASP2 DEFICIENCY
613792	CHROMOSOME 3pter-p25 DELETION SYNDROME
613793	BLOOD GROUP, CROMER SYSTEM; CROM
613794	RETINITIS PIGMENTOSA 20; RP20
613795	LOEYS-DIETZ SYNDROME 3; LDS3
613796	IMMUNODEFICIENCY 31B; IMD31B
613797	PROTEASE, SERINE, 33; PRSS33
613798	COILED-COIL DOMAIN-CONTAINING PROTEIN 39; CCDC39
613799	COILED-COIL DOMAIN-CONTAINING PROTEIN 40; CCDC40
613800	MEIER-GORLIN SYNDROME 2; MGORS2
613801	RETINITIS PIGMENTOSA 40; RP40
613802	MALECTIN; MLEC
613803	MEIER-GORLIN SYNDROME 3; MGORS3
613804	MEIER-GORLIN SYNDROME 4; MGORS4
613805	MEIER-GORLIN SYNDROME 5; MGORS5
613806	CHOLANGITIS, PRIMARY SCLEROSING; PSC
613807	CILIARY DYSKINESIA, PRIMARY, 14; CILD14
613808	CILIARY DYSKINESIA, PRIMARY, 15; CILD15
613809	RETINITIS PIGMENTOSA 39; RP39
613810	RETINITIS PIGMENTOSA 43; RP43
613811	PONTOCEREBELLAR HYPOPLASIA, TYPE 2D; PCH2D
613812	BILE ACID SYNTHESIS DEFECT, CONGENITAL, 3; CBAS3
613813	MDM1 NUCLEAR PROTEIN; MDM1
613814	TETRATRICOPEPTIDE REPEAT DOMAIN-CONTAINING PROTEIN 19; TTC19
613815	CYTOCHROME P450, FAMILY 21, SUBFAMILY A, POLYPEPTIDE 2; CYP21A2
613816	UBIQUITIN PROTEIN LIGASE E3 COMPONENT N-RECOGNIN 7; UBR7
613817	SPERMATOGENESIS-ASSOCIATED SERINE-RICH PROTEIN 2-LIKE; SPATS2L
613818	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 9; MDDGC9
613819	SHORT-RIB THORACIC DYSPLASIA 4 WITH OR WITHOUT POLYDACTYLY; SRTD4
613820	NEPHRONOPHTHISIS 12; NPHP12
613821	PROTEIN PHOSPHATASE 3, REGULATORY SUBUNIT B, BETA; PPP3R2
613822	PROTEIN PHOSPHATASE 4, REGULATORY SUBUNIT 2; PPP4R2
613823	SECKEL SYNDROME 5; SCKL5
613824	NEPHRONOPHTHISIS 9; NPHP9
613825	COMPLEMENT COMPONENT 9 DEFICIENCY; C9D
613826	LEBER CONGENITAL AMAUROSIS 6; LCA6
613827	RETINITIS PIGMENTOSA 48; RP48
613828	GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 8; GEFSP8
613829	LEBER CONGENITAL AMAUROSIS 7; LCA7
613830	NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1D; CSNB1D
613831	UBIQUITIN PROTEIN LIGASE E3 COMPONENT N-RECOGNIN 3; UBR3
613832	MOVED TO 607459
613833	KAT8 REGULATORY NSL COMPLEX SUBUNIT 1-LIKE PROTEIN; KANSL1L
613834	SMOOTH MUSCLE DYSFUNCTION SYNDROME; SMDYS
613835	LEBER CONGENITAL AMAUROSIS 8; LCA8
613836	ADIPONECTIN, SERUM LEVEL OF, QUANTITATIVE TRAIT LOCUS 5; ADIPQTL5
613837	LEBER CONGENITAL AMAUROSIS 11; LCA11
613838	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 16; CMH16
613839	MEGALOBLASTIC ANEMIA DUE TO DIHYDROFOLATE REDUCTASE DEFICIENCY
613840	ZINC FINGER PROTEIN 304; ZNF304
613841	UBINUCLEIN 2; UBN2
613842	GDNF-INDUCIBLE ZINC FINGER PROTEIN 1; GZF1
613843	LEBER CONGENITAL AMAUROSIS 15; LCA15
613844	UBIQUINOL-CYTOCHROME C REDUCTASE HINGE PROTEIN; UQCRH
613845	HYPERURICEMIA, PULMONARY HYPERTENSION, RENAL FAILURE, AND ALKALOSIS SYNDROME; HUPRAS
613846	TECTONIC FAMILY, MEMBER 2; TCTN2
613847	TECTONIC FAMILY, MEMBER 3; TCTN3
613848	OSTEOGENESIS IMPERFECTA, TYPE X; OI10
613849	OSTEOGENESIS IMPERFECTA, TYPE XII; OI12
613850	INOSINE TRIPHOSPHATASE DEFICIENCY
613851	PROLINE-RICH MEMBRANE ANCHOR 1; PRIMA1
613852	FUCOSYLTRANSFERASE 6 DEFICIENCY
613853	MOVED TO 605376
613854	CONGENITAL HEART DEFECTS, MULTIPLE TYPES, 6; CHTD6
613855	EPISODIC ATAXIA, TYPE 5; EA5
613856	ACHROMATOPSIA 4; ACHM4
613857	OROFACIAL CLEFT 13; OFC13
613858	PROTEASE, SERINE, 56; PRSS56
613859	UROMODULIN-LIKE 1; UMODL1
613860	FICOLIN 3 DEFICIENCY
613861	RETINITIS PIGMENTOSA 59; RP59
613862	RETINITIS PIGMENTOSA 38; RP38
613863	GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 7; GEFSP7
613864	ZINC FINGER PROTEIN 317; ZNF317
613865	DEAFNESS, AUTOSOMAL RECESSIVE 61; DFNB61
613866	PHOSPHOLIPASE A AND ACYLTRANSFERASE 2; PLAAT2
613867	PHOSPHOLIPASE A AND ACYLTRANSFERASE 3; PLAAT3
613868	SOLUTE CARRIER FAMILY 14 (UREA TRANSPORTER), MEMBER 1; SLC14A1
613869	MYOPATHY, MYOFIBRILLAR, FATAL INFANTILE HYPERTONIC, ALPHA-B CRYSTALLIN-RELATED
613870	HIRSCHSPRUNG DISEASE, CARDIAC DEFECTS, AND AUTONOMIC DYSFUNCTION; HCAD
613871	FUMARYLACETOACETATE HYDROLASE; FAH
613872	COAGULATION FACTOR X; F10
613873	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 17; CMH17
613874	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 18; CMH18
613875	MOVED TO 192600
613876	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 20; CMH20
613877	LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 4; FPLD4
613878	COAGULATION FACTOR VII; F7
613879	THYROTROPIN-RELEASING HORMONE; TRH
613880	BROMO-ADJACENT HOMOLOGY DOMAIN-CONTAINING PROTEIN 1; BAHD1
613881	CARDIOMYOPATHY, DILATED, 1HH; CMD1HH
613882	HYPOMAGNESEMIA 6, RENAL; HOMG6
613883	KELL BLOOD GROUP METALLOENDOPEPTIDASE; KEL
613884	CHROMOSOME 13q14 DELETION SYNDROME
613885	MECKEL SYNDROME, TYPE 8; MKS8
613886	OBESITY, HYPERPHAGIA, AND DEVELOPMENTAL DELAY; OBHD
613887	CATARACT 36; CTRCT36
613888	RAS HOMOLOG GENE FAMILY, MEMBER T1; RHOT1
613889	RAS HOMOLOG GENE FAMILY, MEMBER T2; RHOT2
613890	3-BETA-HYDROXYSTEROID DEHYDROGENASE 2; HSD3B2
613891	URIDINE MONOPHOSPHATE SYNTHETASE; UMPS
613892	DPY19-LIKE 1; DPY19L1
613893	DPY19-LIKE 2; DPY19L2
613894	DPY19-LIKE 3; DPY19L3
613895	DPY19-LIKE 4; DPY19L4
613896	BISPHOSPHOGLYCERATE MUTASE; BPGM
613897	FANCF GENE; FANCF
613898	3-HYDROXY-3-METHYLGLUTARYL-CoA LYASE; HMGCL
613899	FANCC GENE; FANCC
613900	TRANSGLUTAMINASE 6; TGM6
613901	RNA 2-PRIME,3-PRIME CYCLIC PHOSPHATE AND 5-PRIME-OH LIGASE; RTCB
613902	ZINC FINGER PROTEIN 503; ZNF503
613903	ZINC FINGER PROTEIN 540; ZNF540
613904	ZINC FINGER PROTEIN 569; ZNF569
613905	ZINC FINGER PROTEIN 606; ZNF606
613906	ZINC FINGER PROTEIN 641; ZNF641
613907	ZINC FINGER PROTEIN 652; ZNF652
613908	SPINOCEREBELLAR ATAXIA 35; SCA35
613909	SPINOCEREBELLAR ATAXIA 32; SCA32
613910	ZINC FINGER PROTEIN 480; ZNF480
613911	ZINC FINGER PROTEIN 496; ZNF496
613912	COMPLEMENT FACTOR D DEFICIENCY; CFDD
613913	LIPODYSTROPHY, PARTIAL, ACQUIRED, WITH LOW COMPLEMENT COMPONENT C3, WITH OR WITHOUT GLOMERULONEPHRITIS; APLDC3
613914	ZINC FINGER PROTEIN 746; ZNF746
613915	ZINC FINGER- AND BTB DOMAIN-CONTAINING PROTEIN 42: ZBTB42
613916	DEAFNESS, AUTOSOMAL RECESSIVE 89; DFNB89
613917	MUCIN 22; MUC22
613918	HLA COMPLEX GROUP 22; HCG22
613919	KINESIN FAMILY MEMBER 6; KIF6
613920	CYTOCHROME C OXIDASE ASSEMBLY FACTOR 5; COA5
613921	LIPASE FAMILY, MEMBER J; LIPJ
613922	LIPASE FAMILY, MEMBER K; LIPK
613923	LIPASE FAMILY, MEMBER M; LIPM
613924	LIPASE FAMILY, MEMBER N; LIPN
613925	MEGALENCEPHALIC LEUKOENCEPHALOPATHY WITH SUBCORTICAL CYSTS 2A; MLC2A
613926	MEGALENCEPHALIC LEUKOENCEPHALOPATHY WITH SUBCORTICAL CYSTS 2B, REMITTING, WITH OR WITHOUT IMPAIRED INTELLECTUAL DEVELOPMENT; MLC2B
613927	COMPLEMENT COMPONENT 2; C2
613928	MUCIN-LIKE 3; MUCL3
613929	SERINE PROTEASE INHIBITOR, KAZAL-TYPE, 4; SPINK4
613930	ALOPECIA-INTELLECTUAL DISABILITY SYNDROME 3; APMR3
613931	TARGET OF EGR1; TOE1
613932	TNNI3-INTERACTING KINASE; TNNI3K
613933	ACETYL-CoA CARBOXYLASE-ALPHA DEFICIENCY; ACACAD
613934	TRANSMEMBRANE PROTEIN 25; TMEM25
613935	TRANSMEMBRANE PROTEIN 74; TMEM74
613936	TRANSMEMBRANE PROTEIN 102; TMEM102
613937	TRANSMEMBRANE PROTEIN 184C; TMEM184C
613938	PARASOMNIA, SLEEPWALKING TYPE; PSMNSW
613939	SPERMATOGENESIS-ASSOCIATED PROTEIN 20; SPATA20
613940	AFG2 AAA ATPase HOMOLOG A; AFG2A
613941	SERINE PEPTIDASE INHIBITOR, KUNITZ-TYPE, 3; SPINT3
613942	SAD1 AND UNC84 DOMAIN-CONTAINING PROTEIN 5; SUN5
613943	ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 8; ARCI8
613944	IgA NEPHROPATHY, SUSCEPTIBILITY TO, 2; IGAN2
613945	DNAJ/HSP40 HOMOLOG, SUBFAMILY C, MEMBER 5, BETA; DNAJC5B
613946	DNAJ/HSP40 HOMOLOG, SUBFAMILY C, MEMBER 5, GAMMA; DNAJC5G
613947	SPERMATOGENESIS-ASSOCIATED PROTEIN 6; SPATA6
613948	SPERMATOGENESIS-ASSOCIATED PROTEIN 8; SPATA8
613949	OKT4 EPITOPE DEFICIENCY; OKT4D
613950	SCHIZOPHRENIA 15; SCZD15
613951	FANCONI ANEMIA, COMPLEMENTATION GROUP P; FANCP
613952	TERMINAL NUCLEOTIDYLTRANSFERASE 5C; TENT5C
613953	IMMUNODEFICIENCY 51; IMD51
613954	FRONTOTEMPORAL DEMENTIA AND/OR AMYOTROPHIC LATERAL SCLEROSIS 6; FTDALS6
613955	AMYLOIDOSIS, PRIMARY LOCALIZED CUTANEOUS, 2; PLCA2
613956	CANDIDIASIS, FAMILIAL, 6; CANDF6
613957	SPERMATOGENIC FAILURE 8; SPGF8
613958	SPERMATOGENIC FAILURE 9; SPGF9
613959	SCHIZOPHRENIA 16; SCZD16
613960	GRANULOMATOUS DISEASE, CHRONIC, AUTOSOMAL RECESSIVE, 3; CGD3
613961	TASTE RECEPTOR, TYPE 2, MEMBER 19; TAS2R19
613962	TASTE RECEPTOR, TYPE 2, MEMBER 20; TAS2R20
613963	TASTE RECEPTOR, TYPE 2, MEMBER 30; TAS2R30
613964	TASTE RECEPTOR, TYPE 2, MEMBER 40; TAS2R40
613965	TASTE RECEPTOR, TYPE 2, MEMBER 41; TAS2R41
613966	TASTE RECEPTOR, TYPE 2, MEMBER 42; TAS2R42
613967	TASTE RECEPTOR, TYPE 2, MEMBER 45; TAS2R45
613968	TASTE RECEPTOR, TYPE 2, MEMBER 60; TAS2R60
613969	MYOPIA 19, AUTOSOMAL DOMINANT; MYP19
613970	INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 6, WITH OR WITHOUT SEIZURES; MRD6
613971	MOVED TO 245570
613972	MELANOMA, CUTANEOUS MALIGNANT, SUSCEPTIBILITY TO, 6; CMM6
613973	CYCLIC GMP-AMP SYNTHASE; CGAS
613974	DExD/H-BOX HELICASE 60; DDX60
613975	INTERFERON-INDUCED PROTEIN 44-LIKE; IFI44L
613976	FANCE GENE; FANCE
613977	CYANOSIS, TRANSIENT NEONATAL; TNCY
613978	HEMOGLOBIN H DISEASE; HBH
613979	PRE-mRNA-PROCESSING FACTOR 6; PRPF6
613980	ATRIAL FIBRILLATION, FAMILIAL, 9; ATFB9
613981	HYPOTRICHOSIS 3; HYPT3
613982	OSTEOGENESIS IMPERFECTA, TYPE VI; OI6
613983	RETINITIS PIGMENTOSA 60; RP60
613984	FANCD2 GENE; FANCD2
613985	BETA-THALASSEMIA
613986	PITUITARY HORMONE DEFICIENCY, COMBINED, 6; CPHD6
613987	DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 2; DKCB2
613988	DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 3; DKCB3
613989	DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 2; DKCA2
613990	DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 3; DKCA3
613991	CDC42-BINDING PROTEIN KINASE, GAMMA; CDC42BPG
613992	PROTEIN PHOSPHATASE 2, REGULATORY SUBUNIT B, DELTA; PPP2R2D
613993	MYOSIN, LIGHT CHAIN 7, REGULATORY; MYL7
613994	NEUROBLASTOMA BREAKPOINT FAMILY, MEMBER 4; NBPF4
613995	NEUROBLASTOMA BREAKPOINT FAMILY, MEMBER 5; NBPF5
613996	NEUROBLASTOMA BREAKPOINT FAMILY, MEMBER 6; NBPF6
613997	NEUROBLASTOMA BREAKPOINT FAMILY, MEMBER 7; NBPF7
613998	NEUROBLASTOMA BREAKPOINT FAMILY, MEMBER 8; NBPF8
613999	NEUROBLASTOMA BREAKPOINT FAMILY, MEMBER 9; NBPF9
614000	NEUROBLASTOMA BREAKPOINT FAMILY, MEMBER 10; NBPF10
614001	NEUROBLASTOMA BREAKPOINT FAMILY, MEMBER 11; NBPF11
614002	MOVED TO 608607
614003	NEUROBLASTOMA BREAKPOINT FAMILY, MEMBER 14; NBPF14
614004	MOVED TO 610414
614005	MOVED TO 610414
614006	NEUROBLASTOMA BREAKPOINT FAMILY, MEMBER 19; NBPF19
614007	NEUROBLASTOMA BREAKPOINT FAMILY, MEMBER 20; NBPF20
614008	NESTOR-GUILLERMO PROGERIA SYNDROME; NGPS
614009	BLEEDING DISORDER, PLATELET-TYPE, 13, SUSCEPTIBILITY TO; BDPLT13
614010	INOSITOL MONOPHOSPHATASE DOMAIN-CONTAINING PROTEIN 1; IMPAD1
614011	ENDOGENOUS RETROVIRUS GROUP K, MEMBER 4; ERVK-4
614012	ENDOGENOUS RETROVIRUS GROUP K, MEMBER 5; ERVK-5
614013	ENDOGENOUS RETROVIRUS GROUP K, MEMBER 7; ERVK-7
614014	RIBONUCLEASE, RNase A FAMILY, 9; RNASE9
614015	DIACYLGLYCEROL LIPASE, ALPHA; DAGLA
614016	DIACYLGLYCEROL LIPASE, BETA; DAGLB
614017	CILIARY DYSKINESIA, PRIMARY, 16; CILD16
614018	EPILEPSY, PROGRESSIVE MYOCLONIC, 6; EPM6
614019	LISSENCEPHALY 4; LIS4
614020	INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 14; MRT14
614021	VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 3; CPVT3
614022	ATRIAL FIBRILLATION, FAMILIAL, 10; ATFB10
614023	PHOSPHOSERINE PHOSPHATASE DEFICIENCY; PSPHD
614024	PROTEIN Z DEFICIENCY
614025	HEPATIC LIPASE DEFICIENCY
614026	KINESIN FAMILY MEMBER 26B; KIF26B
614027	INSULINOMA-ASSOCIATED 2; INSM2
614028	APOLIPOPROTEIN C-III DEFICIENCY
614029	SPEEDY/RINGO CELL CYCLE REGULATOR FAMILY, MEMBER A; SPDYA
614030	SPEEDY/RINGO CELL CYCLE REGULATOR FAMILY, MEMBER C; SPDYC
614031	RAN-BINDING PROTEIN 10; RANBP10
614032	TOX HIGH MOBILITY GROUP BOX FAMILY MEMBER 4; TOX4
614033	HYDROXYACYL GLUTATHIONE HYDROLASE DEFICIENCY
614034	HEME OXYGENASE 1 DEFICIENCY; HMOX1D
614035	DEAFNESS, AUTOSOMAL RECESSIVE 29; DFNB29
614036	ALPHA-2-MACROGLOBULIN DEFICIENCY; A2MD
614037	LEUKOTRIENE C4 SYNTHASE DEFICIENCY
614038	LYMPHEDEMA, PRIMARY, WITH MYELODYSPLASIA
614039	CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 1; CDCBM1
614040	ZINC FINGER PROTEIN 467; ZNF467
614041	RB TRANSCRIPTIONAL COREPRESSOR 1; RB1
614042	MOYAMOYA DISEASE 5; MYMY5
614043	LEUCINE-RICH REPEAT IN FLII-INTERACTING PROTEIN 2; LRRFIP2
614044	TRYPSINOGEN DEFICIENCY
614045	FAMILY WITH SEQUENCE SIMILARITY 129, MEMBER B; FAM129B
614046	ARGININE- AND GLUTAMATE-RICH PROTEIN 1; ARGLU1
614047	METHYLENETETRAHYDROFOLATE DEHYDROGENASE 2-LIKE, NADP(+)-DEPENDENT; MTHFD2L
614048	ENDOSOME-LYSOSOME-ASSOCIATED APOPTOSIS AND AUTOPHAGY REGULATOR 2; ELAPOR2
614049	ATRIAL FIBRILLATION, FAMILIAL, 11; ATFB11
614050	ATRIAL FIBRILLATION, FAMILIAL, 12; ATFB12
614051	MOVED TO 212066
614052	MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 2; MC5DN2
614053	MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 3; MC5DN3
614054	RIBOSOMAL MODIFICATION PROTEIN RimK-LIKE FAMILY, MEMBER B; RIMKLB
614055	ACETYL-CoA ACETYLTRANSFERASE-2 DEFICIENCY; ACAT2D
614056	PROTEIN PHOSPHATASE 1, REGULATORY SUBUNIT 26; PPP1R26
614057	MICRO RNA 409; MIR409
614058	KETOHEXOKINASE; KHK
614059	MICRO RNA 338; MIR338
614060	HOXA DISTAL TRANSCRIPT ANTISENSE RNA; HOTTIP
614061	OLFACTOMEDIN 4; OLFM4
614062	CDC42-BINDING PROTEIN KINASE, BETA; CDC42BPB
614063	N-ACETYLASPARTATE DEFICIENCY; NACED
614064	ZINC FINGER- AND BTB DOMAIN-CONTAINING PROTEIN 24; ZBTB24
614065	MYOPATHY, DISTAL, 4; MPD4
614066	SPASTIC PARAPLEGIA 47, AUTOSOMAL RECESSIVE; SPG47
614067	SPASTIC PARAPLEGIA 52, AUTOSOMAL RECESSIVE; SPG52
614068	INTRAFLAGELLAR TRANSPORT 43; IFT43
614069	IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 2; ICF2
614070	PSORIASIS 13, SUSCEPTIBILITY TO; PSORS13
614071	MYOCARDIAL ZONULA ADHERENS PROTEIN; MYZAP
614072	HERMANSKY-PUDLAK SYNDROME 3; HPS3
614073	HERMANSKY-PUDLAK SYNDROME 4; HPS4
614074	HERMANSKY-PUDLAK SYNDROME 5; HPS5
614075	HERMANSKY-PUDLAK SYNDROME 6; HPS6
614076	HERMANSKY-PUDLAK SYNDROME 7; HPS7
614077	HERMANSKY-PUDLAK SYNDROME 8; HPS8
614078	CHONDRODYSPLASIA WITH JOINT DISLOCATIONS, GPAPP TYPE
614079	ASPERGILLOSIS, SUSCEPTIBILITY TO
614080	MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 1; MCAHS1
614081	ANHAPTOGLOBINEMIA; AHP
614082	FANCONI ANEMIA, COMPLEMENTATION GROUP G; FANCG
614083	FANCONI ANEMIA, COMPLEMENTATION GROUP L; FANCL
614084	WEE1 HOMOLOG 2; WEE2
614085	RAD9-, RAD1-, AND HUS1-INTERACTING NUCLEAR ORPHAN 1; RHNO1
614086	MULTICILIATE DIFFERENTIATION AND DNA SYNTHESIS-ASSOCIATED CELL CYCLE PROTEIN; MCIDAS
614087	MOVED TO 227650 AND 609644
614088	INTRACELLULAR ADHESION MOLECULE 4; ICAM4
614089	ATRIAL SEPTAL DEFECT 3; ASD3
614090	SICK SINUS SYNDROME 3, SUSCEPTIBILITY TO; SSS3
614091	SHORT-RIB THORACIC DYSPLASIA 7 WITH OR WITHOUT POLYDACTYLY; SRTD7
614092	RAB-INTERACTING LYSOSOMAL PROTEIN-LIKE 1; RILPL1
614093	RAB-INTERACTING LYSOSOMAL PROTEIN-LIKE 2; RILPL2
614094	MARVEL DOMAIN-CONTAINING PROTEIN 3; MARVELD3
614095	PHOSPHOENOLPYRUVATE CARBOXYKINASE 2, MITOCHONDRIAL; PCK2
614096	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 8; COXPD8
614097	ACATALASEMIA
614098	KEPPEN-LUBINSKY SYNDROME; KPLBS
614099	CRANIOECTODERMAL DYSPLASIA 3; CED3
614100	CUTIS LAXA, NEONATAL, WITH MARFANOID PHENOTYPE
614101	PLASMA FIBRONECTIN DEFICIENCY
614102	IMMUNOGLOBULIN KAPPA LIGHT CHAIN DEFICIENCY; IGKCD
614103	LIPEDEMA
614104	INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 7; MRD7
614105	METHYLMALONATE SEMIALDEHYDE DEHYDROGENASE DEFICIENCY; MMSDHD
614106	MUSCULAR LMNA-INTERACTING PROTEIN; MLIP
614107	KARYOPHERIN ALPHA-7; KPNA7
614108	BPI FOLD-CONTAINING PROTEIN, FAMILY B, MEMBER 2; BPIFB2
614109	BPI FOLD-CONTAINING PROTEIN, FAMILY C; BPIFC
614110	BPI FOLD-CONTAINING PROTEIN, FAMILY B, MEMBER 6; BPIFB6
614111	PYRUVATE DEHYDROGENASE E1-BETA DEFICIENCY; PDHBD
614112	MICRO RNA 320A; MIR320A
614113	INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 2; MRD2
614114	MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 2; MVA2
614115	CORTICAL MALFORMATIONS, OCCIPITAL; OCCM
614116	NEUROPATHY, HEREDITARY SENSORY, TYPE IE; HSN1E
614117	EXOCYST COMPLEX COMPONENT 3-LIKE 1; EXOC3L1
614118	TEASHIRT ZINC FINGER HOMEOBOX 2; TSHZ2
614119	TEASHIRT ZINC FINGER HOMEOBOX 3; TSHZ3
614120	HYDROLETHALUS SYNDROME 2; HLS2
614121	TERMINAL NUCLEOTIDYLTRANSFERASE 2; TENT2
614122	CHITOTRIOSIDASE DEFICIENCY; CHITD
614123	TRANSMEMBRANE AND COILED-COIL DOMAINS PROTEIN 1; TMCO1
614124	GLYCEROPHOSPHOCHOLINE PHOSPHODIESTERASE 1; GPCPD1
614125	DEVELOPMENTAL PLURIPOTENCY-ASSOCIATED GENE 4; DPPA4
614126	MITOCHONDRIAL AMIDOXIME-REDUCING COMPONENT 1; MTARC1
614127	MITOCHONDRIAL AMIDOXIME-REDUCING COMPONENT 2; MTARC2
614128	LACTATE DEHYDROGENASE B DEFICIENCY; LDHBD
614129	PERRAULT SYNDROME 3; PRLTS3
614130	ADENOSINE DEAMINASE DOMAIN-CONTAINING PROTEIN 1, TESTIS-SPECIFIC; ADAD1
614131	FOCAL SEGMENTAL GLOMERULOSCLEROSIS 6; FSGS6
614132	MOVED TO 213980
614133	HEPACAM FAMILY MEMBER 2; HEPACAM2
614134	STICKLER SYNDROME, TYPE IV; STL4
614135	EPIPHYSEAL DYSPLASIA, MULTIPLE, 6; EDM6
614136	TRAFFICKING PROTEIN PARTICLE COMPLEX, SUBUNIT 8; TRAPPC8
614137	TRAFFICKING PROTEIN PARTICLE COMPLEX, SUBUNIT 3-LIKE; TRAPPC3L
614138	TRAFFICKING PROTEIN PARTICLE COMPLEX, SUBUNIT 11; TRAPPC11
614139	TRAFFICKING PROTEIN PARTICLE COMPLEX, SUBUNIT 12; TRAPPC12
614140	SPERM ANTIGEN WITH CALPONIN HOMOLOGY AND COILED-COIL DOMAINS 1-LIKE; SPECC1L
614141	TRIPARTITE MOTIF-CONTAINING PROTEIN 2; TRIM2
614142	CUE DOMAIN-CONTAINING PROTEIN 2; CUEDC2
614143	IGF-LIKE FAMILY RECEPTOR 1; IGFLR1
614144	B9 DOMAIN-CONTAINING PROTEIN 1; B9D1
614145	COILED-COIL DOMAIN-CONTAINING PROTEIN 8; CCDC8
614146	DYNEIN, AXONEMAL, ASSEMBLY FACTOR 9; DNAAF9
614147	C1q- AND TUMOR NECROSIS FACTOR-RELATED PROTEIN 8; C1QTNF8
614148	C1q- AND TUMOR NECROSIS FACTOR-RELATED PROTEIN 9B; C1QTNF9B
614149	NAIL DISORDER, NONSYNDROMIC CONGENITAL, 9; NDNC9
614150	PROTEIN KINASE DOMAIN-CONTAINING PROTEIN, CYTOPLASMIC; PKDCC
614151	RING FINGER AND WD REPEAT DOMAINS-CONTAINING PROTEIN 3; RFWD3
614152	DEAFNESS, AUTOSOMAL DOMINANT 64; DFNA64
614153	SPINOCEREBELLAR ATAXIA 36; SCA36
614154	NOP56 RIBONUCLEAR PROTEIN; NOP56
614155	MICRO RNA 1292; MIR1292
614156	HYPERBILIVERDINEMIA; HBLVD
614157	MOVED TO 161050
614158	BLEEDING DISORDER, PLATELET-TYPE, 14; BDPLT14
614159	ZINC FINGER PROTEIN 644; ZNF644
614160	MUSCLE HYPERTROPHY; MSLHP
614161	PR DOMAIN-CONTAINING PROTEIN 5; PRDM5
614162	IMMUNODEFICIENCY 31C; IMD31C
614163	DELAYED SLEEP PHASE DISORDER, SUSCEPTIBILITY TO; DSPD
614164	GLUTATHIONE PEROXIDASE DEFICIENCY; GPXD
614165	PHEOCHROMOCYTOMA/PARAGANGLIOMA SYNDROME 5; PPGL5
614166	MYOPIA 20, AUTOSOMAL DOMINANT; MYP20
614167	MYOPIA 21, AUTOSOMAL DOMINANT; MYP21
614168	PHOSPHOENOLPYRUVATE CARBOXYKINASE 1, SOLUBLE; PCK1
614169	NEUROBEACHIN-LIKE 2; NBEAL2
614170	BRITTLE CORNEA SYNDROME 2; BCS2
614171	HERMANSKY-PUDLAK SYNDROME 9; HPS9
614172	IMMUNODEFICIENCY 21; IMD21
614173	JOUBERT SYNDROME 13; JBTS13
614174	MEIOSIS/SPERMIOGENESIS-ASSOCIATED PROTEIN 1; MEIG1
614175	MECKEL SYNDROME, TYPE 10; MKS10
614176	ZINC FINGER FYVE DOMAIN-CONTAINING PROTEIN 28; ZFYVE28
614177	EF-HAND CALCIUM-BINDING DOMAIN-CONTAINING PROTEIN 4A; EFCAB4A
614178	CALCIUM RELEASE-ACTIVATED CALCIUM CHANNEL REGULATOR 2A; CRACR2A
614179	IMMUNOGLOBULIN SUPERFAMILY CONTAINING LEUCINE-RICH REPEAT 2; ISLR2
614180	RETINITIS PIGMENTOSA 61; RP61
614181	RETINITIS PIGMENTOSA 62; RP62
614182	HEART DEVELOPMENT PROTEIN WITH EGF-LIKE DOMAINS 1; HEG1
614183	DIS3-LIKE EXOSOME 3-PRIME-5-PRIME EXORIBONUCLEASE; DIS3L
614184	DIS3-LIKE 3-PRIME-5-PRIME EXORIBONUCLEASE 2; DIS3L2
614185	GELEOPHYSIC DYSPLASIA 2; GPHYSD2
614186	LEBER CONGENITAL AMAUROSIS 16; LCA16
614187	HYPERTELORISM, PREAURICULAR SINUS, PUNCTAL PITS, AND DEAFNESS; HPPD
614188	CRANIOSYNOSTOSIS AND DENTAL ANOMALIES; CRSDA
614189	GOLGIN A7 FAMILY, MEMBER B; GOLGA7B
614190	PIGMENTED NODULAR ADRENOCORTICAL DISEASE, PRIMARY, 3; PPNAD3
614191	DEP DOMAIN-CONTAINING PROTEIN 5; DEPDC5
614192	MOVED TO 613675
614193	TRANSFERRIN SERUM LEVEL QUANTITATIVE TRAIT LOCUS 2; TFQTL2
614194	DEDICATOR OF CYTOKINESIS 6; DOCK6
614195	CRANIOFACIAL ANOMALIES AND ANTERIOR SEGMENT DYSGENESIS SYNDROME; CAASDS
614196	NEPHROTIC SYNDROME, TYPE 6; NPHS6
614197	MITOCHONDRIAL CALCIUM UNIPORTER; MCU
614198	MYASTHENIC SYNDROME, CONGENITAL, 16; CMS16
614199	NEPHROTIC SYNDROME, TYPE 5, WITH OR WITHOUT OCULAR ABNORMALITIES; NPHS5
614200	BLEEDING DISORDER, PLATELET-TYPE, 9; BDPLT9
614201	BLEEDING DISORDER, PLATELET-TYPE, 11; BDPLT11
614202	RAFIQ SYNDROME; RAFQS
614203	PARKINSON DISEASE 17; PARK17
614204	PSORIASIS 14, PUSTULAR; PSORS14
614205	THREE M SYNDROME 3; 3M3
614206	CHROMATIN TARGET OF PRMT1; CHTOP
614207	HYPERPHOSPHATASIA WITH IMPAIRED INTELLECTUAL DEVELOPMENT SYNDROME 3; HPMRS3
614208	INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 16; MRT16
614209	MECKEL SYNDROME, TYPE 9; MKS9
614210	LUNG CANCER SUSCEPTIBILITY 5; LNCR5
614211	DEAFNESS, AUTOSOMAL DOMINANT 33; DFNA33
614212	ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED, SUSCEPTIBILITY TO, 4; IIAE4
614213	NEUROPATHY, HEREDITARY SENSORY, TYPE IIC; HSN2C
614214	KELCH-LIKE 6; KLHL6
614215	ACTIVATING SIGNAL COINTEGRATOR 1 COMPLEX, SUBUNIT 1; ASCC1
614216	ACTIVATING SIGNAL COINTEGRATOR 1 COMPLEX, SUBUNIT 2; ASCC2
614217	ACTIVATING SIGNAL COINTEGRATOR 1 COMPLEX, SUBUNIT 3; ASCC3
614218	WD REPEAT-CONTAINING PROTEIN 81; WDR81
614219	ADAMS-OLIVER SYNDROME 2; AOS2
614220	BILIARY CIRRHOSIS, PRIMARY, 4; PBC4
614221	BILIARY CIRRHOSIS, PRIMARY, 5; PBC5
614222	WARBURG MICRO SYNDROME 3; WARBM3
614223	NARCOLEPSY 6, SUSCEPTIBILITY TO; NRCLP6
614224	RETINAL ARTERIAL MACROANEURYSM WITH SUPRAVALVULAR PULMONIC STENOSIS; RAMSVPS
614225	WARBURG MICRO SYNDROME 2; WARBM2
614226	HOLOPROSENCEPHALY 11; HPE11
614227	HYPERURICEMIC NEPHROPATHY, FAMILIAL JUVENILE, 3; HNFJ3
614228	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2O; CMT2O
614229	SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 11; SCAR11
614230	CHROMOSOME 8q21.11 DELETION SYNDROME
614231	MICROCEPHALY, EPILEPSY, AND DIABETES SYNDROME 1; MEDS1
614232	11-BETA-HYDROXYSTEROID DEHYDROGENASE, TYPE II; HSD11B2
614233	HYPERPIGMENTATION, FAMILIAL PROGRESSIVE, 1; FPH1
614234	PRIMARY CILIA FORMATION; PIFO
614235	PDZ DOMAIN-CONTAINING PROTEIN 8; PDZD8
614236	SOLUTE CARRIER FAMILY 38 (AMINO ACID TRANSPORTER), MEMBER 7; SLC38A7
614237	HYPOTRICHOSIS 9; HYPT9
614238	HYPOTRICHOSIS 10; HYPT10
614239	PH DOMAIN-CONTAINING ENDOCYTIC TRAFFICKING ADAPTOR 1; PHETA1
614240	PH DOMAIN-CONTAINING ENDOCYTIC TRAFFICKING ADAPTOR 2; PHETA2
614241	LYSOCARDIOLIPIN ACYLTRANSFERASE 1; LCLAT1
614242	SOLUTE CARRIER FAMILY 16 (MONOCARBOXYLIC ACID TRANSPORTER), MEMBER 9; SLC16A9
614243	5-OXOPROLINASE (ATP-HYDROLYZING); OPLAH
614244	PYRIDOXAL-DEPENDENT DECARBOXYLASE DOMAIN-CONTAINING PROTEIN 1; PDXDC1
614245	ACYL-CoA SYNTHETASE FAMILY, MEMBER 3; ACSF3
614246	N-ALPHA-ACETYLTRANSFERASE 60, NatF CATALYTIC SUBUNIT; NAA60
614247	MICRO RNA 519D; MIR519D
614248	PSEUDOPODIUM-ENRICHED ATYPICAL KINASE 1
614249	INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 18, WITH OR WITHOUT EPILEPSY; MRT18
614250	NARCOLEPSY 7; NRCLP7
614251	PARKINSON DISEASE 18, AUTOSOMAL DOMINANT, SUSCEPTIBILITY TO; PARK18
614252	ANEURYSM, INTRACRANIAL BERRY, 11; ANIB11
614253	MOVED TO 204690
614254	NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT HYPERKINETIC MOVEMENTS AND SEIZURES, AUTOSOMAL DOMINANT; NDHMSD
614255	NESCAV SYNDROME; NESCAVS
614256	INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 10; MRD10
614257	CHROMOSOME 20q11-q12 DELETION SYNDROME
614258	POLYMERASE III, RNA, SUBUNIT A; POLR3A
614259	CILIA- AND FLAGELLA-ASSOCIATED PROTEIN 57; CFAP57
614260	CHROMOSOME 9 OPEN READING FRAME 72; C9ORF72
614261	MICROCEPHALY-CAPILLARY MALFORMATION SYNDROME; MICCAP
614262	ARTHROGRYPOSIS, PERTHES DISEASE, AND UPWARD GAZE PALSY; APUG
614263	BACE1 ANTISENSE RNA: BACE1AS
614264	RHO GTPase-ACTIVATING PROTEIN 30; ARHGAP30
614265	COMBINED MALONIC AND METHYLMALONIC ACIDURIA; CMAMMA
614266	BARRETT ESOPHAGUS
614267	ACYL-CoA THIOESTERASE 6; ACOT6
614268	ADHESION G PROTEIN-COUPLED RECEPTOR F4; ADGRF4
614269	G PROTEIN-COUPLED RECEPTOR 153; GPR153
614270	CILIA- AND FLAGELLA-ASSOCIATED PROTEIN 65; CFAP65
614271	COILED-COIL DOMAIN-CONTAINING PROTEIN 137; CCDC137
614272	FAST KINASE DOMAINS 5; FASTKD5
614273	OLFACTORY RECEPTOR, FAMILY 4, SUBFAMILY C, MEMBER 46; OR4C46
614274	STRAWBERRY NOTCH, DROSOPHILA, HOMOLOG OF, 1; SBNO1
614275	ZINC FINGER PROTEIN 565; ZNF565
614276	PHOSPHOLIPASE C-LIKE 2; PLCL2
614277	UBIQUITIN-CONJUGATING ENZYME E2 W; UBE2W
614278	PLATELET-ACTIVATING FACTOR ACETYLHYDROLASE DEFICIENCY; PAFAD
614279	46,XY SEX REVERSAL 8; SRXY8
614280	EPILEPSY, JUVENILE MYOCLONIC, SUSCEPTIBILITY TO, 9; EJM9
614281	ENDOTHELIAL CELL ADHESION MOLECULE; ESAM
614282	STROMAL CELL-DERIVED FACTOR 4; SDF4
614283	GLUCOCORTICOID-INDUCED TRANSCRIPT 1; GLCCI1
614284	STICKLER SYNDROME, TYPE V; STL5
614285	C1q- AND TUMOR NECROSIS FACTOR-RELATED PROTEIN 9; C1QTNF9
614286	MYELODYSPLASTIC SYNDROME; MDS
614287	OFC1 CANDIDATE GENE 1; OFCC1
614288	ACYL-CoA DEHYDROGENASE FAMILY, MEMBER 11; ACAD11
614289	SUPPRESSOR OF LIN12-LIKE 2; SEL1L2
614290	TETRASOMY 18p
614291	BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 4; BROVCA4
614292	MYOPIA, HIGH, WITH CATARACT AND VITREORETINAL DEGENERATION; MCVD
614293	HYDATIDIFORM MOLE, RECURRENT, 2; HYDM2
614294	CHROMOSOME 15q25 DELETION SYNDROME
614295	BICC FAMILY RNA-BINDING PROTEIN 1; BICC1
614296	WOLFRAM-LIKE SYNDROME, AUTOSOMAL DOMINANT; WFSL
614297	CHROMOSOME 19 OPEN READING FRAME 12; C19ORF12
614298	NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 4; NBIA4
614299	MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 2 WITH HYPERGLYCINEMIA; MMDS2
614300	HYPERMETHIONINEMIA DUE TO ADENOSINE KINASE DEFICIENCY
614301	ATAXIN 1-LIKE; ATXN1L
614302	EMERY-DREIFUSS MUSCULAR DYSTROPHY 7, AUTOSOMAL DOMINANT; EDMD7
614303	EDICT SYNDROME; EDICT
614304	MICRO RNA 137; MIR137
614305	SCLEROSTEOSIS 2; SOST2
614306	COGNITIVE IMPAIRMENT WITH OR WITHOUT CEREBELLAR ATAXIA; CIAT
614307	ALPHA-METHYLACYL-CoA RACEMASE DEFICIENCY; AMACRD
614308	FORMIMINOTRANSFERASE CYCLODEAMINASE N-TERMINAL-LIKE PROTEIN 1; FTCDNL1
614309	tRNA METHYLTRANSFERASE 44 HOMOLOG; TRMT44
614310	CENTROSOMAL PROTEIN, 70-KD; CEP70
614311	SYNAPSE DIFFERENTIATION-INDUCED GENE 1; SYNDIG1
614312	ZINC FINGER MYND-CONTAINING PROTEIN 15; ZMYND15
614313	ACYL-CoA THIOESTERASE 1; ACOT1
614314	ACYL-CoA THIOESTERASE 4; ACOT4
614315	ACYL-CoA THIOESTERASE 12; ACOT12
614316	VESICLE TRANSPORT THROUGH INTERACTION WITH T-SNARES 1A; VTI1A
614317	VESICOURETERAL REFLUX 4; VUR4
614318	VESICOURETERAL REFLUX 5; VUR5
614319	VESICOURETERAL REFLUX 6; VUR6
614320	PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4
614321	MYOPATHY, DISTAL, TATEYAMA TYPE; MPDT
614322	SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 12; SCAR12
614323	NEVOID HYPERMELANOSIS, LINEAR AND WHORLED; LWNH
614324	OVARIAN DYSGENESIS 3; ODG3
614325	PITT-HOPKINS-LIKE SYNDROME 2; PTHSL2
614326	FEINGOLD SYNDROME 2; FGLDS2
614327	TUMOR PREDISPOSITION SYNDROME 1; TPDS1
614328	INFLAMMATORY SKIN AND BOWEL DISEASE, NEONATAL, 1; NISBD1
614329	INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 31; MRT31
614330	COMPLEMENT COMPONENT 1, q SUBCOMPONENT-LIKE 2; C1QL2
614331	COLORECTAL CANCER, HEREDITARY NONPOLYPOSIS, TYPE 6; HNPCC6
614332	CHROMOSOME 2p16.3 DELETION SYNDROME
614333	INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 29; MRT29
614334	DNAJ/HSP40 HOMOLOG, SUBFAMILY C, MEMBER 13; DNAJC13
614335	ARTHROGRYPOSIS, DISTAL, TYPE 1B; DA1B
614336	PRESEQUENCE TRANSLOCASE-ASSOCIATED MOTOR 16; PAM16
614337	LYNCH SYNDROME 4; LYNCH4
614338	PANCREATIC LIPASE DEFICIENCY; PNLIPD
614339	MOVED TO 607596
614340	INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 27; MRT27
614341	INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 33; MRT33
614342	INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 30; MRT30
614343	INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 19; MRT19
614344	INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 23; MRT23
614345	INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 24; MRT24
614346	INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 25; MRT25
614347	INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 28; MRT28
614348	ANDROGEN-DEPENDENT TFPI-REGULATING PROTEIN; ADTRP
614349	ZINC FINGER PROTEIN 638; ZNF638
614350	LYNCH SYNDROME 5; LYNCH5
614351	NUCLEOPORIN, 93-KD; NUP93
614352	NUCLEOPORIN, 205-KD; NUP205
614353	HAS2 ANTISENSE RNA 1; HAS2AS1
614354	PRO2268 GENE
614355	ACYL-CoA SYNTHETASE SHORT CHAIN FAMILY, MEMBER 1; ACSS1
614356	ACYL-CoA SYNTHETASE SHORT CHAIN FAMILY, MEMBER 3; ACSS3
614357	ACYL-CoA SYNTHETASE MEDIUM CHAIN FAMILY, MEMBER 1; ACSM1
614358	ACYL-CoA SYNTHETASE MEDIUM CHAIN FAMILY, MEMBER 2A; ACSM2A
614359	ACYL-CoA SYNTHETASE MEDIUM CHAIN FAMILY, MEMBER 2B; ACSM2B
614360	ACYL-CoA SYNTHETASE MEDIUM CHAIN FAMILY, MEMBER 4; ACSM4
614361	ACYL-CoA SYNTHETASE MEDIUM CHAIN FAMILY, MEMBER 5; ACSM5
614362	ACYL-CoA SYNTHETASE, BUBBLEGUM FAMILY, MEMBER 1; ACSBG1
614363	ACYL-CoA SYNTHETASE, BUBBLEGUM FAMILY, MEMBER 2; ACSBG2
614364	ACETOACETYL-CoA SYNTHETASE; AACS
614365	AMINOADIPATE-SEMIALDEHYDE DEHYDROGENASE; AASDH
614366	POLYMERASE III, RNA, SUBUNIT B; POLR3B
614367	ADAPTOR-RELATED PROTEIN COMPLEX 5, BETA-1 SUBUNIT; AP5B1
614368	ADAPTOR-RELATED PROTEIN COMPLEX 5, MU-1 SUBUNIT; AP5M1
614369	PERIPHERAL NEUROPATHY, MYOPATHY, HOARSENESS, AND HEARING LOSS; PNMHH
614370	SURFACTANT METABOLISM DYSFUNCTION, PULMONARY, 5; SMDP5
614371	DENGUE VIRUS, SUSCEPTIBILITY TO
614372	MANNOSE-BINDING LECTIN DEFICIENCY; MBLD
614373	AMYOTROPHIC LATERAL SCLEROSIS 16, JUVENILE; ALS16
614374	BLOOD GROUP, CHIDO/RODGERS SYSTEM
614375	AORTIC ANEURYSM, FAMILIAL ABDOMINAL, 4; AAA4
614376	SHORT-RIB THORACIC DYSPLASIA 5 WITH OR WITHOUT POLYDACTYLY; SRTD5
614377	NEPHRONOPHTHISIS 13; NPHP13
614378	CRANIOECTODERMAL DYSPLASIA 4; CED4
614379	COMPLEMENT COMPONENT 4B DEFICIENCY; C4BD
614380	COMPLEMENT COMPONENT 4A DEFICIENCY; C4AD
614381	LEUKODYSTROPHY, HYPOMYELINATING, 8, WITH OR WITHOUT OLIGODONTIA AND/OR HYPOGONADOTROPIC HYPOGONADISM; HLD8
614382	BACTEREMIA, SUSCEPTIBILITY TO, 1; BACTS1
614383	BACTEREMIA, SUSCEPTIBILITY TO, 2; BACTS2
614384	MICRO RNA 492; MIR492
614385	COLORECTAL CANCER, HEREDITARY NONPOLYPOSIS, TYPE 7; HNPCC7
614386	PROLINE-RICH TRANSMEMBRANE PROTEIN 2; PRRT2
614387	ZINC FINGER PROTEIN 526; ZNF526
614388	ENCEPHALOPATHY DUE TO DEFECTIVE MITOCHONDRIAL AND PEROXISOMAL FISSION 1; EMPF1
614389	PREGNANCY LOSS, RECURRENT, SUSCEPTIBILITY TO, 1; RPRGL1
614390	PREGNANCY LOSS, RECURRENT, SUSCEPTIBILITY TO, 2; RPRGL2
614391	PREGNANCY LOSS, RECURRENT, SUSCEPTIBILITY TO, 3; RPRGL3
614392	TUDOR DOMAIN-CONTAINING PROTEIN 3; TDRD3
614393	O-ACYL-ADP-RIBOSE DEACYLASE 1; OARD1
614394	INTRAFLAGELLAR TRANSPORT 20; IFT20
614395	GRAFT-VERSUS-HOST DISEASE, SUSCEPTIBILITY TO; GVHDS
614396	G-PATCH DOMAIN-CONTAINING PROTEIN 8; GPATCH8
614397	MAJOR FACILITATOR SUPERFAMILY DOMAIN-CONTAINING PROTEIN 2A; MFSD2A
614398	JUNCTIONAL CADHERIN 5-ASSOCIATED PROTEIN; JCAD
614399	CONGENITAL MYOPATHY 10A, SEVERE VARIANT; CMYP10A
614400	GLUCOCORTICOID THERAPY, RESPONSE TO; GCTR
614401	ACCELERATED TUMOR FORMATION, SUSCEPTIBILITY TO; ACTFS
614402	MICROPHTHALMIA, SYNDROMIC 11; MCOPS11
614403	RHOMBOID 5 HOMOLOG 1; RHBDF1
614404	RHOMBOID 5 HOMOLOG 2; RHBDF2
614405	DEAH-BOX HELICASE 33; DHX33
614406	SLP ADAPTOR- AND CSK-INTERACTING MEMBRANE PROTEIN; SCIMP
614407	MICROCEPHALY, CEREBELLAR HYPOPLASIA, AND CARDIAC CONDUCTION DEFECT SYNDROME; MCHCCD
614408	MOVED TO 160150
614409	SPASTIC PARAPLEGIA 46, AUTOSOMAL RECESSIVE; SPG46
614410	ACTIN FILAMENT-ASSOCIATED PROTEIN 1-LIKE 1; AFAP1L1
614411	GLYCEROL QUANTITATIVE TRAIT LOCUS; GLYCQTL
614412	TESTIS- AND OVARY-SPECIFIC PAZ DOMAIN-CONTAINING PROTEIN 1; TOPAZ1
614413	AMINOACYLASE 3; ACY3
614414	DEAFNESS, AUTOSOMAL RECESSIVE 96; DFNB96
614415	CHILBLAIN LUPUS 2; CHBL2
614416	RADIOHUMERAL FUSIONS WITH OTHER SKELETAL AND CRANIOFACIAL ANOMALIES; RHFCA
614417	EPILEPSY, FAMILIAL TEMPORAL LOBE, 5; ETL5
614418	FEBRILE SEIZURES, FAMILIAL, 11; FEB11
614419	ASPARTATE AMINOTRANSFERASE, SERUM LEVEL OF, QUANTITATIVE TRAIT LOCUS 1
614420	SYSTEMIC LUPUS ERYTHEMATOSUS 16; SLEB16
614421	MOVED TO 277590
614422	CATARACT 37; CTRCT37
614423	TRANSMEMBRANE PROTEIN 237; TMEM237
614424	JOUBERT SYNDROME 14; JBTS14
614425	TELO2-INTERACTING PROTEIN 1; TTI1
614426	TELO2-INTERACTING PROTEIN 2; TTI2
614427	TEASHIRT ZINC FINGER HOMEOBOX 1; TSHZ1
614428	TRANSCRIPTION FACTOR AP2-EPSILON; TFAP2E
614429	VENTRICULAR SEPTAL DEFECT 1; VSD1
614430	ATRIOVENTRICULAR SEPTAL DEFECT 4; AVSD4
614431	VENTRICULAR SEPTAL DEFECT 2; VSD2
614432	VENTRICULAR SEPTAL DEFECT 3; VSD3
614433	ATRIAL SEPTAL DEFECT 8; ASD8
614434	CUTIS LAXA, AUTOSOMAL DOMINANT 2; ADCL2
614435	HYPOPLASTIC LEFT HEART SYNDROME 2; HLHS2
614436	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2P; CMT2P
614437	CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IB; ARCL1B
614438	CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIIB; ARCL3B
614439	ADP-RIBOSYLATION FACTOR-LIKE GTPase 14; ARL14
614440	PLECKSTRIN AND SEC7 DOMAINS-CONTAINING PROTEIN 3; PSD3
614441	PHOAR2-ENTEROPATHY SYNDROME; PHOAR2E
614442	PLECKSTRIN AND SEC7 DOMAINS-CONTAINING PROTEIN 4; PSD4
614443	EBNA1-BINDING PROTEIN 2; EBNA1BP2
614444	RAL GUANINE NUCLEOTIDE EXCHANGE FACTOR WITH PH DOMAIN AND SH3 DOMAIN-BINDING MOTIF 1; RALGPS1
614445	DEVELOPMENTAL PLURIPOTENCY-ASSOCIATED GENE 2; DPPA2
614446	ATPase, CLASS II, TYPE 9B; ATP9B
614447	G0/G1 SWITCH GENE 2; G0S2
614448	GEMININ COILED-COIL DOMAIN-CONTAINING PROTEIN; GMNC
614449	PROTOCADHERIN 20; PCDH20
614450	HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 6; CHNG6
614451	ELONGATION OF VERY LONG CHAIN FATTY ACIDS-LIKE 7; ELOVL7
614452	ATPase FAMILY, AAA DOMAIN-CONTAINING, MEMBER 1; ATAD1
614453	LEUCINE-RICH REPEAT-CONTAINING PROTEIN 7; LRRC7
614454	UBIQUITIN PROTEIN LIGASE E3C; UBE3C
614455	CHARCOT-MARIE-TOOTH DISEASE, DOMINANT INTERMEDIATE E; CMTDIE
614456	MELANOMA, CUTANEOUS MALIGNANT, SUSCEPTIBILITY TO, 8; CMM8
614457	ICHTHYOSIS, SPASTIC QUADRIPLEGIA, AND IMPAIRED INTELLECTUAL DEVELOPMENT; ISQMR
614458	THIAMINE METABOLISM DYSFUNCTION SYNDROME 5 (EPISODIC ENCEPHALOPATHY TYPE); THMD5
614459	TRANSMEMBRANE PROTEIN 138; TMEM138
614460	UBIQUITIN-SPECIFIC PROTEASE 47; USP47
614461	UBIQUINOL-CYTOCHROME C REDUCTASE COMPLEX ASSEMBLY FACTOR 2; UQCC2
614462	HYPERGLYCINEMIA, LACTIC ACIDOSIS, AND SEIZURES; HGCLAS
614463	NMYC DOWNSTREAM-REGULATED GENE 4; NDRG4
614464	JOUBERT SYNDROME 15; JBTS15
614465	JOUBERT SYNDROME 16; JBTS16
614466	CORONARY HEART DISEASE, SUSCEPTIBILITY TO, 6; CHDS6
614467	MOVED TO 212350
614468	FAMILIAL COLD AUTOINFLAMMATORY SYNDROME 3; FCAS3
614469	SERRATE RNA EFFECTOR MOLECULE; SRRT
614470	RAS-ASSOCIATED AUTOIMMUNE LEUKOPROLIFERATIVE DISORDER; RALD
614471	UBIQUITIN-SPECIFIC PROTEASE 19; USP19
614472	RING FINGER PROTEIN 123; RNF123
614473	ARTERIAL CALCIFICATION, GENERALIZED, OF INFANCY, 2; GACI2
614474	ATRIOVENTRICULAR SEPTAL DEFECT 5; AVSD5
614475	ATRIAL SEPTAL DEFECT 9; ASD9
614476	THROMBOSPONDIN TYPE-1 DOMAIN-CONTAINING PROTEIN 4; THSD4
614477	CILIA- AND FLAGELLA-ASSOCIATED PROTEIN 418; CFAP418
614478	CYTOCHROME c OXIDASE ASSEMBLY FACTOR COX14; COX14
614479	MALONYL CoA:ACP ACYLTRANSFERASE, MITOCHONDRIAL; MCAT
614480	HYPERTRIGLYCERIDEMIA, TRANSIENT INFANTILE; HTGTI
614481	ATXN7 ANTISENSE RNA 1; ATXN7AS1
614482	HUPPKE-BRENDEL SYNDROME; HPBDS
614483	BRAIN SMALL VESSEL DISEASE 2; BSVD2
614484	ANAPHASE-PROMOTING COMPLEX, SUBUNIT 13; ANAPC13
614485	TRIGONOCEPHALY 2; TRIGNO2
614486	THROMBOPHILIA DUE TO THROMBOMODULIN DEFECT; THPH12
614487	SPASTIC ATAXIA 5, AUTOSOMAL RECESSIVE; SPAX5
614488	MICRO RNA 1258; MIR1258
614489	MICRO RNA 616; MIR616
614490	BLOOD GROUP, JUNIOR SYSTEM; JR
614491	PSEUDOHYPOALDOSTERONISM, TYPE IIB; PHA2B
614492	PSEUDOHYPOALDOSTERONISM, TYPE IIC; PHA2C
614493	WISKOTT-ALDRICH SYNDROME 2; WAS2
614494	RETINITIS PIGMENTOSA 63; RP63
614495	PSEUDOHYPOALDOSTERONISM, TYPE IID; PHA2D
614496	PSEUDOHYPOALDOSTERONISM, TYPE IIE; PHA2E
614497	MICROPHTHALMIA/COLOBOMA 7; MCOPCB7
614498	RIGIDITY AND MULTIFOCAL SEIZURE SYNDROME, LETHAL NEONATAL; RMFSL
614499	INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 34, WITH VARIANT LISSENCEPHALY; MRT34
614500	CONE-ROD DYSTROPHY 16; CORD16
614501	NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, CRANIOFACIAL ABNORMALITIES, AND SEIZURES; NEDHCS
614502	PIERCER OF MICROTUBULE WALL 1; PIERCE1
614503	KELCH DOMAIN-CONTAINING PROTEIN 8A; KLHDC8A
614504	USHER SYNDROME, TYPE IIIB; USH3B
614505	FK506-BINDING PROTEIN 14; FKBP14
614506	BRCA1-ASSOCIATED ATM ACTIVATOR 1; BRAT1
614507	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ir; CDG1R
614508	MIRROR MOVEMENTS 2; MRMV2
614509	MICRO RNA 99A; MIR99A
614510	MICRO RNA 99B; MIR99B
614511	MYOD FAMILY INHIBITOR DOMAIN-CONTAINING PROTEIN; MDFIC
614512	TORSIN 1A-INTERACTING PROTEIN 1; TOR1AIP1
614513	TORSIN 1A-INTERACTING PROTEIN 2; TOR1AIP2
614514	THROMBOPHILIA DUE TO PROTEIN S DEFICIENCY, AUTOSOMAL RECESSIVE; THPH6
614515	G PROTEIN-COUPLED RECEPTOR 179; GPR179
614516	DOLICHYL PYROPHOSPHATE PHOSPHATASE 1; DOLPP1
614517	BRAIN AND MUSCLE ARNT-LIKE PROTEIN 2; BMAL2
614518	GATA ZINC FINGER DOMAIN-CONTAINING PROTEIN 1; GATAD1
614519	HEMORRHAGE, INTRACEREBRAL, SUSCEPTIBILITY TO; ICH
614520	ENCEPHALOMYOPATHY, MITOCHONDRIAL, DUE TO VOLTAGE-DEPENDENT ANION CHANNEL DEFICIENCY
614521	THROMBOCYTHEMIA 3; THCYT3
614522	KELCH-LIKE 12; KLHL12
614523	MICRO RNA 489; MIR489
614524	FIBROCHONDROGENESIS 2; FBCG2
614525	NFATC2-INTERACTING PROTEIN; NFATC2IP
614526	CHROMOSOME 17q12 DUPLICATION SYNDROME
614527	CHROMOSOME 17q12 DELETION SYNDROME
614528	HIF1A ANTISENSE RNA 1; HIF1AAS1
614529	HIF1A ANTISENSE RNA 2; HIF1AAS2
614530	NADH-UBIQUINONE OXIDOREDUCTASE SUBUNIT A12; NDUFA12
614531	RASGEF DOMAIN FAMILY, MEMBER 1A; RASGEF1A
614532	RASGEF DOMAIN FAMILY, MEMBER 1B; RASGEF1B
614533	CELL DIVISION CYCLE 26; CDC26
614534	ANAPHASE-PROMOTING COMPLEX SUBUNIT 11; ANAPC11
614535	ZINC FINGER SWIM DOMAIN-CONTAINING PROTEIN 7; ZSWIM7
614536	SWIM-TYPE ZINC FINGER DOMAIN-CONTAINING PROTEIN 7-ASSOCIATED PROTEIN 1; SWSAP1
614537	LEUCINE-RICH MELANOCYTE DIFFERENTIATION-ASSOCIATED PROTEIN; LRMDA
614538	MICRO RNA 570; MIR570
614539	HELICASE, DNA, B; HELB
614540	MOVED TO 213600
614541	CHROMOSOME 16q22 DELETION SYNDROME
614542	DIVERGENT PROTEIN KINASE DOMAIN 1A; DIPK1A
614543	DIVERGENT PROTEIN KINASE DOMAIN 1B; DIPK1B
614544	DIVERGENT PROTEIN KINASE DOMAIN 1C; DIPK1C
614545	ENDOPLASMIC RETICULUM MEMBRANE PROTEIN COMPLEX, SUBUNIT 10; EMC10
614546	EFAVIRENZ, POOR METABOLISM OF
614547	FAMILY WITH SEQUENCE SIMILARITY 103, MEMBER A1; FAM103A1
614548	SERINE INCORPORATOR 1; SERINC1
614549	SERINE INCORPORATOR 2; SERINC2
614550	SERINE INCORPORATOR 4; SERINC4
614551	SERINE INCORPORATOR 5; SERINC5
614552	XYLOSIDE XYLOSYLTRANSFERASE 1; XXYLT1
614553	N6 ADENINE-SPECIFIC DNA METHYLTRANSFERASE 1; N6AMT1
614554	FAMILY WITH SEQUENCE SIMILARITY 32, MEMBER A; FAM32A
614555	FERM DOMAIN-CONTAINING PROTEIN 6; FRMD6
614556	AT-RICH INTERACTION DOMAIN-CONTAINING PROTEIN 1B; ARID1B
614557	EHLERS-DANLOS SYNDROME, KYPHOSCOLIOTIC TYPE, 2; EDSKSCL2
614558	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 13; DEE13
614559	INFANTILE CEREBELLAR-RETINAL DEGENERATION; ICRD
614560	MAU2 SISTER CHROMATID COHESION FACTOR; MAU2
614561	LEUKOENCEPHALOPATHY, BRAIN CALCIFICATIONS, AND CYSTS; LCC
614562	MOVED TO 135900
614563	CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 13; CDCBM13
614564	CUTANEOUS TELANGIECTASIA AND CANCER SYNDROME, FAMILIAL; FCTCS
614565	NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1E; CSNB1E
614566	DYNEIN, AXONEMAL, ASSEMBLY FACTOR 3; DNAAF3
614567	DIAPHANOUS-RELATED FORMIN 3; DIAPH3
614568	UNC13 HOMOLOG C; UNC13C
614569	MULTIPLE ENCHONDROMATOSIS, MAFFUCCI TYPE
614570	KINESIN FAMILY MEMBER 18B; KIF18B
614571	CILIOGENESIS AND PLANAR POLARITY EFFECTOR COMPLEX, SUBUNIT 1; CPLANE1
614572	ZINC FINGER PROTEIN 42; ZFP42
614573	G PROTEIN-COUPLED RECEPTOR 158; GPR158
614574	ROGDI ATYPICAL LEUCINE ZIPPER; ROGDI
614575	CEREBELLAR ATAXIA, NEUROPATHY, AND VESTIBULAR AREFLEXIA SYNDROME; CANVAS
614576	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIl; CDG2L
614577	PROGESTIN AND ADIPOQ RECEPTOR FAMILY, MEMBER 3; PAQR3
614578	PROGESTIN AND ADIPOQ RECEPTOR FAMILY, MEMBER 4; PAQR4
614579	PROGESTIN AND ADIPOQ RECEPTOR FAMILY, MEMBER 6; PAQR6
614580	PROGESTIN AND ADIPOQ RECEPTOR FAMILY, MEMBER 9; PAQR9
614581	MONOCYTE-TO-MACROPHAGE DIFFERENTIATION-ASSOCIATED PROTEIN 2; MMD2
614582	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 9; COXPD9
614583	BARAITSER-WINTER SYNDROME 2; BRWS2
614584	PROLYL 4-HYDROXYLASE, TRANSMEMBRANE; P4HTM
614585	FERREDOXIN 2; FDX2
614586	ZINC FINGER DHHC DOMAIN-CONTAINING PROTEIN 5; ZDHHC5
614587	CHAC GLUTATHIONE-SPECIFIC GAMMA-GLUTAMYLCYCLOTRANSFERASE 1; CHAC1
614588	DYSTONIA 21; DYT21
614589	SKI3 SUBUNIT OF SUPERKILLER COMPLEX; SKIC3
614590	PODOCONIOSIS, SUSCEPTIBILITY TO; PDCOS
614591	CEA CELL ADHESION MOLECULE 16; CEACAM16
614592	BENT BONE DYSPLASIA SYNDROME 1; BBDS1
614593	MEIOSIS REGULATOR AND mRNA STABILITY FACTOR 1; MARF1
614594	OLMSTED SYNDROME 1; OLMS1
614595	PREECLAMPSIA/ECLAMPSIA 5; PEE5
614596	MICRO RNA 302A; MIR302A
614597	MICRO RNA 302B; MIR302B
614598	MICRO RNA 302C; MIR302C
614599	MICRO RNA 302D; MIR302D
614600	MICRO RNA 367; MIR367
614601	ZINC FINGER PROTEIN 326; ZNF326
614602	TRICHOHEPATOENTERIC SYNDROME 2; THES2
614603	DDHD DOMAIN-CONTAINING PROTEIN 1; DDHD1
614604	ZINC FINGER DHHC DOMAIN-CONTAINING PROTEIN 7; ZDHHC7
614605	ZINC FINGER DHHC DOMAIN-CONTAINING PROTEIN 21; ZDHHC21
614606	FOCADHESIN; FOCAD
614607	COFFIN-SIRIS SYNDROME 2; CSS2
614608	COFFIN-SIRIS SYNDROME 3; CSS3
614609	COFFIN-SIRIS SYNDROME 4; CSS4
614610	KN MOTIF- AND ANKYRIN REPEAT DOMAIN-CONTAINING PROTEIN 2; KANK2
614611	KN MOTIF- AND ANKYRIN REPEAT DOMAIN-CONTAINING PROTEIN 3; KANK3
614612	KN MOTIF- AND ANKYRIN REPEAT DOMAIN-CONTAINING PROTEIN 4; KANK4
614613	ACRODYSOSTOSIS 2 WITH OR WITHOUT HORMONE RESISTANCE; ACRDYS2
614614	DEAFNESS, AUTOSOMAL DOMINANT 4B; DFNA4B
614615	JOUBERT SYNDROME 17; JBTS17
614616	DIARRHEA 6; DIAR6
614617	DEAFNESS, AUTOSOMAL RECESSIVE 86; DFNB86
614618	HYPEREKPLEXIA 3; HKPX3
614619	HYPEREKPLEXIA 2; HKPX2
614620	INTRAFLAGELLAR TRANSPORT 140; IFT140
614621	UV-SENSITIVE SYNDROME 2; UVSS2
614622	KERATOCONUS 5; KTCN5
614623	KERATOCONUS 6; KTCN6
614624	MITOCHONDRIAL ASSEMBLY OF RIBOSOMAL LARGE SUBUNIT 1; MALSU1
614625	DIFFERENTIATION-ANTAGONIZING NONCODING RNA; DANCR
614626	SMALL NUCLEOLAR RNA, H/ACA BOX, 26; SNORA26
614627	MICRO RNA 4449; MIR4449
614628	KERATOCONUS 8; KTCN8
614629	KERATOCONUS 7; KTCN7
614630	ANDROGLOBIN; ADGB
614631	CDP-L-RIBITOL PYROPHOSPHORYLASE A; CRPPA
614632	UV-STIMULATED SCAFFOLD PROTEIN A; UVSSA
614633	VPS54 SUBUNIT OF GARP COMPLEX; VPS54
614634	CENTROSOMAL PROTEIN 126; CEP126
614635	LONG INTERGENIC NONCODING RNA 538; LINC00538
614636	MYOSIN IH; MYO1H
614637	DESUMOYLATING ISOPEPTIDASE 1; DESI1
614638	DESUMOYLATING ISOPEPTIDASE 2; DESI2
614639	ZINC FINGER- AND BTB DOMAIN-CONTAINING PROTEIN 46; ZBTB46
614640	UV-SENSITIVE SYNDROME 3; UVSS3
614641	LYSOSOME-ASSOCIATED MEMBRANE PROTEIN 5; LAMP5
614642	START DOMAIN-CONTAINING PROTEIN 9; STARD9
614643	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 7; MDDGA7
614644	MEAN PLATELET VOLUME/COUNT QUANTITATIVE TRAIT LOCUS 4; MPVCQTL4
614645	MEAN PLATELET VOLUME/COUNT QUANTITATIVE TRAIT LOCUS 5; MPVCQTL5
614646	MEAN PLATELET VOLUME/COUNT QUANTITATIVE TRAIT LOCUS 6; MPVCQTL6
614647	COENZYME Q6, MONOOXYGENASE; COQ6
614648	RALY-LIKE PROTEIN; RALYL
614649	RING FINGER PROTEIN 170; RNF170
614650	COENZYME Q10 DEFICIENCY, PRIMARY, 6; COQ10D6
614651	COENZYME Q10 DEFICIENCY, PRIMARY, 2; COQ10D2
614652	COENZYME Q10 DEFICIENCY, PRIMARY, 3; COQ10D3
614653	NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE VI; HSAN6
614654	COENZYME Q10 DEFICIENCY, PRIMARY, 5; COQ10D5
614655	STUTTERING, FAMILIAL PERSISTENT, 3; STUT3
614656	PALADIN1; PALD1
614657	ANGIOMOTIN-LIKE 1; AMOTL1
614658	ANGIOMOTIN-LIKE 2; AMOTL2
614659	APC MEMBRANE RECRUITMENT PROTEIN 2; AMER2
614660	PAT1 HOMOLOG 1, PROCESSING BODY mRNA DECAY FACTOR; PATL1
614661	PAT1 HOMOLOG 2; PATL2
614662	CORTISONE REDUCTASE DEFICIENCY 2; CORTRD2
614663	RALY HETEROGENEOUS NUCLEAR RIBONUCLEAR PROTEIN; RALY
614664	TRIGGERING RECEPTOR EXPRESSED ON MYELOID CELLS-LIKE PROTEIN 4; TREML4
614665	MECONIUM ILEUS
614666	COILED-COIL DOMAIN-CONTAINING PROTEIN 78; CCDC78
614667	MITOCHONDRIAL tRNA TRANSLATION OPTIMIZATION 1; MTO1
614668	STUTTERING, FAMILIAL PERSISTENT, 4; STUT4
614669	AURICULOCONDYLAR SYNDROME 2A; ARCND2A
614670	PERIPARTUM CARDIOMYOPATHY, SUSCEPTIBILITY TO
614671	CHROMOSOME 16p11.2 DUPLICATION SYNDROME
614672	CARDIOMYOPATHY, DILATED, 2B; CMD2B
614673	MICROCEPHALY 8, PRIMARY, AUTOSOMAL RECESSIVE; MCPH8
614674	PERIODIC FEVER, MENSTRUAL CYCLE-DEPENDENT
614675	BONE MARROW FAILURE SYNDROME 1; BMFS1
614676	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 21; CMH21
614677	COILED-COIL DOMAIN-CONTAINING PROTEIN 103; CCDC103
614678	PONTOCEREBELLAR HYPOPLASIA, TYPE 1B; PCH1B
614679	CILIARY DYSKINESIA, PRIMARY, 17; CILD17
614680	INFLUENZA, SEVERE, SUSCEPTIBILITY TO
614681	AMINOGLYCOSIDE PHOSPHOTRANSFERASE DOMAIN-CONTAINING PROTEIN 1; AGPHD1
614682	ALANINE-GLYOXYLATE AMINOTRANSFERASE 2-LIKE 1; AGXT2L1
614683	5-PHOSPHOHYDROXY-L-LYSINE PHOSPHO-LYASE; PHYKPL
614684	HYPERTELORISM AND OTHER FACIAL DYSMORPHISM, BRACHYDACTYLY, GENITAL ABNORMALITIES, MENTAL RETARDATION, AND RECURRENT INFLAMMATORY EPISODES
614685	ZINC FINGER PROTEIN 597; ZNF597
614686	FAMILY WITH SEQUENCE SIMILARITY 50, MEMBER B; FAM50B
614687	ALAR CLEFT, ISOLATED
614688	PONTINE TEGMENTAL CAP DYSPLASIA; PTCD
614689	SOLUBLE INTERLEUKIN-6 RECEPTOR, SERUM LEVEL OF, QUANTITATIVE TRAIT LOCUS
614690	CHROMOSOME 4 OPEN READING FRAME 48; C4ORF48
614691	CATARACT 38; CTRCT38
614692	MEMBRANOUS NEPHROPATHY, SUSCEPTIBILITY TO; MBNP
614693	ATM INTERACTOR; ATMIN
614694	REGULATION OF NUCLEAR PRE-mRNA DOMAIN-CONTAINING PROTEIN 1B; RPRD1B
614695	REGULATION OF NUCLEAR PRE-mRNA DOMAIN-CONTAINING 2; RPRD2
614696	MOVED TO 600795
614697	KATANIN, p60 SUBUNIT, A-LIKE PROTEIN 2; KATNAL2
614698	CYTOCHROME c OXIDASE ASSEMBLY FACTOR COX20; COX20
614699	IMMUNODEFICIENCY, COMMON VARIABLE, 7; CVID7
614700	IMMUNODEFICIENCY, COMMON VARIABLE, 8, WITH AUTOIMMUNITY; CVID8
614701	CORNELIA DE LANGE SYNDROME 4 WITH OR WITHOUT MIDLINE BRAIN DEFECTS; CDLS4
614702	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 10; COXPD10
614703	SLIT-ROBO RHO GTPase-ACTIVATING PROTEIN 2B; SRGAP2B
614704	SLIT-ROBO RHO GTPase-ACTIVATING PROTEIN 2C; SRGAP2C
614705	SLIT-ROBO RHO GTPase-ACTIVATING PROTEIN 2D; SRGAP2D
614706	CEROID LIPOFUSCINOSIS, NEURONAL, 11; CLN11
614707	BROWN-VIALETTO-VAN LAERE SYNDROME 2; BVVLS2
614708	SIGNAL PEPTIDE-, CUB DOMAIN-, AND EGF-LIKE DOMAINS-CONTAINING PROTEIN 3; SCUBE3
614709	LYR MOTIF-CONTAINING PROTEIN 1; LYRM1
614710	FAMILY WITH SEQUENCE SIMILARITY 72, MEMBER A; FAM72A
614711	FAMILY WITH SEQUENCE SIMILARITY 72, MEMBER B; FAM72B
614712	FAMILY WITH SEQUENCE SIMILARITY 72, MEMBER D; FAM72D
614713	RAS ASSOCIATION DOMAIN FAMILY, MEMBER 10; RASSF10
614714	POROKERATOSIS 7, MULTIPLE TYPES; POROK7
614715	TRANSMEMBRANE AND IMMUNOGLOBULIN DOMAINS-CONTAINING PROTEIN 2; TMIGD2
614716	CAPPING PROTEIN REGULATOR AND MYOSIN 1 LINKER 3; CARMIL3
614717	ANAPHASE-PROMOTING COMPLEX, SUBUNIT 15; ANAPC15
614718	KINETOCHORE-LOCALIZED ASTRIN/SPAG5-BINDING PROTEIN; KNSTRN
614719	POTASSIUM CHANNEL MODULATORY FACTOR 1; KCMF1
614720	CYCLIN-DEPENDENT KINASE 19; CDK19
614721	TSPY-LIKE 5; TSPYL5
614722	MICRO RNA 3120; MIR3120
614723	ADENINE PHOSPHORIBOSYLTRANSFERASE DEFICIENCY; APRTD
614724	CENTROSOMAL PROTEIN, 63-KD; CEP63
614725	SERINE ACTIVE SITE-CONTAINING PROTEIN 1; SERAC1
614726	TRANSMEMBRANE PROTEIN 165; TMEM165
614727	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIk; CDG2K
614728	SECKEL SYNDROME 6; SCKL6
614729	COP9 SIGNALOSOME, SUBUNIT 6; COPS6
614730	PHOSPHATIDYLINOSITOL GLYCAN ANCHOR BIOSYNTHESIS CLASS O PROTEIN; PIGO
614731	PROSTATE CANCER, HEREDITARY, 2; HPC2
614732	INTRAUTERINE GROWTH RETARDATION, METAPHYSEAL DYSPLASIA, ADRENAL HYPOPLASIA CONGENITA, AND GENITAL ANOMALIES; IMAGE
614733	MICRO RNA 193A; MIR193A
614734	MICRO RNA 193B; MIR193B
614735	MICRO RNA 365A; MIR365A
614736	GLUCOCORTICOID DEFICIENCY 4 WITH OR WITHOUT MINERALOCORTICOID DEFICIENCY; GCCD4
614737	MITOCHONDRIAL PYRUVATE CARRIER 2; MPC2
614738	MITOCHONDRIAL PYRUVATE CARRIER 1; MPC1
614739	3-METHYLGLUTACONIC ACIDURIA WITH DEAFNESS, ENCEPHALOPATHY, AND LEIGH-LIKE SYNDROME; MEGDEL
614740	BASAL CELL CARCINOMA, SUSCEPTIBILITY TO, 7; BCC7
614741	MITOCHONDRIAL PYRUVATE CARRIER DEFICIENCY; MPYCD
614742	PULMONARY FIBROSIS AND/OR BONE MARROW FAILURE SYNDROME, TELOMERE-RELATED, 1; PFBMFT1
614743	PULMONARY FIBROSIS AND/OR BONE MARROW FAILURE SYNDROME, TELOMERE-RELATED, 2; PFBMFT2
614744	FACIAL PARESIS, HEREDITARY CONGENITAL, 3; HCFP3
614745	BLOOD GROUP, JOHN MILTON HAGEN SYSTEM; JMH
614746	URIC ACID CONCENTRATION, SERUM, QUANTITATIVE TRAIT LOCUS 5; UAQTL5
614747	URIC ACID CONCENTRATION, SERUM, QUANTITATIVE TRAIT LOCUS 6; UAQTL6
614748	EPIDERMOLYSIS BULLOSA, JUNCTIONAL 7, WITH INTERSTITIAL LUNG DISEASE AND NEPHROTIC SYNDROME; JEB7
614749	HYPERPHOSPHATASIA WITH IMPAIRED INTELLECTUAL DEVELOPMENT SYNDROME 2; HPMRS2
614750	MYASTHENIC SYNDROME, CONGENITAL, 13; CMS13
614751	NEURONOPATHY, DISTAL HEREDITARY MOTOR, AUTOSOMAL DOMINANT 12; HMND12
614752	INTERLEUKIN 6, SERUM LEVEL OF, QUANTITATIVE TRAIT LOCUS
614753	MALAN SYNDROME; MALNS
614754	DOUBLESEX- AND MAB3-RELATED TRANSCRIPTION FACTOR 3; DMRT3
614755	MICRO RNA 520H; MIR520H
614756	CEREBELLAR DYSFUNCTION WITH VARIABLE COGNITIVE AND BEHAVIORAL ABNORMALITIES; CECBA
614757	INTERFERON-INDUCED TRANSMEMBRANE PROTEIN 5; IFITM5
614758	DYNACTIN 4; DCTN4
614759	CILIA- AND FLAGELLA-ASSOCIATED PROTEIN 53; CFAP53
614760	SOLUTE CARRIER FAMILY 66, MEMBER 1; SLC66A1
614761	GLYCINE N-ACYLTRANSFERASE-LIKE 1; GLYATL1
614762	GLYCINE N-ACYLTRANSFERASE-LIKE 2; GLYATL2
614763	GLYCINE N-ACYLTRANSFERASE-LIKE 3; GLYATL3
614764	KATANIN, p60 SUBUNIT, A-LIKE 1; KATNAL1
614765	STRIATIN, CALMODULIN-BINDING PROTEIN; STRN
614766	STRIATIN, CALMODULIN-BINDING PROTEIN 3; STRN3
614767	STRIATIN, CALMODULIN-BINDING PROTEIN 4; STRN4
614768	TRANSMEMBRANE PROTEIN 66; TMEM66
614769	CYTOCHROME c OXIDASE ASSEMBLY FACTOR 1 HOMOLOG; COA1
614770	PET100 CYTOCHROME c OXIDASE CHAPERONE; PET100
614771	PET117 CYTOCHROME c OXIDASE CHAPERONE; PET117
614772	CYTOCHROME c OXIDASE ASSEMBLY FACTOR 6; COA6
614773	MSS51 MITOCHONDRIAL TRANSLATIONAL ACTIVATOR; MSS51
614774	PENTATRICOPEPTIDE REPEAT DOMAIN-CONTAINING PROTEIN 1; PTCD1
614775	CYTOCHROME C OXIDASE ASSEMBLY FACTOR 3; COA3
614776	SIK FAMILY KINASE 3; SIK3
614777	MMS19 HOMOLOG, CYTOSOLIC IRON-SULFUR ASSEMBLY COMPONENT; MMS19
614778	CYTOSOLIC IRON-SULFUR ASSEMBLY COMPONENT 2B; CIAO2B
614779	HETEROTAXY, VISCERAL, 6, AUTOSOMAL; HTX6
614780	SORTING NEXIN 10; SNX10
614781	TECTONIN BETA-PROPELLER REPEAT-CONTAINING 1; TECPR1
614782	TREMOR, HEREDITARY ESSENTIAL, 4; ETM4
614783	POC1 CENTRIOLAR PROTEIN A; POC1A
614784	POC1 CENTRIOLAR PROTEIN B; POC1B
614785	MITOCHONDRIAL FISSION FACTOR; MFF
614786	TRANSMEMBRANE PROTEIN 207; TMEM207
614787	POGO TRANSPOSABLE ELEMENT-DERIVED PROTEIN WITH ZNF DOMAIN; POGZ
614788	FYVE, RhoGEF, AND PH DOMAIN-CONTAINING PROTEIN 5; FGD5
614789	EGF DOMAIN-SPECIFIC O-LINKED N-ACETYLGLUCOSAMINE TRANSFERASE; EOGT
614790	WT1-INTERACTING PROTEIN; WTIP
614791	MICRO RNA 199B; MIR199B
614792	TRANSMEMBRANE AND UBIQUITIN-LIKE DOMAIN-CONTAINING PROTEIN 1; TMUB1
614793	MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE 21; MAP3K21
614794	1-ACYLGLYCEROL-3-PHOSPHATE O-ACYLTRANSFERASE 3; AGPAT3
614795	1-ACYLGLYCEROL-3-PHOSPHATE O-ACYLTRANSFERASE 4; AGPAT4
614796	1-ACYLGLYCEROL-3-PHOSPHATE O-ACYLTRANSFERASE 5; AGPAT5
614797	PELLINO E3 UBIQUITIN PROTEIN LIGASE 1; PELI1
614798	PELLINO E3 UBIQUITIN PROTEIN LIGASE 2; PELI2
614799	AFG2 INTERACTING RIBOSOME MATURATION FACTOR; AIRIM
614800	SHORT STATURE, OPTIC NERVE ATROPHY, AND PELGER-HUET ANOMALY; SOPH
614801	MSL COMPLEX SUBUNIT 1; MSL1
614802	MSL COMPLEX SUBUNIT 2; MSL2
614803	DOUBLESEX- AND MAB3-RELATED TRANSCRIPTION FACTOR A1; DMRTA1
614804	DOUBLESEX- AND MAB3-RELATED TRANSCRIPTION FACTOR A2; DMRTA2
614805	DOUBLESEX- AND MAB3-RELATED TRANSCRIPTION FACTOR B1; DMRTB1
614806	DOUBLESEX- AND MAB3-RELATED TRANSCRIPTION FACTOR C2; DMRTC2
614807	MYOPATHY, CENTRONUCLEAR, 4; CNM4
614808	AMYOTROPHIC LATERAL SCLEROSIS 18; ALS18
614809	C3 GLOMERULOPATHY 3; C3G3
614810	MULTIPLE SCLEROSIS, SUSCEPTIBILITY TO, 5; MS5
614811	L-3-HYDROXYPROLINE DEHYDRATASE, TRANS; L3HYPDH
614812	NUCLEAR PROTEIN, TRANSCRIPTIONAL REGULATOR, 1; NUPR1
614813	SHORT STATURE, ONYCHODYSPLASIA, FACIAL DYSMORPHISM, AND HYPOTRICHOSIS; SOFT
614814	ADAMS-OLIVER SYNDROME 3; AOS3
614815	JOUBERT SYNDROME 18; JBTS18
614816	LOEYS-DIETZ SYNDROME 4; LDS4
614817	INTERSTITIAL NEPHRITIS, KARYOMEGALIC; KMIN
614818	FRY MICROTUBULE-BINDING PROTEIN; FRY
614819	WEILL-MARCHESANI SYNDROME 3; WMS3
614820	ALTERNATING HEMIPLEGIA OF CHILDHOOD 2; AHC2
614821	PTCSC3 GENE; PTCSC3
614822	SPERMATOGENIC FAILURE 10; SPGF10
614823	AORTIC VALVE DISEASE 2; AOVD2
614824	ADAPTOR-RELATED PROTEIN COMPLEX 5, SIGMA-1 SUBUNIT; AP5S1
614825	RALBP1-ASSOCIATED EPS DOMAIN-CONTAINING PROTEIN 1; REPS1
614826	NYSTAGMUS 7, CONGENITAL, AUTOSOMAL DOMINANT; NYS7
614827	DNAJ/HSP40 HOMOLOG, SUBFAMILY C, MEMBER 11; DNAJC11
614828	PROTEIN O-MANNOSE BETA-1,4-N-ACETYLGLUCOSAMINYLTRANSFERASE 2; POMGNT2
614829	ODONTOGENESIS-ASSOCIATED PHOSPHOPROTEIN; ODAPH
614830	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 8; MDDGA8
614831	SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 13; SCAR13
614832	AMELOGENESIS IMPERFECTA, HYPOMATURATION TYPE, IIA4; AI2A4
614833	MICROCEPHALY, SHORT STATURE, AND POLYMICROGYRIA WITH OR WITHOUT SEIZURES; MSSP
614834	THYROTOXIC PERIODIC PARALYSIS, SUSCEPTIBILITY TO, 3; TTPP3
614835	ACTIN, BETA-LIKE, 2; ACTBL2
614836	HUMAN HERPESVIRUS 8, SUSCEPTIBILITY TO; HHV8S
614837	HYPOGONADOTROPIC HYPOGONADISM 8 WITH OR WITHOUT ANOSMIA; HH8
614838	HYPOGONADOTROPIC HYPOGONADISM 9 WITH OR WITHOUT ANOSMIA; HH9
614839	HYPOGONADOTROPIC HYPOGONADISM 10 WITH OR WITHOUT ANOSMIA; HH10
614840	HYPOGONADOTROPIC HYPOGONADISM 11 WITH OR WITHOUT ANOSMIA; HH11
614841	HYPOGONADOTROPIC HYPOGONADISM 12 WITH OR WITHOUT ANOSMIA; HH12
614842	HYPOGONADOTROPIC HYPOGONADISM 13 WITH OR WITHOUT ANOSMIA; HH13
614843	ODONTOGENIC AMELOBLAST-ASSOCIATED PROTEIN; ODAM
614844	NEPHRONOPHTHISIS 14; NPHP14
614845	NEPHRONOPHTHISIS 15; NPHP15
614846	TETRASOMY 15q26
614847	EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 12; EIG12
614848	CENTROSOMAL PROTEIN, 164-KD; CEP164
614849	ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED (HERPES-SPECIFIC), SUSCEPTIBILITY TO, 5; IIAE5
614850	ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED (HERPES-SPECIFIC), SUSCEPTIBILITY TO, 6; IIAE6
614851	SECKEL SYNDROME 7; SCKL7
614852	MICROCEPHALY 9, PRIMARY, AUTOSOMAL RECESSIVE; MCPH9
614853	CYTOKINE RECEPTOR-LIKE FACTOR 3; CRLF3
614854	LEUCINE-RICH REPEAT-CONTAINING PROTEIN 59; LRRC59
614855	TBC1 DOMAIN FAMILY, MEMBER 14; TBC1D14
614856	OSTEOGENESIS IMPERFECTA, TYPE XIII; OI13
614857	METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, cblJ TYPE; MAHCJ
614858	HYPOGONADOTROPIC HYPOGONADISM 14 WITH OR WITHOUT ANOSMIA; HH14
614859	PEROXISOME BIOGENESIS DISORDER 3A (ZELLWEGER); PBD3A
614860	DYSTONIA 23; DYT23
614861	DEAFNESS, AUTOSOMAL RECESSIVE 98; DFNB98
614862	PEROXISOME BIOGENESIS DISORDER 4A (ZELLWEGER); PBD4A
614863	PEROXISOME BIOGENESIS DISORDER 4B; PBD4B
614864	DYNEIN AXONEMAL ASSEMBLY FACTOR 5; DNAAF5
614865	D4Z4 BINDING ELEMENT TRANSCRIPT, NONCODING; DBET
614866	PEROXISOME BIOGENESIS DISORDER 5A (ZELLWEGER); PBD5A
614867	PEROXISOME BIOGENESIS DISORDER 5B; PBD5B
614868	IMMUNODEFICIENCY 110 WITH LYMPHOPROLIFERATION; IMD110
614869	USHER SYNDROME, TYPE IJ; USH1J
614870	PEROXISOME BIOGENESIS DISORDER 6A (ZELLWEGER); PBD6A
614871	PEROXISOME BIOGENESIS DISORDER 6B; PBD6B
614872	PEROXISOME BIOGENESIS DISORDER 7A (ZELLWEGER); PBD7A
614873	PEROXISOME BIOGENESIS DISORDER 7B; PBD7B
614874	CILIARY DYSKINESIA, PRIMARY, 18; CILD18
614875	METAPHYSEAL ENCHONDROMATOSIS WITH D-2-HYDROXYGLUTARIC ACIDURIA
614876	PEROXISOME BIOGENESIS DISORDER 8A (ZELLWEGER); PBD8A
614877	PEROXISOME BIOGENESIS DISORDER 8B; PBD8B
614878	AUTOINFLAMMATION, ANTIBODY DEFICIENCY, AND IMMUNE DYSREGULATION; APLAID
614879	PEROXISOME BIOGENESIS DISORDER 9B; PBD9B
614880	HYPOGONADOTROPIC HYPOGONADISM 15 WITH OR WITHOUT ANOSMIA; HH15
614881	NEURONOPATHY, DISTAL HEREDITARY MOTOR, AUTOSOMAL RECESSIVE 5; HMNR5
614882	PEROXISOME BIOGENESIS DISORDER 10A (ZELLWEGER); PBD10A
614883	PEROXISOME BIOGENESIS DISORDER 11A (ZELLWEGER); PBD11A
614884	VON WILLEBRAND FACTOR A DOMAIN-CONTAINING PROTEIN 3B; VWA3B
614885	PEROXISOME BIOGENESIS DISORDER 11B; PBD11B
614886	PEROXISOME BIOGENESIS DISORDER 12A (ZELLWEGER); PBD12A
614887	PEROXISOME BIOGENESIS DISORDER 13A (ZELLWEGER); PBD13A
614888	ALPHA- AND GAMMA-ADAPTIN-BINDING PROTEIN; AAGAB
614889	IMMUNODEFICIENCY 28; IMD28
614890	IMMUNODEFICIENCY 29; IMD29
614891	IMMUNODEFICIENCY 30; IMD30
614892	IMMUNODEFICIENCY 31A; IMD31A
614893	IMMUNODEFICIENCY 32A; IMD32A
614894	MOVED TO 226990
614895	CHARCOT-MARIE-TOOTH DISEASE, DEMYELINATING, TYPE 4F; CMT4F
614896	SINOATRIAL NODE DYSFUNCTION AND DEAFNESS; SANDD
614897	HYPOGONADOTROPIC HYPOGONADISM 16 WITH OR WITHOUT ANOSMIA; HH16
614898	SPASTIC PARAPLEGIA 53, AUTOSOMAL RECESSIVE; SPG53
614899	DEAFNESS, AUTOSOMAL RECESSIVE 93; DFNB93
614900	DIAMOND-BLACKFAN ANEMIA 11; DBA11
614901	BRANCHED-CHAIN ALPHA-KETO ACID DEHYDROGENASE KINASE; BCKDK
614902	RHO GTPase-ACTIVATING PROTEIN 33; ARHGAP33
614903	SORTING NEXIN 16; SNX16
614904	SORTING NEXIN 7; SNX7
614905	SORTING NEXIN 8; SNX8
614906	SORTING NEXIN 11; SNX11
614907	PRE-mRNA-PROCESSING FACTOR 39; PRPF39
614908	HEAT SHOCK PROTEIN NUCLEAR IMPORT FACTOR HIKESHI; HIKESHI
614909	TRANSMEMBRANE PROTEIN 174; TMEM174
614910	C1q- AND TUMOR NECROSIS FACTOR-RELATED PROTEIN 6; C1QTNF6
614911	C1q- AND TUMOR NECROSIS FACTOR-RELATED PROTEIN 4; C1QTNF4
614912	TRAB DOMAIN-CONTAINING PROTEIN 2A; TRABD2A
614913	TRAB DOMAIN-CONTAINING PROTEIN 2B; TRABD2B
614914	MICRO RNA 298; MIR298
614915	LETHAL CONGENITAL CONTRACTURE SYNDROME 4; LCCS4
614916	VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 4; CPVT4
614917	REQUIRED FOR MEIOTIC NUCLEAR DIVISION 1 HOMOLOG; RMND1
614918	PENTATRICOPEPTIDE REPEAT DOMAIN-CONTAINING PROTEIN 3; PTCD3
614919	NITRIC OXIDE-ASSOCIATED PROTEIN 1; NOA1
614920	PEROXISOME BIOGENESIS DISORDER 14B; PEX14B
614921	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE It; CDG1T
614922	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 11; COXPD11
614923	BRANCHED-CHAIN KETO ACID DEHYDROGENASE KINASE DEFICIENCY; BCKDKD
614924	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 12; COXPD12
614925	OTOGELIN-LIKE PROTEIN; OTOGL
614926	PERRAULT SYNDROME 2; PRLTS2
614927	ECTODERMAL DYSPLASIA 5, HAIR/NAIL TYPE; ECTD5
614928	ECTODERMAL DYSPLASIA 6, HAIR/NAIL TYPE; ECTD6
614929	ECTODERMAL DYSPLASIA 7, HAIR/NAIL TYPE; ECTD7
614930	LEUCINE-RICH REPEAT-CONTAINING PROTEIN 6; LRRC6
614931	ECTODERMAL DYSPLASIA 9, HAIR/NAIL TYPE; ECTD9
614932	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 13; COXPD13
614933	LONG INTERGENIC NONCODING RNA, MUSCLE DIFFERENTIATION 1; LINCMD1
614934	DEAFNESS, AUTOSOMAL RECESSIVE 70, WITH OR WITHOUT ADULT-ONSET NEURODEGENERATION; DFNB70
614935	CILIARY DYSKINESIA, PRIMARY, 19; CILD19
614936	PALMOPLANTAR KERATODERMA, PUNCTATE TYPE IB; PPKP1B
614937	MYOCLONUS, FAMILIAL, 1; MYOCL1
614938	VAULT RNA 2-1; VTRNA2-1
614939	PHOSPHOGLYCERATE MUTASE FAMILY, MEMBER 5; PGAM5
614940	ECTODERMAL DYSPLASIA 11A, HYPOHIDROTIC/HAIR/TOOTH TYPE, AUTOSOMAL DOMINANT; ECTD11A
614941	ECTODERMAL DYSPLASIA 11B, HYPOHIDROTIC/HAIR/TOOTH TYPE, AUTOSOMAL RECESSIVE; ECTD11B
614942	PHOSPHATIDYLGLYCEROPHOSPHATE SYNTHASE 1; PGS1
614943	TP53-REGULATED INHIBITOR OF APOPTOSIS 1; TRIAP1
614944	DEAFNESS, AUTOSOMAL RECESSIVE 84B; DFNB84B
614945	DEAFNESS, AUTOSOMAL RECESSIVE 18B; DFNB18B
614946	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 14; COXPD14
614947	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 15; COXPD15
614948	TAM41 MITOCHONDRIAL TRANSLOCATOR ASSEMBLY AND MAINTENANCE HOMOLOG; TAMM41
614949	TRANSMEMBRANE PROTEIN 231; TMEM231
614950	TRANSMEMBRANE PROTEIN 17; TMEM17
614951	HEAT REPEAT-CONTAINING PROTEIN 3; HEATR3
614952	SCHLAFEN FAMILY, MEMBER 5; SLFN5
614953	SCHLAFEN FAMILY, MEMBER 11; SLFN11
614954	CONGENITAL HEART DEFECTS, MULTIPLE TYPES, 3; CHTD3
614955	SCHLAFEN FAMILY, MEMBER 12; SLFN12
614956	SCHLAFEN FAMILY, MEMBER 12-LIKE; SLFN12L
614957	SCHLAFEN FAMILY, MEMBER 13; SLFN13
614958	SCHLAFEN FAMILY, MEMBER 14; SLFN14
614959	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 14; DEE14
614960	PHOSPHOLIPASE D FAMILY, MEMBER 6; PLD6
614961	PONTOCEREBELLAR HYPOPLASIA, TYPE 8; PCH8
614962	LEPTIN DEFICIENCY OR DYSFUNCTION; LEPD
614963	LEPTIN RECEPTOR DEFICIENCY; LEPRD
614964	EXTRACELLULAR LEUCINE-RICH REPEAT AND FIBRONECTIN TYPE III DOMAIN-CONTAINING PROTEIN 1; ELFN1
614965	SECERNIN 1; SCRN1
614966	SECERNIN 2; SCRN2
614967	SECERNIN 3; SCRN3
614968	SH2 DOMAIN-CONTAINING PROTEIN 4A; SH2D4A
614969	PONTOCEREBELLAR HYPOPLASIA, TYPE 7; PCH7
614970	JOUBERT SYNDROME 20; JBTS20
614971	TAURINE-UPREGULATED GENE 1, NONCODING; TUG1
614972	CHOLESTASIS, INTRAHEPATIC, OF PREGNANCY 3; ICP3
614973	FOCAL FACIAL DERMAL DYSPLASIA 2, BRAUER-SETLEIS TYPE; FFDD2
614974	FOCAL FACIAL DERMAL DYSPLASIA 4; FFDD4
614975	FOXF1 ADJACENT NONCODING DEVELOPMENTAL REGULATORY RNA; FENDRR
614976	CARPENTER SYNDROME 2; CRPT2
614977	LONG INTERGENIC NONCODING RNA 1081; LINC01081
614978	LONG INTERGENIC NONCODING RNA 1082; LINC01082
614979	RETINAL DYSTROPHY, OPTIC NERVE EDEMA, SPLENOMEGALY, ANHIDROSIS, AND MIGRAINE HEADACHE SYNDROME; ROSAH
614980	CONGENITAL HEART DEFECTS, MULTIPLE TYPES, 2; CHTD2
614981	ATPase INHIBITORY FACTOR 1; ATPIF1
614982	STRUCTURAL MAINTENANCE OF CHROMOSOMES FLEXIBLE HINGE DOMAIN-CONTAINING PROTEIN 1; SMCHD1
614983	BASIC LEUCINE ZIPPER TRANSCRIPTION FACTOR, ATF-LIKE 2; BATF2
614984	DEHYDROGENASE E1 AND TRANSKETOLASE DOMAINS-CONTAINING PROTEIN 1; DHTKD1
614985	HELLP SYNDROME-ASSOCIATED LONG NONCODING RNA; HELLPAR
614986	CALCIUM/CALMODULIN-DEPENDENT PROTEIN KINASE II INHIBITOR 1; CAMK2N1
614987	EPS8-LIKE PROTEIN 1; EPS8L1
614988	EPS8-LIKE PROTEIN 2; EPS8L2
614989	EPS8-LIKE PROTEIN 3; EPS8L3
614990	USHER SYNDROME, TYPE IK; USH1K
614991	UBIQUITIN CARBOXYL-TERMINAL ESTERASE L1, ANTISENSE; UCH1LAS
614992	LONG INTERGENIC NONCODING RNA 237; LINC00237
614993	CAM KINASE-LIKE VESICLE-ASSOCIATED; CAMKV
614994	CALCIUM/CALMODULIN-DEPENDENT PROTEIN KINASE IG; CAMK1G
614995	INTERLEUKIN 17 RECEPTOR E; IL17RE
614996	MYELINATING SCHWANN CELL ELEMENT; MSE
614997	GATA ZINC FINGER DOMAIN-CONTAINING PROTEIN 2A; GATAD2A
614998	GATA ZINC FINGER DOMAIN-CONTAINING PROTEIN 2B; GATAD2B
614999	CYTOCHROME P450, FAMILY 4, SUBFAMILY X, POLYPEPTIDE 1; CYP4X1
615000	TECTONIN BETA-PROPELLER REPEAT-CONTAINING PROTEIN 2; TECPR2
615001	ZINC FINGER CCCH DOMAIN-CONTAINING PROTEIN 12C; ZC3H12C
615002	CALCIUM/CALMODULIN-DEPENDENT PROTEIN KINASE KINASE 2, BETA; CAMKK2
615003	DDHD DOMAIN-CONTAINING PROTEIN 2; DDHD2
615004	LEUCINE-RICH REPEAT, IMMUNOGLOBULIN-LIKE, AND TRANSMEMBRANE DOMAINS-CONTAINING PROTEIN 3; LRIT3
615005	EPILEPSY, NOCTURNAL FRONTAL LOBE, 5; ENFL5
615006	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 15; DEE15
615007	BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 4; IBGC4
615008	NEPHROTIC SYNDROME, TYPE 7; NPHS7
615009	SCHUURS-HOEIJMAKERS SYNDROME; SHMS
615010	AICARDI-GOUTIERES SYNDROME 6; AGS6
615011	PHOSPHOHYDROXYLYSINURIA; PHLU
615012	HISTONE GENE CLUSTER 1, H2A HISTONE FAMILY, MEMBER G; HIST1H2AG
615013	HISTONE GENE CLUSTER 1, H2A HISTONE FAMILY, MEMBER H; HIST1H2AH
615014	HISTONE GENE CLUSTER 2, H2A HISTONE FAMILY, MEMBER B; HIST2H2AB
615015	HISTONE GENE CLUSTER 3, H2A HISTONE; HIST3H2A
615016	OLFACTORY RECEPTOR, FAMILY 2, SUBFAMILY J, MEMBER 3; OR2J3
615017	MICRO RNA 139; MIR139
615018	BLOOD GROUP, SID SYSTEM; SID
615019	ELONGATOR ACETYLTRANSFERASE COMPLEX, SUBUNIT 5; ELP5
615020	ELONGATOR ACETYLTRANSFERASE COMPLEX, SUBUNIT 6; ELP6
615021	BLOOD GROUP, GLOBOSIDE SYSTEM; GLOB
615022	ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 7; ARCI7
615023	ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 9; ARCI9
615024	ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 10; ARCI10
615025	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2Q; CMT2Q
615026	RIBOFLAVIN DEFICIENCY; RBFVD
615027	SIN3-HDAC COMPLEX ASSOCIATED FACTOR; SINHCAF
615028	EPIDERMOLYSIS BULLOSA SIMPLEX 4, LOCALIZED OR GENERALIZED INTERMEDIATE, AUTOSOMAL RECESSIVE; EBS4
615029	PRECEREBELLIN 4; CBLN4
615030	SPASTIC PARAPLEGIA 56, AUTOSOMAL RECESSIVE, WITH OR WITHOUT PSEUDOXANTHOMA ELASTICUM; SPG56
615031	NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE IX, WITH DEVELOPMENTAL DELAY; HSAN9
615032	INTELLECTUAL DEVELOPMENTAL DISORDER WITH AUTISM AND MACROCEPHALY; IDDAM
615033	SPASTIC PARAPLEGIA 54, AUTOSOMAL RECESSIVE; SPG54
615034	DYSTONIA 24; DYT24
615035	SPASTIC PARAPLEGIA 55, AUTOSOMAL RECESSIVE; SPG55
615036	MICRO RNA 410; MIR410
615037	MICRO RNA 487B; MIR487B
615038	OUTER DYNEIN ARM DOCKING COMPLEX SUBUNIT 1; ODAD1
615039	N-DEACETYLASE/N-SULFOTRANSFERASE 4; NDST4
615040	EPISODIC PAIN SYNDROME, FAMILIAL, 1; FEPS1
615041	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 10; MDDGA10
615042	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Iu; CDG1U
615043	SPASTIC PARAPLEGIA 43, AUTOSOMAL RECESSIVE; SPG43
615044	HISTONE GENE CLUSTER 1, H2B HISTONE FAMILY, MEMBER J; HIST1H2BJ
615045	HISTONE GENE CLUSTER 1, H2B HISTONE FAMILY, MEMBER K; HIST1H2BK
615046	HISTONE GENE CLUSTER 3, H2B HISTONE FAMILY, MEMBER B; HIST3H2BB
615047	TETRATRICOPEPTIDE REPEAT-, ANKYRIN REPEAT-, AND COILED-COIL-CONTAINING PROTEIN 2; TANC2
615048	SPINAL MUSCULAR ATROPHY, JOKELA TYPE; SMAJ
615049	WW DOMAIN-CONTAINING ADAPTOR WITH COILED-COIL REGION; WAC
615050	ANKYRIN REPEAT- AND SOCS BOX-CONTAINING PROTEIN 5; ASB5
615051	ANKYRIN REPEAT- AND SOCS BOX-CONTAINING PROTEIN 6; ASB6
615052	ANKYRIN REPEAT- AND SOCS BOX-CONTAINING PROTEIN 7; ASB7
615053	ANKYRIN REPEAT- AND SOCS BOX-CONTAINING PROTEIN 8; ASB8
615054	ANKYRIN REPEAT- AND SOCS BOX-CONTAINING PROTEIN 10; ASB10
615055	ANKYRIN REPEAT- AND SOCS BOX-CONTAINING PROTEIN 13; ASB13
615056	ANKYRIN REPEAT- AND SOCS BOX-CONTAINING PROTEIN 16; ASB16
615057	MOVED TO 244450
615058	NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1F; CSNB1F
615059	HYPOTRICHOSIS 11; HYPT11
615060	SECRETOGLOBIN, FAMILY 1D, MEMBER 1; SCGB1D1
615061	SECRETOGLOBIN, FAMILY 1D, MEMBER 2; SCGB1D2
615062	SECRETOGLOBIN, FAMILY 1D, MEMBER 4; SCGB1D4
615063	SECRETOGLOBIN, FAMILY 2B, MEMBER 2; SCGB2B2
615064	SOLUTE CARRIER FAMILY 25 (CARNITINE/ACYLCARNITINE TRANSLOCASE), MEMBER 29; SLC25A29
615065	ARTHROGRYPOSIS, DISTAL, TYPE 5D; DA5D
615066	OSTEOGENESIS IMPERFECTA, TYPE XIV; OI14
615067	CILIARY DYSKINESIA, PRIMARY, 20; CILD20
615068	ECTOPIC P-GRANULES AUTOPHAGY PROTEIN 5 HOMOLOG; EPG5
615069	H4 HISTONE 16; H4-16
615070	MICRO RNA 590; MIR590
615071	ALAZAMI SYNDROME; ALAZS
615072	BRACHYDACTYLY, TYPE A1, C; BDA1C
615073	DYSTONIA 25; DYT25
615074	GAND SYNDROME; GAND
615075	NEURODEVELOPMENTAL DISORDER WITH SPASTIC DIPLEGIA AND VISUAL DEFECTS; NEDSDV
615076	MITOCHONDRIAL GENOME MAINTENANCE EXONUCLEASE 1; MGME1
615077	TBC1 DOMAIN FAMILY, MEMBER 30; TBC1D30
615078	GOLGI TRANSPORT 1B; GOLT1B
615079	ASUNDER, SPERMATOGENESIS REGULATOR; ASUN
615080	ALZHEIMER DISEASE 17; AD17
615081	SPERMATOGENIC FAILURE 11; SPGF11
615082	C3HEX, ABILITY TO SMELL
615083	COLORECTAL CANCER, SUSCEPTIBILITY TO, 12; CRCS12
615084	MITOCHONDRIAL DNA DEPLETION SYNDROME 11; MTDPS11
615085	OSTEOPETROSIS, AUTOSOMAL RECESSIVE 8; OPTB8
615086	HARBINGER TRANSPOSASE-DERIVED GENE 1; HARBI1
615087	MOVED TO 613091
615088	AUTOPHAGY-RELATED 13; ATG13
615089	AUTOPHAGY-RELATED PROTEIN 101; ATG101
615090	INTERFERON, LAMBDA-4; IFNL4
615091	AUTISM, SUSCEPTIBILITY TO, 19; AUTS19
615092	LEFT VENTRICULAR NONCOMPACTION 7; LVNC7
615093	LYMPHOCYTE ANTIGEN 6 COMPLEX, LOCUS K; LY6K
615094	PROSPERO-RELATED HOMEOBOX 2; PROX2
615095	MICROCEPHALY 10, PRIMARY, AUTOSOMAL RECESSIVE; MCPH10
615096	MICRO RNA 217; MIR217
615097	SOLUTE CARRIER FAMILY 6 (NEUROTRANSMITTER TRANSPORTER, GABA), MEMBER 13; SLC6A13
615098	TETRATRICOPEPTIDE REPEAT DOMAIN-CONTAINING PROTEIN 28; TTC28
615099	ERYTHROFERRONE; ERFE
615100	CTTNBP2 N TERMINUS-LIKE PROTEIN; CTTNBP2NL
615101	TUBULIN, BETA-2A; TUBB2A
615102	TYSHCHENKO SYNDROME
615103	TUBULIN, BETA-6; TUBB6
615104	NCK-ASSOCIATED PROTEIN 5-LIKE; NCKAP5L
615105	METHYLTHIORIBOSE-1-PHOSPHATE ISOMERASE 1; MRI1
615106	MOVED TO 158350
615107	COWDEN SYNDROME 4; CWS4
615108	COWDEN SYNDROME 5; CWS5
615109	COWDEN SYNDROME 6; CWS6
615110	WD REPEAT-CONTAINING PROTEIN 53; WDR53
615111	DENN/MADD DOMAIN-CONTAINING PROTEIN 2D; DENND2D
615112	UROFACIAL SYNDROME 2; UFS2
615113	MICROPHTHALMIA, ISOLATED 8; MCOP8
615114	ZINC FINGER PROTEIN 516; ZNF516
615115	ASXL TRANSCRIPTIONAL REGULATOR 3; ASXL3
615116	SPERMATID MATURATION PROTEIN 1; SPEM1
615117	CHROMOSOME 2 OPEN READING FRAME 88; C2ORF88
615118	MOVED TO 269300
615119	MITOCHONDRIAL COMPLEX IV DEFICIENCY, NUCLEAR TYPE 6; MC4DN6
615120	MYASTHENIC SYNDROME, CONGENITAL, 8; CMS8
615121	STOMATIN-LIKE PROTEIN-2, HYPERPHOSPHORYLATION OF
615122	LYMPHOPROLIFERATIVE SYNDROME 2; LPFS2
615123	ANKYRIN REPEAT DOMAIN-CONTAINING PROTEIN 13A; ANKRD13A
615124	ANKYRIN REPEAT DOMAIN-CONTAINING PROTEIN 13B; ANKRD13B
615125	ANKYRIN REPEAT DOMAIN-CONTAINING PROTEIN 13C; ANKRD13C
615126	ANKYRIN REPEAT DOMAIN-CONTAINING PROTEIN 13D; ANKRD13D
615127	EPILEPSY, FAMILIAL ADULT MYOCLONIC, 4; FAME4
615128	CENTROMERIC PROTEIN X; CENPX
615129	UDP-N-ACETYL-ALPHA-D-GALACTOSAMINE:POLYPEPTIDE N-ACETYLGALACTOSAMINYLTRANSFERASE 5; GALNT5
615130	UDP-N-ACETYL-ALPHA-D-GALACTOSAMINE:POLYPEPTIDE N-ACETYLGALACTOSAMINYLTRANSFERASE 11; GALNT11
615131	UDP-N-ACETYL-ALPHA-D-GALACTOSAMINE:POLYPEPTIDE N-ACETYLGALACTOSAMINYLTRANSFERASE 15; GALNT15
615132	UDP-N-ACETYL-ALPHA-D-GALACTOSAMINE:POLYPEPTIDE N-ACETYLGALACTOSAMINYLTRANSFERASE 16; GALNT16
615133	UDP-N-ACETYL-ALPHA-D-GALACTOSAMINE:POLYPEPTIDE N-ACETYLGALACTOSAMINYLTRANSFERASE-LIKE 5; GALNTL5
615134	MELANOMA, CUTANEOUS MALIGNANT, SUSCEPTIBILITY TO, 9; CMM9
615135	MAPLE SYRUP URINE DISEASE, MILD VARIANT; MSUDMV
615136	UDP-N-ACETYL-ALPHA-D-GALACTOSAMINE:POLYPEPTIDE N-ACETYLGALACTOSAMINYLTRANSFERASE 18; GALNT18
615137	UDP-N-ACETYL-ALPHA-D-GALACTOSAMINE:POLYPEPTIDE N-ACETYLGALACTOSAMINYLTRANSFERASE 17; GALNT17
615138	UDP-N-ACETYL-ALPHA-D-GALACTOSAMINE:POLYPEPTIDE N-ACETYLGALACTOSAMINYLTRANSFERASE-LIKE 6; GALNTL6
615139	FACIAL DYSMORPHISM, IMMUNODEFICIENCY, LIVEDO, AND SHORT STATURE; FILS
615140	CHROMOSOME 12 OPEN READING FRAME 57; C12ORF57
615141	MOVED TO 177700
615142	KINESIN FAMILY MEMBER 2B; KIF2B
615143	UBIQUITIN-SPECIFIC PROTEASE 20; USP20
615144	PROTEASE, SERINE, 55; PRSS55
615145	MICROPHTHALMIA/COLOBOMA 9; MCOPCB9
615146	UBIQUITIN-SPECIFIC PROTEASE 33; USP33
615147	RETINAL DYSTROPHY, IRIS COLOBOMA, AND COMEDOGENIC ACNE SYNDROME; RDCCAS
615148	MICRO RNA 551A; MIR551A
615149	MICRO RNA 495; MIR495
615150	MICRO RNA 191; MIR191
615151	MICRO RNA 30C-1; MIR30C1
615152	KELCH DOMAIN-CONTAINING PROTEIN 10; KLHDC10
615153	MIXED LINEAGE KINASE DOMAIN-LIKE PROTEIN; MLKL
615154	DPY30 DOMAIN-CONTAINING PROTEIN 1; DYDC1
615155	STEEL SYNDROME; STLS
615156	PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 6; PEOA6
615157	MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 2; MC3DN2
615158	MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 3; MC3DN3
615159	MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 4; MC3DN4
615160	MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 5; MC3DN5
615161	MAJOR HISTOCOMPATIBILITY COMPLEX, CLASS II, DQ BETA-2; HLA-DQB2
615162	INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 35; MRT35
615163	CONE-ROD DYSTROPHY 17; CORD17
615164	AKIRIN 1; AKIRIN1
615165	AKIRIN 2; AKIRIN2
615166	C-X9-C MOTIF-CONTAINING 1; CMC1
615167	LEUCINE-RICH REPEATS- AND WD REPEAT DOMAIN-CONTAINING PROTEIN 1; LRWD1
615168	ARCHAELYSIN FAMILY METALLOPEPTIDASE 1; AMZ1
615169	ARCHAELYSIN FAMILY METALLOPEPTIDASE 2; AMZ2
615170	WAHAB SYNDROME
615171	LOC100134040 GENE
615172	RING FINGER PROTEIN, TRANSMEMBRANE 1; RNFT1
615173	LONG INTERGENIC NONCODING RNA, REGULATOR OF REPROGRAMMING; LINC-ROR
615174	L-THREONINE DEHYDROGENASE, PSEUDOGENE; TDH
615175	TLC DOMAIN-CONTAINING PROTEIN 3B; TLCD3B
615176	NPTN INTRONIC TRANSCRIPT 1, NONCODING; NPTNIT1
615177	RING FINGER PROTEIN 126; RNF126
615178	KXDL MOTIF-CONTAINING PROTEIN 1; KXD1
615179	ALBINISM, OCULOCUTANEOUS, TYPE VII; OCA7
615180	TRANSLOCASE OF INNER MITOCHONDRIAL MEMBRANE 21; TIMM21
615181	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 11; MDDGA11
615182	COMBINED D-2- AND L-2-HYDROXYGLUTARIC ACIDURIA; D2L2AD
615183	FA CORE COMPLEX-ASSOCIATED PROTEIN 20; FAAP20
615184	CARDIOMYOPATHY, DILATED, 1II; CMD1II
615185	CHARCOT-MARIE-TOOTH DISEASE, DOMINANT INTERMEDIATE F; CMTDIF
615186	CWC22 SPLICEOSOME-ASSOCIATED PROTEIN HOMOLOG; CWC22
615187	POST-GPI ATTACHMENT TO PROTEINS 2; PGAP2
615188	CATARACT 39, MULTIPLE TYPES; CTRCT39
615189	ANKYRIN REPEAT DOMAIN-CONTAINING PROTEIN 55; ANKRD55
615190	DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 5; DKCB5
615191	LISSENCEPHALY 5; LIS5
615192	BIRTH WEIGHT QUANTITATIVE TRAIT LOCUS 4; BWQTL4
615193	BLEEDING DISORDER, PLATELET-TYPE, 15; BDPLT15
615194	SHORT-CHAIN DEHYDROGENASE/REDUCTASE FAMILY, MEMBER 2; DHRS2
615195	SHORT-CHAIN DEHYDROGENASE/REDUCTASE FAMILY, MEMBER 4-LIKE 1; DHRS4L1
615196	SHORT-CHAIN DEHYDROGENASE/REDUCTASE FAMILY, MEMBER 4-LIKE 2; DHRS4L2
615197	RESTLESS LEGS SYNDROME, SUSCEPTIBILITY TO, 8; RLS8
615198	OSTEOSCLEROTIC METAPHYSEAL DYSPLASIA; OSMD
615199	SOLUTE CARRIER FAMILY 35, MEMBER G5; SLC35G5
615200	PLECKSTRIN HOMOLOGY DOMAIN-CONTAINING PROTEIN, FAMILY F, MEMBER 1; PLEKHF1
615201	MICRO RNA 1909; MIR1909
615202	MICRO RNA 1915; MIR1915
615203	RHOMBOID DOMAIN-CONTAINING PROTEIN 2; RHBDD2
615204	ATP SYNTHASE MEMBRANE SUBUNIT DAPIT; ATP5MD
615205	SERINE PROTEASE INHIBITOR, KAZAL-TYPE, 13; SPINK13
615206	IMMUNODEFICIENCY 11A; IMD11A
615207	IMMUNODEFICIENCY 56; IMD56
615208	PLECKSTRIN HOMOLOGY DOMAIN-CONTAINING PROTEIN, FAMILY F, MEMBER 2; PLEKHF2
615209	MICRO RNA 149; MIR149
615210	PEST-CONTAINING NUCLEAR PROTEIN; PCNP
615211	UBIQUITIN-LIKE PROTEIN CONTAINING PHD AND RING FINGER DOMAINS 2, E3 UBIQUITIN PROTEIN LIGASE; UHRF2
615212	LEUCINE-RICH REPEAT-CONTAINING PROTEIN 38; LRRC38
615213	LEUCINE-RICH REPEAT-CONTAINING PROTEIN 55; LRRC55
615214	AGAMMAGLOBULINEMIA 7, AUTOSOMAL RECESSIVE; AGM7
615215	POTASSIUM CHANNEL, SUBFAMILY U, MEMBER 1; KCNU1
615216	KINESIN FAMILY MEMBER C2; KIFC2
615217	ATAXIA-OCULOMOTOR APRAXIA 3; AOA3
615218	LEUCINE-RICH REPEAT-CONTAINING PROTEIN 52; LRRC52
615219	HYDROCEPHALUS, CONGENITAL, 2, WITH OR WITHOUT BRAIN OR EYE ANOMALIES; HYC2
615220	OSTEOGENESIS IMPERFECTA, TYPE XV; OI15
615221	BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS 16; BMND16
615222	SMITH-MCCORT DYSPLASIA 2; SMC2
615223	INTERFERON, EPSILON; IFNE
615224	ADVANCED SLEEP PHASE SYNDROME, FAMILIAL, 2; FASPS2
615225	PALMOPLANTAR CARCINOMA, MULTIPLE SELF-HEALING; MSPC
615226	POLYDACTYLY, POSTAXIAL, TYPE A6; PAPA6
615227	COMPLEMENT COMPONENT 1, q SUBCOMPONENT-LIKE 3; C1QL3
615228	MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 4B; MC5DN4B
615229	COMPLEMENT COMPONENT 1, q SUBCOMPONENT-LIKE 4; C1QL4
615230	LONG INTERGENIC NONCODING RNA 1080; LINC01080
615231	RING FINGER AND CCCH-TYPE ZINC FINGER DOMAINS-CONTAINING PROTEIN 2; RC3H2
615232	SCHIZOPHRENIA 18; SCZD18
615233	RETINITIS PIGMENTOSA 66; RP66
615234	ANEMIA, HYPOCHROMIC MICROCYTIC, WITH IRON OVERLOAD 2; AHMIO2
615235	CARDIOMYOPATHY, DILATED, 1JJ; CMD1JJ
615236	WOODS SYNDROME
615237	CONGENITAL SHORT BOWEL SYNDROME; CSBS
615238	LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 5; FPLD5
615239	MICRO RNA 7-1; MIR7-1
615240	POTASSIUM CHANNEL TETRAMERIZATION DOMAIN-CONTAINING PROTEIN 15; KCTD15
615241	TERMINAL DIFFERENTIATION-INDUCED NONCODING RNA; TINCR
615242	SMALL INTEGRAL MEMBRANE PROTEIN 1; SMIM1
615243	DEFENSIN, BETA, 114; DEFB114
615244	NEPHROTIC SYNDROME, TYPE 8; NPHS8
615245	MICRO RNA 671; MIR671
615246	ZINC FINGER BED DOMAIN-CONTAINING PROTEIN 2; ZBED2
615247	PROTEIN-O-MANNOSE KINASE; POMK
615248	CARDIOMYOPATHY, DILATED, 1KK; CMD1KK
615249	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 12; MDDGA12
615250	ZINC FINGER BED DOMAIN-CONTAINING PROTEIN 3; ZBED3
615251	ZINC FINGER BED DOMAIN-CONTAINING PROTEIN 5; ZBED5
615252	ZBED6 C TERMINUS-LIKE PROTEIN; ZBED6CL
615253	ZINC FINGER BED DOMAIN-CONTAINING PROTEIN 8; ZBED8
615254	SCAN DOMAIN-CONTAINING PROTEIN 3; SCAND3
615255	METHYLTRANSFERASE-LIKE 18; METTL18
615256	ELECTRON TRANSFER FLAVOPROTEIN BETA-SUBUNIT LYSINE METHYLTRANSFERASE; ETFBKMT
615257	METHYLTRANSFERASE 21A, HSPA LYSINE; METTL21A
615258	EEF1A LYSINE METHYLTRANSFERASE 3; EEF1AKMT3
615259	METHYLTRANSFERASE 21C, AARS1 LYSINE; METTL21C
615260	VALOSIN-CONTAINING PROTEIN LYSINE METHYLTRANSFERASE; VCPKMT
615261	METHYLTRANSFERASE 22, KIN27 LYSINE; METTL22
615262	METHYLTRANSFERASE-LIKE 23; METTL23
615263	EUKARYOTIC ELONGATION FACTOR 2 LYSINE METHYLTRANSFERASE; EEF2KMT
615264	BLOOD GROUP, VEL SYSTEM; VEL
615265	FORMIN-BINDING PROTEIN 4; FNBP4
615266	HYPOGONADOTROPIC HYPOGONADISM 17 WITH OR WITHOUT ANOSMIA; HH17
615267	HYPOGONADOTROPIC HYPOGONADISM 18 WITH OR WITHOUT ANOSMIA; HH18
615268	CEREBELLAR ATAXIA, IMPAIRED INTELLECTUAL DEVELOPMENT, AND DYSEQUILIBRIUM SYNDROME 4; CAMRQ4
615269	HYPOGONADOTROPIC HYPOGONADISM 19 WITH OR WITHOUT ANOSMIA; HH19
615270	HYPOGONADOTROPIC HYPOGONADISM 20 WITH OR WITHOUT ANOSMIA; HH20
615271	HYPOGONADOTROPIC HYPOGONADISM 21 WITH OR WITHOUT ANOSMIA; HH21
615272	FANCONI ANEMIA, COMPLEMENTATION GROUP Q; FANCQ
615273	CONGENITAL DISORDER OF DEGLYCOSYLATION 1; CDDG1
615274	CATARACT 15, MULTIPLE TYPES; CTRCT15
615275	ACONITATE DECARBOXYLASE 1; ACOD1
615276	CERAMIDE SYNTHASE 3; CERS3
615277	CATARACT 19, MULTIPLE TYPES; CTRCT19
615278	CARDIOFACIOCUTANEOUS SYNDROME 2; CFC2
615279	CARDIOFACIOCUTANEOUS SYNDROME 3; CFC3
615280	CARDIOFACIOCUTANEOUS SYNDROME 4; CFC4
615281	HYPOMYELINATION WITH BRAINSTEM AND SPINAL CORD INVOLVEMENT AND LEG SPASTICITY; HBSL
615282	CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 2; CDCBM2
615283	EXOCYST COMPLEX COMPONENT 8; EXOC8
615284	CHARCOT-MARIE-TOOTH DISEASE, TYPE 4B3; CMT4B3
615285	NEUTROPENIA, SEVERE CONGENITAL, 5, AUTOSOMAL RECESSIVE; SCN5
615286	NEURODEVELOPMENTAL DISORDER WITH BRAIN ABNORMALITIES, POOR GROWTH, AND DYSMORPHIC FACIES; NEDBGF
615287	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 13; MDDGA13
615288	DYNEIN REGULATORY COMPLEX, SUBUNIT 1; DRC1
615289	MITOTIC SPINDLE-POSITIONING PROTEIN; MISP
615290	SPINAL MUSCULAR ATROPHY, LOWER EXTREMITY-PREDOMINANT, 2A, CHILDHOOD ONSET, AUTOSOMAL DOMINANT; SMALED2A
615291	BETA-1,3-GALACTOSYLTRANSFERASE 6; B3GALT6
615292	FAMILY WITH SEQUENCE SIMILARITY 111, MEMBER A; FAM111A
615293	MYOFIBROMATOSIS, INFANTILE, 2; IMF2
615294	CILIARY DYSKINESIA, PRIMARY, 21; CILD21
615295	UBIQUITIN-SPECIFIC PROTEASE 34; USP34
615296	INTERLEUKIN 1 FAMILY, MEMBER 10; IL1F10
615297	ADAMS-OLIVER SYNDROME 4; AOS4
615298	SYMPHALANGISM, PROXIMAL, 1B; SYM1B
615299	NUCLEOREDOXIN-LIKE PROTEIN 2; NXNL2
615300	PERRAULT SYNDROME 4; PRLTS4
615301	TRANSMEMBRANE PROTEIN 214; TMEM214
615302	ADENOSINE DEAMINASE, tRNA-SPECIFIC, 3; ADAT3
615303	tRNA GLYCINE (ANTICODON TCC) 1-1; TRG-TCC1-1
615304	tRNA VALINE (ANTICODON CAC) 3-1; TRV-CAC3-1
615305	tRNA ARGININE (ANTICODON ACG) 1-2; TRR-ACG1-2
615306	tRNA VALINE (ANTICODON CAC) 1-6; TRV-CAC1-6
615307	tRNA VALINE (ANTICODON AAC) 5-1; TRV-AAC5-1
615308	tRNA VALINE (ANTICODON AAC) 4-1; TRV-AAC4-1
615309	tRNA THREONINE (ANTICODON AGT) 2-2; TRT-AGT2-2
615310	tRNA VALINE (ANTICODON AAC) 1-1; TRV-AAC1-1
615311	BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS 17; BMND17
615312	ALBINISM, OCULOCUTANEOUS, TYPE V; OCA5
615313	BETA-1,3-N-ACETYLGLUCOSAMINYLTRANSFERASE 7; B3GNT7
615314	CRANIOSYNOSTOSIS 3; CRS3
615315	BETA-1,3-N-ACETYLGLUCOSAMINYLTRANSFERASE 6; B3GNT6
615316	IRON-SULFUR CLUSTER ASSEMBLY FACTOR IBA57; IBA57
615317	IRON-SULFUR CLUSTER ASSEMBLY 2; ISCA2
615318	TRANSMEMBRANE PROTEIN 14C; TMEM14C
615319	IMPACT RWD DOMAIN PROTEIN; IMPACT
615320	GDP-MANNOSE PYROPHOSPHORYLASE B; GMPPB
615321	CHLORIDE INTRACELLULAR CHANNEL 6; CLIC6
615322	NEGATIVE REGULATOR OF REACTIVE OXYGEN SPECIES; NRROS
615323	JOSEPHIN DOMAIN-CONTAINING PROTEIN 1; JOSD1
615324	JOSEPHIN DOMAIN-CONTAINING PROTEIN 2; JOSD2
615325	MOVED TO 601419
615326	INTERFERON, KAPPA; IFNK
615327	DOWLING-DEGOS DISEASE 2; DDD2
615328	SHAHEEN SYNDROME; SHNS
615329	EXOCYST COMPLEX COMPONENT 2; EXOC2
615330	MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 3; MMDS3
615331	INTERFERON REGULATORY FACTOR 2-BINDING PROTEIN 1; IRF2BP1
615332	INTERFERON REGULATORY FACTOR 2-BINDING PROTEIN 2; IRF2BP2
615333	BETA-1,3-N-ACETYLGLUCOSAMINYLTRANSFERASE 5; B3GNT5
615334	CERAMIDE SYNTHASE 4; CERS4
615335	CERAMIDE SYNTHASE 5; CERS5
615336	CERAMIDE SYNTHASE 6; CERS6
615337	BETA-1,3-N-ACETYLGLUCOSAMINYLTRANSFERASE-LIKE 1; B3GNTL1
615338	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 16; DEE16
615339	DNAJ/HSP40 HOMOLOG, SUBFAMILY C, MEMBER 15; DNAJC15
615340	KELCH-LIKE 40: KLHL40
615341	CYTOCHROME P450, FAMILY 4, SUBFAMILY A, POLYPEPTIDE 22; CYP4A22
615342	PULMONARY HYPERTENSION, PRIMARY, 2; PPH2
615343	PULMONARY HYPERTENSION, PRIMARY, 3; PPH3
615344	PULMONARY HYPERTENSION, PRIMARY, 4; PPH4
615345	MYOMAKER; MYMK
615346	PRECOCIOUS PUBERTY, CENTRAL, 2; CPPB2
615347	ATPase FAMILY, AAA DOMAIN-CONTAINING, MEMBER 2B; ATAD2B
615348	NEMALINE MYOPATHY 8; NEM8
615349	EHLERS-DANLOS SYNDROME, SPONDYLODYSPLASTIC TYPE, 2; EDSSPD2
615350	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 14; MDDGA14
615351	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH IMPAIRED INTELLECTUAL DEVELOPMENT), TYPE B, 14; MDDGB14
615352	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 14; MDDGC14
615353	COILED-COIL DOMAIN-CONTAINING PROTEIN 28A; CCDC28A
615354	LIGAND-DEPENDENT NUCLEAR RECEPTOR-INTERACTING FACTOR 1; LRIF1
615355	NOONAN SYNDROME 8; NS8
615356	MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 18; LGMDR18
615357	BETA-1,3-GALACTOSYLTRANSFERASE 8; B3GNT8
615358	ADENYLATE KINASE 9; AK9
615359	MEIOSIS REGULATOR FOR OOCYTE DEVELOPMENT; MIOS
615360	LEBER CONGENITAL AMAUROSIS 17; LCA17
615361	HYPOCALCEMIA, AUTOSOMAL DOMINANT 2; HYPOC2
615362	CEROID LIPOFUSCINOSIS, NEURONAL, 13 (KUFS TYPE); CLN13
615363	ESTROGEN RESISTANCE; ESTRR
615364	ADENYLATE KINASE 7; AK7
615365	ADENYLATE KINASE 8; AK8
615366	NUCLEOLAR PROTEIN 11; NOL11
615367	N-TERMINAL ASPARAGINE AMIDASE; NTAN1
615368	LETHAL CONGENITAL CONTRACTURE SYNDROME 5; LCCS5
615369	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 94; DEE94
615370	ANKYRIN REPEAT AND STERILE ALPHA MOTIF DOMAINS-CONTAINING PROTEIN 6; ANKS6
615371	PULMONARY HYPERTENSION, NEONATAL, SUSCEPTIBILITY TO; PHN
615372	MICRO RNA 1260B; MIR1260B
615373	LEFT VENTRICULAR NONCOMPACTION 8; LVNC8
615374	CONE-ROD DYSTROPHY 18; CORD18
615375	INTERLEUKIN 1 RECEPTOR-ASSOCIATED KINASE 1-BINDING PROTEIN 1; IRAK1BP1
615376	CHARCOT-MARIE-TOOTH DISEASE, RECESSIVE INTERMEDIATE C; CMTRIC
615377	ATRIAL FIBRILLATION, FAMILIAL, 13; ATFB13
615378	ATRIAL FIBRILLATION, FAMILIAL, 14; ATFB14
615379	MICRO RNA 650; MIR650
615380	APOPTOSIS-RESISTANT E3 UBIQUITIN PROTEIN LIGASE 1; AREL1
615381	MANDIBULAR HYPOPLASIA, DEAFNESS, PROGEROID FEATURES, AND LIPODYSTROPHY SYNDROME; MDPL
615382	NEPHRONOPHTHISIS 16; NPHP16
615383	FIDGETIN-LIKE PROTEIN 1; FIGNL1
615384	SCAFFOLDING PROTEIN INVOLVED IN DNA REPAIR; SPIDR
615385	MICRO RNA 485; MIR485
615386	SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 14; SCAR14
615387	IMMUNODEFICIENCY 7; IMD7
615388	ADENOSINE DEAMINASE, tRNA-SPECIFIC, 2; ADAT2
615389	ISOPENTENYL-DIPHOSPHATE DELTA ISOMERASE 2; IDI2
615390	VESICOURETERAL REFLUX 7; VUR7
615391	IDI2 ANTISENSE RNA 1, NONCODING; IDI2AS1
615392	SCM-LIKE PROTEIN WITH 4 MBT DOMAINS 2; SFMBT2
615393	MITOCHONDRIAL TRANSCRIPTION TERMINATION FACTOR 4; MTERF4
615394	NOP2/SUN RNA METHYLTRANSFERASE FAMILY, MEMBER 4; NSUN4
615395	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 16; COXPD16
615396	LEFT VENTRICULAR NONCOMPACTION 10; LVNC10
615397	MECKEL SYNDROME, TYPE 11; MKS11
615398	MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 3; MCAHS3
615399	PAROXYSMAL NOCTURNAL HEMOGLOBINURIA 2; PNH2
615400	EPILEPSY, FAMILIAL ADULT MYOCLONIC, 5; FAME5
615401	IMMUNODEFICIENCY 8 WITH LYMPHOPROLIFERATION; IMD8
615402	DYSCHROMATOSIS UNIVERSALIS HEREDITARIA 3; DUH3
615403	THO COMPLEX, SUBUNIT 6; THOC6
615404	TRANSMEMBRANE 4 L6 FAMILY, MEMBER 20; TM4SF20
615405	GUANINE NUCLEOTIDE-BINDING PROTEIN, GAMMA-12; GNG12
615406	GNG12 ANTISENSE RNA 1, NONCODING; GNG12AS1
615407	ADP-RIBOSYLATION FACTOR-LIKE GTPase 2-BINDING PROTEIN; ARL2BP
615408	OUTER DYNEIN ARM DOCKING COMPLEX SUBUNIT 2; ODAD2
615409	SPERMATOGENESIS-ASSOCIATED PROTEIN 33; SPATA33
615410	MELANOCORTIN 2 RECEPTOR ACCESSORY PROTEIN 2; MRAP2
615411	CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 3; CDCBM3
615412	CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 4; CDCBM4
615413	SPERMATOGENIC FAILURE 12; SPGF12
615414	MICROCEPHALY 11, PRIMARY, AUTOSOMAL RECESSIVE; MCPH11
615415	RENAL-HEPATIC-PANCREATIC DYSPLASIA 2; RHPD2
615416	BASIC HELIX-LOOP-HELIX FAMILY, MEMBER A9; BHLHA9
615417	BET1-LIKE PROTEIN; BET1L
615418	MITOCHONDRIAL DNA DEPLETION SYNDROME 12B (CARDIOMYOPATHIC TYPE), AUTOSOMAL RECESSIVE; MTDPS12B
615419	HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 1; IHPRF1
615420	MYOPIA 22, AUTOSOMAL DOMINANT; MYP22
615421	COILED-COIL DOMAIN-CONTAINING 111; CCDC111
615422	INCLUSION BODY MYOPATHY WITH EARLY-ONSET PAGET DISEASE WITH OR WITHOUT FRONTOTEMPORAL DEMENTIA 2; IBMPFD2
615423	tRNA METHYLTRANSFERASE 10C, MITOCHONDRIAL RNAse P SUBUNIT; TRMT10C
615424	INCLUSION BODY MYOPATHY WITH EARLY-ONSET PAGET DISEASE WITH OR WITHOUT FRONTOTEMPORAL DEMENTIA 3; IBMPFD3
615425	EPIDERMOLYSIS BULLOSA SIMPLEX 3, LOCALIZED OR GENERALIZED INTERMEDIATE, WITH BP230 DEFICIENCY; EBS3
615426	AMYOTROPHIC LATERAL SCLEROSIS 20; ALS20
615427	ELMO/CED12 DOMAIN-CONTAINING PROTEIN 3; ELMOD3
615428	DEAD-BOX HELICASE 47; DDX47
615429	DEAFNESS, AUTOSOMAL RECESSIVE 88; DFNB88
615430	TRANSMEMBRANE PROTEIN 241; TMEM241
615431	MYOPIA 23, AUTOSOMAL RECESSIVE; MYP23
615432	SPECIFIC LANGUAGE IMPAIRMENT 5; SLI5
615433	CHROMOSOME 3q13.31 DELETION SYNDROME
615434	RETINITIS PIGMENTOSA 82 WITH OR WITHOUT SITUS INVERSUS; RP82
615435	ENDOPLASMIC RETICULUM OXIDOREDUCTIN 1-LIKE; ERO1L
615436	AORTIC ANEURYSM, FAMILIAL THORACIC 8; AAT8
615437	ENDOPLASMIC RETICULUM OXIDOREDUCTIN 1-LIKE, BETA; ERO1LB
615438	INFANTILE LIVER FAILURE SYNDROME 1; ILFS1
615439	MACULAR DEGENERATION, AGE-RELATED, 13; ARMD13
615440	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 17; COXPD17
615441	CARDIAC ARRHYTHMIA SYNDROME, WITH OR WITHOUT SKELETAL MUSCLE WEAKNESS; CARDAR
615442	T-CELL RECEPTOR ALPHA CHAIN VARIABLE GENE CLUSTER; TRAV@
615443	T-CELL RECEPTOR ALPHA CHAIN JOINING GENE CLUSTER; TRAJ@
615444	CILIARY DYSKINESIA, PRIMARY, 22; CILD22
615445	T-CELL RECEPTOR BETA CHAIN CONSTANT REGION 2; TRBC2
615446	T-CELL RECEPTOR BETA CHAIN VARIABLE GENE CLUSTER; TRBV@
615447	T-CELL RECEPTOR BETA CHAIN DIVERSITY GENE 1; TRBD1
615448	T-CELL RECEPTOR BETA CHAIN DIVERSITY GENE 2; TRBD2
615449	T-CELL RECEPTOR BETA CHAIN JOINING GENE CLUSTER; TRBJ@
615450	T-CELL RECEPTOR GAMMA CHAIN CONSTANT REGION 2; TRGC2
615451	CILIARY DYSKINESIA, PRIMARY, 23; CILD23
615452	PROSTATE CANCER-ASSOCIATED NONCODING RNA 1; PRNCR1
615453	MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 6; MC3DN6
615454	T-CELL RECEPTOR GAMMA CHAIN VARIABLE GENE CLUSTER; TRGV@
615455	T-CELL RECEPTOR GAMMA CHAIN JOINING GENE CLUSTER; TRGJ@
615456	ELMO/CED12 DOMAIN-CONTAINING PROTEIN 1; ELMOD1
615457	BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 18; BMIQ18
615458	MICROCORNEA, MYOPIC CHORIORETINAL ATROPHY, AND TELECANTHUS; MMCAT
615459	T-CELL RECEPTOR DELTA CHAIN VARIABLE GENE CLUSTER; TRDV@
615460	T-CELL RECEPTOR DELTA CHAIN DIVERSITY GENE CLUSTER; TRDD@
615461	T-CELL RECEPTOR DELTA CHAIN JOINING GENE CLUSTER; TRDJ@
615462	WD REPEAT-CONTAINING PROTEIN 60; WDR60
615463	SZT2 SUBUNIT OF KICSTOR COMPLEX; SZT2
615464	DEAD-BOX HELICASE 59; DDX59
615465	HARTSFIELD SYNDROME; HRTFDS
615466	TALIN ROD DOMAIN-CONTAINING PROTEIN 1; TLNRD1
615467	GLYCOLIPID TRANSFER PROTEIN DOMAIN-CONTAINING PROTEIN 1; GLTPD1
615468	IMMUNODEFICIENCY 12; IMD12
615469	MICRO RNA 574; MIR574
615470	CENTROSOMAL PROTEIN, 89-KD; CEP89
615471	MITOCHONDRIAL DNA DEPLETION SYNDROME 13 (ENCEPHALOMYOPATHIC TYPE); MTDPS13
615472	COATOMER PROTEIN COMPLEX, SUBUNIT ZETA-1; COPZ1
615473	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 17; DEE17
615474	PRIMARY ALDOSTERONISM, SEIZURES, AND NEUROLOGIC ABNORMALITIES; PASNA
615475	DExH-BOX HELICASE 34; DHX34
615476	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 18; DEE18
615477	NEURONAL TYROSINE-PHOSPHORYLATED PHOSPHOINOSITIDE 3-KINASE ADAPTOR 1; NYAP1
615478	NEURONAL TYROSINE-PHOSPHORYLATED PHOSPHOINOSITIDE 3-KINASE ADAPTOR 2; NYAP2
615479	MYOSIN XVI; MYO16
615480	BLADDER CANCER-ASSOCIATED TRANSCRIPT 1, NONCODING; BLACAT1
615481	CILIARY DYSKINESIA, PRIMARY, 24; CILD24
615482	CILIARY DYSKINESIA, PRIMARY, 25; CILD25
615483	BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 5; IBGC5
615484	PENTATRICOPEPTIDE REPEAT DOMAIN-CONTAINING PROTEIN 2; PTCD2
615485	BAINBRIDGE-ROPERS SYNDROME; BRPS
615486	INTERSTITIAL LUNG AND LIVER DISEASE; ILLD
615487	SMALL NUCLEOLAR RNA, H/ACA BOX, 2C; SNORA2C
615488	KAT8 REGULATORY NSL COMPLEX, SUBUNIT 2; KANSL2
615489	MACULAR DEGENERATION, AGE-RELATED, 14; ARMD14
615490	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2R; CMT2R
615491	SPASTIC PARAPLEGIA 79B, AUTOSOMAL RECESSIVE; SPG79B
615492	LONG INTERGENIC NONCODING RNA COX2
615493	INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 37; MRT37
615494	CILIA- AND FLAGELLA-ASSOCIATED PROTEIN 298; CFAP298
615495	GDP-MANNOSE PYROPHOSPHORYLASE A; GMPPA
615496	ATP/GTP-BINDING PROTEIN-LIKE 1; AGBL1
615497	MITOCHONDRIAL ELONGATION FACTOR 1; MIEF1
615498	MITOCHONDRIAL ELONGATION FACTOR 2; MIEF2
615499	PYRUVATE DEHYDROGENASE PHOSPHATASE CATALYTIC SUBUNIT 2; PDP2
615500	CILIARY DYSKINESIA, PRIMARY, 26; CILD26
615501	MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP C; MOCODC
615502	INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 21; MRD21
615503	SHORT-RIB THORACIC DYSPLASIA 8 WITH OR WITHOUT POLYDACTYLY; SRTD8
615504	CILIARY DYSKINESIA, PRIMARY, 27; CILD27
615505	CILIARY DYSKINESIA, PRIMARY, 28; CILD28
615506	TELANGIECTASIA, HEREDITARY HEMORRHAGIC, TYPE 5; HHT5
615507	NISCHARIN; NISCH
615508	ERYTHRODERMA, CONGENITAL, WITH PALMOPLANTAR KERATODERMA, HYPOTRICHOSIS, AND HYPER-IgE; EPKHE
615509	MICRO RNA 675; MIR675
615510	ALACRIMA, ACHALASIA, AND IMPAIRED INTELLECTUAL DEVELOPMENT SYNDROME; AAMR
615511	MYOPATHY DUE TO MYOADENYLATE DEAMINASE DEFICIENCY; MMDD
615512	TRIOSEPHOSPHATE ISOMERASE DEFICIENCY; TPID
615513	IMMUNODEFICIENCY 14A WITH LYMPHOPROLIFERATION, AUTOSOMAL DOMINANT; IMD14A
615514	CYCLIN-DEPENDENT KINASE 12; CDK12
615515	AMYOTROPHIC LATERAL SCLEROSIS 19; ALS19
615516	INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 38; MRT38
615517	HEMOCHROMATOSIS, TYPE 5; HFE5
615518	IMMUNODEFICIENCY 13; IMD13
615519	TARGET OF MYB1-LIKE 2 MEMBRANE TRAFFICKING PROTEIN; TOM1L2
615520	MICRO RNA 297; MIR297
615521	SH3 AND CYSTEINE-RICH DOMAINS 3; STAC3
615522	COLE DISEASE; COLED
615523	CORNEAL DYSTROPHY, FUCHS ENDOTHELIAL, 8; FECD8
615524	MICROPHTHALMIA, SYNDROMIC 12; MCOPS12
615525	COATOMER PROTEIN COMPLEX, SUBUNIT GAMMA-1; COPG1
615526	COATOMER PROTEIN COMPLEX, SUBUNIT ZETA-2; COPZ2
615527	CANDIDIASIS, FAMILIAL, 8; CANDF8
615528	PARKINSON DISEASE 19A, JUVENILE-ONSET; PARK19A
615529	CRANIOSYNOSTOSIS 5, SUSCEPTIBILITY TO; CRS5
615530	PARKINSON DISEASE 20, EARLY-ONSET; PARK20
615531	TRANSMEMBRANE PROTEIN 79; TMEM79
615532	ENDOPLASMIC RETICULUM MEMBRANE-ASSOCIATED RNA DEGRADATION PROTEIN; ERMARD
615533	TRANSMEMBRANE PROTEIN 126B; TMEM126B
615534	TRANSLOCASE OF INNER MITOCHONDRIAL MEMBRANE DOMAIN-CONTAINING PROTEIN 1; TIMMDC1
615535	SPECTRIN REPEAT-CONTAINING NUCLEAR ENVELOPE PROTEIN 4; SYNE4
615536	CHROMOSOME 2 OPEN READING FRAME 80; C2ORF80
615537	RETICULATE ACROPIGMENTATION OF KITAMURA; RAK
615538	CHROMOSOME 22q13 DUPLICATION SYNDROME
615539	EHLERS-DANLOS SYNDROME, MUSCULOCONTRACTURAL TYPE, 2; EDSMC2
615540	DEAFNESS, AUTOSOMAL RECESSIVE 76; DFNB76
615541	INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 39; MRT39
615542	TESTICULAR ANOMALIES WITH OR WITHOUT CONGENITAL HEART DISEASE; TACHD
615543	ACTIN-RELATED PROTEIN 2/3 COMPLEX INHIBITOR; ARPIN
615544	PERIVENTRICULAR NODULAR HETEROTOPIA 6; PVNH6
615545	LEUKEMIA, ACUTE LYMPHOBLASTIC, SUSCEPTIBILITY TO, 3; ALL3
615546	VAN MALDERGEM SYNDROME 2; VMLDS2
615547	SCHAAF-YANG SYNDROME; SHFYNG
615548	NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE VII; HSAN7
615549	ARMADILLO REPEAT-CONTAINING PROTEIN 5; ARMC5
615550	DIAMOND-BLACKFAN ANEMIA 12; DBA12
615551	EPISODIC PAIN SYNDROME, FAMILIAL, 2; FEPS2
615552	EPISODIC PAIN SYNDROME, FAMILIAL, 3; FEPS3
615553	ARTHROGRYPOSIS, IMPAIRED INTELLECTUAL DEVELOPMENT, AND SEIZURES; AMRS
615554	MULTIPLE FIBROADENOMAS OF THE BREAST; MFAB
615555	HYPERPROLACTINEMIA; HPRL
615556	ALPHA-TUBULIN ACETYLTRANSFERASE 1; ATAT1
615557	MELIOIDOSIS, SUSCEPTIBILITY TO
615558	HYPOBETALIPOPROTEINEMIA, FAMILIAL, 1; FHBL1
615559	AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME, TYPE III; ALPS3
615560	OTOFACIOCERVICAL SYNDROME 2, WITH T-CELL DEFICIENCY; OTFCS2
615561	COMPLEMENT FACTOR B DEFICIENCY; CFBD
615562	SPERM-ASSOCIATED ANTIGEN 5; SPAG5
615563	NUCLEAR RECEPTOR-BINDING PROTEIN 2; NRBP2
615564	SIDEROFLEXIN 4; SFXN4
615565	RETINITIS PIGMENTOSA 67; RP67
615566	BTB/POZ DOMAIN-CONTAINING PROTEIN 3; BTBD3
615567	COENZYME Q8B; COQ8B
615568	SWI/SNF COMPLEX ANTAGONIST ASSOCIATED WITH PROSTATE CANCER 1, NONCODING; SCHLAP1
615569	SIDEROFLEXIN 1; SFXN1
615570	SIDEROFLEXIN 2; SFXN2
615571	SIDEROFLEXIN 3; SFXN3
615572	SIDEROFLEXIN 5; SFXN5
615573	NEPHROTIC SYNDROME, TYPE 9; NPHS9
615574	ASPARAGINE SYNTHETASE DEFICIENCY; ASNSD
615575	NEURONOPATHY, DISTAL HEREDITARY MOTOR, AUTOSOMAL DOMINANT 6; HMND6
615576	MICRO RNA 185; MIR185
615577	IMMUNODEFICIENCY, COMMON VARIABLE, 10; CVID10
615578	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 18; COXPD18
615579	ATAXIN 7-LIKE 3B; ATXN7L3B
615580	ZINC FINGER PROTEIN 528; ZNF528
615581	DOUBLE HOMEOBOX 4-LIKE 9; DUX4L9
615582	LOEYS-DIETZ SYNDROME 5; LDS5
615583	VERHEIJ SYNDROME; VRJS
615584	FAMILY WITH SEQUENCE SIMILARITY 111, MEMBER B; FAM111B
615585	SOLUTE CARRIER FAMILY 38 (AMINO ACID TRANSPORTER), MEMBER 8; SLC38A8
615586	CENTROSOMAL PROTEIN, 19-KD; CEP19
615587	NUCLEOPORIN, 188-KD; NUP188
615588	SINGLE-PASS MEMBRANE PROTEIN WITH ASPARTATE-RICH TAIL 1; SMDT1
615589	OTOSCLEROSIS 10; OTSC10
615590	ALZHEIMER DISEASE 18; AD18
615591	MACULAR DEGENERATION, AGE-RELATED, 15; ARMD15
615592	IMMUNODEFICIENCY 15B; IMD15B
615593	IMMUNODEFICIENCY 16; IMD16
615594	APELIN RECEPTOR EARLY ENDOGENOUS LIGAND; APELA
615595	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 19; COXPD19
615596	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Iw, AUTOSOMAL RECESSIVE; CDG1WAR
615597	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ix; CDG1X
615598	PALMOPLANTAR KERATODERMA, NAGASHIMA TYPE; PPKN
615599	NEURODEVELOPMENTAL DISORDER WITH FEEDING DIFFICULTIES, THIN CORPUS CALLOSUM, AND FOOT DEFORMITY; NEDFCF
615600	ZINC FINGER PROTEIN 582; ZNF582
615601	GLUTAMATE DECARBOXYLASE-LIKE 1; GADL1
615602	MEMORY QUANTITATIVE TRAIT LOCUS; MEMRYQTL
615603	CALCINEURIN-LIKE PHOSPHOESTERASE DOMAIN-CONTAINING PROTEIN 1; CPPED1
615604	L-FERRITIN DEFICIENCY; LFTD
615605	FANCONI RENOTUBULAR SYNDROME 3; FRTS3
615606	BUTYROPHILIN-LIKE PROTEIN 8; BTNL8
615607	IMMUNODEFICIENCY 17; IMD17
615608	V-SET IMMUNOREGULATORY RECEPTOR; VSIR
615609	SIAH E3 UBIQUITIN PROTEIN LIGASE FAMILY, MEMBER 3; SIAH3
615610	CADHERIN-RELATED FAMILY, MEMBER 3; CDHR3
615611	CASEINOLYTIC MITOCHONDRIAL MATRIX PEPTIDASE CHAPERONE SUBUNIT; CLPX
615612	DEVELOPMENTAL DYSPLASIA OF THE HIP 2; DDH2
615613	HEPATOCELLULAR CARCINOMA-ASSOCIATED TRANSCRIPT 5; HCCAT5
615614	MMS22-LIKE PROTEIN; MMS22L
615615	IMMUNODEFICIENCY 18; IMD18
615616	ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA, FAMILIAL, 13; ARVD13
615617	IMMUNODEFICIENCY 19; IMD19
615618	PROTEIN O-GLUCOSYLTRANSFERASE 1; POGLUT1
615619	CHOLANGIOCARCINOMA, SUSCEPTIBILITY TO
615620	KAPTIN; KPTN
615621	RETROELEMENT SILENCING FACTOR 1; RESF1
615622	TNF- AND HNRNPL-RELATED IMMUNOREGULATORY LONG NONCODING RNA; THRIL
615623	CYTOCHROME C OXIDASE ASSEMBLY FACTOR 7; COA7
615624	COLORECTAL NEOPLASIA DIFFERENTIALLY EXPRESSED GENE, NONCODING; CRNDE
615625	SPASTIC PARAPLEGIA 72A, AUTOSOMAL DOMINANT; SPG72A
615626	CDAN1-INTERACTING NUCLEASE 1; CDIN1
615627	BRI3-BINDING PROTEIN; BRI3BP
615628	BRAIN PROTEIN I3; BRI3
615629	DEAFNESS, AUTOSOMAL DOMINANT 56; DFNA56
615630	SHORT-RIB THORACIC DYSPLASIA 10 WITH OR WITHOUT POLYDACTYLY; SRTD10
615631	ANEMIA, CONGENITAL DYSERYTHROPOIETIC, TYPE Ib; CDAN1B
615632	NEUROPATHY, HEREDITARY SENSORY, TYPE IF; HSN1F
615633	SHORT-RIB THORACIC DYSPLASIA 11 WITH OR WITHOUT POLYDACTYLY; SRTD11
615634	COILED-COIL-HELIX-COILED-COIL-HELIX DOMAIN-CONTAINING PROTEIN 6; CHCHD6
615635	ZINC FINGER RNA-BINDING PROTEIN; ZFR
615636	JOUBERT SYNDROME 21; JBTS21
615637	INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 41; MRT41
615638	NON-SMC CONDENSIN I COMPLEX SUBUNIT D2; NCAPD2
615639	SMALL CAJAL BODY-SPECIFIC RNA 10; SCARNA10
615640	SMALL CAJAL BODY-SPECIFIC RNA 5; SCARNA5
615641	SMALL CAJAL BODY-SPECIFIC RNA 6; SCARNA6
615642	SMALL CAJAL BODY-SPECIFIC RNA 12; SCARNA12
615643	NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 6; NBIA6
615644	SMALL CAJAL BODY-SPECIFIC RNA 7; SCARNA7
615645	SMALL CAJAL BODY-SPECIFIC RNA 17; SCARNA17
615646	SMALL CAJAL BODY-SPECIFIC RNA 8; SCARNA8
615647	TESTIS-EXPRESSED GENE 19; TEX19
615648	NLR FAMILY, CASPASE RECRUITMENT DOMAIN-CONTAINING 3; NLRC3
615649	DEAFNESS, AUTOSOMAL DOMINANT 54; DFNA54
615650	REGULATOR OF G PROTEIN SIGNALING 22; RGS22
615651	LEUKOENCEPHALOPATHY WITH ATAXIA; LKPAT
615652	ACYL-CoA THIOESTERASE 13; ACOT13
615653	THIOESTERASE SUPERFAMILY MEMBER 5; THEM5
615654	DEAFNESS, AUTOSOMAL DOMINANT 58; DFNA58
615655	ZINC FINGER RANBP2-TYPE DOMAIN-CONTAINING PROTEIN 3; ZRANB3
615656	CHROMOSOME 15q11.2 DELETION SYNDROME
615657	MICRO RNA 142; MIR142
615658	SPASTIC PARAPLEGIA 57, AUTOSOMAL RECESSIVE; SPG57
615659	TRANSMEMBRANE PROTEIN 131; TMEM131
615660	RIBOSOMAL PROTEIN L10A; RPL10A
615661	PROGRAMMED CELL DEATH 2-LIKE PROTEIN; PDCD2L
615662	SERPIN PEPTIDASE INHIBITOR, CLADE B (OVALBUMIN), MEMBER 12; SERPINB12
615663	WARBURG MICRO SYNDROME 4; WARBM4
615664	THYMOCYTE-EXPRESSED POSITIVE SELECTION-ASSOCIATED PROTEIN 1; TESPA1
615665	JOUBERT SYNDROME 22; JBTS22
615666	KIAA1456 GENE; KIAA1456
615667	ERCC EXCISION REPAIR 6-LIKE 2; ERCC6L2
615668	CHROMOSOME 5q12 DELETION SYNDROME
615669	EMBIGIN; EMB
615670	SCHWANNOMATOSIS 2; SWN2
615671	SET DOMAIN-CONTAINING PROTEIN 3; SETD3
615672	MICRO RNA 497; MIR497
615673	MYOPATHY WITH EXTRAPYRAMIDAL SIGNS; MPXPS
615674	DOWLING-DEGOS DISEASE 3; DDD3
615675	MICRO RNA 301A; MIR301A
615676	TESTIS DEVELOPMENT-RELATED GENE 1, NONCODING; TDRG1
615677	SERPIN PEPTIDASE INHIBITOR, CLADE A, MEMBER 9; SERPINA9
615678	SH3 DOMAIN-BINDING GLUTAMIC ACID-RICH PROTEIN-LIKE PROTEIN 2; SH3BGRL2
615679	SH3 DOMAIN-BINDING GLUTAMIC ACID-RICH PROTEIN-LIKE PROTEIN 3; SH3BGRL3
615680	CASPASE RECRUITMENT DOMAIN-CONTAINING PROTEIN 16; CARD16
615681	SPASTIC PARAPLEGIA 62, AUTOSOMAL RECESSIVE; SPG62
615682	SERPIN PEPTIDASE INHIBITOR, CLADE B (OVALBUMIN), MEMBER 11; SERPINB11
615683	SPASTIC PARAPLEGIA 64, AUTOSOMAL RECESSIVE; SPG64
615684	HELICASE FOR MEIOSIS 1; HFM1
615685	SPASTIC PARAPLEGIA 61, AUTOSOMAL RECESSIVE; SPG61
615686	SPASTIC PARAPLEGIA 63, AUTOSOMAL RECESSIVE; SPG63
615687	BECLIN 2; BECN2
615688	VASCULITIS, AUTOINFLAMMATION, IMMUNODEFICIENCY, AND HEMATOLOGIC DEFECTS SYNDROME; VAIHS
615689	ADHESION MOLECULE WITH Ig-LIKE DOMAIN 1; AMIGO1
615690	ADHESION MOLECULE WITH Ig-LIKE DOMAIN 2; AMIGO2
615691	ADHESION MOLECULE WITH Ig-LIKE DOMAIN 3; AMIGO3
615692	CHITINASE DOMAIN-CONTAINING PROTEIN 1; CHID1
615693	COLCA1 GENE; COLCA1
615694	POU CLASS 2 HOMEOBOX-ASSOCIATING FACTOR 3; POU2AF3
615695	HEXAMETHYLENE BIS ACETAMIDE-INDUCIBLE PROTEIN 2; HEXIM2
615696	DOWLING-DEGOS DISEASE 4; DDD4
615697	EPILEPSY, FAMILIAL TEMPORAL LOBE, 6; ETL6
615698	PHOSPHOLIPASE D FAMILY, MEMBER 3; PLD3
615699	ZINC FINGER TRANSLOCATION-ASSOCIATED PROTEIN; ZFTA
615700	PYRIN DOMAIN-CONTAINING PROTEIN 1; PYDC1
615701	PYRIN DOMAIN-CONTAINING PROTEIN 2; PYDC2
615702	OLFACTORY RECEPTOR, FAMILY 5, SUBFAMILY AN, MEMBER 1; OR5AN1
615703	MORBID OBESITY AND SPERMATOGENIC FAILURE; MOSPGF
615704	POIKILODERMA, HEREDITARY FIBROSING, WITH TENDON CONTRACTURES, MYOPATHY, AND PULMONARY FIBROSIS; POIKTMP
615705	SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 15; SCAR15
615706	AURICULOCONDYLAR SYNDROME 3; ARCND3
615707	IMMUNODEFICIENCY 20; IMD20
615708	ZINC FINGER PROTEIN 451; ZNF451
615709	SACRAL AGENESIS WITH VERTEBRAL ANOMALIES; SAVA
615710	MITCHELL-RILEY SYNDROME; MTCHRS
615711	ALZHEIMER DISEASE 19; AD19
615712	OTU DEUBIQUITINASE WITH LINEAR LINKAGE SPECIFICITY; OTULIN
615713	ZINC FINGER MYND DOMAIN-CONTAINING PROTEIN 8; ZMYND8
615714	POLR1H ANTISENSE, PSEUDOGENE; POLR1HASP
615715	BONE MARROW FAILURE SYNDROME 2; BMFS2
615716	HYPERPHOSPHATASIA WITH IMPAIRED INTELLECTUAL DEVELOPMENT SYNDROME 4; HPMRS4
615717	BPI FOLD-CONTAINING PROTEIN, FAMILY B, MEMBER 3; BPIFB3
615718	BPI FOLD-CONTAINING PROTEIN, FAMILY B, MEMBER 4; BPIFB4
615719	TCL1 UPSTREAM NEURAL DIFFERENTIATION-ASSOCIATED RNA; TUNAR
615720	SOLUTE CARRIER FAMILY 7, MEMBER 14; SLC7A14
615721	RENAL HYPODYSPLASIA/APLASIA 2; RHDA2
615722	BOSCH-BOONSTRA-SCHAAF OPTIC ATROPHY SYNDROME; BBSOAS
615723	PREMATURE OVARIAN FAILURE 8; POF8
615724	PREMATURE OVARIAN FAILURE 9; POF9
615725	RETINITIS PIGMENTOSA 68; RP68
615726	PACHYONYCHIA CONGENITA 3; PC3
615727	KILLER CELL IMMUNOGLOBULIN-LIKE RECEPTOR, TWO DOMAINS, LONG CYTOPLASMIC TAIL, 5B; KIR2DL5B
615728	PACHYONYCHIA CONGENITA 4; PC4
615729	STRAWBERRY NOTCH, DROSOPHILA, HOMOLOG OF, 2; SBNO2
615730	DEDICATOR OF CYTOKINESIS 7; DOCK7
615731	NEMALINE MYOPATHY 9; NEM9
615732	NOP2/SUN RNA METHYLTRANSFERASE FAMILY, MEMBER 5; NSUN5
615733	rRNA METHYLTRANSFERASE AND RIBOSOME MATURATION FACTOR BUD23; BUD23
615734	WD REPEAT-CONTAINING PROTEIN 47; WDR47
615735	PALMOPLANTAR KERATODERMA, NONEPIDERMOLYTIC, FOCAL OR DIFFUSE; PPKNEFD
615736	ENDOTHELIAL CELL SURFACE-EXPRESSED CHEMOTAXIS AND APOPTOSIS REGULATOR; ECSCR
615737	IZUMO1 RECEPTOR, JUNO; IZUMO1R
615738	VPS51 SUBUNIT OF GARP COMPLEX; VPS51
615739	POU DOMAIN, CLASS 5, TRANSCRIPTION FACTOR 1B; POU5F1B
615740	TBC1 DOMAIN FAMILY, MEMBER 5; TBC1D5
615741	DAP3-BINDING CELL DEATH ENHANCER 1; DELE1
615742	RGP1 HOMOLOG, RAB6A GEF COMPLEX PARTNER 1; RGP1
615743	SET DOMAIN-CONTAINING PROTEIN 5; SETD5
615744	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 19; DEE19
615745	ATRIAL STANDSTILL 2; ATRST2
615746	ZXD FAMILY ZINC FINGER PROTEIN C; ZXDC
615747	CEA CELL ADHESION MOLECULE 8; CEACAM8
615748	WASH COMPLEX, SUBUNIT 4; WASHC4
615749	ECULIZUMAB, POOR RESPONSE TO
615750	MOYAMOYA DISEASE 6 WITH OR WITHOUT ACHALASIA; MYMY6
615751	CARBONIC ANHYDRASE VA DEFICIENCY, HYPERAMMONEMIA DUE TO; CA5AD
615752	CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 14B (BILATERAL PERISYLVIAN); CDCBM14B
615753	POM121 TRANSMEMBRANE NUCLEOPORIN; POM121
615754	POM121 TRANSMEMBRANE NUCLEOPORIN C; POM121C
615755	FORKHEAD BOX R1; FOXR1
615756	SELENOCYSTEINE INSERTION SEQUENCE-BINDING PROTEIN 2-LIKE; SECISBP2L
615757	KIZUNA CENTROSOMAL PROTEIN; KIZ
615758	IMMUNODEFICIENCY 22; IMD22
615759	KINASE D-INTERACTING SUBSTRATE, 220-KD; KIDINS220
615760	MICROCEPHALY, PROGRESSIVE, WITH SEIZURES AND CEREBRAL AND CEREBELLAR ATROPHY; MSCCA
615761	INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 23; MRD23
615762	GLUTAREDOXIN, CYSTEINE-RICH, 2; GRXCR2
615763	CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 5; CDCBM5
615764	LONG STRESS-INDUCED NONCODING TRANSCRIPT 5; LSINCT5
615765	SOLUTE CARRIER FAMILY 16, MEMBER 11; SLC16A11
615766	MICROTUBULE CROSSLINKING FACTOR 1; MTCL1
615767	IMMUNODEFICIENCY, COMMON VARIABLE, 11; CVID11
615768	SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 16; SCAR16
615769	FAMILY WITH SEQUENCE SIMILARITY 169, MEMBER A; FAM169A
615770	ATRIAL FIBRILLATION, FAMILIAL, 15; ATFB15
615771	CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 6; CDCBM6
615772	WAP FOUR-DISULFIDE CORE DOMAIN 21, PSEUDOGENE; WFDC21P
615773	SUCCINATE DEHYDROGENASE COMPLEX ASSEMBLY FACTOR 3; SDHAF3
615774	OOCYTE/ZYGOTE/EMBRYO MATURATION ARREST 1; OZEMA1
615775	SYNAPTONEMAL COMPLEX CENTRAL ELEMENT PROTEIN 3; SYCE3
615776	CILIARY ROOTLET COILED-COIL PROTEIN; CROCC
615777	DESBUQUOIS DYSPLASIA 2; DBQD2
615778	CLAUDIN 15; CLDN15
615779	CONGENITAL HEART DEFECTS, MULTIPLE TYPES, 4; CHTD4
615780	RETINITIS PIGMENTOSA 69; RP69
615781	ADAPTOR-RELATED PROTEIN COMPLEX 1, SIGMA-3 SUBUNIT; AP1S3
615782	CIRCADIAN-ASSOCIATED REPRESSOR OF TRANSCRIPTION; CIART
615783	N-ACETYLTRANSFERASE 16; NAT16
615784	GLUTATHIONE PEROXIDASE 7; GPX7
615785	WHITE SPONGE NEVUS 2; WSN2
615786	NACC FAMILY, MEMBER 2, BEN AND BTB/POZ DOMAINS-CONTAINING; NACC2
615787	NAD KINASE 2, MITOCHONDRIAL; NADK2
615788	NEDD4-BINDING PROTEIN 2-LIKE 2; N4BP2L2
615789	SHORT STATURE WITH MICROCEPHALY AND DISTINCTIVE FACIES; SSMCF
615790	AT-HOOK DNA-BINDING MOTIF-CONTAINING PROTEIN 1; AHDC1
615791	NUDIX HYDROLASE 18; NUDT18
615792	NUDIX HYDROLASE 15; NUDT15
615793	ISTHMIN 1; ISM1
615794	FIBRONECTIN TYPE III DOMAIN-CONTAINING PROTEIN 3A; FNDC3A
615795	FIBROUS SHEATH-INTERACTING PROTEIN 1; FSIP1
615796	FIBROUS SHEATH-INTERACTING PROTEIN 2; FSIP2
615797	HLA COMPLEX GROUP 9, NONCODING; HCG9
615798	CLAUDIN 6; CLDN6
615799	CLAUDIN 9; CLDN9
615800	FASCIN ACTIN-BUNDLING PROTEIN 3, TESTICULAR; FSCN3
615801	MOVED TO 615714
615802	NEURODEVELOPMENTAL DISORDER WITH DYSMORPHIC FEATURES, SPASTICITY, AND BRAIN ABNORMALITIES; NEDDSBA
615803	PONTOCEREBELLAR HYPOPLASIA, TYPE 10; PCH10
615804	UREIDOIMIDAZOLINE (2-OXO-4-HYDROXY-4-CARBOXY-5-) DECARBOXYLASE; URAD
615805	URATE (HYDROXYISO-) HYDROLASE, PSEUDOGENE; URAHP
615806	SOLUTE CARRIER FAMILY 15 (OLIGOPEPTIDE TRANSPORTER), MEMBER 4; SLC15A4
615807	SECKEL SYNDROME 8; SCKL8
615808	TRANSLATION MACHINERY-ASSOCIATED 7, S. CEREVISIAE, HOMOLOG OF; TMA7
615809	PONTOCEREBELLAR HYPOPLASIA, TYPE 9; PCH9
615810	CHROMOSOME 11 OPEN READING FRAME 54; C11ORF54
615811	PEPTIDYL-PROLYL ISOMERASE-LIKE 3; PPIL3
615812	ABDOMINAL OBESITY-METABOLIC SYNDROME 3; AOMS3
615813	FAMILY WITH SEQUENCE SIMILARITY 193, MEMBER B; FAM193B
615814	SERINE/THREONINE/TYROSINE-INTERACTING PROTEIN; STYX
615815	SMOOTH MUSCLE- AND ENDOTHELIAL CELL-ENRICHED MIGRATION/DIFFERENTIATION-ASSOCIATED LONG NONCODING RNA; SENCR
615816	IMMUNODEFICIENCY 23; IMD23
615817	INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 43; MRT43
615818	RIBOSOMAL RNA PROCESSING 8; RRP8
615819	SULFOTRANSFERASE FAMILY 1A, CYTOSOLIC, PHENOL-PREFERRING, MEMBER 4; SULT1A4
615820	DDB1- AND CUL4-ASSOCIATED FACTOR 8; DCAF8
615821	CARDIOMYOPATHY, DILATED, WITH WOOLLY HAIR, KERATODERMA, AND TOOTH AGENESIS; DCWHKTA
615822	SLX1 HOMOLOG A, STRUCTURE-SPECIFIC ENDONUCLEASE SUBUNIT; SLX1A
615823	SLX1 HOMOLOG B, STRUCTURE-SPECIFIC ENDONUCLEASE SUBUNIT; SLX1B
615824	MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 7; MC3DN7
615825	SUSHI DOMAIN-CONTAINING PROTEIN 2; SUSD2
615826	SPERM-TAIL PG-RICH REPEAT-CONTAINING PROTEIN 1; STPG1
615827	SUSHI DOMAIN-CONTAINING PROTEIN 4; SUSD4
615828	VULTO-VAN SILFHOUT-DE VRIES SYNDROME; VSVS
615829	XIA-GIBBS SYNDROME; XIGIS
615830	PIGMENTED NODULAR ADRENOCORTICAL DISEASE, PRIMARY, 4; PPNAD4
615831	LYR MOTIF-CONTAINING PROTEIN 7; LYRM7
615832	UBIQUITIN-CONJUGATING ENZYME E2 Q FAMILY-LIKE PROTEIN 1; UBE2QL1
615833	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 21; DEE21
615834	INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 26; MRD26
615835	CHROMOSOME 16 INVERSION, 0.45-MB
615836	SERINE/THREONINE PROTEIN KINASE 38-LIKE PROTEIN; STK38L
615837	DEAFNESS, AUTOSOMAL RECESSIVE 101; DFNB101
615838	MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 8; MC3DN8
615839	2,4-DIENOYL-CoA REDUCTASE 2, PEROXISOMAL; DECR2
615840	dCTP PYROPHOSPHATASE 1; DCTPP1
615841	SPERMATOGENIC FAILURE 13; SPGF13
615842	SPERMATOGENIC FAILURE 14; SPGF14
615843	DELTA(4)-DESATURASE, SPHINGOLIPID, 1; DEGS1
615844	TRIOKINASE AND FMN CYCLASE; TKFC
615845	MICRO RNA 190A; MIR190A
615846	AICARDI-GOUTIERES SYNDROME 7; AGS7
615847	CENTROSOMAL PROTEIN, 83-KD; CEP83
615848	TUMOR PREDISPOSITION SYNDROME 3; TPDS3
615849	CULLER-JONES SYNDROME; CJS
615850	VPS53 SUBUNIT OF GARP COMPLEX; VPS53
615851	PONTOCEREBELLAR HYPOPLASIA, TYPE 2E; PCH2E
615852	RAS-ASSOCIATED PROTEIN RAB6B; RAB6B
615853	POLYAMINE OXIDASE; PAOX
615854	SPERMINE OXIDASE; SMOX
615855	TRANSMEMBRANE AND TETRATRICOPEPTIDE REPEAT DOMAINS-CONTAINING PROTEIN 1; TMTC1
615856	TRANSMEMBRANE AND TETRATRICOPEPTIDE REPEAT DOMAINS-CONTAINING PROTEIN 2; TMTC2
615857	2-OXOGLUTARATE- AND IRON-DEPENDENT OXYGENASE DOMAIN-CONTAINING PROTEIN 1; OGFOD1
615858	ROUND SPERMATID BASIC PROTEIN 1; RSBN1
615859	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 23; DEE23
615860	CONE-ROD DYSTROPHY 19; CORD19
615861	NEPHROTIC SYNDROME, TYPE 10; NPHS10
615862	NEPHRONOPHTHISIS 18; NPHP18
615863	DIARRHEA 7, PROTEIN-LOSING ENTEROPATHY TYPE; DIAR7
615864	CENTROSOMAL PROTEIN, 97-KD; CEP97
615865	NEURALIZED E3 UBIQUITIN PROTEIN LIGASE 4; NEURL4
615866	INTELLECTUAL DEVELOPMENTAL DISORDER WITH MICROCEPHALY AND WITH OR WITHOUT OCULAR MALFORMATIONS OR HYPOGONADOTROPIC HYPOGONADISM; IDDMOH
615867	TBC1 DOMAIN FAMILY, MEMBER 32; TBC1D32
615868	SERINE PEPTIDASE INHIBITOR, KAZAL-TYPE, 6; SPINK6
615869	TUMOR NECROSIS FACTOR-ALPHA-INDUCED PROTEIN 8-LIKE 1; TNFAIP8L1
615870	INTRAFLAGELLAR TRANSPORT 27; IFT27
615871	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 24; DEE24
615872	CILIARY DYSKINESIA, PRIMARY, 29; CILD29
615873	HELSMOORTEL-VAN DER AA SYNDROME; HVDAS
615874	RIBOSOMAL L1 DOMAIN-CONTAINING PROTEIN 1; RSL1D1
615875	RWD DOMAIN-CONTAINING PROTEIN 3; RWDD3
615876	RADIAL SPOKE HEAD 3; RSPH3
615877	MICROPHTHALMIA/COLOBOMA AND SKELETAL DYSPLASIA SYNDROME; MCSKS
615878	CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC, 4; PFIC4
615879	TATTON-BROWN-RAHMAN SYNDROME; TBRS
615880	RHO GTPase-ACTIVATING PROTEIN 39; ARHGAP39
615881	PLASMA TRIGLYCERIDE LEVEL QUANTITATIVE TRAIT LOCUS; TGQTL
615882	RAB GTPase-ACTIVATING PROTEIN 1; RABGAP1
615883	MYOPATHY, TUBULAR AGGREGATE, 2; TAM2
615884	ADIPOCYTE PLASMA MEMBRANE-ASSOCIATED PROTEIN; APMAP
615885	HYPOTRICHOSIS 12; HYPT12
615886	FAMILY WITH SEQUENCE SIMILARITY 83, MEMBER G; FAM83G
615887	AMELOGENESIS IMPERFECTA, HYPOMATURATION TYPE, IIA5; AI2A5
615888	BLEEDING DISORDER, PLATELET-TYPE, 18; BDPLT18
615889	LEUKOENCEPHALOPATHY, PROGRESSIVE, WITH OVARIAN FAILURE; LKENP
615890	DYNEIN, CYTOPLASMIC 1, LIGHT INTERMEDIATE CHAIN 1; DYNC1LI1
615891	ZINC FINGER- AND BTB DOMAIN-CONTAINING PROTEIN 8, OPPOSITE STRAND; ZBTB8OS
615892	OROFACIAL CLEFT 14; OFC14
615893	NEURALIZED E3 UBIQUITIN PROTEIN LIGASE 1B; NEURL1B
615894	ZINC FINGER PROTEIN 407; ZNF407
615895	POLYGLUCOSAN BODY MYOPATHY 1 WITH OR WITHOUT IMMUNODEFICIENCY; PGBM1
615896	HYPOTRICHOSIS 13; HYPT13
615897	IMMUNODEFICIENCY 24; IMD24
615898	NADH DEHYDROGENASE (UBIQUINONE) COMPLEX I, ASSEMBLY FACTOR 7; NDUFAF7
615899	OLFACTOMEDIN-LIKE 2A; OLFML2A
615900	AATP/GTP-BINDING PROTEIN-LIKE 5; AGBL5
615901	NCCRP1, F-BOX-ASSOCIATED DOMAIN CONTAINING; NCCRP1
615902	PROTEIN PHOSPHATASE 2, REGULATORY SUBUNIT B-DOUBLE PRIME, GAMMA; PPP2R3C
615903	COILED-COIL-HELIX-COILED-COIL-HELIX DOMAIN-CONTAINING PROTEIN 10; CHCHD10
615904	PEROXIDASIN-LIKE PROTEIN; PXDNL
615905	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 25 WITH AMELOGENESIS IMPERFECTA; DEE25
615906	ORC UBIQUITIN LIGASE 1; OBI1
615907	LYMPHATIC MALFORMATION 4; LMPHM4
615908	MICRO RNA 520C; MIR520C
615909	DIAMOND-BLACKFAN ANEMIA 13; DBA13
615910	NAD(P)HX DEHYDRATASE; NAXD
615911	FRONTOTEMPORAL DEMENTIA AND/OR AMYOTROPHIC LATERAL SCLEROSIS 2; FTDALS2
615912	GLUTATHIONE S-TRANSFERASE C-TERMINAL DOMAIN-CONTAINING PROTEIN; GSTCD
615913	PEPTIDASE M20 DOMAIN-CONTAINING PROTEIN 2; PM20D2
615914	CYCLIN-DEPENDENT KINASE INHIBITOR 2A-INTERACTING PROTEIN; CDKN2AIP
615915	ZONA PELLUCIDA-LIKE DOMAIN-CONTAINING PROTEIN 1; ZPLD1
615916	CARDIOMYOPATHY, DILATED, 1NN; CMD1NN
615917	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 20; COXPD20
615918	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 21; COXPD21
615919	ATAXIA-TELANGIECTASIA-LIKE DISORDER 2; ATLD2
615920	PROLINE-RICH PROTEIN 11; PRR11
615921	PPARGC1- AND ESRR-INDUCED REGULATOR, MUSCLE, 1; PERM1
615922	RETINITIS PIGMENTOSA 70; RP70
615923	EPIPHYSEAL CHONDRODYSPLASIA, MIURA TYPE; ECDM
615924	ENCEPHALOPATHY, PROGRESSIVE, WITH OR WITHOUT LIPODYSTROPHY; PELD
615925	GROWTH HORMONE DEFICIENCY, ISOLATED PARTIAL; GHDP
615926	WEBB-DATTANI SYNDROME; WEDAS
615927	REFILIN A; RFLNA
615928	REFILIN B; RFLNB
615929	ANKYRIN REPEAT DOMAIN-CONTAINING PROTEIN 17; ANKRD17
615930	COLORECTAL ADENOCARCINOMA HYPERMETHYLATED GENE, NONCODING; CAHM
615931	PROLINE-RICH PROTEIN 16; PRR16
615932	POTASSIUM CHANNEL TETRAMERIZATION DOMAIN-CONTAINING PROTEIN 20; KCTD20
615933	BTB/POZ DOMAIN-CONTAINING PROTEIN 10; BTBD10
615934	STING-ASSOCIATED VASCULOPATHY, INFANTILE-ONSET; SAVI
615935	PANCREATIC AGENESIS 2; PAGEN2
615936	RHO GTPase-ACTIVATING PROTEIN 42; ARHGAP42
615937	MEGALENCEPHALY-POLYMICROGYRIA-POLYDACTYLY-HYDROCEPHALUS SYNDROME 2; MPPH2
615938	MEGALENCEPHALY-POLYMICROGYRIA-POLYDACTYLY-HYDROCEPHALUS SYNDROME 3; MPPH3
615939	PROTEIN TYROSINE PHOSPHATASE-LIKE (PROLINE INSTEAD OF CATALYTIC ARGININE), MEMBER B; PTPLB
615940	PROTEIN TYROSINE PHOSPHATASE-LIKE A DOMAIN-CONTAINING PROTEIN 1; PTPLAD1
615941	PROTEIN TYROSINE PHOSPHATASE-LIKE A DOMAIN-CONTAINING PROTEIN 2; PTPLAD2
615942	INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 44; MRT44
615943	MEMBRANE-ASSOCIATED GUANYLATE KINASE, WW AND PDZ DOMAINS-CONTAINING, 3; MAGI3
615944	C2 CALCIUM-DEPENDENT DOMAIN-CONTAINING PROTEIN 3; C2CD3
615945	SPINOCEREBELLAR ATAXIA 37; SCA37
615946	MYOPIA 24, AUTOSOMAL DOMINANT; MYP24
615947	HYPERLIPOPROTEINEMIA, TYPE ID
615948	OROFACIODIGITAL SYNDROME XIV; OFD14
615949	TRANSMEMBRANE PROTEIN 98; TMEM98
615950	SPEG COMPLEX LOCUS; SPEG
615951	ZINC FINGER SWIM DOMAIN-CONTAINING PROTEIN 6; ZSWIM6
615952	AUTOIMMUNE DISEASE, MULTISYSTEM, INFANTILE-ONSET, 1; ADMIO1
615953	KALLIKREIN, DECREASED URINARY ACTIVITY OF
615954	ACTH-INDEPENDENT MACRONODULAR ADRENAL HYPERPLASIA 2; AIMAH2
615955	COILED-COIL DOMAIN-CONTAINING PROTEIN 183; CCDC183
615956	OUTER DYNEIN ARM DOCKING COMPLEX SUBUNIT 3; ODAD3
615957	SPINOCEREBELLAR ATAXIA 38; SCA38
615958	SLX4-INTERACTING PROTEIN; SLX4IP
615959	MYOPATHY, CENTRONUCLEAR, 5; CNM5
615960	PORETTI-BOLTSHAUSER SYNDROME; PTBHS
615961	ACID-LABILE SUBUNIT DEFICIENCY; ACLSD
615962	GLUCOCORTICOID RESISTANCE, GENERALIZED; GCCR
615963	VESICOURETERAL REFLUX 8; VUR8
615964	MIR99A-LET7C CLUSTER HOST GENE, NONCODING; MIR99AHG
615965	MIR100-LET7A2 CLUSTER HOST GENE, NONCODING; MIR100HG
615966	IMMUNODEFICIENCY 26 WITH OR WITHOUT NEUROLOGIC ABNORMALITIES; IMD26
615967	CYTOCHROME P450, FAMILY 2, SUBFAMILY W, POLYPEPTIDE 1; CYP2W1
615968	MYCN UPSTREAM TRANSCRIPT, NONCODING; MYCNUT
615969	ALPHA-FETOPROTEIN DEFICIENCY; AFPD
615970	ALPHA-FETOPROTEIN, HEREDITARY PERSISTENCE OF; HPAFP
615971	REMOVED FROM DATABASE
615972	NANOPHTHALMOS 4; NNO4
615973	CONE-ROD DYSTROPHY 20; CORD20
615974	DEAFNESS, AUTOSOMAL RECESSIVE 102; DFNB102
615975	TRANSMEMBRANE PROTEIN 129; TMEM129
615976	FOXC1 UPSTREAM TRANSCRIPT, NONCODING; FOXCUT
615977	MICRO RNA 339; MIR339
615978	IMMUNODEFICIENCY 27B; IMD27B
615979	INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 45; MRT45
615980	LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 6; FPLD6
615981	BARDET-BIEDL SYNDROME 2; BBS2
615982	BARDET-BIEDL SYNDROME 4; BBS4
615983	BARDET-BIEDL SYNDROME 5; BBS5
615984	BARDET-BIEDL SYNDROME 7; BBS7
615985	BARDET-BIEDL SYNDROME 8; BBS8
615986	BARDET-BIEDL SYNDROME 9; BBS9
615987	BARDET-BIEDL SYNDROME 10; BBS10
615988	BARDET-BIEDL SYNDROME 11; BBS11
615989	BARDET-BIEDL SYNDROME 12; BBS12
615990	BARDET-BIEDL SYNDROME 13; BBS13
615991	BARDET-BIEDL SYNDROME 14; BBS14
615992	BARDET-BIEDL SYNDROME 15; BBS15
615993	BARDET-BIEDL SYNDROME 16; BBS16
615994	BARDET-BIEDL SYNDROME 17; BBS17
615995	BARDET-BIEDL SYNDROME 18; BBS18
615996	BARDET-BIEDL SYNDROME 19; BBS19
615997	DEFENSIN, BETA, 119; DEFB119
615998	RING FINGER PROTEIN 10; RNF10
615999	HYPERTHYROXINEMIA, FAMILIAL DYSALBUMINEMIC; FDAH
616000	ANALBUMINEMIA; ANALBA
616001	BREASTS AND/OR NIPPLES, APLASIA OR HYPOPLASIA OF, 2; BNAH2
616002	FOCAL SEGMENTAL GLOMERULOSCLEROSIS 7; FSGS7
616003	APOPTOGENIC PROTEIN 1, MITOCHONDRIAL; APOPT1
616004	DYSFIBRINOGENEMIA, CONGENITAL
616005	IMMUNODEFICIENCY 36 WITH LYMPHOPROLIFERATION; IMD36
616006	HENNEKAM LYMPHANGIECTASIA-LYMPHEDEMA SYNDROME 2; HKLLS2
616007	CATARACTS, GROWTH HORMONE DEFICIENCY, SENSORY NEUROPATHY, SENSORINEURAL HEARING LOSS, AND SKELETAL DYSPLASIA; CAGSSS
616008	COP9 SIGNALOSOME, SUBUNIT 4; COPS4
616009	COP9 SIGNALOSOME, SUBUNIT 7A; COPS7A
616010	COP9 SIGNALOSOME, SUBUNIT 7B; COPS7B
616011	COP9 SIGNALOSOME, SUBUNIT 8; COPS8
616012	JAGUNAL HOMOLOG 1; JAGN1
616013	tRNA METHYLTRANSFERASE 10A; TRMT10A
616014	RING FINGER PROTEIN 25; RNF25
616015	RING FINGER PROTEIN 180; RNF180
616016	PROTEIN PHOSPHATASE, MAGNESIUM/MANGANESE-DEPENDENT, 1H; PPM1H
616017	TRIPARTITE MOTIF-CONTAINING PROTEIN 69; TRIM69
616018	REMOVED FROM DATABASE
616019	REST COREPRESSOR 2; RCOR2
616020	CYSTEINE/TYROSINE-RICH PROTEIN 1; CYYR1
616021	CYYR1 ANTISENSE RNA 1; CYYR1AS1
616022	NEUTROPENIA, SEVERE CONGENITAL, 6, AUTOSOMAL RECESSIVE; SCN6
616023	SR-RELATED C-TERMINAL DOMAIN-ASSOCIATED FACTOR 4; SCAF4
616024	SR-RELATED C-TERMINAL DOMAIN-ASSOCIATED FACTOR 8; SCAF8
616025	GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 11; GPIBD11
616026	FANCONI RENOTUBULAR SYNDROME 4 WITH MATURITY-ONSET DIABETES OF THE YOUNG; FRTS4
616027	ACTIN-BINDING PROTEIN ANILLIN; ANLN
616028	ADAMS-OLIVER SYNDROME 5; AOS5
616029	ECTODERMAL DYSPLASIA/SHORT STATURE SYNDROME; ECTDS
616030	HYPOGONADOTROPIC HYPOGONADISM 22 WITH OR WITHOUT ANOSMIA; HH22
616031	COILED-COIL DOMAIN-CONTAINING PROTEIN 141; CCDC141
616032	FOCAL SEGMENTAL GLOMERULOSCLEROSIS 8; FSGS8
616033	MICROCEPHALY, SHORT STATURE, AND IMPAIRED GLUCOSE METABOLISM 1; MSSGM1
616034	2,4-DIENOYL-CoA REDUCTASE DEFICIENCY; DECRD
616035	FORKHEAD BOX J3; FOXJ3
616036	MICRO RNA 494; MIR494
616037	CILIARY DYSKINESIA, PRIMARY, 30; CILD30
616038	NEU-LAXOVA SYNDROME 2; NLS2
616039	CHARCOT-MARIE-TOOTH DISEASE, RECESSIVE INTERMEDIATE D; CMTRID
616040	MYASTHENIC SYNDROME, CONGENITAL, 7A, PRESYNAPTIC, AND DISTAL MOTOR NEUROPATHY, AUTOSOMAL DOMINANT; CMS7A
616041	THIOSULFATE SULFURTRANSFERASE (RHODANESE)-LIKE DOMAIN-CONTAINING PROTEIN 1; TSTD1
616042	DEAFNESS, AUTOSOMAL RECESSIVE 103; DFNB103
616043	PROSTATE CANCER-ASSOCIATED TRANSCRIPT 1, NONCODING; PCAT1
616044	DEAFNESS, AUTOSOMAL DOMINANT 65; DFNA65
616045	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 22; COXPD22
616046	PROLINE/SERINE/THREONINE PHOSPHATASE-INTERACTING PROTEIN 2; PSTPIP2
616047	CILIA- AND FLAGELLA-ASSOCIATED PROTEIN 97; CFAP97
616048	ALU-MEDIATED CDKN1A/p21 TRANSCRIPTIONAL REGULATOR, NONCODING; APTR
616049	TRANSLOCASE OF OUTER MITOCHONDRIAL MEMBRANE 34; TOMM34
616050	AUTOINFLAMMATION WITH INFANTILE ENTEROCOLITIS; AIFEC
616051	MICROCEPHALY 13, PRIMARY, AUTOSOMAL RECESSIVE; MCPH13
616052	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 7; MDDGC7
616053	SPINOCEREBELLAR ATAXIA 40; SCA40
616054	ELONGATOR ACETYLTRANSFERASE COMPLEX, SUBUNIT 2; ELP2
616055	EPISODIC ATAXIA, TYPE 8; EA8
616056	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 26; DEE26
616057	TUMOR SUPPRESSOR CANDIDATE 7, NONCODING; TUSC7
616058	TCF21 ANTISENSE RNA INDUCING PROMOTER DEMETHYLATION; TARID
616059	MIRROR MOVEMENTS 3; MRMV3
616060	BLOOD GROUP, DOMBROCK SYSTEM; DO
616061	MAX DIMERIZATION PROTEIN MGA; MGA
616062	ANKYRIN REPEAT- AND LEM DOMAIN-CONTAINING PROTEIN 2; ANKLE2
616063	POROKERATOSIS 8, DISSEMINATED SUPERFICIAL ACTINIC TYPE; POROK8
616064	TUBULOINTERSTITIAL NEPHRITIS ANTIGEN-LIKE PROTEIN 1; TINAGL1
616065	PILR-ALPHA-ASSOCIATED NEURAL PROTEIN; PIANP
616066	SPERMATOGENESIS- AND OOGENESIS-SPECIFIC BASIC HELIX-LOOP-HELIX PROTEIN 2; SOHLH2
616067	46,XY SEX REVERSAL 9; SRXY9
616068	HOXA CLUSTER ANTISENSE RNA 2, NONCODING; HOXAAS2
616069	INFLAMMATORY SKIN AND BOWEL DISEASE, NEONATAL, 2; NISBD2
616070	COILED-COIL DOMAIN-CONTAINING PROTEIN 113; CCDC113
616071	SPERM MICROTUBULE INNER PROTEIN 4; SPMIP4
616072	HETEROCHROMATIN PROTEIN 1-BINDING PROTEIN 3; HP1BP3
616073	DEP DOMAIN-CONTAINING PROTEIN 1B; DEPDC1B
616074	CHEMOKINE-LIKE FACTOR; CKLF
616075	DEFENSIN, BETA, 121; DEFB121
616076	DEFENSIN, BETA, 123; DEFB123
616077	DEFENSIN, BETA, 122, PSEUDOGENE; DEFB122
616078	INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 29; MRD29
616079	RETINAL DYSTROPHY WITH INNER RETINAL DYSFUNCTION AND GANGLION CELL ABNORMALITIES; RDGCA
616080	MICROCEPHALY 12, PRIMARY, AUTOSOMAL RECESSIVE; MCPH12
616081	PONTOCEREBELLAR HYPOPLASIA, TYPE 1C; PCH1C
616082	CHROMOSOME 12 OPEN READING FRAME 4; C12ORF4
616083	INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 30, WITH SPEECH DELAY AND BEHAVIORAL ABNORMALITIES; MRD30
616084	SIDEROBLASTIC ANEMIA WITH B-CELL IMMUNODEFICIENCY, PERIODIC FEVERS, AND DEVELOPMENTAL DELAY; SIFD
616085	ZINC FINGER PROTEIN 37A; ZNF37A
616086	SprT-LIKE N-TERMINAL DOMAIN PROTEIN; SPRTN
616087	TYPE 2 DIABETES 5; T2D5
616088	REGULATOR OF HEMOGLOBINIZATION AND ERYTHROID CELL EXPANSION; RHEX
616089	BLOOD GROUP, GERBICH SYSTEM; GE
616090	MICRO RNA 802; MIR802
616091	METHYLTRANSFERASE-LIKE 17; METTL17
616092	FOCALLY AMPLIFIED LONG NONCODING RNA IN EPITHELIAL CANCER; FALEC
616093	BLOOD GROUP, ABO SYSTEM
616094	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 12; MDDGC12
616095	MONOCARBOXYLATE TRANSPORTER 1 DEFICIENCY; MCT1D
616096	MYOSIN HEAVY CHAIN-ASSOCIATED RNA TRANSCRIPT, NONCODING; MHRT
616097	UBIQUINOL-CYTOCHROME C REDUCTASE COMPLEX ASSEMBLY FACTOR 3; UQCC3
616098	IMMUNODEFICIENCY 37; IMD37
616099	PALMOPLANTAR KERATODERMA AND WOOLLY HAIR; PPKWH
616100	IMMUNE DYSREGULATION WITH AUTOIMMUNITY, IMMUNODEFICIENCY, AND LYMPHOPROLIFERATION; IDAIL
616101	TRANSMEMBRANE PROTEIN 240; TMEM240
616102	THIOREDOXIN-RELATED TRANSMEMBRANE PROTEIN 3; TMX3
616103	LEUCINE-RICH REPEAT, IMMUNOGLOBULIN-LIKE, AND TRANSMEMBRANE DOMAINS-CONTAINING PROTEIN 1; LRIT1
616104	RBPJ-LIKE PROTEIN; RBPJL
616105	SORTING NEXIN 14; SNX14
616106	PSORIASIS 15, PUSTULAR, SUSCEPTIBILITY TO; PSORS15
616107	FATTY ACYL CoA REDUCTASE 1; FAR1
616108	RETINAL DYSTROPHY, JUVENILE CATARACTS, AND SHORT STATURE SYNDROME; RDJCSS
616109	TOP6B-LIKE INITIATOR OF MEIOTIC DOUBLE STRAND BREAKS; TOP6BL
616110	DELTEX E3 UBIQUITIN LIGASE 4; DTX4
616111	MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 9; MC3DN9
616112	LEIOMODIN 3; LMOD3
616113	POLYENDOCRINE-POLYNEUROPATHY SYNDROME; PEPNS
616114	CHROMODOMAIN HELICASE DNA-BINDING PROTEIN 6; CHD6
616115	FAMILIAL COLD AUTOINFLAMMATORY SYNDROME 4; FCAS4
616116	INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 46; MRT46
616117	CARDIAC CONDUCTION DISEASE WITH OR WITHOUT DILATED CARDIOMYOPATHY; CCDD
616118	MACULAR DEGENERATION, EARLY-ONSET; EOMD
616119	CILIA- AND FLAGELLA-ASSOCIATED PROTEIN 126; CFAP126
616120	CWF19-LIKE CELL CYCLE CONTROL FACTOR 1; CWF19L1
616121	GTPase, VERY LARGE INTERFERON-INDUCIBLE, PSEUDOGENE 1; GVINP1
616122	FAMILY WITH SEQUENCE SIMILARITY 86, MEMBER B1; FAM86B1
616123	FAMILY WITH SEQUENCE SIMILARITY 86, MEMBER B2; FAM86B2
616124	FAMILY WITH SEQUENCE SIMILARITY 86, MEMBER C1, PSEUDOGENE; FAM86C1P
616125	PROTEIN ARGININE METHYLTRANSFERASE 9; PRMT9
616126	IMMUNODEFICIENCY 38 WITH BASAL GANGLIA CALCIFICATION; IMD38
616127	SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 17; SCAR17
616128	FAMILY WITH SEQUENCE SIMILARITY 89, MEMBER B; FAM89B
616129	LEUCINE-RICH ADAPTOR PROTEIN 1; LURAP1
616130	LEUCINE-RICH ADAPTOR PROTEIN 1-LIKE; LURAP1L
616131	GASTRIC CANCER-ASSOCIATED TRANSCRIPT 2, NONCODING; GACAT2
616132	GASTRIC CANCER-ASSOCIATED TRANSCRIPT 3, NONCODING; GACAT3
616133	MPV17 MITOCHONDRIAL INNER MEMBRANE PROTEIN-LIKE 2; MPV17L2
616134	H3 HISTONE, FAMILY 3C; H3F3C
616135	INTERFERON-INDUCED PROTEIN WITH TETRATRICOPEPTIDE REPEATS 5; IFIT5
616136	RING FINGER PROTEIN 220; RNF220
616137	MICRO RNA 873; MIR873
616138	PERRAULT SYNDROME 5; PRLTS5
616139	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 27; DEE27
616140	LEUKODYSTROPHY, HYPOMYELINATING, 9; HLD9
616141	MACRO H2A.2 HISTONE; MACROH2A2
616142	FAMILY WITH SEQUENCE SIMILARITY 98, MEMBER B; FAM98B
616143	LYSOPHOSPHOLIPASE II; LYPLA2
616144	WD REPEAT-CONTAINING PROTEIN 73; WDR73
616145	CATEL-MANZKE SYNDROME; CATMANS
616146	TDP-GLUCOSE 4,6-DEHYDRATASE; TGDS
616147	CYCLIN-DEPENDENT KINASE 15; CDK15
616148	TRIPARTITE MOTIF-CONTAINING PROTEIN 59; TRIM59
616149	SOLUTE CARRIER FAMILY 25 (MITOCHONDRIAL CARRIER, PYRIMIDINE NUCLEOTIDE TRANSPORTER), MEMBER 36; SLC25A36
616150	SOLUTE CARRIER FAMILY 25, MEMBER 48; SLC25A48
616151	MACULAR DYSTROPHY, VITELLIFORM, 4; VMD4
616152	MACULAR DYSTROPHY, VITELLIFORM, 5; VMD5
616153	SOLUTE CARRIER FAMILY 25, MEMBER 52; SLC25A52
616154	PEROXISOMAL FATTY ACYL-CoA REDUCTASE 1 DISORDER; PFCRD
616155	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2S; CMT2S
616156	FATTY ACYL CoA REDUCTASE 2; FAR2
616157	SHORT-CHAIN DEHYDROGENASE/REDUCTASE FAMILY, MEMBER 13; DHRS13
616158	NEURODEVELOPMENTAL DISORDER WITH NEONATAL RESPIRATORY INSUFFICIENCY, HYPOTONIA, AND FEEDING DIFFICULTIES; NEDRIHF
616159	SHORT-CHAIN DEHYDROGENASE/REDUCTASE FAMILY, MEMBER 11; DHRS11
616160	SHORT-CHAIN DEHYDROGENASE/REDUCTASE FAMILY, MEMBER 7B; DHRS7B
616161	SHORT-CHAIN DEHYDROGENASE/REDUCTASE FAMILY, MEMBER 7C; DHRS7C
616162	SHORT-CHAIN DEHYDROGENASE/REDUCTASE FAMILY 39U, MEMBER 1; SDR39U1
616163	SHORT-CHAIN DEHYDROGENASE/REDUCTASE FAMILY, MEMBER 12; DHRS12
616164	SHORT-CHAIN DEHYDROGENASE/REDUCTASE FAMILY 42E, MEMBER 1; SDR42E1
616165	NEMALINE MYOPATHY 10; NEM10
616166	AORTIC ANEURYSM, FAMILIAL THORACIC 9; AAT9
616167	DCN1 DOMAIN-CONTAINING PROTEIN 3; DCUN1D3
616168	TRANSLOCASE OF OUTER MITOCHONDRIAL MEMBRANE 6; TOMM6
616169	TRANSLOCASE OF OUTER MITOCHONDRIAL MEMBRANE 5; TOMM5
616170	MACULAR DYSTROPHY WITH CENTRAL CONE INVOLVEMENT; CCMD
616171	MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 2; MCCRP2
616172	GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 9; GEFSP9
616173	NUCLEAR SPECKLE SPLICING REGULATORY PROTEIN 1; NSRP1
616174	CYTOSKELETON-ASSOCIATED PROTEIN 2-LIKE; CKAP2L
616175	UBIQUITIN-CONJUGATING ENZYME E2 J1; UBE2J1
616176	BLEEDING DISORDER, PLATELET-TYPE, 19; BDPLT19
616177	DDRGK DOMAIN-CONTAINING PROTEIN 1; DDRGK1
616178	TRANSMEMBRANE PROTEIN 132E; TMEM132E
616179	THIOREDOXIN DOMAIN-CONTAINING PROTEIN 16; TXNDC16
616180	GOLGIN A8 FAMILY, MEMBER A; GOLGA8A
616181	ZINC FINGER PROTEIN 713; ZNF713
616182	CHRONIC MOUNTAIN SICKNESS, SUSCEPTIBILITY TO
616183	TRANSMEMBRANE PROTEIN 107; TMEM107
616184	CLUSTERED MITOCHONDRIA, D. DISCOIDEUM, HOMOLOG OF; CLUH
616185	OVARIAN DYSGENESIS 4; ODG4
616186	H19/IGF2-IMPRINTING CONTROL REGION
616187	EPILEPSY, PROGRESSIVE MYOCLONIC 7; EPM7
616188	RETINAL DYSTROPHY AND OBESITY; RDOB
616189	CAP METHYLTRANSFERASE 1; CMTR1
616190	CAP METHYLTRANSFERASE 2; CMTR2
616191	DISCS LARGE-ASSOCIATED PROTEIN 4; DLGAP4
616192	ATAXIA, COMBINED CEREBELLAR AND PERIPHERAL, WITH HEARING LOSS AND DIABETES MELLITUS; ACPHD
616193	INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 47; MRT47
616194	UTP15 SMALL SUBUNIT PROCESSOME COMPONENT; UTP15
616195	WD REPEAT-CONTAINING PROTEIN 43; WDR43
616196	DDB1- AND CUL4-ASSOCIATED FACTOR 13; DCAF13
616197	NUCLEOLAR PROTEIN 10; NOL10
616198	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 23; COXPD23
616199	POLYGLUCOSAN BODY MYOPATHY 2; PGBM2
616200	RUIJS-AALFS SYNDROME; RJALS
616201	CHRONIC ATRIAL AND INTESTINAL DYSRHYTHMIA; CAID
616202	CEREBELLOFACIODENTAL SYNDROME; CFDS
616203	SOLUTE CARRIER FAMILY 38, MEMBER 9; SLC38A9
616204	SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 18; SCAR18
616205	MICRO RNA 648; MIR648
616206	NEUROBLASTOMA-ASSOCIATED TRANSCRIPT 1, NONCODING; NBAT1
616207	NEGATIVE REGULATOR OF ANTIVIRAL RESPONSE, NONCODING; NRAV
616208	AMYOTROPHIC LATERAL SCLEROSIS 22 WITH OR WITHOUT FRONTOTEMPORAL DEMENTIA; ALS22
616209	MYOPATHY, ISOLATED MITOCHONDRIAL, AUTOSOMAL DOMINANT; IMMD
616210	CHROMOSOME 4 OPEN READING FRAME 46; C4ORF46
616211	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 28; DEE28
616212	LISSENCEPHALY 6 WITH MICROCEPHALY; LIS6
616213	ZINC FINGER PROTEIN 292; ZNF292
616214	HYPERPROINSULINEMIA
616215	cAMP RESPONSE ELEMENT-BINDING PROTEIN 3-LIKE 1; CREB3L1
616216	THROMBOCYTOPENIA 5; THC5
616217	NEPHRONOPHTHISIS 19; NPHP19
616218	TBC1 DOMAIN FAMILY, MEMBER 13; TBC1D13
616219	FIBROSIS OF EXTRAOCULAR MUSCLES, CONGENITAL, 5; CFEOM5
616220	FOCAL SEGMENTAL GLOMERULOSCLEROSIS 9; FSGS9
616221	AMELOGENESIS IMPERFECTA, TYPE IH; AI1H
616222	TEMPLE SYNDROME
616223	ANGIOPOIETIN-LIKE 8; ANGPTL8
616224	MYASTHENIC SYNDROME, CONGENITAL, 22; CMS22
616225	AUTOPHAGY-RELATED 2A; ATG2A
616226	AUTOPHAGY-RELATED 2B; ATG2B
616227	MYASTHENIC SYNDROME, CONGENITAL, 15; CMS15
616228	MYASTHENIC SYNDROME, CONGENITAL, 14; CMS14
616229	OSTEOGENESIS IMPERFECTA, TYPE XVI; OI16
616230	EPILEPSY, PROGRESSIVE MYOCLONIC, 8; EPM8
616231	MYOPATHY, VACUOLAR, WITH CASQ1 AGGREGATES; VMCQA
616232	MEIOTIC KINETOCHORE FACTOR; MEIKIN
616233	MOVED TO 614881
616234	WD REPEAT- AND COILED-COIL-CONTAINING PROTEIN; WDCP
616235	KATANIN, p80 SUBUNIT, B-LIKE 1; KATNBL1
616236	CHONDROADHERIN-LIKE; CHADL
616237	KINASE NONCATALYTIC C-LOBE DOMAIN-CONTAINING PROTEIN 1; KNDC1
616238	ZINC FINGER- AND BTB DOMAIN-CONTAINING PROTEIN 49; ZBTB49
616239	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 24; COXPD24
616240	OLIGODENDROCYTE MATURATION-ASSOCIATED LONG INTERGENIC NONCODING RNA; OLMALINC
616241	METEORIN-LIKE PROTEIN; METRNL
616242	TRANSMEMBRANE AND COILED-COIL DOMAIN FAMILY, MEMBER 1; TMCC1
616243	TRANSMEMBRANE PROTEIN 131-LIKE; TMEM131L
616244	COILED-COIL-HELIX-COILED-COIL-HELIX DOMAIN-CONTAINING PROTEIN 2; CHCHD2
616245	ENDOPLASMIC RETICULUM MEMBRANE PROTEIN COMPLEX, SUBUNIT 4; EMC4
616246	MYOREGULIN; MRLN
616247	LONG QT SYNDROME 14; LQT14
616248	LETHAL CONGENITAL CONTRACTURE SYNDROME 6; LCCS6
616249	LONG QT SYNDROME 15; LQT15
616250	NACHT DOMAIN- AND WD REPEAT-CONTAINING PROTEIN 1; NWD1
616251	TRPM8 CHANNEL-ASSOCIATED FACTOR 1; TCAF1
616252	TRPM8 CHANNEL-ASSOCIATED FACTOR 2; TCAF2
616253	GS HOMEOBOX 2; GSX2
616254	CASEINOLYTIC PEPTIDASE B; CLPB
616255	SHORT STATURE WITH NONSPECIFIC SKELETAL ABNORMALITIES; SNSK
616256	C-TYPE LECTIN DOMAIN FAMILY 4, MEMBER G; CLEC4G
616257	FK506-BINDING PROTEIN 9; FKBP9
616258	MECKEL SYNDROME 12; MKS12
616259	SMALL NUCLEOLAR RNA HOST GENE 14; SNHG14
616260	TENORIO SYNDROME; TNORS
616261	PSEUDOURIDYLATE SYNTHASE 7, PUTATIVE; PUS7
616262	KELCH-LIKE 21; KLHL21
616263	NEUROLOGIC, ENDOCRINE, AND PANCREATIC DISEASE, MULTISYSTEM, INFANTILE-ONSET 1; IMNEPD1
616264	MAF TRANSCRIPTIONAL REGULATOR RNA, NONCODING; MAFTRR
616265	PEELING SKIN SYNDROME 3; PSS3
616266	CONGENITAL CONTRACTURES OF THE LIMBS AND FACE, HYPOTONIA, AND DEVELOPMENTAL DELAY; CLIFAHDD
616267	ATAXIA-OCULOMOTOR APRAXIA 4; AOA4
616268	ARBOLEDA-THAM SYNDROME; ARTHS
616269	INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 48; MRT48
616270	AMELOGENESIS IMPERFECTA, TYPE IF; AI1F
616271	3-METHYLGLUTACONIC ACIDURIA, TYPE VIIB; MGCA7B
616272	MICRO RNA 520G; MIR520G
616273	PROSTATE CANCER-ASSOCIATED TRANSCRIPT 29, NONCODING; PCAT29
616274	MICRO RNA 4276; MIR4276
616275	FAMILY WITH SEQUENCE SIMILARITY 136, MEMBER A; FAM136A
616276	COENZYME Q10 DEFICIENCY, PRIMARY, 7; COQ10D7
616277	MITOCHONDRIAL SHORT-CHAIN ENOYL-CoA HYDRATASE 1 DEFICIENCY; ECHS1D
616278	BILE ACID SYNTHESIS DEFECT, CONGENITAL, 5; CBAS5
616279	CATARACT 43; CTRCT43
616280	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2U; CMT2U
616281	NEURODEVELOPMENTAL DISORDER WITH SPASTIC PARAPLEGIA AND MICROCEPHALY; NEDSPM
616282	SPASTIC PARAPLEGIA 73, AUTOSOMAL DOMINANT; SPG73
616283	PSEUDOURIDYLATE SYNTHASE 3; PUS3
616284	FILAGGRIN FAMILY MEMBER 2; FLG2
616285	FORMIN-LIKE 2; FMNL2
616286	LETHAL CONGENITAL CONTRACTURE SYNDROME 7; LCCS7
616287	LETHAL CONGENITAL CONTRACTURE SYNDROME 8; LCCS8
616288	FORMIN-LIKE 3; FMNL3
616289	OPTIC ATROPHY 9; OPA9
616290	ZINC FINGER PROTEIN 658; ZNF658
616291	LICHTENSTEIN-KNORR SYNDROME; LIKNS
616292	STABILIZER OF AXONEMAL MICROTUBULES 1; SAXO1
616293	HORNERIN; HRNR
616294	COLE-CARPENTER SYNDROME 2; CLCRP2
616295	PEELING SKIN WITH LEUKONYCHIA, ACRAL PUNCTATE KERATOSES, CHEILITIS, AND KNUCKLE PADS; PLACK
616296	MULTIPLE C2 DOMAINS-CONTAINING TRANSMEMBRANE PROTEIN 1; MCTP1
616297	MULTIPLE C2 DOMAINS-CONTAINING TRANSMEMBRANE PROTEIN 2; MCTP2
616298	SINGLETON-MERTEN SYNDROME 2; SGMRT2
616299	LIPOYLTRANSFERASE 1 DEFICIENCY; LIPT1D
616300	SHORT-RIB THORACIC DYSPLASIA 13 WITH OR WITHOUT POLYDACTYLY; SRTD13
616301	CD300 ANTIGEN-LIKE FAMILY, MEMBER D; CD300LD
616302	FORKHEAD BOX K1; FOXK1
616303	WD REPEAT-CONTAINING PROTEIN 91; WDR91
616304	MYASTHENIC SYNDROME, CONGENITAL, 17; CMS17
616305	FERM DOMAIN-CONTAINING PROTEIN 4A; FRMD4A
616306	FIBRINOGEN SILENCER-BINDING PROTEIN; FSBP
616307	SENIOR-LOKEN SYNDROME 8; SLSN8
616308	BETA-GLOBIN LOCUS TRANSCRIPT 3, NONCODING; BGLT3
616309	FERM DOMAIN-CONTAINING PROTEIN 5; FRMD5
616310	RHO GTPase-ACTIVATING PROTEIN 11B; ARHGAP11B
616311	INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 33; MRD33
616312	LEM DOMAIN-CONTAINING PROTEIN 2; LEMD2
616313	MYASTHENIC SYNDROME, CONGENITAL, 2A, SLOW-CHANNEL; CMS2A
616314	MYASTHENIC SYNDROME, CONGENITAL, 2C, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY; CMS2C
616315	PAXX NONHOMOLOGOUS END JOINING FACTOR; PAXX
616316	FAMILY WITH SEQUENCE SIMILARITY 168, MEMBER A; FAM168A
616317	GLYCEROPHOSPHODIESTER PHOSPHODIESTERASE DOMAIN-CONTAINING PROTEIN 1; GDPD1
616318	GLYCEROPHOSPHODIESTER PHOSPHODIESTERASE DOMAIN-CONTAINING PROTEIN 3; GDPD3
616319	RING FINGER PROTEIN 138; RNF138
616320	FUMARYLACETOACETATE HYDROLASE DOMAIN-CONTAINING PROTEIN 1; FAHD1
616321	MYASTHENIC SYNDROME, CONGENITAL, 3A, SLOW-CHANNEL; CMS3A
616322	MYASTHENIC SYNDROME, CONGENITAL, 3B, FAST-CHANNEL; CMS3B
616323	MYASTHENIC SYNDROME, CONGENITAL, 3C, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY; CMS3C
616324	MYASTHENIC SYNDROME, CONGENITAL, 4B, FAST-CHANNEL; CMS4B
616325	MYASTHENIC SYNDROME, CONGENITAL, 9, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY; CMS9
616326	MYASTHENIC SYNDROME, CONGENITAL, 11, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY; CMS11
616327	CHROMOSOME ALIGNMENT-MAINTAINING PHOSPHOPROTEIN 1; CHAMP1
616328	LONG INTERGENIC NONCODING RNA PINKY
616329	MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 13; MODY13
616330	MYASTHENIC SYNDROME, CONGENITAL, 18; CMS18
616331	ROBINOW SYNDROME, AUTOSOMAL DOMINANT 2; DRS2
616332	ACIDIC RESIDUE METHYLTRANSFERASE 1; ARMT1
616333	WNT SIGNALING PATHWAY ACTIVATING NONCODING RNA; WSPAR
616334	TRANSMEMBRANE PROTEIN 100; TMEM100
616335	MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 3; MCCRP3
616336	ALDO-KETO REDUCTASE FAMILY 1, MEMBER B15; AKR1B15
616337	SUPPRESSOR OF CYTOKINE SIGNALING 4; SOCS4
616338	SOX2 OVERLAPPING TRANSCRIPT, NONCODING; SOX2OT
616339	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 29; DEE29
616340	DEAFNESS, AUTOSOMAL DOMINANT 67; DFNA67
616341	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 30; DEE30
616342	LISSENCEPHALY 7 WITH CEREBELLAR HYPOPLASIA; LIS7
616343	TUMOR PROTEIN p53 PATHWAY COREPRESSOR 1, NONCODING; TP53COR1
616344	TETRATRICOPEPTIDE REPEAT DOMAIN-CONTAINING PROTEIN 23-LIKE; TTC23L
616345	IMMUNODEFICIENCY 39; IMD39
616346	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 31A; DEE31A
616347	PR DOMAIN-CONTAINING PROTEIN 11; PRDM11
616348	ZINC FINGER PROTEIN 695; ZNF695
616349	SORBIN AND SH3 DOMAINS-CONTAINING PROTEIN 2; SORBS2
616350	PROMOTER OF MAT2A ANTISENSE RADIATION-INDUCED CIRCULATING LONG NONCODING RNA; PARTICL
616351	INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 34; MRD34
616352	ACYL-CoA-BINDING DOMAIN-CONTAINING PROTEIN 6; ACBD6
616353	DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 6; DKCB6
616354	SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 20; SCAR20
616355	HOUGE-JANSSENS SYNDROME 1; HJS1
616356	MICRO RNA 31 HOST GENE, NONCODING; MIR31HG
616357	DEAFNESS, AUTOSOMAL DOMINANT 40; DFNA40
616358	MICRO RNA 379; MIR379
616359	COENZYME Q5, METHYLTRANSFERASE; COQ5
616360	TRANSMEMBRANE PROTEIN 135; TMEM135
616361	PARKINSON DISEASE 21; PARK21
616362	HOUGE-JANSSENS SYNDROME 2; HJS2
616363	SMALL PROLINE-RICH PROTEIN 4; SPRR4
616364	WHITE-SUTTON SYNDROME; WHSUS
616365	SCY1-LIKE PROTEIN 2; SCYL2
616366	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 32; DEE32
616367	MANDIBULOFACIAL DYSOSTOSIS WITH ALOPECIA; MFDA
616368	CHOPS SYNDROME; CHOPS
616369	MOVED TO 243605
616370	MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 4; MMDS4
616371	PULMONARY FIBROSIS AND/OR BONE MARROW FAILURE SYNDROME, TELOMERE-RELATED, 4; PFBMFT4
616372	DDB1- AND CUL4-ASSOCIATED FACTOR 4; DCAF4
616373	PULMONARY FIBROSIS AND/OR BONE MARROW FAILURE SYNDROME, TELOMERE-RELATED, 3; PFBMFT3
616374	BEN DOMAIN-CONTAINING PROTEIN 3; BEND3
616375	UNKEMPT FAMILY ZINC FINGER PROTEIN; UNK
616376	MICRO RNA 656; MIR656
616377	PROLINE DEHYDROGENASE (OXIDASE) 2; PRODH2
616378	UBX DOMAIN PROTEIN 1; UBXN1
616379	UBX DOMAIN PROTEIN 7; UBXN7
616380	LAMININ, BETA-4; LAMB4
616381	ZINC FINGER CCHC DOMAIN-CONTAINING PROTEIN 8; ZCCHC8
616382	UDP GLUCURONOSYLTRANSFERASE FAMILY 2, MEMBER A3; UGT2A3
616383	URIDINE DIPHOSPHATE GLUCURONOSYLTRANSFERASE 3 FAMILY, MEMBER A1; UGT3A1
616384	URIDINE DIPHOSPHATE GLUCURONOSYLTRANSFERASE 3 FAMILY, MEMBER A2; UGT3A2
616385	LONG INTERGENIC NONCODING RNA 1018; LINC01018
616386	POTASSIUM CHANNEL TETRAMERIZATION DOMAIN-CONTAINING PROTEIN 17; KCTD17
616387	DOWNREGULATED RNA IN ANDROGEN-INDEPENDENT CELLS, NONCODING; DRAIC
616388	UBIQUITIN DOMAIN-CONTAINING PROTEIN 1; UBTD1
616389	NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1G; CSNB1G
616390	TRICHOTHIODYSTROPHY 2, PHOTOSENSITIVE; TTD2
616391	RAN-BINDING PROTEIN 3-LIKE; RANBP3L
616392	SKINT1-LIKE PSEUDOGENE; SKINTL
616393	INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 38; MRD38
616394	RETINITIS PIGMENTOSA 71; RP71
616395	TRICHOTHIODYSTROPHY 3, PHOTOSENSITIVE; TTD3
616396	SCM POLYCOMB GROUP PROTEIN HOMOLOG 1; SCMH1
616397	PEROXISOMAL MEMBRANE PROTEIN 4; PXMP4
616398	DYSTONIA 26, MYOCLONIC; DYT26
616399	BRUGADA SYNDROME 9; BRGDA9
616400	PALMOPLANTAR KERATODERMA, NONEPIDERMOLYTIC, FOCAL 2; FNEPPK2
616401	SPINDLE APPARATUS COILED-COIL PROTEIN 1; SPDL1
616402	MICROCEPHALY 14, PRIMARY, AUTOSOMAL RECESSIVE; MCPH14
616403	TP53 TARGET GENE 1; TP53TG1
616404	POLYMERASE I, RNA, SUBUNIT A; POLR1A
616405	ADAPTOR PROTEIN 2-ASSOCIATED KINASE 1; AAK1
616406	PYRROLINE-5-CARBOXYLATE REDUCTASE 2; PYCR2
616407	BROWN SYNDROME; BRWNS
616408	PYRROLINE-5-CARBOXYLATE REDUCTASE-LIKE; PYCRL
616409	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 33; DEE33
616410	SPINOCEREBELLAR ATAXIA 41; SCA41
616411	DYSTONIA 27; DYT27
616412	THIOREDOXIN DOMAIN-CONTAINING PROTEIN 5; TXNDC5
616413	BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 6; IBGC6
616414	AUTOIMMUNE INTERSTITIAL LUNG, JOINT, AND KIDNEY DISEASE; AILJK
616415	FAMILIAL ADENOMATOUS POLYPOSIS 3; FAP3
616416	ADHESION G PROTEIN-COUPLED RECEPTOR L1; ADGRL1
616417	ADHESION G PROTEIN-COUPLED RECEPTOR L3; ADGRL3
616418	HYPOMAGNESEMIA, SEIZURES, AND IMPAIRED INTELLECTUAL DEVELOPMENT 1; HOMGSMR1
616419	ADHESION G PROTEIN-COUPLED RECEPTOR L4; ADGRL4
616420	LEUKODYSTROPHY, HYPOMYELINATING, 10; HLD10
616421	MYOCLONIC-ATONIC EPILEPSY; MAE
616422	TRANSCRIPTION ELONGATION FACTOR, MITOCHONDRIAL; TEFM
616423	DExH-BOX HELICASE 30; DHX30
616424	SET DOMAIN-CONTAINING PROTEIN 6; SETD6
616425	46,XY SEX REVERSAL 10; SRXY10
616426	CENTROSOMAL PROTEIN, 192-KD; CEP192
616427	A-KINASE ANCHOR INHIBITOR 1; AKAIN1
616428	MICROPHTHALMIA/COLOBOMA 10; MCOPCB10
616429	SUSHI DOMAIN-CONTAINING PROTEIN 3; SUSD3
616430	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 25; COXPD25
616431	GLYCEROL-3-PHOSPHATE ACYLTRANSFERASE 2, MITOCHONDRIAL; GPAT2
616432	RHO GUANINE NUCLEOTIDE EXCHANGE FACTOR 18; ARHGEF18
616433	IMMUNODEFICIENCY 40; IMD40
616434	IST1 FACTOR ASSOCIATED WITH ESCRT-III; IST1
616435	FANCONI ANEMIA, COMPLEMENTATION GROUP T; FANCT
616436	EPILEPSY, FAMILIAL TEMPORAL LOBE, 7; ETL7
616437	FRONTOTEMPORAL DEMENTIA AND/OR AMYOTROPHIC LATERAL SCLEROSIS 3; FTDALS3
616438	TUMOR NECROSIS FACTOR-ALPHA-INDUCED PROTEIN 8-LIKE 3; TNFAIP8L3
616439	FRONTOTEMPORAL DEMENTIA AND/OR AMYOTROPHIC LATERAL SCLEROSIS 4; FTDALS4
616440	SOLUTE CARRIER FAMILY 32 (GABA VESICULAR TRANSPORTER), MEMBER 1; SLC32A1
616441	OVO-LIKE 2; OVOL2
616442	OVO-LIKE 3; OVOL3
616443	ZINC FINGER, MYM-TYPE 5; ZMYM5
616444	RNA-BINDING MOTIF PROTEIN 19; RBM19
616445	CANDIDIASIS, FAMILIAL, 9; CANDF9
616446	LYMPHOCYTE EXPANSION MOLECULE; LEXM
616447	VIR-LIKE M6A METHYLTRANSFERASE-ASSOCIATED PROTEIN; VIRMA
616448	RAS-ASSOCIATED PROTEIN RAB12; RAB12
616449	BASEL-VANAGAITE-SMIRIN-YOSEF SYNDROME; BVSYS
616450	EF-HAND DOMAIN FAMILY, MEMBER D2; EFHD2
616451	SPASTIC PARAPLEGIA 74, AUTOSOMAL RECESSIVE; SPG74
616452	B-CELL EXPANSION WITH NFKB AND T-CELL ANERGY; BENTA
616453	ZINC FINGER CCCH DOMAIN-CONTAINING PROTEIN 13; ZC3H13
616454	ZINC FINGER PROTEIN 408; ZNF408
616455	ZIMMERMANN-LABAND SYNDROME 2; ZLS2
616456	INO80 COMPLEX, SUBUNIT B; INO80B
616457	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 50; DEE50
616458	PR DOMAIN-CONTAINING PROTEIN 12; PRDM12
616459	AL-RAQAD SYNDROME; ARS
616460	INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 50; MRT50
616461	EPILEPSY, FAMILIAL TEMPORAL LOBE, 8; ETL8
616462	ACROFACIAL DYSOSTOSIS, CINCINNATI TYPE; AFDCIN
616463	ZINC FINGER PROTEIN 232; ZNF232
616464	ECDYSONELESS CELL CYCLE REGULATOR; ECD
616465	VPS50, EARP/GARPII COMPLEX SUBUNIT; VPS50
616466	UNC5 NETRIN RECEPTOR D; UNC5D
616467	DELETED IN PRIMARY CILIARY DYSKINESIA, MOUSE, HOMOLOG OF; DPCD
616468	EXUDATIVE VITREORETINOPATHY 6; EVR6
616469	RETINITIS PIGMENTOSA 72; RP72
616470	ULLRICH CONGENITAL MUSCULAR DYSTROPHY 2; UCMD2
616471	BETHLEM MYOPATHY 2; BTHLM2
616472	UBIQUITIN-ASSOCIATED PROTEIN 2-LIKE; UBAP2L
616473	MICRO RNA 558; MIR558
616474	ZINC FINGER- AND SCAN DOMAIN-CONTAINING PROTEIN 26; ZSCAN26
616475	CENTROSOMAL PROTEIN, 72-KD; CEP72
616476	ATP/GTP-BINDING PROTEIN-LIKE 4; AGBL4
616477	NUCLEAR RECEPTOR-BINDING FACTOR 2; NRBF2
616478	LEUCINE-RICH REPEATS- AND GUANYLATE KINASE DOMAIN-CONTAINING PROTEIN; LRGUK
616479	PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL RECESSIVE 2; PEOB2
616480	KIAA1328 GENE; KIAA1328
616481	CILIARY DYSKINESIA, PRIMARY, 32; CILD32
616482	ACHONDROPLASIA, SEVERE, WITH DEVELOPMENTAL DELAY AND ACANTHOSIS NIGRICANS; SADDAN
616483	INFANTILE LIVER FAILURE SYNDROME 2; ILFS2
616484	TAX1-BINDING PROTEIN 3; TAX1BP3
616485	ZINC FINGER- AND BTB DOMAIN-CONTAINING PROTEIN 21; ZBTB21
616486	NEURODEVELOPMENTAL DISORDER WITH PROGRESSIVE MICROCEPHALY, SPASTICITY, AND BRAIN IMAGING ABNORMALITIES; NEDMISBA
616487	EPIDERMOLYSIS BULLOSA SIMPLEX 5D, GENERALIZED INTERMEDIATE, AUTOSOMAL RECESSIVE; EBS5D
616488	NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE VIII; HSAN8
616489	SILVER-RUSSELL SYNDROME 3; SRS3
616490	JOUBERT SYNDROME 23; JBTS23
616491	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2V; CMT2V
616492	EWING SARCOMA-ASSOCIATED TRANSCRIPT 1, NONCODING; EWSAT1
616493	TRANSCRIPTION ACTIVATION REPRESSOR; TASOR
616494	LEUKODYSTROPHY, HYPOMYELINATING, 11; HLD11
616495	ADP-RIBOSYLATION FACTOR-LIKE GTPase 6-INTERACTING PROTEIN 6; ARL6IP6
616496	NUCLEAR ENVELOPE INTEGRAL MEMBRANE PROTEIN 1; NEMP1
616497	NUCLEAR ENVELOPE INTEGRAL MEMBRANE PROTEIN 2; NEMP2
616498	RETICULOPHAGY REGULATOR 3; RETREG3
616499	TRANSMEMBRANE PROTEIN 203; TMEM203
616500	MITOCHONDRIAL COMPLEX IV DEFICIENCY, NUCLEAR TYPE 9; MC4DN9
616501	MITOCHONDRIAL COMPLEX IV DEFICIENCY, NUCLEAR TYPE 13; MC4DN13
616502	CONE-ROD DYSTROPHY 21; CORD21
616503	LETHAL CONGENITAL CONTRACTURE SYNDROME 9; LCCS9
616504	METHYLTRANSFERASE 14, N6-ADENOSINE-METHYLTRANSFERASE SUBUNIT; METTL14
616505	NEUROPATHY, HEREDITARY MOTOR AND SENSORY, TYPE VIB, WITH OPTIC ATROPHY; HMSN6B
616506	NEURON-DERIVED NEUROTROPHIC FACTOR; NDNF
616507	OSTEOGENESIS IMPERFECTA, TYPE XVII; OI17
616508	SOLUTE CARRIER FAMILY 39 (ZINC TRANSPORTER), MEMBER 11; SLC39A11
616509	CATARACT 44; CTRCT44
616510	GLUCOSAMINE-PHOSPHATE N-ACETYLTRANSFERASE 1; GNPNAT1
616511	MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 14; MODY14
616512	RING FINGER PROTEIN 152; RNF152
616513	La RIBONUCLEOPROTEIN 4B; LARP4B
616514	FAMILY WITH SEQUENCE SIMILARITY 195, MEMBER B; FAM195B
616515	DEAFNESS, AUTOSOMAL RECESSIVE 104; DFNB104
616516	EMERY-DREIFUSS MUSCULAR DYSTROPHY 3, AUTOSOMAL RECESSIVE; EDMD3
616517	ACHROMATOPSIA 7; ACHM7
616518	SOLUTE CARRIER FAMILY 38 (AMINO ACID TRANSPORTER), MEMBER 6; SLC38A6
616519	PHOSPHODIESTERASE 12; PDE12
616520	ADENOSYLHOMOCYSTEINASE-LIKE 2; AHCYL2
616521	INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 39; MRD39
616522	DCN1 DOMAIN-CONTAINING PROTEIN 5; DCUN1D5
616523	MICROFIBRILLAR-ASSOCIATED PROTEIN 3-LIKE; MFAP3L
616524	TRANSMEMBRANE PROTEIN 139; TMEM139
616525	SOLUTE CARRIER FAMILY 38 (AMINO ACID TRANSPORTER), MEMBER 10; SLC38A10
616526	SOLUTE CARRIER FAMILY 38 (AMINO ACID TRANSPORTER), MEMBER 11; SLC38A11
616527	SWI5-DEPENDENT HOMOLOGOUS RECOMBINATION REPAIR PROTEIN 1; SFR1
616528	SWI5 HOMOLOGOUS RECOMBINATION REPAIR PROTEIN; SWI5
616529	YTH N6-METHYLADENOSINE RNA-BINDING PROTEIN 1; YTHDF1
616530	YTH DOMAIN-CONTAINING PROTEIN 2; YTHDC2
616531	NEURODEVELOPMENTAL DISORDER WITH SPASTICITY, HYPOMYELINATING LEUKODYSTROPHY, AND BRAIN ABNORMALITIES; NEDSPLB
616532	ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED (HERPES-SPECIFIC), SUSCEPTIBILITY TO, 7; IIAE7
616533	DEAD-BOX HELICASE 31; DDX31
616534	THYROID CANCER, NONMEDULLARY, 4; NMTC4
616535	THYROID CANCER, NONMEDULLARY, 5; NMTC5
616536	CYSTATIN 9-LIKE; CST9L
616537	V-SET AND TRANSMEMBRANE DOMAINS-CONTAINING PROTEIN 2-LIKE; VSTM2L
616538	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 9; MDDGA9
616539	PERIPHERAL NEUROPATHY WITH VARIABLE SPASTICITY, EXERCISE INTOLERANCE, AND DEVELOPMENTAL DELAY; PNSED
616540	EPILEPSY, PROGRESSIVE MYOCLONIC, 9; EPM9
616541	SHORT STATURE, MICROCEPHALY, AND ENDOCRINE DYSFUNCTION; SSMED
616542	GS HOMEOBOX 1; GSX1
616543	CYSTATIN 9; CST9
616544	RETINITIS PIGMENTOSA 73; RP73
616545	PRELI DOMAIN-CONTAINING PROTEIN 3A; PRELID3A
616546	SHORT-RIB THORACIC DYSPLASIA 14 WITH POLYDACTYLY; SRTD14
616547	LYSOZYME G-LIKE 2; LYG2
616548	LYSOPHOSPHOLIPASE-LIKE 1; LYPLAL1
616549	KLIPPEL-FEIL SYNDROME 4, AUTOSOMAL RECESSIVE, WITH NEMALINE MYOPATHY AND FACIAL DYSMORPHISM; KFS4
616550	TRANSMEMBRANE PROTEIN 120A; TMEM120A
616551	TRANSMEMBRANE PROTEIN 120B; TMEM120B
616552	CARNOSINE N-METHYLTRANSFERASE 1; CARNMT1
616553	DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 6; DKCA6
616554	SPERM-ASSOCIATED ANTIGEN 17; SPAG17
616555	LEUCINE-RICH REPEAT-CONTAINING PROTEIN 37A; LRRC37A
616556	LEUCINE-RICH REPEAT-CONTAINING PROTEIN 37A2; LRRC37A2
616557	LEUCINE-RICH REPEAT-CONTAINING PROTEIN 37A3; LRRC37A3
616558	LEUCINE-RICH REPEAT-CONTAINING PROTEIN 37B; LRRC37B
616559	NOONAN SYNDROME 9; NS9
616560	CD300H ANTIGEN
616561	RAS PROTEIN ACTIVATOR-LIKE 3; RASAL3
616562	RETINITIS PIGMENTOSA 74; RP74
616563	STE20-LIKE PROTEIN KINASE; SLK
616564	NOONAN SYNDROME 10; NS10
616565	ANKYRIN REPEAT DOMAIN-CONTAINING PROTEIN 30B; ANKRD30B
616566	SPONDYLOCOSTAL DYSOSTOSIS 6, AUTOSOMAL RECESSIVE; SCDO6
616567	DEATH-ASSOCIATED PROTEIN KINASE 2; DAPK2
616568	MOVED TO 615848
616569	CYSTEINE SULFINIC ACID DECARBOXYLASE; CSAD
616570	CEREBROOCULOFACIOSKELETAL SYNDROME 3; COFS3
616571	C-TYPE LECTIN DOMAIN FAMILY 18, MEMBER A; CLEC18A
616572	C-TYPE LECTIN DOMAIN FAMILY 18, MEMBER B; CLEC18B
616573	C-TYPE LECTIN DOMAIN FAMILY 18, MEMBER C; CLEC18C
616574	MITOCHONDRIAL CONTACT SITE AND CRISTAE ORGANIZING SYSTEM, 10-KD SUBUNIT; MICOS10
616575	LEUKOCYTE RECEPTOR CLUSTER GENE 8; LENG8
616576	IMMUNODEFICIENCY, COMMON VARIABLE, 12, WITH AUTOIMMUNITY; CVID12
616577	NEURODEVELOPMENTAL DISORDER WITH HEARING LOSS, SEIZURES, AND BRAIN ABNORMALITIES; NEDHSB
616578	ZINC FINGER- AND BTB DOMAIN-CONTAINING PROTEIN 1; ZBTB1
616579	NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, IMPAIRED LANGUAGE, AND DYSMORPHIC FEATURES; NEDHILD
616580	AU-KLINE SYNDROME; AUKS
616581	LYSINE DEMETHYLASE 4E; KDM4E
616582	LIPOLYSIS-STIMULATED LIPOPROTEIN RECEPTOR; LSR
616583	SPONDYLOEPIPHYSEAL DYSPLASIA, STANESCU TYPE; SEDSTN
616584	SPERMATOGENESIS-ASSOCIATED PROTEIN 31, SUBFAMILY A, MEMBER 7; SPATA31A7
616585	RING FINGER- AND SPRY DOMAIN-CONTAINING PROTEIN 1; RSPRY1
616586	SPASTIC PARAPLEGIA 9B, AUTOSOMAL RECESSIVE; SPG9B
616587	FAMILY WITH SEQUENCE SIMILARITY 118, MEMBER B; FAM118B
616588	DIHYDROFOLATE REDUCTASE-LIKE 1; DHFRL1
616589	ADAMS-OLIVER SYNDROME 6; AOS6
616590	ZINC FINGER- AND BTB DOMAIN-CONTAINING PROTEIN 5; ZBTB5
616591	ZINC FINGER- AND BTB DOMAIN-CONTAINING PROTEIN 7C; ZBTB7C
616592	KOSAKI OVERGROWTH SYNDROME; KOGS
616593	C1q- AND TUMOR NECROSIS FACTOR-RELATED PROTEIN 12; C1QTNF12
616594	ARF GTPase-ACTIVATING PROTEIN WITH SH3 DOMAIN, ANKYRIN REPEAT, AND PH DOMAIN 3; ASAP3
616595	ZINC FINGER- AND BTB DOMAIN-CONTAINING PROTEIN 2; ZBTB2
616596	ADP-RIBOSYLATION FACTOR-LIKE GTPase 8B; ARL8B
616597	ADP-RIBOSYLATION FACTOR-LIKE GTPase 8A; ARL8A
616598	BLOC1-RELATED COMPLEX, SUBUNIT 5; BORCS5
616599	BLOC1-RELATED COMPLEX, SUBUNIT 6; BORCS6
616600	BLOC1-RELATED COMPLEX, SUBUNIT 7; BORCS7
616601	BLOC1-RELATED COMPLEX, SUBUNIT 8; BORCS8
616602	CRANIOSYNOSTOSIS 6; CRS6
616603	CUTIS LAXA, AUTOSOMAL DOMINANT 3; ADCL3
616604	CHROMOSOME 14q32 DUPLICATION SYNDROME, 700-KB
616605	GSK3B-INTERACTING PROTEIN; GSKIP
616606	RING CHROMOSOME 14 SYNDROME
616607	KELCH REPEAT- AND BTB/POZ DOMAIN-CONTAINING PROTEIN 8; KBTBD8
616608	MACROPHAGE IMMUNOMETABOLISM REGULATOR; MACIR
616609	TRANSMEMBRANE PROTEIN 65; TMEM65
616610	CANCER SUSCEPTIBILITY CANDIDATE 15, NONCODING; CASC15
616611	LONG INTERGENIC NONCODING RNA 461; LINC00461
616612	COLLAGEN, TYPE VI, ALPHA-4, PSEUDOGENE 2; COL6A4P2
616613	COLLAGEN, TYPE VI, ALPHA-6; COL6A6
616614	HISTONE PARYLATION FACTOR 1; HPF1
616615	CHONDROITIN SULFATE N-ACETYLGALACTOSAMINYLTRANSFERASE 1; CSGALNACT1
616616	CHONDROITIN SULFATE N-ACETYLGALACTOSAMINYLTRANSFERASE 2; CSGALNACT2
616617	HEIMLER SYNDROME 2; HMLR2
616618	ACYL-CoA-BINDING DOMAIN-CONTAINING PROTEIN 5; ACBD5
616619	DPPA2 UPSTREAM-BINDING RNA, NONCODING; DUBR
616620	WD REPEAT-CONTAINING PROTEIN 12; WDR12
616621	DEAD-BOX HELICASE 27; DDX27
616622	IMMUNODEFICIENCY 42; IMD42
616623	FAMILY WITH SEQUENCE SIMILARITY 30, MEMBER A; FAM30A
616624	NUCLEAR CAP-BINDING PROTEIN 3; NCBP3
616625	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2W; CMT2W
616626	CEREBRAL ENDOTHELIAL CELL ADHESION MOLECULE; CERCAM
616627	PODOCALYXIN-LIKE 2; PODXL2
616628	FAMILY WITH SEQUENCE SIMILARITY 220, MEMBER A; FAM220A
616629	SENIOR-LOKEN SYNDROME 9; SLSN9
616630	NEURENSIN 1; NRSN1
616631	POROKERATOSIS 9, MULTIPLE TYPES; POROK9
616632	SEIZURES, CORTICAL BLINDNESS, AND MICROCEPHALY SYNDROME; SCBMS
616633	PROLINE-RICH PROTEIN 12; PRR12
616634	SUSHI, NIDOGEN, AND EGF-LIKE DOMAINS PROTEIN 1; SNED1
616635	CYSTEINE- AND HISTIDINE-RICH PROTEIN 1; CYHR1
616636	IMMUNODEFICIENCY 44; IMD44
616637	TBC1 DOMAIN FAMILY, MEMBER 16; TBC1D16
616638	SMITH-KINGSMORE SYNDROME; SKS
616639	PR DOMAIN-CONTAINING PROTEIN 8; PRDM8
616640	EPILEPSY, PROGRESSIVE MYOCLONIC, 10; EPM10
616641	RING FINGER PROTEIN 141; RNF141
616642	C6ORF89 GENE; C6ORF89
616643	HEPATOMA-DERIVED GROWTH FACTOR-RELATED PROTEIN 3
616644	CUB AND ZONA PELLUCIDA-LIKE DOMAINS 1; CUZD1
616645	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 34; DEE34
616646	KERATIN 25, TYPE I; KRT25
616647	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 35; DEE35
616648	OPTIC ATROPHY 8; OPA8
616649	SPHEROCYTOSIS, TYPE 2; SPH2
616650	KATANIN-INTERACTING PROTEIN; KATNIP
616651	ROIFMAN SYNDROME; RFMN
616652	YUAN-HAREL-LUPSKI SYNDROME; YUHAL
616653	PNN-INTERACTING SERINE/ARGININE-RICH PROTEIN; PNISR
616654	JOUBERT SYNDROME 24; JBTS24
616655	SIPA1-LIKE PROTEIN 3; SIPA1L3
616656	COMM DOMAIN-CONTAINING PROTEIN 8; COMMD8
616657	SPASTIC TETRAPLEGIA, THIN CORPUS CALLOSUM, AND PROGRESSIVE MICROCEPHALY; SPATCCM
616658	MITOCHONDRIAL CONTACT SITE AND CRISTAE ORGANIZING SYSTEM, 13-KD SUBUNIT; MICOS13
616659	TBC1 DOMAIN FAMILY, MEMBER 17; TBC1D17
616660	TRANSMEMBRANE PROTEIN 175: TMEM175
616661	MORC FAMILY CW-TYPE ZINC FINGER PROTEIN 2; MORC2
616662	THUMP DOMAIN-CONTAINING PROTEIN 1; THUMPD1
616663	SMALL NUCLEOLAR RNA, C/D BOX, 118; SNORD118
616664	SMALL NUCLEOLAR RNA, C/D BOX, 13; SNORD13
616665	SYNAPTOPHYSIN-LIKE 1; SYPL1
616666	SEIZURE-RELATED 6, MOUSE, HOMOLOG OF; SEZ6
616667	SEZ6-LIKE PROTEIN 2; SEZ6L2
616668	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2X; CMT2X
616669	IMMUNODEFICIENCY 45; IMD45
616670	EXTENDED SYNAPTOTAGMIN-LIKE PROTEIN 1; ESYT1
616671	KERATIN 76, TYPE II; KRT76
616672	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 27; COXPD27
616673	SPINDLE- AND KINETOCHORE-ASSOCIATED COMPLEX, SUBUNIT 1; SKA1
616674	SPINDLE- AND KINETOCHORE-ASSOCIATED COMPLEX, SUBUNIT 2; SKA2
616675	KERATIN 26, TYPE I; KRT26
616676	KERATIN 27, TYPE I; KRT27
616677	KERATIN 28, TYPE I; KRT28
616678	KERATIN 39, TYPE I; KRT39
616679	KERATIN 40, TYPE I; KRT40
616680	SPASTIC PARAPLEGIA 75, AUTOSOMAL RECESSIVE; SPG75
616681	MICROCEPHALY 16, PRIMARY, AUTOSOMAL RECESSIVE; MCPH16
616682	SEIZURES, SCOLIOSIS, AND MACROCEPHALY/MICROCEPHALY SYNDROME; SSMS
616683	LEUKODYSTROPHY, HYPOMYELINATING, 12; HLD12
616684	CHARCOT-MARIE-TOOTH DISEASE, TYPE 4K; CMT4K
616685	EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 14; EIG14
616686	SYNAPTOTAGMIN-BINDING CYTOPLASMIC RNA-INTERACTING PROTEIN; SYNCRIP
616687	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2Y; CMT2Y
616688	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2Z; CMT2Z
616689	DEHYDRATED HEREDITARY STOMATOCYTOSIS 2; DHS2
616690	CENTROSOMAL PROTEIN, 104-KD; CEP104
616691	EXTENDED SYNAPTOTAGMIN-LIKE PROTEIN 2; ESYT2
616692	EXTENDED SYNAPTOTAGMIN-LIKE PROTEIN 3; ESYT3
616693	ACID-SENSING ION CHANNEL, SUBUNIT 5; ASIC5
616694	ECM29 PROTEASOME ADAPTOR AND SCAFFOLD PROTEIN; ECPAS
616695	SERINE/THREONINE/TYROSINE-INTERACTING PROTEIN-LIKE 1; STYXL1
616696	KIAA0040 GENE; KIAA0040
616697	DEAFNESS, AUTOSOMAL DOMINANT 69; DFNA69
616698	ZINC FINGER PROTEIN 593; ZNF593
616699	COMM DOMAIN-CONTAINING PROTEIN 2; COMMD2
616700	COMM DOMAIN-CONTAINING PROTEIN 3; COMMD3
616701	COMM DOMAIN-CONTAINING PROTEIN 4; COMMD4
616702	ZINC FINGER PROTEIN 589; ZNF589
616703	COMM DOMAIN-CONTAINING PROTEIN 7; COMMD7
616704	COMM DOMAIN-CONTAINING PROTEIN 10; COMMD10
616705	DEAFNESS, AUTOSOMAL RECESSIVE 97; DFNB97
616706	POLY(ADP-RIBOSE) POLYMERASE FAMILY, MEMBER 11; PARP11
616707	DEAFNESS, AUTOSOMAL DOMINANT 68; DFNA68
616708	DESANTO-SHINAWI SYNDROME; DESSH
616709	ALPHA-1,4-N-ACETYLGLUCOSAMINYLTRANSFERASE; A4GNT
616710	PARKINSON DISEASE 22, AUTOSOMAL DOMINANT; PARK22
616711	TAO KINASE 3; TAOK3
616712	START DOMAIN-CONTAINING PROTEIN 7; STARD7
616713	PIPECOLIC ACID OXIDASE; PIPOX
616714	HMG-BOX TRANSCRIPTION FACTOR 1; HBP1
616715	THIOREDOXIN-RELATED TRANSMEMBRANE PROTEIN 2; TMX2
616716	RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 5; RCDP5
616717	TESTIS-EXPRESSED GENE 10; TEX10
616718	NEURITE OUTGROWTH-ASSOCIATED PROTEIN; NGRN
616719	SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 21; SCAR21
616720	MYASTHENIC SYNDROME, CONGENITAL, 19; CMS19
616721	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIn; CDG2N
616722	RETINAL DYSTROPHY AND IRIS COLOBOMA WITH OR WITHOUT CATARACT; RDICC
616723	SPONDYLOEPIMETAPHYSEAL DYSPLASIA, FADEN-ALKURAYA TYPE; SEMDFA
616724	TOOTH AGENESIS, SELECTIVE, 7; STHAG7
616725	DExD/H-BOX HELICASE 60-LIKE PROTEIN; DDX60L
616726	CILIARY DYSKINESIA, PRIMARY, 33; CILD33
616727	PHD FINGER PROTEIN 21B; PHF21B
616728	CLEFT PALATE, PSYCHOMOTOR RETARDATION, AND DISTINCTIVE FACIAL FEATURES; CPRF
616729	OLFACTORY RECEPTOR, FAMILY 2, SUBFAMILY W, MEMBER 3; OR2W3
616730	NEPHROTIC SYNDROME, TYPE 11; NPHS11
616731	NIMA-RELATED KINASE 5; NEK5
616732	OPTIC ATROPHY 10 WITH OR WITHOUT ATAXIA, IMPAIRED INTELLECTUAL DEVELOPMENT, AND SEIZURES; OPA10
616733	COENZYME Q10 DEFICIENCY, PRIMARY, 8; COQ10D8
616734	SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 2; CSCSC2
616735	COILED-COIL DOMAIN-CONTAINING PROTEIN 174: CCDC174
616736	TREMOR, HEREDITARY ESSENTIAL, 5; ETM5
616737	TAKENOUCHI-KOSAKI SYNDROME; TKS
616738	RADIOULNAR SYNOSTOSIS WITH AMEGAKARYOCYTIC THROMBOCYTOPENIA 2; RUSAT2
616739	INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 51; MRT51
616740	IMMUNODEFICIENCY 46; IMD46
616741	PR DOMAIN-CONTAINING PROTEIN 13; PRDM13
616742	NOP58 RIBONUCLEOPROTEIN; NOP58
616743	RAL GUANINE NUCLEOTIDE DISSOCIATION STIMULATOR-LIKE 3; RGL3
616744	AUTOINFLAMMATORY SYNDROME, FAMILIAL, BEHCET-LIKE 1; AIFBL1
616745	BIORIENTATION OF CHROMOSOMES IN CELL DIVISION 1; BOD1
616746	BOD1-LIKE PROTEIN 1; BOD1L1
616747	CHOLINE PHOSPHOTRANSFERASE 1; CHPT1
616748	ECTONUCLEOSIDE TRIPHOSPHATE DIPHOSPHOHYDROLASE 8; ENTPD8
616749	HETEROTAXY, VISCERAL, 7, AUTOSOMAL; HTX7
616750	ZINC FINGER DHHC DOMAIN-CONTAINING PROTEIN 16; ZDHHC16
616751	CHOLINE/ETHANOLAMINE PHOSPHOTRANSFERASE 1; CEPT1
616752	NEURONAL VESICLE TRAFFICKING-ASSOCIATED PROTEIN 2; NSG2
616753	ECTONUCLEOSIDE TRIPHOSPHATE DIPHOSPHOHYDROLASE 7; ENTPD7
616754	BOMBAY PHENOTYPE
616755	TRIPARTITE MOTIF-CONTAINING PROTEIN 62; TRIM62
616756	SPASTIC PARAPLEGIA AND PSYCHOMOTOR RETARDATION WITH OR WITHOUT SEIZURES; SPPRS
616757	TRANSMEMBRANE PROTEIN 150A; TMEM150A
616758	KERATINOCYTE DIFFERENTIATION FACTOR 1; KDF1
616759	NITRIC OXIDE SYNTHASE-INTERACTING PROTEIN; NOSIP
616760	WOOLLY HAIR, AUTOSOMAL RECESSIVE 3; ARWH3
616761	SUSHI DOMAIN-CONTAINING PROTEIN 6; SUSD6
616762	CENTRIOLE-, CILIA-, AND SPINDLE-ASSOCIATED PROTEIN; CCSAP
616763	LEUKODYSTROPHY AND ACQUIRED MICROCEPHALY WITH OR WITHOUT DYSTONIA; LDAMD
616764	SOLUTE CARRIER FAMILY 46, MEMBER 3; SLC46A3
616765	STERILE ALPHA MOTIF DOMAIN-CONTAINING PROTEIN 11; SAMD11
616766	THIOREDOXIN-RELATED TRANSMEMBRANE PROTEIN 4; TMX4
616767	CALPAIN, SMALL SUBUNIT 2; CAPNS2
616768	TUBULIN, BETA-8; TUBB8
616769	NITRILASE FAMILY MEMBER 2; NIT2
616770	MICRO RNA 218-1; MIR218-1
616771	MICRO RNA 218-2; MIR218-2
616772	MANNOSIDASE, ALPHA, CLASS 1C, MEMBER 1; MAN1C1
616773	MITOGUARDIN 1; MIGA1
616774	MITOGUARDIN 2; MIGA2
616775	ZINC FINGER PROTEIN 683; ZNF683
616776	DUAL-SPECIFICITY PHOSPHATASE 15; DUSP15
616777	SECKEL SYNDROME 9; SCKL9
616778	DUAL-SPECIFICITY PHOSPHATASE 22; DUSP22
616779	CEREBRAL ARTERIOPATHY, AUTOSOMAL DOMINANT, WITH SUBCORTICAL INFARCTS AND LEUKOENCEPHALOPATHY, TYPE 2; CADASIL2
616780	OOCYTE/ZYGOTE/EMBRYO MATURATION ARREST 2; OZEMA2
616781	JOUBERT SYNDROME 25; JBTS25
616782	GLUCOSAMINYL (N-ACETYL) TRANSFERASE 4; GCNT4
616783	UBX DOMAIN PROTEIN 10; UBXN10
616784	JOUBERT SYNDROME 26; JBTS26
616785	PUTATIVE HOMEODOMAIN TRANSCRIPTION FACTOR 2; PHTF2
616786	MITOGEN-ACTIVATED PROTEIN KINASE-BINDING PROTEIN 1; MAPKBP1
616787	CLUSTERIN-ASSOCIATED PROTEIN 1; CLUAP1
616788	OROFACIAL CLEFT 15; OFC15
616789	IMPAIRED INTELLECTUAL DEVELOPMENT AND DISTINCTIVE FACIAL FEATURES WITH OR WITHOUT CARDIAC DEFECTS; MRFACD
616790	PROTEIN PHOSPHATASE 4, REGULATORY SUBUNIT 4; PPP4R4
616791	PIGGYBAC TRANSPOSABLE ELEMENT-DERIVED GENE 5; PGBD5
616792	NEUROBLASTOMA, SUSCEPTIBILITY TO, 7; NBLST7
616793	PHOSPHOLIPASE A2, GROUP IIF; PLA2G2F
616794	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 28; COXPD28
616795	SPINOCEREBELLAR ATAXIA 42; SCA42
616796	RETINOL DEHYDROGENASE 14; RDH14
616797	EFR3 HOMOLOG B; EFR3B
616798	ZINC FINGER PROTEIN 28; ZFP28
616799	SYNAPTONEMAL COMPLEX PROTEIN 2-LIKE; SYCP2L
616800	LOXL1 ANTISENSE RNA 1, NONCODING; LOXL1AS1
616801	HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 2; IHPRF2
616802	T CELL-INTERACTING ACTIVATING RECEPTOR ON MYELOID CELLS 1; TARM1
616803	LAMB-SHAFFER SYNDROME; LAMSHF
616804	V-SET AND TRANSMEMBRANE DOMAINS-CONTAINING PROTEIN 1; VSTM1
616805	MYC TARGET IN MYELOID CELLS 1; MYCT1
616806	WILMS TUMOR 6; WT6
616807	FAS-BINDING FACTOR 1; FBF1
616808	SHIFTLESS ANTIVIRAL INHIBITOR OF RIBOSOMAL FRAMESHIFTING; SHFL
616809	HYPERPHOSPHATASIA WITH IMPAIRED INTELLECTUAL DEVELOPMENT SYNDROME 6; HPMRS6
616810	IMMUNOGLOBULIN SUPERFAMILY, DCC SUBCLASS, MEMBER 4; IGDCC4
616811	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 29; COXPD29
616812	MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 25; LGMDR25
616813	ARF GTPase-ACTIVATING PROTEIN WITH GTPase DOMAIN, ANKYRIN REPEAT, AND PLECKSTRIN HOMOLOGY DOMAIN 3; AGAP3
616814	OOCYTE/ZYGOTE/EMBRYO MATURATION ARREST 15; OZEMA15
616815	TRANSMEMBRANE PROTEIN 199; TMEM199
616816	HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION; IHPMR
616817	MICROCEPHALY, SHORT STATURE, AND IMPAIRED GLUCOSE METABOLISM 2; MSSGM2
616818	IgA NEPHROPATHY, SUSCEPTIBILITY TO, 3; IGAN3
616819	CORPUS CALLOSUM, AGENESIS OF, WITH FACIAL ANOMALIES AND CEREBELLAR ATAXIA; CCAFCA
616820	METHENYLTETRAHYDROFOLATE SYNTHETASE DOMAIN-CONTAINING PROTEIN; MTHFSD
616821	THROMBOSPONDIN TYPE 1 DOMAIN-CONTAINING PROTEIN 1; THSD1
616822	MON2, REGULATOR OF ENDOSOME-TO-GOLGI TRAFFICKING; MON2
616823	DOP1 LEUCINE ZIPPER-LIKE PROTEIN A; DOP1A
616824	TMF1-REGULATED NUCLEAR PROTEIN 1; TRNP1
616825	NUCLEAR RECEPTOR COACTIVATOR 5; NCOA5
616826	EPS15-LIKE PROTEIN 1; EPS15L1
616827	MUSCULAR DYSTROPHY, AUTOSOMAL RECESSIVE, WITH CARDIOMYOPATHY AND TRIANGULAR TONGUE; MDRCMTT
616828	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIo; CDG2O
616829	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIp; CDG2P
616830	TRANSPORT AND GOLGI ORGANIZATION 2 HOMOLOG; TANGO2
616831	LUSCAN-LUMISH SYNDROME; LLS
616832	MYOMESIN 3; MYOM3
616833	PAGET DISEASE OF BONE 6; PDB6
616834	MICROCEPHALY, CONGENITAL CATARACT, AND PSORIASIFORM DERMATITIS; MCCPD
616835	MEIER-GORLIN SYNDROME 6; MGORS6
616836	G-PATCH DOMAIN-CONTAINING PROTEIN 2; GPATCH2
616837	HUMAN PLURIPOTENCY-ASSOCIATED TRANSCRIPT 5, NONCODING
616838	C-TYPE LECTIN DOMAIN FAMILY 17, MEMBER A; CLEC17A
616839	EXERCISE INTOLERANCE, RIBOFLAVIN-RESPONSIVE; RREI
616840	PARKINSON DISEASE 23, AUTOSOMAL RECESSIVE EARLY-ONSET; PARK23
616841	ZINC FINGER PROTEIN 468; ZNF468
616842	DNase1 HYPERSENSITIVITY, CHROMOSOME 6, SITE 1; DHS6S1
616843	LYMPHATIC MALFORMATION 6; LMPHM6
616844	DNAJ/HSP40 HOMOLOG, SUBFAMILY C, MEMBER 17; DNAJC17
616845	C-TYPE LECTIN DOMAIN FAMILY 14, MEMBER A; CLEC14A
616846	ENDOPLASMIC RETICULUM MEMBRANE PROTEIN COMPLEX, SUBUNIT 1; EMC1
616847	ZINC FINGER PROTEIN 543; ZNF543
616848	MIER1 TRANSCRIPTIONAL REGULATOR; MIER1
616849	BRACHYDACTYLY, TYPE A1, D; BDA1D
616850	WD REPEAT-CONTAINING PROTEIN 83; WDR83
616851	CATARACT 45; CTRCT45
616852	MYOPATHY, SCAPULOHUMEROPERONEAL; SHPM
616853	FAMILY WITH SEQUENCE SIMILARITY 72, MEMBER C: FAM72C
616854	EVEN-PLUS SYNDROME; EVPLS
616855	CYTOCHROME c OXIDASE, SUBUNIT 8C; COX8C
616856	BROMODOMAIN- AND PHD FINGER-CONTAINING PROTEIN 3; BRPF3
616857	CHLORIDE CHANNEL ACCESSORY 4; CLCA4
616858	COWDEN SYNDROME 7; CWS7
616859	SPASTICITY, CHILDHOOD-ONSET, WITH HYPERGLYCINEMIA; SPAHGC
616860	ANEMIA, SIDEROBLASTIC, 3, PYRIDOXINE-REFRACTORY; SIDBA3
616861	SOLUTE CARRIER FAMILY 12 (POTASSIUM/CHLORIDE TRANSPORTER), MEMBER 9; SLC12A9
616862	RIBOSOMAL PROTEIN L34; RPL34
616863	HAO-FOUNTAIN SYNDROME; HAFOUS
616864	HEXOSAMINIDASE D; HEXD
616865	POLY(A) POLYMERASE, GAMMA; PAPOLG
616866	SPINAL MUSCULAR ATROPHY WITH CONGENITAL BONE FRACTURES 1; SMABF1
616867	SPINAL MUSCULAR ATROPHY WITH CONGENITAL BONE FRACTURES 2; SMABF2
616868	DIARRHEA 8, SECRETORY SODIUM, CONGENITAL; DIAR8
616869	C-TERMINAL DOMAIN NUCLEAR ENVELOPE PHOSPHATASE 1 REGULATORY SUBUNIT 1; CNEP1R1
616870	TRANSMEMBRANE PROTEIN 14A; TMEM14A
616871	MYELOPROLIFERATIVE/LYMPHOPROLIFERATIVE NEOPLASMS, FAMILIAL (MULTIPLE TYPES), SUSCEPTIBILITY TO; MPLPF
616872	TRANSMEMBRANE 9 SUPERFAMILY, MEMBER 3; TM9SF3
616873	IMMUNODEFICIENCY, COMMON VARIABLE, 13; CVID13
616874	TRANSMEMBRANE BAX INHIBITOR MOTIF-CONTAINING PROTEIN 4; TMBIM4
616875	CEREBELLAR ATROPHY, VISUAL IMPAIRMENT, AND PSYCHOMOTOR RETARDATION; CAVIPMR
616876	TRANSMEMBRANE p24 TRAFFICKING PROTEIN 5; TMED5
616877	TRANSMEMBRANE PROTEIN 9; TMEM9
616878	METABOLIC CRISES, RECURRENT, WITH RHABDOMYOLYSIS, CARDIAC ARRHYTHMIAS, AND NEURODEGENERATION; MECRCN
616879	TBC1 DOMAIN FAMILY, MEMBER 22A; TBC1D22A
616880	TBC1 DOMAIN FAMILY, MEMBER 22B; TBC1D22B
616881	LEUKODYSTROPHY, HYPOMYELINATING, 13; HLD13
616882	ADVANCED SLEEP PHASE SYNDROME, FAMILIAL, 3; FASPS3
616883	SRP RECEPTOR SUBUNIT, BETA; SRPRB
616884	UNC79 HOMOLOG, NALCN CHANNEL COMPLEX SUBUNIT; UNC79
616885	CALCIUM-REGULATED HEAT-STABLE PROTEIN 1; CARHSP1
616886	GSE1 COILED-COIL PROTEIN; GSE1
616887	INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 52; MRT52
616888	TRANSMEMBRANE PROTEIN 8B; TMEM8B
616889	CENTROSOMAL PROTEIN, 68-KD; CEP68
616890	SPLIT-FOOT MALFORMATION WITH MESOAXIAL POLYDACTYLY; SFMMP
616891	SMALL TRANSMEMBRANE REGULATOR OF ION TRANSPORT 1; STRIT1
616892	NEPHROTIC SYNDROME, TYPE 12; NPHS12
616893	NEPHROTIC SYNDROME, TYPE 13; NPHS13
616894	ROBINOW SYNDROME, AUTOSOMAL DOMINANT 3; DRS3
616895	SURVIVAL-ASSOCIATED MITOCHONDRIAL MELANOMA-SPECIFIC ONCOGENIC NONCODING RNA; SAMMSON
616896	MITOCHONDRIAL DNA DEPLETION SYNDROME 14 (CARDIOENCEPHALOMYOPATHIC TYPE); MTDPS14
616897	OSTEOCHONDRODYSPLASIA, COMPLEX LETHAL, SYMOENS-BARNES-GISTELINCK TYPE; OCLSBG
616898	CHROMOSOME 15q14 DELETION SYNDROME
616899	TBC1 DOMAIN-CONTAINING KINASE; TBCK
616900	HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 3; IHPRF3
616901	DEVELOPMENTAL DELAY WITH SHORT STATURE, DYSMORPHIC FACIAL FEATURES, AND SPARSE HAIR 1; DEDSSH1
616902	CHROMOSOME 11p13 DELETION SYNDROME, DISTAL
616903	THIOPURINES, POOR METABOLISM OF, 2; THPM2
616904	DEDICATOR OF CYTOKINESIS 5; DOCK5
616905	MORF4 FAMILY-ASSOCIATED PROTEIN 1; MRFAP1
616906	CANCER SUSCEPTIBILITY CANDIDATE 1; CASC1
616907	SPASTIC PARAPLEGIA 76, AUTOSOMAL RECESSIVE; SPG76
616908	PATCHED DOMAIN-CONTAINING PROTEIN 4; PTCHD4
616909	COILED-COIL DOMAIN-CONTAINING PROTEIN 68; CCDC68
616910	IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 3; ICF3
616911	IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 4; ICF4
616912	ENAH/VASP-LIKE PROTEIN; EVL
616913	BLEEDING DISORDER, PLATELET-TYPE, 20; BDPLT20
616914	MARFANOID-PROGEROID-LIPODYSTROPHY SYNDROME; MFLS
616915	REMOVED FROM DATABASE
616916	SMALL ADP-RIBOSYLATION FACTOR GTPase-ACTIVATING PROTEIN 2; SMAP2
616917	NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT HYPOTONIA, SEIZURES, AND CEREBELLAR ATROPHY; NEDHSCA
616918	PHOSPHATIDYLINOSITOL GLYCAN ANCHOR BIOSYNTHESIS CLASS G PROTEIN; PIGG
616919	FERM AND PDZ DOMAINS-CONTAINING PROTEIN 1; FRMPD1
616920	HEART AND BRAIN MALFORMATION SYNDROME; HBMS
616921	DYSKINESIA, LIMB AND OROFACIAL, INFANTILE-ONSET; IOLOD
616922	STRIATAL DEGENERATION, AUTOSOMAL DOMINANT 2; ADSD2
616923	RING FINGER PROTEIN 207; RNF207
616924	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2CC; CMT2CC
616925	DDHRS4 ANTISENSE RNA 1, NONCODING; DHRS4AS1
616926	FXYD DOMAIN-CONTAINING ION TRANSPORT REGULATOR 4; FXYD4
616927	EXOCYST COMPLEX COMPONENT 3-LIKE 2; EXOC3L2
616928	TRANSMEMBRANE PROTEIN 45A; TMEM45A
616929	TRANSCRIPTION TERMINATION FACTOR 2, MITOCHONDRIAL; MTERF2
616930	TRANSCRIPTION TERMINATION FACTOR 3, MITOCHONDRIAL; MTERF3
616931	FUCOSYLTRANSFERASE 10; FUT10
616932	FUCOSYLTRANSFERASE 11; FUT11
616933	FORTY-TWO-THREE DOMAIN-CONTAINING PROTEIN 1; FYTTD1
616934	MEIOSIS-SPECIFIC PROTEIN WITH COILED-COIL DOMAIN; MEIOC
616935	FAS-ASSOCIATED FACTOR FAMILY, MEMBER 2; FAF2
616936	CHROMODOMAIN HELICASE DNA-BINDING PROTEIN 9; CHD9
616937	THROMBOCYTOPENIA 6; THC6
616938	COFFIN-SIRIS SYNDROME 5; CSS5
616939	CHOREA, CHILDHOOD-ONSET, WITH PSYCHOMOTOR RETARDATION; COCPMR
616940	EXONUCLEASE 3-PRIME-TO-5-PRIME DOMAIN-CONTAINING PROTEIN 2; EXD2
616941	AGAMMAGLOBULINEMIA 8A, AUTOSOMAL DOMINANT; AGM8A
616942	PROTEIN DISULFIDE ISOMERASE, FAMILY A, MEMBER 5; PDIA5
616943	TRICHOTHIODYSTROPHY 6, NONPHOTOSENSITIVE; TTD6
616944	INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 41; MRD41
616945	CLAVESIN 2; CLVS2
616946	PREMATURE OVARIAN FAILURE 11; POF11
616947	PREMATURE OVARIAN FAILURE 12; POF12
616948	SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 22; SCAR22
616949	SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 23; SCAR23
616950	SPERMATOGENIC FAILURE 15; SPGF15
616951	MTSS I-BAR DOMAIN-CONTAINING PROTEIN 2; MTSS2
616952	MITOCHONDRIAL CALCIUM UNIPORTER REGULATOR 1; MCUR1
616953	CUTA DIVALENT CATION TOLERANCE HOMOLOG; CUTA
616954	YOU-HOOVER-FONG SYNDROME; YHFS
616955	RRAD- AND GEM-LIKE GTPase 2; REM2
616956	TUBULIN POLYMERIZATION-PROMOTING PROTEIN FAMILY, MEMBER 2; TPPP2
616957	TUBULIN POLYMERIZATION-PROMOTING PROTEIN FAMILY, MEMBER 3; TPPP3
616958	MOVED TO 608653
616959	RETINITIS PIGMENTOSA AND ERYTHROCYTIC MICROCYTOSIS; RPEM
616960	GTPase, IMAP FAMILY, MEMBER 6; GIMAP6
616961	GTPase, IMAP FAMILY, MEMBER 7; GIMAP7
616962	GTPase, IMAP FAMILY, MEMBER 8; GIMAP8
616963	HYPERCALCEMIA, INFANTILE, 2; HCINF2
616964	MOVED TO 615225
616965	ADHESION G PROTEIN-COUPLED RECEPTOR G5; ADGRG5
616966	ABHYDROLASE DOMAIN-CONTAINING PROTEIN 6, ACYLGLYCEROL LIPASE; ABHD6
616967	THIOREDOXIN DOMAIN-CONTAINING PROTEIN 17; TXNDC17
616968	DEAFNESS, AUTOSOMAL DOMINANT 70; DFNA70
616969	DEAFNESS, AUTOSOMAL DOMINANT 66; DFNA66
616970	MARVEL DOMAIN-CONTAINING PROTEIN 1; MARVELD1
616971	ENDOPLASMIC RETICULUM-GOLGI INTERMEDIATE COMPARTMENT PROTEIN 3; ERGIC3
616972	MICRO RNA 490; MIR490
616973	INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 42; MRD42
616974	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 30; COXPD30
616975	NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT ANOMALIES OF THE BRAIN, EYE, OR HEART; NEDBEH
616976	TRIPARTITE MOTIF-CONTAINING PROTEIN 40; TRIM40
616977	INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 43; MRD43
616978	COILED COIL-HELIX-COILED COIL-HELIX DOMAIN-CONTAINING PROTEIN 5; CHCHD5
616979	DEATH DOMAIN-CONTAINING PROTEIN 1; DTHD1
616980	CELL CYCLE REGULATOR OF NONHOMOLOGOUS END JOINING; CYREN
616981	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 37; DEE37
616982	PR DOMAIN-CONTAINING PROTEIN 6; PRDM6
616983	ECTONUCLEOTIDE PYROPHOSPHATASE/PHOSPHODIESTERASE 6; ENPP6
616984	NEUROPEPTIDE VF PRECURSOR; NPVF
616985	MTRNR2-LIKE 1; MTRNR2L1
616986	LONG INTERGENIC NONCODING RNA AC011288.2
616987	CHROMOSOME 6 OPEN READING FRAME 120; C6ORF120
616988	CHRONIC LYMPHOCYTIC LEUKEMIA UPREGULATED GENE 1; CLLU1
616989	CHRONIC LYMPHOCYTIC LEUKEMIA UPREGULATED 1, OPPOSITE STRAND; CLLU1OS
616990	CLUSTERIN-LIKE PROTEIN 1; CLUL1
616991	MUCIN 21, CELL SURFACE-ASSOCIATED; MUC21
616992	CHROMOSOME 8 OPEN READING FRAME 17; C8ORF17
616993	TRANSMEMBRANE PROTEIN 243; TMEM243
616994	CRANIOFACIAL DYSMORPHISM, SKELETAL ANOMALIES, AND IMPAIRED INTELLECTUAL DEVELOPMENT SYNDROME 2; CFSMR2
616995	CLOCK-INTERACTING PACEMAKER; CIPC
616996	TRIPARTITE MOTIF-CONTAINING PROTEIN 56; TRIM56
616997	ECTONUCLEOTIDE PYROPHOSPHATASE/PHOSPHODIESTERASE 7; ENPP7
616998	LLP HOMOLOG, LONG-TERM SYNAPTIC FACILITATION FACTOR; LLPH
616999	RNA-BINDING FOX1 HOMOLOG 3; RBFOX3
617000	ECTONUCLEOTIDE PYROPHOSPHATASE/PHOSPHODIESTERASE 4; ENPP4
617001	ECTONUCLEOTIDE PYROPHOSPHATASE/PHOSPHODIESTERASE 5; ENPP5
617002	BICD FAMILY-LIKE CARGO ADAPTOR 1; BICDL1
617003	BICD FAMILY-LIKE CARGO ADAPTOR 2; BICDL2
617004	POLYCYSTIC LIVER DISEASE 2 WITH OR WITHOUT KIDNEY CYSTS; PCLD2
617005	CLAUDIN 17; CLDN17
617006	AUTOIMMUNE DISEASE, MULTISYSTEM, INFANTILE-ONSET, 2; ADMIO2
617007	TRIPARTITE MOTIF-CONTAINING PROTEIN 35; TRIM35
617008	CEREBRAL PALSY, SPASTIC QUADRIPLEGIC, 3; CPSQ3
617009	ANKYRIN REPEAT DOMAIN-CONTAINING PROTEIN 53; ANKRD53
617010	UNC51-LIKE KINASE 4; ULK4
617011	MACROCEPHALY, DYSMORPHIC FACIES, AND PSYCHOMOTOR RETARDATION; MDFPMR
617012	POLIOVIRUS RECEPTOR-RELATED IMMUNOGLOBULIN DOMAIN-CONTAINING PROTEIN; PVRIG
617013	HYPERMANGANESEMIA WITH DYSTONIA 2; HMNDYT2
617014	NEUTROPENIA, SEVERE CONGENITAL, 7, AUTOSOMAL RECESSIVE; SCN7
617015	PHOSPHOLIPASE C, PHOSPHATIDYLINOSITOL-SPECIFIC, X DOMAIN-CONTAINING PROTEIN 2; PLCXD2
617016	PHOSPHOLIPASE C, PHOSPHATIDYLINOSITOL-SPECIFIC, X DOMAIN-CONTAINING PROTEIN 3; PLCXD3
617017	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2T; CMT2T
617018	SPINOCEREBELLAR ATAXIA 43; SCA43
617019	TRANSMEMBRANE PROTEIN 230; TMEM230
617020	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 38; DEE38
617021	HYDROPS, LACTIC ACIDOSIS, AND SIDEROBLASTIC ANEMIA; HLASA
617022	LETHAL CONGENITAL CONTRACTURE SYNDROME 10; LCCS10
617023	RETINITIS PIGMENTOSA 75; RP75
617024	NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1H; CSNB1H
617025	NEVUS COMEDONICUS; NC
617026	PONTOCEREBELLAR HYPOPLASIA, TYPE 2F; PCH2F
617027	HYPERALDOSTERONISM, FAMILIAL, TYPE IV; HALD4
617028	INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 54; MRT54
617029	SEMAPHORIN 4B; SEMA4B
617030	MYOPATHY, DISTAL, 5; MPD5
617031	PRE-mRNA-PROCESSING FACTOR 38A; PRPF38A
617032	PROTEIN-GLUCOSYLGALACTOSYLHYDROXYLYSINE GLUCOSIDASE; PGGHG
617033	CELLULAR ARGININE SENSOR FOR MTORC1 PROTEIN 2; CASTOR2
617034	CELLULAR ARGININE SENSOR FOR MTORC1 PROTEIN 1; CASTOR1
617035	PATENT DUCTUS ARTERIOSUS 2; PDA2
617036	ALKALINE CERAMIDASE 3; ACER3
617037	NONCODING RNA ACTIVATED BY DNA DAMAGE; NORAD
617038	LONG INTERGENIC NONCODING RNA 1370; LINC01370
617039	PATENT DUCTUS ARTERIOSUS 3; PDA3
617040	MICRO RNA 1231; MIR1231
617041	DUANE RETRACTION SYNDROME 3 WITH OR WITHOUT DEAFNESS; DURS3
617042	GASDERMIN D; GSDMD
617043	RHO GUANINE NUCLEOTIDE EXCHANGE FACTOR 17; ARHGEF17
617044	SHORT STATURE, DEVELOPMENTAL DELAY, AND CONGENITAL HEART DEFECTS; SDDHD
617045	ZINC FINGER PROTEIN 703; ZNF703
617046	SPASTIC PARAPLEGIA 77, AUTOSOMAL RECESSIVE; SPG77
617047	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 26; CMH26
617048	DNAJ/HSP40 HOMOLOG, SUBFAMILY C, MEMBER 21; DNAJC21
617049	CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC, 5; PFIC5
617050	HERMANSKY-PUDLAK SYNDROME 10; HPS10
617051	NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY AND GRAY SCLERAE; NEDMIGS
617052	BONE MARROW FAILURE SYNDROME 3; BMFS3
617053	MIRAGE SYNDROME; MIRAGE
617054	STRIATONIGRAL DEGENERATION, CHILDHOOD-ONSET; SNDC
617055	PERCHING SYNDROME; PERCHING
617056	TUBULOINTERSTITIAL KIDNEY DISEASE, AUTOSOMAL DOMINANT, 5; ADTKD5
617057	CYTOSOLIC THIOURIDYLASE, SUBUNIT 2; CTU2
617058	TSR3 RIBOSOME MATURATION FACTOR; TSR3
617059	ZINC FINGER DBF DOMAIN-CONTAINING PROTEIN 2; ZDBF2
617060	LACTASE-LIKE PROTEIN; LCTL
617061	INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 44, WITH MICROCEPHALY; MRD44
617062	OKUR-CHUNG NEURODEVELOPMENTAL SYNDROME; OCNDS
617063	MEIER-GORLIN SYNDROME 7; MGORS7
617064	GTP-BINDING ELONGATION FACTOR GUF1; GUF1
617065	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 40; DEE40
617066	MUSCULAR DYSTROPHY, CONGENITAL, DAVIGNON-CHAUVEAU TYPE; MDCDC
617067	LY6/PLAUR DOMAIN-CONTAINING PROTEIN 8; LYPD8
617068	PORTAL HYPERTENSION, NONCIRRHOTIC, 1; NCPH1
617069	PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL RECESSIVE 3; PEOB3
617070	PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL RECESSIVE 4; PEOB4
617071	LONG NONCODING RNA 13
617072	MYOPATHY, AUTOSOMAL RECESSIVE, WITH RIGID SPINE AND DISTAL JOINT CONTRACTURES; MRRSDC
617073	TOOTH AGENESIS, SELECTIVE, 8; STHAG8
617074	SMITH-MAGENIS SYNDROME CHROMOSOME REGION, CANDIDATE GENE 8; SMCR8
617075	NASOPHARYNGEAL CARCINOMA, SUSCEPTIBILITY TO, 3; NPCA3
617076	FK506-BINDING PROTEIN-LIKE; FKBPL
617077	ZINC FINGER PROTEIN 618; ZNF618
617078	DEATH EFFECTOR DOMAIN-CONTAINING PROTEIN 2; DEDD2
617079	LONG INTERGENIC NONCODING RNA 673; LINC00673
617080	SEIZURES, BENIGN FAMILIAL INFANTILE, 5; BFIS5
617081	OMA1 ZINC METALLOPEPTIDASE; OMA1
617082	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Iaa; CDG1AA
617083	DYNEIN, CYTOPLASMIC 2, LIGHT INTERMEDIATE CHAIN 1; DYNC2LI1
617084	TRANSMEMBRANE PROTEIN 59; TMEM59
617085	FIN BUD INITIATION FACTOR, ZEBRAFISH, HOMOLOG OF; FIBIN
617086	ENCEPHALOPATHY DUE TO DEFECTIVE MITOCHONDRIAL AND PEROXISOMAL FISSION 2; EMPF2
617087	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, AUTOSOMAL RECESSIVE, TYPE 2A2B; CMT2A2B
617088	SHORT-RIB THORACIC DYSPLASIA 15 WITH POLYDACTYLY; SRTD15
617089	NUCLEOLUS AND NEURAL PROGENITOR PROTEIN; NEPRO
617090	MICROCEPHALY 17, PRIMARY, AUTOSOMAL RECESSIVE; MCPH17
617091	CILIARY DYSKINESIA, PRIMARY, 34; CILD34
617092	CILIARY DYSKINESIA, PRIMARY, 35; CILD35
617093	GROWTH RETARDATION, IMPAIRED INTELLECTUAL DEVELOPMENT, HYPOTONIA, AND HEPATOPATHY; GRIDHH
617094	INTRAFLAGELLAR TRANSPORT 52; IFT52
617095	OUTER DYNEIN ARM DOCKING COMPLEX SUBUNIT 4; ODAD4
617096	TRANSMEMBRANE PROTEIN 59-LIKE; TMEM59L
617097	LONG INTERGENIC NONCODING RNA 1194; LINC01194
617098	RIBONUCLEASE K; RNASEK
617099	AUTOINFLAMMATION, PANNICULITIS, AND DERMATOSIS SYNDROME; AIPDS
617100	FAMILIAL ADENOMATOUS POLYPOSIS 4; FAP4
617101	INTELLECTUAL DEVELOPMENTAL DISORDER WITH PERSISTENCE OF FETAL HEMOGLOBIN
617102	SHORT-RIB THORACIC DYSPLASIA 16 WITH OR WITHOUT POLYDACTYLY; SRTD16
617103	ZINC FINGER PROTEIN 668; ZNF668
617104	PHOSPHATIDYLINOSITOL 5-PHOSPHATE 4-KINASE, TYPE II, GAMMA; PIP4K2C
617105	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 41; DEE41
617106	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 42; DEE42
617107	THAUVIN-ROBINET-FAIVRE SYNDROME; TROFAS
617108	SESSILE SERRATED POLYPOSIS CANCER SYNDROME; SSPCS
617109	CREB3 RECRUITMENT FACTOR; CREBRF
617110	CENTROSOMAL PROTEIN, 78-KD; CEP78
617111	MACULAR DYSTROPHY, PATTERNED, 3; MDPT3
617112	KIAA0753 GENE; KIAA0753
617113	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 43; DEE43
617114	MYOPATHY, MYOFIBRILLAR, 7; MFM7
617115	PEELING SKIN SYNDROME 5; PSS5
617116	EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 2; FFEVF2
617117	LONG INTERGENIC NONCODING RNA 663; LINC00663
617118	EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 3; FFEVF3
617119	BARDET-BIEDL SYNDROME 22; BBS22
617120	JOUBERT SYNDROME 27; JBTS27
617121	JOUBERT SYNDROME 28; JBTS28
617122	C1QTNF9B ANTISENSE RNA 1; C1QTNF9BAS1
617123	RETINITIS PIGMENTOSA 76; RP76
617124	PEPTIDASE M20 DOMAIN-CONTAINING PROTEIN 1; PM20D1
617125	INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 56; MRT56
617126	ALAZAMI-YUAN SYNDROME; ALYUS
617127	OROFACIODIGITAL SYNDROME XV; OFD15
617128	INHIBITORY SYNAPTIC FACTOR 1; INSYN1
617129	INHIBITORY SYNAPTIC FACTOR 2A; INSYN2A
617130	MEMBRANE-ANCHORED JUNCTION PROTEIN; MAJIN
617131	TELOMERE REPEAT-BINDING BOUQUET FORMATION PROTEIN 2; TERB2
617132	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 44; DEE44
617133	SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 24; SCAR24
617134	TRANSMEMBRANE AND COILED-COIL DOMAINS PROTEIN 3; TMCO3
617135	L3MBTL HISTONE METHYL-LYSINE-BINDING PROTEIN 4; L3MBTL4
617136	TFAP2A ANTISENSE RNA 2; TFAP2AAS2
617137	FRONTOMETAPHYSEAL DYSPLASIA 2; FMD2
617138	SKI FAMILY TRANSCRIPTIONAL COREPRESSOR 2; SKOR2
617139	LECTIN, GALACTOSIDE-BINDING, SOLUBLE, 7B; LGALS7B
617140	ZTTK SYNDROME; ZTTKS
617141	ANIRIDIA 2; AN2
617142	ANIRIDIA 3; AN3
617143	MYASTHENIC SYNDROME, CONGENITAL, 20, PRESYNAPTIC; CMS20
617144	MICRO RNA 4435-2 HOST GENE, NONCODING; MIR4435-2HG
617145	NEURODEGENERATION WITH ATAXIA, DYSTONIA, AND GAZE PALSY, CHILDHOOD-ONSET; NADGP
617146	ARTHROGRYPOSIS, DISTAL, WITH IMPAIRED PROPRIOCEPTION AND TOUCH; DAIPT
617147	COILED-COIL DOMAIN-CONTAINING PROTEIN 14; CCDC14
617148	DEUTEROSOME ASSEMBLY PROTEIN 1; DEUP1
617149	CENTROSOMAL PROTEIN 20; CEP20
617150	ZINC FINGER DHHC DOMAIN-CONTAINING PROTEIN 3; ZDHHC3
617151	SULFOTRANSFERASE FAMILY 1C, MEMBER 3; SULT1C3
617152	SULFOTRANSFERASE FAMILY 6B, MEMBER 1; SULT6B1
617153	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 45; DEE45
617154	MRN COMPLEX-INTERACTING PROTEIN; MRNIP
617155	SUPPRESSION OF TUMORIGENICITY 18; ST18
617156	MITOCHONDRIAL DNA DEPLETION SYNDROME 15 (HEPATOCEREBRAL TYPE); MTDPS15
617157	SHORT STATURE, BRACHYDACTYLY, IMPAIRED INTELLECTUAL DEVELOPMENT, AND SEIZURES; SBIDDS
617158	MYOPATHY, DISTAL, WITH RIMMED VACUOLES; DMRV
617159	SIFRIM-HITZ-WEISS SYNDROME; SIHIWES
617160	PROMININ 2; PROM2
617161	GSG1-LIKE PROTEIN; GSG1L
617162	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 46; DEE46
617163	RING FINGER PROTEIN 186; RNF186
617164	SHORT STATURE-MICROGNATHIA SYNDROME; SSMG
617165	FAMILY WITH SEQUENCE SIMILARITY 213, MEMBER A; FAM213A
617166	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 47; DEE47
617167	SOLUTE CARRIER FAMILY 35, MEMBER G1; SLC35G1
617168	AORTIC ANEURYSM, FAMILIAL THORACIC 10; AAT10
617169	INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 74; MRT74
617170	CWC27 SPLICEOSOME-ASSOCIATED CYCLOPHILIN; CWC27
617171	NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA AND IMPAIRED EXPRESSIVE LANGUAGE AND WITH OR WITHOUT SEIZURES; NEDHELS
617172	GLUTATHIONE PEROXIDASE 8; GPX8
617173	LODDER-MERLA SYNDROME, TYPE 1, WITH IMPAIRED INTELLECTUAL DEVELOPMENT AND CARDIAC ARRHYTHMIA; LDMLS1
617174	EHLERS-DANLOS SYNDROME, PERIODONTAL TYPE, 2; EDSPD2
617175	RETINAL DYSTROPHY WITH OR WITHOUT EXTRAOCULAR ANOMALIES; RDEOA
617176	MICRO RNA 4271; MIR4271
617177	MYOSIN LIGHT CHAIN 10; MYL10
617178	RING FINGER PROTEIN 166; RNF166
617179	PROMOTER OF CDKN1A ANTISENSE DNA DAMAGE-ACTIVATED RNA; PANDAR
617180	CHITAYAT SYNDROME; CHYTS
617181	TRANSMEMBRANE CHANNEL-LIKE PROTEIN 4; TMC4
617182	LODDER-MERLA SYNDROME, TYPE 2, WITH DEVELOPMENTAL DELAY AND WITH OR WITHOUT CARDIAC ARRHYTHMIA; LDMLS2
617183	HAREL-YOON SYNDROME; HAYOS
617184	MITOCHONDRIAL DNA DEPLETION SYNDROME 12A (CARDIOMYOPATHIC TYPE), AUTOSOMAL DOMINANT; MTDPS12A
617185	NOP2/SUN RNA METHYLTRANSFERASE FAMILY, MEMBER 7; NSUN7
617186	ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN EDEMA AND/OR LEUKOENCEPHALOPATHY, 1; PEBEL1
617187	SPERMATOGENIC FAILURE 16; SPGF16
617188	INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 57; MRT57
617189	TRANSMEMBRANE PROTEIN 110; TMEM110
617190	SHASHI-PENA SYNDROME; SHAPNS
617191	p38-INHIBITED CUTANEOUS SQUAMOUS CELL CARCINOMA-ASSOCIATED LONG INTERGENIC NONCODING RNA; PICSAR
617192	ENDONUCLEASE/EXONUCLEASE/PHOSPHATASE FAMILY DOMAIN-CONTAINING PROTEIN 1; EEPD1
617193	ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN ATROPHY AND THIN CORPUS CALLOSUM; PEBAT
617194	LETHAL CONGENITAL CONTRACTURE SYNDROME 11; LCCS11
617195	MUSCULOSKELETAL EMBRYONIC NUCLEAR PROTEIN 1; MUSTN1
617196	TRANSMEMBRANE CHANNEL-LIKE PROTEIN 3; TMC3
617197	TRANSMEMBRANE CHANNEL-LIKE PROTEIN 5; TMC5
617198	TRANSMEMBRANE CHANNEL-LIKE PROTEIN 7; TMC7
617199	NOP2/SUN RNA METHYLTRANSFERASE FAMILY, MEMBER 6; NSUN6
617200	OLIGODENDROCYTIC MYELIN PARANODAL AND INNER LOOP PROTEIN; OPALIN
617201	PERIVENTRICULAR NODULAR HETEROTOPIA 7; PVNH7
617202	FORKHEAD BOX I2; FOXI2
617203	TRANSMEMBRANE PROTEIN 87B; TMEM87B
617204	VIMENTIN-TYPE INTERMEDIATE FILAMENT-ASSOCIATED COILED-COIL PROTEIN; VMAC
617205	HETEROTAXY, VISCERAL, 8, AUTOSOMAL; HTX8
617206	NEURALIZED E3 UBIQUITIN PROTEIN LIGASE 3; NEURL3
617207	ENCEPHALOPATHY, PROGRESSIVE, WITH AMYOTROPHY AND OPTIC ATROPHY; PEAMO
617208	MAM DOMAIN-CONTAINING PROTEIN 4; MAMDC4
617209	GLUTAMINYL-tRNA AMIDOTRANSFERASE SUBUNIT QRSL1; QRSL1
617210	GLUTAMYL-tRNA AMIDOTRANSFERASE, SUBUNIT C; GATC
617211	DERMOKINE; DMKN
617212	KERATINOCYTE DIFFERENTIATION-ASSOCIATED PROTEIN; KRTDAP
617213	SEDOHEPTULOKINASE DEFICIENCY; SHPKD
617214	SPERMATOGENIC FAILURE 17; SPGF17
617215	CHROMOSOME 17 OPEN READING FRAME 49; C17ORF49
617216	ZINC FINGER PROTEIN 420; ZNF420
617217	AMELOGENESIS IMPERFECTA, HYPOMATURATION TYPE, IIA6; AI2A6
617218	TRANSMEMBRANE AND TETRATRICOPEPTIDE REPEAT DOMAINS-CONTAINING PROTEIN 3; TMTC3
617219	CHROMOSOME 19q13.11 DELETION SYNDROME, PROXIMAL
617220	PYRIDINE NUCLEOTIDE-DISULFIDE OXIDOREDUCTASE DOMAIN-CONTAINING PROTEIN 1; PYROXD1
617221	HEXOKINASE DOMAIN-CONTAINING PROTEIN 1; HKDC1
617222	SUDDEN CARDIAC FAILURE, INFANTILE; SCFI
617223	SUDDEN CARDIAC FAILURE, ALCOHOL-INDUCED; SCFAI
617224	GROWTH ARREST-SPECIFIC 2-LIKE 3; GAS2L3
617225	SPASTIC PARAPLEGIA 78, AUTOSOMAL RECESSIVE; SPG78
617226	MITOGEN-ACTIVATED PROTEIN KINASE 1-INTERACTING PROTEIN 1-LIKE PROTEIN; MAPK1IP1L
617227	ATPase FAMILY, AAA DOMAIN-CONTAINING, MEMBER 3C; ATAD3C
617228	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 31; COXPD31
617229	FAMILY WITH SEQUENCE SIMILARITY 53, MEMBER A; FAM53A
617230	ZFP1 ZINC FINGER PROTEIN; ZFP1
617231	PHOSPHOLYSINE PHOSPHOHISTIDINE INORGANIC PYROPHOSPHATE PHOSPHATASE; LHPP
617232	MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 21; LGMDR21
617233	WD REPEAT-CONTAINING PROTEIN 70; WDR70
617234	OOCYTE/ZYGOTE/EMBRYO MATURATION ARREST 16; OZEMA16
617235	MYOCLONUS, INTRACTABLE, NEONATAL; NEIMY
617236	CONE-ROD DYSTROPHY AND HEARING LOSS 1; CRDHL1
617237	IMMUNODEFICIENCY 49; IMD49
617238	MYOPIA 25, AUTOSOMAL DOMINANT; MYP25
617239	MYASTHENIC SYNDROME, CONGENITAL, 21, PRESYNAPTIC; CMS21
617240	HAND2 ANTISENSE RNA 1, NONCODING; HAND2AS1
617241	LUNG DISEASE, IMMUNODEFICIENCY, AND CHROMOSOME BREAKAGE SYNDROME; LICS
617242	TRANS-2,3-ENOYL-CoA REDUCTASE-LIKE PROTEIN; TECRL
617243	FANCONI ANEMIA, COMPLEMENTATION GROUP V; FANCV
617244	FANCONI ANEMIA, COMPLEMENTATION GROUP R; FANCR
617245	HECT, C2, AND WW DOMAINS-CONTAINING E3 UBIQUITIN-PROTEIN LIGASE 2; HECW2
617246	NSE2 (MMS21) HOMOLOG, SMC5-SMC6 COMPLEX SUMO LIGASE; NSMCE2
617247	FANCONI ANEMIA, COMPLEMENTATION GROUP U; FANCU
617248	3-METHYLGLUTACONIC ACIDURIA, TYPE VIII; MGCA8
617249	FAMILY WITH SEQUENCE SIMILARITY 122, MEMBER A; FAM122A
617250	ELKS/RAB6-INTERACTING/CAST FAMILY, MEMBER 2; ERC2
617251	UNCOMBABLE HAIR SYNDROME 2; UHS2
617252	UNCOMBABLE HAIR SYNDROME 3; UHS3
617253	SECKEL SYNDROME 10; SCKL10
617254	LAMIN TAIL DOMAIN-CONTAINING PROTEIN 1; LMNTD1
617255	LISSENCEPHALY 8; LIS8
617256	SOLUTE CARRIER FAMILY 7, MEMBER 13; SLC7A13
617257	SPERMATOGENESIS-ASSOCIATED PROTEIN 46; SPATA46
617258	MYOPATHY, MYOFIBRILLAR, 8; MFM8
617259	DDB1- AND CUL4-ASSOCIATED FACTOR 1; DCAF1
617260	GLOBAL DEVELOPMENTAL DELAY, ABSENT OR HYPOPLASTIC CORPUS CALLOSUM, AND DYSMORPHIC FACIES; GDACCF
617261	TRANSMEMBRANE PROTEIN 261; TMEM261
617262	ATP5S-LIKE PROTEIN; ATP5SL
617263	NSE1 HOMOLOG, SMC5-SMC6 COMPLEX COMPONENT; NSMCE1
617264	SR-RELATED C-TERMINAL DOMAIN-ASSOCIATED FACTOR 1; SCAF1
617265	POTASSIUM CHANNEL TETRAMERIZATION DOMAIN-CONTAINING PROTEIN 9; KCTD9
617266	KIAA0825 GENE; KIAA0825
617267	MATRIX AAA PEPTIDASE-INTERACTING PROTEIN 1; MAIP1
617268	NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, SEIZURES, AND ABSENT LANGUAGE; NDHSAL
617269	SOCS2 ANTISENSE RNA 1, NONCODING; SOCS2AS1
617270	INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 58; MRT58
617271	NEPHRONOPHTHISIS 20; NPHP20
617272	GLAUCOMA 3, PRIMARY CONGENITAL, E; GLC3E
617273	CBY1-INTERACTING BAR DOMAIN-CONTAINING PROTEIN 1; CIBAR1
617274	CBY1-INTERACTING BAR DOMAIN-CONTAINING PROTEIN 2; CIBAR2
617275	TOOTH AGENESIS, SELECTIVE, 9; STHAG9
617276	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 48; DEE48
617277	DYNEIN HEAVY CHAIN DOMAIN 1; DNHD1
617278	DENN DOMAIN-CONTAINING PROTEIN 5A; DENND5A
617279	DENN DOMAIN-CONTAINING PROTEIN 5B; DENND5B
617280	ATRIAL FIBRILLATION, FAMILIAL, 18; ATFB18
617281	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 49; DEE49
617282	DYSTONIA, CHILDHOOD-ONSET, WITH OPTIC ATROPHY AND BASAL GANGLIA ABNORMALITIES; DYTOABG
617283	YTH DOMAIN-CONTAINING PROTEIN 1; YTHDC1
617284	DYSTONIA 28, CHILDHOOD-ONSET; DYT28
617285	HIGH MOBILITY GROUP BOX 4; HMGB4
617286	PITX2 ADJACENT NONCODING RNA; PANCR
617287	PHOSPHOLIPID PHOSPHATASE-RELATED PROTEIN 5; PLPPR5
617288	SERINE PEPTIDASE INHIBITOR, KAZAL-TYPE, 7; SPINK7
617289	FAMILY WITH SEQUENCE SIMILARITY 53, MEMBER B; FAM53B
617290	EPILEPSY, EARLY-ONSET, 1, VITAMIN B6-DEPENDENT; EPEO1
617291	TRANSMEMBRANE PROTEIN 150B; TMEM150B
617292	TRANSMEMBRANE PROTEIN 150C; TMEM150C
617293	MATRIX REMODELING-ASSOCIATED PROTEIN 8; MXRA8
617294	EPIDERMOLYSIS BULLOSA SIMPLEX 6, GENERALIZED INTERMEDIATE, WITH OR WITHOUT CARDIOMYOPATHY; EBS6
617295	RUN DOMAIN-CONTAINING PROTEIN 3B; RUNDC3B
617296	SPASTIC PARAPLEGIA, INTELLECTUAL DISABILITY, NYSTAGMUS, AND OBESITY; SINO
617297	AMELOGENESIS IMPERFECTA, TYPE IJ; AI1J
617298	APOPTOSIS-INDUCING FACTOR, MITOCHONDRIA-ASSOCIATED, 3; AIFM3
617299	RPA-INTERACTING PROTEIN; RPAIN
617300	LYMPHATIC MALFORMATION 7; LMPHM7
617301	GLYCINE ENCEPHALOPATHY WITH NORMAL SERUM GLYCINE
617302	OPTIC ATROPHY 11; OPA11
617303	MUCOPOLYSACCHARIDOSIS-PLUS SYNDROME; MPSPS
617304	RETINITIS PIGMENTOSA 77; RP77
617305	FAMILY WITH SEQUENCE SIMILARITY 26, MEMBER F; FAM26F
617306	COLOBOMA, OSTEOPETROSIS, MICROPHTHALMIA, MACROCEPHALY, ALBINISM, AND DEAFNESS; COMMAD
617307	CHROMOSOME 14 OPEN READING FRAME 39; C14ORF39
617308	BILE ACID SYNTHESIS DEFECT, CONGENITAL, 6; CBAS6
617309	IMMUNOGLOBULIN-LIKE AND FIBRONECTIN TYPE III DOMAINS-CONTAINING PROTEIN 1; IGFN1
617310	ANKYRIN REPEAT AND STERILE ALPHA MOTIF DOMAINS-CONTAINING PROTEIN 3; ANKS3
617311	ZYMOGEN GRANULE PROTEIN, 16-KD; ZG16
617312	FHF COMPLEX SUBUNIT HOOK-INTERACTING PROTEIN 2A; FHIP2A
617313	SH2 DOMAIN-CONTAINING ADAPTOR PROTEIN F; SHF
617314	SH3 DOMAIN- AND SYLF DOMAIN-CONTAINING PROTEIN 1; SH3YL1
617315	ANTERIOR SEGMENT DYSGENESIS 6; ASGD6
617316	TP53 TARGET GENE 5; TP53TG5
617317	ZFP30 ZINC FINGER PROTEIN; ZFP30
617318	RUN DOMAIN- AND SH3 DOMAIN-CONTAINING PROTEIN 1; RUSC1
617319	ANTERIOR SEGMENT DYSGENESIS 8; ASGD8
617320	ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 12; ARCI12
617321	YAO SYNDROME; YAOS
617322	SH3KBP1-BINDING PROTEIN 1; SHKBP1
617323	INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 59; MRT59
617324	SHISA FAMILY, MEMBER 2; SHISA2
617325	SHISA FAMILY, MEMBER 3; SHISA3
617326	SHISA FAMILY, MEMBER 4; SHISA4
617327	SHISA FAMILY, MEMBER 6; SHISA6
617328	SHISA FAMILY, MEMBER 7; SHISA7
617329	SHISA FAMILY, MEMBER 8; SHISA8
617330	HYPOTONIA, ATAXIA, AND DELAYED DEVELOPMENT SYNDROME; HADDS
617331	MAJOR FACILITATOR SUPERFAMILY DOMAIN-CONTAINING PROTEIN 4B; MFSD4B
617332	TELOMERE REPEAT-BINDING BOUQUET FORMATION PROTEIN 1; TERB1
617333	INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND PTOSIS; IDDDFP
617334	ZINC FINGER DHHC-TYPE CONTAINING 23; ZDHHC23
617335	EMOPAMIL-BINDING PROTEIN-LIKE; EBPL
617336	CONGENITAL MYOPATHY 24; CMYP24
617337	ECTODERMAL DYSPLASIA 12, HYPOHIDROTIC/HAIR/TOOTH/NAIL TYPE; ECTD12
617338	NUDIX HYDROLASE 16-LIKE 1; NUDT16L1
617339	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 51; DEE51
617340	URIDINE PHOSPHORYLASE 2; UPP2
617341	CEREBRORETINAL MICROANGIOPATHY WITH CALCIFICATIONS AND CYSTS 2; CRMCC2
617342	PEPTIDYL-tRNA HYDROLASE DOMAIN-CONTAINING 1; PTRHD1
617343	HYPERPARATHYROIDISM 4; HRPT4
617344	PEAK1-RELATED KINASE-ACTIVATING PSEUDOKINASE 1; PRAG1
617345	ATP/GTP-BINDING PROTEIN-LIKE 2; AGBL2
617346	ATP/GTP-BINDING PROTEIN-LIKE 3; AGBL3
617347	HYPERLIPOPROTEINEMIA, TYPE III
617348	CARBOXYPEPTIDASE X, M14 FAMILY, MEMBER 2; CPXM2
617349	AORTIC ANEURYSM, FAMILIAL THORACIC 11, SUSCEPTIBILITY TO; AAT11
617350	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 52; DEE52
617351	IMMUNOGLOBULIN SUPERFAMILY, MEMBER 10; IGSF10
617352	MULCHANDANI-BHOJ-CONLIN SYNDROME; MBCS
617353	DYNEIN, LIGHT CHAIN, TCTEX-TYPE, 2B; DYNLT2B
617354	CHROMOBOX 8; CBX8
617355	EP300-INTERACTING INHIBITOR OF DIFFERENTIATION 2B; EID2B
617356	SUBCOMMISSURAL ORGAN SPONDIN; SSPO
617357	ZINC FINGER PROTEIN 222; ZNF222
617358	SYNDECAN-BINDING PROTEIN 2; SDCBP2
617359	STORKHEAD BOX 2; STOX2
617360	CONGENITAL HEART DEFECTS, DYSMORPHIC FACIAL FEATURES, AND INTELLECTUAL DEVELOPMENTAL DISORDER; CHDFIDD
617361	TRANSMEMBRANE PROTEIN 108; TMEM108
617362	DEAH-BOX HELICASE 37; DHX37
617363	TRANSMEMBRANE PROTEIN 132A; TMEM132A
617364	CONGENITAL HEART DEFECTS AND ECTODERMAL DYSPLASIA; CHDED
617365	AAR2 SPLICING FACTOR; AAR2
617366	COILED-COIL DOMAIN-CONTAINING PROTEIN 91; CCDC91
617367	KIAA1217 GENE; KIAA1217
617368	SH3 DOMAIN-BINDING PROTEIN 1; SH3BP1
617369	HYALURONAN-BINDING PROTEIN 4; HABP4
617370	PEROXISOME BIOGENESIS DISORDER 10B; PBD10B
617371	ZINC FINGER PROTEIN 462; ZNF462
617372	SHC TRANSFORMING PROTEIN 4; SHC4
617373	PROLINE-RICH COILED-COIL PROTEIN 2C; PRRC2C
617374	INHIBITOR OF CDK, CYCLIN A1-INTERACTING PROTEIN 1; INCA1
617375	KELCH DOMAIN-CONTAINING PROTEIN 9; KLHDC9
617376	PROLINE-RICH CYCLIN A1-INTERACTING PROTEIN; PROCA1
617377	SYNAPSE DEFECTIVE RHO GTPase HOMOLOG 1; SYDE1
617378	MYOSIN LIGHT CHAIN 11; MYL11
617379	MYOSIN XIX; MYO19
617380	TRANSLOCASE OF INNER MITOCHONDRIAL MEMBRANE 29; TIMM29
617381	NUDIX HYDROLASE 16; NUDT16
617382	START DOMAIN-CONTAINING PROTEIN 10; STARD10
617383	AVASCULAR NECROSIS OF FEMORAL HEAD, PRIMARY, 2; ANFH2
617384	HYPERPHENYLALANINEMIA, MILD, NON-BH4-DEFICIENT; HPANBH4
617385	ATPase, H+ TRANSPORTING, LYSOSOMAL, 31-KD, V1 SUBUNIT E, ISOFORM 1; ATP6V1E2
617386	NUCLEAR RECEPTOR SUBFAMILY 1, GROUP H, MEMBER 5, PSEUDOGENE; NR1H5P
617387	GLUTAMINE-RICH PROTEIN 1; QRICH1
617388	AUTOINFLAMMATION WITH ARTHRITIS AND DYSKERATOSIS; AIADK
617389	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 53; DEE53
617390	KIAA1958 GENE; KIAA1958
617391	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 54; DEE54
617392	ECTODERMAL DYSPLASIA 13, HAIR/TOOTH TYPE; ECTD13
617393	NEURODEVELOPMENTAL DISORDER WITH EPILEPSY, CATARACTS, FEEDING DIFFICULTIES, AND DELAYED BRAIN MYELINATION; NECFM
617394	SCLEROSING CHOLANGITIS, NEONATAL; NSC
617395	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIq; CDG2Q
617396	ANAUXETIC DYSPLASIA 2; ANXD2
617397	PSEUDO-TORCH SYNDROME 2; PTORCH2
617398	FK506-BINDING PROTEIN 15; FKBP15
617399	PEROXISOMAL MEMBRANE PROTEIN 2; PXMP2
617400	EPOXIDE HYDROLASE 3; EPHX3
617401	EPOXIDE HYDROLASE 4; EPHX4
617402	CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIC; ARCL2C
617403	CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IID; ARCL2D
617404	MUSCULAR DYSTROPHY, CONGENITAL, WITH CATARACTS AND INTELLECTUAL DISABILITY; MDCCAID
617405	SHORT-RIB THORACIC DYSPLASIA 17 WITH OR WITHOUT POLYDACTYLY; SRTD17
617406	BARDET-BIEDL SYNDROME 21; BBS21
617407	POLYCOMB GROUP RING FINGER PROTEIN 5; PCGF5
617408	DIAMOND-BLACKFAN ANEMIA 16; DBA16
617409	DIAMOND-BLACKFAN ANEMIA 17; DBA17
617410	ZINC FINGER PROTEIN 419; ZNF419
617411	ADP-RIBOSYLATION FACTOR GUANINE NUCLEOTIDE EXCHANGE FACTOR 3; ARFGEF3
617412	BRACHYCEPHALY, TRICHOMEGALY, AND DEVELOPMENTAL DELAY; BTDD
617413	PRUNE EXOPOLYPHOSPHATASE 1; PRUNE1
617414	RIBOSOMAL PROTEIN L14; RPL14
617415	RIBOSOMAL PROTEIN L31; RPL31
617416	RIBOSOMAL PROTEIN L3-LIKE; RPL3L
617417	RIBOSOMAL PROTEIN L7-LIKE 1; RPL7L1
617418	WD REPEAT-CONTAINING PROTEIN 59; WDR59
617419	PROLYL 3-HYDROXYLASE 4; P3H4
617420	KICSTOR SUBUNIT 2; KICS2
617421	INTEGRIN-ALPHA FG-GAP REPEAT-CONTAINING PROTEIN 2; ITFG2
617422	ACTIVITY-DEPENDENT NEUROPROTECTOR HOMEOBOX 2; ADNP2
617423	PROLINE-RICH PROTEIN 14; PRR14
617424	WD REPEAT-CONTAINING PROTEIN 26; WDR26
617425	IMMUNOSKELETAL DYSPLASIA WITH NEURODEVELOPMENTAL ABNORMALITIES; ISDNA
617426	CYSTEINE-RICH C-TERMINAL 1; CRCT1
617427	S100 CALCIUM-BINDING PROTEIN A7A; S100A7A
617428	CHROMOSOME 1 OPEN READING FRAME 43; C1ORF43
617429	UBIQUITIN-CONJUGATING ENZYME E2 Q1; UBE2Q1
617430	ADHESION G PROTEIN-COUPLED RECEPTOR F1; ADGRF1
617431	UBIQUITIN-SPECIFIC PEPTIDASE 53; USP53
617432	INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 60; MRT60
617433	RETINITIS PIGMENTOSA 78; RP78
617434	LONG NONCODING RNA HOST2
617435	LOPES-MACIEL-RODAN SYNDROME; LOMARS
617436	GON7 SUBUNIT OF KEOPS COMPLEX; GON7
617437	S100 CALCIUM-BINDING PROTEIN A16; S100A16
617438	CHROMOBOX 6; CBX6
617439	CRANIOSYNOSTOSIS 7; CRS7
617440	PAPILLARY THYROID CARCINOMA SUSCEPTIBILITY CANDIDATE 1 GENE; PTCSC1
617441	THROMBOCYTOPENIA, ANEMIA, AND MYELOFIBROSIS; THAMY
617442	PREMATURE OVARIAN FAILURE 13; POF13
617443	BLEEDING DISORDER, PLATELET-TYPE, 21; BDPLT21
617444	ZINC FINGER PROTEIN 479; ZNF479
617445	UBIQUITIN-SPECIFIC PEPTIDASE 48; USP48
617446	CHAC CATION TRANSPORT REGULATOR HOMOLOG 2; CHAC2
617447	PABP-DEPENDENT POLY(A) NUCLEASE 2; PAN2
617448	PABP-DEPENDENT POLY(A) NUCLEASE 3; PAN3
617449	TRANSMEMBRANE PROTEIN 260; TMEM260
617450	JANSEN-DE VRIES SYNDROME; JDVS
617451	ALDO-KETO REDUCTASE FAMILY 1, MEMBER E2; AKR1E2
617452	INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES, SEIZURES, AND DISTAL LIMB ANOMALIES; IDDFSDA
617453	TETRATRICOPEPTIDE REPEAT DOMAIN-CONTAINING PROTEIN 26; TTC26
617454	POLYMERASE III, RNA, SUBUNIT C; POLR3C
617455	POLYMERASE III, RNA, SUBUNIT F; POLR3F
617456	POLYMERASE III, RNA, SUBUNIT G; POLR3G
617457	POLYMERASE III, RNA, SUBUNIT G-LIKE; POLR3GL
617458	PRKR-INTERACTING PROTEIN 1, IL11-INDUCIBLE; PRKRIP1
617459	TRANSMEMBRANE AND COILED-COIL DOMAIN FAMILY, MEMBER 3; TMCC3
617460	RETINITIS PIGMENTOSA 79; RP79
617461	YBEY METALLOPEPTIDASE; YBEY
617462	PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR-GAMMA, COACTIVATOR-RELATED PROTEIN 1; PPRC1
617463	UNKEMPT FAMILY-LIKE ZINC FINGER; UNKL
617464	UNC5 FAMILY C-TERMINAL-LIKE PROTEIN; UNC5CL
617465	SMALL INTEGRAL MEMBRANE PROTEIN 20; SMIM20
617466	TOWNES-BROCKS SYNDROME 2; TBS2
617467	FERM DOMAIN-CONTAINING PROTEIN 4B; FRMD4B
617468	ARTHROGRYPOSIS MULTIPLEX CONGENITA 1, NEUROGENIC, WITH MYELIN DEFECT; AMC1
617469	AFG1-LIKE ATPase; AFG1L
617470	UBIQUITIN-SPECIFIC PEPTIDASE-LIKE 1; USPL1
617471	SERPIN PEPTIDASE INHIBITOR, CLADE A, MEMBER 12; SERPINA12
617472	TENASCIN N; TNN
617473	ATP SYNTHASE, H+ TRANSPORTING, MITOCHONDRIAL F0 COMPLEX, SUBUNIT G; ATP5L
617474	ZINC FINGER PROTEIN 609; ZNF609
617475	SPECIFIC GRANULE DEFICIENCY 2; SGD2
617476	CNKSR FAMILY, MEMBER 3; CNKSR3
617477	ZINC FINGER PROTEIN 324; ZNF324
617478	STRUCTURAL HEART DEFECTS AND RENAL ANOMALIES SYNDROME; SHDRA
617479	SSU2 HOMOLOG; SSUH2
617480	46,XX SEX REVERSAL 4; SRXX4
617481	NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, HYPOTONIA, AND VARIABLE BRAIN ANOMALIES; NMIHBA
617482	TP53 TARGET GENE 3; TP53TG3
617483	CORNICHON FAMILY AMPA RECEPTOR AUXILIARY PROTEIN 4; CNIH4
617484	GAMETOCYTE-SPECIFIC FACTOR 1; GTSF1
617485	WD REPEAT- AND FYVE DOMAIN-CONTAINING PROTEIN 3; WDFY3
617486	G-PATCH DOMAIN-CONTAINING PROTEIN 3; GPATCH3
617487	DNAJ/HSP40 HOMOLOG, SUBFAMILY B, MEMBER 14; DNAJB14
617488	RNA PSEUDOURIDYLATE SYNTHASE DOMAIN-CONTAINING PROTEIN 4; RPUSD4
617489	LONG INTERGENIC NONCODING RNA 305; LINC00305
617490	CATION CHANNEL, SPERM-ASSOCIATED, AUXILIARY SUBUNIT DELTA; CATSPERD
617491	NOP2/SUN RNA METHYLTRANSFERASE FAMILY, MEMBER 3; NSUN3
617492	OLFACTOMEDIN 2; OLFM2
617493	NEURODEVELOPMENTAL DISORDER WITH INVOLUNTARY MOVEMENTS; NEDIM
617494	ECHINODERM MICROTUBULE-ASSOCIATED PROTEIN-LIKE 2; EML2
617495	FAMILY WITH SEQUENCE SIMILARITY 19, MEMBER A1, CC MOTIF CHEMOKINE-LIKE; FAM19A1
617496	FAMILY WITH SEQUENCE SIMILARITY 19, MEMBER A2, CC MOTIF CHEMOKINE-LIKE; FAM19A2
617497	FAMILY WITH SEQUENCE SIMILARITY 19, MEMBER A3, CC MOTIF CHEMOKINE-LIKE; FAM19A3
617498	FAMILY WITH SEQUENCE SIMILARITY 19, MEMBER A4, CC MOTIF CHEMOKINE-LIKE; FAM19A4
617499	FAMILY WITH SEQUENCE SIMILARITY 19, MEMBER A5, CC MOTIF CHEMOKINE-LIKE; FAM19A5
617500	UROTHELIAL CANCER-ASSOCIATED GENE 1; UCA1
617501	LYSINE ACETYLTRANSFERASE 14; KAT14
617502	WD REPEAT-CONTAINING PROTEIN 41; WDR41
617503	DENN DOMAIN-CONTAINING PROTEIN 3; DENND3
617504	SIPA1-LIKE PROTEIN 1; SIPA1L1
617505	TRANSLOCATION-ASSOCIATED MEMBRANE PROTEIN 1-LIKE 1; TRAM1L1
617506	NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR 2; NSLH2
617507	PEHO-LIKE SYNDROME; PEHOL
617508	ZINC FINGER PROTEIN 598; ZNF598
617509	VON WILLEBRAND FACTOR A DOMAIN-CONTAINING PROTEIN 8; VWA8
617510	CATION CHANNEL, SPERM-ASSOCIATED, AUXILIARY SUBUNIT EPSILON; CATSPERE
617511	CATION CHANNEL, SPERM-ASSOCIATED, AUXILIARY SUBUNIT ZETA; CATSPERZ
617512	ZINC FINGER PROTEIN 318; ZNF318
617513	OXOGLUTARATE DEHYDROGENASE-LIKE PROTEIN; OGDHL
617514	IMMUNODEFICIENCY 52; IMD52
617515	RHOMBOID DOMAIN-CONTAINING 1; RHBDD1
617516	STANKIEWICZ-ISIDOR SYNDROME; STISS
617517	RIBOSOMAL PROTEIN S6 KINASE C1; RPS6KC1
617518	BSD DOMAIN-CONTAINING PROTEIN 1; BSDC1
617519	NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, NEUROPATHY, AND DEAFNESS; NEDHND
617520	MICROCEPHALY 18, PRIMARY, AUTOSOMAL DOMINANT; MCPH18
617521	YIP1 DOMAIN FAMILY, MEMBER 1; YIPF1
617522	YIP1 DOMAIN FAMILY, MEMBER 2; YIPF2
617523	NEURODEVELOPMENTAL DISORDER WITH MIDBRAIN AND HINDBRAIN MALFORMATIONS; NEDMHM
617524	ERYTHROKERATODERMIA VARIABILIS ET PROGRESSIVA 2; EKVP2
617525	ERYTHROKERATODERMIA VARIABILIS ET PROGRESSIVA 3; EKVP3
617526	ERYTHROKERATODERMIA VARIABILIS ET PROGRESSIVA 4; EKVP4
617527	NEURODEVELOPMENTAL DISORDER WITH PROGRESSIVE MICROCEPHALY, SPASTICITY, AND BRAIN ANOMALIES; NDMSBA
617528	PROTEASOME ASSEMBLY CHAPERONE 3; PSMG3
617529	FAST KINASE DOMAINS 1; FASTKD1
617530	FAST KINASE DOMAINS 3; FASTKD3
617531	COLLAGEN BETA(1-O)GALACTOSYLTRANSFERASE 1; COLGALT1
617532	INTELLECTUAL DEVELOPMENTAL DISORDER WITH NEUROPSYCHIATRIC FEATURES; IDDNPF
617533	COLLAGEN BETA(1-O)GALACTOSYLTRANSFERASE 2; COLGALT2
617534	YIP1 DOMAIN FAMILY, MEMBER 4; YIPF4
617535	FAS APOPTOTIC INHIBITORY MOLECULE; FAIM
617536	BAI1-ASSOCIATED PROTEIN 2-LIKE 2; BAIAP2L2
617537	RAHMAN SYNDROME; RMNS
617538	ELONGATION FACTOR-LIKE GTPase 1; EFL1
617539	CHLORIDE CHANNEL CLIC-LIKE 1; CLCC1
617540	PITUITARY ADENOMA 5, MULTIPLE TYPES; PITA5
617541	ANKYRIN REPEAT- AND ZINC FINGER DOMAIN-CONTAINING 1; ANKZF1
617542	GAZE PALSY, FAMILIAL HORIZONTAL, WITH PROGRESSIVE SCOLIOSIS 2, WITH IMPAIRED INTELLECTUAL DEVELOPMENT; HGPPS2
617543	POLYCOMB GROUP RING FINGER PROTEIN 3; PCGF3
617544	LONG INTERGENIC NONCODING RNA 672; LINC00672
617545	MINICHROMOSOME MAINTENANCE DOMAIN-CONTAINING PROTEIN 2; MCMDC2
617546	HELT bHLH TRANSCRIPTION FACTOR; HELT
617547	RETINAL DYSTROPHY WITH OR WITHOUT MACULAR STAPHYLOMA; RDMS
617548	WAP 4-DISULFIDE CORE DOMAIN 2; WFDC2
617549	TUMOR PROTEIN p53-INDUCIBLE NUCLEAR PROTEIN 2; TP53INP2
617550	PROTEASOME ASSEMBLY CHAPERONE 4; PSMG4
617551	SID1 TRANSMEMBRANE FAMILY, MEMBER 2; SIDT2
617552	RHO GUANINE NUCLEOTIDE EXCHANGE FACTOR 26; ARHGEF26
617553	Fc FRAGMENT OF IgG-BINDING PROTEIN; FCGBP
617554	FYVE, RhoGEF, AND PH DOMAIN-CONTAINING PROTEIN 3; FGD3
617555	FCH AND DOUBLE SH3 DOMAINS PROTEIN 1; FCHSD1
617556	FCH AND DOUBLE SH3 DOMAINS PROTEIN 2; FCHSD2
617557	GABRIELE-DE VRIES SYNDROME; GADEVS
617558	CILIA- AND FLAGELLA-ASSOCIATED PROTEIN 43; CFAP43
617559	CILIA- AND FLAGELLA-ASSOCIATED PROTEIN 44; CFAP44
617560	SPASTIC ATAXIA 8, AUTOSOMAL RECESSIVE, WITH HYPOMYELINATING LEUKODYSTROPHY; SPAX8
617561	COHEN-GIBSON SYNDROME; COGIS
617562	MECKEL SYNDROME 13; MKS13
617563	OROFACIODIGITAL SYNDROME XVI; OFD16
617564	MEIER-GORLIN SYNDROME 8; MGORS8
617565	PERRAULT SYNDROME 6; PRLTS6
617566	ZINC FINGER PROTEIN 568; ZNF568
617567	TUMOR PROTEIN D52-LIKE 3; TPD52L3
617568	UPSTREAM TRANSCRIPTION FACTOR FAMILY, MEMBER 3; USF3
617569	KINESIN FAMILY, MEMBER 15; KIF15
617570	DAZ-INTERACTING ZINC FINGER PROTEIN 1-LIKE; DZIP1L
617571	ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 14; ARCI14
617572	EXUDATIVE VITREORETINOPATHY 7; EVR7
617573	C-TYPE LECTIN DOMAIN FAMILY 12, MEMBER B; CLEC12B
617574	ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 13; ARCI13
617575	RENI SYNDROME; RENI
617576	SPERMATOGENIC FAILURE 18; SPGF18
617577	CILIARY DYSKINESIA, PRIMARY, 37; CILD37
617578	FER3-LIKE bHLH TRANSCRIPTION FACTOR; FERD3L
617579	CLAUDIN 10; CLDN10
617580	TETRASPANIN 16; TSPAN16
617581	C2 CALCIUM-DEPENDENT DOMAIN-CONTAINING PROTEIN 2; C2CD2
617582	C2 CALCIUM-DEPENDENT DOMAIN-CONTAINING PROTEIN 2-LIKE; C2CD2L
617583	SULFIREDOXIN 1; SRXN1
617584	SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 25; SCAR25
617585	IMMUNODEFICIENCY 53; IMD53
617586	FERM, ARHGEF, AND PLECKSTRIN DOMAINS-CONTAINING PROTEIN 2; FARP2
617587	SMALL PROLINE-RICH PROTEIN 2D; SPRR2D
617588	SMALL PROLINE-RICH PROTEIN 2E; SPRR2E
617589	SMALL PROLINE-RICH PROTEIN 2F; SPRR2F
617590	SMALL PROLINE-RICH PROTEIN 2G; SPRR2G
617591	PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 3; PRAAS3
617592	SPERMATOGENIC FAILURE 19; SPGF19
617593	SPERMATOGENIC FAILURE 20; SPGF20
617594	JUNCTIONAL CADHERIN COMPLEX REGULATOR; JHY
617595	BIRK-LANDAU-PEREZ SYNDROME; BILAPES
617596	MALEYLACETOACETATE ISOMERASE DEFICIENCY; MAAID
617597	RETINOL SATURASE; RETSAT
617598	MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 3; MVA3
617599	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 55; DEE55
617600	INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 45; MRD45
617601	INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 46; MRD46
617602	CONGENITAL HEART DEFECTS AND SKELETAL MALFORMATIONS SYNDROME; CHDSKM
617603	RNA-BINDING MOTIF PROTEIN 24; RBM24
617604	MICROCEPHALY, SHORT STATURE, AND LIMB ABNORMALITIES; MISSLA
617605	DEAFNESS, AUTOSOMAL DOMINANT 71; DFNA71
617606	DEAFNESS, AUTOSOMAL DOMINANT 72; DFNA72
617607	AMELOGENESIS IMPERFECTA, TYPE IIIB; AI3B
617608	ALPHA KINASE 3; ALPK3
617609	NEPHROTIC SYNDROME, TYPE 15; NPHS15
617610	POLYCYSTIC KIDNEY DISEASE 5; PKD5
617611	PICALM-INTERACTING MITOTIC REGULATOR; PIMREG
617612	ARMADILLO REPEAT-CONTAINING PROTEIN 9; ARMC9
617613	MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 5; MMDS5
617614	SPOUT DOMAIN-CONTAINING METHYLTRANSFERASE 1; SPOUT1
617615	TRANSMEMBRANE PROTEIN 258; TMEM258
617616	SKRABAN-DEARDORFF SYNDROME; SKDEAS
617617	SPRY4 INTRONIC TRANSCRIPT 1, NONCODING; SPRY4IT1
617618	TOG ARRAY REGULATOR OF AXONEMAL MICROTUBULES 1; TOGARAM1
617619	MISATO MITOCHONDRIAL DISTRIBUTION AND MORPHOLOGY REGULATOR 1; MSTO1
617620	LEUCINE-RICH REPEAT-CONTAINING PROTEIN 3; LRRC3
617621	PAX3- AND PAX7-BINDING PROTEIN 1; PAXBP1
617622	JOUBERT SYNDROME 30; JBTS30
617623	SPEEDY/RINGO CELL CYCLE REGULATOR FAMILY, MEMBER E1; SPDYE1
617624	SPEEDY/RINGO CELL CYCLE REGULATOR FAMILY, MEMBER E2; SPDYE2
617625	SPEEDY/RINGO CELL CYCLE REGULATOR FAMILY, MEMBER E3; SPDYE3
617626	FIBROMATOSIS, GINGIVAL, 5; GINGF5
617627	SMALL REGULATORY POLYPEPTIDE OF AMINO ACID RESPONSE; SPAAR
617628	SPEEDY/RINGO CELL CYCLE REGULATOR FAMILY, MEMBER E4; SPDYE4
617629	SCHIZOPHRENIA 19; SCZD19
617630	G PROTEIN-COUPLED RECEPTOR 37-LIKE 1; GPR37L1
617631	IQ DOMAIN-CONTAINING PROTEIN E; IQCE
617632	EF-HAND CALCIUM-BINDING DOMAIN-CONTAINING PROTEIN 7; EFCAB7
617633	SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 26; SCAR26
617634	COILED-COIL GLUTAMATE-RICH PROTEIN 2; CCER2
617635	INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 47; MRD47
617636	CMKLR2 ANTISENSE RNA; CMKLR2AS
617637	DEAFNESS, AUTOSOMAL RECESSIVE 106; DFNB106
617638	IMMUNODEFICIENCY 11B WITH ATOPIC DERMATITIS; IMD11B
617639	DEAFNESS, AUTOSOMAL RECESSIVE 107; DFNB107
617640	SUPPRESSOR OF TUMORIGENICITY 7-LIKE PROTEIN; ST7L
617641	CONGENITAL ANOMALIES OF KIDNEY AND URINARY TRACT SYNDROME WITH OR WITHOUT HEARING LOSS, ABNORMAL EARS, OR DEVELOPMENTAL DELAY; CAKUTHED
617642	POLYDACTYLY, POSTAXIAL, TYPE A7; PAPA7
617643	CEREBELLAR ATROPHY, DEVELOPMENTAL DELAY, AND SEIZURES; CADEDS
617644	SPERMATOGENIC FAILURE 21; SPGF21
617645	KELCH REPEAT- AND BTB/POZ DOMAIN-CONTAINING PROTEIN 4; KBTBD4
617646	BAH DOMAIN- AND COILED-COIL DOMAIN-CONTAINING PROTEIN 1; BAHCC1
617647	PROSTATE CANCER-ASSOCIATED TRANSCRIPT 18, NONCODING; PCAT18
617648	BMP2-INDUCIBLE KINASE; BMP2K
617649	UBIQUITIN-CONJUGATING ENZYME E2 O; UBE2O
617650	PTGS2 ANTISENSE NFKB1 COMPLEX-MEDIATED EXPRESSION REGULATOR RNA, NONCODING; PACERR
617651	EQTN, MOB3B, IFNK, AND C9ORF72 ENHANCER RNA I, NONCODING
617652	MOB KINASE ACTIVATOR 3B; MOB3B
617653	EQUATORIN; EQTN
617654	DEAFNESS, AUTOSOMAL RECESSIVE 108; DFNB108
617655	PECANEX 1; PCNX1
617656	PECANEX 2; PCNX2
617657	PECANEX 3; PCNX3
617658	SULFIDE:QUINONE OXIDOREDUCTASE; SQOR
617659	LIPOYL(OCTANOYL) TRANSFERASE 2; LIPT2
617660	VERTEBRAL, CARDIAC, RENAL, AND LIMB DEFECTS SYNDROME 1; VCRL1
617661	VERTEBRAL, CARDIAC, RENAL, AND LIMB DEFECTS SYNDROME 2; VCRL2
617662	JOINT LAXITY, SHORT STATURE, AND MYOPIA; JLSM
617663	DEAFNESS, AUTOSOMAL DOMINANT 73; DFNA73
617664	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 32; COXPD32
617665	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 56; DEE56
617666	FRASER SYNDROME 2; FRASRS2
617667	FRASER SYNDROME 3; FRASRS3
617668	ENCEPHALOPATHY, NEONATAL SEVERE, WITH LACTIC ACIDOSIS AND BRAIN ABNORMALITIES; NELABA
617669	ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN ATROPHY AND SPASTICITY; PEBAS
617670	MEIOSIS-SPECIFIC PROTEIN WITH OB DOMAINS; MEIOB
617671	HELIX SYNDROME; HELIX
617672	NEURODEGENERATION, CHILDHOOD-ONSET, WITH BRAIN ATROPHY; CONDBA
617673	SPERMATOGENESIS-ASSOCIATED PROTEIN 22; SPATA22
617674	STRESS-ASSOCIATED ENDOPLASMIC RETICULUM PROTEIN 1; SERP1
617675	MYOPATHY, MITOCHONDRIAL, AND ATAXIA; MMYAT
617676	PROTEASOME 26S SUBUNIT, NON-ATPase, 3; PSMD3
617677	ZO2-ASSOCIATED SPECKLE PROTEIN
617678	PROSTATE CANCER-ASSOCIATED TRANSCRIPT 2, NONCODING; PCAT2
617679	KELCH-LIKE 20; KLHL20
617680	SSU72 HOMOLOG, RNA POLYMERASE II CTD PHOSPHATASE; SSU72
617681	BLEPHAROCHEILODONTIC SYNDROME 2; BCDS2
617682	PILAROWSKI-BJORNSSON SYNDROME; PILBOS
617683	EGF-LIKE, FIBRONECTIN TYPE III, AND LAMININ G DOMAINS-CONTAINING PROTEIN; EGFLAM
617684	Ly1 ANTIBODY-REACTIVE PROTEIN; LYAR
617685	CADHERIN 26; CDH26
617686	PITUITARY ADENOMA 3, MULTIPLE TYPES; PITA3
617687	TBC1 DOMAIN FAMILY, MEMBER 23; TBC1D23
617688	PROSTATE ANDROGEN-REGULATED MUCIN-LIKE PROTEIN 1; PARM1
617689	COLD-SHOCK DOMAIN-CONTAINING PROTEIN C2; CSDC2
617690	OVARIAN DYSGENESIS 5; ODG5
617691	SPINOCEREBELLAR ATAXIA 44; SCA44
617692	PR DOMAIN-CONTAINING PROTEIN 15; PRDM15
617693	VITRIN; VIT
617694	AL KAISSI SYNDROME; ALKAS
617695	PONTOCEREBELLAR HYPOPLASIA, TYPE 11; PCH11
617696	LONG INTERGENIC NONCODING RNA 1488; LINC01488
617697	LONG INTERGENIC NONCODING RNA 2757; LINC02747
617698	3-METHYLGLUTACONIC ACIDURIA, TYPE IX; MGCA9
617699	GID COMPLEX, SUBUNIT 4; GID4
617700	UBIQUITIN-CONJUGATING ENZYME E2 F; UBE2F
617701	CANCER SUSCEPTIBILITY CANDIDATE 8, NONCODING; CASC8
617702	CANCER SUSCEPTIBILITY CANDIDATE 21, NONCODING; CASC21
617703	CANCER SUSCEPTIBILITY CANDIDATE 19, NONCODING; CASC19
617704	CANCER SUSCEPTIBILITY CANDIDATE 11, NONCODING; CASC11
617705	COLON CANCER-ASSOCIATED TRANSCRIPT 1, NONCODING; CCAT1
617706	SPERMATOGENIC FAILURE 22; SPGF22
617707	SPERMATOGENIC FAILURE 23; SPGF23
617708	CELL DIVISION CYCLE 123; CDC123
617709	NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, ATAXIA, AND SEIZURES; NEDMAS
617710	NEURODEVELOPMENTAL DISORDER, MITOCHONDRIAL, WITH ABNORMAL MOVEMENTS AND LACTIC ACIDOSIS, WITH OR WITHOUT SEIZURES; NEMMLAS
617711	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 91; DEE91
617712	OOCYTE/ZYGOTE/EMBRYO MATURATION ARREST 3; OZEMA3
617713	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 33; COXPD33
617714	CAVEOLAE-ASSOCIATED PROTEIN 4; CAVIN4
617715	MAM AND LDL RECEPTOR CLASS A DOMAIN-CONTAINING PROTEIN 1; MALRD1
617716	RHO GTPase-ACTIVATING PROTEIN 44; ARHGAP44
617717	AUDITORY NEUROPATHY AND OPTIC ATROPHY; ANOA
617718	IMMUNODEFICIENCY 71 WITH INFLAMMATORY DISEASE AND CONGENITAL THROMBOCYTOPENIA; IMD71
617719	EPIPHYSEAL DYSPLASIA, MULTIPLE, 7; EDM7
617720	PROTEIN PHOSPHATASE 1, REGULATORY SUBUNIT 42; PPP1R42
617721	NEURONOPATHY, DISTAL HEREDITARY MOTOR, AUTOSOMAL DOMINANT 9; HMND9
617722	THIOREDOXIN-LIKE 4B; TXNL4B
617723	RIBOSOMAL RNA-PROCESSING 12; RRP12
617724	TSC22 DOMAIN FAMILY, MEMBER 2; TSC22D2
617725	FUCOSE MUTAROTASE; FUOM
617726	CASPASE RECRUITMENT DOMAIN-CONTAINING PROTEIN 19; CARD19
617727	TRANSMEMBRANE 9 SUPERFAMILY, MEMBER 4; TM9SF4
617728	CENTROSOMAL PROTEIN, 295-KD; CEP295
617729	GALLOWAY-MOWAT SYNDROME 3; GAMOS3
617730	GALLOWAY-MOWAT SYNDROME 4; GAMOS4
617731	GALLOWAY-MOWAT SYNDROME 5; GAMOS5
617732	FACIAL PALSY, CONGENITAL, WITH PTOSIS AND VELOPHARYNGEAL DYSFUNCTION; FPVEPD
617733	ZINC FINGER PROTEIN 518A; ZNF518A
617734	ZINC FINGER PROTEIN 518B; ZNF518B
617735	CHROMOSOME 10 OPEN READING FRAME 90; C10ORF90
617736	MORN REPEAT-CONTAINING PROTEIN 4; MORN4
617737	SPHINGOMYELIN PHOSPHODIESTERASE, ACID-LIKE, 3B; SMPDL3B
617738	KELCH REPEAT- AND BTB DOMAIN-CONTAINING PROTEIN 6; KBTBD6
617739	KELCH REPEAT- AND BTB DOMAIN-CONTAINING PROTEIN 7; KBTBD7
617740	V-SET AND IMMUNOGLOBULIN DOMAINS-CONTAINING PROTEIN 10-LIKE; VSIG10L
617741	WD REPEAT-CONTAINING PROTEIN 20; WDR20
617742	KAT8 REGULATORY NSL COMPLEX, SUBUNIT 3; KANSL3
617743	OOCYTE/ZYGOTE/EMBRYO MATURATION ARREST 4; OZEMA4
617744	IMMUNODEFICIENCY, DEVELOPMENTAL DELAY, AND HYPOHOMOCYSTEINEMIA; IMDDHH
617745	MAJOR FACILITATOR SUPERFAMILY DOMAIN-CONTAINING PROTEIN 12; MFSD12
617746	SWEENEY-COX SYNDROME; SWCOS
617747	NUCLEAR BODY PROTEIN SP140-LIKE; SP140L
617748	TUDOR DOMAIN-CONTAINING PROTEIN 5; TDRD5
617749	ACTN3 DEFICIENCY
617750	LIM AND CALPONIN HOMOLOGY DOMAINS-CONTAINING PROTEIN 1; LIMCH1
617751	INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 48; MRD48
617752	CLARK-BARAITSER SYNDROME; CLABARS
617753	RIO KINASE 1; RIOK1
617754	RIO KINASE 2; RIOK2
617755	NEURODEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND DISTAL LIMB ANOMALIES; NEDDFL
617756	ERYTHROKERATODERMIA VARIABILIS ET PROGRESSIVA 5; EKVP5
617757	JOUBERT SYNDROME 32; JBTS32
617758	ZINC FINGER PROTEIN 692; ZNF692
617759	RNA PSEUDOURIDYLATE SYNTHASE DOMAIN-CONTAINING PROTEIN 3; RPUSD3
617760	MYOPATHY, CENTRONUCLEAR, 6, WITH FIBER-TYPE DISPROPORTION; CNM6
617761	JOUBERT SYNDROME 31; JBTS31
617762	LEUKODYSTROPHY, PROGRESSIVE, EARLY CHILDHOOD-ONSET; PLDECO
617763	SHORT STATURE, HEARING LOSS, RETINITIS PIGMENTOSA, AND DISTINCTIVE FACIES; SHRF
617764	ZYG11-RELATED CELL CYCLE REGULATOR; ZER1
617765	IMMUNODEFICIENCY, COMMON VARIABLE, 14; CVID14
617766	FAMILY WITH SEQUENCE SIMILARITY 192, MEMBER A; FAM192A
617767	JOUBERT SYNDROME 33; JBTS33
617768	KLEEFSTRA SYNDROME 2; KLEFS2
617769	SPINOCEREBELLAR ATAXIA 45; SCA45
617770	SPINOCEREBELLAR ATAXIA 46; SCA46
617771	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 57; DEE57
617772	DEAFNESS, AUTOSOMAL DOMINANT 34, WITH OR WITHOUT INFLAMMATION; DFNA34
617773	INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 61; MRT61
617774	LON PEPTIDASE 2, PEROXISOMAL; LONP2
617775	CHROMOSOME 10 OPEN READING FRAME 99; C10ORF99
617776	BAGE FAMILY, MEMBER 2; BAGE2
617777	BAGE FAMILY, MEMBER 3; BAGE3
617778	THIOREDOXIN DOMAIN-CONTAINING PROTEIN 15; TXNDC15
617779	TRANSMEMBRANE PROTEIN 256; TMEM256
617780	COMBINED IMMUNODEFICIENCY AND MEGALOBLASTIC ANEMIA WITH OR WITHOUT HYPERHOMOCYSTEINEMIA; CIMAH
617781	RETINITIS PIGMENTOSA 80; RP80
617782	GREB1-LIKE RETINOIC ACID RECEPTOR COACTIVATOR; GREB1L
617783	NEPHROTIC SYNDROME, TYPE 16; NPHS16
617784	FANCONI ANEMIA, COMPLEMENTATION GROUP W; FANCW
617785	PAPILIN, PROTEOGLYCAN-LIKE SULFATED GLYCOPROTEIN; PAPLN
617786	CHAPERONIN CONTAINING T-COMPLEX POLYPEPTIDE 1, SUBUNIT 8; CCT8
617787	INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 50, WITH BEHAVIORAL ABNORMALITIES; MRD50
617788	INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 51; MRD51
617789	THIOREDOXIN DOMAIN-CONTAINING PROTEIN 8; TXNDC8
617790	THIOREDOXIN DOMAIN-CONTAINING PROTEIN 2; TXNDC2
617791	LEUCINE-RICH REPEAT- AND COILED-COIL DOMAIN-CONTAINING CENTROSOMAL PROTEIN 1; LRRCC1
617792	THIOREDOXIN DOMAIN-CONTAINING PROTEIN 11; TXNDC11
617793	EEF1A LYSINE METHYLTRANSFERASE 1; EEF1AKMT1
617794	EEF1A LYSINE METHYLTRANSFERASE 2; EEF1AKMT2
617795	ELONGIN BC- AND POLYCOMB REPRESSIVE COMPLEX 2-ASSOCIATED PROTEIN; EPOP
617796	INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 52; MRD52
617797	SRC-RELATED KINASE LACKING C-TERMINAL REGULATORY TYROSINE AND N-TERMINAL MYRISTYLATION SITES; SRMS
617798	INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 53; MRD53
617799	INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 54; MRD54
617800	MICROCEPHALY 19, PRIMARY, AUTOSOMAL RECESSIVE; MCPH19
617801	CYCLASE-ASSOCIATED ACTIN CYTOSKELETON REGULATORY PROTEIN 1; CAP1
617802	NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, SEIZURES, AND CORTICAL ATROPHY; NDMSCA
617803	TRANSMEMBRANE PROTEIN 26; TMEM26
617804	NEURODEVELOPMENTAL DISORDER WITH VARIABLE MOTOR AND LANGUAGE IMPAIRMENT; NEDMIAL
617805	RENAL HYPODYSPLASIA/APLASIA 3; RHDA3
617806	TRANSMEMBRANE PROTEIN 86B; TMEM86B
617807	NEURODEVELOPMENTAL DISORDER WITH ATAXIC GAIT, ABSENT SPEECH, AND DECREASED CORTICAL WHITE MATTER; NDAGSCW
617808	COFFIN-SIRIS SYNDROME 6; CSS6
617809	GELEOPHYSIC DYSPLASIA 3; GPHYSD3
617810	GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 15; GPIBD15
617811	DNA REPLICATION REGULATOR AND SPLICEOSOMAL FACTOR SMU1; SMU1
617812	SOLUTE CARRIER FAMILY 35, MEMBER G2; SLC35G2
617813	TRANSMEMBRANE PROTEIN 88; TMEM88
617814	TRANSMEMBRANE PROTEIN 95; TMEM95
617815	POLYMERASE III, RNA, SUBUNIT E; POLR3E
617816	GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 16; GPIBD16
617817	TUBULIN-GAMMA COMPLEX-ASSOCIATED PROTEIN 2; TUBGCP2
617818	TUBULIN-GAMMA COMPLEX-ASSOCIATED PROTEIN 3; TUBGCP3
617819	RAL GUANINE NUCLEOTIDE EXCHANGE FACTOR WITH PH DOMAIN AND SH3 DOMAIN-BINDING MOTIF 2; RALGPS2
617820	NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT HYPERKINETIC MOVEMENTS AND SEIZURES, AUTOSOMAL RECESSIVE; NDHMSR
617821	EHLERS-DANLOS SYNDROME, ARTHROCHALASIA TYPE, 2; EDSARTH2
617822	ALKURAYA-KUCINSKAS SYNDROME; ALKKUCS
617823	PWWP DOMAIN-CONTAINING PROTEIN 2A; PWWP2A
617824	BROMODOMAIN AND WD REPEAT DOMAIN-CONTAINING PROTEIN 1; BRWD1
617825	GLUCOCORTICOID DEFICIENCY 5; GCCD5
617826	UNC50, INNER NUCLEAR MEMBRANE RNA-BINDING PROTEIN; UNC50
617827	IMMUNODEFICIENCY 55; IMD55
617828	ZINC FINGER HOMEOBOX 2; ZFHX2
617829	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 92; DEE92
617830	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 58; DEE58
617831	INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 55, WITH SEIZURES; MRD55
617832	SENTAN, CILIA APICAL STRUCTURAL PROTEIN; SNTN
617833	ZFHX2 ANTISENSE RNA 1, NONCODING; ZFHX2AS1
617834	PLECKSTRIN HOMOLOGY DOMAIN-CONTAINING PROTEIN, FAMILY J, MEMBER 1; PLEKHJ1
617835	PYRUVATE DEHYDROGENASE PHOSPHATASE REGULATORY SUBUNIT; PDPR
617836	DEVELOPMENTAL DELAY AND SEIZURES WITH OR WITHOUT MOVEMENT ABNORMALITIES; DEDSM
617837	GDNF FAMILY RECEPTOR ALPHA-LIKE PROTEIN; GFRAL
617838	FAMILY WITH SEQUENCE SIMILARITY 234, MEMBER B; FAM234B
617839	AMYOTROPHIC LATERAL SCLEROSIS 23; ALS23
617840	tRNA ISOPENTENYLTRANSFERASE 1; TRIT1
617841	PROTEASOME SUBUNIT, ALPHA-TYPE, 8; PSMA8
617842	PROTEASOME 26S SUBUNIT, NON-ATPase, 1; PSMD1
617843	RWD DOMAIN-CONTAINING PROTEIN 2B; RWDD2B
617844	PROTEASOME 26S SUBUNIT, NON-ATPase, 8; PSMD8
617845	MAJOR FACILITATOR SUPERFAMILY DOMAIN-CONTAINING PROTEIN 2B; MFSD2B
617846	PHD FINGER PROTEIN 5A; PHF5A
617847	SPLICING FACTOR 3B, SUBUNIT 5; SF3B5
617848	DEAD-BOX HELICASE 46; DDX46
617849	U2 SMALL NUCLEAR RIBONUCLEOPROTEIN-ASSOCIATED SURP DOMAIN-CONTAINING PROTEIN; U2SURP
617850	SERTA DOMAIN-CONTAINING PROTEIN 1; SERTAD1
617851	SERTA DOMAIN-CONTAINING PROTEIN 2; SERTAD2
617852	SEC23-INTERACTING PROTEIN; SEC23IP
617853	SMALL VASOHIBIN-BINDING PROTEIN; SVBP
617854	INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 56; MRD56
617855	BASE METHYLTRANSFERASE OF 25S rRNA 2 HOMOLOG; BMT2
617856	THYMOCYTE SELECTION-ASSOCIATED PROTEIN FAMILY, MEMBER 2; THEMIS2
617857	PROTEASOME 26S SUBUNIT, NON-ATPase, 6; PSMD6
617858	PROTEASOME INHIBITOR SUBUNIT 1; PSMF1
617859	DISCS LARGE-ASSOCIATED PROTEIN 5; DLGAP5
617860	SURFACTANT-ASSOCIATED PROTEIN 3; SFTA3
617861	MYB-RELATED TRANSCRIPTION FACTOR, PARTNER OF PROFILIN; MYPOP
617862	NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, EPILEPSY, AND BRAIN ATROPHY; NEDMEBA
617863	INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 69; MRD69
617864	NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT SEIZURES AND GAIT ABNORMALITIES; NEDSGA
617865	NEURODEVELOPMENTAL DISORDER WITH MOVEMENT ABNORMALITIES, ABNORMAL GAIT, AND AUTISTIC FEATURES; NEDMAGA
617866	SHORT-RIB THORACIC DYSPLASIA 18 WITH POLYDACTYLY; SRTD18
617867	TUMOR PROTEIN p53-INDUCIBLE PROTEIN 11; TP53I11
617868	NUCLEAR ASSEMBLY FACTOR 1 RIBONUCLEOPROTEIN; NAF1
617869	NK1 HOMEOBOX 1; NKX1-1
617870	CENTROSOMAL PROTEIN 350; CEP350
617871	RETINITIS PIGMENTOSA 81; RP81
617872	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 34; COXPD34
617873	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 35; COXPD35
617874	POLYCYSTIC LIVER DISEASE 3 WITH OR WITHOUT KIDNEY CYSTS; PCLD3
617875	POLYCYSTIC LIVER DISEASE 4 WITH OR WITHOUT KIDNEY CYSTS; PCLD4
617876	RNA, U7 SMALL NUCLEAR, 1; RNU7-1
617877	SHORT STATURE, FACIAL DYSMORPHISM, AND SKELETAL ANOMALIES WITH OR WITHOUT CARDIAC ANOMALIES 1; SSFSC1
617878	TUBULIN, ALPHA-3D; TUBA3D
617879	LEBER CONGENITAL AMAUROSIS WITH EARLY-ONSET DEAFNESS; LCAEOD
617880	POC5 CENTRIOLAR PROTEIN; POC5
617881	CHROMOSOME 4 OPEN READING FRAME 54; C4ORF54
617882	CHARCOT-MARIE-TOOTH DISEASE, DOMINANT INTERMEDIATE G; CMTDIG
617883	FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS
617884	HEPATOMA-DERIVED GROWTH FACTOR-LIKE PROTEIN 2; HDGFL2
617885	BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 19; BMIQ19
617886	ZINC FINGER PROTEIN 512B; ZNF512B
617887	AGMATINASE; AGMAT
617888	ZINC FINGER PROTEIN 580; ZNF580
617889	PYRIDINE NUCLEOTIDE-DISULPHIDE OXIDOREDUCTASE DOMAIN-CONTAINING PROTEIN 2; PYROXD2
617890	ZINC FINGER PROTEIN 664; ZNF664
617891	ZINC FINGER PROTEIN 655; ZNF655
617892	AMYOTROPHIC LATERAL SCLEROSIS, SUSCEPTIBILITY TO, 24; ALS24
617893	RIBOSOMAL PROTEIN L36; RPL36
617894	TRANSMEMBRANE PROTEIN 50B; TMEM50B
617895	SHORT-RIB THORACIC DYSPLASIA 19 WITH OR WITHOUT POLYDACTYLY; SRTD19
617896	ZIC FAMILY, MEMBER 5; ZIC5
617897	CITRATE SYNTHASE LYSINE METHYLTRANSFERASE; CSKMT
617898	MULTIPLE SYNOSTOSES SYNDROME 4; SYNS4
617899	LEUKODYSTROPHY, HYPOMYELINATING, 14; HLD14
617900	ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED (HERPES-SPECIFIC), SUSCEPTIBILITY TO, 8; IIAE8
617901	DEXAMETHASONE-INDUCED GENE; DEXI
617902	GALECTIN-LIKE PROTEIN; LGALSL
617903	NEURODEVELOPMENTAL DISORDER WITH POOR LANGUAGE AND LOSS OF HAND SKILLS; NDPLHS
617904	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 59; DEE59
617905	HYPOXIA-INDUCIBLE LIPID DROPLET-ASSOCIATED PROTEIN; HILPDA
617906	CILIA- AND FLAGELLA-ASSOCIATED PROTEIN 20; CFAP20
617907	ERYTHROCYTOSIS, FAMILIAL, 5; ECYT5
617908	ZINC FINGER PROTEIN 473; ZNF473
617909	LSM10, U7 SMALL NUCLEAR RNA-ASSOCIATED PROTEIN; LSM10
617910	LSM11, U7 SMALL NUCLEAR RNA-ASSOCIATED PROTEIN; LSM11
617911	DIAMOND-BLACKFAN ANEMIA-LIKE; DBAL
617912	CONGENITAL HEART DEFECTS, MULTIPLE TYPES, 5; CHTD5
617913	NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, CATARACTS, AND RENAL ABNORMALITIES; NEDMCR
617914	MICROCEPHALY 20, PRIMARY, AUTOSOMAL RECESSIVE; MCPH20
617915	HYPOTONIA, ATAXIA, DEVELOPMENTAL DELAY, AND TOOTH ENAMEL DEFECT SYNDROME; HADDTS
617916	NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 7; NBIA7
617917	NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 8; NBIA8
617918	STRIATIN-INTERACTING PROTEIN 1; STRIP1
617919	STRIATIN-INTERACTING PROTEIN 2; STRIP2
617920	AMYLOIDOSIS, PRIMARY LOCALIZED CUTANEOUS, 3; PLCA3
617921	AMYOTROPHIC LATERAL SCLEROSIS, SUSCEPTIBILITY TO, 25; ALS25
617922	GLYCOPHORIN A; GYPA
617923	GLYCOPHORIN B; GYPB
617924	EPILEPSY, JUVENILE MYOCLONIC, SUSCEPTIBILITY TO, 10; EJM10
617925	SHORT-RIB THORACIC DYSPLASIA 20 WITH POLYDACTYLY; SRTD20
617926	OROFACIODIGITAL SYNDROME XVII; OFD17
617927	OROFACIODIGITAL SYNDROME XVIII; OFD18
617928	KERATOCONUS 9; KTCN9
617929	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 60; DEE60
617930	CHROMOSOME 1p35 DELETION SYNDROME
617931	SPINOCEREBELLAR ATAXIA 47; SCA47
617932	RHOPHILIN 2; RHPN2
617933	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 61; DEE61
617934	AE-BINDING PROTEIN 2; AEBP2
617935	EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 4; FFEVF4
617936	BUTYRYLCHOLINESTERASE DEFICIENCY; BCHED
617937	RNA-BINDING MOTIF PROTEIN 11; RBM11
617938	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 62; DEE62
617939	ZINC FINGER PROTEIN 69; ZFP69
617940	PLECKSTRIN HOMOLOGY DOMAIN- AND RhoGEF DOMAIN-CONTAINING PROTEIN G3; PLEKHG3
617941	SHWACHMAN-DIAMOND SYNDROME 2; SDS2
617942	ABHYDROLASE DOMAIN-CONTAINING PROTEIN 17A, DEPALMITOYLASE; ABHD17A
617943	ABHYDROLASE DOMAIN-CONTAINING PROTEIN 17B, DEPALMITOYLASE; ABHD17B
617944	ABHYDROLASE DOMAIN-CONTAINING PROTEIN 17C, DEPALMITOYLASE; ABHD17C
617945	BTB DOMAIN-CONTAINING PROTEIN 8; BTBD8
617946	ENDOPLASMIC RETICULUM-GOLGI INTERMEDIATE COMPARTMENT PROTEIN 1; ERGIC1
617947	WD REPEAT-CONTAINING PROTEIN 74; WDR74
617948	ELLIPTOCYTOSIS 3; EL3
617949	CILIA- AND FLAGELLA-ASSOCIATED PROTEIN 69; CFAP69
617950	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 36; COXPD36
617951	LEUKODYSTROPHY, HYPOMYELINATING, 15; HLD15
617952	OSTEOGENESIS IMPERFECTA, TYPE XVIII; OI18
617953	HYPERTHYROXINEMIA, EUTHYROID, CAUSED BY GENERALIZED 5-PRIME-DEIODINASE DEFICIENCY
617954	MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 6; MMDS6
617955	PHENYTOIN TOXICITY
617956	BETA-GLUCOPYRANOSIDE TASTING; BGLPT
617957	LEUCINE RICH REPEATS- AND IQ MOTIF-CONTAINING PROTEIN 3; LRRIQ3
617958	INTERACTOR OF LITTLE ELONGATION COMPLEX ELL SUBUNIT 1; ICE1
617959	SPERMATOGENIC FAILURE 24; SPGF24
617960	SPERMATOGENIC FAILURE 25; SPGF25
617961	SPERMATOGENIC FAILURE 26; SPGF26
617962	ZINC FINGER PROTEIN 827; ZNF827
617963	TUDOR DOMAIN-CONTAINING PROTEIN 9; TDRD9
617964	LEUKODYSTROPHY, HYPOMYELINATING, 16; HLD16
617965	SPERMATOGENIC FAILURE 27; SPGF27
617966	LOW DENSITY LIPOPROTEIN CHOLESTEROL LEVEL QUANTITATIVE TRAIT LOCUS 7; LDLCQ7
617967	HYDROCEPHALUS, CONGENITAL, 3, WITH BRAIN ANOMALIES; HYC3
617968	WD REPEAT-CONTAINING PROTEIN 63; WDR63
617969	COILED-COIL DOMAIN-CONTAINING PROTEIN 63; CCDC63
617970	RH-NULL, AMORPH TYPE; RHNA
617971	METHEMOGLOBINEMIA, BETA TYPE
617972	ZINC FINGER DHHC DOMAIN-CONTAINING PROTEIN 20; ZDHHC20
617973	METHEMOGLOBINEMIA, ALPHA TYPE
617974	SPONDYLOEPIMETAPHYSEAL DYSPLASIA, DI ROCCO TYPE; SEMDDR
617975	FAMILY WITH SEQUENCE SIMILARITY 210, MEMBER A; FAM210A
617976	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 63; DEE63
617977	NEURODEVELOPMENTAL DISORDER WITH SPASTIC QUADRIPLEGIA AND BRAIN ABNORMALITIES WITH OR WITHOUT SEIZURES; NEDSBAS
617978	CYFIP-RELATED RAC1 INTERACTOR B; CYRIB
617979	LONG NONCODING RNA NEAR ACOD1
617980	ERYTHROCYTOSIS, FAMILIAL, 6; ECYT6
617981	ERYTHROCYTOSIS, FAMILIAL, 7; ECYT7
617982	VERVERI-BRADY SYNDROME; VERBRAS
617983	MICROCEPHALY 21, PRIMARY, AUTOSOMAL RECESSIVE; MCPH21
617984	MICROCEPHALY 22, PRIMARY, AUTOSOMAL RECESSIVE; MCPH22
617985	MICROCEPHALY 23, PRIMARY, AUTOSOMAL RECESSIVE; MCPH23
617986	LOW DENSITY LIPOPROTEIN RECEPTOR CLASS A DOMAIN-CONTAINING PROTEIN 3; LDLRAD3
617987	METHYLTRANSFERASE 13, EEF1A LYSINE AND N-TERMINAL METHYLTRANSFERASE; METTL13
617988	JABERI-ELAHI SYNDROME; JABELS
617989	N-ALPHA-ACETYLTRANSFERASE 30, NatC CATALYTIC SUBUNIT; NAA30
617990	N-ALPHA-ACETYLTRANSFERASE 38, NatC AUXILIARY SUBUNIT; NAA38
617991	CHUNG-JANSEN SYNDROME; CHUJANS
617992	DEAFNESS, CONGENITAL HEART DEFECTS, AND POSTERIOR EMBRYOTOXON; DCHE
617993	TUMORAL CALCINOSIS, HYPERPHOSPHATEMIC, FAMILIAL, 2; HFTC2
617994	TUMORAL CALCINOSIS, HYPERPHOSPHATEMIC, FAMILIAL, 3; HFTC3
617995	IMPDH2 ENZYME ACTIVITY, VARIATION IN; IMPDH2V
617996	OOCYTE/ZYGOTE/EMBRYO MATURATION ARREST 5; OZEMA5
617997	RCC1 DOMAIN-CONTAINING PROTEIN 1; RCCD1
617998	GRB2-ASSOCIATED REGULATOR OF MAPK1, SUBTYPE 1; GAREM1
617999	GRB2-ASSOCIATED REGULATOR OF MAPK1, SUBTYPE 2; GAREM2
618000	EHLERS-DANLOS SYNDROME, CLASSIC-LIKE, 2; EDSCLL2
618001	RAB11 EFFECTOR CONTAINING LIS1 HOMOLOGY DOMAIN, COILED-COIL DOMAINS, AND HEAT REPEATS; RELCH
618002	MICROTUBULE-ASSOCIATED SERINE/THREONINE KINASE 4; MAST4
618003	DEAFNESS, AUTOSOMAL RECESSIVE 57; DFNB57
618004	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 64; DEE64
618005	CONGENITAL DISORDER OF GLYCOSYLATION WITH DEFECTIVE FUCOSYLATION 1; CDGF1
618006	LEUKODYSTROPHY, HYPOMYELINATING, 17; HLD17
618007	MOVED TO 613658
618008	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 65; DEE65
618009	INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 61; MRD61
618010	GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 17; GPIBD17
618011	HYPEREKPLEXIA 4; HKPX4
618012	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 93; DEE93
618013	DEAFNESS, AUTOSOMAL RECESSIVE 109; DFNB109
618014	PREMATURE OVARIAN FAILURE 14; POF14
618015	PROTOPORPHYRIA, ERYTHROPOIETIC, 2; EPP2
618016	RNA-BINDING REGION-CONTAINING PROTEIN 3; RNPC3
618017	ANKYRIN REPEAT DOMAIN-CONTAINING PROTEIN 16; ANKRD16
618018	DRUG METABOLISM, ALTERED, CYP2C8-RELATED
618019	RHIZOMELIC SKELETAL DYSPLASIA WITH OR WITHOUT PELGER-HUET ANOMALY; SKPHA
618020	KELCH-LIKE 22; KLHL22
618021	TETRAAMELIA SYNDROME 2; TETAMS2
618022	HUMEROFEMORAL HYPOPLASIA WITH RADIOTIBIAL RAY DEFICIENCY; HHRRD
618023	NOTCH2 N-TERMINAL-LIKE A; NOTCH2NLA
618024	NOTCH2 N-TERMINAL-LIKE B; NOTCH2NLB
618025	NOTCH2 N-TERMINAL-LIKE C; NOTCH2NLC
618026	NOTCH2 N-TERMINAL-LIKE R; NOTCH2NLR
618027	COFFIN-SIRIS SYNDROME 7; CSS7
618028	SHIELD COMPLEX, SUBUNIT 1; SHLD1
618029	SHIELD COMPLEX, SUBUNIT 2; SHLD2
618030	SHIELD COMPLEX, SUBUNIT 3; SHLD3
618031	CORNEAL DYSTROPHY, POSTERIOR POLYMORPHOUS, 4; PPCD4
618032	ZINC FINGER PROTEIN 768; ZNF768
618033	ZINC FINGER PROTEIN 689; ZNF689
618034	SOLUTE CARRIER FAMILY 43, MEMBER 3; SLC43A3
618035	TBC1 DOMAIN FAMILY, MEMBER 9; TBC1D9
618036	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2DD; CMT2DD
618037	ZINC FINGER PROTEIN 536; ZNF536
618038	SHORTAGE IN CHIASMATA 1; SHOC1
618039	TBC1 DOMAIN FAMILY, MEMBER 9B; TBC1D9B
618040	DIGEORGE SYNDROME CRITICAL REGION GENE 5; DGCR5
618041	PURINE-RICH ELEMENT-BINDING PROTEIN G; PURG
618042	IMMUNODEFICIENCY 100 WITH PULMONARY ALVEOLAR PROTEINOSIS AND HYPOGAMMAGLOBULINEMIA; IMD100
618043	POU DOMAIN, CLASS 6, TRANSCRIPTION FACTOR 1; POU6F1
618044	C2 CALCIUM-DEPENDENT DOMAIN-CONTAINING PROTEIN 5; C2CD5
618045	DNA DAMAGE-INDUCED APOPTOSIS SUPPRESSOR; DDIAS
618046	OLFACTORY RECEPTOR, FAMILY 1, SUBFAMILY A, MEMBER 1; OR1A1
618047	OLFACTORY RECEPTOR, FAMILY 1, SUBFAMILY A, MEMBER 2; OR1A2
618048	PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 2; PRAAS2
618049	PARKINSONISM-DYSTONIA 2, INFANTILE-ONSET; PKDYS2
618050	INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 57; MRD57
618051	INNATE IMMUNITY ACTIVATOR; INAVA
618052	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 27; CMH27
618053	ANDROGEN RECEPTOR-REGULATED LONG NONCODING RNA 1; ARLNC1
618054	MEMBRANE INTEGRAL NOTCH2-ASSOCIATED RECEPTOR 1; MINAR1
618055	CELLULAR REPRESSOR OF E1A-STIMULATED GENES 1; CREG1
618056	NEURODEVELOPMENTAL DISORDER WITH CEREBELLAR ATROPHY AND WITH OR WITHOUT SEIZURES; NEDCAS
618057	DRUG METABOLISM, ALTERED, CES1-RELATED
618058	CILIA- AND FLAGELLA-ASSOCIATED PROTEIN 300; CFAP300
618059	WD REPEAT-CONTAINING PROTEIN 25; WDR25
618060	INTELLECTUAL DEVELOPMENTAL DISORDER WITH OR WITHOUT EPILEPSY OR CEREBELLAR ATAXIA; IDDECA
618061	POLYCYSTIC KIDNEY DISEASE 6 WITH OR WITHOUT POLYCYSTIC LIVER DISEASE; PKD6
618062	CYSTEINE-RICH SECRETORY PROTEIN 3; CRISP3
618063	CILIARY DYSKINESIA, PRIMARY, 38; CILD38
618064	CYTOCHROME c OXIDASE ASSEMBLY FACTOR 16; COX16
618065	PONTOCEREBELLAR HYPOPLASIA, TYPE 1D; PCH1D
618066	HOMEOBOX B CLUSTER ANTISENSE RNA 1, NONCODING; HOXBAS1
618067	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 66; DEE66
618068	SPERMATOGENIC LEUCINE ZIPPER PROTEIN 1; SPZ1
618069	CCR4-NOT TRANSCRIPTION COMPLEX, SUBUNIT 6-LIKE; CNOT6L
618070	ATPase, H+ TRANSPORTING, LYSOSOMAL, 42-KD, V1 SUBUNIT C, ISOFORM 2; ATP6V1C2
618071	ATPase, H+ TRANSPORTING, LYSOSOMAL, 13-KD, V1 SUBUNIT G, ISOFORM 3; ATP6V1G3
618072	ATPase, H+ TRANSPORTING, LYSOSOMAL, 38-KD, V0 SUBUNIT D, ISOFORM 2; ATP6V0D2
618073	STERILE ALPHA MOTIF DOMAIN-CONTAINING PROTEIN 12; SAMD12
618074	EPILEPSY, FAMILIAL ADULT MYOCLONIC, 6; FAME6
618075	EPILEPSY, FAMILIAL ADULT MYOCLONIC, 7; FAME7
618076	NEURODEVELOPMENTAL DISORDER WITH SPASTICITY AND POOR GROWTH; NEDSG
618077	INFLAMMATORY BOWEL DISEASE 29; IBD29
618078	OVARIAN DYSGENESIS 6; ODG6
618079	LOW DENSITY LIPOPROTEIN CHOLESTEROL LEVEL QUANTITATIVE TRAIT LOCUS 8; LDLCQ8
618080	WD REPEAT-AND FYVE DOMAIN-CONTAINING PROTEIN 1; WDFY1
618081	IMMUNOGLOBULIN-LIKE DOMAIN-CONTAINING RECEPTOR 2; ILDR2
618082	WD REPEAT-CONTAINING PROTEIN 33; WDR33
618083	WW-BINDING PROTEIN 11; WBP11
618084	PEELING SKIN SYNDROME 6; PSS6
618085	POLYAMINE-MODULATED FACTOR 1-BINDING PROTEIN 1; PMFBP1
618086	SPERMATOGENIC FAILURE 28; SPGF28
618087	SPINOCEREBELLAR ATAXIA 42, EARLY-ONSET, SEVERE, WITH NEURODEVELOPMENTAL DEFICITS; SCA42ND
618088	NEURODEVELOPMENTAL DISORDER WITH REGRESSION, ABNORMAL MOVEMENTS, LOSS OF SPEECH, AND SEIZURES; NEDAMSS
618089	INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND BEHAVIORAL ABNORMALITIES; IDDFBA
618090	NEURODEVELOPMENTAL DISORDER WITH EPILEPSY AND HYPOPLASIA OF THE CORPUS CALLOSUM; NEDEHCC
618091	SPERMATOGENIC FAILURE 29; SPGF29
618092	INTELLECTUAL DEVELOPMENTAL DISORDER WITH SPEECH DELAY, DYSMORPHIC FACIES, AND T-CELL ABNORMALITIES; IDDSFTA
618093	SPINOCEREBELLAR ATAXIA 48; SCA48
618094	DEAFNESS, AUTOSOMAL RECESSIVE 110; DFNB110
618095	INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 63; MRT63
618096	PREMATURE OVARIAN FAILURE 15; POF15
618097	MICROCEPHALY, GROWTH RESTRICTION, AND INCREASED SISTER CHROMATID EXCHANGE 2; MGRISCE2
618098	PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL RECESSIVE 5; PEOB5
618099	MITOCHONDRIAL RIBOSOMAL RNA METHYLTRANSFERASE 1; MRM1
618100	MPV17 MITOCHONDRIAL INNER MEMBRANE PROTEIN-LIKE; MPV17L
618101	MATRIX METALLOPROTEINASE 27; MMP27
618102	SUMO-INTERACTING MOTIFS-CONTAINING PROTEIN 1; SIMC1
618103	INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 64; MRT64
618104	MEMBRANE METALLOENDOPEPTIDASE-LIKE 1; MMEL1
618105	SIALIC ACID-BINDING IMMUNOGLOBULIN-LIKE LECTIN 15; SIGLEC15
618106	INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 58; MRD58
618107	OSTEOPETROSIS, AUTOSOMAL DOMINANT 3; OPTA3
618108	IMMUNODEFICIENCY 57 WITH AUTOINFLAMMATION; IMD57
618109	INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 65; MRT65
618110	SPERMATOGENIC FAILURE 30; SPGF30
618111	ZINC FINGER PROTEIN 64; ZFP64
618112	SPERMATOGENIC FAILURE 31; SPGF31
618113	ENCEPHALITIS/ENCEPHALOPATHY, MILD, WITH REVERSIBLE MYELIN VACUOLIZATION; MMERV
618114	LIDDLE SYNDROME 2; LIDLS2
618115	SPERMATOGENIC FAILURE 32; SPGF32
618116	BONE MARROW FAILURE SYNDROME 4; BMFS4
618117	OVARIAN DYSGENESIS 7; ODG7
618118	ECHINODERM MICROTUBULE-ASSOCIATED PROTEIN-LIKE 3; EML3
618119	ECHINODERM MICROTUBULE-ASSOCIATED PROTEIN-LIKE 5; EML5
618120	MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 5; MC5DN5
618121	ATP SYNTHASE PERIPHERAL STALK, SUBUNIT D; ATP5PD
618122	MTR4 EXOSOME RNA HELICASE; MTREX
618123	POLYDACTYLY, POSTAXIAL, TYPE A8; PAPA8
618124	PERIPHERAL NEUROPATHY, AUTOSOMAL RECESSIVE, WITH OR WITHOUT IMPAIRED INTELLECTUAL DEVELOPMENT; PNRIID
618125	KASH DOMAIN-CONTAINING PROTEIN 5; KASH5
618126	LIDDLE SYNDROME 3; LIDLS3
618127	CYTOCHROME C OXIDASE, SUBUNIT 6B2; COX6B2
618128	GANGLIOSIDE-INDUCED DIFFERENTIATION-ASSOCIATED PROTEIN 2; GDAP2
618129	MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL DOMINANT 4; LGMDD4
618130	N-TERMINAL EF-HAND CALCIUM-BINDING PROTEIN 2; NECAB2
618131	IMMUNODEFICIENCY 58; IMD58
618132	SIALIC ACID-BINDING IMMUNOGLOBULIN-LIKE LECTIN 14; SIGLEC14
618133	NEUREXOPHILIN AND PC-ESTERASE DOMAIN FAMILY, MEMBER 4; NXPE4
618134	UROTENSIN 2B; UTS2B
618135	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 8; MDDGC8
618136	MAD2L1-BINDING PROTEIN; MAD2L1BP
618137	MIS18 KINETOCHORE PROTEIN A: MIS18A
618138	MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 23; LGMDR23
618139	MIS18-BINDING PROTEIN 1; MIS18BP1
618140	DEAFNESS, AUTOSOMAL DOMINANT 74; DFNA74
618141	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 67; DEE67
618142	MICROCEPHALY, FACIAL DYSMORPHISM, RENAL AGENESIS, AND AMBIGUOUS GENITALIA SYNDROME; MFRG
618143	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 95; DEE95
618144	USHER SYNDROME, TYPE IV; USH4
618145	DEAFNESS, AUTOSOMAL RECESSIVE 111; DFNB111
618146	CILIA- AND FLAGELLA-ASSOCIATED PROTEIN 251; CFAP251
618147	INTELLECTUAL DEVELOPMENTAL DISORDER WITH HYPERTELORISM AND DISTINCTIVE FACIES; IDDHDF
618148	EXTRAORAL HALITOSIS DUE TO METHANETHIOL OXIDASE DEFICIENCY; EHMTO
618149	OROFACIAL CLEFT 8; OFC8
618150	SAUL-WILSON SYNDROME; SWILS
618151	TESTIS-EXPRESSED BASIC PROTEIN 1; TSBP1
618152	SPERMATOGENIC FAILURE 33; SPGF33
618153	SPERMATOGENIC FAILURE 34; SPGF34
618154	HENNEKAM LYMPHANGIECTASIA-LYMPHEDEMA SYNDROME 3; HKLLS3
618155	OPHTHALMOPLEGIA, EXTERNAL, WITH RIB AND VERTEBRAL ANOMALIES; EORVA
618156	SQUALENE SYNTHASE DEFICIENCY; SQSD
618157	ISOLATED GROWTH HORMONE DEFICIENCY, TYPE IV; IGHD4
618158	INTELLECTUAL DEVELOPMENTAL DISORDER WITH MACROCEPHALY, SEIZURES, AND SPEECH DELAY; IDDMSSD
618159	PROTEIN PHOSPHATASE 1, REGULATORY SUBUNIT 21; PPP1R21
618160	PITUITARY HORMONE DEFICIENCY, COMBINED OR ISOLATED, 7; CPHD7
618161	JOUBERT SYNDROME 35; JBTS35
618162	SPONDYLOEPIMETAPHYSEAL DYSPLASIA, KRAKOW TYPE; SEMDK
618163	TRANSMEMBRANE PROTEIN 94; TMEM94
618164	CARDIAC, FACIAL, AND DIGITAL ANOMALIES WITH DEVELOPMENTAL DELAY; CAFDADD
618165	BONE MARROW FAILURE SYNDROME 5; BMFS5
618166	CYCLIN N-TERMINAL DOMAIN-CONTAINING PROTEIN 1; CNTD1
618167	OSTEOCHONDRODYSPLASIA, BRACHYDACTYLY, AND OVERLAPPING MALFORMED DIGITS; OCBMD
618168	DIARRHEA 9; DIAR9
618169	POU3F3-ADJACENT NONCODING TRANSCRIPT 1; PANTR1
618170	NEURODEGENERATION, CHILDHOOD-ONSET, STRESS-INDUCED, WITH VARIABLE ATAXIA AND SEIZURES; CONDSIAS
618171	KINESIN FAMILY MEMBER 16B; KIF16B
618172	LONG NONCODING RNA UPREGULATOR OF ANTIVIRAL RESPONSE INTERFERON SIGNALING; LUARIS
618173	RETINITIS PIGMENTOSA 83; RP83
618174	CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 9; CDCBM9
618175	WARBURG-CINOTTI SYNDROME; WRCN
618176	NEPHROTIC SYNDROME, TYPE 17; NPHS17
618177	NEPHROTIC SYNDROME, TYPE 18; NPHS18
618178	NEPHROTIC SYNDROME, TYPE 19; NPHS19
618179	MICROCEPHALY 24, PRIMARY, AUTOSOMAL RECESSIVE; MCPH24
618180	ECTODERMAL DYSPLASIA 14, HAIR/TOOTH TYPE, WITH OR WITHOUT HYPOHIDROSIS; ECTD14
618181	ZINC FINGER- AND BTB DOMAIN-CONTAINING PROTEIN 11; ZBTB11
618182	ORTHOSTATIC HYPOTENSION 2; ORTHYP2
618183	DIARRHEA 10, PROTEIN-LOSING ENTEROPATHY TYPE; DIAR10
618184	NEUROPATHY, CONGENITAL HYPOMYELINATING, 2; CHN2
618185	PERIVENTRICULAR NODULAR HETEROTOPIA 8; PVNH8
618186	NEUROPATHY, CONGENITAL HYPOMYELINATING, 3; CHN3
618187	OVARIAN DYSGENESIS 8; ODG8
618188	HYPERPARATHYROIDISM, TRANSIENT NEONATAL; HRPTTN
618189	CARDIOMYOPATHY, DILATED, 2C; CMD2C
618190	LUNG CANCER-ASSOCIATED TRANSCRIPT 1, NONCODING; LUCAT1
618191	CEA CELL ADHESION MOLECULE 21; CEACAM21
618192	PROSTATE CANCER-ASSOCIATED TRANSCRIPT 19, NONCODING; PCAT19
618193	POLYCYSTIC LIPOMEMBRANOUS OSTEODYSPLASIA WITH SCLEROSING LEUKOENCEPHALOPATHY 2; PLOSL2
618194	SCAVENGER RECEPTOR CYSTEINE-RICH FAMILY MEMBER WITH 5 DOMAINS; SSC5D
618195	INTELLECTUAL DEVELOPMENTAL DISORDER AND RETINITIS PIGMENTOSA; IDDRP
618196	CAPILLARY MALFORMATION-ARTERIOVENOUS MALFORMATION 2; CMAVM2
618197	MYASTHENIC SYNDROME, CONGENITAL, 23, PRESYNAPTIC; CMS23
618198	MYASTHENIC SYNDROME, CONGENITAL, 24, PRESYNAPTIC; CMS24
618199	APOBEC1 COMPLEMENTATION FACTOR; A1CF
618200	MIDASIN AAA ATPase 1; MDN1
618201	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 68; DEE68
618202	DNAJ/HSP40 HOMOLOG, SUBFAMILY C, MEMBER 30; DNAJC30
618203	TRANSMEMBRANE AND TETRATRICOPEPTIDE REPEAT DOMAINS-CONTAINING PROTEIN 4; TMTC4
618204	IMMUNODEFICIENCY 15A; IMD15A
618205	SNIJDERS BLOK-CAMPEAU SYNDROME; SNIBCPS
618206	ZINC FINGER CCCH DOMAIN-CONTAINING PROTEIN 7B; ZC3H7B
618207	SEC1 FAMILY DOMAIN-CONTAINING PROTEIN 1; SCFD1
618208	LONG INTERGENIC NONCODING RNA 1159; LINC01159
618209	HOXD ANTISENSE GROWTH-ASSOCIATED LONG NONCODING RNA; HAGLR
618210	LIPID RAFT LINKING PROTEIN 1; RFTN1
618211	PITRILYSIN METALLOPEPTIDASE 1; PITRM1
618212	LONG INTERGENIC NONCODING RNA, p53-INDUCED TRANSCRIPT; LINC-PINT
618213	INFLAMMATORY BOWEL DISEASE, IMMUNODEFICIENCY, AND ENCEPHALOPATHY; IBDIMDE
618214	LONG INTERGENIC NONCODING RNA 1157; LINC01157
618215	LIPID RAFT LINKING PROTEIN 2; RFTN2
618216	MIRLET7B HOST GENE, NONCODING; MIRLET7BHG
618217	EGFR LONG NONCODING DOWNSTREAM RNA; ELDR
618218	BAKER-GORDON SYNDROME; BAGOS
618219	POLYDACTYLY, POSTAXIAL, TYPE A9; PAPA9
618220	RETINITIS PIGMENTOSA 84; RP84
618221	INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 66; MRT66
618222	MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 2; MC1DN2
618223	VERTEBRAL ANOMALIES AND VARIABLE ENDOCRINE AND T-CELL DYSFUNCTION; VETD
618224	MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 3; MC1DN3
618225	MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 4; MC1DN4
618226	MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 5; MC1DN5
618227	LEUCINE-RICH REPEAT-CONTAINING PROTEIN 56; LRRC56
618228	MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 6; MC1DN6
618229	MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 7; MC1DN7
618230	MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 8; MC1DN8
618231	EPIDERMODYSPLASIA VERRUCIFORMIS, SUSCEPTIBILITY TO, 2; EV2
618232	MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 9; MC1DN9
618233	MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 10; MC1DN10
618234	MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 11; MC1DN11
618235	MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 13; MC1DN13
618236	MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 14; MC1DN14
618237	MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 15; MC1DN15
618238	MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 16; MC1DN16
618239	MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 17; MC1DN17
618240	MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 18; MC1DN18
618241	MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 19; MC1DN19
618242	MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 21; MC1DN21
618243	MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 22; MC1DN22
618244	MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 23; MC1DN23
618245	MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 24; MC1DN24
618246	MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 25; MC1DN25
618247	MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 26; MC1DN26
618248	MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 27; MC1DN27
618249	MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 28; MC1DN28
618250	MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 29; MC1DN29
618251	MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 31; MC1DN31
618252	MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 32; MC1DN32
618253	MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 33; MC1DN33
618254	CILIARY DYSKINESIA, PRIMARY, 39; CILD39
618255	MYOGENESIS-REGULATING GLYCOSIDASE; MYORG
618256	BIPARENTAL MITOCHONDRIAL DNA TRANSMISSION
618257	DEAFNESS, AUTOSOMAL RECESSIVE 112; DFNB112
618258	SEC11 HOMOLOG A, SIGNAL PEPTIDASE COMPLEX SUBUNIT; SEC11A
618259	LONG INTERGENIC NONCODING RNA 1565; LINC01565
618260	COILED-COIL DOMAIN-CONTAINING PROTEIN 47; CCDC47
618261	LYMPHOPROLIFERATIVE SYNDROME 3; LPFS3
618262	cAMP RESPONSE ELEMENT-BINDING PROTEIN 5; CREB5
618263	CALCIUM HOMEOSTASIS MODULATOR 3; CALHM3
618264	MIRROR MOVEMENTS 4; MRMV4
618265	ARTHROGRYPOSIS, CLEFT PALATE, CRANIOSYNOSTOSIS, AND IMPAIRED INTELLECTUAL DEVELOPMENT; ACCIID
618266	PONTOCEREBELLAR HYPOPLASIA, TYPE 12; PCH12
618267	EPIDERMODYSPLASIA VERRUCIFORMIS, SUSCEPTIBILITY TO, 3; EV3
618268	TRICHOHEPATONEURODEVELOPMENTAL SYNDROME; THNS
618269	ZINC FINGER PROTEIN 341; ZNF341
618270	CONGENITAL ANOMALIES OF KIDNEY AND URINARY TRACT 3; CAKUT3
618271	SEC61 TRANSLOCON, ALPHA-2 SUBUNIT; SEC61A2
618272	GLOBAL DEVELOPMENTAL DELAY, LUNG CYSTS, OVERGROWTH, AND WILMS TUMOR; GLOW
618273	MEGA-CORPUS-CALLOSUM SYNDROME WITH CEREBELLAR HYPOPLASIA AND CORTICAL MALFORMATIONS; MCCCHCM
618274	PEPTIDYLPROLYL ISOMERASE DOMAIN- AND WD40 REPEAT-CONTAINING PROTEIN 1; PPWD1
618275	HYPOTRICHOSIS 14; HYPT14
618276	NEURODEGENERATION, CHILDHOOD-ONSET, WITH CEREBELLAR ATROPHY; CONDCA
618277	NHL REPEAT-CONTAINING PROTEIN 2; NHLRC2
618278	FIBROSIS, NEURODEGENERATION, AND CEREBRAL ANGIOMATOSIS; FINCA
618279	CHARCOT-MARIE-TOOTH DISEASE, DEMYELINATING, TYPE 1G; CMT1G
618280	CARDIAC-UROGENITAL SYNDROME; CUGS
618281	VON WILLEBRAND FACTOR A DOMAIN-CONTAINING PROTEIN 2; VWA2
618282	HYPER-IgE SYNDROME 3, AUTOSOMAL RECESSIVE, WITH RECURRENT INFECTIONS; HIES3
618283	VISUAL IMPAIRMENT AND PROGRESSIVE PHTHISIS BULBI; VIPB
618284	MICROCEPHALY, CATARACTS, IMPAIRED INTELLECTUAL DEVELOPMENT, AND DYSTONIA WITH ABNORMAL STRIATUM; MCIDDS
618285	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 69; DEE69
618286	MACROCEPHALY, ACQUIRED, WITH IMPAIRED INTELLECTUAL DEVELOPMENT; MACID
618287	AUTOINFLAMMATORY DISEASE, FAMILIAL, BEHCET-LIKE 3; AIFBL3
618288	5-HYDROXYMETHYLCYTOSINE-BINDING PROTEIN, EMBRYONIC STEM CELL-SPECIFIC; HMCES
618289	ENDOSOME-ASSOCIATED TRAFFICKING REGULATOR 1; ENTR1
618290	WD REPEAT-CONTAINING PROTEIN 90; WDR90
618291	SPINAL MUSCULAR ATROPHY, LOWER EXTREMITY-PREDOMINANT, 2B, PRENATAL ONSET, AUTOSOMAL DOMINANT; SMALED2B
618292	NEURODEVELOPMENTAL DISORDER WITH IMPAIRED INTELLECTUAL DEVELOPMENT, HYPOTONIA, AND ATAXIA; NEDIDHA
618293	INTERFERON-INDUCED TRANSMEMBRANE PROTEIN 10; IFITM10
618294	TRANSMEMBRANE PROTEIN 91; TMEM91
618295	INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 67; MRT67
618296	TRANSMEMBRANE PROTEIN 233; TMEM233
618297	PROLINE-RICH TRANSMEMBRANE PROTEIN 1; PRRT1
618298	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 70; DEE70
618299	LOW DENSITY LIPOPROTEIN RECEPTOR-RELATED PROTEIN 12; LRP12
618300	CILIARY DYSKINESIA, PRIMARY, 40; CILD40
618301	KAZRIN, PERIPLAKIN-INTERACTING PROTEIN; KAZN
618302	INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 68; MRT68
618303	CAVEOLAE-ASSOCIATED PROTEIN 3; CAVIN3
618304	GLUTAMINE-RICH PROTEIN 2; QRICH2
618305	ATP1A1 ANTISENSE RNA 1, NONCODING; ATP1A1AS1
618306	PROLINE-RICH PROTEIN 7; PRR7
618307	EPIDERMODYSPLASIA VERRUCIFORMIS, SUSCEPTIBILITY TO, 4; EV4
618308	NOP9 NUCLEOLAR PROTEIN; NOP9
618309	EPIDERMODYSPLASIA VERRUCIFORMIS, SUSCEPTIBILITY TO, 5; EV5
618310	DIAMOND-BLACKFAN ANEMIA 18; DBA18
618311	RIBOSOME BIOGENESIS REGULATOR 1 HOMOLOG; RRS1
618312	DIAMOND-BLACKFAN ANEMIA 19; DBA19
618313	DIAMOND-BLACKFAN ANEMIA 20; DBA20
618314	HYPOMAGNESEMIA, SEIZURES, AND IMPAIRED INTELLECTUAL DEVELOPMENT 2; HOMGSMR2
618315	RIBOSOMAL PROTEIN L35; RPL35
618316	INTELLECTUAL DEVELOPMENTAL DISORDER WITH CARDIAC DEFECTS AND DYSMORPHIC FACIES; IDDCDF
618317	BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 7, AUTOSOMAL RECESSIVE; IBGC7
618318	CILIA- AND FLAGELLA-ASSOCIATED PROTEIN 119; CFAP119
618319	PR DOMAIN-CONTAINING PROTEIN 10; PRDM10
618320	SECRETORY PHOSPHOLIPASE A2, GROUP IIE; PLA2G2E
618321	ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN EDEMA AND/OR LEUKOENCEPHALOPATHY, 2; PEBEL2
618322	UBIQUITIN-SPECIFIC PROTEASE 38; USP38
618323	MYASTHENIC SYNDROME, CONGENITAL, 25, PRESYNAPTIC; CMS25
618324	CONGENITAL DISORDER OF GLYCOSYLATION WITH DEFECTIVE FUCOSYLATION 2; CDGF2
618325	LISSENCEPHALY 9 WITH COMPLEX BRAINSTEM MALFORMATION; LIS9
618326	ZINC FINGER CCHC DOMAIN-CONTAINING PROTEIN 3; ZCCHC3
618327	CAPPING PROTEIN INHIBITING REGULATOR OF ACTIN DYNAMICS; CRACD
618328	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 71; DEE71
618329	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 37; COXPD37
618330	GLOBAL DEVELOPMENTAL DELAY WITH OR WITHOUT IMPAIRED INTELLECTUAL DEVELOPMENT; GDDI
618331	ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH EPISODIC RHABDOMYOLYSIS; PEERB
618332	MENKE-HENNEKAM SYNDROME 1; MKHK1
618333	MENKE-HENNEKAM SYNDROME 2; MKHK2
618334	CYTOCHROME b(-254) CHAPERONE 1; CYBC1
618335	LONG INTERGENIC NONCODING RNA 958; LINC00958
618336	INTRAUTERINE GROWTH RETARDATION, METAPHYSEAL DYSPLASIA, ADRENAL HYPOPLASIA CONGENITA, GENITAL ANOMALIES, AND IMMUNODEFICIENCY; IMAGEI
618337	FERM DOMAIN-CONTAINING PROTEIN 8; FRMD8
618338	THIOL METHYLTRANSFERASE 1A; TMT1A
618339	INFANTILE CATARACT, SKIN ABNORMALITIES, GLUTAMATE EXCESS, AND IMPAIRED INTELLECTUAL DEVELOPMENT; CASGID
618340	SUBMAXILLARY GLAND ANDROGEN-REGULATED PROTEIN 3A; SMR3A
618341	SPERMATOGENIC FAILURE 35; SPGF35
618342	INTELLECTUAL DEVELOPMENTAL DISORDER WITH ABNORMAL BEHAVIOR, MICROCEPHALY, AND SHORT STATURE; IDDABS
618343	POLYMICROGYRIA WITH OR WITHOUT VASCULAR-TYPE EHLERS-DANLOS SYNDROME; PMGEDSV
618344	PROLINE-RICH PROTEIN 15; PRR15
618345	RETINITIS PIGMENTOSA 85; RP85
618346	MICROCEPHALY, GROWTH DEFICIENCY, SEIZURES, AND BRAIN MALFORMATIONS; MIGSB
618347	GALLOWAY-MOWAT SYNDROME 6; GAMOS6
618348	GALLOWAY-MOWAT SYNDROME 7; GAMOS7
618349	GALLOWAY-MOWAT SYNDROME 8; GAMOS8
618350	MICROTUBULE-ASSOCIATED PROTEIN 11; MAP11
618351	MICROCEPHALY 25, PRIMARY, AUTOSOMAL RECESSIVE; MCPH25
618352	CENTRAL CENTRIFUGAL CICATRICIAL ALOPECIA; CCCA
618353	OOCYTE/ZYGOTE/EMBRYO MATURATION ARREST 6; OZEMA6
618354	HOUGE-JANSSENS SYNDROME 3; HJS3
618355	ALG10 ALPHA-1,2-GLUCOSYLTRANSFERASE; ALG10
618356	NEURODEVELOPMENTAL DISORDER WITH CENTRAL AND PERIPHERAL MOTOR DYSFUNCTION; NEDCPMD
618357	EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 15; EIG15
618358	CONE-ROD DYSTROPHY AND HEARING LOSS 2; CRDHL2
618359	ZINC FINGER PROTEIN 197; ZNF197
618360	BRAIN SMALL VESSEL DISEASE 3; BSVD3
618361	DUAL-SPECIFICITY PHOSPHATASE 23; DUSP23
618362	COFFIN-SIRIS SYNDROME 8; CSS8
618363	SHORT STATURE, AMELOGENESIS IMPERFECTA, AND SKELETAL DYSPLASIA WITH SCOLIOSIS; SSASKS
618364	MYOCLONUS, FAMILIAL, 2; MYOCL2
618365	ZINC FINGER- AND SCAN DOMAIN-CONTAINING PROTEIN 10; ZSCAN10
618366	VPS8 CORVET COMPLEX SUBUNIT; VPS8
618367	NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, EPILEPSY, AND HYPOMYELINATION; NEDMEHM
618368	DUAL-SPECIFICITY PHOSPHATASE 26; DUSP26
618369	SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 27; SCAR27
618370	NEXN ANTISENSE RNA 1, NONCODING; NEXNAS1
618371	TURNPENNY-FRY SYNDROME; TPFS
618372	GASTROINTESTINAL ULCERATION, RECURRENT, WITH DYSFUNCTIONAL PLATELETS; GURDP
618373	CANCER, ALOPECIA, PIGMENT DYSCRASIA, ONYCHODYSTROPHY, AND KERATODERMA; CAPOK
618374	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 72; DEE72
618375	FATTY ACID AMIDE HYDROLASE PSEUDOGENE 1; FAAHP1
618376	PROTEASE, SERINE, 23; PRSS23
618377	PAIN SENSITIVITY QUANTITATIVE TRAIT LOCUS 1; PAINQTL1
618378	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 38; COXPD38
618379	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 73; DEE73
618380	FAMILY WITH SEQUENCE SIMILARITY 83, MEMBER D; FAM83D
618381	FACIAL DYSMORPHISM, HYPERTRICHOSIS, EPILEPSY, INTELLECTUAL/DEVELOPMENTAL DELAY, AND GINGIVAL OVERGROWTH SYNDROME; FHEIG
618382	CYTOSOLIC IRON-SULFUR ASSEMBLY COMPONENT 2A; CIAO2A
618383	INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 69; MRT69
618384	LEUKOENCEPHALOPATHY, ACUTE REVERSIBLE, WITH INCREASED URINARY ALPHA-KETOGLUTARATE; ARLIAK
618385	CYCLASE-ASSOCIATED ACTIN CYTOSKELETON REGULATORY PROTEIN 2; CAP2
618386	AMELOGENESIS IMPERFECTA, TYPE IIIC; AI3C
618387	SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE, WITH AXONAL NEUROPATHY 3; SCAN3
618388	FETAL AKINESIA DEFORMATION SEQUENCE 2; FADS2
618389	FETAL AKINESIA DEFORMATION SEQUENCE 3; FADS3
618390	BONE MORPHOGENETIC PROTEIN/RETINOIC ACID-INDUCIBLE NEURAL-SPECIFIC PROTEIN 3; BRINP3
618391	DIPHTHAMIDE BIOSYNTHESIS PROTEIN 6; DPH6
618392	SPONDYLOEPIPHYSEAL DYSPLASIA, KONDO-FU TYPE; SEDKF
618393	FETAL AKINESIA DEFORMATION SEQUENCE 4; FADS4
618394	IMMUNODEFICIENCY 60 AND AUTOIMMUNITY; IMD60
618395	SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH JOINT LAXITY, TYPE 3; SEMDJL3
618396	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 74; DEE74
618397	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 39; COXPD39
618398	T-CELL LYMPHOMA, SUBCUTANEOUS PANNICULITIS-LIKE; SPTCL
618399	GLYCOSYLTRANSFERASE 8 DOMAIN-CONTAINING PROTEIN 1; GLT8D1
618400	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2EE; CMT2EE
618401	FAMILY WITH SEQUENCE SIMILARITY 170, MEMBER A; FAM170A
618402	INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 70; MRT70
618403	FAMILY WITH SEQUENCE SIMILARITY 124, MEMBER B; FAM124B
618404	LEUKODYSTROPHY, HYPOMYELINATING, 18; HLD18
618405	ZINC FINGER PROTEIN 717; ZNF717
618406	BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 20; BMIQ20
618407	MINDY LYSINE-48 DEUBIQUITINASE 1; MINDY1
618408	MINDY LYSINE-48 DEUBIQUITINASE 2; MINDY2
618409	FAMILY WITH SEQUENCE SIMILARITY 8, MEMBER A1; FAM8A1
618410	DEAFNESS, AUTOSOMAL RECESSIVE 113; DFNB113
618411	FTSJ RNA 2-PRIME-O-METHYLTRANSFERASE 3; FTSJ3
618412	GLOBAL DEVELOPMENTAL DELAY, PROGRESSIVE ATAXIA, AND ELEVATED GLUTAMINE; GDPAG
618413	FAMILY WITH SEQUENCE SIMILARITY 149, MEMBER B1; FAM149B1
618414	CONGENITAL MYOPATHY 14; CMYP14
618415	CATARACT 48; CTRCT48
618416	METABOLIC CRISES, RECURRENT, WITH VARIABLE ENCEPHALOMYOPATHIC FEATURES AND NEUROLOGIC REGRESSION; MECREN
618417	MEIOTIC DOUBLE-STRANDED BREAK FORMATION PROTEIN 4; MEI4
618418	SPASTIC PARAPLEGIA 80, AUTOSOMAL DOMINANT; SPG80
618419	MYOECTODERMAL GONADAL DYSGENESIS SYNDROME; MEGD
618420	SPERMATOGENIC FAILURE 36; SPGF36
618421	REC114 MEIOTIC RECOMBINATION PROTEIN; REC114
618422	DEAFNESS, AUTOSOMAL RECESSIVE 100; DFNB100
618423	ANKYRIN REPEAT DOMAIN-CONTAINING PROTEIN 31; ANKRD31
618424	ARMADILLO REPEAT-CONTAINING PROTEIN 2; ARMC2
618425	NEURODEVELOPMENTAL DISORDER WITH IMPAIRED SPEECH AND HYPERKINETIC MOVEMENTS; NEDISHM
618426	ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED, SUSCEPTIBILITY TO, 9; IIAE9
618427	PROTON-ACTIVATED CHLORIDE CHANNEL 1; PACC1
618428	REMOVED FROM DATABASE
618429	SPERMATOGENIC FAILURE 37; SPGF37
618430	DEVELOPMENTAL DELAY WITH VARIABLE INTELLECTUAL IMPAIRMENT AND BEHAVIORAL ABNORMALITIES; DDVIBA
618431	HYDATIDIFORM MOLE, RECURRENT, 3; HYDM3
618432	HYDATIDIFORM MOLE, RECURRENT, 4; HYDM4
618433	SPERMATOGENIC FAILURE 38; SPGF38
618434	DEAFNESS, AUTOSOMAL RECESSIVE 94; DFNB94
618435	ARTHROGRYPOSIS, DISTAL, TYPE 2B2; DA2B2
618436	ARTHROGRYPOSIS, DISTAL, TYPE 2B3; DA2B3
618437	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 75; DEE75
618438	SPASTIC ATAXIA 9, AUTOSOMAL RECESSIVE; SPAX9
618439	UBIQUITIN-SPECIFIC PROTEASE 45; USP45
618440	OCULOSKELETODENTAL SYNDROME; OCSKD
618441	ADHESION G PROTEIN-COUPLED RECEPTOR G3; ADGRG3
618442	POTASSIUM CHANNEL TETRAMERIZATION DOMAIN-CONTAINING PROTEIN 8; KCTD8
618443	NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT VARIABLE BRAIN ABNORMALITIES; NEDBA
618444	PLASMINOGEN RECEPTOR WITH C-TERMINAL LYSINE; PLGRKT
618445	GHRELIN OPPOSITE STRAND, NONCODING; GHRLOS
618446	GLYPICAN 2; GPC2
618447	LONG QT SYNDROME 8; LQT8
618448	G PROTEIN-COUPLED RECEPTOR 139; GPR139
618449	CILIARY DYSKINESIA, PRIMARY, 41; CILD41
618450	RHOTEKIN 2; RTKN2
618451	NEURODEGENERATION, EARLY-ONSET, WITH CHOREOATHETOID MOVEMENTS AND MICROCYTIC ANEMIA; NDCAMA
618452	PLECKSTRIN HOMOLOGY DOMAIN-CONTAINING PROTEIN, FAMILY B, MEMBER 2; PLEKHB2
618453	INTELLECTUAL DEVELOPMENTAL DISORDER WITH SHORT STATURE AND VARIABLE SKELETAL ANOMALIES; IDDSSA
618454	DEVELOPMENTAL DELAY WITH OR WITHOUT DYSMORPHIC FACIES AND AUTISM; DEDDFA
618455	HEPHAESTIN-LIKE PROTEIN 1; HEPHL1
618456	DEAFNESS, AUTOSOMAL RECESSIVE 114; DFNB114
618457	DEAFNESS, AUTOSOMAL RECESSIVE 115; DFNB115
618458	KNOBLOCH SYNDROME 2; KNO2
618459	IMMUNODEFICIENCY 62; IMD62
618460	KHAN-KHAN-KATSANIS SYNDROME; 3KS
618461	NADH DEHYDROGENASE (UBIQUINONE) COMPLEX I, ASSEMBLY FACTOR 8; NDUFAF8
618462	BLEEDING DISORDER, PLATELET-TYPE, 22; BDPLT22
618463	HYPOALPHALIPOPROTEINEMIA, PRIMARY, 2
618464	PHEOCHROMOCYTOMA/PARAGANGLIOMA SYNDROME 6; PPGL6
618465	BROMODOMAIN-CONTAINING PROTEIN 9; BRD9
618466	BIOGENESIS OF RIBOSOMES BRIX1; BRIX1
618467	SMC5-SMC6 COMPLEX LOCALIZATION FACTOR 1; SLF1
618468	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 76; DEE76
618469	CONTRACTURES, PTERYGIA, AND SPONDYLOCARPOTARSAL FUSION SYNDROME 1B; CPSFS1B
618470	INTELLECTUAL DEVELOPMENTAL DISORDER WITH SEVERE SPEECH AND AMBULATION DEFECTS; IDDSSAD
618471	RIBOSOME PRODUCTION FACTOR 2 HOMOLOG; RPF2
618472	ASPARAGINASE; ASPG
618473	EUKARYOTIC TRANSLATION INITIATION FACTOR 1A DOMAIN-CONTAINING PROTEIN; EIF1AD
618474	WDR83 OPPOSITE STRAND; WDR83OS
618475	PHEOCHROMOCYTOMA/PARAGANGLIOMA SYNDROME 7; PPGL7
618476	BRAIN ABNORMALITIES, NEURODEGENERATION, AND DYSOSTEOSCLEROSIS; BANDDOS
618477	URIDINE-CYTIDINEURIA; URCTU
618478	FYN-BINDING PROTEIN 2; FYB2
618479	CEREBELLAR, OCULAR, CRANIOFACIAL, AND GENITAL SYNDROME; COFG
618480	NEURODEVELOPMENTAL DISORDER WITH SEIZURES AND SPEECH AND WALKING IMPAIRMENT; NEDSSWI
618481	DEAFNESS, AUTOSOMAL RECESSIVE 99; DFNB99
618482	GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 10; GEFSP10
618483	LLGL SCRIBBLE CELL POLARITY COMPLEX COMPONENT 2; LLGL2
618484	ARTHROGRYPOSIS MULTIPLEX CONGENITA 3, MYOGENIC TYPE; AMC3
618485	ZBTB40 INTRONIC TRANSCRIPT 1, NONCODING; ZBTB40IT1
618486	PHOSPHOLIPASE B DOMAIN-CONTAINING PROTEIN 1; PLBD1
618487	G PROTEIN-COUPLED RECEPTOR 151; GPR151
618488	PHOSPHOLIPASE D FAMILY, MEMBER 4; PLD4
618489	BROMODOMAIN-CONTAINING PROTEIN 7; BRD7
618490	G PROTEIN-COUPLED RECEPTOR 107; GPR107
618491	G PROTEIN-COUPLED RECEPTOR 108; GPR108
618492	NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY AND STRUCTURAL BRAIN ANOMALIES; NEDMIBA
618493	HYPOTONIA, HYPOVENTILATION, IMPAIRED INTELLECTUAL DEVELOPMENT, DYSAUTONOMIA, EPILEPSY, AND EYE ABNORMALITIES; HIDEA
618494	CONGENITAL HYPOTONIA, EPILEPSY, DEVELOPMENTAL DELAY, AND DIGITAL ANOMALIES; CHEDDA
618495	IMMUNODEFICIENCY 63 WITH LYMPHOPROLIFERATION AND AUTOIMMUNITY; IMD63
618496	AORTIC VALVE DISEASE 3; AOVD3
618497	NEURODEVELOPMENTAL DISORDER WITH SEIZURES AND NONEPILEPTIC HYPERKINETIC MOVEMENTS; NEDNEH
618498	POLYDACTYLY, POSTAXIAL, TYPE A10; PAPA10
618499	NOONAN SYNDROME 11; NS11
618500	HOLOPROSENCEPHALY 12 WITH OR WITHOUT PANCREATIC AGENESIS; HPE12
618501	CEREBELLAR ATROPHY WITH SEIZURES AND VARIABLE DEVELOPMENTAL DELAY; CASVDD
618502	BRD4-INTERACTING CHROMATIN REMODELING COMPLEX-ASSOCIATED PROTEIN-LIKE; BICRAL
618503	PROTEIN O-GLUCOSYLTRANSFERASE 3; POGLUT3
618504	INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 71; MRT71
618505	STOLERMAN NEURODEVELOPMENTAL SYNDROME; NEDSST
618506	INTELLECTUAL DEVELOPMENTAL DISORDER WITH SPEECH DELAY AND DYSMORPHIC FACIES; IDDSDF
618507	WOUND- AND KERATINOCYTE MIGRATION-ASSOCIATED LONG NONCODING RNA 1; WAKMAR1
618508	WOUND- AND KERATINOCYTE MIGRATION-ASSOCIATED LONG NONCODING RNA 2; WAKMAR2
618509	OLFACTORY RECEPTOR, FAMILY 2, SUBFAMILY M, MEMBER 7; OR2M7
618510	DYSTROTELIN; DYTN
618511	NEUROPATHY, HEREDITARY MOTOR AND SENSORY, TYPE VIC, WITH OPTIC ATROPHY; HMSN6C
618512	O'DONNELL-LURIA-RODAN SYNDROME; ODLURO
618513	LEBER CONGENITAL AMAUROSIS 19; LCA19
618514	BRMS1-LIKE TRANSCRIPTIONAL REPRESSOR; BRMS1L
618515	TRANSMEMBRANE PROTEIN 33; TMEM33
618516	OLFACTORY RECEPTOR, FAMILY 14, SUBFAMILY I, MEMBER 1; OR14I1
618517	ANGIOPOIETIN-LIKE 7; ANGPTL7
618518	LONG INTERGENIC NONCODING RNA 261; LINC00261
618519	CHROMOSOME 2 OPEN READING FRAME 68; C2ORF68
618520	EF-HAND CALCIUM-BINDING DOMAIN-CONTAINING PROTEIN 9; EFCAB9
618521	ARMADILLO REPEAT-CONTAINING PROTEIN 8; ARMC8
618522	INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 59; MRD59
618523	HYPER-IgE SYNDROME 4B, AUTOSOMAL RECESSIVE, WITH RECURRENT INFECTIONS; HIES4B
618524	CONGENITAL MYOPATHY 16; CMYP16
618525	COILED-COIL DOMAIN-CONTAINING PROTEIN 33; CCDC33
618526	PEAK FAMILY MEMBER 3; PEAK3
618527	ICHTHYOTIC KERATODERMA, SPASTICITY, HYPOMYELINATION, AND DYSMORPHIC FACIAL FEATURES; IKSHD
618528	MITOCHONDRIAL DNA DEPLETION SYNDROME 16 (HEPATIC TYPE); MTDPS16
618529	ROBINOW SYNDROME, AUTOSOMAL RECESSIVE 2; RRS2
618530	SERINE/THREONINE KINASE-LIKE DOMAIN-CONTAINING PROTEIN 1; STKLD1
618531	ERYTHROKERATODERMIA VARIABILIS ET PROGRESSIVA 6; EKVP6
618532	CLK4-ASSOCIATING SERINE/ARGININE-RICH PROTEIN; CLASRP
618533	DEAFNESS, AUTOSOMAL DOMINANT 37; DFNA37
618534	IMMUNODEFICIENCY 64 WITH LYMPHOPROLIFERATION; IMD64
618535	ECTODERMAL DYSPLASIA 15, HYPOHIDROTIC/HAIR TYPE; ECTD15
618536	CACTIN, SPLICEOSOME C COMPLEX SUBUNIT; CACTIN
618537	ARGININE VASOPRESSIN-INDUCED PROTEIN 1; AVPI1
618538	CANNABINOID RECEPTOR-INTERACTING PROTEIN 1; CNRIP1
618539	CALCIUM HOMEOSTASIS ENDOPLASMIC RETICULUM PROTEIN; CHERP
618540	CELLULAR REPRESSOR OF E1A-STIMULATED GENES 2; CREG2
618541	HYPOPIGMENTATION, ORGANOMEGALY, AND DELAYED MYELINATION AND DEVELOPMENT; HOD
618542	RAB, MEMBER OF RAS ONCOGENE FAMILY-LIKE 3; RABL3
618543	CILIA- AND FLAGELLA-ASSOCIATED PROTEIN 46; CFAP46
618544	ZINC FINGER- AND SCAN DOMAIN-CONTAINING PROTEIN 16; ZSCAN16
618545	GRPE-LIKE 2, MITOCHONDRIAL; GRPEL2
618546	TRICHOTHIODYSTROPHY 7, NONPHOTOSENSITIVE; TTD7
618547	NEURODEVELOPMENTAL DISORDER WITH VISUAL DEFECTS AND BRAIN ANOMALIES; NEDVIBA
618548	MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 4; MCAHS4
618549	HEPATITIS, FULMINANT VIRAL, SUSCEPTIBILITY TO; FVH
618550	OOCYTE/ZYGOTE/EMBRYO MATURATION ARREST 7; OZEMA7
618551	MICROTUBULE-ASSOCIATED PROTEIN 10; MAP10
618552	SPERM ACROSOME-ASSOCIATED PROTEIN 9; SPACA9
618553	BONE MARROW-ASSOCIATED LONG NONCODING RNA; BMNCR
618554	ZINC FINGER PROTEIN 84; ZNF84
618555	NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE1I; CSNB1I
618556	ENERGY HOMEOSTASIS-ASSOCIATED PROTEIN; ENHO
618557	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 78; DEE78
618558	G PROTEIN SIGNALING MODULATOR 3; GPSM3
618559	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 79; DEE79
618560	BETA-1,4-N-ACETYL-GALACTOSAMINYLTRANSFERASE 4; B4GALNT4
618561	CELL WALL BIOGENESIS PROTEIN 43 C-TERMINAL HOMOLOG; CWH43
618562	TESTIS-EXPRESSED GENE 261; TEX261
618563	SOLUTE CARRIER FAMILY 10 (SODIUM/BILE ACID COTRANSPORTER FAMILY), MEMBER 4; SLC10A4
618564	MICROANGIOPATHY AND LEUKOENCEPHALOPATHY, PONTINE, AUTOSOMAL DOMINANT; PADMAL
618565	H1.7 LINKER HISTONE; H1-7
618566	ADENINE NUCLEOTIDE TRANSLOCASE LYSINE METHYLTRANSFERASE; ANTKMT
618567	MITOCHONDRIAL DNA DEPLETION SYNDROME 17; MTDPS17
618568	ATP SYNTHASE C SUBUNIT LYSINE N-METHYLTRANSFERASE; ATPSCKMT
618569	NEURODEVELOPMENTAL DISORDER WITH ATAXIA, HYPOTONIA, AND MICROCEPHALY; NEDAHM
618570	TRIPARTITE MOTIF-CONTAINING PROTEIN 71; TRIM71
618571	NEURODEVELOPMENTAL DISORDER WITH CATARACTS, POOR GROWTH, AND DYSMORPHIC FACIES; NDCAGF
618572	NEURODEVELOPMENTAL DISORDER WITH CEREBELLAR HYPOPLASIA AND SPASTICITY; NEDCHS
618573	HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 7; CHNG7
618574	DUAL-SPECIFICITY PHOSPHATASE DOMAIN- AND PROLINE ISOMERASE DOMAIN-CONTAINING PROTEIN 1; DUPD1
618575	E2F1 mRNA STABILIZING LONG NONCODING RNA; EMSLR
618576	ZINC FINGER- AND BTB DOMAIN-CONTAINING PROTEIN 10; ZBTB10
618577	NEURODEVELOPMENTAL DISORDER WITH STRUCTURAL BRAIN ANOMALIES AND DYSMORPHIC FACIES; NEDBAF
618578	CONGENITAL MYOPATHY 19; CMYP19
618579	DISTAL MEMBRANE ARM ASSEMBLY COMPLEX 2-LIKE PROTEIN; DMAC2L
618580	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 80; DEE80
618581	ANKYRIN REPEAT DOMAIN-CONTAINING PROTEIN 34B; ANKRD34B
618582	SOLUTE CARRIER FAMILY 10 (SODIUM/BILE ACID COTRANSPORTER FAMILY), MEMBER A5; SLC10A5
618583	MITOCHONDRIAL TRANSCRIPTION RESCUE FACTOR 1; MTRES1
618584	NME/NM23 FAMILY, MEMBER 9; NME9
618585	COILED-COIL DOMAIN-CONTAINING PROTEIN 51; CCDC51
618586	WD REPEAT-CONTAINING PROTEIN 37; WDR37
618587	INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 60, WITH SEIZURES; MRD60
618588	PROTEIN DISULFIDE ISOMERASE-LIKE PROTEIN, TESTIS-EXPRESSED; PDILT
618589	GASTROKINE 2; GKN2
618590	NEURODEVELOPMENTAL DISORDER WITH BRAIN ANOMALIES, SEIZURES, AND SCOLIOSIS; NEDBSS
618591	SHORT SLEEP, FAMILIAL NATURAL, 2; FNSS2
618592	RING FINGER PROTEIN 217; RNF217
618593	ZINC FINGER PROTEIN 398; ZNF398
618594	NEPHROTIC SYNDROME, TYPE 21; NPHS21
618595	CYTOSKELETON-ASSOCIATED PROTEIN 4; CKAP4
618596	EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 16; EIG16
618597	BRAIN-ENRICHED GUANYLATE KINASE-ASSOCIATED PROTEIN; BEGAIN
618598	SPASTIC TETRAPLEGIA AND AXIAL HYPOTONIA, PROGRESSIVE; STAHP
618599	CADHERIN 24; CDH24
618600	CALCIUM-BINDING PROTEIN, SPERMATID-ASSOCIATED 1; CABS1
618601	EXONUCLEASE 5; EXO5
618602	ADAM METALLOPEPTIDASE DOMAIN-CONTAINING PROTEIN 32; ADAM32
618603	NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA AND VARIABLE INTELLECTUAL AND BEHAVIORAL ABNORMALITIES; NEDHIB
618604	SNIJDERS BLOK-FISHER SYNDROME; SNIBFIS
618605	ANKYRIN REPEAT DOMAIN-CONTAINING PROTEIN 9; ANKRD9
618606	PONTOCEREBELLAR HYPOPLASIA, TYPE 13; PCH13
618607	Yjef N-TERMINAL DOMAIN-CONTAINING PROTEIN 3; YJEFN3
618608	INTELLECTUAL DEVELOPMENTAL DISORDER WITH NASAL SPEECH, DYSMORPHIC FACIES, AND VARIABLE SKELETAL ANOMALIES; IDNADFS
618609	HemK METHYLTRANSFERASE FAMILY, MEMBER 1; HEMK1
618610	HOMEOBOX-CONTAINING PROTEIN 1; HMBOX1
618611	HOMOLOGOUS RECOMBINATION FACTOR WITH OB-FOLD; HROB
618612	LOWER URINARY TRACT OBSTRUCTION, CONGENITAL; LUTO
618613	RETINITIS PIGMENTOSA 86; RP86
618614	CHIBBY FAMILY, MEMBER 2; CBY2
618615	HEPATOCELLULAR CARCINOMA-UPREGULATED EZH2-ASSOCIATED LONG NONCODING RNA; HEIH
618616	MITOGEN-ACTIVATED PROTEIN KINASE 15; MAPK15
618617	ZINC FINGER HIT DOMAIN-CONTAINING PROTEIN 1; ZNHIT1
618618	SPONDYLOEPIPHYSEAL DYSPLASIA, NISHIMURA TYPE; SEDN
618619	WEISS-KRUSZKA SYNDROME; WSKA
618620	ABDOMINAL OBESITY-METABOLIC SYNDROME 4; AOMS4
618621	ZINC FINGER DHHC-TYPE PALMITOYLTRANSFERASE 2; ZDHHC2
618622	NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, ARTHROGRYPOSIS, AND STRUCTURAL BRAIN ANOMALIES; NEDMABA
618623	HIG1 HYPOXIA-INDUCIBLE DOMAIN FAMILY, MEMBER 1A; HIGD1A
618624	NOONAN SYNDROME 12; NS12
618625	ROTHMUND-THOMSON SYNDROME, TYPE 1; RTS1
618626	PHOSPHORYLATED C-TERMINAL DOMAIN-INTERACTING FACTOR 1; PCIF1
618627	GERM CELL-LESS 1, SPERMATOGENESIS-ASSOCIATED; GMCL1
618628	METHYLTRANSFERASE 5, N6-ADENOSINE; METTL5
618629	GERM CELL-LESS 2, SPERMATOGENESIS ASSOCIATED; GMCL2
618630	tRNA METHYLTRANSFERASE SUBUNIT 11-2; TRMT112
618631	NRDE2, NECESSARY FOR RNA INTERFERENCE, DOMAIN CONTAINING; NRDE2
618632	USHER SYNDROME, TYPE 1M; USH1M
618633	SOLUTE CARRIER FAMILY 5 (LOW-AFFINITY GLUCOSE COTRANSPORTER), MEMBER 4; SLC5A4
618634	DELETED IN LYMPHOCYTIC LEUKEMIA 7; DLEU7
618635	SIDDIQI SYNDROME; SIDDIS
618636	SOLUTE CARRIER FAMILY 5 (SODIUM/GLUCOSE COTRANSPORTER), MEMBER 10; SLC5A10
618637	OCULOPHARYNGEAL MYOPATHY WITH LEUKOENCEPHALOPATHY 1; OPML1
618638	HECT DOMAIN E3 UBIQUITIN PROTEIN LIGASE 3; HECTD3
618639	NUTM2B ANTISENSE RNA 1; NUTM2BAS1
618640	ZINC FINGER CCCH DOMAIN-CONTAINING PROTEIN 3; ZC3H3
618641	INFANTILE LIVER FAILURE SYNDROME 3; ILFS3
618642	SH3 DOMAIN-CONTAINING RING FINGER PROTEIN 1; SH3RF1
618643	SPERMATOGENIC FAILURE 39; SPGF39
618644	OSTEOGENESIS IMPERFECTA, TYPE XX; OI20
618645	PHD FINGER PROTEIN 12; PHF12
618646	DIENCEPHALIC-MESENCEPHALIC JUNCTION DYSPLASIA SYNDROME 2; DMJDS2
618647	C1q- AND TNF-RELATED PROTEIN 2; C1QTNF2
618648	IMMUNODEFICIENCY 65, SUSCEPTIBILITY TO VIRAL INFECTIONS; IMD65
618649	HECT DOMAIN E3 UBIQUITIN PROTEIN LIGASE 1; HECTD1
618650	RING FINGER PROTEIN 169; RNF169
618651	HALPERIN-BIRK SYNDROME; HLBKS
618652	NEUROOCULOCARDIOGENITOURINARY SYNDROME; NOCGUS
618653	INTELLECTUAL DEVELOPMENTAL DISORDER WITH IMPAIRED LANGUAGE AND DYSMORPHIC FACIES; IDDILF
618654	CONGENITAL MYOPATHY 8; CMYP8
618655	MYOPATHY, DISTAL, 6, ADULT-ONSET, AUTOSOMAL DOMINANT; MPD6
618656	PROLINE- AND GLUTAMATE-RICH PROTEIN WITH COILED-COIL DOMAIN 1; PERCC1
618657	La RIBONUCLEOPROTEIN 4; LARP4
618658	ZIMMERMANN-LABAND SYNDROME 3; ZLS3
618659	NEURODEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND DISTAL SKELETAL ANOMALIES; NEDDFSA
618660	HEMOLYTIC ANEMIA DUE TO GLUTATHIONE REDUCTASE DEFICIENCY
618661	CILIA- AND FLAGELLA-ASSOCIATED PROTEIN 70; CFAP70
618662	DIARRHEA 11, MALABSORPTIVE, CONGENITAL; DIAR11
618663	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 81; DEE81
618664	SPERMATOGENIC FAILURE 40; SPGF40
618665	INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 72; MRT72
618666	SITOSTEROLEMIA 2; STSL2
618667	HYDROCEPHALUS, CONGENITAL, 4; HYC4
618668	GAMMA-AMINOBUTYRIC ACID RECEPTOR, RH0-3; GABRR3
618669	YTH N6-METHYLADENOSINE RNA-BINDING PROTEIN 3; YTHDF3
618670	SPERMATOGENIC FAILURE 41; SPGF41
618671	ZINC FINGER DHHC DOMAIN-CONTAINING PALMITOYLTRANSFERASE 19; ZDHHC19
618672	INTELLECTUAL DEVELOPMENTAL DISORDER WITH SPEECH DELAY, AUTISM, AND DYSMORPHIC FACIES; IDDSADF
618673	ZYG11 FAMILY, MEMBER B, CELL CYCLE REGULATOR; ZYG11B
618674	PULMONARY FIBROSIS AND/OR BONE MARROW FAILURE SYNDROME, TELOMERE-RELATED, 5; PFBMFT5
618675	ZYG11 FAMILY, MEMBER A, CELL CYCLE REGULATOR; ZYG11A
618676	ZINC FINGER- AND BTB DOMAIN-CONTAINING PROTEIN 43; ZBTB43
618677	CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 10; CDCBM10
618678	CARBOXYLESTERASE 5A; CES5A
618679	GDNF FAMILY RECEPTOR ALPHA-4; GFRA4
618680	PANCREATIC CANCER, SUSCEPTIBILITY TO, 5; PNCA5
618681	LESSEL-KUBISCH SYNDROME; LSKB
618682	CILIA- AND FLAGELLA-ASSOCIATED PROTEIN 276; CFAP276
618683	MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 6; MC5DN6
618685	TRANSMEMBRANE PROTEIN 63A; TMEM63A
618686	TEKTIN 5; TEKT5
618687	INTELLECTUAL DEVELOPMENTAL DISORDER WITH SHORT STATURE AND BEHAVIORAL ABNORMALITIES; IDDSSBA
618688	LEUKODYSTROPHY, HYPOMYELINATING, 19, TRANSIENT INFANTILE; HLD19
618689	NETRIN G2; NTNG2
618690	PSORIASIS SUSCEPTIBILITY 1 CANDIDATE GENE 3, NONCODING; PSORS1C3
618691	TRANSMEMBRANE PROTEIN 266; TMEM266
618692	VESTIGIAL-LIKE FAMILY MEMBER 4; VGLL4
618693	CHYMOTRYPSIN-LIKE ELASTASE 3A; CELA3A
618694	CHYMOTRYPSIN-LIKE ELASTASE 3A; CELA3B
618695	CILIARY DYSKINESIA, PRIMARY, 42; CILD42
618696	GOLGI-ASSOCIATED OLFACTORY SIGNALING REGULATOR; GFY
618697	RETINITIS PIGMENTOSA 87 WITH CHOROIDAL INVOLVEMENT; RP87
618698	DOUBLE HOMEOBOX B; DUXB
618699	CILIARY DYSKINESIA, PRIMARY, 43; CILD43
618700	CYTOPLASMIC POLYADENYLATED HOMEOBOX-LIKE; CPHXL
618701	LEUCINE TWENTY HOMEOBOX; LEUTX
618702	SHORT STATURE AND MICROCEPHALY WITH GENITAL ANOMALIES; SSMGA
618703	ZINC FINGER PROTEIN 281; ZNF281
618704	CILIA- AND FLAGELLA-ASSOCIATED PROTEIN 221; CFAP221
618705	MBT DOMAIN-CONTAINING PROTEIN 1; MBTD1
618706	HOXA CLUSTER ANTISENSE RNA 3, NONCODING; HOXAAS3
618707	NEURODEVELOPMENTAL DISORDER WITH ABSENT LANGUAGE AND VARIABLE SEIZURES; NEDALVS
618708	NEIGHBOR OF BRCA1 GENE 2, NONCODING; NBR2
618709	NEURODEVELOPMENTAL DISORDER WITH NONSPECIFIC BRAIN ABNORMALITIES AND WITH OR WITHOUT SEIZURES; NEDBAS
618710	PARTNER OF NOB1; PNO1
618711	METHYLTRANSFERASE-LIKE 15; METTL15
618712	ANKYRIN REPEAT DOMAIN-CONTAINING PROTEIN 45; ANKRD45
618713	CYSTIN 1; CYS1
618714	RAP1 GTPase-ACTIVATING PROTEIN 2; RAP1GAP2
618715	ZINC FINGER DHHC-TYPE PALMITOYLTRANSFERASE 6; ZDHHC6
618716	AUTOPHAGY 16-LIKE 2; ATG16L2
618717	EPITHELIAL MITOGEN; EPGN
618718	NEURODEVELOPMENTAL DISORDER WITH BEHAVIORAL ABNORMALITIES, ABSENT SPEECH, AND HYPOTONIA; NEDBASH
618719	MEGABLADDER, CONGENITAL; MGBL
618720	PEPTIDE DEFORMYLASE, MITOCHONDRIAL; PDF
618721	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 82; DEE82
618722	FAMILY WITH SEQUENCE SIMILARITY 210, MEMBER B; FAM210B
618723	PREMATURE OVARIAN FAILURE 16; POF16
618724	HEYN-SPROUL-JACKSON SYNDROME; HESJAS
618725	INTELLECTUAL DEVELOPMENTAL DISORDER WITH BEHAVIORAL ABNORMALITIES AND CRANIOFACIAL DYSMORPHISM WITH OR WITHOUT SEIZURES; IDDBCS
618726	NIMA-RELATED KINASE 10; NEK10
618727	ECTODERMAL DYSPLASIA WITH FACIAL DYSMORPHISM AND ACRAL, OCULAR, AND BRAIN ANOMALIES; EDFAOB
618728	SPONDYLOEPIMETAPHYSEAL DYSPLASIA, ISIDOR-TOUTAIN TYPE; SEMDIST
618729	LIANG-WANG SYNDROME; LIWAS
618730	NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, CORTICAL MALFORMATIONS, AND SPASTICITY; NEDMCMS
618731	NEURODEVELOPMENTAL DISORDER WITH BRAIN ANOMALIES AND WITH OR WITHOUT VERTEBRAL OR CARDIAC ANOMALIES; NEDBAVC
618732	POIRIER-BIENVENU NEURODEVELOPMENTAL SYNDROME; POBINDS
618733	NEUROMUSCULAR OCULOAUDITORY SYNDROME; NMOAS
618734	ANEURYSM, INTRACRANIAL BERRY, 12; ANIB12
618735	TETRATRICOPEPTIDE REPEAT DOMAIN-CONTAINING PROTEIN 29; TTC29
618736	STRUCTURAL BRAIN ANOMALIES WITH IMPAIRED INTELLECTUAL DEVELOPMENT AND CRANIOSYNOSTOSIS; BAIDCS
618737	CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 15; CDCBM15
618738	TUBULIN TYROSINE LIGASE-LIKE 4; TTLL4
618739	CTD SMALL PHOSPHATASE-LIKE PROTEIN 2; CTDSPL2
618740	COILED-COIL DOMAIN-CONTAINING PROTEIN 154; CCDC154
618741	NEURODEVELOPMENTAL DISORDER WITH EPILEPSY, SPASTICITY, AND BRAIN ATROPHY; NEDESBA
618742	ZINC FINGER- AND BTB DOMAIN-CONTAINING PROTEIN 8A; ZBTB8A
618743	PHOSPHOLIPID PHOSPHATASE 7; PLPP7
618744	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 83; DEE83
618745	SPERMATOGENIC FAILURE 42; SPGF42
618746	CORTEXIN 3; CTXN3
618747	CHROMOSOME 1 OPEN READING FRAME 61; C1ORF61
618748	INTELLECTUAL DEVELOPMENTAL DISORDER WITH HYPOTONIA AND BEHAVIORAL ABNORMALITIES; IDDHBA
618749	LEUCINE-RICH REPEAT-CONTAINING PROTEIN 17; LRRC17
618750	ACTIVATOR OF BASAL TRANSCRIPTION 1; ABT1
618751	SPERMATOGENIC FAILURE 43; SPGF43
618752	NEUTROPENIA, SEVERE CONGENITAL, 8, AUTOSOMAL DOMINANT; SCN8
618753	LEUCINE-RICH REPEAT-CONTAINING PROTEIN 41; LRRC41
618754	CARBOXYPEPTIDASE Q; CPQ
618755	SHORT TRANSMEMBRANE MITOCHONDRIAL PROTEIN 1; STMP1
618756	ABHYDROLASE DOMAIN-CONTAINING PROTEIN 10, DEPALMITOYLASE; ABHD10
618757	CYTOCHROME b561 FAMILY, MEMBER A3; CYB561A3
618758	DYNEIN REGULATORY COMPLEX SUBUNIT 3; DRC3
618759	CALCIUM-BINDING PROTEIN 7; CABP7
618760	NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA AND AUTISTIC FEATURES WITH OR WITHOUT HYPERKINETIC MOVEMENTS; NEDHAHM
618761	CATIFA SYNDROME; CATIFA
618762	2-PRIME-DEOXYNUCLEOSIDE 5-PRIME-PHOSPHATE N-HYDROLASE 1; DNPH1
618763	JOUBERT SYNDROME 36; JBTS36
618764	CDK2-ASSOCIATED CULLIN DOMAIN-CONTAINING PROTEIN 1; CACUL1
618765	ESF1 NUCLEOLAR PRE-rRNA-PROCESSING PROTEIN; ESF1
618766	ARTHROGRYPOSIS MULTIPLEX CONGENITA 4, NEUROGENIC, WITH AGENESIS OF THE CORPUS CALLOSUM; AMC4
618767	CORNEAL DYSTROPHY, MEESMANN, 2; MECD2
618768	SPASTIC PARAPLEGIA 81, AUTOSOMAL RECESSIVE; SPG81
618769	DYNEIN REGULATORY COMPLEX SUBUNIT 7; DRC7
618770	SPASTIC PARAPLEGIA 82, AUTOSOMAL RECESSIVE; SPG82
618771	ABHYDROLASE DOMAIN-CONTAINING PROTEIN 14A; ABHD14A
618772	CDK5 AND ABL ENZYME SUBSTRATE 2; CABLES2
618773	LYMPHATIC MALFORMATION 8; LMPHM8
618774	CEBALID SYNDROME; CEBALID
618775	MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 10; MC3DN10
618776	MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 34; MC1DN34
618777	CALPAIN 8; CAPN8
618778	DEAFNESS, AUTOSOMAL DOMINANT 75; DFNA75
618779	COFFIN-SIRIS SYNDROME 11; CSS11
618780	CONGENITAL HEART DEFECTS, MULTIPLE TYPES, 7; CHTD7
618781	CILIARY DYSKINESIA, PRIMARY, 44; CILD44
618782	LONG QT SYNDROME 16; LQT16
618783	CYCLIN I; CCNI
618784	PITH DOMAIN-CONTAINING PROTEIN 1; PITHD1
618785	CELL DIVISION CYCLE-ASSOCIATED PROTEIN 2; CDCA2
618786	IMAGAWA-MATSUMOTO SYNDROME; IMMAS
618787	DEAFNESS, AUTOSOMAL DOMINANT 76; DFNA76
618788	COILED-COIL DOMAIN-CONTAINING PROTEIN 134; CCDC134
618789	CDV3 HOMOLOG; CDV3
618790	POTASSIUM CHANNEL TETRAMERIZATION DOMAIN-CONTAINING PROTEIN 21; KCTD21
618791	POTASSIUM CHANNEL TETRAMERIZATION DOMAIN-CONTAINING PROTEIN 6; KCTD6
618792	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 84; DEE84
618793	INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 62; MRD62
618794	KELCH REPEAT- AND BTB/POZ DOMAIN-CONTAINING PROTEIN 11; KBTBD11
618795	JUVENILE ARTHRITIS; JUVAR
618796	SAC3 DOMAIN-CONTAINING PROTEIN 1; SAC3D1
618797	NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, NEONATAL RESPIRATORY INSUFFICIENCY, AND THERMODYSREGULATION; NEDHRIT
618798	BECK-FAHRNER SYNDROME; BEFAHRS
618799	CALCYPHOSINE-LIKE PROTEIN; CAPSL
618800	SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 28; SCAR28
618801	CILIARY DYSKINESIA, PRIMARY, 45; CILD45
618802	tRNA-HISTIDINE GUANYLYLTRANSFERASE 1-LIKE PROTEIN; THG1L
618803	RESPIRATORY PAPILLOMATOSIS, JUVENILE RECURRENT, CONGENITAL; JRRP
618804	SANDESTIG-STEFANOVA SYNDROME; SANDSTEF
618805	TRIOKINASE AND FMN CYCLASE DEFICIENCY SYNDROME; TKFCD
618806	T-CELL LYMPHOPENIA, INFANTILE, WITH OR WITHOUT NAIL DYSTROPHY, AUTOSOMAL DOMINANT; TLIND
618807	LIPOPROTEIN(a) QUANTITATIVE TRAIT LOCUS; LPAQTL
618808	INTELLECTUAL DEVELOPMENTAL DISORDER WITH POOR GROWTH AND WITH OR WITHOUT SEIZURES OR ATAXIA; IDPOGSA
618809	PIGB OPPOSITE STRAND 1; PIGBOS1
618810	PONTOCEREBELLAR HYPOPLASIA, HYPOTONIA, AND RESPIRATORY INSUFFICIENCY SYNDROME, NEONATAL LETHAL; PHRINL
618811	MITOCHONDRIAL DNA DEPLETION SYNDROME 18; MTDPS18
618812	UBIQUINOL-CYTOCHROME C REDUCTASE COMPLEX ASSEMBLY FACTOR 6; UQCC6
618813	TUBULIN TYROSINE LIGASE-LIKE 7; TTLL7
618814	KILLER CELL LECTIN-LIKE RECEPTOR F2; KLRF2
618815	CHROMOSOME 1p36.33 DUPLICATION SYNDROME, ATAD3 GENE CLUSTER, AUTOSOMAL DOMINANT
618816	CDY-LIKE PROTEIN 2; CDYL2
618817	TRANSMEMBRANE PROTEIN 11; TMEM11
618818	HOST CELL FACTOR C1 REGULATOR 1; HCFC1R1
618819	PBX HOMEOBOX-INTERACTING PROTEIN 1; PBXIP1
618820	GENITOURINARY AND/OR BRAIN MALFORMATION SYNDROME; GUBS
618821	RHIZOMELIC LIMB SHORTENING WITH DYSMORPHIC FEATURES; RLSDF
618822	CONGENITAL MYOPATHY 9A; CMYP9A
618823	CONGENITAL MYOPATHY 9B, PROXIMAL, WITH MINICORE LESIONS; CMYP9B
618824	BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 8, AUTOSOMAL RECESSIVE; IBGC8
618825	INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 63, WITH MACROCEPHALY; MRD63
618826	RETINITIS PIGMENTOSA 88; RP88
618827	MYOPIA 27, AUTOSOMAL DOMINANT; MYP27
618828	NABAIS SA-DE VRIES SYNDROME, TYPE 1; NSDVS1
618829	NABAIS SA-DE VRIES SYNDROME, TYPE 2; NSDVS2
618830	AUTISM, SUSCEPTIBILITY TO, 20; AUTS20
618831	TRANSMEMBRANE PROTEIN 37; TMEM37
618832	EPILEPSY, EARLY-ONSET, 2, WITH OR WITHOUT DEVELOPMENTAL DELAY; EPEO2
618833	RAL GTPase-ACTIVATING PROTEIN, NONCATALYTIC SUBUNIT BETA; RALGAPB
618834	LATE ENDOSOMAL/LYSOSOMAL ADAPTOR, MITOGEN-ACTIVATED PROTEIN KINASE AND MAMMALIAN TARGET OF RAPAMYCIN ACTIVATOR 4; LAMTOR4
618835	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 40; COXPD40
618836	RAL GTPase-ACTIVATING PROTEIN, CATALYTIC SUBUNIT ALPHA-2; RALGAPA2
618837	LYSOSOME-ASSOCIATED PROTEIN, TRANSMEMBRANE 4, ALPHA; LAPTM4A
618838	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 41; COXPD41
618839	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 42; COXPD42
618840	ALOPECIA-INTELLECTUAL DISABILITY SYNDROME 4; APMR4
618841	HYPOGONADOTROPIC HYPOGONADISM 25 WITH ANOSMIA; HH25
618842	HORMA DOMAIN-CONTAINING PROTEIN 2; HORMAD2
618843	LAYILIN; LAYN
618844	L3MBTL HISTONE METHYL-LYSINE-BINDING PROTEIN 3; L3MBTL3
618845	VERTEBRAL, CARDIAC, RENAL, AND LIMB DEFECTS SYNDROME 3; VCRL3
618846	DIETS-JONGMANS SYNDROME; DIJOS
618847	IMMUNODEFICIENCY 66; IMD66
618848	MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 26; LGMDR26
618849	BONE MARROW FAILURE SYNDROME 6; BMFS6
618850	HYPERVALINEMIA AND HYPERLEUCINE-ISOLEUCINEMIA; HVLI
618851	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 43; COXPD43
618852	AUTOINFLAMMATION WITH EPISODIC FEVER AND LYMPHADENOPATHY; AIEFL
618853	ANAUXETIC DYSPLASIA 3; ANXD3
618854	SIGNAL PEPTIDASE COMPLEX, SUBUNIT 3; SPCS3
618855	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 44; COXPD44
618856	DIABETES MELLITUS, PERMANENT NEONATAL, 2; PNDM2
618857	DIABETES MELLITUS, PERMANENT NEONATAL, 3; PNDM3
618858	DIABETES MELLITUS, PERMANENT NEONATAL, 4; PNDM4
618859	NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT AUTISTIC FEATURES AND/OR STRUCTURAL BRAIN ABNORMALITIES; NEDASB
618860	CHROMOSOME 1 OPEN READING FRAME 87; C1ORF87
618861	IGLON FAMILY, MEMBER 5; IGLON5
618862	NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, MICROCEPHALY, AND SEIZURES; NEDHYMS
618863	RETINAL DYSTROPHY WITH LEUKODYSTROPHY; RDLKD
618864	CHROMOSOME 19 OPEN READING FRAME 48, PSEUDOGENE; C19ORF48P
618865	CEP85-LIKE PROTEIN; CEP85L
618866	TREMOR, HEREDITARY ESSENTIAL, 6; ETM6
618867	RAS HOMOLOG GENE FAMILY, MEMBER F, FILOPODIA-ASSOCIATED; RHOF
618868	NEURODEGENERATION, CHILDHOOD-ONSET, WITH ATAXIA, TREMOR, OPTIC ATROPHY, AND COGNITIVE DECLINE; CONATOC
618869	RING FINGER PROTEIN 144B; RNF144B
618870	SKELETAL DYSPLASIA, MILD, WITH JOINT LAXITY AND ADVANCED BONE AGE; SDJLABA
618871	RHO GUANINE NUCLEOTIDE EXCHANGE FACTOR 16; ARHGEF16
618872	NIZON-ISIDOR SYNDROME; NIZIDS
618873	LISSENCEPHALY 10; LIS10
618874	CHROMOSOME 17q11.2 DUPLICATION SYNDROME, 1.4-MB
618875	SEIZURES, EARLY-ONSET, WITH NEURODEGENERATION AND BRAIN CALCIFICATIONS; SENEBAC
618876	EPILEPSY, PROGRESSIVE MYOCLONIC, 11; EPM11
618877	LEUKOENCEPHALOPATHY, DEVELOPMENTAL DELAY, AND EPISODIC NEUROLOGIC REGRESSION SYNDROME; LEUDEN
618878	LEUKOENCEPHALOPATHY, MOTOR DELAY, SPASTICITY, AND DYSARTHRIA SYNDROME; LEMSPAD
618879	NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA AND CEREBELLAR ATROPHY, WITH OR WITHOUT SEIZURES; NEDHCAS
618880	GLAUCOMA, PRIMARY CLOSED-ANGLE; GLCC
618881	GALACTOSEMIA IV; GALAC4
618882	IMERSLUND-GRASBECK SYNDROME 2; IGS2
618883	HYPOPARATHYROIDISM, FAMILIAL ISOLATED, 2; FIH2
618884	PROTEINURIA, CHRONIC BENIGN; PROCHOB
618885	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIt; CDG2T
618886	PSEUDO-TORCH SYNDROME 3; PTORCH3
618887	NUCLEAR FACTOR KAPPA-B INHIBITOR, DELTA; NFKBID
618888	CAS SCAFFOLD PROTEIN FAMILY, MEMBER 4; CASS4
618889	LIBERFARB SYNDROME; LIBF
618890	NEURODEVELOPMENTAL DISORDER AND STRUCTURAL BRAIN ANOMALIES WITH OR WITHOUT SEIZURES AND SPASTICITY; NEDBASS
618891	MICROCEPHALY, DEVELOPMENTAL DELAY, AND BRITTLE HAIR SYNDROME; MDBH
618892	HARDEROPORPHYRIA; HARPO
618893	NUCLEOLAR PROTEIN 4-LIKE; NOL4L
618894	REACTIVE OXYGEN SPECIES MODULATOR 1; ROMO1
618895	IZUMO FAMILY, MEMBER 2; IZUMO2
618896	IZUMO FAMILY, MEMBER 3; IZUMO3
618897	IZUMO FAMILY, MEMBER 4; IZUMO4
618898	CENTROSOMAL PROTEIN, 85-KD; CEP85
618899	MANNOSIDASE, ALPHA, CLASS 2B, MEMBER 2; MAN2B2
618900	ZINC FINGER CW-TYPE DOMAIN- AND PWWP DOMAIN-CONTAINING PROTEIN 1; ZCWPW1
618901	46,XX SEX REVERSAL 5; SRXX5
618902	METHYLTRANSFERASE 2A, METHYLCYTIDINE; METTL2A
618903	METHYLTRANSFERASE 6, METHYLCYTIDINE; METTL6
618904	DALR ANTICODON-BINDING DOMAIN-CONTAINING PROTEIN 3; DALRD3
618905	SILVER-RUSSELL SYNDROME 2; SRS2
618906	INTELLECTUAL DEVELOPMENTAL DISORDER WITH AUTISTIC FEATURES AND LANGUAGE DELAY, WITH OR WITHOUT SEIZURES; IDDALDS
618907	SILVER-RUSSELL SYNDROME 4; SRS4
618908	SILVER-RUSSELL SYNDROME 5; SRS5
618909	ILK-ASSOCIATED SERINE/THREONINE PHOSPHATASE; ILKAP
618910	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 86; DEE86
618911	CHROMOSOME 16 OPEN READING FRAME 92; C16ORF92
618912	NEURONOPATHY, DISTAL HEREDITARY MOTOR, AUTOSOMAL RECESSIVE 8; HMNR8
618913	FANCONI RENOTUBULAR SYNDROME 5; FRTS5
618914	NEURODEVELOPMENTAL, JAW, EYE, AND DIGITAL SYNDROME; NEDJED
618915	DEAFNESS, AUTOSOMAL DOMINANT 77; DFNA77
618916	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 87; DEE87
618917	NEURODEVELOPMENTAL DISORDER WITH LANGUAGE IMPAIRMENT AND BEHAVIORAL ABNORMALITIES; NEDLIB
618918	PERIVENTRICULAR NODULAR HETEROTOPIA 9; PVNH9
618919	KELCH-LIKE FAMILY, MEMBER 42; KLHL42
618920	ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA, FAMILIAL, 14; ARVD14
618921	LACTAMASE, BETA-2; LACTB2
618922	NEURODEVELOPMENTAL DISORDER WITH SEIZURES, HYPOTONIA, AND BRAIN IMAGING ABNORMALITIES; NEDSHBA
618923	FATTY ACID-BINDING PROTEIN 12; FABP12
618924	EPISODIC ATAXIA, TYPE 9; EA9
618925	G PROTEIN-COUPLED RECEPTOR 171; GPR171
618926	OSTEOMODULIN; OMD
618927	KERATIN-ASSOCIATED PROTEIN 24-1; KRTAP24-1
618928	LACTATE DEHYDROGENASE A-LIKE PROTEIN 6A; LDHAL6A
618929	AGENESIS OF CORPUS CALLOSUM, CARDIAC, OCULAR, AND GENITAL SYNDROME; ACOGS
618930	ANKYRIN REPEAT DOMAIN-CONTAINING PROTEIN 18B; ANKRD18B
618931	ZINC FINGER NFX1-TYPE DOMAIN-CONTAINING PROTEIN 1; ZNFX1
618932	OLIGOSACCHARYLTRANSFERASE COMPLEX, SUBUNIT 4, NONCATALYTIC; OST4
618933	SH3 DOMAIN-CONTAINING RING FINGER PROTEIN 3; SH3RF3
618934	COILED-COIL SERINE-RICH PROTEIN 1; CCSER1
618935	GRANULOMATOUS DISEASE, CHRONIC, AUTOSOMAL RECESSIVE, 5; CGD5
618936	SPERMATOGENESIS-ASSOCIATED PROTEIN 25; SPATA25
618937	PROTEIN PHOSPHATASE 1, REGULATORY SUBUNIT 35; PPP1R35
618938	LONG NONCODING RNA ASSOCIATED WITH SART3 REGULATION OF SPLICING; LASTR
618939	TREACHER COLLINS SYNDROME 4; TCS4
618940	OCULOPHARYNGODISTAL MYOPATHY 2; OPDM2
618941	COILED-COIL DOMAIN-CONTAINING PROTEIN 32; CCDC32
618942	IQ MOTIF- AND ANKYRIN REPEAT-CONTAINING PROTEIN 1; IQANK1
618943	SMALL NUCLEOLAR RNA, C/D BOX, 8; SNORD8
618944	HYPER-IgE SYNDROME 5, AUTOSOMAL RECESSIVE, WITH RECURRENT INFECTIONS; HIES5
618945	SPERM ACROSOME-ASSOCIATED PROTEIN 6; SPACA6
618946	LLLL MOTIF- AND CFNLAS MOTIF-CONTAINING PROTEIN 1; LLCFC1
618947	ARTHROGRYPOSIS MULTIPLEX CONGENITA 5; AMC5
618948	HETEROTAXY, VISCERAL, 9, AUTOSOMAL, WITH MALE INFERTILITY; HTX9
618949	RIBOSOMAL MODIFICATION PROTEIN RimK-LIKE FAMILY, MEMBER A; RIMKLA
618950	SULEIMAN-EL-HATTAB SYNDROME; SULEHS
618951	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 45; COXPD45
618952	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 46; COXPD46
618953	CYTOCHROME P450, FAMILY 4, SUBFAMILY Z, MEMBER 1; CYP4Z1
618954	CYTOCHROME P450, FAMILY 4, SUBFAMILY Z, MEMBER 2, PSEUDOGENE; CYP4Z2P
618955	RETINITIS PIGMENTOSA 89; RP89
618956	RHEB-LIKE PROTEIN 1; RHEBL1
618957	ANKYRIN REPEAT DOMAIN-CONTAINING PROTEIN 27; ANKRD27
618958	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 47; COXPD47
618959	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 88; DEE88
618960	MITCHELL SYNDROME; MITCH
618961	SPONDYLOMETAPHYSEAL DYSPLASIA WITH CORNEAL DYSTROPHY; SMDCD
618962	OVOCHYMASE 2; OVCH2
618963	IMMUNODEFICIENCY 69; IMD69
618964	REQUIRED FOR MEIOTIC NUCLEAR DIVISION 5 HOMOLOG A; RMND5A
618965	TRANSMEMBRANE PROTEIN 9 SUPERFAMILY, MEMBER 1; TM9SF1
618966	TRANSMEMBRANE PROTEIN 161A; TMEM161A
618967	ATP-BINDING CASSETTE, SUBFAMILY F, MEMBER 3; ABCF3
618968	CHROMOSOME 1 OPEN READING FRAME 146; C1ORF146
618969	IMMUNODEFICIENCY 70; IMD70
618970	CONE-ROD SYNAPTIC DISORDER SYNDROME, CONGENITAL NONPROGRESSIVE; CRSDS
618971	TOLCHIN-LE CAIGNEC SYNDROME; TOLCAS
618972	MITOCHONDRIAL DNA DEPLETION SYNDROME 19; MTDPS19
618973	SODIUM-DEPENDENT MULTIVITAMIN TRANSPORTER DEFICIENCY; SMVTD
618974	LI-GHORBANI-WEISZ-HUBSHMAN SYNDROME; LIGOWS
618975	CONGENITAL MYOPATHY 17; CMYP17
618976	MYOCARDIN-INDUCED SMOOTH MUSCLE LONG NONCODING RNA, INDUCER OF DIFFERENTIATION; MYOSLID
618977	OPTIC ATROPHY 12; OPA12
618978	TRANSMEMBRANE PROTEIN 163; TMEM163
618979	HIGH DENSITY LIPOPROTEIN CHOLESTEROL LEVEL QUANTITATIVE TRAIT LOCUS 7; HDLCQ7
618980	CENTROSOMAL PROTEIN, 112-KD; CEP112
618981	VPS35 ENDOSOMAL PROTEIN-SORTING FACTOR-LIKE; VPS35L
618982	IMMUNODEFICIENCY 72 WITH AUTOINFLAMMATION AND LYMPHOPROLIFERATION; IMD72
618983	BLOOD GROUP, LEWIS SYSTEM; LE
618984	SAD1 AND UNC84 DOMAIN-CONTAINING PROTEIN 3; SUN3
618985	GROWTH HORMONE INSENSITIVITY SYNDROME WITH IMMUNE DYSREGULATION 2, AUTOSOMAL DOMINANT; GHISID2
618986	IMMUNODEFICIENCY 73B WITH DEFECTIVE NEUTROPHIL CHEMOTAXIS AND LYMPHOPENIA; IMD73B
618987	IMMUNODEFICIENCY 73C WITH DEFECTIVE NEUTROPHIL CHEMOTAXIS AND HYPOGAMMAGLOBULINEMIA; IMD73C
618988	CLARIN 2; CLRN2
618989	TRANSMEMBRANE PROTEIN 119; TMEM119
618990	EVA1 HOMOLOG A, REGULATOR OF PROGRAMMED CELL DEATH; EVA1A
618991	SEMAPHORIN 4G; SEMA4G
618992	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH IMPAIRED INTELLECTUAL DEVELOPMENT), TYPE B, 15; MDDGB15
618993	RING FINGER PROTEIN 208; RNF208
618994	4-HYDROXYPHENYLPYRUVATE DIOXYGENASE-LIKE; HPDL
618995	BPES CANDIDATE GENE 1; BPESC1
618996	LEUCINE-RICH REPEAT-CONTAINING PROTEIN 3B; LRRC3B
618997	CYTIDINE AND DEOXYCYTIDYLATE DEAMINASE DOMAIN-CONTAINING PROTEIN 1; CDADC1
618998	IMMUNE DYSREGULATION AND SYSTEMIC HYPERINFLAMMATION SYNDROME; IMDYSHI
618999	AUTOINFLAMMATION, IMMUNE DYSREGULATION, AND EOSINOPHILIA; AIIDE
619000	INTELLECTUAL DEVELOPMENTAL DISORDER WITH SEIZURES AND LANGUAGE DELAY; IDDSELD
619001	ANGEL HOMOLOG 2; ANGEL2
619002	LEUCINE-RICH REPEAT-CONTAINING PROTEIN 18; LRRC18
619003	MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 35; MC1DN35
619004	DEEAH SYNDROME; DEEAH
619005	NEURODEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES, IMPAIRED SPEECH, AND HYPOTONIA; NEDDISH
619006	BASIC IMMUNOGLOBULIN-LIKE VARIABLE MOTIF-CONTAINING PROTEIN; BIVM
619007	RETINITIS PIGMENTOSA 90; RP90
619008	LONG INTERGENIC NONCODING RNA 598; LINC00598
619009	OOCYTE/ZYGOTE/EMBRYO MATURATION ARREST 8; OZEMA8
619010	ATXN7-LIKE 3; ATXN7L3
619011	OOCYTE/ZYGOTE/EMBRYO MATURATION ARREST 9; OZEMA9
619012	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 48; COXPD48
619013	RAJAB INTERSTITIAL LUNG DISEASE WITH BRAIN CALCIFICATIONS 2; RILDBC2
619014	TETRATRICOPEPTIDE REPEAT DOMAIN-CONTAINING PROTEIN 5; TTC5
619015	ENY2 TRANSCRIPTION AND EXPORT COMPLEX 2 SUBUNIT; ENY2
619016	IFAP SYNDROME 2; IFAP2
619017	RHOMBOID-LIKE 3; RHBDL3
619018	MICRO RNA 30B; MIR30B
619019	MICRO RNA 30D; MIR30D
619020	LRP2-BINDING PROTEIN; LRP2BP
619021	ANKYRIN REPEAT DOMAIN-CONTAINING PROTEIN 37; ANKRD37
619022	TRANSMEMBRANE PROTEIN 229B; TMEM229B
619023	OLIGOSACCHARYLTRANSFERASE COMPLEX, NONCATALYTIC SUBUNIT; OSTC
619024	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 49; COXPD49
619025	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 50; COXPD50
619026	NEURODEVELOPMENTAL DISORDER WITH PROGRESSIVE SPASTICITY AND BRAIN WHITE MATTER ABNORMALITIES; NEDSWMA
619027	SPASTIC PARAPLEGIA 83, AUTOSOMAL RECESSIVE; SPG83
619028	COENZYME Q10 DEFICIENCY, PRIMARY, 9; COQ10D9
619029	KERATINOCYTE-ASSOCIATED PROTEIN 2; KRTCAP2
619030	SKELETAL MUSCLE GLYCOGEN CONTENT AND METABOLISM QUANTITATIVE TRAIT LOCUS; SMGMQTL
619031	INTELLECTUAL DEVELOPMENTAL DISORDER WITH EPILEPSY, BEHAVIORAL ABNORMALITIES, AND COARSE FACIES; IDDEBF
619032	RETICULOCALBIN 3; RCN3
619033	VISSERS-BODMER SYNDROME; VIBOS
619034	RNA-BINDING PROTEIN, mRNA-PROCESSING FACTOR, 2; RBPMS2
619035	MICRO RNA 29B2; MIR29B2
619036	MYOPATHY, EPILEPSY, AND PROGRESSIVE CEREBRAL ATROPHY; MEPCA
619037	LEUCINE-RICH REPEAT-CONTAINING PROTEIN 34; LRRC34
619038	SPOC DOMAIN-CONTAINING PROTEIN 1; SPOCD1
619039	REPLICATION INITIATOR 1; REPIN1
619040	MYOFIBRILLAR MYOPATHY 10; MFM10
619041	MONOSOMY 7 MYELODYSPLASIA AND LEUKEMIA SYNDROME 2; M7MLS2
619042	SPINAL MUSCULAR ATROPHY, INFANTILE, JAMES TYPE; SMAJI
619043	INOSITOL-PENTAKISPHOSPHATE 2-KINASE; IPPK
619044	SPERMATOGENIC FAILURE 44; SPGF44
619045	SERINE HYDROLASE-LIKE 2; SERHL2
619046	MITOCHONDRIAL COMPLEX IV DEFICIENCY, NUCLEAR TYPE 3; MC4DN3
619047	PROTEIN PHOSPHATASE 1, REGULATORY SUBUNIT 32; PPP1R32
619048	MITOCHONDRIAL COMPLEX IV DEFICIENCY, NUCLEAR TYPE 4; MC4DN4
619049	TESTIS DEVELOPMENT-RELATED PROTEIN; TDRP
619050	3-HYDROXY-3-METHYLGLUTARYL-CoA LYASE-LIKE PROTEIN 1; HMGCLL1
619051	MITOCHONDRIAL COMPLEX IV DEFICIENCY, NUCLEAR TYPE 7; MC4DN7
619052	MITOCHONDRIAL COMPLEX IV DEFICIENCY, NUCLEAR TYPE 8; MC4DN8
619053	MITOCHONDRIAL COMPLEX IV DEFICIENCY, NUCLEAR TYPE 10; MC4DN10
619054	MITOCHONDRIAL COMPLEX IV DEFICIENCY, NUCLEAR TYPE 11; MC4DN11
619055	MITOCHONDRIAL COMPLEX IV DEFICIENCY, NUCLEAR TYPE 12; MC4DN12
619056	NEURODEVELOPMENTAL DISORDER WITH SPEECH IMPAIRMENT AND DYSMORPHIC FACIES; NEDSID
619057	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 51; COXPD51
619058	MITOCHONDRIAL COMPLEX IV DEFICIENCY, NUCLEAR TYPE 14; MC4DN14
619059	MITOCHONDRIAL COMPLEX IV DEFICIENCY, NUCLEAR TYPE 15; MC4DN15
619060	MITOCHONDRIAL COMPLEX IV DEFICIENCY, NUCLEAR TYPE 16; MC4DN16
619061	MITOCHONDRIAL COMPLEX IV DEFICIENCY, NUCLEAR TYPE 17; MC4DN17
619062	MITOCHONDRIAL COMPLEX IV DEFICIENCY, NUCLEAR TYPE 18; MC4DN18
619063	MITOCHONDRIAL COMPLEX IV DEFICIENCY, NUCLEAR TYPE 19; MC4DN19
619064	MITOCHONDRIAL COMPLEX IV DEFICIENCY, NUCLEAR TYPE 20; MC4DN20
619065	MITOCHONDRIAL COMPLEX IV DEFICIENCY, NUCLEAR TYPE 21; MC4DN21
619066	ZINC FINGER PROTEIN 532; ZNF532
619067	HYDROXYSTEROID DEHYDROGENASE-LIKE PROTEIN 1; HSDL1
619068	LEUCINE-RICH REPEAT-CONTAINING PROTEIN 19; LRRC19
619069	TERMINAL NUCLEOTIDYLTRANSFERASE 5B; TENT5B
619070	LETM1 DOMAIN-CONTAINING PROTEIN 1; LETMD1
619071	LEUKODYSTROPHY, HYPOMYELINATING, 20; HLD20
619072	NEURODEVELOPMENTAL DISORDER WITH SEIZURES AND BRAIN ATROPHY; NEDSEBA
619073	VITAMIN D-DEPENDENT RICKETS, TYPE 3; VDDR3
619074	CLEFT PALATE, PROLIFERATIVE RETINOPATHY, AND DEVELOPMENTAL DELAY; CPPRDD
619075	BACHMANN-BUPP SYNDROME; BABS
619076	NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, SEIZURES, AND BRAIN ATROPHY; NEDMISB
619077	HEAT-SHOCK PROTEIN FAMILY A (HSP70) MEMBER 4-LIKE PROTEIN; HSPA4L
619078	KELCH-LIKE FAMILY, MEMBER 11; KLHL11
619079	INFLAMMATORY BOWEL DISEASE (CROHN DISEASE) 30; IBD30
619080	KILQUIST SYNDROME; KILQS
619081	DEAFNESS, AUTOSOMAL DOMINANT 78; DFNA78
619082	MICROCORNEA, ROD-CONE DYSTROPHY, CATARACT, AND POSTERIOR STAPHYLOMA 1; MRCS1
619083	DELPIRE-MCNEILL SYNDROME; DELMNES
619084	TIGGER TRANSPOSABLE ELEMENT-DERIVED GENE 3; TIGD3
619085	PROGENITOR RENEWAL-ASSOCIATED NONCODING RNA; PRANCR
619086	DEAFNESS, AUTOSOMAL DOMINANT 79; DFNA79
619087	NOONAN SYNDROME 13; NS13
619088	NUCLEAR GTPase, GERMINAL CENTER-ASSOCIATED; NUGGC
619089	GIPC PDZ DOMAIN-CONTAINING FAMILY, MEMBER 2; GIPC2
619090	DEVELOPMENTAL DELAY, IMPAIRED GROWTH, DYSMORPHIC FACIES, AND AXONAL NEUROPATHY; DIGFAN
619091	NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, IMPAIRED LANGUAGE, AND GAIT ABNORMALITIES; NEDMILG
619092	NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, IMPAIRED LANGUAGE, EPILEPSY, AND GAIT ABNORMALITIES; NEDMILEG
619093	DEAFNESS, AUTOSOMAL RECESSIVE 116; DFNB116
619094	SPERMATOGENIC FAILURE 45; SPGF45
619095	SPERMATOGENIC FAILURE 46; SPGF46
619096	MISMATCH REPAIR CANCER SYNDROME 2; MMRCS2
619097	MISMATCH REPAIR CANCER SYNDROME 3; MMRCS3
619098	MEIOSIS 1-ASSOCIATED PROTEIN; M1AP
619099	INTELLECTUAL DEVELOPMENTAL DISORDER WITH SPEECH DELAY AND AXONAL PERIPHERAL NEUROPATHY; IDDSAPN
619100	COILED-COIL DOMAIN-CONTAINING PROTEIN 25; CCDC25
619101	MISMATCH REPAIR CANCER SYNDROME 4; MMRCS4
619102	SPERMATOGENIC FAILURE 47; SPGF47
619103	NEURODEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES, SLEEP DISTURBANCE, AND BRAIN ABNORMALITIES; NEDFASB
619104	RNA-BINDING MOTIF PROTEIN 47; RBM47
619105	MICRO RNA 30E; MIR30E
619106	PRRT3 ANTISENSE RNA 1, NONCODING; PRRT3AS1
619107	SORTING NEXIN 33; SNX33
619108	SPERMATOGENIC FAILURE 48; SPGF48
619109	YIP1-INTERACTING FACTOR HOMOLOG B, MEMBRANE-TRAFFICKING PROTEIN; YIF1B
619110	ARTHROGRYPOSIS, DISTAL, TYPE 1C; DA1C
619111	COACH SYNDROME 2; COACH2
619112	NEURONOPATHY, DISTAL HEREDITARY MOTOR, AUTOSOMAL DOMINANT 13; HMND13
619113	COACH SYNDROME 3; COACH3
619114	SET AND MYND DOMAIN-CONTAINING PROTEIN 5; SMYD5
619115	COMBINED OSTEOGENESIS IMPERFECTA AND EHLERS-DANLOS SYNDROME 1; OIEDS1
619116	SOLUTE CARRIER FAMILY 39 (ZINC TRANSPORTER), MEMBER 9; SLC39A9
619117	ADP-RIBOSYLATION FACTOR-LIKE GTPase 16; ARL16
619118	ATPase 13A1; ATP13A1
619119	ATPase 13A5; ATP13A5
619120	COMBINED OSTEOGENESIS IMPERFECTA AND EHLERS-DANLOS SYNDROME 2; OIEDS2
619121	NEURODEVELOPMENTAL DISORDER WITH CARDIOMYOPATHY, SPASTICITY, AND BRAIN ABNORMALITIES; NEDCASB
619122	VERTEBRAL HYPERSEGMENTATION AND OROFACIAL ANOMALIES; VHO
619123	CARDIOFACIONEURODEVELOPMENTAL SYNDROME; CFNDS
619124	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 89; DEE89
619125	KAYA-BARAKAT-MASSON SYNDROME; KABAMAS
619126	IMMUNODEFICIENCY 75 WITH LYMPHOPROLIFERATION; IMD75
619127	MANDIBULOACRAL DYSPLASIA PROGEROID SYNDROME; MDPS
619128	HYDROXYPYRUVATE ISOMERASE; HYI
619129	CILIA- AND FLAGELLA-ASSOCIATED PROTEIN 58; CFAP58
619130	THROMBOCYTOPENIA 7; THC7
619131	OSTEOGENESIS IMPERFECTA, TYPE XXI; OI21
619132	FRONTOTEMPORAL DEMENTIA AND/OR AMYOTROPHIC LATERAL SCLEROSIS 8; FTDALS8
619133	AMYOTROPHIC LATERAL SCLEROSIS 26 WITH OR WITHOUT FRONTOTEMPORAL DEMENTIA; ALS26
619134	SET AND MYND DOMAIN-CONTAINING PROTEIN 4; SMYD4
619135	RITSCHER-SCHINZEL SYNDROME 3; RTSC3
619136	SOLUTE CARRIER FAMILY 37 (GLUCOSE-6-PHOSPHATE TRANSPORTER), MEMBER A2; SLC37A2
619137	SOLUTE CARRIER FAMILY 37, MEMBER A3; SLC37A3
619138	NEDD4-BINDING PROTEIN 1; N4BP1
619139	NEDD4-BINDING PROTEIN 2; N4BP2
619140	NEDD4-BINDING PROTEIN 3; N4BP3
619141	FRONTOTEMPORAL DEMENTIA AND/OR AMYOTROPHIC LATERAL SCLEROSIS 5; FTDALS5
619142	CARDIOACROFACIAL DYSPLASIA 1; CAFD1
619143	CARDIOACROFACIAL DYSPLASIA 2; CAFD2
619144	SPERMATOGENIC FAILURE 49; SPGF49
619145	SPERMATOGENIC FAILURE 50; SPGF50
619146	PREMATURE OVARIAN FAILURE 17; POF17
619147	LEUKOENCEPHALOPATHY, PROGRESSIVE, INFANTILE-ONSET, WITH OR WITHOUT DEAFNESS; LEPID
619148	CHROMOSOME 13q33-q34 DELETION SYNDROME
619149	LESSEL-KREIENKAMP SYNDROME; LESKRES
619150	INTELLECTUAL DEVELOPMENTAL DISORDER WITH PAROXYSMAL DYSKINESIA OR SEIZURES; IDDPADS
619151	AMED SYNDROME, DIGENIC; AMEDS
619152	TBC1 DOMAIN FAMILY, MEMBER 2B; TBC1D2B
619153	SOLUTE CARRIER FAMILY 25 (MITOCHONDRIAL CARRIER, NAD+ TRANSPORTER), MEMBER 51; SLC25A51
619154	LEUCINE-RICH REPEAT-CONTAINING PROTEIN 47; LRRC47
619155	NEPHROTIC SYNDROME, TYPE 22; NPHS22
619156	DYNEIN, AXONEMAL, INTERMEDIATE CHAIN 4; DNAI4
619157	NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT EARLY-ONSET GENERALIZED EPILEPSY; NEDEGE
619158	PHOSPHATIDYLINOSITOL 3-KINASE-INTERACTING PROTEIN 1; PIK3IP1
619159	CEA CELL ADHESION MOLECULE 4; CEACAM4
619160	CEA CELL ADHESION MOLECULE 7; CEACAM7
619161	CARPAL TUNNEL SYNDROME 2; CTS2
619162	FORKHEAD BOX J2; FOXJ2
619163	RING FINGER PROTEIN 130; RNF130
619164	IMMUNODEFICIENCY 76; IMD76
619165	OCULOCUTANEOUS ALBINISM, TYPE VIII; OCA8
619166	MITOCHONDRIAL COMPLEX II DEFICIENCY, NUCLEAR TYPE 2; MC2DN2
619167	MITOCHONDRIAL COMPLEX II DEFICIENCY, NUCLEAR TYPE 3; MC2DN3
619168	TRANSMEMBRANE PROTEIN 109; TMEM109
619169	GTP-BINDING PROTEIN 4; GTPBP4
619170	MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 36; MC1DN36
619171	GUANYLYL CYCLASE DOMAIN-CONTAINING PROTEIN 1; GUCD1
619172	HERMANSKY-PUDLAK SYNDROME 11; HPS11
619173	NEURODEGENERATION, CHILDHOOD-ONSET, WITH HYPOTONIA, RESPIRATORY INSUFFICIENCY, AND BRAIN IMAGING ABNORMALITIES; CONRIBA
619174	DEAFNESS, AUTOSOMAL RECESSIVE 117; DFNB117
619175	PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 5; PRAAS5
619176	OOCYTE/ZYGOTE/EMBRYO MATURATION ARREST 10; OZEMA10
619177	SPERMATOGENIC FAILURE 51; SPGF51
619178	MYOFIBRILLAR MYOPATHY 11; MFM11
619179	MICROCEPHALY 26, PRIMARY, AUTOSOMAL DOMINANT; MCPH26
619180	MICROCEPHALY 27, PRIMARY, AUTOSOMAL DOMINANT; MCPH27
619181	FAMILY WITH SEQUENCE SIMILARITY 177, MEMBER A1; FAM177A1
619182	GASTRIC ADENOCARCINOMA AND PROXIMAL POLYPOSIS OF THE STOMACH; GAPPS
619183	PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 4; PRAAS4
619184	SHORT STATURE, FACIAL DYSMORPHISM, AND SKELETAL ANOMALIES WITH OR WITHOUT CARDIAC ANOMALIES 2; SSFSC2
619185	JOUBERT SYNDROME 37; JBTS37
619186	PLECKSTRIN HOMOLOGY DOMAIN-CONTAINING PROTEIN, FAMILY M, MEMBER 3; PLEKHM3
619187	GALECTIN-RELATED INTERFIBER PROTEIN; GRIFIN
619188	INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 64; MRD64
619189	LI-CAMPEAU SYNDROME; LICAS
619190	INTERACTOR OF HORMAD1 1; IHO1
619191	EPILEPSY, PROGRESSIVE MYOCLONIC, 12; EPM12
619192	SOLUTE CARRIER FAMILY 7, MEMBER 6 OPPOSITE STRAND; SLC7A6OS
619193	TUBULIN TYROSINE LIGASE-LIKE 8; TTLL8
619194	NEUROFACIOSKELETAL SYNDROME WITH OR WITHOUT RENAL AGENESIS; NFSRA
619195	TUBULIN TYROSINE LIGASE-LIKE 3; TTLL3
619196	DEAFNESS, CONGENITAL, AND ADULT-ONSET PROGRESSIVE LEUKOENCEPHALOPATHY; DEAPLE
619197	EUKARYOTIC TRANSLATION INITIATION FACTOR 3, SUBUNIT L; EIF3L
619198	SUCCINATE DEHYDROGENASE COMPLEX ASSEMBLY FACTOR 4; SDHAF4
619199	6-PHOSPHOGLUCONATE DEHYDROGENASE DEFICIENCY; PGDD
619200	SORTING NEXIN FAMILY, MEMBER 21; SNX21
619201	NEPHROTIC SYNDROME, TYPE 23; NPHS23
619202	SPERMATOGENIC FAILURE 52; SPGF52
619203	PREMATURE OVARIAN FAILURE 18; POF18
619204	NUCLEOLAR PRE-rRNA-PROCESSING PROTEIN NIP7; NIP7
619205	GROWTH HORMONE-INDUCIBLE TRANSMEMBRANE PROTEIN; GHITM
619206	SCHWANNOMIN-INTERACTING PROTEIN 1; SCHIP1
619207	INO80 COMPLEX, SUBUNIT D; INO80D
619208	OLMSTED SYNDROME 2; OLMS2
619209	ERYTHROKERATODERMIA VARIABILIS ET PROGRESSIVA 7; EKVP7
619210	HEPARAN SULFATE-GLUCOSAMINE 3-SULFOTRANSFERASE 6; HS3ST6
619211	HIPPOCALCIN-LIKE 4; HPCAL4
619212	IGF1R ANTISENSE IMPRINTED NONCODING RNA; IRAIN
619213	ZINC FINGER SWIM DOMAIN-CONTAINING PROTEIN 8; ZSWIM8
619214	ZINC FINGER PROTEIN 639; ZNF639
619215	OCULOMOTOR-ABDUCENS SYNKINESIS; OCABSN
619216	NEURONOPATHY, DISTAL HEREDITARY MOTOR, AUTOSOMAL RECESSIVE 7; HMNR7
619217	ENDOVE SYNDROME, LIMB-ONLY TYPE; ENDOVESL
619218	ENDOVE SYNDROME, LIMB-BRAIN TYPE; ENDOVESLB
619219	CHROMOSOME 2 OPEN READING FRAME 69; C2ORF69
619220	IMMUNODEFICIENCY 78 WITH AUTOIMMUNITY AND DEVELOPMENTAL DELAY; IMD78
619221	SULFIDE:QUINONE OXIDOREDUCTASE DEFICIENCY; SQORD
619222	SUPPRESSOR OF CANCER CELL INVASION; SCAI
619223	IMMUNODEFICIENCY 77; IMD77
619224	MITOCHONDRIAL COMPLEX II DEFICIENCY, NUCLEAR TYPE 4; MC2DN4
619225	RIBOSOMAL PROTEIN L13A; RPL13A
619226	BLISTERING, ACANTHOLYTIC, OF ORAL AND LARYNGEAL MUCOSA; ABOLM
619227	VERTEBRAL, CARDIAC, TRACHEOESOPHAGEAL, RENAL, AND LIMB DEFECTS; VCTERL
619228	DEVELOPMENTAL DELAY WITH DYSMORPHIC FACIES AND DENTAL ANOMALIES; DEFDA
619229	DEN HOED-DE BOER-VOISIN SYNDROME; DHDBV
619230	SIN3A-ASSOCIATED PROTEIN, 25-KD; SAP25
619231	STERILE ALPHA MOTIF DOMAIN-CONTAINING PROTEIN 4B; SAMD4B
619232	BILE ACID CONJUGATION DEFECT 1; BACD1
619233	STERILE ALPHA MOTIF DOMAIN-CONTAINING PROTEIN 14; SAMD14
619234	SHORT STATURE, OLIGODONTIA, DYSMORPHIC FACIES, AND MOTOR DELAY; SOFM
619235	RIBONUCLEASE P/MRP SUBUNIT p25; RPP25
619236	KIAA0408 GENE; KIAA0408
619237	KIAA0232 GENE; KIAA0232
619238	IMMUNODEFICIENCY 79; IMD79
619239	NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT AUTISM OR SEIZURES; NEDAUS
619240	GDP-D-GLUCOSE PHOSPHORYLASE 1; GDPGP1
619241	JUPITER MICROTUBULE-ASSOCIATED HOMOLOG 2; JPT2
619242	JUPITER MICROTUBULE-ASSOCIATED HOMOLOG 1; JPT1
619243	GLOBAL DEVELOPMENTAL DELAY WITH SPEECH AND BEHAVIORAL ABNORMALITIES; GDSBA
619244	NEURODEVELOPMENTAL DISORDER WITH CEREBRAL ATROPHY AND VARIABLE FACIAL DYSMORPHISM; NEDCAFD
619245	PREMATURE OVARIAN FAILURE 19; POF19
619246	SPEXIN HORMONE; SPX
619247	SPINDLE- AND KINETOCHORE-ASSOCIATED COMPLEX, SUBUNIT 3; SKA3
619248	VITREORETINOPATHY WITH PHALANGEAL EPIPHYSEAL DYSPLASIA; VPED
619249	COILED-COIL DOMAIN-CONTAINING PROTEIN 186; CCDC186
619250	RUN DOMAIN-CONTAINING PROTEIN 1; RUNDC1
619251	ACTIN-LIKE 9; ACTL9
619252	BASIC LEUCINE ZIPPER DOMAIN- AND W2 DOMAIN-CONTAINING PROTEIN 1; BZW1
619253	WSC DOMAIN-CONTAINING PROTEIN 2; WSCD2
619254	ZINC FINGER PROTEIN 17; ZNF17
619255	BARALLE-MACKEN SYNDROME; BARMACS
619256	HYPERCHOLANEMIA, FAMILIAL, 2; FHCA2
619257	HR UPSTREAM OPEN READING FRAME; HRURF
619258	SPERMATOGENIC FAILURE 53; SPGF53
619259	NEURODEGENERATION WITH ATAXIA AND LATE-ONSET OPTIC ATROPHY; NDAXOA
619260	SPONDYLOEPIPHYSEAL DYSPLASIA, SENSORINEURAL HEARING LOSS, IMPAIRED INTELLECTUAL DEVELOPMENT, AND LEBER CONGENITAL AMAUROSIS; SHILCA
619261	KERATINOCYTE-ASSOCIATED PROTEIN 3; KRTCAP3
619262	KELCH-LIKE 17; KLHL17
619263	NEPHROTIC SYNDROME, TYPE 24; NPHS24
619264	NEURODEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND VARIABLE SEIZURES; NEDDFAS
619265	TRIPARTITE MOTIF-CONTAINING PROTEIN 52; TRIM52
619266	TRIM52 ANTISENSE RNA 1, NONCODING; TRIM52AS1
619267	GLANZMANN THROMBASTHENIA 2; GT2
619268	ALZAHRANI-KUWAHARA SYNDROME; ALKUS
619269	ODONTOCHONDRODYSPLASIA 2 WITH HEARING LOSS AND DIABETES; ODCD2
619270	INTRAFLAGELLAR TRANSPORT-ASSOCIATED PROTEIN; IFTAP
619271	BLEEDING DISORDER, PLATELET-TYPE, 24; BDPLT24
619272	MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 37; MC1DN37
619273	CIMDAG SYNDROME; CIMDAG
619274	DEAFNESS, AUTOSOMAL DOMINANT 80; DFNA80
619275	BASIC LEUCINE ZIPPER DOMAIN- AND W2 DOMAIN-CONTAINING PROTEIN 2; BZW2
619276	BREAK REPAIR MEIOTIC RECOMBINASE RECRUITMENT FACTOR 1; BRME1
619277	CILIARY MICROTUBULE INNER PROTEIN 1; CIMIP1
619278	MICROCEPHALY, EPILEPSY, AND DIABETES SYNDROME 2; MEDS2
619279	PARKINSONISM WITH POLYNEUROPATHY; PKNPY
619280	COILED-COIL DOMAIN-CONTAINING PROTEIN 59; CCDC59
619281	IMMUNODEFICIENCY 14B, AUTOSOMAL RECESSIVE; IMD14B
619282	FAMILY WITH SEQUENCE SIMILARITY 131, MEMBER B; FAM131B
619283	RING FINGER PROTEIN 44; RNF44
619284	ZINC FINGER RNA-BINDING PROTEIN 2; ZFR2
619285	TRANSMEMBRANE PROTEIN 218; TMEM218
619286	NEURODEVELOPMENTAL DISORDER WITH SPASTICITY, CATARACTS, AND CEREBELLAR HYPOPLASIA; NEDSCAC
619287	COILED-COIL DOMAIN-CONTAINING PROTEIN 66; CCDC66
619288	COILED-COIL DOMAIN-CONTAINING PROTEIN 69; CCDC69
619289	ZINC FINGER PROTEIN 91, ATYPICAL E3 UBIQUITIN LIGASE; ZFP91
619290	MAHVASH DISEASE; MVAH
619291	DYSTONIA 30; DYT30
619292	VPS9 DOMAIN-CONTAINING PROTEIN 1; VPS9D1
619293	BLEPHAROPHIMOSIS-IMPAIRED INTELLECTUAL DEVELOPMENT SYNDROME; BIS
619294	NIBAN APOPTOSIS REGULATOR 1; NIBAN1
619295	ZINC FINGER DHHC-TYPE PALMITOYLTRANSFERASE 14; ZDHHC14
619296	TESTIS-ASSOCIATED ONCOGENIC LONG NONCODING RNA; THORLNC
619297	KINSSHIP SYNDROME; KINS
619298	ZINC FINGER PROTEIN 777; ZNF777
619299	ZINC FINGER PROTEIN 646; ZNF646
619300	ZINC FINGER PROTEIN 394; ZNF394
619301	PONTOCEREBELLAR HYPOPLASIA, TYPE 14; PCH14
619302	PONTOCEREBELLAR HYPOPLASIA, TYPE 15; PCH15
619303	PONTOCEREBELLAR HYPOPLASIA, TYPE 1E; PCH1E
619304	PONTOCEREBELLAR HYPOPLASIA, TYPE 1F; PCH1F
619305	TANDEM C2 DOMAINS PROTEIN, NUCLEAR; TC2N
619306	NEURODEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND CEREBELLAR HYPOPLASIA; NEDFACH
619307	MAGNESIUM TRANSPORTER MRS2; MRS2
619308	PROTEIN PHOSPHATASE, MAGNESIUM/MANGANESE-DEPENDENT, 1E; PPM1E
619309	PROTEIN PHOSPHATASE, MAGNESIUM/MANGANESE-DEPENDENT, 1F; PPM1F
619310	LEUKODYSTROPHY, HYPOMYELINATING, 21; HLD21
619311	HIATT-NEU-COOPER NEURODEVELOPMENTAL SYNDROME; HINCONS
619312	RADIO-TARTAGLIA SYNDROME; RATARS
619313	IMMUNODEFICIENCY 80 WITH OR WITHOUT CONGENITAL CARDIOMYOPATHY; IMD80
619314	BURATTI-HAREL SYNDROME; BURHAS
619315	SOLUTE CARRIER FAMILY 35, MEMBER E2B; SLC35E2B
619316	TETRATRICOPEPTIDE REPEAT- AND ANKYRIN REPEAT-CONTAINING PROTEIN 1; TRANK1
619317	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 6B; DEE6B
619318	OCULOGASTROINTESTINAL NEURODEVELOPMENTAL SYNDROME; OGIN
619319	LYMPHATIC MALFORMATION 9; LMPHM9
619320	INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 65; MRD65
619321	GROWTH RESTRICTION, HYPOPLASTIC KIDNEYS, ALOPECIA, AND DISTINCTIVE FACIES; GKAF
619322	MARBACH-RUSTAD PROGEROID SYNDROME; MARUPS
619323	NEURODEVELOPMENTAL DISORDER WITH SEIZURES AND GINGIVAL OVERGROWTH; NEDSGO
619324	HYPERTRIGLYCERIDEMIA 2; HYTG2
619325	COFFIN-SIRIS SYNDROME 12; CSS12
619326	BDV SYNDROME; BDVS
619327	LEUCINE-RICH REPEAT-CONTAINING PROTEIN 15; LRRC15
619328	LEUKODYSTROPHY, HYPOMYELINATING, 22; HLD22
619329	FIBROMUSCULAR DYSPLASIA, MULTIFOCAL; FMDMF
619330	TatD DNase DOMAIN-CONTAINING PROTEIN 2; TATDN2
619331	MTOR-ASSOCIATED PROTEIN, EAK7 HOMOLOG; MEAK7
619332	LYSOSOMAL ENZYME TRAFFICKING FACTOR; LYSET
619333	NEURODEVELOPMENTAL DISORDER WITH CEREBELLAR ATROPHY AND MOTOR DYSFUNCTION; NEDCAM
619334	ARTHROGRYPOSIS MULTIPLEX CONGENITA 6; AMC6
619335	GRANULE-ASSOCIATED RAC AND RHOG EFFECTOR 1; GARRE1
619336	METAXIN 3; MTX3
619337	NEUROMEDIN S; NMS
619338	CATARACTS, SPASTIC PARAPARESIS, AND SPEECH DELAY; CSPSD
619339	BARTSOCAS-PAPAS SYNDROME 2; BPS2
619340	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 96; DEE96
619341	PRAJA RING FINGER UBIQUITIN LIGASE 2; PJA2
619342	POST-GPI ATTACHMENT TO PROTEINS 6; PGAP6
619343	CHROMOSOME 1p36 DELETION SYNDROME, PROXIMAL
619344	PURKINJE CELL PROTEIN 2; PCP2
619345	DYSOSTOSIS MULTIPLEX, AIN-NAZ TYPE; DMAN
619346	ADENOSINE DEAMINASE-LIKE PROTEIN; ADAL
619347	COILED-COIL DOMAIN-CONTAINING PROTEIN 96; CCDC96
619348	ANKYRIN REPEAT- AND LEM DOMAIN-CONTAINING PROTEIN 1; ANKLE1
619349	COP9 SIGNALOSOME, SUBUNIT 9; COPS9
619350	VISCERAL MYOPATHY 2; VSCM2
619351	MEGACYSTIS-MICROCOLON-INTESTINAL HYPOPERISTALSIS SYNDROME 2; MMIHS2
619352	ATAXIA, INTENTION TREMOR, AND HYPOTONIA SYNDROME, CHILDHOOD-ONSET; ATITHS
619353	PAR3 FAMILY CELL POLARITY REGULATOR, BETA; PARD3B
619354	DEAFNESS, CATARACT, IMPAIRED INTELLECTUAL DEVELOPMENT, AND POLYNEUROPATHY; DCIDP
619355	MITOCHONDRIAL COMPLEX IV DEFICIENCY, NUCLEAR TYPE 22; MC4DN22
619356	ONYCHODYSTROPHY, OSTEODYSTROPHY, IMPAIRED INTELLECTUAL DEVELOPMENT, AND SEIZURES SYNDROME; OORS
619357	ADENYLATE KINASE 6; AK6
619358	MICROTUBULE-ASSOCIATED SCAFFOLD PROTEIN 2; MTUS2
619359	BONE MORPHOGENETIC PROTEIN/RETINOIC ACID-INDUCIBLE NEURAL-SPECIFIC PROTEIN 2; BRINP2
619360	ANGIOEDEMA, HEREDITARY, 4; HAE4
619361	ANGIOEDEMA, HEREDITARY, 5; HAE5
619362	MEGACYSTIS-MICROCOLON-INTESTINAL HYPOPERISTALSIS SYNDROME 3; MMIHS3
619363	ANGIOEDEMA, HEREDITARY, 6; HAE6
619364	TatD DNase DOMAIN-CONTAINING PROTEIN 1; TATDN1
619365	MEGACYSTIS-MICROCOLON-INTESTINAL HYPOPERISTALSIS SYNDROME 4; MMIHS4
619366	ANGIOEDEMA, HEREDITARY, 7; HAE7
619367	ANGIOEDEMA, HEREDITARY, 8; HAE8
619368	LEUCINE-RICH REPEAT-CONTAINING PROTEIN 14; LRRC14
619369	LYMPHATIC MALFORMATION 10; LMPHM10
619370	KH DOMAIN-CONTAINING PROTEIN 4, PRE-mRNA SPLICING FACTOR; KHDC4
619371	CARDIOMYOPATHY, DILATED, 2D; CMD2D
619372	URB2 RIBOSOME BIOGENESIS HOMOLOG; URB2
619373	NEURODEVELOPMENTAL DISORDER WITH INFANTILE EPILEPTIC SPASMS; NEDIES
619374	IMMUNODEFICIENCY 81; IMD81
619375	AUTOINFLAMMATORY SYNDROME, FAMILIAL, WITH OR WITHOUT IMMUNODEFICIENCY; AISIMD
619376	FAUNDES-BANKA SYNDROME; FABAS
619377	OSTEOOTOHEPATOENTERIC SYNDROME; OOHE
619378	SMALL NUCLEOLAR RNA, H/ACA BOX, 31; SNORA31
619379	SPERMATOGENIC FAILURE 54; SPGF54
619380	SPERMATOGENIC FAILURE 55; SPGF55
619381	IMMUNODEFICIENCY 82 WITH SYSTEMIC INFLAMMATION; IMD82
619382	LEBER-LIKE HEREDITARY OPTIC NEUROPATHY, AUTOSOMAL RECESSIVE 1; LHONAR1
619383	NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, FACIAL DYSMORPHISM, AND BRAIN ABNORMALITIES; NEDHFBA
619384	ZINC FINGER- AND BTB DOMAIN-CONTAINING PROTEIN 39; ZBTB39
619385	ZINC FINGER PROTEIN 510; ZNF510
619386	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 52; COXPD52
619387	CILIOGENESIS-ASSOCIATED TTC17-INTERACTING PROTEIN; CATIP
619388	TETRATRICOPEPTIDE REPEAT DOMAIN-CONTAINING PROTEIN 17; TTC17
619389	SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 29; SCAR29
619390	COLLAGEN, TYPE XX, ALPHA-1; COL20A1
619391	COILED-COIL DOMAIN-CONTAINING PROTEIN 157; CCDC157
619392	CHROMOSOME 14 OPEN READING FRAME 180; C14ORF180
619393	KELCH REPEAT- AND BTB DOMAIN-CONTAINING PROTEIN 2; KBTBD2
619394	CARBONYL REDUCTASE 4; CBR4
619395	MYELIN EXPRESSION FACTOR 2; MYEF2
619396	ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED (HERPES-SPECIFIC), SUSCEPTIBILITY TO, 10; IIAE10
619397	ZINC FINGER PROTEIN-LIKE 1; ZFPL1
619398	INFLAMMATORY BOWEL DISEASE (INFANTILE ULCERATIVE COLITIS) 31, AUTOSOMAL RECESSIVE; IBD31
619399	TETRASPANIN 18; TSPAN18
619400	VISCERAL LEIOMYOPATHY, AFRICAN DEGENERATIVE; ADL
619401	LYMPHATIC MALFORMATION 11; LMPHM11
619402	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 28; CMH28
619403	COLON CANCER-ASSOCIATED TRANSCRIPT 2, NONCODING; CCAT2
619404	tRNA METHYLTRANSFERASE 61B; TRMT61B
619405	SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 30; SCAR30
619406	HYPOKALEMIC TUBULOPATHY AND DEAFNESS; HKTD
619407	WHIM SYNDROME 2; WHIMS2
619408	TRIPARTITE MOTIF-CONTAINING PROTEIN 65; TRIM65
619409	TRANSLOCATOR PROTEIN 2; TSPO2
619410	TUBULIN TYROSINE LIGASE-LIKE 12; TTLL12
619411	SIGNAL PEPTIDASE COMPLEX, SUBUNIT 2; SPCS2
619412	SEC14-LIKE LIPID-BINDING PROTEIN 5; SEC14L5
619413	COILED-COIL DOMAIN-CONTAINING PROTEIN 144A; CCDC144A
619414	MITOCHONDRIAL FISSION REGULATOR 1; MTFR1
619415	TAU TUBULIN KINASE 1; TTBK1
619416	TRIPARTITE MOTIF-CONTAINING PROTEIN 60; TRIM60
619417	TRIPARTITE MOTIF-CONTAINING PROTEIN 61; TRIM61
619418	NEUROLOGIC, ENDOCRINE, AND PANCREATIC DISEASE, MULTISYSTEM, INFANTILE-ONSET 2; IMNEPD2
619419	NAC-ALPHA DOMAIN-CONTAINING PROTEIN; NACAD
619420	MARTSOLF SYNDROME 2; MARTS2
619421	DYNACTIN-ASSOCIATED PROTEIN; DYNAP
619422	SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 31; SCAR31
619423	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 53; COXPD53
619424	MYOPATHY, MYOFIBRILLAR, 12, INFANTILE-ONSET, WITH CARDIOMYOPATHY; MFM12
619425	MITOCHONDRIAL DNA DEPLETION SYNDROME 16B (NEUROOPHTHALMIC TYPE); MTDPS16B
619426	WHITE-KERNOHAN SYNDROME; WHIKERS
619427	ZINC FINGER PROTEIN 410; ZNF410
619428	FOCAL SEGMENTAL GLOMERULOSCLEROSIS AND NEURODEVELOPMENTAL SYNDROME; FSGSNEDS
619429	TRANSMEMBRANE AND COILED-COIL DOMAIN FAMILY, MEMBER 2; TMCC2
619430	SERINE PEPTIDASE INHIBITOR, KUNITZ-TYPE, 4; SPINT4
619431	MEGACYSTIS-MICROCOLON-INTESTINAL HYPOPERISTALSIS SYNDROME 5; MMIHS5
619432	N-ALPHA-ACETYLTRANSFERASE 11, NatA CATALYTIC SUBUNIT; NAA11
619433	CARDIOMYOPATHY, FAMILIAL RESTRICTIVE, 6; RCM6
619434	SUN DOMAIN-CONTAINING OSSIFICATION FACTOR; SUCO
619435	RITSCHER-SCHINZEL SYNDROME 4; RTSC4
619436	CILIARY DYSKINESIA, PRIMARY, 46; CILD46
619437	IMMUNODEFICIENCY 84; IMD84
619438	N-ALPHA-ACETYLTRANSFERASE 35, NatC AUXILIARY SUBUNIT; NAA35
619439	POLY(ADP-RIBOSE) POLYMERASE FAMILY, MEMBER 6; PARP6
619440	GLUTAMINE- AND SERINE-RICH PROTEIN 1; QSER1
619441	ENCEPHALITIS, ACUTE, INFECTION (VIRAL)-INDUCED, SUSCEPTIBILITY TO, 11; IIAE11
619442	TUB-LIKE PROTEIN 4; TULP4
619443	MEIS HOMEOBOX 3; MEIS3
619444	COILED-COIL DOMAIN-CONTAINING PROTEIN 7; CCDC7
619445	DIARRHEA 12, WITH MICROVILLUS ATROPHY; DIAR12
619446	RETINAL DYSTROPHY AND MICROVILLUS INCLUSION DISEASE; RDMVID
619447	FAMILY WITH SEQUENCE SIMILARITY 189, MEMBER B; FAM189B
619448	STEROID RECEPTOR-ASSOCIATED AND -REGULATED PROTEIN; SRARP
619449	RIBOSOMAL RNA-PROCESSING PROTEIN 7 HOMOLOG A; RRP7A
619450	MICRO RNA 874; MIR874
619451	CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIE; ARCL2E
619452	ANENCEPHALY 2; ANPH2
619453	MICROCEPHALY 28, PRIMARY, AUTOSOMAL RECESSIVE; MCPH28
619454	RING FINGER PROTEIN 144A; RNF144A
619455	SH3 AND PX DOMAINS-CONTAINING PROTEIN 2A; SH3PXD2A
619456	CDC42 SMALL EFFECTOR 1; CDC42SE1
619457	CDC42 SMALL EFFECTOR 2; CDC42SE2
619458	METHYL-CpG-BINDING DOMAIN PROTEIN 6; MBD6
619459	ZINC FINGER ZZ-TYPE DOMAIN- AND EF-HAND DOMAIN-CONTAINING PROTEIN 1; ZZEF1
619460	LUO-SCHOCH-YAMAMOTO SYNDROME; LUSYAM
619461	MYASTHENIC SYNDROME, CONGENITAL, 7B, PRESYNAPTIC, AUTOSOMAL RECESSIVE; CMS7B
619462	HEMOLYTIC DISEASE OF FETUS AND NEWBORN, RH-INDUCED; HDFNRH
619463	PORTAL HYPERTENSION, NONCIRRHOTIC, 2; NCPH2
619464	SICK SINUS SYNDROME 4; SSS4
619465	VISCERAL NEUROPATHY, FAMILIAL, 2, AUTOSOMAL RECESSIVE; VSCN2
619466	CILIARY DYSKINESIA, PRIMARY, 47, AND LISSENCEPHALY; CILD47
619467	USMANI-RIAZUDDIN SYNDROME, AUTOSOMAL DOMINANT; USRISD
619468	NEPHRONOPHTHISIS-LIKE NEPHROPATHY 2; NPHPL2
619469	TRANSMEMBRANE PROTEIN 222; TMEM222
619470	NEURODEVELOPMENTAL DISORDER WITH MOTOR AND SPEECH DELAY AND BEHAVIORAL ABNORMALITIES; NEDMOSBA
619471	BARDET-BIEDL SYNDROME 20; BBS20
619472	VISS SYNDROME; VISS
619473	OCULOPHARYNGODISTAL MYOPATHY 3; OPDM3
619474	R3H DOMAIN-CONTAINING PROTEIN 1; R3HDM1
619475	DEVELOPMENTAL DELAY, IMPAIRED SPEECH, AND BEHAVIORAL ABNORMALITIES; DDISBA
619476	JOUBERT SYNDROME 38; JBTS38
619477	FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY 3, DIGENIC; FSHD3
619478	FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY 4, DIGENIC; FSHD4
619479	SHORT-RIB THORACIC DYSPLASIA 21 WITHOUT POLYDACTYLY; SRTD21
619480	NEURODEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND THIN CORPUS CALLOSUM; NEDDFAC
619481	BILE ACID MALABSORPTION, PRIMARY, 2; PBAM2
619482	CENTRAL HYPOVENTILATION SYNDROME, CONGENITAL, 2, AND AUTONOMIC DYSFUNCTION; CCHS2
619483	CENTRAL HYPOVENTILATION SYNDROME, CONGENITAL, 3; CCHS3
619484	CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC, 6; PFIC6
619485	PAPPALYSIN 2; PAPPA2
619486	AICARDI-GOUTIERES SYNDROME 8; AGS8
619487	AICARDI-GOUTIERES SYNDROME 9; AGS9
619488	DEGCAGS SYNDROME; DEGCAGS
619489	SHORT STATURE, DAUBER-ARGENTE TYPE; SSDA
619490	LMBR1 DOMAIN-CONTAINING PROTEIN 2; LMBRD2
619491	PARKINSON DISEASE 24, AUTOSOMAL DOMINANT, SUSCEPTIBILITY TO; PARK24
619492	CARDIOMYOPATHY, DILATED, 2E; CMD2E
619493	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE 2v; CDG2V
619494	SMALL NUCLEOLAR RNA HOST GENE 11, NONCODING; SNHG11
619495	ADAM METALLOPEPTIDASE DOMAIN-CONTAINING PROTEIN 18; ADAM18
619496	ZINC FINGER PROTEIN 358; ZNF358
619497	N-ALPHA-ACETYLTRANSFERASE 16, NatA AUXILIARY SUBUNIT; NAA16
619498	ZINC FINGER CCCH DOMAIN-CONTAINING PROTEIN 4; ZC3H4
619499	ZINC FINGER PROTEIN 383; ZNF383
619500	DEAFNESS, AUTOSOMAL DOMINANT 81; DFNA81
619501	VENTRICULOMEGALY AND ARTHROGRYPOSIS; VENARG
619502	SPERM MICROTUBULE INNER PROTEIN 6; SPMIP6
619503	NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA AND DYSMORPHIC FACIES; NEDHYDF
619504	CHOPRA-AMIEL-GORDON SYNDROME; CAGS
619505	ZINC FINGER PROTEIN 431; ZNF431
619506	ZINC FINGER PROTEIN 415; ZNF415
619507	ZINC FINGER PROTEIN 425; ZNF425
619508	ZINC FINGER PROTEIN 445; ZNF445
619509	ZINC FINGER PROTEIN 418; ZNF418
619510	IMMUNODEFICIENCY 85 AND AUTOIMMUNITY; IMD85
619511	ZINC FINGER PROTEIN 354C; ZNF354C
619512	NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA AND BRAIN ABNORMALITIES; NEDHYBA
619513	SWT1 RNA ENDORIBONUCLEASE HOMOLOG; SWT1
619514	SHC-BINDING AND SPINDLE-ASSOCIATED PROTEIN 1-LIKE PROTEIN; SHCBP1L
619515	SPERMATOGENIC FAILURE 56; SPGF56
619516	BIFUNCTIONAL APOPTOSIS REGULATOR; BFAR
619517	NEURODEVELOPMENTAL DISORDER WITH SEIZURES AND BRAIN ABNORMALITIES; NEDSBA
619518	MUSCULAR DYSTROPHY, CONGENITAL HEARING LOSS, AND OVARIAN INSUFFICIENCY SYNDROME; MDHLO
619519	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2FF; CMT2FF
619520	BOX H/ACA SMALL NUCLEOLAR RNA-ENDED LONG NONCODING RNA THAT ENHANCES PRE-rRNA TRANSCRIPTION; SLERT
619521	EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 18; EIG18
619522	NEURODEVELOPMENTAL-CRANIOFACIAL SYNDROME WITH VARIABLE RENAL AND CARDIAC ABNORMALITIES; NECRC
619523	ANEMIA, SIDEROBLASTIC, 5; SIDBA5
619524	ZINC FINGER PROTEIN 764; ZNF764
619525	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIw; CDG2W
619526	ZINC FINGER PROTEIN 706; ZNF706
619527	PONTOCEREBELLAR HYPOPLASIA, TYPE 16; PCH16
619528	SPERMATOGENIC FAILURE 57; SPGF57
619529	PARN-LIKE RIBONUCLEASE DOMAIN-CONTAINING EXONUCLEASE 1; PNLDC1
619530	SOLUTE CARRIER FAMILY 35, MEMBER C2; SLC35C2
619531	CONE-ROD DYSTROPHY 22; CORD22
619532	ADENOSINE DEAMINASE DOMAIN-CONTAINING PROTEIN 2; ADAD2
619533	RAD21 COHESIN COMPLEX COMPONENT-LIKE 1; RAD21L1
619534	BILIARY, RENAL, NEUROLOGIC, AND SKELETAL SYNDROME; BRENS
619535	RING FINGER PROTEIN 115; RNF115
619536	UBIQUITIN-SPECIFIC PEPTIDASE 31; USP31
619537	ANGEL HOMOLOG 1; ANGEL1
619538	CEREBRAL CAVERNOUS MALFORMATIONS 4; CCM4
619539	NEUROOCULAR SYNDROME; NOC
619540	PROTEIN PHOSPHATASE 1, REGULATORY SUBUNIT 3E; PPP1R3E
619541	PROTEIN PHOSPHATASE 1, REGULATORY SUBUNIT 3G; PPP1R3G
619542	KING-DENBOROUGH SYNDROME; KDS
619543	BOUDIN-MORTIER SYNDROME; BOMOS
619544	PROLINE-RICH COILED-COIL PROTEIN 2B; PRRC2B
619545	HYPOPLASTIC FEMURS AND PELVIS; HYPOFP
619546	OLFACTORY RECEPTOR, FAMILY 10, SUBFAMILY J, MEMBER 5; OR10J5
619547	RAB15, MEMBER RAS ONCOGENE FAMILY; RAB15
619548	USMANI-RIAZUDDIN SYNDROME, AUTOSOMAL RECESSIVE; USRISR
619549	IMMUNODEFICIENCY 86; IMD86
619550	RAB40B, MEMBER RAS ONCOGENE FAMILY; RAB40B
619551	RAB40C, MEMBER RAS ONCOGENE FAMILY; RAB40C
619552	MAGO HOMOLOG B, EXON JUNCTION COMPLEX SUBUNIT; MAGOHB
619553	DEAFNESS, AUTOSOMAL RECESSIVE 118, WITH COCHLEAR APLASIA; DFNB118
619554	MITOCHONDRIAL TRANSLATIONAL INITIATION FACTOR 3; MTIF3
619555	EPIDERMOLYSIS BULLOSA SIMPLEX 2A, GENERALIZED SEVERE; EBS2A
619556	INTELLECTUAL DEVELOPMENTAL DISORDER WITH HYPOTONIA, IMPAIRED SPEECH, AND DYSMORPHIC FACIES; IDDHISD
619557	SHORT STATURE, IMPAIRED INTELLECTUAL DEVELOPMENT, MICROCEPHALY, HYPOTONIA, AND OCULAR ANOMALIES; SIMHA
619558	RAB39A, MEMBER RAS ONCOGENE FAMILY; RAB39A
619559	EF-HAND CALCIUM-BINDING DOMAIN-CONTAINING PROTEIN 14; EFCAB14
619560	MICRO RNA 135B; MIR135B
619561	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 97; DEE97
619562	JOUBERT SYNDROME 39; JBTS39
619563	MICAL-LIKE PROTEIN 1; MICALL1
619564	CALAXIN; CLXN
619565	DYSTONIA 31; DYT31
619566	MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 27; LGMDR27
619567	EF-HAND CALCIUM-BINDING DOMAIN-CONTAINING PROTEIN 3; EFCAB3
619568	ENDONUCLEASE DOMAIN-CONTAINING PROTEIN 1; ENDOD1
619569	CHROMOSOME 9 OPEN READING FRAME 78; C9ORF78
619570	UHRF1-BINDING PROTEIN 1; UHRF1BP1
619571	ANKYRIN REPEAT DOMAIN-CONTAINING PROTEIN 49; ANKRD49
619572	MICRO RNA 15B; MIR15B
619573	IMMUNODEFICIENCY 87 AND AUTOIMMUNITY; IMD87
619574	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2HH; CMT2HH
619575	DEVELOPMENTAL DELAY WITH OR WITHOUT INTELLECTUAL IMPAIRMENT OR BEHAVIORAL ABNORMALITIES; DDIB
619576	CEREBELLAR ATAXIA, BRAIN ABNORMALITIES, AND CARDIAC CONDUCTION DEFECTS; CABAC
619577	ZINC FINGER CCCH DOMAIN- AND G-PATCH DOMAIN-CONTAINING PROTEIN; ZGPAT
619578	AFG2 AAA ATPase HOMOLOG B; AFG2B
619579	KH DOMAIN- AND NYN DOMAIN-CONTAINING PROTEIN; KHNYN
619580	NEURODEVELOPMENTAL DISORDER WITH IMPAIRED LANGUAGE AND ATAXIA AND WITH OR WITHOUT SEIZURES; NEDLAS
619581	SOLUTE CARRIER FAMILY 45, MEMBER 4; SLC45A4
619582	JOUBERT SYNDROME 40; JBTS40
619583	EH DOMAIN-BINDING PROTEIN 1-LIKE 1; EHBP1L1
619584	WSC DOMAIN-CONTAINING PROTEIN 1; WSCD1
619585	SPERMATOGENIC FAILURE 58; SPGF58
619586	TSPY-LIKE 4; TSPYL4
619587	ZINC FINGER PROTEIN 629; ZNF629
619588	EPIDERMOLYSIS BULLOSA SIMPLEX 2B, GENERALIZED INTERMEDIATE; EBS2B
619589	BRAF-ACTIVATED NONCODING RNA; BANCR
619590	PHOSPHOLIPID PHOSPHATASE-RELATED PROTEIN 1; PLPPR1
619591	PHOSPHOLIPID PHOSPHATASE-RELATED PROTEIN 2; PLPPR2
619593	CATARACT 49; CTRCT49
619594	EPIDERMOLYSIS BULLOSA SIMPLEX 2C, LOCALIZED; EBS2C
619595	DEVELOPMENTAL DELAY, HYPOTONIA, MUSCULOSKELETAL DEFECTS, AND BEHAVIORAL ABNORMALITIES; DEHMBA
619596	OCIA DOMAIN-CONTAINING PROTEIN 1; OCIAD1
619597	tRNA SELENOCYSTEINE 1-ASSOCIATED PROTEIN 1; TRNAU1AP
619598	RHIZOMELIC DYSPLASIA, AIN-NAZ TYPE; RHZDAN
619599	EPIDERMOLYSIS BULLOSA SIMPLEX 2D, GENERALIZED, INTERMEDIATE OR SEVERE, AUTOSOMAL RECESSIVE; EBS2D
619600	AMINOPEPTIDASE O; AOPEP
619601	BCDIN3 DOMAIN-CONTAINING RNA METHYLTRANSFERASE; BCDIN3D
619602	FETAL AKINESIA, RESPIRATORY INSUFFICIENCY, MICROCEPHALY, POLYMICROGYRIA, AND DYSMORPHIC FACIES; FARIMPD
619603	GALLOWAY-MOWAT SYNDROME 9; GAMOS9
619604	TRANSMEMBRANE PROTEIN 92; TMEM92
619605	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 98; DEE98
619606	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 99; DEE99
619607	HETEROTAXY, VISCERAL, 10, AUTOSOMAL, WITH MALE INFERTILITY; HTX10
619608	HETEROTAXY, VISCERAL, 11, AUTOSOMAL, WITH MALE INFERTILITY; HTX11
619609	GALLOWAY-MOWAT SYNDROME 10; GAMOS10
619610	KINESIN FAMILY MEMBER 19; KIF19
619611	INTERSTITIAL LUNG DISEASE 1; ILD1
619612	B-CELL RECEPTOR-ASSOCIATED PROTEIN 29; BCAP29
619613	DELAYED PUBERTY, SELF-LIMITED; DPSL
619614	RETINITIS PIGMENTOSA 92; RP92
619615	DEAFNESS, AUTOSOMAL RECESSIVE 119; DFNB119
619616	NEURODEVELOPMENTAL DISORDER WITH HEARING LOSS AND SPASTICITY; NEDHLS
619617	EF-HAND CALCIUM-BINDING DOMAIN-CONTAINING PROTEIN 2; EFCAB2
619618	LY6/PLAUR DOMAIN-CONTAINING PROTEIN 5; LYPD5
619619	SERPIN FAMILY A, MEMBER 11; SERPINA11
619620	CHYMOTRYPSINOGEN B2; CTRB2
619621	SPASTIC PARAPLEGIA 84, AUTOSOMAL RECESSIVE; SPG84
619622	LYMPHOCYTE TRANSMEMBRANE ADAPTOR 1; LAX1
619623	LEUCINE-RICH REPEAT NEURONAL PROTEIN 1; LRRN1
619624	LEMUR TYROSINE KINASE 3; LMTK3
619625	CHROMOSOME 11 OPEN READING FRAME 58; C11ORF58
619626	METHYLTRANSFERASE 4, N6-ADENOSINE; METTL4
619627	HEAT REPEAT-CONTAINING PROTEIN 5B; HEATR5B
619628	AFTIPHILIN; AFTPH
619629	SMALL NUCLEAR RIBONUCLEOPROTEIN U4/U6.U5, SUBUNIT 27; SNRNP27
619630	IMMUNODEFICIENCY 88; IMD88
619631	SMALL NUCLEAR RIBONUCLEOPROTEIN U11/U12, SUBUNIT 35; SNRNP35
619632	IMMUNODEFICIENCY 89 AND AUTOIMMUNITY; IMD89
619633	OCIA DOMAIN-CONTAINING PROTEIN 2; OCIAD2
619634	O-SIALOGLYCOPROTEIN ENDOPEPTIDASE-LIKE 1; OSGEPL1
619635	ZINC FINGER FYVE DOMAIN-CONTAINING PROTEIN 19; ZFYVE19
619636	ACROMESOMELIC DYSPLASIA 4; AMD4
619637	DYSTONIA 32; DYT32
619638	SPONDYLOMETAPHYSEAL DYSPLASIA, PAGNAMENTA TYPE; SMDP
619639	NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA AND GROSS MOTOR AND SPEECH DELAY; NEDHMS
619640	LYSINE DEMETHYLASE 7A; KDM7A
619641	HENGEL-MAROOFIAN-SCHOLS SYNDROME; HEMARS
619642	TRANSMEMBRANE p24 TRAFFICKING PROTEIN 2; TMED2
619643	OOCYTE/ZYGOTE/EMBRYO MATURATION ARREST 11; OZEMA11
619644	IMMUNODEFICIENCY 91 AND HYPERINFLAMMATION; IMD91
619645	SPERMATOGENIC FAILURE 59; SPGF59
619646	SPERMATOGENIC FAILURE 60; SPGF60
619647	DYSKINESIA WITH OROFACIAL INVOLVEMENT, AUTOSOMAL RECESSIVE; DSKOR
619648	ZAKI SYNDROME; ZKS
619649	CHROMOSOME 16q12 DUPLICATION SYNDROME
619650	VHL-LIKE PROTEIN; VHLL
619651	NEURODEVELOPMENTAL DISORDER WITH HYPERKINETIC MOVEMENTS AND DYSKINESIA; NEDHYD
619652	IMMUNODEFICIENCY 92; IMD92
619653	NEURODEVELOPMENTAL DISORDER, NONPROGRESSIVE, WITH SPASTICITY AND TRANSIENT OPISTHOTONUS; NEDSTO
619654	CHROMOSOME 3 OPEN READING FRAME 33; C3ORF33
619655	RIBOSOMAL PROTEIN L10-LIKE; RPL10L
619656	LOEYS-DIETZ SYNDROME 6; LDS6
619657	CONGENITAL HEART DEFECTS, MULTIPLE TYPES, 8, WITH OR WITHOUT HETEROTAXY; CHTD8
619658	CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC, 7, WITH OR WITHOUT HEARING LOSS; PFIC7
619659	SYNAPTOSOME-ASSOCIATED PROTEIN 47; SNAP47
619660	BCL2-LIKE 15; BCL2L15
619661	LEUKOENCEPHALOPATHY, HEREDITARY DIFFUSE, WITH SPHEROIDS 2; HDLS2
619662	CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC, 8; PFIC8
619663	UTP25 SMALL SUBUNIT PROCESSOR COMPONENT; UTP25
619664	EF-HAND CALCIUM-BINDING DOMAIN-CONTAINING PROTEIN 6; EFCAB6
619665	OVARIAN DYSGENESIS 9; ODG9
619666	VILLIN-LIKE PROTEIN; VILL
619667	SOLUTE CARRIER FAMILY 35, MEMBER F6; SLC35F6
619668	DEOXYRIBOSE-PHOSPHATE ALDOLASE; DERA
619669	PIERCER OF MICROTUBULE WALL 2; PIERCE2
619670	ALK AND LTK LIGAND 1; ALKAL1
619671	ALK AND LTK LIGAND 2; ALKAL2
619672	SPERMATOGENIC FAILURE 61; SPGF61
619673	SPERMATOGENIC FAILURE 62; SPGF62
619674	PROTEASE-ASSOCIATED DOMAIN-CONTAINING PROTEIN 1; PRADC1
619675	U-BOX DOMAIN-CONTAINING PROTEIN 5; UBOX5
619676	TESTIS-EXPRESSED GENE 37; TEX37
619677	CLAUDIN DOMAIN-CONTAINING PROTEIN 1; CLDND1
619678	CHROMOSOME 22 OPEN READING FRAME 23; C22ORF23
619679	TSSK6-ACTIVATING COCHAPERONE; TSACC
619680	MARBACH-SCHAAF NEURODEVELOPMENTAL SYNDROME; MASNS
619681	DYSTONIA, EARLY-ONSET, AND/OR SPASTIC PARAPLEGIA; DYTSPG
619682	ALL-TRANS RETINOIC ACID-INDUCED DIFFERENTIATION FACTOR; ATRAID
619683	B-BOX- AND SPRY DOMAIN-CONTAINING PROTEIN; BSPRY
619684	MITOCHONDRIA-LOCALIZED GLUTAMIC ACID-RICH PROTEIN; MGARP
619685	NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, SEIZURES, AND NEONATAL CHOLESTASIS; NEDMSC
619686	SPASTIC PARAPLEGIA 85, AUTOSOMAL RECESSIVE; SPG85
619687	DYSTONIA 33; DYT33
619688	LEUKODYSTROPHY, HYPOMYELINATING, 23, WITH ATAXIA, DEAFNESS, LIVER DYSFUNCTION, AND DILATED CARDIOMYOPATHY; HLD23
619689	SPERMATOGENIC FAILURE 63; SPGF63
619690	BRUNET-WAGNER NEURODEVELOPMENTAL SYNDROME; BRUWAG
619691	TRICHOTHIODYSTROPHY 8, NONPHOTOSENSITIVE; TTD8
619692	TRICHOTHIODYSTROPHY 9, NONPHOTOSENSITIVE; TTD9
619693	AGAMMAGLOBULINEMIA 9, AUTOSOMAL RECESSIVE; AGM9
619694	DEVELOPMENTAL DELAY WITH VARIABLE NEUROLOGIC AND BRAIN ABNORMALITIES; DENBA
619695	RAUCH-STEINDL SYNDROME; RAUST
619696	SPERMATOGENIC FAILURE 64; SPGF64
619697	OOCYTE/ZYGOTE/EMBRYO MATURATION ARREST 12; OZEMA12
619698	MUCOPOLYSACCHARIDOSIS, TYPE X; MPS10
619699	FERGUSON-BONNI NEURODEVELOPMENTAL SYNDROME; FERBON
619700	CHROMOSOME 1 OPEN READING FRAME 127; C1ORF127
619701	YOON-BELLEN NEURODEVELOPMENTAL SYNDROME; YOBELN
619702	HETEROTAXY, VISCERAL, 12, AUTOSOMAL; HTX12
619703	CILIATED LEFT-RIGHT ORGANIZER METALLOPEPTIDASE; CIROP
619704	ZINC FINGER CCCH DOMAIN-CONTAINING PROTEIN 15; ZC3H15
619705	IMMUNODEFICIENCY 93 AND HYPERTROPHIC CARDIOMYOPATHY; IMD93
619706	LEUCINE-RICH REPEAT NEURONAL PROTEIN 4; LRRN4
619707	AGAMMAGLOBULINEMIA 10, AUTOSOMAL DOMINANT; AGM10
619708	GASTROINTESTINAL DEFECTS AND IMMUNODEFICIENCY SYNDROME 2; GIDID2
619709	KIAA0930 GENE; KIAA0930
619710	HYALURONAN AND PROTEOGLYCAN LINK PROTEIN 4; HAPLN4
619711	CHROMOSOME 19 OPEN READING FRAME 33; C19ORF33
619712	SPERMATOGENIC FAILURE 65; SPGF65
619713	CADHERIN-RELATED FAMILY, MEMBER 2; CDHR2
619714	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Iw, AUTOSOMAL DOMINANT; CDG1WAD
619715	WIZ ZINC FINGER PROTEIN; WIZ
619716	ACTIN-RELATED PROTEIN 8; ACTR8
619717	INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 73; MRT73
619718	HYPOGONADOTROPIC HYPOGONADISM 26 WITH OR WITHOUT ANOSMIA; HH26
619719	INTELLECTUAL DISABILITY AND MYOPATHY SYNDROME; IDMYS
619720	BRYANT-LI-BHOJ NEURODEVELOPMENTAL SYNDROME 1; BRYLIB1
619721	BRYANT-LI-BHOJ NEURODEVELOPMENTAL SYNDROME 2; BRYLIB2
619722	TRANSMEMBRANE PROTEIN 53; TMEM53
619723	SERINE CARBOXYPEPTIDASE 1; SCPEP1
619724	DYSTONIA 34, MYOCLONIC; DYT34
619725	NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT VARIABLE MOVEMENT OR BEHAVIORAL ABNORMALITIES; NEDMAB
619726	HYALURONAN AND PROTEOGLYCAN LINK PROTEIN 2; HAPLN2
619727	CRANIOTUBULAR DYSPLASIA, IKEGAWA TYPE; CTDI
619728	ABHYDROLASE DOMAIN-CONTAINING PROTEIN 4, N-ACYL PHOSPHOLIPASE B; ABHD4
619729	ACTIN-RELATED PROTEIN 6; ACTR6
619730	ACTIN-RELATED PROTEIN 5; ACTR5
619731	ACTIN-RELATED PROTEIN 10; ACTR10
619732	2-PHOSPHOXYLOSE PHOSPHATASE 1; PXYLP1
619733	INCLUSION BODY MYOPATHY AND BRAIN WHITE MATTER ABNORMALITIES; IBMWMA
619734	EPENDYMIN-RELATED PROTEIN 1; EPDR1
619735	SPASTIC PARAPLEGIA 86, AUTOSOMAL RECESSIVE; SPG86
619736	TEEBI HYPERTELORISM SYNDROME 2; TBHS2
619737	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 54; COXPD54
619738	PARKINSONISM-DYSTONIA 3, CHILDHOOD-ONSET; PKDYS3
619739	ASPARAGINE SYNTHETASE DOMAIN-CONTAINING PROTEIN 1; ASNSD1
619740	ASNSD1 UPSTREAM OPEN READING FRAME; ASDURF
619741	ZINC FINGER, MATRIN-TYPE 5; ZMAT5
619742	CHARCOT-MARIE-TOOTH DISEASE, DEMYELINATING, TYPE 1I; CMT1I
619743	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 55; COXPD55
619744	ZINC FINGER CCHC DOMAIN-CONTAINING PROTEIN 17; ZCCHC17
619745	NOONAN SYNDROME 14; NS14
619746	ZINC FINGER C3HC-TYPE DOMAIN-CONTAINING PROTEIN 1; ZC3HC1
619747	CARDIOMYOPATHY, DILATED, 2F; CMD2F
619748	LEUCINE-RICH REPEAT NEURONAL PROTEIN 3; LRRN3
619749	VEZATIN, ADHERENS JUNCTIONS TRANSMEMBRANE PROTEIN; VEZT
619750	IMMUNODEFICIENCY 94 WITH AUTOINFLAMMATION AND DYSMORPHIC FACIES; IMD94
619751	STUVE-WIEDEMANN SYNDROME 2; STWS2
619752	HYPER-IgE SYNDROME 4A, AUTOSOMAL DOMINANT, WITH RECURRENT INFECTIONS; HIES4A
619753	PYM HOMOLOG 1, EXON JUNCTION COMPLEX-ASSOCIATED FACTOR; PYM1
619754	YIP1 DOMAIN FAMILY, MEMBER 7; YIPF7
619755	HYPOGONADOTROPIC HYPOGONADISM 27 WITHOUT ANOSMIA; HH27
619756	UBIQUITIN-CONJUGATING ENZYME E2 J2; UBE2J2
619757	ANKYRIN REPEAT- AND SOCS BOX-CONTAINING PROTEIN 15; ASB15
619758	TESSADORI-BICKNELL-VAN HAAFTEN NEURODEVELOPMENTAL SYNDROME 1; TEBIVANED1
619759	TESSADORI-BICKNELL-VAN HAAFTEN NEURODEVELOPMENTAL SYNDROME 2; TEBIVANED2
619760	ATP23 METALLOPEPTIDASE AND ATP SYNTHASE ASSEMBLY FACTOR HOMOLOG; ATP23
619761	CEREBELLAR DYSFUNCTION, IMPAIRED INTELLECTUAL DEVELOPMENT, AND HYPOGONADOTROPIC HYPOGONADISM; CDIDHH
619762	KURY-ISIDOR SYNDROME; KURIS
619763	WD AND TETRATRICOPEPTIDE REPEATS PROTEIN 1; WDTC1
619764	CHARCOT-MARIE-TOOTH DISEASE, DEMYELINATING, TYPE 1H; CMT1H
619765	CRYSTALLIN BETA-GAMMA DOMAIN-CONTAINING PROTEIN 2; CRYBG2
619766	YLP MOTIF-CONTAINING PROTEIN 1; YLPM1
619767	PULMONARY FIBROSIS AND/OR BONE MARROW FAILURE SYNDROME, TELOMERE-RELATED, 6; PFBMFT6
619768	ARRESTIN DOMAIN-CONTAINING PROTEIN 1; ARRDC1
619769	MACROCEPHALY, NEURODEVELOPMENTAL DELAY, LYMPHOID HYPERPLASIA, AND PERSISTENT FETAL HEMOGLOBIN; MNDLFH
619770	YDJC CHITOOLIGOSACCHARIDE DEACETYLASE HOMOLOG; YDJC
619771	VRK SERINE/THREONINE KINASE 3; VRK3
619772	PROTEASOMAL ATPase-ASSOCIATED FACTOR 1; PAAF1
619773	IMMUNODEFICIENCY 95; IMD95
619774	IMMUNODEFICIENCY 96; IMD96
619775	CONGENITAL DISORDER OF DEGLYCOSYLATION 2; CDDG2
619776	C2 CALCIUM-DEPENDENT DOMAIN-CONTAINING PROTEIN 6; C2CD6
619777	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 100; DEE100
619778	ANKYRIN REPEAT DOMAIN-CONTAINING PROTEIN 42; ANKRD42
619779	AFAP1 ANTISENSE RNA 1, NONCODING; AFAP1AS1
619780	MITOCHONDRIAL DNA DEPLETION SYNDROME 20 (MNGIE TYPE); MTDPS20
619781	MYOPIA 28, AUTOSOMAL RECESSIVE; MYP28
619782	SPERM ACROSOME DEVELOPMENTAL REGULATOR; SPACDR
619783	EPIDERMOLYSIS BULLOSA, JUNCTIONAL 2A, INTERMEDIATE; JEB2A
619784	EPIDERMOLYSIS BULLOSA, JUNCTIONAL 2B, SEVERE; JEB2B
619785	EPIDERMOLYSIS BULLOSA, JUNCTIONAL 3A, INTERMEDIATE; JEB3A
619786	EPIDERMOLYSIS BULLOSA, JUNCTIONAL 3B, SEVERE; JEB3B
619787	EPIDERMOLYSIS BULLOSA, JUNCTIONAL 4, INTERMEDIATE; JEB4
619788	ARRESTIN DOMAIN-CONTAINING PROTEIN 4; ARRDC4
619789	ANEMIA, CONGENITAL DYSERYTHROPOIETIC, TYPE IIIb, AUTOSOMAL RECESSIVE; CDAN3B
619790	OCULOPHARYNGODISTAL MYOPATHY 4; OPDM4
619791	ATPase, PHOSPHOLIPID-TRANSPORTING, 10B; ATP10B
619792	ATP SYNTHASE MEMBRANE SUBUNIT F; ATP5MF
619793	RESTRICTIVE DERMOPATHY 2; RSDM2
619794	VON WILLEBRAND FACTOR C DOMAIN-CONTAINING PROTEIN 2-LIKE; VWC2L
619795	OSTEOGENESIS IMPERFECTA, TYPE XXII; OI22
619796	FLAGELLUM-ASSOCIATED PROTEIN CONTAINING COILED-COIL DOMAINS 1; FLACC1
619797	NEURODEVELOPMENTAL DISORDER WITH CENTRAL HYPOTONIA AND DYSMORPHIC FACIES; NEDCHF
619798	E74-LIKE ETS TRANSCRIPTION FACTOR 2; ELF2
619799	SPERMATOGENIC FAILURE 66; SPGF66
619800	HMG BOX-CONTAINING PROTEIN 3; HMGXB3
619801	RNA POLYMERASE III, SUBUNIT H; POLR3H
619802	IMMUNODEFICIENCY 97 WITH AUTOINFLAMMATION; IMD97
619803	SPERMATOGENIC FAILURE 67; SPGF67
619804	DEAFNESS, AUTOSOMAL DOMINANT 82; DFNA82
619805	SPERMATOGENIC FAILURE 68; SPGF68
619806	SPINOCEREBELLAR ATAXIA 49; SCA49
619807	MYOSIN-BINDING PROTEIN H-LIKE; MYBPHL
619808	DEAFNESS, AUTOSOMAL DOMINANT 83; DFNA83
619809	UDP GLUCURONOSYLTRANSFERASE FAMILY 2, MEMBER A2; UGT2A2
619810	DEAFNESS, AUTOSOMAL DOMINANT 84; DFNA84
619811	UHRF1-BINDING PROTEIN 1-LIKE; UHRF1BP1L
619812	BLOOD GROUP, EMM SYSTEM; EMM
619813	NEUTROPENIA, SEVERE CONGENITAL, 9, AUTOSOMAL DOMINANT; SCN9
619814	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 101; DEE101
619815	ATPase, PHOSPHOLIPID-TRANSPORTING, 10D; ATP10D
619816	EPIDERMOLYSIS BULLOSA, JUNCTIONAL 5A, INTERMEDIATE; JEB5A
619817	EPIDERMOLYSIS BULLOSA, JUNCTIONAL 6, WITH PYLORIC ATRESIA; JEB6
619818	ELONGATION FACTOR 1; ELOF1
619819	ZINC FINGER CCCH DOMAIN-CONTAINING PROTEIN 7A; ZC3H7A
619820	ATONAL bHLH TRANSCRIPTION FACTOR 8; ATOH8
619821	ENDONUCLEASE V; ENDOV
619822	BCL2-LIKE 13; BCL2L13
619823	ACIDIC NUCLEAR PHOSPHOPROTEIN 32 FAMILY, MEMBER B; ANP32B
619824	AGAMMAGLOBULINEMIA 8B, AUTOSOMAL RECESSIVE; AGM8B
619825	AORTIC ANEURYSM, FAMILIAL THORACIC 12; AAT12
619826	SPERMATOGENIC FAILURE 69; SPGF69
619827	INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 75, WITH NEUROPSYCHIATRIC FEATURES AND VARIANT LISSENCEPHALY; MRT75
619828	SPERMATOGENIC FAILURE 70; SPGF70
619829	COILED-COIL DOMAIN-CONTAINING PROTEIN 146; CCDC146
619830	DEVELOPING BRAIN HOMEOBOX 1; DBX1
619831	SPERMATOGENIC FAILURE 71; SPGF71
619832	AUDITORY NEUROPATHY, AUTOSOMAL DOMINANT 3; AUNA3
619833	NEURODEVELOPMENTAL DISORDER WITH NEUROMUSCULAR AND SKELETAL ABNORMALITIES; NEDNMS
619834	OVARIAN DYSGENESIS 10; ODG10
619835	3-METHYLGLUTACONIC ACIDURIA, TYPE VIIA; MGCA7A
619836	HYPOALPHALIPOPROTEINEMIA, PRIMARY, 2, INTERMEDIATE
619837	MORN REPEAT-CONTAINING PROTEIN 5; MORN5
619838	TUBULIN TYROSINE LIGASE-LIKE 9; TTLL9
619839	SORTING NEXIN 31; SNX31
619840	MACROTHROMBOCYTOPENIA, ISOLATED, 2, AUTOSOMAL DOMINANT; MACTHC2
619841	CHILTON-OKUR-CHUNG NEURODEVELOPMENTAL SYNDROME; CHOCNS
619842	RHO FAMILY-INTERACTING CELL POLARIZATION REGULATOR 1; RIPOR1
619843	DENN DOMAIN-CONTAINING PROTEIN 4B; DENND4B
619844	INTELLECTUAL DEVELOPMENTAL DISORDER WITH OR WITHOUT PERIPHERAL NEUROPATHY; IDDPN
619845	RETINITIS PIGMENTOSA 93; RP93
619846	IMMUNODEFICIENCY 99 WITH HYPOGAMMAGLOBULINEMIA AND AUTOIMMUNE CYTOPENIAS; IMD99
619847	NEURODEGENERATION, CHILDHOOD-ONSET, WITH PROGRESSIVE MICROCEPHALY; CONPM
619848	TBCC DOMAIN-CONTAINING PROTEIN 1; TBCCD1
619849	CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC, 9; PFIC9
619850	ALPHA-1,3-GALACTOSYLTRANSFERASE 2; A3GALT2
619851	LEUKODYSTROPHY, HYPOMYELINATING, 24; HLD24
619852	GOLGI-ASSOCIATED RAB2 INTERACTOR FAMILY, MEMBER 4; GARIN4
619853	FATTY ACID HYDROXYLASE DOMAIN-CONTAINING PROTEIN 2; FAXDC2
619854	NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, IMPAIRED SPEECH, AND BEHAVIORAL ABNORMALITIES; NEDHISB
619855	THYROID HORMONE METABOLISM, ABNORMAL, 2; THMA2
619856	ANKYRIN REPEAT DOMAIN-CONTAINING PROTEIN 50; ANKRD50
619857	SPERMATOGENESIS-ASSOCIATED PROTEIN 3; SPATA3
619858	AUTOINFLAMMATORY-PANCYTOPENIA SYNDROME; AIPCS
619859	PHOSPHORIBOSYLAMINOIMIDAZOLE CARBOXYLASE DEFICIENCY; PAICSD
619860	DCSTAMP DOMAIN-CONTAINING PROTEIN 1; DCST1
619861	DCSTAMP DOMAIN-CONTAINING PROTEIN 1; DCST2
619862	SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 32; SCAR32
619863	JUNCTOPHILIN 4; JPH4
619864	LEUKODYSTROPHY, CHILDHOOD-ONSET, REMITTING; CORLK
619865	TRANSMEMBRANE PROTEIN 14B; TMEM14B
619866	CFAP97 DOMAIN-CONTAINING PROTEIN 1; CFAP97D1
619867	SPERMATOGENIC FAILURE 72; SPGF72
619868	CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC, 10; PFIC10
619869	NEUROCARDIOFACIODIGITAL SYNDROME; NCFD
619870	COILED-COIL DOMAIN-CONTAINING PROTEIN 82; CCDC82
619871	CORNEAL DYSTROPHY, PUNCTIFORM AND POLYCHROMATIC PRE-DESCEMET; PPPCD
619872	IMMUNODEFICIENCY 101 (VARICELLA ZOSTER VIRUS-SPECIFIC); IMD101
619873	PARENTI-MIGNOT NEURODEVELOPMENTAL SYNDROME; PMNDS
619874	CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC, 11; PFIC11
619875	SOLUTE CARRIER ORGANIC ANION TRANSPORTER FAMILY, MEMBER 1B7; SLCO1B7
619876	NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, HYPOTONIA, NYSTAGMUS, AND SEIZURES; NEDMHS
619877	DENTICI-NOVELLI NEURODEVELOPMENTAL SYNDROME; DENNED
619878	SPERMATOGENIC FAILURE 73; SPGF73
619879	MECKEL SYNDROME 14; MKS14
619880	NEURODEVELOPMENTAL DISORDER WITH POOR GROWTH AND SKELETAL ANOMALIES; NEDGS
619881	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 102; DEE102
619882	tRNA YW-SYNTHESIZING PROTEIN 5; TYW5
619883	GOLGI-ASSOCIATED RAB2B INTERACTOR FAMILY, MEMBER 3; GARIN3
619884	OSTEOPOROSIS, CHILDHOOD- OR JUVENILE-ONSET, WITH DEVELOPMENTAL DELAY; OPDD
619885	TETRATRICOPEPTIDE REPEAT DOMAIN-CONTAINING PROTEIN 39A; TTC39A
619886	R3H DOMAIN-CONTAINING PROTEIN 2; R3HDM2
619887	RENAL HYPODYSPLASIA/APLASIA 4; RHDA4
619888	GASTRIC CARCINOMA PROLIFERATION-ENHANCING TRANSCRIPT 1, NONCODING; GHET1
619889	T-COMPLEX PROTEIN 11-LIKE 2; TCP11L2
619890	GOLGI-ASSOCIATED RAB2 INTERACTOR 5A; GARIN5A
619891	WD REPEAT-CONTAINING PROTEIN 93; WDR93
619892	ZINC FINGER ZZ-TYPE DOMAIN-CONTAINING PROTEIN 3; ZZZ3
619893	KELCH-LIKE FAMILY, MEMBER 25; KLHL25
619894	ABHYDROLASE DOMAIN-CONTAINING PROTEIN 15; ABHD15
619895	HOLOPROSENCEPHALY 14; HPE14
619896	MICROTUBULE-ASSOCIATED TYROSINE CARBOXYPEPTIDASE 2; MATCAP2
619897	CARDIOMYOPATHY, DILATED, 2G; CMD2G
619898	GOLGI-ASSOCIATED RAB2 INTERACTOR FAMILY, MEMBER 2; GARIN2
619899	NALCN CHANNEL AUXILIARY FACTOR 1; NALF1
619900	KDEL ENDOPLASMIC RETICULUM PROTEIN RETENTION RECEPTOR 3; KDELR3
619901	EUKARYOTIC TRANSLATION INITIATION FACTOR 1; EIF1
619902	HEPATORENOCARDIAC DEGENERATIVE FIBROSIS; HRCDF
619903	PERIPHERAL MOTOR NEUROPATHY, CHILDHOOD-ONSET, BIOTIN-RESPONSIVE; COMNB
619904	GOLGI-ASSOCIATED RAB2 INTERACTOR 1A; GARIN1A
619905	GOLGI-ASSOCIATED RAB2 INTERACTOR 1B; GARIN1B
619906	DExD-BOX HELICASE 39A; DDX39A
619907	PHD FINGER PROTEIN 14; PHF14
619908	NEURODEVELOPMENTAL DISORDER WITH LANGUAGE DELAY AND SEIZURES; NEDLDS
619909	PONTOCEREBELLAR HYPOPLASIA, TYPE 17; PCH17
619910	INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 66; MRD66
619911	INTELLECTUAL DEVELOPMENTAL DISORDER WITH LANGUAGE IMPAIRMENT AND EARLY-ONSET DOPA-RESPONSIVE DYSTONIA-PARKINSONISM; IDLDP
619912	MYOMIXER; MYMX
619913	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 103; DEE103
619914	SEL1L FAMILY, MEMBER 3; SEL1L3
619915	RNA-BINDING MOTIF PROTEIN 34; RBM34
619916	ZINC FINGER PROTEIN 799; ZNF799
619917	SUSHI DOMAIN-CONTAINING PROTEIN 5; SUSD5
619918	TUBULIN, ALPHA-3E; TUBA3E
619919	RHO GUANINE NUCLEOTIDE EXCHANGE FACTOR 38; ARHGEF38
619920	ANKYRIN REPEAT- AND DEATH DOMAIN-CONTAINING PROTEIN 1B; ANKDD1B
619921	DYSTONIA 35, CHILDHOOD-ONSET; DYT35
619922	NEURODEVELOPMENTAL DISORDER WITH DYSTONIA AND SEIZURES; NEDDS
619923	PROTEIN PHOSPHATASE 1, REGULATORY SUBUNIT 36; PPP1R36
619924	IMMUNODEFICIENCY 105; IMD105
619925	WASH COMPLEX, SUBUNIT 3; WASHC3
619926	KELCH-LIKE FAMILY, MEMBER 18; KLHL18
619927	INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 67; MRD67
619928	PHD FINGER PROTEIN 24; PHF24
619929	TESTIS-EXPRESSED GENE 2; TEX2
619930	ZINC FINGER, MATRIN-TYPE 2; ZMAT2
619931	INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 76; MRT76
619932	GLUCOSE-FRUCTOSE OXIDOREDUCTASE DOMAIN-CONTAINING PROTEIN 1; GFOD1
619933	GLUCOSE-FRUCTOSE OXIDOREDUCTASE DOMAIN-CONTAINING PROTEIN 2; GFOD2
619934	INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 68; MRD68
619935	IMMUNODEFICIENCY 106, SUSCEPTIBILITY TO VIRAL INFECTIONS; IMD106
619936	ANKYRIN REPEAT- AND SOCS BOX-CONTAINING PROTEIN 17; ASB17
619937	SPERMATOGENIC FAILURE 74; SPGF74
619938	PREMATURE OVARIAN FAILURE 20; POF20
619939	OLFACTORY RECEPTOR, FAMILY 4, SUBFAMILY M, MEMBER 1; OR4M1
619940	XK-RELATED PROTEIN 8; XKR8
619941	CAREY-FINEMAN-ZITER SYNDROME 2; CFZS2
619942	ZINC FINGER PROTEIN 541; ZNF541
619943	POTASSIUM CHANNEL TETRAMERIZATION DOMAIN-CONTAINING PROTEIN 19; KCTD19
619944	COILED-COIL SERINE-RICH PROTEIN 2; CCSER2
619945	FAMILY WITH SEQUENCE SIMILARITY 184, MEMBER B; FAM184B
619946	MCF.2 CELL LINE-DERIVED TRANSFORMING SEQUENCE-LIKE 2; MCF2L2
619947	WAARDENBURG SYNDROME, TYPE 2F; WS2F
619948	INTERACTION PROTEIN FOR CYTOHESIN EXCHANGE FACTORS 1; IPCEF1
619949	SPERMATOGENIC FAILURE 75; SPGF75
619950	TESSADORI-BICKNELL-VAN HAAFTEN NEURODEVELOPMENTAL SYNDROME 3; TEBIVANED3
619951	TESSADORI-BICKNELL-VAN HAAFTEN NEURODEVELOPMENTAL SYNDROME 4; TEBIVANED4
619952	TRANSMEMBRANE PROTEIN 63B; TMEM63B
619953	TRANSMEMBRANE PROTEIN 63C; TMEM63C
619954	SYNAPTONEMAL COMPLEX CENTRAL ELEMENT PROTEIN 1-LIKE; SYCE1L
619955	DWORSCHAK-PUNETHA NEURODEVELOPMENTAL SYNDROME; DWOPNED
619956	PIGY UPSTREAM OPEN READING FRAME; PYURF
619957	ATTENTION DEFICIT-HYPERACTIVITY DISORDER 8; ADHD8
619958	GLYCOSYLATED LYSOSOMAL MEMBRANE PROTEIN; GLMP
619959	ACCES SYNDROME; ACCES
619960	RAB5-INTERACTING FACTOR; RAB5IF
619961	FORKHEAD BOX B1; FOXB1
619962	FORKHEAD BOX B2; FOXB2
619963	ANOCTAMIN 9; ANO9
619964	DEVELOPMENTAL DELAY, IMPAIRED SPEECH, AND BEHAVIORAL ABNORMALITIES, WITH OR WITHOUT SEIZURES; DEDISB
619965	ALPHA KINASE 2; ALPK2
619966	SPASTIC PARAPLEGIA 87, AUTOSOMAL RECESSIVE; SPG87
619967	CONGENITAL MYOPATHY 11; CMYP11
619968	ACYL-CoA-BINDING DOMAIN-CONTAINING PROTEIN 4; ACBD4
619969	ZINC FINGER- AND BTB DOMAIN-CONTAINING PROTEIN 47; ZBTB47
619970	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 104; DEE104
619971	NEURODEVELOPMENTAL DISORDER WITH EPILEPSY AND BRAIN ATROPHY; NEDEBA
619972	NEURODEVELOPMENTAL DISORDER WITH SEVERE MOTOR IMPAIRMENT, ABSENT LANGUAGE, CEREBRAL HYPOMYELINATION, AND BRAIN ATROPHY; NEDMLHB
619973	DNAJ/HSP40 HEAT-SHOCK PROTEIN FAMILY, MEMBER C16; DNAJC16
619974	ESPIN-LIKE PROTEIN; ESPNL
619975	TUMOR PREDISPOSITION SYNDROME 2; TPDS2
619976	MAJOR FACILITATOR SUPERFAMILY DOMAIN-CONTAINING PROTEIN 1; MFSD1
619977	MACULAR DYSTROPHY, RETINAL, 4; MCDR4
619978	MICROTUBULE-ASSOCIATED TYROSINE CARBOXYPEPTIDASE 1; MATCAP1
619979	CHROMOSOME 18 OPEN READING FRAME 32; C18ORF32
619980	BRADDOCK-CAREY SYNDROME 1; BRDCS1
619981	BRADDOCK-CAREY SYNDROME 2; BRDCS2
619982	VIM ANTISENSE RNA 1; VIMAS1
619983	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 105 WITH HYPOPITUITARISM; DEE105
619984	NUCLEAR PORE COMPLEX-INTERACTING PROTEIN FAMILY, MEMBER B3; NPIPB3
619985	GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 25; GPIBD25
619986	IMMUNODEFICIENCY 107, SUSCEPTIBILITY TO INVASIVE STAPHYLOCOCCUS AUREUS INFECTION; IMD107
619987	NOTCH-REGULATED ANKYRIN REPEAT-CONTAINING PROTEIN; NRARP
619988	INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 77; MRT77
619989	NEURODEVELOPMENTAL DISORDER WITH SPEECH DELAY AND VARIABLE OCULAR ANOMALIES; NEDSOA
619990	TRANSMEMBRANE p24 TRAFFICKING PROTEIN 7; TMED7
619991	LIVER DISEASE, SEVERE CONGENITAL; SCOLIV
619992	CHROMOSOME 3 OPEN READING FRAME 20; C3ORF20
619993	PROLINE-RICH TRANSMEMBRANE PROTEIN 3; PRRT3
619994	DYNEIN LIGHT CHAIN, TCTEX-TYPE FAMILY, MEMBER 5; DYNLT5
619995	NEURODEVELOPMENTAL DISORDER WITH INTENTION TREMOR, PYRAMIDAL SIGNS, DYSPRAXIA, AND OCULAR ANOMALIES; NEDITPO
619996	ARGININE- AND SERINE-RICH COILED-COIL PROTEIN 2; RSRC2
619997	SOLUTE CARRIER FAMILY 35, MEMBER F5; SLC35F5
619998	NUCLEOPORIN 42; NUP42
619999	N-ALPHA-ACETYLTRANSFERASE 40, NatD CATALYTIC SUBUNIT; NAA40
620000	TRANSMEMBRANE PROTEIN 167A; TMEM167A
620001	NEURODEVELOPMENTAL DISORDER WITH SPASTICITY, SEIZURES, AND BRAIN ABNORMALITIES; NEDSSBA
620002	CHROMOSOME 5 OPEN READING FRAME 47; C5ORF47
620003	TBC1 DOMAIN FAMILY, MEMBER 12; TBC1D12
620004	NMRA-LIKE REDOX SENSOR 1; NMRAL1
620005	PRIMORDIAL DWARFISM-IMMUNODEFICIENCY-LIPODYSTROPHY SYNDROME; PDIL
620006	RAD54-LIKE 2; RAD54L2
620007	INTELLECTUAL DEVELOPMENTAL DISORDER WITH MUSCLE TONE ABNORMALITIES AND DISTAL SKELETAL DEFECTS; IDDMDS
620008	H2A.Z VARIANT HISTONE 2; H2AZ2
620009	KERATODERMA-ICHTHYOSIS-DEAFNESS SYNDROME, AUTOSOMAL RECESSIVE; KDIDAR
620010	CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC, 12; PFIC12
620011	NEURONOPATHY, DISTAL HEREDITARY MOTOR, AUTOSOMAL RECESSIVE 6; HMNR6
620012	DEVELOPMENTAL DELAY, HYPOTONIA, AND IMPAIRED LANGUAGE; DEDHIL
620013	RIBOSOMAL RNA-PROCESSING 9, U3 SMALL NUCLEOLAR RNA-BINDING PROTEIN; RRP9
620014	LYMPHATIC MALFORMATION 12; LMPHM12
620015	ADVANCE SLEEP PHASE SYNDROME, FAMILIAL, 4; FASPS4
620016	MAX DIMERIZATION PROTEIN 4; MXD4
620017	NURIM; NRM
620018	PROTEIN DISULFIDE ISOMERASE, FAMILY A, MEMBER 4; PDIA4
620019	ARTHROGRYPOSIS, DISTAL, TYPE 11; DA11
620020	G3BP STRESS GRANULE ASSEMBLY FACTOR 2; G3BP2
620021	INTELLECTUAL DEVELOPMENTAL DISORDER WITH AUTISM AND DYSMORPHIC FACIES; IDDADF
620022	STICKLER SYNDROME, TYPE VI; STL6
620023	NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, MOVEMENT ABNORMALITIES, AND SEIZURES; NEDMIMS
620024	NEURODEVELOPMENTAL DISORDER WITH SEIZURES, MICROCEPHALY, AND BRAIN ABNORMALITIES; NEDSMBA
620025	DIAPHRAGMATIC HERNIA 4, WITH CARDIOVASCULAR DEFECTS; DIH4
620026	ZINC FINGER- AND SCAN DOMAIN-CONTAINING PROTEIN 1; ZSCAN1
620027	NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, SHORT STATURE, AND SPEECH DELAY; NEDMISS
620028	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 106; DEE106
620029	NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, LANGUAGE DELAY, AND SKELETAL DEFECTS WITH OR WITHOUT SEIZURES; NEDHLSS
620030	ARGININE- AND SERINE-RICH PROTEIN 1; RSRP1
620031	POLYHOMEOTIC HOMOLOG 3; PHC3
620032	CILIARY DYSKINESIA, PRIMARY, 48, WITHOUT SITUS INVERSUS; CILD48
620033	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 107; DEE107
620034	NIPA-LIKE DOMAIN-CONTAINING PROTEIN 3; NIPAL3
620035	SMAD5 ANTISENSE RNA 1, NONCODING; SMAD5AS1
620036	IMMEDIATE-EARLY RESPONSE GENE 2; IER2
620037	FAMILY WITH SEQUENCE SIMILARITY 193, MEMBER A; FAM193A
620038	NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, HYPOTONIA, AND ABSENT LANGUAGE; NEDMHAL
620039	POGO TRANSPOSABLE ELEMENT-DERIVED PROTEIN WITH KRAB DOMAIN; POGK
620040	DYSKERATOSIS CONGENITA, DIGENIC; DKCD
620041	5-PRIME-NUCLEOTIDASE, CYTOSOLIC IIIB; NT5C3B
620042	PHYTANOYL-CoA DIOXYGENASE DOMAIN-CONTAINING PROTEIN 1; PHYHD1
620043	RETINOL DEHYDROGENASE 16; RDH16
620044	BONE MARROW FAILURE AND DIABETES MELLITUS SYNDROME; BMFDMS
620045	INTESTINAL DYSMOTILITY SYNDROME; IDMTS
620046	PROFILIN FAMILY, MEMBER 4; PFN4
620047	MICROCEPHALY 29, PRIMARY, AUTOSOMAL RECESSIVE; MCPH29
620048	RETENTION IN ENDOPLASMIC RETICULUM SORTING RECEPTOR 1; RER1
620049	NEPHROTIC SYNDROME, TYPE 26; NPHS26
620050	PHD FINGER PROTEIN 20-LIKE 1; PHF20L1
620051	RING FINGER PROTEIN 41, E3 UBIQUITIN PROTEIN LIGASE; RNF41
620052	ENDOSOMAL TRANSMEMBRANE EPSIN INTERACTOR 2; ENTREP2
620053	LONG INTERGENIC NONCODING RNA 974; LINC00974
620054	PHD FINGER PROTEIN 13; PHF13
620055	PWP1 HOMOLOG, ENDONUCLEIN; PWP1
620056	POLYCYSTIC KIDNEY DISEASE 7; PKD7
620057	PHD FINGER PROTEIN 7; PHF7
620058	FAMILIAL APOLIPOPROTEIN GENE CLUSTER DELETION SYNDROME
620059	LONG INTERGENIC NONCODING RNA 472; LINC00472
620060	TETRATRICOPEPTIDE REPEAT DOMAIN-CONTAINING PROTEIN 7B; TTC7B
620061	CDK2-ASSOCIATED PROTEIN 2; CDK2AP2
620062	DEVELOPMENTAL DELAY WITH SHORT STATURE, DYSMORPHIC FACIAL FEATURES, AND SPARSE HAIR 2; DEDSSH2
620063	DNA POLYMERASE ALPHA-2, ACCESSORY SUBUNIT; POLA2
620064	OXOEICOSANOID RECEPTOR 1; OXER1
620065	DEVELOPMENTAL DELAY, BEHAVIORAL ABNORMALITIES, AND NEUROPSYCHIATRIC DISORDERS; DEDBANP
620066	NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, CEREBRAL ATROPHY, AND VISUAL IMPAIRMENT; NEDMVIC
620067	CARDIAC VALVULAR DYSPLASIA 2; CVDP2
620068	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2II; CMT2II
620069	ANKYRIN REPEAT- AND IBR DOMAIN-CONTAINING PROTEIN 1; ANKIB1
620070	NEURODEVELOPMENTAL DISORDER WITH SHORT STATURE, PROMINENT FOREHEAD, AND FEEDING DIFFICULTIES; NEDSFF
620071	BIRK-AHARONI SYNDROME; BKAH
620072	DIAMOND-BLACKFAN ANEMIA 21; DBA21
620073	NEURODEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND SKELETAL AND BRAIN ABNORMALITIES; NEDDFSB
620074	LTV1 RIBOSOME BIOGENESIS FACTOR; LTV1
620075	NEURODEVELOPMENTAL DISORDER WITH FACIAL DYSMORPHISM, ABSENT LANGUAGE, AND PSEUDO-PELGER-HUET ANOMALY; NEDFLPH
620076	BENT BONE DYSPLASIA SYNDROME 2; BBDS2
620077	PROTEIN-L-ISOASPARTATE (D-ASPARTATE) O-METHYLTRANSFERASE DOMAIN-CONTAINING PROTEIN 2; PCMTD2
620078	FAMILY WITH SEQUENCE SIMILARITY 168, MEMBER B; FAM168B
620079	LONG INTERGENIC NONCODING RNA 467; LINC00467
620080	NEURONOPATHY, DISTAL HEREDITARY MOTOR, AUTOSOMAL DOMINANT 10; HMND10
620081	RNA-BINDING MOTIF PROTEIN 26; RBM26
620082	RNA-BINDING MOTIF PROTEIN 27; RBM27
620083	NEURODEVELOPMENTAL DISORDER WITH CRANIOFACIAL DYSMORPHISM AND SKELETAL DEFECTS; NEDCDS
620084	SPERMATOGENIC FAILURE 76; SPGF76
620085	HYPERMETABOLISM DUE TO UNCOUPLED MITOCHONDRIAL OXIDATIVE PHOSPHORYLATION 2; HUMOP2
620086	INTELLECTUAL DEVELOPMENTAL DISORDER WITH OCULAR ANOMALIES AND DISTINCTIVE FACIAL FEATURES; IDDOF
620087	DDB1- AND CUL4-ASSOCIATED FACTOR 12; DCAF12
620088	WWC2 ANTISENSE RNA 1, NONCODING; WWC2AS1
620089	NEURODEGENERATION, CHILDHOOD-ONSET, WITH MULTISYSTEM INVOLVEMENT DUE TO MITOCHONDRIAL DYSFUNCTION; CONDMIM
620090	ZINC FINGER PROTEIN 675; ZNF675
620091	PROTEIN-L-ISOASPARTATE (D-ASPARTATE) O-METHYLTRANSFERASE DOMAIN-CONTAINING PROTEIN 1; PCMTD1
620092	MIER FAMILY, MEMBER 2; MIER2
620093	ACTIN MATURATION PROTEASE; ACTMAP
620094	NEURODEVELOPMENTAL DISORDER WITH EYE MOVEMENT ABNORMALITIES AND ATAXIA; NEDEMA
620095	ZINC FINGER CCHC DOMAIN-CONTAINING PROTEIN 2; ZCCHC2
620096	RING FINGER PROTEIN 185; RNF185
620097	PHOSPHOLIPASE B DOMAIN CONTAINING 2; PLBD2
620098	DEVELOPMENTAL DELAY WITH VARIABLE INTELLECTUAL DISABILITY AND DYSMORPHIC FACIES; DIDDF
620099	CLEIDOCRANIAL DYSPLASIA 2; CLCD2
620100	MIER FAMILY, MEMBER 3; MIER3
620101	RAS HOMOLOG FAMILY, MEMBER V; RHOV
620102	RETINITIS PIGMENTOSA 95; RP95
620103	SPERMATOGENIC FAILURE 77; SPGF77
620104	AMELOGENESIS IMPERFECTA, TYPE IK; AI1K
620105	C-TYPE LECTIN DOMAIN FAMILY 4, MEMBER F; CLEC4F
620106	SPASTIC PARAPLEGIA 88, AUTOSOMAL DOMINANT; SPG88
620107	OROFACIODIGITAL SYNDROME XIX; OFD19
620108	TRANSMEMBRANE PROTEIN 151A; TMEM151A
620109	DDB1- AND CUL4-ASSOCIATED FACTOR 15; DCAF15
620110	WW AND C2 DOMAINS-CONTAINING PROTEIN 2; WWC2
620111	CHARCOT-MARIE-TOOTH DISEASE, DEMYELINATING, TYPE 1J; CMT1J
620112	APOA1 ANTISENSE RNA, NONCODING; APOA1AS
620113	NEURODEVELOPMENTAL DISORDER WITH GROWTH RETARDATION, DYSMORPHIC FACIES, AND CORPUS CALLOSUM ABNORMALITIES; NEDGFC
620114	NEURODEVELOPMENTAL DISORDER WITH SPEECH IMPAIRMENT AND WITH OR WITHOUT SEIZURES; NEDSIS
620115	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 108; DEE108
620116	FATTY LIVER DISEASE, PROTECTION FROM; FLDP
620117	MICRO RNA 887; MIR887
620118	ZINC FINGER PROTEIN 490; ZNF490
620119	LONG NONCODING RNA CRYBG3
620120	DENN DOMAIN-CONTAINING PROTEIN 2A; DENND2A
620121	IRON OVERLOAD, SUSCEPTIBILITY TO; IO
620122	DENN DOMAIN-CONTAINING PROTEIN 11; DENND11
620123	FIBROSIN-LIKE 1; FBRSL1
620124	ZINC FINGER PROTEIN 492; ZNF492
620125	PSEUDOHYPOALDOSTERONISM, TYPE IB2, AUTOSOMAL RECESSIVE; PHA1B2
620126	PSEUDOHYPOALDOSTERONISM, TYPE IB3, AUTOSOMAL RECESSIVE; PHA1B3
620127	MICRO RNA 151A; MIR151A
620128	FOLLISTATIN-LIKE 5; FSTL5
620129	NYN DOMAIN- AND RETROVIRAL INTEGRASE-CONTAINING PROTEIN; NYNRIN
620130	OUTER DENSE FIBER OF SPERM TAILS 2-LIKE PROTEIN; ODF2L
620131	DEFENSIN, BETA, 126; DEFB126
620132	ZINC FINGER SWIM DOMAIN-CONTAINING PROTEIN 5; ZSWIM5
620133	DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 8; DKCB8
620134	PLECKSTRIN HOMOLOGY DOMAIN- AND RhoGEF DOMAIN-CONTAINING PROTEIN G1; PLEKHG1
620135	MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 39; MC1DN39
620136	NUDC DOMAIN-CONTAINING PROTEIN 2; NUDCD2
620137	MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 11; MC3DN11
620138	MYOPATHY WITH MYALGIA, INCREASED SERUM CREATINE KINASE, AND WITH OR WITHOUT EPISODIC RHABDOMYOLYSIS; MMCKR
620139	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 56; COXPD56
620140	SYNCOLLIN; SYCN
620141	DEVELOPMENTAL DELAY, LANGUAGE IMPAIRMENT, AND OCULAR ABNORMALITIES; DEVLO
620142	CENTROSOMAL AT-AC SPLICING FACTOR; CENATAC
620143	TRANSMEMBRANE PROTEIN 232; TMEM232
620144	CACHE DOMAIN-CONTAINING PROTEIN 1; CACHD1
620145	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 109; DEE109
620146	CRYSTALLIN BETA-GAMMA DOMAIN-CONTAINING PROTEIN 3; CRYBG3
620147	RNA-BINDING MOTIF PROTEIN 46; RBM46
620148	ICHTHYOSIS, ANNULAR EPIDERMOLYTIC, 2; AEI2
620149	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 110; DEE110
620150	EPIDERMOLYTIC HYPERKERATOSIS 2A, AUTOSOMAL DOMINANT; EHK2A
620151	WOLMAN DISEASE; WOLD
620152	HYPOMAGNESEMIA 7, RENAL, WITH OR WITHOUT DILATED CARDIOMYOPATHY; HOMG7
620153	MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 4; MVA4
620154	OOCYTE/ZYGOTE/EMBRYO MATURATION ARREST 13; OZEMA13
620155	RABIN-PAPPAS SYNDROME; RAPAS
620156	CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 11; CDCBM11
620157	INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 70; MRD70
620158	SPINOCEREBELLAR ATAXIA 50; SCA50
620159	PNMA FAMILY, MEMBER 8B; PNMA8B
620160	IQ MOTIF-CONTAINING PROTEIN N; IQCN
620161	CONGENITAL MYOPATHY 15; CMYP15
620162	ZINC FINGER PROTEIN 471; ZNF471
620163	ZFP14 ZINC FINGER PROTEIN; ZFP14
620164	ZINC FINGER- AND BTB DOMAIN-CONTAINING PROTEIN 26; ZBTB26
620165	LEUCINE-RICH REPEATS- AND CALPONIN HOMOLOGY DOMAIN-CONTAINING PROTEIN 4; LRCH4
620166	MUSCULAR DYSTROPHY, CONGENITAL, WITH OR WITHOUT SEIZURES; MYOS
620167	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 57; COXPD57
620168	ATOS HOMOLOG A; ATOSA
620169	ATOS HOMOLOG B; ATOSB
620170	SPERMATOGENIC FAILURE 78; SPGF78
620171	NHS-LIKE PROTEIN 1; NHSL1
620172	NACHT DOMAIN- AND WD REPEAT-CONTAINING PROTEIN 2; NWD2
620173	TOOTH AGENESIS, SELECTIVE, 10; STHAG10
620174	SPINOCEREBELLAR ATAXIA 27B, LATE-ONSET; SCA27B
620175	RUBICON-LIKE AUTOPHAGY ENHANCER; RUBCNL
620176	DEAD-BOX HELICASE 55; DDX55
620177	HYPOTRICHOSIS 15; HYPT15
620178	GRAM DOMAIN-CONTAINING PROTEIN 1A; GRAMD1A
620179	GRAM DOMAIN-CONTAINING PROTEIN 1B; GRAMD1B
620180	GRAM DOMAIN-CONTAINING PROTEIN 1C; GRAMD1C
620181	GRAM DOMAIN-CONTAINING PROTEIN 2A; GRAMD2A
620182	GRAM DOMAIN-CONTAINING PROTEIN 2B; GRAMD2B
620183	MICROCEPHALY 30, PRIMARY, AUTOSOMAL RECESSIVE; MCPH30
620184	ATELIS SYNDROME 1; ATELS1
620185	ATELIS SYNDROME 2; ATELS2
620186	BRANCHIAL ARCH ABNORMALITIES, CHOANAL ATRESIA, ATHELIA, HEARING LOSS, AND HYPOTHYROIDISM SYNDROME; BCAHH
620187	CILIA- AND FLAGELLA-ASSOCIATED PROTEIN 74; CFAP74
620188	TRANSPORT AND GOLGI ORGANIZATION 6 HOMOLOG; TANGO6
620189	MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 7 WITH INFLAMMATION AND TUMOR PREDISPOSITION; MVA7
620190	ABHYDROLASE DOMAIN-CONTAINING PROTEIN 16B; ABHD16B
620191	NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, DYSMORPHIC FACIES, AND SKIN ABNORMALITIES; NEDHFS
620192	LACRIMOAURICULODENTODIGITAL SYNDROME 2; LADD2
620193	LACRIMOAURICULODENTODIGITAL SYNDROME 3; LADD3
620194	NEURODEVELOPMENTAL DISORDER WITH POOR GROWTH, LARGE EARS, AND DYSMORPHIC FACIES; NEDGEF
620195	OBESITY AND HYPOPIGMENTATION; OBHP
620196	SPERMATOGENIC FAILURE 79; SPGF79
620197	CILIARY DYSKINESIA, PRIMARY, 49, WITHOUT SITUS INVERSUS; CILD49
620198	THYROID HORMONE METABOLISM, ABNORMAL, 3; THMA3
620199	INFLAMMATORY POIKILODERMA WITH HAIR ABNORMALITIES AND ACRAL KERATOSES; IPHAK
620200	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIy; CDG2Y
620201	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIz; CDG2Z
620202	VESICLE AMINE TRANSPORT PROTEIN 1-LIKE; VAT1L
620203	CARDIOMYOPATHY, DILATED, 2H; CMD2H
620204	RNA, U12 SMALL NUCLEAR; RNU12
620205	INOSITOL 1,4,5-TRISPHOSPHATE RECEPTOR-INTERACTING PROTEIN; ITPRIP
620206	STERILE ALPHA MOTIF-DOMAIN CONTAINING PROTEIN 1; SAMD1
620207	BLOOD GROUP, ER; ER
620208	SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 33; SCAR33
620209	HECT DOMAIN E3 UBIQUITIN PROTEIN LIGASE 4; HECTD4
620210	NEURODEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND ISCHIOPUBIC HYPOPLASIA; NEDFIH
620211	HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 8; HHF8
620212	SH3 DOMAIN-BINDING KINASE 1; SBK1
620213	SANT AND BTB DOMAIN REGULATOR OF CSR; SANBR
620214	HHIP-LIKE 2; HHIPL2
620215	MEMBRANE INTEGRAL NOTCH2-ASSOCIATED RECEPTOR 2; MINAR2
620216	SOLUTE CARRIER FAMILY 5 (SODIUM/GLUCOSE COTRANSPORTER), MEMBER 9; SLC5A9
620217	CENTROSOMAL PROTEIN, 44-KD; CEP44
620218	SHISA-LIKE 2A; SHISAL2A
620219	SHISA-LIKE 2B; SHISAL2B
620220	SHISA-LIKE 1; SHISAL1
620221	SPASTIC PARAPLEGIA 79A, AUTOSOMAL DOMINANT, WITH ATAXIA; SPG79A
620222	SPERMATOGENIC FAILURE 80; SPGF80
620223	EXTRACELLULAR LEUCINE-RICH REPEAT AND FIBRONECTIN TYPE III DOMAIN-CONTAINING PROTEIN 2; ELFN2
620224	NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, DYSMORPHIC FACIES, AND SKELETAL ANOMALIES, WITH OR WITHOUT SEIZURES; NEDFSS
620225	SUPPRESSOR OF GLUCOSE, AUTOPHAGY-ASSOCIATED PROTEIN 1; SOGA1
620226	UBIQUITIN-SPECIFIC PEPTIDASE 37; USP37
620227	DEAFNESS, AUTOSOMAL DOMINANT 85; DFNA85
620228	RETINITIS PIGMENTOSA 96; RP96
620229	FHF COMPLEX SUBUNIT HOOK-INTERACTING PROTEIN 1B; FHIP1B
620230	FHF COMPLEX SUBUNIT HOOK-INTERACTING PROTEIN 2B; FHIP2B
620231	SHORT QT SYNDROME 7; SQT7
620232	JOINT CONTRACTURES, OSTEOCHONDROMAS, AND B-CELL LYMPHOMA; JCOSL
620233	RESPIRATORY INFECTIONS, RECURRENT, AND FAILURE TO THRIVE WITH OR WITHOUT DIARRHEA; RIFTD
620234	ANKYRIN REPEAT DOMAIN-CONTAINING PROTEIN 24; ANKRD24
620235	RHABDOMYOLYSIS, SUSCEPTIBILITY TO, 1; RHABDO1
620236	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 29, WITH POLYGLUCOSAN BODIES; CMH29
620237	INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 78; MRT78
620238	DEAFNESS, AUTOSOMAL RECESSIVE 120; DFNB120
620239	BETA-1,3-GALACTOSYLTRANSFERASE 9; B3GALT9
620240	DEVELOPMENTAL DELAY WITH HYPOTONIA, MYOPATHY, AND BRAIN ABNORMALITIES; DEDHMB
620241	HYDROCEPHALUS, CONGENITAL, 5, SUSCEPTIBILITY TO; HYC5
620242	NEURODEVELOPMENTAL DISORDER WITH POOR GROWTH AND BEHAVIORAL ABNORMALITIES; NEDGBA
620243	LEUKODYSTROPHY, HYPOMYELINATING, 25; HLD25
620244	LYMPHATIC MALFORMATION 13; LMPHM13
620245	EPISODIC KINESIGENIC DYSKINESIA 3; EKD3
620246	CONGENITAL MYOPATHY 18; CMYP18
620247	CARDIOMYOPATHY, DILATED, 1OO; CMD1OO
620248	TRANSMEMBRANE PROTEIN 80; TMEM80
620249	CONGENITAL MYOPATHY 10B, MILD VARIANT; CMYP10B
620250	NEURODEVELOPMENTAL DISORDER WITH SEIZURES, SPASTICITY, AND COMPLETE OR PARTIAL AGENESIS OF THE CORPUS CALLOSUM; NEDSSCC
620251	CENTROSOMAL PROTEIN 170B; CEP170B
620252	TRANSMEMBRANE PROTEIN 245; TMEM245
620253	CATARACT 50 WITH OR WITHOUT GLAUCOMA; CTRCT50
620254	RING FINGER PROTEIN, TRANSMEMBRANE 2; RNFT2
620255	MAJOR FACILITATOR SUPERFAMILY DOMAIN-CONTAINING PROTEIN 13A; MFSD13A
620256	CLARIN 3; CLRN3
620257	TRANSMEMBRANE PROTEIN 158; TMEM158
620258	TRANSMEMBRANE PROTEIN 160; TMEM160
620259	ANKYRIN REPEAT DOMAIN-CONTAINING PROTEIN 18A; ANKRD18A
620260	TRANSMEMBRANE PROTEIN 132B; TMEM132B
620261	ENDOPLASMIC RETICULUM MEMBRANE PROTEIN COMPLEX, SUBUNIT 6; EMC6
620262	ANKYRIN REPEAT DOMAIN-CONTAINING PROTEIN 36; ANKRD36
620263	OOCYTE-SECRETED PROTEIN 2; OOSP2
620264	POST-GPI ATTACHMENT TO PROTEINS, GalNAc TRANSFERASE, 4; PGAP4
620265	CONGENITAL MYOPATHY 2B, SEVERE INFANTILE, AUTOSOMAL RECESSIVE; CMYP2B
620266	RAB7A-INTERACTING MON1-CCZ1 COMPLEX SUBUNIT 1; RIMOC1
620267	REGULATOR OF MON1-CCZ1; RMC1
620268	FH2 DOMAIN-CONTAINING PROTEIN 1; FHDC1
620269	LEUKODYSTROPHY, HYPOMYELINATING, 26, WITH CHONDRODYSPLASIA; HLD26
620270	NEURODEVELOPMENTAL DISORDER WITH ABSENT SPEECH AND MOVEMENT AND BEHAVIORAL ABNORMALITIES; NEDSMB
620271	TRANSMEMBRANE PROTEIN 41B; TMEM41B
620272	TRANSMEMBRANE PROTEIN 235; TMEM235
620273	ENDOPLASMIC RETICULUM MEMBRANE PROTEIN COMPLEX, SUBUNIT 3; EMC3
620274	WD REPEAT-CONTAINING PROTEIN 87; WDR87
620275	MITOCHONDRIAL COMPLEX IV DEFICIENCY, NUCLEAR TYPE 23; MC4DN23
620276	OOCYTE/ZYGOTE/EMBRYO MATURATION ARREST 14; OZEMA14
620277	SPERMATOGENIC FAILURE 81; SPGF81
620278	CONGENITAL MYOPATHY 2C, SEVERE INFANTILE, AUTOSOMAL DOMINANT; CMYP2C
620279	DYNEIN ASSEMBLY FACTOR WITH WD REPEATS 1; DAW1
620280	DEAFNESS, AUTOSOMAL DOMINANT 86; DFNA86
620281	DEAFNESS, AUTOSOMAL DOMINANT 87; DFNA87
620282	IMMUNODEFICIENCY 109 WITH LYMPHOPROLIFERATION; IMD109
620283	DEAFNESS, AUTOSOMAL DOMINANT 88; DFNA88
620284	DEAFNESS, AUTOSOMAL DOMINANT 89; DFNA89
620285	AMYOTROPHIC LATERAL SCLEROSIS 27, JUVENILE; ALS27
620286	MYOPATHY, SARCOPLASMIC BODY; MYOSB
620287	TRANSMEMBRANE PROTEIN 71; TMEM71
620288	TRANSMEMBRANE EPIDIDYMAL PROTEIN 1; TEDDM1
620289	TRANSMEMBRANE PROTEIN 234; TMEM234
620290	TRANSMEMBRANE PROTEIN 219; TMEM219
620291	WD REPEAT-CONTAINING PROTEIN 18; WDR18
620292	NEURODEVELOPMENTAL DISORDER WITH LANGUAGE DELAY AND BEHAVIORAL ABNORMALITIES, WITH OR WITHOUT SEIZURES; NEDLBAS
620293	TMEM9 DOMAIN FAMILY, MEMBER B; TMEM9B
620294	CONGENITAL HEART DEFECTS, MULTIPLE TYPES, 9; CHTD9
620295	DDB1- AND CUL4-ASSOCIATED FACTOR 10; DCAF10
620296	AUTOINFLAMMATION WITH PULMONARY AND CUTANEOUS VASCULITIS; AIPCV
620297	SOLUTE CARRIER FAMILY 35, MEMBER A4; SLC35A4
620298	SOLUTE CARRIER FAMILY 35, MEMBER A5; SLC35A5
620299	MAJOR FACILITATOR SUPERFAMILY DOMAIN-CONTAINING PROTEIN 4A; MFSD4A
620300	MITOCHONDRIAL TRIFUNCTIONAL PROTEIN DEFICIENCY 2; MTPD2
620301	MAJOR FACILITATOR SUPERFAMILY DOMAIN-CONTAINING PROTEIN 9; MFSD9
620302	WD REPEAT-CONTAINING PROTEIN 76; WDR76
620303	PITUITARY HORMONE DEFICIENCY, COMBINED OR ISOLATED, 8; CPHD8
620304	NUCLEOLAR PROTEIN 9; NOL9
620305	NEUROOCULORENAL SYNDROME; NORS
620306	NEURODEGENERATION AND SEIZURES DUE TO COPPER TRANSPORT DEFECT; NSCT
620307	WD REPEAT-CONTAINING PROTEIN 24; WDR24
620308	MAJOR FACILITATOR SUPERFAMILY DOMAIN-CONTAINING PROTEIN 3; MFSD3
620309	FAMILY WITH SEQUENCE SIMILARITY 171, MEMBER B; FAM171B
620310	CONGENITAL MYOPATHY 20; CMYP20
620311	PREMATURE OVARIAN FAILURE 21; POF21
620312	LEUKOENCEPHALOPATHY WITH VANISHING WHITE MATTER 2; VWM2
620313	LEUKOENCEPHALOPATHY WITH VANISHING WHITE MATTER 3; VWM3
620314	LEUKOENCEPHALOPATHY WITH VANISHING WHITE MATTER 4; VWM4
620315	LEUKOENCEPHALOPATHY WITH VANISHING WHITE MATTER 5; VWM5
620316	CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 12; CDCBM12
620317	NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY AND SPEECH DELAY, WITH OR WITHOUT BRAIN ABNORMALITIES; NEDMSBA
620318	SOLUTE CARRIER FAMILY 49, MEMBER 3; SLC49A3
620319	OOCYTE/ZYGOTE/EMBRYO MATURATION ARREST 17; OZEMA17
620320	HEMATURIA, BENIGN FAMILIAL, 2; BFH2
620321	C1q DEFICIENCY 2; C1QD2
620322	C1q DEFICIENCY 3; C1QD3
620323	SPASTIC PARAPLEGIA 70, AUTOSOMAL RECESSIVE; SPG70
620324	SOLUTE CARRIER FAMILY 15, MEMBER 5; SLC15A5
620325	TRANSMEMBRANE PROTEIN 144; TMEM144
620326	CONGENITAL MYOPATHY 21 WITH EARLY RESPIRATORY FAILURE; CMYP21
620327	NEURODEGENERATION WITH DEVELOPMENTAL DELAY, EARLY RESPIRATORY FAILURE, MYOCLONIC SEIZURES, AND BRAIN ABNORMALITIES; NDDRSB
620328	SOLUTE CARRIER FAMILY 44, MEMBER 3; SLC44A3
620329	SOLUTE CARRIER FAMILY 44, MEMBER 5; SLC44A5
620330	INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 71, WITH BEHAVIORAL ABNORMALITIES; MRD71
620331	HATIPOGLU IMMUNODEFICIENCY SYNDROME; HATIS
620332	OOCYTE/ZYGOTE/EMBRYO MATURATION ARREST 18; OZEMA18
620333	OOCYTE/ZYGOTE/EMBRYO MATURATION ARREST 19; OZEMA19
620334	TRIPARTITE MOTIF-CONTAINING PROTEIN 42; TRIM42
620335	CELL DIVISION CYCLE 20B; CDC20B
620336	ZINC FINGER SWIM DOMAIN-CONTAINING PROTEIN 3; ZSWIM3
620337	SOLUTE CARRIER FAMILY 35, MEMBER E1; SLC35E1
620338	SOLUTE CARRIER FAMILY 9, MEMBER C2; SLC9C2
620339	SOLUTE CARRIER FAMILY 23, MEMBER 3; SLC23A3
620340	NIPA-LIKE DOMAIN-CONTAINING PROTEIN 1; NIPAL1
620341	WD REPEAT-CONTAINING PROTEIN 75; WDR75
620342	CONE-ROD DYSTROPHY 24; CORD24
620343	BASAL CELL NEVUS SYNDROME 2; BCNS2
620344	PROLONGED ELECTRORETINAL RESPONSE SUPPRESSION 2; PERRS2
620345	MAJOR FACILITATOR SUPERFAMILY DOMAIN-CONTAINING PROTEIN 5; MFSD5
620346	MAJOR FACILITATOR SUPERFAMILY DOMAIN-CONTAINING PROTEIN 11; MFSD11
620347	MAJOR FACILITATOR SUPERFAMILY DOMAIN-CONTAINING PROTEIN 14A; MFSD14A
620348	MAJOR FACILITATOR SUPERFAMILY DOMAIN-CONTAINING PROTEIN 14B; MFSD14B
620349	SOLUTE CARRIER FAMILY 35, MEMBER F1; SLC35F1
620350	SOLUTE CARRIER FAMILY 35, MEMBER F2; SLC35F2
620351	CONGENITAL MYOPATHY 22A, CLASSIC; CMYP22A
620352	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 31B; DEE31B
620353	SPERMATOGENIC FAILURE 82; SPGF82
620354	SPERMATOGENIC FAILURE 83; SPGF83
620355	SOLUTE CARRIER FAMILY 35, MEMBER E3; SLC35E3
620356	CILIARY DYSKINESIA, PRIMARY, 50; CILD50
620357	DIARRHEA 13; DIAR13
620358	MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 4A; MC5DN4A
620359	MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 7; MC5DN7
620360	TETRAPEPTIDE REPEAT HOMEOBOX 2; TPRX2
620361	RNA, U5D SMALL NUCLEAR 1; RNU5D-1
620362	RNA, U5E SMALL NUCLEAR 1; RNU5E-1
620363	RNA, U5F SMALL NUCLEAR 1; RNU5F-1
620364	COMBINED LOW LDL AND FIBRINOGEN; CLDLFIB
620365	PULMONARY FIBROSIS AND/OR BONE MARROW FAILURE SYNDROME, TELOMERE-RELATED, 7; PFBMFT7
620366	OSTEOPETROSIS, AUTOSOMAL RECESSIVE 9; OPTB9
620367	PULMONARY FIBROSIS AND/OR BONE MARROW FAILURE SYNDROME, TELOMERE-RELATED, 8; PFBMFT8
620368	CEREBRORETINAL MICROANGIOPATHY WITH CALCIFICATIONS AND CYSTS 3; CRMCC3
620369	CONGENITAL MYOPATHY 22B, SEVERE FETAL; CMYP22B
620370	RECON PROGEROID SYNDROME; RECON
620371	NEURODEVELOPMENTAL DISORDER WITH INTRACRANIAL HEMORRHAGE, SEIZURES, AND SPASTICITY; NEDIHSS
620372	HYPERSULFATURIA; HYSULF
620373	ADIPOSE-SECRETED SIGNALING PROTEIN; ADISSP
620374	NEPHROLITHIASIS, CALCIUM OXALATE, 2, WITH OR WITHOUT NEPHROCALCINOSIS; CAON2
620375	MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 28; LGMDR28
620376	AUTOINFLAMMATORY DISEASE, SYSTEMIC, WITH VASCULITIS; SAIDV
620377	ARMADILLO REPEAT-CONTAINING PROTEIN 12; ARMC12
620378	CHARCOT-MARIE-TOOTH DISEASE, DOMINANT INTERMEDIATE A; CMTDIA
620379	SPASTIC PARAPLEGIA 89, AUTOSOMAL RECESSIVE; SPG89
620380	LEUCINE ZIPPER/EF-HAND-CONTAINING TRANSMEMBRANE PROTEIN 2; LETM2
620381	CILIA- AND FLAGELLA-ASSOCIATED PROTEIN 61; CFAP61
620382	ZINC FINGER CCHC DOMAIN-CONTAINING PROTEIN 9; ZCCHC9
620383	OOCYTE/ZYGOTE/EMBRYO MATURATION ARREST 20; OZEMA20
620384	AUDITORY NEUROPATHY, AUTOSOMAL DOMINANT 2; AUNA2
620385	ARMADILLO REPEAT-CONTAINING PROTEIN 1; ARMC1
620386	NEMALINE MYOPATHY 5B, AUTOSOMAL RECESSIVE, CHILDHOOD-ONSET; NEM5B
620387	TBC1 DOMAIN FAMILY, MEMBER 21; TBC1D21
620388	DYSBINDIN DOMAIN-CONTAINING PROTEIN 1; DBNDD1
620389	NEMALINE MYOPATHY 5C, AUTOSOMAL DOMINANT; NEM5C
620390	HEAT REPEAT-CONTAINING PROTEIN 1; HEATR1
620391	POLY(ADP-RIBOSE) POLYMERASE FAMILY, MEMBER 16; PARP16
620392	ACTIN-BINDING TRANSCRIPTION MODULATOR; ABITRAM
620393	INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 79; MRT79
620394	PROTEIN SERINE KINASE H2; PSKH2
620395	CYCLIN J; CCNJ
620396	CYCLIN P; CCNP
620397	AURORA KINASE A- AND NINEIN-INTERACTING PROTEIN; AUNIP
620398	GLYCINE ENCEPHALOPATHY 2; GCE2
620399	AARF DOMAIN-CONTAINING KINASE 1; ADCK1
620400	PULMONARY FIBROSIS AND/OR BONE MARROW FAILURE SYNDROME, TELOMERE-RELATED, 9; PFBMFT9
620402	NEURONOPATHY, DISTAL HEREDITARY MOTOR, AUTOSOMAL RECESSIVE 9; HMNR9
620403	INKA-BOX ACTIN REGULATOR 2; INKA2
620404	CYSTEINE- AND SERINE-RICH NUCLEAR PROTEIN 2; CSRNP2
620405	CYSTEINE- AND SERINE-RICH NUCLEAR PROTEIN 3; CSRNP3
620406	MCTS FAMILY, MEMBER 2; MCTS2
620407	MER1 REPEAT-CONTAINING IMPRINTED TRANSCRIPT 1, NONCODING; MIMT1
620408	MICRO RNA 337; MIR337
620409	SPERMATOGENIC FAILURE 84; SPGF84
620410	LOW DENSITY LIPOPROTEIN CHOLESTEROL LEVEL QUANTITATIVE TRAIT LOCUS 3; LDLCQ3
620411	PALMOPLANTAR KERATODERMA, EPIDERMOLYTIC, 2; EPPK2
620412	NONCODING RNA ASSOCIATED WITH MAP KINASE PATHWAY AND GROWTH ARREST; NAMA
620413	GOLGI-ASSOCIATED KINASE 1A; GASK1A
620414	SH3 DOMAIN-BINDING KINASE FAMILY, MEMBER 2; SBK2
620415	WOOLLY HAIR-SKIN FRAGILITY SYNDROME; WHSF
620416	SPASTIC PARAPLEGIA 90A, AUTOSOMAL DOMINANT; SPG90A
620417	SPASTIC PARAPLEGIA 90B, AUTOSOMAL RECESSIVE; SPG90B
620418	NEGATIVE REGULATOR OF INTERFERON RESPONSE, NONCODING; NRIR
620419	CYCLIN I FAMILY, MEMBER 2; CCNI2
620420	HIG1 HYPOXIA-INDUCIBLE DOMAIN FAMILY, MEMBER 1B; HIGD1B
620421	DDB1- AND CUL4-ASSOCIATED FACTOR 4-LIKE 2; DCAF4L2
620422	RETINITIS PIGMENTOSA 97; RP97
620423	MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 7; MMDS7
620424	ZYGOTE ARREST 1-LIKE; ZAR1L
620425	CATARACTS, HEARING IMPAIRMENT, NEPHROTIC SYNDROME, AND ENTEROCOLITIS 2; CHINE2
620426	INKA BOX ACTIN REGULATOR 1; INKA1
620427	DYSTONIA 37, EARLY-ONSET, WITH STRIATAL LESIONS; DYT37
620428	NEURODEVELOPMENTAL DISORDER WITH MOTOR AND LANGUAGE DELAY, OCULAR DEFECTS, AND BRAIN ABNORMALITIES; NEDMLOB
620429	TRANSMEMBRANE PROTEIN 64; TMEM64
620430	AUTOIMMUNE DISEASE, MULTISYSTEM, INFANTILE-ONSET, 3; ADMIO3
620431	FLYWCH-TYPE ZINC FINGER PROTEIN 1; FLYWCH1
620432	OSTEOCLAST STIMULATORY TRANSMEMBRANE PROTEIN; OCSTAMP
620433	TRANSMEMBRANE PROTEIN 186; TMEM186
620434	TRANSMEMBRANE PROTEIN 223; TMEM223
620435	UBIQUINOL-CYTOCHROME C REDUCTASE COMPLEX ASSEMBLY FACTOR 5; UQCC5
620436	TRANSMEMBRANE p24 TRAFFICKING PROTEIN 9; TMED9
620437	TRANSMEMBRANE p24 TRAFFICKING PROTEIN 3; TMED3
620438	CILIARY DYSKINESIA, PRIMARY, 51; CILD51
620439	INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 72; MRD72
620440	GRB2-BINDING ADAPTOR PROTEIN, TRANSMEMBRANE; GAPT
620441	ZINC FINGER PROTEIN 470; ZNF470
620442	BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 5; BROVCA5
620443	DISABLING PANSCLEROTIC MORPHEA OF CHILDHOOD; DPMC
620444	CRANIOFACIAL MICROSOMIA 2; CFM2
620445	NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY AND MOVEMENT ABNORMALITIES; NEDMIM
620446	TETRASPANIN 17; TSPAN17
620447	MEGALENCEPHALIC LEUKOENCEPHALOPATHY WITH SUBCORTICAL CYSTS 3; MLC3
620448	MEGALENCEPHALIC LEUKOENCEPHALOPATHY WITH SUBCORTICAL CYSTS 4, REMITTING; MLC4
620449	IMMUNODEFICIENCY 112; IMD112
620450	INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 73; MRD73
620451	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 58; COXPD58
620452	AMYOTROPHIC LATERAL SCLEROSIS 28; ALS28
620453	DYSTONIA 22, JUVENILE-ONSET; DYT22JO
620454	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIaa; CDG2AA
620455	NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA AND SPEECH DELAY, WITH OR WITHOUT SEIZURES; NEDHSS
620456	DYSTONIA 22, ADULT-ONSET; DYT22AO
620457	AURICULOCONDYLAR SYNDROME 4; ARCND4
620458	AURICULOCONDYLAR SYNDROME 2B; ARCND2B
620459	BIRT-HOGG-DUBE SYNDROME 2; BHD2
620460	OCULOPHARYNGEAL MUSCULAR DYSTROPHY 2; OPMD2
620461	ENCEPHALITIS, ACUTE, INFECTION-INDUCED, SUSCEPTIBILITY TO, 12; IIAE12
620462	CARDIOMYOPATHY, DILATED, 2I; CMD2I
620463	ERYTHROID DIFFERENTIATION REGULATORY FACTOR 1; EDRF1
620464	REST COREPRESSOR 3; RCOR3
620465	EPILEPSY, EARLY-ONSET, 3, WITH OR WITHOUT DEVELOPMENTAL DELAY; EPEO3
620466	ZINC FINGER PROTEIN 28; ZNF28
620467	La RIBONUCLEOPROTEIN 1B; LARP1B
620468	VERTEBRAE DEVELOPMENT-ASSOCIATED GENE; VRTN
620469	CRANIAL DYSINNERVATION DISORDER, CONGENITAL, WITH ABSENT CORNEAL REFLEX AND DEVELOPMENTAL DELAY; CCDDRD
620470	CONGENITAL SMOOTH MUSCLE HAMARTOMA, WITH OR WITHOUT HEMIHYPERTROPHY; CSMH
620471	FORKHEAD BOX O3B; FOXO3B
620472	TRAFFICKING PROTEIN PARTICLE COMPLEX, SUBUNIT 2B; TRAPPC2B
620473	ZINC FINGER HIT DOMAIN-CONTAINING PROTEIN 6; ZNHIT6
620474	ADIPOGENESIS-ASSOCIATED MTH938 DOMAIN-CONTAINING PROTEIN; AAMDC
620475	THROMBOCYTOPENIA 8, WITH DYSMORPHIC FEATURES AND DEVELOPMENTAL DELAY; THC8
620476	MRT4 HOMOLOG, RIBOSOME MATURATION FACTOR; MRTO4
620477	ZYMOGEN GRANULE PROTEIN 16B; ZG16B
620478	THROMBOCYTOPENIA 9; THC9
620479	CENTRIOLAR SATELLITE-ASSOCIATED TUBULIN POLYGLUTAMYLASE COMPLEX REGULATOR 1; CSTPP1
620480	TRIPARTITE MOTIF FAMILY LIKE-PROTEIN 2; TRIML2
620481	AMEGAKARYOCYTIC THROMBOCYTOPENIA, CONGENITAL, 2; CAMT2
620482	PARKINSON DISEASE 25, AUTOSOMAL RECESSIVE EARLY-ONSET, WITH IMPAIRED INTELLECTUAL DEVELOPMENT; PARK25
620483	VARIEGATE PORPHYRIA, CHILDHOOD-ONSET; VPCO
620484	THROMBOCYTOPENIA 10; THC10
620485	TUBULIN TYROSINE LIGASE-LIKE 13; TTLL13
620486	BLEEDING DISORDER, PLATELET-TYPE, 25; BDPLT25
620487	CILIOGENESIS AND PLANAR POLARITY EFFECTOR COMPLEX, SUBUNIT 2; CPLANE2
620488	NUCLEAR TRANSCRIPTION FACTOR, X BOX-BINDING-LIKE 1; NFXL1
620489	NEURODEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND BEHAVIORAL ABNORMALITIES; NEDFBA
620490	SPERMATOGENIC FAILURE 85; SPGF85
620491	MATURIN, NEURAL PROGENITOR DIFFERENTIATION REGULATOR HOMOLOG; MTURN
620492	MEDIATOR COMPLEX SUBUNIT 31; MED31
620493	STERILE ALPHA MOTIF DOMAIN-CONTAINING PROTEIN 7; SAMD7
620494	NEURODEVELOPMENTAL DISORDER WITH IMPAIRED LANGUAGE, BEHAVIORAL ABNORMALITIES, AND DYSMORPHIC FACIES; NEDLBF
620495	REGULATOR OF DNA CLASS I CROSSOVER INTERMEDIATES 1; REDIC1
620496	BASAL BODY ORIENTATION FACTOR 1; BBOF1
620497	LEUCINE-RICH REPEAT-CONTAINING PROTEIN 49; LRRC49
620498	TRANSCRIPTION ELONGATION REGULATOR 1-LIKE; TCERG1L
620499	SPERMATOGENIC FAILURE 86; SPGF86
620500	SPERMATOGENIC FAILURE 87; SPGF87
620501	ZIEGLER-HUANG SYNDROME; ZHS
620502	NEURODEVELOPMENTAL DISORDER WITH LANGUAGE DELAY AND VARIABLE COGNITIVE ABNORMALITIES; NEDLC
620503	FIDGETIN-LIKE PROTEIN 2; FIGNL2
620504	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 111; DEE111
620505	INTRAFLAGELLAR TRANSPORT 22; IFT22
620506	INTRAFLAGELLAR TRANSPORT 46; IFT46
620507	ICHTHYOSIS WITH ERYTHROKERATODERMA; IEKD
620508	CCR4-NOT TRANSCRIPTION COMPLEX, SUBUNIT 10; CNOT10
620509	CCR4-NOT TRANSCRIPTION COMPLEX, SUBUNIT 11; CNOT11
620510	XEROSIS AND GROWTH FAILURE WITH IMMUNE AND PULMONARY DYSFUNCTION SYNDROME; XGIP
620511	FLIEDNER-ZWEIER SYNDROME; FZS
620512	SPASTIC PARAPLEGIA 18A, AUTOSOMAL DOMINANT; SPG18A
620513	UNC119 LIPID-BINDING CHAPERONE B; UNC119B
620514	IMMUNE DYSREGULATION, AUTOIMMUNITY, AND AUTOINFLAMMATION; IDAA
620515	NEURODEVELOPMENTAL DISORDER WITH MOTOR REGRESSION, PROGRESSIVE SPASTIC PARAPLEGIA, AND OROMOTOR DYSFUNCTION; NEDRSO
620516	STERILE ALPHA MOTIF DOMAIN-CONTAINING 3; SAMD3
620517	STERILE ALPHA MOTIF DOMAIN-CONTAINING 5; SAMD5
620518	KELCH DOMAIN-CONTAINING PROTEIN 4; KLHDC4
620519	ARRHYTHMOGENIC CARDIOMYOPATHY WITH VARIABLE ECTODERMAL ABNORMALITIES; ARCME
620520	CALMODULIN-LIKE 4; CALML4
620521	KELCH DOMAIN-CONTAINING PROTEIN 7B; KLHDC7B
620522	ONCOMODULIN 2; OCM2
620523	RING FINGER PROTEIN 122; RNF122
620524	DDB1- AND CUL4-ASSOCIATED FACTOR 16; DCAF16
620525	LONG INTERGENIC NONCODING RNA 2228; LINC02228
620526	SMALL GLUTAMINE-RICH TETRATRICOPEPTIDE REPEAT COCHAPERONE, BETA; SGTB
620527	TRIPARTITE MOTIF-CONTAINING PROTEIN 58; TRIM58
620528	NEURONOPATHY, DISTAL HEREDITARY MOTOR, AUTOSOMAL DOMINANT 11; HMND11
620529	RING FINGER PROTEIN 121; RNF121
620530	CHROMOSOME 4 OPEN READING FRAME 3; C4ORF3
620531	SMALL INTEGRAL MEMBRANE PROTEIN 6; SMIM6
620532	HYPER-IgE SYNDROME 6, AUTOSOMAL DOMINANT, WITH RECURRENT INFECTIONS; HIES6
620533	LONG INTERGENIC NONCODING RNA 520; LINC00520
620534	NEUTROPENIA, SEVERE CONGENITAL, 10, AUTOSOMAL RECESSIVE; SCN10
620535	DEVELOPMENTAL DELAY, DYSMORPHIC FACIES, AND BRAIN ANOMALIES; DEVDFB
620536	ALPORT SYNDROME 3B, AUTOSOMAL RECESSIVE; ATS3B
620537	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 112; DEE112
620538	SPASTIC PARAPLEGIA 91, AUTOSOMAL DOMINANT, WITH OR WITHOUT CEREBELLAR ATAXIA; SPG91
620539	ZINC FINGER SWIM DOMAIN-CONTAINING PROTEIN 4; ZSWIM4
620540	DEVELOPMENTAL DELAY WITH OR WITHOUT EPILEPSY; DEVEP
620541	PROAPOPTOTIC NUCLEOLAR PROTEIN 1; PANO1
620542	NEURONOPATHY, DISTAL HEREDITARY MOTOR, AUTOSOMAL RECESSIVE 10; HMNR10
620543	ZINC FINGER CONTAINING UBIQUITIN PEPTIDASE 1; ZUP1
620544	PPP1R13B DIVERGENT TRANSCRIPT, NONCODING; PPP1R13BDT
620545	ARTHROGRYPOSIS, DISTAL, TYPE 12; DA12
620546	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIbb; CDG2BB
620547	SPERMATOGENIC FAILURE 88; SPGF88
620548	PREMATURE OVARIAN FAILURE 22; POF22
620549	F-BOX PROTEIN 48; FBXO48
620550	OPTIC ATROPHY 14; OPA14
620551	DEAFNESS, AUTOSOMAL RECESSIVE 121; DFNB121
620552	CUE DOMAIN-CONTAINING PROTEIN 1; CUEDC1
620553	COILED-COIL DOMAIN-CONTAINING PROTEIN 93; CCDC93
620554	ZINC FINGER PROTEIN 432; ZNF432
620555	SMALL NUCLEOLAR RNA HOST GENE 20; SNHG20
620556	RING FINGER PROTEIN 133; RNF133
620557	IQ MOTIF- AND UBIQUITIN DOMAIN-CONTAINING PROTEIN; IQUB
620558	CRANIOMETADIAPHYSEAL OSTEOSCLEROSIS WITH HIP DYSPLASIA; CMDOH
620559	CYCLIN Y-LIKE 1; CCNYL1
620560	CEBPA DIVERGENT TRANSCRIPT; CEBPA-DT
620561	DENN DOMAIN-CONTAINING PROTEIN 6A; DENND6A
620562	DENN DOMAIN-CONTAINING PROTEIN 6B; DENND6B
620563	UBIQUITIN-SPECIFIC PEPTIDASE 50; USP50
620564	ANTAGONIST OF MITOTIC EXIT NETWORK 1 HOMOLOG; AMN1
620565	IMMUNODEFICIENCY 113 WITH AUTOIMMUNITY AND AUTOINFLAMMATION; IMD113
620566	CLAUDIN 22; CLDN22
620567	ZINC FINGER PROTEIN 507; ZNF507
620568	CORNELIA DE LANGE SYNDROME 6; CDLS6
620569	LEBER-LIKE HEREDITARY OPTIC NEUROPATHY, AUTOSOMAL RECESSIVE 2; LHONAR2
620570	CILIARY DYSKINESIA, PRIMARY, 52; CILD52
620571	MICRO RNA 512-1; MIR512-1
620572	MICRO RNA 512-2; MIR512-2
620573	MICRO RNA 520E; MIR520E
620574	MICRO RNA 515-1; MIR515-1
620575	MICRO RNA 519E; MIR519E
620576	OTOSCLEROSIS 11; OTSC11
620577	FATTY ACID DESATURASE 6; FADS6
620578	UBIQUINOL-CYTOCHROME C REDUCTASE COMPLEX ASSEMBLY FACTOR 4; UQCC4
620579	COILED-COIL DOMAIN-CONTAINING PROTEIN 3; CCDC3
620580	DEAQ-BOX RNA-DEPENDENT ATPase 1; DQX1
620581	OXIDOREDUCTASE NAD-BINDING DOMAIN-CONTAINING PROTEIN 1; OXNAD1
620582	CHROMOSOME 1 OPEN READING FRAME 210; C1ORF210
620583	OPTIC ATROPHY 15; OPA15
620584	MICRO RNA 498; MIR498
620585	MICRO RNA 520F; MIR520F
620586	MICRO RNA 515-2; MIR515-2
620587	MICRO RNA 519C; MIR519C
620588	MICRO RNA 520A; MIR520A
620589	MICRO RNA 526B; MIR526B
620590	RADICAL S-ADENOSYL METHIONINE DOMAIN-CONTAINING PROTEIN 1; RSAD1
620591	MICRO RNA 519B; MIR519B
620592	MICRO RNA 525; MIR525
620593	MICRO RNA 523; MIR523
620594	MICRO RNA 518F; MIR518F
620595	MICRO RNA 520B; MIR520B
620596	MICRO RNA 518B; MIR518B
620597	MICRO RNA 526A1; MIR526A1
620598	MICRO RNA 518C; MIR518C
620599	MICRO RNA 524; MIR524
620600	MICRO RNA 517A; MIR517A
620601	GARG-MISHRA PROGEROID SYNDROME; GMPGS
620602	LYMPHATIC MALFORMATION 14; LMPHM14
620603	IMMUNODEFICIENCY 114, FOLATE-RESPONSIVE; IMD114
620604	PROSTAGLANDIN REDUCTASE 3; PTGR3
620605	CYTOCHROME P450, FAMILY 27, SUBFAMILY C, MEMBER 1; CYP27C1
620606	SPASTIC PARAPLEGIA 72B, AUTOSOMAL RECESSIVE; SPG72B
620608	TESTIS-EXPRESSED GENE 264; TEX264
620609	LONG-OLSEN-DISTELMAIER SYNDROME; LNGODS
620610	OOCYTE/ZYGOTE/EMBRYO MATURATION ARREST 21; OZEMA21
620611	MICRO RNA 521-2; MIR521-2
620612	MICRO RNA 520D; MIR520D
620613	MICRO RNA 517B; MIR517B
620614	MICRO RNA 516B2; MIR516B2
620615	MICRO RNA 526A2; MIR526A2
620616	MICRO RNA 518E; MIR518E
620617	MICRO RNA 518A1; MIR518A1
620618	MICRO RNA 518D; MIR518D
620619	MICRO RNA 516B1; MIR516B1
620620	MICRO RNA 518A2; MIR518A2
620621	MICRO RNA 517C; MIR517C
620622	MICRO RNA 521-1; MIR521-1
620623	MICRO RNA 522; MIR522
620624	MICRO RNA 519A1; MIR519A1
620625	MICRO RNA 527; MIR527
620626	MICRO RNA 516A1; MIR516A1
620627	MICRO RNA 516A2; MIR516A2
620628	MICRO RNA 519A2; MIR519A2
620629	OPTIC ATROPHY 16; OPA16
620630	TRANSMEMBRANE PROTEIN 170A; TMEM170A
620631	ENDOPLASMIC RETICULUM MEMBRANE PROTEIN COMPLEX, SUBUNIT 7; EMC7
620632	IMMUNODEFICIENCY 115 WITH AUTOINFLAMMATION; IMD115
620633	GOLGI TRANSPORT 1A; GOLT1A
620634	IMMUNITY-RELATED GTPase CINEMA; IRGC
620635	CARDIOMYOPATHY, DILATED, 2J; CMD2J
620636	NEURODEGENERATION, CHILDHOOD-ONSET, WITH CEREBELLAR ATAXIA AND COGNITIVE DECLINE; CONDCAC
620637	CADHERIN-LIKE DOMAIN- AND PC-ESTERASE DOMAIN-CONTAINING PROTEIN 1; CPED1
620638	POTASSIUM CHANNEL TETRAMERIZATION DOMAIN-CONTAINING PROTEIN 4; KCTD4
620639	OSTEOGENESIS IMPERFECTA, TYPE XXIII; OI23
620640	RING FINGER PROTEIN 145; RNF145
620641	TAN-ALMURSHEDI SYNDROME; TANALS
620642	CILIARY DYSKINESIA, PRIMARY, 53; CILD53
620643	MICRO RNA 1323; MIR1323
620644	MICRO RNA 1283-1; MIR1283-1
620645	MICRO RNA 1283-2; MIR283-2
620646	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 59; COXPD59
620647	PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL RECESSIVE 6; PEOB6
620648	BUTYROPHILIN-LIKE PROTEIN 9; BTNL9
620649	PHOSPHOLIPASE A2, GROUP IVE; PLA2G4E
620650	GLYOXALASE DOMAIN-CONTAINING PROTEIN 4; GLOD4
620651	DIABETES, DEAFNESS, DEVELOPMENTAL DELAY, AND SHORT STATURE SYNDROME; DDDS
620652	SH3 DOMAIN-BINDING PROTEIN 5-LIKE; SH3BP5L
620653	INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 80, WITH VARIANT LISSENCEPHALY; MRT80
620654	THROMBOCYTOPENIA 11 WITH MULTIPLE CONGENITAL ANOMALIES AND DYSMORPHIC FACIES; THC11
620655	ALFADHEL SYNDROME; AFDL
620656	PLECKSTRIN AND SEC7 DOMAINS-CONTAINING PROTEIN 2; PSD2
620660	CCZ1 HOMOLOG, VACUOLAR PROTEIN TRAFFICKING- AND BIOGENESIS-ASSOCIATED PROTEIN; CCZ1
620661	CHROMOSOME 10 OPEN READING FRAME 88; C10ORF88
620662	HOXHA-ALIU SYNDROME; HXAL
620663	SPONDYLOEPIMETAPHYSEAL DYSPLASIA, GUO-CAMPEAU TYPE; SEMDGC
620664	RHO GUANINE NUCLEOTIDE EXCHANGE FACTOR 37; ARHGEF37
620665	PLECKSTRIN HOMOLOGY DOMAIN- AND RhoGEF DOMAIN-CONTAINING PROTEIN G4B; PLEKHG4B
620666	SPASTIC ATAXIA 10, AUTOSOMAL RECESSIVE; SPAX10
620667	CENTROSOMAL PROTEIN, 128-KD; CEP128
620668	IMMUNODEFICIENCY 117; IMD117
620669	NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 9; NBIA9
620670	IMMUNODEFICIENCY, COMMON VARIABLE, 15; CVID15
620671	POU CLASS 2 HOMEOBOX-ASSOCIATING FACTOR 2; POU2AF2
620672	LEUCINE-RICH REPEAT-CONTAINING PROTEIN 24; LRRC24
620673	MICROTUBULE-ASSOCIATED PROTEIN 1, LIGHT CHAIN 3, BETA-2; MAP1LC3B2
620674	NEUTROPENIA, SEVERE CONGENITAL, 11, AUTOSOMAL DOMINANT; SCN11
620675	LEUKODYSTROPHY, HYPOMYELINATING, 27; HLD27
620676	COILED-COIL DOMAIN-CONTAINING PROTEIN 61; CCDC61
620677	TRANSMEMBRANE PROTEIN 192; TMEM192
620678	RAS AND RAB INTERACTOR-LIKE PROTEIN; RINL
620679	LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 8; FPLD8
620680	LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 5; CGL5
620681	MYOCLONIC EPILEPSY OF LAFORA 2; MELF2
620682	SUZ RNA-BINDING DOMAIN-CONTAINING PROTEIN 1; SZRD1
620683	LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 9; FPLD9
620684	HGH1 HOMOLOG; HGH1
620685	CHROMOSOME 19 OPEN READING FRAME 53; C19ORF53
620686	PREMATURE OVARIAN FAILURE 23; POF23
620687	MOYAMOYA DISEASE 7; MYMY7
620688	INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 74; MRD74
620689	LSM FAMILY, MEMBER 14B; LSM14B
620690	DEVELOPMENTAL DYSPLASIA OF THE HIP 3; DDH3
620691	BUD13 HOMOLOG; BUD13
620692	NANOG NEIGHBOR HOMEOBOX; NANOGNB
620693	ASTEROID HOMOLOG 1; ASTE1
620694	TUBULIN TYROSINE LIGASE-LIKE 11; TTLL11
620695	NOTOCHORD HOMEOBOX; NOTO
620696	RBPJ-INTERACTING AND TUBULIN-ASSOCIATED PROTEIN 1; RITA1
620697	ZINC FINGER CCHC DOMAIN-CONTAINING PROTEIN 14; ZCCHC14
620698	MAPLE SYRUP URINE DISEASE, TYPE IB; MSUD1B
620699	MAPLE SYRUP URINE DISEASE, TYPE II; MSUD2
620700	INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 81; MRT81
620701	TETRATRICOPEPTIDE REPEAT DOMAIN 36; TTC36
620702	MITOCHONDRIAL CALCIUM UNIPORTER, DOMINANT-NEGATIVE SUBUNIT BETA; MCUB
620703	YUKSEL-VOGEL-BAUER SYNDROME; YUVOB
620704	ENCEPHALOPATHY, PORPHYRIA-RELATED; ENCEP
620705	SPERMATOGENIC FAILURE 89; SPGF89
620706	DEVELOPING BRAIN HOMEOBOX 2; DBX2
620707	EPIDERMOLYTIC HYPERKERATOSIS 2B, AUTOSOMAL RECESSIVE; EHK2B
620708	LEUCINE-RICH REPEAT-CONTAINING PROTEIN 23; LRRC23
620709	TUBULIN POLYGLUTAMYLASE COMPLEX, SUBUNIT 1; TPGS1
620710	TUBULIN POLYGLUTAMYLASE COMPLEX, SUBUNIT 2; TPGS2
620711	LEUKOENCEPHALOPATHY, PORPHYRIA-RELATED; LENCEP
620712	POLYDACTYLY-MACROCEPHALY SYNDROME; PDMCS
620713	MITOCHONDRIAL MATRIX IMPORT FACTOR 23; MIX23
620714	DEAFNESS, AUTOSOMAL RECESSIVE 122; DFNB122
620715	BLEEDING DISORDER, VASCULAR-TYPE; BDVAS
620716	D-GLUTAMATE CYCLASE; DGLUCY
620717	MITOCHONDRIAL NUCLEOID-ASSOCIATED PROTEIN 1; MTNAP1
620718	OROFACIODIGITAL SYNDROME XX; OFD20
620719	NEURODEVELOPMENTAL DISORDER WITH MOTOR ABNORMALITIES, SEIZURES, AND FACIAL DYSMORPHISM; NEDMSF
620720	ZINC FINGER PROTEIN 549; ZNF549
620721	TRANSMEMBRANE PROTEIN 242; TMEM242
620722	DEAFNESS, AUTOSOMAL DOMINANT 90; DFNA90
620723	LONG INTERGENIC NONCODING RNA 2381; LINC02381
620724	ENOYL COENZYME A HYDRATASE DOMAIN-CONTAINING PROTEIN 2; ECHDC2
620725	BETHLEM MYOPATHY 1B; BTHLM1B
620726	BETHLEM MYOPATHY 1C; BTHLM1C
620727	ULLRICH CONGENITAL MUSCULAR DYSTROPHY 1B; UCMD1B
620728	ULLRICH CONGENITAL MUSCULAR DYSTROPHY 1C; UCMD1C
620729	HYPERFERRITINEMIA; HRFT
620730	HYPEREMESIS GRAVIDARUM, SUSCEPTIBILITY TO; HG
620731	MICROPHTHALMIA/COLOBOMA 11; MCOPCB11
620732	NEURODEVELOPMENTAL DISORDER WITH HYPERKINETIC MOVEMENTS, SEIZURES, AND STRUCTURAL BRAIN ABNORMALITIES; NEDMSB
620733	MICRO RNA 708; MIR708
620734	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 30, ATRIAL; CMH30
620735	SERINE DEHYDRATASE-LIKE PROTEIN; SDSL
620736	COENZYME Q10A; COQ10A
620737	COENZYME Q10B; COQ10B
620738	ZONE OF POLARIZING ACTIVITY REGULATORY SEQUENCE; ZRS
620739	RCC1-LIKE PROTEIN; RCC1L
620740	STATHMIN 4; STMN4
620741	INTRAFLAGELLAR TRANSPORT 70A; IFT70A
620742	INTRAFLAGELLAR TRANSPORT 70B; IFT70B
620743	SDE2 TELOMERE MAINTENANCE HOMOLOG; SDE2
620744	SPERMATOGENIC FAILURE 90; SPGF90
620745	DEAFNESS, AUTOSOMAL RECESSIVE 123; DFNB123
620746	NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA AND CHARACTERISTIC BRAIN ABNORMALITIES; NEDHBA
620747	NEURODEVELOPMENTAL DISORDER WITH EARLY-ONSET PARKINSONISM AND BEHAVIORAL ABNORMALITIES; NEDPBA
620748	MEGALENCEPHALY-POLYDACTYLY SYNDROME; MPAPA
620749	ZINC FINGER PROTEIN 438; ZNF438
620750	PRELI DOMAIN-CONTAINING PROTEIN 2; PRELID2
620751	RETROTRANSPOSON GAG-LIKE 10; RTL10
620752	TRANSMEMBRANE PROTEIN 177; TMEM177
620753	COILED-COIL DOMAIN-CONTAINING PROTEIN 90B; CCDC90B
620754	PRELI DOMAIN-CONTAINING PROTEIN 3B; PRELID3B
620755	GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 12; GEFSP12
620756	ENOYL COENZYME A HYDRATASE DOMAIN-CONTAINING PROTEIN 3; ECHDC3
620757	THROMBOCYTOPENIA 12 WITH OR WITHOUT MYOPATHY; THC12
620758	TRANSLOCASE OF INNER MITOCHONDRIAL MEMBRANE 23B; TIMM23B
620759	POLG ALTERNATIVE READING FRAME; POLGARF
620760	MITOCHONDRIAL LACTATE DEHYDROGENASE REGULATOR; MLDHR
620761	CHROMOSOME 9 OPEN READING FRAME 85; C9ORF85
620762	MACULAR DYSTROPHY WITH OR WITHOUT CONE DYSFUNCTION; MDCD
620763	CORNEAL DYSTROPHY, LISCH EPITHELIAL; LECD
620764	MITOCHONDRIAL SHEATH FORMATION-ASSOCIATED; MISFA
620765	MITOCHONDRIAL FISSION REGULATOR 1-LIKE PROTEIN; MTFR1L
620766	FORMATION OF MITOCHONDRIAL COMPLEX V ASSEMBLY FACTOR 1 HOMOLOG; FMC1
620767	SECKEL SYNDROME 11; SCKL11
620768	RIBOSOME-BINDING FACTOR A; RBFA
620769	HYDROXYACYL-THIOESTER DEHYDRATASE, TYPE 2; HTD2
620770	MITOREGULIN; MTLN
620771	JEFFRIES-LAKHANI NEURODEVELOPMENTAL SYNDROME; JELANS
620772	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 113; DEE113
620773	PROLINE- AND SERINE-RICH PROTEIN 1; PROSER1
620774	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 114; DEE114
620775	NEUROMUSCULAR DISORDER, CONGENITAL, WITH DYSMORPHIC FACIES; NMDF
620777	PULMONARY HYPERTENSION, PRIMARY, 6; PPH6
620778	KILLER CELL IMMUNOGLOBULIN-LIKE RECEPTOR, THREE DOMAINS, SHORT CYTOPLASMIC TAIL, 1; KIR3DS1
